id	adverseevents_frequency	adverseevents_frequency_units	adverseevents_liability	adverseevents_severity	adverseevents_type	adverseevents_comment	adverseevents_dlt	tox_id
1	5 pts		Abdominal pain	below serious				1
2	1 pts		Black stools	below serious				1
3	1 pts		Clostridium difficile infection	below serious				1
4	5 pts		Constipation	below serious				1
5	2 pts		Diarrhea	below serious				1
6	2 pts		Dry mouth	below serious				1
7	1 pts		Function liver abnormal	below serious				1
8	6 pts		Nausea and vomiting	below serious				1
9	5 pts		Dizziness	below serious				1
10	1 pts		Abnormal dreams	below serious				1
11	14 pts		Drowsiness	below serious				1
12	2 pts		Insomnia	below serious				1
13	2 pts		Ovarian cyst	below serious				1
14	2 pts		Menstrual disorder	below serious				1
15	2 pts		Arthralgia	below serious				1
16	4 pts		Back pain	below serious				1
17	4 pts		Pain	below serious				1
18	2 pts		Pelvic pain	below serious				1
19	1 pts		Infection	below serious				1
20	6 pts		Infection	below serious				1
21	2 pts		Cough	below serious				1
22	1 pts		Dysuria	below serious				1
23	1 pts		Prostate infection	below serious				1
24	2 pts		Urinary tract infection	below serious				1
25	1 pts		Anaphylactic reaction	serious				3
26	1 pts		Syncope	serious				3
27	3 pts		Altered mood	serious				3
28	1 pts		Bronchospasm	serious				3
29	14 pts		Cognitive disorder	below serious				3
30	3 pts		Dizziness	below serious				3
31	43 pts		Fatigue	below serious				3
32	36 pts		Dry mouth	below serious				3
33	7 pts		Streptococcal pharyngitis	below serious				3
34	7 pts		Pharyngitis streptococcal	below serious				3
35	1 pts		Dry mouth	below serious				2
36	32		Sedation					10
37	32		Dry mouth					10
38	20		Postural hypotension					10
39	24		Weight gain					10
40	8		Ataxia					10
41	12		Constipation					10
42	20		Lethargy					10
43	8		Edema					10
44	12		Headache					10
45	12		Pruritus					10
46	4		Bad taste					10
47	4		Nausea					10
48	4		Diarrhea					10
49	8		Blurred vision					10
50	4		Ankle edema		discontinuation			10
51	4		Dizziness		discontinuation			10
52	20		Bradycardia	grade 3	discontinuation	the study was terminated when 1 subject in the 100-mg group developed severe bradycardia		6
53	20		Agitation					6
54	20		Dry mouth					6
55	20		Drowsiness					6
56	20		Language disorder					6
57			Tachycardia			OVERDOSAGE		9
58			Mental status changes			OVERDOSAGE		8
59			Thought disorder					4
60			Mental concentration difficult					4
61	75		Dry mouth					7
62	68.8		Sleepiness					7
63	25		Dizziness					7
64	18.8		Constipation					7
65	6.3		Palpitations					7
66	6.3		Malaise					7
67	51.8		Drowsiness					5
68	7.4		Nausea					5
69	7.4		Headache					5
70	63		Dry mouth					5
71	7.4		Thirst					5
72	7.4		Tiredness					5
73	18.5		Bad taste					5
74	7.4		Attention concentration difficulty					5
75	3.7		Hyperglycaemia					5
76	10		Drowsiness		discontinuation			5
77	10		Dry mouth		discontinuation			5
78						No AEs are reported		18
79	1 pts		Nausea					15
80	1 pts		Vomiting					15
81	1 pts		Fanconi syndrome					15
82	40		Gastrointestinal symptom NOS	mild				11
83	18		Skin rash					11
84			ALT increased					11
85			AST increased					11
86			Toxicity renal			WARNING		16
87			Hepatotoxicity			WARNING		16
88			Gastrointestinal hemorrhage			WARNING		16
89	2 pts		Abnormal liver function tests		discontinuation	leads to discontinuation		17
90	2 pts		Drug-induced hepatitis		discontinuation	leads to discontinuation		17
91	1 pts		Skin rash		discontinuation	leads to discontinuation		17
92	1 pts		Glycosuria		discontinuation	leads to discontinuation		17
93	1 pts		Proteinuria		discontinuation	leads to discontinuation		17
94	1 pts		Henoch-Schonlein purpura		discontinuation	leads to discontinuation		17
95	1 pts		Hyperactivity		discontinuation	leads to discontinuation		17
96	1 pts		Insomnia		discontinuation	leads to discontinuation		17
97	1 pts		Drug fever		discontinuation	leads to discontinuation		17
98	1 pts		Cataract		discontinuation	leads to discontinuation		17
99	1 pts		Hepatitis		discontinuation	leads to dose interruption		13
100	1 pts		Nausea					14
101	1 pts		Diarrhea					14
102						No AEs are reported		12
103	4 pts		Vomiting	below serious				28
104	11 pts		Blood creatine phosphokinase increased	below serious				28
105	4 pts		Injection site pain	below serious				28
106						No information on AE is provided. Multiple intravenous infusions of peramivir were well tolerated up to 800 mg once a day and 400 mg twice daily for 6 days.		23
107						No information on AE is provided. Multiple intravenous infusions of peramivir were well tolerated up to 800 mg once a day and 400 mg twice daily for 6 days.		20
108						No information on AE is provided.		22
109						No information on AE is provided.		19
110	3		Alanine aminotransferase	grade 2-4				25
111	5		Serum glucose	grade 2-4				26
112	4		Creatine phosphokinase	grade 2-4				25
113	8		Neutrophils	grade 2-4				25
114						No information on AE is provided		21
115	<1		Lymphadenopathy		discontinuation	leads to discontinuation		24
116	<1		Gingival pain		discontinuation	leads to discontinuation		24
117	<1		Salivary gland pain		discontinuation	leads to discontinuation		24
118	<1		Rash		discontinuation	leads to discontinuation		24
119	<1		Abdominal pain upper		discontinuation	leads to discontinuation		27
120	<1		Arthralgia		discontinuation	leads to discontinuation		27
121	<1		Drug eruption		discontinuation	leads to discontinuation		27
122	<1		Eczema		discontinuation	leads to discontinuation		27
123	<1		Rash		discontinuation	leads to discontinuation		27
124	42.9		Leukopenia					29
125	14.3		Neutropenia					29
126	42.9		Hyperglycemia					29
127	28.6		Hypertension					29
128	14.3		AST increased					29
129	14.3		ALT increased					29
130	14.3		Diarrhea					29
131						No AEs are reported		32
132	1 pts		Flushing					30
133						No AEs are reported		31
134						No AEs are reported		33
135						No AEs are reported		34
136						No AEs are reported		35
137	<1		Myelodysplastic syndrome	grade 5	discontinuation	WARNING		41
138	<1		Acute myeloid leukemia	grade 5	discontinuation	WARNING		41
139	<1		Pneumonitis	grade 5	discontinuation	WARNING		42
140	16		Anemia	grade 1-2				40
141	18		Anemia	grade 3-4				40
142	35		Abdominal discomfort	grade 1-2				40
143	8		Abdominal discomfort	grade 3-4				40
144	21		Decreased appetite	grade 1-2				40
145	1		Decreased appetite	grade 3-4				40
146	30		Diarrhea	grade 1-2				40
147	1		Diarrhea	grade 3-4				40
148	25		Dyspepsia	grade 1-4				40
149	58		Asthenia	grade 1-2				40
150	8		Asthenia	grade 3-4				40
151	26		Nasopharyngitis	grade 1-4				40
152	21		Arthralgia	grade 1-4				40
153	21		Musculoskeletal pain	grade 1-4				40
154	22		Myalgia	grade 1-4				40
155	18		Neutropenia	grade 1-2				40
156	7		Neutropenia	grade 3-4				40
157	39		Lymphopenia	grade 1-2				40
158	17		Lymphopenia	grade 3-4				40
159	57		Mean corpuscular volume increased	grade 1-4				40
160	28		Creatinine increased	grade 1-2				40
161	2		Creatinine increased	grade 3-4				40
162	10-20		Cough					40
163	10-20		Constipation					40
164	10-20		Dysgeusia					40
165	10-20		Peripheral edema					40
166	10-20		Back pain					40
167	10-20		Dizziness					40
168	10-20		Headache					40
169	10-20		Urinary tract infection					40
170	10-20		Dyspnea					40
171	10-20		Rash					40
172	1-10		Leukopenia					40
173	1-10		Stomatitis					40
174	1-10		Peripheral neuropathy					40
175	1-10		Pyrexia					40
176	1-10		Hypomagnesemia					40
177	1-10		Hyperglycemia					40
178	1-10		Anxiety					40
179	1-10		Depression					40
180	1-10		Insomnia					40
181	1-10		Dysuria					40
182	1-10		Urinary incontinence					40
183	1-10		Vulvovaginal disorder					40
184	1-10		Dry skin					40
185	1-10		Eczema					40
186	1-10		Pruritis					40
187	1-10		Hypertension					40
188	1-10		Venous thrombosis					40
189	1-10		Hot flush					40
190	61		Nausea	grade 1-2	discontinuation	leads to dose reduction or interruption		43
191	3		Nausea	grade 3-4	discontinuation	leads to dose reduction or interruption		43
192	39		Vomiting	grade 1-2	discontinuation	leads to dose reduction or interruption		43
193	4		Vomiting	grade 3-4	discontinuation	leads to dose reduction or interruption		43
194	58		Fatigue	grade 1-2	discontinuation	leads to dose reduction or interruption		43
195	8		Fatigue	grade 3-4	discontinuation	leads to dose reduction or interruption		43
196	75		Anemia	grade 1-2	discontinuation	leads to dose reduction or interruption		43
197	15		Anemia	grade 3-4	discontinuation	leads to dose reduction or interruption		43
198	27		Thrombocytopenia	grade 1-2	discontinuation	leads to dose interruption		43
199	3		Thrombocytopenia	grade 3-4	discontinuation	leads to dose interruption		43
200	62		Fatigue	grade 1-2	discontinuation	leads to dose interruption or reduction		37
201	4		Fatigue	grade 3-4	discontinuation	leads to dose interruption or reduction		37
202	31		Diarrhea	grade 1-2				37
203	2		Diarrhea	grade 3-4				37
204	19		Abscess oral	grade 1-2				37
205	19		Aphthous ulcer	grade 1-2				37
206	19		Gingival abscess	grade 1-2				37
207	19		Gingival disorder	grade 1-2				37
208	19		Gingival pain	grade 1-2				37
209	19		Gingivitis	grade 1-2				37
210	19		Mouth ulceration	grade 1-2				37
211	19		Mucosal infection	grade 1-2				37
212	19		Mucosal inflammation	grade 1-2				37
213	19		Oral candidiasis	grade 1-2				37
214	19		Oral discomfort	grade 1-2				37
215	19		Oral herpes	grade 1-2				37
216	19		Oral infection	grade 1-2				37
217	19		Oral mucosal erythema	grade 1-2				37
218	19		Oral pain	grade 1-2				37
219	19		Oropharyngeal discomfort	grade 1-2				37
220	19		Oropharyngeal pain	grade 1-2				37
221	1		Abscess oral	grade 3-4				37
222	1		Aphthous ulcer	grade 3-4				37
223	1		Gingival abscess	grade 3-4				37
224	1		Gingival disorder	grade 3-4				37
225	1		Gingival pain	grade 3-4				37
226	1		Gingivitis	grade 3-4				37
227	1		Mouth ulceration	grade 3-4				37
228	1		Mucosal infection	grade 3-4				37
229	1		Mucosal inflammation	grade 3-4				37
230	1		Oral candidiasis	grade 3-4				37
231	1		Oral discomfort	grade 3-4				37
232	1		Oral herpes	grade 3-4				37
233	1		Oral infection	grade 3-4				37
234	1		Oral mucosal erythema	grade 3-4				37
235	1		Oral pain	grade 3-4				37
236	1		Oropharyngeal discomfort	grade 3-4				37
237	1		Oropharyngeal pain	grade 3-4				37
238	36		Nasopharyngitis	grade 1-4				37
239	36		Sinusitis	grade 1-4				37
240	36		Rhinitis	grade 1-4				37
241	36		Influenza	grade 1-4				37
242	22		Decreased appetite	grade 1-4				37
243	30		Arthralgia	grade 1-4				37
244	30		Myalgia	grade 1-4				37
245	27		Dysgeusia	grade 1-4				37
246	25		Headache	grade 1-2				37
247	1		Headache	grade 3-4				37
248	<20		Rash					37
249	<20		Cough					37
250	<20		Dyspepsia					37
251	<20		Leukopenia					37
252	<20		Hypomagnesemia					37
253	<20		Dizziness					37
254	<20		Thrombocytopenia					37
255	<20		Creatinine increased					37
256	<20		Lymphopenia					37
257	<20		Edema					37
258	89		Mean corpuscular volume increased	grade 1-4				37
259	66		Decreased hemoglobin	grade 1-2				37
260	17		Decreased hemoglobin	grade 3-4				37
261	64		Leukocyte count decreased	grade 1-2				37
262	5		Leukocyte count decreased	grade 3-4				37
263	56		Lymphocyte count low	grade 1-2				37
264	11		Lymphocyte count low	grade 3-4				37
265	44		Absolute neutrophil count decreased	grade 1-2				37
266	7		Absolute neutrophil count decreased	grade 3-4				37
267	44		Creatinine serum increased	grade 1-4				37
268	40		Platelets decreased	grade 1-2				37
269	2		Platelets decreased	grade 3-4				37
270	24		Anemia	grade 1-2	discontinuation	leads to dose interruption or reduction |leads to discontinuation		38
271	20		Anemia	grade 3-4	discontinuation	leads to dose interruption or reduction |leads to discontinuation		38
272	9		Neutropenia		discontinuation	leads to dose interruption or reduction |leads to discontinuation		38
273	73		Nausea	grade 1-2	discontinuation	leads to dose interruption		38
274	3		Nausea	grade 3-4	discontinuation	leads to dose interruption		38
275	34		Vomiting	grade 1-2	discontinuation	leads to dose interruption		38
276	3		Vomiting	grade 3-4	discontinuation	leads to dose interruption		38
277						No information on AEs is available		36
278	9 pts		Thrombocytopenia		discontinuation	leads to discontinuation | leads to dose interruption		39
279	2 pts		Myelodysplastic syndrome		discontinuation	leads to discontinuation		39
280	2 pts		Acute myeloid leukemia		discontinuation	leads to discontinuation		39
281						AEs not specified		45
282						AEs not specified		44
283			Overgrowth of nonsusceptible organisms					47
284			Allergic reaction					47
285	1.3		Ear pruritus					46
286	1.1		Nausea					46
287	2 pts		Chest pain	serious				49
288	1 pts		Deep vein thrombosis	serious				49
289	1 pts		Haematochezia	serious				49
290	2 pts		Respiratory failure	serious				49
291	1 pts		Arthralgia	below serious				49
292	3 pts		Chest pain	below serious				49
293	4 pts		Dizziness	below serious				49
294	2 pts		Drug eruption	below serious				49
295	12 pts		Dyspepsia	below serious				49
296	2 pts		Fatigue	below serious				49
297	4 pts		Nausea	below serious				49
298	3 pts		Palpitations	below serious				49
299	2 pts		Photosensitivity reaction	below serious				49
300	1 pts		Somnolence	below serious				49
301	1 pts		Transaminases increased	below serious				49
302	1 pts		Vertigo	below serious				49
303	1 pts		Thrombocytopenia	serious				50
304	1 pts		Acute myocardial infarction	serious				50
305	3 pts		Angina pectoris	serious				50
306	1 pts		Arrhythmia	serious				50
307	1 pts		Cardiac arrest	serious				50
308	2 pts		Cardiac failure congestive	serious				50
309	1 pts		Mitral valve incompetence	serious				50
310	1 pts		Myocardial ischaemia	serious				50
311	1 pts		Sick sinus syndrome	serious				50
312	1 pts		Abdominal pain	serious				50
313	1 pts		Gastrointestinal haemorrhage	serious				50
314	1 pts		Ileus	serious				50
315	1 pts		Melaena	serious				50
316	3 pts		Nausea	serious				50
317	1 pts		Peptic ulcer haemorrhage	serious				50
318	1 pts		Umbilical hernia, obstructive	serious				50
319	1 pts		Volvulus	serious				50
320	1 pts		Vomiting	serious				50
321	1 pts		Hepatitis	serious				50
322	1 pts		Lower respiratory tract infection	serious				50
323	1 pts		Urinary tract infection	serious				50
324	1 pts		Viral upper respiratory tract infection	serious				50
325	1 pts		Ankle fracture	serious				50
326	1 pts		Hand fracture	serious				50
327	2 pts		Fracture rib	serious				50
328	1 pts		Road traffic accident	serious				50
329	1 pts		Traumatic brain injury	serious				50
330	1 pts		Alanine aminotransferase increased	serious				50
331	1 pts		Aspartate aminotransferase increased	serious				50
332	1 pts		Weight decreased	serious				50
333	1 pts		Arthritis	serious				50
334	1 pts		Cervical spinal stenosis	serious				50
335	1 pts		Intervertebral disc protrusion	serious				50
336	1 pts		Osteoarthritis	serious				50
337	1 pts		Rotator cuff syndrome	serious				50
338	1 pts		Gastric cancer	serious				50
339	1 pts		Hepatic neoplasm malignant	serious				50
340	1 pts		Hypopharyngeal cancer	serious				50
341	1 pts		Ischaemic stroke	serious				50
342	1 pts		Spinal cord compression	serious				50
343	1 pts		Psychotic disorder	serious				50
344	1 pts		Urethral pain	serious				50
345	1 pts		Urinary retention	serious				50
346	1 pts		Benign prostatic hyperplasia	serious				50
347	1 pts		Cough	serious				50
348	1 pts		Hypoxia	serious				50
349	1 pts		Interstitial lung disease	serious				50
350	20 pts		Abdominal pain upper	below serious				50
351	62 pts		Diarrhoea	below serious				50
352	49 pts		Dyspepsia	below serious				50
353	33 pts		Gastrooesophageal reflux	below serious				50
354	100 pts		Nausea	below serious				50
355	24 pts		Stomach discomfort	below serious				50
356	36 pts		Vomiting	below serious				50
357	16 pts		Asthenia	below serious				50
358	38 pts		Bronchitis	below serious				50
359	14 pts		Influenza	below serious				50
360	33 pts		Nasopharyngitis	below serious				50
361	61 pts		Upper respiratory tract infection	below serious				50
362	35 pts		Weight decreased	below serious				50
363	44 pts		Anorexia	below serious				50
364	20 pts		Decreased appetite	below serious				50
365	26 pts		Arthralgia	below serious				50
366	14 pts		Musculoskeletal pain	below serious				50
367	49 pts		Dizziness	below serious				50
368	25 pts		Dysgeusia	below serious				50
369	72 pts		Headache	below serious				50
370	31 pts		Insomnia	below serious				50
371	70 pts		Cough	below serious				50
372	16 pts		Photosensitivity reaction	below serious				50
373	27 pts		Pruritis	below serious				50
374	78 pts		Rash	below serious				50
375	58 pts		Fatigue	below serious				50
376	1 pts		Cardiac failure	serious				48
377	1 pts		Cardiac failure congestive	serious				48
378	1 pts		Retinal detachment	serious				48
379	1 pts		Campylobacter gastroenteritis	serious				48
380	1 pts		Gastroenteritis	serious				48
381	1 pts		Influenza	serious				48
382	1 pts		Respiratory tract infection	serious				48
383	1 pts		Respiratory tract infection bacterial	serious				48
384	1 pts		Urinary tract infection	serious				48
385	1 pts		Urosepsis	serious				48
386	1 pts		Procedural pain	serious				48
387	1 pts		Spinal fracture	serious				48
388	1 pts		Wrist fracture	serious				48
389	1 pts		Decreased appetite	serious				48
390	1 pts		Gout	serious				48
391	1 pts		Hyponatraemia	serious				48
392	1 pts		Musculoskeletal pain	serious				48
393	1 pts		Prostate cancer	serious				48
394	1 pts		Loss of consciousness	serious				48
395	1 pts		Chronic obstructive pulmonary disease	serious				48
396	1 pts		Cough	serious				48
397	1 pts		Pulmonary embolism	serious				48
398	1 pts		Respiratory disorder	serious				48
399	7 pts		Constipation	below serious				48
400	23 pts		Diarrhoea	below serious				48
401	17 pts		Dyspepsia	below serious				48
402	10 pts		Gastrooesophageal reflux disease	below serious				48
403	40 pts		Nausea	below serious				48
404	14 pts		Vomiting	below serious				48
405	21 pts		Fatigue	below serious				48
406	10 pts		Bronchitis	below serious				48
407	7 pts		Nasopharyngitis	below serious				48
408	11 pts		Respiratory tract infection	below serious				48
409	12 pts		Upper respiratory tract infection	below serious				48
410	11 pts		Weight decreased	below serious				48
411	18 pts		Decreased appetite	below serious				48
412	8 pts		Back pain	below serious				48
413	13 pts		Headache	below serious				48
414	7 pts		Depression	below serious				48
415	19 pts		Cough	below serious				48
416	8 pts		Photosensitivity reaction	below serious				48
417	9 pts		Rash	below serious				48
418	1.3		Rash		discontinuation	leads to discontinuation		51
419	1.1		Nausea		discontinuation	leads to discontinuation		51
420	3		Rash		discontinuation	leads to dose reduction or interruption		51
421	3		Nausea		discontinuation	leads to dose reduction or interruption		51
422	3		Diarrhea		discontinuation	leads to dose reduction or interruption		51
423	3		Photosensitivity reaction		discontinuation	leads to dose reduction or interruption		51
424	0.8		Weight decreased		discontinuation	leads to discontinuation		52
425	0.6		Photosensitivity reaction		discontinuation	leads to discontinuation		52
426	0.5		Respiratory failure		discontinuation	leads to discontinuation		52
427	0.5		Hepatic enzyme increased		discontinuation	leads to discontinuation		52
428	0.5		Bladder cancer		discontinuation	leads to discontinuation		52
429	0.3		Vomiting		discontinuation	leads to discontinuation		52
430	0.3		GERD		discontinuation	leads to discontinuation		52
431	0.3		Malaise		discontinuation	leads to discontinuation		52
432	0.3		Dysgeusia		discontinuation	leads to discontinuation		52
433	1 pts		Cardiogenic shock	serious				56
434	1 pts		Myocardial infarction	serious				56
435	1 pts		Intestinal infarction	serious				56
436	1 pts		Clostridium difficile infection	serious				56
437	1 pts		Influenza	serious				56
438	1 pts		Lyme disease	serious				56
439	1 pts		Sepsis	serious				56
440	1 pts		Vascular graft complication	serious				56
441	1 pts		Liver function test increased	serious				56
442	1 pts		Hypocalcaemia	serious				56
443	1 pts		Hypokalaemia	serious				56
444	1 pts		Hyponatraemia	serious				56
445	1 pts		Polymyalgia rheumatica	serious				56
446	1 pts		Spinal column stenosis	serious				56
447	1 pts		Osteoarthritis spinal	serious				56
448	1 pts		Adenocarcinoma	serious				56
449	1 pts		Benign neoplasm of adrenal gland	serious				56
450	1 pts		Squamous cell carcinoma	serious				56
451	1 pts		Ataxia	serious				56
452	1 pts		Chronic obstructive pulmonary disease	serious				56
453	1 pts		Hypoxia	serious				56
454	1 pts		Pulmonary hypertension	serious				56
455	1 pts		Pulmonary oedema	serious				56
456	2 pts		Respiratory failure	serious				56
457	43 pts		Diarrhoea	below serious				56
458	5 pts		Gastrooesophageal reflux disease	below serious				56
459	10 pts		Vomiting	below serious				56
460	11 pts		Fatigue	below serious				56
461	8 pts		Influenza	below serious				56
462	3 pts		Lower respiratory tract infection	below serious				56
463	4 pts		Respiratory tract infection	below serious				56
464	3 pts		Tooth abscess	below serious				56
465	4 pts		Eosinophil count increased	below serious				56
466	3 pts		International normalised ratio increased	below serious				56
467	3 pts		Prothrombin time prolonged	below serious				56
468	13 pts		Weight decreased	below serious				56
469	12 pts		Decreased appetite	below serious				56
470	5 pts		Dizziness	below serious				56
471	5 pts		Idiopathic pulmonary fibrosis	below serious				56
472	3 pts		Oropharyngeal pain	below serious				56
473	1 pts		Leukopenia	serious				57
474	1 pts		Thrombotic microangiopathy	serious				57
475	1 pts		Arrhythmia	serious				57
476	1 pts		Atrioventricular block complete	serious				57
477	1 pts		Cardiac failure	serious				57
478	1 pts		Cardiac failure congestive	serious				57
479	1 pts		Palpitations	serious				57
480	1 pts		Pericardial effusion	serious				57
481	1 pts		Pleuropericarditis	serious				57
482	1 pts		Ventricular fibrillation	serious				57
483	1 pts		Vertigo	serious				57
484	1 pts		Glaucoma	serious				57
485	1 pts		Retinal detachment	serious				57
486	1 pts		Colitis	serious				57
487	1 pts		Gastrointestinal disorder	serious				57
488	1 pts		Haematochezia	serious				57
489	1 pts		Ileus	serious				57
490	1 pts		Ileus paralytic	serious				57
491	1 pts		Intestinal pseudo-obstruction	serious				57
492	1 pts		Lower gastrointestinal haemorrhage	serious				57
493	1 pts		Pancreatitis acute	serious				57
494	1 pts		Rectal haemorrhage	serious				57
495	1 pts		Upper gastrointestinal haemorrhage	serious				57
496	1 pts		Multiple organ dysfunction syndrome	serious				57
497	1 pts		Systemic inflammatory response syndrome	serious				57
498	1 pts		Bile duct stone	serious				57
499	1 pts		Cholecystitis	serious				57
500	1 pts		Hepatocellular injury	serious				57
501	1 pts		Liver disorder	serious				57
502	1 pts		Liver injury	serious				57
503	2 pts		Anti-neutrophil cytoplasmic antibody positive vasculitis	serious				57
504	1 pts		Adenovirus infection	serious				57
505	1 pts		Appendicitis	serious				57
506	1 pts		Device related infection	serious				57
507	2 pts		Diverticulitis	serious				57
508	2 pts		Gangrene	serious				57
509	1 pts		Gastroenteritis	serious				57
510	1 pts		Influenza	serious				57
511	2 pts		Lower respiratory tract infection	serious				57
512	10 pts		Pneumonia	serious				57
513	1 pts		Pneumonia bacterial	serious				57
514	1 pts		Pyelonephritis	serious				57
515	3 pts		Respiratory tract infection	serious				57
516	2 pts		Sepsis	serious				57
517	1 pts		Septic shock	serious				57
518	1 pts		Skin infection	serious				57
519	1 pts		Systemic candida	serious				57
520	1 pts		Urinary tract infection	serious				57
521	1 pts		Urosepsis	serious				57
522	1 pts		Femur fracture	serious				57
523	1 pts		Joint dislocation	serious				57
524	1 pts		Postoperative ileus	serious				57
525	1 pts		Forced vital capacity decreased	serious				57
526	1 pts		Haemoglobin decreased	serious				57
527	1 pts		Neutrophil count decreased	serious				57
528	1 pts		White blood cell count decreased	serious				57
529	1 pts		Hypokalaemia	serious				57
530	1 pts		Arthritis	serious				57
531	1 pts		Musculoskeletal pain	serious				57
532	1 pts		Osteonecrosis	serious				57
533	1 pts		Polymyalgia rheumatica	serious				57
534	1 pts		Scleroderma	serious				57
535	1 pts		Basal cell carcinoma	serious				57
536	1 pts		Benign mesothelioma	serious				57
537	1 pts		Adenocarcinoma lung	serious				57
538	1 pts		Malignant melanoma	serious				57
539	1 pts		Mesothelioma malignant	serious				57
540	2 pts		Squamous cell carcinoma of skin	serious				57
541	1 pts		Sweat gland tumour	serious				57
542	1 pts		Cerebral amyloid angiopathy	serious				57
543	1 pts		Cerebral microhaemorrhage	serious				57
544	1 pts		Cerebrovascular disorder	serious				57
545	1 pts		Depressed level of consciousness	serious				57
546	1 pts		Seizure	serious				57
547	1 pts		Haemorrhage subarachnoid	serious				57
548	1 pts		Syncope	serious				57
549	1 pts		Delirium	serious				57
550	1 pts		Major depression	serious				57
551	3 pts		Acute kidney injury	serious				57
552	1 pts		Scleroderma renal crisis	serious				57
553	1 pts		Benign prostatic hyperplasia	serious				57
554	3 pts		Ovarian cyst	serious				57
555	1 pts		Acute lung injury	serious				57
556	1 pts		Hypoxia	serious				57
557	10 pts		Interstitial lung disease	serious				57
558	1 pts		Painful respiration	serious				57
559	2 pts		Pleural effusion	serious				57
560	2 pts		Aspiration pneumonia	serious				57
561	1 pts		Pneumothorax spontaneous	serious				57
562	5 pts		Pulmonary hypertension	serious				57
563	1 pts		Actinic keratosis	serious				57
564	1 pts		Digital pitting scar	serious				57
565	1 pts		Deep vein thrombosis	serious				57
566	2 pts		Extremity necrosis	serious				57
567	1 pts		Hypertensive crisis	serious				57
568	1 pts		Peripheral arterial occlusive disease	serious				57
569	1 pts		Peripheral artery occlusion	serious				57
570	1 pts		Vena cava thrombosis	serious				57
571	36 pts		Abdominal pain	below serious				57
572	21 pts		Abdominal pain upper	below serious				57
573	218 pts		Diarrhoea	below serious				57
574	96 pts		Nausea	below serious				57
575	78 pts		Vomiting	below serious				57
576	33 pts		Fatigue	below serious				57
577	20 pts		Pyrexia	below serious				57
578	16 pts		Influenza	below serious				57
579	22 pts		Alanine aminotransferase increased	below serious				57
580	16 pts		Aspartate aminotransferase increased	below serious				57
581	19 pts		Gamma-glutamyltransferase increased	below serious				57
582	39 pts		Weight decreased	below serious				57
583	28 pts		Decreased appetite	below serious				57
584	20 pts		Back pain	below serious				57
585	16 pts		Myalgia	below serious				57
586	15 pts		Pain in extremity	below serious				57
587	19 pts		Dizziness	below serious				57
588	34 pts		Headache	below serious				57
589	56 pts		Skin ulcer	below serious				57
590	1 pts		Blood loss anaemia	serious				58
591	3 pts		Acute myocardial infarction	serious				58
592	1 pts		Arteriosclerosis coronary artery	serious				58
593	5 pts		Atrial fibrillation	serious				58
594	1 pts		Bradycardia	serious				58
595	1 pts		Cardiac arrest	serious				58
596	3 pts		Cardiac failure	serious				58
597	1 pts		Cardiac failure chronic	serious				58
598	1 pts		Coronary artery occlusion	serious				58
599	1 pts		Supraventricular tachycardia	serious				58
600	1 pts		Mixed deafness	serious				58
601	1 pts		Retinal vascular thrombosis	serious				58
602	1 pts		Colitis ischaemic	serious				58
603	1 pts		Constipation	serious				58
604	3 pts		Diarrhoea	serious				58
605	1 pts		Dyspepsia	serious				58
606	3 pts		Gastrointestinal haemorrhage	serious				58
607	1 pts		Gastrooesophageal reflux disease	serious				58
608	1 pts		Haematemesis	serious				58
609	1 pts		Haemorrhoids	serious				58
610	1 pts		Pancreatitis	serious				58
611	1 pts		Pancreatitis acute	serious				58
612	1 pts		Rectal prolapse	serious				58
613	1 pts		Asthenia	serious				58
614	2 pts		Condition aggravated	serious				58
615	1 pts		Death	serious				58
616	1 pts		Cholecystitis acute	serious				58
617	6 pts		Drug-induced liver injury	serious				58
618	3 pts		Liver injury	serious				58
619	2 pts		Appendicitis	serious				58
620	1 pts		Atypical pneumonia	serious				58
621	1 pts		Bacterial sepsis	serious				58
622	1 pts		Clostridium difficile colitis	serious				58
623	2 pts		Diverticulitis	serious				58
624	1 pts		Gastroenteritis norovirus	serious				58
625	1 pts		Herpes zoster oticus	serious				58
626	1 pts		Infection localised	serious				58
627	1 pts		Meningitis aseptic	serious				58
628	1 pts		Orchitis	serious				58
629	24 pts		Pneumonia	serious				58
630	1 pts		Pneumonia legionella	serious				58
631	1 pts		Pseudomembranous colitis	serious				58
632	1 pts		Pulmonary sepsis	serious				58
633	1 pts		Pyelonephritis acute	serious				58
634	2 pts		Septic shock	serious				58
635	1 pts		Skin infection	serious				58
636	1 pts		Staphylococcal sepsis	serious				58
637	2 pts		Urinary tract infection	serious				58
638	1 pts		Viral infection	serious				58
639	1 pts		Viral upper respiratory tract infection	serious				58
640	1 pts		Coronary artery restenosis	serious				58
641	2 pts		Spinal fracture	serious				58
642	1 pts		Thoracic vertebral fracture	serious				58
643	2 pts		Alanine aminotransferase increased	serious				58
644	2 pts		Aspartate aminotransferase increased	serious				58
645	1 pts		Rotavirus test positive	serious				58
646	1 pts		Transaminases increased	serious				58
647	1 pts		Hypokalaemia	serious				58
648	2 pts		Osteoarthritis	serious				58
649	1 pts		Polymyositis	serious				58
650	1 pts		Spinal pain	serious				58
651	1 pts		Systemic scleroderma	serious				58
652	1 pts		Bladder cancer	serious				58
653	1 pts		Bronchial carcinoma	serious				58
654	1 pts		Colon cancer	serious				58
655	1 pts		Hepatic cancer	serious				58
656	1 pts		Hepatocellular carcinoma	serious				58
657	2 pts		Small cell lung cancer	serious				58
658	1 pts		Transitional cell carcinoma	serious				58
659	1 pts		Cerebellar infarction	serious				58
660	1 pts		Cerebral infarction	serious				58
661	1 pts		Cerebrovascular accident	serious				58
662	1 pts		Dementia	serious				58
663	1 pts		Neuropathy peripheral	serious				58
664	1 pts		Sciatica	serious				58
665	1 pts		Syncope	serious				58
666	1 pts		Anxiety disorder	serious				58
667	3 pts		Acute kidney injury	serious				58
668	1 pts		Glomerulonephritis	serious				58
669	1 pts		Haematuria	serious				58
670	1 pts		Renal failure	serious				58
671	1 pts		Prostatitis	serious				58
672	16 pts		Acute respiratory failure	serious				58
673	1 pts		Eosinophilic pneumonia chronic	serious				58
674	3 pts		Hypoxia	serious				58
675	2 pts		Idiopathic interstitial pneumonia	serious				58
676	2 pts		Organising pneumonia	serious				58
677	1 pts		Pleuritic pain	serious				58
678	2 pts		Pneumomediastinum	serious				58
679	1 pts		Pneumonitis	serious				58
680	7 pts		Pulmonary fibrosis	serious				58
681	1 pts		Respiratory arrest	serious				58
682	11 pts		Respiratory failure	serious				58
683	2 pts		Hypertensive crisis	serious				58
684	2 pts		Vasculitis	serious				58
685	34 pts		Abdominal pain	below serious				58
686	33 pts		Abdominal pain upper	below serious				58
687	239 pts		Diarrhoea	below serious				58
688	100 pts		Nausea	below serious				58
689	64 pts		Vomiting	below serious				58
690	18 pts		Asthenia	below serious				58
691	17 pts		Chest pain	below serious				58
692	34 pts		Fatigue	below serious				58
693	19 pts		Hepatic function abnormal	below serious				58
694	54 pts		Nasopharyngitis	below serious				58
695	18 pts		Respiratory tract infection	below serious				58
696	26 pts		Upper respiratory tract infection	below serious				58
697	22 pts		Urinary tract infection	below serious				58
698	47 pts		Alanine aminotransferase increased	below serious				58
699	41 pts		Aspartate aminotransferase increased	below serious				58
700	22 pts		Gamma-glutamyltransferase increased	below serious				58
701	49 pts		Weight decreased	below serious				58
702	54 pts		Decreased appetite	below serious				58
703	28 pts		Back pain	below serious				58
704	19 pts		Dizziness	below serious				58
705	37 pts		Headache	below serious				58
706	49 pts		Dyspnoea	below serious				58
707	1 pts		Gamma-glutamyltransferase increased	grade 3			TRUE	63
708	1 pts		Gamma-glutamyltransferase increased	grade 3			TRUE	64
709	2 pts		Elevated liver enzymes	grade 3			TRUE	53
710	5		Diarrhea		discontinuation	leads to discontinuation		59
711	2		Nausea		discontinuation	leads to discontinuation		59
712	2		Decreased appetite		discontinuation	leads to discontinuation		59
713			Nasopharyngitis					54
714						Adverse events reported were consistent with the existing safety profile for drug		55
715	1.1		Weight decreased		discontinuation	leads to discontinuation		60
716	0.6		Alanine aminotransferase increased		discontinuation	leads to discontinuation		60
717	1		Vomiting		discontinuation	leads to discontinuation		61
718	1		Abdominal pain		discontinuation	leads to discontinuation		61
719	0.7		Asthenia		discontinuation	leads to discontinuation		61
720	0.6		Hepatic enzyme increased		discontinuation	leads to discontinuation		61
721	0.4		Aspartate aminotransferase increased		discontinuation	leads to discontinuation		61
722	0.4		Blood bilirubin increased		discontinuation	leads to discontinuation		61
723	10.9		Diarrhea		discontinuation	leads to dose reduction		62
724	2.1		Nausea		discontinuation	leads to dose reduction		62
725	0.8		Decreased appetite		discontinuation	leads to dose reduction		62
726	0.6		Weight decreased		discontinuation	leads to dose reduction		62
727	0.8		Abdominal pain		discontinuation	leads to dose reduction		62
728	0.8		Abdominal pain upper		discontinuation	leads to dose reduction		62
729	0.4		Transaminases increased		discontinuation	leads to dose reduction		62
730	0.7		Hepatic function abnormal		discontinuation	leads to dose reduction		62
731						No AEs are reported		65
732	1 pts		Bladder spasm	below serious				68
733	1 pts		Back pain	below serious				68
734	1 pts		Abdominal pain	below serious				68
735	1 pts		Constipation	below serious				68
736	1 pts		Mental status changes	below serious				68
737	1 pts		Abdominal cramp	below serious				68
738	16.7		Gastrointestinal disorder (NOS)					69
739	16.7		Nausea					69
740	33.3		CNS disorder (NOS)					69
741	16.7		Somnolence					69
742	16.7		Dizziness					69
743	33.3		Myalgia					70
744	16.7		Restless leg syndrome					70
745	50		Dizziness					70
746	0.9		Diarrhea		discontinuation	leads to discontinuation		67
747	0.9		Abdominal pain		discontinuation	leads to discontinuation		67
748	1.1		Nausea		discontinuation	leads to discontinuation		67
749	0.5		Vomiting		discontinuation	leads to discontinuation		67
750	0.2		Depression		discontinuation	leads to discontinuation		67
751	0.2		Hypotension		discontinuation	leads to discontinuation		67
752	0.5		Dizziness		discontinuation	leads to discontinuation		67
753	0.2		Abdominal discomfort		discontinuation	leads to discontinuation		67
754	3.1		Diarrhea		discontinuation	leads to discontinuation		66
755	2.9		Abdominal pain		discontinuation	leads to discontinuation		66
756	1.1		Nausea		discontinuation	leads to discontinuation		66
757	0.9		Vomiting		discontinuation	leads to discontinuation		66
758	0.2		Depression		discontinuation	leads to discontinuation		66
759	0.2		Hypotension		discontinuation	leads to discontinuation		66
760	0.2		Influenza like illness		discontinuation	leads to discontinuation		66
761	0.2		Chills		discontinuation	leads to discontinuation		66
762	1.1		Abdominal pain upper		discontinuation	leads to discontinuation		66
763	0.9		Hyperhidrosis		discontinuation	leads to discontinuation		66
764	0.4		Back pain		discontinuation	leads to discontinuation		66
765	0.4		Myalgia		discontinuation	leads to discontinuation		66
766	0.4		Liver function test abnormal		discontinuation	leads to discontinuation		66
767	0.4		Headache		discontinuation	leads to discontinuation		66
768	1.3		Bradycardia	grade 2		combined events are DLT	TRUE	71
769	1.3		Dizziness	grade 2				71
770	1.3		Nausea	grade 2				71
771	1.3		Dizziness	grade 3		combined events are DLT	TRUE	71
772	1.3		Dysequilibrium	grade 2		combined events are DLT	TRUE	71
773	1.3		Hypotension	grade 2		combined events are DLT	TRUE	71
774	1.3		Vomiting	grade 2		combined events are DLT	TRUE	71
775			Nausea					73
776	12.5		Nausea	grade 1-2				72
777	16.7		Vomiting					76
778	29.2		Nausea	grade 1-2				76
779	1		Atrioventricular block second degree					74
780	<1		Atrioventricular block					74
781	<1		Atrioventricular block first degree					74
782	<1		Sinoatrial block					74
783	1		Supraventricular tachycardia					74
784	<1		Arrhythmia supraventricular					74
785	<1		Atrial tachycardia					74
786	1		Ventricular tachycardia					74
787	<1		Ventricular extrasystoles					74
788	<1		Tachycardia					74
789	13		Nasopharyngitis					75
790	11		Upper respiratory tract infection					75
791	6		Influenza					75
792	6		Sinusitis					75
793	6		Infection urinary tract					75
794	3		Bronchitis					75
795	3		Gastroenteritis					75
796	3		Viral infection					75
797	2		Gastroenteritis viral					75
798	2		Ear infection					75
799	2		Oral herpes					75
800	2		Pharyngitis					75
801	2		Pneumonia					75
802	10		Diarrhoea					75
803	8		Abdominal pain upper					75
804	8		Nausea					75
805	7		Dyspepsia					75
806	6		Abdominal pain					75
807	6		Constipation					75
808	5		Gastrooesophageal reflux disease					75
809	4		Vomiting					75
810	3		Abdominal distension					75
811	2		Dysphagia					75
812	2		Flatulence					75
813	2		Toothache					75
814	2		Gastritis					75
815	2		Dry mouth					75
816	17		Headache					75
817	10		Dizziness					75
818	2		Paraesthesia					75
819	2		Neuropathy peripheral					75
820	2		Syncope					75
821	2		Dysgeusia					75
822	2		Somnolence					75
823	14		Arthralgia					75
824	9		Back pain					75
825	8		Pain in extremity					75
826	5		Bone pain					75
827	3		Myalgia					75
828	3		Musculoskeletal pain					75
829	7		Fatigue					75
830	4		Asthenia					75
831	4		Oedema peripheral					75
832	3		Chest pain					75
833	3		Pyrexia					75
834	2		Influenza like illness					75
835	6		Cough					75
836	4		Epistaxis					75
837	4		Oropharyngeal pain					75
838	2		Nasal congestion					75
839	2		Throat irritation					75
840	5		Blood creatine phosphokinase increased					75
841	2		Weight decreased					75
842	2		ALT increased					75
843	2		Rash					75
844	2		Pruritus					75
845	2		Dermatitis contact					75
846	2		Dry skin					75
847	2		Laceration					75
848	2		Contusion					75
849	5		Palpitations					75
850	2		Dysmenorrhoea					75
851	2		Metrorrhagia					75
852	2		Splenomegaly					75
853	2		Anxiety					75
854	2		Hypertension					75
855	2		Flushing					75
856	2		Haematuria					75
857	2		Hepatomegaly					75
858	2		Hypersensitivity					75
859	26 pts		Headache	below serious				80
860	41 pts		Somnolence	below serious				80
861	1 pts		Pneumonia	serious				77
862	13 pts		Somnolence	below serious				77
863	1 pts		Meniere's disease	serious				81
864	1 pts		Autoimmune thyroiditis	serious				81
865	1 pts		Compression fracture	serious				81
866	1 pts		Fall	serious				81
867	1 pts		Ulna fracture	serious				81
868	1 pts		Musculoskeletal chest pain	serious				81
869	1 pts		Hypoxic-ischaemic encephalopathy	serious				81
870	29 pts		Headache	below serious				81
871	40 pts		Somnolence	below serious				81
872	1 pts		Atrial fibrillation	serious				78
873	1 pts		Ankle fracture	serious				78
874	19 pts		Headache	below serious				78
875	20 pts		Somnolence	below serious				78
876	1 pts		Ankle fracture	serious				79
877	67		Somnolence					82
878	83		Fatigue					82
879	17		Insomnia					82
880	33		Dizziness					82
881	33		Phlebitis					82
882	25		Diarrhea	grade 3				84
883	25		Pneumonia	grade 3				84
884	25		Edema peripheral	grade 3				84
885	50		AST increased	grade 3				84
886	50		ALT increased	grade 3				84
887	50		Absolute neutrophil count decreased	grade 3				84
888	50		Platelets decreased	grade 3				84
889	25		Vomiting	all grades				84
890	25		Rash	all grades				84
891	25		Chills	all grades				84
892	25		Fatigue	all grades				84
893	25		Constipation	all grades				84
894	25		Nausea	all grades				84
895	25		Insomnia	all grades				84
896	25		Edema peripheral	all grades				84
897	25		Arterial pressure NOS increased	all grades				84
898	25		Bilirubin increased	all grades				84
899	25		Glucose increased	all grades				84
900	25		Glucose decreased	all grades				84
901	25		Hemoglobin decreased	all grades				84
902	25		Pyrexia	all grades				84
903	25		Night sweats	all grades				84
904	14		Hepatotoxicity	serious|grade 5		WARNING		83
905	14		Diarrhea	serious|grade 5		WARNING		83
906	14		Colitis	serious|grade 5		WARNING		83
907			Pneumonitis	serious|grade 5		WARNING		83
908	10		Hepatotoxicity		discontinuation	leads to discontinuation		85
909	10		Diarrhea		discontinuation	leads to discontinuation		85
910	10		Colitis		discontinuation	leads to discontinuation		85
911	15		Transaminases increased		discontinuation	leads to dose reduction		85
912	15		Diarrhea		discontinuation	leads to dose reduction		85
913	15		Colitis		discontinuation	leads to dose reduction		85
914	15		Rash		discontinuation	leads to dose reduction		85
915			Application site irritation			AEs for dose were from Study 200/200A		86
916			Application site erythema			AEs for dose were from Study 200/200A		86
917			Application site reaction			AEs for dose were from Study 200/200A		86
918			Application site stinging	grade 2	dose interruption	AEs for dose were from Study 200/200A		86
919			Pruritus	grade 2	dose interruption	AEs for dose were from Study 200/200A		86
920			Irritation skin	grade 3	dose interruption	AEs for dose were from Study 200/200A		86
921	0.5		Application site erythema	grade 2	discontinuation			88
922	0.5		Application site exfoliation	grade 2	discontinuation			88
923	0.5		Ingrowing nail		dose interruption			87
924	0.5		Application site pain		dose interruption			87
925	0.5		Application site discharge		dose interruption			87
926	0.5		Application site exfoliation		dose interruption			87
927	0.5		Application site edema		discontinuation			87
928	0.5		Edema peripheral		discontinuation			87
929	0.5		Application site erythema		discontinuation			87
930	0.5		Erythema		discontinuation			87
931	0.5		Application site induration		discontinuation			87
932	0.5		Skin induration					87
933	0.5		Application site reaction		discontinuation			87
934	0.5		Skin maceration		discontinuation			87
935	0.5		Application site pruritus		dose interruption			87
936	0.5		Pruritus		discontinuation			87
937	0.5		Dermatitis contact					89
938	1.01		Hypercholesterolaemia					91
939	0.51		Blood creatinine increased					91
940	0.38		Blood glucose increased					91
941	0.38		Blood urea increased					91
942	0.38		Hyperglycaemia					91
943	0.38		Hyperlipidaemia					91
944	5.44		Upper respiratory tract infection					90
945	3.29		Back pain					90
946	2.65		Application site exfoliation					90
947	2.53		Ingrowing nail					90
948	2.53		Procedural pain					90
949	2.4		Muscle strain					90
950	2.15		Arthralgia					90
951			Fatigue	grade 3			TRUE	95
952	1 pts		Atrial fibrillation				TRUE	92
953	1 pts		Diarrhea				TRUE	92
954	2 pts		Fatigue	grade 3			TRUE	92
955	1 pts		Atrial fibrillation				TRUE	93
956	1 pts		Vomiting				TRUE	93
957	1 pts		Nausea				TRUE	93
958	1 pts		Nausea	grade 2				92
959	1 pts		Vomiting	grade 2				92
960	1 pts		Lethargy	grade 3				92
961	1 pts		Diarrhea	grade 3				92
962	41		Nausea	grade 1-2				94
963	1		Nausea	grade 3-4				94
964	32		Fatigue	grade 1-2				94
965	5		Fatigue	grade 3-4	discontinuation	leads to discontinuation		94
966	33		Pyrexia	grade 1-2				94
967	2		Pyrexia	grade 3-4				94
968	21		Anemia	grade 1-2				94
969	11		Anemia	grade 3-4	discontinuation	leads to discontinuation		94
970	28		Vomiting	grade 1-2				94
971	1		Vomiting	grade 3-4				94
972	22		Constipation	grade 1-2				94
973	1		Constipation	grade 3-4				94
974	21		Diarrhea	grade 1-2				94
975	2		Diarrhea	grade 3-4				94
976	16		Dyspnea	grade 1-2				94
977	6		Dyspnea	grade 3-4				94
978	19		Rash	grade 1-2				94
979	1		Rash	grade 3-4				94
980	20		Peripheral edema	grade 1-2				94
981	19		Cough	grade 1-2				94
982	9		Thrombocytopenia	grade 1-2				94
983	7		Thrombocytopenia	grade 3-4				94
984	13		Pruritus	grade 1-2				94
985	3		Pruritus	grade 3-4				94
986	15		Chills	grade 1-2				94
987	1		Chills	grade 3-4				94
988	14		Blood lactate dehydrogenase increased	grade 1-2				94
989	2		Blood lactate dehydrogenase increased	grade 3-4				94
990	13		Decreased appetite	grade 1-2				94
991	2		Decreased appetite	grade 3-4				94
992	15		Headache	grade 1-2				94
993	14		Infusion site pain	grade 1-2				94
994	8		Hypokalemia	grade 1-2				94
995	4		Hypokalemia	grade 3-4				94
996	7		QT prolonged	grade 1-2				94
997	4		QT prolonged	grade 3-4				94
998	10		Abdominal pain	grade 1-2				94
999	1		Abdominal pain	grade 3-4				94
1000	7		Hypotension	grade 1-2				94
1001	3		Hypotension	grade 3-4				94
1002	9		Phlebitis	grade 1-2				94
1003	1		Phlebitis	grade 3-4				94
1004	10		Dizziness	grade 1-2				94
1005	1 pts		Tumor lysis syndrome	grade 4		died due to multi-organ failure		94
1006			Febrile neutropenia		discontinuation	leads to discontinuation		94
1007	> 2		Pneumonia	serious|grade 5				94
1008	> 2		Sepsis	serious|grade 5				94
1009			Hypertension		discontinuation			98
1010	7		Nausea		discontinuation			99
1011	14		Cytopenia					99
1012	100		Platelets decreased					97
1013	37.5		Neutrophil count					97
1014	6.5		Nausea					96
1015	13		Diarrhea					96
1016	10.9		Headache					96
1017	2.2		Vomiting		discontinuation			96
1018	0.1		Acute psychosis		discontinuation			101
1019	1.1		Application site dermatitis		discontinuation			103
1020	0.2		Application site eczema		discontinuation			101
1021	0.3		Application site erythema		discontinuation			101
1022	0.1		Application site exfoliation		discontinuation			101
1023	0.2		Application site irritation		discontinuation			101
1024	0.1		Application site pain		discontinuation			101
1025	0.2		Application site pruritus		discontinuation			101
1026	0.1		Application site reaction		discontinuation			101
1027	0.2		Application site swelling		discontinuation			101
1028	0.5		Application site vesicles		discontinuation			101
1029	0.1		Blood glucose abnormal		discontinuation			101
1030	0.1		Dermatitis		discontinuation			101
1031	0.2		Dermatitis contact		discontinuation			101
1032	0.1		Headache		discontinuation			101
1033	0.1		Intracranial aneurysm		discontinuation			101
1034	0.1		Lung squamous cell carcinoma stage unspecified		discontinuation			101
1035	0.1		Lymphadenopathy		discontinuation			101
1036	0.1		Prostate cancer		discontinuation			101
1037	0.1		Extrasystoles ventricular		discontinuation			101
1038	0.4		Coronary artery disease					100
1039	0.4		Seizure					100
1040	0.4		Large intestine infection					100
1041	0.4		Pneumonia					100
1042	0.4		Numbness in leg					100
1043	2.2		Application site dermatitis					102
1044	1.6		Application site vesicles					102
1045	1.1		Application site pain					102
1046	2.3		Ingrowing nail					102
1047	2.2		Contact dermatitis					102
1048	2		Eczema					102
1049	1.1		Rash					102
1050						impossible to link AEs with the definite dose		106
1051			Bleeding			WARNING		105
1052	0.2		Melaena		discontinuation	leads to discontinuation		104
1053	0.2		Rectal haemorrhage		discontinuation	leads to discontinuation		104
1054	0.3		Haemorrhage intracranial		discontinuation	leads to discontinuation		104
1055	0.2		Haematuria		discontinuation	leads to discontinuation		104
1056	0.4		Epistaxis		discontinuation	leads to discontinuation		104
1057	0.2		Increased tendency to bruise		discontinuation	leads to discontinuation		104
1058	0.3		Anaemia		discontinuation	leads to discontinuation		104
1059	0.1		Visual acuity reduced		discontinuation	leads to discontinuation		104
1060	0.1		Hypertransaminasaemia		discontinuation	leads to discontinuation		104
1061	0.1		Transaminases abnormal		discontinuation	leads to discontinuation		104
1062	0.1		Initial insomnia		discontinuation	leads to discontinuation		104
1063	0.1		Depressive symptom		discontinuation	leads to discontinuation		104
1064	0.1		Varicose vein		discontinuation	leads to discontinuation		104
1065	0.1		Vein pain		discontinuation	leads to discontinuation		104
1066	0.1		Venous thrombosis					104
1067	100		Vomiting	all grades				109
1068	17		Abdominal pain	all grades				109
1069	33		Fatigue	all grades				109
1070	50		Blood creatinine increased	all grades				109
1071	50		Decreased appetite	all grades				109
1072	33		Alanine aminotransferase increased	all grades				109
1073	33		Aspartate aminotransferase increased	all grades				109
1074	33		Neutropenia	all grades				109
1075	50		Rash	all grades				109
1076	17		Maculopapular rash					109
1077	33		Stomatitis					109
1078	69		Nausea	all grades				107
1079	2.6		Nausea	grade 3-4	discontinuation	leads to dose interruption or reduction		107
1080	85		Diarrhea	all grades				107
1081	4.8		Diarrhea	grade 3-4	discontinuation	leads to dose interruption or reduction		107
1082	67		Vomiting	all grades				107
1083	5		Vomiting	grade 3-4	discontinuation	leads to dose interruption or reduction		107
1084	40		Abdominal pain	all grades				107
1085	40		Abdominal pain upper	all grades				107
1086	40		Abdominal discomfort	all grades				107
1087	40		Epigastric discomfort	all grades				107
1088	3.7		Abdominal pain	grade 3-4				107
1089	3.7		Abdominal pain upper	grade 3-4				107
1090	3.7		Abdominal discomfort	grade 3-4				107
1091	3.7		Epigastric discomfort	grade 3-4				107
1092	20		Constipation	all grades				107
1093	15		Dyspepsia	all grades				107
1094	15		Gastroesophageal reflux disease	all grades				107
1095	15		Dysphagia	all grades				107
1096	0.5		Dyspepsia	grade 3-4				107
1097	0.5		Gastroesophageal reflux disease	grade 3-4				107
1098	0.5		Dysphagia	grade 3-4				107
1099	45		Fatigue	all grades				107
1100	45		Asthenia	all grades				107
1101	7		Fatigue	grade 3-4				107
1102	7		Asthenia	grade 3-4				107
1103	21		Non-cardiac chest pain	all grades				107
1104	1.1		Non-cardiac chest pain	grade 3-4				107
1105	19		Back pain	all grades				107
1106	1.6		Back pain	grade 3-4				107
1107	19		Pyrexia	all grades				107
1108	13		Pain in extremity	all grades				107
1109	11		Musculoskeletal pain	all grades				107
1110	0.5		Musculoskeletal pain	grade 3-4				107
1111	11		Pruritus	all grades				107
1112	0.5		Pruritus	grade 3-4				107
1113	34		Decreased appetite	all grades				107
1114	1.1		Decreased appetite	grade 3-4				107
1115	24		Weight loss	all grades				107
1116	3.7		Weight loss	grade 3-4				107
1117	21		Rash	all grades				107
1118	21		Dermatitis acneiform	all grades				107
1119	21		Rash maculo-papular	all grades				107
1120	1.1		Rash	grade 3-4				107
1121	1.1		Dermatitis acneiform	grade 3-4				107
1122	1.1		Rash maculo-papular	grade 3-4				107
1123	19		Headache	all grades				107
1124	0.5		Headache	all grades				107
1125	12		Dizziness	grade 3-4				107
1126	1.1		Dizziness	grade 3-4				107
1127	12		QT interval prolonged	all grades				107
1128	2.6		QT interval prolonged	grade 3-4				107
1129	4.2		Pericardial effusion	all grades				107
1130	4.2		Pericarditis	all grades				107
1131	1.6		Pericardial effusion	grade 3-4				107
1132	1.6		Pericarditis	grade 3-4				107
1133	25		Cough	all grades				107
1134	4		Pneumonia	serious				107
1135	4		Pleural effusion	serious				107
1136	91		ALT increased	all grades				107
1137	34		ALT increased	grade 3-4	discontinuation	leads to dose interruption or reduction	TRUE	107
1138	86		AST increased	all grades				107
1139	21		AST increased	grade 3-4	discontinuation	leads to dose interruption or reduction	TRUE	107
1140	84		GGT increased	all grades				107
1141	49		GGT increased	grade 3-4	discontinuation	leads to dose interruption or reduction		107
1142	81		Alkaline phosphatase increased	all grades				107
1143	12		Alkaline phosphatase increased	grade 3-4				107
1144	77		Creatinine increased	all grades				107
1145	4.2		Creatinine increased	grade 3-4	discontinuation	leads to discontinuation | leads to dose interruption or reduction		107
1146	53		Hyperglycemia	all grades				107
1147	10		Hyperglycemia	grade 3-4				107
1148	38		Hypophosphatemia	all grades				107
1149	3.7		Hypophosphatemia	grade 3-4				107
1150	37		Amylase increased	all grades				107
1151	8		Amylase increased	grade 3-4	discontinuation	leads to discontinuation		107
1152	15		Hyperbilirubinemia	all grades				107
1153	0.5		Hyperbilirubinemia	grade 3-4				107
1154	13		Lipase increased	all grades				107
1155	6		Lipase increased	grade 3-4	discontinuation	leads to discontinuation		107
1156	67		Anemia	all grades				107
1157	4.2		Anemia	grade 3-4				107
1158	27		Neutropenia	all grades				107
1159	2.1		Neutropenia	grade 3-4				107
1160	16		Thrombocytopenia	all grades				107
1161	1		Thrombocytopenia	grade 3-4				107
1162	4		Vision decreased					107
1163	4		Blurred vision					107
1164	4		Photopsia					107
1165	4		Accommodation disorder					107
1166	4		Presbyopia					107
1167	4		Visual acuity reduced					107
1168	4		Vitreous floaters					107
1169	4		Bradycardia					107
1170	2		Hepatotoxicity					107
1171	2		Renal failure					107
1172	33		Diarrhea	all grades	discontinuation	leads to dose interruption		110
1173	100		Nausea	all grades	discontinuation	leads to dose interruption		111
1174	1 pts		Lipase increased	grade 3	discontinuation	leads to dose interruption or reduction	TRUE	112
1175	4		Pneumonitis	all grades				108
1176	3		Pneumonitis	grade 3-4	discontinuation	leads to discontinuation		108
1177	35 pts		Abdominal discomfort	below serious				113
1178	14 pts		Nausea	below serious				113
1179	10 pts		Vomiting	below serious				113
1180			Nausea	grade 1-2			TRUE	115
1181			Vomiting	grade 1-2			TRUE	115
1182	0.3		Stevens-Johnson syndrome		discontinuation			119
1183	0.3		Rash		discontinuation			119
1184	0.3		Diarrhea	grade 4	discontinuation			119
1185	0.3		Hyperbilirubinemia		discontinuation			119
1186	0.3		Thrombocytopenia		discontinuation			119
1187	0.3		Arthritis		discontinuation			119
1188	0.8		AST increased		discontinuation			118
1189	0.8		ALT increased		discontinuation			118
1190	0.8		Vomiting		discontinuation			118
1191	0.8		Anorexia		discontinuation			118
1192	0.8		Blood urea nitrogen increased		discontinuation			118
1193	0.8		Creatinine increased		discontinuation			118
1194	0.8		Oliguria		discontinuation			118
1195	6.7		Nausea	grade 3				114
1196	6.7		Vomiting	grade 3				114
1197	6.7		Diarrhoea	grade 3				114
1198	1.1		Motion sickness		discontinuation			116
1199	1.1		Headache		discontinuation			116
1200	3		Vomiting	grade 3-4				117
1201	3		Vomiting	grade 4-5				117
1202	7.2		Mean arterial pressure high					120
1203						well tolerated. No AEs published		121
1204	0.07		Supraventricular extrasystoles		discontinuation			122
1205	0.07		Tachycardia		discontinuation			122
1206	0.07		Constipation		discontinuation			122
1207	0.07		Diarrhoea		discontinuation			125
1208	0.07		Dyspepsia		discontinuation			130
1209	0.07		Gastritis		discontinuation			125
1210	0.07		Vomiting		discontinuation			126
1211	0.07		Fatigue		discontinuation			122
1212	0.07		Local swelling		discontinuation			124
1213	0.07		Oedema peripheral		discontinuation			122
1214	0.07		Cholestasis		discontinuation			122
1215	0.07		ALT increased		discontinuation			122
1216	0.07		AST increased		discontinuation			122
1217	0.07		GGT increased		discontinuation			122
1218	0.07		Blood creatine increased		discontinuation			130
1219	0.07		Blood creatine increased		discontinuation			122
1220	0.07		Hyperglycaemia		discontinuation			122
1221	0.07		Dizziness		discontinuation			125
1222	0.07		Headache		discontinuation			122
1223	0.07		Loss of consciousness		discontinuation			122
1224	0.07		Somnolence		discontinuation			130
1225	0.07		Syncope		discontinuation			122
1226	0.07		Transient ischaemic attack		discontinuation			122
1227	0.07		Disorientation		discontinuation			124
1228	0.07		Insomnia		discontinuation			130
1229	0.14		Insomnia		discontinuation			122
1230	0.14		Nightmare		discontinuation			122
1231	0.07		Renal pain		discontinuation			122
1232	0.07		Rash		discontinuation			127
1233	0.07		Rash		discontinuation			124
1234	0.07		Rash		discontinuation			122
1235	0.9		Ventricular arrhythmia		discontinuation			128
1236	0.9		Gastritis		discontinuation			128
1237	0.9		Local swelling		discontinuation			128
1238	0.9		Electrocardiogram ST segment elevation		discontinuation			128
1239	0.9		Ataxia		discontinuation			128
1240	0.9		Dizziness		discontinuation			128
1241	0.9		Confusional state		discontinuation			128
1242	0.9		Disorientation		discontinuation			128
1243	0.9		Rash		discontinuation			128
1244	0.7		Supraventricular extrasystoles		discontinuation			123
1245	0.7		Vomiting		discontinuation			123
1246	0.7		Headache		discontinuation			123
1247	0.7		Syncope		discontinuation			123
1248	0.7		Insomnia		discontinuation			123
1249	1.3		Nightmare		discontinuation			123
1250	0.7		Anger		discontinuation			123
1251	0.7		Depression		discontinuation			123
1252	0.6		Diarrhoea		discontinuation			131
1253	0.6		Dyspepsia		discontinuation			131
1254	0.6		Hypoaesthesia oral		discontinuation			131
1255	0.6		Blood creatine phosphokinase increased		discontinuation			131
1256	1.2		Somnolence		discontinuation			131
1257	0.6		Insomnia		discontinuation			131
1258	0.2		Supraventricular extrasystoles		discontinuation			129
1259	0.2		Ventricular arrhythmia		discontinuation			129
1260	0.2		Diarrhoea		discontinuation			129
1261	0.2		Dyspepsia		discontinuation			129
1262	0.2		Gastritis		discontinuation			129
1263	0.2		Hypoaesthesia oral		discontinuation			129
1264	0.2		Vomiting		discontinuation			129
1265	0.2		Local swelling		discontinuation			129
1266	0.5		Somnolence		discontinuation			129
1267	0.2		Ataxia		discontinuation			129
1268	0.2		Dizziness		discontinuation			129
1269	0.2		Headache		discontinuation			129
1270	0.2		Syncope		discontinuation			129
1271	0.5		Insomnia		discontinuation			129
1272	0.5		Nightmare		discontinuation			129
1273	0.2		Anger		discontinuation			129
1274	0.2		Confusional state		discontinuation			129
1275	0.2		Depression		discontinuation			129
1276	0.2		Disorientation		discontinuation			129
1277	0.2		Rash		discontinuation			129
1278	14		Cough					133
1279	10		Headache					133
1280	7		Nasopharyngitis					133
1281	3		Upper respiratory tract infection					133
1282	3		Oropharyngeal pain					133
1283						No AEs are reported		132
1284	1 pts		Creatine phosphokinase increased					134
1285	1 pts		Rash					134
1286						No AEs are reported		137
1287	3 pts		Photosensitivity reaction					135
1288	2 pts		Diarrhea					135
1289	2 pts		Abdominal pain upper					135
1290						No AEs are reported		136
1291	13.5		Headache					139
1292	10.8		Diarrhoea					139
1293	10.8		Fatigue					139
1294	10.8		Pruritus					139
1295	8.1		Anorexia					139
1296	8.1		Back pain					139
1297	8.1		Myalgia					139
1298	<1		Pruritus		discontinuation	leads to discontinuation		138
1299	<1		Psoriasis		discontinuation	leads to discontinuation		138
1300	1		Rash		discontinuation	leads to discontinuation		138
1301	<1		Rash erythematous		discontinuation	leads to discontinuation		138
1302	<1		Skin burning sensation		discontinuation	leads to discontinuation		138
1303	<1		Aggression		discontinuation	leads to discontinuation		138
1304	<1		Blood bilirubin increased		discontinuation	leads to discontinuation		138
1305	<1		Major depression		discontinuation	leads to discontinuation		138
1306	<1		Stomatitis		discontinuation	leads to discontinuation		138
1307	<1		Headache		discontinuation	leads to discontinuation		138
1308	<1		Pain		discontinuation	leads to discontinuation		138
1309	3 pts		Diarrhea	grade 1-2				140
1310	2 pts		Nausea	grade 1-2				140
1311	2 pts		Vomiting	grade 1-2				140
1312	1 pts		Constipation	grade 1-2				140
1313	1 pts		Decreased appetite	grade 1-2				140
1314	1 pts		Dyspepsia	grade 1-2				140
1315	4 pts		Fatigue	grade 1-2				140
1316	2 pts		Headache	grade 1-2				140
1317	3 pts		Muscle spasms	grade 1-2				140
1318	3 pts		Myalgia	grade 1-2				140
1319	2 pts		Pyrexia	grade 1-2				140
1320	1 pts		Rash	grade 1-2				140
1321	3 pts		Cough	grade 1-2				140
1322	2 pts		Arthralgia	grade 1-2				140
1323	2 pts		Edema	grade 1-2				140
1324	1 pts		Hypersensitivity	grade 3			TRUE	144
1325	1 pts		Neutropenia	grade 2	discontinuation	leads to dose reduction	TRUE	143
1326			Pneumonia	grade 3	discontinuation	leads to dose reduction	TRUE	142
1327			Sepsis	grade 3	discontinuation	leads to dose reduction	TRUE	142
1328	1 pts		Stomatitis	grade 3	discontinuation	leads to discontinuation		142
1329	46		Diarrhea	grade 1-2				141
1330	5		Diarrhea	grade 3-4				141
1331	31		Nausea	grade 1-2				141
1332	25		Constipation	grade 1-2				141
1333	19		Abdominal pain	grade 1-2				141
1334	5		Abdominal pain	grade 3-4				141
1335	23		Vomiting	grade 1-2				141
1336	16		Stomatitis	grade 1-2				141
1337	1		Stomatitis	grade 3-4				141
1338	11		Dyspepsia	grade 1-2				141
1339	34		Upper respiratory tract infection	grade 1-2				141
1340	11		Urinary tract infection	grade 1-2				141
1341	3		Urinary tract infection	grade 3-4				141
1342	7		Pneumonia	grade 1-2				141
1343	7		Pneumonia	grade 3-4				141
1344	9		Skin infection	grade 1-2				141
1345	5		Skin infection	grade 3-4				141
1346	12		Sinusitis	grade 1-2				141
1347	1		Sinusitis	grade 3-4				141
1348	36		Fatigue	grade 1-2				141
1349	5		Fatigue	grade 3-4				141
1350	32		Peripheral edema	grade 1-2				141
1351	3		Peripheral edema	grade 3-4				141
1352	17		Pyrexia	grade 1-2				141
1353	1		Pyrexia	grade 3-4				141
1354	11		Asthenia	grade 1-2				141
1355	3		Asthenia	grade 3-4				141
1356	30		Bruising	grade 1-2				141
1357	22		Rash	grade 1-2				141
1358	3		Rash	grade 3-4				141
1359	11		Petechiae	grade 1-2				141
1360	36		Musculoskeletal pain	grade 1-2				141
1361	1		Musculoskeletal pain	grade 3-4				141
1362	14		Muscle spasms	grade 1-2				141
1363	11		Arthralgia	grade 1-2				141
1364	23		Dyspnea	grade 1-2				141
1365	4		Dyspnea	grade 3-4				141
1366	19		Cough	grade 1-2				141
1367	11		Epistaxis	grade 1-2				141
1368	19		Decreased appetite	grade 1-2				141
1369	2		Decreased appetite	grade 3-4				141
1370	8		Dehydration	grade 1-2				141
1371	4		Dehydration	grade 3-4				141
1372	14		Dizziness	grade 1-2				141
1373	13		Headache	grade 1-2				141
1374	40		Platelets decreased	grade 1-2				141
1375	17		Platelets decreased	grade 3-4				141
1376	18		Neutrophil count decreased	grade 1-2				141
1377	29		Neutrophil count decreased	grade 3-4				141
1378	32		Hemoglobin decreased	grade 1-2				141
1379	9		Hemoglobin decreased	grade 3-4				141
1380	1.8		Subdural hematoma		discontinuation	leads to discontinuation		141
1381	15		Hyperuricemia					141
1382	5		Hemorrhage	grade 3				141
1383	25		Infection	grade 3				141
1384	29		Neutropenia	grade 3-4	discontinuation	leads to dose reduction		141
1385	17		Thrombocytopenia	grade 3-4	discontinuation	leads to dose reduction		141
1386	9		Anemia	grade 3-4	discontinuation	leads to dose reduction		141
1387	1 pts		Confusion			suicide attempt		145
1388	1 pts		Rigidity			suicide attempt		145
1389	1 pts		Seizures			suicide attempt		145
1390	1 pts		Hypoxemia			suicide attempt		145
1391	1 pts		Cardiac arrest			suicide attempt		145
1392	>=1		Dizziness		discontinuation	leads to discontinuation		147
1393	>=1		Nausea		discontinuation	leads to discontinuation		148
1394	>=1		Vomiting		discontinuation	leads to discontinuation		149
1395	>=1		Ataxia		discontinuation	leads to discontinuation		150
1396	>=1		Diplopia		discontinuation	leads to discontinuation		151
1397	>=1		Somnolence		discontinuation	leads to discontinuation		152
1398	>=1		Headache		discontinuation	leads to discontinuation		153
1399	>=1		Blurred vision		discontinuation	leads to discontinuation		154
1400	>=1		Vertigo		discontinuation	leads to discontinuation		155
1401	>=1		Asthenia		discontinuation	leads to discontinuation		156
1402	>=1		Fatigue		discontinuation	leads to discontinuation		157
1403	>=1		Rash		discontinuation	leads to discontinuation		158
1404	>=1		Dysarthria		discontinuation	leads to discontinuation		159
1405	>=1		Tremor		discontinuation	leads to discontinuation		160
1406	>=1		Dizziness		discontinuation	leads to discontinuation		146
1407	>=1		Nausea		discontinuation	leads to discontinuation		146
1408	>=1		Vomiting		discontinuation	leads to discontinuation		146
1409	>=1		Ataxia		discontinuation	leads to discontinuation		146
1410	>=1		Diplopia		discontinuation	leads to discontinuation		146
1411	>=1		Somnolence		discontinuation	leads to discontinuation		146
1412	>=1		Headache		discontinuation	leads to discontinuation		146
1413	>=1		Blurred vision		discontinuation	leads to discontinuation		146
1414	>=1		Vertigo		discontinuation	leads to discontinuation		146
1415	>=1		Asthenia		discontinuation	leads to discontinuation		146
1416	>=1		Fatigue		discontinuation	leads to discontinuation		146
1417	>=1		Rash		discontinuation	leads to discontinuation		146
1418	>=1		Dysarthria		discontinuation	leads to discontinuation		146
1419	>=1		Tremor		discontinuation	leads to discontinuation		146
1420	1		Hypersensitivity reaction	grade 3-4		FDA warning		161
1421			Anaemia		discontinuation			162
1422	1 pts		Acute respiratory distress syndrome	serious				164
1423	1 pts		Aspiration pneumonia	serious				164
1424	6 pts		Pneumonia	serious				164
1425	1 pts		Community acquired infection	serious				164
1426	1 pts		Lower respiratory tract infection bacterial	serious				164
1427	1 pts		Acute myocardial infarction	serious				164
1428	1 pts		Arteriospasm coronary	serious				164
1429	1 pts		Atrial flutter	serious				164
1430	1 pts		Coronary artery disease	serious				164
1431	1 pts		Diastolic dysfunction	serious				164
1432	1 pts		Gastric mucosal hypertrophy	serious				164
1433	1 pts		Hiatus hernia	serious				164
1434	1 pts		Small intestinal obstruction	serious				164
1435	1 pts		Umbilical hernia	serious				164
1436	1 pts		Chest pain	serious				164
1437	1 pts		Device malfunction	serious				164
1438	1 pts		Hernia obstructive	serious				164
1439	1 pts		Pyrexia	serious				164
1440	1 pts		Cystitis radiation	serious				164
1441	1 pts		Incisional hernia	serious				164
1442	1 pts		Laceration	serious				164
1443	1 pts		Post procedural haemorrhage	serious				164
1444	1 pts		Head and neck cancer	serious				164
1445	1 pts		Malignant mediastinal neoplasm	serious				164
1446	1 pts		Myelodysplastic syndrome	serious				164
1447	1 pts		Rectal cancer	serious				164
1448	1 pts		Squamous cell carcinoma	serious				164
1449	2 pts		Thrombocytopenia	serious				164
1450	1 pts		Cerebrovascular accident	serious				164
1451	1 pts		Transient ischaemic attack	serious				164
1452	1 pts		Intestinal operation	serious				164
1453	1 pts		Malignant tumour excision	serious				164
1454	1 pts		Skin lesion excision	serious				164
1455	1 pts		Hypotension	serious				164
1456	1 pts		Allergy to arthropod bite	serious				164
1457	1 pts		Fluid retention	serious				164
1458	1 pts		Pain in extremity	serious				164
1459	1 pts		Renal failure acute	serious				164
1460	1 pts		Skin haemorrhage	serious				164
1461	24 pts		Dyspnoea	below serious				164
1462	14 pts		Oedema peripheral	below serious				164
1463	13 pts		Anaemia	below serious				164
1464	11 pts		Dizziness	below serious				164
1465	9 pts		Alanine aminotransferase increased	below serious				164
1466	9 pts		Nausea	below serious				164
1467	8 pts		Insomnia	below serious				164
1468	7 pts		Chest pain	below serious				164
1469	6 pts		Arthralgia	below serious				164
1470	6 pts		Fatigue	below serious				164
1471	6 pts		Weight decreased	below serious				164
1472	1 pts		Acute kidney injury	serious				167
1473	1 pts		Dizziness	serious				167
1474	1 pts		Endocarditis	serious				167
1475	2 pts		Pneumonia	serious				167
1476	1 pts		Respiratory failure	serious				167
1477	3 pts		Right ventricular failure	serious				167
1478	1 pts		Septic shock	serious				167
1479	1 pts		Transient ischaemic attack	serious				167
1480	6 pts		Bronchitis	below serious				167
1481	13 pts		Headache	below serious				167
1482	11 pts		Upper respiratory tract infection	below serious				167
1483	1 pts		Acute right ventricular failure	serious				165
1484	1 pts		Oedema peripheral	serious				165
1485	1 pts		Weight increased	serious				165
1486	2 pts		Bone pain	below serious				165
1487	2 pts		Dizziness	below serious				165
1488	2 pts		Dyspnoea	below serious				165
1489	2 pts		Fatigue	below serious				165
1490	6 pts		Haemoglobin decreased	below serious				165
1491	8 pts		Oedema peripheral	below serious				165
1492	3 pts		Pain in extremity	below serious				165
1493	2 pts		Pharyngitis	below serious				165
1494	3 pts		Upper respiratory tract infection	below serious				165
1495	2 pts		Urinary tract infection	below serious				165
1496	1 pts		Cardiac failure acute	serious				166
1497	1 pts		Cardiorenal syndrome	serious				166
1498	1 pts		Left ventricular failure	serious				166
1499	1 pts		Ventricular tachycardia	serious				166
1500	1 pts		Mouth haemorrhage	serious				166
1501	1 pts		Sudden death	serious				166
1502	2 pts		Pneumonia	serious				166
1503	1 pts		Respiratory tract infection bacterial	serious				166
1504	1 pts		Hypoglycaemia	serious				166
1505	1 pts		Chronic respiratory failure	serious				166
1506	1 pts		Congestion pulmonary	serious				166
1507	1 pts		Pulmonary congestion	serious				166
1508	1 pts		Pulmonary mass	serious				166
1509	1 pts		Pulmonary oedema	serious				166
1510	1 pts		Respiratory failure	serious				166
1511	1 pts		Jugular vein thrombosis	serious				166
1512	2 pts		Anaemia	below serious				166
1513	2 pts		Mitral valve incompetence	below serious				166
1514	3 pts		Diarrhoea	below serious				166
1515	2 pts		Respiratory tract infection	below serious				166
1516	2 pts		Haemoglobin decreased	below serious				166
1517	2 pts		Fluid retention	below serious				166
1518	2 pts		Hypokalaemia	below serious				166
1519	2 pts		Hepatic neoplasm	below serious				166
1520	2 pts		Dizziness	below serious				166
1521	5 pts		Headache	moderate			TRUE	168
1522	2 pts		Nausea				TRUE	168
1523	2 pts		Vomiting				TRUE	168
1524			Fetal damage			WARNING		163
1525						No AEs are reported		169
1526	17		Headache	mild				171
1527	17		Flushing	mild				171
1528	4		Nasal congestion	mild				171
1529	4		Vomiting	mild				173
1530	22		Headache	moderate				173
1531	4		Glutamate dehydrogenase increased					173
1532	9		Micturition urgency	mild				173
1533	22		Flushing	mild				173
1534	4		Hypotension	moderate				173
1535						impossible to link AEs with the definite dose		172
1536			Fetal damage			WARNING		170
1537						There were no overall differences between treatment groups and no dose-related differences in the incidence of AEs or TEAEs		175
1538						no differences noted between the bazedoxifene and placebo groups in terms of adverse event frequency		174
1539	24 pts		Nausea	below serious				191
1540	16 pts		Dry mouth	below serious				191
1541	6 pts		Dyspepsia	below serious				191
1542	3 pts		Flatulence	below serious				191
1543	6 pts		Accidental overdose	below serious				191
1544	1 pts		Anorexia	below serious				191
1545	20 pts		Headache	below serious				191
1546	10 pts		Dizziness	below serious				191
1547	2 pts		Restlessness	below serious				191
1548	1 pts		Atrial fibrillation	serious				201
1549	1 pts		Coronary artery disease	serious				201
1550	1 pts		Head injury	serious				201
1551	1 pts		Convulsion	serious				201
1552	44 pts		Nausea	below serious				201
1553	16 pts		Dry mouth	below serious				201
1554	14 pts		Diarrhoea	below serious				201
1555	7 pts		Vomiting	below serious				201
1556	6 pts		Abdominal pain upper	below serious				201
1557	3 pts		Flatulence	below serious				201
1558	2 pts		Feeling jittery	below serious				201
1559	2 pts		Decreased appetite	below serious				201
1560	3 pts		Anorexia	below serious				201
1561	24 pts		Headache	below serious				201
1562	9 pts		Dizziness	below serious				201
1563	9 pts		Somnolence	below serious				201
1564	5 pts		Sedation	below serious				201
1565	3 pts		Tension headache	below serious				201
1566	3 pts		Tremor	below serious				201
1567	3 pts		Restlessness	below serious				201
1568	5 pts		Anxiety	below serious				201
1569	3 pts		Orgasm abnormal	below serious				201
1570	1 pts		Yawning	below serious				201
1571	1 pts		Drug hypersensitivity	serious				202
1572	1 pts		Herpes zoster	serious				202
1573	1 pts		Injury	serious				202
1574	1 pts		Colon cancer	serious				202
1575	1 pts		Renal cell carcinoma	serious				202
1576	1 pts		Cerebrovascular accident	serious				202
1577	1 pts		Convulsion	serious				202
1578	57 pts		Nausea	below serious				202
1579	34 pts		Diarrhoea	below serious				202
1580	25 pts		Dry mouth	below serious				202
1581	12 pts		Abdominal pain	below serious				202
1582	9 pts		Constipation	below serious				202
1583	8 pts		Vomiting	below serious				202
1584	7 pts		Nasopharyngitis	below serious				202
1585	6 pts		Urinary tract infection	below serious				202
1586	8 pts		Accidental overdose	below serious				202
1587	7 pts		Back pain	below serious				202
1588	51 pts		Headache	below serious				202
1589	11 pts		Somnolence	below serious				202
1590	7 pts		Depression	below serious				202
1591	6 pts		Initial insomnia	below serious				202
1592	1 pts		Hernia inguinal	serious				192
1593	1 pts		Pyrexia	serious				192
1594	5 pts		Palpitations	below serious				192
1595	24 pts		Nausea	below serious				192
1596	13 pts		Diarrhoea	below serious				192
1597	3 pts		Fatigue	below serious				192
1598	4 pts		Irritability	below serious				192
1599	5 pts		Upper respiratory tract infection	below serious				192
1600	4 pts		Influenza	below serious				192
1601	6 pts		Back pain	below serious				192
1602	20 pts		Headache	below serious				192
1603	7 pts		Dizziness	below serious				192
1604	5 pts		Sedation	below serious				192
1605	3 pts		Insomnia	below serious				192
1606	1 pts		Abortion spontaneous	serious				180
1607	37 pts		Nausea	below serious				180
1608	17 pts		Diarrhoea	below serious				180
1609	9 pts		Constipation	below serious				180
1610	8 pts		Vomiting	below serious				180
1611	7 pts		Fatigue	below serious				180
1612	6 pts		Upper respiratory tract infection	below serious				180
1613	5 pts		Gastroenteritis viral	below serious				180
1614	3 pts		Back pain	below serious				180
1615	18 pts		Headache	below serious				180
1616	5 pts		Sedation	below serious				180
1617	4 pts		Insomnia	below serious				180
1618	1 pts		Therapeutic agent toxicity	serious				203
1619	37 pts		Nausea	below serious				203
1620	12 pts		Dry mouth	below serious				203
1621	8 pts		Diarrhoea	below serious				203
1622	5 pts		Constipation	below serious				203
1623	3 pts		Dyspepsia	below serious				203
1624	3 pts		Vomiting	below serious				203
1625	8 pts		Nasopharyngitis	below serious				203
1626	4 pts		Gastroenteritis viral	below serious				203
1627	3 pts		Overdose	below serious				203
1628	5 pts		Increased appetite	below serious				203
1629	6 pts		Back pain	below serious				203
1630	3 pts		Neck pain	below serious				203
1631	15 pts		Headache	below serious				203
1632	12 pts		Dizziness	below serious				203
1633	9 pts		Somnolence	below serious				203
1634	3 pts		Memory impairment	below serious				203
1635	3 pts		Tremor	below serious				203
1636	7 pts		Insomnia	below serious				203
1637	4 pts		Cough	below serious				203
1638	3 pts		Hot flush	below serious				203
1639	1 pts		Hypertensive crisis	serious				178
1640	3 pts		Vertigo	below serious				178
1641	11 pts		Nausea	below serious				178
1642	2 pts		Constipation	below serious				178
1643	3 pts		Fatigue	below serious				178
1644	1 pts		Tachycardia	serious				204
1645	4 pts		Vertigo	below serious				204
1646	22 pts		Nausea	below serious				204
1647	3 pts		Diarrhoea	below serious				204
1648	3 pts		Constipation	below serious				204
1649	5 pts		Fatigue	below serious				204
1650	5 pts		Influenza	below serious				204
1651	16 pts		Headache	below serious				204
1652	5 pts		Dizziness	below serious				204
1653	3 pts		Somnolence	below serious				204
1654	3 pts		Sedation	below serious				204
1655	3 pts		Restlessness	below serious				204
1656	3 pts		Hyperhidrosis	below serious				204
1657	1 pts		Suicide attempt	serious				181
1658	3 pts		Vertigo	below serious				181
1659	18 pts		Nausea	below serious				181
1660	4 pts		Diarrhoea	below serious				181
1661	1 pts		Fatigue	below serious				181
1662	9 pts		Dizziness	below serious				181
1663	3 pts		Somnolence	below serious				181
1664	2 pts		Restlessness	below serious				181
1665	2 pts		Hyperhidrosis	below serious				181
1666	18 pts		Nausea	below serious				205
1667	5 pts		Dry mouth	below serious				205
1668	3 pts		Abdominal pain	below serious				205
1669	5 pts		Nasopharyngitis	below serious				205
1670	3 pts		Influenza	below serious				205
1671	9 pts		Dizziness	below serious				205
1672	6 pts		Somnolence	below serious				205
1673	5 pts		Hyperhidrosis	below serious				205
1674	1 pts		Major depression	serious				208
1675	10 pts		Constipation	below serious				208
1676	10 pts		Dry mouth	below serious				208
1677	34 pts		Nausea	below serious				208
1678	11 pts		Fatigue	below serious				208
1679	7 pts		Decreased appetite	below serious				208
1680	14 pts		Dizziness	below serious				208
1681	4 pts		Somnolence	below serious				208
1682	6 pts		Hyperhidrosis	below serious				208
1683	1 pts		Stress fracture	serious				189
1684	1 pts		Suicidal ideation	serious				189
1685	5 pts		Tinnitus	below serious				189
1686	52 pts		Nausea	below serious				189
1687	22 pts		Diarrhoea	below serious				189
1688	7 pts		Vomiting	below serious				189
1689	6 pts		Dyspepsia	below serious				189
1690	3 pts		Abdominal pain upper	below serious				189
1691	4 pts		Flatulence	below serious				189
1692	7 pts		Fatigue	below serious				189
1693	3 pts		Irritability	below serious				189
1694	3 pts		Urinary tract infection bacterial	below serious				189
1695	3 pts		Muscle strain	below serious				189
1696	3 pts		Heart rate increased	below serious				189
1697	6 pts		Back pain	below serious				189
1698	4 pts		Myalgia	below serious				189
1699	3 pts		Muscle spasms	below serious				189
1700	26 pts		Headache	below serious				189
1701	15 pts		Dizziness	below serious				189
1702	1 pts		Dysgeusia	below serious				189
1703	4 pts		Sedation	below serious				189
1704	2 pts		Rhinorrhoea	below serious				189
1705	2 pts		Hot flush	below serious				189
1706	51 pts		Nausea	below serious				195
1707	22 pts		Dry mouth	below serious				195
1708	12 pts		Diarrhoea	below serious				195
1709	14 pts		Constipation	below serious				195
1710	13 pts		Vomiting	below serious				195
1711	5 pts		Dyspepsia	below serious				195
1712	6 pts		Abdominal pain upper	below serious				195
1713	8 pts		Fatigue	below serious				195
1714	3 pts		Irritability	below serious				195
1715	1 pts		Urinary tract infection bacterial	below serious				195
1716	4 pts		Gastroenteritis viral	below serious				195
1717	2 pts		Muscle spasms	below serious				195
1718	20 pts		Dizziness	below serious				195
1719	6 pts		Somnolence	below serious				195
1720	1 pts		Dysgeusia	below serious				195
1721	5 pts		Sedation	below serious				195
1722	4 pts		Tension headache	below serious				195
1723	13 pts		Insomnia	below serious				195
1724	5 pts		Libido decreased	below serious				195
1725	4 pts		Hot flush	below serious				195
1726	1 pts		Kidney infection	serious				182
1727	1 pts		Suicide attempt	serious				182
1728	42 pts		Nausea	below serious				182
1729	20 pts		Diarrhoea	below serious				182
1730	12 pts		Constipation	below serious				182
1731	9 pts		Vomiting	below serious				182
1732	7 pts		Dyspepsia	below serious				182
1733	4 pts		Gastrooesophageal reflux disease	below serious				182
1734	2 pts		Abdominal distension	below serious				182
1735	10 pts		Viral upper respiratory tract infection	below serious				182
1736	4 pts		Nasopharyngitis	below serious				182
1737	5 pts		Gastroenteritis viral	below serious				182
1738	4 pts		Sinusitis	below serious				182
1739	4 pts		Fall	below serious				182
1740	1 pts		Road traffic accident	below serious				182
1741	3 pts		Back pain	below serious				182
1742	3 pts		Musculoskeletal pain	below serious				182
1743	24 pts		Headache	below serious				182
1744	13 pts		Dizziness	below serious				182
1745	7 pts		Somnolence	below serious				182
1746	1 pts		Dysgeusia	below serious				182
1747	4 pts		Abnormal dreams	below serious				182
1748	4 pts		Generalised pruritus	below serious				182
1749	2 pts		Pruritus	below serious				182
1750	2 pts		Hot flush	below serious				182
1751	44 pts		Nausea	below serious				196
1752	9 pts		Constipation	below serious				196
1753	8 pts		Vomiting	below serious				196
1754	1 pts		Gastrooesophageal reflux disease	below serious				196
1755	3 pts		Abdominal discomfort	below serious				196
1756	3 pts		Abdominal distension	below serious				196
1757	3 pts		Irritability	below serious				196
1758	7 pts		Nasopharyngitis	below serious				196
1759	1 pts		Sinusitis	below serious				196
1760	3 pts		Fall	below serious				196
1761	3 pts		Ligament sprain	below serious				196
1762	3 pts		Muscle strain	below serious				196
1763	3 pts		Road traffic accident	below serious				196
1764	4 pts		Increased appetite	below serious				196
1765	4 pts		Back pain	below serious				196
1766	3 pts		Musculoskeletal pain	below serious				196
1767	24 pts		Headache	below serious				196
1768	7 pts		Somnolence	below serious				196
1769	4 pts		Dysgeusia	below serious				196
1770	6 pts		Abnormal dreams	below serious				196
1771	5 pts		Generalised pruritus	below serious				196
1772	3 pts		Pruritus	below serious				196
1773	4 pts		Hypertension	below serious				196
1774	3 pts		Hot flush	below serious				196
1775	1 pts		Suicidal ideation	serious				183
1776	47 pts		Nausea	below serious				183
1777	24 pts		Dry mouth	below serious				183
1778	7 pts		Vomiting	below serious				183
1779	16 pts		Constipation	below serious				183
1780	10 pts		Flatulence	below serious				183
1781	2 pts		Arthralgia	below serious				183
1782	7 pts		Tension headache	below serious				183
1783	4 pts		Somnolence	below serious				183
1784	4 pts		Vision blurred	below serious				190
1785	51 pts		Nausea	below serious				190
1786	18 pts		Vomiting	below serious				190
1787	14 pts		Constipation	below serious				190
1788	15 pts		Diarrhoea	below serious				190
1789	5 pts		Flatulence	below serious				190
1790	6 pts		Arthralgia	below serious				190
1791	6 pts		Somnolence	below serious				190
1792	6 pts		Insomnia	below serious				190
1793	4 pts		Anxiety	below serious				190
1794	5 pts		Nausea	below serious				193
1795	4 pts		Vomiting	below serious				193
1796	1 pts		Chest discomfort	below serious				193
1797	1 pts		Tenderness	below serious				193
1798	6 pts		Post lumbar puncture syndrome	below serious				193
1799	6 pts		Back pain	below serious				193
1800	1 pts		Musculoskeletal stiffness	below serious				193
1801	4 pts		Headache	below serious				193
1802	1 pts		Dizziness	below serious				193
1803	1 pts		Paraesthesia	below serious				193
1804	1 pts		Tension headache	below serious				193
1805	1 pts		Hyperhidrosis	below serious				193
1806	1 pts		Brain contusion	serious				206
1807	1 pts		Road traffic accident	serious				206
1808	1 pts		Cerebral haematoma	serious				206
1809	1 pts		Haemorrhage subarachnoid	serious				206
1810	20 pts		Nausea	below serious				206
1811	24 pts		Nasopharyngitis	below serious				206
1812	10 pts		Headache	below serious				206
1813	3 pts		Vertigo	below serious				206
1814	1 pts		Tinnitus	below serious				206
1815	1 pts		Blepharospasm	below serious				206
1816	2 pts		Gastritis	below serious				206
1817	2 pts		Toothache	below serious				206
1818	1 pts		Stomatitis	below serious				206
1819	1 pts		Salivary hypersecretion	below serious				206
1820	1 pts		Oedema peripheral	below serious				206
1821	1 pts		Chest pain	below serious				206
1822	1 pts		Pyrexia	below serious				206
1823	2 pts		Hepatic function abnormal	below serious				206
1824	1 pts		Gingivitis	below serious				206
1825	1 pts		Otitis media	below serious				206
1826	1 pts		Otitis media chronic	below serious				206
1827	1 pts		Periodontitis	below serious				206
1828	1 pts		Road traffic accident	below serious				206
1829	1 pts		Arthropod sting	below serious				206
1830	1 pts		Brain contusion	below serious				206
1831	1 pts		Blood bilirubin increased	below serious				206
1832	1 pts		Blood uric acid increased	below serious				206
1833	1 pts		Blood urine present	below serious				206
1834	1 pts		Blood cholesterol increased	below serious				206
1835	1 pts		Low density lipoprotein increased	below serious				206
1836	2 pts		Decreased appetite	below serious				206
1837	1 pts		Hyperlipidaemia	below serious				206
1838	1 pts		Muscle tightness	below serious				206
1839	1 pts		Dizziness postural	below serious				206
1840	1 pts		Cerebral haematoma	below serious				206
1841	1 pts		Haemorrhage subarachnoid	below serious				206
1842	2 pts		Insomnia	below serious				206
1843	1 pts		Initial insomnia	below serious				206
1844	1 pts		Self injurious behaviour	below serious				206
1845	1 pts		Pollakiuria	below serious				206
1846	1 pts		Irregular menstruation	below serious				206
1847	1 pts		Menstruation irregular	below serious				206
1848	1 pts		Asthma	below serious				206
1849	4 pts		Rash	below serious				206
1850	1 pts		Dermatitis seborrhoeic	below serious				206
1851	1 pts		Urticaria	below serious				206
1852	1 pts		Hypertension	below serious				206
1853	1 pts		Suicidal behaviour	serious				184
1854	35 pts		Nausea	below serious				184
1855	13 pts		Diarrhoea	below serious				184
1856	12 pts		Somnolence	below serious				184
1857	8 pts		Suicidal ideation	below serious				184
1858	1 pts		Ventricular extrasystoles	below serious				184
1859	1 pts		Vertigo	below serious				184
1860	1 pts		Tinnitus	below serious				184
1861	1 pts		Motion sickness	below serious				184
1862	1 pts		Asthenopia	below serious				184
1863	1 pts		Ocular hypertension	below serious				184
1864	1 pts		Visual impairment	below serious				184
1865	5 pts		Constipation	below serious				184
1866	4 pts		Abdominal pain upper	below serious				184
1867	3 pts		Dyspepsia	below serious				184
1868	1 pts		Toothache	below serious				184
1869	2 pts		Abdominal distension	below serious				184
1870	1 pts		Stomatitis	below serious				184
1871	1 pts		Dental caries	below serious				184
1872	1 pts		Epigastric discomfort	below serious				184
1873	5 pts		Thirst	below serious				184
1874	3 pts		Fatigue	below serious				184
1875	1 pts		Oedema peripheral	below serious				184
1876	1 pts		Facial pain	below serious				184
1877	1 pts		Irritability	below serious				184
1878	1 pts		Non-cardiac chest pain	below serious				184
1879	2 pts		Oral herpes	below serious				184
1880	1 pts		Laryngitis	below serious				184
1881	1 pts		Pericoronitis	below serious				184
1882	1 pts		Varicella	below serious				184
1883	1 pts		Road traffic accident	below serious				184
1884	1 pts		Arthropod bite	below serious				184
1885	1 pts		Laceration	below serious				184
1886	1 pts		Procedural dizziness	below serious				184
1887	3 pts		Alanine aminotransferase increased	below serious				184
1888	2 pts		Liver function test abnormal	below serious				184
1889	2 pts		Blood bilirubin increased	below serious				184
1890	1 pts		Blood uric acid increased	below serious				184
1891	1 pts		Blood urine present	below serious				184
1892	1 pts		Glucose urine present	below serious				184
1893	1 pts		Platelet count decreased	below serious				184
1894	1 pts		Transaminases increased	below serious				184
1895	1 pts		Weight increased	below serious				184
1896	1 pts		White blood cell count decreased	below serious				184
1897	1 pts		White blood cell count increased	below serious				184
1898	1 pts		Dehydration	below serious				184
1899	3 pts		Back pain	below serious				184
1900	1 pts		Muscle fatigue	below serious				184
1901	1 pts		Neck pain	below serious				184
1902	5 pts		Dizziness	below serious				184
1903	1 pts		Dizziness postural	below serious				184
1904	2 pts		Dysgeusia	below serious				184
1905	1 pts		Amnesia	below serious				184
1906	1 pts		Hypoaesthesia	below serious				184
1907	1 pts		Paraesthesia	below serious				184
1908	1 pts		Tension headache	below serious				184
1909	2 pts		Nightmare	below serious				184
1910	1 pts		Agitation	below serious				184
1911	1 pts		Suicidal behaviour	below serious				184
1912	1 pts		Dysuria	below serious				184
1913	1 pts		Oropharyngeal pain	below serious				184
1914	1 pts		Rhinorrhoea	below serious				184
1915	1 pts		Rash	below serious				184
1916	1 pts		Dermatitis contact	below serious				184
1917	1 pts		Erythema	below serious				184
1918	1 pts		Heat rash	below serious				184
1919	1 pts		Papule	below serious				184
1920	3 pts		Hypertension	below serious				184
1921	32 pts		Nausea	below serious				185
1922	16 pts		Headache	below serious				185
1923	1 pts		Type 1 diabetes mellitus	serious				197
1924	1 pts		Hypertension	serious				197
1925	43 pts		Nausea	below serious				197
1926	26 pts		Headache	below serious				197
1927	1 pts		Abdominal pain upper	serious				186
1928	1 pts		Cholecystitis acute	serious				186
1929	1 pts		Appendicitis	serious				186
1930	1 pts		Hand fracture	serious				186
1931	1 pts		Type 2 diabetes mellitus	serious				186
1932	1 pts		Abortion missed	serious				186
1933	2 pts		Suicidal ideation	serious				186
1934	1 pts		Panic attack	serious				186
1935	56 pts		Nasopharyngitis	below serious				186
1936	292 pts		Nausea	below serious				186
1937	91 pts		Headache	below serious				186
1938	58 pts		Dry mouth	below serious				186
1939	1 pts		Vertigo	serious				207
1940	1 pts		Ankle fracture	serious				207
1941	1 pts		Intraductal proliferative breast lesion	serious				207
1942	9 pts		Upper respiratory tract infection	below serious				207
1943	7 pts		Nasopharyngitis	below serious				207
1944	4 pts		Nausea	below serious				207
1945	5 pts		Weight increased	below serious				207
1946	8 pts		Back pain	below serious				207
1947	1 pts		Post procedural cellulitis	serious				187
1948	1 pts		Pyelonephritis	serious				187
1949	1 pts		Completed suicide	serious				187
1950	1 pts		Nephrolithiasis	serious				187
1951	9 pts		Upper respiratory tract infection	below serious				187
1952	7 pts		Nasopharyngitis	below serious				187
1953	5 pts		Nausea	below serious				187
1954	7 pts		Weight increased	below serious				187
1955	9 pts		Upper respiratory tract infection	below serious				198
1956	8 pts		Nasopharyngitis	below serious				198
1957	13 pts		Nausea	below serious				198
1958	8 pts		Weight increased	below serious				198
1959	1 pts		Altered state of consciousness	serious				188
1960	21 pts		Nausea	below serious				188
1961	9 pts		Vomiting	below serious				188
1962	7 pts		Somnolence	below serious				188
1963	1 pts		Anaesthetic complication	serious				199
1964	1 pts		Haemorrhage subarachnoid	serious				199
1965	1 pts		Cerebral haemorrhage	serious				199
1966	25 pts		Nausea	below serious				199
1967	6 pts		Vomiting	below serious				199
1968	11 pts		Somnolence	below serious				199
1969	2 pts		Itching	below serious				200
1970	10 pts		Nausea	below serious				200
1971	4 pts		Dizziness	below serious				200
1972	4 pts		Dry mouth	below serious				200
1973	3 pts		Insomnia	below serious				200
1974	3 pts		Vomiting	below serious				200
1975	3 pts		Bloating	below serious				200
1976	1 pts		Anxiety	below serious				200
1977	1 pts		Sensitivity of teeth	below serious				200
1978	1 pts		Loss of libido	below serious				200
1979	2 pts		Stomach pain	below serious				200
1980	1 pts		Heart rate increased	below serious				200
1981	1 pts		Swallowing difficult	below serious				200
1982	1 pts		Restlessness	below serious				200
1983	1 pts		Depressed mood	below serious				200
1984	1 pts		Somnolence	below serious				200
1985	1 pts		Shortness of breath	below serious				200
1986	26 pts		Nausea	below serious				179
1987	4 pts		Decreased appetite	below serious				179
1988	7 pts		Somnolence	below serious				179
1989	14 pts		Libido decreased	below serious				179
1990	7 pts		Orgasm abnormal	below serious				179
1991	1 pts		Insomnia	below serious				179
1992	2 pts		Ejaculation delayed	below serious				179
1993	18 pts		Nausea	below serious				194
1994	3 pts		Fatigue	below serious				194
1995	7 pts		Somnolence	below serious				194
1996	3 pts		Orgasm abnormal	below serious				194
1997	1 pts		Insomnia	below serious				194
1998	3 pts		Ejaculation delayed	below serious				194
1999						No AEs are reported		210
2000						No AEs are reported		209
2001						No AEs are reported		212
2002			Suicide attempt			No AEs are reported		211
2003			Nausea		discontinuation	leads to discontinuation		176
2004			Suicidal ideation			WARNING		176
2005			Suicidal behavior			WARNING		176
2006			Reaction skin		discontinuation	leads to discontinuation		177
2007			Vomiting		discontinuation	leads to discontinuation		177
2008	20		Nausea					214
2009	7		Headache					214
2010	5		Abdominal pain					214
2011	2		Diarrhea					214
2012	2		Dizziness					214
2013	2		Oropharyngeal pain					214
2014	2		Vomiting					214
2015	2		Viral infection					214
2016						No AEs are reported		213
2017	4 pts		Anaemia	serious				216
2018	1 pts		Atrial flutter	serious				216
2019	1 pts		Cardio-respiratory arrest	serious				216
2020	1 pts		Deafness neurosensory	serious				216
2021	1 pts		Retinal tear	serious				216
2022	2 pts		Diarrhoea	serious				216
2023	1 pts		Duodenal ulcer haemorrhage	serious				216
2024	1 pts		Dyspepsia	serious				216
2025	2 pts		Dysphagia	serious				216
2026	1 pts		Gastric perforation	serious				216
2027	1 pts		Gastrointestinal haemorrhage	serious				216
2028	1 pts		Glossitis	serious				216
2029	1 pts		Intestinal haemorrhage	serious				216
2030	1 pts		Melaena	serious				216
2031	1 pts		Nausea	serious				216
2032	1 pts		Pancreatitis	serious				216
2033	1 pts		Pancreatitis relapsing	serious				216
2034	1 pts		Stomatitis	serious				216
2035	1 pts		Vomiting	serious				216
2036	1 pts		Disease recurrence	serious				216
2037	1 pts		Malaise	serious				216
2038	1 pts		Mucosal inflammation	serious				216
2039	1 pts		Non-cardiac chest pain	serious				216
2040	1 pts		Pyrexia	serious				216
2041	1 pts		Sudden death	serious				216
2042	1 pts		Bile duct stone	serious				216
2043	1 pts		Cholecystitis	serious				216
2044	1 pts		Cholelithiasis	serious				216
2045	1 pts		Hepatic failure	serious				216
2046	1 pts		Hypersensitivity	serious				216
2047	1 pts		Carbuncle	serious				216
2048	2 pts		Cellulitis	serious				216
2049	1 pts		Cellulitis of male external genital organ	serious				216
2050	1 pts		Erysipelas	serious				216
2051	1 pts		Groin infection	serious				216
2052	1 pts		Infection	serious				216
2053	1 pts		Oropharyngeal candidiasis	serious				216
2054	1 pts		Upper respiratory tract infection	serious				216
2055	1 pts		Urethritis	serious				216
2056	1 pts		Accidental overdose	serious				216
2057	2 pts		Osteoradionecrosis	serious				216
2058	1 pts		Post procedural haemorrhage	serious				216
2059	1 pts		Radiation fibrosis	serious				216
2060	1 pts		Radiation necrosis	serious				216
2061	1 pts		Aspartate aminotransferase increased	serious				216
2062	1 pts		Blood bilirubin increased	serious				216
2063	1 pts		Electrocardiogram QT prolonged	serious				216
2064	1 pts		Gamma-glutamyltransferase increased	serious				216
2065	3 pts		Decreased appetite	serious				216
2066	1 pts		Hypokalaemia	serious				216
2067	2 pts		Hyponatraemia	serious				216
2068	1 pts		Groin pain	serious				216
2069	1 pts		Neck pain	serious				216
2070	2 pts		Scleroderma	serious				216
2071	3 pts		Basal cell carcinoma	serious				216
2072	2 pts		Metastases to lung	serious				216
2073	2 pts		Oropharyngeal squamous cell carcinoma	serious				216
2074	1 pts		Recurrent cancer	serious				216
2075	1 pts		Squamous cell carcinoma of skin	serious				216
2076	1 pts		Carotid artery thrombosis	serious				216
2077	2 pts		Cerebrovascular accident	serious				216
2078	1 pts		Migraine	serious				216
2079	1 pts		Partial seizures with secondary generalisation	serious				216
2080	1 pts		Spinal cord compression	serious				216
2081	1 pts		Wernicke's encephalopathy	serious				216
2082	1 pts		Device occlusion	serious				216
2083	2 pts		Acute kidney injury	serious				216
2084	1 pts		Renal failure	serious				216
2085	1 pts		Renal impairment	serious				216
2086	1 pts		Balanoposthitis	serious				216
2087	1 pts		Aspiration	serious				216
2088	3 pts		Interstitial lung disease	serious				216
2089	1 pts		Laryngeal stenosis	serious				216
2090	1 pts		Pneumonitis	serious				216
2091	2 pts		Pneumothorax	serious				216
2092	1 pts		Pulmonary hypertension	serious				216
2093	1 pts		Respiratory arrest	serious				216
2094	1 pts		Respiratory failure	serious				216
2095	1 pts		Respiratory tract oedema	serious				216
2096	1 pts		Dermatitis exfoliative	serious				216
2097	1 pts		Deep vein thrombosis	serious				216
2098	23 pts		Anaemia	below serious				216
2099	21 pts		Abdominal pain	below serious				216
2100	22 pts		Cheilitis	below serious				216
2101	335 pts		Diarrhoea	below serious				216
2102	55 pts		Dry mouth	below serious				216
2103	42 pts		Dyspepsia	below serious				216
2104	48 pts		Dysphagia	below serious				216
2105	23 pts		Gastrooesophageal reflux disease	below serious				216
2106	23 pts		Oral pain	below serious				216
2107	107 pts		Stomatitis	below serious				216
2108	40 pts		Vomiting	below serious				216
2109	61 pts		Fatigue	below serious				216
2110	126 pts		Mucosal inflammation	below serious				216
2111	29 pts		Pyrexia	below serious				216
2112	21 pts		Conjunctivitis	below serious				216
2113	85 pts		Paronychia	below serious				216
2114	67 pts		Weight decreased	below serious				216
2115	74 pts		Decreased appetite	below serious				216
2116	26 pts		Muscle spasms	below serious				216
2117	34 pts		Dysgeusia	below serious				216
2118	54 pts		Epistaxis	below serious				216
2119	22 pts		Acne	below serious				216
2120	112 pts		Dermatitis acneiform	below serious				216
2121	76 pts		Dry skin	below serious				216
2122	28 pts		Erythema	below serious				216
2123	30 pts		Palmar-plantar erythrodysaesthesia syndrome	below serious				216
2124	58 pts		Pruritus	below serious				216
2125	188 pts		Rash	below serious				216
2126	40 pts		Skin fissures	below serious				216
2127	1 pts		Diarrhoea	serious				217
2128	1 pts		Dysphagia	serious				217
2129	1 pts		Oesophagitis	serious				217
2130	1 pts		Gastroenteritis	serious				217
2131	1 pts		Pneumonia	serious				217
2132	1 pts		Osteoarthritis	serious				217
2133	1 pts		Laryngeal oedema	serious				217
2134	2 pts		Cheilitis	below serious				217
2135	2 pts		Constipation	below serious				217
2136	17 pts		Diarrhoea	below serious				217
2137	4 pts		Stomatitis	below serious				217
2138	2 pts		Fatigue	below serious				217
2139	3 pts		Mucosal inflammation	below serious				217
2140	3 pts		Paronychia	below serious				217
2141	2 pts		Upper respiratory tract infection	below serious				217
2142	2 pts		Neutrophil count	below serious				217
2143	2 pts		Reticulocyte count increased	below serious				217
2144	7 pts		Weight decreased	below serious				217
2145	4 pts		Decreased appetite	below serious				217
2146	2 pts		Neck pain	below serious				217
2147	2 pts		Rhinorrhoea	below serious				217
2148	2 pts		Acne	below serious				217
2149	2 pts		Dermatitis	below serious				217
2150	3 pts		Dry skin	below serious				217
2151	14 pts		Rash	below serious				217
2152	50		Skin rash	grade 3			TRUE	218
2153	50		Diarrhoea	grade 3			TRUE	218
2154	5.6		Fatigue	grade 3			TRUE	219
2155	5.6		ALT increased	grade 3			TRUE	219
2156	11.1		Diarrhoea	grade 3			TRUE	226
2157	16.7		Diarrhoea	grade 3			TRUE	227
2158	16.7		Diarrhoea	grade 2			TRUE	227
2159			Nausea			OVERDOSAGE		215
2160			Vomiting			OVERDOSAGE		215
2161			Asthenia			OVERDOSAGE		215
2162			Dizziness			OVERDOSAGE		215
2163			Headache			OVERDOSAGE		215
2164			Abdominal pain			OVERDOSAGE		215
2165			Amylase increased			OVERDOSAGE		215
2166	16		Rash	grade 3				220
2167	11		Paronychia	grade 3				220
2168	1		Cystitis	grade 3				220
2169	4		Decreased appetite	grade 3				220
2170	15		Diarrhea	grade 3				222
2171	8		Stomatitis	grade 3				222
2172	1.3		Diarrhea		discontinuation			221
2173	0.9		Paronychia		discontinuation			221
2174	1		Interstitial lung disease		discontinuation			221
2175	1		Weight decreased	grade 3				223
2176	1		Nausea	grade 3				223
2177	4		Vomiting	grade 3				223
2178	3		Dermatitis acneiform	grade 3				223
2179	2		Hypokalaemia	grade 3				223
2180	2		ALT increased	grade 3				223
2181	2		AST increased	grade 3				223
2182	<1		Stomatitis	grade 4				223
2183	2		Hypokalaemia	grade 4				223
2184	84.6		Diarrhoea					224
2185	72.3		Rash					224
2186	13.6		Dermatitis acneiform					224
2187	58.2		Stomatitis					224
2188	38.5		Nail disorder					224
2189	20.8		Decreased appetite					224
2190	18.7		Nausea					224
2191	17.7		Pruritus					224
2192	14.6		Epistaxis					224
2193	14.4		Dry skin					224
2194	14.4		Fatigue					224
2195	13.3		Vomiting					224
2196	9.2		Eye disorders NEC					224
2197	7.7		Palmar-plantar erythrodysaesthesia syndrome					224
2198	38.7		Diarrhoea	grade 3				224
2199	13.3		Rash	grade 3				224
2200	1.3		Dermatitis acneiform	grade 3				224
2201	2.8		Stomatitis	grade 3				224
2202	4.9		Nail disorder	grade 3				224
2203	2.8		Decreased appetite	grade 3				224
2204	1.3		Nausea	grade 3				224
2205	0.3		Pruritus	grade 3				224
2206	0.3		Dry skin	grade 3				224
2207	3.1		Fatigue	grade 3				224
2208	1.5		Vomiting	grade 3				224
2209	0.5		Eye disorders NEC	grade 3				224
2210	1.3		Palmar-plantar erythrodysaesthesia syndrome	grade 3				224
2211	1		Diarrhoea	grade 4				224
2212	3.8		ALT increased					225
2213	2.8		AST increased					225
2214	0.8		Alkaline phosphatase increased					225
2215	0.3		Bilirubin increased					225
2216	0.3		GGT increased					225
2217	1		Hyperbilirubinaemia					225
2218	1.5		Hypoalbuminaemia					225
2219	0.3		Acute hepatic failure					225
2220	0.3		Anorectal varices					225
2221	0.3		Cytolytic hepatitis					225
2222	0.3		Hepatic pain					225
2223	0.3		Hepatitis acute					225
2224	7.1		Skin rash	grade 3				233
2225	0.5		Skin rash	grade 4				233
2226	4		Fatigue	grade 3				233
2227	1		Peripheral edema	grade 3				233
2228	1		Acneiform dermatitis	grade 3				233
2229	1		Nausea	grade 3				233
2230	<1		Alopecia	grade 3				233
2231	12		Hypertension	grade 3				233
2232	1		Vomiting	grade 3				233
2233			Rash	grade 3			TRUE	237
2234			Central serous retinopathy	grade 2			TRUE	228
2235			Diarrhoea	grade 3			TRUE	228
2236			Rash	grade 3			TRUE	228
2237			Central serous retinopathy	grade 2			TRUE	230
2238	49		Acneiform dermatitis	grade 1				234
2239	34		Diarrhoea	grade 1				234
2240	19		Fatigue	grade 1				234
2241	26		Peripheral oedema	grade 1				234
2242	20		Nausea	grade 1				234
2243	7		Vomiting	grade 1				234
2244	14		Pruritus	grade 1				234
2245	16		Fissures of skin	grade 1				234
2246	9		Decreased appetite	grade 1				234
2247	9		Eye disorders NEC	grade 1				234
2248	4		Mucosal inflammation	grade 1				234
2249	3		Constipation	grade 1				234
2250	3		Left ventricular ejection fraction decreased	grade 1				234
2251	7		Periorbital oedema	grade 1				234
2252	1		Thrombocytopenia	grade 1				234
2253	3		Dry mouth	grade 1				234
2254	31		Acneiform dermatitis	grade 2				234
2255	10		Diarrhoea	grade 2				234
2256	10		Fatigue	grade 2				234
2257	3		Peripheral oedema	grade 2				234
2258	6		Nausea	grade 2				234
2259	4		Vomiting	grade 2				234
2260	6		Pruritus	grade 2				234
2261	6		Fissures of skin	grade 2				234
2262	1		Decreased appetite	grade 2				234
2263	1		Constipation	grade 2				234
2264	6		Left ventricular ejection fraction decreased	grade 2				234
2265	4		Acneiform dermatitis	grade 3				234
2266	1		Diarrhoea	grade 3				234
2267	1		Fatigue	grade 3				234
2268	1		Vomiting	grade 3				234
2269	1		Eye disorders NEC	grade 3				234
2270	1		Left ventricular ejection fraction decreased	grade 3				234
2271	7		Cardiomyopathy			serious adverse reactions		235
2272	0.5		Detachment of retinal pigment epithelium			serious adverse reactions		236
2273	0.6		Retinal vein occlusion			serious adverse reactions		236
2274	2.4		Interstitial lung disease			serious adverse reactions		236
2275	6		Skin rash			serious adverse reactions		236
2276						OVERDOSAGE		231
2277	28		Detachment of retinal pigment epithelium			OVERDOSAGE		229
2278	0.9		Left ventricular dysfunction		discontinuation			238
2279	0.5		Cardiac failure		discontinuation			238
2280	0.5		Myocardial infarction		discontinuation			238
2281	0.5		Tachycardia		discontinuation			238
2282	0.5		ALT increased		discontinuation			238
2283	0.5		Bilirubin increased		discontinuation			238
2284	0.5		GGT increased		discontinuation			238
2285	0.5		CPK increased		discontinuation			238
2286	0.9		Pneumonitis		discontinuation			238
2287	0.9		Renal failure		discontinuation			238
2288	0.9		Rash		discontinuation			238
2289	0.5		Erythema nodosum		discontinuation			238
2290	0.5		Chorioretinopathy		discontinuation			238
2291	0.5		Retinal detachment		discontinuation			238
2292	0.5		Hepatic failure		discontinuation			238
2293	0.5		Hepatitis		discontinuation			238
2294	0.5		Hepatobiliary disease		discontinuation			238
2295	0.5		Duodenal perforation		discontinuation			238
2296	0.5		Esophagitis		discontinuation			238
2297	0.5		Vomiting		discontinuation			238
2298	0.5		Diarrhea		discontinuation			238
2299	0.5		Abdominal pain upper		discontinuation			238
2300	0.5		Face edema		discontinuation			238
2301	0.5		Edema peripheral		discontinuation			238
2302	0.5		Fatigue		discontinuation			238
2303	0.5		Pyrexia		discontinuation			238
2304	0.5		Decreased appetite		discontinuation			238
2305	0.5		Hyponatremia		discontinuation			238
2306	0.5		Cell death		discontinuation			238
2307	0.5		Hypersensitivity		discontinuation			238
2308	0.5		Corneal graft rejection		discontinuation			238
2309	0.5		Anemia		discontinuation			238
2310	13		Hypertension	grade 3				239
2311	8		Rash	grade 3				239
2312	4		Fatigue	grade 3				239
2313	2		Anemia	grade 3				239
2314	1		Dehydration	grade 3				239
2315	2		ALT increased	grade 3				239
2316	1		Dyspnea	grade 3				239
2317	1		Hypoalbuminemia	grade 3				239
2318	2		Pruritus	grade 3				239
2319	1		Vomiting	grade 3				239
2320	1		CPK increased	grade 3				239
2321	1		Cellulitis	grade 3				239
2322	1		Infection	grade 3				239
2323	0.5		Rash	grade 4				239
2324	0.5		Dehydration	grade 4				239
2325	0.5		Dyspnea	grade 4				239
2326	4		Rash		dose interruption			239
2327	2		Diarrhea		dose interruption			239
2328	2		Peripheral edema		dose interruption			239
2329	1		Transaminases increased		dose interruption			239
2330	1		Cardiac disorder		dose interruption			239
2331	1		Cellulitis		dose interruption			239
2332	1		Nausea		dose interruption			239
2333	1		Pyrexia		dose interruption			239
2334	9		Rash		dose reduction			239
2335	0.9		Acne		dose reduction			239
2336	0.9		Dermatitis acneiform		dose reduction			239
2337	0.9		Pruritus		dose reduction			239
2338	0.5		Erythema		dose reduction			239
2339	0.5		Rash maculo-papular		dose reduction			239
2340	0.5		Rash papular		dose reduction			239
2341	0.5		Skin ulcer		dose reduction			239
2342	0.5		Toxic skin eruption		dose reduction			239
2343	3		ALT increased		dose reduction			239
2344	0.9		AST increased		dose reduction			239
2345	0.9		CPK increased		dose reduction			239
2346	0.5		Alkaline phosphatase increased		dose reduction			239
2347	0.5		Electrocardiogram abnormal		dose reduction			239
2348	0.5		Decreased hemoglobin		dose reduction			239
2349	0.9		Stomatitis		dose reduction			239
2350	0.5		Abdominal pain		dose reduction			239
2351	0.5		Anal ulcer		dose reduction			239
2352	0.5		Diarrhea		dose reduction			239
2353	0.5		Lip ulceration		dose reduction			239
2354	0.5		Oral pain		dose reduction			239
2355	0.9		Rash pustular		dose reduction			239
2356	0.5		Folliculitis		dose reduction			239
2357	0.5		Klebsiella infection		dose reduction			239
2358	0.5		Nail infection		dose reduction			239
2359	0.5		Pulpitis dental		dose reduction			239
2360	0.9		Fatigue		dose reduction			239
2361	0.9		Mucosal inflammation		dose reduction			239
2362	0.5		Pyrexia		dose reduction			239
2363	0.9		Rhabdomyolysis		dose reduction			239
2364	0.5		Neck pain		dose reduction			239
2365	0.5		Exertional dyspnea		dose reduction			239
2366	0.5		Interstitial lung disease		dose reduction			239
2367	0.5		Nasal ulcer		dose reduction			239
2368	0.5		Conduction disorder		dose reduction			239
2369	0.5		Left ventricular dysfunction		dose reduction			239
2370	0.9		Hypertension		dose reduction			239
2371	0.5		Central serous retinopathy		dose reduction			239
2372	0.5		Hypertriglyceridemia		dose reduction			239
2373	7		Rash	grade 3	dose reduction			239
2374	0.5		Acne	grade 3	dose reduction			239
2375	0.9		Pruritus	grade 3	dose reduction			239
2376	0.5		Rash papular	grade 3	dose reduction			239
2377	0.9		ALT increased	grade 3	dose reduction			239
2378	0.5		CPK increased	grade 3	dose reduction			239
2379	0.5		Decreased hemoglobin	grade 3	dose reduction			239
2380	0.5		Stomatitis	grade 3	dose reduction			239
2381	0.5		Abdominal pain	grade 3	dose reduction			239
2382	0.5		Lip ulceration	grade 3	dose reduction			239
2383	0.5		Oral pain	grade 3	dose reduction			239
2384	0.5		Rash pustular	grade 3	dose reduction			239
2385	0.5		Folliculitis	grade 3	dose reduction			239
2386	0.5		Klebsiella infection	grade 3	dose reduction			239
2387	0.9		Fatigue	grade 3	dose reduction			239
2388	0.9		Mucosal inflammation	grade 3	dose reduction			239
2389	0.9		Rhabdomyolysis	grade 3	dose reduction			239
2390	0.5		Exertional dyspnea	grade 3	dose reduction			239
2391	0.5		Interstitial lung disease	grade 3	dose reduction			239
2392	0.5		Conduction disorder	grade 3	dose reduction			239
2393	0.9		Hypertension	grade 3	dose reduction			239
2394	0.5		Hypertriglyceridemia	grade 3	dose reduction			239
2395	8.3		Fatigue		discontinuation			232
2396	25		Squamous cell carcinoma of skin	grade 3				240
2397	5		Pyrexia	grade 2				240
2398	4		Squamous cell carcinoma of skin	grade 3-4	discontinuation	WARNING		242
2399	4		Keratoacanthoma	grade 3-4	discontinuation	WARNING		242
2400	37		Hyperkeratosis	all grades				242
2401	1		Hyperkeratosis	grade 3-4				242
2402	22		Alopecia	all grades				242
2403	20		Palmar-plantar erythrodysesthesia syndrome	all grades				242
2404	2		Palmar-plantar erythrodysesthesia syndrome	grade 3-4				242
2405	17		Rash	all grades				242
2406	32		Headache	all grades	discontinuation	leads to dose reduction		242
2407	27		Arthralgia	all grades	discontinuation	leads to dose reduction		242
2408	1		Arthralgia	grade 3-4	discontinuation	leads to dose reduction		242
2409	27		Papilloma	all grades				242
2410	12		Cough	all grades				242
2411	10		Nasopharyngitis	all grades				242
2412	3		Chills		discontinuation	leads to dose reduction		242
2413	3		Palmar-plantar erythrodysesthesia syndrome		discontinuation	leads to dose reduction		242
2414	50		Hyperglycemia	all grades				242
2415	6		Hyperglycemia	grade 3-4				242
2416	37		Hypophosphatemia		discontinuation	leads to dose interruptions		242
2417	6		Hypophosphatemia		discontinuation	leads to dose interruptions		242
2418	19		Alkaline phosphatase increased					242
2419	8		Hyponatremia					242
2420	2		Hyponatremia					242
2421	<10		Pancreatitis		discontinuation	leads to dose interruptions		242
2422	<10		Bullous rash					242
2423	<10		Nephritis interstitial					242
2424	28		Pyrexia	all grades	discontinuation	leads to dose reduction/interruptions		243
2425	3		Pyrexia	grade 3-4	discontinuation	leads to dose reduction/interruptions		243
2426	12		Back pain	all grades	discontinuation	leads to dose interruption/Delay		245
2427	3		Back pain	grade 3-4	discontinuation	leads to dose interruption/Delay		245
2428	11		Myalgia	all grades	discontinuation	leads to dose reduction/interruptions		245
2429	11		Constipation	all grades	discontinuation	leads to dose reduction/interruptions		244
2430	2		Constipation	grade 3-4	discontinuation	leads to dose reduction/interruptions		244
2431	2		Fatigue		discontinuation	leads to dose reduction/interruptions		243
2432	1 pts		Constipation	serious	discontinuation	leads to discontinuation		246
2433	1 pts		Hepatic pain	serious	discontinuation	leads to discontinuation		246
2434	1 pts		Myocardial infarction	serious	discontinuation	leads to discontinuation		246
2435	2 pts		Tricuspid valve disease		discontinuation	leads to discontinuation		246
2436	2 pts		Muscular weakness	serious	discontinuation	leads to discontinuation		246
2437	2 pts		Pancytopenia		discontinuation	leads to discontinuation		251
2438	1 pts		Lymphocytopenia		discontinuation	leads to discontinuation		251
2439	1 pts		Infarct myocardial	grade 5	discontinuation	leads to discontinuation		251
2440	1 pts		Acute coronary syndrome	grade 5	discontinuation	leads to discontinuation		251
2441	1 pts		Heart attack		discontinuation	leads to discontinuation		251
2442	1 pts		Abdominal pain	severe	discontinuation	leads to discontinuation		251
2443	1 pts		Glissonitis		discontinuation	leads to discontinuation		251
2444	1 pts		Creatinine increased		discontinuation	leads to discontinuation		251
2445	1 pts		Epileptic seizure		discontinuation	leads to discontinuation		251
2446	1 pts		Cerebral hemorrhage	grade 5	discontinuation	leads to discontinuation		251
2447	1 pts		Hyponatremia		discontinuation	leads to discontinuation		251
2448	1		Pain		discontinuation	leads to dose reduction		247
2449	1		Hyperkeratosis		discontinuation	leads to dose reduction		247
2450	1		Hyperhidrosis		discontinuation	leads to dose reduction		248
2451	1		Migraine		discontinuation	leads to dose reduction		248
2452	1		Syncope		discontinuation	leads to dose reduction		248
2453	1		Vomiting		discontinuation	leads to dose reduction/interruptions		248
2454	1		Diarrhea		discontinuation	leads to dose reduction/interruptions		248
2455	1		Nausea		discontinuation	leads to dose reduction/interruptions		248
2456	1		Atrial fibrillation		discontinuation	leads to dose reduction		248
2457	1		Alanine aminotransferase increased		discontinuation	leads to dose reduction/interruptions		248
2458	1		Aspartate aminotransferase increased		discontinuation	leads to dose reduction		248
2459	1		Diabetes mellitus		discontinuation	leads to dose reduction		248
2460	1		Diabetes mellitus inadequate control		discontinuation	leads to dose reduction		248
2461	1		Pulmonary edema		discontinuation	leads to dose reduction		248
2462	1		Respiratory distress		discontinuation	leads to dose reduction		248
2463	1		Pleural effusion		discontinuation	leads to dose interruption/Delay		248
2464	1		Alkaline phosphatase increased		discontinuation	leads to dose interruption/Delay		248
2465	1		Ejection fraction decreased		discontinuation	leads to dose interruption/Delay		248
2466	1		Gamma-glutamyltransferase increased		discontinuation	leads to dose interruption/Delay		248
2467	1		Oropharyngeal pain		discontinuation	leads to dose interruption/Delay		249
2468	1		Malaise		discontinuation	leads to dose interruption/Delay		249
2469	1		Small intestinal perforation		discontinuation	leads to dose interruption/Delay		249
2470	1		Neutropenia		discontinuation	leads to dose interruption/Delay		249
2471	1		Thrombocytopenia		discontinuation	leads to dose interruption/Delay		249
2472	1		Cataract		discontinuation	leads to dose interruption/Delay		249
2473	1		Gastrointestinal infection		discontinuation	leads to dose interruption/Delay		249
2474	1		Back pain		discontinuation	leads to dose interruption/Delay		250
2475	1		Muscle spasms		discontinuation	leads to dose interruption/Delay		250
2476	1		Musculoskeletal stiffness		discontinuation	leads to dose interruption/Delay		250
2477	1		Pemphigoid		discontinuation	leads to dose interruption/Delay		250
2478	1		Hyperkeratosis		discontinuation	leads to dose interruption/Delay		250
2479	1		Urinary bladder polyp		discontinuation	leads to dose interruption/Delay		250
2480	1		Urinary retention		discontinuation	leads to dose interruption/Delay		250
2481	1 pts		Squamous cell carcinoma of skin	grade 3			TRUE	252
2482	1 pts		Syncope	grade 3			TRUE	252
2483	1 pts		Pyrexia	grade 2			TRUE	252
2484	1 pts		Hyponatraemia	grade 4			TRUE	241
2485	1 pts		Squamous cell carcinoma of skin	grade 3			TRUE	241
2486						No AEs are reported		255
2487	1 pts		Nasopharyngitis					253
2488	1 pts		Constipation					253
2489	1 pts		Hot flush					253
2490	1 pts		Muscle twitching					253
2491	1 pts		Application site rash					254
2492	3 pts		Pollakiuria	below serious				267
2493	1 pts		Anaemia vitamin B12 deficiency	serious				268
2494	1 pts		Disseminated intravascular coagulation	serious				268
2495	1 pts		Anaemia hypochromic	serious				268
2496	2 pts		Anaemia iron deficiency	serious				268
2497	1 pts		Lymphadenopathy	serious				268
2498	1 pts		Pancytopenia	serious				268
2499	12 pts		Acute coronary syndrome	serious				268
2500	21 pts		Angina pectoris	serious				268
2501	2 pts		Arrhythmia	serious				268
2502	4 pts		Arteriosclerosis coronary artery	serious				268
2503	1 pts		Atrioventricular block first degree	serious				268
2504	1 pts		Cardiac tamponade	serious				268
2505	4 pts		Cardio-respiratory arrest	serious				268
2506	1 pts		Cor pulmonale	serious				268
2507	3 pts		Coronary artery occlusion	serious				268
2508	2 pts		Hypertensive heart disease	serious				268
2509	1 pts		Myocarditis	serious				268
2510	1 pts		Right ventricular failure	serious				268
2511	2 pts		Ventricular extrasystoles	serious				268
2512	1 pts		Vertigo positional	serious				268
2513	2 pts		Goitre	serious				268
2514	1 pts		Hypothyroidism	serious				268
2515	1 pts		Inappropriate antidiuretic hormone secretion	serious				268
2516	2 pts		Thyroid mass	serious				268
2517	7 pts		Diabetic retinopathy	serious				268
2518	2 pts		Maculopathy	serious				268
2519	1 pts		Ischaemic optic neuropathy	serious				268
2520	3 pts		Retinal detachment	serious				268
2521	1 pts		Uveitis	serious				268
2522	1 pts		Vitreous adhesions	serious				268
2523	4 pts		Vitreous haemorrhage	serious				268
2524	1 pts		Abdominal fat apron	serious				268
2525	1 pts		Abdominal incarcerated hernia	serious				268
2526	1 pts		Abdominal pain lower	serious				268
2527	1 pts		Anal haemorrhage	serious				268
2528	1 pts		Colitis	serious				268
2529	3 pts		Diarrhoea	serious				268
2530	1 pts		Diverticulum	serious				268
2531	1 pts		Diverticulum intestinal haemorrhagic	serious				268
2532	2 pts		Duodenal ulcer	serious				268
2533	2 pts		Duodenitis	serious				268
2534	1 pts		Faeces discoloured	serious				268
2535	1 pts		Food poisoning	serious				268
2536	2 pts		Gastric ulcer	serious				268
2537	3 pts		Gastritis	serious				268
2538	4 pts		Hernia inguinal	serious				268
2539	7 pts		Intestinal obstruction	serious				268
2540	1 pts		Intestinal perforation	serious				268
2541	1 pts		Leukoplakia oral	serious				268
2542	1 pts		Lower gastrointestinal haemorrhage	serious				268
2543	1 pts		Melaena	serious				268
2544	1 pts		Obstructive pancreatitis	serious				268
2545	4 pts		Pancreatitis	serious				268
2546	1 pts		Rectal polyp	serious				268
2547	1 pts		Small intestinal haemorrhage	serious				268
2548	1 pts		Umbilical hernia	serious				268
2549	4 pts		Upper gastrointestinal haemorrhage	serious				268
2550	3 pts		Cardiac death	serious				268
2551	1 pts		Complication associated with device	serious				268
2552	1 pts		Critical illness	serious				268
2553	7 pts		Death	serious				268
2554	1 pts		Gait disturbance	serious				268
2555	1 pts		General physical health deterioration	serious				268
2556	1 pts		Hernia incarcerated	serious				268
2557	8 pts		Non-cardiac chest pain	serious				268
2558	2 pts		Pyrexia	serious				268
2559	1 pts		Systemic inflammatory response syndrome	serious				268
2560	1 pts		Cholangitis acute	serious				268
2561	1 pts		Cholangitis sclerosing	serious				268
2562	5 pts		Cholecystitis acute	serious				268
2563	3 pts		Cholecystitis chronic	serious				268
2564	5 pts		Cholelithiasis	serious				268
2565	1 pts		Hepatic function abnormal	serious				268
2566	1 pts		Abdominal sepsis	serious				268
2567	3 pts		Abscess limb	serious				268
2568	1 pts		Acute hepatitis B	serious				268
2569	2 pts		Arthritis bacterial	serious				268
2570	1 pts		Atypical pneumonia	serious				268
2571	1 pts		Campylobacter colitis	serious				268
2572	2 pts		Clostridium difficile colitis	serious				268
2573	1 pts		Clostridium difficile infection	serious				268
2574	2 pts		Cystitis	serious				268
2575	1 pts		Device related infection	serious				268
2576	5 pts		Diabetic gangrene	serious				268
2577	4 pts		Diverticulitis	serious				268
2578	1 pts		Ear infection	serious				268
2579	1 pts		Empyema	serious				268
2580	1 pts		Enterobacter infection	serious				268
2581	1 pts		Gas gangrene	serious				268
2582	1 pts		Gastroenteritis bacterial	serious				268
2583	1 pts		Graft infection	serious				268
2584	1 pts		Haemophilus infection	serious				268
2585	3 pts		Influenza	serious				268
2586	1 pts		Laryngitis	serious				268
2587	2 pts		Fasciitis necrotising	serious				268
2588	1 pts		Onychomycosis	serious				268
2589	2 pts		Osteomyelitis acute	serious				268
2590	1 pts		Chronic osteomyelitis	serious				268
2591	1 pts		Perineal abscess	serious				268
2592	1 pts		Pharyngeal abscess	serious				268
2593	1 pts		Pneumococcal pneumonia	serious				268
2594	1 pts		Pneumonia streptococcal	serious				268
2595	1 pts		Pulmonary sepsis	serious				268
2596	4 pts		Pyelonephritis acute	serious				268
2597	1 pts		Rectal abscess	serious				268
2598	1 pts		Respiratory tract infection viral	serious				268
2599	1 pts		Scrub typhus	serious				268
2600	1 pts		Soft tissue infection	serious				268
2601	1 pts		Infection staphylococcal	serious				268
2602	1 pts		Subcutaneous abscess	serious				268
2603	1 pts		Tonsillitis	serious				268
2604	25 pts		Urinary tract infection	serious				268
2605	1 pts		Urinary tract infection fungal	serious				268
2606	6 pts		Wound infection	serious				268
2607	1 pts		Concussion	serious				268
2608	1 pts		Facial bones fracture	serious				268
2609	4 pts		Femoral neck fracture	serious				268
2610	5 pts		Femur fracture	serious				268
2611	2 pts		Fibula fracture	serious				268
2612	1 pts		Foot fracture	serious				268
2613	1 pts		Fracture displacement	serious				268
2614	4 pts		Humerus fracture	serious				268
2615	1 pts		Joint dislocation	serious				268
2616	1 pts		Ligament rupture	serious				268
2617	1 pts		Limb injury	serious				268
2618	1 pts		Meniscus injury	serious				268
2619	1 pts		Muscle strain	serious				268
2620	1 pts		Post procedural haemorrhage	serious				268
2621	1 pts		Postoperative thrombosis	serious				268
2622	1 pts		Postoperative wound complication	serious				268
2623	2 pts		Pubis fracture	serious				268
2624	1 pts		Road traffic accident	serious				268
2625	1 pts		Soft tissue injury	serious				268
2626	1 pts		Sternal fracture	serious				268
2627	1 pts		Stress fracture	serious				268
2628	1 pts		Haemorrhage subdural	serious				268
2629	2 pts		Thermal burn	serious				268
2630	1 pts		Thoracic vertebral fracture	serious				268
2631	2 pts		Tibia fracture	serious				268
2632	2 pts		Ulna fracture	serious				268
2633	2 pts		Vascular graft occlusion	serious				268
2634	1 pts		Aspiration bronchial	serious				268
2635	1 pts		Biopsy kidney	serious				268
2636	2 pts		Blood creatine phosphokinase increased	serious				268
2637	1 pts		Blood urea increased	serious				268
2638	5 pts		Glomerular filtration rate decreased	serious				268
2639	1 pts		Cachexia	serious				268
2640	9 pts		Diabetic ketoacidosis	serious				268
2641	1 pts		Fluid retention	serious				268
2642	17 pts		Hypoglycaemia	serious				268
2643	1 pts		Hypophagia	serious				268
2644	1 pts		Lactic acidosis	serious				268
2645	2 pts		Obesity	serious				268
2646	2 pts		Back pain	serious				268
2647	1 pts		Cervical spinal stenosis	serious				268
2648	1 pts		Haemarthrosis	serious				268
2649	1 pts		Intervertebral disc degeneration	serious				268
2650	2 pts		Muscular weakness	serious				268
2651	2 pts		Musculoskeletal chest pain	serious				268
2652	1 pts		Osteitis	serious				268
2653	1 pts		Osteochondrosis	serious				268
2654	1 pts		Spinal column stenosis	serious				268
2655	4 pts		Osteoarthritis spinal	serious				268
2656	1 pts		Symphysiolysis	serious				268
2657	1 pts		Acute leukaemia	serious				268
2658	2 pts		Adenocarcinoma of colon	serious				268
2659	1 pts		B-cell lymphoma	serious				268
2660	2 pts		Basal cell carcinoma	serious				268
2661	5 pts		Bladder cancer	serious				268
2662	1 pts		Brain cancer metastatic	serious				268
2663	1 pts		Brain neoplasm	serious				268
2664	3 pts		Breast cancer	serious				268
2665	2 pts		Cholangiocarcinoma	serious				268
2666	1 pts		Colon adenoma	serious				268
2667	6 pts		Colon cancer	serious				268
2668	1 pts		Endometrial adenocarcinoma	serious				268
2669	3 pts		Gastric cancer	serious				268
2670	1 pts		Gastric neoplasm	serious				268
2671	1 pts		Hepatic neoplasm	serious				268
2672	1 pts		Invasive breast carcinoma	serious				268
2673	2 pts		Invasive ductal breast carcinoma	serious				268
2674	1 pts		Invasive lobular breast carcinoma	serious				268
2675	1 pts		Large intestine benign neoplasm	serious				268
2676	1 pts		Laryngeal cancer	serious				268
2677	2 pts		Lung cancer metastatic	serious				268
2678	2 pts		Lung neoplasm	serious				268
2679	1 pts		Malignant meningioma	serious				268
2680	2 pts		Metastases to bone	serious				268
2681	1 pts		Metastatic renal cell carcinoma	serious				268
2682	1 pts		Myelodysplastic syndrome	serious				268
2683	1 pts		Oesophageal adenocarcinoma	serious				268
2684	1 pts		Ovarian endometrioid carcinoma	serious				268
2685	1 pts		Pancreatic carcinoma metastatic	serious				268
2686	1 pts		Pancreatic neoplasm	serious				268
2687	8 pts		Prostate cancer	serious				268
2688	2 pts		Prostatic adenoma	serious				268
2689	1 pts		Rectal adenoma	serious				268
2690	1 pts		Renal oncocytoma	serious				268
2691	1 pts		Salivary gland neoplasm	serious				268
2692	2 pts		Squamous cell carcinoma of skin	serious				268
2693	2 pts		Transitional cell cancer of the renal pelvis and ureter	serious				268
2694	3 pts		Transitional cell carcinoma	serious				268
2695	1 pts		Brain injury	serious				268
2696	2 pts		Brain oedema	serious				268
2697	2 pts		Carpal tunnel syndrome	serious				268
2698	1 pts		Cauda equina syndrome	serious				268
2699	1 pts		Cerebellar haemorrhage	serious				268
2700	1 pts		Cerebellar stroke	serious				268
2701	1 pts		Chronic inflammatory demyelinating polyradiculoneuropathy	serious				268
2702	1 pts		Clonus	serious				268
2703	2 pts		Dementia	serious				268
2704	1 pts		Diabetic autonomic neuropathy	serious				268
2705	1 pts		Diabetic hyperosmolar coma	serious				268
2706	1 pts		Embolic cerebral infarction	serious				268
2707	2 pts		Encephalopathy	serious				268
2708	1 pts		Facial paralysis	serious				268
2709	1 pts		Generalised tonic-clonic seizure	serious				268
2710	1 pts		Haemorrhagic transformation stroke	serious				268
2711	1 pts		Intracranial mass	serious				268
2712	1 pts		Ischaemic neuropathy	serious				268
2713	1 pts		Lumbosacral radiculopathy	serious				268
2714	1 pts		Metabolic encephalopathy	serious				268
2715	1 pts		Myelopathy	serious				268
2716	1 pts		Paraparesis	serious				268
2717	1 pts		Parkinson's disease	serious				268
2718	1 pts		Peripheral sensorimotor neuropathy	serious				268
2719	1 pts		Polyneuropathy	serious				268
2720	2 pts		Seizure	serious				268
2721	1 pts		Spinal cord compression	serious				268
2722	4 pts		Syncope	serious				268
2723	2 pts		Tension headache	serious				268
2724	10 pts		Transient ischaemic attack	serious				268
2725	1 pts		Vasculitis cerebral	serious				268
2726	1 pts		VIth nerve paralysis	serious				268
2727	1 pts		Abortion spontaneous	serious				268
2728	1 pts		Retained products of conception	serious				268
2729	2 pts		Confusional state	serious				268
2730	1 pts		Substance-induced psychotic disorder	serious				268
2731	1 pts		Suicide attempt	serious				268
2732	1 pts		Anuria	serious				268
2733	1 pts		Bladder cyst	serious				268
2734	1 pts		Calculus urinary	serious				268
2735	12 pts		Diabetic nephropathy	serious				268
2736	1 pts		Nephrolithiasis	serious				268
2737	2 pts		Nephrotic syndrome	serious				268
2738	1 pts		Bladder neurogenic	serious				268
2739	1 pts		Colic renal	serious				268
2740	10 pts		Renal impairment	serious				268
2741	1 pts		Renal injury	serious				268
2742	1 pts		Renal tubular necrosis	serious				268
2743	1 pts		Stress urinary incontinence	serious				268
2744	1 pts		Ureterolithiasis	serious				268
2745	2 pts		Urinary retention	serious				268
2746	1 pts		Adenomyosis	serious				268
2747	1 pts		Cervix disorder	serious				268
2748	1 pts		Cystocele	serious				268
2749	1 pts		Ovarian cyst	serious				268
2750	1 pts		Rectocele	serious				268
2751	1 pts		Uterine prolapse	serious				268
2752	1 pts		Uterovaginal prolapse	serious				268
2753	1 pts		Prolapse vaginal	serious				268
2754	2 pts		Asthma	serious				268
2755	1 pts		Bronchiectasis	serious				268
2756	1 pts		Bronchitis chronic	serious				268
2757	1 pts		Bronchospasm	serious				268
2758	1 pts		Chronic respiratory failure	serious				268
2759	2 pts		Cough	serious				268
2760	1 pts		Dyspnoea at rest	serious				268
2761	1 pts		Hypoxia	serious				268
2762	1 pts		Laryngeal haematoma	serious				268
2763	1 pts		Pleuritic pain	serious				268
2764	7 pts		Pulmonary embolism	serious				268
2765	4 pts		Pulmonary fibrosis	serious				268
2766	1 pts		Pulmonary infarction	serious				268
2767	2 pts		Angioedema	serious				268
2768	15 pts		Diabetic foot	serious				268
2769	1 pts		Diabetic ulcer	serious				268
2770	1 pts		Drug eruption	serious				268
2771	1 pts		Erythema	serious				268
2772	1 pts		Neuropathic ulcer	serious				268
2773	1 pts		Generalised rash	serious				268
2774	18 pts		Skin ulcer	serious				268
2775	1 pts		Accelerated hypertension	serious				268
2776	1 pts		Aortic dissection	serious				268
2777	1 pts		Arterial disorder	serious				268
2778	1 pts		Arterial insufficiency	serious				268
2779	1 pts		Circulatory collapse	serious				268
2780	9 pts		Extremity necrosis	serious				268
2781	2 pts		Haematoma	serious				268
2782	4 pts		Hypotension	serious				268
2783	1 pts		Claudication intermittent	serious				268
2784	1 pts		Leriche syndrome	serious				268
2785	2 pts		Peripheral artery occlusion	serious				268
2786	5 pts		Disorder peripheral vascular	serious				268
2787	1 pts		Peripheral venous disease	serious				268
2788	1 pts		Haemorrhagic shock	serious				268
2789	1 pts		Subclavian artery stenosis	serious				268
2790	1 pts		Thrombosis	serious				268
2791	1 pts		Vascular occlusion	serious				268
2792	65 pts		Diabetic retinopathy	below serious				268
2793	54 pts		Nausea	below serious				268
2794	45 pts		Onychomycosis	below serious				268
2795	202 pts		Urinary tract infection	below serious				268
2796	56 pts		Pain in extremity	below serious				268
2797	69 pts		Headache	below serious				268
2798	85 pts		Skin ulcer	below serious				268
2799	57 pts		Hypotension	below serious				268
2800	1 pts		Pneumonia	serious				269
2801	5.9		Urinary tract infections					260
2802	5.1		Urination abnormal NOS					260
2803	2.8		Thirst					260
2804	1.8		Constipation					260
2805	2.1		Nausea					260
2806	10.6		Genital infection female					258
2807	1.6		Vulvovaginal pruritus					258
2808	4.2		Genital infection male					259
2809	4.4		Urinary tract infections					266
2810	4.6		Urination abnormal NOS					266
2811	2.4		Thirst					266
2812	2.4		Constipation					266
2813	2.3		Nausea					266
2814	11.6		Genital infection female					261
2815	3.2		Vulvovaginal pruritus					261
2816	3.8		Genital infection male					263
2817	0.7		Infection mycotic		discontinuation	leads to discontinuation		262
2818	0.5		Infection mycotic		discontinuation	leads to discontinuation		264
2819	2 pts		Hypersensitivity		discontinuation	leads to discontinuation		265
2820			Limb amputation			An approximately 2-fold increased risk of lower limb amputations		265
2821	0.2		Nausea		discontinuation	leads to discontinuation		256
2822	0.4		Pneumonia		discontinuation	leads to discontinuation		256
2823	0.4		Vulvovaginal mycotic infection		discontinuation	leads to discontinuation		256
2824	0.2		Glomerular filtration rate decreased		discontinuation	leads to discontinuation		256
2825	0.2		Weight decreased		discontinuation	leads to discontinuation		256
2826	0.1		Pollakiuria		discontinuation	leads to discontinuation		256
2827	0.6		Epidermal and dermal conditions		discontinuation	leads to discontinuation		256
2828	0.2		Blood creatinine increased		discontinuation	leads to discontinuation		257
2829	0.2		Blood potassium increased		discontinuation	leads to discontinuation		257
2830	0.6		Glomerular filtration rate decreased		discontinuation	leads to discontinuation		257
2831	0.1		Weight decreased		discontinuation	leads to discontinuation		257
2832	0.2		Pollakiuria		discontinuation	leads to discontinuation		257
2833	1 pts		Bronchitis	serious				270
2834	1 pts		Depression	serious				270
2835	1 pts		Acute myocardial infarction	serious				270
2836	1 pts		Chronic obstructive pulmonary disease	serious				270
2837	1 pts		Hypoxia	serious				270
2838	1 pts		Upper limb fracture	serious				270
2839	20 pts		Hot flush	below serious				270
2840	1 pts		Hot flushes		discontinuation	leads to discontinuation		273
2841	1 pts		Dizziness		discontinuation	leads to discontinuation		273
2842			Chest pain		discontinuation	leads to discontinuation		273
2843			Thromboembolic stroke			WARNING		271
2844			Hemorrhagic stroke			WARNING		271
2845			Deep vein thrombosis			WARNING		271
2846	1		Nausea		discontinuation	leads to discontinuation		272
2847	0.7		Muscle spasms		discontinuation	leads to discontinuation		272
2848	1		Headache		discontinuation	leads to discontinuation		272
2849	0.7		Hyperhidrosis		discontinuation	leads to discontinuation		272
2850	0.7		Rash		discontinuation	leads to discontinuation		272
2851	2		Hot flush		discontinuation	leads to discontinuation		272
2852	2 pts		Dyspnea	grade 3			TRUE	274
2853	1 pts		Neutropenia	grade 4			TRUE	274
2854	1 pts		Fatigue	grade 3			TRUE	280
2855	2 pts		Neutropenia	grade 4			TRUE	277
2856	4 pts		Neutropenia	grade 3-4			TRUE	282
2857	1 pts		Neutropenia	grade 4			TRUE	281
2858	1 pts		Thrombocytopenia	grade 4			TRUE	278
2859	3 pts		Diarrhea	grade 3			TRUE	276
2860	3 pts		Thrombocytopenia	grade 3			TRUE	276
2861	3 pts		Lung infection	grade 3			TRUE	276
2862	3 pts		Neutropenia	grade 4			TRUE	276
2863	1 pts		Lung infection	grade 3			TRUE	276
2864	1 pts		Thrombocytopenia	grade 3			TRUE	276
2865			Birth defects	grade 5	discontinuation	WARNING		279
2866	3		Venous thromboembolism	serious	discontinuation	WARNING		279
2867	47		Neutropenia	grade 3-4				279
2868	22		Anemia	grade 3-4				279
2869	22		Thrombocytopenia	grade 3-4				279
2870	1		Dizziness	grade 3-4				279
2871						No AEs are reported		275
2872	1 pts		Palpitations	serious				285
2873	1 pts		Irritable bowel syndrome	serious				285
2874	1 pts		Chest pain (non-cardiac)	serious				285
2875	1 pts		Gastroenteritis	serious				285
2876	1 pts		Disorder peripheral vascular	serious				285
2877	12 pts		Nasopharyngitis	below serious				285
2878	10 pts		Headache	below serious				285
2879	7 pts		Back pain	below serious				285
2880	7 pts		Urinary tract infection	below serious				285
2881	4 pts		Hypertension	below serious				285
2882	5 pts		Pharyngitis	below serious				285
2883	1 pts		Angina pectoris	serious				288
2884	1 pts		Claudication intermittent	serious				288
2885	9 pts		Headache	below serious				288
2886	5 pts		Hypertension	below serious				288
2887	1 pts		Chest pain (non-cardiac)	serious				295
2888	2 pts		Abdominal pain upper	below serious				295
2889	1 pts		Arthralgia	below serious				295
2890	2 pts		Dizziness	below serious				295
2891	1 pts		Myalgia	below serious				295
2892	2 pts		Nausea	below serious				295
2893	1 pts		Pain in extremity	below serious				295
2894	1 pts		Upper respiratory tract infection	below serious				295
2895	1 pts		Vision blurred	below serious				295
2896	2 pts		Abdominal pain	below serious				286
2897	1 pts		Abdominal pain upper	below serious				286
2898	2 pts		Arthralgia	below serious				286
2899	2 pts		Constipation	below serious				286
2900	2 pts		Gastroenteritis viral	below serious				286
2901	2 pts		Hyperglycaemia	below serious				286
2902	1 pts		Myalgia	below serious				286
2903	1 pts		Nausea	below serious				286
2904	2 pts		Neck pain	below serious				286
2905	1 pts		Pain in extremity	below serious				286
2906	2 pts		Paraesthesia	below serious				286
2907	4 pts		Rash	below serious				286
2908	1 pts		Vision blurred	below serious				286
2909	1 pts		Weight decreased	below serious				286
2910	1 pts		Chest pain (non-cardiac)	serious				289
2911	1 pts		Abdominal pain	below serious				289
2912	3 pts		Abdominal pain upper	below serious				289
2913	3 pts		Dizziness	below serious				289
2914	2 pts		Gastroenteritis	below serious				289
2915	4 pts		Headache	below serious				289
2916	1 pts		Nausea	below serious				289
2917	3 pts		Pain in extremity	below serious				289
2918	2 pts		Pharyngolaryngeal pain	below serious				289
2919	2 pts		Somnolence	below serious				289
2920	2 pts		Upper respiratory tract infection	below serious				289
2921	2 pts		Vision blurred	below serious				289
2922	2 pts		Weight decreased	below serious				289
2923	2 pts		Back pain	below serious				293
2924	1 pts		Dizziness	below serious				293
2925	2 pts		Nausea	below serious				293
2926	1 pts		Upper respiratory tract infection	below serious				293
2927	1 pts		Arthralgia	below serious				284
2928	2 pts		Cough	below serious				284
2929	1 pts		Dizziness	below serious				284
2930	3 pts		Fatigue	below serious				284
2931	1 pts		Gastroenteritis viral	below serious				284
2932	4 pts		Headache	below serious				284
2933	3 pts		Myalgia	below serious				284
2934	5 pts		Nausea	below serious				284
2935	2 pts		Oedema peripheral	below serious				284
2936	2 pts		Pain in extremity	below serious				284
2937	2 pts		Pharyngolaryngeal pain	below serious				284
2938	1 pts		Upper respiratory tract infection	below serious				284
2939	1 pts		Weight decreased	below serious				284
2940	125 pts		Acute myocardial infarction	serious				290
2941	86 pts		Angina pectoris	serious				290
2942	66 pts		Myocardial infarction	serious				290
2943	63 pts		Cardiac failure congestive	serious				290
2944	35 pts		Coronary artery disease	serious				290
2945	20 pts		Myocardial ischaemia	serious				290
2946	20 pts		Coronary artery stenosis	serious				290
2947	14 pts		Cardiac arrest	serious				290
2948	14 pts		Cardiogenic shock	serious				290
2949	9 pts		Ischaemic cardiomyopathy	serious				290
2950	7 pts		Supraventricular tachycardia	serious				290
2951	6 pts		Atrioventricular block complete	serious				290
2952	4 pts		Cardiomyopathy	serious				290
2953	3 pts		Left ventricular failure	serious				290
2954	3 pts		Cardiopulmonary failure	serious				290
2955	2 pts		Acute left ventricular failure	serious				290
2956	2 pts		Coronary artery insufficiency	serious				290
2957	1 pts		Arteriospasm coronary	serious				290
2958	1 pts		Atrioventricular block	serious				290
2959	1 pts		Atrioventricular block second degree	serious				290
2960	1 pts		Cardiac valve disease	serious				290
2961	1 pts		Cardiovascular insufficiency	serious				290
2962	1 pts		Intracardiac thrombus	serious				290
2963	1 pts		Nodal rhythm	serious				290
2964	1 pts		Palpitations	serious				290
2965	1 pts		Sinus bradycardia	serious				290
2966	1 pts		Ventricular arrhythmia	serious				290
2967	1 pts		Ventricular dyskinesia	serious				290
2968	49 pts		Pneumonia	serious				290
2969	14 pts		Bronchitis	serious				290
2970	10 pts		Septic shock	serious				290
2971	5 pts		Pyelonephritis	serious				290
2972	5 pts		Osteomyelitis	serious				290
2973	3 pts		Infection localised	serious				290
2974	2 pts		Arthritis bacterial	serious				290
2975	2 pts		Viral infection	serious				290
2976	2 pts		Atypical pneumonia	serious				290
2977	2 pts		Carbuncle	serious				290
2978	2 pts		Diarrhoea infectious	serious				290
2979	2 pts		Upper respiratory tract infection	serious				290
2980	2 pts		Wound infection staphylococcal	serious				290
2981	1 pts		Acinetobacter bacteraemia	serious				290
2982	1 pts		Acute sinusitis	serious				290
2983	1 pts		Anal abscess	serious				290
2984	1 pts		Bacterial diarrhoea	serious				290
2985	1 pts		Bacterial pyelonephritis	serious				290
2986	1 pts		Dacryocanaliculitis	serious				290
2987	1 pts		Dengue fever	serious				290
2988	1 pts		Diabetic foot infection	serious				290
2989	1 pts		Diabetic gangrene	serious				290
2990	1 pts		Escherichia sepsis	serious				290
2991	1 pts		Extradural abscess	serious				290
2992	1 pts		Gastrointestinal infection	serious				290
2993	1 pts		Incision site infection	serious				290
2994	1 pts		Korean haemorrhagic fever	serious				290
2995	1 pts		Liver abscess	serious				290
2996	1 pts		Malaria	serious				290
2997	1 pts		Meningitis	serious				290
2998	1 pts		Orchitis	serious				290
2999	1 pts		Osteomyelitis acute	serious				290
3000	1 pts		Periodontitis	serious				290
3001	1 pts		Pharyngitis streptococcal	serious				290
3002	1 pts		Pleural infection bacterial	serious				290
3003	1 pts		Pneumonia viral	serious				290
3004	1 pts		Post procedural cellulitis	serious				290
3005	1 pts		Scrotal abscess	serious				290
3006	1 pts		Scrub typhus	serious				290
3007	1 pts		Infection staphylococcal	serious				290
3008	1 pts		Tuberculosis	serious				290
3009	1 pts		Urethritis	serious				290
3010	1 pts		Viraemia	serious				290
3011	15 pts		Ischaemic stroke	serious				290
3012	7 pts		Convulsion	serious				290
3013	2 pts		Haemorrhage subarachnoid	serious				290
3014	2 pts		Carotid artery disease	serious				290
3015	2 pts		Hypoglycaemic seizure	serious				290
3016	2 pts		Migraine	serious				290
3017	2 pts		VIIth nerve paralysis	serious				290
3018	1 pts		Brain stem haemorrhage	serious				290
3019	1 pts		Central pain syndrome	serious				290
3020	1 pts		Cerebrovascular insufficiency	serious				290
3021	1 pts		Grand mal convulsion	serious				290
3022	1 pts		Hypoaesthesia	serious				290
3023	1 pts		Hypoglycaemic coma	serious				290
3024	1 pts		Ischaemic cerebral infarction	serious				290
3025	1 pts		Lumbar radiculopathy	serious				290
3026	1 pts		Petit mal epilepsy	serious				290
3027	1 pts		Thrombotic cerebral infarction	serious				290
3028	1 pts		Dementia vascular	serious				290
3029	1 pts		Vertebrobasilar insufficiency	serious				290
3030	43 pts		Renal failure acute	serious				290
3031	8 pts		Renal impairment	serious				290
3032	5 pts		Haematuria	serious				290
3033	4 pts		Nephrolithiasis	serious				290
3034	6 pts		Urinary retention	serious				290
3035	2 pts		Prerenal failure	serious				290
3036	1 pts		Calculus bladder	serious				290
3037	1 pts		Bladder calculus	serious				290
3038	1 pts		Cystitis haemorrhagic	serious				290
3039	1 pts		Obstructive uropathy	serious				290
3040	1 pts		Renal injury	serious				290
3041	1 pts		Urinary incontinence	serious				290
3042	1 pts		Urinary tract obstruction	serious				290
3043	24 pts		Acute pulmonary oedema	serious				290
3044	9 pts		Pulmonary embolism	serious				290
3045	7 pts		Acute respiratory failure	serious				290
3046	4 pts		Pleural effusion	serious				290
3047	3 pts		Interstitial lung disease	serious				290
3048	2 pts		Acute respiratory distress syndrome	serious				290
3049	3 pts		Pneumothorax	serious				290
3050	2 pts		Pulmonary mass	serious				290
3051	2 pts		Haemothorax	serious				290
3052	2 pts		Hypoxia	serious				290
3053	1 pts		Asphyxia	serious				290
3054	1 pts		Bronchial hyperreactivity	serious				290
3055	1 pts		Bullous lung disease	serious				290
3056	1 pts		Cough	serious				290
3057	1 pts		Laryngeal oedema	serious				290
3058	1 pts		Pneumonitis	serious				290
3059	1 pts		Respiratory arrest	serious				290
3060	1 pts		Respiratory distress	serious				290
3061	1 pts		Tracheal stenosis	serious				290
3062	1 pts		Vocal cord polyp	serious				290
3063	3 pts		Multi-organ failure	serious				290
3064	3 pts		Oedema peripheral	serious				290
3065	2 pts		Adverse drug reaction	serious				290
3066	2 pts		General physical health deterioration	serious				290
3067	1 pts		Device dislocation	serious				290
3068	1 pts		Hyperpyrexia	serious				290
3069	6 pts		Pancreatitis	serious				290
3070	6 pts		Upper gastrointestinal haemorrhage	serious				290
3071	6 pts		Abdominal pain	serious				290
3072	4 pts		Gastrooesophageal reflux disease	serious				290
3073	2 pts		Diabetic gastroparesis	serious				290
3074	3 pts		Impaired gastric emptying	serious				290
3075	2 pts		Hernia inguinal	serious				290
3076	2 pts		Oesophagitis	serious				290
3077	2 pts		Chronic pancreatitis	serious				290
3078	3 pts		Pancreatitis relapsing	serious				290
3079	2 pts		Rectal haemorrhage	serious				290
3080	2 pts		Intestinal ischaemia	serious				290
3081	2 pts		Small intestinal obstruction	serious				290
3082	1 pts		Colitis ulcerative	serious				290
3083	1 pts		Crohn's disease	serious				290
3084	1 pts		Dental caries	serious				290
3085	1 pts		Diverticulitis intestinal haemorrhagic	serious				290
3086	1 pts		Duodenal ulcer haemorrhage	serious				290
3087	1 pts		Enteritis	serious				290
3088	1 pts		Enterocolitis	serious				290
3089	1 pts		Gastric haemorrhage	serious				290
3090	1 pts		Gastrointestinal angiodysplasia	serious				290
3091	1 pts		Gastrointestinal motility disorder	serious				290
3092	1 pts		Intestinal angina	serious				290
3093	1 pts		Intestinal infarction	serious				290
3094	1 pts		Irritable bowel syndrome	serious				290
3095	1 pts		Large intestinal obstruction	serious				290
3096	1 pts		Lip haematoma	serious				290
3097	1 pts		Mallory-Weiss syndrome	serious				290
3098	1 pts		Oesophageal pain	serious				290
3099	1 pts		Oesophageal spasm	serious				290
3100	1 pts		Pancreatic cyst	serious				290
3101	1 pts		Peritonitis sclerosing	serious				290
3102	19 pts		Coronary artery restenosis	serious				290
3103	3 pts		Arterial restenosis	serious				290
3104	2 pts		Head injury	serious				290
3105	3 pts		Spinal compression fracture	serious				290
3106	2 pts		Ankle fracture	serious				290
3107	2 pts		Lower limb fracture	serious				290
3108	2 pts		Muscle strain	serious				290
3109	2 pts		Post procedural haemorrhage	serious				290
3110	2 pts		Postoperative wound complication	serious				290
3111	1 pts		Arterial injury	serious				290
3112	1 pts		Arteriovenous fistula site complication	serious				290
3113	1 pts		Chemical poisoning	serious				290
3114	1 pts		Chest injury	serious				290
3115	1 pts		Coronary artery reocclusion	serious				290
3116	1 pts		Craniocerebral injury	serious				290
3117	1 pts		Inflammation of wound	serious				290
3118	1 pts		Joint dislocation	serious				290
3119	1 pts		Muscle rupture	serious				290
3120	1 pts		Open fracture	serious				290
3121	1 pts		Patella fracture	serious				290
3122	1 pts		Postoperative thoracic procedure complication	serious				290
3123	1 pts		Tendon rupture	serious				290
3124	1 pts		Tibia fracture	serious				290
3125	1 pts		Transfusion reaction	serious				290
3126	6 pts		Peripheral artery stenosis	serious				290
3127	3 pts		Deep vein thrombosis	serious				290
3128	3 pts		Hypertensive emergency	serious				290
3129	3 pts		Aortic stenosis	serious				290
3130	3 pts		Claudication intermittent	serious				290
3131	3 pts		Orthostatic hypotension	serious				290
3132	1 pts		Angiopathy	serious				290
3133	1 pts		Aortic thrombosis	serious				290
3134	1 pts		Arterial insufficiency	serious				290
3135	1 pts		Peripheral artery aneurysm	serious				290
3136	1 pts		Peripheral artery thrombosis	serious				290
3137	1 pts		Haemorrhagic shock	serious				290
3138	1 pts		Subclavian artery stenosis	serious				290
3139	1 pts		Thrombosis	serious				290
3140	1 pts		Venous insufficiency	serious				290
3141	1 pts		Venous occlusion	serious				290
3142	18 pts		Hypoglycaemia	serious				290
3143	5 pts		Hyperkalaemia	serious				290
3144	2 pts		Hyponatraemia	serious				290
3145	1 pts		Lactic acidosis	serious				290
3146	16 pts		Musculoskeletal chest pain	serious				290
3147	5 pts		Back pain	serious				290
3148	2 pts		Intervertebral disc disorder	serious				290
3149	1 pts		Arthralgia	serious				290
3150	1 pts		Arthritis	serious				290
3151	1 pts		Costochondritis	serious				290
3152	1 pts		Fibromyalgia	serious				290
3153	1 pts		Flank pain	serious				290
3154	1 pts		Haemarthrosis	serious				290
3155	1 pts		Muscle haemorrhage	serious				290
3156	1 pts		Muscle spasms	serious				290
3157	1 pts		Muscle twitching	serious				290
3158	1 pts		Musculoskeletal discomfort	serious				290
3159	1 pts		Musculoskeletal pain	serious				290
3160	1 pts		Myalgia	serious				290
3161	1 pts		Myositis	serious				290
3162	1 pts		Rhabdomyolysis	serious				290
3163	1 pts		Torticollis	serious				290
3164	4 pts		Prostate cancer	serious				290
3165	3 pts		Breast cancer	serious				290
3166	2 pts		Gastric cancer	serious				290
3167	2 pts		Renal cell carcinoma	serious				290
3168	3 pts		Squamous cell carcinoma	serious				290
3169	2 pts		Adenocarcinoma gastric	serious				290
3170	2 pts		Lung neoplasm malignant	serious				290
3171	2 pts		Squamous cell carcinoma of lung	serious				290
3172	1 pts		Adenocarcinoma of colon	serious				290
3173	1 pts		Basal cell carcinoma	serious				290
3174	1 pts		Benign salivary gland neoplasm	serious				290
3175	1 pts		Breast cancer stage III	serious				290
3176	1 pts		Gallbladder cancer	serious				290
3177	1 pts		Hepatocellular carcinoma	serious				290
3178	1 pts		Lentigo maligna	serious				290
3179	1 pts		Lip neoplasm	serious				290
3180	1 pts		Lip squamous cell carcinoma	serious				290
3181	1 pts		Adenocarcinoma lung	serious				290
3182	1 pts		Lung cancer metastatic	serious				290
3183	1 pts		Malignant melanoma	serious				290
3184	1 pts		Metastatic neoplasm	serious				290
3185	1 pts		Non-Hodgkin's lymphoma	serious				290
3186	1 pts		Osteoma	serious				290
3187	1 pts		Ovarian neoplasm	serious				290
3188	1 pts		Plasma cell myeloma	serious				290
3189	1 pts		Rectal cancer	serious				290
3190	1 pts		Rectal cancer metastatic	serious				290
3191	1 pts		Signet-ring cell carcinoma	serious				290
3192	1 pts		Spinal cord neoplasm	serious				290
3193	1 pts		Squamous cell carcinoma of skin	serious				290
3194	5 pts		Cholecystitis	serious				290
3195	4 pts		Cholecystitis acute	serious				290
3196	2 pts		Hepatic function abnormal	serious				290
3197	2 pts		Jaundice cholestatic	serious				290
3198	1 pts		Cholangitis acute	serious				290
3199	1 pts		Febrile neutropenia	serious				290
3200	1 pts		Anaemia haemolytic	serious				290
3201	1 pts		Lymphopenia	serious				290
3202	2 pts		Amylase increased	serious				290
3203	1 pts		Alanine aminotransferase increased	serious				290
3204	1 pts		Aspartate aminotransferase increased	serious				290
3205	1 pts		Blood creatine phosphokinase increased	serious				290
3206	1 pts		Blood creatinine increased	serious				290
3207	1 pts		Electrocardiogram ST segment depression	serious				290
3208	1 pts		Gamma-glutamyltransferase increased	serious				290
3209	1 pts		Liver function test abnormal	serious				290
3210	1 pts		Neutrophil count decreased	serious				290
3211	1 pts		Oxygen saturation decreased	serious				290
3212	7 pts		Diabetic foot	serious				290
3213	4 pts		Skin ulcer	serious				290
3214	2 pts		Necrosis skin	serious				290
3215	1 pts		Decubitus ulcer	serious				290
3216	1 pts		Drug eruption	serious				290
3217	1 pts		Dry gangrene	serious				290
3218	1 pts		Rash	serious				290
3219	1 pts		Cataract subcapsular	serious				290
3220	1 pts		Dacryostenosis acquired	serious				290
3221	1 pts		Open angle glaucoma	serious				290
3222	1 pts		Retinal detachment	serious				290
3223	1 pts		Retinopathy	serious				290
3224	2 pts		Major depression	serious				290
3225	1 pts		Alcohol abuse	serious				290
3226	1 pts		Confusional state	serious				290
3227	1 pts		Altered mood	serious				290
3228	1 pts		Schizophrenia, paranoid type	serious				290
3229	1 pts		Prostatitis	serious				290
3230	1 pts		Scrotal mass	serious				290
3231	3 pts		Vertigo	serious				290
3232	3 pts		Vertigo positional	serious				290
3233	1 pts		Congenital megaureter	serious				290
3234	1 pts		Goitre	serious				290
3235	130 pts		Anaemia	below serious				290
3236	122 pts		Diarrhoea	below serious				290
3237	70 pts		Constipation	below serious				290
3238	56 pts		Nausea	below serious				290
3239	102 pts		Urinary tract infection	below serious				290
3240	81 pts		Bronchitis	below serious				290
3241	64 pts		Influenza	below serious				290
3242	140 pts		Blood creatine phosphokinase increased	below serious				290
3243	132 pts		Glomerular filtration rate decreased	below serious				290
3244	91 pts		Blood creatinine increased	below serious				290
3245	59 pts		Creatinine renal clearance decreased	below serious				290
3246	167 pts		Hypoglycaemia	below serious				290
3247	81 pts		Hyperkalaemia	below serious				290
3248	56 pts		Dyslipidaemia	below serious				290
3249	68 pts		Arthralgia	below serious				290
3250	81 pts		Dizziness	below serious				290
3251	203 pts		Renal impairment	below serious				290
3252	1 pts		Cerebral infarction	serious				296
3253	1 pts		Meningioma	serious				296
3254	1 pts		Abdominal distension	below serious				296
3255	1 pts		Abdominal pain upper	below serious				296
3256	3 pts		Bronchitis	below serious				296
3257	1 pts		Hyperlipidaemia	below serious				296
3258	1 pts		Hernia inguinal	serious				287
3259	1 pts		Cholelithiasis	serious				287
3260	4 pts		Flatulence	below serious				287
3261	2 pts		Abdominal distension	below serious				287
3262	1 pts		Abdominal pain upper	below serious				287
3263	7 pts		Nasopharyngitis	below serious				287
3264	2 pts		Bronchitis	below serious				287
3265	3 pts		Urticaria	below serious				287
3266	1 pts		Crohn's disease	serious				291
3267	3 pts		Abdominal distension	below serious				291
3268	3 pts		Abdominal pain upper	below serious				291
3269	10 pts		Nasopharyngitis	below serious				291
3270	5 pts		Headache	below serious				291
3271	3 pts		Malaise	below serious				291
3272	1 pts		Gastroenteritis	serious				294
3273	1 pts		Papillary thyroid cancer	serious				294
3274	2 pts		Abdominal distension	below serious				294
3275	2 pts		Abdominal pain upper	below serious				294
3276	8 pts		Nasopharyngitis	below serious				294
3277	2 pts		Bronchitis	below serious				294
3278	1 pts		Hyperlipidaemia	below serious				294
3279	1 pts		Urticaria	below serious				294
3280	4 pts		Blood creatine phosphokinase increased	below serious				294
3281	1 pts		Cholangitis acute	serious				292
3282	1 pts		Intraductal papilloma of breast	serious				292
3283	6 pts		Hyperlipidaemia	below serious				292
3284	5 pts		Upper respiratory tract infection	below serious				292
3285	2 pts		Blood triglycerides increased	below serious				292
3286	6 pts		Headache					297
3287	4 pts		Dizziness					297
3288	3 pts		Constipation					297
3289						No AEs are reported		298
3290	8 pts		Acute myocardial infarction		discontinuation	leads to discontinuation		283
3291	2 pts		Angina unstable		discontinuation	leads to discontinuation		283
3292	12 pts		Myocardial infarction		discontinuation	leads to discontinuation		283
3293	2 pts		Abdominal pain		discontinuation	leads to discontinuation		283
3294	1 pts		Diarrhea		discontinuation	leads to discontinuation		283
3295	3 pts		Nausea		discontinuation	leads to discontinuation		283
3296	4 pts		Edema peripheral		discontinuation	leads to discontinuation		283
3297	6 pts		Blood creatinine increased		discontinuation	leads to discontinuation		283
3298	3 pts		Creatinine renal clearance abnormal		discontinuation	leads to discontinuation		283
3299	22 pts		Creatinine renal clearance decreased		discontinuation	leads to discontinuation		283
3300	10 pts		Lipase increased		discontinuation	leads to discontinuation		283
3301	3 pts		Hyperglycemia		discontinuation	leads to discontinuation		283
3302	4 pts		Dizziness		discontinuation	leads to discontinuation		283
3303	2 pts		Headache		discontinuation	leads to discontinuation		283
3304	13 pts		Renal impairment		discontinuation	leads to discontinuation		283
3305	2 pts		Rash		discontinuation	leads to discontinuation		283
3306	3 pts		Rash pruritic		discontinuation	leads to discontinuation		283
3307						No AEs are reported		299
3308	11.4		Death			WARNING		300
3309	1 pts		Pregnancy	serious				301
3310	1 pts		Hospitalization	serious				301
3311	1 pts		Sickle cell crisis	below serious				301
3312	1 pts		Sickle cell crisis	below serious				301
3313	2 pts		Nose bleed	below serious				302
3314	1 pts		Shortness of breath	below serious				302
3315	1 pts		Haematochezia					303
3316	1 pts		Alanine aminotransferase increased					303
3317	1 pts		Headache		discontinuation	leads to discontinuation		310
3318	1 pts		Nausea		discontinuation	leads to discontinuation		310
3319			Poisoning			No AEs are reported		305
3320						No AEs are reported		304
3321	1 pts		Hepatotoxicity		discontinuation	leads to discontinuation		309
3322			Intoxication			No AEs are reported		307
3323			Thromboembolic event			WARNING		308
3324						No AEs are reported		306
3325	7		Diarrhea		discontinuation	leads to discontinuation		313
3326	3		Abdominal pain		discontinuation	leads to discontinuation		313
3327	3		Nausea		discontinuation	leads to discontinuation		313
3328	3		Gastroenteritis		discontinuation	leads to discontinuation		313
3329	3		Weight loss		discontinuation	leads to discontinuation		313
3330	3		Headache		discontinuation	leads to discontinuation		313
3331	3		Uncontrolled INR		discontinuation	leads to discontinuation		313
3332	34		Alanine aminotransferase increase			WARNING		313
3333	34		Aspartate aminotransferase increase			WARNING		313
3334	6		Fatty liver			WARNING		313
3335	1 pts		Headache		discontinuation	leads to discontinuation		315
3336						No AEs are reported		312
3337			Gastrointestinal injury		discontinuation	leads to discontinuation		311
3338	5 pts		Diarrhea		discontinuation	leads to dose reduction		314
3339	3 pts		Nausea		discontinuation	leads to dose reduction		314
3340	3 pts		Abdominal discomfort		discontinuation	leads to dose reduction		314
3341	1 pts		Vomiting		discontinuation	leads to dose reduction		314
3342	5 pts		Diarrhea		discontinuation	leads to dose interruption		314
3343	4 pts		Vomiting		discontinuation	leads to dose interruption		314
3344	3 pts		Nausea		discontinuation	leads to dose interruption		314
3345	3 pts		Gastroenteritis		discontinuation	leads to dose interruption		314
3346	2 pts		Influenza		discontinuation	leads to dose interruption		314
3347	2 pts		Chest pain		discontinuation	leads to dose interruption		314
3348	2 pts		Pyrexia		discontinuation	leads to dose interruption		314
3349	4		Thrombocytopenia		discontinuation	leads to discontinuation		317
3350	1		Infection		discontinuation	leads to discontinuation		317
3351	30		Thrombocytopenia		discontinuation	leads to dose delays or dose reduction		317
3352	13		Neutropenia		discontinuation	leads to dose delays or dose reduction		317
3353	12		Lipase increased		discontinuation	leads to dose delays or dose reduction		317
3354	11		Rash		discontinuation	leads to dose delays or dose reduction		317
3355	11		Abdominal pain		discontinuation	leads to dose delays or dose reduction		317
3356	6		Pancreatitis		discontinuation	leads to dose delays or dose reduction		317
3357	6		ALT increased		discontinuation	leads to dose delays or dose reduction		317
3358	6		AST increased		discontinuation	leads to dose delays or dose reduction		317
3359	6		GGT increased		discontinuation	leads to dose delays or dose reduction		317
3360	5		Myocardial ischemia	serious	discontinuation	WARNING		317
3361	34 pts		Arterial thrombosis	serious	discontinuation	WARNING		317
3362	8 pts		Ischemia cerebral	serious	discontinuation	WARNING		317
3363	7 pts		Peripheral arterial ischemia	serious	discontinuation	WARNING		317
3364	5		Arterial stenosis	serious	discontinuation	WARNING		317
3365	14 pts		Myocardial infarction	serious	discontinuation	WARNING		317
3366	2		Cerebrovascular event	serious	discontinuation	WARNING		317
3367	3 pts		Extremity necrosis	serious	discontinuation	WARNING		317
3368	4 pts		Ischemia	serious	discontinuation	WARNING		318
3369	1 pts		Rash maculo-papular	grade 3			TRUE	316
3370	4 pts		Lipase increased	grade 3-4			TRUE	319
3371	4 pts		Blood amylase increased	grade 3-4			TRUE	319
3372	1 pts		Fatigue	grade 3			TRUE	319
3373	1 pts		Alanine aminotransferase increased	grade 3			TRUE	319
3374	1 pts		Aspartate aminotransferase increased	grade 3			TRUE	319
3375	1 pts		Palpitations	below serious				323
3376	3 pts		Abdominal discomfort	below serious				323
3377	1 pts		Abdominal distension	below serious				323
3378	2 pts		Abdominal pain	below serious				323
3379	2 pts		Diarrhoea	below serious				323
3380	1 pts		Eructation	below serious				323
3381	17 pts		Nausea	below serious				323
3382	2 pts		Toothache	below serious				323
3383	6 pts		Vomiting	below serious				323
3384	1 pts		Nasopharyngitis	below serious				323
3385	1 pts		Musculoskeletal chest pain	below serious				323
3386	2 pts		Dizziness	below serious				323
3387	17 pts		Headache	below serious				323
3388	1 pts		Syncope vasovagal	below serious				323
3389	1 pts		Viral infection	severe				325
3390	1 pts		Dehydration	severe				325
3391	1 pts		Herpes simplex skin chronic ulcers		discontinuation	leads to discontinuation		325
3392	3 pts		Nausea					324
3393			Infection	serious		WARNING		320
3394			Lymphoma			WARNING		320
3395	2.5		Pneumonia		discontinuation	leads to discontinuation		321
3396	2.5		Herpes zoster		discontinuation	leads to discontinuation		321
3397	1.5		Aspartate aminotransferase increased		discontinuation	leads to discontinuation		321
3398	1.5		ALT increased		discontinuation	leads to discontinuation		321
3399	1.5		Creatinine increased		discontinuation	leads to discontinuation		321
3400	1		Gastrointestinal disorders		discontinuation	leads to discontinuation		321
3401	0.4		Respiratory disorder		discontinuation	leads to discontinuation		321
3402	0.1		Eye disorders		discontinuation	leads to discontinuation		321
3403	1		Skin disorder		discontinuation	leads to discontinuation		321
3404	0.3		Hepatobiliary disorders		discontinuation	leads to discontinuation		321
3405	0.1		Immune system disorders		discontinuation	leads to discontinuation		321
3406	0.1		Psychiatric disorders		discontinuation	leads to discontinuation		321
3407	2.7		Pneumonia		discontinuation	leads to discontinuation		322
3408	2.7		Herpes zoster		discontinuation	leads to discontinuation		322
3409	2		Aspartate aminotransferase increased		discontinuation	leads to discontinuation		322
3410	2		ALT increased		discontinuation	leads to discontinuation		322
3411	2		Creatinine increased		discontinuation	leads to discontinuation		322
3412	1.5		Gastrointestinal disorders		discontinuation	leads to discontinuation		322
3413	0.6		Respiratory disorder		discontinuation	leads to discontinuation		322
3414	0.2		Eye disorders		discontinuation	leads to discontinuation		322
3415	0.3		Skin disorder		discontinuation	leads to discontinuation		322
3416	0.3		Vascular disorders		discontinuation	leads to discontinuation		322
3417	0.1		Immune system disorders		discontinuation	leads to discontinuation		322
3418	0.1		Reproductive system and breast disorders		discontinuation	leads to discontinuation		322
3419	1 pts		Anasarca	grade 3				327
3420	1 pts		Haematemesis	grade 3			TRUE	327
3421	1 pts		Pulmonary aspergillosis	grade 4			TRUE	327
3422	1 pts		Skin rash	grade 3			TRUE	327
3423	1 pts		Scalp pain	grade 3			TRUE	327
3424	1 pts		Hyperglycaemia	grade 3			TRUE	336
3425			Diabetic hyperosmolar coma				TRUE	336
3426			Hypotension				TRUE	326
3427	2		Pancytopenia		discontinuation	leads to discontinuation		333
3428	2		Thrombocytopenia		discontinuation	leads to discontinuation		330
3429	2		Alanine aminotransferase increased		discontinuation	leads to discontinuation		330
3430	74		Thrombocytopenia	all grades				330
3431	67		Thrombocytopenia	grade 3-4				330
3432	61		Anemia	all grades				330
3433	36		Anemia	grade 3-4				330
3434	50		Neutropenia	all grades				330
3435	45		Neutropenia	grade 3-4				330
3436	17		Lymphopenia	all grades				330
3437	16		Lymphopenia	grade 3-4				330
3438	10		Bone marrow failure	all grades				330
3439	10		Bone marrow failure	grade 3-4				330
3440	10		Febrile neutropenia	all grades				330
3441	10		Febrile neutropenia	grade 3-4				330
3442	42		Diarrhea	all grades				330
3443	1		Diarrhea	grade 3-4				330
3444	32		Nausea	all grades				330
3445	1		Nausea	grade 3-4				330
3446	15		Constipation	grade 1-2				330
3447	14		Abdominal pain upper	grade 1-2				330
3448	12		Vomiting	grade 1-2				330
3449	26		Fatigue	all grades				330
3450	5		Fatigue	grade 3-4				330
3451	24		Pyrexia	all grades				330
3452	1		Pyrexia	grade 3-4				330
3453	23		Asthenia	all grades				330
3454	1		Asthenia	grade 3-4				330
3455	13		Edema peripheral	grade 1-2				330
3456	34		Infusion site reactions	grade 1-2				330
3457	19		Arthralgia	all grades				330
3458	1		Arthralgia	grade 3-4				330
3459	13		Pain in extremity	all grades				330
3460	1		Pain in extremity	grade 3-4				330
3461	11		Back pain	all grades				330
3462	2		Back pain	grade 3-4				330
3463	19		Headache	all grades				330
3464	1		Headache	grade 3-4				330
3465	10		Insomnia	grade 1-2				330
3466	16		Cough	all grades				330
3467	1		Cough	grade 3-4				330
3468	15		Epistaxis	all grades				330
3469	1		Epistaxis	grade 3-4				330
3470	15		Alopecia	grade 1-2				330
3471	10		Rash	grade 1-2				330
3472	51		Anemia	all grades				332
3473	36		Anemia	grade 3-4				332
3474	20		Febrile neutropenia	all grades				332
3475	16		Febrile neutropenia	grade 3-4				332
3476	20		Neutropenia	all grades				332
3477	18		Neutropenia	grade 3-4				332
3478	56		Thrombocytopenia	all grades				332
3479	49		Thrombocytopenia	grade 3-4				332
3480	35		Diarrhea	all grades				332
3481	7		Diarrhea	grade 3-4				332
3482	27		Nausea	all grades				332
3483	4		Nausea	grade 3-4				332
3484	15		Vomiting	all grades				332
3485	2		Vomiting	grade 3-4				332
3486	13		Abdominal pain	grade 1-2				332
3487	31		Fatigue	all grades				332
3488	9		Fatigue	grade 3-4				332
3489	29		Pyrexia	all grades				332
3490	2		Pyrexia	grade 3-4				332
3491	24		Asthenia	all grades				332
3492	2		Asthenia	grade 3-4				332
3493	13		Chills	grade 1-2				332
3494	22		Infusion site reactions	grade 1-2				332
3495	13		Anorexia	all grades				332
3496	2		Anorexia	grade 3-4				332
3497	11		Pain in extremity	all grades				332
3498	2		Pain in extremity	grade 3-4				332
3499	13		Headache	grade 1-2				332
3500	15		Cough	grade 1-2				332
3501	11		Dyspnea	all grades				332
3502	2		Dyspnea	grade 3-4				332
3503	11		Epistaxis	all grades				332
3504	2		Epistaxis	grade 3-4				332
3505	56		Bacterial infection	all grades				332
3506	20		Bacterial infection	grade 3-4				332
3507	56		Infection viral	all grades				332
3508	20		Infection viral	grade 3-4				332
3509	56		Fungal infection	all grades				332
3510	20		Fungal infection	grade 3-4				332
3511	56		Infection NOS	all grades				332
3512	20		Infection NOS	grade 3-4				332
3513	1 pts		Gastrointestinal disorders		discontinuation	leads to dose interruption		328
3514	1 pts		Gingival hemorrhage		discontinuation	leads to dose interruption		328
3515	1 pts		Alopecia		discontinuation	leads to dose interruption		328
3516	1 pts		Thrombocytopenia	grade 4	discontinuation	leads to dose interruption		328
3517	1 pts		Neutropenia	grade 4	discontinuation	leads to dose interruption		328
3518	2		Alanine aminotransferase increased		discontinuation	leads to discontinuation		334
3519	1		Bone marrow failure		discontinuation	leads to discontinuation		331
3520	1		Sepsis		discontinuation	leads to discontinuation		331
3521	1		Multiorgan failure		discontinuation	leads to discontinuation		331
3522	1		Gout		discontinuation	leads to discontinuation		331
3523	1		Renal failure		discontinuation	leads to discontinuation		331
3524	1		Tachyarrhythmia		discontinuation	leads to discontinuation		335
3525	1		Diplopia		discontinuation	leads to discontinuation		335
3526	1 pts		Gingival hemorrhage		discontinuation	leads to discontinuation		329
3527	1 pts		Gastrointestinal disorders		discontinuation	leads to discontinuation		329
3528	1 pts		Alopecia		discontinuation	leads to discontinuation		329
3529	1 pts		Thrombocytopenia	grade 4	discontinuation	leads to discontinuation		329
3530	1 pts		Neutropenia	grade 4	discontinuation	leads to discontinuation		329
3531	1 pts		Gastrooesophageal reflux disease	serious				337
3532	1 pts		Sepsis	serious				337
3533	1 pts		Cystitis	serious				337
3534	1 pts		Escherichia infection	serious				337
3535	1 pts		Pneumonia	serious				337
3536	3 pts		Diarrhoea	below serious				337
3537	4 pts		Nausea	below serious				337
3538	2 pts		Gait disturbance	below serious				337
3539	4 pts		Blood glucose increased	below serious				337
3540	4 pts		Back pain	below serious				337
3541	5 pts		Muscle spasms	below serious				337
3542	6 pts		Dizziness	below serious				337
3543	1 pts		Cardiac failure congestive	serious				338
3544	1 pts		Hyperglycaemia	serious				338
3545	1 pts		Basal cell carcinoma	serious				338
3546	1 pts		Renal failure acute	serious				338
3547	1 pts		Asthma	serious				338
3548	3 pts		Fatigue	below serious				338
3549	3 pts		Gait disturbance	below serious				338
3550	5 pts		Nasopharyngitis	below serious				338
3551	4 pts		Fall	below serious				338
3552	2 pts		Back pain	below serious				338
3553	3 pts		Muscle spasms	below serious				338
3554	2 pts		Dizziness	below serious				338
3555	9 pts		Somnolence	below serious				338
3556	4 pts		Hypertension	below serious				338
3557	4 pts		Orthostatic hypotension	below serious				338
3558	1 pts		Anaemia	serious				339
3559	1 pts		Atrial fibrillation	serious				339
3560	1 pts		Cardiac failure congestive	serious				339
3561	1 pts		Tachycardia	serious				339
3562	2 pts		Sepsis	serious				339
3563	1 pts		Cellulitis	serious				339
3564	1 pts		Labyrinthitis	serious				339
3565	1 pts		Osteomyelitis	serious				339
3566	1 pts		Sinusitis	serious				339
3567	1 pts		Wound infection staphylococcal	serious				339
3568	1 pts		Fall	serious				339
3569	1 pts		Hypoglycaemia	serious				339
3570	1 pts		Dizziness	serious				339
3571	1 pts		Encephalopathy	serious				339
3572	1 pts		Syncope	serious				339
3573	1 pts		Bronchial hyperreactivity	serious				339
3574	5 pts		Nausea	below serious				339
3575	4 pts		Fatigue	below serious				339
3576	5 pts		Gait disturbance	below serious				339
3577	4 pts		Contusion	below serious				339
3578	7 pts		Fall	below serious				339
3579	3 pts		Blood glucose increased	below serious				339
3580	4 pts		Back pain	below serious				339
3581	4 pts		Muscle spasms	below serious				339
3582	6 pts		Pain in extremity	below serious				339
3583	15 pts		Dizziness	below serious				339
3584	5 pts		Somnolence	below serious				339
3585	1 pts		Atrial fibrillation	serious				340
3586	1 pts		Vertigo	serious				340
3587	1 pts		Pancreatitis acute	serious				340
3588	1 pts		Multi-organ failure	serious				340
3589	1 pts		Cholelithiasis	serious				340
3590	1 pts		Urinary tract infection	serious				340
3591	1 pts		Blood pressure systolic increased	serious				340
3592	1 pts		Aphasia	serious				340
3593	1 pts		Balance disorder	serious				340
3594	1 pts		Cerebrovascular accident	serious				340
3595	1 pts		Homicidal ideation	serious				340
3596	1 pts		Suicide attempt	serious				340
3597	1 pts		Renal failure acute	serious				340
3598	1 pts		Diabetic neuropathy	serious				340
3599	1 pts		Urinary retention	serious				340
3600	1 pts		Benign prostatic hyperplasia	serious				340
3601	1 pts		Atelectasis	serious				340
3602	1 pts		Blood pressure fluctuation	serious				340
3603	4 pts		Diarrhoea	below serious				340
3604	5 pts		Nausea	below serious				340
3605	4 pts		Fatigue	below serious				340
3606	3 pts		Gait disturbance	below serious				340
3607	5 pts		Contusion	below serious				340
3608	7 pts		Fall	below serious				340
3609	4 pts		Weight increased	below serious				340
3610	2 pts		Back pain	below serious				340
3611	4 pts		Muscle spasms	below serious				340
3612	15 pts		Dizziness	below serious				340
3613	11 pts		Somnolence	below serious				340
3614	1 pts		Foot fracture	serious				342
3615	1 pts		Nasopharyngitis	serious				342
3616	1 pts		Partial seizures with secondary generalisation	serious				342
3617	2 pts		Aggression	serious				342
3618	1 pts		Gastroduodenitis	serious				342
3619	1 pts		Pituitary tumour benign	below serious				342
3620	1 pts		Multiple allergies	below serious				342
3621	8 pts		Fatigue	below serious				342
3622	1 pts		Local swelling	below serious				342
3623	2 pts		Pyrexia	below serious				342
3624	6 pts		Irritability	below serious				342
3625	1 pts		Adjustment disorder	below serious				342
3626	6 pts		Aggression	below serious				342
3627	2 pts		Anger	below serious				342
3628	1 pts		Anxiety	below serious				342
3629	3 pts		Bradyphrenia	below serious				342
3630	3 pts		Confusional state	below serious				342
3631	1 pts		Depressed mood	below serious				342
3632	2 pts		Euphoric mood	below serious				342
3633	1 pts		Intentional self-injury	below serious				342
3634	2 pts		Altered mood	below serious				342
3635	3 pts		Mood swings	below serious				342
3636	1 pts		Self-injurious ideation	below serious				342
3637	1 pts		Irregular menstruation	below serious				342
3638	1 pts		Menstruation irregular	below serious				342
3639	1 pts		Concussion	below serious				342
3640	3 pts		Contusion	below serious				342
3641	2 pts		Excoriation	below serious				342
3642	1 pts		Joint injury	below serious				342
3643	1 pts		Laceration	below serious				342
3644	1 pts		Ligament rupture	below serious				342
3645	1 pts		Muscle strain	below serious				342
3646	1 pts		Wrist fracture	below serious				342
3647	1 pts		Platelet count decreased	below serious				342
3648	5 pts		Weight increased	below serious				342
3649	1 pts		White blood cell count decreased	below serious				342
3650	1 pts		Bradycardia	below serious				342
3651	2 pts		Epistaxis	below serious				342
3652	1 pts		Nasal congestion	below serious				342
3653	1 pts		Allergic rhinitis	below serious				342
3654	2 pts		Rhinorrhoea	below serious				342
3655	1 pts		Tachypnoea	below serious				342
3656	1 pts		Anaemia	below serious				342
3657	1 pts		Leukopenia	below serious				342
3658	4 pts		Ataxia	below serious				342
3659	2 pts		Balance disorder	below serious				342
3660	2 pts		Clumsiness	below serious				342
3661	1 pts		Depressed level of consciousness	below serious				342
3662	2 pts		Disturbance in attention	below serious				342
3663	26 pts		Dizziness	below serious				342
3664	1 pts		Drooling	below serious				342
3665	1 pts		Dysarthria	below serious				342
3666	1 pts		Hypoaesthesia	below serious				342
3667	1 pts		Hypotonia	below serious				342
3668	2 pts		Lethargy	below serious				342
3669	1 pts		Memory impairment	below serious				342
3670	2 pts		Slow speech	below serious				342
3671	13 pts		Somnolence	below serious				342
3672	1 pts		Syncope	below serious				342
3673	1 pts		Tremor	below serious				342
3674	1 pts		Mydriasis	below serious				342
3675	3 pts		Vision blurred	below serious				342
3676	1 pts		Visual impairment	below serious				342
3677	1 pts		Tinnitus	below serious				342
3678	4 pts		Abdominal pain upper	below serious				342
3679	2 pts		Diarrhoea	below serious				342
3680	2 pts		Abdominal discomfort	below serious				342
3681	1 pts		Dry mouth	below serious				342
3682	1 pts		Gastrooesophageal reflux disease	below serious				342
3683	1 pts		Hyperchlorhydria	below serious				342
3684	2 pts		Nausea	below serious				342
3685	1 pts		Haematuria	below serious				342
3686	1 pts		Dermal cyst	below serious				342
3687	1 pts		Dermatitis contact	below serious				342
3688	1 pts		Heat rash	below serious				342
3689	1 pts		Rash	below serious				342
3690	1 pts		Swelling face	below serious				342
3691	1 pts		Urticaria	below serious				342
3692	1 pts		Arthralgia	below serious				342
3693	1 pts		Back pain	below serious				342
3694	1 pts		Epiphyses premature fusion	below serious				342
3695	1 pts		Joint swelling	below serious				342
3696	2 pts		Musculoskeletal pain	below serious				342
3697	1 pts		Myositis	below serious				342
3698	3 pts		Decreased appetite	below serious				342
3699	1 pts		Hypernatraemia	below serious				342
3700	1 pts		Hypertriglyceridaemia	below serious				342
3701	4 pts		Increased appetite	below serious				342
3702	1 pts		Obesity	below serious				342
3703	1 pts		Fungal skin infection	below serious				342
3704	1 pts		Influenza	below serious				342
3705	1 pts		Pharyngitis	below serious				342
3706	1 pts		Respiratory tract infection	below serious				342
3707	1 pts		Skin infection	below serious				342
3708	2 pts		Tonsillitis	below serious				342
3709	2 pts		Urinary tract infection	below serious				342
3710	1 pts		Vaginitis bacterial	below serious				342
3711	2 pts		Viral upper respiratory tract infection	below serious				342
3712	1 pts		Foot fracture	serious				341
3713	1 pts		Accidental overdose	serious				341
3714	1 pts		Intentional overdose	serious				341
3715	1 pts		Hand fracture	serious				341
3716	1 pts		Ligament rupture	serious				341
3717	1 pts		Nasopharyngitis	serious				341
3718	4 pts		Convulsion	serious				341
3719	1 pts		Partial seizures with secondary generalisation	serious				341
3720	1 pts		Simple partial seizures	serious				341
3721	1 pts		Status epilepticus	serious				341
3722	4 pts		Aggression	serious				341
3723	1 pts		Suicidal ideation	serious				341
3724	1 pts		Suicide attempt	serious				341
3725	1 pts		Gastroduodenitis	serious				341
3726	1 pts		Testicular necrosis	serious				341
3727	1 pts		Pneumonia	serious				341
3728	1 pts		Pituitary tumour benign	below serious				341
3729	1 pts		Multiple allergies	below serious				341
3730	1 pts		Drug hypersensitivity	below serious				341
3731	13 pts		Fatigue	below serious				341
3732	1 pts		Local swelling	below serious				341
3733	8 pts		Pyrexia	below serious				341
3734	1 pts		Gait disturbance	below serious				341
3735	7 pts		Irritability	below serious				341
3736	10 pts		Aggression	below serious				341
3737	2 pts		Anger	below serious				341
3738	1 pts		Anxiety	below serious				341
3739	3 pts		Bradyphrenia	below serious				341
3740	3 pts		Confusional state	below serious				341
3741	1 pts		Depressed mood	below serious				341
3742	4 pts		Mood swings	below serious				341
3743	1 pts		Self-injurious ideation	below serious				341
3744	1 pts		Abnormal behaviour	below serious				341
3745	1 pts		Daydreaming	below serious				341
3746	1 pts		Depression	below serious				341
3747	3 pts		Nervousness	below serious				341
3748	1 pts		Regressive behaviour	below serious				341
3749	1 pts		Somnambulism	below serious				341
3750	1 pts		Irregular menstruation	below serious				341
3751	1 pts		Menstruation irregular	below serious				341
3752	1 pts		Testicular torsion	below serious				341
3753	2 pts		Concussion	below serious				341
3754	3 pts		Contusion	below serious				341
3755	2 pts		Excoriation	below serious				341
3756	1 pts		Laceration	below serious				341
3757	1 pts		Ligament rupture	below serious				341
3758	1 pts		Muscle strain	below serious				341
3759	1 pts		Wrist fracture	below serious				341
3760	2 pts		Accidental overdose	below serious				341
3761	2 pts		Animal bite	below serious				341
3762	1 pts		Fall	below serious				341
3763	1 pts		Foot fracture	below serious				341
3764	2 pts		Hand fracture	below serious				341
3765	2 pts		Head injury	below serious				341
3766	1 pts		Limb injury	below serious				341
3767	1 pts		Sunburn	below serious				341
3768	8 pts		Weight increased	below serious				341
3769	1 pts		White blood cell count decreased	below serious				341
3770	2 pts		Alanine aminotransferase increased	below serious				341
3771	2 pts		Aspartate aminotransferase increased	below serious				341
3772	1 pts		Blood cholesterol increased	below serious				341
3773	1 pts		Blood glucose decreased	below serious				341
3774	1 pts		Blood pressure decreased	below serious				341
3775	1 pts		Blood sodium increased	below serious				341
3776	1 pts		Blood triglycerides increased	below serious				341
3777	1 pts		Electrocardiogram T wave abnormal	below serious				341
3778	3 pts		Bradycardia	below serious				341
3779	1 pts		Angina pectoris	below serious				341
3780	1 pts		Sinus bradycardia	below serious				341
3781	1 pts		Nasal congestion	below serious				341
3782	1 pts		Allergic rhinitis	below serious				341
3783	1 pts		Diaphragmatic spasm	below serious				341
3784	1 pts		Dyspnoea	below serious				341
3785	1 pts		Snoring	below serious				341
3786	2 pts		Anaemia	below serious				341
3787	1 pts		Leukopenia	below serious				341
3788	5 pts		Ataxia	below serious				341
3789	3 pts		Balance disorder	below serious				341
3790	2 pts		Clumsiness	below serious				341
3791	10 pts		Convulsion	below serious				341
3792	2 pts		Disturbance in attention	below serious				341
3793	34 pts		Dizziness	below serious				341
3794	1 pts		Drooling	below serious				341
3795	2 pts		Dysarthria	below serious				341
3796	1 pts		Hypoaesthesia	below serious				341
3797	1 pts		Hypotonia	below serious				341
3798	4 pts		Lethargy	below serious				341
3799	1 pts		Memory impairment	below serious				341
3800	3 pts		Simple partial seizures	below serious				341
3801	2 pts		Slow speech	below serious				341
3802	22 pts		Somnolence	below serious				341
3803	2 pts		Syncope	below serious				341
3804	3 pts		Tremor	below serious				341
3805	2 pts		Aphasia	below serious				341
3806	1 pts		Complex partial seizures	below serious				341
3807	1 pts		Coordination abnormal	below serious				341
3808	1 pts		Dyskinesia	below serious				341
3809	1 pts		Dyspraxia	below serious				341
3810	3 pts		Epilepsy	below serious				341
3811	1 pts		Migraine	below serious				341
3812	1 pts		Partial seizures	below serious				341
3813	1 pts		Postictal headache	below serious				341
3814	1 pts		Mydriasis	below serious				341
3815	2 pts		Vision blurred	below serious				341
3816	1 pts		Visual impairment	below serious				341
3817	1 pts		Myopia	below serious				341
3818	1 pts		Visual acuity reduced	below serious				341
3819	6 pts		Vertigo	below serious				341
3820	1 pts		Tinnitus	below serious				341
3821	4 pts		Abdominal pain upper	below serious				341
3822	4 pts		Diarrhoea	below serious				341
3823	6 pts		Vomiting	below serious				341
3824	2 pts		Abdominal discomfort	below serious				341
3825	1 pts		Dry mouth	below serious				341
3826	1 pts		Gastrooesophageal reflux disease	below serious				341
3827	2 pts		Nausea	below serious				341
3828	1 pts		Dyspepsia	below serious				341
3829	1 pts		Enterocolitis	below serious				341
3830	1 pts		Toothache	below serious				341
3831	1 pts		Haematuria	below serious				341
3832	1 pts		Crystalluria	below serious				341
3833	2 pts		Enuresis	below serious				341
3834	1 pts		Dermal cyst	below serious				341
3835	2 pts		Dermatitis contact	below serious				341
3836	3 pts		Rash	below serious				341
3837	1 pts		Swelling face	below serious				341
3838	1 pts		Urticaria	below serious				341
3839	2 pts		Acne	below serious				341
3840	1 pts		Dermatitis acneiform	below serious				341
3841	1 pts		Macule	below serious				341
3842	1 pts		Photosensitivity reaction	below serious				341
3843	1 pts		Rash maculo-papular	below serious				341
3844	1 pts		Dermatitis seborrhoeic	below serious				341
3845	1 pts		Arthralgia	below serious				341
3846	1 pts		Back pain	below serious				341
3847	1 pts		Epiphyses premature fusion	below serious				341
3848	2 pts		Musculoskeletal pain	below serious				341
3849	1 pts		Myositis	below serious				341
3850	2 pts		Muscle spasms	below serious				341
3851	2 pts		Pain in extremity	below serious				341
3852	1 pts		Tendonitis	below serious				341
3853	4 pts		Decreased appetite	below serious				341
3854	1 pts		Hypernatraemia	below serious				341
3855	1 pts		Hypertriglyceridaemia	below serious				341
3856	4 pts		Increased appetite	below serious				341
3857	1 pts		Obesity	below serious				341
3858	3 pts		Bronchitis	below serious				341
3859	1 pts		Fungal skin infection	below serious				341
3860	2 pts		Influenza	below serious				341
3861	13 pts		Nasopharyngitis	below serious				341
3862	1 pts		Pharyngitis	below serious				341
3863	1 pts		Respiratory tract infection	below serious				341
3864	1 pts		Skin infection	below serious				341
3865	2 pts		Tonsillitis	below serious				341
3866	3 pts		Urinary tract infection	below serious				341
3867	3 pts		Viral upper respiratory tract infection	below serious				341
3868	1 pts		Acarodermatitis	below serious				341
3869	1 pts		Cellulitis	below serious				341
3870	1 pts		Cystitis	below serious				341
3871	1 pts		Fungal infection	below serious				341
3872	2 pts		Gastroenteritis	below serious				341
3873	1 pts		Laryngitis	below serious				341
3874	1 pts		Infection localised	below serious				341
3875	1 pts		Oral herpes	below serious				341
3876	1 pts		Pneumonia	below serious				341
3877	1 pts		Rhinitis	below serious				341
3878	1 pts		Viral infection	below serious				341
3879	1 pts		Bacterial vaginosis	below serious				341
3880	1 pts		Miliaria	below serious				341
3881	1 pts		Somnolence			POISONING		346
3882	1 pts		Bradycardia			POISONING		346
3883	1 pts		Hyponatremia			POISONING		346
3884	1 pts		Drowsiness			POISONING		343
3885	1 pts		Ataxia			POISONING		343
3886	1 pts		Coordination and balance disturbances			POISONING		344
3887	20		Hostility		discontinuation	WARNING		348
3888	20		Aggression		discontinuation	WARNING		348
3889			Irritability		discontinuation	WARNING		348
3890			Anger		discontinuation	WARNING		348
3891			Anxiety		discontinuation	WARNING		348
3892			Dizziness		discontinuation	leads to discontinuation		347
3893			Somnolence		discontinuation	leads to discontinuation		347
3894			Vertigo		discontinuation	leads to discontinuation		347
3895			Ataxia		discontinuation	leads to discontinuation		347
3896			Blurred vision		discontinuation	leads to discontinuation		347
3897			Dysarthria		discontinuation	leads to discontinuation		347
3898	1 pts		Agitation					345
3899	1 pts		Aggressive behavior					345
3900	42		Voice alteration			MTD level for single-agent regorafenib treatment in a 21 days on/seven days off schedule		350
3901	67		Hand and foot skin reaction			MTD level for single-agent regorafenib treatment in a 21 days on/seven days off schedule		350
3902	25		Mucositis			MTD level for single-agent regorafenib treatment in a 21 days on/seven days off schedule		350
3903	50		Diarrhea			MTD level for single-agent regorafenib treatment in a 21 days on/seven days off schedule		350
3904	50		Hypertension			MTD level for single-agent regorafenib treatment in a 21 days on/seven days off schedule		350
3905	17		Fatigue			MTD level for single-agent regorafenib treatment in a 21 days on/seven days off schedule		350
3906	50		Anorexia			MTD level for single-agent regorafenib treatment in a 21 days on/seven days off schedule		350
3907	50		Rash			MTD level for single-agent regorafenib treatment in a 21 days on/seven days off schedule		350
3908	33		Alopecia			MTD level for single-agent regorafenib treatment in a 21 days on/seven days off schedule		350
3909	25		Hand and foot skin reaction	grade 3		MTD level for single-agent regorafenib treatment in a 21 days on/seven days off schedule		350
3910	8		Mucositis	grade 3		MTD level for single-agent regorafenib treatment in a 21 days on/seven days off schedule		350
3911	17		Diarrhea	grade 3		MTD level for single-agent regorafenib treatment in a 21 days on/seven days off schedule		350
3912	17		Hypertension	grade 3		MTD level for single-agent regorafenib treatment in a 21 days on/seven days off schedule		350
3913	8		Anorexia	grade 3		MTD level for single-agent regorafenib treatment in a 21 days on/seven days off schedule		350
3914	8		Rash	grade 3		MTD level for single-agent regorafenib treatment in a 21 days on/seven days off schedule		350
3915	25		Infection				TRUE	359
3916	13		Hand and foot skin reaction				TRUE	359
3917	8		Allergic reaction				TRUE	360
3918	8		Vomiting				TRUE	360
3919			Dysphonia			OVERDOSAGE		349
3920			Dry mouth			OVERDOSAGE		349
3921			Decreased appetite			OVERDOSAGE		349
3922	75		Voice alteration					349
3923	58		Hand and foot skin reaction			OVERDOSAGE		349
3924	67		Mucositis			OVERDOSAGE		349
3925	58		Diarrhea			OVERDOSAGE		349
3926	42		Hypertension			OVERDOSAGE		349
3927	58		Fatigue			OVERDOSAGE		349
3928	42		Anorexia					349
3929	25		Rash					349
3930	25		Alopecia					349
3931	8		Voice alteration	grade 3				349
3932	42		Hand and foot skin reaction	grade 3				349
3933	8		Diarrhea	grade 3				349
3934	25		Hypertension	grade 3				349
3935	8		Fatigue	grade 3				349
3936	8		Rash	grade 3				349
3937	17		Hand and foot skin reaction				TRUE	361
3938	8		Pruritic rash				TRUE	361
3939	8		Abdominal pain				TRUE	361
3940	8		Asthma bronchial				TRUE	361
3941	4		General physical health deterioration		discontinuation			351
3942	1		Palmar-plantar erythrodysaesth.		discontinuation			351
3943	1		Decreased appetite		discontinuation			351
3944	1		Pneumonia		discontinuation			351
3945	1		Rash		discontinuation			351
3946	18.2		Palmar-plantar erythrodysaesth.		dose reduction			352
3947	3.8		Diarrhea		dose reduction			352
3948	3.2		Hypertension		dose reduction			352
3949	2		Fatigue		dose reduction			352
3950	2		Rash		dose reduction			352
3951	1.2		Mucositis		dose reduction			352
3952	1		Abdominal pain		dose reduction			352
3953	1		Asthenia		dose reduction			352
3954	18.8		Palmar-plantar erythrodysaesth.		dose interruption			353
3955	6.2		Diarrhea		dose interruption			353
3956	4.6		Pyrexia		dose interruption			353
3957	4		Fatigue		dose interruption			353
3958	3.6		Rash		dose interruption			353
3959	3.6		Hyperbilirubinemia		dose interruption			353
3960	3		Decreased appetite		dose interruption			353
3961	2.8		Asthenia		dose interruption			353
3962	2.6		Hypertension		dose interruption			353
3963	2.4		Abdominal pain		dose interruption			353
3964	2.2		Stomatitis		dose interruption			353
3965	2		Dyspnea		dose interruption			353
3966	1.8		AST increased		dose interruption			353
3967	1.8		Vomiting		dose interruption			353
3968	1.6		Thrombocytopenia		dose interruption			353
3969	1.4		ALT increased		dose interruption			353
3970	1.2		Proteinuria		dose interruption			353
3971	17.4		Hemorrhage	grade 1				354
3972	1.8		Hemorrhage	grade 2				354
3973	1.4		Hemorrhage	grade 3				354
3974	0.8		Hemorrhage	grade 5				354
3975	17		Palmar-plantar erythrodysaesth.	grade 3				355
3976	5		Rash	grade 3				355
3977	0.8		Pulmonary embolism	grade 3				356
3978	0.6		Venous thromboembolism	grade 3				356
3979	1		Arterial thromboembolism	grade 3				356
3980	5		Decreased appetite	grade 3				357
3981	8		Diarrhea	grade 3				357
3982	4		Mucositis	grade 3				357
3983	<1		Weight loss	grade 3				357
3984	9		Infection	grade 3				357
3985	8		Hypertension	grade 3				357
3986	3		Pain	grade 3				357
3987	2		Fever	grade 3				357
3988	6		Rash	grade 3				357
3989	2		Hemorrhage	grade 3				357
3990	<1		Headache	grade 3				357
3991	15		Asthenia	grade 3				357
3992	1.6		Hepatic failure	grade 5	discontinuation			358
3993	2 pts		Appendicitis	serious				363
3994	1 pts		Erysipelas	serious				363
3995	1 pts		Infected cyst	serious				363
3996	2 pts		Pneumonia	serious				363
3997	1 pts		Ovarian germ cell teratoma benign	serious				363
3998	1 pts		Uterine leiomyoma	serious				363
3999	1 pts		Anaemia	serious				363
4000	1 pts		Lymphadenitis	serious				363
4001	2 pts		Major depression	serious				363
4002	1 pts		Psychosomatic disease	serious				363
4003	1 pts		Somatoform disorder	serious				363
4004	1 pts		Cervical myelopathy	serious				363
4005	1 pts		Facial nerve disorder	serious				363
4006	1 pts		Parkinsonism	serious				363
4007	1 pts		Status epilepticus	serious				363
4008	1 pts		Varicose vein	serious				363
4009	1 pts		Venous thrombosis	serious				363
4010	1 pts		Abdominal pain lower	serious				363
4011	1 pts		Abdominal wall haematoma	serious				363
4012	1 pts		Colitis	serious				363
4013	1 pts		Colitis ulcerative	serious				363
4014	1 pts		Crohn's disease	serious				363
4015	1 pts		Nausea	serious				363
4016	1 pts		Peritonitis	serious				363
4017	1 pts		Toothache	serious				363
4018	1 pts		Cholecystitis	serious				363
4019	1 pts		Cholecystitis acute	serious				363
4020	6 pts		Cholelithiasis	serious				363
4021	1 pts		Eczema	serious				363
4022	1 pts		Costochondritis	serious				363
4023	1 pts		Osteochondrosis	serious				363
4024	1 pts		Benign prostatic hyperplasia	serious				363
4025	2 pts		Endometriosis	serious				363
4026	1 pts		Fallopian tube cyst	serious				363
4027	1 pts		Metrorrhagia	serious				363
4028	1 pts		Haemorrhage uterine	serious				363
4029	2 pts		Lipase increased	serious				363
4030	1 pts		Concussion	serious				363
4031	1 pts		Contrast media reaction	serious				363
4032	1 pts		Femoral neck fracture	serious				363
4033	1 pts		Multiple drug overdose	serious				363
4034	1 pts		Meniscus operation	serious				363
4035	22 pts		Gastroenteritis	below serious				363
4036	34 pts		Upper respiratory tract infection	below serious				363
4037	22 pts		Dizziness	below serious				363
4038	81 pts		Headache	below serious				363
4039	34 pts		Paraesthesia	below serious				363
4040	19 pts		Abdominal pain upper	below serious				363
4041	54 pts		Diarrhoea	below serious				363
4042	32 pts		Nausea	below serious				363
4043	15 pts		Vomiting	below serious				363
4044	38 pts		Alopecia	below serious				363
4045	41 pts		Alanine aminotransferase increased	below serious				363
4046	1 pts		Bacteraemia	serious				362
4047	1 pts		Cytomegalovirus hepatitis	serious				362
4048	3 pts		Pyelonephritis	serious				362
4049	1 pts		Renal abscess	serious				362
4050	1 pts		Urinary tract infection enterococcal	serious				362
4051	1 pts		Adrenal adenoma	serious				362
4052	1 pts		Uterine leiomyoma	serious				362
4053	1 pts		Neutropenia	serious				362
4054	1 pts		Altered mood	serious				362
4055	1 pts		Convulsion	serious				362
4056	1 pts		Monoparesis	serious				362
4057	1 pts		Syncope	serious				362
4058	1 pts		Circulatory collapse	serious				362
4059	1 pts		Orthostatic hypotension	serious				362
4060	1 pts		Thrombophlebitis	serious				362
4061	1 pts		Haemothorax	serious				362
4062	1 pts		Pulmonary embolism	serious				362
4063	1 pts		Anal fissure	serious				362
4064	1 pts		Aphthous stomatitis	serious				362
4065	1 pts		Diarrhoea	serious				362
4066	1 pts		Duodenal ulcer	serious				362
4067	4 pts		Hernia inguinal	serious				362
4068	1 pts		Intestinal functional disorder	serious				362
4069	1 pts		Cholecystitis chronic	serious				362
4070	1 pts		Hepatitis toxic	serious				362
4071	1 pts		Necrosis skin	serious				362
4072	1 pts		Arthralgia	serious				362
4073	1 pts		Tendonitis	serious				362
4074	1 pts		Colic renal	serious				362
4075	1 pts		Urethral stenosis	serious				362
4076	1 pts		Abortion missed	serious				362
4077	2 pts		Abortion spontaneous	serious				362
4078	1 pts		Post abortion haemorrhage	serious				362
4079	1 pts		Menorrhagia	serious				362
4080	1 pts		Haemorrhage uterine	serious				362
4081	1 pts		Uterine polyp	serious				362
4082	1 pts		Asthenia	serious				362
4083	1 pts		Hepatic enzyme increased	serious				362
4084	1 pts		Neutrophil count decreased	serious				362
4085	2 pts		Ankle fracture	serious				362
4086	1 pts		Burns third degree	serious				362
4087	1 pts		Fall	serious				362
4088	1 pts		Hand fracture	serious				362
4089	1 pts		Ligament injury	serious				362
4090	1 pts		Muscle strain	serious				362
4091	1 pts		Post-traumatic pain	serious				362
4092	1 pts		Spinal compression fracture	serious				362
4093	1 pts		Tibia fracture	serious				362
4094	29 pts		Bronchitis	below serious				362
4095	20 pts		Gastroenteritis	below serious				362
4096	43 pts		Influenza	below serious				362
4097	23 pts		Sinusitis	below serious				362
4098	32 pts		Upper respiratory tract infection	below serious				362
4099	36 pts		Urinary tract infection	below serious				362
4100	33 pts		Depression	below serious				362
4101	17 pts		Dizziness	below serious				362
4102	67 pts		Headache	below serious				362
4103	35 pts		Paraesthesia	below serious				362
4104	19 pts		Cough	below serious				362
4105	20 pts		Abdominal pain upper	below serious				362
4106	64 pts		Diarrhoea	below serious				362
4107	49 pts		Nausea	below serious				362
4108	18 pts		Vomiting	below serious				362
4109	47 pts		Alopecia	below serious				362
4110	19 pts		Rash	below serious				362
4111	52 pts		Fatigue	below serious				362
4112	47 pts		Alanine aminotransferase increased	below serious				362
4113	3.6		ALT increased		discontinuation			365
4114	0.4		Hepatic enzyme increased		discontinuation			365
4115	4.7		ALT increased		discontinuation			366
4116	4.7		AST increased		discontinuation			366
4117	4.7		Neutropenia		discontinuation			366
4118						No serious adverse events occurred during the time the patient was admitted (<24 h). No long-term overdose-related symptoms or complaints were reported.		364
4119			Hepatotoxicity		discontinuation	WARNING		368
4120			Liver injury	severe	discontinuation	WARNING		368
4121			Liver failure	grade 5	discontinuation	WARNING		368
4122			Disorder fetal		discontinuation	WARNING		368
4123	1.9		Peripheral neuropathy		discontinuation			369
4124	2.6		ALT increased		discontinuation			367
4125						No information on AEs is available		372
4126						No information on AEs is available		370
4127	29 pts		Thrombocytopenia		discontinuation	leads to discontinuation		371
4128	17 pts		Elevated liver enzymes		discontinuation	leads to discontinuation		371
4129	11 pts		Neutropenia		discontinuation	leads to discontinuation		371
4130	18 pts		Anaemia	serious				373
4131	1 pts		Anaemia iron deficiency	serious				373
4132	1 pts		Neutropenia	serious				373
4133	1 pts		Pancytopenia	serious				373
4134	10 pts		Atrial fibrillation	serious				373
4135	11 pts		Acute myocardial infarction	serious				373
4136	5 pts		Acute coronary syndrome	serious				373
4137	3 pts		Angina pectoris	serious				373
4138	1 pts		Congestive cardiomyopathy	serious				373
4139	1 pts		Hypertensive heart disease	serious				373
4140	1 pts		Ventricular extrasystoles	serious				373
4141	1 pts		Vertigo	serious				373
4142	1 pts		Goitre	serious				373
4143	1 pts		Inappropriate antidiuretic hormone secretion	serious				373
4144	1 pts		Cataract	serious				373
4145	2 pts		Retinal artery occlusion	serious				373
4146	3 pts		Diarrhoea	serious				373
4147	3 pts		Nausea	serious				373
4148	4 pts		Upper gastrointestinal haemorrhage	serious				373
4149	2 pts		Small intestinal obstruction	serious				373
4150	2 pts		Duodenal ulcer haemorrhage	serious				373
4151	1 pts		Abdominal pain lower	serious				373
4152	1 pts		Diverticulum intestinal haemorrhagic	serious				373
4153	2 pts		Gastric ulcer haemorrhage	serious				373
4154	1 pts		Large intestine polyp	serious				373
4155	2 pts		Lower gastrointestinal haemorrhage	serious				373
4156	1 pts		Pancreatitis acute	serious				373
4157	1 pts		Peritoneal haemorrhage	serious				373
4158	1 pts		Haemorrhage peritoneal	serious				373
4159	1 pts		Rectal stenosis	serious				373
4160	1 pts		Subileus	serious				373
4161	1 pts		Duodenal ulcer	serious				373
4162	1 pts		Gastritis	serious				373
4163	15 pts		General physical health deterioration	serious				373
4164	10 pts		Disease progression	serious				373
4165	5 pts		Death	serious				373
4166	5 pts		Fatigue	serious				373
4167	2 pts		Gait disturbance	serious				373
4168	3 pts		Pain	serious				373
4169	2 pts		Pyrexia	serious				373
4170	1 pts		Chest pain	serious				373
4171	1 pts		Drowning	serious				373
4172	1 pts		Oedema generalized	serious				373
4173	2 pts		Non-cardiac chest pain	serious				373
4174	1 pts		Oedema	serious				373
4175	1 pts		Adverse drug reaction	serious				373
4176	2 pts		Device occlusion	serious				373
4177	1 pts		Local swelling	serious				373
4178	1 pts		Hepatic failure	serious				373
4179	1 pts		Hepatic function abnormal	serious				373
4180	1 pts		Jaundice	serious				373
4181	1 pts		Jaundice cholestatic	serious				373
4182	1 pts		Drug hypersensitivity	serious				373
4183	14 pts		Pneumonia	serious				373
4184	8 pts		Urinary tract infection	serious				373
4185	5 pts		Urosepsis	serious				373
4186	4 pts		Gastroenteritis	serious				373
4187	2 pts		Device related infection	serious				373
4188	2 pts		Cellulitis	serious				373
4189	1 pts		Appendicitis perforated	serious				373
4190	2 pts		Diverticulitis	serious				373
4191	1 pts		Gastroenteritis staphylococcal	serious				373
4192	2 pts		Lower respiratory tract infection	serious				373
4193	1 pts		Peritonitis	serious				373
4194	1 pts		Wound infection	serious				373
4195	1 pts		Chronic sinusitis	serious				373
4196	12 pts		Fall	serious				373
4197	7 pts		Femoral neck fracture	serious				373
4198	3 pts		Femur fracture	serious				373
4199	4 pts		Spinal compression fracture	serious				373
4200	2 pts		Road traffic accident	serious				373
4201	4 pts		Humerus fracture	serious				373
4202	3 pts		Wrist fracture	serious				373
4203	3 pts		Hip fracture	serious				373
4204	2 pts		Toxicity to various agents	serious				373
4205	2 pts		Cystitis radiation	serious				373
4206	1 pts		Clavicle fracture	serious				373
4207	1 pts		Extradural haematoma	serious				373
4208	1 pts		Facial bones fracture	serious				373
4209	1 pts		Foreign body	serious				373
4210	2 pts		Gastroenteritis radiation	serious				373
4211	1 pts		Head injury	serious				373
4212	1 pts		Radius fracture	serious				373
4213	1 pts		Skeletal injury	serious				373
4214	1 pts		Traumatic fracture	serious				373
4215	1 pts		Traumatic intracranial haemorrhage	serious				373
4216	1 pts		Upper limb fracture	serious				373
4217	1 pts		Contrast media reaction	serious				373
4218	1 pts		Contusion	serious				373
4219	2 pts		Lower limb fracture	serious				373
4220	1 pts		Procedural pain	serious				373
4221	2 pts		Vascular pseudoaneurysm	serious				373
4222	2 pts		Haemoglobin decreased	serious				373
4223	1 pts		Coagulation time prolonged	serious				373
4224	1 pts		Electrocardiogram repolarisation abnormality	serious				373
4225	1 pts		Weight decreased	serious				373
4226	3 pts		Hypercalcaemia	serious				373
4227	1 pts		Hyperkalaemia	serious				373
4228	2 pts		Hypokalaemia	serious				373
4229	1 pts		Type 2 diabetes mellitus	serious				373
4230	1 pts		Metabolic acidosis	serious				373
4231	15 pts		Fracture pathological	serious				373
4232	8 pts		Osteoarthritis	serious				373
4233	4 pts		Intervertebral disc protrusion	serious				373
4234	2 pts		Arthralgia	serious				373
4235	2 pts		Spinal column stenosis	serious				373
4236	1 pts		Musculoskeletal pain	serious				373
4237	1 pts		Myalgia	serious				373
4238	1 pts		Rhabdomyolysis	serious				373
4239	1 pts		Osteoarthritis spinal	serious				373
4240	1 pts		Arthritis	serious				373
4241	18 pts		Metastatic pain	serious				373
4242	2 pts		Gastric cancer	serious				373
4243	4 pts		Transitional cell carcinoma	serious				373
4244	2 pts		Adenocarcinoma of colon	serious				373
4245	2 pts		Metastases to central nervous system	serious				373
4246	2 pts		Metastases to spine	serious				373
4247	2 pts		Rectal cancer	serious				373
4248	2 pts		Malignant melanoma	serious				373
4249	2 pts		Tonsil cancer	serious				373
4250	1 pts		Adenocarcinoma gastric	serious				373
4251	1 pts		Bladder cancer	serious				373
4252	1 pts		Bladder transitional cell carcinoma	serious				373
4253	1 pts		Colon cancer	serious				373
4254	1 pts		Colorectal cancer	serious				373
4255	3 pts		Hepatocellular carcinoma	serious				373
4256	1 pts		Intestinal adenocarcinoma	serious				373
4257	1 pts		Lung neoplasm malignant	serious				373
4258	1 pts		Metastases to bladder	serious				373
4259	2 pts		Metastases to bone	serious				373
4260	1 pts		Metastases to bone marrow	serious				373
4261	1 pts		Metastases to breast	serious				373
4262	1 pts		Metastases to peritoneum	serious				373
4263	1 pts		Osteosarcoma	serious				373
4264	1 pts		Renal cell carcinoma	serious				373
4265	1 pts		Small cell lung cancer limited stage	serious				373
4266	1 pts		Thyroid adenoma	serious				373
4267	1 pts		Tumour pain	serious				373
4268	3 pts		B-cell lymphoma	serious				373
4269	1 pts		Gastrointestinal stromal tumour	serious				373
4270	35 pts		Spinal cord compression	serious				373
4271	8 pts		Syncope	serious				373
4272	7 pts		Cerebrovascular accident	serious				373
4273	4 pts		Cauda equina syndrome	serious				373
4274	6 pts		Transient ischaemic attack	serious				373
4275	3 pts		Presyncope	serious				373
4276	1 pts		Ataxia	serious				373
4277	2 pts		Cerebral infarction	serious				373
4278	1 pts		Cervicobrachial syndrome	serious				373
4279	1 pts		Meningorrhagia	serious				373
4280	1 pts		Spinal cord ischaemia	serious				373
4281	2 pts		Haemorrhage subarachnoid	serious				373
4282	1 pts		Neuralgia	serious				373
4283	6 pts		Renal failure acute	serious				373
4284	3 pts		Haemorrhage urinary bladder	serious				373
4285	3 pts		Renal failure	serious				373
4286	1 pts		Renal failure chronic	serious				373
4287	1 pts		Urine flow decreased	serious				373
4288	1 pts		Bladder neck obstruction	serious				373
4289	1 pts		Pelvic pain	serious				373
4290	1 pts		Prostatic obstruction	serious				373
4291	1 pts		Prostatitis	serious				373
4292	1 pts		Testicular pain	serious				373
4293	5 pts		Chronic obstructive pulmonary disease	serious				373
4294	3 pts		Dyspnoea	serious				373
4295	2 pts		Pleural effusion	serious				373
4296	1 pts		Acute pulmonary oedema	serious				373
4297	1 pts		Aspiration	serious				373
4298	1 pts		Haemothorax	serious				373
4299	1 pts		Hydrothorax	serious				373
4300	1 pts		Nasal polyps	serious				373
4301	1 pts		Organising pneumonia	serious				373
4302	3 pts		Aspiration pneumonia	serious				373
4303	1 pts		Pneumonitis	serious				373
4304	1 pts		Tracheal obstruction extrinsic	serious				373
4305	2 pts		Toxic skin eruption	serious				373
4306	1 pts		Rash	serious				373
4307	1 pts		Swelling face	serious				373
4308	1 pts		Cancer hormonal therapy	serious				373
4309	4 pts		Deep vein thrombosis	serious				373
4310	4 pts		Hypertension	serious				373
4311	1 pts		Aortic aneurysm rupture	serious				373
4312	2 pts		Circulatory collapse	serious				373
4313	1 pts		Hypovolaemic shock	serious				373
4314	1 pts		Lymphoedema	serious				373
4315	1 pts		Aortic stenosis	serious				373
4316	1 pts		Subclavian artery stenosis	serious				373
4317	1 pts		Haemolytic uraemic syndrome	serious				373
4318	2 pts		Idiopathic thrombocytopenic purpura	serious				373
4319	1 pts		Lymphadenopathy	serious				373
4320	1 pts		Atrioventricular block complete	serious				373
4321	1 pts		Bradycardia	serious				373
4322	3 pts		Cardiac arrest	serious				373
4323	5 pts		Cardiac failure	serious				373
4324	2 pts		Cardiac failure congestive	serious				373
4325	1 pts		Cardiopulmonary failure	serious				373
4326	6 pts		Coronary artery disease	serious				373
4327	2 pts		Left ventricular failure	serious				373
4328	1 pts		Mitral valve disease	serious				373
4329	6 pts		Myocardial infarction	serious				373
4330	2 pts		Supraventricular tachycardia	serious				373
4331	1 pts		Ventricular fibrillation	serious				373
4332	1 pts		Wolff-Parkinson-White syndrome	serious				373
4333	1 pts		Eyelid ptosis	serious				373
4334	1 pts		Retinal vein occlusion	serious				373
4335	1 pts		Anal stenosis	serious				373
4336	1 pts		Gastrointestinal ulcer	serious				373
4337	1 pts		Ileus	serious				373
4338	1 pts		Oesophageal spasm	serious				373
4339	1 pts		Peptic ulcer	serious				373
4340	1 pts		Device malfunction	serious				373
4341	3 pts		Multi-organ failure	serious				373
4342	1 pts		Bile duct stone	serious				373
4343	1 pts		Cholangitis	serious				373
4344	1 pts		Hepatic cyst	serious				373
4345	1 pts		Acute sinusitis	serious				373
4346	1 pts		Arthritis bacterial	serious				373
4347	1 pts		Cholecystitis infective	serious				373
4348	2 pts		Infection	serious				373
4349	1 pts		Meningitis pneumococcal	serious				373
4350	1 pts		Postoperative wound infection	serious				373
4351	1 pts		Pulmonary sepsis	serious				373
4352	1 pts		Back injury	serious				373
4353	1 pts		Cervical vertebral fracture	serious				373
4354	1 pts		Joint injury	serious				373
4355	1 pts		Post procedural bile leak	serious				373
4356	1 pts		Renal haematoma	serious				373
4357	1 pts		Fracture rib	serious				373
4358	1 pts		Spinal fracture	serious				373
4359	1 pts		Sternal fracture	serious				373
4360	1 pts		Thoracic vertebral fracture	serious				373
4361	1 pts		Biopsy	serious				373
4362	1 pts		Ejection fraction decreased	serious				373
4363	1 pts		Electrocardiogram abnormal	serious				373
4364	1 pts		Malnutrition	serious				373
4365	1 pts		Bursitis	serious				373
4366	1 pts		Synovial cyst	serious				373
4367	1 pts		Acute myeloid leukaemia	serious				373
4368	2 pts		Basal cell carcinoma	serious				373
4369	1 pts		Colorectal adenocarcinoma	serious				373
4370	1 pts		Diffuse large B-cell lymphoma	serious				373
4371	1 pts		Gastric cancer recurrent	serious				373
4372	1 pts		Gastrointestinal cancer metastatic	serious				373
4373	1 pts		Glioblastoma multiforme	serious				373
4374	1 pts		Metastases to chest wall	serious				373
4375	1 pts		Metastases to penis	serious				373
4376	1 pts		Metastatic neoplasm	serious				373
4377	1 pts		Myxofibrosarcoma	serious				373
4378	1 pts		Non-Hodgkin's lymphoma	serious				373
4379	1 pts		Plasma cell myeloma	serious				373
4380	1 pts		Small cell lung cancer	serious				373
4381	1 pts		Cervical cord compression	serious				373
4382	1 pts		Convulsion	serious				373
4383	1 pts		Cranial nerve paralysis	serious				373
4384	1 pts		Grand mal convulsion	serious				373
4385	2 pts		Haemorrhage intracranial	serious				373
4386	1 pts		Headache	serious				373
4387	1 pts		Hypoxic-ischaemic encephalopathy	serious				373
4388	1 pts		Loss of consciousness	serious				373
4389	1 pts		Neurological symptom	serious				373
4390	1 pts		Dizziness	serious				373
4391	1 pts		Delirium	serious				373
4392	1 pts		Calculus ureteric	serious				373
4393	2 pts		Nephrolithiasis	serious				373
4394	1 pts		Colic renal	serious				373
4395	1 pts		Urethral stenosis	serious				373
4396	1 pts		Bronchiectasis	serious				373
4397	2 pts		Pneumothorax	serious				373
4398	1 pts		Umbilical hernia repair	serious				373
4399	1 pts		Aneurysm	serious				373
4400	1 pts		Peripheral artery stenosis	serious				373
4401	2 pts		Calculus urinary	serious				373
4402	1 pts		Status epilepticus	serious				373
4403	76 pts		Anaemia	below serious				373
4404	211 pts		Nausea	below serious				373
4405	220 pts		Constipation	below serious				373
4406	160 pts		Diarrhoea	below serious				373
4407	56 pts		Abdominal pain	below serious				373
4408	332 pts		Fatigue	below serious				373
4409	122 pts		Asthenia	below serious				373
4410	115 pts		Oedema peripheral	below serious				373
4411	70 pts		Urinary tract infection	below serious				373
4412	74 pts		Nasopharyngitis	below serious				373
4413	61 pts		Upper respiratory tract infection	below serious				373
4414	136 pts		Fall	below serious				373
4415	122 pts		Weight decreased	below serious				373
4416	182 pts		Decreased appetite	below serious				373
4417	280 pts		Back pain	below serious				373
4418	206 pts		Arthralgia	below serious				373
4419	124 pts		Pain in extremity	below serious				373
4420	112 pts		Musculoskeletal pain	below serious				373
4421	73 pts		Musculoskeletal chest pain	below serious				373
4422	59 pts		Myalgia	below serious				373
4423	102 pts		Headache	below serious				373
4424	85 pts		Dizziness	below serious				373
4425	67 pts		Dysgeusia	below serious				373
4426	78 pts		Insomnia	below serious				373
4427	93 pts		Haematuria	below serious				373
4428	62 pts		Pollakiuria	below serious				373
4429	95 pts		Cough	below serious				373
4430	88 pts		Dyspnoea	below serious				373
4431	159 pts		Hot flush	below serious				373
4432	148 pts		Hypertension	below serious				373
4433	45 pts		Muscular weakness	below serious				373
4434	31 pts		Rash	below serious				373
4435	3 pts		Urinary retention	serious				374
4436	1 pts		Calculus bladder	serious				374
4437	1 pts		Bladder calculus	serious				374
4438	4 pts		Lung infection	serious				374
4439	1 pts		Pneumonia	serious				374
4440	1 pts		Arthritis infective	serious				374
4441	1 pts		Cellulitis	serious				374
4442	1 pts		Influenza	serious				374
4443	1 pts		Subcutaneous abscess	serious				374
4444	1 pts		Urosepsis	serious				374
4445	2 pts		Gastrointestinal haemorrhage	serious				374
4446	2 pts		Intestinal obstruction	serious				374
4447	2 pts		Upper gastrointestinal haemorrhage	serious				374
4448	1 pts		Duodenal ulcer	serious				374
4449	1 pts		Gastric mucosal lesion	serious				374
4450	1 pts		Hernia inguinal	serious				374
4451	1 pts		Small intestinal obstruction	serious				374
4452	1 pts		Muscular weakness	serious				374
4453	1 pts		Osteonecrosis of jaw	serious				374
4454	1 pts		B-cell lymphoma	serious				374
4455	2 pts		Cerebral infarction	serious				374
4456	2 pts		Dizziness	serious				374
4457	1 pts		Cerebrovascular accident	serious				374
4458	1 pts		Loss of consciousness	serious				374
4459	1 pts		Haemorrhagic anaemia	serious				374
4460	1 pts		Medical device change	serious				374
4461	1 pts		Nephrostomy tube removal	serious				374
4462	1 pts		Ureteral stent removal	serious				374
4463	2 pts		Cardiac failure	serious				374
4464	1 pts		Acute myocardial infarction	serious				374
4465	1 pts		Cardiopulmonary failure	serious				374
4466	1 pts		Supraventricular tachycardia	serious				374
4467	2 pts		Decreased appetite	serious				374
4468	1 pts		Cachexia	serious				374
4469	1 pts		Neutrophil count decreased	serious				374
4470	1 pts		Spinal compression fracture	serious				374
4471	1 pts		Prostatic haemorrhage	serious				374
4472	1 pts		Hypertension	serious				374
4473	1 pts		Cataract	serious				374
4474	19 pts		Back pain	below serious				374
4475	15 pts		Arthralgia	below serious				374
4476	17 pts		Constipation	below serious				374
4477	14 pts		Nausea	below serious				374
4478	25 pts		Fatigue	below serious				374
4479	13 pts		Nasopharyngitis	below serious				374
4480	24 pts		Decreased appetite	below serious				374
4481	17 pts		Dizziness	below serious				374
4482	16 pts		Hypertension	below serious				374
4483	10 pts		Insomnia	below serious				374
4484	10 pts		Musculoskeletal pain	below serious				374
4485	10 pts		Asthenia	below serious				374
4486	3 pts		Anaemia	serious				375
4487	1 pts		Lymph node pain	serious				375
4488	1 pts		Thrombocytopenia	serious				375
4489	1 pts		Conjunctivitis	serious				375
4490	2 pts		Abdominal distension	serious				375
4491	7 pts		Abdominal pain	serious				375
4492	1 pts		Abdominal pain upper	serious				375
4493	5 pts		Ascites	serious				375
4494	1 pts		Constipation	serious				375
4495	1 pts		Lower gastrointestinal haemorrhage	serious				375
4496	1 pts		Nausea	serious				375
4497	1 pts		Oesophageal varices haemorrhage	serious				375
4498	2 pts		Upper gastrointestinal haemorrhage	serious				375
4499	2 pts		Vomiting	serious				375
4500	2 pts		Asthenia	serious				375
4501	1 pts		Chest pain	serious				375
4502	2 pts		General physical health deterioration	serious				375
4503	2 pts		Oedema peripheral	serious				375
4504	1 pts		Pain	serious				375
4505	1 pts		Pyrexia	serious				375
4506	1 pts		Hepatic failure	serious				375
4507	1 pts		Clostridium difficile colitis	serious				375
4508	1 pts		Lower respiratory tract infection	serious				375
4509	2 pts		Sepsis	serious				375
4510	1 pts		Alanine aminotransferase increased	serious				375
4511	1 pts		Aspartate aminotransferase increased	serious				375
4512	2 pts		Blood bilirubin increased	serious				375
4513	1 pts		Blood creatinine increased	serious				375
4514	1 pts		Decreased appetite	serious				375
4515	1 pts		Fluid intake reduced	serious				375
4516	1 pts		Hyperkalaemia	serious				375
4517	1 pts		Metabolic acidosis	serious				375
4518	3 pts		Back pain	serious				375
4519	1 pts		Bone pain	serious				375
4520	2 pts		Muscular weakness	serious				375
4521	14 pts		Malignant neoplasm progression	serious				375
4522	1 pts		Metastases to central nervous system	serious				375
4523	2 pts		Headache	serious				375
4524	1 pts		Spinal cord compression	serious				375
4525	1 pts		Mental status changes	serious				375
4526	1 pts		Hydronephrosis	serious				375
4527	4 pts		Renal failure acute	serious				375
4528	1 pts		Cough	serious				375
4529	1 pts		Epistaxis	serious				375
4530	1 pts		Pulmonary embolism	serious				375
4531	12 pts		Anaemia	below serious				375
4532	6 pts		Abdominal distension	below serious				375
4533	14 pts		Abdominal pain	below serious				375
4534	12 pts		Ascites	below serious				375
4535	15 pts		Constipation	below serious				375
4536	9 pts		Dyspepsia	below serious				375
4537	28 pts		Nausea	below serious				375
4538	11 pts		Vomiting	below serious				375
4539	11 pts		Asthenia	below serious				375
4540	37 pts		Fatigue	below serious				375
4541	7 pts		Oedema peripheral	below serious				375
4542	16 pts		Aspartate aminotransferase increased	below serious				375
4543	15 pts		Weight decreased	below serious				375
4544	33 pts		Decreased appetite	below serious				375
4545	10 pts		Back pain	below serious				375
4546	7 pts		Headache	below serious				375
4547	13 pts		Insomnia	below serious				375
4548	12 pts		Gynaecomastia	below serious				375
4549	11 pts		Cough	below serious				375
4550	13 pts		Pruritus	below serious				375
4551	6 pts		Hypertension	below serious				375
4552	33		Convulsions	grade 3-4				376
4553	17		Fatigue	grade 3-4				379
4554	3		Fatigue		discontinuation	leads to discontinuation		379
4555	33		Rash		discontinuation	leads to discontinuation	TRUE	377
4556	33		Seizure		discontinuation	leads to discontinuation	TRUE	378
4557	4		Seizure		discontinuation	leads to discontinuation	TRUE	383
4558	5		Seizure		discontinuation	leads to discontinuation	TRUE	382
4559	0.9		Seizure		discontinuation	leads to discontinuation		380
4560	50.6		Asthenia	grade 1-4				380
4561	9		Asthenia	grade 3-4				380
4562	50.6		Fatigue	grade 1-4				380
4563	9		Fatigue	grade 3-4				380
4564	15.4		Peripheral edema	grade 1-4				380
4565	1		Peripheral edema	grade 3-4				380
4566	26.4		Back pain	grade 1-4				380
4567	5.3		Back pain	grade 3-4				380
4568	20.5		Arthralgia	grade 1-4				380
4569	2.5		Arthralgia	grade 3-4				380
4570	15		Musculoskeletal pain	grade 1-4				380
4571	1.3		Musculoskeletal pain	grade 3-4				380
4572	9.8		Muscular weakness	grade 1-4				380
4573	1.5		Muscular weakness	grade 3-4				380
4574	2.6		Musculoskeletal stiffness	grade 1-4				380
4575	0.3		Musculoskeletal stiffness	grade 3-4				380
4576	21.8		Diarrhea	grade 1-4				380
4577	1.1		Diarrhea	grade 3-4				380
4578	20.3		Hot flush	grade 1-4				380
4579	6.4		Hypertension	grade 1-4				380
4580	2.1		Hypertension	grade 3-4				380
4581	12.1		Headache	grade 1-4				380
4582	0.9		Headache	grade 3-4				380
4583	9.5		Dizziness	grade 1-4				380
4584	0.5		Dizziness	grade 3-4				380
4585	9.5		Vertigo	grade 1-4				380
4586	0.5		Vertigo	grade 3-4				380
4587	7.4		Cauda equina syndrome	grade 1-4				380
4588	6.6		Cauda equina syndrome	grade 3-4				380
4589	6.6		Paresthesia	grade 1-4				380
4590	4.3		Amnesia	grade 1-4				380
4591	4.3		Memory impairment	grade 1-4				380
4592	4.3		Cognitive disorder	grade 1-4				380
4593	4.3		Disturbance in attention	grade 1-4				380
4594	0.3		Amnesia	grade 3-4				380
4595	0.3		Memory impairment	grade 3-4				380
4596	0.3		Cognitive disorder	grade 3-4				380
4597	0.3		Disturbance in attention	grade 3-4				380
4598	4		Hypoesthesia	grade 1-4				380
4599	0.3		Hypoesthesia	grade 3-4				380
4600	10.9		Nasopharyngitis	grade 1-4				380
4601	10.9		Upper respiratory tract infection	grade 1-4				380
4602	10.9		Sinusitis	grade 1-4				380
4603	10.9		Rhinitis	grade 1-4				380
4604	10.9		Pharyngitis	grade 1-4				380
4605	10.9		Laryngitis	grade 1-4				380
4606	8.5		Pneumonia	grade 1-4				380
4607	8.5		Lower respiratory tract infection	grade 1-4				380
4608	8.5		Bronchitis	grade 1-4				380
4609	8.5		Lung infection	grade 1-4				380
4610	2.4		Pneumonia	grade 3-4				380
4611	2.4		Lower respiratory tract infection	grade 3-4				380
4612	2.4		Bronchitis	grade 3-4				380
4613	2.4		Lung infection	grade 3-4				380
4614	8.8		Insomnia	grade 1-4				380
4615	6.5		Anxiety	grade 1-4				380
4616	0.3		Anxiety	grade 3-4				380
4617	6.9		Hematuria	grade 1-4				380
4618	1.8		Hematuria	grade 3-4				380
4619	4.8		Pollakiuria	grade 1-4				380
4620	4.6		Fall	grade 1-4				380
4621	0.3		Fall	grade 3-4				380
4622	3.8		Pruritus	grade 1-4				380
4623	3.5		Dry skin	grade 1-4				380
4624	3.3		Epistaxis	grade 1-4				380
4625	0.1		Epistaxis	grade 3-4				380
4626	15		Neutropenia	grade 1-4				380
4627	3		Bilirubin increased	grade 1-4				380
4628	1		Infection	grade 5	discontinuation	leads to discontinuation		380
4629	1		Sepsis	grade 5	discontinuation	leads to discontinuation		380
4630	0.2		Thrombocytopenia		discontinuation	leads to discontinuation		381
4631	0.2		Colonic obstruction		discontinuation	leads to discontinuation		381
4632	0.2		Diarrhea		discontinuation	leads to discontinuation		381
4633	0.6		Fatigue		discontinuation	leads to discontinuation		381
4634	0.2		Rash		discontinuation	leads to discontinuation		381
4635	2 pts		Abdominal pain	serious				384
4636	2 pts		Acute myocardial infarction	serious				384
4637	2 pts		Carotid artery stenosis	serious				384
4638	2 pts		Cerebrovascular accident	serious				384
4639	2 pts		Constipation	serious				384
4640	2 pts		Humerus fracture	serious				384
4641	3 pts		Lobar pneumonia	serious				384
4642	5 pts		Myocardial infarction	serious				384
4643	2 pts		Disorder peripheral vascular	serious				384
4644	2 pts		Transient ischaemic attack	serious				384
4645	1 pts		Angina unstable	serious				384
4646	1 pts		Atrial fibrillation	serious				384
4647	1 pts		Atrial thrombosis	serious				384
4648	1 pts		Sick sinus syndrome	serious				384
4649	1 pts		Supraventricular tachycardia	serious				384
4650	1 pts		Retinal detachment	serious				384
4651	1 pts		Abdominal hernia	serious				384
4652	1 pts		Abdominal hernia obstructive	serious				384
4653	1 pts		Diverticulum	serious				384
4654	1 pts		Gastric haemorrhage	serious				384
4655	1 pts		Pancreatitis	serious				384
4656	1 pts		Chest pain	serious				384
4657	1 pts		Condition aggravated	serious				384
4658	1 pts		Cholecystitis	serious				384
4659	1 pts		Cholelithiasis	serious				384
4660	1 pts		Drug hypersensitivity	serious				384
4661	1 pts		Pneumonia haemophilus	serious				384
4662	1 pts		Haemophilus pneumonia	serious				384
4663	1 pts		Urosepsis	serious				384
4664	1 pts		Clavicle fracture	serious				384
4665	1 pts		Femoral neck fracture	serious				384
4666	1 pts		Intentional overdose	serious				384
4667	1 pts		Multiple drug overdose	serious				384
4668	1 pts		Open fracture	serious				384
4669	1 pts		Procedural complication	serious				384
4670	1 pts		Thoracic vertebral fracture	serious				384
4671	1 pts		Ulna fracture	serious				384
4672	1 pts		Diabetic ketoacidosis	serious				384
4673	1 pts		Arthritis	serious				384
4674	1 pts		Osteoarthritis spinal	serious				384
4675	1 pts		Bladder transitional cell carcinoma recurrent	serious				384
4676	1 pts		Breast cancer	serious				384
4677	1 pts		Bronchioloalveolar carcinoma	serious				384
4678	1 pts		Lung adenocarcinoma metastatic	serious				384
4679	1 pts		Lung cancer metastatic	serious				384
4680	1 pts		Squamous cell carcinoma	serious				384
4681	1 pts		T-cell lymphoma	serious				384
4682	1 pts		Cerebral infarction	serious				384
4683	1 pts		Convulsion	serious				384
4684	1 pts		Myelopathy	serious				384
4685	1 pts		Presyncope	serious				384
4686	1 pts		Anxiety	serious				384
4687	1 pts		Depression	serious				384
4688	1 pts		Scleroderma renal crisis	serious				384
4689	1 pts		Acute respiratory failure	serious				384
4690	1 pts		Pulmonary embolism	serious				384
4691	1 pts		Angioneurotic oedema	serious				384
4692	85 pts		Headache	below serious				384
4693	76 pts		Nasopharyngitis	below serious				384
4694	65 pts		Upper respiratory tract infection	below serious				384
4695	42 pts		Diarrhoea	below serious				384
4696	29 pts		Cough	below serious				384
4697	27 pts		Hypertension	below serious				384
4698	27 pts		Sinusitis	below serious				384
4699	1 pts		Acute myocardial infarction	serious				385
4700	2 pts		Angina unstable	serious				385
4701	1 pts		Atrioventricular block	serious				385
4702	1 pts		Cardiac failure	serious				385
4703	1 pts		Cardiac fibrillation	serious				385
4704	1 pts		Extrasystoles	serious				385
4705	1 pts		Mitral valve incompetence	serious				385
4706	1 pts		Angle closure glaucoma	serious				385
4707	1 pts		Cataract cortical	serious				385
4708	1 pts		Open angle glaucoma	serious				385
4709	1 pts		Retinal detachment	serious				385
4710	1 pts		Acute abdomen	serious				385
4711	1 pts		Diarrhoea	serious				385
4712	1 pts		Intestinal ischaemia	serious				385
4713	1 pts		Pancreatitis acute	serious				385
4714	1 pts		Chest pain	serious				385
4715	2 pts		Sudden cardiac death	serious				385
4716	8 pts		Pneumonia	serious				385
4717	1 pts		Sepsis	serious				385
4718	1 pts		Femur fracture	serious				385
4719	1 pts		Foot fracture	serious				385
4720	1 pts		Bladder cancer	serious				385
4721	1 pts		Bladder cancer recurrent	serious				385
4722	1 pts		Bronchial carcinoma	serious				385
4723	1 pts		Adenocarcinoma lung	serious				385
4724	1 pts		Lung neoplasm malignant	serious				385
4725	1 pts		Meningioma	serious				385
4726	1 pts		Metastatic bronchial carcinoma	serious				385
4727	1 pts		Metastatic malignant melanoma	serious				385
4728	1 pts		Pancreatic carcinoma	serious				385
4729	1 pts		Renal neoplasm	serious				385
4730	1 pts		Tongue neoplasm malignant stage unspecified	serious				385
4731	1 pts		Transitional cell carcinoma	serious				385
4732	1 pts		Dizziness	serious				385
4733	1 pts		Ischaemic stroke	serious				385
4734	1 pts		Sciatica	serious				385
4735	1 pts		Depression suicidal	serious				385
4736	1 pts		Renal failure acute	serious				385
4737	1 pts		Phimosis	serious				385
4738	1 pts		Acute respiratory failure	serious				385
4739	2 pts		Epistaxis	serious				385
4740	1 pts		Pneumothorax	serious				385
4741	2 pts		Pulmonary embolism	serious				385
4742	1 pts		Vocal cord polyp	serious				385
4743	1 pts		Cardiovascular insufficiency	serious				385
4744	1 pts		Deep vein thrombosis	serious				385
4745	1 pts		Femoral artery occlusion	serious				385
4746	1 pts		Hypertensive crisis	serious				385
4747	1 pts		Iliac artery embolism	serious				385
4748	1 pts		Iliac artery thrombosis	serious				385
4749	1 pts		Peripheral ischaemia	serious				385
4750	102 pts		Nasopharyngitis	below serious				385
4751	30 pts		Back pain	below serious				385
4752	29 pts		Cough	below serious				385
4753	1 pts		Ileitis	serious				386
4754	1 pts		Diverticulum	serious				386
4755	5 pts		Cough	below serious				386
4756	5 pts		Upper respiratory tract infection	below serious				386
4757	5 pts		Appendicitis	serious				388
4758	1 pts		Infectious colitis	serious				388
4759	1 pts		Arthritis bacterial	serious				388
4760	14 pts		Cellulitis	serious				388
4761	1 pts		Peritonitis bacterial	serious				388
4762	3 pts		Pneumonia bacterial	serious				388
4763	1 pts		Osteomyelitis	serious				388
4764	1 pts		Extradural abscess	serious				388
4765	2 pts		Clostridium difficile colitis	serious				388
4766	1 pts		Tongue abscess	serious				388
4767	1 pts		Tooth abscess	serious				388
4768	66 pts		Pneumonia	serious				388
4769	1 pts		Pulmonary sepsis	serious				388
4770	1 pts		Septic shock	serious				388
4771	1 pts		Urosepsis	serious				388
4772	1 pts		Pneumococcal pneumonia	serious				388
4773	1 pts		Streptococcal bacteraemia	serious				388
4774	1 pts		Tuberculosis	serious				388
4775	1 pts		Cystitis	serious				388
4776	2 pts		Pyelonephritis	serious				388
4777	2 pts		Gastroenteritis viral	serious				388
4778	1 pts		Pneumonia viral	serious				388
4779	1 pts		Anal cancer	serious				388
4780	1 pts		Anal canal cancer	serious				388
4781	1 pts		Bladder transitional cell carcinoma	serious				388
4782	1 pts		Carcinoid tumour of the stomach	serious				388
4783	1 pts		Adenocarcinoma of colon	serious				388
4784	1 pts		Dermatofibrosarcoma protuberans	serious				388
4785	2 pts		Hepatic cancer	serious				388
4786	2 pts		Hepatic cancer metastatic	serious				388
4787	1 pts		Hepatocellular carcinoma	serious				388
4788	1 pts		Hepatic adenoma	serious				388
4789	1 pts		Laryngeal cancer	serious				388
4790	1 pts		Benign meningioma	serious				388
4791	1 pts		Adenocarcinoma	serious				388
4792	1 pts		Metastatic squamous cell carcinoma	serious				388
4793	4 pts		Squamous cell carcinoma	serious				388
4794	1 pts		Squamous cell carcinoma of head and neck	serious				388
4795	1 pts		Non-Hodgkin's lymphoma	serious				388
4796	5 pts		Adenocarcinoma lung	serious				388
4797	1 pts		Lung adenocarcinoma stage IV	serious				388
4798	1 pts		Adenocarcinoma lung stage IV	serious				388
4799	1 pts		Lung cancer non-small cell stage IIIB	serious				388
4800	6 pts		Squamous cell carcinoma of lung	serious				388
4801	1 pts		Oesophageal carcinoma	serious				388
4802	1 pts		Pancreatic carcinoma	serious				388
4803	4 pts		Prostate cancer	serious				388
4804	1 pts		Clear cell renal cell carcinoma	serious				388
4805	2 pts		Renal cell carcinoma	serious				388
4806	1 pts		Lung neoplasm	serious				388
4807	1 pts		Lung cancer metastatic	serious				388
4808	6 pts		Lung neoplasm malignant	serious				388
4809	2 pts		Malignant melanoma	serious				388
4810	1 pts		Bowen's disease	serious				388
4811	2 pts		Transitional cell carcinoma	serious				388
4812	1 pts		Vaginal cancer stage 0	serious				388
4813	6 pts		Anaemia	serious				388
4814	1 pts		Haemorrhagic anaemia	serious				388
4815	1 pts		Immune thrombocytopenic purpura	serious				388
4816	3 pts		Drug hypersensitivity	serious				388
4817	1 pts		Diabetic ketoacidosis	serious				388
4818	1 pts		Gout	serious				388
4819	1 pts		Obesity	serious				388
4820	5 pts		Hyperglycaemia	serious				388
4821	1 pts		Lactic acidosis	serious				388
4822	4 pts		Hyponatraemia	serious				388
4823	4 pts		Dehydration	serious				388
4824	2 pts		Anxiety	serious				388
4825	1 pts		Substance use disorder	serious				388
4826	1 pts		Basal ganglia haemorrhage	serious				388
4827	1 pts		Carotid artery occlusion	serious				388
4828	9 pts		Cerebrovascular accident	serious				388
4829	1 pts		Lacunar infarction	serious				388
4830	1 pts		Carotid artery disease	serious				388
4831	7 pts		Syncope	serious				388
4832	1 pts		Paraplegia	serious				388
4833	1 pts		Neuropathy peripheral	serious				388
4834	1 pts		Radiculopathy	serious				388
4835	8 pts		Transient ischaemic attack	serious				388
4836	1 pts		Retinal aneurysm	serious				388
4837	1 pts		Macular fibrosis	serious				388
4838	1 pts		Vertigo positional	serious				388
4839	2 pts		Atrioventricular block second degree	serious				388
4840	1 pts		Hypertensive heart disease	serious				388
4841	1 pts		Cardiomyopathy	serious				388
4842	1 pts		Ischaemic cardiomyopathy	serious				388
4843	21 pts		Coronary artery disease	serious				388
4844	2 pts		Coronary artery occlusion	serious				388
4845	2 pts		Coronary artery stenosis	serious				388
4846	21 pts		Cardiac failure congestive	serious				388
4847	14 pts		Acute myocardial infarction	serious				388
4848	10 pts		Angina pectoris	serious				388
4849	7 pts		Angina unstable	serious				388
4850	1 pts		Pericardial effusion	serious				388
4851	3 pts		Bradycardia	serious				388
4852	1 pts		Tachycardia	serious				388
4853	2 pts		Right ventricular failure	serious				388
4854	24 pts		Atrial fibrillation	serious				388
4855	4 pts		Atrial flutter	serious				388
4856	1 pts		Sinus tachycardia	serious				388
4857	6 pts		Cardiac arrest	serious				388
4858	1 pts		Cardio-respiratory arrest	serious				388
4859	1 pts		Pulseless electrical activity	serious				388
4860	1 pts		Ventricular arrhythmia	serious				388
4861	1 pts		Ventricular extrasystoles	serious				388
4862	3 pts		Ventricular tachycardia	serious				388
4863	4 pts		Aortic aneurysm	serious				388
4864	1 pts		Aortic occlusion	serious				388
4865	1 pts		Shock	serious				388
4866	1 pts		Haematoma	serious				388
4867	2 pts		Peripheral venous disease	serious				388
4868	5 pts		Deep vein thrombosis	serious				388
4869	1 pts		Pelvic venous thrombosis	serious				388
4870	1 pts		Superficial thrombophlebitis	serious				388
4871	3 pts		Disorder peripheral vascular	serious				388
4872	2 pts		Claudication intermittent	serious				388
4873	3 pts		Peripheral arterial occlusive disease	serious				388
4874	3 pts		Hypertension	serious				388
4875	8 pts		Hypotension	serious				388
4876	1 pts		Arteriovenous fistula	serious				388
4877	1 pts		Vena cava thrombosis	serious				388
4878	1 pts		Pickwickian syndrome	serious				388
4879	2 pts		Respiratory arrest	serious				388
4880	4 pts		Hypoxia	serious				388
4881	1 pts		Pulmonary fibrosis	serious				388
4882	1 pts		Haemothorax	serious				388
4883	4 pts		Pleural effusion	serious				388
4884	1 pts		Pulmonary hypertension	serious				388
4885	2 pts		Pulmonary oedema	serious				388
4886	16 pts		Acute respiratory failure	serious				388
4887	1 pts		Chronic respiratory failure	serious				388
4888	1 pts		Gastrointestinal polyp haemorrhage	serious				388
4889	1 pts		Intestinal polyp	serious				388
4890	2 pts		Colitis ischaemic	serious				388
4891	4 pts		Small intestinal obstruction	serious				388
4892	1 pts		Duodenal ulcer haemorrhage	serious				388
4893	1 pts		Faecaloma	serious				388
4894	1 pts		Gastric haemorrhage	serious				388
4895	1 pts		Gastric ulcer haemorrhage	serious				388
4896	6 pts		Abdominal pain	serious				388
4897	1 pts		Enterovesical fistula	serious				388
4898	1 pts		Ileus	serious				388
4899	1 pts		Intestinal ischaemia	serious				388
4900	1 pts		Incarcerated inguinal hernia	serious				388
4901	2 pts		Intestinal perforation	serious				388
4902	1 pts		Large intestinal obstruction	serious				388
4903	1 pts		Large intestinal stenosis	serious				388
4904	1 pts		Haematemesis	serious				388
4905	1 pts		Melaena	serious				388
4906	1 pts		Enlargement parotid gland	serious				388
4907	1 pts		Cholangitis	serious				388
4908	1 pts		Cholangitis acute	serious				388
4909	2 pts		Cholecystitis	serious				388
4910	2 pts		Cholecystitis acute	serious				388
4911	1 pts		Jaundice cholestatic	serious				388
4912	1 pts		Stasis dermatitis	serious				388
4913	1 pts		Subcutaneous emphysema	serious				388
4914	1 pts		Bursitis	serious				388
4915	6 pts		Back pain	serious				388
4916	4 pts		Musculoskeletal chest pain	serious				388
4917	6 pts		Osteoarthritis	serious				388
4918	1 pts		Cervical spinal stenosis	serious				388
4919	4 pts		Lumbar spinal stenosis	serious				388
4920	1 pts		Spinal column stenosis	serious				388
4921	1 pts		Pollakiuria	serious				388
4922	1 pts		Bladder necrosis	serious				388
4923	1 pts		Renal mass	serious				388
4924	5 pts		Renal failure	serious				388
4925	2 pts		Renal impairment	serious				388
4926	2 pts		Nephrolithiasis	serious				388
4927	1 pts		Renal artery thrombosis	serious				388
4928	1 pts		Haematuria	serious				388
4929	1 pts		Breast mass	serious				388
4930	1 pts		Prostatomegaly	serious				388
4931	1 pts		Asthenia	serious				388
4932	1 pts		Fatigue	serious				388
4933	1 pts		Sudden death	serious				388
4934	2 pts		Systemic inflammatory response syndrome	serious				388
4935	5 pts		Chest pain	serious				388
4936	17 pts		Non-cardiac chest pain	serious				388
4937	1 pts		Hepatic enzyme increased	serious				388
4938	1 pts		Coronary vascular graft stenosis	serious				388
4939	3 pts		Haemorrhage subarachnoid	serious				388
4940	1 pts		Ankle fracture	serious				388
4941	5 pts		Femoral neck fracture	serious				388
4942	3 pts		Femur fracture	serious				388
4943	1 pts		Forearm fracture	serious				388
4944	5 pts		Hip fracture	serious				388
4945	1 pts		Humerus fracture	serious				388
4946	1 pts		Radial head dislocation	serious				388
4947	1 pts		Radius fracture	serious				388
4948	8 pts		Fall	serious				388
4949	1 pts		Fat embolism	serious				388
4950	6 pts		Road traffic accident	serious				388
4951	1 pts		Radiation dysphagia	serious				388
4952	1 pts		Radiation mucositis	serious				388
4953	1 pts		Fractured sacrum	serious				388
4954	1 pts		Spinal compression fracture	serious				388
4955	1 pts		Spinal fracture	serious				388
4956	4 pts		Fracture rib	serious				388
4957	1 pts		Device malfunction	serious				388
4958	65 pts		Sinusitis	below serious				388
4959	90 pts		Urinary tract infection	below serious				388
4960	78 pts		Viral upper respiratory tract infection	below serious				388
4961	40 pts		Anaemia	below serious				388
4962	44 pts		Dizziness	below serious				388
4963	64 pts		Hypertension	below serious				388
4964	67 pts		Cough	below serious				388
4965	60 pts		Constipation	below serious				388
4966	38 pts		Gastrooesophageal reflux disease	below serious				388
4967	77 pts		Nausea	below serious				388
4968	50 pts		Arthralgia	below serious				388
4969	40 pts		Muscle spasms	below serious				388
4970	69 pts		Back pain	below serious				388
4971	1 pts		Acute myocardial infarction	serious				387
4972	1 pts		Atrial fibrillation	serious				387
4973	1 pts		Cardiac failure acute	serious				387
4974	1 pts		Chest pain	serious				387
4975	1 pts		Bronchitis	serious				387
4976	1 pts		Chronic obstructive pulmonary disease	serious				387
4977	1 pts		Pleural effusion	serious				387
4978	8 pts		Dysgeusia	below serious				387
4979						No AEs are reported		389
4980						No AEs are reported		393
4981	12.5		Muscle spasm					390
4982	12.5		Dysgeusia					390
4983	12.5		Somnolence					390
4984	0.4		Fatigue		discontinuation	leads to discontinuation		392
4985	0.2		Non-cardiac chest pain		discontinuation	leads to discontinuation		392
4986	0.4		Dizziness		discontinuation	leads to discontinuation		392
4987	0.2		Dyspnea		discontinuation	leads to discontinuation		392
4988	2.9		COPD		discontinuation	leads to discontinuation		392
4989	0.2		Pruritus		discontinuation	leads to discontinuation		392
4990	0.3		Non-cardiac chest pain		discontinuation	leads to discontinuation		391
4991	0.2		Headache		discontinuation	leads to discontinuation		391
4992	0.2		Dyspnea		discontinuation	leads to discontinuation		391
4993	2		COPD		discontinuation	leads to discontinuation		391
4994	0.2		Pruritus		discontinuation	leads to discontinuation		391
4995	0.2		Syncope		discontinuation	leads to discontinuation		391
4996			Adverse event		discontinuation	leads to dose reduction. Specific AEs are not mentioned	TRUE	394
4997	1 pts		Sepsis	serious	discontinuation	leads to discontinuation		395
4998	1 pts		Colon cancer	serious	discontinuation	leads to discontinuation		395
4999	75		Lymphopenia	grade 3-5				395
5000	50		Thrombocytopenia	grade 3-5				395
5001	50		Anaemia	grade 3-5				395
5002	50		Neutropenia	grade 3-5				395
5003	75		Pyrexia	grade 1-2				395
5004	50		Blood creatinine increased	grade 1-2				395
5005	25		White blood cell count increased	grade 1-2				395
5006	25		White blood cell count decreased	grade 3-5				395
5007	50		Nausea	grade 1-2				395
5008	50		Stomatitis	grade 1-2				395
5009	25		Neutrophil count increased	grade 1-2				395
5010	25		Nasopharyngitis	grade 1-2				395
5011	50		Vomiting	grade 1-2				395
5012	50		C-reactive protein increased	grade 1-2				395
5013	50		Hypophosphataemia	grade 1-2				395
5014	50		Hypertension	grade 1-2				395
5015	25		Malaise	grade 1-2				395
5016	25		Aspartate aminotransferase increased	grade 1-2				395
5017	25		Blood lactate dehydrogenase increased	grade 1-2				395
5018	25		Haematocrit decreased	grade 1-2				395
5019	25		Red blood cell count decreased	grade 1-2				395
5020	25		Weight gain	grade 1-2				395
5021	2		Congestive heart failure		discontinuation	leads to discontinuation		396
5022	1		Cardiac arrest		discontinuation	leads to discontinuation		396
5023	1		Dyspnea		discontinuation	leads to discontinuation		396
5024	1		Blood creatinine increased		discontinuation	leads to discontinuation		396
5025	1		Acute renal failure		discontinuation	leads to discontinuation		396
5026	2		Pneumonia		discontinuation	leads to discontinuation		397
5027	1		Pyrexia		discontinuation	leads to discontinuation		397
5028	1		Thrombocytopenia		discontinuation	leads to discontinuation		397
5029	4 pts		Nasopharyngitis	below serious				405
5030	2 pts		Nasopharyngitis	below serious				399
5031	1 pts		Atrial fibrillation	serious				406
5032	1 pts		Angina pectoris	serious				406
5033	1 pts		Clostridial infection	serious				406
5034	1 pts		Gastroenteritis	serious				406
5035	2 pts		Prostate cancer	serious				406
5036	1 pts		Malignant melanoma	serious				406
5037	1 pts		Metastases to lymph nodes	serious				406
5038	1 pts		Cervical spinal stenosis	serious				406
5039	1 pts		Osteoarthritis	serious				406
5040	1 pts		Spinal column stenosis	serious				406
5041	1 pts		Renal failure acute	serious				406
5042	1 pts		Angioplasty	serious				406
5043	1 pts		Gastric banding	serious				406
5044	1 pts		Atrial fibrillation	serious				400
5045	1 pts		Cardiac failure	serious				400
5046	1 pts		Supraventricular tachycardia	serious				400
5047	1 pts		Appendicitis	serious				400
5048	1 pts		Sepsis	serious				400
5049	1 pts		Bladder cancer	serious				400
5050	1 pts		Colon cancer metastatic	serious				400
5051	1 pts		Lung carcinoma cell type unspecified recurrent	serious				400
5052	1 pts		Lumbar spinal stenosis	serious				400
5053	3 pts		Chest pain	serious				400
5054	1 pts		Calculus ureteric	serious				400
5055	1 pts		Haematuria	serious				400
5056	1 pts		Cerebral haemorrhage traumatic	serious				400
5057	1 pts		Post procedural haematoma	serious				400
5058	1 pts		Anemia	serious				400
5059	1 pts		Diverticulitis	serious				401
5060	1 pts		Pyelonephritis acute	serious				401
5061	1 pts		Hernia inguinal	serious				401
5062	1 pts		Non-cardiac chest pain	serious				401
5063	1 pts		Liver function test abnormal	serious				401
5064	1 pts		Breast cancer	serious				401
5065	1 pts		Orthostatic hypotension	serious				401
5066	49 pts		Hypertension	below serious				401
5067	15 pts		Nasopharyngitis	below serious				401
5068	1 pts		Bronchitis acute	serious				404
5069	1 pts		Radius fracture	serious				404
5070	1 pts		Bipolar disorder	serious				404
5071	47 pts		Hypertension	below serious				404
5072	25 pts		Nasopharyngitis	below serious				404
5073	5 pts		Nasopharyngitis	below serious				402
5074	9 pts		Hypertension	below serious				402
5075	1 pts		Abortion spontaneous	serious				407
5076	1 pts		Pelvic pain	serious				407
5077	4 pts		Dry mouth	below serious				407
5078	3 pts		Constipation	below serious				407
5079	5 pts		Nasopharyngitis	below serious				407
5080	11 pts		Hypertension	below serious				407
5081	1 pts		Acute myocardial infarction	serious				408
5082	1 pts		Atrial fibrillation	serious				408
5083	1 pts		Diverticulum	serious				408
5084	1 pts		Flatulence	serious				408
5085	1 pts		Vomiting	serious				408
5086	1 pts		Asthenia	serious				408
5087	1 pts		Chest pain	serious				408
5088	1 pts		Chills	serious				408
5089	1 pts		Non-cardiac chest pain	serious				408
5090	1 pts		Oedema peripheral	serious				408
5091	1 pts		Soft tissue infection	serious				408
5092	1 pts		Fall	serious				408
5093	1 pts		Femur fracture	serious				408
5094	1 pts		Musculoskeletal pain	serious				408
5095	1 pts		Breast cancer	serious				408
5096	1 pts		Intraductal proliferative breast lesion	serious				408
5097	1 pts		Chronic obstructive pulmonary disease	serious				408
5098	1 pts		Hypoxia	serious				408
5099	1 pts		Knee operation	serious				408
5100	23 pts		Headache	below serious				408
5101	1 pts		Headache	below serious				403
5102	3		Cardiac disorders					411
5103	3.6		Eye disorders					411
5104	1.8		Constipation					411
5105	2.4		Dyspepsia					411
5106						No AEs are reported		409
5107	0.2		Constipation		discontinuation	leads to discontinuation		398
5108	0.2		Hypertension		discontinuation	leads to discontinuation		398
5109	0.1		Tachycardia		discontinuation	leads to discontinuation		398
5110	0.5		Atrial fibrillation		discontinuation	leads to discontinuation		398
5111	0.5		Palpitations		discontinuation	leads to discontinuation		398
5112	0.5		Edema peripheral		discontinuation	leads to discontinuation		398
5113	0.5		Pyrexia		discontinuation	leads to discontinuation		398
5114	0.4		ALT increased		discontinuation	leads to discontinuation		398
5115	0.4		AST increased		discontinuation	leads to discontinuation		398
5116	0.4		Bilirubin increased		discontinuation	leads to discontinuation		398
5117	0.4		Liver enzyme abnormal		discontinuation	leads to discontinuation		398
5118	0.3		Hypertensive crisis		discontinuation	leads to discontinuation		398
5119	2		Pulse rate increased					410
5120	1 pts		Coronary artery disease	serious				412
5121	1 pts		Infected skin ulcer	serious				412
5122	1 pts		Anaemia	serious				412
5123	1 pts		Prostate cancer	serious				412
5124	1 pts		Angina pectoris	serious				412
5125	1 pts		Depression	serious				412
5126	2 pts		Cerebrovascular accident	serious				412
5127	13 pts		Diarrhoea	below serious				412
5128	6 pts		Constipation	below serious				412
5129	5 pts		Fatigue	below serious				412
5130	19 pts		Upper respiratory tract infection	below serious				412
5131	22 pts		Nasopharyngitis	below serious				412
5132	9 pts		Urinary tract infection	below serious				412
5133	5 pts		Gastroenteritis viral	below serious				412
5134	8 pts		Influenza	below serious				412
5135	5 pts		Bronchitis	below serious				412
5136	5 pts		Gastroenteritis	below serious				412
5137	32 pts		Hypoglycemia	below serious				412
5138	10 pts		Arthralgia	below serious				412
5139	16 pts		Headache	below serious				412
5140	11 pts		Dizziness	below serious				412
5141	5 pts		Cough	below serious				412
5142	6 pts		Hypertension	below serious				412
5143	5 pts		Depression	below serious				412
5144	8 pts		Back pain	below serious				412
5145	1 pts		Uterine leiomyoma	serious				415
5146	1 pts		Thymoma	serious				415
5147	1 pts		Abdominal abscess	serious				415
5148	2 pts		Non-cardiac chest pain	serious				415
5149	1 pts		Coronary artery occlusion	serious				415
5150	1 pts		Hypotension	serious				415
5151	1 pts		Osteoarthritis	serious				415
5152	2 pts		Gastroenteritis	serious				415
5153	1 pts		Conversion disorder	serious				415
5154	1 pts		Back pain	serious				415
5155	1 pts		Intervertebral disc protrusion	serious				415
5156	1 pts		Anaphylactic shock	serious				415
5157	1 pts		Dehydration	serious				415
5158	1 pts		Cholecystitis	serious				415
5159	1 pts		Adverse drug reaction	serious				415
5160	24 pts		Nausea	below serious				415
5161	19 pts		Fatigue	below serious				415
5162	29 pts		Nasopharyngitis	below serious				415
5163	23 pts		Urinary tract infection	below serious				415
5164	18 pts		Gastroenteritis viral	below serious				415
5165	15 pts		Influenza	below serious				415
5166	8 pts		Gastroenteritis	below serious				415
5167	13 pts		Procedural pain	below serious				415
5168	75 pts		Hypoglycemia	below serious				415
5169	37 pts		Headache	below serious				415
5170	18 pts		Dizziness	below serious				415
5171	21 pts		Cough	below serious				415
5172	13 pts		Hypertension	below serious				415
5173	6 pts		Depression	below serious				415
5174	30 pts		Back pain	below serious				415
5175	2 pts		Cholelithiasis	serious				413
5176	1 pts		Meniscus lesion	serious				413
5177	1 pts		Uterine leiomyoma	serious				413
5178	1 pts		Non-cardiac chest pain	serious				413
5179	1 pts		Arthralgia	serious				413
5180	1 pts		Back injury	serious				413
5181	1 pts		Foot fracture	serious				413
5182	1 pts		Prostate cancer	serious				413
5183	1 pts		Abscess limb	serious				413
5184	1 pts		Cellulitis staphylococcal	serious				413
5185	1 pts		Arthropathy psoriatic	serious				413
5186	1 pts		Abdominal pain	serious				413
5187	1 pts		Tibia fracture	serious				413
5188	1 pts		Neoplasm thyroid	serious				413
5189	1 pts		Migraine	serious				413
5190	1 pts		Uterine mass	serious				413
5191	1 pts		Heart rate increased	serious				413
5192	1 pts		Nasal turbinate hypertrophy	serious				413
5193	1 pts		Oral mucosal hypertrophy	serious				413
5194	1 pts		Tonsillar hypertrophy	serious				413
5195	1 pts		Nasal septum deviation	serious				413
5196	1 pts		Intervertebral disc displacement	serious				413
5197	2 pts		Lumbar spinal stenosis	serious				413
5198	1 pts		Atrial fibrillation	serious				413
5199	1 pts		Sick sinus syndrome	serious				413
5200	1 pts		Vertigo	serious				413
5201	1 pts		Arthritis	serious				413
5202	1 pts		Cervical dysplasia	serious				413
5203	1 pts		Tendon rupture	serious				413
5204	2 pts		Gastritis	serious				413
5205	1 pts		Lymphadenopathy	serious				413
5206	1 pts		Ovarian adenoma	serious				413
5207	1 pts		Transient ischaemic attack	serious				413
5208	61 pts		Nausea	below serious				413
5209	41 pts		Constipation	below serious				413
5210	27 pts		Dry mouth	below serious				413
5211	53 pts		Fatigue	below serious				413
5212	61 pts		Urinary tract infection	below serious				413
5213	55 pts		Back pain	below serious				413
5214	125 pts		Headache	below serious				413
5215	50 pts		Dizziness	below serious				413
5216	1 pts		Hypertension	serious				416
5217	1 pts		Musculoskeletal chest pain	serious				416
5218	2 pts		Cholelithiasis	serious				416
5219	2 pts		Breast cancer	serious				416
5220	1 pts		Muscular weakness	serious				416
5221	1 pts		Adenocarcinoma lung	serious				416
5222	1 pts		Meniscus lesion	serious				416
5223	1 pts		Pneumonia	serious				416
5224	1 pts		Uterine leiomyoma	serious				416
5225	1 pts		Menorrhagia	serious				416
5226	1 pts		Dysmenorrhoea	serious				416
5227	1 pts		Acute myocardial infarction	serious				416
5228	1 pts		Meningitis aseptic	serious				416
5229	1 pts		Angina pectoris	serious				416
5230	2 pts		Dyspnoea	serious				416
5231	1 pts		Alcoholic psychosis	serious				416
5232	1 pts		Neuroendocrine carcinoma	serious				416
5233	1 pts		Pleural effusion	serious				416
5234	1 pts		Hypoaesthesia facial	serious				416
5235	2 pts		Multiple myeloma	serious				416
5236	3 pts		Cellulitis	serious				416
5237	1 pts		Nausea	serious				416
5238	1 pts		Intestinal perforation	serious				416
5239	1 pts		Mental disorder	serious				416
5240	1 pts		Suicidal ideation	serious				416
5241	1 pts		Acute coronary syndrome	serious				416
5242	3 pts		Myocardial infarction	serious				416
5243	1 pts		Arthropod bite	serious				416
5244	1 pts		Non-cardiac chest pain	serious				416
5245	1 pts		Back pain	serious				416
5246	1 pts		Syncope	serious				416
5247	1 pts		Pericarditis	serious				416
5248	1 pts		Gastroenteritis	serious				416
5249	1 pts		Urinary tract infection	serious				416
5250	1 pts		Hand fracture	serious				416
5251	1 pts		Animal bite	serious				416
5252	1 pts		Biliary dyskinesia	serious				416
5253	1 pts		Depression	serious				416
5254	1 pts		Acute psychosis	serious				416
5255	1 pts		Chest discomfort	serious				416
5256	1 pts		Splenic rupture	serious				416
5257	1 pts		Arthralgia	serious				416
5258	3 pts		Cholecystitis	serious				416
5259	145 pts		Nausea	below serious				416
5260	98 pts		Diarrhoea	below serious				416
5261	80 pts		Constipation	below serious				416
5262	87 pts		Dry mouth	below serious				416
5263	134 pts		Fatigue	below serious				416
5264	204 pts		Upper respiratory tract infection	below serious				416
5265	201 pts		Nasopharyngitis	below serious				416
5266	122 pts		Sinusitis	below serious				416
5267	107 pts		Urinary tract infection	below serious				416
5268	101 pts		Back pain	below serious				416
5269	250 pts		Headache	below serious				416
5270	140 pts		Dizziness	below serious				416
5271	1 pts		Atrial fibrillation	serious				417
5272	1 pts		Palpitations	serious				417
5273	1 pts		Chest pain	serious				417
5274	1 pts		Bile duct stone	serious				417
5275	1 pts		Cholecystitis acute	serious				417
5276	1 pts		Cholelithiasis	serious				417
5277	1 pts		Chronic obstructive pulmonary disease	serious				417
5278	1 pts		Dyspnoea	serious				417
5279	16 pts		Nausea	below serious				417
5280	12 pts		Constipation	below serious				417
5281	10 pts		Dry mouth	below serious				417
5282	11 pts		Fatigue	below serious				417
5283	19 pts		Headache	below serious				417
5284	9 pts		Dizziness	below serious				417
5285	8 pts		Abnormal dreams	below serious				417
5286	6 pts		Insomnia	below serious				417
5287	1 pts		Cellulitis	serious				414
5288	1 pts		Animal bite	serious				414
5289	1 pts		Wound	serious				414
5290	1 pts		Wrist fracture	serious				414
5291	1 pts		Blood carbon monoxide increased	serious				414
5292	1 pts		Pain in extremity	serious				414
5293	1 pts		Bipolar disorder	serious				414
5294	1 pts		Suicidal ideation	serious				414
5295	13 pts		Constipation	below serious				414
5296	7 pts		Dry mouth	below serious				414
5297	6 pts		Fatigue	below serious				414
5298	23 pts		Headache	below serious				414
5299	11 pts		Dizziness	below serious				414
5300	8 pts		Abnormal dreams	below serious				414
5301	20 pts		Abdominal distress	below serious				418
5302	19 pts		Headache	below serious				418
5303	16 pts		Anxiety depression	below serious				418
5304	11 pts		Rash	below serious				418
5305	1.3		Headache		discontinuation	leads to discontinuation		420
5306	0.9		Depression		discontinuation	leads to discontinuation		420
5307	0.7		Dizziness		discontinuation	leads to discontinuation		420
5308	0.2		Migraine		discontinuation	leads to discontinuation		421
5309	<0.1		Convulsion		discontinuation	leads to discontinuation		421
5310	0.4		Anxiety		discontinuation	leads to discontinuation		421
5311	0.2		Suicidal ideation		discontinuation	leads to discontinuation		421
5312	0.2		Depressed mood		discontinuation	leads to discontinuation		421
5313	1 pts		Nausea					419
5314	1 pts		Inappropriate laughter					419
5315	1 pts		Disorientation					419
5316	3 pts		Nasopharyngitis	below serious				422
5317	8 pts		Headache	below serious				422
5318	5 pts		Flushing	below serious				422
5319	5 pts		Nasopharyngitis	below serious				423
5320	12 pts		Headache	below serious				423
5321	10 pts		Flushing	below serious				423
5322	1 pts		Palpitations		discontinuation	leads to discontinuation		426
5323	1 pts		Dizziness		discontinuation	leads to discontinuation		426
5324	1 pts		Heart rate increased		discontinuation	leads to discontinuation		426
5325	2 pts		Dizziness		discontinuation	leads to discontinuation		424
5326	1 pts		Pigmentation disorder		discontinuation	leads to discontinuation		424
5327	1 pts		Chest discomfort		discontinuation	leads to discontinuation		424
5328	1 pts		Headache		discontinuation	leads to discontinuation		424
5329	1 pts		Diarrhea		discontinuation	leads to discontinuation		424
5330	1 pts		Dyspepsia		discontinuation	leads to discontinuation		424
5331	1 pts		Pruritus		discontinuation	leads to discontinuation		424
5332	1 pts		Eye swelling		discontinuation	leads to discontinuation		424
5333	1 pts		Back pain		discontinuation	leads to discontinuation		425
5334	2 pts		Headache		discontinuation	leads to discontinuation		425
5335	1 pts		Erection increased		discontinuation	leads to discontinuation		425
5336	1 pts		Blood pressure increased		discontinuation	leads to discontinuation		428
5337	3 pts		Eye irritation		discontinuation	leads to discontinuation		427
5338	1 pts		Abnormal sensation in eye		discontinuation	leads to discontinuation		427
5339	1 pts		Lacrimation increased		discontinuation	leads to discontinuation		427
5340	3 pts		Eye pruritus		discontinuation	leads to discontinuation		427
5341	1 pts		Blepharitis		discontinuation	leads to discontinuation		427
5342	2 pts		Intraocular pressure increased		discontinuation	leads to discontinuation		427
5343	1 pts		Pulmonary fibrosis		discontinuation	leads to discontinuation		427
5344	1 pts		Scleritis		discontinuation	leads to discontinuation		427
5345	1 pts		Dry skin		discontinuation	leads to discontinuation		427
5346	2 pts		Conjunctival disorder		discontinuation	leads to discontinuation		427
5347	2 pts		Ocular hyperemia		discontinuation	leads to discontinuation		427
5348	2 pts		Headache		discontinuation	leads to discontinuation		427
5349	1 pts		Hypertrichosis		discontinuation	leads to discontinuation		427
5350	1 pts		Cough		discontinuation	leads to discontinuation		427
5351	2 pts		Eye pain		discontinuation	leads to discontinuation		427
5352	1 pts		Vision blurred		discontinuation	leads to discontinuation		427
5353	1 pts		Pancreatic pseudocyst	serious				433
5354	1 pts		Pancreatitis	serious				433
5355	1 pts		Anaphylactic shock	serious				433
5356	1 pts		Influenza	serious				433
5357	1 pts		Myringitis bullous	serious				433
5358	1 pts		Pneumonia	serious				433
5359	1 pts		Sinusitis	serious				433
5360	1 pts		Hepatic enzyme increased	serious				433
5361	1 pts		Weight decreased	serious				433
5362	2 pts		Hypoglycaemia	serious				433
5363	1 pts		Musculoskeletal chest pain	serious				433
5364	1 pts		Cervix carcinoma	serious				433
5365	1 pts		Abortion spontaneous	serious				433
5366	1 pts		Haematuria	serious				433
5367	1 pts		IgA nephropathy	serious				433
5368	1 pts		Cough	serious				433
5369	1 pts		Pleuritic pain	serious				433
5370	17 pts		Oropharyngeal pain	below serious				433
5371	17 pts		Nasal congestion	below serious				433
5372	12 pts		Productive cough	below serious				433
5373	9 pts		Rales	below serious				433
5374	8 pts		Sinus congestion	below serious				433
5375	5 pts		Wheezing	below serious				433
5376	5 pts		Pleuritic pain	below serious				433
5377	19 pts		Upper respiratory tract infection	below serious				433
5378	6 pts		Rhinitis	below serious				433
5379	13 pts		Abdominal pain	below serious				433
5380	13 pts		Nausea	below serious				433
5381	11 pts		Diarrhoea	below serious				433
5382	9 pts		Vomiting	below serious				433
5383	5 pts		Alanine aminotransferase increased	below serious				433
5384	5 pts		Blood glucose increased	below serious				433
5385	5 pts		Aspartate aminotransferase increased	below serious				433
5386	6 pts		Bacteria sputum identified	below serious				433
5387	19 pts		Headache	below serious				433
5388	10 pts		Dizziness	below serious				433
5389	6 pts		Sinus headache	below serious				433
5390	7 pts		Arthralgia	below serious				433
5391	12 pts		Rash	below serious				433
5392	6 pts		Acne	below serious				433
5393	10 pts		Pyrexia	below serious				433
5394	1 pts		Abdominal pain	serious				432
5395	1 pts		Hepatic enzyme increased	serious				432
5396	1 pts		Conversion disorder	serious				432
5397	1 pts		Pyrexia	serious				432
5398	1 pts		Muscle strain	serious				432
5399	7 pts		Oropharyngeal pain	below serious				432
5400	5 pts		Nasal congestion	below serious				432
5401	2 pts		Pharyngeal erythema	below serious				432
5402	2 pts		Allergic rhinitis	below serious				432
5403	6 pts		Nasopharyngitis	below serious				432
5404	6 pts		Upper respiratory tract infection	below serious				432
5405	3 pts		Bronchitis	below serious				432
5406	4 pts		Otitis media	below serious				432
5407	2 pts		Pharyngitis streptococcal	below serious				432
5408	2 pts		Rhinitis	below serious				432
5409	6 pts		Abdominal pain upper	below serious				432
5410	3 pts		Diarrhoea	below serious				432
5411	2 pts		Gastrooesophageal reflux disease	below serious				432
5412	3 pts		Aspartate aminotransferase increased	below serious				432
5413	3 pts		Eosinophil count increased	below serious				432
5414	2 pts		Culture throat positive	below serious				432
5415	2 pts		Forced expiratory volume decreased	below serious				432
5416	2 pts		Neutrophil count decreased	below serious				432
5417	2 pts		White blood cell count decreased	below serious				432
5418	7 pts		Cystic fibrosis lung	below serious				432
5419	7 pts		Headache	below serious				432
5420	2 pts		Myalgia	below serious				432
5421	2 pts		Neck pain	below serious				432
5422	1 pts		Cellulitis	serious				434
5423	1 pts		Constipation	serious				434
5424	3 pts		Bacterial disease carrier	below serious				434
5425	1 pts		Bronchitis	below serious				434
5426	1 pts		Candidiasis	below serious				434
5427	1 pts		Ear infection	below serious				434
5428	1 pts		Folliculitis	below serious				434
5429	1 pts		Oral herpes	below serious				434
5430	1 pts		Scarlet fever	below serious				434
5431	1 pts		Tonsillitis	below serious				434
5432	1 pts		Varicella	below serious				434
5433	10 pts		Cough	below serious				434
5434	5 pts		Sputum increased	below serious				434
5435	5 pts		Nasal congestion	below serious				434
5436	5 pts		Oropharyngeal pain	below serious				434
5437	3 pts		Dyspnoea	below serious				434
5438	4 pts		Wheezing	below serious				434
5439	3 pts		Upper-airway cough syndrome	below serious				434
5440	1 pts		Respiratory tract congestion	below serious				434
5441	1 pts		Tonsillolith	below serious				434
5442	5 pts		Diarrhoea	below serious				434
5443	4 pts		Abdominal pain	below serious				434
5444	2 pts		Abdominal discomfort	below serious				434
5445	1 pts		Palatal oedema	below serious				434
5446	2 pts		Influenza like illness	below serious				434
5447	1 pts		Irritability	below serious				434
5448	3 pts		Forced expiratory volume decreased	below serious				434
5449	1 pts		Blood creatine phosphokinase increased	below serious				434
5450	1 pts		Liver function test abnormal	below serious				434
5451	1 pts		Platelet count increased	below serious				434
5452	6 pts		Headache	below serious				434
5453	1 pts		Exostosis	below serious				434
5454	1 pts		Animal bite	below serious				434
5455	1 pts		Hand fracture	below serious				434
5456	1 pts		Ligament sprain	below serious				434
5457	1 pts		Muscle strain	below serious				434
5458	1 pts		Tendon rupture	below serious				434
5459	1 pts		Thermal burn	below serious				434
5460	1 pts		Rosacea	below serious				434
5461	1 pts		Iron deficiency	below serious				434
5462	1 pts		COPD exacerbation	serious				430
5463	3 pts		COPD exacerbation	below serious				430
5464	2 pts		Headache	below serious				430
5465	2 pts		Loose stools	below serious				430
5466	1 pts		Skin abrasion	below serious				431
5467			Dizziness					429
5468			Diarrhea					429
5469	1 pts		ALT increased		discontinuation	leads to discontinuation		435
5470	2 pts		Elevated liver enzymes		discontinuation	leads to discontinuation		436
5471	1 pts		Croup		discontinuation	leads to discontinuation		436
5472	1 pts		Sepsis		discontinuation	leads to discontinuation		436
5473	1 pts		Elevated liver enzymes		discontinuation	leads to discontinuation		437
5474	2 pts		Vomiting		discontinuation	leads to discontinuation		437
5475	1 pts		Gastroenteritis		discontinuation	leads to discontinuation		437
5476	1 pts		Retching		discontinuation	leads to discontinuation		437
5477	1 pts		Rash		discontinuation	leads to discontinuation		437
5478	1 pts		Cough increased		discontinuation	leads to discontinuation		437
5479	1 pts		Cardiac failure congestive	serious				439
5480	1 pts		Abdominal pain	serious				439
5481	1 pts		Chest pain	serious				439
5482	1 pts		Hepatic enzyme increased	serious				439
5483	1 pts		Adenocarcinoma lung	serious				439
5484	1 pts		Colic renal	serious				439
5485	1 pts		Emphysema	serious				439
5486	1 pts		Pneumothorax	serious				439
5487	17 pts		Nausea	below serious				439
5488	10 pts		Abdominal pain	below serious				439
5489	12 pts		Constipation	below serious				439
5490	8 pts		Vomiting	below serious				439
5491	9 pts		Abdominal pain upper	below serious				439
5492	5 pts		Dry mouth	below serious				439
5493	3 pts		Dyspepsia	below serious				439
5494	3 pts		Abdominal pain lower	below serious				439
5495	5 pts		Asthenia	below serious				439
5496	4 pts		Influenza	below serious				439
5497	3 pts		Urinary tract infection	below serious				439
5498	6 pts		Weight decreased	below serious				439
5499	10 pts		Decreased appetite	below serious				439
5500	3 pts		Hypomagnesaemia	below serious				439
5501	35 pts		Muscle spasms	below serious				439
5502	6 pts		Back pain	below serious				439
5503	5 pts		Musculoskeletal pain	below serious				439
5504	4 pts		Pain in extremity	below serious				439
5505	3 pts		Myalgia	below serious				439
5506	35 pts		Dysgeusia	below serious				439
5507	4 pts		Ageusia	below serious				439
5508	3 pts		Anxiety	below serious				439
5509	3 pts		Depression	below serious				439
5510	28 pts		Alopecia	below serious				439
5511	6 pts		Rash	below serious				439
5512	4 pts		Pruritus	below serious				439
5513	1 pts		Gastric ulcer	serious				440
5514	1 pts		Oesophagitis	serious				440
5515	1 pts		Bladder neoplasm	serious				440
5516	1 pts		Malignant melanoma	serious				440
5517	3 pts		Diarrhoea	below serious				440
5518	1 pts		Fatigue	below serious				440
5519	1 pts		Bronchitis	below serious				440
5520	1 pts		Decreased appetite	below serious				440
5521	7 pts		Muscle spasms	below serious				440
5522	1 pts		Muscular weakness	below serious				440
5523	5 pts		Dysgeusia	below serious				440
5524	1 pts		Ageusia	below serious				440
5525	1 pts		Nerve compression	below serious				440
5526	3 pts		Alopecia	below serious				440
5527	1 pts		Hypertension	below serious				440
5528	3 pts		Taste disturbance	below serious				441
5529						No AEs reported. PMID: 21300762 contains AEs information, but without dose relation		438
5530			Gamma-glutamyltransferase increased	grade 3			TRUE	448
5531			Hypokalemia	grade 4			TRUE	446
5532			Thrombocytopenia	grade 3			TRUE	447
5533			Birth defects	grade 5|severe		WARNING		442
5534	29.7		Nausea	grade 1-2				444
5535	0.7		Nausea	grade 3				444
5536	28.3		Diarrhea	grade 1-2				444
5537	0.7		Diarrhea	grade 3				444
5538	21		Constipation	grade 1-2				444
5539	13.8		Vomiting	grade 1-2				444
5540	34.1		Fatigue	grade 1-2				444
5541	5.1		Fatigue	grade 3				444
5542	0.7		Fatigue	grade 4				444
5543	42.2		Weight loss	grade 1-2				444
5544	7.2		Weight loss	grade 3				444
5545	23.2		Decreased appetite	grade 1-2				444
5546	2.2		Decreased appetite	grade 3				444
5547	68.1		Muscle spasms	grade 1-2				444
5548	3.6		Muscle spasms	grade 3				444
5549	15.2		Arthralgia	grade 1-2				444
5550	0.7		Arthralgia	grade 3				444
5551	55.1		Dysgeusia	grade 1-2				444
5552	10.9		Ageusia	grade 1-2				444
5553	63.8		Alopecia	grade 1-2				444
5554	3 pts		Amenorrhea					443
5555	4		Hyponatremia	grade 3				444
5556	1		Hypokalemia	grade 3				444
5557	2		Azotemia	grade 3				444
5558	1 pts		Metastatic malignant melanoma	grade 4	discontinuation	leads to discontinuation		445
5559	1 pts		Ischaemic stroke	grade 3	discontinuation	leads to discontinuation		445
5560	1 pts		Fatigue	grade 3	discontinuation	leads to discontinuation		445
5561	2 pts		Muscle spasms	grade 3	discontinuation	leads to discontinuation		445
5562	1 pts		Metastatic squamous cell carcinoma	grade 4	discontinuation	leads to discontinuation		445
5563	1 pts		Acute myocardial infarction	grade 5	discontinuation	leads to discontinuation		445
5564	1 pts		Dysgeusia	grade 1	discontinuation	leads to discontinuation		445
5565	1 pts		Weight decreased	grade 2	discontinuation	leads to discontinuation		445
5566	1 pts		Asthenia	grade 3	discontinuation	leads to discontinuation		445
5567	1 pts		Aphagia	grade 3	discontinuation	leads to discontinuation		445
5568	1 pts		Paraesthesia	grade 2	discontinuation	leads to discontinuation		445
5569	1 pts		Cellulitis	grade 3	discontinuation	leads to discontinuation		445
5570	1 pts		Hypovolaemic shock	grade 5	discontinuation	leads to discontinuation		445
5571	3 pts		Acute coronary syndrome	serious				449
5572	3 pts		Acute myocardial infarction	serious				449
5573	2 pts		Angina pectoris	serious				449
5574	1 pts		Atrial fibrillation	serious				449
5575	2 pts		Cardiac failure congestive	serious				449
5576	1 pts		Myocardial infarction	serious				449
5577	1 pts		Cataract	serious				449
5578	1 pts		Retinal haemorrhage	serious				449
5579	1 pts		Haemorrhage retinal	serious				449
5580	2 pts		Abdominal pain	serious				449
5581	2 pts		Diarrhoea	serious				449
5582	1 pts		Enteritis	serious				449
5583	1 pts		Haemorrhoidal haemorrhage	serious				449
5584	1 pts		Large intestinal stenosis	serious				449
5585	1 pts		Oesophageal disorder	serious				449
5586	1 pts		Pancreatic cyst	serious				449
5587	2 pts		Pancreatitis acute	serious				449
5588	1 pts		Small intestinal obstruction	serious				449
5589	1 pts		Umbilical hernia	serious				449
5590	1 pts		Upper gastrointestinal haemorrhage	serious				449
5591	1 pts		Asthenia	serious				449
5592	1 pts		Biliary colic	serious				449
5593	5 pts		Cholecystitis	serious				449
5594	1 pts		Cholelithiasis	serious				449
5595	1 pts		Anaphylactic reaction	serious				449
5596	1 pts		Anal abscess	serious				449
5597	2 pts		Appendicitis	serious				449
5598	1 pts		Diverticulitis	serious				449
5599	1 pts		Gastroenteritis	serious				449
5600	1 pts		Orchitis	serious				449
5601	1 pts		Otitis externa	serious				449
5602	1 pts		Otitis media chronic	serious				449
5603	2 pts		Pneumonia bacterial	serious				449
5604	1 pts		Pulmonary tuberculosis	serious				449
5605	1 pts		Pyelonephritis acute	serious				449
5606	1 pts		Tonsillitis	serious				449
5607	1 pts		Abdominal wound dehiscence	serious				449
5608	1 pts		Fibula fracture	serious				449
5609	1 pts		Ligament sprain	serious				449
5610	1 pts		Meniscus injury	serious				449
5611	1 pts		Snake bite	serious				449
5612	1 pts		Wound	serious				449
5613	1 pts		Dehydration	serious				449
5614	2 pts		Hyperglycaemia	serious				449
5615	1 pts		Hyperlipidaemia	serious				449
5616	1 pts		Bursitis	serious				449
5617	1 pts		Bladder cancer	serious				449
5618	1 pts		Colon cancer	serious				449
5619	1 pts		Gastrointestinal tract adenoma	serious				449
5620	1 pts		Rectal cancer	serious				449
5621	1 pts		Squamous cell carcinoma	serious				449
5622	1 pts		Cerebral haemorrhage	serious				449
5623	2 pts		Cerebral infarction	serious				449
5624	1 pts		Haemorrhagic stroke	serious				449
5625	1 pts		Myelopathy	serious				449
5626	2 pts		Acute kidney injury	serious				449
5627	2 pts		Nephrolithiasis	serious				449
5628	1 pts		Disorder renal	serious				449
5629	1 pts		Varicocele	serious				449
5630	1 pts		Dyspnoea	serious				449
5631	2 pts		Pneumothorax	serious				449
5632	1 pts		Toxic skin eruption	serious				449
5633	1 pts		Aortic intramural haematoma	serious				449
5634	2 pts		Hypertension	serious				449
5635	1 pts		Peripheral artery aneurysm	serious				449
5636	73 pts		Hypothyroidism	below serious				449
5637	25 pts		Abdominal pain	below serious				449
5638	25 pts		Abdominal pain upper	below serious				449
5639	24 pts		Constipation	below serious				449
5640	168 pts		Diarrhoea	below serious				449
5641	22 pts		Dyspepsia	below serious				449
5642	36 pts		Nausea	below serious				449
5643	46 pts		Stomatitis	below serious				449
5644	20 pts		Vomiting	below serious				449
5645	41 pts		Asthenia	below serious				449
5646	75 pts		Fatigue	below serious				449
5647	19 pts		Malaise	below serious				449
5648	33 pts		Upper respiratory tract infection	below serious				449
5649	31 pts		Alanine aminotransferase increased	below serious				449
5650	28 pts		Aspartate aminotransferase increased	below serious				449
5651	34 pts		Blood creatinine increased	below serious				449
5652	48 pts		Blood thyroid stimulating hormone increased	below serious				449
5653	25 pts		Weight decreased	below serious				449
5654	45 pts		Decreased appetite	below serious				449
5655	59 pts		Arthralgia	below serious				449
5656	21 pts		Musculoskeletal pain	below serious				449
5657	25 pts		Myalgia	below serious				449
5658	35 pts		Pain in extremity	below serious				449
5659	42 pts		Dizziness	below serious				449
5660	24 pts		Dysgeusia	below serious				449
5661	48 pts		Headache	below serious				449
5662	20 pts		Insomnia	below serious				449
5663	84 pts		Proteinuria	below serious				449
5664	34 pts		Cough	below serious				449
5665	149 pts		Dysphonia	below serious				449
5666	19 pts		Dyspnoea	below serious				449
5667	29 pts		Epistaxis	below serious				449
5668	20 pts		Oropharyngeal pain	below serious				449
5669	20 pts		Alopecia	below serious				449
5670	25 pts		Dry skin	below serious				449
5671	115 pts		Palmar-plantar erythrodysaesthesia syndrome	below serious				449
5672	46 pts		Rash	below serious				449
5673	231 pts		Hypertension	below serious				449
5674						No AEs are reported		450
5675	1 pts		Stomatitis				TRUE	451
5676	2 pts		Hypertension				TRUE	453
5677	1 pts		Hemoptysis				TRUE	453
5678	1 pts		Stomatitis				TRUE	453
5679	1 pts		Hypertension				TRUE	452
5680	1 pts		Stomatitis				TRUE	452
5681	1 pts		Pancreatitis				TRUE	452
5682	1 pts		Bowel ischemia				TRUE	452
5683	1 pts		Thromboembolism				TRUE	452
5684	11 pts		Disease progression		discontinuation	leads to discontinuation		454
5685	4 pts		Fatigue		discontinuation	leads to discontinuation		454
5686	3 pts		Transient ischemic attack		discontinuation	leads to discontinuation		454
5687	2 pts		Asthenia		discontinuation	leads to discontinuation		454
5688	2 pts		Pleural effusion		discontinuation	leads to discontinuation		454
5689	2 pts		Decreased appetite		discontinuation	leads to discontinuation		454
5690	1 pts		Palmar-plantar erythrodysaesthesia syndrome		discontinuation	leads to discontinuation		454
5691	1 pts		Dyspnea		discontinuation	leads to discontinuation		454
5692	1 pts		Anemia		discontinuation	leads to discontinuation		454
5693	1 pts		Vomiting		discontinuation	leads to discontinuation		454
5694	1 pts		Retinal vein thrombosis		discontinuation	leads to discontinuation		454
5695	1 pts		Ascites		discontinuation	leads to discontinuation		454
5696	1 pts		Blood creatinine increased		discontinuation	leads to discontinuation		454
5697	1 pts		Hypoglycemia		discontinuation	leads to discontinuation		454
5698	1 pts		Altered state of consciousness		discontinuation	leads to discontinuation		454
5699	1 pts		Cerebral hemorrhage		discontinuation	leads to discontinuation		454
5700	1 pts		Dyspnea exertional		discontinuation	leads to discontinuation		454
5701	1 pts		Pneumothorax		discontinuation	leads to discontinuation		454
5702	1 pts		Hypertension		discontinuation	leads to discontinuation		454
5703	1 pts		Eye pain	severe	discontinuation	leads to discontinuation		456
5704	1 pts		Application site pain	severe	discontinuation	leads to discontinuation		456
5705	1 pts		Periorbital edema	severe	discontinuation	leads to discontinuation		456
5706	1 pts		Erythema		discontinuation	leads to discontinuation		457
5707	1 pts		Skin exfoliation		discontinuation	leads to discontinuation		457
5708	1 pts		Lymphangitis		discontinuation	leads to discontinuation		455
5709	1 pts		Lymphopenia	below serious				460
5710	1 pts		Dry mouth	below serious				460
5711	1 pts		Influenza	below serious				460
5712	1 pts		Oral herpes	below serious				460
5713	1 pts		Alanine aminotransferase increased	below serious				460
5714	1 pts		Aspartate aminotransferase increased	below serious				460
5715	1 pts		Synovial cyst	below serious				460
5716	1 pts		Myalgia	below serious				462
5717	2 pts		Pain in extremity	below serious				462
5718	2 pts		Lymphopenia	below serious				461
5719	1 pts		Neutropenia	below serious				461
5720	1 pts		Abdominal pain upper	below serious				461
5721	1 pts		Tooth abscess	below serious				461
5722	1 pts		Alanine aminotransferase increased	below serious				461
5723	2 pts		Haematocrit decreased	below serious				461
5724	2 pts		Haemoglobin decreased	below serious				461
5725	1 pts		Lymphocyte count decreased	below serious				461
5726	1 pts		Mean cell haemoglobin concentration decreased	below serious				461
5727	1 pts		Mean cell volume increased	below serious				461
5728	1 pts		Neutrophil count decreased	below serious				461
5729	1 pts		Occult blood positive	below serious				461
5730	1 pts		Red blood cell count decreased	below serious				461
5731	1 pts		Red cell distribution width increased	below serious				461
5732	1 pts		Reticulocyte count increased	below serious				461
5733	1 pts		White blood cell count decreased	below serious				461
5734	1 pts		Congestive cardiac failure	serious				463
5735	1 pts		Interstitial lung disease	serious				463
5736	1 pts		Anaemia	below serious				463
5737	1 pts		Leukocytosis	below serious				463
5738	1 pts		Neutropenia	below serious				463
5739	1 pts		Atrial fibrillation	below serious				463
5740	1 pts		Palpitations	below serious				463
5741	1 pts		Breath odour	below serious				463
5742	1 pts		Chest pain	below serious				463
5743	1 pts		Urinary tract infection	below serious				463
5744	1 pts		Accidental overdose	below serious				463
5745	1 pts		Alanine aminotransferase increased	below serious				463
5746	1 pts		Blood cholesterol increased	below serious				463
5747	1 pts		Platelet count decreased	below serious				463
5748	1 pts		Reticulocyte count decreased	below serious				463
5749	1 pts		White blood cell count decreased	below serious				463
5750	1 pts		Colic renal	below serious				463
5751	1 pts		Chronic obstructive pulmonary disease	below serious				463
5752	1 pts		Dyspnoea	below serious				463
5753	1 pts		Night sweats	below serious				463
5754	1 pts		Mass excision	below serious				463
5755	1.3		Fatigue	grade 3				469
5756	2		Asthenia	grade 3				469
5757	0.7		Fever	grade 3				469
5758	1.3		Anxiety	grade 3				469
5759	1.3		Insomnia	grade 3				469
5760	0.7		Pneumonia			Serious Adverse Events		469
5761	1.3		Fever			Serious Adverse Events		469
5762	2		Anemia			Serious Adverse Events		469
5763	2		Asthenia			Serious Adverse Events		469
5764	1.3		Systemic inflammatory response syndrome			Serious Adverse Events		469
5765	1.3		Anxiety			Serious Adverse Events		469
5766	1.3		Constitutional syndrome			Serious Adverse Events		469
5767	1.3		Insomnia			Serious Adverse Events		469
5768	6		Thrombocytopenia	grade 4				466
5769	20		Thrombocytopenia	grade 4			TRUE	468
5770	60		Thrombocytopenia	grade 3				468
5771	33		Thrombocytopenia	grade 4				464
5772	40		Thrombocytopenia	grade 3	discontinuation			468
5773	10.3		Anemia	grade 3				458
5774	1.9		Diarrhea	grade 3				458
5775	0.6		Epistaxis	grade 3				458
5776	0.6		Dizziness	grade 3				458
5777	3.2		Pneumonia	grade 3				458
5778	1.3		Thrombocytopenia	grade 4				458
5779	5.2		Anemia	grade 4				458
5780	1.9		Pneumonia	grade 4				458
5781	1		Thrombocytopenia		discontinuation			458
5782	1		Neutropenia		discontinuation			458
5783	1		Anemia		discontinuation			458
5784	1		Diarrhea		discontinuation			458
5785	1		Septic shock		discontinuation			458
5786	1		Subdural hematoma		discontinuation			458
5787	1		Hemorrhage retroperitoneal		discontinuation			458
5788	34		Thrombocytopenia					458
5789	31		Anemia					458
5790	15		Headache					458
5791	15		Dizziness					458
5792	14		Confusion					458
5793	33		Thrombocytopenia	grade 3				465
5794	23		Thrombocytopenia	grade 3				467
5795	7.1		Thrombocytopenia	grade 3				459
5796	2 pts		Delirium					470
5797	1 pts		Somnolence		discontinuation	leads to discontinuation		470
5798	1 pts		Depressed mood		discontinuation	leads to discontinuation		470
5799	1 pts		Libido decreased		discontinuation	leads to discontinuation		470
5800	1 pts		Erectile dysfunction		discontinuation	leads to discontinuation		470
5801	1 pts		Insomnia		discontinuation	leads to discontinuation		470
5802	1 pts		Dysarthria		discontinuation	leads to discontinuation		470
5803	1 pts		Unsteady gait		discontinuation	leads to discontinuation		470
5804	1 pts		Dizziness		discontinuation	leads to discontinuation		470
5805	2 pts		Transaminases increased		discontinuation	leads to discontinuation		473
5806	1 pts		Dizziness		discontinuation	leads to discontinuation		475
5807	1 pts		Somnolence		discontinuation	leads to discontinuation		475
5808	1 pts		Somnolence		discontinuation	leads to discontinuation		474
5809	1 pts		Transaminases increased		discontinuation	leads to discontinuation		471
5810	1 pts		Transaminases increased		discontinuation	leads to discontinuation		472
5811	1 pts		Decreased white cell count	below serious				476
5812	1 pts		Gastrointestinal upset	below serious				476
5813	4 pts		Muscular pain	below serious				476
5814	1 pts		Decreased white cell count	below serious				477
5815	2 pts		Gastrointestinal upset	below serious				477
5816	3 pts		Muscular pain	below serious				477
5817	5 pts		Neutropenia	serious				483
5818	1 pts		Intestinal dilatation	serious				483
5819	1 pts		Intestinal obstruction	serious				483
5820	1 pts		Volvulus	serious				483
5821	1 pts		Obstruction	serious				483
5822	1 pts		Pyrexia	serious				483
5823	1 pts		Bacterial disease carrier	serious				483
5824	2 pts		Bronchitis	serious				483
5825	1 pts		Device related infection	serious				483
5826	2 pts		Pneumonia	serious				483
5827	1 pts		Wound infection	serious				483
5828	1 pts		Chemical eye injury	serious				483
5829	1 pts		Postoperative ileus	serious				483
5830	1 pts		Toxicity to various agents	serious				483
5831	1 pts		Unintentional medical device removal	serious				483
5832	1 pts		Oromandibular dystonia	serious				483
5833	1 pts		Device malfunction	serious				483
5834	1 pts		Urinary bladder rupture	serious				483
5835	1 pts		Choking	serious				483
5836	1 pts		Cough	serious				483
5837	1 pts		Respiratory disorder	serious				483
5838	1 pts		Colectomy	serious				483
5839	1 pts		Intestinal anastomosis	serious				483
5840	1 pts		Intrathecal pump insertion	serious				483
5841	1 pts		Laparotomy	serious				483
5842	2 pts		Medical device battery replacement	serious				483
5843	1 pts		Tracheostomy	serious				483
5844	1 pts		Tracheostomy tube removal	serious				483
5845	1 pts		Wound treatment	serious				483
5846	1 pts		Thrombosis	serious				483
5847	12 pts		Anaemia	below serious				483
5848	3 pts		Influenza	below serious				483
5849	4 pts		Pain	below serious				483
5850	7 pts		Bronchitis	below serious				483
5851	11 pts		Nasopharyngitis	below serious				483
5852	4 pts		Rhinitis	below serious				483
5853	8 pts		Upper respiratory tract infection	below serious				483
5854	4 pts		Viral infection	below serious				483
5855	6 pts		Laceration	below serious				483
5856	3 pts		Body temperature increased	below serious				483
5857	10 pts		Neutrophil count decreased	below serious				483
5858	19 pts		Serum ferritin decreased	below serious				483
5859	9 pts		Iron deficiency	below serious				483
5860	8 pts		Arthralgia	below serious				483
5861	3 pts		Muscle spasms	below serious				483
5862	10 pts		Pain in extremity	below serious				483
5863	25 pts		Dystonia	below serious				483
5864	3 pts		Migraine	below serious				483
5865	3 pts		Urinary incontinence	below serious				483
5866	10 pts		Cough	below serious				483
5867	9 pts		Oropharyngeal pain	below serious				483
5868	4 pts		Rhinorrhoea	below serious				483
5869	3 pts		Hyperhidrosis	below serious				483
5870	4 pts		Rash	below serious				483
5871	30		Neutropenic sepsis		discontinuation			479
5872	10		Fatigue		discontinuation			479
5873			Arthralgia	non-serious	discontinuation			478
5874			Joint effusion	non-serious	discontinuation			478
5875			Nausea	non-serious	discontinuation			478
5876			Abdominal discomfort	non-serious	discontinuation			478
5877			Fatigue	non-serious	discontinuation			478
5878			Joint swelling	non-serious	discontinuation			478
5879			Epistaxis	non-serious	discontinuation			478
5880			Upper respiratory tract infections	non-serious	discontinuation			478
5881			Upper abdominal pain	non-serious	discontinuation			478
5882			Vomiting	non-serious	discontinuation			478
5883			Palpitation	non-serious	discontinuation			478
5884			Agranulocytosis	grade 3-5	discontinuation	WARNINGS		482
5885			Fetal damage		discontinuation	WARNINGS		482
5886	0.78		Aspartate aminotransferase increased		discontinuation	WARNINGS		480
5887	0.16		Alanine aminotransferase increased		discontinuation	WARNINGS		480
5888	1.6		Nausea		discontinuation	Gastrointestinal symptoms such as nausea, vomiting, and abdominal pain were the most frequent adverse reactions reported by patients participating in clinical trials and led to the discontinuation of Ferriprox therapy in 1.6% of patients.		481
5889	1.6		Vomiting		discontinuation	Gastrointestinal symptoms such as nausea, vomiting, and abdominal pain were the most frequent adverse reactions reported by patients participating in clinical trials and led to the discontinuation of Ferriprox therapy in 1.6% of patients.		481
5890	1.6		Abdominal pain		discontinuation	Gastrointestinal symptoms such as nausea, vomiting, and abdominal pain were the most frequent adverse reactions reported by patients participating in clinical trials and led to the discontinuation of Ferriprox therapy in 1.6% of patients.		481
5891	1 pts		Fatigue	grade 3	discontinuation	leads to discontinuation		486
5892	2.2		ALT increased		discontinuation	leads to discontinuation		485
5893	1.5		Pneumonitis		discontinuation	leads to discontinuation		485
5894	1 pts		Autoimmune thyroiditis		discontinuation	leads to discontinuation		484
5895						no serious AEs reported		487
5896			Laryngeal disorder		discontinuation	WARNINGS		490
5897						no AEs info		489
5898						no AEs info		488
5899						AEs not reported		491
5900			Pancytopenia	grade 4			TRUE	504
5901	60		Rash				TRUE	500
5902	60		Fatigue				TRUE	500
5903			ALT increased	grade 3				503
5904	17		Arthralgia	grade 3			TRUE	499
5905	50		Rash	grade 3			TRUE	499
5906	33		Squamous cell carcinoma, keratoacanthoma-type	grade 3				499
5907	33		Fatigue	grade 3				499
5908	17		Pruritus	grade 3				499
5909	17		Lymphopenia	grade 3				499
5910	3		Arthralgia	grade 3				492
5911	3		Rash	grade 3				492
5912	31		Squamous cell carcinoma, keratoacanthoma-type	grade 3				492
5913	3		Nausea	grade 3				492
5914	6		Fatigue	grade 3				492
5915	3		Photosensitivity reaction	grade 3				492
5916	6		Palmar-plantar erythrodysesthesia syndrome	grade 3				492
5917	38		Squamous cell carcinoma, keratoacanthoma-type	grade 3				502
5918	50		Squamous cell carcinoma, keratoacanthoma-type	grade 3				501
5919	8		Rash	grade 3				493
5920	3		Photosensitivity reaction	grade 3				493
5921	<1		Alopecia	grade 3				493
5922	1		Pruritus	grade 3				493
5923	1		Hyperkeratosis	grade 3				493
5924	2		Rash maculo-papular	grade 3				493
5925	<1		Rash papular	grade 3				493
5926	4		Arthralgia	grade 3				493
5927	<1		Myalgia	grade 3				493
5928	<1		Pain in extremity	grade 3				493
5929	<1		Back pain	grade 3				493
5930	2		Fatigue	grade 3				493
5931	<1		Edema peripheral	grade 3				493
5932	<1		Pyrexia	grade 3				493
5933	<1		Asthenia	grade 3				493
5934	2		Nausea	grade 3				493
5935	<1		Diarrhea	grade 3				493
5936	1		Vomiting	grade 3				493
5937	<1		Constipation	grade 3				493
5938	<1		Headache	grade 3				493
5939	<1		Skin papilloma	grade 3				493
5940	22		Squamous cell carcinoma of skin	grade 3				493
5941	<1		Seborrheic keratosis	grade 3				493
5942	3		GGT increased	grade 3				493
5943	37		Rash					493
5944	33		Photosensitivity reaction					493
5945	45		Alopecia					493
5946	23		Pruritus					493
5947	24		Hyperkeratosis					493
5948	9		Rash maculo-papular					493
5949	8		Actinic keratosis					493
5950	19		Dry skin					493
5951	5		Rash papular					493
5952	14		Erythema					493
5953	53		Arthralgia					493
5954	13		Myalgia					493
5955	18		Pain in extremity					493
5956	8		Musculoskeletal pain					493
5957	8		Back pain					493
5958	38		Fatigue					493
5959	17		Edema peripheral					493
5960	19		Pyrexia					493
5961	11		Asthenia					493
5962	35		Nausea					493
5963	28		Diarrhea					493
5964	18		Vomiting					493
5965	12		Constipation					493
5966	23		Headache					493
5967	14		Dysgeusia					493
5968	21		Skin papilloma					493
5969	24		Squamous cell carcinoma of skin					493
5970	10		Seborrheic keratosis					493
5971	5		GGT increased					493
5972	18		Decreased appetite					493
5973	8		Cough					493
5974	10		Sunburn					493
5975	2		Arthralgia		discontinuation			494
5976	2		Dysphagia		discontinuation			494
5977	2		Pneumonia		discontinuation			494
5978	1		Brain metastases		discontinuation			494
5979	1		Dyspnea		discontinuation			494
5980	1		Pneumonia		discontinuation			494
5981	1		Thrombocytopenia		discontinuation			494
5982	1		Abdominal pain		discontinuation			494
5983	1		Aortic aneurysm rupture		discontinuation			494
5984	1		Ascites		discontinuation			494
5985	1		Atrial fibrillation		discontinuation			494
5986	1		Blood alkaline phosphatase increased		discontinuation			494
5987	1		Blood bilirubin increased		discontinuation			494
5988	1		Chest pain		discontinuation			494
5989	1		Choking		discontinuation			494
5990	1		Cognitive disorder		discontinuation			494
5991	1		Hyperemia of conjunctiva		discontinuation			494
5992	1		Dehydration		discontinuation			494
5993	1		Diplopia		discontinuation			494
5994	1		Dyspepsia		discontinuation			494
5995	1		Esophageal pain		discontinuation			494
5996	1		Fatigue		discontinuation			494
5997	1		Gait disturbance		discontinuation			494
5998	1		GGT increased		discontinuation			494
5999	1		Gastroesophageal reflux		discontinuation			494
6000	1		Hepatitis acute		discontinuation			494
6001	1		Hyponatremia		discontinuation			494
6002	1		Intracranial tumor hemorrhage		discontinuation			494
6003	1		Myocardial infarction		discontinuation			494
6004	1		Pain		discontinuation			494
6005	1		Pancreatitis		discontinuation			494
6006	1		Rash		discontinuation			494
6007	1		Renal impairment		discontinuation			494
6008	1		Stevens-Johnson syndrome		discontinuation			494
6009	1		Thrombocytopenia		discontinuation			494
6010	1		Toxic skin eruption		discontinuation			494
6011	2.7		LDH increased	grade 3				495
6012	3		Alkaline phosphatase increased	grade 3				495
6013	2.7		ALT increased	grade 3				495
6014	11.3		GGT increased	grade 3				495
6015	<1		AST increased	grade 3				495
6016	1.8		Bilirubin increased	grade 3				495
6017	<1		Arthritis	grade 3				496
6018	<1		Joint effusion	grade 3				496
6019	<1		Atrial fibrillation	grade 3				496
6020	<1		Myocardial infarction	grade 3				496
6021	<1		Pericarditis	grade 3				496
6022	2.1		QT interval prolonged	grade 3				496
6023	16.4		Skin squamous cell carcinoma recurrent	grade 3				497
6024	8.3		Rash	grade 3				497
6025	8.6		Keratoacanthoma	grade 3				497
6026	4.5		Arthralgia	grade 3				497
6027	3.3		GGT increased	grade 3				497
6028	2.7		Photosensitivity reaction	grade 3				497
6029	2.4		Maculopapular rash	grade 3				497
6030	2.7		Blood alkaline phosphatase increased	grade 3				497
6031	2.1		Fatigue	grade 3				497
6032	2.1		Dyspnea	grade 3				497
6033	2.1		Nausea	grade 3				497
6034	1.8		ALT increased	grade 3				497
6035	1.5		Pain in extremity	grade 3				497
6036	1.5		Pruritus	grade 3				497
6037	1.2		Vomiting	grade 3				497
6038	1.2		Pain	grade 3				497
6039	1.2		Blood bilirubin increased	grade 3				497
6040	1.2		Hyperkeratosis	grade 3				497
6041	<1		Anemia	grade 3				497
6042	<1		Thrombocytopenia	grade 3				497
6043	<1		Neutropenia	grade 3				497
6044	2.1		Hyperglycemia	grade 3				498
6045	1.5		Creatinine increased	grade 3				498
6046	1.2		Hyperkalemia	grade 3				498
6047	2		Hypercalcemia	grade 3				498
6048	3.7		Decreased hemoglobin	grade 3				498
6049	8.3		Lymphocyte count decreased	grade 3				498
6050	1.3		Hypoalbuminemia	grade 3				498
6051	3.5		Hypophosphatemia	grade 3				498
6052	<1		Neutrophil count decreased	grade 3				498
6053	<1		WBC decreased	grade 3				498
6054	<1		Platelets decreased	grade 3				498
6055	1 pts		Leukocytosis	serious				505
6056	3 pts		Angina pectoris	serious				505
6057	4 pts		Atrial fibrillation	serious				505
6058	11 pts		Cardiac arrest	serious				505
6059	2 pts		Cardiac failure acute	serious				505
6060	1 pts		Cardiac tamponade	serious				505
6061	17 pts		Cardiogenic shock	serious				505
6062	1 pts		Cardiopulmonary failure	serious				505
6063	1 pts		Coronary artery occlusion	serious				505
6064	2 pts		Dressler's syndrome	serious				505
6065	2 pts		Left ventricular failure	serious				505
6066	1 pts		Torsade de pointes	serious				505
6067	1 pts		Ventricular septal defect acquired	serious				505
6068	1 pts		Vertigo	serious				505
6069	1 pts		Colitis ischaemic	serious				505
6070	2 pts		Gastrointestinal haemorrhage	serious				505
6071	1 pts		Gastrointestinal telangiectasia	serious				505
6072	1 pts		Haematemesis	serious				505
6073	1 pts		Haematochezia	serious				505
6074	1 pts		Intestinal ischaemia	serious				505
6075	2 pts		Retroperitoneal haematoma	serious				505
6076	1 pts		Asthenia	serious				505
6077	1 pts		Cardiac death	serious				505
6078	1 pts		Device malfunction	serious				505
6079	2 pts		Multi-organ failure	serious				505
6080	2 pts		Sudden death	serious				505
6081	1 pts		Vessel puncture site haematoma	serious				505
6082	2 pts		Cholecystitis acute	serious				505
6083	1 pts		Biliary sepsis	serious				505
6084	1 pts		Bronchitis	serious				505
6085	1 pts		Groin infection	serious				505
6086	2 pts		Pneumonia	serious				505
6087	1 pts		Relapsing fever	serious				505
6088	1 pts		Sepsis	serious				505
6089	1 pts		Septic shock	serious				505
6090	1 pts		Skin infection	serious				505
6091	1 pts		Urosepsis	serious				505
6092	1 pts		Femoral neck fracture	serious				505
6093	3 pts		Procedural haemorrhage	serious				505
6094	1 pts		Subdural haematoma	serious				505
6095	1 pts		Traumatic haematoma	serious				505
6096	1 pts		Upper limb fracture	serious				505
6097	1 pts		Hepatic enzyme increased	serious				505
6098	1 pts		Nutritional condition abnormal	serious				505
6099	1 pts		Platelet count decreased	serious				505
6100	2 pts		Troponin increased	serious				505
6101	1 pts		Dehydration	serious				505
6102	1 pts		Diabetes mellitus	serious				505
6103	1 pts		Musculoskeletal chest pain	serious				505
6104	1 pts		Fracture pathological	serious				505
6105	1 pts		Cardiac myxoma	serious				505
6106	1 pts		Rectal neoplasm	serious				505
6107	1 pts		Renal cancer metastatic	serious				505
6108	1 pts		Cerebrovascular accident	serious				505
6109	1 pts		Haemorrhage intracranial	serious				505
6110	1 pts		Hemiparesis	serious				505
6111	1 pts		Lacunar infarction	serious				505
6112	1 pts		Presyncope	serious				505
6113	1 pts		Syncope	serious				505
6114	1 pts		Suicide attempt	serious				505
6115	1 pts		Haematuria	serious				505
6116	2 pts		Renal failure acute	serious				505
6117	1 pts		Acute respiratory distress syndrome	serious				505
6118	2 pts		Dyspnoea	serious				505
6119	1 pts		Lung disorder	serious				505
6120	1 pts		Pleural effusion	serious				505
6121	4 pts		Pulmonary oedema	serious				505
6122	2 pts		Aortic dissection	serious				505
6123	1 pts		Haematoma	serious				505
6124	1 pts		Haemodynamic instability	serious				505
6125	1 pts		Hypertension	serious				505
6126	1 pts		Thrombophlebitis	serious				505
6127	44 pts		Hypotension	below serious				505
6128	28 pts		Hypokalaemia	below serious				505
6129	28 pts		Bradycardia	below serious				505
6130	1 pts		Acute myocardial infarction type 2	serious				506
6131	1 pts		Subarachnoid hemorrhage	serious				506
6132	1 pts		Parapneumonic effusion	serious				506
6133	1 pts		Deep vein thrombosis leg	serious				506
6134	1 pts		Urinary tract infection	serious				506
6135	1 pts		Thrombocytosis	below serious				506
6136	1 pts		Anemia	below serious				506
6137	1 pts		Leukemoid reaction	below serious				506
6138	2 pts		Atrial fibrillation	below serious				506
6139	1 pts		Dysgeusia	below serious				506
6140	1 pts		Diarrhea	below serious				506
6141	1 pts		Upper gastrointestinal bleeding	below serious				506
6142	1 pts		Bleeding vaginal	below serious				506
6143	1 pts		Hematoma	below serious				506
6144	50		Gastrointestinal disorder NOS			The most frequent AEs were dizziness, dermatitis, hyperhidrosis and nausea. Three moderate GI AEs led to breaking of the blind, and these together with an SAE and an AE of mild dyspnoea, met dose stopping criteria for the study which did not progress to Cohort C. (PMID 24040849 doesn`t have access; data are listed here https://www.google.ru/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwji45rs27fuAhVmiYsKHW3hA2MQFjAGegQICBAC&url=https%3A%2F%2Fwww.tga.gov.au%2Ffile%2F797%2Fdownload&usg=AOvVaw3STEHV1bh8A3ZobpKVV1Gj)	TRUE	507
6145	16.7		Sinus arrest	serious		One volunteer receiving ticagrelor 1260 mg had a serious AE	TRUE	507
6146	16.7		High grade atrioventricular block	serious		One volunteer receiving ticagrelor 1260 mg had a serious AE	TRUE	507
6147	16.7		Ventricular escape rhythm	serious		One volunteer receiving ticagrelor 1260 mg had a serious AE	TRUE	507
6148						No adverse reactions leading to discontinuation were reported		508
6149			Bleeding	grade 3-5	discontinuation	WARNING		510
6150	0.9		Dyspnea		discontinuation	WARNING		509
6151						No adverse reactions leading to discontinuation were reported		511
6152						No adverse reactions leading to discontinuation were reported		516
6153	4.3		Bleeding	grade 3-5	discontinuation	WARNING		512
6154			Spinal epidural hematoma		discontinuation	WARNING. Epidural or spinal hematomas have occurred in patients treated with XARELTO who are receiving neuraxial anesthesia or undergoing spinal puncture. These hematomas may result in long-term or permanent paralysis.		514
6155	1.7		Bleeding		discontinuation	WARNING		515
6156	2		Bleeding		discontinuation	WARNING		513
6157	4 pts		Confusional state	below serious				518
6158	5 pts		Diarrhea	below serious				518
6159	3 pts		Disturbance in attention	below serious				518
6160	21 pts		Dizziness	below serious				518
6161	1 pts		Dry mouth	below serious				518
6162	1 pts		Increased appetite	below serious				518
6163	1 pts		Malaise	below serious				518
6164	1 pts		Nasal congestion	below serious				518
6165	1 pts		Oropharyngeal pain	below serious				518
6166	2 pts		Panic attack	below serious				518
6167	2 pts		Rash	below serious				518
6168	3 pts		Vision blurred	below serious				518
6169	2 pts		Vomiting	below serious				518
6170	9.2		Dizziness		discontinuation	leads to discontinuation		519
6171	6.5		Confusional state		discontinuation	leads to discontinuation		519
6172	2.6		Ataxia		discontinuation	leads to discontinuation		519
6173	3.9		Somnolence		discontinuation	leads to discontinuation		519
6174	2.6		Dysarthria		discontinuation	leads to discontinuation		519
6175	1.3		Headache		discontinuation	leads to discontinuation		519
6176	3.3		Fatigue		discontinuation	leads to discontinuation		519
6177	1.3		Vision blurred		discontinuation	leads to discontinuation		519
6178	2.6		Tremor		discontinuation	leads to discontinuation		519
6179	2.6		Nausea		discontinuation	leads to discontinuation		519
6180	0.7		Speech disorder		discontinuation	leads to discontinuation		519
6181	0.7		Memory impairment		discontinuation	leads to discontinuation		519
6182	2		Diplopia		discontinuation	leads to discontinuation		519
6183	1.3		Gait disturbance		discontinuation	leads to discontinuation		519
6184	0.7		Balance disorder		discontinuation	leads to discontinuation		519
6185	1.3		Vomiting		discontinuation	leads to discontinuation		519
6186	1.3		Anxiety		discontinuation	leads to discontinuation		519
6187	2		Disturbance in attention		discontinuation	leads to discontinuation		519
6188	11.8		Urinary tract infection					519
6189	7.8		Influenza					519
6190	5.9		Constipation					519
6191	5.9		Urinary hesitation					519
6192	5.2		Dysuria					519
6193	5.2		Disorientation					519
6194	2 pts		Mucocutaneous disorder		discontinuation	leads to discontinuation		521
6195	1 pts		Maculopathy		discontinuation	leads to discontinuation		522
6196	6		Dizziness		discontinuation	leads to discontinuation		517
6197	4		Confusional state		discontinuation	leads to discontinuation		517
6198	3		Fatigue		discontinuation	leads to discontinuation		517
6199	3		Somnolence		discontinuation	leads to discontinuation		517
6200			Agitation					520
6201			Aggressive behavior					520
6202			Irritability					520
6203	17 pts		Febrile neutropenia	serious				523
6204	1 pts		Cardiac arrest	serious				523
6205	2 pts		Cardiac failure congestive	serious				523
6206	1 pts		Pericarditis	serious				523
6207	1 pts		Blindness	serious				523
6208	1 pts		Abdominal distension	serious				523
6209	1 pts		Ascites	serious				523
6210	5 pts		Diarrhoea	serious				523
6211	1 pts		Gastrooesophageal reflux disease	serious				523
6212	1 pts		Haematochezia	serious				523
6213	5 pts		Nausea	serious				523
6214	1 pts		Neutropenic colitis	serious				523
6215	7 pts		Vomiting	serious				523
6216	2 pts		Adverse drug reaction	serious				523
6217	2 pts		Asthenia	serious				523
6218	1 pts		Inflammation	serious				523
6219	1 pts		Multi-organ failure	serious				523
6220	1 pts		Oedema peripheral	serious				523
6221	1 pts		Cholecystitis acute	serious				523
6222	1 pts		Hepatic function abnormal	serious				523
6223	1 pts		Portal hypertension	serious				523
6224	3 pts		Acute graft versus host disease	serious				523
6225	2 pts		Graft versus host disease in skin	serious				523
6226	1 pts		Appendicitis	serious				523
6227	1 pts		Aspergillosis	serious				523
6228	3 pts		Bacteraemia	serious				523
6229	1 pts		Bacterial infection	serious				523
6230	1 pts		Candidiasis	serious				523
6231	1 pts		Cystitis	serious				523
6232	4 pts		Cytomegalovirus infection	serious				523
6233	2 pts		Cytomegalovirus viraemia	serious				523
6234	1 pts		Device related infection	serious				523
6235	1 pts		Diverticulitis	serious				523
6236	1 pts		Enterobacter sepsis	serious				523
6237	1 pts		Enterococcal sepsis	serious				523
6238	1 pts		Escherichia sepsis	serious				523
6239	4 pts		Pneumonia	serious				523
6240	1 pts		Pneumonia cytomegaloviral	serious				523
6241	1 pts		Pneumonia fungal	serious				523
6242	2 pts		Pseudomonal bacteraemia	serious				523
6243	1 pts		Pyelonephritis	serious				523
6244	1 pts		Infection staphylococcal	serious				523
6245	1 pts		Urinary tract infection enterococcal	serious				523
6246	2 pts		Viral haemorrhagic cystitis	serious				523
6247	3 pts		Accidental overdose	serious				523
6248	1 pts		Craniocerebral injury	serious				523
6249	1 pts		Drug dispensing error	serious				523
6250	1 pts		Medication error	serious				523
6251	1 pts		Transfusion reaction	serious				523
6252	1 pts		Transplant failure	serious				523
6253	1 pts		Alanine aminotransferase increased	serious				523
6254	1 pts		Aspartate aminotransferase increased	serious				523
6255	1 pts		Blood albumin decreased	serious				523
6256	1 pts		Liver function test abnormal	serious				523
6257	1 pts		Decreased appetite	serious				523
6258	2 pts		Dehydration	serious				523
6259	1 pts		Fluid imbalance	serious				523
6260	1 pts		Back pain	serious				523
6261	1 pts		Chondrocalcinosis pyrophosphate	serious				523
6262	1 pts		Rhabdomyolysis	serious				523
6263	2 pts		Acute myeloid leukaemia recurrent	serious				523
6264	1 pts		Adenocarcinoma pancreas	serious				523
6265	1 pts		Diffuse large B-cell lymphoma recurrent	serious				523
6266	1 pts		Leukaemia recurrent	serious				523
6267	1 pts		Myelodysplastic syndrome	serious				523
6268	1 pts		Non-Hodgkin's lymphoma recurrent	serious				523
6269	1 pts		Autonomic nervous system imbalance	serious				523
6270	1 pts		Autonomic neuropathy	serious				523
6271	1 pts		Headache	serious				523
6272	1 pts		Hypoaesthesia	serious				523
6273	1 pts		Leukoencephalopathy	serious				523
6274	1 pts		Posterior reversible encephalopathy syndrome	serious				523
6275	1 pts		Haemorrhage subarachnoid	serious				523
6276	2 pts		Syncope	serious				523
6277	2 pts		Delirium	serious				523
6278	8 pts		Renal failure acute	serious				523
6279	1 pts		Acute respiratory distress syndrome	serious				523
6280	1 pts		Dyspnoea	serious				523
6281	1 pts		Hypoxia	serious				523
6282	1 pts		Organising pneumonia	serious				523
6283	1 pts		Pleural effusion	serious				523
6284	1 pts		Pulmonary embolism	serious				523
6285	2 pts		Respiratory failure	serious				523
6286	1 pts		Purpura	serious				523
6287	2 pts		Jugular vein thrombosis	serious				523
6288	1 pts		Shock	serious				523
6289	1 pts		Venoocclusive disease	serious				523
6290	40 pts		Anaemia	below serious				523
6291	128 pts		Febrile neutropenia	below serious				523
6292	54 pts		Thrombocytopenia	below serious				523
6293	16 pts		Abdominal distension	below serious				523
6294	20 pts		Abdominal pain upper	below serious				523
6295	44 pts		Dyspepsia	below serious				523
6296	29 pts		Oesophagitis	below serious				523
6297	119 pts		Vomiting	below serious				523
6298	107 pts		Mucosal inflammation	below serious				523
6299	78 pts		Oedema peripheral	below serious				523
6300	17 pts		Oral candidiasis	below serious				523
6301	30 pts		Fluid overload	below serious				523
6302	21 pts		Hypocalcaemia	below serious				523
6303	45 pts		Hypokalaemia	below serious				523
6304	51 pts		Hypomagnesaemia	below serious				523
6305	37 pts		Hypophosphataemia	below serious				523
6306	28 pts		Pain in extremity	below serious				523
6307	44 pts		Dizziness	below serious				523
6308	31 pts		Dysgeusia	below serious				523
6309	22 pts		Neuropathy peripheral	below serious				523
6310	17 pts		Tremor	below serious				523
6311	47 pts		Anxiety	below serious				523
6312	16 pts		Confusional state	below serious				523
6313	39 pts		Dyspnoea	below serious				523
6314	43 pts		Oropharyngeal pain	below serious				523
6315	17 pts		Alopecia	below serious				523
6316	18 pts		Erythema	below serious				523
6317	32 pts		Pruritus	below serious				523
6318	52 pts		Rash	below serious				523
6319			Hypersensitivity reaction		discontinuation	WARNINGS. Acute hypersensitivity reactions (angioedema, dyspnea, pruritus, and rash)		525
6320			Multidrug resistant bacterial infection		discontinuation	WARNINGS		525
6321	0.5		Vomiting		discontinuation			524
6322	1 pts		DRESS syndrome		discontinuation	leads to discontinuation		528
6323			Nausea					526
6324			Headache					526
6325			Diarrhea					526
6326			Decreased appetite					526
6327			Dysgeusia					526
6328			Vomiting					526
6329	22		Anemia		discontinuation	leads to discontinuation		527
6330	20		Skin disorder		discontinuation	leads to discontinuation		527
6331	6		Fatigue		discontinuation	leads to discontinuation		527
6332	4		Nausea		discontinuation	leads to discontinuation		527
6333	4		Vomiting		discontinuation	leads to discontinuation		527
6334			Alanine aminotransferase increase		discontinuation			529
6335			Aspartate aminotransferase increased		discontinuation			529
6336	1		Depressive disorders	severe	discontinuation	WARNINGS. Severe depressive disorders (depressed mood, depression, dysphoria, major depression, mood altered, negative thoughts, suicide attempt, suicidal ideation) have been reported.		530
6337			Fat redistribution		discontinuation	WARNINGS		532
6338			Immune reconstitution syndrome		discontinuation	WARNINGS		532
6339	0.29		Suicide attempt		discontinuation			530
6340	0.1		Rash		discontinuation			531
6341	1 pts		Vomiting					534
6342						No AEs are reported		535
6343						No AEs are reported		533
6344	1 pts		Myocardial infarction	serious				536
6345	8 pts		Influenza	below serious				536
6346	15 pts		Nasopharyngitis	below serious				536
6347	11 pts		Dizziness	below serious				536
6348	13 pts		Septic shock	serious				537
6349	11 pts		Gastroenteritis	serious				537
6350	10 pts		Infection localised	serious				537
6351	14 pts		Pyelonephritis	serious				537
6352	7 pts		Influenza	serious				537
6353	6 pts		Pyelonephritis acute	serious				537
6354	4 pts		Device related infection	serious				537
6355	4 pts		Upper respiratory tract infection	serious				537
6356	3 pts		Bacteraemia	serious				537
6357	3 pts		Postoperative wound infection	serious				537
6358	3 pts		Lung infection	serious				537
6359	2 pts		Clostridium difficile colitis	serious				537
6360	2 pts		Escherichia sepsis	serious				537
6361	2 pts		Infection	serious				537
6362	2 pts		Pneumonia bacterial	serious				537
6363	2 pts		Pulmonary sepsis	serious				537
6364	2 pts		Soft tissue infection	serious				537
6365	2 pts		Gastroenteritis viral	serious				537
6366	2 pts		Herpes zoster	serious				537
6367	2 pts		Intervertebral discitis	serious				537
6368	2 pts		Scrotal abscess	serious				537
6369	1 pts		Abdominal sepsis	serious				537
6370	1 pts		Abdominal wall abscess	serious				537
6371	1 pts		Clostridium difficile infection	serious				537
6372	1 pts		Disseminated tuberculosis	serious				537
6373	1 pts		Endocarditis bacterial	serious				537
6374	1 pts		Enteritis infectious	serious				537
6375	1 pts		Epididymitis	serious				537
6376	1 pts		Escherichia bacteraemia	serious				537
6377	1 pts		Fungal peritonitis	serious				537
6378	1 pts		Gastroenteritis norovirus	serious				537
6379	1 pts		Gastrointestinal bacterial infection	serious				537
6380	1 pts		Gastrointestinal infection	serious				537
6381	1 pts		H1N1 influenza	serious				537
6382	1 pts		Histoplasmosis disseminated	serious				537
6383	1 pts		Infected dermal cyst	serious				537
6384	1 pts		Infectious colitis	serious				537
6385	1 pts		Injection site abscess	serious				537
6386	1 pts		Klebsiella bacteraemia	serious				537
6387	1 pts		Klebsiella infection	serious				537
6388	1 pts		Klebsiella sepsis	serious				537
6389	1 pts		Leptospirosis	serious				537
6390	1 pts		Meningitis viral	serious				537
6391	1 pts		Mycoplasma infection	serious				537
6392	1 pts		Oral candidiasis	serious				537
6393	1 pts		Orchitis	serious				537
6394	1 pts		Abscess peritonsillar	serious				537
6395	1 pts		Pneumonia klebsiella	serious				537
6396	1 pts		Pneumonia legionella	serious				537
6397	1 pts		Pneumococcal pneumonia	serious				537
6398	1 pts		Pseudomembranous colitis	serious				537
6399	1 pts		Pseudomonas infection	serious				537
6400	1 pts		Scrub typhus	serious				537
6401	1 pts		Sialoadenitis	serious				537
6402	1 pts		Streptococcal bacteraemia	serious				537
6403	1 pts		Tonsillitis	serious				537
6404	1 pts		Tracheobronchitis	serious				537
6405	1 pts		Urinary tract infection pseudomonal	serious				537
6406	1 pts		Viraemia	serious				537
6407	1 pts		Viral tonsillitis	serious				537
6408	9 pts		Prostate cancer	serious				537
6409	7 pts		Lung neoplasm malignant	serious				537
6410	3 pts		Adenocarcinoma lung	serious				537
6411	3 pts		Renal cancer	serious				537
6412	2 pts		Hepatocellular carcinoma	serious				537
6413	2 pts		Lung neoplasm	serious				537
6414	2 pts		Meningioma	serious				537
6415	2 pts		Pancreatic carcinoma	serious				537
6416	2 pts		Prostate cancer metastatic	serious				537
6417	1 pts		Basosquamous carcinoma of skin	serious				537
6418	1 pts		Brain neoplasm	serious				537
6419	1 pts		Cardiac neoplasm unspecified	serious				537
6420	1 pts		Diffuse large B-cell lymphoma	serious				537
6421	1 pts		Endometrial cancer	serious				537
6422	1 pts		Gallbladder cancer	serious				537
6423	1 pts		Gastric adenoma	serious				537
6424	1 pts		Intraductal proliferative breast lesion	serious				537
6425	1 pts		Laryngeal cancer	serious				537
6426	1 pts		Lung cancer metastatic	serious				537
6427	1 pts		Metastases to lung	serious				537
6428	1 pts		Metastases to spine	serious				537
6429	1 pts		Metastatic malignant melanoma	serious				537
6430	1 pts		Myeloproliferative neoplasm	serious				537
6431	1 pts		Neuroendocrine tumour	serious				537
6432	1 pts		Non-small cell lung cancer	serious				537
6433	1 pts		Oesophageal adenocarcinoma	serious				537
6434	1 pts		Oesophageal carcinoma	serious				537
6435	1 pts		Pancreatic carcinoma metastatic	serious				537
6436	1 pts		Pancreatic neoplasm	serious				537
6437	1 pts		Penile squamous cell carcinoma	serious				537
6438	1 pts		Prostatic adenoma	serious				537
6439	1 pts		Schwannoma	serious				537
6440	1 pts		Sebaceous adenoma	serious				537
6441	1 pts		Testis cancer	serious				537
6442	1 pts		Tongue cancer recurrent	serious				537
6443	1 pts		Tongue neoplasm malignant stage unspecified	serious				537
6444	1 pts		Transitional cell cancer of the renal pelvis and ureter	serious				537
6445	1 pts		Tumour of ampulla of Vater	serious				537
6446	1 pts		Vulval cancer	serious				537
6447	19 pts		Anaemia	serious				537
6448	2 pts		Lymphadenopathy	serious				537
6449	2 pts		Haemorrhagic anaemia	serious				537
6450	1 pts		Eosinophilia	serious				537
6451	1 pts		Febrile neutropenia	serious				537
6452	1 pts		Lymphadenitis	serious				537
6453	1 pts		Nephrogenic anaemia	serious				537
6454	2 pts		Hypersensitivity	serious				537
6455	1 pts		Drug hypersensitivity	serious				537
6456	1 pts		Hyperthyroidism	serious				537
6457	1 pts		Thyroid mass	serious				537
6458	11 pts		Dehydration	serious				537
6459	9 pts		Diabetes mellitus	serious				537
6460	10 pts		Diabetic metabolic decompensation	serious				537
6461	6 pts		Hyponatraemia	serious				537
6462	7 pts		Metabolic acidosis	serious				537
6463	3 pts		Hypokalaemia	serious				537
6464	4 pts		Type 2 diabetes mellitus	serious				537
6465	2 pts		Gout	serious				537
6466	2 pts		Hyperlipasaemia	serious				537
6467	2 pts		Lactic acidosis	serious				537
6468	2 pts		Hypocalcaemia	serious				537
6469	1 pts		Abnormal loss of weight	serious				537
6470	1 pts		Decreased appetite	serious				537
6471	1 pts		Failure to thrive	serious				537
6472	1 pts		Fluid imbalance	serious				537
6473	1 pts		Hyperphosphataemia	serious				537
6474	1 pts		Hypertriglyceridaemia	serious				537
6475	1 pts		Vitamin D deficiency	serious				537
6476	1 pts		Adjustment disorder	serious				537
6477	1 pts		Affect lability	serious				537
6478	61 pts		Ischaemic stroke	serious				537
6479	27 pts		Transient ischaemic attack	serious				537
6480	10 pts		Haemorrhagic stroke	serious				537
6481	8 pts		Dementia	serious				537
6482	7 pts		Diabetic neuropathy	serious				537
6483	4 pts		Dizziness	serious				537
6484	3 pts		Haemorrhage intracranial	serious				537
6485	2 pts		Altered state of consciousness	serious				537
6486	2 pts		Cerebral haemorrhage	serious				537
6487	2 pts		Coma diabetic	serious				537
6488	2 pts		Encephalopathy hypertensive	serious				537
6489	2 pts		Hemiplegia	serious				537
6490	2 pts		Intracranial aneurysm	serious				537
6491	2 pts		Neuropathy peripheral	serious				537
6492	2 pts		Partial seizures	serious				537
6493	2 pts		Sciatica	serious				537
6494	1 pts		Carotid sinus syndrome	serious				537
6495	1 pts		Carpal tunnel syndrome	serious				537
6496	1 pts		Cervical radiculopathy	serious				537
6497	1 pts		Dyskinesia	serious				537
6498	1 pts		Intracranial pressure increased	serious				537
6499	1 pts		Lacunar stroke	serious				537
6500	1 pts		Metabolic encephalopathy	serious				537
6501	1 pts		Multiple sclerosis	serious				537
6502	1 pts		Neuritis cranial	serious				537
6503	1 pts		Neuroglycopenia	serious				537
6504	1 pts		Paraesthesia	serious				537
6505	1 pts		Post stroke seizure	serious				537
6506	1 pts		Spinal cord compression	serious				537
6507	1 pts		Spinal epidural haematoma	serious				537
6508	6 pts		Vitreous haemorrhage	serious				537
6509	4 pts		Macular hole	serious				537
6510	3 pts		Retinal vein occlusion	serious				537
6511	1 pts		Amaurosis	serious				537
6512	1 pts		Blindness	serious				537
6513	1 pts		Blindness unilateral	serious				537
6514	1 pts		Cataract cortical	serious				537
6515	1 pts		Corneal decompensation	serious				537
6516	1 pts		Cystoid macular oedema	serious				537
6517	1 pts		Diabetic retinal oedema	serious				537
6518	1 pts		Dry age-related macular degeneration	serious				537
6519	1 pts		Macular oedema	serious				537
6520	1 pts		Ischaemic optic neuropathy	serious				537
6521	1 pts		Retinal artery embolism	serious				537
6522	1 pts		Retinal artery occlusion	serious				537
6523	1 pts		Retinopathy	serious				537
6524	4 pts		Deafness neurosensory	serious				537
6525	2 pts		Deafness unilateral	serious				537
6526	2 pts		Hypoacusis	serious				537
6527	1 pts		Conductive deafness	serious				537
6528	77 pts		Angina unstable	serious				537
6529	78 pts		Acute myocardial infarction	serious				537
6530	42 pts		Angina pectoris	serious				537
6531	34 pts		Atrial fibrillation	serious				537
6532	26 pts		Coronary artery disease	serious				537
6533	24 pts		Cardiac failure chronic	serious				537
6534	25 pts		Cardiac arrest	serious				537
6535	20 pts		Myocardial ischaemia	serious				537
6536	13 pts		Left ventricular failure	serious				537
6537	13 pts		Atrial flutter	serious				537
6538	10 pts		Cardiac failure acute	serious				537
6539	7 pts		Sinus node dysfunction	serious				537
6540	5 pts		Atrioventricular block second degree	serious				537
6541	6 pts		Coronary artery occlusion	serious				537
6542	4 pts		Ischaemic cardiomyopathy	serious				537
6543	3 pts		Cardiopulmonary failure	serious				537
6544	2 pts		Arrhythmia	serious				537
6545	2 pts		Cardiovascular insufficiency	serious				537
6546	2 pts		Sinus bradycardia	serious				537
6547	2 pts		Cardiac disorder	serious				537
6548	2 pts		Mitral valve incompetence	serious				537
6549	2 pts		Pericardial effusion	serious				537
6550	1 pts		Aortic valve disease	serious				537
6551	1 pts		Cardiac tamponade	serious				537
6552	1 pts		Conduction disorder	serious				537
6553	1 pts		Cyanosis	serious				537
6554	1 pts		Degenerative mitral valve disease	serious				537
6555	1 pts		Mitral valve stenosis	serious				537
6556	1 pts		Pericarditis constrictive	serious				537
6557	1 pts		Pulseless electrical activity	serious				537
6558	1 pts		Tachyarrhythmia	serious				537
6559	1 pts		Tricuspid valve incompetence	serious				537
6560	1 pts		Trifascicular block	serious				537
6561	32 pts		Hypertension	serious				537
6562	18 pts		Peripheral arterial occlusive disease	serious				537
6563	8 pts		Aortic stenosis	serious				537
6564	6 pts		Orthostatic hypotension	serious				537
6565	4 pts		Aortic aneurysm	serious				537
6566	4 pts		Hypovolaemic shock	serious				537
6567	3 pts		Venous thrombosis limb	serious				537
6568	2 pts		Circulatory collapse	serious				537
6569	2 pts		Claudication intermittent	serious				537
6570	2 pts		Superficial thrombophlebitis	serious				537
6571	2 pts		Varicose ulceration	serious				537
6572	1 pts		Arterial insufficiency	serious				537
6573	1 pts		Arterial rupture	serious				537
6574	1 pts		Blood pressure inadequately controlled	serious				537
6575	1 pts		Diabetic vascular disorder	serious				537
6576	1 pts		Embolism arterial	serious				537
6577	1 pts		Embolism venous	serious				537
6578	1 pts		Femoral artery aneurysm	serious				537
6579	1 pts		Iliac artery occlusion	serious				537
6580	1 pts		Peripheral artery thrombosis	serious				537
6581	1 pts		Peripheral venous disease	serious				537
6582	1 pts		Subclavian artery stenosis	serious				537
6583	1 pts		Thrombosis	serious				537
6584	16 pts		Pulmonary oedema	serious				537
6585	4 pts		Hypoxia	serious				537
6586	3 pts		Pulmonary mass	serious				537
6587	2 pts		Haemoptysis	serious				537
6588	2 pts		Aspiration pneumonia	serious				537
6589	2 pts		Respiratory distress	serious				537
6590	2 pts		Asphyxia	serious				537
6591	2 pts		Emphysema	serious				537
6592	2 pts		Wheezing	serious				537
6593	1 pts		Acute respiratory distress syndrome	serious				537
6594	1 pts		Aspiration	serious				537
6595	1 pts		Atelectasis	serious				537
6596	1 pts		Eosinophilic pneumonia	serious				537
6597	1 pts		Haemothorax	serious				537
6598	1 pts		Interstitial lung disease	serious				537
6599	1 pts		Laryngeal oedema	serious				537
6600	1 pts		Mediastinal mass	serious				537
6601	1 pts		Mendelson's syndrome	serious				537
6602	1 pts		Pneumonitis	serious				537
6603	1 pts		Portopulmonary hypertension	serious				537
6604	1 pts		Vocal cord polyp	serious				537
6605	8 pts		Upper gastrointestinal haemorrhage	serious				537
6606	9 pts		Diarrhoea	serious				537
6607	7 pts		Pancreatitis acute	serious				537
6608	6 pts		Pancreatitis	serious				537
6609	6 pts		Vomiting	serious				537
6610	4 pts		Large intestine polyp	serious				537
6611	4 pts		Lower gastrointestinal haemorrhage	serious				537
6612	4 pts		Colitis ischaemic	serious				537
6613	3 pts		Gastric ulcer	serious				537
6614	3 pts		Chronic gastritis	serious				537
6615	2 pts		Haemorrhoids	serious				537
6616	3 pts		Melaena	serious				537
6617	2 pts		Abdominal adhesions	serious				537
6618	2 pts		Colitis	serious				537
6619	2 pts		Diverticulum intestinal haemorrhagic	serious				537
6620	1 pts		Abdominal hernia obstructive	serious				537
6621	1 pts		Abdominal tenderness	serious				537
6622	1 pts		Anal fissure	serious				537
6623	1 pts		Barrett's oesophagus	serious				537
6624	1 pts		Duodenal perforation	serious				537
6625	1 pts		Duodenal vascular ectasia	serious				537
6626	1 pts		Duodenitis haemorrhagic	serious				537
6627	1 pts		Enteritis	serious				537
6628	1 pts		Enterocolitis haemorrhagic	serious				537
6629	1 pts		Enterovesical fistula	serious				537
6630	1 pts		Faecaloma	serious				537
6631	1 pts		Gastric antral vascular ectasia	serious				537
6632	1 pts		Gastritis erosive	serious				537
6633	1 pts		Gastritis haemorrhagic	serious				537
6634	1 pts		Haematemesis	serious				537
6635	1 pts		Large intestinal obstruction	serious				537
6636	1 pts		Mechanical ileus	serious				537
6637	1 pts		Oedema mouth	serious				537
6638	1 pts		Pancreatic failure	serious				537
6639	1 pts		Retroperitoneal fibrosis	serious				537
6640	1 pts		Tongue oedema	serious				537
6641	10 pts		Cholelithiasis	serious				537
6642	10 pts		Cholecystitis acute	serious				537
6643	7 pts		Cholecystitis	serious				537
6644	5 pts		Hepatic cirrhosis	serious				537
6645	3 pts		Hepatic failure	serious				537
6646	2 pts		Biliary colic	serious				537
6647	2 pts		Hepatic steatosis	serious				537
6648	1 pts		Autoimmune hepatitis	serious				537
6649	1 pts		Bile duct obstruction	serious				537
6650	1 pts		Biliary dyspepsia	serious				537
6651	1 pts		Jaundice	serious				537
6652	1 pts		Portal hypertension	serious				537
6653	1 pts		Portal vein thrombosis	serious				537
6654	2 pts		Angioedema	serious				537
6655	3 pts		Pemphigoid	serious				537
6656	2 pts		Pruritus	serious				537
6657	1 pts		Decubitus ulcer	serious				537
6658	1 pts		Dermal cyst	serious				537
6659	1 pts		Dermatitis bullous	serious				537
6660	1 pts		Dermatitis exfoliative generalised	serious				537
6661	1 pts		Ichthyosis acquired	serious				537
6662	1 pts		Lentigo	serious				537
6663	1 pts		Rash	serious				537
6664	1 pts		Necrosis skin	serious				537
6665	1 pts		Skin ulcer haemorrhage	serious				537
6666	1 pts		Swelling face	serious				537
6667	1 pts		Toxic epidermal necrolysis	serious				537
6668	3 pts		Intervertebral disc protrusion	serious				537
6669	3 pts		Rhabdomyolysis	serious				537
6670	3 pts		Osteoarthritis spinal	serious				537
6671	3 pts		Arthritis	serious				537
6672	3 pts		Back pain	serious				537
6673	2 pts		Intervertebral disc disorder	serious				537
6674	2 pts		Musculoskeletal pain	serious				537
6675	2 pts		Polymyalgia rheumatica	serious				537
6676	2 pts		Spinal pain	serious				537
6677	2 pts		Spondylolisthesis	serious				537
6678	2 pts		Rotator cuff syndrome	serious				537
6679	1 pts		Bursitis	serious				537
6680	1 pts		Fibromyalgia	serious				537
6681	1 pts		Gouty arthritis	serious				537
6682	1 pts		Joint range of motion decreased	serious				537
6683	1 pts		Limb discomfort	serious				537
6684	1 pts		Myopathy	serious				537
6685	1 pts		Neuropathic arthropathy	serious				537
6686	1 pts		Osteonecrosis	serious				537
6687	1 pts		Fracture pathological	serious				537
6688	1 pts		Periostitis	serious				537
6689	1 pts		Rheumatoid arthritis	serious				537
6690	1 pts		Vertebral osteophyte	serious				537
6691	49 pts		Chronic kidney disease	serious				537
6692	32 pts		Renal failure	serious				537
6693	9 pts		Diabetic nephropathy	serious				537
6694	5 pts		Haematuria	serious				537
6695	7 pts		Nephrotic syndrome	serious				537
6696	4 pts		Hydronephrosis	serious				537
6697	4 pts		Ureterolithiasis	serious				537
6698	2 pts		Calculus bladder	serious				537
6699	2 pts		Bladder calculus	serious				537
6700	1 pts		Acute prerenal failure	serious				537
6701	1 pts		Glomerulonephritis membranous	serious				537
6702	1 pts		Renal pain	serious				537
6703	1 pts		Urethral haemorrhage	serious				537
6704	2 pts		Acquired hydrocele	serious				537
6705	1 pts		Acquired phimosis	serious				537
6706	1 pts		Haemorrhagic ovarian cyst	serious				537
6707	1 pts		Accessory spleen	serious				537
6708	1 pts		Atrial septal defect	serious				537
6709	1 pts		Myocardial bridging	serious				537
6710	7 pts		Cardiac death	serious				537
6711	5 pts		Pyrexia	serious				537
6712	3 pts		Multiple organ dysfunction syndrome	serious				537
6713	3 pts		Generalised oedema	serious				537
6714	2 pts		Chest discomfort	serious				537
6715	2 pts		Vascular stent restenosis	serious				537
6716	2 pts		Catheter site haemorrhage	serious				537
6717	2 pts		Chills	serious				537
6718	2 pts		Complication associated with device	serious				537
6719	2 pts		General physical health deterioration	serious				537
6720	2 pts		Necrobiosis	serious				537
6721	1 pts		Application site haemorrhage	serious				537
6722	1 pts		Feeling abnormal	serious				537
6723	1 pts		Medical device site joint inflammation	serious				537
6724	1 pts		Systemic inflammatory response syndrome	serious				537
6725	1 pts		Ulcer haemorrhage	serious				537
6726	1 pts		Vascular stent occlusion	serious				537
6727	36 pts		Glomerular filtration rate decreased	serious				537
6728	2 pts		Blood pressure increased	serious				537
6729	2 pts		Arteriogram coronary	serious				537
6730	2 pts		Blood glucose increased	serious				537
6731	1 pts		Catheterisation cardiac	serious				537
6732	1 pts		Echocardiogram	serious				537
6733	1 pts		Ejection fraction decreased	serious				537
6734	1 pts		Electrocardiogram T wave inversion	serious				537
6735	1 pts		Influenza A virus test positive	serious				537
6736	1 pts		Intracardiac pressure increased	serious				537
6737	1 pts		Liver function test increased	serious				537
6738	10 pts		Femur fracture	serious				537
6739	5 pts		Contusion	serious				537
6740	4 pts		Tibia fracture	serious				537
6741	5 pts		Fracture rib	serious				537
6742	5 pts		Subdural haematoma	serious				537
6743	5 pts		Ankle fracture	serious				537
6744	3 pts		Foot fracture	serious				537
6745	3 pts		Patella fracture	serious				537
6746	2 pts		Craniocerebral injury	serious				537
6747	2 pts		Incisional hernia	serious				537
6748	1 pts		Anastomotic complication	serious				537
6749	1 pts		Animal bite	serious				537
6750	1 pts		Arterial bypass occlusion	serious				537
6751	1 pts		Arteriovenous fistula thrombosis	serious				537
6752	1 pts		Colon injury	serious				537
6753	1 pts		Coronary artery restenosis	serious				537
6754	1 pts		Endotracheal intubation complication	serious				537
6755	1 pts		Fracture displacement	serious				537
6756	1 pts		Joint injury	serious				537
6757	1 pts		Limb crushing injury	serious				537
6758	1 pts		Peritoneal dialysis complication	serious				537
6759	1 pts		Pneumothorax traumatic	serious				537
6760	1 pts		Postoperative delirium	serious				537
6761	1 pts		Postoperative respiratory distress	serious				537
6762	1 pts		Radius fracture	serious				537
6763	1 pts		Skull fractured base	serious				537
6764	1 pts		Spinal compression fracture	serious				537
6765	1 pts		Sternal fracture	serious				537
6766	1 pts		Stomal hernia	serious				537
6767	1 pts		Thoracic vertebral fracture	serious				537
6768	1 pts		Traumatic intracranial haemorrhage	serious				537
6769	1 pts		Vascular pseudoaneurysm	serious				537
6770	1 pts		Wrist fracture	serious				537
6771	2 pts		Coronary revascularisation	serious				537
6772	1 pts		Hospitalisation	serious				537
6773	1 pts		Homicide	serious				537
6774	1 pts		Limb prosthesis user	serious				537
6775	196 pts		Urinary tract infection	below serious				537
6776	1022 pts		Hypoglycaemia	below serious				537
6777	202 pts		Glomerular filtration rate decreased	below serious				537
6778	1 pts		Prolapsed disc NOS	serious				538
6779	1 pts		Coordination disturbance	serious				538
6780	1 pts		Abdominal pain	serious				538
6781	1 pts		Dorsal pain	below serious				538
6782	1 pts		Toothache	below serious				538
6783						No AEs are reported		539
6784						No adverse reactions leading to discontinuation were reported		540
6785			Hepatotoxicity		discontinuation	WARNING		542
6786			Apparent mineralocorticoid excess		discontinuation	WARNING		542
6787			Secondary adrenocortical insufficiency		discontinuation	WARNING		542
6788	<1		Aspartate aminotransferase increased		discontinuation	WARNING		543
6789	<1		Alanine aminotransferase increased		discontinuation	WARNING		543
6790	<1		Urosepsis		discontinuation	WARNING		543
6791	<1		Cardiac failure		discontinuation	WARNING		543
6792	39		Fatigue	grade 1-2				545
6793	2.2		Fatigue	grade 3-4				545
6794	25		Edema peripheral	grade 1-2				545
6795	25		Pitting edema	grade 1-2				545
6796	25		Generalized edema	grade 1-2				545
6797	8.7		Pyrexia	grade 1-2				545
6798	0.6		Pyrexia	grade 3-4				545
6799	30		Arthritis	grade 1-2				545
6800	30		Arthralgia	grade 1-2				545
6801	30		Joint swelling	grade 1-2				545
6802	30		Joint stiffness	grade 1-2				545
6803	6.6		Groin pain	grade 1-2				545
6804	23		Constipation	grade 1-2				545
6805	22		Diarrhea	grade 1-2				545
6806	11		Dyspepsia	grade 1-2				545
6807	22		Hot flush	grade 1-2				545
6808	0.2		Hot flush	grade 3-4				545
6809	22		Hypertension	grade 1-2				545
6810	3.9		Hypertension	grade 3-4				545
6811	17		Cough	grade 1-2				545
6812	12		Dyspnea	grade 1-2				545
6813	2.4		Dyspnea	grade 3-4				545
6814	14		Insomnia	grade 1-2				545
6815	0.2		Insomnia	grade 3-4				545
6816	13		Contusion	grade 1-2				545
6817	5.9		Fall	grade 1-2				545
6818	13		Upper respiratory tract infection	grade 1-2				545
6819	8		Nasopharyngitis	grade 1-2				545
6820	10		Hematuria	grade 1-2				545
6821	1.3		Hematuria	grade 3-4				545
6822	8.1		Rash	grade 1-2				545
6823	29.3		Lymphopenia	grade 1-2				544
6824	8.7		Lymphopenia	grade 3-4				544
6825	50.5		Hyperglycemia	grade 1-2				544
6826	6.5		Hyperglycemia	grade 3-4				544
6827	35.9		ALT high	grade 1-2				544
6828	6.1		ALT high	grade 3-4				544
6829	33.9		AST high	grade 1-2				544
6830	3.1		AST high	grade 3-4				544
6831	32.6		Hypernatremia	grade 1-2				544
6832	0.4		Hypernatremia	grade 3-4				544
6833	14.2		Hypokalemia	grade 1-2				544
6834	2.8		Hypokalemia	grade 3-4				544
6835	1.6		Cardiac failure	grade 3-4				544
6836	5 pts		Cardiac failure		discontinuation	leads to discontinuation		544
6837	2 pts		Cardiac failure	grade 5				544
6838	1		AST high		discontinuation	leads to discontinuation		544
6839	1		ALT high		discontinuation	leads to discontinuation		544
6840						no AEs are reported. were tolerated up to 2000 mg orally once daily without reaching maximum tolerated dose (MTD).		541
6841	12 pts		Pneumonia	serious				546
6842	3 pts		Diarrhoea	serious				546
6843	3 pts		Rash	serious				546
6844	3 pts		Transient ischemic attack	serious				546
6845	2 pts		Febrile neutropenia	serious				546
6846	2 pts		Headache	serious				546
6847	2 pts		Hypertension	serious				546
6848	2 pts		Memory impairment	serious				546
6849	2 pts		Productive cough	serious				546
6850	1 pts		Convulsion	serious				546
6851	2 pts		Cough	serious				546
6852	4 pts		Dyspnoea	serious				546
6853	1 pts		Pneumonitis	serious				546
6854	1 pts		Sepsis	serious				546
6855	2 pts		Chest discomfort	serious				546
6856	2 pts		Pneumothorax	serious				546
6857	1 pts		Ileal perforation	serious				546
6858	1 pts		Muscular weakness	serious				546
6859	45 pts		Diarrhoea	below serious				546
6860	13 pts		Nausea	below serious				546
6861	29 pts		Anorexia	below serious				546
6862	14 pts		Insomnia	below serious				546
6863	19 pts		Dyspnoea	below serious				546
6864	29 pts		Productive cough	below serious				546
6865	23 pts		Pruritus	below serious				546
6866	8 pts		Constipation	below serious				546
6867	4 pts		Dry mouth	below serious				546
6868	8 pts		Stomatitis	below serious				546
6869	6 pts		Vomiting	below serious				546
6870	9 pts		Asthenia	below serious				546
6871	7 pts		Chest discomfort	below serious				546
6872	12 pts		Chest pain	below serious				546
6873	7 pts		Mucosal inflammation	below serious				546
6874	5 pts		Pyrexia	below serious				546
6875	4 pts		Paronychia	below serious				546
6876	9 pts		Pneumonia	below serious				546
6877	8 pts		Headache	below serious				546
6878	5 pts		Anxiety	below serious				546
6879	8 pts		Dysphonia	below serious				546
6880	7 pts		Dyspnoea exertional	below serious				546
6881	5 pts		Haemoptysis	below serious				546
6882	8 pts		Pharyngolaryngeal pain	below serious				546
6883	9 pts		Acne	below serious				546
6884	6 pts		Flushing	below serious				546
6885	10 pts		Dry skin	below serious				546
6886	4 pts		Hyperhidrosis	below serious				546
6887	58 pts		Rash	below serious				546
6888	8 pts		Skin lesion	below serious				546
6889	13 pts		Hypertension	below serious				546
6890	4 pts		Vision blurred	below serious				546
6891	2 pts		Lung infection	serious				547
6892	3 pts		Pneumonia	serious				547
6893	1 pts		Respiratory tract infection	serious				547
6894	1 pts		Sepsis	serious				547
6895	1 pts		Viral upper respiratory tract infection	serious				547
6896	1 pts		Bladder cancer	serious				547
6897	1 pts		Inappropriate antidiuretic hormone secretion	serious				547
6898	1 pts		Decreased appetite	serious				547
6899	1 pts		Cerebrovascular accident	serious				547
6900	1 pts		Dizziness	serious				547
6901	1 pts		Generalised tonic-clonic seizure	serious				547
6902	1 pts		Cardiac arrest	serious				547
6903	1 pts		Ventricular extrasystoles	serious				547
6904	1 pts		Haemoptysis	serious				547
6905	1 pts		Interstitial lung disease	serious				547
6906	1 pts		Pleural effusion	serious				547
6907	1 pts		Aspiration pneumonia	serious				547
6908	1 pts		Pneumothorax	serious				547
6909	1 pts		Pulmonary embolism	serious				547
6910	2 pts		Respiratory failure	serious				547
6911	3 pts		Diarrhoea	serious				547
6912	1 pts		Large intestine polyp	serious				547
6913	1 pts		Photosensitivity reaction	serious				547
6914	1 pts		Rash	serious				547
6915	1 pts		Stevens-Johnson syndrome	serious				547
6916	1 pts		Musculoskeletal chest pain	serious				547
6917	1 pts		Fracture pathological	serious				547
6918	1 pts		Multi-organ failure	serious				547
6919	1 pts		Troponin increased	serious				547
6920	1 pts		Post procedural haemorrhage	serious				547
6921	9 pts		Urinary tract infection	below serious				547
6922	19 pts		Decreased appetite	below serious				547
6923	14 pts		Hypocalcaemia	below serious				547
6924	9 pts		Hypokalaemia	below serious				547
6925	9 pts		Hypomagnesaemia	below serious				547
6926	15 pts		Insomnia	below serious				547
6927	12 pts		Headache	below serious				547
6928	6 pts		Keratopathy	below serious				547
6929	47 pts		Hypertension	below serious				547
6930	8 pts		Abdominal pain	below serious				547
6931	78 pts		Diarrhoea	below serious				547
6932	6 pts		Dyspepsia	below serious				547
6933	18 pts		Nausea	below serious				547
6934	6 pts		Stomatitis	below serious				547
6935	9 pts		Acne	below serious				547
6936	12 pts		Dermatitis acneiform	below serious				547
6937	15 pts		Dry skin	below serious				547
6938	6 pts		Erythema	below serious				547
6939	6 pts		Palmar-plantar erythrodysaesthesia syndrome	below serious				547
6940	13 pts		Photosensitivity reaction	below serious				547
6941	40 pts		Rash	below serious				547
6942	7 pts		Rash maculo-papular	below serious				547
6943	7 pts		Arthralgia	below serious				547
6944	7 pts		Proteinuria	below serious				547
6945	19 pts		Asthenia	below serious				547
6946	13 pts		Fatigue	below serious				547
6947	16 pts		Alanine aminotransferase increased	below serious				547
6948	15 pts		Aspartate aminotransferase increased	below serious				547
6949	7 pts		Blood creatinine increased	below serious				547
6950	34 pts		Electrocardiogram QT prolonged	below serious				547
6951	8 pts		Weight decreased	below serious				547
6952	12.5		Intestinal obstruction	grade 3			TRUE	561
6953	25		Diarrhea	grade 3			TRUE	561
6954	12.5		Colitis	grade 3			TRUE	561
6955	12.5		Hypertension	grade 3			TRUE	561
6956	12.5		Fatigue	grade 3			TRUE	561
6957	12.5		Thrombocytopenia	grade 3			TRUE	561
6958	12.5		Diarrhea	grade 2			TRUE	560
6959	12.5		Folliculitis	grade 2			TRUE	560
6960	12.5		ALT increased	grade 3			TRUE	560
6961	12.5		Rash	grade 3			TRUE	560
6962	12.5		Folliculitis	grade 3	discontinuation			560
6963	4		Rash	grade 2			TRUE	553
6964	12.5		Hypophosphatemia	grade 3			TRUE	551
6965	12.5		Diarrhea	grade 2			TRUE	551
6966	4		Congestive cardiac failure	grade 3	discontinuation			553
6967			Vomiting	grade 2	discontinuation			557
6968	33.3		Hypertension	grade 3			TRUE	552
6969	33.3		Hypertension	grade 3			TRUE	554
6970	33.3		Diarrhea	grade 3			TRUE	554
6971	33.3		Headache	grade 3			TRUE	554
6972	33.3		Toxic skin eruption	grade 2			TRUE	554
6973	33.3		Hypertension	grade 3			TRUE	558
6974	33.3		Alanine aminotransferase increased	grade 3			TRUE	558
6975	16.7		Fatigue	grade 3				552
6976	33.3		Lymphopenia	grade 3				556
6977	50		Diarrhea					549
6978	5		Diarrhea	grade 3-4				549
6979	28		Rash					549
6980	3		Rash	grade 3-4				549
6981	1.3		Rash		discontinuation			549
6982	23		Nausea					549
6983	1		Nausea	grade 3-4				549
6984	20		Anorexia					549
6985	2		Anorexia	grade 3-4				549
6986	20		Fatigue					549
6987	4		Fatigue	grade 3-4				549
6988	15		Dyspnea					549
6989	4		Dyspnea	grade 3-4				549
6990	1		Dyspnea		discontinuation			549
6991	13		Cough					549
6992	0.8		Cough	grade 3-4				549
6993	12		Dermatitis acneiform					549
6994	0.6		Dermatitis acneiform	grade 3-4				549
6995	14		Vomiting					549
6996	2		Vomiting	grade 3-4				549
6997	9		Constipation					549
6998	10		Dry skin					549
6999	0.3		Dry skin	grade 3-4				549
7000	16		Hypertension					549
7001	4		Hypertension	grade 3-4				549
7002	6		Pruritus					549
7003	0.5		Pruritus	grade 3-4				549
7004	1.1		Pneumonia		discontinuation			549
7005			Eczema	grade 1	discontinuation			559
7006			Folliculitis	grade 2	discontinuation			562
7007	5.1		QT interval prolonged			WARNINGS		550
7008	0.2		Torsades de pointes			WARNINGS		550
7009	0.2		Sudden death	grade 5		WARNINGS		550
7010	2.5		Skin disorder		discontinuation			555
7011	1.7		Asthenia		discontinuation			555
7012	0.9		Fatigue		discontinuation			555
7013	0.9		Pyrexia		discontinuation			555
7014	0.9		Diarrhea		discontinuation			555
7015	0.9		Creatinine increased		discontinuation			555
7016	0.9		Electrocardiogram QTc interval prolonged		discontinuation			555
7017	0.9		Hypertension		discontinuation			555
7018	0.4		General physical health deterioration		discontinuation			555
7019	0.4		Dysphagia		discontinuation			555
7020	0.4		Nausea		discontinuation			555
7021	0.4		Pancreatitis		discontinuation			555
7022	0.4		Peritonitis		discontinuation			555
7023	0.4		Small intestinal perforation		discontinuation			555
7024	0.4		Vomiting		discontinuation			555
7025	0.4		Systolic dysfunction		discontinuation			555
7026	0.4		Chylothorax		discontinuation			555
7027	0.4		Cough		discontinuation			555
7028	0.4		Dysphonia		discontinuation			555
7029	0.4		Dyspnea		discontinuation			555
7030	0.4		Pneumonitis		discontinuation			555
7031	0.4		Peripheral ischemia		discontinuation			555
7032	0.4		Peripheral sensorimotor neuropathy		discontinuation			555
7033	0.4		Vision blurred		discontinuation			555
7034	0.4		Arthralgia		discontinuation			555
7035	0.4		Germ cell cancer		discontinuation			555
7036	3.9		Rash	grade 3				555
7037	0.9		Acneiform dermatitis	grade 3				555
7038	1.7		Photosensitivity reaction	grade 3				555
7039	1.3		Generalized erythema	grade 3				555
7040	0.4		Skin exfoliation	grade 3				555
7041	0.4		Palmar-plantar erythrodysaesth.	grade 3				555
7042	0.4		Dermatitis bullous	grade 3				555
7043	0.4		Skin candida	grade 3				555
7044	0.4		Erysipelas	grade 3				555
7045	0.4		Pneumonitis	grade 3				555
7046	1.7		Dyspnea	grade 3				555
7047	0.8		Respiratory failure	grade 3				555
7048	3		Diarrhea	grade 3				555
7049	1		Nausea	grade 3				555
7050	6		Hypertension	grade 3				555
7051	1		Headache	grade 3				555
7052	6		Fatigue	grade 3				555
7053	4		Decreased appetite	grade 3				555
7054	<1		Dermatitis acneiform	grade 3				555
7055	1		Vomiting	grade 3				555
7056	3		Asthenia	grade 3				555
7057	2		Abdominal pain	grade 3				555
7058	8		QT interval prolonged	grade 3				555
7059	2		Photosensitivity reaction	grade 3				555
7060	2		Hypocalcaemia	grade 3				555
7061	1		Pruritus	grade 3				555
7062	1		Weight decreased	grade 3				555
7063	2		Depression	grade 3				555
7064	2		ALT increased	grade 3				555
7065	6		Calcium decreased	grade 3				555
7066	9		Calcium increased	grade 3				555
7067	2		Glucose increased	grade 3				555
7068	<1		Magnesium decreased	grade 3				555
7069	<1		Potassium decreased	grade 3				555
7070	<1		Potassium increased	grade 3				555
7071	<1		Hemoglobin decreased	grade 3				555
7072	<1		Neutrophil count decreased	grade 3				555
7073	<1		WBC decreased	grade 3				555
7074			Rash			OVERDOSAGE		548
7075			Blood pressure systolic increased			OVERDOSAGE		548
7076			Blood pressure diastolic increased			OVERDOSAGE		548
7077	3 pts		Insomnia	below serious				573
7078	3 pts		Nausea	below serious				573
7079	2 pts		Depression	below serious				573
7080	2 pts		Allergic reaction	below serious				573
7081	3 pts		Fatigue	below serious				577
7082	5 pts		Somnolence	below serious				577
7083	4 pts		Dizziness	below serious				577
7084	1 pts		Breast cancer	serious				581
7085	1 pts		Gastroesophageal reflux disease	serious				581
7086	41 pts		Dizziness	below serious				581
7087	9 pts		Fatigue	below serious				581
7088	11 pts		Flatulence	below serious				581
7089	15 pts		Headache	below serious				581
7090	14 pts		Nasopharyngitis	below serious				581
7091	12 pts		Nausea	below serious				581
7092	23 pts		Somnolence	below serious				581
7093	11 pts		Upper respiratory tract infection	below serious				581
7094	5 pts		Weight increased	below serious				581
7095	1 pts		Breast cancer	serious				574
7096	1 pts		Lung neoplasm malignant	serious				574
7097	1 pts		Nerve compression	serious				574
7098	1 pts		Pneumothorax	serious				574
7099	1 pts		Fracture rib	serious				574
7100	1 pts		Urinary tract infection	serious				574
7101	35 pts		Dizziness	below serious				574
7102	9 pts		Fatigue	below serious				574
7103	7 pts		Flatulence	below serious				574
7104	17 pts		Headache	below serious				574
7105	11 pts		Nasopharyngitis	below serious				574
7106	16 pts		Nausea	below serious				574
7107	35 pts		Somnolence	below serious				574
7108	13 pts		Vomiting	below serious				574
7109	9 pts		Weight increased	below serious				574
7110	1 pts		Ovarian cancer	serious				582
7111	1 pts		Attempted suicide	serious				582
7112	6 pts		Nausea	below serious				582
7113	32 pts		Dizziness	below serious				582
7114	13 pts		Somnolence	below serious				582
7115	10 pts		Sedation	below serious				582
7116	1 pts		Chest pain	serious				575
7117	1 pts		Accidental overdose	serious				575
7118	14 pts		Nausea	below serious				575
7119	36 pts		Dizziness	below serious				575
7120	16 pts		Somnolence	below serious				575
7121	3 pts		Sedation	below serious				575
7122	1 pts		Appetite fluctuation	below serious				578
7123	1 pts		Diarrhea	below serious				578
7124	2 pts		Dizziness	below serious				578
7125	1 pts		Insomnia	below serious				578
7126	2 pts		Somnolence	below serious				578
7127	1 pts		Anxiety	below serious				565
7128	1 pts		Unsteady gait	below serious				579
7129	1 pts		Confusion	below serious				579
7130	1 pts		Incoordination	below serious				579
7131	1 pts		Dizziness	below serious				566
7132	1 pts		Fatigue	below serious				566
7133	1 pts		Headache	below serious				566
7134	1 pts		Pruritus	below serious				566
7135	1 pts		Respiratory, thoracic and mediastinal disorders	below serious				566
7136	2 pts		Vomiting	below serious				566
7137	20 pts		Dizziness	below serious				580
7138	41 pts		Somnolence	below serious				580
7139	1 pts		Allergic contact dermatitis	below serious				576
7140	1 pts		Anxiety	below serious				576
7141	4 pts		Aspiration	below serious				576
7142	1 pts		Atrioventricular block	below serious				576
7143	1 pts		Sputum bloody	below serious				576
7144	1 pts		Chest pain	below serious				576
7145	1 pts		Congestive heart failure	below serious				576
7146	2 pts		Delirium	below serious				576
7147	6 pts		Dysphagia	below serious				576
7148	1 pts		Dyspnea	below serious				576
7149	1 pts		Elevated liver enzymes	below serious				576
7150	1 pts		Eye pain	below serious				576
7151	1 pts		Tingling	below serious				576
7152	1 pts		Fall	below serious				576
7153	1 pts		Hematochezia	below serious				576
7154	3 pts		Hematoma	below serious				576
7155	11 pts		Hyperglycemia	below serious				576
7156	2 pts		Hypoalbuminemia	below serious				576
7157	14 pts		Hypocalcemia	below serious				576
7158	2 pts		Hypomagnesemia	below serious				576
7159	14 pts		Hypophosphatemia	below serious				576
7160	7 pts		Hypotension	below serious				576
7161	1 pts		Bradycardia	below serious				576
7162	1 pts		Infection	below serious				576
7163	1 pts		Cellulitis of arm	below serious				576
7164	1 pts		Neck numbness	below serious				576
7165	1 pts		Weakness of upper extremities	below serious				576
7166	1 pts		Swelling of limb	below serious				576
7167	1 pts		Microcytic anemia	below serious				576
7168	1 pts		Myasthenia gravis	below serious				576
7169	1 pts		Wound dehiscence	below serious				576
7170	1 pts		Oropharyngeal hemorrhage	below serious				576
7171	1 pts		Orthostatic hypotension	below serious				576
7172	1 pts		Paraesthesia foot	below serious				576
7173	1 pts		Pleural effusion	below serious				576
7174	1 pts		Pneumonitis	below serious				576
7175	1 pts		Pressure ulcer	below serious				576
7176	1 pts		Renal failure	below serious				576
7177	1 pts		Respiratory acidosis	below serious				576
7178	14 pts		Sinus tachycardia	below serious				576
7179	1 pts		Stoma site bleeding	below serious				576
7180	1 pts		Dehiscence	below serious				576
7181	1 pts		Hematemesis	below serious				576
7182	1 pts		Supraventricular tachycardia	below serious				576
7183	2 pts		Thrombosis	below serious				576
7184	1 pts		Tongue edema	below serious				576
7185	1 pts		Tracheitis	below serious				576
7186	17		Dry mouth					569
7187	4		Fatigue					569
7188	2		Somnolence					569
7189	9		Dizziness					569
7190	4		Headache					569
7191	2		Constipation					569
7192	7		Ataxia					569
7193	2		Feeling drunk					569
7194	4		Concentration impaired					569
7195	11		Hyperglycaemia					569
7196	9		Oedema					569
7197	2		Urinary retention					569
7198	2		Emotional lability					569
7199	2		Pruritus					569
7200	4		Excess sweating					569
7201	2		Weight gain					569
7202	2		Blurry vision					569
7203	60		Dry mouth					568
7204	8		Fatigue					568
7205	8		Somnolence					568
7206	4		Insomnia					568
7207	8		Dizziness					568
7208	2		Headache					568
7209	2		Constipation					568
7210	10		Ataxia					568
7211	4		Feeling drunk					568
7212	4		Concentration impaired					568
7213	6		Hyperglycaemia					568
7214	8		Oedema					568
7215	2		Abdominal cramp					568
7216	4		Urinary retention					568
7217	2		Swallowing difficult					568
7218	2		Blurry vision					568
7219	1 pts		Death		discontinuation	leads to discontinuation		570
7220	19		Dizziness					564
7221	14		Somnolence					564
7222	7		Peripheral oedema					564
7223	14		Gait disturbance					564
7224						No AEs were reported		563
7225	1.2		Somnolence		discontinuation	leads to discontinuation		571
7226	0.8		Dizziness		discontinuation	leads to discontinuation		571
7227	0.6		Ataxia		discontinuation	leads to discontinuation		571
7228	8 pts		Death		discontinuation	leads to discontinuation		572
7229	28		Dizziness		discontinuation	leads to discontinuation		567
7230	21		Somnolence		discontinuation	leads to discontinuation		567
7231	3 pts		Respiratory failure	serious				584
7232	2 pts		Pneumothorax	serious				584
7233	1 pts		Bronchospasm	serious				584
7234	1 pts		Emphysema	serious				584
7235	1 pts		Pleural effusion	serious				584
7236	1 pts		Pleurisy	serious				584
7237	1 pts		Pneumonitis	serious				584
7238	7 pts		Atrial fibrillation	serious				584
7239	2 pts		Angina unstable	serious				584
7240	1 pts		Atrial tachycardia	serious				584
7241	1 pts		Cardiac arrest	serious				584
7242	1 pts		Palpitations	serious				584
7243	1 pts		Bacteraemia	serious				584
7244	1 pts		Chronic sinusitis	serious				584
7245	1 pts		Diverticulitis	serious				584
7246	1 pts		Wound sepsis	serious				584
7247	2 pts		Abdominal pain	serious				584
7248	2 pts		Haematochezia	serious				584
7249	2 pts		Hernia inguinal	serious				584
7250	2 pts		Pancreatitis acute	serious				584
7251	1 pts		Colitis ulcerative	serious				584
7252	1 pts		Constipation	serious				584
7253	1 pts		Diarrhoea	serious				584
7254	1 pts		Diverticulum intestinal	serious				584
7255	1 pts		Epigastric discomfort	serious				584
7256	1 pts		Flatulence	serious				584
7257	1 pts		Gastrointestinal haemorrhage	serious				584
7258	1 pts		Hiatus hernia	serious				584
7259	1 pts		Ileus	serious				584
7260	1 pts		Nausea	serious				584
7261	1 pts		Oesophageal spasm	serious				584
7262	1 pts		Rectal haemorrhage	serious				584
7263	1 pts		Upper gastrointestinal haemorrhage	serious				584
7264	1 pts		Vomiting	serious				584
7265	3 pts		Syncope	serious				584
7266	1 pts		Carotid artery disease	serious				584
7267	1 pts		Convulsion	serious				584
7268	1 pts		Dizziness	serious				584
7269	1 pts		Ischaemic stroke	serious				584
7270	1 pts		Parkinson's disease	serious				584
7271	1 pts		Sciatica	serious				584
7272	2 pts		Colon cancer	serious				584
7273	1 pts		Adenoma benign	serious				584
7274	1 pts		Bladder cancer	serious				584
7275	1 pts		Bladder neoplasm	serious				584
7276	1 pts		Colon adenoma	serious				584
7277	1 pts		Adenocarcinoma lung	serious				584
7278	1 pts		Lung cancer metastatic	serious				584
7279	1 pts		Lung neoplasm malignant	serious				584
7280	1 pts		Metastases to bone	serious				584
7281	1 pts		Metastases to liver	serious				584
7282	1 pts		Small cell lung cancer metastatic	serious				584
7283	1 pts		Uterine leiomyoma	serious				584
7284	1 pts		Aortic aneurysm	serious				584
7285	1 pts		Arterial disorder	serious				584
7286	1 pts		Femoral arterial stenosis	serious				584
7287	1 pts		Haematoma	serious				584
7288	1 pts		Peripheral arterial occlusive disease	serious				584
7289	1 pts		Peripheral ischaemia	serious				584
7290	1 pts		Asthenia	serious				584
7291	1 pts		Chest discomfort	serious				584
7292	1 pts		Death	serious				584
7293	1 pts		Injection site inflammation	serious				584
7294	1 pts		Inflammation injection site	serious				584
7295	1 pts		Non-cardiac chest pain	serious				584
7296	1 pts		Ankle fracture	serious				584
7297	1 pts		Vascular graft complication	serious				584
7298	1 pts		Gouty arthritis	serious				584
7299	1 pts		Neck mass	serious				584
7300	1 pts		Suicide attempt	serious				584
7301	1 pts		Calculus urinary	serious				584
7302	1 pts		Haematuria	serious				584
7303	1 pts		Nephrolithiasis	serious				584
7304	1 pts		Colic renal	serious				584
7305	1 pts		Renal failure acute	serious				584
7306	1 pts		Blepharochalasis	serious				584
7307	1 pts		Glaucoma	serious				584
7308	1 pts		Retinal detachment	serious				584
7309	1 pts		Anticoagulation drug level above therapeutic	serious				584
7310	1 pts		Angioedema	serious				584
7311	1 pts		Eczema	serious				584
7312	1 pts		Skin ulcer	serious				584
7313	1 pts		Cataract operation	serious				584
7314	1 pts		Hepatitis	serious				584
7315	1 pts		Malnutrition	serious				584
7316	1 pts		Adenomatous polyposis coli	serious				584
7317	1 pts		Hyperthyroidism	serious				584
7318	1 pts		Physical assault	serious				584
7319	57 pts		Nasopharyngitis	below serious				584
7320	62 pts		Diarrhoea	below serious				584
7321	40 pts		Nausea	below serious				584
7322	92 pts		Weight decreased	below serious				584
7323	1 pts		Hyperventilation	serious				585
7324	1 pts		Pneumothorax	serious				585
7325	1 pts		Pulmonary oedema	serious				585
7326	1 pts		Respiratory distress	serious				585
7327	18 pts		Pneumonia	serious				585
7328	2 pts		Bronchitis	serious				585
7329	1 pts		Clostridium difficile colitis	serious				585
7330	1 pts		Infection localised	serious				585
7331	1 pts		Pneumonia primary atypical	serious				585
7332	1 pts		Pulmonary tuberculosis	serious				585
7333	1 pts		Septic shock	serious				585
7334	1 pts		Urinary tract infection	serious				585
7335	1 pts		Urosepsis	serious				585
7336	3 pts		Atrial fibrillation	serious				585
7337	3 pts		Cardiopulmonary failure	serious				585
7338	2 pts		Cardiac arrest	serious				585
7339	2 pts		Cardio-respiratory arrest	serious				585
7340	1 pts		Mitral valve stenosis	serious				585
7341	1 pts		Supraventricular tachyarrhythmia	serious				585
7342	1 pts		Ventricular fibrillation	serious				585
7343	1 pts		Ventricular tachycardia	serious				585
7344	4 pts		Prostate cancer	serious				585
7345	2 pts		Non-small cell lung cancer	serious				585
7346	1 pts		Acute myeloid leukaemia	serious				585
7347	1 pts		Bronchial carcinoma	serious				585
7348	1 pts		Chronic lymphocytic leukaemia	serious				585
7349	1 pts		Colon cancer	serious				585
7350	1 pts		Lung neoplasm malignant	serious				585
7351	1 pts		Metastases to liver	serious				585
7352	1 pts		Non-small cell lung cancer metastatic	serious				585
7353	1 pts		Oesophageal neoplasm	serious				585
7354	4 pts		Diarrhoea	serious				585
7355	2 pts		Pancreatitis acute	serious				585
7356	2 pts		Abdominal pain upper	serious				585
7357	2 pts		Intestinal polyp	serious				585
7358	1 pts		Haemorrhoidal haemorrhage	serious				585
7359	1 pts		Nausea	serious				585
7360	1 pts		Vomiting	serious				585
7361	1 pts		Asthenia	serious				585
7362	1 pts		Malaise	serious				585
7363	2 pts		Cerebral infarction	serious				585
7364	1 pts		Dizziness	serious				585
7365	1 pts		Hypoxic encephalopathy	serious				585
7366	1 pts		Optic neuritis	serious				585
7367	1 pts		Wernicke's encephalopathy	serious				585
7368	1 pts		Ankle fracture	serious				585
7369	1 pts		Cervical vertebral fracture	serious				585
7370	1 pts		Comminuted fracture	serious				585
7371	1 pts		Device dislocation	serious				585
7372	1 pts		Eye penetration	serious				585
7373	1 pts		Femur fracture	serious				585
7374	1 pts		Foot fracture	serious				585
7375	1 pts		Humerus fracture	serious				585
7376	1 pts		Procedural pain	serious				585
7377	1 pts		Tibia fracture	serious				585
7378	1 pts		Hypotension	serious				585
7379	1 pts		Ischaemia	serious				585
7380	1 pts		Peripheral artery aneurysm	serious				585
7381	3 pts		Hypokalaemia	serious				585
7382	1 pts		Diabetic ketoacidosis	serious				585
7383	1 pts		Hyponatraemia	serious				585
7384	1 pts		Malnutrition	serious				585
7385	1 pts		Metabolic acidosis	serious				585
7386	3 pts		Renal failure acute	serious				585
7387	1 pts		Renal failure	serious				585
7388	2 pts		Depression	serious				585
7389	1 pts		Completed suicide	serious				585
7390	1 pts		Mental status changes	serious				585
7391	1 pts		Urticaria	serious				585
7392	1 pts		Cholelithiasis	serious				585
7393	1 pts		Arthralgia	serious				585
7394	1 pts		Coronary artery bypass	serious				585
7395	1 pts		Knee arthroplasty	serious				585
7396	1 pts		Blood creatinine increased	serious				585
7397	1 pts		Blood urea increased	serious				585
7398	2 pts		Benign prostatic hyperplasia	serious				585
7399	64 pts		Diarrhoea	below serious				585
7400	65 pts		Weight decreased	below serious				585
7401	1 pts		Atrial fibrillation	serious				586
7402	1 pts		Carotid artery stenosis	serious				586
7403	1 pts		Diabetic vascular disorder	serious				586
7404	1 pts		Death	serious				586
7405	1 pts		Gastric ulcer	serious				586
7406	1 pts		Hypercapnic respiratory failure	serious				586
7407	1 pts		Hyponatremia	serious				586
7408	1 pts		Insomnia	serious				586
7409	5 pts		COPD exacerbation	serious				586
7410	6 pts		Weight loss	below serious				586
7411	2 pts		Headache	below serious				586
7412	5 pts		Common cold	below serious				586
7413	1 pts		Abdominal pain	below serious				586
7414	1 pts		Appetite lost	below serious				586
7415	4 pts		Cramp of limb	below serious				586
7416	3 pts		Diarrhea	below serious				586
7417	2 pts		Nausea	below serious				586
7418	1 pts		Insomnia	below serious				586
7419	1 pts		Pneumonia	below serious				586
7420	7 pts		Weight loss	below serious				587
7421	11 pts		Nausea	below serious				587
7422	10 pts		Decreased appetite	below serious				587
7423	9 pts		Dizziness	below serious				587
7424	2.4		Diarrhea		discontinuation	leads to discontinuation		588
7425	1.6		Nausea		discontinuation	leads to discontinuation		588
7426	1 pts		Headache					583
7427	1 pts		Gastrointestinal disorders					583
7428	1 pts		Dizziness					583
7429	1 pts		Palpitations					583
7430	1 pts		Lightheadedness					583
7431	1 pts		Clamminess					583
7432	1 pts		Arterial hypotension					583
7433	1 pts		Non-cardiac chest pain	serious				590
7434	1 pts		Suicidal ideation	serious				590
7435	1 pts		Myocardial infarction	serious				590
7436	83 pts		Diarrhoea	below serious				590
7437	63 pts		Nausea	below serious				590
7438	18 pts		Dizziness	below serious				590
7439	15 pts		Insomnia	below serious				590
7440	5 pts		Diarrhea	below serious				591
7441	4 pts		Lightheadedness	below serious				591
7442	3 pts		Dreaming abnormal	below serious				591
7443	8 pts		Headache	below serious				591
7444	13 pts		Nausea	below serious				591
7445	5 pts		Vomiting	below serious				591
7446	1 pts		Suicidal ideation	serious				589
7447	55 pts		Nausea	below serious				589
7448	57 pts		Diarrhoea	below serious				589
7449	13 pts		Vomiting	below serious				589
7450	7 pts		Fatigue	below serious				589
7451	32 pts		Headache	below serious				589
7452	12 pts		Dizziness	below serious				589
7453	12 pts		Insomnia	below serious				589
7454	58 pts		Nausea	below serious				592
7455	48 pts		Diarrhoea	below serious				592
7456	17 pts		Vomiting	below serious				592
7457	13 pts		Fatigue	below serious				592
7458	25 pts		Headache	below serious				592
7459	21 pts		Dizziness	below serious				592
7460	13 pts		Insomnia	below serious				592
7461	1 pts		Laceration	serious				593
7462	1 pts		Infection urinary tract	serious				593
7463	1 pts		Impaired gastric emptying	serious				593
7464	1 pts		Stab wound	serious				593
7465	60 pts		Nausea	below serious				593
7466	56 pts		Diarrhoea	below serious				593
7467	22 pts		Dizziness	below serious				593
7468	12 pts		Somnolence	below serious				593
7469	15 pts		Insomnia	below serious				593
7470	4 pts		Ejaculation delayed	below serious				594
7471	4 pts		Erectile dysfunction	below serious				594
7472	1 pts		Alanine aminotransferase increased	serious				596
7473	1 pts		Mental status changes	serious				596
7474	53 pts		Nausea	below serious				596
7475	11 pts		Vomiting	below serious				596
7476	15 pts		Diarrhoea	below serious				596
7477	8 pts		Dizziness	below serious				596
7478	1 pts		Intentional overdose	serious				597
7479	1 pts		Pilonidal cyst	serious				597
7480	1 pts		Suicide attempt	serious				597
7481	50 pts		Nausea	below serious				597
7482	28 pts		Abdominal pain upper	below serious				597
7483	21 pts		Vomiting	below serious				597
7484	16 pts		Diarrhoea	below serious				597
7485	13 pts		Nasopharyngitis	below serious				597
7486	30 pts		Headache	below serious				597
7487	13 pts		Dizziness	below serious				597
7488	6 pts		Headache	below serious				595
7489	3 pts		Heartburn	below serious				595
7490	4 pts		Decreased appetite	below serious				595
7491	6 pts		Increased appetite	below serious				595
7492	5 pts		Dry mouth	below serious				595
7493	5 pts		Insomnia	below serious				595
7494	2 pts		Libido decreased	below serious				595
7495	2 pts		Male sexual dysfunction	below serious				595
7496	40 pts		Nausea	below serious				598
7497	24 pts		Vomiting	below serious				598
7498	16 pts		Diarrhoea	below serious				598
7499	13 pts		Abdominal pain upper	below serious				598
7500	6 pts		Upper respiratory tract infection	below serious				598
7501	12 pts		Somnolence	below serious				598
7502	10 pts		Dizziness	below serious				598
7503	10 pts		Insomnia	below serious				598
7504	1.2		Diarrhea		discontinuation			604
7505	1.3		Nausea		discontinuation			603
7506	1		Anxiety		discontinuation			603
7507	0.92		Palpitations		discontinuation			602
7508	0.92		Diarrhea		discontinuation			602
7509	0.46		Nausea		discontinuation			602
7510	0.46		Depression		discontinuation			602
7511	0.46		Fatigue		discontinuation			602
7512			Tachycardia		discontinuation			599
7513			Seizure		discontinuation			599
7514			Serotonin syndrome		discontinuation			599
7515			Serotonin syndrome		discontinuation	serotonin syndrome, including restlessness, hyperthermia, mydriasis, dystonia, agitation, seizure-like activity, roving eye movement, tachycardia, and elevated creatine kinase		600
7516			Suicidal ideation		discontinuation	WARNING		605
7517			Serotonin syndrome		discontinuation	WARNING		605
7518			Neuroleptic malignant syndrome		discontinuation	WARNING		605
7519			Seizures		discontinuation	WARNING		605
7520			Bleeding		discontinuation	WARNING		605
7521			Hypomania		discontinuation	WARNING		605
7522			Hyponatremia		discontinuation	WARNING		605
7523	1.78		Syncope convulsive		discontinuation	1 patient		601
7524	3.5		Emesis		discontinuation	2 patients		606
7525	1.78		Palpitations		discontinuation	1 patient		606
7526			Diarrhea, Clostridium difficile		discontinuation	WARNING		610
7527			Anaphylactic shock		discontinuation	WARNING		610
7528			Hypersensitivity reaction	severe	discontinuation	WARNING		610
7529			Diarrhea, Clostridium difficile		discontinuation	WARNING		609
7530			Anaphylactic shock		discontinuation	WARNING		609
7531			Hypersensitivity reaction	severe	discontinuation	WARNING		609
7532			Diarrhea, Clostridium difficile		discontinuation	WARNING		608
7533			Anaphylactic shock		discontinuation	WARNING		608
7534			Hypersensitivity reaction	severe	discontinuation	WARNING		608
7535	1.2		Vaginal pain or burning		discontinuation			607
7536			Diarrhea, Clostridium difficile		discontinuation	WARNING		611
7537			Reaction skin	severe	discontinuation	WARNING		611
7538			Toxic epidermal necrolysis	grade 3-5	discontinuation	WARNING		611
7539	22		Neutropenia					615
7540	18		Neutropenia					614
7541	4		Thrombocytopenia					614
7542	4		Anemia	severe				614
7543	4		Renal impairment					614
7544						No serious AEs reported		613
7545	48		Fever					612
7546	13		Infection					612
7547	10		Chills					612
7548	15		Sepsis					612
7549	44		Diarrhea					612
7550	14		Anorexia					612
7551	13		Vomiting					612
7552	41		Leukopenia					612
7553	25		Anemia					612
7554	6		Thrombocytopenia					612
7555	9		Neuropathy					612
7556	12		Sweating					612
7557	5		Pruritus					612
7558	9		Catheter infection					612
7559	8		Catheter sepsis					612
7560			Headache		discontinuation	patient died (the death of patient was probably independent of EDTA)		617
7561			Restlessness		discontinuation	patient died (the death of patient was probably independent of EDTA)		616
7562			Hypocalcemia		discontinuation	patient died (the death of patient was probably independent of EDTA)		616
7563			Kidney tubule disorder		discontinuation	Renal tubular vacuolization; patient died (the death of patient was probably independent of EDTA)		620
7564			Hypocalcemia		discontinuation	patient died		619
7565			Acute renal insufficiency		discontinuation	patient died		619
7566	3		Acute renal failure		discontinuation			618
7567	13		Nephrotoxicity	mild				618
7568	44		Thrombocytopenia	grade 4			TRUE	623
7569	44		Neutropenia	grade 4			TRUE	623
7570	57		Thrombocytopenia	grade 4			TRUE	621
7571	57		Neutropenia	grade 4			TRUE	621
7572	1.8		Toxic reaction (NOS)	grade 4	discontinuation	TRUE		622
7573	3.6		Bacterial infection	grade 5	discontinuation	TRUE		622
7574	1.8		Systemic herpes zoster infection	grade 5	discontinuation	TRUE		622
7575			Bone marrow depression	severe	discontinuation	WARNING		624
7576	2		Hypersensitivity reaction		discontinuation	WARNING		624
7577			Anaphylaxis		discontinuation	WARNING		624
7578			Gastrointestinal toxicity		discontinuation	WARNING		624
7579			Nausea		discontinuation	WARNING		624
7580			Vomiting		discontinuation	WARNING		624
7581			Diarrhea		discontinuation	WARNING		624
7582			Mucositis oral		discontinuation	WARNING		624
7583			Fetal damage		discontinuation	WARNING		624
7584			Infertility		discontinuation	WARNING		624
7585						no DLT occurred		627
7586	33.3		Neutropenia	grade 4			TRUE	625
7587	16.7		Thrombocytopenia	grade 4			TRUE	625
7588	16.7		Constipation	grade 3			TRUE	625
7589	20		Bilirubin total increased	grade 3				628
7590	20		Diarrhea	grade 3				628
7591	12		Diarrhea	grade 3-5			TRUE	633
7592	4		Lipase increased	grade 4			TRUE	633
7593	12		Transaminases increased	grade 3-5			TRUE	633
7594	4		Nausea and vomiting	grade 3-5			TRUE	633
7595	16.7		Neutropenia	grade 4		Patient 1	TRUE	630
7596	16.7		Thrombocytopenia			Patient 1	TRUE	630
7597	16.7		Neutropenia			Patient 2	TRUE	630
7598	33.3		Neutropenia	grade 4			TRUE	626
7599	16.7		Thrombocytopenia			Patient 3	TRUE	626
7600	16.7		Neutropenia			Patient 3	TRUE	626
7601	33.3		Febrile neutropenia				TRUE	629
7602	16.7		Thrombocytopenia	grade 4			TRUE	629
7603			Myelosuppression		discontinuation	WARNING		632
7604			Immunosuppression		discontinuation	WARNING. Severe immunosuppression may lead to serious and sometimes fatal infections		632
7605			Bone marrow failure		discontinuation	WARNING		632
7606			Infection		discontinuation	WARNING		632
7607			Urinary tract toxicity		discontinuation	WARNING		632
7608			Toxicity renal		discontinuation	WARNING		632
7609			Cystitis hemorrhagic		discontinuation	WARNING		632
7610			Pyelitis		discontinuation	WARNING		632
7611			Ureteritis		discontinuation	WARNING		632
7612			Hematuria		discontinuation	WARNING		632
7613			Cardiotoxicity		discontinuation	WARNING		632
7614			Myocarditis		discontinuation	WARNING		632
7615			Myopericarditis		discontinuation	WARNING		632
7616			Pericardial effusion		discontinuation	WARNING		632
7617			Arrhythmia (NOS)		discontinuation	WARNING		632
7618			Congestive heart failure		discontinuation	WARNING. May be fatal		632
7619			Pulmonary toxicity		discontinuation	WARNING		632
7620			Pneumonitis		discontinuation	WARNING		632
7621			Pulmonary fibrosis		discontinuation	WARNING		632
7622			Pulmonary veno-occlusive disease		discontinuation	WARNING		632
7623			Respiratory failure		discontinuation	WARNING		632
7624			Metastases		discontinuation	WARNING		632
7625			Venoocclusive liver disease		discontinuation	WARNING. Fatal outcome can occur.		632
7626			Fetal damage		discontinuation	WARNING		632
7627			Myelosuppression		discontinuation	WARNING		631
7628			Immunosuppression		discontinuation	WARNING. Severe immunosuppression may lead to serious and sometimes fatal infections		631
7629			Bone marrow failure		discontinuation	WARNING		631
7630			Infection		discontinuation	WARNING		631
7631			Urinary tract toxicity		discontinuation	WARNING		631
7632			Toxicity renal		discontinuation	WARNING		631
7633			Cystitis hemorrhagic		discontinuation	WARNING		631
7634			Pyelitis		discontinuation	WARNING		631
7635			Ureteritis		discontinuation	WARNING		631
7636			Hematuria		discontinuation	WARNING		631
7637			Cardiotoxicity		discontinuation	WARNING		631
7638			Myocarditis		discontinuation	WARNING		631
7639			Myopericarditis		discontinuation	WARNING		631
7640			Pericardial effusion		discontinuation	WARNING		631
7641			Arrhythmia (NOS)		discontinuation	WARNING		631
7642			Congestive heart failure		discontinuation	WARNING. May be fatal		631
7643			Pulmonary toxicity		discontinuation	WARNING		631
7644			Pneumonitis		discontinuation	WARNING		631
7645			Pulmonary fibrosis		discontinuation	WARNING		631
7646			Pulmonary veno-occlusive disease		discontinuation	WARNING		631
7647			Respiratory failure		discontinuation	WARNING		631
7648			Metastases		discontinuation	WARNING		631
7649			Venoocclusive liver disease		discontinuation	WARNING. Fatal outcome can occur.		631
7650			Fetal damage		discontinuation	WARNING		631
7651						No information on AE is provided		636
7652						No information on AE is provided		637
7653						No information on AE is provided		635
7654	31		Forced expiratory volume decreased					638
7655	19		Rales					638
7656	8		Red blood cell sedimentation rate increased					638
7657	6		Dysphonia					638
7658	5		Wheezing					638
7659			Hypersensitivity					634
7660			Eyelids itchy sensation of					634
7661			Swelling					634
7662			Redness of eyelid conjunctiva					634
7663	0.5		Drug-induced hepatitis		discontinuation	WARNING		640
7664	4.3		Dyspepsia	severe	discontinuation			639
7665	4.3		Lipase increased		discontinuation			639
7666	4.3		Aspartate aminotransferase abnormal		discontinuation			639
7667	1 pts		Hypotension	severe				641
7668	3 pts		Nausea					641
7669	2 pts		Urticaria					641
7670	1 pts		Wheezing					641
7671	1 pts		Pruritus					641
7672	1 pts		Tingling					641
7673	1 pts		Nasal congestion					641
7674	1 pts		Coughing					641
7675			Hepatotoxicity					642
7676						No information on AE is provided		643
7677						No information on AE is provided		646
7678						No information on AE is provided		645
7679	6.8		Infective exacerbation of bronchiectasis		discontinuation	leads to discontinuation		647
7680	4.5		Dyspnea		discontinuation	leads to discontinuation		647
7681	1 pts		Cough		discontinuation	leads to discontinuation		647
7682	1 pts		Oropharyngeal pain		discontinuation	leads to discontinuation		647
7683	1 pts		Respiratory disorder		discontinuation	leads to discontinuation		647
7684	1 pts		Pneumonia		discontinuation	leads to discontinuation		647
7685			Hypersensitivity pneumonitis			WARNING		644
7686			Hemoptysis			WARNING		644
7687			Bronchospasm			WARNING		644
7688						No information on AE is provided		648
7689	1 pts		Agranulocytosis		discontinuation	leads to discontinuation		650
7690	3 pts		Toxic optic neuropathy		discontinuation	leads to discontinuation		649
7691			Pain	mild				654
7692			Pain	mild				653
7693						No AEs are reported		652
7694						No AEs are reported		655
7695						No AEs are reported		651
7696	1.1		Abnormal vision		discontinuation	leads to discontinuation		656
7697	0.6		Burning sensation		discontinuation	leads to discontinuation		656
7698	0.3		Instillation site burning		discontinuation	leads to discontinuation		656
7699	0.5		Conjunctivitis		discontinuation	leads to discontinuation		656
7700	0.6		Sensation of foreign body		discontinuation	leads to discontinuation		656
7701	0.2		Asthma		discontinuation	leads to discontinuation		656
7702	0.2		Chest pain		discontinuation	leads to discontinuation		656
7703	0.3		Insomnia		discontinuation	leads to discontinuation		656
7704	0.5		Rash		discontinuation	leads to discontinuation		656
7705	2 pts		Intraocular pressure increased		discontinuation	leads to discontinuation		657
7706	3		Arthralgia		discontinuation			658
7707	2.6		Myalgia		discontinuation			658
7708	1.1		Nausea		discontinuation			658
7709	0.7		Myasthenia		discontinuation			658
7710	0.3		Flatulence		discontinuation			658
7711	0.3		Pain		discontinuation			658
7712	0.3		Pharyngitis		discontinuation			658
7713	0.3		Dysphagia		discontinuation			658
7714	0.3		Dizziness		discontinuation			658
7715	0.3		Chest pain		discontinuation			658
7716	0.3		Asthenia		discontinuation			658
7717	0.3		Rash		discontinuation			658
7718	0.3		Vomiting		discontinuation			658
7719	0.3		Anorexia		discontinuation			658
7720						No information on AE is provided		659
7721			Nausea		discontinuation			660
7722			Vomiting		discontinuation			660
7723			Grand mal seizure		discontinuation			660
7724			Lethargy		discontinuation			660
7725			Coma		discontinuation			660
7726			Nystagmus		discontinuation			661
7727			Hyperreflexia		discontinuation			661
7728	0.3		Hepatotoxicity		discontinuation			665
7729	2.9		Hypersensitivity		discontinuation			665
7730			Generalized tonic-clonic seizure		discontinuation			662
7731			Seizures	severe	discontinuation			663
7732			Metabolic acidosis		discontinuation			663
7733			Coma		discontinuation			663
7734			Oliguria		discontinuation			663
7735			Lethargy		discontinuation			664
7736			Seizures		discontinuation			664
7737			Coma		discontinuation			664
7738			Tachycardia		discontinuation			664
7739			Hepatitis	grade 5	discontinuation	WARNING		666
7740	2 pts		Granulocytopenia	grade 4				669
7741	1 pts		Anxiety	grade 4				669
7742	1 pts		Depression	grade 4				669
7743	7		Malaise	grade 3				669
7744	7		Fatigue	grade 3				669
7745	7		Lethargy	grade 3				669
7746	6		Nausea	grade 3				669
7747	3		Vomiting	grade 3				669
7748	1 pts		Paresthesia	grade 3				669
7749						No information on AE is provided		668
7750						No information on AE is provided		667
7751	2 pts		Thrombocytopenia	serious				676
7752	1 pts		Anaemia	serious				676
7753	1 pts		Neutropenia	serious				676
7754	1 pts		Pancytopenia	serious				676
7755	4 pts		Cardiac arrest	serious				676
7756	1 pts		Cardio-respiratory arrest	serious				676
7757	2 pts		Pancreatitis	serious				676
7758	1 pts		Caecitis	serious				676
7759	1 pts		Ileus	serious				676
7760	1 pts		Intestinal obstruction	serious				676
7761	1 pts		Upper gastrointestinal haemorrhage	serious				676
7762	1 pts		Vomiting	serious				676
7763	1 pts		Chest pain	serious				676
7764	1 pts		Chills	serious				676
7765	1 pts		Mucosal inflammation	serious				676
7766	1 pts		Multi-organ failure	serious				676
7767	2 pts		Hepatic failure	serious				676
7768	1 pts		Bile duct stone	serious				676
7769	1 pts		Cholecystitis	serious				676
7770	1 pts		Cholecystitis acute	serious				676
7771	1 pts		Hepatic steatosis	serious				676
7772	1 pts		Hepatocellular injury	serious				676
7773	1 pts		Hyperbilirubinaemia	serious				676
7774	1 pts		Liver disorder	serious				676
7775	1 pts		Allergic oedema	serious				676
7776	1 pts		Drug hypersensitivity	serious				676
7777	1 pts		Hypersensitivity	serious				676
7778	13 pts		Septic shock	serious				676
7779	7 pts		Pneumonia	serious				676
7780	3 pts		Device related infection	serious				676
7781	2 pts		Bacterial sepsis	serious				676
7782	2 pts		Pneumonia bacterial	serious				676
7783	2 pts		Pseudomonal sepsis	serious				676
7784	1 pts		Clostridium difficile colitis	serious				676
7785	1 pts		Enterococcal bacteraemia	serious				676
7786	1 pts		Gastroenteritis	serious				676
7787	1 pts		Pneumonia klebsiella	serious				676
7788	1 pts		Infection staphylococcal	serious				676
7789	1 pts		Streptococcal sepsis	serious				676
7790	3 pts		Blood creatinine increased	serious				676
7791	2 pts		Creatinine renal clearance decreased	serious				676
7792	1 pts		Lymphocyte count decreased	serious				676
7793	1 pts		White blood cell count decreased	serious				676
7794	2 pts		Hypokalaemia	serious				676
7795	1 pts		Hyperammonaemia	serious				676
7796	1 pts		Hyperglycaemia	serious				676
7797	1 pts		Hyponatraemia	serious				676
7798	1 pts		Back pain	serious				676
7799	1 pts		Joint swelling	serious				676
7800	1 pts		Metastases to bone marrow	serious				676
7801	1 pts		Metastases to central nervous system	serious				676
7802	1 pts		Cerebral ischaemia	serious				676
7803	1 pts		Cerebrovascular accident	serious				676
7804	1 pts		Encephalitis	serious				676
7805	1 pts		Encephalopathy hepatic	serious				676
7806	1 pts		Intracranial venous sinus thrombosis	serious				676
7807	1 pts		Meningism	serious				676
7808	1 pts		Nephropathy toxic	serious				676
7809	1 pts		Renal tubular necrosis	serious				676
7810	2 pts		Acute respiratory distress syndrome	serious				676
7811	2 pts		Pulmonary haemorrhage	serious				676
7812	1 pts		Bronchial obstruction	serious				676
7813	1 pts		Bronchospasm	serious				676
7814	1 pts		Dyspnoea	serious				676
7815	1 pts		Pneumothorax	serious				676
7816	1 pts		Respiratory distress	serious				676
7817	1 pts		Rash papular	serious				676
7818	1 pts		Hypotension	serious				676
7819	42 pts		Thrombocytopenia	below serious				676
7820	118 pts		Nausea	below serious				676
7821	39 pts		Abdominal pain upper	below serious				676
7822	14 pts		Dyspepsia	below serious				676
7823	56 pts		Oedema peripheral	below serious				676
7824	18 pts		Chest pain	below serious				676
7825	15 pts		Oedema	below serious				676
7826	22 pts		Oral herpes	below serious				676
7827	15 pts		Pneumonia	below serious				676
7828	33 pts		Antithrombin III decreased	below serious				676
7829	19 pts		Blood fibrinogen decreased	below serious				676
7830	19 pts		Aspartate aminotransferase increased	below serious				676
7831	16 pts		Blood bilirubin increased	below serious				676
7832	20 pts		Blood creatinine increased	below serious				676
7833	13 pts		Weight decreased	below serious				676
7834	83 pts		Hypokalaemia	below serious				676
7835	24 pts		Hypoalbuminaemia	below serious				676
7836	18 pts		Hypocalcaemia	below serious				676
7837	15 pts		Fluid retention	below serious				676
7838	13 pts		Hyperuricaemia	below serious				676
7839	12 pts		Hypomagnesaemia	below serious				676
7840	34 pts		Back pain	below serious				676
7841	12 pts		Depression	below serious				676
7842	39 pts		Rash	below serious				676
7843	19 pts		Erythema	below serious				676
7844	17 pts		Alopecia	below serious				676
7845	13 pts		Pruritus	below serious				676
7846	15 pts		Haematoma	below serious				676
7847	1 pts		Cardio-respiratory arrest	grade 5				673
7848	1 pts		Cardio-respiratory arrest	grade 5				674
7849	1 pts		Cardiac arrest					670
7850	1 pts		Vomiting					670
7851	1 pts		Generalized epileptic seizure					670
7852	2 pts		Cardiac arrest	grade 5				671
7853	1 pts		Cardiac arrest	grade 5				672
7854	3.4		Creatinine increased		discontinuation	leads to discontinuation		675
7855	3.4		Nervous system disorder NOS		discontinuation	leads to discontinuation		675
7856			QT interval prolonged		discontinuation	WARNING		677
7857						No adverse reactions leading to discontinuation were reported		678
7858	20		Burn	moderate				679
7859	55		Peeling	moderate				679
7860	30		Erythema	moderate				679
7861			Hepatotoxicity		discontinuation			680
7862			Seizures		discontinuation			682
7863						no serious AEs occurred		681
7864			Myelosuppression	severe	discontinuation	WARNING		683
7865			Seizures		discontinuation	WARNING		683
7866			Venoocclusive disease		discontinuation	WARNING		683
7867			Fetal damage		discontinuation	WARNING		683
7868						No AEs reported during the treatment by the drug; however, AEs were reported during withdrawal its, e.g., mental distress, anxiety, insomnia and irritability.		684
7869	0.5		Dizziness		discontinuation	leads to discontinuation		685
7870	0.5		Headache		discontinuation	leads to discontinuation		685
7871	0.2		Diarrhea		discontinuation	leads to discontinuation		685
7872	0.2		Stomach discomfort		discontinuation	leads to discontinuation		685
7873	0.2		Upper abdominal pain		discontinuation	leads to discontinuation		685
7874	0.2		Intervertebral disc protrusion		discontinuation	leads to discontinuation		685
7875	0.2		Pain in extremity		discontinuation	leads to discontinuation		685
7876	0.2		Abdominal distension		discontinuation	leads to discontinuation		685
7877	0.7		Dizziness		discontinuation	leads to discontinuation		686
7878	0.4		Headache		discontinuation	leads to discontinuation		686
7879	0.7		Stomach discomfort		discontinuation	leads to discontinuation		686
7880	0.7		Upper abdominal pain		discontinuation	leads to discontinuation		686
7881	0.7		Somnolence		discontinuation	leads to discontinuation		686
7882	0.4		Nausea		discontinuation	leads to discontinuation		686
7883	0.4		Rash		discontinuation	leads to discontinuation		686
7884	0.4		Nephrolithiasis		discontinuation	leads to discontinuation		686
7885	0.4		Intervertebral disc protrusion		discontinuation	leads to discontinuation		686
7886	0.4		Fatigue		discontinuation	leads to discontinuation		686
7887	0.4		Disorientation		discontinuation	leads to discontinuation		686
7888	0.4		Paraesthesia		discontinuation	leads to discontinuation		686
7889	0.4		Skin papilloma		discontinuation	leads to discontinuation		686
7890			Convulsive seizure		discontinuation			689
7891			Comatose		discontinuation			689
7892			Vomiting		discontinuation			689
7893			Irritability		discontinuation			688
7894			Myoclonic jerks		discontinuation			688
7895			Exaggerated startle response		discontinuation			688
7896			Vomiting		discontinuation			688
7897			Bone marrow depression	mild	discontinuation			688
7898			Abnormal EEG		discontinuation			688
7899			Acute renal failure		discontinuation			687
7900			Seizures		discontinuation			687
7901			Bone marrow depression		discontinuation	WARNING		690
7902			Carcinogenicity		discontinuation	WARNING		690
7903			Infertility		discontinuation	WARNING		690
7904			Convulsions		discontinuation	WARNING		691
7905			Metastases		discontinuation	WARNING		691
7906			Leukemia		discontinuation	WARNING		691
7907	rare		Skin rash		discontinuation	WARNING		692
7908	rare		Erythema multiforme		discontinuation	WARNING		692
7909	rare		Toxic epidermal necrolysis		discontinuation	WARNING		692
7910	rare		Stevens-Johnson syndrome		discontinuation	WARNING		692
7911	50.7		Toothache					697
7912	28.4		Upper respiratory tract infection					697
7913	27.1		Headache					697
7914	13.8		Sinusitis					697
7915	7.6		Influenza-like symptoms					697
7916	6.7		Back pain					697
7917	6.2		Tooth disorder					697
7918	6.2		Bronchitis					697
7919	5.8		Abscess					697
7920	4.9		Pain					697
7921	4		Allergy					697
7922	4		Myalgia					697
7923	3.6		Gum hyperplasia					697
7924	3.6		Pharyngitis					697
7925	3.1		Arthralgia					697
7926	3.1		Dysmenorrhea					697
7927	3.1		Dyspepsia					697
7928	2.7		Rhinitis					697
7929	2.7		Coughing					697
7930	2.7		Arthrosis					697
7931	2.2		Hypertension					697
7932	2.2		Stomatitis ulcerative					697
7933	2.2		Tendinitis					697
7934			Distress epigastric			OVERDOSAGE		693
7935			Nausea			OVERDOSAGE		693
7936			Alcohol intoxication			OVERDOSAGE		693
7937			Redness	grade 2				694
7938			Burning sensation	grade 1	discontinuation			695
7939			Petechial rash	grade 1	discontinuation			695
7940			Scab		discontinuation			695
7941			Papule		discontinuation			696
7942			Erythema	grade 2	discontinuation			696
7943			Edema	grade 1	discontinuation			696
7944						No adverse effects leading to discontinuation were reported		700
7945			Lymphopenia	grade 3-4	discontinuation			698
7946	50		Neutropenia	grade 4			TRUE	699
7947	50		Leukopenia	grade 4			TRUE	699
7948	35 pts		Skin irritation					701
7949	1 pts		Late onset epilepsy					703
7950	1 pts		Late onset epilepsy					702
7951						No adverse reactions leading to discontinuation were reported		706
7952	66.7		Cerebellar disorder NOS	grade 4	discontinuation			704
7953	66.7		Diarrhea	grade 3	discontinuation			704
7954	33.3		Cerebellar disorder NOS	grade 4	discontinuation			705
7955	16.7		Cerebellar disorder NOS	grade 5	discontinuation	TRUE		705
7956			Bone marrow depression		discontinuation	WARNING		707
7957			Leukopenia		discontinuation	WARNING		707
7958			Thrombocytopenia		discontinuation	WARNING		707
7959			Anemia		discontinuation	WARNING		707
7960			Nausea		discontinuation	WARNING		707
7961			Vomiting		discontinuation	WARNING		707
7962			Diarrhea		discontinuation	WARNING		707
7963			Abdominal pain		discontinuation	WARNING		707
7964			Oral ulceration		discontinuation	WARNING		707
7965			Hepatic dysfunction NOS		discontinuation	WARNING		707
7966	53 pts		Gastrointestinal disorder NOS		discontinuation	leads to discontinuation		708
7967	7 pts		Hypersensitivity		discontinuation	leads to discontinuation		708
7968	5 pts		Gastrointestinal disturbance		discontinuation	leads to discontinuation		709
7969	3 pts		Anemia neonatal					712
7970	3 pts		Hypoalbuminemia					712
7971	2 pts		Hyperglycemia					712
7972	1 pts		Peripheral edema					712
7973	2 pts		Patent ductus arteriosus					712
7974	1 pts		Anemia neonatal					713
7975	1 pts		Peripheral edema					713
7976	2 pts		Dermatitis diaper					713
7977	1 pts		Transaminases increased		discontinuation	leads to dose reduction		710
7978	1 pts		Allergic reaction		discontinuation	leads to discontinuation		710
7979	1 pts		Leukopenia					710
7980	11 pts		Diarrhea					710
7981	9 pts		Nausea					710
7982	9 pts		Vomiting					710
7983	6 pts		Headache					710
7984	3 pts		Oral candidiasis					710
7985	2 pts		Rash					710
7986	0.2		Nausea		discontinuation	leads to discontinuation		711
7987	0.1		Vulval mycotic infection		discontinuation	leads to discontinuation		711
7988	0.1		Rash		discontinuation	leads to discontinuation		711
7989	1 pts		Anaemia	serious				718
7990	1 pts		Anaemia microcytic	serious				718
7991	1 pts		Adrenocortical insufficiency acute	serious				718
7992	1 pts		Ophthalmoplegia	serious				718
7993	1 pts		Abdominal pain	serious				718
7994	2 pts		Diarrhoea	serious				718
7995	1 pts		Diverticulum intestinal	serious				718
7996	1 pts		Gastric ulcer haemorrhage	serious				718
7997	1 pts		Oesophageal ulcer	serious				718
7998	1 pts		Implant site effusion	serious				718
7999	1 pts		Injection site pain	serious				718
8000	3 pts		Pyrexia	serious				718
8001	1 pts		Cholelithiasis	serious				718
8002	2 pts		Hepatic failure	serious				718
8003	1 pts		Cellulitis	serious				718
8004	1 pts		Gastroenteritis	serious				718
8005	1 pts		Hepatitis A	serious				718
8006	1 pts		Infection	serious				718
8007	2 pts		Lobar pneumonia	serious				718
8008	1 pts		Lung infection	serious				718
8009	1 pts		Staphylococcal sepsis	serious				718
8010	1 pts		Urinary tract infection	serious				718
8011	1 pts		Urosepsis	serious				718
8012	1 pts		Blood creatinine increased	serious				718
8013	1 pts		International normalised ratio decreased	serious				718
8014	1 pts		Arthralgia	serious				718
8015	1 pts		Muscular weakness	serious				718
8016	2 pts		Bladder cancer	serious				718
8017	1 pts		Colon cancer	serious				718
8018	1 pts		Gastrointestinal tract adenoma	serious				718
8019	1 pts		Brain oedema	serious				718
8020	1 pts		Syncope	serious				718
8021	1 pts		IgA nephropathy	serious				718
8022	1 pts		Nephritis interstitial	serious				718
8023	1 pts		Nephrosclerosis	serious				718
8024	6 pts		Renal failure	serious				718
8025	6 pts		Renal failure acute	serious				718
8026	2 pts		Renal failure chronic	serious				718
8027	1 pts		Anoxia	serious				718
8028	1 pts		Cough	serious				718
8029	1 pts		Dyspnoea	serious				718
8030	1 pts		Hypoxia	serious				718
8031	2 pts		Pleural effusion	serious				718
8032	1 pts		Pleural fistula	serious				718
8033	7 pts		Respiratory failure	serious				718
8034	1 pts		Circulatory collapse	serious				718
8035	1 pts		Peripheral embolism	serious				718
8036	2.4		Hypotension		discontinuation			715
8037	2.4		Bradycardia		discontinuation			715
8038	5.1		Hematemesis		discontinuation			716
8039	1		Sinus bradycardia		discontinuation			717
8040	2		Hypotension		discontinuation			717
8041	6.1		Hemorrhage		discontinuation			717
8042	2		Vomiting		discontinuation			717
8043	1		Nausea		discontinuation			717
8044	1		Respiratory failure		discontinuation			717
8045	1		Gastro intestinal bleeding		discontinuation			717
8046	4.4		Bleeding		discontinuation			714
8047	0.6		Cardiovascular symptom		discontinuation			714
8048	0.6		Shock cardiogenic		discontinuation			714
8049	0.3		Coronary occlusion		discontinuation			714
8050	0.4		Nausea		discontinuation			714
8051	15					Of 27 patients, 4 (15%) tolerated dose of 0.5 g.		720
8052	19					Of 27 patients, 5 (19%) tolerated dose of 0.75 g.		721
8053	19					Of 27 patients, 5 (19%) tolerated dose of 1.0 g.		719
8054	11					Of 27 patients, 3 (11%) tolerated dose of 1.25 g.		722
8055	37					Of 27 patients, 10 (37%) tolerated the highest planned dose of 1.5 g.		723
8056	9.4		Vomiting		discontinuation			724
8057	9.4		Nausea		discontinuation			724
8058	6.25		Diarrhea		discontinuation			724
8059	6.25		Granulocytopenia		discontinuation			724
8060	3.1		Thrombocytopenia		discontinuation			724
8061	3.1		Rash		discontinuation			724
8062						No adverse reactions leading to discontinuation were reported		725
8063	3 pts		Vomiting of medication		discontinuation	leads to discontinuation		726
8064	2 pts		Consciousness decreased		discontinuation	leads to discontinuation		726
8065	3 pts		Convulsions			serious adverse events		726
8066	3 pts		Stomatitis			serious adverse events		726
8067	2 pts		Diarrhea	grade 2-3		serious adverse events		726
8068	1 pts		Pulmonary edema			serious adverse events		726
8069	1 pts		Tetany			serious adverse events		726
8070	1 pts		Hypertensive crisis			serious adverse events		726
8071	1 pts		Cerebrovascular accident			serious adverse events		726
8072			Sensation of heat	grade 1-2				727
8073						No information on AE is provided		728
8074	1 pts		Generalized tonic-clonic seizure		discontinuation	leads to discontinuation		742
8075	32 pts		Extravasation					732
8076	42 pts		Allergic reaction					735
8077	74 pts		Adverse event					737
8078	23 pts		Extravasation					731
8079	46 pts		Allergic reaction					734
8080	69 pts		Adverse event					736
8081	5 pts		Extravasation					730
8082	3 pts		Allergic reaction					733
8083	8 pts		Adverse event					739
8084	18 pts		Extravasation					729
8085	8 pts		Allergic reaction					738
8086	26 pts		Adverse event					740
8087	1 pts		Hepatotoxicity		discontinuation	leads to discontinuation		741
8088						No SAEs were observed		743
8089			Angina			WARNING		744
8090	27		Malaise and fatigue					746
8091	27		Cough					746
8092	27		Temperature regulation disorder NOS					746
8093	9		Nausea and vomiting					746
8094	18		Ear, nose and throat infection					746
8095	9		Ear disorder					746
8096	18		Pharyngitis					746
8097	25		Malaise and fatigue					748
8098	17		Ear, nose and throat infection					748
8099	8		Cough					748
8100	17		Headache					748
8101	8		Nausea and vomiting					748
8102	8		Ear, nose and throat infection					748
8103	9 pts		Diarrhea					745
8104	2 pts		Abdominal discomfort					745
8105	1 pts		Nausea and vomiting					745
8106	6 pts		Malaise and fatigue					745
8107	6 pts		Headache					745
8108	4 pts		Disorder sleep					745
8109	2 pts		Cognitive disorders					745
8110	2 pts		Oral ulceration					745
8111	2 pts		Oral lesion					745
8112	3 pts		Muscle pain					745
8113	1 pts		Arthralgia					745
8114	2 pts		Temperature regulation disorder					745
8115	6 pts		Coughing					745
8116	35		Headache					747
8117	27		Malaise and fatigue					747
8118	10		Chills & fever					747
8119	33		Nausea					747
8120	18		Diarrhea					747
8121	13		Nausea and vomiting					747
8122	10		Decreased appetite					747
8123	9		Abdominal pain					747
8124	6		Abdominal cramps					747
8125	5		Dyspepsia					747
8126	12		Neuropathy					747
8127	11		Insomnia disorder					747
8128	10		Dizziness					747
8129	9		Depressive disorders					747
8130	20		Nasal disorders NEC					747
8131	18		Cough					747
8132	9		Skin rash					747
8133	12		Musculoskeletal pain					747
8134	8		Myalgia					747
8135	5		Arthralgia					747
8136			Myelosuppression	grade 5	discontinuation	WARNING		751
8137			Pulmonary toxicity		discontinuation	WARNING		751
8138			Pulmonary fibrosis		discontinuation	WARNING		751
8139			Acute leukemia		discontinuation	WARNING		751
8140			Myelodysplasia		discontinuation	WARNING		751
8141			Hepatotoxicity		discontinuation	WARNING		751
8142			Nephrotoxicity		discontinuation	WARNING		751
8143			Fetal damage		discontinuation	WARNING		751
8144	33.3		Neurotoxicity	grade 4			TRUE	750
8145	50		Gastrointestinal toxicity	grade 4			TRUE	749
8146	50		Sinusoidal obstruction syndrome	grade 4			TRUE	749
8147	6		Yellow skin					752
8148			Contact dermatitis			1 patient		753
8149	33.3		Headache					755
8150	0		Hypoaesthesia					755
8151	8.3		Malaise					755
8152	0		Myalgia					755
8153	16.7		Nausea					755
8154	0		Pharyngitis					755
8155	8.3		Somnolence					755
8156	0		Upper respiratory infection					755
8157	16.7		Vomiting					755
8158	8.3		Dizziness					755
8159	8.3		Abdominal pain					755
8160	0		Coughing					755
8161	0		Diarrhea					755
8162	8.3		Anorexia					755
8163	0		Flushing					755
8164	0		Injection site reaction					755
8165	0		Back pain					755
8166	0		Dyspepsia					755
8167	8.3		Paraesthesia					755
8168	0		Renal pain					755
8169	0		Rigors					755
8170	8.3		Fatigue					755
8171	0		Conjunctivitis					755
8172	0		Arthralgia					755
8173	0		Application site reaction					755
8174	0		Photophobia					755
8175	0		Dehydration					755
8176	0		Dysuria					755
8177	0		Sweating increased					755
8178	43.8		Headache					754
8179	0		Hypoaesthesia					754
8180	0		Malaise					754
8181	0		Myalgia					754
8182	0		Nausea					754
8183	0		Pharyngitis					754
8184	6.3		Somnolence					754
8185	0		Upper respiratory infection					754
8186	0		Vomiting					754
8187	6.3		Dizziness					754
8188	6.3		Abdominal pain					754
8189	0		Coughing					754
8190	6.3		Diarrhea					754
8191	0		Anorexia					754
8192	12.5		Flushing					754
8193	12.5		Injection site reaction					754
8194	6.3		Back pain					754
8195	12.5		Dyspepsia					754
8196	6.3		Paraesthesia					754
8197	6.3		Renal pain					754
8198	12.5		Rigors					754
8199	0		Fatigue					754
8200	6.3		Conjunctivitis					754
8201	12.5		Arthralgia					754
8202	31.3		Application site reaction					754
8203	18.8		Photophobia					754
8204	6.3		Dehydration					754
8205	6.3		Dysuria					754
8206	6.3		Sweating increased					754
8207			Serotonin syndrome		discontinuation	WARNING		756
8208	33.3		Febrile neutropenia	grade 4			TRUE	758
8209	33.3		Hyponatremia	grade 3			TRUE	758
8210						No DLT AEs, no adverse reactions leading to discontinuation were reported		757
8211	16.7		Dysphagia	grade 3			TRUE	760
8212	33.3		Mucositis	grade 3			TRUE	760
8213			Bone marrow depression		discontinuation	WARNING		759
8214			Thrombocytopenia		discontinuation	WARNING		759
8215			Leukopenia		discontinuation	WARNING		759
8216			Hemolytic uremic syndrome		discontinuation	WARNING		759
8217	3 pts		Weakness				TRUE	764
8218	3 pts		Ataxia				TRUE	764
8219	3 pts		Confusion				TRUE	764
8220	3 pts		Coma				TRUE	764
8221	2 pts		Weakness				TRUE	763
8222	2 pts		Ataxia				TRUE	763
8223	2 pts		Confusion				TRUE	763
8224	2 pts		Coma				TRUE	763
8225	1 pts		Somnolence	severe				765
8226			Somnolence	severe		WARNING		762
8227			Convulsions	severe		WARNING		762
8228			Numbness	severe		WARNING		762
8229			Paresthesia	severe		WARNING		762
8230			Weakness	severe		WARNING		762
8231			Paralysis	severe		WARNING		762
8232						No AEs are reported		761
8233						impossible to link AEs with the definite dose		766
8234	1 pts		Neuropathic pain		discontinuation	leads to discontinuation		768
8235			Hepatic failure	grade 5		WARNING		767
8236			Hypotension	grade 3-5	discontinuation	WARNINGS		773
8237			Hypoglycemia	grade 5	discontinuation	WARNINGS		773
8238			Acute pancreatitis	grade 5	discontinuation	WARNINGS		773
8239			Cardiac arrhythmias	grade 5	discontinuation	WARNINGS		773
8240			Cardiac arrhythmias	grade 5	discontinuation	WARNINGS		773
8241			Hypotension	grade 3-5	discontinuation	WARNINGS		772
8242			Hypoglycemia	grade 5	discontinuation	WARNINGS		772
8243			Acute pancreatitis	grade 5	discontinuation	WARNINGS		772
8244			Cardiac arrhythmias	grade 5	discontinuation	WARNINGS		772
8245			Cardiac arrhythmias	grade 5	discontinuation	WARNINGS		772
8246			Extravasation			WARNINGS		773
8247			Injection site ulceration			WARNINGS		773
8248			Injection site necrosis			WARNINGS		773
8249			Slough injection site			WARNINGS		773
8250			Extravasation			WARNINGS		772
8251			Injection site ulceration			WARNINGS		772
8252			Injection site necrosis			WARNINGS		772
8253			Slough injection site			WARNINGS		772
8254			Impaired renal function					770
8255			Hepatic impairment					770
8256			Hypotension					770
8257			Cardiopulmonary arrest					770
8258						No adverse reactions leading to discontinuation were reported		769
8259			Acute pancreatitis		discontinuation			771
8260	100		Hepatotoxicity	grade 3	discontinuation	dose-limiting		774
8261	100		Aspartate aminotransferase increase	grade 4	discontinuation	dose-limiting		774
8262	100		Alanine aminotransferase increase	grade 4	discontinuation	dose-limiting		774
8263	100		Lactate dehydrogenase increased		discontinuation			774
8264	100		Fever		discontinuation			774
8265	100		Nausea		discontinuation			774
8266	100		Aspartate aminotransferase increase	grade 3				775
8267	100		Alanine aminotransferase increase	grade 3				775
8268						No adverse reactions leading to discontinuation were reported		777
8269						No adverse reactions leading to discontinuation were reported		776
8270			Hepatotoxicity		discontinuation	WARNING		780
8271	5.8		Hepatotoxicity		discontinuation			779
8272	43.75		Arthralgia		discontinuation			778
8273	37.5		Distress gastrointestinal		discontinuation			778
8274	25		Pruritus		discontinuation			778
8275	25		Fatigue		discontinuation			778
8276	18.8		Generalized maculopapular rash		discontinuation			778
8277	18.8		Insomnia		discontinuation			778
8278	12.5		Vertigo		discontinuation			778
8279						No adverse reactions leading to discontinuation were observed		781
8280			Hepatotoxicity		discontinuation	WARNINGS		783
8281			Hyperbilirubinemia			WARNINGS		783
8282			Tear discoloration			WARNINGS		783
8283			Discoloration urine			WARNINGS		783
8284			Discoloration fecal			WARNINGS		783
8285			Clostridium difficile colitis			WARNINGS		783
8286	0.28		Hepatitis		discontinuation			782
8287	0.28		ALT increased		discontinuation			782
8288	0.28		AST increased		discontinuation			782
8289	0.28		LDH increased		discontinuation			782
8290	0.28		Bilirubin increased		discontinuation			782
8291	2		Leukopenia	grade 5	discontinuation			785
8292	2		Acute tubular necrosis	grade 5	discontinuation			785
8293						No adverse reactions leading to discontinuation were attributable to streptozocin.		784
8294			Acute hepatitis B	severe		WARNING		788
8295			Lactic acidosis	severe|grade 5		WARNING		788
8296			Hepatomegaly	severe|grade 5		WARNING		788
8297	4		CK increased		discontinuation	leads to discontinuation		787
8298	4		Nausea		discontinuation	leads to discontinuation		787
8299	4		Diarrhea		discontinuation	leads to discontinuation		787
8300	4		Fatigue		discontinuation	leads to discontinuation		787
8301	4		Myalgia		discontinuation	leads to discontinuation		787
8302	4		Myopathy		discontinuation	leads to discontinuation		787
8303						No information on AE is provided		786
8304	6 pts		CK increased		discontinuation	leads to dose interruption		789
8305	2 pts		Nausea		discontinuation	leads to dose interruption		789
8306	4 pts		Diarrhea		discontinuation	leads to dose interruption		789
8307	2 pts		Fatigue		discontinuation	leads to dose interruption		789
8308	2 pts		Myalgia		discontinuation	leads to dose interruption		789
8309	1 pts		Myopathy		discontinuation	leads to dose interruption		789
8310	1 pts		Pain in extremity		discontinuation	leads to dose interruption		789
8311	1 pts		Nasopharyngitis		discontinuation	leads to dose interruption		789
8312	1 pts		Hepatic pain		discontinuation	leads to dose interruption		789
8313	1 pts		Gastroenteritis		discontinuation	leads to dose interruption		789
8314	1 pts		Gastritis		discontinuation	leads to dose interruption		789
8315	1 pts		Dyspnea		discontinuation	leads to dose interruption		789
8316	1 pts		Dizziness		discontinuation	leads to dose interruption		789
8317	1 pts		Blood potassium decreased		discontinuation	leads to dose interruption		789
8318	1 pts		Asthenia		discontinuation	leads to dose interruption		789
8319	1 pts		Anosmia		discontinuation	leads to dose interruption		789
8320	1 pts		Amenorrhea		discontinuation	leads to dose interruption		789
8321	1 pts		ALT increased		discontinuation	leads to dose interruption		789
8322	1 pts		Abdominal tenderness		discontinuation	leads to dose interruption		789
8323	1 pts		Abdominal pain		discontinuation	leads to dose interruption		789
8324	5.6		Vomiting	grade 3	discontinuation	one case of vomiting and diarrhea, which was of severe intensity and which occurred during the multiple-dose 1,600-mg phase. This patient was withdrawn from the study		790
8325	5.6		Diarrhea	grade 3	discontinuation	one case of vomiting and diarrhea, which was of severe intensity and which occurred during the multiple-dose 1,600-mg phase. This patient was withdrawn from the study		790
8326			Nausea	grade 1-2				791
8327			Diarrhea	grade 1-2				791
8328			Abdominal pain	grade 1-2				791
8329			Headache	grade 1-2				791
8330			Taste disturbance	grade 1-2				791
8331			Dizziness	grade 1-2				791
8332			Allergic reaction		discontinuation	1 patient		792
8333			Alanine aminotransferase increase		discontinuation	1 patient. Developed marked, but clinically asymptomatic, liver function abnormalities 3 days after completing telithromycin treatment on study day 13 (alanine aminotransferase, aspartate aminotransferase, and lactate dehydrogenase levels increased to 2.9-, 7.6-, and 2.5-fold the upper limit of normal, respectively)		792
8334			Aspartate aminotransferase increase		discontinuation	1 patient. Developed marked, but clinically asymptomatic, liver function abnormalities 3 days after completing telithromycin treatment on study day 13 (alanine aminotransferase, aspartate aminotransferase, and lactate dehydrogenase levels increased to 2.9-, 7.6-, and 2.5-fold the upper limit of normal, respectively)		792
8335			Lactate dehydrogenase increased		discontinuation	1 patient. Developed marked, but clinically asymptomatic, liver function abnormalities 3 days after completing telithromycin treatment on study day 13 (alanine aminotransferase, aspartate aminotransferase, and lactate dehydrogenase levels increased to 2.9-, 7.6-, and 2.5-fold the upper limit of normal, respectively)		792
8336	1.4		Vomiting	grade 3	discontinuation	3 patients		793
8337	0.45		Nausea	grade 3	discontinuation	1 patient experienced severe nausea and vomiting that necessitated treatment withdrawal		793
8338	0.45		Alanine aminotransferase increase	grade 3	discontinuation	1 patient experienced severe liver function test abnormalities on day 5 [alanine aminotransferase (ALT) concentration, 418 U/L; aspartate aminotransferase (AST) concentration, 295 U/L] that resolved on treatment discontinuation		793
8339	0.45		Aspartate aminotransferase increase	grade 3	discontinuation	1 patient experienced severe liver function test abnormalities on day 5 [alanine aminotransferase (ALT) concentration, 418 U/L; aspartate aminotransferase (AST) concentration, 295 U/L] that resolved on treatment discontinuation		793
8340	4.1		Headache					793
8341	3.6		Taste perversion					793
8342	12.7		Diarrhea					793
8343	9.8		Diarrhea					794
8344	5.3		Nausea					794
8345	3.8		Nausea					794
8346			Acute hepatic failure	grade 4-5				795
8347			Liver injury	grade 4-5				795
8348			Hepatitis fulminant	grade 4				795
8349			Hepatic necrosis	grade 4				795
8350			Hepatic enzymes increased	grade 2				795
8351			Hepatitis	grade 2				795
8352			Jaundice	grade 2				795
8353			Electrocardiogram QTc interval prolonged					795
8354			Visual disturbances			KETEK (telithromycin) may cause visual disturbances particularly in slowing the ability to accommodate and the ability to release accommodation. Visual disturbances included blurred vision, difficulty focusing, and diplopia. Most events were mild to moderate; however, severe cases have been reported.		795
8355			Blurred vision			KETEK (telithromycin) may cause visual disturbances particularly in slowing the ability to accommodate and the ability to release accommodation. Visual disturbances included blurred vision, difficulty focusing, and diplopia. Most events were mild to moderate; however, severe cases have been reported.		795
8356			Difficulty focusing eyes			KETEK (telithromycin) may cause visual disturbances particularly in slowing the ability to accommodate and the ability to release accommodation. Visual disturbances included blurred vision, difficulty focusing, and diplopia. Most events were mild to moderate; however, severe cases have been reported.		795
8357			Diplopia			KETEK (telithromycin) may cause visual disturbances particularly in slowing the ability to accommodate and the ability to release accommodation. Visual disturbances included blurred vision, difficulty focusing, and diplopia. Most events were mild to moderate; however, severe cases have been reported.		795
8358			Loss of consciousness					795
8359			Vagal reaction					795
8360	2 pts		Thrombocytopenia	grade 4			TRUE	797
8361	1 pts		Anaemia	grade 3				797
8362	2 pts		Neutropenia	grade 3				797
8363	1 pts		Anaemia	grade 4				798
8364	1 pts		Neutropenia	grade 4		Toxicity after the first cycle of therapy.		799
8365	2 pts		Thrombocytopenia	grade 3		Toxicity after the first cycle of therapy.		799
8366	2 pts		Neutropenia	grade 4		Toxicity after the first cycle of therapy.		796
8367	1 pts		Thrombocytopenia	grade 4		Toxicity after the first cycle of therapy.		796
8368	19		Anorexia	all grades		Concomitant with focal radiotherapy		802
8369	4		Dizziness	all grades		Concomitant with focal radiotherapy		802
8370	54		Fatigue	all grades		Concomitant with focal radiotherapy		802
8371	19		Headache	all grades		Concomitant with focal radiotherapy		802
8372	3		Weakness	all grades		Concomitant with focal radiotherapy		802
8373	4		Confusion	all grades		Concomitant with focal radiotherapy		802
8374	6		Convulsions	all grades		Concomitant with focal radiotherapy		802
8375	3		Memory impairment	all grades		Concomitant with focal radiotherapy		802
8376	9		Vision blurred	all grades		Concomitant with focal radiotherapy		802
8377	5		Allergic reaction	all grades		Concomitant with focal radiotherapy		802
8378	2		Abdominal pain	all grades		Concomitant with focal radiotherapy		802
8379	18		Constipation	all grades		Concomitant with focal radiotherapy		802
8380	6		Diarrhea	all grades		Concomitant with focal radiotherapy		802
8381	36		Nausea	all grades		Concomitant with focal radiotherapy		802
8382	7		Stomatitis	all grades		Concomitant with focal radiotherapy		802
8383	20		Vomiting	all grades		Concomitant with focal radiotherapy		802
8384	7		Radiation injury NOS	all grades		Concomitant with focal radiotherapy		802
8385	2		Arthralgia	all grades		Concomitant with focal radiotherapy		802
8386	4		Thrombocytopenia	all grades		Concomitant with focal radiotherapy		802
8387	5		Insomnia	all grades		Concomitant with focal radiotherapy		802
8388	5		Coughing	all grades		Concomitant with focal radiotherapy		802
8389	4		Dyspnea	all grades		Concomitant with focal radiotherapy		802
8390	69		Alopecia	all grades		Concomitant with focal radiotherapy		802
8391	2		Dry skin	all grades		Concomitant with focal radiotherapy		802
8392	5		Erythema	all grades		Concomitant with focal radiotherapy		802
8393	4		Pruritus	all grades		Concomitant with focal radiotherapy		802
8394	19		Rash	all grades		Concomitant with focal radiotherapy		802
8395	27		Anorexia	all grades		Maintenance Phase		800
8396	5		Dizziness	all grades		Maintenance Phase		800
8397	61		Fatigue	all grades		Maintenance Phase		800
8398	23		Headache	all grades		Maintenance Phase		800
8399	7		Weakness	all grades		Maintenance Phase		800
8400	5		Confusion	all grades		Maintenance Phase		800
8401	11		Convulsions	all grades		Maintenance Phase		800
8402	7		Memory impairment	all grades		Maintenance Phase		800
8403	8		Vision blurred	all grades		Maintenance Phase		800
8404	3		Allergic reaction	all grades		Maintenance Phase		800
8405	5		Abdominal pain	all grades		Maintenance Phase		800
8406	22		Constipation	all grades		Maintenance Phase		800
8407	10		Diarrhea	all grades		Maintenance Phase		800
8408	49		Nausea	all grades		Maintenance Phase		800
8409	9		Stomatitis	all grades		Maintenance Phase		800
8410	29		Vomiting	all grades		Maintenance Phase		800
8411	2		Radiation injury NOS	all grades		Maintenance Phase		800
8412	6		Arthralgia	all grades		Maintenance Phase		800
8413	8		Thrombocytopenia	all grades		Maintenance Phase		800
8414	4		Insomnia	all grades		Maintenance Phase		800
8415	8		Coughing	all grades		Maintenance Phase		800
8416	5		Dyspnea	all grades		Maintenance Phase		800
8417	55		Alopecia	all grades		Maintenance Phase		800
8418	5		Dry skin	all grades		Maintenance Phase		800
8419	1		Erythema	all grades		Maintenance Phase		800
8420	5		Pruritus	all grades		Maintenance Phase		800
8421	13		Rash	all grades		Maintenance Phase		800
8422	5		Taste perversion	all grades		Maintenance Phase		800
8423	41		Headache	all grades				801
8424	34		Fatigue	all grades				801
8425	13		Asthenia	all grades				801
8426	13		Fever	all grades				801
8427	8		Back pain	all grades				801
8428	11		Edema peripheral	all grades				801
8429	23		Convulsions	all grades				801
8430	18		Hemiparesis	all grades				801
8431	12		Dizziness	all grades				801
8432	11		Coordination abnormal	all grades				801
8433	10		Amnesia	all grades				801
8434	10		Insomnia	all grades				801
8435	9		Paresthesia	all grades				801
8436	9		Somnolence	all grades				801
8437	8		Paresis	all grades				801
8438	8		Urinary incontinence	all grades				801
8439	8		Ataxia	all grades				801
8440	7		Dysphasia	all grades				801
8441	6		Convulsions local	all grades				801
8442	6		Abnormal gait	all grades				801
8443	5		Confusion	all grades				801
8444	8		Adrenal hypercorticism	all grades				801
8445	53		Nausea	all grades				801
8446	42		Vomiting	all grades				801
8447	33		Constipation	all grades				801
8448	16		Diarrhea	all grades				801
8449	9		Abdominal pain	all grades				801
8450	9		Anorexia	all grades				801
8451	5		Weight increase	all grades				801
8452	5		Myalgia	all grades				801
8453	7		Anxiety	all grades				801
8454	6		Depression	all grades				801
8455	6		Breast pain female	all grades				801
8456	11		Infection viral	all grades				801
8457	8		Upper respiratory tract infection	all grades				801
8458	8		Pharyngitis	all grades				801
8459	6		Sinusitis	all grades				801
8460	5		Coughing	all grades				801
8461	8		Rash	all grades				801
8462	8		Pruritus	all grades				801
8463	8		Urinary tract infection	all grades				801
8464	6		Micturition frequency increased	all grades				801
8465	5		Diplopia	all grades				801
8466	5		Abnormal vision	all grades				801
8467	33.3		Mucositis	grade 3				805
8468	33.3		Gastrointestinal toxicity	grade 3				805
8469	25		Leukopenia	grade 3				804
8470	12.5		Thrombocytopenia	grade 4				804
8471	28.6		Leukopenia	grade 3			TRUE	807
8472	28.6		Thrombocytopenia	grade 3			TRUE	807
8473	28.6		Thrombocytopenia	grade 4			TRUE	807
8474	16		Leukopenia	grade 3				803
8475	8		Leukopenia	grade 4				803
8476	16		Thrombocytopenia	grade 3				803
8477	12		Thrombocytopenia	grade 4				803
8478			Myelosuppression	severe	discontinuation	WARNING		806
8479			Bone marrow failure	severe	discontinuation	WARNING		806
8480			Disorder fetal		discontinuation	WARNING		806
8481	50		Nausea					810
8482	50		Vomiting					810
8483			Nausea					811
8484			Vomiting					811
8485			Gastrointestinal disorder NOS			GI adverse events were dose limiting at 300mg, and dose escalation was halted at this dose.	TRUE	809
8486	50		Gastrointestinal disorder (NOS)		discontinuation	nausea and/or vomiting		808
8487			Anaphylaxis		discontinuation	WARNING		813
8488			Anaphylactoid reaction		discontinuation	WARNING		813
8489			Hepatic dysfunction NOS		discontinuation	WARNING		813
8490			Liver failure		discontinuation	WARNING		813
8491			Pancreatitis	grade 5	discontinuation	WARNING		813
8492			Fetal damage		discontinuation	WARNING		813
8493			Tooth discoloration		discontinuation	WARNING. The use of TYGACIL during tooth development may cause permanent discoloration of the teeth.		813
8494			Diarrhea, Clostridium difficile		discontinuation	WARNING		813
8495	1		Nausea		discontinuation			812
8496	1		Vomiting		discontinuation			812
8497						No SAEs were observed		815
8498						No SAEs were observed		816
8499						No SAEs were observed		814
8500						No serious AEs reported		818
8501	4 pts		Proteinuria					817
8502	3 pts		Stomatitis					817
8503	2 pts		Itching					817
8504	1 pts		Discomfort epigastric					817
8505	6		Anemia			Naïve to d-penicillamine.		819
8506	12		Nausea			Naïve to d-penicillamine.		819
8507			Emesis			Naïve to d-penicillamine.		819
8508	6		Diarrhea			Naïve to d-penicillamine.		819
8509	6		Abdominal pain			Naïve to d-penicillamine.		819
8510	18		Oral ulceration			Naïve to d-penicillamine.		819
8511			Fever			Naïve to d-penicillamine.		819
8512	12		Weakness			Naïve to d-penicillamine.		819
8513			Fatigue			Naïve to d-penicillamine.		819
8514	6		Edema peripheral			Naïve to d-penicillamine.		819
8515	6		Chest pain			Naïve to d-penicillamine.		819
8516			Anorexia			Naïve to d-penicillamine.		819
8517	12		Arthralgia			Naïve to d-penicillamine.		819
8518	6		Proteinuria			Naïve to d-penicillamine.		819
8519	6		Impotence			Naïve to d-penicillamine.		819
8520	6		Cough			Naïve to d-penicillamine.		819
8521	12		Rash			Naïve to d-penicillamine.		819
8522			Ecchymosis			Naïve to d-penicillamine.		819
8523	6		Pruritus			Naïve to d-penicillamine.		819
8524			Urticaria			Naïve to d-penicillamine.		819
8525	6		Skin wrinkling			Naïve to d-penicillamine.		819
8526	2		Anemia			Prevously treated with d-penicillamine.		820
8527	25		Nausea			Prevously treated with d-penicillamine.		820
8528	10		Emesis			Prevously treated with d-penicillamine.		820
8529	18		Diarrhea			Prevously treated with d-penicillamine.		820
8530			Abdominal pain			Prevously treated with d-penicillamine.		820
8531	12		Oral ulceration			Prevously treated with d-penicillamine.		820
8532	8		Fever			Prevously treated with d-penicillamine.		820
8533	4		Weakness			Prevously treated with d-penicillamine.		820
8534	14		Fatigue			Prevously treated with d-penicillamine.		820
8535	6		Edema peripheral			Prevously treated with d-penicillamine.		820
8536			Chest pain			Prevously treated with d-penicillamine.		820
8537	8		Anorexia			Prevously treated with d-penicillamine.		820
8538			Arthralgia			Prevously treated with d-penicillamine.		820
8539	10		Proteinuria			Prevously treated with d-penicillamine.		820
8540			Impotence			Prevously treated with d-penicillamine.		820
8541			Cough			Prevously treated with d-penicillamine.		820
8542	14		Rash			Prevously treated with d-penicillamine.		820
8543	6		Ecchymosis			Prevously treated with d-penicillamine.		820
8544	4		Pruritus			Prevously treated with d-penicillamine.		820
8545	8		Urticaria			Prevously treated with d-penicillamine.		820
8546	6		Skin wrinkling			Prevously treated with d-penicillamine.		820
8547	33.3		Granulocytopenia	grade 4			TRUE	821
8548	33.3		Fatigue	grade 3			TRUE	821
8549	16.7		Granulocytopenia	grade 4				823
8550	33.3		Neutropenia	grade 4			TRUE	822
8551	3 pts		Endophthalmitis	serious				824
8552	5 pts		Dizziness	below serious				824
8553	4 pts		Vomiting	below serious				824
8554	5 pts		Visual disturbances	below serious				824
8555	3 pts		Diarrhea	below serious				824
8556	2 pts		Lethargy	below serious				824
8557	2 pts		Nausea	below serious				824
8558	1 pts		Skin reaction	below serious				824
8559	1 pts		Stomach pain	below serious				824
8560	1 pts		Photophobia		discontinuation	leads to discontinuation		828
8561	1 pts		Defective color vision		discontinuation	leads to discontinuation		828
8562	1 pts		Hallucination visual		discontinuation	leads to discontinuation		828
8563	1 pts		Photophobia		discontinuation	leads to discontinuation		827
8564	1 pts		Fatigue		discontinuation	leads to discontinuation		827
8565	1 pts		Concentration impaired		discontinuation	leads to discontinuation		827
8566	1 pts		Insomnia		discontinuation	leads to discontinuation		827
8567	31 pts		CRP increased		discontinuation	leads to discontinuation		825
8568	31 pts		Bilirubin increased		discontinuation	leads to discontinuation		825
8569	73 pts		Function liver abnormal		discontinuation	leads to discontinuation		826
8570	16 pts		Hallucination, visual		discontinuation	leads to discontinuation		826
8571	6 pts		Skin rash		discontinuation	leads to discontinuation		826
8572	3 pts		Kidney dysfunction		discontinuation	leads to discontinuation		826
8573	2 pts		Electrocardiogram QTc interval prolonged		discontinuation	leads to discontinuation		826
8574	1 pts		Gastrointestinal symptom NOS		discontinuation	leads to discontinuation		826
8575			Irritation skin		discontinuation			829
8576						No SAEs were observed		830
8577	2 pts		Vulvovaginal discomfort					831
8578	2 pts		Toxic reaction (NOS)	grade 5	discontinuation	Poisoning		832
8579						No adverse effects leading to discontinuation were reported		833
8580			Nausea		discontinuation			834
8581	0.96		Allergic skin reaction		discontinuation	One patient with skin allergy and anaphylaxis was hospitalized		837
8582	0.96		Anaphylaxis		discontinuation	One patient with skin allergy and anaphylaxis was hospitalized		836
8583			Headache	severe	discontinuation	4 patients due to side effects such as severe headache, vomiting, urticaria, fever and severe orthostatic changes		835
8584			Vomiting		discontinuation	4 patients due to side effects such as severe headache, vomiting, urticaria, fever and severe orthostatic changes		835
8585			Urticaria		discontinuation	4 patients due to side effects such as severe headache, vomiting, urticaria, fever and severe orthostatic changes		835
8586			Fever		discontinuation	4 patients due to side effects such as severe headache, vomiting, urticaria, fever and severe orthostatic changes		835
8587			Orthostatic dysregulation	severe	discontinuation	4 patients due to side effects such as severe headache, vomiting, urticaria, fever and severe orthostatic changes		835
8588	1 pts		Myalgia	below serious				838
8589	1 pts		Dizziness	below serious				838
8590	1 pts		Sneezing	below serious				838
8591			Headache					840
8592			Sore throat					840
8593			Indigestion					840
8594			Nose bleed					840
8595			Eye infection					840
8596			Headache					839
8597			Sore throat					839
8598			Indigestion					839
8599			Nose bleed					839
8600			Eye infection					839
8601	1 pts		Vomiting		discontinuation	leads to discontinuation		841
8602	1 pts		Diarrhea		discontinuation	leads to discontinuation		841
8603			Hepatic failure	grade 5|acute				843
8604						No AEs are reported		842
8605	83.3		Neutropenia	grade 4			TRUE	844
8606	33.3		Infection	severe			TRUE	844
8607	66.7		Thrombocytopenia	grade 4			TRUE	844
8608	66.7		Neutropenia	grade 4			TRUE	845
8609	33.3		Febrile neutropenia	grade 5	discontinuation		TRUE	845
8610	66.7		Thrombocytopenia	grade 4			TRUE	845
8611	66.7		Anemia	grade 4			TRUE	845
8612			Myelosuppression	grade 3-5	discontinuation	WARNING. Myelosuppression can be severe and lead to fatal infections		846
8613			CNS toxicity	grade 3-5	discontinuation	WARNING		846
8614			Encephalopathy	grade 3-5	discontinuation	WARNING		846
8615			Nephrotoxicity	severe	discontinuation	WARNING		846
8616			Renal failure	severe	discontinuation	WARNING		846
8617			Cystitis hemorrhagic	severe	discontinuation	WARNING		846
8618	2 pts		Skin infection		discontinuation	leads to discontinuation		850
8619	1 pts		Skin infection	severe	discontinuation	leads to discontinuation		849
8620	1 pts		Vomiting					848
8621	14 pts		Nausea					848
8622	1 pts		Watery diarrhoea					848
8623	3 pts		Loose bowels					848
8624	12 pts		Abdominal pain					848
8625	19 pts		Eructation					848
8626	15 pts		Flatus					848
8627	21 pts		Nocturia					848
8628	5 pts		Discolouration urine					848
8629	3 pts		Itchy skin					848
8630	2 pts		Blister					848
8631	1 pts		Skin rash					848
8632	2 pts		Bruising					848
8633	9 pts		Wheezing					848
8634	9 pts		Breathlessness					848
8635	3 pts		Nocturnal dyspnoea					848
8636	6 pts		Ankle swelling					847
8637	10 pts		Feeling of warmth					847
8638	4 pts		Chest pain					847
8639	14 pts		Headache					847
8640	6 pts		Paraesthesia					847
8641	10 pts		Dizziness					847
8642						no AEs reported		853
8643						no AEs reported		852
8644			Bladder irritation					851
8645			Micturition painful					851
8646			Micturition frequency					851
8647			Albuminuria					851
8648			Hematuria					851
8649						No AEs are reported		854
8650	12 pts		Vomiting		discontinuation	leads to discontinuation		857
8651	12 pts		Intracranial hypertension		discontinuation	leads to discontinuation		857
8652	2 pts		Convulsions		discontinuation	leads to discontinuation		857
8653			Phototoxicity					855
8654	1 pts		Metabolic acidosis		discontinuation	leads to discontinuation		856
8655	1 pts		Coma		discontinuation	leads to discontinuation		856
8656	4.8		Acne			treatment related Aes		858
8657	2.8		Dermatitis			treatment related Aes		858
8658	1.2		Dry skin			treatment related Aes		858
8659	1.2		Eczema			treatment related Aes		858
8660	1.2		Erythema			treatment related Aes		858
8661	2		Pruritus			treatment related Aes		858
8662	0.4		Rosacea			treatment related Aes		858
8663	0.8		Seborrhea			treatment related Aes		858
8664	1.2		Skin discomfort			treatment related Aes		858
8665	0.8		Sunburn			treatment related Aes		858
8666	0.8		Conjunctivitis			treatment related Aes		858
8667	0.4		Taste perversion			treatment related Aes		858
8668	2.8		Dermatitis			treatment related Aes		859
8669	0.4		Eczema			treatment related Aes		859
8670	0.8		Erythema			treatment related Aes		859
8671	0.8		Skin discomfort			treatment related Aes		859
8672	1.6		Sunburn			treatment related Aes		859
8673	0.4		Conjunctivitis			treatment related Aes		859
8674	2.5		Dermatitis			treatment related Aes		860
8675	1.3		Eczema			treatment related Aes		860
8676			Eczema					861
8677	16.7		Rash					862
8678						No AEs are reported		864
8679	3 pts		Hemochromatosis	grade 5				863
8680	0.84		Nausea		discontinuation	case 1		865
8681	0.84		Vomiting		discontinuation	case 1		865
8682	1.68		Gas		discontinuation	case 1 and 3		865
8683	0.84		Diarrhea	severe	discontinuation	case 2		865
8684	1.68		Gastrointestinal discomfort		discontinuation	case 2 and 3		865
8685	0.84		Burning in abdomen		discontinuation	case 3		865
8686	0.84		Diarrhea		discontinuation	case 4		865
8687	0.84		Anorexia		discontinuation	case 4		865
8688	0.84		Nausea	severe	discontinuation	case 4		865
8689	0.84		Vomiting	severe	discontinuation	case 4		865
8690	< 1		Metabolic acidosis		discontinuation			866
8691	< 1		Injection site reactions		discontinuation			866
8692	0.32		Bradycardia		discontinuation	1 patient		866
8693	0.32		Abdominal distension		discontinuation	1 patient		866
8694	0.32		Injection site extravasation		discontinuation	1 patient		866
8695	0.32		Hemorrhage injection site		discontinuation	1 patient		866
8696	0.32		Blister		discontinuation	1 patient		866
8697	0.32		Subdural hematoma		discontinuation	1 patient		866
8698	0.32		Hyperammonemia		discontinuation	1 patient		866
8699	0.32		Hypoglycemia		discontinuation	1 patient		866
8700	0.32		Clonus		discontinuation	1 patient		866
8701	0.32		Coma		discontinuation	1 patient		866
8702	0.32		Increased intracranial pressure		discontinuation	1 patient		866
8703	0.32		Hypercapnia		discontinuation	1 patient		866
8704	0.32		Kussmaul respiration		discontinuation	1 patient		866
8705	0.32		Respiratory distress		discontinuation	1 patient		866
8706	0.32		Respiratory failure		discontinuation	1 patient		866
8707	0.32		Pruritis		discontinuation	1 patient		866
8708	0.32		Maculo-papular rash		discontinuation	1 patient		866
8709			Neurotoxicity			PRECAUTIONS		867
8710			Pancytopenia		discontinuation			868
8711			Gastric pain		discontinuation			868
8712			Diarrhea		discontinuation			868
8713			Aplasia bone marrow		discontinuation			868
8714						No major adverse events were reported		869
8715						No adverse reactions leading to discontinuation were reported		870
8716						There were no adverse side effects that warranted discontinuance of medication		872
8717	2 pts		Nasal stuffiness		discontinuation	leads to discontinuation		873
8718	1 pts		Edema lip		discontinuation	leads to discontinuation		873
8719	1 pts		Leukopenia		discontinuation	leads to discontinuation		873
8720						no adverse reactions were reported, only abstract is available		871
8721			Toxic reaction (NOS)	grade 5				874
8722						No information on AE is provided		875
8723						No adverse reactions leading to discontinuation were reported		876
8724	1.7		Nausea		discontinuation			877
8725						No SAEs were observed		878
8726	2		Hypersensitivity					879
8727			Respiratory distress	grade 4				879
8728			Shock	grade 4				879
8729			Angioedema	grade 4				879
8730			Urticaria	grade 4				879
8731			Pruritus	grade 4				879
8732						no AEs reported		882
8733						no AEs reported		881
8734			Fluid overload					883
8735			Electrolytes serum low (NOS)					883
8736			Overhydration					883
8737			Pulmonary edema					883
8738			Peripheral edema					883
8739			Hypokalemia	grade 3				883
8740			Serum osmolality increased			In very low birth weight infants, excessive or rapid administration of dextrose injection may result in increased serum osmolality and possible intracerebral hemorrhage.		883
8741			Intracerebral hemorrhage			In very low birth weight infants, excessive or rapid administration of dextrose injection may result in increased serum osmolality and possible intracerebral hemorrhage.		883
8742						no AEs reported		880
8743						No information on AE is provided		884
8744						Ten patients (66.7%) in the oral PUVA groupcomplained about slight to moderate nausea (10), dizziness(five) or headache (three) after the intake of 8-MOP that lastedup to 2 h. No patient discontinued treatment because of adverse effects.		886
8745			Cataract		discontinuation	WARNING. There are more AEs for Methoxsalen with UV radiation treatment, but they are related to UVA		885
8746	12 pts		Localised skin reaction					888
8747						No information on AE is provided		887
8748			Application site erythema		discontinuation			889
8749			Redness facial		discontinuation			889
8750			Telangiectasia	grade 3-4	discontinuation			889
8751			Rosacea		discontinuation			889
8752			Facial flushing		discontinuation			889
8753			Acne		discontinuation			889
8754			Acne papular		discontinuation			889
8755			Acne aggravated		discontinuation			889
8756			Skin irritation		discontinuation			889
8757			Peeling		discontinuation			889
8758			Perioral dermatitis		discontinuation			889
8759			Facial hair increased		discontinuation			889
8760			Dry skin		discontinuation			889
8761			Saliva discolouration		discontinuation			889
8762						No AEs were observed		891
8763	5 pts		Anemia	grade 1			TRUE	890
8764	1 pts		Leukopenia	grade 1			TRUE	890
8765	2 pts		Nausea	grade 1			TRUE	890
8766	3 pts		Vomiting	grade 2			TRUE	890
8767	2 pts		Hypersensitivity reaction	grade 1			TRUE	890
8768	7 pts		Hypersensitivity reaction	grade 2			TRUE	890
8769	1 pts		Diarrhoea	below serious				897
8770	1 pts		Medical device site reaction	below serious				897
8771	1 pts		Blood cholesterol increased	below serious				897
8772	1 pts		Arthralgia	below serious				897
8773	1 pts		Eye irritation	below serious				898
8774	1 pts		Headache	below serious				898
8775	1 pts		Nasal congestion	below serious				898
8776	1 pts		AST increased	below serious				895
8777	1 pts		Blood bilirubin increased	below serious				896
8778	1 pts		Neck pain	below serious				896
8779	1 pts		Pain in extremity	below serious				896
8780	1 pts		Oropharyngeal pain	below serious				896
8781	20		Somnolence					899
8782	40		Somnolence			testing of the next dose of 54 mg was canceled		900
8783	74		Eosinophilia					901
8784	65		Pruritus					901
8785	64		Musculoskeletal pain					901
8786	58		Headache					901
8787	48		Lymphocytopenia					901
8788	39		Tachycardia					901
8789	34		Postural orthostatic tachycardia syndrome					901
8790	18		Tachycardia					901
8791	37		Rash					901
8792	31		Abdominal pain					901
8793	30		Hypotension					902
8794	22		Orthostatic hypotension					902
8795	27		Pyrexia					902
8796	25		Leukocytosis					902
8797	23		Influenza like illness					902
8798	20		Neutropenia					902
8799	17		Cough					902
8800	13		Lymph node pain					902
8801	12		Dizziness					902
8802	15		Gastroenteritis					902
8803	12		Hyponatremia					902
8804	11		Peripheral swelling					902
8805	8		Eye pain					902
8806	7		Eye pruritus					902
8807	3		Visual impairment					902
8808	2		Eyelid edema					902
8809	2		Conjunctivitis allergic					902
8810	2		Ocular discomfort					902
8811	2		Conjunctival hyperemia					902
8812	1		Lacrimation increased					902
8813	18		Eosinophilia	grade 4				903
8814	23		Lymphocytopenia	grade 3				903
8815	7		Neutrophils	grade 4				903
8816	5		Eosinopenia	grade 3				903
8817	3		GGT increased	grade 2-3				903
8818	1.4		Bilirubin increased	grade 2				903
8819	1		AST increased	grade 2-3				903
8820	1		ALT increased	grade 2-3				903
8821	52		Generalized pruritus					892
8822	41		Rash					892
8823	48		Postural orthostatic tachycardia syndrome					892
8824	18		Orthostatic hypotension					892
8825	20		Lymph node pain					892
8826	80		Generalized pruritus					893
8827	53		Rash					893
8828	31		Postural orthostatic tachycardia syndrome					893
8829	29		Orthostatic hypotension					893
8830	36		Lymph node pain					893
8831	88		Generalized pruritus					894
8832	63		Rash					894
8833	63		Postural orthostatic tachycardia syndrome					894
8834	60		Orthostatic hypotension					894
8835	63		Lymph node pain					894
8836	42		Musculoskeletal disorder					904
8837	38		Diarrhea					904
8838	33		Upper respiratory tract signs and symptoms					904
8839	29		Headache					904
8840	27		Nausea					904
8841	26		Abdominal pain					904
8842	26		Cough					904
8843	18		Edema					904
8844	11		Dizziness					904
8845	10		Hypertension					904
8846	10		Pruritus					904
8847	9		Tachycardia					904
8848	9		Toothache					904
8849	8		Anemia					904
8850	7		Renal insufficiency					904
8851	7		Fatigue					904
8852	7		Pneumonia					904
8853	6		Urinary tract infection					904
8854	6		Chest pain					904
8855	6		Insomnia					904
8856	2		Myocardial infarction					904
8857	3		Diarrhea					904
8858	2		Vomiting					904
8859	3		Pneumonia					904
8860	2		Infection					904
8861	8		Renal impairment					904
8862	2		Nephrotic syndrome					904
8863	2		Dyspnea					904
8864						No adverse effects leading to discontinuation were reported		905
8865						No AEs were reported		907
8866						none of symptoms was considered to be related to the doranidazole administration.		906
8867	19.2		Thrombocytopenia	grade 4			TRUE	909
8868	26.9		Anemia	grade 4			TRUE	909
8869	18		Nausea	grade 3			TRUE	909
8870	18		Vomiting	grade 3			TRUE	909
8871	14		Chemical cystitis	grade 3			TRUE	909
8872	23		Neutropenic sepsis	grade 4			TRUE	909
8873	14		Diarrhea	grade 3			TRUE	909
8874	10		Neutropenia	grade 4			TRUE	908
8875	10		Anemia	grade 4			TRUE	908
8876						No AEs were reported		910
8877	1 pts		Mucositis oral	grade 2				914
8878	1 pts		Mucositis oral	grade 3				914
8879	1 pts		Thrombocytopenia	grade 3				914
8880	1 pts		Neutropenia	grade 3				914
8881	1 pts		Myelosuppression	grade 4			TRUE	912
8882	1 pts		Thrombocytopenia	grade 4			TRUE	912
8883	1 pts		Hyperbilirubinaemia	grade 4			TRUE	912
8884	2 pts		Mucositis oral	grade 4			TRUE	912
8885	1 pts		Anaphylactic reaction	grade 4			TRUE	912
8886	1 pts		Mucositis oral	grade 3				912
8887	1 pts		Neutropenia	grade 3				912
8888	9 pts		Hyperbilirubinaemia				TRUE	912
8889	4 pts		Leukopenia	grade 1				916
8890	8 pts		Leukopenia	grade 2				916
8891	4 pts		Leukopenia	grade 3				916
8892	8 pts		Leukopenia	grade 4				916
8893	5 pts		Neutropenia	grade 1			TRUE	916
8894	8 pts		Neutropenia	grade 2			TRUE	916
8895	5 pts		Neutropenia	grade 3			TRUE	916
8896	8 pts		Neutropenia	grade 4			TRUE	916
8897	6 pts		Thrombocytopenia	grade 1			TRUE	916
8898	8 pts		Thrombocytopenia	grade 2			TRUE	916
8899	3 pts		Thrombocytopenia	grade 3			TRUE	916
8900	8 pts		Thrombocytopenia	grade 4			TRUE	916
8901	3 pts		Leukopenia	grade 2				915
8902	3 pts		Leukopenia	grade 3				915
8903	3 pts		Leukopenia	grade 4				915
8904	3 pts		Neutropenia	grade 2			TRUE	915
8905	3 pts		Neutropenia	grade 3			TRUE	915
8906	3 pts		Neutropenia	grade 4			TRUE	915
8907	3 pts		Thrombocytopenia	grade 1			TRUE	915
8908	3 pts		Thrombocytopenia	grade 2			TRUE	915
8909	3 pts		Thrombocytopenia	grade 4			TRUE	915
8910	1 pts		Leukopenia	grade 2				911
8911	1 pts		Leukopenia	grade 3				911
8912	1 pts		Leukopenia	grade 4				911
8913	1 pts		Neutropenia	grade 2			TRUE	911
8914	1 pts		Neutropenia	grade 3			TRUE	911
8915	1 pts		Neutropenia	grade 4			TRUE	911
8916	1 pts		Thrombocytopenia	grade 2			TRUE	911
8917	1 pts		Thrombocytopenia	grade 3			TRUE	911
8918	1 pts		Thrombocytopenia	grade 4			TRUE	911
8919	14 pts		Leucopenia	grade 1				917
8920	23 pts		Leucopenia	grade 2				917
8921	11 pts		Leucopenia	grade 3				917
8922	2 pts		Leucopenia	grade 4				917
8923	16 pts		Thrombocytopenia	grade 1				917
8924	2 pts		Thrombocytopenia	grade 2				917
8925	4 pts		Thrombocytopenia	grade 3				917
8926	4 pts		Thrombocytopenia	grade 4				917
8927	30 pts		Anemia	grade 1				917
8928	17 pts		Anemia	grade 2				917
8929	1 pts		Anemia	grade 3				917
8930	8 pts		Granulocytopenia	grade 1				917
8931	21 pts		Granulocytopenia	grade 2				917
8932	12 pts		Granulocytopenia	grade 3				917
8933	7 pts		Granulocytopenia	grade 4				917
8934	2 pts		Lymphopenia	grade 2				917
8935	2 pts		Lymphopenia	grade 3				917
8936	1 pts		Lymphopenia	grade 4				917
8937	25 pts		Nausea	grade 1			TRUE	917
8938	19 pts		Nausea	grade 2			TRUE	917
8939	1 pts		Nausea	grade 3			TRUE	917
8940	17 pts		Vomiting	grade 1			TRUE	917
8941	11 pts		Vomiting	grade 2			TRUE	917
8942	8 pts		Diarrhea	grade 1				917
8943	10 pts		Diarrhea	grade 2				917
8944	1 pts		Diarrhea	grade 3				917
8945	23 pts		Stomatitis	grade 1				917
8946	14 pts		Stomatitis	grade 2				917
8947	2 pts		Stomatitis	grade 3				917
8948	10 pts		Rash	grade 1				917
8949	11 pts		Rash	grade 2				917
8950	1 pts		Rash	grade 3				917
8951	1 pts		Leucopenia	grade 1				913
8952	1 pts		Leucopenia	grade 2				913
8953	3 pts		Leucopenia	grade 3				913
8954	1 pts		Thrombocytopenia	grade 2				913
8955	2 pts		Anemia	grade 1				913
8956	5 pts		Anemia	grade 2				913
8957	2 pts		Granulocytopenia	grade 2				913
8958	3 pts		Granulocytopenia	grade 3				913
8959	1 pts		Lymphopenia	grade 2				913
8960	1 pts		Lymphopenia	grade 4				913
8961	2 pts		Nausea	grade 1				913
8962	4 pts		Nausea	grade 2				913
8963	2 pts		Vomiting	grade 2				913
8964	1 pts		Diarrhea	grade 1				913
8965	1 pts		Diarrhea	grade 3				913
8966	1 pts		Diarrhea	grade 4				913
8967	1 pts		Stomatitis	grade 1				913
8968	1 pts		Stomatitis	grade 2				913
8969	2 pts		Stomatitis	grade 3				913
8970	1 pts		Rash	grade 1				913
8971	1 pts		Rash	grade 2				913
8972						No adverse effects leading to discontinuation were reported		919
8973						There were 2 adverse events, which were not serious, and 4 abnormal changes in clinical laboratory findings, which were slight and not serious, in a total of 3 cases.		918
8974						No AEs are reported		921
8975						No AEs are reported		922
8976			Dizziness					920
8977			Stomach cramps					920
8978			Delusions					920
8979			Atopic dermatitis		discontinuation			923
8980						No AEs were reported		924
8981	1 pts		Erythematous eruption		discontinuation			925
8982			International normalized ratio increased					926
8983			Drug eruption					927
8984	1 pts		Burning skin		discontinuation			928
8985			Cyanosis					930
8986			Gasping			OVERDOSAGE		931
8987			Blurred vision			OVERDOSAGE		931
8988			Cyanosis			OVERDOSAGE		931
8989			Cardio-respiratory distress			OVERDOSAGE		931
8990			Vertigo			OVERDOSAGE		929
8991			Tinnitus			OVERDOSAGE		929
8992			Temporal arteritis			OVERDOSAGE		929
8993			Headache dull			OVERDOSAGE		929
8994			Weakness			OVERDOSAGE		929
8995			Lightheadedness					933
8996			Dizziness					933
8997	1 pts		Thrombocytopenia	serious	discontinuation			934
8998			Nausea and vomiting					932
8999	2 pts		Apnoea			accidental intoxication		936
9000	2 pts		Cyanosis			accidental intoxication		936
9001	2 pts		Tachycardia			accidental intoxication		936
9002	2 pts		Flushing			accidental intoxication		936
9003	2 pts		Irritability			accidental intoxication		936
9004	1 pts		Hypotension					938
9005						impossible to link AEs with the definite dose: """""""""""""""".In the DH group, 36% of patients had a sedation problem, 16% had sleepiness (deep sedation) problem, and 1% had an excitement problem. The other 47% of patients reported no side effects.		937
9006	1 pts		Seizures	grade 5		suicide attempt		935
9007	1 pts		Cardiac dysrhythmias	grade 5		suicide attempt		935
9008			Contact dermatitis					939
9009			Contact dermatitis		discontinuation			942
9010			Leiomyosarcoma					940
9011	35		Diarrhoea					941
9012	55		Faecal incontinence					941
9013	15		Rash					941
9014			Skin discoloration			OVERDOSAGE		943
9015	1 pts		Nausea			One patient experienced nausea, diarrhea, 8-pound weight loss, and pain in hands and feet on DHC. The symptoms abated after DHC was stopped and did not return when it was restarted. Other patients have not experienced similar or other symptoms, other than occasional diarrhea, controlled by dose adjustment. There have been no other clinically significant side effects.		944
9016	1 pts		Diarrhea			One patient experienced nausea, diarrhea, 8-pound weight loss, and pain in hands and feet on DHC. The symptoms abated after DHC was stopped and did not return when it was restarted. Other patients have not experienced similar or other symptoms, other than occasional diarrhea, controlled by dose adjustment. There have been no other clinically significant side effects.		944
9017	1 pts		Weight loss			One patient experienced nausea, diarrhea, 8-pound weight loss, and pain in hands and feet on DHC. The symptoms abated after DHC was stopped and did not return when it was restarted. Other patients have not experienced similar or other symptoms, other than occasional diarrhea, controlled by dose adjustment. There have been no other clinically significant side effects.		944
9018	1 pts		Pain in hand			One patient experienced nausea, diarrhea, 8-pound weight loss, and pain in hands and feet on DHC. The symptoms abated after DHC was stopped and did not return when it was restarted. Other patients have not experienced similar or other symptoms, other than occasional diarrhea, controlled by dose adjustment. There have been no other clinically significant side effects.		944
9019			Contact dermatitis					945
9020			Epigastric pain			OVERDOSAGE		947
9021			Nausea			OVERDOSAGE		947
9022			Diarrhea			OVERDOSAGE		947
9023			Disturbance of liver function tests			OVERDOSAGE		947
9024			Injury to kidney			OVERDOSAGE		947
9025			Rhabdomyolysis			OVERDOSAGE		947
9026			Death			OVERDOSAGE		946
9027			Allergy			Among others patch testing revealed positive reaction to diperodon 1% in a man with developed pruritis ani afetr many topical applications and suppositories.		948
9028	100		Allergic contact dermatitis		discontinuation			949
9029	5.9		Vomiting					950
9030						No serious drug-related adverse events were reported.		952
9031						No adverse effects leading to discontinuation were reported		951
9032						No information on AE is provided		965
9033			Death	grade 5	discontinuation	leads to discontinuation		955
9034			Death	grade 5	discontinuation	leads to discontinuation		962
9035			Death	grade 5	discontinuation	leads to discontinuation		957
9036			Death	grade 5	discontinuation	leads to discontinuation		964
9037			Death	grade 5	discontinuation	leads to discontinuation		957
9038			Death	grade 5	discontinuation	leads to discontinuation		961
9039			Death	grade 5	discontinuation	leads to discontinuation		954
9040			Death	grade 5	discontinuation	leads to discontinuation		964
9041			Death	grade 5	discontinuation	leads to discontinuation		956
9042			Death	grade 5	discontinuation	leads to discontinuation		953
9043			Death	grade 5	discontinuation	leads to discontinuation		959
9044			Death	grade 5	discontinuation	leads to discontinuation		963
9045			Death	grade 5	discontinuation	leads to discontinuation		962
9046			Death	grade 5	discontinuation	leads to discontinuation		958
9047			Death	grade 5	discontinuation	leads to discontinuation		960
9048	5		Skin erythema desquamative			No severe side effects were reported. 5% of patients complained about erythema and desquamation during the treatment, evaluated as mild and transient.		966
9049	1 pts		Burning sensation					967
9050	2 pts		Erythema					967
9051			Allergic rash		discontinuation			968
9052	1.7		Leukocytopenia					969
9053	5.1		Anemia					969
9054	1.7		Nausea					969
9055	3.4		Elevated liver enzymes					969
9056	1.7		Oral ulceration					969
9057			Contact dematitis					970
9058						no AEs reported		971
9059			Allergic contact dermatitis		discontinuation			973
9060			Allergic contact dermatitis		discontinuation			972
9061			Pruritus					974
9062						No AEs are reported		976
9063	1 pts		Respiratory failure	acute	discontinuation	developed acute respiratory failure with intermittent arrest of breathing for up to 15 sec, in between sighing breaths and normal ones. For two weeks his mother had been taking pentoxyverine-containing cough drops for an upper respiratory tract infection.		975
9064	28.1		Tremor	slight				977
9065	3.5		Tremor	moderate				977
9066	17.5		Sweating	slight				977
9067	1.8		Sweating	moderate				977
9068	29.8		Nervousness	slight				977
9069	5.3		Nervousness	moderate				977
9070	8.8		Nervousness	extreme				977
9071	5.3		Faintness					977
9072			Skin irritation					978
9073			Contact dermatitis					980
9074			Contact dermatitis					979
9075			Cholestatic jaundice	mild	discontinuation			982
9076						No adverse reactions leading to discontinuation were reported		981
9077			Skin irritation	grade 1				983
9078			Photosensitivity					984
9079			Photosensitivity					985
9080			Photosensitivity					986
9081			Skin irritation	grade 1				987
9082	2		Dermatitis		discontinuation			988
9083	6.7		Application site erythema		discontinuation			989
9084	1		Aplastic anemia			A patient is described who appeared to be suffering from mercury intoxication caused by local application of merbromin to an operation wound and who developed aplastic anemia, which we ascribed to merbromin.		990
9085	8		Allergy			Description of eight allergy cases developed after topical application of mercurochrome, a 2% solution of merbromin.		991
9086	1 pts		Skin rash		discontinuation			993
9087	2 pts		Anemia					993
9088	1 pts		Diarrhea					993
9089	1 pts		Nausea					993
9090	1 pts		Headache					993
9091	3 pts		Aspartate aminotransferase increase					993
9092	3 pts		Alanine aminotransferase					993
9093	2 pts		Headache	mild				992
9094						No significant adverse effects were attributed to cefpirome		994
9095			Deliria		discontinuation			997
9096			Hallucination		discontinuation			997
9097			Confusion		discontinuation			997
9098			Deliria		discontinuation			996
9099			Excitement		discontinuation			996
9100						No adverse effects leading to discontinuation were reported.		995
9101			Paralytic ileus	grade 5				1002
9102			Abdominal distension		discontinuation	leads to dose reduction		998
9103			Dilated pupils			POISONING		1000
9104			Fever			POISONING		1000
9105	1 pts		Paralytic ileus			POISONING		1001
9106	1 pts		Hypotonic urinary bladder			POISONING		1001
9107	1 pts		Irritable			POISONING		999
9108	1 pts		Hypertonia			POISONING		999
9109	1 pts		Dilated pupils			POISONING		999
9110	0.34		Dyspepsia		discontinuation			1003
9111	0.34		Nausea		discontinuation			1003
9112	0.34		Abdominal pain		discontinuation			1003
9113	0.62		Pyrosis		discontinuation	at least possibly related to study medication		1004
9114	1.2		Epigastralgia		discontinuation	at least possibly related to study medication		1004
9115	0.62		Diarrhoea		discontinuation	at least possibly related to study medication		1004
9116	1.85		Gastralgia		discontinuation	at least possibly related to study medication		1004
9117	0.62		Haematocrit abnormal		discontinuation	at least possibly related to study medication		1004
9118	0.62		Hepatic enzymes increased		discontinuation	at least possibly related to study medication		1004
9119	0.62		Dyspnoea		discontinuation	at least possibly related to study medication		1004
9120	0.62		Abdominal pain		discontinuation	at least possibly related to study medication		1004
9121	0.62		Vertigo		discontinuation	at least possibly related to study medication		1004
9122	0.62		Erythema		discontinuation	at least possibly related to study medication		1004
9123	0.62		Melena		discontinuation	at least possibly related to study medication		1004
9124	0.62		Pruritis		discontinuation	at least possibly related to study medication		1004
9125			Gastric pain		discontinuation			1005
9126			Dyspepsia		discontinuation			1005
9127			Diarrhea		discontinuation			1005
9128			Headache		discontinuation			1005
9129						There were no adverse reactions or any aggravation of complications.		1006
9130			Liver disorder		discontinuation			1007
9131			Aplastic anemia		discontinuation			1007
9132			Peptic ulcer		discontinuation			1007
9133			Pancytopenia		discontinuation			1007
9134			Agranulocytosis		discontinuation			1007
9135			Nephrotic syndrome		discontinuation			1007
9136			Hemorrhagic colitis		discontinuation			1007
9137			Thrombocytopenia		discontinuation			1007
9138			Interstitial pneumonia		discontinuation			1007
9139						No adverse effects were recorded.		1008
9140						No adverse effects leading to discontinuation were reported.		1010
9141	0.42		Dizziness					1009
9142	0.04		Dizziness postural					1009
9143	0.32		Headache					1009
9144	0.17		Hot flushes					1009
9145	0.11		Palpitations					1009
9146	0.04		Edema					1009
9147	0.09		Edema peripheral					1009
9148						No adverse effects leading to discontinuation were reported.		1011
9149						No adverse effects leading to discontinuation were reported.		1012
9150						No AEs were reported		1013
9151						No AEs were reported		1014
9152	11 pts		Hepatotoxicity	severe	discontinuation			1015
9153	12		Liver disorder					1016
9154	4		Nausea					1016
9155	1.7		Drug fever		dose interruption			1017
9156	1.7		Oedema		dose interruption			1017
9157	1.7		Thrombocytopenia		dose interruption			1017
9158	13		Blurred vision					1018
9159			Nasal congestion					1018
9160			Increased salivation					1018
9161			Constipation					1018
9162	13		Galactorrhea					1018
9163			Drowsiness					1018
9164			Excitement					1018
9165			Dry mouth					1018
9166	4.3		Akathisia		discontinuation			1018
9167			Depression		discontinuation			1018
9168	4.3		Tremor		discontinuation			1018
9169			Death	grade 5				1020
9170						The source does not contain information about AEs or lack thereof		1021
9171						The source does not contain information about AEs or lack thereof		1019
9172						No serious drug-related adverse events occurred.		1023
9173	4.2		Taste changed		discontinuation			1022
9174	5 pts		Headache					1024
9175	6 pts		Tachycardia					1024
9176	5 pts		Postural hypotension					1024
9177	2 pts		Dizziness					1024
9178	2 pts		Asthenia					1024
9179	2 pts		Lacrimation					1024
9180						No adverse effects leading to discontinuation were reported		1025
9181	1 pts		Myasthenia		discontinuation	Myasthenia-like syndrome was suspected because of a probable overdose of cibenzoline and administration of cibenzoline was withdrawn.		1028
9182						No patients experienced serious adverse drug effects requiring discontinuation of anti-arrhythmic therapy		1031
9183	1 pts		Dry mouth		discontinuation			1029
9184	1 pts		Cardiac pain		discontinuation			1029
9185	1 pts		Dizziness		dose reduction			1030
9186	1 pts		Cardiac pain		dose interruption			1030
9187	1 pts		Abnormal vision		dose reduction			1030
9188	1 pts		Dry mouth			did not receive extended treatment		1027
9189	1 pts		Hypoglycemia	severe	discontinuation			1026
9190						No adverse effects were recorded.		1032
9191						No adverse effects leading to discontinuation were reported.		1033
9192			Nausea					1034
9193			Headache					1034
9194			Anxiety		discontinuation			1035
9195			Dizziness		discontinuation			1035
9196			Headache		discontinuation			1035
9197			Bronchial obstruction		discontinuation			1035
9198			Palpitations		discontinuation			1035
9199			Sleep disturbance		discontinuation			1035
9200	2.5		Hypokalaemia		discontinuation			1035
9201			Nausea		discontinuation			1035
9202			Tiredness		discontinuation			1035
9203			Sweating		discontinuation			1035
9204						No adverse effects leading to discontinuation were reported		1036
9205						No adverse reactions were observed in the indirect or direct monitoring studies		1037
9206	40		Supraventricular tachycardia					1039
9207	5		Chest tightness		discontinuation			1038
9208	5		Sinus tachycardia		discontinuation			1038
9209	5		Fatigue		discontinuation			1038
9210	5		Respiratory distress		discontinuation			1038
9211	7.9		Headache					1041
9212	3		Drowsiness					1041
9213	2.1		Dry mouth					1041
9214						No AEs were reported		1042
9215						No AEs were reported		1040
9216	0.5		Respiratory disorder		discontinuation	leads to discontinuation		1043
9217	1.1		Respiratory failure		discontinuation	leads to discontinuation		1043
9218	0.5		Toxic skin eruption		discontinuation	leads to discontinuation		1043
9219						No AEs were reported		1044
9220			Jaundice, unspecified, not of newborn	serious	discontinuation			1045
9221			Thrombocytopenia, unspecified	serious	discontinuation			1045
9222			Acute fulminant hepatitis	serious	discontinuation			1045
9223			Hepatic failure	serious	discontinuation			1045
9224	2.5		Headache	grade 3	discontinuation			1046
9225						Erdosteine was well tolerated and no treatment-related adverse event was reported.		1047
9226			Erythema annulare centrifugum		discontinuation			1049
9227			Excitation					1050
9228			Muscle weakness					1050
9229			Drowsiness					1050
9230			Hypotonia					1050
9231	8.3		Drowsiness		discontinuation			1048
9232	8.3		Gastralgia		discontinuation			1048
9233						No AEs were reported		1051
9234						No AEs were reported		1052
9235	2.5		Constipation					1053
9236			Unstable angina		discontinuation			1054
9237			Angina unstable		discontinuation			1054
9238			Acute myocardial infarction	grade 5				1054
9239	2 pts		Deterioration mental (NOS)					1055
9240			Headache	grade 1-2				1056
9241			Dizziness	grade 1-2				1056
9242			Pharyngitis	grade 1-2				1056
9243						The source does not contain information about AEs or lack thereof		1057
9244						The source does not contain information about AEs or lack thereof		1058
9245	0.7		Facial swelling		discontinuation			1059
9246	0.4		Dizziness	grade 1-2	discontinuation			1059
9247	0.4		Abdominal pain		discontinuation			1059
9248	1.1		Nausea		discontinuation			1059
9249	0.4		Chest pain		discontinuation			1059
9250	0.4		ALT increased		discontinuation			1059
9251	0.4		Flatulence		discontinuation			1059
9252	0.4		Dyspnea		discontinuation			1059
9253	0.4		Tachycardia		discontinuation			1059
9254	0.4		Vomiting		discontinuation			1059
9255	10		Hirsutism					1060
9256	10		Hoarseness					1060
9257			Weight gain					1060
9258			Seborrhea					1060
9259			Acne					1060
9260	9		Tremor			Digital tremor		1062
9261	11		Palpitations					1062
9262			Palpitation					1063
9263			Tremor muscle			Skeletal muscle tremor		1063
9264			Tachycardia			Occasionally		1063
9265			Palpitation			Occasionally		1061
9266			Tremor muscle			Skeletal muscle tremor		1061
9267			Tachycardia			Occasionally		1061
9268	33.3		Abdominal distension	grade 1				1064
9269	16.7		Nausea	grade 1				1064
9270			Drug-induced hepatitis	grade 3	discontinuation			1065
9271	16.7		Gastrointestinal disorder	grade 1	discontinuation			1066
9272			Dry mouth					1067
9273			Dry mouth					1069
9274			Leukocyturia					1069
9275			Tachyarrhythmia					1069
9276	8.9		Dry mouth		discontinuation			1068
9277			Hemolysis					1070
9278						No adverse effects leading to discontinuation were reported.		1071
9279	3.4		Heart failure					1073
9280	20.7		Hypotension					1073
9281	3.4		Bradycardia					1073
9282	3.4		Nausea					1073
9283	3.4		Chest discomfort					1073
9284	3.4		Liver function test increased					1073
9285						No adverse effects leading to discontinuation were reported.		1072
9286	3		Fatigue		discontinuation			1074
9287	1.7		Diarrhea					1076
9288	1.7		Dizziness					1076
9289	0.9		Dysuria					1076
9290	1.7		Dyspepsia					1076
9291	0.9		Abdominal pain					1076
9292	0.9		Colic renal					1076
9293	0.9		Faeces soft					1076
9294	0.9		Gastritis					1076
9295	5.1		Nausea					1076
9296	0.9		Toothache					1076
9297	0.9		Vomiting					1076
9298	2.6		Upper abdominal pain					1076
9299	6.8		Headache					1076
9300	3.4		Somnolence					1076
9301	0.8		Upper abdominal pain					1077
9302	4.2		Headache					1077
9303	0.8		Somnolence					1077
9304	0.8		Dizziness					1077
9305	0.8		Dysgeusia					1077
9306	1 pts		Consciousness loss					1075
9307						No SAEs were observed		1078
9308						No adverse effects leading to discontinuation were reported.		1079
9309	1 pts		Glutamic-oxaloacetic transaminase increased					1080
9310	1 pts		Alkaline phosphatase					1080
9311	1 pts		Glutamic-pyruvic transaminase increased					1080
9312	1 pts		Gamma glutamyl transpeptidase increased					1080
9313						The source does not contain information about AEs or lack thereof		1081
9314			Anaphylaxis					1083
9315	3.6		Dizziness	grade 2	discontinuation			1082
9316			Nausea					1082
9317	3.6		Drowsiness	grade 2	discontinuation			1082
9318			Headache					1082
9319			Diarrhea					1082
9320			Uric acid increased					1085
9321						AEs were not observed		1084
9322	1.7		Nausea		discontinuation			1087
9323	1.7		Joint pain		discontinuation			1087
9324	1.7		Vomiting		discontinuation			1087
9325	1.7		Other alteration of consciousness		discontinuation			1087
9326	1.7		Diarrhea		discontinuation			1087
9327	1.7		Abdominal pain		discontinuation			1087
9328	1.7		Hepatic disease		discontinuation			1087
9329	1.7		Pruritus		discontinuation			1087
9330			Hyperuricemia		discontinuation			1086
9331			Renal failure		discontinuation			1086
9332	0.75		Headache	grade 3	discontinuation			1089
9333	0.75		Headache		discontinuation			1089
9334	0.75		Hypotension	grade 3	discontinuation			1089
9335	0.75		Flushing		discontinuation			1089
9336	0.19		Tachycardia		discontinuation			1088
9337	0.38		Hypotension		discontinuation			1088
9338	0.19		Headache		discontinuation			1088
9339	0.01		Erythema	grade 3	discontinuation			1090
9340	0.01		Itching	grade 3	discontinuation			1090
9341	1 pts		Orthostatic hypotension		discontinuation			1091
9342	1 pts		Dizziness		discontinuation			1091
9343	1 pts		Palpitation		discontinuation			1091
9344						No adverse effects were recorded.		1092
9345						No major possible side effects of OLP, including arrhythmia or hypotension requiring the suspension of OLP administration, were observed in any of the patients		1093
9346	1		Menstruation abnormal		discontinuation			1094
9347	2		Exanthema		discontinuation			1094
9348						There were no premature withdrawals due to drug-related adverse reactions.		1096
9349	5.3		Somnolence					1095
9350	5.3		Cramps					1095
9351						No adverse effects leading to discontinuation were reported		1097
9352						No adverse effects were noted and no abnormal changes in vital signs or ECG were detected.		1098
9353						No serious adverse events were reported or observed.		1099
9354	12.5		Erythema		discontinuation			1100
9355	12.5		Erythema					1101
9356			Erythema			Erythema and hives:12.5%		1101
9357			Injection site irritation		discontinuation	Termination of the trial		1101
9358			Hives		discontinuation	Erythema and hives:12.5%		1101
9359			Injection site pain		discontinuation	Termination of the trial		1101
9360	0.7		Asthma	grade 3	discontinuation			1102
9361	1.4		Vomiting	grade 2	discontinuation			1102
9362	0.7		Akathisia	grade 2	discontinuation			1102
9363	2.9		Injection site erythema	grade 2	discontinuation			1102
9364	2.9		Injection site swelling	grade 2				1102
9365	0.7		ALT increased		discontinuation			1102
9366	0.7		AST increased		discontinuation			1102
9367	0.7		Dizziness		discontinuation			1102
9368	0.7		Convulsion	grade 2	discontinuation			1102
9369	0.7		Edema face	grade 2	discontinuation			1102
9370	0.7		Hypoesthesia	grade 2	discontinuation			1102
9371	0.7		Injection site phlebitis		discontinuation			1102
9372	0.7		Edema	grade 2	discontinuation			1102
9373	0.7		Discomfort		discontinuation			1102
9374	9 pts		Gastric pain					1104
9375	1 pts		Diarrhoea					1104
9376	2 pts		Vomiting					1104
9377	1 pts		Headache					1104
9378	1 pts		Dyspepsia					1104
9379						No AEs were observed		1103
9380	1 pts		Distress gastrointestinal	serious				1105
9381	3 pts		Blood alkaline phosphatase abnormal					1105
9382	3 pts		ALT increased					1105
9383	3 pts		Aspartate aminotransferase abnormal					1105
9384	3 pts		GGTP abnormal					1105
9385	1 pts		Seizure	serious				1105
9386						The source does not contain information about AEs or lack thereof		1107
9387						The source does not contain information about AEs or lack thereof		1106
9388	7.4		Heartburn	grade 1				1109
9389	1.8		Skin rash		discontinuation			1109
9390	1.8		Nausea	grade 1				1109
9391	13		Diarrhea	grade 1				1109
9392						The source does not contain information about AEs or lack thereof		1108
9393	15		Nausea					1111
9394	9		Vomiting					1111
9395	6		Salivary hypersecretion					1111
9396	9		Fatigue					1111
9397	6		Pyrexia					1111
9398	6		Bronchitis					1111
9399	6		Nasopharyngitis					1111
9400	27		Weight decreased					1111
9401	6		Weight increased					1111
9402	46		Decreased appetite					1111
9403	67		Somnolence					1111
9404	27		Ataxia					1111
9405	18		Hypotonia					1111
9406	15		Tremor					1111
9407	12		Dysarthria					1111
9408	27		Agitation					1111
9409	12		Insomnia					1111
9410	9		Aggression					1111
9411	< 1		Status epilepticus		discontinuation	leads to discontinuation		1110
9412	< 1		Drowsiness		discontinuation	leads to discontinuation		1110
9413	< 1		Balance impaired NOS		discontinuation	leads to discontinuation		1110
9414	< 1		Sialorrhea		discontinuation	leads to discontinuation		1110
9415						No patient had drug-related side effects.		1112
9416	30.8		Sedation	grade 3	discontinuation			1114
9417	30.8		Dizziness	grade 3	discontinuation			1114
9418			Delusion		discontinuation			1113
9419			Sudden onset of sleep		discontinuation			1113
9420			Neuroleptic malignant syndrome		discontinuation			1113
9421			Hallucination		discontinuation			1113
9422			Delirium		discontinuation			1113
9423	1.3		Angina pectoris		discontinuation			1116
9424						No adverse effects leading to discontinuation were reported		1115
9425						The patient remained almost asymptomatic		1117
9426	14.3		Extrapyramidal symptoms		discontinuation			1119
9427	14.3		Rigidity		discontinuation			1119
9428	12.5		Extrapyramidal symptoms		discontinuation			1118
9429	12.5		Sedation		discontinuation			1118
9430			Embolism					1121
9431			Cholecystitis					1121
9432	0.7		Bleeding vaginal		discontinuation			1121
9433			Drug-induced hepatitis		discontinuation			1122
9434	12		Uterine bleeding		dose reduction			1120
9435	1 pts		Weakness					1123
9436	0.07		ALT increased	grade 1-2				1124
9437	0.07		Vomiting	grade 1-2				1124
9438	0.07		Fatigue	grade 1-2				1124
9439	0.07		Nausea	grade 1-2				1124
9440	0.07		Syncope	grade 1-2				1124
9441	0.14		Constipation	grade 1-2				1124
9442	0.07		Abdominal distension	grade 1-2				1124
9443	0.14		Belching	grade 1-2				1124
9444	0.07		Chest pain	grade 1-2				1124
9445	0.07		Malaise	grade 1-2				1124
9446	0.07		Headache	grade 1-2				1124
9447	0.07		Esophageal acid reflux	grade 1-2				1124
9448	5.6		Constipation	grade 1-2				1125
9449	5.6		Headache	grade 1-2				1125
9450						No adverse effects leading to discontinuation were reported.		1127
9451	0.93		Palpitation		discontinuation			1129
9452	0.93		Flushing		discontinuation			1129
9453	0.93		Headache		discontinuation			1129
9454	0.93		Eyelid ptosis		discontinuation			1129
9455	0.93		Blurred vision					1129
9456	0.93		Nausea		discontinuation			1129
9457	0.93		Giddiness		discontinuation			1129
9458	0.93		Discomfort epigastric		discontinuation			1129
9459	0.93		General malaise		discontinuation			1129
9460	9		Postural hypotension	grade 3				1126
9461						No adverse effects leading to discontinuation were reported.		1128
9462						No AEs were observed		1131
9463						No AEs were observed		1132
9464	1 pts		Hypokalaemia					1130
9465	1 pts		Hypercalcaemia					1130
9466						AEs were not observed		1134
9467						AEs were not observed		1133
9468						The source does not contain information about AEs or lack thereof		1136
9469	50		Dizziness	grade 1				1135
9470	6 pts		Contact dematitis		discontinuation			1137
9471						No drug-treatment related effects were detected or reported.		1138
9472	1 pts		Oedema		discontinuation			1140
9473	2 pts		Diarrhoea					1140
9474	3 pts		Diarrhea	mild				1139
9475						No adverse effects leading to discontinuation were reported.		1141
9476	33		Cushingoid					1143
9477	20		Weight increased					1143
9478	14		Increased appetite					1143
9479	12		Upper respiratory tract infection					1143
9480	12		Cough					1143
9481	12		Pollakiuria					1143
9482	10		Nasopharyngitis					1143
9483	10		Hirsutism					1143
9484	10		Central obesity					1143
9485	8		Erythema					1143
9486	8		Irritability					1143
9487	8		Rhinorrhea					1143
9488	6		Abdominal discomfort					1143
9489	60		Cushingoid					1144
9490	35		Hirsutism					1144
9491	28		Weight increased					1144
9492	28		Erythema					1144
9493	25		Central obesity					1144
9494	18		Abdominal pain					1144
9495	15		Pollakiuria					1144
9496	10		Constipation					1144
9497	10		Irritability					1144
9498	9		Abnormal behavior					1144
9499	9		Pyrexia					1144
9500	7		Back pain					1144
9501	7		Rash					1144
9502	6		Contusion					1144
9503	6		Nausea					1144
9504	6		Psychomotor hyperactivity					1144
9505	6		Epistaxis					1144
9506	6		Skin striae					1144
9507	69		Cushingoid					1142
9508	49		Erythema					1142
9509	37		Hirsutism					1142
9510	34		Headache					1142
9511	32		Weight increased					1142
9512	15		Constipation					1142
9513	14		Abdominal pain upper					1142
9514	11		Skin striae					1142
9515	11		Acne					1142
9516	8		Abdominal discomfort					1142
9517						AEs were not observed		1146
9518						The source does not contain information about AEs or lack thereof		1145
9519						The source does not contain information about AEs or lack thereof		1147
9520						The source does not contain information about AEs or lack thereof		1148
9521			Drowsiness					1150
9522						No adverse effects leading to discontinuation were reported		1149
9523						No AEs were reported		1152
9524	1 pts		Anorexia					1151
9525	9 pts		Hypercalcemia					1151
9526						No AEs were reported		1154
9527						No AEs were reported		1153
9528	8 pts		Drowsiness					1155
9529						No adverse effects leading to discontinuation were reported		1156
9530	1.4		Nausea	grade 2	discontinuation			1157
9531	1.4		Headache	grade 2	discontinuation			1157
9532						No AEs were reported		1158
9533						AEs were not observed		1159
9534						No AEs were reported		1161
9535						No AEs were reported		1160
9536						No adverse effects leading to discontinuation were reported.		1162
9537						No adverse side effects were recorded.		1163
9538	7.1		Pseudomembranous colitis	grade 3	discontinuation	possibly related		1165
9539						No adverse effects leading to discontinuation were reported.		1164
9540						Bimosiamose was safe and well-tolerated.		1168
9541						No adverse effects leading to discontinuation were reported		1169
9542						No adverse effects leading to discontinuation were reported		1166
9543						No adverse event occurred in the group treatedwith  the  highest  dose  of  300 mg  Bimosiamose disodium.		1167
9544	6 pts		Agranulocytosis	severe	discontinuation			1170
9545						injection was well tolerated with no novel safety issues reported.		1171
9546	4 pts		Erythema		discontinuation	leads to discontinuation		1172
9547	4 pts		Blistering		discontinuation	leads to discontinuation		1172
9548	4 pts		Fatigue		discontinuation	leads to discontinuation		1172
9549	4 pts		Fever		discontinuation	leads to discontinuation		1172
9550	4 pts		Chills		discontinuation	leads to discontinuation		1172
9551	16.7		Weight gain					1173
9552						There was no evidence that gefarnate caused any side-effects.No haematological or biochemical abnormalities were recorded after treatment with gefarnate.		1174
9553	12.4		Breast tension					1175
9554	13.1		Headache					1175
9555	6		Nausea					1175
9556	8.4		Nervousness					1175
9557	2.9		Dizziness					1175
9558	3.9		Depression					1175
9559	5.8		Acne					1175
9560	1		Oedema					1175
9561	2 pts		Aspartate aminotransferase increased	grade 1				1179
9562	2 pts		Alanine aminotransferase increase	grade 1				1179
9563	1 pts		Nausea	grade 1				1179
9564	1 pts		Absolute neutrophil count	grade 1				1179
9565	2 pts		Absolute neutrophil count	grade 2				1179
9566	1 pts		Absolute neutrophil count	grade 3				1179
9567	1 pts		Platelet count decreased	grade 1				1179
9568	1 pts		Anemia	grade 2				1179
9569	3 pts		Aspartate aminotransferase increased	grade 1				1180
9570	3 pts		Alanine aminotransferase increase	grade 1				1180
9571	3 pts		Nausea	grade 1				1180
9572	2 pts		Vomiting	grade 1				1180
9573	1 pts		Mucositis	grade 1				1180
9574	1 pts		Mucositis	grade 2				1180
9575	1 pts		Absolute neutrophil count	grade 2				1180
9576	1 pts		Absolute neutrophil count	grade 3				1180
9577	1 pts		Absolute neutrophil count	grade 4				1180
9578	2 pts		Platelet count decreased	grade 1				1180
9579	1 pts		Anemia	grade 2				1180
9580	2 pts		Neutropenia	grade 4			TRUE	1180
9581	2 pts		Aspartate aminotransferase increased	grade 1				1176
9582	1 pts		Aspartate aminotransferase increased	grade 2				1176
9583	2 pts		Alanine aminotransferase increase	grade 1				1176
9584	1 pts		Alanine aminotransferase increase	grade 2				1176
9585	2 pts		Nausea	grade 1				1176
9586	1 pts		Vomiting	grade 1				1176
9587	1 pts		Vomiting	grade 2				1176
9588	1 pts		Mucositis	grade 1				1176
9589	2 pts		Mucositis	grade 2				1176
9590	2 pts		Absolute neutrophil count	grade 1				1176
9591	1 pts		Absolute neutrophil count	grade 2				1176
9592	1 pts		Absolute neutrophil count	grade 3				1176
9593	2 pts		Absolute neutrophil count	grade 4				1176
9594	1 pts		Platelet count decreased	grade 3				1176
9595	1 pts		Platelet count decreased	grade 4				1176
9596	2 pts		Thrombocytopenia	grade 4			TRUE	1176
9597	4 pts		Thrombocytopenia	grade 3			TRUE	1176
9598	1 pts		Anemia	grade 2			TRUE	1176
9599	2 pts		Anemia	grade 3			TRUE	1176
9600	21 pts		Nausea	grade 1-2				1182
9601	10 pts		Fatigue	grade 1-2				1182
9602	13 pts		WBC decreased	grade 1-2				1182
9603	15 pts		Phlebitis	grade 1-2				1182
9604	19 pts		Vomiting	grade 1-2				1182
9605	9 pts		Absolute neutrophil count	grade 1-2				1182
9606	9 pts		Platelet count decreased	grade 1-2				1182
9607	8 pts		Alkaline phosphatase	grade 1-2				1182
9608	6 pts		Transaminitis	grade 1-2				1182
9609	7 pts		RBC urine	grade 1-2				1182
9610	2 pts		Pain	grade 1-2				1182
9611	6 pts		Absolute neutrophil count	grade 3-4				1182
9612	7 pts		WBC decreased	grade 3-4				1182
9613	4 pts		Nausea	grade 3-4				1182
9614	3 pts		Vomiting	grade 3-4				1182
9615	1 pts		Platelet count decreased	grade 3-4				1182
9616	1 pts		RBC urine	grade 3-4				1182
9617	4 pts		Myelosuppression				TRUE	1181
9618	2 pts		Myelosuppression				TRUE	1177
9619	2 pts		Neutropenia	grade 3				1183
9620	2 pts		Neutropenia	grade 4				1183
9621	2 pts		Platelet count decreased	grade 4				1183
9622	1 pts		Platelet count decreased				TRUE	1183
9623	2 pts		Hemoglobin decreased	grade 3				1183
9624	2 pts		Neutropenia	grade 4				1178
9625	2 pts		Neutropenia				TRUE	1178
9626	2 pts		Platelet count decreased	grade 3				1178
9627	2 pts		Platelet count decreased				TRUE	1178
9628	3 pts		Hemoglobin decreased	grade 3				1178
9629	1 pts		Exfoliative dermatitis		discontinuation	leads to discontinuation		1185
9630	1 pts		Abdominal pain		discontinuation	leads to discontinuation		1184
9631	1 pts		Vomiting		discontinuation	leads to discontinuation		1184
9632	1 pts		Rash		discontinuation	leads to discontinuation		1184
9633	1 pts		Confused			leads to discontinuation		1184
9634	1 pts		Stevens-Johnson syndrome		discontinuation	leads to discontinuation		1186
9635	1 pts		Thrombocytosis					1187
9636	12.2		Taste abnormality			Anethole trithione		1193
9637	12.2		Diarrhea			Anethole trithione		1193
9638	12.2		Meteorism			Anethole trithione		1193
9639			Cheilitis					1190
9640	100		Flatulence			Anethole trithione		1188
9641	11.1		Gastrointestinal upset	grade 1		Anethole trithione		1189
9642	11.1		Diarrhea	grade 1		Anethole trithione		1189
9643	11.1		Flatulence			Anethole trithione		1189
9644			Contact dermatitis					1192
9645			Allergic contact dermatitis					1191
9646	0.8		Anorexia		discontinuation			1195
9647	0.8		Chills					1195
9648	0.8		Fever					1195
9649	2.3		Eruption		discontinuation			1195
9650	2		Serum transaminase increased		discontinuation	The causal relationship to aspoxicillin was considered uncertain		1194
9651						No AEs were observed		1196
9652						No adverse clinical effects were noted, and none of the subjects developed any laboratory abnormalities.		1197
9653	2 pts		Hepatotoxicity		discontinuation			1198
9654						There were no severe adverse events that required withdrawal from this study.		1199
9655	7.7		Nausea	grade 3				1201
9656	84.6		Thrombocytopenia	grade 1				1201
9657	7.7		Hypertension	grade 3				1201
9658	60		Thrombocytopenia	grade 2-3			TRUE	1200
9659						No adverse effects leading to discontinuation were reported; no DLTs		1202
9660			Lactic acidosis		discontinuation			1203
9661			Lactic acidosis	grade 5	discontinuation			1204
9662			Lactic acidosis	grade 5	discontinuation			1205
9663			Scalp irritation					1206
9664			Irritation skin			Hands irritation		1206
9665			Flaking skin					1206
9666			Stinging					1206
9667			Irritation of eyes					1206
9668						No AEs are reported		1207
9669			Leukocytopenia					1208
9670	16.7		Leukopenia					1209
9671	8.3		Thrombopenia					1209
9672	8.3		Anorexia					1209
9673	44.4		Fatigue	grade 4			TRUE	1213
9674	22.2		Leukopenia	grade 4			TRUE	1213
9675	11.1		Neutropenia	grade 4			TRUE	1213
9676	22.2		Febrile neutropenia	grade 4			TRUE	1213
9677	11.1		Anorexia	grade 4			TRUE	1213
9678	44.4		Diarrhea	grade 4			TRUE	1213
9679	11.1		Neurological symptoms NOS	grade 4			TRUE	1213
9680	22.2		Anemia	grade 4			TRUE	1212
9681	11.1		Neutropenia	grade 4			TRUE	1212
9682	11.1		Thrombocytopenia	grade 4			TRUE	1212
9683	11.1		Febrile neutropenia	grade 4			TRUE	1212
9684	33.3		Fatigue	grade 4			TRUE	1212
9685	22.2		Anorexia	grade 4			TRUE	1212
9686	11.1		Diarrhea	grade 4			TRUE	1212
9687	11.1		Mucositis	grade 4			TRUE	1212
9688	16.7		Neutropenia	grade 4			TRUE	1211
9689	33.3		Fatigue	grade 4			TRUE	1211
9690	16.7		Anorexia	grade 4			TRUE	1211
9691	33.3		Fatigue	grade 4			TRUE	1210
9692	33.3		Diarrhea	grade 4			TRUE	1210
9693	1		Anorexia	grade 3				1214
9694	0.7		Nausea and vomiting	grade 3				1214
9695	1		Diarrhea	grade 3				1214
9696	0.5		Skin disorder	grade 3				1214
9697	0.7		Respiratory symptom	grade 3				1214
9698	2.7		Leukocytopenia	grade 3				1214
9699	3.2		Hypochromia	grade 3				1214
9700	2.7		Neutropenia	grade 3				1214
9701	3.7		Thrombocytopenia	grade 3				1214
9702	1.2		Blood urea nitrogen increased	grade 3				1214
9703	0.2		Hematuria	grade 3				1214
9704	13.9		Bladder irritation					1216
9705	10.4		Flushing					1216
9706	7		Dizziness					1216
9707	6.1		Nausea					1216
9708	4.3		Fatigue					1216
9709	1.7		Thrombocytopenia					1216
9710	1.7		Appetite lost					1216
9711	1.7		Diarrhea					1216
9712	1.7		Defecation urgency					1216
9713	0.9		Hematuria					1216
9714	0.9		Gastric pain					1216
9715	0.9		Constipation					1216
9716	0.9		Angina					1216
9717	0.9		Antabuse effect					1216
9718			Leukoencephalopathy		discontinuation			1215
9719			Bradycardia					1217
9720			Vomiting					1217
9721			Hot flush					1217
9722			Sweating					1217
9723			Salivation					1217
9724			Hypotension					1217
9725						No adverse effects leading to discontinuation were reported		1218
9726			Pseudomembranous colitis			Potentially Fatal		1219
9727			Nephrotoxicity			Potentially Fatal		1219
9728						The source does not contain information about AEs or lack thereof		1221
9729	2.4		Nervousness					1220
9730	5		Nausea					1220
9731	2.4		Malaise					1220
9732	2.4		Insomnia					1220
9733	2.4		Headache					1220
9734	2.4		Vomiting					1220
9735	5		Dizziness					1220
9736	22		Arthralgia		discontinuation			1220
9737			Pyrexia		discontinuation			1222
9738			Skin eruption		discontinuation			1222
9739	6.25		Haemolysis		discontinuation			1223
9740	6.25		Urticaria		discontinuation			1223
9741	25		Fever		discontinuation			1223
9742						AEs were not observed		1224
9743			Abdominal pain		discontinuation			1226
9744			Dyspepsia		discontinuation			1226
9745			Nausea		discontinuation			1226
9746			Gastritis		discontinuation			1225
9747			Atrial flutter		discontinuation			1225
9748			Gastroesophageal reflux disease		discontinuation			1225
9749			Nausea		discontinuation			1225
9750			Enteritis		discontinuation			1225
9751			Contact dermatitis					1228
9752			Cushings syndrome		discontinuation			1229
9753						AEs were not observed		1227
9754						No adverse effects leading to discontinuation were reported		1231
9755			QT prolonged		discontinuation			1230
9756			Stupor					1233
9757			Miosis					1233
9758			Hypertension					1233
9759			Neuroleptic malignant syndrome					1232
9760	1 pts		Convulsions		discontinuation	leads to discontinuation. overdose without ill effects		1234
9761						The source does not contain information about AEs or lack thereof		1235
9762						No AEs were reported		1236
9763			Stomachache					1237
9764			Nausea					1237
9765			Hoarseness	grade 1-2				1238
9766			Hirsutism	grade 1-2				1238
9767						The source does not contain information about AEs or lack thereof		1240
9768						The source does not contain information about AEs or lack thereof		1239
9769	1 pts		Eruption					1241
9770						Reported adverse events (AEs) were generally mild, and nontreatment limiting. None of the AEs were associated with study drug use, since no difference was observed in the frequencies of any of the AEs reported between the placebo week (week 1) and any of the active drug weeks		1242
9771	5.3		Rash	grade 3	discontinuation			1243
9772	9		Liver function test abnormal		discontinuation			1245
9773	6		Epigastric pain		discontinuation			1245
9774	3		Gastric ulcer		discontinuation			1245
9775	5		Itching	grade 2	discontinuation			1244
9776	5		Skin eruption	grade 2	discontinuation			1244
9777	5		Headache	grade 2	discontinuation			1244
9778	5		Epigastric pain	grade 2	discontinuation			1244
9779	1 pts		Rash	severe	discontinuation			1247
9780	6 pts		Headaches					1247
9781	4 pts		Nausea					1247
9782	3 pts		Contact dermatitis		discontinuation			1246
9783	1 pts		Insomnia		discontinuation	leads to discontinuation		1250
9784	1 pts		Psychosis		discontinuation	leads to discontinuation		1250
9785	1 pts		Oliguria		discontinuation	leads to discontinuation		1250
9786	1 pts		Photosensitivity		discontinuation	leads to discontinuation		1250
9787	9 pts		Nausea		discontinuation	leads to discontinuation		1250
9788	2 pts		Dysgeusia					1248
9789	1 pts		Psychosis		discontinuation	leads to discontinuation		1248
9790	1 pts		Photosensitivity					1248
9791	8 pts		Vomiting					1248
9792	5 pts		Nausea		discontinuation	leads to discontinuation		1248
9793	1 pts		Hot flushes					1248
9794	2 pts		Sleeplessness					1248
9795	1 pts		Angina pectoris					1248
9796	1 pts		Eosinophilia					1248
9797	1 pts		Oliguria		discontinuation	leads to discontinuation		1249
9798	1 pts		Photosensitivity		discontinuation	leads to discontinuation		1249
9799	2 pts		Nausea					1249
9800	1 pts		Nausea		discontinuation	leads to discontinuation		1249
9801	2 pts		Vomiting					1249
9802	2 pts		Sleeplessness					1249
9803	3 pts		Nausea		discontinuation	leads to discontinuation		1251
9804	3 pts		Vomiting		discontinuation	leads to discontinuation		1251
9805	1 pts		Hot flushes					1251
9806	3 pts		Sleeplessness					1251
9807	1 pts		Sleeplessness		discontinuation	leads to discontinuation		1251
9808	25 pts		Nervous system disorders					1252
9809	7 pts		Gastrointestinal disorders		discontinuation	leads to discontinuation		1252
9810	7 pts		Gastrointestinal disorders		discontinuation	leads to discontinuation		1252
9811	25 pts		Gastrointestinal disorders					1252
9812						No severe adverse events were observed during follow-up.		1253
9813			Hypersensitivity		discontinuation			1254
9814						No significant side-effects or accompanying symptoms were observed in any of the cases.		1255
9815			Malaise					1256
9816						No AEs are reported		1257
9817						No AEs are reported		1258
9818						No AEs were reported		1259
9819						No AEs were reported		1260
9820	1 pts		Pruritus cutaneous		discontinuation			1261
9821	1 pts		Angioedema		discontinuation			1261
9822	1 pts		Urticaria					1261
9823						All side effects observed were mild		1262
9824						Reported adverse events were usually mild and transient, and there were no differences in adverse reaction rates related to gender, age, duration of therapy, or total daily dosage within the range of 5 to 20 mg. The most common adverse events include headache, flushing, nausea, palpitation, peripheral edema, and chest pain, all of which are possibly due to excessive vasodilatation.		1263
9825	0.3		Fatigue extreme		discontinuation			1265
9826	0.3		Nervousness		discontinuation			1265
9827	0.3		Nausea		discontinuation			1265
9828						The source does not contain information about AEs or lack thereof		1264
9829	1 pts		Dry skin					1266
9830	8.3		Itching		discontinuation			1267
9831						No adverse effects leading to discontinuation were reported		1268
9832			Hyponatremia		discontinuation			1269
9833			Hypokalemia		discontinuation			1269
9834						No adverse effects leading to discontinuation were reported		1270
9835						No serious AEs were reported.		1271
9836						The source does not contain information about AEs or lack thereof		1272
9837	11		Ventricular fibrillation			VF/TdP 11%		1273
9838	15		Non-sustained ventricular tachycardia			FPVC/NSVT 15%		1273
9839	15		Premature ventricular contractions			FPVC/NSVT 15%		1273
9840	1		Hypotension					1273
9841	11		Torsades de pointes			VF/TdP 11%		1273
9842			Auditory hallucinations		discontinuation			1274
9843			Disorientation		discontinuation			1274
9844						Side effects were not observed.		1276
9845	4.3		Headache		discontinuation			1275
9846						No AEs are reported		1279
9847	1 pts		Chest pain			POISONING		1277
9848	1 pts		Headache			POISONING		1277
9849	1 pts		Flushing			POISONING		1277
9850	1 pts		Shortness of breath			POISONING		1277
9851						No AEs are reported		1278
9852						No AEs were reported		1280
9853	9 pts		Fever					1282
9854	9 pts		Tachypnea					1282
9855	9 pts		Tachycardia					1282
9856	2 pts		Apnea	grade 5	discontinuation			1282
9857						No AEs are reported		1281
9858	1 pts		Metabolic acidosis	severe	discontinuation	POISONING		1283
9859	1 pts		Metabolic acidosis	severe	discontinuation	POISONING		1285
9860			Pulmonary edema					1286
9861			Pulmonary edema	grade 5				1284
9862			Congestion pulmonary	grade 5				1284
9863						No adverse events were serious or resulted in discontinuation		1287
9864						No adverse effects leading to discontinuation were reported		1288
9865	4.5		Vertigo					1289
9866	4.5		Headache					1289
9867	29.5		Drowsiness					1289
9868	29.5		Ataxia					1289
9869	2.27		Trance		discontinuation			1289
9870	2.27		Constipation		discontinuation			1289
9871	2.27		Erythematous rash		discontinuation			1289
9872	4.5		Anorexia					1289
9873	4.5		Dysarthria					1289
9874			Drowsiness					1290
9875			Depression					1290
9876	18.75		Rash					1290
9877	16.7		Headache					1290
9878	20.8		Dizziness					1290
9879	2		Rash		discontinuation			1292
9880						No adverse effects leading to discontinuation were reported		1293
9881			Myocardial infarct		discontinuation			1291
9882						None of the patients experienced any unwanted side effects.		1295
9883	1.35		Condition worsened		discontinuation			1296
9884			Gastrointestinal bleed		discontinuation			1294
9885			Toxic epidermal necrolysis		discontinuation			1294
9886			Peptic ulcer		discontinuation			1294
9887			Anaphylactoid shock		discontinuation			1294
9888			Nephrotic syndrome		discontinuation			1294
9889			Asthmatic attack		discontinuation			1294
9890			Acute renal failure		discontinuation			1294
9891			Mucocutaneous disorder		discontinuation	Mucocutaneous-ocular syndrome		1294
9892						There were no serious adverse events or sideeffects ofthe medication during the study		1297
9893						No subject experienced any adverse clinical effect associated with single-dose piperacillin-tazobactam administration.		1299
9894			Anaphylactic shock	grade 3-4	discontinuation			1298
9895			Anaphylactic reaction	grade 3-4	discontinuation			1298
9896			Diarrhea, Clostridium difficile		discontinuation			1298
9897			Anaphylactoid reaction	grade 3-4	discontinuation			1298
9898						5 drop-outs due to unspecified adverse events		1300
9899	2.3		Gastralgia		discontinuation			1301
9900	2.3		Flushing		discontinuation			1301
9901	4 pts		Tiredness					1302
9902	1 pts		Dizziness					1302
9903	1 pts		Feeling of relaxation					1302
9904	1 pts		Feeling of warmth					1302
9905	3 pts		Hepatitis		discontinuation			1303
9906						No adverse effects leading to discontinuation were reported.		1304
9907	1 pts		Headache	mild				1305
9908	1 pts		Chest ache					1305
9909						No adverse reactions leading to discontinuation were reported		1307
9910						No adverse reactions leading to discontinuation were reported		1306
9911	9.5		Diarrhea					1309
9912	5.28		Skin rash					1309
9913	6.33		Fever					1309
9914	7.39		Congestive cardiac failure					1309
9915	1.8		Dizziness					1308
9916	2.6		Aspartate aminotransferase increase					1308
9917	2.6		Gamma-glutamyltransferase increased					1308
9918	0.9		Platelet count increased					1308
9919	0.9		Fatigue					1308
9920	3.5		Nausea					1308
9921	3.3		Diarrhea					1308
9922	0.9		Vomiting					1308
9923	7		Alanine aminotransferase increase					1308
9924						No adverse effects leading to discontinuation were reported; no DLTs		1311
9925	100		Leukopenia	grade 3	discontinuation			1312
9926						Discontinuation of therapy was not required in any patient.		1310
9927	2		Transaminase glutamic-pyruvic increased					1313
9928	0.7		ALP increased					1313
9929	1.28		Rash					1313
9930	2.1		Eosinophilia					1313
9931	2		Transaminase glutamic-oxalacetic increased					1313
9932						None of the patients experienced adverse effects related to sulbutiamine.		1314
9933			Headache		discontinuation	On the evening of the ninth day of therapy, after 110 g had been given, the patient, who previously had been bearing up well under treatment, complained of severe headache and nausea. Sulfaguanidine therapy was withheld at this time.		1316
9934			Nausea		discontinuation	On the evening of the ninth day of therapy, after 110 g had been given, the patient, who previously had been bearing up well under treatment, complained of severe headache and nausea. Sulfaguanidine therapy was withheld at this time.		1316
9935			Anuria					1315
9936			Skin rash	severe	discontinuation			1319
9937			Itching	severe	discontinuation			1319
9938			Hepatitis	acute	discontinuation			1319
9939			Fever		discontinuation			1319
9940	33		Skin rash		discontinuation			1317
9941			Exfoliative dermatitis	grade 5	discontinuation			1318
9942			Headache					1320
9943			Skin rash					1320
9944			Leukopenia					1320
9945			Drug fever					1320
9946						No adverse effects leading to discontinuation were reported		1321
9947						No adverse reactions leading to discontinuation were reported		1322
9948	4 pts		Granulocytopenia	grade 4			TRUE	1324
9949	3 pts		Diarrhea	grade 3-4			TRUE	1323
9950	3 pts		Diarrhea	grade 3-4			TRUE	1327
9951	1 pts		Granulocytopenia	grade 4				1326
9952	1 pts		Nausea	grade 3				1326
9953	1 pts		Thrombocytopenia	grade 3				1326
9954	5 pts		Vomiting	grade 1-2				1326
9955	4 pts		Fatigue	grade 1-2				1326
9956	4 pts		Diarrhoea	grade 1-2				1326
9957	3 pts		Fatigue	grade 1-2				1325
9958	2 pts		Nausea	grade 1-2				1325
9959	3.2		Gastrin increased					1328
9960	1.5		Nausea		discontinuation			1329
9961	1.5		Stomach pain		discontinuation			1329
9962						No AEs were observed		1330
9963			Vertigo		discontinuation|dose reduction			1331
9964			Drowsiness		discontinuation|dose reduction			1331
9965			Dry mouth		discontinuation|dose reduction			1331
9966			Nausea		discontinuation|dose reduction			1331
9967			Itching		discontinuation|dose reduction			1331
9968			Appetite lost		discontinuation|dose reduction			1331
9969			Diarrhoea		discontinuation|dose reduction			1331
9970			Constipation		dose interruption|dose reduction			1331
9971						No adverse effects leading to discontinuation were reported.		1332
9972	1 pts		Jaundice		discontinuation	leads to discontinuation		1333
9973	1 pts		Pruritus		discontinuation	leads to discontinuation		1333
9974						No adverse effects leading to discontinuation are mentioned.		1334
9975	1 pts		Erythema multiforme		discontinuation			1336
9976	1 pts		Allergic contact dermatitis	severe	discontinuation			1337
9977	5 pts		Congenital hydrocephalus			was found in their children		1335
9978	1 pts		Hand-and-foot syndrome	grade 2				1345
9979	1 pts		Rash	grade 1				1345
9980	1 pts		Granulocytopenia	grade 1				1345
9981	2 pts		Granulocytopenia	grade 4			TRUE	1345
9982	1 pts		Platelet count decreased	grade 1				1345
9983	2 pts		Platelet count decreased	grade 3				1345
9984	2 pts		Mucositis	grade 3			TRUE	1343
9985	2 pts		Hand-and-foot syndrome	grade 3			TRUE	1343
9986	13		Mucositis	grade 3				1344
9987	6		Hand-and-foot syndrome	grade 3				1344
9988	4		Rash	grade 3				1344
9989	1 pts		Hematotoxicity		discontinuation	leads to discontinuation		1342
9990	1 pts		Skin toxicity		discontinuation	leads to discontinuation		1342
9991	3 pts		Hematotoxicity		discontinuation	leads to discontinuation		1338
9992	3 pts		Skin toxicity		discontinuation	leads to discontinuation		1338
9993	1 pts		Septic shock				TRUE	1338
9994	1 pts		Fatigue				TRUE	1338
9995	1 pts		Esophageal discomfort				TRUE	1338
9996	2 pts		Neutropenia	grade 3			TRUE	1341
9997	3 pts		Neutropenia	grade 4			TRUE	1341
9998	1 pts		Leukopenia	grade 4			TRUE	1341
9999	2 pts		Thrombocytopenia	grade 3			TRUE	1341
10000	1 pts		Anemia	grade 3			TRUE	1341
10001	1 pts		Neutropenic fever	grade 3			TRUE	1341
10002	4 pts		Neutropenia	grade 4			TRUE	1340
10003	1 pts		Leukopenia	grade 3			TRUE	1340
10004	1 pts		Thrombocytopenia	grade 3			TRUE	1340
10005	1 pts		Anemia	grade 3			TRUE	1340
10006	2 pts		Neutropenia	grade 3				1339
10007	1 pts		Neutropenia	grade 4				1339
10008	1 pts		Leukopenia	grade 3				1339
10009	1 pts		Leukopenia	grade 4				1339
10010						No adverse effects leading to discontinuation were reported		1346
10011						No AEs were reported		1347
10012						No toxic effects or side-effects were noted		1348
10013						The source does not contain information about AEs or lack thereof		1349
10014	5		Gastrointestinal upset					1350
10015						No AEs were reported		1351
10016						No AEs were reported		1352
10017			Palpitation					1354
10018			Increased thirst					1354
10019	1 pts		Urination difficulty					1354
10020						No AEs were reported		1353
10021						No AEs were reported		1355
10022						No adverse effects leading to discontinuation were reported		1356
10023						No adverse effects leading to discontinuation were reported		1357
10024	1 pts		Appetite lost					1359
10025	1 pts		Hyperactivity		discontinuation|dose reduction			1359
10026	2 pts		Irritability					1359
10027	5 pts		Drowsiness					1359
10028	2 pts		Drowsiness		dose reduction			1358
10029			Posterior capsule opacification		discontinuation			1360
10030			Ocular hypertension		discontinuation			1360
10031			Glaucoma					1360
10032						No AEs were reported		1361
10033	1 pts		Coma	grade 4	discontinuation			1362
10034						No AEs were reported		1363
10035	0.5		Allergy		discontinuation			1364
10036	4		Coronary insufficiency					1365
10037			General malaise					1365
10038			Chest tightness					1365
10039	8		Pain		discontinuation			1366
10040	4		Rash		discontinuation			1366
10041	4		Impotence		discontinuation			1366
10042	9		Nausea	grade 3			TRUE	1367
10043	9		Anorexia	grade 4			TRUE	1367
10044	9		Dehydration				TRUE	1367
10045	14.3		Hyperbilirubinemia	grade 2			TRUE	1368
10046	28.6		Fatigue	grade 3-4			TRUE	1368
10047	1.7		Leucopenia	grade 3-5		curated AEs are unlikely relates to gimeracil		1372
10048	6.7		Neutropenia	grade 3-5		curated AEs are unlikely relates to gimeracil		1372
10049	1.1		Febrile neutropenia	grade 3-5		curated AEs are unlikely relates to gimeracil		1372
10050	2.8		Anaemia	grade 3-5		curated AEs are unlikely relates to gimeracil		1372
10051	1.7		Thrombocytopenia	grade 3-5		curated AEs are unlikely relates to gimeracil		1372
10052	3.4		Stomatitis	grade 3-5		curated AEs are unlikely relates to gimeracil		1372
10053	1.4		Nausea	grade 3-5		curated AEs are unlikely relates to gimeracil		1372
10054	2		Vomiting	grade 3-5		curated AEs are unlikely relates to gimeracil		1372
10055	9.8		Decreased appetite	grade 3-5		curated AEs are unlikely relates to gimeracil		1372
10056	8.4		Diarrhoea	grade 3-5		curated AEs are unlikely relates to gimeracil		1372
10057	0.8		Constipation	grade 3-5		curated AEs are unlikely relates to gimeracil		1372
10058	1.4		Maculopapular rash	grade 3-5		curated AEs are unlikely relates to gimeracil		1372
10059	0.6		Weight loss	grade 3-5		curated AEs are unlikely relates to gimeracil		1372
10060	0.6		Dyspnea	grade 3-5		curated AEs are unlikely relates to gimeracil		1372
10061	35		Nausea	all grades		curated AEs are unlikely relates to gimeracil		1369
10062	32		Fatigue	all grades		curated AEs are unlikely relates to gimeracil		1369
10063	30		Diarrhoea	all grades		curated AEs are unlikely relates to gimeracil		1369
10064	17		Vomiting	all grades		curated AEs are unlikely relates to gimeracil		1369
10065	18		Anorexia	all grades		curated AEs are unlikely relates to gimeracil		1369
10066	17		Rash	all grades		curated AEs are unlikely relates to gimeracil		1369
10067	9.6		Diarrhoea	grade 3-5		curated AEs are unlikely relates to gimeracil		1369
10068	2.5		Nausea	grade 3-5		curated AEs are unlikely relates to gimeracil		1369
10069	2.5		Vomiting	grade 3-5		curated AEs are unlikely relates to gimeracil		1369
10070	2.5		Abdominal pain	grade 3-5		curated AEs are unlikely relates to gimeracil		1369
10071	1.9		Stomatitis	grade 3-5		curated AEs are unlikely relates to gimeracil		1369
10072	5.1		Dehydration	grade 3-5		curated AEs are unlikely relates to gimeracil		1369
10073	12.4		Anorexia	grade 3-4		curated AEs are unlikely relates to gimeracil		1370
10074	5.2		Hyponatraemia	grade 3-4		curated AEs are unlikely relates to gimeracil		1370
10075	5.6		Nausea	grade 3-4		curated AEs are unlikely relates to gimeracil		1370
10076	5.6		Neutrophil count decreased	grade 3-4		curated AEs are unlikely relates to gimeracil		1370
10077	12.8		Anaemia	grade 3-4		curated AEs are unlikely relates to gimeracil		1370
10078	0.9		Leucopenia	grade 3-4		curated AEs are unlikely relates to gimeracil		1370
10079	0.4		Neutropenic infection	grade 3-4		curated AEs are unlikely relates to gimeracil		1370
10080						No AEs are reported		1371
10081						No adverse effects were mentioned.		1373
10082	27		Nausea					1374
10083	18		Headache					1374
10084	5		Vomiting					1374
10085	6		Pain					1374
10086	0.002		Cardiac failure	grade 5	discontinuation			1375
10087	1 pts		Nystagmus					1377
10088						The side effects observed were few, mild in nature, and did not require a decrease in dose or withdrawal of treatment in any of the patients.		1376
10089	1		Eruption	grade 1				1378
10090	2		Diarrhea	grade 1-2				1378
10091	1		Hoarseness	grade 2				1378
10092						AEs were not observed		1379
10093						No adverse effects leading to discontinuation were reported.		1381
10094						No adverse effects leading to discontinuation were reported.		1380
10095			Lethargy					1383
10096	20		Ataxia					1383
10097	20		Dizziness					1383
10098						None of the events reported were considered to be clinically serious.		1382
10099			Delirium					1384
10100	83.3		Hallucination auditory					1384
10101			Hepatic failure	grade 3				1385
10102						No AEs were observed		1386
10103						No AEs were observed		1387
10104	13.6		Contact dematitis					1388
10105			Opioid abuse		discontinuation			1390
10106			Opioid type dependence		discontinuation			1390
10107			Withdrawal syndrome neonatal	grade 4	discontinuation			1390
10108			Respiratory depression	grade 3-5	discontinuation			1390
10109			Hyporeflexia		discontinuation			1389
10110			Renal failure	grade 1	discontinuation			1389
10111			Coma		discontinuation			1389
10112			Fever		discontinuation			1389
10113			Disseminated intravascular coagulation		discontinuation			1389
10114			Hepatocellular injury		discontinuation			1389
10115						No adverse effects mentioned		1391
10116						No adverse effects leading to discontinuation were reported		1392
10117						No adverse effects leading to discontinuation were reported.		1393
10118						No adverse effects leading to discontinuation were reported.		1395
10119			Seizure	grade 5	discontinuation			1394
10120			Unconsciousness	grade 5	discontinuation			1394
10121			Coma	grade 5	discontinuation			1394
10122			Renal failure	grade 5	discontinuation			1394
10123	1.6		Upper abdominal pain		discontinuation			1396
10124						No adverse effects leading to discontinuation were reported.		1398
10125						No adverse effects were recorded.		1397
10126			Interstitial pneumonitis					1399
10127						No adverse effects leading to discontinuation were reported		1402
10128						The reported AE was mild or moderate in intensity and there were no SAEs, deaths or withdrawals.		1401
10129						The reported AE was mild or moderate in intensity and there were no SAEs, deaths or withdrawals.		1400
10130	5.3		ALT increased	grade 3	discontinuation			1404
10131	5.3		Hepatic failure	grade 5	discontinuation			1404
10132	5.3		Hyperglycemia	grade 5	discontinuation			1404
10133	5.3		Ketoacidosis	grade 5	discontinuation			1404
10134	5.3		Multi-organ failure	grade 5	discontinuation			1404
10135	5.3		AST increased	grade 3	discontinuation			1404
10136	16.7		Intracerebral hemorrhage	grade 5	discontinuation		TRUE	1405
10137	16.7		Acute renal failure	grade 5		possibly related		1405
10138	16.7		Hepatic failure	grade 5		possibly related		1405
10139	16.7		Headache	grade 3			TRUE	1403
10140	16.7		Myalgia	grade 3			TRUE	1403
10141	6.7		Diarrhea		discontinuation			1406
10142	5.3		Salivation					1407
10143	5.3		Drowsiness					1407
10144						No adverse effects leading to discontinuation were reported		1408
10145						The drug was well tolerated, without particular side effects, as revealed both by clinical and laboratory examination		1409
10146	8 pts		Diarrhea					1410
10147	3 pts		Stomachache					1410
10148	2 pts		Hemoglobin decreased					1410
10149	6 pts		Cold					1410
10150			Hypokalemia					1411
10151						No adverse effects leading to discontinuation were reported		1412
10152	4 pts		Neutropenia	grade 5	discontinuation			1413
10153			Granulocytopenia	severe	discontinuation			1414
10154	92		Blistering					1415
10155	23		Pain					1415
10156	46		Abnormal pigmentation					1415
10157						No significant toxicity (>grade 2) was observed that could be linked to lycopene ingestion.		1416
10158						No adverse effects leading to discontinuation were reported		1417
10159	100		Glycopenia			clinically intolerable dose		1421
10160			QT increased	grade 3			TRUE	1420
10161	16.7		Esophageal bleeding				TRUE	1422
10162	16.7		Gastric ulcer				TRUE	1422
10163	16.7		QT increased				TRUE	1419
10164	50		Nausea	grade 1-2				1418
10165	50		Vomiting	grade 1-2				1418
10166	45		Sweating			it was severe in 2 patients		1418
10167			Headache			OVERDOSAGE		1427
10168			Nausea			OVERDOSAGE		1427
10169			Weakness			OVERDOSAGE		1427
10170			Numbness of limbs			OVERDOSAGE		1427
10171			Eczema					1423
10172			Contact dermatitis					1425
10173			Allergic reaction					1426
10174			Photosensitivity					1424
10175			Contact dermatitis					1428
10176			Contact dermatitis					1429
10177	1.7		Burn					1430
10178	1.7		Redness					1430
10179	1.7		Itching					1430
10180	1.7		Urticaria					1430
10181	0.4		Urticaria		discontinuation			1430
10182	0.4		Skin irritation		discontinuation			1430
10183	0.4		Urticaria		discontinuation			1431
10184	0.4		Redness		discontinuation			1431
10185	0.4		Allergic reaction		discontinuation			1431
10186	2		Eczema			flare-up of the previous eczema		1432
10187			Contact dematitis					1433
10188			Goitre					1435
10189			Goitre					1434
10190	15 pts		Somnolence					1437
10191	12 pts		Dry mouth					1437
10192	6 pts		Malaise					1437
10193	5 pts		Constipation					1437
10194	5 pts		Anorexia					1437
10195	3 pts		Diarrhoea					1437
10196	2 pts		Depression					1437
10197	2 pts		Weight gain					1437
10198	1 pts		Mental confusion					1437
10199	1 pts		Postural hypotension					1437
10200	2 pts		Depression		discontinuation			1436
10201	2 pts		Tiredness		discontinuation			1436
10202	1 pts		Diarrhoea		discontinuation			1436
10203	1 pts		Rash		discontinuation			1436
10204	1 pts		Blackout		discontinuation			1436
10205			Coma	grade 1				1438
10206	1		Contact dermatitis					1439
10207	50		Diarrhea					1440
10208	16.7		Nausea					1440
10209			Metabolic disorder	grade 2	discontinuation	N-acetyl tyrosyluria		1441
10210	2.9		Contact dermatitis			patch test		1442
10211			Hypothyroidism					1443
10212	3.13		Application site discomfort		discontinuation	1 patient		1444
10213			Contact dermatitis		discontinuation	leads to discontinuation		1445
10214			Cardiopulmonary arrest	grade 5				1447
10215			Anisocoria					1448
10216						The source does not contain information about AEs or lack thereof		1446
10217			Anaphylaxis					1450
10218			Asthma		discontinuation			1449
10219			Contact dematitis					1451
10220						The source does not contain information about AEs or lack thereof		1452
10221						The source does not contain information about AEs or lack thereof		1454
10222	3.2		Irritation skin					1453
10223						No AEs were observed		1455
10224						No patients withdrew from the study.The majority of events were mild in severity, and none were considered to be definitely, probably or possibly related to the study medication. There were no treatment-emergent serious adverse events.		1456
10225			Drug-induced hepatitis		discontinuation			1458
10226			Contact dermatitis		discontinuation			1457
10227						No adverse effects leading to discontinuation were reported.		1459
10228						No adverse effects leading to discontinuation were reported		1460
10229	95		Allergic contact dermatitis					1461
10230	2 pts		Nausea	grade 2				1463
10231	4 pts		Diarrhea	grade 1				1463
10232	2 pts		Diarrhea	grade 2				1463
10233	1 pts		Vomiting	grade 1				1463
10234	3 pts		Nausea	grade 1				1463
10235	1 pts		Diarrhea	grade 2				1462
10236	12.5		Sensitization					1464
10237						No adverse effects leading to discontinuation were reported		1465
10238						No adverse effects were mentioned.		1466
10239			Exanthema					1467
10240	1.1		Asthma		discontinuation			1469
10241	3.4		Nausea		discontinuation			1469
10242	3.4		Vomiting		discontinuation			1469
10243						The source does not contain information about AEs or lack thereof		1468
10244	4.7		Hepatic impairment		discontinuation			1470
10245			Contact dermatitis		discontinuation			1471
10246						No adverse effects leading to discontinuation were reported.		1474
10247						No adverse effects leading to discontinuation were reported.		1473
10248						No adverse effects leading to discontinuation were reported.		1472
10249	47		Panic attacks					1476
10250			Panic reaction					1475
10251	2 pts		Transaminases increased	grade 3	discontinuation	leads to discontinuation		1479
10252	7		Asthenia	grade 2-4				1477
10253	7		Pain	grade 2-4				1477
10254	5		Headache	grade 2-4				1477
10255	4		Abdominal pain	grade 2-4				1477
10256	3		Back pain	grade 2-4				1477
10257	3		Chest pain	grade 2-4				1477
10258	2		Fever	grade 2-4				1477
10259	11		Diarrhea	grade 2-4				1477
10260	8		Nausea	grade 2-4				1477
10261	4		Vomiting	grade 2-4				1477
10262	3		Anorexia	grade 2-4				1477
10263	3		Dyspepsia	grade 2-4				1477
10264	3		Flatulence	grade 2-4				1477
10265	2		Pneumonia	grade 2-4				1477
10266	4		Depression	grade 2-4				1477
10267	3		Insomnia	grade 2-4				1477
10268	3		Peripheral neuropathy	grade 2-4				1477
10269	1		Dizziness	grade 2-4				1477
10270	5		Rash	grade 2-4				1477
10271	3		Sweating	grade 2-4				1477
10272	3		Myalgia	grade 2-4				1477
10273	2		Weight loss	grade 2-4				1477
10274	11		Asthenia	grade 2-4				1478
10275	12		Pain	grade 2-4				1478
10276	8		Headache	grade 2-4				1478
10277	7		Abdominal pain	grade 2-4				1478
10278	4		Back pain	grade 2-4				1478
10279	3		Chest pain	grade 2-4				1478
10280	4		Fever	grade 2-4				1478
10281	16		Diarrhea	grade 2-4				1478
10282	11		Nausea	grade 2-4				1478
10283	7		Vomiting	grade 2-4				1478
10284	4		Anorexia	grade 2-4				1478
10285	4		Dyspepsia	grade 2-4				1478
10286	4		Flatulence	grade 2-4				1478
10287	3		Pneumonia	grade 2-4				1478
10288	8		Depression	grade 2-4				1478
10289	4		Insomnia	grade 2-4				1478
10290	5		Peripheral neuropathy	grade 2-4				1478
10291	3		Dizziness	grade 2-4				1478
10292	7		Rash	grade 2-4				1478
10293	3		Sweating	grade 2-4				1478
10294	4		Myalgia	grade 2-4				1478
10295	4		Weight loss	grade 2-4				1478
10296	<1		Gastrointestinal disorder NOS	grade 2-4	discontinuation	leads to discontinuation		1478
10297	2		Anaphylaxis			WARNING		1480
10298	2		Dyspnea	severe		WARNING		1480
10299	2		Hypotension	severe		WARNING		1480
10300	2		Generalized urticaria	severe		WARNING		1480
10301	2		Angioedema	severe		WARNING		1480
10302	6 pts		Infection	below serious				1482
10303						No AEs are reported		1484
10304						No AEs are reported		1486
10305						No AEs are reported		1483
10306						No AEs are reported		1485
10307						No AEs are reported		1481
10308						No information on AE is provided		1487
10309	32 pts		Heavy menstrual bleeding	below serious				1492
10310	13 pts		Bleeding time prolonged	below serious				1492
10311	30 pts		Musculoskeletal pain	below serious				1492
10312	32 pts		Skin irritation	below serious				1492
10313	15 pts		Irritability	below serious				1492
10314	55 pts		Spotting menstrual	below serious				1492
10315	8 pts		Bloating	below serious				1492
10316	46 pts		Breast tenderness	below serious				1492
10317	12 pts		Fatigue	below serious				1492
10318			Flushing			Overdosage		1491
10319			Tiredness			Overdosage		1491
10320			Nasal congestion			Overdosage		1491
10321			Blood estradiol increased			Overdosage		1491
10322			Nasal congestion			Overdosage		1490
10323			Blood estradiol increased			Overdosage		1490
10324	0.5		Muscle spasm	grade 1	discontinuation			1488
10325	0.5		Dysuria	grade 3	discontinuation			1488
10326	0.5		Edema peripheral	grade 1	discontinuation			1489
10327	0.5		Headache	grade 1	discontinuation			1489
10328	0.5		Chloasma	grade 1	discontinuation			1489
10329	1 pts		Paget's disease	serious				1495
10330	1 pts		Sleep apnea	serious				1495
10331	1 pts		Lower urinary tract symptoms	below serious				1495
10332	1 pts		Hematocrit increased	below serious				1495
10333	1 pts		Application site reaction	below serious				1496
10334	1 pts		Allergic rhinitis	below serious				1496
10335	1 pts		Chronic obstructive pulmonary disease	serious				1498
10336	1 pts		Pneumonia	serious				1498
10337	1 pts		Asthma	below serious				1498
10338	1 pts		Sinus congestion	below serious				1498
10339	1 pts		Cardiac failure congestive	below serious				1498
10340	1 pts		Myocardial infarction	below serious				1498
10341	1 pts		Hyperparathyroidism	below serious				1498
10342	1 pts		Fungal skin infection	below serious				1498
10343	1 pts		Pneumonia	below serious				1498
10344	1 pts		Viral infection	below serious				1498
10345	1 pts		Dizziness	below serious				1498
10346	1 pts		Renal failure	below serious				1498
10347	1 pts		Hirsutism	below serious				1498
10348	1 pts		Anorexia nervosa	serious				1497
10349	2 pts		Gastrointestinal disorders	serious				1497
10350	3 pts		Oily skin	below serious				1497
10351	1 pts		Leukocytosis	serious				1494
10352	1 pts		Thrombotic thrombocytopenic purpura	serious				1494
10353	1 pts		Abdominal pain	serious				1494
10354	1 pts		Gastrointestinal disorders	serious				1494
10355	1 pts		Wound dehiscence	serious				1494
10356	1 pts		Platelet count decreased	serious				1494
10357	1 pts		Nasal congestion	serious				1494
10358	1 pts		Hypertension	serious				1494
10359	1 pts		Constipation	below serious				1494
10360	1 pts		Diarrhea	below serious				1494
10361	1 pts		Sinusitis	below serious				1494
10362	1 pts		Skin infection	below serious				1494
10363	2 pts		Wound infection	below serious				1494
10364	1 pts		Dehydration	below serious				1494
10365	1 pts		Arthritis	below serious				1494
10366	1 pts		Pain in extremity	below serious				1494
10367	1 pts		Peripheral sensory neuropathy	below serious				1494
10368	1 pts		Syncope	below serious				1494
10369	1 pts		Breast pain	below serious				1494
10370	1 pts		Dryness vaginal	below serious				1494
10371	13 pts		Hirsutism	below serious				1494
10372	1 pts		Pruritus	below serious				1494
10373	9 pts		Rash acneiform	below serious				1494
10374	6.5		Cardiac disorders					1499
10375	6.4		Atherosclerosis					1499
10376	5.6		Hematocrit increased		discontinuation	leads to discontinuation, TESTOSTERONE Enanthate		1493
10377	5.6		Hypertension		discontinuation	leads to discontinuation, TESTOSTERONE Enanthate		1493
10378	5.6		Prostate specific antigen increased		discontinuation	leads to discontinuation, TESTOSTERONE Enanthate		1493
10379			Tardive dyskinesia		discontinuation	WARNING		1501
10380			Neuroleptic malignant syndrome		discontinuation	WARNING. Potentially fatal		1501
10381			Fall		discontinuation	WARNING. Fluphenazine decanoate may cause somnolence, postural hypotension, motor and sensory instability, which may lead to falls and, consequently, fractures or other injuries.		1501
10382						No adverse reactions leading to discontinuation were reported		1500
10383	3.3		Akathisia		discontinuation			1502
10384	3.3		Dyskinesia		discontinuation			1502
10385	3.3		Hypertonia		discontinuation			1502
10386	3.3		Stupor		discontinuation			1502
10387						impossible to link AEs with the definite dose: Almost all AEs were mild to moderate, most commonly gastrointestinal disorders and flushing. One patient on the standard high dosehad a serious AE (relapse requiring plasmapheresis).		1504
10388						No AEs are reported		1505
10389						No AEs are reported		1503
10390	1 pts		Cheilitis	below serious				1509
10391	2 pts		Constipation	below serious				1509
10392	1 pts		Salivary hypersecretion	below serious				1509
10393	1 pts		Vomiting	below serious				1509
10394	2 pts		Malaise	below serious				1509
10395	1 pts		Thirst	below serious				1509
10396	1 pts		Fall	below serious				1509
10397	1 pts		Subcutaneous haematoma	below serious				1509
10398	1 pts		Blood pressure decreased	below serious				1509
10399	1 pts		Weight increased	below serious				1509
10400	1 pts		Increased appetite	below serious				1509
10401	1 pts		Arthralgia	below serious				1509
10402	1 pts		Osteoarthritis	below serious				1509
10403	3 pts		Akathisia	below serious				1509
10404	3 pts		Dystonia	below serious				1509
10405	1 pts		Headache	below serious				1509
10406	1 pts		Sedation	below serious				1509
10407	2 pts		Tremor	below serious				1509
10408	1 pts		Depressive symptom	below serious				1509
10409	1 pts		Insomnia	below serious				1509
10410	1 pts		Mania	below serious				1509
10411	1 pts		Pruritus	below serious				1509
10412	2 pts		Torsades de pointes	serious				1512
10413	13 pts		Electrocardiogram QTc interval prolonged	below serious				1512
10414				grade 5		WARNING		1508
10415			Foetal movement disorder			attempt to suicide		1511
10416			Foetal movement disorder					1511
10417	1 pts		Drowsiness			Poisoning		1510
10418	1 pts		Bradypsychia			Poisoning		1510
10419	1 pts		Resting tremor			Poisoning		1510
10420	1 pts		Alopecia areata		discontinuation	leads to discontinuation		1513
10421				grade 5		WARNING		1507
10422						No information on AE is provided		1506
10423	11 pts		Anorgasmia	below serious				1516
10424	7 pts		Myoclonus	below serious				1516
10425	9 pts		Tremor	below serious				1516
10426	1 pts		Agitation	below serious				1515
10427	1 pts		Taste altered	below serious				1515
10428	1 pts		Automobile accident	below serious				1515
10429	2 pts		Bilirubin total high	below serious				1515
10430	2 pts		Headache NOS	below serious				1515
10431	2 pts		Insomnia	below serious				1515
10432	1 pts		Generalized joint pain	below serious				1515
10433	4 pts		Sexual dysfunction	below serious				1515
10434	1 pts		Ankle sprain	below serious				1515
10435	1 pts		Vomiting	below serious				1515
10436	22 pts		Nausea	below serious				1514
10437	5 pts		Diarrhoea	below serious				1514
10438	5 pts		Fatigue	below serious				1514
10439	6 pts		Decreased appetite	below serious				1514
10440	10 pts		Somnolence	below serious				1514
10441	6 pts		Dizziness	below serious				1514
10442	18 pts		Libido decreased	below serious				1514
10443	14 pts		Orgasm abnormal	below serious				1514
10444	6 pts		Anxiety	below serious				1514
10445	6 pts		Insomnia	below serious				1514
10446	5 pts		Ejaculation delayed	below serious				1514
10447	1 pts		Lethargy					1518
10448	1 pts		Ataxia					1518
10449	1 pts		Nystagmus					1518
10450						impossible to link AEs with the definite dose		1517
10451						No AEs are reported		1520
10452	1 pts		Ischemic colitis			suicide attempt		1519
10453						No AEs are reported		1521
10454	1 pts		Acute respiratory failure			attempt to suicide		1528
10455	1 pts		Sinus bradycardia			attempt to suicide		1526
10456	1 pts		Hypotension	severe		attempt to suicide		1526
10457	1 pts		Encephalopathy					1529
10458	1 pts		Tonic seizures					1527
10459						No information on AE is provided		1525
10460			Hypotension	severe		WARNING		1524
10461			Cardiac arrhythmias			WARNING		1524
10462			Hypotension	severe		WARNING		1523
10463			Cardiac arrhythmias			WARNING		1523
10464			Nystagmus	grade 5				1522
10465			Ataxia	grade 5				1522
10466			Dysarthria	grade 5				1522
10467			Tremor	grade 5				1522
10468			Hyperreflexia	grade 5				1522
10469			Lethargy	grade 5				1522
10470			Slurred speech	grade 5				1522
10471			Blurred vision	grade 5				1522
10472			Nausea	grade 5				1522
10473			Vomiting	grade 5				1522
10474	8 pts		Dysgeusia	below serious				1532
10475	1 pts		Hypoaesthesia oral	below serious				1532
10476	2 pts		Disturbance in attention	below serious				1532
10477	3 pts		Throat irritation	below serious				1532
10478	10 pts		Dysgeusia	below serious				1534
10479	2 pts		Hypoaesthesia oral	below serious				1534
10480	3 pts		Dizziness	below serious				1534
10481	10 pts		Somnolence	below serious				1534
10482	16 pts		Dysgeusia	below serious				1535
10483	1 pts		Hypoaesthesia oral	below serious				1535
10484	3 pts		Oral discomfort	below serious				1535
10485	6 pts		Fatigue	below serious				1535
10486	1 pts		Disturbance in attention	below serious				1535
10487	10 pts		Somnolence	below serious				1535
10488	3 pts		Pharyngeal hypoaesthesia	below serious				1535
10489	2 pts		Hypotension	below serious				1535
10490	10 pts		Dysgeusia	below serious				1536
10491	15 pts		Sedation	below serious				1536
10492	1 pts		Gastroenteritis	serious				1533
10493	12 pts		Dysgeusia	below serious				1533
10494	12 pts		Dizziness	below serious				1533
10495	12 pts		Sedation	below serious				1533
10496	10 pts		CNS depression					1530
10497	10 pts		Sinus tachycardia					1530
10498	10 pts		Hypertension					1530
10499	10 pts		Hypothermia					1530
10500	6 pts		Generalized onset motor seizure					1530
10501	1 pts		Paroxysmal atrial tachycardia					1530
10502	2 pts		Renal insufficiency					1530
10503	14		Dysgeusia					1531
10504	12		Sedation					1531
10505	3		Throat irritation					1531
10506			Weight gain					1537
10507						No AEs are reported		1538
10508	10 pts		Cough	below serious				1540
10509	2 pts		Chest tightness	below serious				1540
10510	3 pts		Nausea	below serious				1540
10511	1 pts		Liver function test increased	below serious				1540
10512	3 pts		Sore throat	below serious				1540
10513	5 pts		Injection site erythema	below serious				1539
10514	1 pts		Tingling feet/hands		discontinuation	leads to discontinuation		1543
10515	1 pts		Nausea		discontinuation	leads to discontinuation		1543
10516	1 pts		Movement disorder NOS		discontinuation	leads to discontinuation		1543
10517	1 pts		Blurred vision		discontinuation	leads to discontinuation		1543
10518	3 pts		Bronchospasm		discontinuation	leads to discontinuation		1545
10519	1 pts		Hypotension		discontinuation	leads to discontinuation		1542
10520	1 pts		Tachycardia		discontinuation	leads to discontinuation		1542
10521	1 pts		Arrhythmia ventricular		discontinuation	leads to discontinuation		1542
10522	1 pts		Supraventricular arrhythmias		discontinuation	leads to discontinuation		1542
10523	1 pts		Motor unrest compulsive		discontinuation	leads to discontinuation		1542
10524	1 pts		Dyspnea		discontinuation	leads to discontinuation		1542
10525	1 pts		Circulatory collapse		discontinuation	leads to discontinuation		1544
10526	26 pts		Cough					1541
10527	26 pts		Painful respiration					1541
10528	26 pts		Throat irritation					1541
10529			Hypoglycemia					1548
10530			Restlessness					1548
10531			Sinus tachycardia					1548
10532			Agitation					1548
10533			Tremor NEC					1548
10534			Hypokalemia	grade 1				1548
10535			Tremor				TRUE	1546
10536	0.6		Pancreatic carcinoma		discontinuation			1547
10537	0.6		Papillary thyroid cancer		discontinuation			1547
10538	0.6		Gastrointestinal carcinoma		discontinuation			1547
10539	0.6		Exacerbation of asthma		discontinuation			1547
10540	28.6		Neutropenia	grade 4		The MTDs was defined as 175 mg/m2 in previously treated patients	TRUE	1550
10541	14.3		Neutropenia	grade 3		The MTDs was defined as 175 mg/m2 in previously treated patients	TRUE	1551
10542	25		Neutropenia	grade 3		The MTDs was defined as 220 mg/m2 in untreated patients	TRUE	1553
10543	25		Neutropenia	grade 4		The MTDs was defined as 220 mg/m2 in untreated patients	TRUE	1553
10544	14		Neutropenia	grade 4			TRUE	1552
10545	25		Neutropenia	grade 4			TRUE	1549
10546	12.5		Thrombocytopenia	grade 4			TRUE	1549
10547	12.5		Leukopenia	grade 4			TRUE	1549
10548	12.5		Diarrhea	grade 3			TRUE	1549
10549	12.5		Diarrhea	grade 4	discontinuation		TRUE	1549
10550	3		Nausea and vomiting		discontinuation			1555
10551	1		Fatigue		discontinuation			1555
10552	12		Leukopenia	grade 4			TRUE	1555
10553	25		Neutropenia	grade 4			TRUE	1555
10554	29		Leukopenia	grade 3			TRUE	1555
10555	20		Neutropenia	grade 3			TRUE	1555
10556	4		Thrombocytopenia	grade 4			TRUE	1555
10557	2		Neutropenic sepsis	grade 5	discontinuation			1555
10558	1		Bleeding	grade 5	discontinuation			1555
10559			Myelosuppression	severe	discontinuation	WARNING		1554
10560						No AEs were described		1557
10561						No AEs were reported		1556
10562			Cushing's syndrome		discontinuation			1559
10563						No patients were withdrawn from the study		1558
10564	1.1		Asthenia					1562
10565	1.1		Pain					1562
10566	3.4		Headache					1562
10567	2.3		Migraine					1562
10568	2.3		Dyspepsia					1562
10569	1.1		Gastrointestinal disorder					1562
10570	3.4		Nausea					1562
10571	1.1		Diarrhoea					1562
10572	1.1		Myalgia					1562
10573	1.1		Dizziness					1562
10574	1.1		Abnormal thinking					1562
10575						No serious AEs reported		1561
10576	4.6		Abdominal pain					1560
10577	3.4		Back pain					1560
10578	3.2		Headache					1560
10579	2.3		Nausea					1560
10580	2.1		Constipation					1560
10581	7.5		Abnormal liver function tests					1560
10582	3		ALT increased					1560
10583	3		CPK increased					1560
10584	3.4		AST increased					1560
10585	6.2		Respiratory disorder					1560
10586	2.3		Rhinitis					1560
10587	1.1		Urticaria					1560
10588	1.4		Rash					1560
10589	1 pts		Allergic reaction		discontinuation	leads to discontinuation	TRUE	1564
10590	1 pts		Intraocular pressure increased		discontinuation	leads to discontinuation		1564
10591			Glaucoma		discontinuation	WARNING		1563
10592			Posterior subcapsular cataract		discontinuation	WARNING		1563
10593			Motor tic			Dose was decreased from 15 mg/day to 12 and then 9 mg/day	TRUE	1571
10594			Lethargy		discontinuation			1565
10595			Tachycardia		discontinuation			1565
10596			Hypokalemia		discontinuation			1565
10597			Dyskinesia		discontinuation			1565
10598			Dystonia		discontinuation			1565
10599			Dyskinesia		discontinuation			1570
10600			Dystonia		discontinuation			1570
10601			Tremor		discontinuation			1570
10602			Diaphoresis		discontinuation			1570
10603			Tachycardia		discontinuation			1570
10604	0.9		Depressive symptom		discontinuation			1568
10605	0.9		Psychotic disorder		discontinuation			1568
10606	0.4		Anxiety		discontinuation			1568
10607	0.4		Insomnia		discontinuation			1568
10608	0.4		Agitation		discontinuation			1568
10609	0.4		Abnormal dreams		discontinuation			1568
10610	0.4		Libido decreased		discontinuation			1568
10611	0.4		Substance abuse		discontinuation			1568
10612	0.4		Suicidal ideation		discontinuation			1568
10613	0.4		Paranoid schizophrenia		discontinuation			1568
10614	0.9		Akathisia		discontinuation			1568
10615	0.9		Headache		discontinuation			1568
10616	0.4		Dystonia		discontinuation			1568
10617	0.4		Dizziness		discontinuation			1568
10618	0.4		Tardive dyskinesia		discontinuation			1568
10619	0.4		Dyskinesia		discontinuation			1568
10620	0.4		Oromandibular dystonia		discontinuation			1568
10621	0.4		Extrapyramidal disorder		discontinuation			1568
10622	0.9		Erectile dysfunction		discontinuation			1568
10623	0.4		Amenorrhea		discontinuation			1568
10624	0.4		Ejaculation failure		discontinuation			1568
10625	0.4		Galactorrhea		discontinuation			1568
10626	0.4		Gynecomastia		discontinuation			1568
10627	0.9		Injection site pain		discontinuation			1568
10628	0.4		Chest discomfort		discontinuation			1568
10629	0.9		Weight increased		discontinuation			1568
10630	0.4		Semen volume decreased		discontinuation			1568
10631			Loss of consciousness		discontinuation			1566
10632			Cerebrovascular disorder (NOS)		discontinuation	WARNING		1567
10633			Stroke		discontinuation	WARNING		1567
10634			Transient ischemic attack	grade 3-5	discontinuation	WARNING		1567
10635			Neuroleptic malignant syndrome		discontinuation	WARNING		1567
10636			QT interval prolonged		discontinuation	WARNING		1567
10637			Tardive dyskinesia		discontinuation	WARNING		1567
10638			Hyperglycemia		discontinuation	WARNING		1567
10639			Dyslipidemia		discontinuation	WARNING		1567
10640			Weight gain		discontinuation	WARNING		1567
10641			Hyperprolactinemia		discontinuation	WARNING		1567
10642			Intestinal stricture NOS		discontinuation	WARNING		1567
10643			Orthostatic hypotension		discontinuation	WARNING		1567
10644			Syncope		discontinuation	WARNING		1567
10645			Leukopenia		discontinuation	WARNING		1567
10646			Neutropenia		discontinuation	WARNING		1567
10647			Agranulocytosis		discontinuation	WARNING		1567
10648			Cognitive impairment		discontinuation	WARNING		1567
10649			Motor dysfunction NOS		discontinuation	WARNING		1567
10650			Seizures		discontinuation	WARNING		1567
10651			Cerebrovascular disorder (NOS)		discontinuation	WARNING		1569
10652			Stroke		discontinuation	WARNING		1569
10653			Transient ischemic attack		discontinuation	WARNING		1569
10654			Neuroleptic malignant syndrome		discontinuation	WARNING		1569
10655			QT interval prolonged		discontinuation	WARNING		1569
10656			Tardive dyskinesia		discontinuation	WARNING		1569
10657			Hyperglycemia		discontinuation	WARNING		1569
10658			Dyslipidemia		discontinuation	WARNING		1569
10659			Weight gain		discontinuation	WARNING		1569
10660			Hyperprolactinemia		discontinuation	WARNING		1569
10661			Seizures		discontinuation	WARNING		1569
10662			Orthostatic hypotension		discontinuation	WARNING		1569
10663			Syncope		discontinuation	WARNING		1569
10664			Leukopenia		discontinuation	WARNING		1569
10665			Neutropenia		discontinuation	WARNING		1569
10666			Agranulocytosis		discontinuation	WARNING		1569
10667			Cognitive impairment		discontinuation	WARNING		1569
10668			Motor dysfunction NOS		discontinuation	WARNING		1569
10669			Death					1572
10670			Hypotension					1573
10671	0.9		Bradycardia		discontinuation			1575
10672	1.8		Hypotension		discontinuation			1575
10673	0.9		Hypercapnia		discontinuation			1575
10674	1.8		Elevated triglycerides		discontinuation			1575
10675	0.9		Junctional bradycardia		discontinuation			1575
10676	2.7		Sinus bradycardia		discontinuation			1574
10677	1.8		Cardiac arrest		discontinuation			1574
10678	1.8		Hypotension		discontinuation			1574
10679	0.9		Hypercapnia		discontinuation			1574
10680	0.9		Cardiac function failure		discontinuation			1574
10681	8.2		Elevated triglycerides		discontinuation			1574
10682			Ventricular tachycardia			Overdosage		1577
10683			Grand mal seizure			Overdosage		1578
10684						No information on AE is provided		1576
10685	0.7		Pruritus	grade 1-3	discontinuation			1579
10686	0.4		Glossitis	grade 1-4	discontinuation			1579
10687	1.1		Dry cough	all grades	discontinuation			1579
10688	2		Dysphagia	grade 1-2	discontinuation			1580
10689	2		Hypotension	grade 1-2	discontinuation			1580
10690	10.5					The patient was stable the entire time and did not demonstrate any evidence of metronidazole toxicity		1585
10691	13.5		Nausea and vomiting				TRUE	1581
10692	12.8		Generalised onset motor seizure				TRUE	1581
10693	10.9		Neurotoxicity NOS				TRUE	1581
10694	14.5		Gastrointestinal toxicity				TRUE	1582
10695	13.7		Central nervous system toxicity				TRUE	1582
10696	9.6		Hepatotoxicity		discontinuation	leads to discontinuation		1584
10697	7.6					In this neonate, a I0-fold metronidazole overdose showed no serious adverse effects		1583
10698			Granulocytopenia		discontinuation			1589
10699						No AEs are reported		1588
10700						No AEs are reported		1587
10701						No AEs are reported		1586
10702			Cushing's syndrome		discontinuation			1592
10703						No adverse effects leading to discontinuation were mentioned		1590
10704						No adverse effects leading to discontinuation were mentioned		1591
10705	53.1		Fatigue					1593
10706	53.1		Visual disorders NEC					1593
10707	45.8		Muscular weakness					1593
10708	45.2		Nausea					1593
10709	44.7		Anorexia					1593
10710	36.3		Psychic disorder NOS					1593
10711	36.3		Abdominal pain					1593
10712	33		Dizziness					1593
10713	30.2		Bad dreams					1593
10714	25.1		Headache					1593
10715	22.9		Diarrhoea					1593
10716	22.3		Vomiting					1593
10717	5		Pain retrosternal					1593
10718			Color blindness acquired					1594
10719	10 pts		Flushing	below serious				1596
10720	2 pts		Diarrhea	below serious				1596
10721	1 pts		Nausea	below serious				1596
10722	1 pts		Joint pain	below serious				1596
10723			Hypotension	grade 3				1598
10724			Acute renal failure					1599
10725			Mental status changes					1599
10726			Fever					1599
10727			Microangiopathic hemolytic anemia					1599
10728			Thrombocytopenia					1599
10729			Coagulopathy					1599
10730			Hyperglycemia					1599
10731			AST increased					1599
10732			Creatine phosphokinase increased					1599
10733			Flushing	grade 3				1595
10734	14		Diarrhea					1597
10735	11		Nausea					1597
10736	9		Vomiting					1597
10737	8		Cough					1597
10738	55		Flushing					1597
10739	6		Flushing		discontinuation			1600
10740	2		Rash		discontinuation			1600
10741	2		Diarrhea		discontinuation			1600
10742	1		Nausea		discontinuation			1600
10743	1		Vomiting		discontinuation			1600
10744						impossible to link AEs with the definite dose		1602
10745						No information on AE is provided		1605
10746						No information on AE is provided		1604
10747						No information on AE is provided		1603
10748						No information on AE is provided		1601
10749	1 pts		Benign paroxysmal postural vertigo	serious				1606
10750	1 pts		Pre-syncope	below serious				1606
10751						No AEs are reported		1610
10752						No AEs are reported		1607
10753						No AEs are reported		1608
10754						accidentally. No AEs are reported		1609
10755	3 pts		Angina pectoris	serious				1613
10756	1 pts		Angina unstable	serious				1613
10757	3 pts		Atrial fibrillation	serious				1613
10758	2 pts		Cardio-respiratory arrest	serious				1613
10759	1 pts		Cor pulmonale	serious				1613
10760	3 pts		Coronary artery disease	serious				1613
10761	1 pts		Myocardial ischaemia	serious				1613
10762	1 pts		Vertigo	serious				1613
10763	1 pts		Iridocyclitis	serious				1613
10764	1 pts		Barrett's oesophagus	serious				1613
10765	1 pts		Diverticular perforation	serious				1613
10766	1 pts		Gastric ulcer haemorrhage	serious				1613
10767	1 pts		Gastritis erosive	serious				1613
10768	1 pts		Hiatus hernia	serious				1613
10769	1 pts		Intestinal perforation	serious				1613
10770	1 pts		Pancreatitis acute	serious				1613
10771	3 pts		Non-cardiac chest pain	serious				1613
10772	1 pts		Oedema peripheral	serious				1613
10773	1 pts		Cholecystitis	serious				1613
10774	1 pts		Bronchopneumonia	serious				1613
10775	1 pts		Clostridial infection	serious				1613
10776	1 pts		Clostridium difficile colitis	serious				1613
10777	1 pts		Gastroenteritis bacterial	serious				1613
10778	1 pts		Osteomyelitis	serious				1613
10779	1 pts		Osteotomy	serious				1613
10780	1 pts		Osteomyelitis acute	serious				1613
10781	1 pts		Postoperative wound infection	serious				1613
10782	3 pts		Sepsis	serious				1613
10783	1 pts		Urinary tract infection	serious				1613
10784	1 pts		Accidental overdose	serious				1613
10785	1 pts		Ankle fracture	serious				1613
10786	1 pts		Cervical vertebral fracture	serious				1613
10787	1 pts		Head injury	serious				1613
10788	1 pts		Incisional hernia	serious				1613
10789	1 pts		Open wound	serious				1613
10790	1 pts		Tibia fracture	serious				1613
10791	1 pts		Muscular weakness	serious				1613
10792	1 pts		Rotator cuff syndrome	serious				1613
10793	1 pts		Brain neoplasm	serious				1613
10794	1 pts		Metastases to lymph nodes	serious				1613
10795	1 pts		Oesophageal carcinoma	serious				1613
10796	1 pts		Squamous cell carcinoma	serious				1613
10797	1 pts		Throat cancer	serious				1613
10798	1 pts		Carotid artery disease	serious				1613
10799	1 pts		Headache	serious				1613
10800	1 pts		Ischaemic stroke	serious				1613
10801	1 pts		Sensory disturbance	serious				1613
10802	1 pts		Transient ischaemic attack	serious				1613
10803	2 pts		Major depression	serious				1613
10804	1 pts		Mental status changes	serious				1613
10805	1 pts		Nephropathy	serious				1613
10806	1 pts		Renal artery stenosis	serious				1613
10807	1 pts		Renal failure	serious				1613
10808	1 pts		Acute respiratory distress syndrome	serious				1613
10809	1 pts		Bronchiectasis	serious				1613
10810	1 pts		Hypoxia	serious				1613
10811	1 pts		Respiratory arrest	serious				1613
10812	1 pts		Urticaria	serious				1613
10813	1 pts		Aortic aneurysm	serious				1613
10814	1 pts		Hypertensive crisis	serious				1613
10815	1 pts		Hypotension	serious				1613
10816	2 pts		Iliac artery stenosis	serious				1613
10817	1 pts		Peripheral arterial occlusive disease	serious				1613
10818	43 pts		Bronchitis	below serious				1613
10819	38 pts		Nasopharyngitis	below serious				1613
10820	22 pts		Upper respiratory tract infection	below serious				1613
10821	35 pts		Headache	below serious				1613
10822						No adverse reactions leading to discontinuation were mentioned		1611
10823			Bronchospasm paradoxical	grade 4	discontinuation	WARNING		1612
10824	4 pts		Nausea	grade 1-2				1625
10825	3 pts		Fatigue	grade 1-2				1625
10826	3 pts		Diarrhea	grade 1-2				1625
10827	2 pts		Vomiting	grade 1-2				1625
10828	1 pts		Anorexia	grade 3			TRUE	1625
10829	1 pts		Dehydration	grade 3			TRUE	1625
10830	1 pts		Headache	grade 1-2				1625
10831	1 pts		Pyrexia	grade 1-2				1625
10832	1 pts		Diarrhea	grade 3-4				1625
10833	1 pts		Anorexia	grade 3-4				1625
10834	1 pts		Nausea	grade 1-2				1623
10835	2 pts		Fatigue	grade 1-2				1623
10836	1 pts		Diarrhea	grade 1-2				1623
10837	1 pts		Vomiting	grade 1-2				1623
10838	1 pts		Anorexia	grade 1-2				1623
10839	1 pts		Lethargy	grade 1-2				1623
10840	1 pts		Pyrexia	grade 1-2				1623
10841	3 pts		Nausea	grade 1-2				1624
10842	3 pts		Fatigue	grade 1-2				1624
10843	1 pts		Diarrhea	grade 1-2				1624
10844	2 pts		Anorexia	grade 1-2				1624
10845	3 pts		Fatigue	grade 1-2				1614
10846	1 pts		Nausea	grade 1-2				1614
10847	1 pts		Diarrhea	grade 1-2				1614
10848	1 pts		Anorexia	grade 1-2				1614
10849	2 pts		Lethargy	grade 1-2				1614
10850	1 pts		Headache	grade 1-2				1614
10851	1 pts		Dehydration	grade 3			TRUE	1614
10852	1 pts		Hyponatremia	grade 3			TRUE	1614
10853	7 pts		Nausea	grade 1-2				1621
10854	2 pts		Fatigue	grade 1-2				1621
10855	4 pts		Diarrhea	grade 1-2				1621
10856	4 pts		Vomiting	grade 1-2				1621
10857	1 pts		Anorexia	grade 1-2				1621
10858	2 pts		Lethargy	grade 1-2				1621
10859	2 pts		Headache	grade 1-2				1621
10860	1 pts		Pyrexia	grade 1-2				1621
10861	1 pts		Chills	grade 1-2				1621
10862	1 pts		Proteinuria	grade 1-2				1621
10863	1 pts		Nausea	grade 3-4				1621
10864	1 pts		Vomiting	grade 3-4				1621
10865	1 pts		Tumor lysis syndrome	grade 3			TRUE	1621
10866	4 pts		Nausea	grade 1-2				1619
10867	1 pts		Fatigue	grade 1-2				1619
10868	3 pts		Diarrhea	grade 1-2				1619
10869	2 pts		Vomiting	grade 1-2				1619
10870	2 pts		Anorexia	grade 1-2				1619
10871	2 pts		Lethargy	grade 1-2				1619
10872	1 pts		Headache	grade 1-2				1619
10873	1 pts		Pyrexia	grade 1-2				1619
10874	3 pts		Chills	grade 1-2				1619
10875	2 pts		Proteinuria	grade 1-2				1619
10876	1 pts		Anorexia	grade 3-4				1619
10877	1 pts		Lethargy	grade 3-4				1619
10878	1 pts		Proteinuria	grade 3-4				1619
10879	3 pts		Rash	grade 2			TRUE	1619
10880	3 pts		Lethargy	grade 3			TRUE	1619
10881	1 pts		Bleeding time prolonged	grade 3			TRUE	1619
10882	1 pts		Hypocalcemia	grade 3			TRUE	1619
10883	2 pts		Nausea	grade 1-2				1622
10884	4 pts		Anorexia	grade 1-2				1622
10885	1 pts		Fatigue	grade 1-2				1622
10886	1 pts		Diarrhea	grade 1-2				1622
10887	2 pts		Lethargy	grade 1-2				1622
10888	1 pts		Vomiting	grade 1-2				1622
10889	2 pts		Headache	grade 1-2				1622
10890	4 pts		Nausea	grade 1-2				1620
10891	4 pts		Anorexia	grade 1-2				1620
10892	2 pts		Fatigue	grade 1-2				1620
10893	3 pts		Diarrhea	grade 1-2				1620
10894	3 pts		Lethargy	grade 1-2				1620
10895	3 pts		Vomiting	grade 1-2				1620
10896	2 pts		Rash	grade 1-2				1620
10897	1 pts		Pruritus	grade 1-2				1620
10898	1 pts		Anemia	grade 1-2				1620
10899	1 pts		Dyspnea	grade 1-2				1620
10900	1 pts		Proteinuria	grade 3-4				1620
10901	7 pts		Nausea	grade 1-2				1616
10902	9 pts		Anorexia	grade 1-2				1616
10903	8 pts		Fatigue	grade 1-2				1616
10904	6 pts		Diarrhea	grade 1-2				1616
10905	2 pts		Lethargy	grade 1-2				1616
10906	3 pts		Vomiting	grade 1-2				1616
10907	3 pts		Headache	grade 1-2				1616
10908	4 pts		Proteinuria	grade 1-2				1616
10909	3 pts		Rash	grade 1-2				1616
10910	2 pts		Pruritus	grade 1-2				1616
10911	2 pts		Anemia	grade 1-2				1616
10912	2 pts		Dyspnea	grade 1-2				1616
10913	1 pts		Fatigue	grade 3-4				1616
10914	1 pts		Lethargy	grade 3-4				1616
10915	1 pts		Dyspnea	grade 3-4				1616
10916	1 pts		Toxic myocarditis	grade 2			TRUE	1615
10917	1 pts		T wave inversion	grade 2			TRUE	1615
10918	1 pts		Cardiac troponin increased	grade 4			TRUE	1615
10919	6 pts		Dyspnea	grade 3			TRUE	1615
10920	6 pts		Constipation	grade 3			TRUE	1615
10921	6 pts		Proteinuria	grade 2			TRUE	1615
10922	6 pts		Fatigue	grade 4			TRUE	1615
10923	6 pts		Lethargy	grade 3			TRUE	1615
10924	2 pts		Nausea	grade 1-2				1618
10925	2 pts		Anorexia	grade 1-2				1618
10926	2 pts		Fatigue	grade 1-2				1618
10927	1 pts		Diarrhea	grade 1-2				1618
10928	1 pts		Headache	grade 1-2				1618
10929	1 pts		Proteinuria	grade 1-2				1618
10930	1 pts		Pruritus	grade 1-2				1618
10931	1 pts		Anemia	grade 1-2				1618
10932	1 pts		Nausea	grade 3-4				1618
10933	1 pts		Rash	grade 3-4				1618
10934	1 pts		Fatigue	grade 3-4				1618
10935	3 pts		Nausea	grade 3			TRUE	1617
10936	3 pts		Fatigue	grade 3			TRUE	1617
10937	1 pts		Rash	grade 3			TRUE	1617
10938	1 pts		Proteinuria	grade 2			TRUE	1617
10939	16 pts		Fluid retention		discontinuation	leads to discontinuation		1632
10940	2 pts		Fatigue	grade 3-4			TRUE	1630
10941	2 pts		Asthenia	grade 3-4			TRUE	1630
10942	1 pts		Skin toxicity	grade 3-4			TRUE	1630
10943	1 pts		Nail toxicity	grade 3-4				1630
10944	1 pts		Diarrhea	grade 3-4			TRUE	1630
10945	1 pts		Alopecia	grade 2				1630
10946	2 pts		Leukopenia	grade 3				1630
10947	3 pts		Fatigue	grade 3-4			TRUE	1631
10948	3 pts		Asthenia	grade 3-4			TRUE	1631
10949			Hepatotoxicity	grade 5		WARNING		1629
10950			Hypersensitivity	severe	discontinuation	WARNING		1628
10951			Neutropenia	severe				1626
10952			Asthenia	mild				1626
10953			Epidermal and dermal conditions					1626
10954			Paresthesia	mild				1626
10955			Neutropenia	severe				1627
10956			Asthenia	mild				1627
10957			Epidermal and dermal conditions					1627
10958			Paresthesia	mild				1627
10959	7.4		Dermatitis contact					1633
10960	1.9		Skin atrophy					1633
10961	1.5		Rash					1633
10962	1.9		Upper respiratory tract infection					1633
10963	1.9		Folliculitis					1633
10964	1.1		Sinusitis					1633
10965	1.9		Excoriation					1633
10966	1.1		Skin abrasion					1633
10967	2.6		Application site pain					1633
10968	3 pts		Telangiectasia					1634
10969	4 pts		Skin atrophy					1634
10970	10 pts		Burning sensation					1634
10971	2 pts		Application site atrophy					1634
10972	2 pts		Headache					1634
10973			Cardiovascular risk		discontinuation	WARNINGS		1636
10974			Hyperkalemia		discontinuation	WARNINGS		1636
10975			Hepatic disease		discontinuation	WARNINGS		1636
10976			Blood pressure high		discontinuation	WARNINGS		1636
10977			Lipid metabolism disorder		discontinuation	WARNINGS		1636
10978			Headache		discontinuation	WARNINGS		1636
10979			Uterine bleeding		discontinuation	WARNINGS		1636
10980	1.6		Migraine headache		discontinuation			1635
10981	1		Nausea and vomiting		discontinuation			1635
10982	2.2		Menstrual irregularity		discontinuation	menstrual irregularities (including menometrorrhagia, menorrhagia, metrorrhagia and vaginal hemorrhage)		1638
10983	4.6		Nausea and vomiting		discontinuation			1637
10984	4.2		Menstrual irregularity		discontinuation	menstrual irregularity (including vaginal hemorrhage, menorrhagia, menstrual disorder, menstruation irregular and metrorrhagia)		1637
10985	1.8		Fatigue		discontinuation			1637
10986	1.4		Breast tenderness		discontinuation			1637
10987	1.4		Depression		discontinuation			1637
10988	1.1		Headache		discontinuation			1637
10989	1.1		Irritability		discontinuation			1637
10990	23 pts		Anaemia	serious				1639
10991	1 pts		Anaemia vitamin B12 deficiency	serious				1639
10992	1 pts		Anaemia haemolytic	serious				1639
10993	1 pts		Lymphadenopathy mediastinal	serious				1639
10994	1 pts		Neutropenia	serious				1639
10995	1 pts		Normochromic normocytic anaemia	serious				1639
10996	1 pts		Pernicious anaemia	serious				1639
10997	1 pts		Angina pectoris	serious				1639
10998	1 pts		Bradycardia	serious				1639
10999	1 pts		Sinus arrhythmia	serious				1639
11000	2 pts		Hydrocele	serious				1639
11001	1 pts		Phimosis	serious				1639
11002	1 pts		Vitello-intestinal duct remnant	serious				1639
11003	1 pts		Deafness bilateral	serious				1639
11004	1 pts		Sudden hearing loss	serious				1639
11005	4 pts		Vertigo	serious				1639
11006	3 pts		Vertigo positional	serious				1639
11007	1 pts		Adrenocortical insufficiency acute	serious				1639
11008	2 pts		Goitre	serious				1639
11009	2 pts		Angle closure glaucoma	serious				1639
11010	1 pts		Cataract	serious				1639
11011	1 pts		Corneal degeneration	serious				1639
11012	1 pts		Dacryostenosis acquired	serious				1639
11013	1 pts		Ischaemic optic neuropathy	serious				1639
11014	1 pts		Retinal detachment	serious				1639
11015	1 pts		Visual acuity reduced	serious				1639
11016	2 pts		Abdominal hernia	serious				1639
11017	1 pts		Abdominal pain	serious				1639
11018	4 pts		Abdominal pain upper	serious				1639
11019	1 pts		Abdominal wall haematoma	serious				1639
11020	1 pts		Anal fissure	serious				1639
11021	1 pts		Change of bowel habit	serious				1639
11022	2 pts		Colitis	serious				1639
11023	1 pts		Colonic fistula	serious				1639
11024	1 pts		Colonic pseudo-obstruction	serious				1639
11025	4 pts		Constipation	serious				1639
11026	1 pts		Duodenal polyp	serious				1639
11027	5 pts		Duodenal ulcer	serious				1639
11028	1 pts		Dyspepsia	serious				1639
11029	1 pts		Gastric polyps	serious				1639
11030	10 pts		Gastritis	serious				1639
11031	1 pts		Gastroduodenal ulcer	serious				1639
11032	1 pts		Gastroduodenitis haemorrhagic	serious				1639
11033	9 pts		Gastrooesophageal reflux disease	serious				1639
11034	1 pts		Haematochezia	serious				1639
11035	2 pts		Ileus	serious				1639
11036	12 pts		Hernia inguinal	serious				1639
11037	1 pts		Inguinal hernia, obstructive	serious				1639
11038	1 pts		Intestinal ischaemia	serious				1639
11039	1 pts		Large intestine perforation	serious				1639
11040	6 pts		Large intestine polyp	serious				1639
11041	2 pts		Mallory-Weiss syndrome	serious				1639
11042	2 pts		Melaena	serious				1639
11043	1 pts		Obstruction gastric	serious				1639
11044	1 pts		Oedema mouth	serious				1639
11045	1 pts		Oesophageal food impaction	serious				1639
11046	2 pts		Peptic ulcer	serious				1639
11047	2 pts		Peptic ulcer perforation	serious				1639
11048	1 pts		Rectal prolapse	serious				1639
11049	1 pts		Salivary gland calculus	serious				1639
11050	1 pts		Small intestinal haemorrhage	serious				1639
11051	8 pts		Small intestinal obstruction	serious				1639
11052	1 pts		Small intestinal perforation	serious				1639
11053	1 pts		Small intestinal ulcer haemorrhage	serious				1639
11054	1 pts		Tongue disorder	serious				1639
11055	4 pts		Umbilical hernia	serious				1639
11056	1 pts		Oesophageal varices	serious				1639
11057	1 pts		Varices oesophageal	serious				1639
11058	3 pts		Adverse drug reaction	serious				1639
11059	2 pts		Device dislocation	serious				1639
11060	1 pts		Device malfunction	serious				1639
11061	1 pts		Drug intolerance	serious				1639
11062	1 pts		Gait disturbance	serious				1639
11063	1 pts		Generalised oedema	serious				1639
11064	1 pts		Granuloma	serious				1639
11065	2 pts		Multi-organ failure	serious				1639
11066	1 pts		Puncture site haemorrhage	serious				1639
11067	1 pts		Pyrexia	serious				1639
11068	1 pts		Spinal pain	serious				1639
11069	1 pts		Submandibular mass	serious				1639
11070	1 pts		Bile duct stone	serious				1639
11071	1 pts		Biliary dyskinesia	serious				1639
11072	1 pts		Drug-induced liver injury	serious				1639
11073	1 pts		Hepatic congestion	serious				1639
11074	1 pts		Hepatic cyst	serious				1639
11075	1 pts		Hepatic failure	serious				1639
11076	2 pts		Hepatic function abnormal	serious				1639
11077	1 pts		Hepatitis	serious				1639
11078	1 pts		Hepatitis acute	serious				1639
11079	1 pts		Corneal graft rejection	serious				1639
11080	1 pts		Acute hepatitis B	serious				1639
11081	2 pts		Appendicitis perforated	serious				1639
11082	2 pts		Dengue fever	serious				1639
11083	6 pts		Diverticulitis	serious				1639
11084	3 pts		Gastroenteritis	serious				1639
11085	3 pts		Hepatitis C	serious				1639
11086	1 pts		Hepatitis E	serious				1639
11087	1 pts		Infected bites	serious				1639
11088	1 pts		Influenza	serious				1639
11089	1 pts		Laryngitis	serious				1639
11090	1 pts		Liver abscess	serious				1639
11091	1 pts		Lower respiratory tract infection	serious				1639
11092	1 pts		Mycetoma mycotic	serious				1639
11093	1 pts		Osteomyelitis	serious				1639
11094	2 pts		Otitis media chronic	serious				1639
11095	1 pts		Scrub typhus	serious				1639
11096	1 pts		Sialoadenitis	serious				1639
11097	1 pts		Sinusitis	serious				1639
11098	1 pts		Tooth abscess	serious				1639
11099	1 pts		Urosepsis	serious				1639
11100	1 pts		Viral infection	serious				1639
11101	1 pts		Abdominal wound dehiscence	serious				1639
11102	2 pts		Acetabulum fracture	serious				1639
11103	6 pts		Ankle fracture	serious				1639
11104	1 pts		Arthropod sting	serious				1639
11105	3 pts		Brain contusion	serious				1639
11106	1 pts		Burns second degree	serious				1639
11107	1 pts		Burns third degree	serious				1639
11108	1 pts		Chemical burns of eye	serious				1639
11109	1 pts		Delayed recovery from anaesthesia	serious				1639
11110	1 pts		Dislocation of vertebra	serious				1639
11111	5 pts		Femoral neck fracture	serious				1639
11112	3 pts		Fibula fracture	serious				1639
11113	4 pts		Foot fracture	serious				1639
11114	1 pts		Forearm fracture	serious				1639
11115	1 pts		Fracture	serious				1639
11116	1 pts		Fracture displacement	serious				1639
11117	5 pts		Head injury	serious				1639
11118	2 pts		Incisional hernia	serious				1639
11119	4 pts		Laceration	serious				1639
11120	1 pts		Ligament injury	serious				1639
11121	3 pts		Ligament rupture	serious				1639
11122	1 pts		Limb traumatic amputation	serious				1639
11123	4 pts		Lower limb fracture	serious				1639
11124	3 pts		Lumbar vertebral fracture	serious				1639
11125	1 pts		Mouth injury	serious				1639
11126	1 pts		Muscle injury	serious				1639
11127	1 pts		Near drowning	serious				1639
11128	2 pts		Patella fracture	serious				1639
11129	2 pts		Pelvic fracture	serious				1639
11130	1 pts		Periprosthetic osteolysis	serious				1639
11131	1 pts		Post procedural fistula	serious				1639
11132	1 pts		Prescribed overdose	serious				1639
11133	1 pts		Pulmonary contusion	serious				1639
11134	1 pts		Renal haematoma	serious				1639
11135	5 pts		Road traffic accident	serious				1639
11136	1 pts		Soft tissue injury	serious				1639
11137	5 pts		Spinal compression fracture	serious				1639
11138	1 pts		Sternal fracture	serious				1639
11139	1 pts		Haemorrhage subdural	serious				1639
11140	1 pts		Thoracic vertebral fracture	serious				1639
11141	1 pts		Tongue injury	serious				1639
11142	5 pts		Toxicity to various agents	serious				1639
11143	1 pts		Ulnar nerve injury	serious				1639
11144	4 pts		Wrist fracture	serious				1639
11145	1 pts		Anticoagulation drug level increased	serious				1639
11146	1 pts		Haemoglobin decreased	serious				1639
11147	1 pts		International normalised ratio increased	serious				1639
11148	1 pts		Decreased appetite	serious				1639
11149	8 pts		Hyperkalaemia	serious				1639
11150	2 pts		Hypochloraemia	serious				1639
11151	1 pts		Hypophagia	serious				1639
11152	2 pts		Ankle impingement	serious				1639
11153	2 pts		Arthralgia	serious				1639
11154	2 pts		Arthritis reactive	serious				1639
11155	6 pts		Back pain	serious				1639
11156	1 pts		Gouty arthritis	serious				1639
11157	1 pts		Haemarthrosis	serious				1639
11158	1 pts		Intervertebral disc compression	serious				1639
11159	8 pts		Intervertebral disc protrusion	serious				1639
11160	13 pts		Lumbar spinal stenosis	serious				1639
11161	1 pts		Myalgia	serious				1639
11162	1 pts		Osteitis	serious				1639
11163	52 pts		Osteoarthritis	serious				1639
11164	2 pts		Osteoporosis	serious				1639
11165	1 pts		Pain in extremity	serious				1639
11166	1 pts		Polymyalgia rheumatica	serious				1639
11167	1 pts		Arthropathy psoriatic	serious				1639
11168	4 pts		Spinal column stenosis	serious				1639
11169	7 pts		Osteoarthritis spinal	serious				1639
11170	2 pts		Spondylolisthesis	serious				1639
11171	2 pts		Trigger finger	serious				1639
11172	1 pts		Adenocarcinoma of appendix	serious				1639
11173	1 pts		Adenocarcinoma of the cervix	serious				1639
11174	1 pts		Adenoid cystic carcinoma	serious				1639
11175	1 pts		Adenolymphoma	serious				1639
11176	1 pts		Basosquamous carcinoma	serious				1639
11177	1 pts		Benign gastric neoplasm	serious				1639
11178	1 pts		Benign salivary gland neoplasm	serious				1639
11179	3 pts		Bile duct cancer	serious				1639
11180	15 pts		Bladder cancer	serious				1639
11181	1 pts		Bladder cancer recurrent	serious				1639
11182	1 pts		Bladder papilloma	serious				1639
11183	1 pts		Bone cancer	serious				1639
11184	1 pts		Bone neoplasm	serious				1639
11185	4 pts		Bowen's disease	serious				1639
11186	3 pts		Bronchial carcinoma	serious				1639
11187	1 pts		Central nervous system lymphoma	serious				1639
11188	2 pts		Cervix carcinoma	serious				1639
11189	1 pts		Cholesteatoma	serious				1639
11190	4 pts		Chronic lymphocytic leukaemia	serious				1639
11191	4 pts		Colon adenoma	serious				1639
11192	1 pts		Colon cancer stage I	serious				1639
11193	2 pts		Diffuse large B-cell lymphoma	serious				1639
11194	1 pts		Gallbladder cancer	serious				1639
11195	1 pts		Gastric adenoma	serious				1639
11196	5 pts		Gastric cancer	serious				1639
11197	1 pts		Gastric cancer stage IV	serious				1639
11198	1 pts		Gastrointestinal cancer metastatic	serious				1639
11199	1 pts		Gastrointestinal tract adenoma	serious				1639
11200	1 pts		Glioma	serious				1639
11201	2 pts		Hepatic cancer metastatic	serious				1639
11202	1 pts		Intraocular melanoma	serious				1639
11203	2 pts		Laryngeal squamous cell carcinoma	serious				1639
11204	1 pts		Leukaemia	serious				1639
11205	2 pts		Lip and/or oral cavity cancer	serious				1639
11206	1 pts		Lip squamous cell carcinoma	serious				1639
11207	1 pts		Lipoma	serious				1639
11208	6 pts		Adenocarcinoma lung	serious				1639
11209	1 pts		Lung adenocarcinoma stage IV	serious				1639
11210	1 pts		Adenocarcinoma lung stage IV	serious				1639
11211	3 pts		Lung carcinoma cell type unspecified stage IV	serious				1639
11212	1 pts		Lung squamous cell carcinoma stage III	serious				1639
11213	1 pts		Lymphocytic leukaemia	serious				1639
11214	10 pts		Malignant melanoma	serious				1639
11215	2 pts		Malignant neoplasm of ampulla of Vater	serious				1639
11216	1 pts		Meningioma	serious				1639
11217	2 pts		Metastases to bone	serious				1639
11218	1 pts		Metastases to liver	serious				1639
11219	1 pts		Metastases to spine	serious				1639
11220	1 pts		Metastatic bronchial carcinoma	serious				1639
11221	1 pts		Metastatic renal cell carcinoma	serious				1639
11222	1 pts		Metastatic squamous cell carcinoma	serious				1639
11223	3 pts		Myelodysplastic syndrome	serious				1639
11224	1 pts		Neuroendocrine carcinoma metastatic	serious				1639
11225	6 pts		Non-Hodgkin's lymphoma	serious				1639
11226	2 pts		Oesophageal adenocarcinoma	serious				1639
11227	1 pts		Ovarian granulosa-theca cell tumour	serious				1639
11228	8 pts		Pancreatic carcinoma	serious				1639
11229	1 pts		Plasmablastic lymphoma	serious				1639
11230	1 pts		Plasmacytoma	serious				1639
11231	1 pts		Pleural mesothelioma	serious				1639
11232	3 pts		Prostate cancer recurrent	serious				1639
11233	1 pts		Prostate cancer stage I	serious				1639
11234	1 pts		Rectal cancer metastatic	serious				1639
11235	1 pts		Rectosigmoid cancer	serious				1639
11236	7 pts		Renal cancer	serious				1639
11237	2 pts		Renal cancer metastatic	serious				1639
11238	3 pts		Renal cell carcinoma	serious				1639
11239	1 pts		Renal cell carcinoma recurrent	serious				1639
11240	1 pts		Renal cell carcinoma stage I	serious				1639
11241	1 pts		Renal cell carcinoma stage III	serious				1639
11242	1 pts		Renal oncocytoma	serious				1639
11243	1 pts		Retroperitoneal cancer	serious				1639
11244	2 pts		Squamous cell carcinoma of the tongue	serious				1639
11245	1 pts		T-cell prolymphocytic leukaemia	serious				1639
11246	2 pts		Thyroid cancer	serious				1639
11247	1 pts		Tonsil cancer	serious				1639
11248	1 pts		Tracheal cancer	serious				1639
11249	1 pts		Tracheal neoplasm	serious				1639
11250	7 pts		Transitional cell carcinoma	serious				1639
11251	1 pts		Urethral neoplasm	serious				1639
11252	1 pts		Basal ganglia haemorrhage	serious				1639
11253	1 pts		Brain injury	serious				1639
11254	1 pts		Cervicobrachial syndrome	serious				1639
11255	2 pts		Cognitive disorder	serious				1639
11256	1 pts		Complex partial seizures	serious				1639
11257	1 pts		Cubital tunnel syndrome	serious				1639
11258	2 pts		Dementia Alzheimer's type	serious				1639
11259	7 pts		Dizziness	serious				1639
11260	1 pts		Facial paresis	serious				1639
11261	1 pts		Hypersomnia	serious				1639
11262	3 pts		Lumbar radiculopathy	serious				1639
11263	1 pts		Myasthenia gravis	serious				1639
11264	1 pts		Myasthenia gravis crisis	serious				1639
11265	1 pts		Nerve root compression	serious				1639
11266	1 pts		Nervous system disorder	serious				1639
11267	1 pts		Neuralgia	serious				1639
11268	1 pts		Postictal state	serious				1639
11269	1 pts		Radiculitis lumbosacral	serious				1639
11270	1 pts		Retrograde amnesia	serious				1639
11271	1 pts		Delirium	serious				1639
11272	4 pts		Depression	serious				1639
11273	1 pts		Drug abuse	serious				1639
11274	1 pts		Drug dependence	serious				1639
11275	1 pts		Mental status changes	serious				1639
11276	1 pts		Nicotine dependence	serious				1639
11277	1 pts		Paranoid personality disorder	serious				1639
11278	2 pts		Suicidal ideation	serious				1639
11279	1 pts		Calculus bladder	serious				1639
11280	1 pts		Bladder calculus	serious				1639
11281	6 pts		Calculus ureteric	serious				1639
11282	3 pts		Hydronephrosis	serious				1639
11283	10 pts		Nephrolithiasis	serious				1639
11284	1 pts		Renal artery stenosis	serious				1639
11285	2 pts		Renal failure acute	serious				1639
11286	1 pts		Renal tubular necrosis	serious				1639
11287	1 pts		Tubulointerstitial nephritis	serious				1639
11288	1 pts		Urinary bladder polyp	serious				1639
11289	1 pts		Atrophic vulvovaginitis	serious				1639
11290	15 pts		Benign prostatic hyperplasia	serious				1639
11291	1 pts		Calculus prostatic	serious				1639
11292	1 pts		Epididymal cyst	serious				1639
11293	1 pts		Genital rash	serious				1639
11294	1 pts		Metrorrhagia	serious				1639
11295	1 pts		Pelvic floor muscle weakness	serious				1639
11296	1 pts		Prostatism	serious				1639
11297	1 pts		Prostatitis	serious				1639
11298	4 pts		Prostatomegaly	serious				1639
11299	1 pts		Uterine polyp	serious				1639
11300	1 pts		Uterovaginal prolapse	serious				1639
11301	1 pts		Haemorrhage vaginal	serious				1639
11302	8 pts		Asthma	serious				1639
11303	1 pts		Atelectasis	serious				1639
11304	1 pts		Chronic respiratory disease	serious				1639
11305	2 pts		Dyspnoea	serious				1639
11306	9 pts		Epistaxis	serious				1639
11307	1 pts		Hyperventilation	serious				1639
11308	1 pts		Idiopathic pulmonary fibrosis	serious				1639
11309	2 pts		Interstitial lung disease	serious				1639
11310	1 pts		Laryngeal cyst	serious				1639
11311	1 pts		Lung disorder	serious				1639
11312	1 pts		Orthopnoea	serious				1639
11313	4 pts		Pleural effusion	serious				1639
11314	1 pts		Pleuritic pain	serious				1639
11315	1 pts		Pulmonary arterial hypertension	serious				1639
11316	1 pts		Pulmonary embolism	serious				1639
11317	3 pts		Pulmonary oedema	serious				1639
11318	1 pts		Respiratory distress	serious				1639
11319	4 pts		Respiratory failure	serious				1639
11320	2 pts		Sleep apnoea syndrome	serious				1639
11321	1 pts		Stridor	serious				1639
11322	1 pts		Angioedema	serious				1639
11323	1 pts		Dermatitis psoriasiform	serious				1639
11324	1 pts		Eczema asteatotic	serious				1639
11325	1 pts		Hyperkeratosis	serious				1639
11326	1 pts		Lichen sclerosus	serious				1639
11327	1 pts		Pemphigoid	serious				1639
11328	1 pts		Pruritus	serious				1639
11329	1 pts		Rash	serious				1639
11330	1 pts		Angiodysplasia	serious				1639
11331	1 pts		Arteriovenous fistula	serious				1639
11332	1 pts		Deep vein thrombosis	serious				1639
11333	6 pts		Haematoma	serious				1639
11334	1 pts		Hypotension	serious				1639
11335	1 pts		Lymphocele	serious				1639
11336	1 pts		Lymphorrhoea	serious				1639
11337	1 pts		Temporal arteritis	serious				1639
11338	1 pts		Diarrhea	below serious				1640
11339	1 pts		AST increased	serious				1641
11340	5 pts		Dehydration	serious				1641
11341	1 pts		Fatigue	serious				1641
11342	7 pts		Fever	serious				1641
11343	1 pts		Hemorrhage gastrointestinal	serious				1641
11344	1 pts		Kidney infection	serious				1641
11345	1 pts		Device malfunction	serious				1641
11346	1 pts		Penicillin allergy	serious				1641
11347	1 pts		Peritoneal infection	serious				1641
11348	2 pts		Pulmonary effusion	serious				1641
11349	1 pts		Lung infection	serious				1641
11350	1 pts		Syncope	serious				1641
11351	1 pts		Thrombosis	serious				1641
11352	1 pts		Duodenal ulcer	serious				1641
11353	1 pts		Urinary tract infection	serious				1641
11354	5 pts		Vomiting	serious				1641
11355	4 pts		Wound infection	serious				1641
11356	1 pts		Wound complication	serious				1641
11357	8 pts		AST increased	below serious				1641
11358	1 pts		Constitutional syndrome	below serious				1641
11359	3 pts		Alkaline phosphatase increased	below serious				1641
11360	1 pts		Alkalosis metabolic	below serious				1641
11361	1 pts		Allergic rhinitis	below serious				1641
11362	1 pts		Anal fissure	below serious				1641
11363	5 pts		Ascites	below serious				1641
11364	5 pts		Back pain	below serious				1641
11365	1 pts		Bladder infection	below serious				1641
11366	1 pts		Sepsis	below serious				1641
11367	1 pts		Blurred vision	below serious				1641
11368	1 pts		Bronchospasm	below serious				1641
11369	1 pts		Catheter infection	below serious				1641
11370	1 pts		Colitis	below serious				1641
11371	3 pts		Confusion	below serious				1641
11372	7 pts		Constipation	below serious				1641
11373	2 pts		Dehydration	below serious				1641
11374	2 pts		Tooth infection	below serious				1641
11375	1 pts		Dry eye syndrome	below serious				1641
11376	1 pts		Dry mouth	below serious				1641
11377	9 pts		Edema limbs	below serious				1641
11378	6 pts		Pain in extremity	below serious				1641
11379	6 pts		Fatigue	below serious				1641
11380	1 pts		Gastrooesophageal reflux disease	below serious				1641
11381	2 pts		Hemorrhage gastrointestinal	below serious				1641
11382	1 pts		Headache	below serious				1641
11383	1 pts		Hot flashes	below serious				1641
11384	1 pts		Hyperglycemia	below serious				1641
11385	1 pts		Hypokalemia	below serious				1641
11386	1 pts		Hypothyroidism	below serious				1641
11387	3 pts		Insomnia	below serious				1641
11388	2 pts		Kidney infection	below serious				1641
11389	1 pts		Kidney pain	below serious				1641
11390	1 pts		Memory impairment	below serious				1641
11391	1 pts		Ear pain	below serious				1641
11392	2 pts		Anxiety	below serious				1641
11393	1 pts		Altered mood	below serious				1641
11394	2 pts		Muscle cramps	below serious				1641
11395	1 pts		Muscle spasm	below serious				1641
11396	17 pts		Nausea	below serious				1641
11397	1 pts		Sensory neuropathy	below serious				1641
11398	2 pts		Kidney stone	below serious				1641
11399	1 pts		Meningioma	below serious				1641
11400	1 pts		Temperature intolerance	below serious				1641
11401	4 pts		Oropharyngeal infections (SMQ)	below serious				1641
11402	1 pts		Photophobia	below serious				1641
11403	3 pts		Psychosis	below serious				1641
11404	2 pts		Respiratory infection	below serious				1641
11405	10 pts		Allergic rhinitis	below serious				1641
11406	1 pts		Seizure	below serious				1641
11407	1 pts		Shingles	below serious				1641
11408	1 pts		Shoulder pain	below serious				1641
11409	6 pts		Sinus infection	below serious				1641
11410	1 pts		Syncope	below serious				1641
11411	7 pts		Throat pain	below serious				1641
11412	1 pts		Tinnitus	below serious				1641
11413	1 pts		Infected toe	below serious				1641
11414	1 pts		Tonsillitis	below serious				1641
11415	1 pts		Upper respiratory infection	below serious				1641
11416	1 pts		Vaginal infection	below serious				1641
11417	1 pts		Blurred vision	below serious				1641
11418	3 pts		Voice alteration	below serious				1641
11419	15 pts		Weight gain	below serious				1641
11420	1 pts		Atrioventricular block first degree	serious				1642
11421	1 pts		Cholecystitis	serious				1642
11422	1 pts		Liver disorder	serious				1642
11423	1 pts		Bile duct stone	serious				1642
11424	1 pts		Hepatitis B	serious				1642
11425	2 pts		Sepsis	serious				1642
11426	1 pts		Blood bilirubin increased	serious				1642
11427	1 pts		Liver function test abnormal	serious				1642
11428	1 pts		Carotid bruit	serious				1642
11429	1 pts		Intervertebral disc disorder	serious				1642
11430	1 pts		Tumour of ampulla of Vater	serious				1642
11431	1 pts		Radiculopathy	serious				1642
11432	1 pts		Depression	serious				1642
11433	1 pts		Disorder peripheral vascular	serious				1642
11434	8 pts		Nasopharyngitis	below serious				1642
11435	1 pts		Acute myocardial infarction	serious				1643
11436	5 pts		Alanine aminotransferase	below serious				1643
11437	3 pts		Blood glucose decreased	below serious				1643
11438	4 pts		Haemoglobin decreased	below serious				1643
11439						suicide attempt		1645
11440	12.5		Vomiting					1644
11441						No AEs are reported		1646
11442			Dizziness		discontinuation			1647
11443	2.7		Syncope		discontinuation	1 patient		1648
11444	6.7		Dizziness		discontinuation			1651
11445	3.8		Asthenia		discontinuation			1651
11446	2		Somnolence		discontinuation			1651
11447	1.6		Chest pain		discontinuation			1651
11448	1.2		Headache		discontinuation			1651
11449	1.2		Dyspnea		discontinuation			1651
11450	1		Prostate carcinoma		discontinuation			1651
11451			Syncope			WARNINGS		1650
11452			Postural hypotension			WARNINGS		1650
11453			Priapism			WARNINGS		1650
11454						No adverse reactions leading to discontinuation were specifically mentioned in the label for MTD		1649
11455	0.5		Fever		discontinuation			1652
11456	1.1		Headache		discontinuation			1652
11457	0.5		Postural hypotension		discontinuation			1652
11458	0.5		Syncope		discontinuation			1652
11459	0.5		Nausea		discontinuation			1652
11460	2		Dizziness		discontinuation			1652
11461	0.5		Vertigo		discontinuation			1652
11462	0.5		Dyspnea		discontinuation			1652
11463	0.6		Blurred vision		discontinuation			1652
11464	0.6		Amblyopia		discontinuation			1652
11465	0.5		Urinary tract infection		discontinuation			1652
11466	1.6		Asthenia		discontinuation			1653
11467	1.3		Headache		discontinuation			1653
11468	1.4		Palpitations		discontinuation			1653
11469	0.5		Postural hypotension		discontinuation			1653
11470	0.5		Syncope		discontinuation			1653
11471	0.6		Tachycardia		discontinuation			1653
11472	0.8		Nausea		discontinuation			1653
11473	0.6		Peripheral edema		discontinuation			1653
11474	3.1		Dizziness		discontinuation			1653
11475	0.8		Paresthesia		discontinuation			1653
11476	0.6		Somnolence		discontinuation			1653
11477	0.9		Dyspnea		discontinuation			1653
11478	0.6		Nasal congestion		discontinuation			1653
11479	0.6		Blurred vision		discontinuation			1653
11480	8 pts		Facial swelling	below serious				1664
11481	1 pts		Depression	below serious				1663
11482	1 pts		Insomnia	below serious				1663
11483	1 pts		Oropharyngeal pain	below serious				1663
11484	1 pts		Paranasal sinus discomfort	below serious				1663
11485	1 pts		Sinus congestion	below serious				1663
11486	2 pts		Bleeding	below serious				1665
11487	1 pts		Perforation	below serious				1665
11488	1 pts		Cardiovascular collapse	grade 5		attempt to suicide		1657
11489	1 pts		Acidosis	grade 5		attempt to suicide		1657
11490	1 pts		Hypothermia	grade 5		attempt to suicide		1657
11491	1 pts		Cardiovascular collapse	grade 5		attempt to suicide		1658
11492	1 pts		Acidosis	grade 5		attempt to suicide		1659
11493	1 pts		Hypothermia	grade 5		attempt to suicide		1659
11494	1 pts		Polyuria					1656
11495	1 pts		Acidosis					1656
11496	1 pts		Acute respiratory distress syndrome	serious				1661
11497	1 pts		Tachypnea	serious				1661
11498	1 pts		Septic shock	serious				1661
11499	1 pts		Breathlessness	serious				1661
11500	1 pts		Wound sepsis	serious				1661
11501	1 pts		Septicemia	serious				1661
11502			Coronary thrombosis	serious|grade 5		WARNING		1655
11503			Myocardial infarction	serious|grade 5		WARNING		1655
11504			Stroke	serious|grade 5		WARNING		1655
11505			Mouth hemorrhage	serious|grade 5		WARNING		1655
11506			Stomach ulcer	serious|grade 5		WARNING		1655
11507			Perforation stomach	serious|grade 5		WARNING		1655
11508			Coronary thrombosis	serious|grade 5		WARNING		1654
11509			Myocardial infarction	serious|grade 5		WARNING		1654
11510			Stroke	serious|grade 5		WARNING		1654
11511			Mouth hemorrhage	serious|grade 5		WARNING		1654
11512			Stomach ulcer	serious|grade 5		WARNING		1654
11513			Perforation stomach	serious|grade 5		WARNING		1654
11514	2		Dizziness		discontinuation	leads to discontinuation		1660
11515	1 pts		Headache		discontinuation	leads to discontinuation		1660
11516	2 pts		Headache		discontinuation	leads to discontinuation		1662
11517			Cardiac neurosis			Overdosage		1667
11518			Myocardial infarction			Overdosage		1667
11519	2.3		Jitteriness		discontinuation			1669
11520	2.3		Headache		discontinuation			1669
11521	2.3		Myalgia		discontinuation			1669
11522	2.3		Thirst		discontinuation			1669
11523	2.3		Abdominal cramp		discontinuation			1669
11524	2.3		Dry skin		discontinuation			1669
11525	2.3		Fatigue		discontinuation			1669
11526	2.3		Dizziness		discontinuation			1669
11527	2.3		Diarrhea		discontinuation			1669
11528	2.3		Blepharitis		discontinuation			1669
11529	2.3		Menses irregular		discontinuation			1669
11530	2.3		Vomiting		discontinuation			1669
11531	3.3		Vomiting		discontinuation			1668
11532	3.1		Irritability	grade 2	discontinuation			1666
11533	1		Affect lability	grade 2	discontinuation			1666
11534	1		Initial insomnia	grade 3	discontinuation			1666
11535	1		Acrodermatitis	grade 2	discontinuation			1666
11536	3 pts		Insomnia	below serious				1673
11537			Depression		discontinuation			1670
11538			Urticaria		discontinuation			1671
11539			Excitation		discontinuation			1671
11540			Convulsions generalized			Overdosage		1672
11541			Tachycardia			Overdosage		1672
11542			Vasculitis cerebral			Overdosage		1672
11543	1 pts		Transfusion	serious				1674
11544	2 pts		Urination abnormal NOS	serious				1674
11545	1 pts		Lower extremity dysfunction	below serious				1674
11546	3 pts		Rash	below serious				1674
11547	3 pts		Hematuria	below serious				1674
11548	3 pts		Catheter site discomfort	below serious				1674
11549	1 pts		Vaginal yeast infection	below serious				1674
11550	1 pts		Hematoma infection	below serious				1674
11551			Pneumonia		discontinuation			1675
11552			Interstitial pneumonitis		discontinuation			1676
11553			Fibrosis					1676
11554	28		Nausea		discontinuation			1677
11555						No information on AE is provided		1678
11556			Nausea					1679
11557			Vomiting					1679
11558			Dizziness					1679
11559			Headaches					1679
11560			Depression mental					1679
11561			Confusion					1679
11562			Bone marrow depression					1679
11563	10 pts		Nausea	below serious				1682
11564	2 pts		Anxiety	below serious				1682
11565	8 pts		Nausea	below serious				1684
11566	5 pts		Decreased appetite	below serious				1684
11567	9 pts		Depression	below serious				1684
11568	7 pts		Nausea	below serious				1681
11569	4 pts		Dizziness	below serious				1681
11570	5 pts		Headache	below serious				1681
11571	3 pts		Headache	below serious				1685
11572	3 pts		Diarrhea	below serious				1685
11573	1 pts		Flu	below serious				1686
11574	8 pts		Abdominal discomfort	below serious				1683
11575	9 pts		Abdominal pain	below serious				1683
11576	6 pts		Diarrhoea	below serious				1683
11577	3 pts		Flatulence	below serious				1683
11578	1 pts		Haematochezia	below serious				1683
11579	16 pts		Infrequent bowel movements	below serious				1683
11580	19 pts		Nausea	below serious				1683
11581	7 pts		Vomiting	below serious				1683
11582	8 pts		Application site erythema	below serious				1683
11583	7 pts		Application site pain	below serious				1683
11584	4 pts		Application site papules	below serious				1683
11585	13 pts		Application site pruritus	below serious				1683
11586	2 pts		Application site rash	below serious				1683
11587	5 pts		Fatigue	below serious				1683
11588	3 pts		Feeling drunk	below serious				1683
11589	5 pts		Feeling hot	below serious				1683
11590	2 pts		Decreased appetite	below serious				1683
11591	7 pts		Dizziness	below serious				1683
11592	2 pts		Somnolence	below serious				1683
11593	2 pts		Oropharyngeal pain	below serious				1683
11594	1 pts		Vomiting		discontinuation	leads to discontinuation		1687
11595	1 pts		Hypertension		discontinuation	leads to discontinuation		1687
11596	1 pts		Tachycardia		discontinuation	leads to discontinuation		1687
11597	5 pts		Nausea		discontinuation	leads to discontinuation		1680
11598			Weakness					1689
11599			Common cold	grade 1				1689
11600			Cough					1689
11601			Rhinorrhea					1689
11602			Vomiting					1689
11603			Sleepiness					1689
11604			Coma			OVERDOSAGE		1690
11605			Common cold			OVERDOSAGE		1690
11606			Nausea			OVERDOSAGE		1690
11607			Diarrhoea			OVERDOSAGE		1690
11608			Back pain			OVERDOSAGE		1690
11609			Headache	grade 3		OVERDOSAGE		1690
11610			Appetite lost			OVERDOSAGE		1690
11611			Dry cough			OVERDOSAGE		1690
11612			Pyrexia			OVERDOSAGE		1690
11613			Abdominal pain	grade 3		OVERDOSAGE		1690
11614			Vomiting			OVERDOSAGE		1690
11615			Disorientation			OVERDOSAGE		1690
11616	8.9		Sedation	grade 1				1688
11617	6.7		Sedation	grade 2				1688
11618	5.5		Dizziness					1688
11619	4.4		Nausea					1688
11620	2.2		Nose dryness					1688
11621	1 pts		Cheilitis	below serious				1699
11622	10 pts		Constipation	below serious				1699
11623	2 pts		Vomiting	below serious				1699
11624	3 pts		Hunger	below serious				1699
11625	6 pts		Malaise	below serious				1699
11626	16 pts		Thirst	below serious				1699
11627	4 pts		Contusion	below serious				1699
11628	2 pts		Fall	below serious				1699
11629	5 pts		Blood triglycerides increased	below serious				1699
11630	10 pts		Weight increased	below serious				1699
11631	7 pts		Increased appetite	below serious				1699
11632	1 pts		Arthralgia	below serious				1699
11633	3 pts		Akathisia	below serious				1699
11634	7 pts		Dizziness	below serious				1699
11635	5 pts		Headache	below serious				1699
11636	2 pts		Sedation	below serious				1699
11637	25 pts		Somnolence	below serious				1699
11638	3 pts		Tremor	below serious				1699
11639	1 pts		Mania	below serious				1699
11640	1 pts		Schizophrenia	serious				1696
11641	1 pts		Altered mood	serious				1696
11642	5 pts		Constipation	below serious				1696
11643	5 pts		Weight increased	below serious				1696
11644	3 pts		Blood triglycerides increased	below serious				1696
11645	1 pts		Extrapyramidal disorder	below serious				1696
11646	8 pts		Somnolence	below serious				1696
11647	3 pts		Pyrexia	below serious				1696
11648	1 pts		Hepatic function abnormal	below serious				1696
11649	5 pts		Thirst	below serious				1696
11650	3 pts		Dizziness	below serious				1696
11651	3 pts		White blood cell count increased	below serious				1696
11652	3 pts		Gamma-glutamyltransferase increased	below serious				1696
11653	3 pts		Tachycardia	below serious				1696
11654	1 pts		Pancreatitis	serious				1700
11655	1 pts		Cholecystitis	serious				1700
11656	1 pts		Paralysis	serious				1700
11657	1 pts		Hypertension	serious				1700
11658	19 pts		Constipation	below serious				1700
11659	18 pts		Dry mouth	below serious				1700
11660	11 pts		Thirst	below serious				1700
11661	11 pts		Hepatic function abnormal	below serious				1700
11662	24 pts		Nasopharyngitis	below serious				1700
11663	11 pts		Alanine aminotransferase increased	below serious				1700
11664	59 pts		Weight increased	below serious				1700
11665	46 pts		Increased appetite	below serious				1700
11666	14 pts		Akathisia	below serious				1700
11667	13 pts		Dizziness	below serious				1700
11668	15 pts		Hypersomnia	below serious				1700
11669	29 pts		Sedation	below serious				1700
11670	59 pts		Somnolence	below serious				1700
11671	14 pts		Tremor	below serious				1700
11672	11 pts		Anxiety	below serious				1700
11673	3 pts		Headache	below serious				1698
11674	9 pts		Weight increased	below serious				1698
11675	3 pts		Sedation	below serious				1698
11676	4 pts		Somnolence	below serious				1698
11677	1 pts		Vomiting	below serious				1698
11678	1 pts		Nausea	below serious				1698
11679	4 pts		Increased appetite	below serious				1698
11680	2 pts		Dry mouth	below serious				1698
11681	2 pts		Overdose	serious				1697
11682	1 pts		Rash	below serious				1697
11683	2 pts		Visual disturbances	below serious				1695
11684	1 pts		Urinary retention	below serious				1695
11685	1 pts		Rhabdomyolysis		discontinuation	leads to discontinuation		1703
11686	1		Accidental injury		discontinuation	leads to discontinuation		1702
11687	3		Somnolence		discontinuation	leads to discontinuation		1702
11688			Adverse event	grade 5		WARNING		1701
11689			Drowsiness					1691
11690			Slurred speech					1691
11691						acute ingestion. No AEs are reported		1693
11692	0.2		Weight gain		discontinuation	leads to discontinuation		1694
11693	6.6		Dizziness					1692
11694	1 pts		Nausea	grade 3-4				1705
11695	1 pts		Vomiting	grade 3-4				1705
11696	1 pts		Fatigue	grade 3-4	discontinuation		TRUE	1705
11697	1 pts		Edema	grade 3-4				1705
11698	1 pts		Central nervous system toxicity	grade 3-4	discontinuation		TRUE	1705
11699	1 pts		Nausea	grade 3-4			TRUE	1710
11700	1 pts		Vomiting	grade 3-4			TRUE	1710
11701	1 pts		Hypocalcemia	grade 3-4			TRUE	1710
11702						No AEs are reported		1704
11703	2 pts		Fatigue	grade 3			TRUE	1711
11704	2 pts		Somnolence	grade 3			TRUE	1711
11705	1 pts		Anemia	grade 3			TRUE	1711
11706	1 pts		Neutropenia	grade 3			TRUE	1711
11707	1 pts		Fatigue	grade 3			TRUE	1707
11708	1 pts		Anemia	grade 3				1708
11709	2 pts		Fatigue	grade 2	discontinuation		TRUE	1708
11710	2 pts		Light-headed	grade 2				1708
11711	2 pts		Edema	grade 2				1708
11712	1 pts		Nausea	grade 2				1708
11713	1 pts		Vomiting	grade 2				1708
11714	1 pts		Orientation disturbed	grade 2				1708
11715	1 pts		Musculoskeletal injury	grade 2				1708
11716	2 pts		Constipation	grade 1				1708
11717	1 pts		Fever	grade 1				1708
11718	1 pts		Pulmonary irritation	grade 1				1708
11719	2 pts		Nausea	grade 1				1706
11720	1 pts		Gait instability	grade 1				1706
11721	2 pts		Syncope vasovagal	grade 2				1706
11722	1 pts		Diarrhea	grade 1				1706
11723	2 pts		Nausea	grade 3			TRUE	1709
11724	1 pts		Vomiting	grade 3			TRUE	1709
11725	2 pts		Gait instability	grade 3			TRUE	1709
11726	2 pts		Lightheadedness	grade 3			TRUE	1709
11727	1 pts		Confusion	grade 3			TRUE	1709
11728			Tachypnea					1712
11729			Metabolic acidosis	grade 3		Overdosage		1714
11730			Coma			Overdosage		1714
11731			Leukopenia		discontinuation			1713
11732	1.4		Discomfort epigastric	severe	discontinuation			1716
11733	5.6		Serum transaminase increased		discontinuation			1716
11734	9.9		Leukopenia		discontinuation			1716
11735	4.2		Pancreatitis	acute	discontinuation			1716
11736	1.4		Thrombocytopenia		discontinuation			1716
11737	6.3		Hepatotoxicity		discontinuation			1717
11738	4.8		Digestion impaired		discontinuation			1717
11739			Vomiting	mild	discontinuation			1715
11740			Diarrhea	mild	discontinuation			1715
11741			Malignant neoplasm NOS		discontinuation	WARNING		1718
11742			Lymphoma		discontinuation	WARNING		1718
11743			Hepatosplenic T-cell lymphoma		discontinuation	WARNING		1718
11744	5 pts		Epistaxis	below serious				1721
11745	5 pts		Pyrexia	below serious				1721
11746	18 pts		Epistaxis	below serious				1722
11747						No AEs were reported		1725
11748						No AEs were reported		1724
11749	17 pts		Nasal mucosal disorder NOS		discontinuation	leads to discontinuation		1720
11750	2 pts		Headache					1723
11751	1 pts		Presyncope		discontinuation	led to discontinuation from the study		1723
11752	1 pts		Nausea					1723
11753	1 pts		Tonsillar hypertrophy					1723
11754	1 pts		Cerumen impaction					1723
11755	1 pts		Oropharyngeal pain					1723
11756	1 pts		Anxiety					1723
11757	25		Headache					1719
11758	2		Respiratory tract disorders NEC					1719
11759	5		Pain					1719
11760	4		Back pain					1719
11761	4		Dysphonia					1719
11762			Hallucinations					1727
11763			Coma					1727
11764						No SAEs were observed		1726
11765	1 pts		Hemolytic anemia		discontinuation	leads to discontinuation		1730
11766						No information on AE is provided		1728
11767	1 pts		Hoigne's syndrome		discontinuation	leads to discontinuation		1731
11768	1 pts		Hemolytic anemia		discontinuation	leads to discontinuation		1729
11769	1 pts		Pancytopenia		discontinuation	leads to discontinuation		1729
11770			Hypersensitivity		discontinuation	WARNING		1732
11771			Azotemia		discontinuation	WARNING. In patients with renal disease		1732
11772			Systemic lupus erythematosus reactivation		discontinuation	WARNING		1732
11773						No information on AE is provided		1735
11774	2 pts		Headache					1736
11775	2 pts		Abdominal pain					1736
11776	2 pts		Nausea					1736
11777	2 pts		Anorexia					1736
11778	2 pts		Vomiting					1736
11779						AEs were not reported		1734
11780						AEs were not reported		1733
11781			Diarrhea	severe	discontinuation	leads to discontinuation		1737
11782						No information on AE is provided		1739
11783	0.4 - 0.9		Headache		discontinuation	leads to discontinuation		1740
11784	0.4 - 0.9		Transaminases increased		discontinuation	leads to discontinuation		1740
11785	0.4 - 0.9		Fatigue		discontinuation	leads to discontinuation		1740
11786	0.4 - 0.9		Cough		discontinuation	leads to discontinuation		1740
11787						No information on AE is provided		1738
11788	23.1		Constipation					1741
11789	15.4		Diarrhea					1741
11790	30.8		Headache					1741
11791	15.4		Fatigue					1741
11792	15.4		Anorexia					1741
11793	7.7		Weight loss					1741
11794	7.7		Dizziness					1741
11795	15.4		Neutropenia					1741
11796	15.4		Mucosal inflammation					1741
11797	7.7		Dyspnea					1741
11798	7.7		Insomnia					1741
11799	7.7		Thrombocytopenia					1741
11800	7.7		Injection site bruising					1741
11801	2.2		Pain injection site					1741
11802	27.5		Constipation					1742
11803	17.6		Headache					1742
11804	15		Leukopenia					1742
11805	6.9		Asthenia					1742
11806	9		Abdominal pain					1742
11807	5.6		Decreased appetite					1742
11808	1.3		Anemia					1742
11809	4.3		Diarrhea					1742
11810	2.6		Abnormal liver function tests					1742
11811	3		Alopecia					1742
11812	0.4		Pain					1742
11813	13.9		Headache					1743
11814	4.2		Constipation					1743
11815	2.4		Somnolence					1743
11816	1.2		Dizziness					1743
11817	1.8		Dyspepsia					1743
11818	3		Back pain					1743
11819	14		Headache					1745
11820	5		Asthenia					1745
11821	4		Somnolence					1745
11822	4		Diarrhea					1745
11823	3		Constipation					1745
11824	10.1		Pain					1744
11825	9.4		Constipation					1744
11826	9.4		Anemia					1744
11827	8.6		Headache					1744
11828	7.9		Fever					1744
11829	6		Abdominal pain					1744
11830	5.6		Hepatic enzymes increased					1744
11831	4.9		Insomnia					1744
11832	4.5		Bradycardia					1744
11833	4.1		Dizziness					1744
11834	3.7		Leukocytosis					1744
11835	3.4		Anxiety					1744
11836	3.4		Hypotension					1744
11837	3.4		Diarrhea					1744
11838	3		Flatulence					1744
11839	3		Infection					1744
11840	3		Dyspepsia					1744
11841	2.6		Hypertension					1744
11842	2.6		Urinary tract infection					1744
11843	2.2		Oliguria					1744
11844	2.2		Coughing					1744
11845	17 pts		Drowsiness					1746
11846	12 pts		Dry mouth					1746
11847	7 pts		Irritability					1746
11848	3 pts		Dizziness					1746
11849	1 pts		Drowsiness		discontinuation	leads to dose reduction		1746
11850	3 pts		Sleep disturbance		discontinuation	leads to discontinuation		1749
11851	2 pts		Urinary tract signs and symptoms NEC		discontinuation	leads to discontinuation		1749
11852	2 pts		Palpitations		discontinuation	leads to discontinuation		1749
11853	1 pts		Anxiety		discontinuation	leads to discontinuation		1749
11854	1 pts		Dry mouth		discontinuation	leads to discontinuation		1749
11855	3 pts		Dizziness		discontinuation	leads to discontinuation		1749
11856	1 pts		Flushing		discontinuation	leads to discontinuation		1749
11857	1 pts		Constipation		discontinuation	leads to discontinuation		1749
11858	1 pts		Nausea		discontinuation	leads to discontinuation		1748
11859			Suicidal ideation	grade 5	discontinuation	WARNING		1747
11860	38 pts		Thermal burn	below serious				1751
11861	1 pts		Joint pain	below serious				1751
11862	15 pts		Hoarseness of voice	below serious				1752
11863	2 pts		Thrush	below serious				1752
11864	15 pts		Sore throat	below serious				1752
11865	4.8		Burning sensation					1750
11866	4.8		Pruritus					1750
11867	4.8		Skin atrophy					1750
11868	4.8		Tingling					1750
11869	4.8		Furunculosis					1750
11870	1 pts		Glucocorticoid decreased					1753
11871	1 pts		Skin and subcutaneous conditions NEC					1753
11872	1 pts		Skin bacterial infection					1753
11873	1 pts		Gastrointestinal disorders	serious				1755
11874	13 pts		Dry mouth	below serious				1755
11875	3 pts		Dyspepsia	below serious				1755
11876	2 pts		Pain in extremity	below serious				1755
11877	2 pts		Facial flushing		discontinuation	leads to discontinuation		1759
11878	2 pts		Genital and urinary tract disorders NEC		discontinuation	leads to discontinuation		1759
11879	1 pts		Cognitive function abnormal		discontinuation	leads to discontinuation		1759
11880	76		Dry mouth					1758
11881	26		Palpitation					1758
11882	23		Dry eyes					1758
11883	23		Urinary retention					1758
11884	1.9		Nausea		discontinuation	leads to discontinuation		1754
11885	1.2		Dry mouth		discontinuation	leads to discontinuation		1754
11886	1 pts		Memory loss		discontinuation	leads to discontinuation		1757
11887	1 pts		Stupor		discontinuation	leads to discontinuation		1756
11888	1 pts		Disorientation		discontinuation	leads to discontinuation		1756
11889	1 pts		Awaking excitability		discontinuation	leads to discontinuation		1756
11890	1 pts		Dilated pupils		discontinuation	leads to discontinuation		1756
11891	1 pts		Dry skin		discontinuation	leads to discontinuation		1756
11892	1 pts		Cardiac arrhythmia		discontinuation	leads to discontinuation		1756
11893	1 pts		Retention of urine		discontinuation	leads to discontinuation		1756
11894	1 pts		Chest pain		discontinuation	leads to discontinuation		1761
11895	1 pts		Jaw pain		discontinuation	leads to discontinuation		1761
11896	3.6		Nervous system disorders					1761
11897	2.7		Headache					1761
11898	8		Gastrointestinal disorders					1761
11899	2.7		Dry mouth					1761
11900	3.6		Nausea					1761
11901			Ischemic colitis	acute	discontinuation	leads to discontinuation		1763
11902						Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to estimate their frequency reliably or to establish a causal relationship to drug exposure.		1760
11903			Eye pain					1762
11904			Blurred vision					1762
11905			Photophobia					1762
11906			Allergic conjunctivitis					1762
11907			Methemoglobinemia					1765
11908	1 pts		Visceral congestion	grade 5				1764
11909	1 pts		Aspiration	grade 5				1764
11910	0.3		Amnesia		discontinuation			1766
11911	0.3		Judgement impaired		discontinuation			1766
11912	0.3		Memory impairment		discontinuation			1766
11913	0.3		Paraesthesia		discontinuation			1766
11914	1		Depression		discontinuation			1766
11915	0.3		Anxiety		discontinuation			1766
11916	0.3		Vision blurred		discontinuation			1766
11917	0.3		Eye pain		discontinuation			1766
11918	0.3		Abdominal pain		discontinuation			1766
11919	0.3		Tuberculosis skin test positive		discontinuation			1766
11920	0.3		Nephrolithiasis		discontinuation			1766
11921	12.9		Disorder sleep					1766
11922	8.1		Depression					1766
11923	9.5		Anxiety					1766
11924	4.1		Cardiac arrhythmia					1766
11925	1		Ischemic heart disease					1766
11926	3.1		Disturbance in attention					1766
11927	2		Memory impairment					1766
11928	1.4		Cognitive disorders					1766
11929	0.3		Language disorder					1766
11930	4.1		Ocular disorders NEC					1766
11931	1.4		Dyskinesias and movement disorders NEC					1766
11932	6		Anorexia					1768
11933	6		Back pain					1768
11934	6		Chapped lips					1768
11935	6		Dry skin					1768
11936	6		Dyspepsia					1768
11937	6		Early satiety					1768
11938	6		Irregular pulse					1768
11939	6		Nausea					1768
11940	6		Abdominal pain					1767
11941	6		Dizziness					1767
11942	6		Early satiety					1767
11943	6		Intermittent headache					1767
11944	6		Nausea					1767
11945	6		Swollen lips					1767
11946	6		Upper respiratory infection					1767
11947			Tachycardia			OVERDOSAGE		1769
11948			Hypertension			OVERDOSAGE		1769
11949			Visual disorders NEC			OVERDOSAGE		1769
11950			Nausea			OVERDOSAGE		1769
11951			Insomnia			OVERDOSAGE		1769
11952			Anxiety			OVERDOSAGE		1769
11953						No information on AE is provided		1770
11954						No information on AE is provided		1772
11955						No information on AE is provided		1771
11956	0.88		Nausea	grade 3	discontinuation	1 patient with nausea and alteration of taste		1779
11957	0.88		Taste alteration	grade 3	discontinuation	1 patient with nausea and alteration of taste		1779
11958	0.57		Rash		discontinuation	1 patient		1776
11959	0.57		Vomiting		discontinuation	1 patient		1776
11960	1.7		Abdominal pain		discontinuation	2 patients, one withdrew		1777
11961						no AEs resulting in discontinuation reported		1774
11962						no AEs resulting in discontinuation reported		1773
11963	0.8		Diarrhea					1780
11964	1.2		Rash					1780
11965	0.8		Abdominal pain					1780
11966	1.7		Infection					1780
11967	1.2		Headache					1780
11968	2.5		Vomiting					1780
11969	1.2		Rhinitis					1780
11970	0.4		Gastroenteritis					1780
11971	0.4		Epistaxis					1780
11972	2.1		Ear pain					1780
11973	1.2		Cough increased					1780
11974	0.8		Nausea					1780
11975	0.46		Stomach cramps		discontinuation	1 patient was discontinued because of nausea and stomach cramps		1780
11976	0.46		Nausea		discontinuation	1 patient was discontinued because of nausea and stomach cramps		1780
11977			Hypersensitivity reaction	serious|grade 5	discontinuation	WARNINGS		1778
11978			Diarrhea, Clostridium difficile	mild|grade 5	discontinuation	WARNINGS		1778
11979						no AEs reported		1775
11980	79		Depression		discontinuation	Overdosage		1783
11981	48		Headache		discontinuation	Overdosage		1783
11982	59		Tiredness		discontinuation	Overdosage		1783
11983	53		Bloating		discontinuation	Overdosage		1783
11984	38		Irritability		discontinuation	Overdosage		1783
11985	40		Neuropathy		discontinuation	Overdosage		1783
11986	34		Paraesthesia		discontinuation	Overdosage		1782
11987	19.2		Hyperaesthesia		discontinuation	Overdosage		1782
11988	26		Bone pain		discontinuation	Overdosage		1782
11989	19.2		Muscle weakness		discontinuation	Overdosage		1782
11990	12.2		Numbness		discontinuation	Overdosage		1782
11991	10.5		Fasciculation		discontinuation	Overdosage		1782
11992	1.5		Somnolence		discontinuation			1781
11993	0.7		Syncope		discontinuation			1781
11994	0.7		Dizziness		discontinuation			1781
11995	5		Stenocardia	grade 3	discontinuation	1 patient		1785
11996	5		Distress gastrointestinal	grade 3	discontinuation	1 patient		1785
11997	5		Skin rash	grade 3	discontinuation	1 patient		1785
11998	9		Thrombopenia					1785
11999	5		Creatinine serum increased			1 patient		1785
12000	5		Elevated liver enzyme levels			1 patient		1785
12001	23		Malaise			Suffering from at least three of the following side effects: vomiting, gastric distress, tiredness, dizziness, headache, nervousness, sleep disorders, myalgia, constipation		1785
12002	5		Diarrhea			1 patient		1785
12003	17.24		Skin rash	grade 3	discontinuation			1786
12004	3.45		Neutropenia	grade 3	discontinuation	1 patient		1786
12005	6.9		Acute renal failure	grade 3	discontinuation			1786
12006	1.16		Skin rash			1 patient		1784
12007	18.75		Neutropenia					1784
12008	1.16		Febrile neutropenia			1 patient		1784
12009	1.16		Stevens Johnson syndrome	grade 3	discontinuation	1 patient		1784
12010	25		Thrombocytopenia	grade 4	discontinuation	Severe thrombocytopenia and major bleeding. All four patients with major bleeding subsequently died.		1784
12011	25		Major bleed	grade 4	discontinuation	Severe thrombocytopenia and major bleeding. All four patients with major bleeding subsequently died.		1784
12012	5.5		Dry mouth		discontinuation			1788
12013	5.5		Constipation		discontinuation			1788
12014	5.5		Malaise	moderate	discontinuation			1788
12015	16.7		Nausea	severe	discontinuation			1789
12016	16.7		Weakness	severe	discontinuation			1789
12017						Amiloride at a daily dose of 75 mg was well tolerated and free of side effects.		1787
12018	1 pts		Glucose high	serious				1798
12019	1 pts		Acute depression	serious				1798
12020	1 pts		Agitation	below serious				1798
12021	1 pts		Aspartate aminotransferase increased	below serious				1798
12022	1 pts		Blood alkaline phosphatase high	below serious				1798
12023	1 pts		Taste altered	below serious				1798
12024	3 pts		Bilirubin total high	below serious				1798
12025	1 pts		Chlamydial infection	below serious				1798
12026	1 pts		Constipation	below serious				1798
12027	1 pts		Subcutaneous cyst	below serious				1798
12028	2 pts		Depressed mood	below serious				1798
12029	2 pts		Dry mouth	below serious				1798
12030	1 pts		Flank pain	below serious				1798
12031	3 pts		Blood glucose increased	below serious				1798
12032	1 pts		Headache NOS	below serious				1798
12033	1 pts		Urge incontinence	below serious				1798
12034	1 pts		Insomnia	below serious				1798
12035	1 pts		Generalized joint pain	below serious				1798
12036	1 pts		Lightheadedness	below serious				1798
12037	1 pts		Lymph gland infection	below serious				1798
12038	1 pts		Lymphadenopathy cervical	below serious				1798
12039	4 pts		Nausea	below serious				1798
12040	1 pts		Nose bleed	below serious				1798
12041	1 pts		Prostatitis	below serious				1798
12042	1 pts		Sexual dysfunction	below serious				1798
12043	1 pts		Syphilis	below serious				1798
12044	1 pts		Tooth infection	below serious				1798
12045	1 pts		Upper respiratory infection	below serious				1798
12046	1 pts		Visual disturbance	below serious				1798
12047	1 pts		Vomiting	below serious				1798
12048	1 pts		Weight loss	below serious				1798
12049	1 pts		Anaemia					1793
12050	1 pts		Transaminases increased					1793
12051			Nephrotoxicity		discontinuation	leads to discontinuation		1797
12052			Hepatotoxicity		discontinuation	leads to discontinuation		1797
12053			Myelosuppression		discontinuation	leads to discontinuation		1797
12054	8 pts		Xerosis			discontinuation or dose reduction		1794
12055	11 pts		Alopecia			discontinuation or dose reduction		1794
12056	13 pts		Fatigue			discontinuation or dose reduction		1794
12057	10 pts		Nausea and vomiting			discontinuation or dose reduction		1794
12058	7 pts		Anorexia			discontinuation or dose reduction		1794
12059	6 pts		Headache			discontinuation or dose reduction		1794
12060	5 pts		Arthralgia			discontinuation or dose reduction		1794
12061	4 pts		Cheilitis			discontinuation or dose reduction		1794
12062	2 pts		Xerostomia			discontinuation or dose reduction		1794
12063	3 pts		Dizziness			discontinuation or dose reduction		1794
12064	2 pts		Neuropathy			discontinuation or dose reduction		1794
12065	2 pts		Abdominal discomfort			discontinuation or dose reduction		1794
12066	2 pts		ALP increased			discontinuation or dose reduction		1794
12067	3 pts		Anemia		discontinuation	leads to discontinuation		1795
12068	1 pts		Transaminases increased		discontinuation	leads to discontinuation		1795
12069	345 pts		Abortions spontaneous					1791
12070	249 pts		Abortions spontaneous					1792
12071	5.4		Vomiting					1796
12072	2.8		Abdominal pain					1796
12073	2.3		Nausea					1796
12074	2.1		Diarrhea					1796
12075	13		Headache					1790
12076	7		Nausea					1790
12077	6		Abdominal pain					1790
12078	3		Diarrhea					1790
12079	1		Dyspepsia					1790
12080	1		Dizziness					1790
12081	1		Taste perversion					1790
12082						no severe adverse reactions were encountered.		1800
12083						No AEs are reported		1801
12084						impossible to link AEs with the definite dose		1799
12085	2.6		Diarrhea					1803
12086	10.52		Aspartate aminotransferase abnormal					1803
12087	7.9		Alkaline phosphatase increased					1803
12088						no AEs reported		1802
12089	75		Malaise and fatigue	grade 3			TRUE	1804
12090	25		Hypotension	grade 3			TRUE	1804
12091	40		Malaise and fatigue	grade 3			TRUE	1805
12092	33		Appetite lost					1810
12093	24		Dry mouth					1810
12094	29		Constipation					1810
12095	24		Listlessness					1810
12096	19		Urinary retention					1810
12097	19		Blurred vision					1810
12098	19		Muscle weakness					1810
12099	10.5		Excitement					1810
12100	14		Sweating decreased					1810
12101	10.5		Mental confusion					1810
12102	10.5		Skin rash					1810
12103	10.5		Nausea					1810
12104	10.5		Vomiting					1810
12105	10.5		Nervousness					1810
12106	26		Dry mouth	grade 1-2				1809
12107	32		Visual disturbance	grade 1-2				1809
12108	10.5		Constipation	grade 1-2				1809
12109	63		Dry mouth					1815
12110	32		Confusion					1814
12111	26		Memory disturbance					1814
12112	16		Lightheadedness					1814
12113	10.5		Blurred vision					1814
12114			Mental impairment			WARNING		1808
12115			Physical impairment					1813
12116			Paralytic ileus	grade 3-5	discontinuation	WARNING		1806
12117			Hyperthermia	grade 3-5				1811
12118			Heat stroke	grade 3-5				1811
12119			Paralytic ileus	grade 3-5	discontinuation	WARNING		1807
12120			Hyperthermia	grade 3-5				1812
12121			Heat stroke	grade 3-5				1812
12122			Anhidrosis	grade 3-5				1813
12123						No AEs reported		1816
12124	1 pts		Itching		discontinuation	leads to discontinuation		1817
12125	1 pts		Rash		discontinuation	leads to discontinuation		1817
12126	1 pts		Nausea		discontinuation	leads to discontinuation		1817
12127	1 pts		Pallor		discontinuation	leads to discontinuation		1817
12128	1 pts		Vomiting		discontinuation	leads to discontinuation		1818
12129			Hypercapnic respiratory failure					1819
12130			Respiratory depression	grade 5		WARNING		1820
12131			Cardiomyopathy			WARNING		1824
12132			Acute myeloid leukaemia			WARNING		1823
12133			Myelodysplastic syndrome			WARNING		1823
12134			Myelosuppression	severe		WARNING		1823
12135			Tissue injury	severe	discontinuation	WARNING		1823
12136	1 pts		Sinus tachycardia					1822
12137	1 pts		Neutropenia	grade 4				1822
12138	1 pts		Thrombocytopenia					1822
12139	1 pts		Mucositis	severe				1822
12140	1 pts		Sepsis	severe				1822
12141	1 pts		Mucositis	severe				1821
12142	1 pts		Chills					1821
12143	1 pts		Pyrexia					1821
12144	17.4		Headache					1825
12145	4.3		Earache			1 patient		1825
12146			Circulatory collapse			In one subject circulatory collapse occurred after ingestion of 12,000 mg eprosartan. The subject recovered completely.		1826
12147						No adverse events, such as bradycardia, hypotension, congestive heart failure, or bronchospasm, occurred in any of our study patients		1829
12148	1 pts		Delirium		discontinuation	leads to discontinuation		1830
12149						No AEs were reported		1828
12150	25		Hypotension asymptomatic					1827
12151	12		Hypotension symptomatic					1827
12152	8		Infusion site reactions					1827
12153	7		Nausea					1827
12154	3		Dizziness					1827
12155	3		Somnolence					1827
12156	2 pts		Anaemia	serious				1836
12157	5 pts		Angina unstable	serious				1836
12158	2 pts		Arrhythmia	serious				1836
12159	1 pts		Arteriosclerosis coronary artery	serious				1836
12160	3 pts		Atrial flutter	serious				1836
12161	1 pts		Atrial tachycardia	serious				1836
12162	1 pts		Atrial thrombosis	serious				1836
12163	1 pts		Cardiac disorder	serious				1836
12164	7 pts		Cardiac failure congestive	serious				1836
12165	2 pts		Cardio-respiratory arrest	serious				1836
12166	1 pts		Coronary artery stenosis	serious				1836
12167	1 pts		Myocardial ischaemia	serious				1836
12168	1 pts		Palpitations	serious				1836
12169	1 pts		Pericarditis	serious				1836
12170	2 pts		Ventricular tachycardia	serious				1836
12171	1 pts		Vertigo	serious				1836
12172	1 pts		Vertigo positional	serious				1836
12173	1 pts		Disorder vestibular	serious				1836
12174	1 pts		Goitre	serious				1836
12175	1 pts		Inappropriate antidiuretic hormone secretion	serious				1836
12176	1 pts		Abdominal hernia	serious				1836
12177	1 pts		Colitis ischaemic	serious				1836
12178	2 pts		Gastritis	serious				1836
12179	1 pts		Haemorrhoids	serious				1836
12180	1 pts		Impaired gastric emptying	serious				1836
12181	1 pts		Hernia inguinal	serious				1836
12182	2 pts		Intestinal obstruction	serious				1836
12183	1 pts		Obstruction gastric	serious				1836
12184	1 pts		Oesophageal obstruction	serious				1836
12185	1 pts		Pancreatitis	serious				1836
12186	1 pts		Vomiting	serious				1836
12187	1 pts		Adhesion	serious				1836
12188	1 pts		Chest discomfort	serious				1836
12189	1 pts		Generalised oedema	serious				1836
12190	3 pts		Non-cardiac chest pain	serious				1836
12191	2 pts		Cholelithiasis	serious				1836
12192	1 pts		Hepatitis alcoholic	serious				1836
12193	1 pts		Arthritis infective	serious				1836
12194	1 pts		Bacteraemia	serious				1836
12195	1 pts		Bronchopneumonia	serious				1836
12196	1 pts		Cholecystitis infective	serious				1836
12197	3 pts		Clostridium difficile infection	serious				1836
12198	1 pts		Cystitis	serious				1836
12199	1 pts		Endocarditis	serious				1836
12200	1 pts		Incision site cellulitis	serious				1836
12201	2 pts		Infection	serious				1836
12202	1 pts		Septic shock	serious				1836
12203	1 pts		Upper respiratory tract infection	serious				1836
12204	6 pts		Urinary tract infection	serious				1836
12205	1 pts		Viral infection	serious				1836
12206	1 pts		Device toxicity	serious				1836
12207	11 pts		Fall	serious				1836
12208	2 pts		Hip fracture	serious				1836
12209	1 pts		Intentional overdose	serious				1836
12210	1 pts		Limb injury	serious				1836
12211	1 pts		Lower limb fracture	serious				1836
12212	2 pts		Meniscus injury	serious				1836
12213	1 pts		Periprosthetic fracture	serious				1836
12214	1 pts		Postoperative fever	serious				1836
12215	1 pts		Procedural nausea	serious				1836
12216	1 pts		Procedural pain	serious				1836
12217	1 pts		Radiation oesophagitis	serious				1836
12218	2 pts		Road traffic accident	serious				1836
12219	1 pts		Traumatic haematoma	serious				1836
12220	1 pts		Vascular bypass dysfunction	serious				1836
12221	1 pts		Blood glucose increased	serious				1836
12222	1 pts		Electrocardiogram abnormal	serious				1836
12223	1 pts		Haemoglobin decreased	serious				1836
12224	2 pts		International normalised ratio increased	serious				1836
12225	1 pts		White blood cell count increased	serious				1836
12226	5 pts		Dehydration	serious				1836
12227	2 pts		Diabetes mellitus inadequate control	serious				1836
12228	3 pts		Failure to thrive	serious				1836
12229	2 pts		Hyperglycaemia	serious				1836
12230	3 pts		Hyponatraemia	serious				1836
12231	1 pts		Iron deficiency	serious				1836
12232	3 pts		Arthralgia	serious				1836
12233	1 pts		Bursa disorder	serious				1836
12234	1 pts		Exostosis	serious				1836
12235	1 pts		Muscular weakness	serious				1836
12236	10 pts		Osteoarthritis	serious				1836
12237	1 pts		Tendonitis	serious				1836
12238	1 pts		Basal cell carcinoma	serious				1836
12239	1 pts		Benign salivary gland neoplasm	serious				1836
12240	2 pts		Brain neoplasm	serious				1836
12241	1 pts		Colorectal cancer	serious				1836
12242	1 pts		Diffuse large B-cell lymphoma stage IV	serious				1836
12243	1 pts		Haemangioma	serious				1836
12244	4 pts		Lung neoplasm malignant	serious				1836
12245	3 pts		Malignant melanoma	serious				1836
12246	1 pts		Metastases to central nervous system	serious				1836
12247	1 pts		Metastatic squamous cell carcinoma	serious				1836
12248	1 pts		Neuroendocrine carcinoma	serious				1836
12249	5 pts		Prostate cancer	serious				1836
12250	1 pts		Prostate cancer recurrent	serious				1836
12251	2 pts		Renal cancer	serious				1836
12252	1 pts		Renal cancer metastatic	serious				1836
12253	1 pts		Renal cell carcinoma	serious				1836
12254	1 pts		Salivary gland cancer	serious				1836
12255	2 pts		Squamous cell carcinoma	serious				1836
12256	1 pts		Basilar artery stenosis	serious				1836
12257	1 pts		Cognitive disorder	serious				1836
12258	4 pts		Dementia	serious				1836
12259	1 pts		Epilepsy	serious				1836
12260	1 pts		Headache	serious				1836
12261	1 pts		Hypoaesthesia	serious				1836
12262	2 pts		Parkinson's disease	serious				1836
12263	1 pts		Haemorrhage subarachnoid	serious				1836
12264	4 pts		Transient ischaemic attack	serious				1836
12265	4 pts		Transient ischaemic attack	serious				1836
12266	1 pts		Dementia vascular	serious				1836
12267	2 pts		Alcohol abuse	serious				1836
12268	1 pts		Binge drinking	serious				1836
12269	1 pts		Completed suicide	serious				1836
12270	1 pts		Confusional state	serious				1836
12271	1 pts		Delirium tremens	serious				1836
12272	3 pts		Depression	serious				1836
12273	1 pts		Mental disorder	serious				1836
12274	2 pts		Mental status changes	serious				1836
12275	1 pts		Post-traumatic stress disorder	serious				1836
12276	1 pts		Suicidal behaviour	serious				1836
12277	3 pts		Suicidal ideation	serious				1836
12278	2 pts		Hydronephrosis	serious				1836
12279	1 pts		Nephropathy	serious				1836
12280	1 pts		Renal failure chronic	serious				1836
12281	1 pts		Erectile dysfunction	serious				1836
12282	1 pts		Prostatic haemorrhage	serious				1836
12283	1 pts		Prostatitis	serious				1836
12284	9 pts		Chronic obstructive pulmonary disease	serious				1836
12285	2 pts		Dyspnoea	serious				1836
12286	1 pts		Dyspnoea exertional	serious				1836
12287	1 pts		Haemoptysis	serious				1836
12288	1 pts		Pleural effusion	serious				1836
12289	3 pts		Pulmonary embolism	serious				1836
12290	1 pts		Respiratory failure	serious				1836
12291	1 pts		Rash	serious				1836
12292	1 pts		Angioplasty	serious				1836
12293	1 pts		Cholecystectomy	serious				1836
12294	1 pts		Coronary angioplasty	serious				1836
12295	1 pts		Elective procedure	serious				1836
12296	1 pts		Hip arthroplasty	serious				1836
12297	1 pts		Knee arthroplasty	serious				1836
12298	1 pts		Medical device removal	serious				1836
12299	1 pts		Oesophagogastric fundoplasty	serious				1836
12300	1 pts		Parotidectomy	serious				1836
12301	1 pts		Wound treatment	serious				1836
12302	2 pts		Aortic aneurysm	serious				1836
12303	1 pts		Aortic occlusion	serious				1836
12304	1 pts		Arterial occlusive disease	serious				1836
12305	1 pts		Femoral artery occlusion	serious				1836
12306	1 pts		Labile hypertension	serious				1836
12307	2 pts		Orthostatic hypotension	serious				1836
12308	1 pts		Disorder peripheral vascular	serious				1836
12309	1 pts		Lymphadenopathy	below serious				1836
12310	1 pts		Vertigo	below serious				1836
12311	1 pts		Adrenal mass	below serious				1836
12312	1 pts		Eye haemorrhage	below serious				1836
12313	3 pts		Eye irritation	below serious				1836
12314	2 pts		Eye pain	below serious				1836
12315	1 pts		Eye pruritus	below serious				1836
12316	4 pts		Eye swelling	below serious				1836
12317	1 pts		Photophobia	below serious				1836
12318	1 pts		Visual acuity reduced	below serious				1836
12319	2 pts		Abdominal pain upper	below serious				1836
12320	1 pts		Cheilitis	below serious				1836
12321	3 pts		Diarrhoea	below serious				1836
12322	1 pts		Diverticulum	below serious				1836
12323	1 pts		Dyspepsia	below serious				1836
12324	1 pts		Gastrooesophageal reflux disease	below serious				1836
12325	1 pts		Gingival pain	below serious				1836
12326	5 pts		Nausea	below serious				1836
12327	3 pts		Fatigue	below serious				1836
12328	1 pts		Feeling of body temperature change	below serious				1836
12329	1 pts		Hernia	below serious				1836
12330	1 pts		Local swelling	below serious				1836
12331	1 pts		Malaise	below serious				1836
12332	11 pts		Pain	below serious				1836
12333	1 pts		Syringe issue	below serious				1836
12334	1 pts		Temperature intolerance	below serious				1836
12335	2 pts		Tenderness	below serious				1836
12336	1 pts		Vessel puncture site haematoma	below serious				1836
12337	1 pts		Hypersensitivity	below serious				1836
12338	1 pts		Seasonal allergy	below serious				1836
12339	4 pts		Bronchitis	below serious				1836
12340	1 pts		Cellulitis	below serious				1836
12341	1 pts		Folliculitis	below serious				1836
12342	1 pts		Fungal infection	below serious				1836
12343	2 pts		Herpes zoster	below serious				1836
12344	2 pts		Infection	below serious				1836
12345	1 pts		Influenza	below serious				1836
12346	5 pts		Nasopharyngitis	below serious				1836
12347	1 pts		Oral herpes	below serious				1836
12348	2 pts		Pneumonia	below serious				1836
12349	1 pts		Accidental exposure to product	below serious				1836
12350	1 pts		Arthropod sting	below serious				1836
12351	5 pts		Fall	below serious				1836
12352	1 pts		Laceration	below serious				1836
12353	1 pts		Muscle rupture	below serious				1836
12354	1 pts		Body temperature increased	below serious				1836
12355	1 pts		Emergency care examination	below serious				1836
12356	1 pts		Gout	below serious				1836
12357	1 pts		Arthralgia	below serious				1836
12358	3 pts		Back pain	below serious				1836
12359	1 pts		Foot deformity	below serious				1836
12360	1 pts		Musculoskeletal pain	below serious				1836
12361	1 pts		Neck pain	below serious				1836
12362	1 pts		Pain in extremity	below serious				1836
12363	1 pts		Polymyalgia rheumatica	below serious				1836
12364	1 pts		Basal cell carcinoma	below serious				1836
12365	1 pts		Haemangioma	below serious				1836
12366	1 pts		Transitional cell carcinoma	below serious				1836
12367	1 pts		Burning sensation	below serious				1836
12368	4 pts		Dizziness	below serious				1836
12369	5 pts		Headache	below serious				1836
12370	2 pts		Hypoaesthesia	below serious				1836
12371	1 pts		Syncope	below serious				1836
12372	1 pts		Tunnel vision	below serious				1836
12373	1 pts		Abnormal dreams	below serious				1836
12374	1 pts		Anxiety	below serious				1836
12375	1 pts		Psychotic disorder	below serious				1836
12376	22 pts		Sleep disorder	below serious				1836
12377	1 pts		Dysuria	below serious				1836
12378	1 pts		Haemorrhage urinary tract	below serious				1836
12379	1 pts		Pollakiuria	below serious				1836
12380	1 pts		Chronic obstructive pulmonary disease	below serious				1836
12381	1 pts		Nasal congestion	below serious				1836
12382	1 pts		Productive cough	below serious				1836
12383	1 pts		Pulmonary mass	below serious				1836
12384	1 pts		Rhinorrhoea	below serious				1836
12385	1 pts		Sinus disorder	below serious				1836
12386	5 pts		Acne	below serious				1836
12387	2 pts		Blister	below serious				1836
12388	1 pts		Blood blister	below serious				1836
12389	1 pts		Decubitus ulcer	below serious				1836
12390	447 pts		Dermatitis	below serious				1836
12391	1 pts		Dermatitis allergic	below serious				1836
12392	2 pts		Hyperhidrosis	below serious				1836
12393	5 pts		Photosensitivity reaction	below serious				1836
12394	1 pts		Post inflammatory pigmentation change	below serious				1836
12395	1 pts		Scab	below serious				1836
12396	1 pts		Seborrhoea	below serious				1836
12397	2 pts		Dermatitis seborrhoeic	below serious				1836
12398	1 pts		Skin discomfort	below serious				1836
12399	3 pts		Skin haemorrhage	below serious				1836
12400	1 pts		Skin tightness	below serious				1836
12401	1 pts		Skin ulcer	below serious				1836
12402	1 pts		Urticaria	below serious				1836
12403	1 pts		Oral surgery	below serious				1836
12404	1 pts		Wound drainage	below serious				1836
12405	7 pts		Haemorrhage	below serious				1836
12406	1 pts		Temporal arteritis	below serious				1836
12407	4 pts		Ataxia	grade 3	discontinuation	leads to discontinuation	TRUE	1834
12408	3 pts		Anorexia					1834
12409	2 pts		Nausea	severe				1834
12410	2 pts		Vomiting					1834
12411	1 pts		Stomatitis	severe				1834
12412	3 pts		Diarrhea					1834
12413	1 pts		Weakness					1834
12414	1 pts		Hair loss					1834
12415	1 pts		Peeling					1834
12416	3 pts		Ataxia					1835
12417	4 pts		Anorexia					1835
12418	2 pts		Nausea	severe				1835
12419	3 pts		Vomiting					1835
12420	3 pts		Stomatitis	mild				1835
12421	2 pts		Diarrhea					1835
12422	2 pts		Weakness					1835
12423	2 pts		Hair loss					1835
12424	1 pts		Loss of eyelashes					1835
12425	2 pts		Peeling					1835
12426	2 pts		Peeling					1835
12427						No AEs are reported		1832
12428						No AEs are reported		1833
12429	2 pts		Diarrhea	grade 3-4			TRUE	1839
12430	2 pts		Diarrhea	grade 3-4			TRUE	1838
12431	1 pts		Diarrhea	grade 3			TRUE	1837
12432	12		Irritation skin		discontinuation	leads to discontinuation		1831
12433	2 pts		Stomach upset	below serious				1849
12434	1 pts		Increased blood pressure	below serious				1849
12435			Tachycardia			Overdosage		1847
12436			Hypotension			Overdosage		1847
12437			Depression			Overdosage		1847
12438			Defect conduction (NOS)			Overdosage		1847
12439			Hypokalemia			Overdosage		1847
12440			Cardio-respiratory arrest	grade 5		Overdosage		1842
12441			Vomiting			Overdosage		1845
12442			Ventricular tachycardia			Overdosage		1845
12443			Cardio-respiratory arrest	grade 5		Overdosage		1843
12444			Atrioventricular dyssynchrony			Overdosage		1841
12445			Hypotension			Overdosage		1844
12446			Ventricular tachyarrhythmia			Overdosage		1844
12447			Hypokalemia			Overdosage		1844
12448			Conduction defects (SMQ)			Overdosage		1844
12449	13		Lymphopenia	grade 3-4				1840
12450	13		Nausea	grade 3			TRUE	1840
12451	13		Vomiting	grade 3			TRUE	1840
12452	13		Anemia	grade 1-2				1840
12453	13		Thrombocytopenia	grade 1-2				1840
12454	38		Anorexia	grade 1-2				1840
12455	13		Bradycardia	grade 1-2				1840
12456	25		Constipation	grade 1-2				1840
12457	25		Diarrhea	grade 1-2				1840
12458	88		Fatigue	grade 1-2				1840
12459	13		Hypotension	grade 1-2				1840
12460	50		Nausea	grade 1-2				1840
12461	13		Rash	grade 1-2				1840
12462	25		Vomiting	grade 1-2				1840
12463	6.7		Heart block	grade 3			TRUE	1846
12464	14.3		Rash	grade 3			TRUE	1848
12465						No adverse reactions leading to discontinuation were reported		1850
12466						No adverse reactions leading to discontinuation were reported		1852
12467			Headache		discontinuation			1853
12468						No patients withdrew from the study due to adverse events.		1851
12469			Syncope hypotensive		discontinuation	WARNING		1854
12470			Pulmonary venous hypertension		discontinuation	WARNING		1854
12471			Bronchospasm		discontinuation	WARNING		1854
12472	0.64		Hypokalemia		discontinuation			1855
12473	5 pts		Renal disorders NEC					1857
12474	23 pts		Renal disorders NEC		discontinuation	leads to discontinuation		1856
12475	23 pts		Gastrointestinal disorders NEC		discontinuation	leads to discontinuation		1856
12476	1 pts		Atrial fibrillation	serious				1862
12477	3 pts		Palpitations	below serious				1862
12478			Thyroid hormones increased			Overdosage		1858
12479			Systolic pressure increased			Overdosage		1858
12480			Hyperthyroidism			Overdosage		1859
12481			Seizures			Overdosage		1859
12482			Hypertension	grade 1		Overdosage		1860
12483			Tachycardia	grade 1		Overdosage		1860
12484	2.8		Alanine aminotransferase increased		discontinuation			1861
12485	30		Drowsiness					1864
12486						No adverse effects leading to discontinuation were reported		1863
12487			Vomiting			Overdosage		1866
12488			Ache stomach			Overdosage		1866
12489			Increased salivation			Overdosage		1866
12490			Sweating			Overdosage		1866
12491			Jaw movements disturbance			Overdosage		1866
12492			Tremor muscle			Overdosage		1866
12493			Diarrhoea			Overdosage		1866
12494			Neuromuscular blockade			Overdosage		1867
12495						No information on AE is provided		1865
12496	1 pts		Abscess bacterial	serious				1870
12497	1 pts		Anaphylactic reaction	serious				1870
12498	1 pts		Arthritis bacterial	serious				1870
12499	1 pts		Cellulitis	serious				1870
12500	1 pts		Cerebral malaria	serious				1870
12501	1 pts		Cerebral palsy	serious				1870
12502	1 pts		Congenital absence of bile ducts	serious				1870
12503	4 pts		Death	serious				1870
12504	6 pts		Diarrhoea	serious				1870
12505	5 pts		Febrile convulsion	serious				1870
12506	1 pts		Femur fracture	serious				1870
12507	1 pts		Haemoglobin decreased	serious				1870
12508	1 pts		Head injury	serious				1870
12509	1 pts		Hepatic enzyme increased	serious				1870
12510	1 pts		Hydrocephalus	serious				1870
12511	3 pts		Lobar pneumonia	serious				1870
12512	6 pts		Lower respiratory tract infection	serious				1870
12513	42 pts		Malaria	serious				1870
12514	1 pts		Malnutrition	serious				1870
12515	3 pts		Bacterial meningitis	serious				1870
12516	1 pts		Oedema	serious				1870
12517	1 pts		Pericarditis tuberculous	serious				1870
12518	1 pts		Pneumocystis jiroveci pneumonia	serious				1870
12519	2 pts		Aspiration pneumonia	serious				1870
12520	1 pts		Pyrexia	serious				1870
12521	2 pts		Respiratory tract infection	serious				1870
12522	3 pts		Sickle cell anaemia	serious				1870
12523	3 pts		Anaemia sickle cell	serious				1870
12524	1 pts		Traumatic shock	serious				1870
12525	1 pts		Urinary tract infection	serious				1870
12526	62 pts		Conjunctivitis	below serious				1870
12527	76 pts		Conjunctivitis bacterial	below serious				1870
12528	55 pts		Dermatitis atopic	below serious				1870
12529	57 pts		Diarrhoea	below serious				1870
12530	73 pts		Haemoglobin decreased	below serious				1870
12531	122 pts		Malaria	below serious				1870
12532	145 pts		Neutrophil count decreased	below serious				1870
12533	97 pts		Oral candidiasis	below serious				1870
12534			Neutropenia	mild				1871
12535			Hyperlactatemia					1871
12536			Hepatotoxicity	grade 5	discontinuation	WARNING		1869
12537			Reaction skin	severe	discontinuation	WARNING		1869
12538						No AEs are reported		1868
12539	2		Rash		discontinuation	leads to discontinuation		1872
12540	1		Stevens-Johnson syndrome		discontinuation	leads to discontinuation		1872
12541	1		Transaminases increased		discontinuation	leads to discontinuation		1872
12542	1		ALT increased		discontinuation	leads to discontinuation		1872
12543	<1		GGT increased		discontinuation	leads to discontinuation		1872
12544	<1		AST increased		discontinuation	leads to discontinuation		1872
12545	<1		Hepatic enzyme increased		discontinuation	leads to discontinuation		1872
12546	1		Hepatitis		discontinuation	leads to discontinuation		1872
12547	1		Hepatotoxicity		discontinuation	leads to discontinuation		1872
12548	<1		Hepatitis acute		discontinuation	leads to discontinuation		1872
12549	<1		Hepatitis toxic		discontinuation	leads to discontinuation		1872
12550	1		Nausea		discontinuation	leads to discontinuation		1872
12551	1		Malaise		discontinuation	leads to discontinuation		1872
12552	1		Pyrexia		discontinuation	leads to discontinuation		1872
12553	1		Fatigue		discontinuation	leads to discontinuation		1872
12554	<1		Vascular disorders		discontinuation	leads to discontinuation		1872
12555	2		Rash		discontinuation	leads to discontinuation		1873
12556	<1		Drug rash with eosinophilia and systemic symptoms		discontinuation	leads to discontinuation		1873
12557	1		Transaminases increased		discontinuation	leads to discontinuation		1873
12558	<1		ALT increased		discontinuation	leads to discontinuation		1873
12559	<1		GGT increased		discontinuation	leads to discontinuation		1873
12560	<1		AST increased		discontinuation	leads to discontinuation		1873
12561	<1		Hepatic enzyme increased		discontinuation	leads to discontinuation		1873
12562	1		Hepatitis		discontinuation	leads to discontinuation		1873
12563	<1		Hepatotoxicity		discontinuation	leads to discontinuation		1873
12564	<1		Hepatitis acute		discontinuation	leads to discontinuation		1873
12565	<1		Hepatitis toxic		discontinuation	leads to discontinuation		1873
12566	<1		Nausea		discontinuation	leads to discontinuation		1873
12567	<1		Malaise		discontinuation	leads to discontinuation		1873
12568	<1		Pyrexia		discontinuation	leads to discontinuation		1873
12569	<1		Fatigue		discontinuation	leads to discontinuation		1873
12570	<1		Vascular disorders		discontinuation	leads to discontinuation		1873
12571	<1		Musculoskeletal and connective tissue disorders		discontinuation	leads to discontinuation		1873
12572			Weakness		discontinuation			1876
12573			Lethargy		discontinuation			1876
12574			Dizziness		discontinuation			1876
12575			Gait abnormal NOS		discontinuation			1876
12576			Restlessness		discontinuation			1876
12577			Grand mal seizure		discontinuation			1876
12578			Hyperreflexia		discontinuation			1876
12579			Coma		discontinuation			1876
12580			Depression central nervous system		discontinuation			1876
12581			Depressed level of consciousness		discontinuation	patient died		1875
12582			Seizures		discontinuation	patient died		1875
12583			Tachycardia		discontinuation	patient died		1875
12584			Acute myocarditis	grade 5	discontinuation	patient died		1875
12585			Muscular tone excessive		discontinuation	patient died		1874
12586			Hyperthermia	severe	discontinuation	patient died		1874
12587			Coma		discontinuation	patient died		1874
12588			Cardiovascular collapse		discontinuation	patient died		1874
12589			Acute renal failure		discontinuation	patient died		1874
12590			Hemolysis		discontinuation	patient died		1874
12591			Rhabdomyolysis		discontinuation	patient died		1874
12592			Disseminated intravascular coagulation		discontinuation	patient died		1874
12593			Suicidal ideation		discontinuation	WARNING		1877
12594			Crisis hypertensive		discontinuation	WARNING. Sometimes fatal		1878
12595	2.5		Epigastric discomfort		discontinuation			1881
12596	2.5		Diarrhoea		discontinuation			1881
12597	2.5		Loose stools		discontinuation			1881
12598	0.74		Chest pain		discontinuation			1879
12599	0.74		Rash		discontinuation			1879
12600	0.74		Vomiting		discontinuation			1879
12601	0.74		Exanthema		discontinuation	exanthema with pyrosis		1879
12602	0.74		Injection site pain		discontinuation			1879
12603			Nausea		discontinuation			1880
12604			Abdominal pain		discontinuation			1880
12605			Gastric ulcer		discontinuation			1880
12606			Duodenal ulcer		discontinuation			1880
12607	2.6		Gastrointestinal disorders		discontinuation			1882
12608	0.85		Haemorrhage of digestive tract		discontinuation			1882
12609	0.85		Headache		discontinuation			1882
12610	0.85		Oedema		discontinuation			1882
12611	0.85		Pruritus		discontinuation			1882
12612	0.85		Erythema facial		discontinuation			1882
12613	0.85		Hematoma		discontinuation			1882
12614			Cardiac thrombosis	grade 3-5	discontinuation	WARNING		1883
12615			Myocardial infarction	grade 3-5	discontinuation	WARNING		1883
12616			Stroke	grade 3-5	discontinuation	WARNING		1883
12617			Gastrointestinal disorder NOS	serious	discontinuation	WARNING		1883
12618			Bleeding	serious	discontinuation	WARNING		1883
12619			Ulceration	serious	discontinuation	WARNING		1883
12620			Perforation stomach	grade 3-5	discontinuation	WARNING		1883
12621			Perforation of intestine	grade 3-5	discontinuation	WARNING		1883
12622	1 pts		Urinary tract infection	serious				1884
12623	1 pts		Myocardial infarction	serious				1884
12624	1 pts		Chronic obstructive pulmonary disease	serious				1884
12625	1 pts		Haemorrhoidal haemorrhage	serious				1884
12626	1 pts		Intervertebral disc protrusion	serious				1884
12627	1 pts		Neck pain	serious				1884
12628	1 pts		Uterine prolapse	serious				1884
12629	1 pts		Extradural haematoma	serious				1884
12630	1 pts		Humerus fracture	serious				1884
12631	24 pts		Nausea	below serious				1884
12632	18 pts		Fatigue	below serious				1884
12633	11 pts		Somnolence	below serious				1884
12634	10 pts		Muscle spasms	below serious				1884
12635	9 pts		Arthralgia	below serious				1884
12636	1 pts		Pneumonia	serious				1885
12637	1 pts		Injury	serious				1885
12638	1 pts		Transient ischaemic attack	serious				1885
12639	26 pts		Nausea	below serious				1885
12640	35 pts		Dizziness	below serious				1885
12641	20 pts		Headache	below serious				1885
12642	28 pts		Somnolence	below serious				1885
12643	1 pts		Rash	below serious				1886
12644	1 pts		Headache	below serious				1886
12645	1 pts		Coordination impaired	below serious				1886
12646	1 pts		Dizziness	below serious				1886
12647	1 pts		Painful urination	below serious				1886
12648	1 pts		Menstrual irregularity	below serious				1886
12649	1 pts		Difficulty sleeping	below serious				1886
12650	1 pts		Anxiety	below serious				1886
12651	2 pts		Poor concentration	below serious				1886
12652	1 pts		General malaise	below serious				1886
12653	1 pts		Fatigue	below serious				1886
12654	2 pts		Energy decreased	below serious				1886
12655	1		Hallucination		discontinuation	early Parkinson's disease		1889
12656	0.8		Peripheral edema		discontinuation	early Parkinson's disease		1889
12657	0.6		Abdominal pain upper		discontinuation	early Parkinson's disease		1889
12658	0.6		Myocardial infarction		discontinuation	early Parkinson's disease		1889
12659	0.6		Nausea		discontinuation	early Parkinson's disease		1889
12660	0.6		Pneumonia		discontinuation	early Parkinson's disease		1889
12661	0.6		Vomiting		discontinuation	early Parkinson's disease		1889
12662	1.3		Hallucination		discontinuation	advanced Parkinson's disease		1888
12663	0.5		Hypotension		discontinuation	advanced Parkinson's disease		1888
12664	0.5		Peripheral edema		discontinuation	advanced Parkinson's disease		1888
12665	3.6		Drowsiness				TRUE	1887
12666	1.8		Muscle spasms				TRUE	1887
12667	1.8		Insomnia				TRUE	1887
12668	1.8		Vertigo				TRUE	1887
12669	1.8		Ankle swelling				TRUE	1887
12670	3.6		Hallucination				TRUE	1887
12671	1.8		Nausea				TRUE	1887
12672	6.1		Gastrointestinal discomfort		discontinuation			1890
12673	4.3		Hallucinations		discontinuation			1890
12674	3		Sleepiness		discontinuation			1890
12675	2.5		Dizziness		discontinuation			1890
12676	1.2		Memory loss		discontinuation			1890
12677	0.6		Paranoia		discontinuation			1890
12678	3 pts		Cardiotoxicity					1896
12679			Tremor			Five patients complained of muscle cramps, two patients had diifficulty in falling asleep, two patients had chest pain and one patient suffered from restlessness. The mean symptom scores for tremor and palpitation		1891
12680			Palpitation			Five patients complained of muscle cramps, two patients had diifficulty in falling asleep, two patients had chest pain and one patient suffered from restlessness. The mean symptom scores for tremor and palpitation		1891
12681	1 pts		Nausea			Poisoning		1895
12682	1 pts		Tachycardia			Poisoning		1895
12683	1 pts		Tremor			Poisoning		1895
12684	1 pts		Hyperglycemia			Poisoning		1895
12685	1 pts		Hypokalemia			Poisoning		1895
12686	1 pts		Tachycardia					1893
12687	1 pts		Abdominal pain					1894
12688	1 pts		Jitteriness					1894
12689	1 pts		Palpitations					1894
12690	1 pts		Tachycardia					1892
12691	1 pts		Systolic murmur					1892
12692	1 pts		Tremor					1892
12693	4 pts		Nausea					1898
12694	1 pts		Vomiting					1898
12695	4 pts		Lightheadedness					1898
12696	11 pts		Gastrointestinal disorder NOS		discontinuation	leads to discontinuation		1897
12697	4 pts		CNS disorder (NOS)		discontinuation	leads to discontinuation		1897
12698	2 pts		Dizziness		discontinuation	leads to discontinuation		1897
12699	2 pts		Dermatitis		discontinuation	leads to discontinuation		1897
12700						impossible to link AEs with the definite dose: with no serious or severe TEAEs. The most common TEAE was headache.		1900
12701						impossible to link AEs with the definite dose: with no serious or severe TEAEs. The most common TEAE was headache.		1902
12702			Back pain					1899
12703			Myalgia					1899
12704			Abnormal vision					1899
12705	19 pts		Headache		discontinuation	leads to discontinuation		1901
12706	10 pts		Flushing		discontinuation	leads to discontinuation		1901
12707	5 pts		Rhinitis		discontinuation	leads to discontinuation		1901
12708	4 pts		Tachycardia		discontinuation	leads to discontinuation		1901
12709	5 pts		Nausea		discontinuation	leads to discontinuation		1901
12710	4 pts		Liver function test abnormal		discontinuation	leads to discontinuation		1901
12711	3 pts		Dizziness		discontinuation	leads to discontinuation		1901
12712	3 pts		Hypesthesia		discontinuation	leads to discontinuation		1901
12713	3 pts		Abdominal pain		discontinuation	leads to discontinuation		1901
12714	3 pts		Palpitations		discontinuation	leads to discontinuation		1901
12715						No adverse reactions leading to discontinuation were reported. At the 2.4- and 2.8-mg/m2 dose levels, 50% of the patients had grade 3 or greater toxicity.		1905
12716	33.3		Neutropenia	grade 4			TRUE	1903
12717	33.3		Thrombocytopenia	grade 4			TRUE	1903
12718			Obstipation			% is not indicated	TRUE	1903
12719	33.3		Myalgia	grade 3			TRUE	1903
12720						No adverse reactions leading to discontinuation were reported		1904
12721	14.3		Motor polyneuropathy	grade 3			TRUE	1907
12722	14.3		Seizure	grade 4			TRUE	1907
12723	14.3		Hepatotoxicity	grade 4			TRUE	1907
12724	10		Peripheral neuropathy		discontinuation	Adverse reactions related to neuropathy and leading to treatment discontinuation were decreased vibratory sense, facial palsy, hyporeflexia, constipation, asthenia, fatigue, and musculoskeletal pain, each reported in at least 1 patient.		1906
12725	2		Tumor lysis syndrome		discontinuation			1906
12726	10 pts		Anaemia	serious				1908
12727	2 pts		Disseminated intravascular coagulation	serious				1908
12728	1 pts		Leukopenia	serious				1908
12729	3 pts		Thrombocytopenia	serious				1908
12730	6 pts		Atrial fibrillation	serious				1908
12731	1 pts		Cardiac tamponade	serious				1908
12732	1 pts		Cardio-respiratory arrest	serious				1908
12733	2 pts		Pericarditis	serious				1908
12734	1 pts		Right ventricular failure	serious				1908
12735	2 pts		Abdominal pain	serious				1908
12736	1 pts		Abdominal pain upper	serious				1908
12737	4 pts		Constipation	serious				1908
12738	2 pts		Diarrhoea	serious				1908
12739	1 pts		Gastrointestinal pain	serious				1908
12740	12 pts		Nausea	serious				1908
12741	1 pts		Oesophageal stenosis	serious				1908
12742	6 pts		Vomiting	serious				1908
12743	1 pts		Chest pain	serious				1908
12744	2 pts		Death	serious				1908
12745	8 pts		Fatigue	serious				1908
12746	2 pts		General physical health deterioration	serious				1908
12747	5 pts		Malaise	serious				1908
12748	5 pts		Pyrexia	serious				1908
12749	1 pts		Bile duct stone	serious				1908
12750	1 pts		Cholelithiasis	serious				1908
12751	1 pts		Cellulitis	serious				1908
12752	1 pts		Diverticulitis	serious				1908
12753	1 pts		Lower respiratory tract infection	serious				1908
12754	13 pts		Pneumonia	serious				1908
12755	2 pts		Sepsis	serious				1908
12756	1 pts		Upper respiratory tract infection	serious				1908
12757	8 pts		Accidental overdose	serious				1908
12758	2 pts		Overdose	serious				1908
12759	1 pts		Alanine aminotransferase increased	serious				1908
12760	1 pts		Blood alkaline phosphatase increased	serious				1908
12761	1 pts		Blood bilirubin increased	serious				1908
12762	1 pts		Blood creatinine increased	serious				1908
12763	1 pts		C-reactive protein increased	serious				1908
12764	1 pts		Gamma-glutamyltransferase increased	serious				1908
12765	1 pts		International normalised ratio increased	serious				1908
12766	4 pts		Decreased appetite	serious				1908
12767	5 pts		Dehydration	serious				1908
12768	1 pts		Hyperkalaemia	serious				1908
12769	1 pts		Hypokalaemia	serious				1908
12770	1 pts		Flank pain	serious				1908
12771	1 pts		Muscular weakness	serious				1908
12772	2 pts		Bladder cancer	serious				1908
12773	1 pts		Neuroendocrine carcinoma	serious				1908
12774	1 pts		Pericarditis malignant	serious				1908
12775	1 pts		Dizziness	serious				1908
12776	1 pts		Anxiety	serious				1908
12777	1 pts		Depression	serious				1908
12778	1 pts		Disorientation	serious				1908
12779	1 pts		Renal impairment	serious				1908
12780	1 pts		Urinary retention	serious				1908
12781	1 pts		Acute respiratory distress syndrome	serious				1908
12782	1 pts		Hypoxia	serious				1908
12783	6 pts		Pleural effusion	serious				1908
12784	1 pts		Pleuritic pain	serious				1908
12785	3 pts		Pneumothorax	serious				1908
12786	3 pts		Pulmonary embolism	serious				1908
12787	1 pts		Respiratory acidosis	serious				1908
12788	45 pts		Anaemia	below serious				1908
12789	22 pts		Thrombocytopenia	below serious				1908
12790	28 pts		Abdominal pain	below serious				1908
12791	80 pts		Constipation	below serious				1908
12792	142 pts		Diarrhoea	below serious				1908
12793	31 pts		Dry mouth	below serious				1908
12794	189 pts		Nausea	below serious				1908
12795	131 pts		Vomiting	below serious				1908
12796	153 pts		Fatigue	below serious				1908
12797	18 pts		Malaise	below serious				1908
12798	38 pts		Pyrexia	below serious				1908
12799	29 pts		Blood creatinine increased	below serious				1908
12800	19 pts		C-reactive protein increased	below serious				1908
12801	67 pts		Weight decreased	below serious				1908
12802	133 pts		Decreased appetite	below serious				1908
12803	19 pts		Dehydration	below serious				1908
12804	20 pts		Musculoskeletal pain	below serious				1908
12805	23 pts		Dizziness	below serious				1908
12806	27 pts		Dysgeusia	below serious				1908
12807	23 pts		Headache	below serious				1908
12808	28 pts		Insomnia	below serious				1908
12809	97 pts		Dyspnoea	below serious				1908
12810	1 pts		Fatigue	grade 3	discontinuation	leads to dose reduction	TRUE	1910
12811	8		Thrombocytopenia	grade 3-4	discontinuation	leads to discontinuation		1909
12812	17		Anemia	grade 3-4	discontinuation	leads to discontinuation		1909
12813	25		Deep vein thrombosis	grade 3-4	discontinuation	leads to discontinuation		1909
12814	25		Pyrexia	grade 3-4	discontinuation			1909
12815	17		Hypotension	grade 3-4				1909
12816	17		Pulmonary embolism	grade 3-4	discontinuation			1909
12817	8		Sepsis	grade 3-4				1909
12818	27		Fatigue	all grades				1909
12819	11		Diarrhea					1909
12820	8		Nausea					1909
12821	11		Dysgeusia					1909
12822	3		Weight loss					1909
12823	11		Vomiting					1909
12824	3		Anorexia					1909
12825	8		Blood creatinine increased					1909
12826	5		Dehydration					1909
12827	5		Anemia					1909
12828						No AEs reported		1911
12829			Drug dependence					1912
12830	1.4		Intermenstrual bleeding		discontinuation			1913
12831	4		Amenorrhoea		discontinuation			1913
12832	0.5		Menstruation delayed		discontinuation			1913
12833	2.1		Bleeding		discontinuation	heavy		1913
12834	0.7		Menstrual cramps		discontinuation			1913
12835	4.7		Bleeding		discontinuation	irregular		1913
12836	0.2		Oedema		discontinuation			1913
12837	0.2		Hypertension		discontinuation			1913
12838	0.2		Genital boil		discontinuation			1913
12839	0.5		Painful joints		discontinuation			1913
12840	0.2		Pain		discontinuation			1913
12841	2.1		Migraine headache		discontinuation			1913
12842	0.7		Dizziness		discontinuation			1913
12843	0.7		Nervousness		discontinuation			1913
12844	0.2		Irritable		discontinuation			1913
12845	1.9		Depression		discontinuation			1913
12846	0.2		Dysphoria		discontinuation			1913
12847	0.2		Lethargy		discontinuation			1913
12848	1.2		Loss of libido		discontinuation			1913
12849	0.5		Eye inflammation		discontinuation			1913
12850	1.2		Vomiting		discontinuation			1913
12851	1.4		Flatulence		discontinuation			1913
12852	1.2		Breast tenderness		discontinuation			1913
12853	0.2		Urinary hesitancy		discontinuation			1913
12854	0.5		Acne		discontinuation			1913
12855	1.6		Weight gain		discontinuation			1913
12856	0.6		Nausea		discontinuation			1914
12857	1.1		Bleeding breakthrough		discontinuation			1914
12858	2.8		Mastopathy		discontinuation			1914
12859	3.9		Dysmenorrhoea		discontinuation			1914
12860	3.9		Neuropathy		discontinuation			1914
12861	1.1		Headache		discontinuation			1914
12862	0.6		Abnormal weight gain		discontinuation			1914
12863	0.6		Thrombophlebitis		discontinuation			1914
12864	<2		Hypertension		discontinuation	leads to discontinuation		1919
12865	<0.7		Tachycardia		discontinuation	leads to discontinuation		1919
12866	6		Dry mouth					1919
12867	20.1		Anorexia					1919
12868	12.1		Insomnia					1919
12869	11.4		Increased appetite					1919
12870	3.4		Nausea					1919
12871	4		Dyspepsia					1919
12872	4.7		Nervousness					1919
12873	2.7		Asthenia					1919
12874	4.7		Dizziness					1919
12875	6.7		Constipation					1919
12876	5.4		Rash					1919
12877	2		Palpitations					1919
12878	1.3		Vasodilation					1919
12879	1.3		Dyspnea					1919
12880	0.7		Taste perversion					1919
12881	2		Hypertension					1919
12882	0.7		Tachycardia					1919
12883	2		Paresthesia					1919
12884	<1.2		Hypertension		discontinuation	leads to discontinuation		1920
12885	<1.8		Tachycardia		discontinuation	leads to discontinuation		1920
12886	11.8		Dry mouth					1920
12887	18.9		Anorexia					1920
12888	8.3		Insomnia					1920
12889	16.6		Increased appetite					1920
12890	4.1		Nausea					1920
12891	4.1		Dyspepsia					1920
12892	5.3		Nervousness					1920
12893	7.1		Asthenia					1920
12894	8.9		Dizziness					1920
12895	13		Constipation					1920
12896	4.1		Rash					1920
12897	2.4		Vasodilation					1920
12898	0.6		Dyspnea					1920
12899	1.2		Taste perversion					1920
12900	1.2		Hypertension					1920
12901	1.2		Sweating					1920
12902	1.8		Tachycardia					1920
12903	1.2		Ecchymosis					1920
12904	2.4		Paresthesia					1920
12905	<2		Hypertension		discontinuation	leads to discontinuation		1921
12906	<3		Tachycardia		discontinuation	leads to discontinuation		1921
12907	16.7		Dry mouth					1921
12908	18.7		Anorexia					1921
12909	9.4		Insomnia					1921
12910	16.7		Increased appetite					1921
12911	3.4		Nausea					1921
12912	4.4		Dyspepsia					1921
12913	6.4		Nervousness					1921
12914	7.9		Asthenia					1921
12915	7.9		Dizziness					1921
12916	10.8		Constipation					1921
12917	4.9		Rash					1921
12918	4.9		Palpitation					1921
12919	2		Vasodilation					1921
12920	1.5		Dyspnea					1921
12921	2		Taste perversion					1921
12922	4.9		Hypertension					1921
12923	1		Sweating					1921
12924	4.4		Tachycardia					1921
12925	0.5		Ecchymosis					1921
12926	3.9		Paresthesia					1921
12927	<2		Hypertension		discontinuation	leads to discontinuation		1922
12928	<3		Tachycardia		discontinuation	leads to discontinuation		1922
12929	25.5		Dry mouth					1922
12930	21.4		Anorexia					1922
12931	10.2		Insomnia					1922
12932	14.3		Increased appetite					1922
12933	5.1		Nausea					1922
12934	8.2		Dyspepsia					1922
12935	7.7		Nervousness					1922
12936	6.1		Asthenia					1922
12937	8.2		Dizziness					1922
12938	11.7		Constipation					1922
12939	7.1		Rash					1922
12940	2.6		Palpitation					1922
12941	2		Vasodilation					1922
12942	1		Dyspnea					1922
12943	2.6		Taste perversion					1922
12944	5.1		Hypertension					1922
12945	2.6		Sweating					1922
12946	7.7		Tachycardia					1922
12947	3.1		Ecchymosis					1922
12948	2		Paresthesia					1922
12949	<1.4		Hypertension		discontinuation	leads to discontinuation		1916
12950	<3		Tachycardia		discontinuation	leads to discontinuation		1916
12951	32.2		Dry mouth					1916
12952	32.2		Anorexia					1916
12953	10.3		Insomnia					1916
12954	11.6		Increased appetite					1916
12955	8.2		Nausea					1916
12956	5.5		Dyspepsia					1916
12957	12.3		Nervousness					1916
12958	8.9		Asthenia					1916
12959	12.3		Dizziness					1916
12960	12.3		Constipation					1916
12961	4.1		Rash					1916
12962	4.1		Palpitation					1916
12963	4.8		Vasodilation					1916
12964	1.4		Dyspnea					1916
12965	4.1		Taste perversion					1916
12966	1.4		Hypertension					1916
12967	4.1		Sweating					1916
12968	6.8		Tachycardia					1916
12969	1.4		Ecchymosis					1916
12970	3.4		Paresthesia					1916
12971	2		Hypertension		discontinuation	leads to discontinuation		1918
12972	3		Tachycardia		discontinuation	leads to discontinuation		1918
12973	31.8		Dry mouth					1918
12974	31.8		Anorexia					1918
12975	24.5		Insomnia					1918
12976	21.2		Increased appetite					1918
12977	12.6		Nausea					1918
12978	12.6		Dyspepsia					1918
12979	11.3		Nervousness					1918
12980	10.6		Asthenia					1918
12981	7.9		Dizziness					1918
12982	7.9		Constipation					1918
12983	7.3		Rash					1918
12984	6		Palpitation					1918
12985	5.3		Vasodilation					1918
12986	4.6		Dyspnea					1918
12987	4.6		Taste perversion					1918
12988	3.3		Hypertension					1918
12989	2.6		Sweating					1918
12990	2.6		Tachycardia					1918
12991	2		Ecchymosis					1918
12992	1.3		Paresthesia					1918
12993	2 pts		Palpitations					1923
12994	1 pts		Palpitations		discontinuation	leads to discontinuation		1923
12995	1 pts		Palpitations					1917
12996	1 pts		Paresthesia					1917
12997	1 pts		Anxiety					1917
12998	1 pts		Insomnia					1917
12999	1 pts		Fatigue					1917
13000	0.4		Hypertension		discontinuation	leads to discontinuation		1915
13001	0.4		Tachycardia		discontinuation	leads to discontinuation		1915
13002	3		Arthralgia		discontinuation			1924
13003	2.6		Myalgia		discontinuation			1924
13004	1.1		Nausea		discontinuation			1924
13005	0.7		Myasthenia		discontinuation			1924
13006	0.3		Flatulence		discontinuation			1924
13007	0.3		Pain		discontinuation			1924
13008	0.3		Pharyngitis		discontinuation			1924
13009	0.3		Dysphagia		discontinuation			1924
13010	0.3		Dizziness		discontinuation			1924
13011	0.3		Chest pain		discontinuation			1924
13012	0.3		Asthenia		discontinuation			1924
13013	0.3		Rash		discontinuation			1924
13014	0.3		Vomiting		discontinuation			1924
13015	0.3		Anorexia		discontinuation			1924
13016	5 pts		Serum potassium decreased					1925
13017	5 pts		Rise in blood pressure					1925
13018	3 pts		Cellulitis	below serious				1930
13019	1 pts		Cellulitis	below serious				1933
13020	1 pts		Rash	below serious				1931
13021	1 pts		Hemorrhoidal hemorrhage	below serious				1932
13022	3 pts		Headache					1929
13023	1 pts		Constipation					1929
13024						The most adverse events reported being local reactions: 47 versus 44 were possibly or probably related to treatment in the ketoprofen and placebo groups, respectively.		1926
13025	1 pts		Epigastric pain	mild				1927
13026	1 pts		Lip swelling		discontinuation	leads to discontinuation		1928
13027	1 pts		Rash	mild	discontinuation	leads to discontinuation		1928
13028	1 pts		Headache	below serious				1938
13029	2 pts		Dizzy on standing	below serious				1938
13030	2 pts		Dry mouth	below serious				1938
13031	1 pts		Nausea	below serious				1938
13032	1 pts		Thirst	below serious				1938
13033	2 pts		Fatigue	below serious				1938
13034	2 pts		Headache	below serious				1937
13035	2 pts		Nausea	below serious				1937
13036	1 pts		Swelling of hands	below serious				1937
13037	1 pts		Melanoma		discontinuation	leads to discontinuation		1941
13038	1 pts		Melanoma	grade 5				1940
13039	1 pts		Alopecia		discontinuation	leads to discontinuation/leads to dose reduction		1939
13040	1 pts		Red neck		discontinuation	leads to discontinuation/leads to dose reduction		1939
13041	1 pts		Flushing of face		discontinuation	leads to discontinuation/leads to dose reduction		1939
13042	2		Cough		discontinuation	leads to discontinuation		1935
13043						No information on AE is provided		1934
13044	1		Dry throat		discontinuation	leads to discontinuation		1936
13045	1		Tightness in chest		discontinuation	leads to discontinuation		1936
13046	1 pts		Extrapyramidal disorder	serious				1942
13047	1 pts		Neuroleptic malignant syndrome	serious				1942
13048	1 pts		Aggression	serious				1942
13049	1 pts		Schizophrenia	serious				1942
13050	9 pts		Nausea	below serious				1942
13051	5 pts		Nasopharyngitis	below serious				1942
13052	7 pts		Dizziness	below serious				1942
13053	13 pts		Extrapyramidal disorder	below serious				1942
13054	16 pts		Headache	below serious				1942
13055	11 pts		Somnolence	below serious				1942
13056	1 pts		Varicella	serious				1943
13057	1 pts		Depression	serious				1943
13058	1 pts		Schizophrenia	serious				1943
13059	1 pts		Suicidal ideation	serious				1943
13060	1 pts		Thrombophlebitis	serious				1943
13061	10 pts		Nausea	below serious				1943
13062	5 pts		Nasopharyngitis	below serious				1943
13063	4 pts		Dizziness	below serious				1943
13064	22 pts		Extrapyramidal disorder	below serious				1943
13065	11 pts		Headache	below serious				1943
13066	22 pts		Somnolence	below serious				1943
13067	12 pts		Tremor	below serious				1943
13068	8 pts		Constipation	below serious				1946
13069	7 pts		Diarrhea	below serious				1946
13070	2 pts		Nausea	below serious				1946
13071	7 pts		Abdominal discomfort	below serious				1946
13072	15 pts		Vomiting	below serious				1946
13073	12 pts		Decreased appetite	below serious				1946
13074	16 pts		Increased appetite	below serious				1946
13075	5 pts		Drowsiness	below serious				1946
13076	21 pts		Tiredness	below serious				1946
13077	3 pts		Fever	below serious				1946
13078	8 pts		Weight gain	below serious				1946
13079	3 pts		Muscle rigidity	below serious				1946
13080	3 pts		Tremor	below serious				1946
13081	3 pts		Nervousness	below serious				1946
13082	3 pts		Repetitive speech	below serious				1946
13083	3 pts		Restlessness	below serious				1946
13084	3 pts		Feeling sad	below serious				1946
13085	3 pts		Self injurious behavior	below serious				1946
13086	3 pts		Enuresis	below serious				1946
13087	4 pts		Dizziness	below serious				1946
13088	3 pts		Nose bleed	below serious				1946
13089	2 pts		Restlessness	below serious				1952
13090	1 pts		Decreased activity	below serious				1952
13091	2 pts		Drowsiness	below serious				1952
13092	1 pts		Vertigo	below serious				1952
13093	1 pts		Cold extremities	below serious				1952
13094	2 pts		Blurred vision	below serious				1952
13095	2 pts		Sexual disorder NOS	below serious				1952
13096	1 pts		Joint stiffness	below serious				1952
13097	1 pts		Rhabdomyolysis	serious				1953
13098	1 pts		Pneumonia	serious				1953
13099	1 pts		Cellulitis	serious				1953
13100	3 pts		Abrasions	below serious				1953
13101	12 pts		Akathisia	below serious				1953
13102	6 pts		Drowsiness	below serious				1953
13103	8 pts		Fatigue	below serious				1953
13104	3 pts		Depressed mood	below serious				1953
13105	4 pts		Hypernatremia	below serious				1953
13106	3 pts		Hypocalcemia	below serious				1953
13107	8 pts		ALT increased	below serious				1953
13108	6 pts		Aspartate aminotransferase increased	below serious				1953
13109	4 pts		Restlessness	below serious				1953
13110	3 pts		Sleep disturbance	below serious				1953
13111	6 pts		Infection upper respiratory	below serious				1953
13112	2 pts		Suicidal ideation	serious				1954
13113	1 pts		Gun shot wound	serious				1954
13114	1 pts		Injury	serious				1954
13115	1 pts		Multiple injuries	serious				1954
13116	1 pts		Diabetes mellitus	serious				1954
13117	1 pts		Hyperglycaemia	serious				1954
13118	1 pts		Pancreatic carcinoma	serious				1954
13119	1 pts		Hallucination, auditory	serious				1954
13120	1 pts		Suicide attempt	serious				1954
13121	16 pts		Headache	below serious				1954
13122	27 pts		Insomnia	below serious				1954
13123	16 pts		Tremor	below serious				1954
13124	7 pts		Abdominal pain	below serious				1950
13125	2 pts		Bruising	below serious				1950
13126	6 pts		Constipation	below serious				1950
13127	9 pts		Diarrhea	below serious				1950
13128	5 pts		Dizziness	below serious				1950
13129	6 pts		Dry mouth	below serious				1950
13130	5 pts		Enuresis	below serious				1950
13131	6 pts		Headache	below serious				1950
13132	8 pts		Insomnia	below serious				1950
13133	7 pts		Malaise	below serious				1950
13134	4 pts		Mucosal ulceration	below serious				1950
13135	10 pts		Nausea	below serious				1950
13136	5 pts		Restlessness	below serious				1950
13137	7 pts		Sedation	below serious				1950
13138	7 pts		Tinnitus	below serious				1950
13139	8 pts		Tremor	below serious				1950
13140	10 pts		Vomiting	below serious				1950
13141	4 pts		Weight loss	below serious				1950
13142						impossible to link AEs with the definite dose: AEs reported by two or more subjects during at least one aripiprazole treatment period, regardless of the dose, were headache, nausea, and lightheadedness. No SAEs occurred.		1951
13143						impossible to link AEs with the definite dose: AEs reported by two or more patients in any aripiprazole treatment group were lightheadedness, headache, tachycardia, nausea, asthenia, dyspepsia, vomiting, agitation, somnolence, anxiety, insomnia, pain in extremities, constipation and orthostatic hypotension		1948
13144	17		Abdominal pain upper					1947
13145	17		Vomiting					1947
13146	17		Dizziness					1947
13147	50		Headache					1947
13148	33		Sedation					1947
13149	17		Somnolence					1947
13150			Adverse event	grade 5		WARNING		1945
13151			Vomiting					1944
13152			Somnolence					1944
13153			Tremor					1944
13154			Acidosis					1944
13155			Aggression					1944
13156			Aspartate aminotransferase increased					1944
13157			Atrial fibrillation					1944
13158			Coma					1944
13159			Confusional state					1944
13160			Convulsion					1944
13161			Blood creatine phosphokinase increased					1944
13162			Depressed level of consciousness					1944
13163			Hypertension					1944
13164			Hypokalemia					1944
13165			Hypotension					1944
13166			Lethargy					1944
13167			Loss of consciousness					1944
13168			QT prolonged					1944
13169			Aspiration pneumonia					1944
13170			Respiratory arrest					1944
13171			Status epilepticus					1944
13172			Tachycardia					1944
13173			Vomiting					1949
13174			Somnolence					1949
13175			Tremor					1949
13176			Acidosis					1949
13177			Aggression					1949
13178			Aspartate aminotransferase increased					1949
13179			Atrial fibrillation					1949
13180			Coma					1949
13181			Confusional state					1949
13182			Convulsion					1949
13183			Blood creatine phosphokinase increased					1949
13184			Depressed level of consciousness					1949
13185			Hypertension					1949
13186			Hypokalemia					1949
13187			Hypotension					1949
13188			Lethargy					1949
13189			Loss of consciousness					1949
13190			QT prolonged					1949
13191			Aspiration pneumonia					1949
13192			Respiratory arrest					1949
13193			Status epilepticus					1949
13194			Tachycardia					1949
13195						No AEs were reported		1957
13196						No AEs were reported		1958
13197	4.3		Rash					1956
13198	1.4		Diarrhea					1956
13199	1		Fever					1956
13200	12		Pain					1955
13201	2.9		Erythema					1955
13202	0.9		Induration					1955
13203	2.1		Phlebitis					1955
13204	6.3		Blood eosinophils increased					1955
13205	3.6		Increased platelets					1955
13206	3.2		Neutropenia					1955
13207	3.8		AST increased					1955
13208	6.5		ALT increased					1955
13209	5.8		Increased serum creatinine					1955
13210	36 pts		Lightheadedness	below serious				1964
13211	17 pts		Drowsiness	below serious				1964
13212	36 pts		Gastrointestinal disorder	below serious				1964
13213	28 pts		Headache	below serious				1964
13214	16 pts		Insomnia	below serious				1964
13215	13 pts		Allergic sinusitis	below serious				1964
13216	1 pts		Light headedness	below serious				1963
13217	1 pts		Nausea	below serious				1962
13218	1 pts		Headache	below serious				1962
13219	1 pts		Fatigue	below serious				1962
13220	5 pts		Frozen gait	below serious				1965
13221	3 pts		Tremor	below serious				1965
13222	2 pts		Dizziness	below serious				1965
13223	2 pts		Fatigue	below serious				1965
13224	1 pts		Bradycardia	below serious				1965
13225	1 pts		Constipation	below serious				1965
13226	1 pts		Dysphagia	below serious				1965
13227	1 pts		Fuzzy	below serious				1965
13228	1 pts		Gastritis and duodenitis	below serious				1965
13229	1 pts		Gastrointestinal disorder (NOS)	below serious				1965
13230	1 pts		Cramp in hand	below serious				1965
13231	1 pts		Headache	below serious				1965
13232	1 pts		Increased agitation	below serious				1965
13233	1 pts		Increased appetite	below serious				1965
13234	1 pts		Balance impaired NOS	below serious				1965
13235	1 pts		Dystonia	below serious				1965
13236	1 pts		Irritability	below serious				1965
13237	1 pts		Pain in knee	below serious				1965
13238	1 pts		Pain	below serious				1965
13239	1 pts		Insomnia	below serious				1965
13240	1 pts		Joint stiffness	below serious				1965
13241	1 pts		Pain neck/shoulder	below serious				1965
13242	1 pts		Leg pain	below serious				1965
13243	1 pts		Nasal congestion	below serious				1965
13244	1 pts		Numbness	below serious				1965
13245	1 pts		Infection respiratory	below serious				1965
13246	1 pts		Nausea		discontinuation	leads to discontinuation		1961
13247	1 pts		Drowsiness	grade 3	discontinuation	leads to discontinuation		1961
13248	1 pts		Dizziness	grade 3	discontinuation	leads to discontinuation		1961
13249	29 pts		Headache					1960
13250	10 pts		Asthenia					1960
13251	16 pts		Accidental injury					1960
13252	13 pts		Nausea					1960
13253	5 pts		Dyspepsia					1960
13254	6 pts		Diarrhea					1960
13255	34 pts		Vomiting					1960
13256	14 pts		Lightheadedness					1960
13257	5 pts		Somnolence					1960
13258	5 pts		Insomnia					1960
13259	5 pts		Nervousness					1960
13260	5 pts		Upper respiratory tract infection					1960
13261	5 pts		Drug intolerance		discontinuation	leads to discontinuation		1959
13262	1 pts		Death	serious				1967
13263	1 pts		Stroke	serious				1967
13264	1 pts		Accidental injury	serious				1967
13265	1 pts		Intentional overdose	serious				1968
13266	1 pts		Deep vein thrombosis	serious				1968
13267	1 pts		Cancer	serious				1966
13268	1 pts		Trauma	serious				1966
13269	1 pts		Clot blood	serious				1966
13270	6 pts		Blood pressure abnormal	below serious				1966
13271	2 pts		Electrolyte disturbance	below serious				1966
13272	4 pts		Infection	below serious				1966
13273	2 pts		Trauma	below serious				1966
13274	1 pts		Thoracic vertebral fracture	serious				1969
13275	1 pts		Muscle cramps			suicide attempt		1971
13276	1 pts		Hyperkalemia		discontinuation	leads to discontinuation		1970
13277	8.3		Dizziness					1970
13278	9.2		Headache					1970
13279	5.8		Back pain					1970
13280	5.8		Upper respiratory tract infection					1970
13281	5		Nasopharyngitis					1970
13282	5		Diarrhea					1970
13283	5		Hypoglycemia					1970
13284	4.2		Peripheral edema					1970
13285	4.2		Nausea					1970
13286	2.3		Headache		discontinuation	leads to discontinuation		1973
13287	2.3		Dizziness		discontinuation	leads to discontinuation		1973
13288	0.5		Creatinine increased		discontinuation	leads to discontinuation		1974
13289	0.5		Potassium increased		discontinuation	leads to discontinuation		1974
13290			Disorder fetal		discontinuation	leads to discontinuation		1972
13291	8 pts		Headache	grade 2-5	discontinuation	leads to discontinuation		1975
13292	1 pts		Depression	serious				1977
13293	1 pts		Hypertension	serious				1977
13294	5 pts		Somnolence	below serious				1977
13295	9 pts		Weight gain	below serious				1977
13296	2 pts		Dizziness	below serious				1977
13297	5 pts		Increased appetite	below serious				1977
13298	1 pts		Hypertension	below serious				1977
13299	1 pts		Eye irritation	below serious				1978
13300	5 pts		Diarrhea	below serious				1978
13301	1 pts		Taste abnormality	below serious				1978
13302	10 pts		Increased appetite	below serious				1978
13303	2 pts		Dry mouth	below serious				1978
13304	2 pts		Tiredness	below serious				1978
13305	1 pts		Accidental injury	below serious				1978
13306	1 pts		Pain	below serious				1978
13307	1 pts		Ear infection	below serious				1978
13308	1 pts		Sore throat	below serious				1978
13309	1 pts		Throat infection	below serious				1978
13310	1 pts		Sensory level abnormal	below serious				1978
13311	7 pts		Irritability	below serious				1978
13312	3 pts		Difficulty sleeping	below serious				1978
13313	2 pts		Nervousness	below serious				1978
13314	2 pts		Obsessive-compulsive disorders and symptoms	below serious				1978
13315	2 pts		Speech impairment NOS	below serious				1978
13316	1 pts		Increased activity	below serious				1978
13317	1 pts		Psychological disorder NOS	below serious				1978
13318	1 pts		Decreased activity	below serious				1978
13319	1 pts		Suicidal ideation	below serious				1978
13320	3 pts		Enuresis	below serious				1978
13321	1 pts		Hair disorder	below serious				1978
13322	1 pts		Sweating	below serious				1978
13323	1 pts		Nose bleed	below serious				1978
13324	1 pts		Compulsions	below serious				1978
13325	1 pts		Disinhibition	below serious				1978
13326	1 pts		Emotional instability	below serious				1978
13327	2 pts		Self injurious behavior	below serious				1978
13328						No AEs are reported		1980
13329	1 pts		Angle closure glaucoma		discontinuation	leads to discontinuation		1981
13330			Suicidal tendency			WARNING		1979
13331			Suicidal behavior			WARNING		1979
13332	10.4		Somnolence		discontinuation	leads to discontinuation		1976
13333	1.5		Nausea		discontinuation	leads to discontinuation		1976
13334	1 pts		Abdominal incarcerated hernia	serious				1983
13335	1 pts		Bacteremia	serious				1983
13336	1 pts		Urinary tract infection	serious				1983
13337	5 pts		Injection site granuloma	below serious				1983
13338	21 pts		Injection site pain	below serious				1983
13339	3.6		Headache	grade 3	discontinuation			1982
13340	3.6		Nausea	grade 1	discontinuation			1982
13341	3.6		Vomiting	grade 1	discontinuation			1982
13342	3.6		Abdominal discomfort	grade 2	discontinuation			1982
13343	3.6		Heartburn	grade 2	discontinuation			1982
13344	4.5		Nausea		discontinuation			1985
13345	2.6		Diarrhea		discontinuation			1985
13346	1.3		Abdominal pain		discontinuation			1985
13347	1.3		Dyspepsia		discontinuation			1985
13348	1.3		Vomiting		discontinuation			1985
13349	1.3		Pyrexia		discontinuation			1985
13350	0.6		Headache		discontinuation			1985
13351	0.6		Depression		discontinuation			1985
13352	0.6		Sinus bradycardia		discontinuation			1985
13353	0.6		Rash		discontinuation			1985
13354	0.6		Arrhythmia nodal		discontinuation			1985
13355	0.6		Nodal arrhythmia		discontinuation			1985
13356	0.6		Gastropathy		discontinuation			1985
13357	0.6		Dry mouth		discontinuation			1985
13358	0.6		Transaminases increased	grade 3	discontinuation			1985
13359	0.7		Ischemic foot		discontinuation			1984
13360			Transaminases increased		discontinuation			1986
13361	5		Bizarre dreams					1987
13362	9		Dizziness					1987
13363	8		Fatigue					1987
13364	<1		Hallucinations					1987
13365	10		Insomnia					1987
13366	7		Nervousness					1987
13367	4		Weakness					1987
13368	3		Paresthesia					1987
13369	5		Dyspnea					1987
13370	6		Edema					1987
13371	<1		Heart failure					1987
13372	<1		Palpitations					1987
13373	3		Chest pain					1987
13374	7		Joint pain					1987
13375	3		Muscle cramps					1987
13376	10		Muscle pain					1987
13377	4		Abdominal discomfort					1987
13378	5		Nausea					1987
13379	1		Pruritus					1987
13380	<1		Rash					1987
13381	<2		Anxiety	uncertain				1987
13382	<2		Lethargy	uncertain				1987
13383	<2		Visual disturbances	uncertain				1987
13384	<2		Hyperhidrosis	uncertain				1987
13385	<2		Bradycardia	uncertain				1987
13386	<2		Claudication	uncertain				1987
13387	<2		Cold extremities	uncertain				1987
13388	<2		Heart block	uncertain				1987
13389	<2		Syncope	uncertain				1987
13390	<2		Tachycardia	uncertain				1987
13391	<2		Weight gain	uncertain				1987
13392	<2		Hypotension	uncertain				1987
13393	<2		Diarrhea	uncertain				1987
13394	<2		Vomiting	uncertain				1987
13395	<2		Wheezing	uncertain				1987
13396	<2		Impotence	uncertain				1987
13397	<2		Pollakiuria	uncertain				1987
13398	<2		Eye discomfort	uncertain				1987
13399						No patient discontinued the study prematurely due to an adverse event related to the study drug, 0.14 than 0.3 mg/kg		1990
13400	1 pts		Headache					1989
13401	1 pts		Vertigo					1989
13402	1 pts		Disturbance in attention					1989
13403	1 pts		Disorder eye					1989
13404	1 pts		Rhinorrhea					1988
13405	1 pts		Sneezing					1988
13406	1 pts		Blister					1988
13407	1 pts		Hepatitis	acute	discontinuation			1992
13408						No AEs are reported		1991
13409			Disorder fetal			WARNING		1993
13410	4.1		Hypotension		discontinuation	leads to discontinuation		1994
13411	2.4		Hyperkalemia		discontinuation	leads to discontinuation		1994
13412	0.6		Headache		discontinuation	leads to discontinuation		1995
13413	0.3		Dizziness		discontinuation	leads to discontinuation		1995
13414	4		Pruritus		discontinuation			1996
13415	2 pts		Leukopenia					1999
13416						impossible to link AEs with the definite dose: Nausea and vomiting were seen in 6 of 14 courses but were generally mild and readily controlled with antiemetics at all dose levels. Hepatotoxicity, as manifested by 2-3-fold eleva tions of the serum transaminases, was observed in 6 of 14 courses. Another patient had mild, reversible changes in serum creatinine occurring 2 weeks after fludarabine phosphate treatment. Two patients developed erythematous maculopapular rashes while receiving fludarabine phosphate and combination antibiotic therapy. Both episodes were mild and resolved after altering the antibiotic regimen.		2001
13417	1 pts		Myelosuppression		discontinuation	leads to dose reduction	TRUE	2003
13418						No information about AEs is found		2000
13419			CNS toxicity			WARNING		1997
13420			Hemolytic anemia			WARNING		1997
13421			Pulmonary toxicity			WARNING		1997
13422			CNS toxicity			WARNING		1998
13423			Hemolytic anemia			WARNING		1998
13424			Pulmonary toxicity			WARNING		1998
13425	1 pts		Thrombocytopenia		discontinuation	leads to discontinuation		2002
13426	3 pts		Anemia hemolytic autoimmune		discontinuation	leads to discontinuation		2002
13427	1 pts		Pneumonia		discontinuation	leads to discontinuation		2002
13428	1 pts		Anemia		discontinuation	leads to discontinuation		2002
13429	1 pts		Foot drop		discontinuation	leads to discontinuation		2002
13430	1 pts		Sepsis		discontinuation	leads to discontinuation		2002
13431	1 pts		Bronchitis		discontinuation	leads to discontinuation		2002
13432	1 pts		Rash		discontinuation	leads to discontinuation		2002
13433	1 pts		Face edema		discontinuation	leads to discontinuation		2002
13434						No adverse effects leading to discontinuation were reported		2004
13435	68 pts		Flatulence					2006
13436	13 pts		Diarrhea					2006
13437	1 pts		Loose stools					2006
13438	4 pts		Abdominal pain					2006
13439	3 pts		Nausea					2006
13440	1 pts		Constipation					2006
13441	10 pts		Hypoglycaemic episode					2006
13442	2 pts		Appetite lost					2006
13443	1 pts		Weight loss					2006
13444	1 pts		Burning anal					2006
13445	1 pts		Heartburn					2006
13446	13.7		Flatulence					2007
13447	2.2		Diarrhoea					2007
13448	0.07		Hypoglycaemia					2007
13449	0.01		Function liver abnormal					2007
13450	26		Flatulence		discontinuation	two patients were discontinued due to flatulence		2005
13451	17		Diarrhea		discontinuation	four patients were discontinued due to diarrhea		2005
13452	7		Abdominal pain		discontinuation	two patients were discontinued due to abdominal pain		2005
13453	14 pts		Vomiting	below serious				2015
13454	10 pts		Facial swelling	below serious				2015
13455	9 pts		Nausea and vomiting	below serious				2014
13456			Hepatitis toxic			Overdosage		2012
13457			Nephropathy			Overdosage		2013
13458	6		Alanine aminotransferase increase		discontinuation			2010
13459			Thrombocytopenia			Overdosage		2011
13460	1.1		Elevated liver enzymes		discontinuation			2008
13461	1.1		Transaminitis		discontinuation			2008
13462	1.1		Elevated liver enzymes		discontinuation			2009
13463	1.1		Transaminitis		discontinuation			2009
13464			Diffuse pain		discontinuation			2016
13465			Diarrhea		discontinuation			2016
13466			Hypoglycemia			WARNING		2017
13467	1 pts		Diarrhea	serious				2023
13468	1 pts		Gastroenteritis	below serious				2023
13469	1 pts		Diarrhea	below serious				2023
13470	1 pts		Post lumbar puncture syndrome	below serious				2023
13471	4 pts		Exfoliation	below serious				2023
13472	5 pts		Dry lips	below serious				2023
13473	1 pts		Dry eyes	below serious				2023
13474	2 pts		Alopecia	below serious				2023
13475	2 pts		Hypertensive crisis	below serious				2023
13476	1 pts		Gingivitis	below serious				2023
13477	2 pts		Pruritus	below serious				2023
13478	1 pts		Eczema	below serious				2023
13479	1 pts		Dry skin	below serious				2023
13480	1 pts		Back pain	below serious				2023
13481	1 pts		Dry mouth	below serious				2023
13482	1 pts		Infected insect bite	below serious				2023
13483	12.5		Nausea		discontinuation			2020
13484	12.5		Headache		discontinuation			2020
13485	12.5		Sweating		discontinuation			2020
13486	12.5		Epistaxis		discontinuation			2020
13487	13		Headache		discontinuation			2019
13488	4.3		Paronychia		discontinuation			2019
13489	4.3		Gastritis		discontinuation			2019
13490	4.3		Hypertriglyceridaemia		discontinuation			2019
13491	4.3		ALT increased		discontinuation			2019
13492			Hepatitis		discontinuation	WARNINGS		2021
13493						No information on AE is provided		2018
13494			Vomiting			Overdosage		2022
13495						No SAEs were observed. Acrivastine's impairing effects in both driving tests were similarly dose-related. The 8-rag dose had a small, but significant, effect on highway driving in the first trial. The 16-rag and 24-mg doses significantly impaired driving in both tests during the first trial and the 24-mg dose did so again during the second trial.		2024
13496	9.2		Irritation skin	severe	discontinuation			2027
13497	7.5		Irritation skin	severe	discontinuation			2025
13498			Erythema		discontinuation	WARNING		2026
13499			Scales		discontinuation	WARNING		2026
13500			Application site dryness		discontinuation	WARNING		2026
13501			Stinging		discontinuation	WARNING		2026
13502			Parkinsonism aggravated		discontinuation	1 case		2028
13503	11		Neutropenic sepsis	grade 5	discontinuation	1 out of 9 patients		2029
13504			Granulocytopenia	grade 5	discontinuation	WARNINGS		2032
13505			Pancytopenia	grade 5	discontinuation	WARNINGS		2032
13506			Bone marrow depression			WARNINGS		2032
13507			Aplastic anemia			WARNINGS		2032
13508			Agranulocytosis			WARNINGS		2032
13509			Disorder fetal			WARNINGS		2032
13510	0.7		Leukopenia		discontinuation			2033
13511	3.8		Hepatic dysfunction NOS		discontinuation	No adverse reactions reported		2031
13512						No untoward effects were reported		2030
13513	3 pts		Nausea	below serious				2036
13514	14 pts		Fatigue	below serious				2036
13515	26 pts		Dizziness	below serious				2036
13516	6 pts		Headache	below serious				2036
13517	3 pts		Lethargy	below serious				2036
13518	45 pts		Somnolence	below serious				2036
13519	5 pts		Hiccups	below serious				2036
13520	1 pts		Death	grade 5	discontinuation	leads to discontinuation		2035
13521	29.5		Insomnia		discontinuation	leads to discontinuation		2034
13522	16.5		Nausea and vomiting		discontinuation	leads to discontinuation		2034
13523	19.3		Light headedness		discontinuation	leads to discontinuation		2034
13524	13.6		Diarrhea		discontinuation	leads to discontinuation		2034
13525	17.3		Abnormal involuntary movements		discontinuation	leads to discontinuation		2034
13526	10.6		Saliva decreased		discontinuation	leads to discontinuation		2034
13527	17		Headache		discontinuation	leads to discontinuation		2034
13528	6.9		Muscle twitching		discontinuation	leads to discontinuation		2034
13529	13.3		Weight loss		discontinuation	leads to discontinuation		2034
13530	6.6		Coordination impaired		discontinuation	leads to discontinuation		2034
13531	12.8		Decreased appetite		discontinuation	leads to discontinuation		2034
13532	5.9		Muscle tone disorder		discontinuation	leads to discontinuation		2034
13533	5.8		Weakness		discontinuation	leads to discontinuation		2034
13534	14.4		Sweating		discontinuation	leads to discontinuation		2034
13535	19.2		Anxiety		discontinuation	leads to discontinuation		2034
13536	18.4		Fatigue		discontinuation	leads to discontinuation		2034
13537	10.5		Irritability		discontinuation	leads to discontinuation		2034
13538	12.2		Tachycardia		discontinuation	leads to discontinuation		2034
13539	10.3		Cognitive disorder		discontinuation	leads to discontinuation		2034
13540	5.5		Memory impairment		discontinuation	leads to discontinuation		2034
13541	5.1		Depression		discontinuation	leads to discontinuation		2034
13542	10		Blurred vision		discontinuation	leads to discontinuation		2034
13543	5		Confusional state		discontinuation	leads to discontinuation		2034
13544	4 pts		Dry mouth	below serious				2044
13545	1 pts		Swelling of tongue	below serious				2043
13546			Arrest cardiac		discontinuation			2039
13547			Ventricular tachycardia		discontinuation			2039
13548			Status epilepticus		discontinuation			2038
13549			Agitation		discontinuation			2038
13550			Diaphoresis		discontinuation			2038
13551			Vomiting		discontinuation			2038
13552			Sinus tachycardia		discontinuation			2038
13553			Mydriasis		discontinuation			2038
13554	15		Hallucinations		discontinuation			2037
13555	5		Balance disorder		discontinuation			2037
13556	5		Confusional state		discontinuation			2037
13557	5		Dry mouth		discontinuation			2037
13558	5		Hypersensitive skin		discontinuation			2037
13559	5		Subdural hematoma		discontinuation			2037
13560	5		Constipation		discontinuation			2037
13561	7.9		Visual hallucinations		discontinuation			2041
13562	4.8		Visual hallucinations			3 patients had a dose interruption or reduction (to 137 mg)	TRUE	2041
13563	4.8		Peripheral edema		discontinuation			2041
13564	4.8		Dry mouth		discontinuation			2041
13565	3.7		Serotonin syndrome	serious	discontinuation			2042
13566	3.7		Dry mouth		discontinuation			2042
13567			CNS toxicity	grade 5	discontinuation	patient died		2040
13568	1 pts		Anaemia	serious				2050
13569	3 pts		Acute myocardial infarction	serious				2050
13570	1 pts		Angina pectoris	serious				2050
13571	1 pts		Angina unstable	serious				2050
13572	2 pts		Atrial fibrillation	serious				2050
13573	1 pts		Sinus tachycardia	serious				2050
13574	4 pts		Cardiac failure congestive	serious				2050
13575	1 pts		Cardiomegaly	serious				2050
13576	1 pts		Dilatation atrial	serious				2050
13577	1 pts		Tricuspid valve incompetence	serious				2050
13578	1 pts		Palpitations	serious				2050
13579	1 pts		Extrasystoles	serious				2050
13580	1 pts		Electromechanical dissociation	serious				2050
13581	1 pts		Acute vestibular syndrome	serious				2050
13582	1 pts		Visual impairment	serious				2050
13583	4 pts		Constipation	serious				2050
13584	2 pts		Nausea	serious				2050
13585	1 pts		Colonic polyp	serious				2050
13586	1 pts		Small intestinal obstruction	serious				2050
13587	1 pts		Upper gastrointestinal haemorrhage	serious				2050
13588	4 pts		Oedema peripheral	serious				2050
13589	1 pts		Oedema	serious				2050
13590	2 pts		Pain	serious				2050
13591	2 pts		Pyrexia	serious				2050
13592	2 pts		Fatigue	serious				2050
13593	1 pts		Catheter site haemorrhage	serious				2050
13594	1 pts		Influenza like illness	serious				2050
13595	1 pts		Hyperthermia	serious				2050
13596	1 pts		Pharyngitis	serious				2050
13597	1 pts		Sinusitis	serious				2050
13598	9 pts		Pneumonia	serious				2050
13599	3 pts		Bronchitis	serious				2050
13600	1 pts		Bronchopneumonia	serious				2050
13601	1 pts		Infection	serious				2050
13602	2 pts		Cellulitis	serious				2050
13603	2 pts		Sepsis	serious				2050
13604	2 pts		Influenza	serious				2050
13605	1 pts		Urinary tract infection	serious				2050
13606	1 pts		Oral candidiasis	serious				2050
13607	1 pts		Conjunctivitis viral	serious				2050
13608	1 pts		Road traffic accident	serious				2050
13609	1 pts		Fracture rib	serious				2050
13610	1 pts		Electrocardiogram ST-T segment abnormal	serious				2050
13611	1 pts		Electrocardiogram T wave inversion	serious				2050
13612	1 pts		Computerised tomogram thorax abnormal	serious				2050
13613	4 pts		Hyperkalaemia	serious				2050
13614	2 pts		Hypokalaemia	serious				2050
13615	2 pts		Hyperglycaemia	serious				2050
13616	1 pts		Anorexia	serious				2050
13617	1 pts		Diabetic ketoacidosis	serious				2050
13618	1 pts		Hypophosphataemia	serious				2050
13619	1 pts		Back pain	serious				2050
13620	1 pts		Musculoskeletal pain	serious				2050
13621	1 pts		Clubbing	serious				2050
13622	1 pts		Pain in jaw	serious				2050
13623	1 pts		Myalgia	serious				2050
13624	1 pts		Squamous cell carcinoma	serious				2050
13625	1 pts		Prostate cancer	serious				2050
13626	1 pts		Prostate cancer metastatic	serious				2050
13627	1 pts		Lung neoplasm malignant	serious				2050
13628	5 pts		Headache	serious				2050
13629	1 pts		Cerebrovascular accident	serious				2050
13630	1 pts		Ischaemic stroke	serious				2050
13631	1 pts		Somnolence	serious				2050
13632	1 pts		Carotid artery stenosis	serious				2050
13633	1 pts		Coma	serious				2050
13634	1 pts		Grand mal convulsion	serious				2050
13635	1 pts		Nerve compression	serious				2050
13636	1 pts		Hypoaesthesia	serious				2050
13637	3 pts		Anxiety	serious				2050
13638	1 pts		Delirium	serious				2050
13639	1 pts		Insomnia	serious				2050
13640	2 pts		Renal failure acute	serious				2050
13641	1 pts		Renal failure	serious				2050
13642	1 pts		Benign prostatic hyperplasia	serious				2050
13643	20 pts		Idiopathic pulmonary fibrosis	serious				2050
13644	2 pts		Emphysema	serious				2050
13645	2 pts		Pulmonary fibrosis	serious				2050
13646	1 pts		Pulmonary alveolar haemorrhage	serious				2050
13647	17 pts		Dyspnoea	serious				2050
13648	1 pts		Respiratory arrest	serious				2050
13649	4 pts		Cough	serious				2050
13650	4 pts		Haemoptysis	serious				2050
13651	1 pts		Productive cough	serious				2050
13652	5 pts		Acute respiratory failure	serious				2050
13653	4 pts		Respiratory failure	serious				2050
13654	4 pts		Nasal congestion	serious				2050
13655	1 pts		Allergic rhinitis	serious				2050
13656	1 pts		Choking	serious				2050
13657	1 pts		Rhinorrhoea	serious				2050
13658	1 pts		Hypoxia	serious				2050
13659	1 pts		Pneumothorax	serious				2050
13660	1 pts		Pneumonitis	serious				2050
13661	1 pts		Hiccups	serious				2050
13662	1 pts		Pleurisy	serious				2050
13663	4 pts		Hypotension	serious				2050
13664	3 pts		Hypertension	serious				2050
13665	1 pts		Subclavian vein thrombosis	serious				2050
13666	1 pts		Flushing	serious				2050
13667	1 pts		Hot flush	serious				2050
13668	1 pts		Cardiac ventricular disorder	serious				2050
13669	1 pts		Peripheral ischaemia	serious				2050
13670	73 pts		Oedema peripheral	below serious				2050
13671	47 pts		Upper respiratory tract infection	below serious				2050
13672	47 pts		Headache	below serious				2050
13673	40 pts		Dyspnoea	below serious				2050
13674	37 pts		Nasopharyngitis	below serious				2050
13675	19 pts		Idiopathic pulmonary fibrosis	below serious				2050
13676	27 pts		Nasal congestion	below serious				2050
13677	20 pts		Diarrhoea	below serious				2050
13678	20 pts		Sinusitis	below serious				2050
13679	18 pts		Back pain	below serious				2050
13680	20 pts		Dizziness	below serious				2050
13681	2 pts		Anemia	below serious				2048
13682	1 pts		Hypertension	below serious				2048
13683	1 pts		Jaw fracture	serious				2051
13684	8 pts		Edema	below serious				2051
13685	4 pts		Diarrhea	below serious				2051
13686	4 pts		Paraesthesia	below serious				2051
13687	3 pts		Epistaxis	below serious				2051
13688			Fetal damage	grade 5		WARNING		2046
13689			Liver injury	serious		WARNING		2047
13690						No AEs are reported		2045
13691						impossible to link AEs with the definite dose. AEs occurred in 100% of patients during the study period. The most common were nasopharyngitis (86%), pyrexia (38%), back pain (33%), cough (24%), and diarrhea (24%).		2049
13692	4.7		Burn					2052
13693	4.7		Itching					2052
13694	4.7		Irritation skin					2052
13695	4.7		Mucosal dryness					2052
13696	4.7		Folliculitis					2052
13697	4.7		Hypertrichosis					2052
13698	4.7		Acneiform eruption					2052
13699	4.7		Skin hypopigmentation					2052
13700	4.7		Perioral dermatitis					2052
13701	4.7		Allergic contact dermatitis					2052
13702	4.7		Skin maceration					2052
13703	4.7		Secondary infection					2052
13704	4.7		Skin atrophy					2052
13705	4.7		Striae					2052
13706	4.7		Miliaria					2052
13707	1 pts		Periorbital edema		discontinuation	leads to dose interruption		2053
13708	2 pts		Hair color changes					2053
13709	1 pts		Folliculitis					2053
13710	9 pts		Stinging					2053
13711	17 pts		Itching					2053
13712	8 pts		Burn					2053
13713	30		Nausea and vomiting	grade 3-4				2055
13714	96		Nausea and vomiting	all grades				2055
13715	8		Hypotension	grade 3-4				2055
13716	61		Hypotension	all grades				2055
13717	<3		Blood pressure decreased		discontinuation	leads to discontinuation		2055
13718	8		Nausea and vomiting	grade 3-4				2054
13719	53		Nausea and vomiting	all grades				2054
13720	3		Hypotension	grade 3-4				2054
13721	15		Hypotension	all grades				2054
13722						No adverse reactions leading to discontinuation were reported		2056
13723	rare		Skeletal muscle weakness		discontinuation	WARNING		2057
13724	1 pts		Cerebellar hemorrhage	grade 5	discontinuation	1 case		2058
13725	1 pts		Cardiac disorder NOS		discontinuation	1 case		2058
13726	1 pts		Hepatic lesion		discontinuation	1 case		2058
13727	2 pts		Thrombocytopenia	severe	discontinuation	leads to discontinuation		2060
13728	2 pts		Pseudohermaphroditism			WARNING		2059
13729	4 pts		Skin rash	below serious				2061
13730	2 pts		Ankle edema	below serious				2061
13731	2 pts		Fatigue	below serious				2061
13732	3 pts		Respiratory tract infection	below serious				2061
13733	2 pts		Itchy skin	below serious				2061
13734	14		Drowsiness					2062
13735	14		Dry mouth					2062
13736	12		Constipation					2062
13737	7		Blurred vision					2062
13738	>1		Anxiety					2062
13739	>1		Insomnia					2062
13740	>1		Nervousness					2062
13741	>1		Nightmare					2062
13742	>1		Restlessness					2062
13743	>1		Palpitations					2062
13744	>1		Tremor					2062
13745	>1		Confusion					2062
13746	>1		Excitement					2062
13747	>1		Ataxia					2062
13748	>1		Edema					2062
13749	>1		Skin rash					2062
13750	>1		Prolactin increased					2062
13751	>1		Nausea					2062
13752	>1		Dizziness					2062
13753	>1		Headache					2062
13754	>1		Fatigue					2062
13755	>1		Weakness					2062
13756	>1		Appetite excessive					2062
13757	>1		Perspiration excessive					2062
13758	<1		Accommodation disturbance					2062
13759	<1		Mydriasis					2062
13760	<1		Micturition disorder					2062
13761	<1		Urinary retention					2062
13762	<1		Nasal stuffiness					2062
13763	<1		Hypotension					2062
13764	<1		Hypertension					2062
13765	<1		Syncope					2062
13766	<1		Tachycardia					2062
13767	<1		Drug fever					2062
13768	<1		Urticaria					2062
13769	<1		Photosensitized					2062
13770	<1		Pruritus					2062
13771	<1		Vasculitis					2062
13772	<1		Hepatitis					2062
13773	<1		Tingling					2062
13774	<1		Tinnitus					2062
13775	<1		Disorientation					2062
13776	<1		Seizures					2062
13777	<1		Hypomania					2062
13778	<1		Numbness					2062
13779	<1		Incoordination					2062
13780	<1		Concentration impairment					2062
13781	<1		Hyperthermia					2062
13782	<1		Extrapyramidal symptoms					2062
13783	<1		Tardive dyskinesia					2062
13784	<1		Leukopenia					2062
13785	<1		Agranulocytosis					2062
13786	<1		Epigastric distress					2062
13787	<1		Vomiting					2062
13788	<1		Flatulence					2062
13789	<1		Abdominal pain					2062
13790	<1		Taste peculiar					2062
13791	<1		Diarrhea					2062
13792	<1		Libido disorder					2062
13793	<1		Impotence					2062
13794	<1		Menstrual irregularity					2062
13795	<1		Breast enlargement					2062
13796	<1		Inappropriate antidiuretic hormone secretion					2062
13797	<1		Galactorrhea					2062
13798	<1		Lacrimation					2062
13799	<1		Weight gain					2062
13800	<1		Weight loss					2062
13801	<1		Impaired liver function					2062
13802	<1		Painful ejaculation					2062
13803	1 pts		Lower gastrointestinal hemorrhage	serious				2067
13804	1 pts		Pneumonia	serious				2067
13805	2 pts		Diarrhea	below serious				2067
13806	2 pts		Fever	below serious				2067
13807	1 pts		Abdominal distension	below serious				2067
13808	1 pts		Confusion	below serious				2067
13809	1 pts		Cough	below serious				2067
13810	1 pts		Gastroenteritis	below serious				2067
13811	1 pts		Insomnia	below serious				2067
13812	1 pts		Oral thrush	below serious				2067
13813	1 pts		Cramps	below serious				2067
13814	1 pts		Sinus congestion	below serious				2067
13815	1 pts		Upper respiratory infection	below serious				2067
13816	1 pts		Weight loss	below serious				2067
13817	7.7		Headache					2064
13818						No information on AE is provided		2063
13819			Testicular disorder	grade 2	discontinuation			2066
13820			Slipped femoral capital epiphysis		discontinuation			2065
13821	1 pts		Confusional state	serious				2070
13822	1 pts		Lymphopenia	serious				2070
13823	1 pts		Myocardial infarction	serious				2070
13824	2 pts		Infusion site cellulitis	serious				2070
13825	1 pts		Eosinophil count decreased	serious				2070
13826	1 pts		Haematocrit decreased	serious				2070
13827	1 pts		Blood disorder	serious				2070
13828	1 pts		Haemoglobin decreased	serious				2070
13829	1 pts		Red blood cell count decreased	serious				2070
13830	1 pts		Hypotension	serious				2070
13831	1 pts		Autoimmune haemolytic anaemia	serious				2070
13832	1 pts		Constipation	serious				2070
13833	1 pts		Diarrhoea	serious				2070
13834	1 pts		Umbilical hernia	serious				2070
13835	1 pts		Chest pain	serious				2070
13836	1 pts		Infusion site extravasation	serious				2070
13837	1 pts		Angina pectoris	serious				2070
13838	1 pts		Gastrointestinal haemorrhage	serious				2070
13839	1 pts		Cholelithiasis	serious				2070
13840	2 pts		Fall	serious				2070
13841	1 pts		Forearm fracture	serious				2070
13842	1 pts		Lower limb fracture	serious				2070
13843	1 pts		Radius fracture	serious				2070
13844	1 pts		Fracture pathological	serious				2070
13845	1 pts		Lung neoplasm malignant	serious				2070
13846	1 pts		Lower respiratory tract infection	serious				2070
13847	1 pts		Pneumonia	serious				2070
13848	1 pts		Urosepsis	serious				2070
13849	1 pts		Lymphoma	serious				2070
13850	1 pts		Metastases to liver	serious				2070
13851	1 pts		Neuroleptic malignant syndrome	serious				2070
13852	1 pts		Parkinson's disease	serious				2070
13853	1 pts		Carotid artery stenosis	serious				2070
13854	1 pts		On and off phenomenon	serious				2070
13855	1 pts		Radicular syndrome	serious				2070
13856	1 pts		Delirium	serious				2070
13857	1 pts		Device difficult to use	serious				2070
13858	1 pts		Paranoia	serious				2070
13859	1 pts		Urinary retention	serious				2070
13860	1 pts		Pulmonary embolism	serious				2070
13861	1 pts		Deep brain stimulation	serious				2070
13862	46 pts		Infusion site nodule	below serious				2070
13863	15 pts		Infusion site erythema	below serious				2070
13864	6 pts		Fatigue	below serious				2070
13865	7 pts		Oedema peripheral	below serious				2070
13866	5 pts		Infusion site pruritus	below serious				2070
13867	19 pts		Somnolence	below serious				2070
13868	10 pts		Headache	below serious				2070
13869	14 pts		Dyskinesia	below serious				2070
13870	11 pts		Dizziness	below serious				2070
13871	20 pts		Nausea	below serious				2070
13872	8 pts		Vomiting	below serious				2070
13873	5 pts		Dyspepsia	below serious				2070
13874	13 pts		Insomnia	below serious				2070
13875	6 pts		Hallucination, visual	below serious				2070
13876	6 pts		Sleep disorder	below serious				2070
13877	5 pts		Hallucination	below serious				2070
13878	7 pts		Nasopharyngitis	below serious				2070
13879	6 pts		Urinary tract infection	below serious				2070
13880	6 pts		Arthralgia	below serious				2070
13881	7 pts		Back pain	below serious				2070
13882	6 pts		Orthostatic hypotension	below serious				2070
13883	5 pts		Eosinophilia	below serious				2070
13884	5 pts		Electrocardiogram QT prolonged	below serious				2070
13885	187 pts		Nausea and vomiting		discontinuation	leads to discontinuation		2071
13886	1 pts		Somnolence					2073
13887	1 pts		Dysgeusia					2073
13888	1 pts		Dizziness					2073
13889	1 pts		Orthostatic hypotension					2073
13890						AE is missing		2075
13891	1 pts		Somnolence					2076
13892	1 pts		Yawning					2076
13893	1 pts		Flushing					2076
13894						AE is missing. MTD was not reached		2072
13895	16 pts		Cognitive impairment		discontinuation	leads to discontinuation		2074
13896	14 pts		Skin reaction		discontinuation	leads to discontinuation		2074
13897	12 pts		Posture abnormal		discontinuation	leads to discontinuation		2074
13898	11 pts		Psychosis		discontinuation	leads to discontinuation		2074
13899	11 pts		Anxiety/depression		discontinuation	leads to discontinuation		2074
13900	3 pts		Hypotension		discontinuation	leads to discontinuation		2074
13901	1 pts		Gastrointestinal disorder (NOS)		discontinuation	leads to discontinuation		2074
13902	1 pts		Cardiovascular disorder		discontinuation	leads to discontinuation		2074
13903	1 pts		Weight loss		discontinuation	leads to discontinuation		2074
13904	1 pts		Excessive daytime sleepiness		discontinuation	leads to discontinuation		2074
13905	9 pts		Respiratory tract signs and symptoms		discontinuation	leads to discontinuation		2077
13906	1		Hallucination		discontinuation	leads to discontinuation		2069
13907	3		Nausea		discontinuation	leads to discontinuation		2068
13908	2		Vomiting		discontinuation	leads to discontinuation		2068
13909	1 pts		Anemia	serious				2082
13910	1 pts		Clot blood	serious				2082
13911	1 pts		Hospital acquired pneumonia	serious				2082
13912	2 pts		Headache	below serious				2082
13913	2 pts		Hot flashes	below serious				2082
13914	2 pts		Nausea	below serious				2082
13915	2 pts		Paresthesia	below serious				2082
13916	2 pts		Wound dehiscence	below serious				2082
13917	6 pts		Wound infection	below serious				2082
13918	14 pts		Constipation	below serious				2080
13919	7 pts		Diarrhea	below serious				2080
13920	7 pts		Dry mouth	below serious				2080
13921	13 pts		Abdominal pain	below serious				2080
13922	18 pts		Weakness	below serious				2080
13923	2 pts		Nightmares	below serious				2080
13924	2 pts		Sleepiness	below serious				2080
13925	8 pts		Sweating	below serious				2080
13926	5 pts		Pain in extremity	below serious				2080
13927	7 pts		Dizziness	below serious				2080
13928	10 pts		Nervousness	below serious				2080
13929	2 pts		Nightmares	below serious				2080
13930	2 pts		Depression	below serious				2080
13931	3 pts		Sexual dysfunction	below serious				2080
13932	1 pts		Hypoglycemia	serious				2081
13933	1 pts		Bruising	below serious				2081
13934	3 pts		Gastrointestinal pain	below serious				2081
13935	1 pts		Hypokalemia	below serious				2081
13936	1 pts		Diarrhea	below serious				2081
13937	1 pts		Musculoskeletal pain	below serious				2081
13938	1 pts		Fainting	below serious				2081
13939	1 pts		Renal bleeding	below serious				2081
13940	1 pts		Fibromyalgia	below serious				2081
13941	2 pts		Dizziness	below serious				2081
13942	1 pts		Constipation	below serious				2081
13943	1 pts		Rhinitis	below serious				2081
13944	2 pts		Headache	below serious				2081
13945	1 pts		Malaise	below serious				2081
13946	1 pts		Pain in limb	below serious				2081
13947	1 pts		Nosebleed	below serious				2081
13948						impossible to find supplementary materials where are AEs		2079
13949	2 pts		Dyspnea		discontinuation	leads to discontinuation		2078
13950	1 pts		Nerve injury, peripheral		discontinuation	leads to discontinuation		2078
13951	1 pts		Dyspnea		discontinuation	leads to discontinuation		2078
13952	1 pts		Hyperhidrosis		discontinuation	leads to discontinuation		2078
13953	2 pts		Fatigue	below serious				2090
13954	2 pts		Nausea	below serious				2090
13955	3		Bradycardia		discontinuation			2087
13956	3		Ventricular tachycardia		discontinuation			2087
13957	12.5		Bradycardia		discontinuation			2085
13958	6.2		Vertigo		discontinuation			2085
13959	3		Bronchospasm		discontinuation			2085
13960	3		Fatigue		discontinuation			2085
13961	3		Bradycardia		discontinuation			2086
13962	3		Arrhythmia		discontinuation			2086
13963	11		Fatigue				TRUE	2088
13964	31		Bradycardia				TRUE	2089
13965			Somnolence					2084
13966			Exertional dyspnea					2084
13967			Death	grade 5		Overdosage		2083
13968						No adverse reactions leading to discontinuation were reported		2091
13969	6		Rash	grade 1-2	discontinuation			2093
13970	4		Diarrhea		discontinuation			2093
13971	3		Nausea		discontinuation			2093
13972	4		Rash		discontinuation			2094
13973	<1		Vomiting		discontinuation			2095
13974	2		ALT increased		discontinuation			2095
13975	2		Aspartate aminotransferase increase		discontinuation			2095
13976	1		Creatinine increased		discontinuation	One patient		2096
13977	1		Blood urea nitrogen increased		discontinuation	One patient		2096
13978	1		Amylase increased		discontinuation	One patient		2096
13979			Methemoglobinemia					2092
13980			Rash					2092
13981			Hemoglobin decreased		discontinuation	WARNING		2100
13982			Leukopenia		discontinuation	WARNING		2100
13983			Agranulocytosis		discontinuation	WARNING		2100
13984			Thrombocytopenia		discontinuation	WARNING		2100
13985			Proteinuria		discontinuation	WARNING		2100
13986			Hematuria		discontinuation	WARNING		2100
13987			Pruritus		discontinuation	WARNING		2100
13988			Rash		discontinuation	WARNING		2100
13989			Stomatitis		discontinuation	WARNING		2100
13990			Diarrhea		discontinuation	WARNING		2100
13991			Encephalopathy		discontinuation			2097
13992			Peripheral neuropathy		discontinuation			2097
13993	0.9		Distress gastrointestinal		discontinuation			2098
13994	3.5		Diarrhea		discontinuation			2098
13995	3.5		Rash		discontinuation			2098
13996	2.6		Mucosal ulceration		discontinuation			2098
13997	0.9		Leukopenia		discontinuation			2098
13998	2.6		Proteinuria		discontinuation			2098
13999	7.5		Exanthema		discontinuation			2102
14000	6		Pruritus		discontinuation			2102
14001	3		Diarrhea		discontinuation			2102
14002	1.5		Nausea		discontinuation			2102
14003	1.5		Bowel obstruction		discontinuation			2102
14004	1.5		Glomerulonephritis		discontinuation			2102
14005	1.5		Nephropathies		discontinuation			2102
14006	1.5		Polyneuropathy		discontinuation			2102
14007	1.5		Sweating		discontinuation	general reaction (sweating and ache, dryness of mouth)		2102
14008	1.5		Ache		discontinuation	general reaction (sweating and ache, dryness of mouth)		2102
14009	1.5		Dry mouth		discontinuation	general reaction (sweating and ache, dryness of mouth)		2102
14010						No subjects were withdrawn from thestudy because of TEAEs, and there were no significant adverse events (SAE) or deaths.		2101
14011	1.4		Stomatitis		discontinuation			2099
14012	1.4		Diarrhea		discontinuation			2099
14013	1.4		Eosinophilia		discontinuation			2099
14014	1.4		Leukopenia		discontinuation			2099
14015	2 pts		Diarrhea	grade 3-4			TRUE	2107
14016						impossible to link AEs with the definite dose		2108
14017						No AEs are reported		2103
14018	>2		Leukopenia		discontinuation	leads to discontinuation |leads to dose reduction or modification		2105
14019	>2		Thrombocytopenia		discontinuation	leads to discontinuation |leads to dose reduction or modification		2105
14020	>2		Neutropenia		discontinuation	leads to discontinuation |leads to dose reduction or modification		2105
14021	>2		Leukopenia		discontinuation	leads to discontinuation |leads to dose reduction or modification		2106
14022	>2		Thrombocytopenia		discontinuation	leads to discontinuation |leads to dose reduction or modification		2106
14023	>2		Neutropenia		discontinuation	leads to discontinuation |leads to dose reduction or modification		2106
14024	1 pts		Diarrhea					2104
14025	1 pts		Nausea					2104
14026	1 pts		Vomiting					2104
14027	2.1		Nausea		discontinuation	leads to discontinuation		2109
14028	1.7		Diarrhea		discontinuation	leads to discontinuation		2109
14029	1.3		Vomiting		discontinuation	leads to discontinuation		2109
14030	20		Neutropenia		discontinuation	leads to dose interruption		2109
14031	8		Thrombocytopenia		discontinuation	leads to dose interruption		2109
14032	6		Nausea		discontinuation	leads to dose interruption		2109
14033	6		Neutropenia		discontinuation	leads to dose reduction		2109
14034	3.4		Diarrhea		discontinuation	leads to dose reduction		2109
14035	1.7		Thrombocytopenia		discontinuation	leads to dose reduction		2109
14036	1.7		Nausea		discontinuation	leads to dose reduction		2109
14037						No AEs are reported		2110
14038	1 pts		Dizziness	serious				2117
14039	1 pts		Gastrointestinal haemorrhage	serious				2117
14040	1 pts		Alcohol withdrawal syndrome	serious				2117
14041	5 pts		Bed wetting	below serious				2117
14042	20 pts		Confusion	below serious				2117
14043	10 pts		Obstructive sleep apnoea syndrome	below serious				2117
14044	10 pts		Movements disturbance NOS	below serious				2117
14045	23 pts		Dizziness	below serious				2117
14046	4 pts		Double vision	below serious				2117
14047	34 pts		Drowsiness	below serious				2117
14048	13 pts		Perspiration excessive	below serious				2117
14049	5 pts		Hallucinations	below serious				2117
14050	22 pts		Headache	below serious				2117
14051	7 pts		Palpitations	below serious				2117
14052	7 pts		Hypotension	below serious				2117
14053	13 pts		Itching	below serious				2117
14054	4 pts		Loss of consciousness	below serious				2117
14055	12 pts		Involuntary muscle movement	below serious				2117
14056	14 pts		Muscle stiffness	below serious				2117
14057	11 pts		Paresthesia	below serious				2117
14058	8 pts		Rash	below serious				2117
14059	9 pts		Slurred speech	below serious				2117
14060	4 pts		Ankles swelling	below serious				2117
14061	1 pts		Increased appetite	below serious				2118
14062	3 pts		Insomnia	below serious				2118
14063	1 pts		Depression	below serious				2118
14064	25 pts		Sedation	below serious				2119
14065	12 pts		Dizziness	below serious				2119
14066	8 pts		Itchy rash	below serious				2119
14067	5 pts		Fatigue	below serious				2119
14068	5 pts		Nausea	below serious				2119
14069	4 pts		Constipation	below serious				2119
14070	5 pts		Headache	below serious				2119
14071	1 pts		Drowsiness	serious				2120
14072	20 pts		Sedation	below serious				2120
14073	8 pts		Dizziness	below serious				2120
14074	4 pts		Headache	below serious				2120
14075	16.7		Drowsiness	grade 1-2	discontinuation			2112
14076	8.3		Fatigue	grade 1-2	discontinuation			2112
14077	8.3		Confusion	grade 1-2	discontinuation			2112
14078	8.3		Dizziness	grade 1-2	discontinuation			2112
14079	8.3		Insomnia	grade 1-2	discontinuation			2112
14080	8.3		Constipation	grade 1-2	discontinuation			2112
14081	8.3		Depression	grade 1-2	discontinuation			2112
14082	41.7		Drowsiness	grade 3	discontinuation			2111
14083			Supraventricular tachyarrhythmia			Overdosage		2113
14084			Cardiac conduction disorders			Overdosage		2113
14085			Respiration depressed			Overdosage		2115
14086			Areflexia			Overdosage		2115
14087			Hypotonia			Overdosage		2115
14088			Bradycardia			Overdosage		2115
14089			Cardiac conduction disorders			Overdosage		2114
14090			Hypertension			Overdosage		2114
14091			Respiratory depression			Overdosage		2114
14092			Coma			Overdosage		2114
14093			Hypotonia			Overdosage		2114
14094			Hyporeflexia			Overdosage		2114
14095			Hypotension			Overdosage		2116
14096	16.7		Transaminitis	grade 3			TRUE	2121
14097	16.7		Hyperbilirubinemia	grade 3			TRUE	2121
14098	3.57		Pancreatitis	grade 2	discontinuation		TRUE	2122
14099	2.2		Granulocytopenia	severe	discontinuation			2124
14100	2.2		Erythema	grade 2	discontinuation			2125
14101	2.2		Triglyceride increased	grade 2	discontinuation			2125
14102			Birth defects		discontinuation	WARNING		2123
14103			Hyperlipidemia		discontinuation	WARNING		2123
14104			Pancreatitis		discontinuation	WARNING		2123
14105			Hepatotoxicity		discontinuation	WARNING		2123
14106			Cholestasis		discontinuation	WARNING		2123
14107			Hepatic failure		discontinuation	WARNING		2123
14108			Hypothyroidism		discontinuation	WARNING		2123
14109			Neutropenia		discontinuation	WARNING		2123
14110			Photosensitivity		discontinuation	WARNING		2123
14111	45.2		Gynaecomastia					2128
14112	57.1		Breast pain					2128
14113	16.7		Hot flushes					2128
14114	31		Constipation					2128
14115	2.4		Dry skin					2128
14116	9.5		Insomnia					2128
14117	11.9		Rash					2128
14118	14.3		Back pain					2128
14119	19		Asthenia					2128
14120	19		Diarrhoea					2128
14121	16.7		Urinary tract infection					2128
14122	11.9		Arthralgia					2128
14123	14.3		Pharyngitis					2128
14124	23.8		Pain					2128
14125	6.9		Back pain					2126
14126	10.3		Constipation					2126
14127	50		Libido decreased					2126
14128	57		Impotence					2126
14129	6.9		Dyspepsia					2126
14130	6.9		Dysuria					2126
14131	6.9		Haematuria					2126
14132	17.2		Pain					2126
14133	6.9		Pelvic pain					2126
14134	6.9		Somnolence					2126
14135	6.9		Urinary incontinence					2126
14136	6.9		Urinary urgency					2126
14137	10.3		Weight gain					2126
14138	79		Gynaecomastia					2126
14139	79		Breast tenderness					2126
14140	41		Hot flushes					2126
14141	35		General body pain			Regardless of causality		2127
14142	25		Back pain			Regardless of causality		2127
14143	22		Asthenia			Regardless of causality		2127
14144	21		Pelvic pain			Regardless of causality		2127
14145	18		Infection			Regardless of causality		2127
14146	11		Abdominal pain			Regardless of causality		2127
14147	8		Chest pain			Regardless of causality		2127
14148	7		Headache			Regardless of causality		2127
14149	7		Flu syndrome			Regardless of causality		2127
14150	53		Hot flashes			Regardless of causality		2127
14151	8		Hypertension			Regardless of causality		2127
14152	22		Constipation			Regardless of causality		2127
14153	15		Nausea			Regardless of causality		2127
14154	12		Diarrhea			Regardless of causality		2127
14155	7		Liver function test increased			Regardless of causality		2127
14156	7		Dyspepsia			Regardless of causality		2127
14157	6		Flatulence			Regardless of causality		2127
14158	6		Anorexia			Regardless of causality		2127
14159	6		Vomiting			Regardless of causality		2127
14160	11		Anemia			Regardless of causality		2127
14161	13		Peripheral edema			Regardless of causality		2127
14162	7		Weight loss			Regardless of causality		2127
14163	6		Hyperglycemia			Regardless of causality		2127
14164	5		Alkaline phosphatase increased			Regardless of causality		2127
14165	5		Weight gain			Regardless of causality		2127
14166	9		Bone pain			Regardless of causality		2127
14167	7		Myasthenia			Regardless of causality		2127
14168	5		Arthritis			Regardless of causality		2127
14169	4		Fracture pathological			Regardless of causality		2127
14170	10		Dizziness			Regardless of causality		2127
14171	8		Paresthesia			Regardless of causality		2127
14172	7		Insomnia			Regardless of causality		2127
14173	5		Anxiety			Regardless of causality		2127
14174	4		Depression			Regardless of causality		2127
14175	13		Dyspnea			Regardless of causality		2127
14176	8		Cough increased			Regardless of causality		2127
14177	8		Pharyngitis			Regardless of causality		2127
14178	6		Bronchitis			Regardless of causality		2127
14179	4		Pneumonia			Regardless of causality		2127
14180	4		Rhinitis			Regardless of causality		2127
14181	9		Rash			Regardless of causality		2127
14182	6		Sweating			Regardless of causality		2127
14183	12		Nocturia			Regardless of causality		2127
14184	12		Hematuria			Regardless of causality		2127
14185	9		Urinary tract infection			Regardless of causality		2127
14186	9		Gynecomastia			Regardless of causality		2127
14187	7		Impotence			Regardless of causality		2127
14188	6		Breast pain			Regardless of causality		2127
14189	6		Urinary frequency			Regardless of causality		2127
14190	5		Urinary retention			Regardless of causality		2127
14191	5		Urination impaired			Regardless of causality		2127
14192	4		Urinary incontinence			Regardless of causality		2127
14193	1 pts		Eczema		discontinuation	leads to discontinuation		2129
14194	1 pts		Dry eye		discontinuation	leads to discontinuation		2129
14195	1 pts		Eye inflammation		discontinuation	leads to discontinuation		2129
14196	1 pts		Contact dermatitis		discontinuation	leads to discontinuation		2129
14197	3 pts		Conjunctival hyperemia		discontinuation	leads to discontinuation		2130
14198	1 pts		Headache		discontinuation	leads to discontinuation		2130
14199	1 pts		Blurred vision		discontinuation	leads to discontinuation		2130
14200	1 pts		Nausea		discontinuation	leads to discontinuation		2130
14201	1 pts		Eye irritation		discontinuation	leads to discontinuation		2131
14202	1 pts		Eye pruritus		discontinuation	leads to discontinuation		2131
14203	1 pts		Ocular discomfort		discontinuation	leads to discontinuation		2131
14204	1 pts		Conjunctival hyperemia		discontinuation	leads to discontinuation		2131
14205	1 pts		Maculopathy		discontinuation	leads to discontinuation		2131
14206	5 pts		Thrombocytopenia	all grades				2133
14207	3 pts		Sensory neuropathy	grade 3				2133
14208	1 pts		Abdominal pain	grade 3				2133
14209	1 pts		Constipation	grade 3				2133
14210	1 pts		Depressed level of consciousness	grade 3				2133
14211	1 pts		Fatigue	grade 3				2133
14212	1 pts		Headache	grade 3				2133
14213	1 pts		Pain	grade 3				2133
14214	1 pts		Hypokalemia	grade 3				2133
14215	1 pts		Thrombocytopenia	grade 3			TRUE	2132
14216	1 pts		Sensory neuropathy	grade 3			TRUE	2132
14217	1 pts		Fatigue	grade 3			TRUE	2132
14218	1 pts		Diarrhea	grade 3-4				2132
14219	1 pts		Hypotension	grade 3-4				2132
14220	1 pts		Hypoxia	grade 3-4				2132
14221	1 pts		Infection	grade 3-4				2132
14222			Acidosis	grade 3-4				2132
14223			CPK increased	grade 3-4				2132
14224			Blood bicarbonate low	grade 3-4				2132
14225			Hypokalemia	grade 3-4				2132
14226			Alanine aminotransferase increase	grade 3-4				2132
14227	18		Thrombocytopenia	grade 3				2134
14228	17		Thrombocytopenia	grade 4-5				2134
14229	30		Neutropenia	grade 3				2134
14230	10		Neutropenia	grade 4-5				2134
14231	12		Anemia	grade 3				2134
14232	1		Anemia	grade 4-5				2134
14233	19		Leukopenia	grade 3				2134
14234	2		Leukopenia	grade 4-5				2134
14235	14		Lymphopenia	grade 3				2134
14236	5		Lymphopenia	grade 4-5				2134
14237	3		Nausea	grade 3				2134
14238	6		Diarrhea	grade 3				2134
14239	1		Diarrhea	grade 4-5				2134
14240	4		Vomiting	grade 3				2134
14241	1		Constipation	grade 3				2134
14242	<1		Abdominal pain upper	grade 3				2134
14243	12		Peripheral neuropathy	grade 3				2134
14244	1		Peripheral neuropathy	grade 4-5				2134
14245	8		Neuralgia	grade 3				2134
14246	1		Neuralgia	grade 4-5				2134
14247	2		Paresthesia	grade 3				2134
14248	6		Fatigue	grade 3				2134
14249	1		Fatigue	grade 4-5				2134
14250	5		Asthenia	grade 3				2134
14251	1		Pyrexia	grade 3				2134
14252	3		Herpes zoster	grade 3				2134
14253	2		Anorexia	grade 3				2134
14254	1		Rash	grade 3				2134
14255	< 1		Insomnia	grade 3				2134
14256	8		Peripheral neuropathy		discontinuation	leads to discontinuation		2136
14257	1 pts		Cardiogenic shock	grade 5	discontinuation	leads to discontinuation		2136
14258	1 pts		Respiratory insufficiency	grade 5	discontinuation	leads to discontinuation		2136
14259	1 pts		Congestive heart failure	grade 5	discontinuation	leads to discontinuation		2136
14260	1 pts		Cardiac arrest	grade 5	discontinuation	leads to discontinuation		2136
14261	3		Diarrhea	serious				2136
14262	2		Dehydration	serious				2136
14263	2		Herpes zoster	serious				2136
14264	2		Pyrexia	serious				2136
14265	2		Nausea	serious				2136
14266	2		Vomiting	serious				2136
14267	2		Dyspnea	serious				2136
14268	2		Thrombocytopenia	serious				2136
14269	2		Constipation	grade 3				2136
14270	2		Anorexia	grade 3				2136
14271	2		Paresthesia	grade 3				2136
14272	6		Anaemia NOS	grade 3				2136
14273	<1		Anaemia NOS	grade 4				2136
14274	<1		Headache	grade 3				2136
14275	11		Neutropenia	grade 3				2136
14276	2		Neutropenia	grade 4				2136
14277	<1		Rash NOS	grade 3				2136
14278	2		Abdominal pain	grade 3				2136
14279	3		Weakness	grade 3				2136
14280	2		Fatigue		discontinuation	leads to discontinuation		2136
14281	2		Thrombocytopenia		discontinuation	leads to discontinuation		2136
14282	2		Diarrhea		discontinuation	leads to discontinuation		2136
14283	1		Hypotension		discontinuation	leads to discontinuation		2135
14284	< 1		Pyrexia		discontinuation	leads to discontinuation		2135
14285	< 1		Weakness		discontinuation	leads to discontinuation		2135
14286	< 1		Asthenia		discontinuation	leads to discontinuation		2135
14287	3 pts		Headache	below serious				2139
14288	2 pts		Skin irritation	below serious				2138
14289			Bradycardia			poisoning from the accidental exposure to brimonidine topical gel		2140
14290			Somnolence			poisoning from the accidental exposure to brimonidine topical gel		2140
14291			Somnolence		discontinuation	leads to discontinuation		2141
14292	0.6		Contact dermatitis		discontinuation	leads to discontinuation		2137
14293	0.3		Erythema		discontinuation	leads to discontinuation		2137
14294	14.3		Hypokalemia	moderate	discontinuation			2143
14295			Anorexia	moderate	discontinuation	anorexia + fatigue - 9.5%		2143
14296			Fatigue	moderate	discontinuation	anorexia + fatigue - 9.5%		2143
14297	4.8		Polyuria	moderate	discontinuation			2143
14298						No adverse reactions leading to discontinuation were reported		2142
14299						No adverse reactions leading to drug-related discontinuation were observed		2144
14300			Cardiac valvulopathy			WARNINGS		2145
14301			Cardiac valvulopathy			WARNINGS		2147
14302			Pleural effusion		discontinuation	WARNINGS		2147
14303			Pulmonary fibrosis		discontinuation	WARNINGS		2147
14304			Pericardial fibrosis			WARNINGS		2147
14305			Retroperitoneal fibrosis			WARNINGS		2147
14306	1.4		Headache		discontinuation			2146
14307	0.9		Nausea		discontinuation			2146
14308	0.9		Vomiting		discontinuation			2146
14309	1 pts		Hypercalcemia				TRUE	2149
14310	1 pts		Hypercalcemia				TRUE	2150
14311	2 pts		Hypercalcemia				TRUE	2151
14312	3 pts		Hypercalcemia				TRUE	2148
14313	11 pts		Hypercalcemia					2152
14314	1 pts		Pancreatitis					2152
14315	3 pts		Nausea					2152
14316	1 pts		Fatigue					2152
14317	28.6		Hand-and-foot syndrome	grade 3			TRUE	2153
14318	14.29		Diarrhea	grade 3			TRUE	2153
14319	14.29		Hand-and-foot syndrome	grade 3			TRUE	2154
14320			Coagulopathy		discontinuation	WARNING.May result in bleeding, death.		2155
14321			Diarrhea		discontinuation	WARNING. May be severe.		2155
14322			Cardiotoxicity		discontinuation	WARNING		2155
14323			Dehydration		discontinuation	WARNING		2155
14324			Renal failure		discontinuation	WARNING		2155
14325			Fetal damage		discontinuation	WARNING		2155
14326			Mucocutaneous disorder	severe	discontinuation	WARNING		2155
14327			Stevens Johnson syndrome		discontinuation	WARNING		2155
14328			Toxic epidermal necrolysis		discontinuation	WARNING		2155
14329			Hyperbilirubinemia		discontinuation	WARNING		2155
14330						No AEs were observed		2156
14331	1 pts		Dehydration	serious				2157
14332	1 pts		Convulsion	serious				2157
14333	18 pts		Application site pain	below serious				2157
14334	20 pts		Pain in extremity	below serious				2157
14335	26 pts		Burning sensation	below serious				2157
14336	0.9		Neuralgia		discontinuation			2159
14337			Irritation of eyes			WARNING		2158
14338			Respiratory tract irritation			WARNING		2158
14339			Transient blood pressure increase			WARNING		2158
14340	12		Nervous system disorder		discontinuation			2160
14341	8.8		Skin and subcutaneous conditions NEC		discontinuation			2160
14342			Fatigue		discontinuation	fatigue and somnolence (6 patients - 6.6%)		2160
14343			Somnolence		discontinuation	fatigue and somnolence (6 patients - 6.6%)		2160
14344	0.23		Atrioventricular block second degree	moderate	discontinuation			2161
14345	0.23		Suicidal ideation	serious	discontinuation			2161
14346	0.23		Suicide attempt	serious	discontinuation			2161
14347			Skin and subcutaneous conditions NEC	grade 3-5	discontinuation	WARNING		2162
14348			Toxic epidermal necrolysis	grade 3-5	discontinuation	WARNING		2162
14349			Stevens-Johnson syndrome	grade 3-5	discontinuation	WARNING		2162
14350			Aplastic anemia		discontinuation	WARNING		2162
14351			Agranulocytosis		discontinuation	WARNING		2162
14352			Thrombocytopenia	grade 3-4			TRUE	2163
14353	4.2		Adult respiratory distress syndrome	grade 5	discontinuation			2163
14354	9		Pulmonary toxicity		discontinuation			2164
14355	45		Leukopenia	grade 3-4		Hematologic toxicity was dose-limiting and prevented escalation of BCNU dose.	TRUE	2164
14356	27		Thrombocytopenia	grade 3-4		Hematologic toxicity was dose-limiting and prevented escalation of BCNU dose.	TRUE	2164
14357			Marrow depression of		discontinuation	WARNING		2165
14358			Thrombocytopenia		discontinuation	WARNING		2165
14359			Leukopenia		discontinuation	WARNING		2165
14360			Pulmonary toxicity		discontinuation	WARNING		2165
14361			Administration site extravasation		discontinuation	WARNING		2165
14362			Carcinogenicity		discontinuation	WARNING		2165
14363			Fetal damage		discontinuation	WARNING		2165
14364	2		Gastrointestinal disturbance		discontinuation	leads to discontinuation		2166
14365	3		Gastrointestinal disturbance		discontinuation	leads to discontinuation		2167
14366	0.7		Diarrhoea		discontinuation	leads to discontinuation		2166
14367	1.4		Diarrhoea		discontinuation	leads to discontinuation		2167
14368	1 pts		Gastrointestinal disturbance		discontinuation	leads to discontinuation		2168
14369						No AEs are reported		2169
14370	0.8		Rash		discontinuation	leads to discontinuation		2172
14371	1.1		Rash		discontinuation	leads to discontinuation		2170
14372	2		Rash		discontinuation	leads to discontinuation		2171
14373						No information on AE is provided		2173
14374	160 pts		Gastrointestinal disorders					2176
14375	0.9		Gastrointestinal disorders		discontinuation	leads to discontinuation		2176
14376						No AEs were reported		2174
14377						no clinically significant adverse clinical events		2175
14378	1 pts		Periorbital cellulitis	serious				2177
14379	1 pts		Pneumonia	serious				2177
14380	1 pts		Depression	serious				2177
14381	9 pts		Abdominal discomfort	below serious				2177
14382	4 pts		Abdominal pain upper	below serious				2177
14383	6 pts		Diarrhoea	below serious				2177
14384	4 pts		Chest pain	below serious				2177
14385	6 pts		Fatigue	below serious				2177
14386	4 pts		Ear infection	below serious				2177
14387	3 pts		Gastroenteritis	below serious				2177
14388	3 pts		Gastroenteritis viral	below serious				2177
14389	6 pts		Influenza	below serious				2177
14390	6 pts		Nasopharyngitis	below serious				2177
14391	3 pts		Albumin urine present	below serious				2177
14392	3 pts		Arthralgia	below serious				2177
14393	16 pts		Headache	below serious				2177
14394	8 pts		Cough	below serious				2177
14395	3 pts		Dyspnoea	below serious				2177
14396	6 pts		Oropharyngeal pain	below serious				2177
14397	2 pts		Abdominal discomfort	below serious				2183
14398	2 pts		Abdominal pain upper	below serious				2183
14399	1 pts		Epigastric discomfort	below serious				2183
14400	1 pts		Erosive duodenitis	below serious				2183
14401	2 pts		Gastritis	below serious				2183
14402	8 pts		Gastritis erosive	below serious				2183
14403	2 pts		Stomatitis	below serious				2183
14404	1 pts		Alanine aminotransferase increased	below serious				2183
14405	1 pts		Somnolence	below serious				2183
14406	1 pts		Thrombocytopenic purpura	serious				2184
14407	1 pts		Acute cardiac event	serious				2184
14408	1 pts		Aortic valve incompetence	serious				2184
14409	1 pts		Atrial fibrillation	serious				2184
14410	1 pts		Cardiomegaly	serious				2184
14411	1 pts		Chest pain - cardiac	serious				2184
14412	1 pts		Pulmonary oedema	serious				2184
14413	1 pts		Tachycardia	serious				2184
14414	1 pts		Deafness	serious				2184
14415	7 pts		Gastrointestinal disorder	serious				2184
14416	1 pts		Small intestinal obstruction	serious				2184
14417	6 pts		Abdominal pain	serious				2184
14418	1 pts		Diarrhoea	serious				2184
14419	1 pts		Diverticulitis	serious				2184
14420	1 pts		Diverticulum	serious				2184
14421	2 pts		Gastric ulcer	serious				2184
14422	1 pts		Gastritis	serious				2184
14423	1 pts		Pancreatitis	serious				2184
14424	1 pts		Rectal haemorrhage	serious				2184
14425	1 pts		Vomiting	serious				2184
14426	6 pts		Chest pain	serious				2184
14427	1 pts		Condition aggravated	serious				2184
14428	3 pts		Death	serious				2184
14429	1 pts		Fibrosis	serious				2184
14430	1 pts		Oedema peripheral	serious				2184
14431	1 pts		Perforated ulcer	serious				2184
14432	1 pts		Suprapubic pain	serious				2184
14433	1 pts		Hepatic function abnormal	serious				2184
14434	3 pts		Abscess	serious				2184
14435	7 pts		Cellulitis	serious				2184
14436	6 pts		Infection	serious				2184
14437	2 pts		Sepsis	serious				2184
14438	1 pts		Uterine infection	serious				2184
14439	1 pts		Head injury	serious				2184
14440	1 pts		Post procedural complication	serious				2184
14441	1 pts		Road traffic accident	serious				2184
14442	1 pts		Seroma	serious				2184
14443	2 pts		Hepatic enzyme increased	serious				2184
14444	1 pts		Ankle fracture	serious				2184
14445	4 pts		Arthralgia	serious				2184
14446	1 pts		Bone pain	serious				2184
14447	3 pts		Fracture	serious				2184
14448	1 pts		Humerus fracture	serious				2184
14449	1 pts		Intervertebral disc degeneration	serious				2184
14450	1 pts		Intervertebral disc protrusion	serious				2184
14451	2 pts		Lower limb fracture	serious				2184
14452	1 pts		Fracture rib	serious				2184
14453	1 pts		Tibia fracture	serious				2184
14454	1 pts		Adenocarcinoma of colon	serious				2184
14455	1 pts		Adrenal adenoma	serious				2184
14456	1 pts		Basal cell carcinoma	serious				2184
14457	3 pts		Breast cancer recurrent	serious				2184
14458	1 pts		Colon cancer	serious				2184
14459	1 pts		Gallbladder cancer	serious				2184
14460	2 pts		Malignant melanoma	serious				2184
14461	1 pts		Malignant neoplasm progression	serious				2184
14462	3 pts		Metastases to central nervous system	serious				2184
14463	2 pts		Metastases to lung	serious				2184
14464	2 pts		Metastasis	serious				2184
14465	1 pts		Ovarian cancer	serious				2184
14466	1 pts		Pancreatic carcinoma	serious				2184
14467	1 pts		Rectal cancer	serious				2184
14468	5 pts		Second primary malignancy	serious				2184
14469	1 pts		Vulval cancer	serious				2184
14470	1 pts		Cerebellar infarction	serious				2184
14471	1 pts		Nervous system disorder	serious				2184
14472	1 pts		Neurological symptom	serious				2184
14473	1 pts		Peripheral sensory neuropathy	serious				2184
14474	2 pts		Depression	serious				2184
14475	3 pts		Psychiatric symptom	serious				2184
14476	1 pts		Nephrolithiasis	serious				2184
14477	1 pts		Colic renal	serious				2184
14478	1 pts		Adnexal torsion	serious				2184
14479	1 pts		Breast necrosis	serious				2184
14480	1 pts		Breast pain	serious				2184
14481	2 pts		Haemorrhage vaginal	serious				2184
14482	1 pts		Alveolitis	serious				2184
14483	8 pts		Dyspnoea	serious				2184
14484	1 pts		Pleural effusion	serious				2184
14485	1 pts		Productive cough	serious				2184
14486	5 pts		Pulmonary embolism	serious				2184
14487	1 pts		Respiratory disorder	serious				2184
14488	2 pts		Erysipelas	serious				2184
14489	3 pts		Rash	serious				2184
14490	1 pts		Swelling of eyelid	serious				2184
14491	1 pts		Urticaria	serious				2184
14492	1 pts		Abortion induced	serious				2184
14493	1 pts		Oophorectomy bilateral	serious				2184
14494	1 pts		Deep vein thrombosis	serious				2184
14495	1 pts		Epistaxis	serious				2184
14496	1 pts		Haematemesis	serious				2184
14497	178 pts		Hypertension	below serious				2184
14498	25		Rash	grade 3			TRUE	2181
14499	12.5		Fistula	grade 3			TRUE	2178
14500	33.3		Osteonecrosis	grade 3			TRUE	2182
14501	33.3		Trismus	grade 3			TRUE	2182
14502	33.3		Folliculitis	grade 2			TRUE	2182
14503	33.3		Nausea	grade 2			TRUE	2182
14504	33.3		Bleeding rectal	grade 2			TRUE	2182
14505	0.3		Urticaria	grade 1	discontinuation			2180
14506			Hypertension		discontinuation			2179
14507	7 pts		Polyneuropathy		discontinuation	leads to discontinuation		2185
14508	1 pts		Hypokalemia	below serious				2195
14509	1 pts		Hyponatremia	below serious				2195
14510			Hypokalemia					2186
14511						AEs not reported		2187
14512			Dry mouth			There was no dose relationship to reported side effects		2193
14513			Energy decreased			There was no dose relationship to reported side effects		2193
14514			Muscle cramps			There was no dose relationship to reported side effects		2193
14515			Nausea			There was no dose relationship to reported side effects		2193
14516			Dizziness postural			There was no dose relationship to reported side effects		2193
14517			Indigestion			There was no dose relationship to reported side effects		2193
14518			Dreaming excessive			There was no dose relationship to reported side effects		2193
14519			Constipation			There was no dose relationship to reported side effects		2193
14520			Nervousness			There was no dose relationship to reported side effects		2193
14521			Headaches			There was no dose relationship to reported side effects		2193
14522			Gas			There was no dose relationship to reported side effects		2193
14523			Tiredness			There was no dose relationship to reported side effects		2193
14524			Trouble falling asleep			There was no dose relationship to reported side effects		2193
14525			Urination frequency of			There was no dose relationship to reported side effects		2193
14526			Decreased appetite			There was no dose relationship to reported side effects		2193
14527	5.3		Headaches					2194
14528	15.8		Dizziness					2194
14529	5.3		Cramps					2194
14530	10.5		Orthostatic hypotension					2194
14531	5.3		Dry mouth					2194
14532	0.6		Blood creatinine increased		discontinuation			2190
14533	0.6		Blood urea increased		discontinuation			2190
14534	0.6		Headache		discontinuation			2190
14535	1.3		Hypokalemia		discontinuation			2190
14536	3.3		Dizziness					2191
14537	7.2		Headache					2191
14538	1.7		Plasminogen activator inhibitor increased					2191
14539	6.1		Hypokalemia					2191
14540	2.2		Dyslipidemia					2191
14541	1.1		Asthenia					2191
14542	1.7		Urinary tract infection					2191
14543	1.1		Back pain					2191
14544	2.8		Fatigue					2191
14545	1.1		Blood uric acid increased					2191
14546	0.6		Muscle spasms					2191
14547	2.2		Peripheral edema					2191
14548	1.1		Upper respiratory tract infection					2191
14549	1.7		Blood creatine phosphokinase increased					2191
14550	2.2		Palpitations					2191
14551	0.6		Hematuria					2191
14552	1.1		Hypertriglyceridemia					2191
14553	1.7		Blood potassium decreased					2191
14554	0.6		Edema					2191
14555	6.4		Blood creatinine increased		discontinuation			2189
14556	3.8		Dizziness		discontinuation			2189
14557	0.6		Hypotension		discontinuation			2189
14558	0.6		Blood urea increased		discontinuation			2189
14559	0.6		Headache		discontinuation			2189
14560	0.6		Fatigue		discontinuation			2189
14561	0.6		Diarrhea		discontinuation			2189
14562	18.6		Blood creatinine increased					2188
14563	13.5		Dizziness					2188
14564	5.8		Headache					2188
14565	3.2		Hypokalemia					2188
14566	6.4		Blood creatine phosphokinase increased					2188
14567	4.5		Blood uric acid increased					2188
14568	5.1		Blood urea increased					2188
14569	3.2		Diarrhea					2188
14570	3.8		Fatigue					2188
14571	4.5		Nasopharyngitis					2188
14572	4.5		Upper respiratory infection					2188
14573	1.9		Hyperuricemia					2188
14574	1.9		Blood potassium decreased					2188
14575	8.7		Dizziness					2192
14576	4.3		Headache					2192
14577	6.5		Plasminogen activator inhibitor increased					2192
14578	1.1		Hypokalemia					2192
14579	3.8		Dyslipidemia					2192
14580	3.3		Asthenia					2192
14581	1.6		Urinary tract infection					2192
14582	3.8		Back pain					2192
14583	3.3		Fatigue					2192
14584	2.2		Blood uric acid increased					2192
14585	2.7		Muscle spasms					2192
14586	2.2		Peripheral edema					2192
14587	2.2		Upper respiratory tract infection					2192
14588	0.5		Blood creatine phosphokinase increased					2192
14589	1.6		Palpitations					2192
14590	1.6		Hematuria					2192
14591	0.5		Hypertriglyceridemia					2192
14592	2.7		Blood creatinine increased					2192
14593	2.2		Diarrhea					2192
14594	2.2		C-reactive protein increased					2192
14595	2.2		Hypotension					2192
14596						AEs for placebo were more than for the definite drug		2201
14597	1 pts		Lobar pneumonia	serious				2199
14598	1 pts		Asthma	serious				2199
14599	6 pts		Pyrexia	below serious				2199
14600	5 pts		Ear infection	below serious				2199
14601	5 pts		Pharyngitis	below serious				2199
14602	4 pts		Rhinitis	below serious				2199
14603	18 pts		Upper respiratory tract infection	below serious				2199
14604	6 pts		Cough	below serious				2199
14605	7 pts		Allergic rhinitis	below serious				2199
14606	1 pts		Laryngitis	serious				2200
14607	1 pts		Epistaxis	serious				2200
14608	1 pts		Myringoplasty	serious				2200
14609	3 pts		Ear infection	below serious				2200
14610	6 pts		Influenza	below serious				2200
14611	4 pts		Lower respiratory tract infection	below serious				2200
14612	19 pts		Upper respiratory tract infection	below serious				2200
14613	4 pts		Cough	below serious				2200
14614	2 pts		Cough	below serious				2204
14615	1 pts		Asthenia	below serious				2204
14616	1 pts		Chest pain	below serious				2204
14617	1 pts		Decreased activity	below serious				2204
14618						No AEs are reported		2203
14619						No AEs are reported		2202
14620						No information about AEs is found		2198
14621						No information about AEs is found		2196
14622	1 pts		Burning sensation	severe	discontinuation	leads to discontinuation		2197
14623	0.36		Nail injury		discontinuation	great toenail “broke away”		2205
14624	0.36		Creatine phosphokinase increased		discontinuation			2205
14625	1 pts		Gastrointestinal discomfort	below serious				2207
14626	1 pts		Diarrhea	below serious				2207
14627	1 pts		Hypertension	below serious				2207
14628	4		Headache	grade 3	discontinuation			2209
14629	2		Headache	grade 3	discontinuation			2210
14630	4		Palpitation		discontinuation			2209
14631	3		Palpitation		discontinuation			2210
14632						No information on AE is provided		2208
14633			Headache					2206
14634	42 pts		Anaemia	serious				2213
14635	2 pts		Coagulopathy	serious				2213
14636	1 pts		Anaemia haemolytic	serious				2213
14637	5 pts		Haemorrhagic anaemia	serious				2213
14638	1 pts		Haemorrhagic disorder	serious				2213
14639	4 pts		Leukocytosis	serious				2213
14640	2 pts		Leukopenia	serious				2213
14641	2 pts		Neutropenia	serious				2213
14642	47 pts		Acute myocardial infarction	serious				2213
14643	52 pts		Angina unstable	serious				2213
14644	7 pts		Aortic valve stenosis	serious				2213
14645	12 pts		Atrial flutter	serious				2213
14646	1 pts		Atrial tachycardia	serious				2213
14647	5 pts		Atrioventricular block	serious				2213
14648	12 pts		Bradycardia	serious				2213
14649	1 pts		Block bundle branch	serious				2213
14650	60 pts		Cardiac arrest	serious				2213
14651	6 pts		Cardiac failure acute	serious				2213
14652	27 pts		Cardio-respiratory arrest	serious				2213
14653	12 pts		Cardiogenic shock	serious				2213
14654	1 pts		Cardiovascular disorder	serious				2213
14655	28 pts		Coronary artery disease	serious				2213
14656	1 pts		Coronary artery insufficiency	serious				2213
14657	5 pts		Coronary artery stenosis	serious				2213
14658	1 pts		Dilatation ventricular	serious				2213
14659	2 pts		Left ventricular dysfunction	serious				2213
14660	1 pts		Mitral valve calcification	serious				2213
14661	2 pts		Mitral valve disease	serious				2213
14662	109 pts		Myocardial infarction	serious				2213
14663	11 pts		Myocardial ischaemia	serious				2213
14664	6 pts		Palpitations	serious				2213
14665	8 pts		Pericardial effusion	serious				2213
14666	3 pts		Pericarditis	serious				2213
14667	2 pts		Right ventricular failure	serious				2213
14668	2 pts		Sinus tachycardia	serious				2213
14669	1 pts		Supraventricular extrasystoles	serious				2213
14670	1 pts		Ventricular tachyarrhythmia	serious				2213
14671	12 pts		Ventricular tachycardia	serious				2213
14672	1 pts		Adenomatous polyposis coli	serious				2213
14673	6 pts		Congenital cystic kidney disease	serious				2213
14674	2 pts		Gastrointestinal arteriovenous malformation	serious				2213
14675	1 pts		Left ventricle outflow tract obstruction	serious				2213
14676	1 pts		Meniere's disease	serious				2213
14677	4 pts		Vertigo	serious				2213
14678	1 pts		Vertigo positional	serious				2213
14679	1 pts		Disorder vestibular	serious				2213
14680	1 pts		Adrenal insufficiency	serious				2213
14681	2 pts		Parathyroid gland enlargement	serious				2213
14682	1 pts		Thyroid cyst	serious				2213
14683	1 pts		Thyroiditis	serious				2213
14684	1 pts		Age-related macular degeneration	serious				2213
14685	8 pts		Cataract	serious				2213
14686	1 pts		Cataract cortical	serious				2213
14687	2 pts		Conjunctivitis	serious				2213
14688	1 pts		Diabetic retinopathy	serious				2213
14689	1 pts		Exophthalmos	serious				2213
14690	3 pts		Eye haemorrhage	serious				2213
14691	1 pts		Atrophy optic	serious				2213
14692	3 pts		Retinal detachment	serious				2213
14693	1 pts		Retinal vein thrombosis	serious				2213
14694	1 pts		Hypertensive retinopathy	serious				2213
14695	1 pts		Visual impairment	serious				2213
14696	2 pts		Vitreous haemorrhage	serious				2213
14697	1 pts		Abdominal distension	serious				2213
14698	1 pts		Abdominal hernia obstructive	serious				2213
14699	5 pts		Abdominal pain upper	serious				2213
14700	1 pts		Abdominal rigidity	serious				2213
14701	2 pts		Abdominal strangulated hernia	serious				2213
14702	1 pts		Barrett's oesophagus	serious				2213
14703	9 pts		Colitis ischaemic	serious				2213
14704	8 pts		Constipation	serious				2213
14705	2 pts		Diabetic gastroparesis	serious				2213
14706	32 pts		Diarrhoea	serious				2213
14707	1 pts		Dieulafoy's vascular malformation	serious				2213
14708	2 pts		Diverticular perforation	serious				2213
14709	1 pts		Diverticulum	serious				2213
14710	7 pts		Duodenal ulcer	serious				2213
14711	3 pts		Dyspepsia	serious				2213
14712	3 pts		Dysphagia	serious				2213
14713	5 pts		Enteritis	serious				2213
14714	1 pts		Erosive oesophagitis	serious				2213
14715	3 pts		Faecaloma	serious				2213
14716	1 pts		Gastric hypermotility	serious				2213
14717	12 pts		Gastric ulcer	serious				2213
14718	2 pts		Gastric ulcer haemorrhage	serious				2213
14719	1 pts		Gastritis haemorrhagic	serious				2213
14720	1 pts		Gastroduodenitis	serious				2213
14721	2 pts		Gastrointestinal angiodysplasia	serious				2213
14722	54 pts		Gastrointestinal haemorrhage	serious				2213
14723	2 pts		Gastrointestinal inflammation	serious				2213
14724	1 pts		Gastrointestinal ulcer haemorrhage	serious				2213
14725	4 pts		Gastrooesophageal reflux disease	serious				2213
14726	5 pts		Haematemesis	serious				2213
14727	1 pts		Haemorrhagic erosive gastritis	serious				2213
14728	5 pts		Haemorrhoids	serious				2213
14729	1 pts		Hernial eventration	serious				2213
14730	2 pts		Hiatus hernia	serious				2213
14731	6 pts		Ileus	serious				2213
14732	6 pts		Impaired gastric emptying	serious				2213
14733	2 pts		Intestinal haemorrhage	serious				2213
14734	9 pts		Intestinal ischaemia	serious				2213
14735	1 pts		Intestinal mass	serious				2213
14736	5 pts		Intestinal obstruction	serious				2213
14737	1 pts		Intestinal perforation	serious				2213
14738	1 pts		Intestinal ulcer	serious				2213
14739	1 pts		Irritable bowel syndrome	serious				2213
14740	1 pts		Ischaemic gastritis	serious				2213
14741	1 pts		Intestinal large ulcer	serious				2213
14742	1 pts		Lumbar hernia	serious				2213
14743	1 pts		Mechanical ileus	serious				2213
14744	3 pts		Melaena	serious				2213
14745	2 pts		Mesenteric artery stenosis	serious				2213
14746	20 pts		Nausea	serious				2213
14747	1 pts		Necrotising colitis	serious				2213
14748	1 pts		Achalasia oesophageal	serious				2213
14749	1 pts		Oesophageal food impaction	serious				2213
14750	1 pts		Oesophageal perforation	serious				2213
14751	6 pts		Oesophagitis	serious				2213
14752	1 pts		Oesophagitis haemorrhagic	serious				2213
14753	2 pts		Chronic pancreatitis	serious				2213
14754	1 pts		Peptic ulcer haemorrhage	serious				2213
14755	1 pts		Haemorrhage retroperitoneal	serious				2213
14756	1 pts		Short-bowel syndrome	serious				2213
14757	5 pts		Small intestinal obstruction	serious				2213
14758	1 pts		Stomach mass	serious				2213
14759	1 pts		Stress ulcer	serious				2213
14760	1 pts		Subileus	serious				2213
14761	1 pts		Tooth loss	serious				2213
14762	1 pts		Tooth socket haemorrhage	serious				2213
14763	11 pts		Upper gastrointestinal haemorrhage	serious				2213
14764	33 pts		Vomiting	serious				2213
14765	3 pts		Catheter site haematoma	serious				2213
14766	1 pts		Catheter site pain	serious				2213
14767	1 pts		Catheter site swelling	serious				2213
14768	4 pts		Chest discomfort	serious				2213
14769	4 pts		Chills	serious				2213
14770	2 pts		Device dislocation	serious				2213
14771	2 pts		Device occlusion	serious				2213
14772	1 pts		Drug intolerance	serious				2213
14773	1 pts		Drug withdrawal syndrome	serious				2213
14774	1 pts		Fat necrosis	serious				2213
14775	1 pts		Hernia	serious				2213
14776	1 pts		Hernia pain	serious				2213
14777	2 pts		Hyperthermia	serious				2213
14778	1 pts		Implant site haematoma	serious				2213
14779	1 pts		Influenza like illness	serious				2213
14780	1 pts		Localised oedema	serious				2213
14781	8 pts		Multi-organ failure	serious				2213
14782	1 pts		Necrosis	serious				2213
14783	27 pts		Non-cardiac chest pain	serious				2213
14784	1 pts		Organ failure	serious				2213
14785	1 pts		Pelvic mass	serious				2213
14786	1 pts		Precancerous mucosal lesion	serious				2213
14787	42 pts		Pyrexia	serious				2213
14788	2 pts		Spinal pain	serious				2213
14789	1 pts		Systemic inflammatory response syndrome	serious				2213
14790	3 pts		Bile duct stone	serious				2213
14791	3 pts		Cholangitis	serious				2213
14792	1 pts		Cholangitis acute	serious				2213
14793	7 pts		Cholecystitis acute	serious				2213
14794	1 pts		Cholecystitis chronic	serious				2213
14795	16 pts		Cholelithiasis	serious				2213
14796	2 pts		Cholestasis	serious				2213
14797	2 pts		Gallbladder polyp	serious				2213
14798	1 pts		Hepatic function abnormal	serious				2213
14799	1 pts		Hepatic lesion	serious				2213
14800	1 pts		Amyloidosis	serious				2213
14801	6 pts		Kidney transplant rejection	serious				2213
14802	2 pts		Abdominal abscess	serious				2213
14803	4 pts		Abdominal wall abscess	serious				2213
14804	3 pts		Abscess	serious				2213
14805	9 pts		Abscess limb	serious				2213
14806	1 pts		Abscess neck	serious				2213
14807	1 pts		Abscess of eyelid	serious				2213
14808	1 pts		Abscess oral	serious				2213
14809	1 pts		Acute sinusitis	serious				2213
14810	6 pts		Appendicitis	serious				2213
14811	1 pts		Appendicitis perforated	serious				2213
14812	1 pts		Arteriosclerotic gangrene	serious				2213
14813	25 pts		Arteriovenous graft site infection	serious				2213
14814	4 pts		Arthritis bacterial	serious				2213
14815	2 pts		Arthritis infective	serious				2213
14816	27 pts		Bacteraemia	serious				2213
14817	1 pts		Bacterial infection	serious				2213
14818	1 pts		Biliary tract infection	serious				2213
14819	26 pts		Bronchitis	serious				2213
14820	2 pts		Catheter site cellulitis	serious				2213
14821	1 pts		Cellulitis orbital	serious				2213
14822	3 pts		Clostridial infection	serious				2213
14823	1 pts		Clostridium colitis	serious				2213
14824	9 pts		Clostridium difficile colitis	serious				2213
14825	2 pts		Dengue fever	serious				2213
14826	29 pts		Device related infection	serious				2213
14827	9 pts		Diverticulitis	serious				2213
14828	13 pts		Endocarditis	serious				2213
14829	2 pts		Enteritis infectious	serious				2213
14830	2 pts		Enterobacter bacteraemia	serious				2213
14831	1 pts		Enterobacter pneumonia	serious				2213
14832	3 pts		Enterobacter sepsis	serious				2213
14833	3 pts		Enterococcal bacteraemia	serious				2213
14834	1 pts		Enterococcal infection	serious				2213
14835	2 pts		Enterocolitis infectious	serious				2213
14836	1 pts		Escherichia bacteraemia	serious				2213
14837	2 pts		Eye infection	serious				2213
14838	1 pts		Fungal oesophagitis	serious				2213
14839	1 pts		Gas gangrene	serious				2213
14840	24 pts		Gastroenteritis	serious				2213
14841	8 pts		Gastroenteritis viral	serious				2213
14842	1 pts		Giardiasis	serious				2213
14843	3 pts		H1N1 influenza	serious				2213
14844	2 pts		Haematoma infection	serious				2213
14845	2 pts		Haemophilus infection	serious				2213
14846	1 pts		Helicobacter infection	serious				2213
14847	2 pts		Hepatitis C	serious				2213
14848	4 pts		Herpes zoster	serious				2213
14849	1 pts		Implant site infection	serious				2213
14850	3 pts		Infected fistula	serious				2213
14851	1 pts		Infectious peritonitis	serious				2213
14852	1 pts		Infective aneurysm	serious				2213
14853	1 pts		Infective tenosynovitis	serious				2213
14854	4 pts		Influenza	serious				2213
14855	1 pts		Joint abscess	serious				2213
14856	1 pts		Klebsiella bacteraemia	serious				2213
14857	11 pts		Lower respiratory tract infection	serious				2213
14858	1 pts		Lower respiratory tract infection bacterial	serious				2213
14859	1 pts		Bacterial meningitis	serious				2213
14860	1 pts		Cryptococcal meningitis	serious				2213
14861	1 pts		Meningitis viral	serious				2213
14862	1 pts		Nasal abscess	serious				2213
14863	1 pts		Orchitis	serious				2213
14864	1 pts		Periorbital cellulitis	serious				2213
14865	2 pts		Perirectal abscess	serious				2213
14866	1 pts		Peritoneal abscess	serious				2213
14867	9 pts		Peritonitis	serious				2213
14868	1 pts		Abscess peritonsillar	serious				2213
14869	1 pts		Pilonidal cyst	serious				2213
14870	1 pts		Pneumonia escherichia	serious				2213
14871	1 pts		Pneumonia fungal	serious				2213
14872	2 pts		Pneumonia primary atypical	serious				2213
14873	2 pts		Pneumonia viral	serious				2213
14874	1 pts		Post procedural infection	serious				2213
14875	1 pts		Post procedural pneumonia	serious				2213
14876	3 pts		Postoperative abscess	serious				2213
14877	1 pts		Pseudomonas infection	serious				2213
14878	1 pts		Pulmonary tuberculosis	serious				2213
14879	1 pts		Pyelocystitis	serious				2213
14880	9 pts		Pyelonephritis	serious				2213
14881	2 pts		Pyelonephritis acute	serious				2213
14882	1 pts		Rectal abscess	serious				2213
14883	2 pts		Renal cyst infection	serious				2213
14884	1 pts		Respiratory tract infection bacterial	serious				2213
14885	1 pts		Respiratory tract infection viral	serious				2213
14886	1 pts		Scrotal abscess	serious				2213
14887	123 pts		Sepsis	serious				2213
14888	1 pts		Serratia bacteraemia	serious				2213
14889	9 pts		Staphylococcal bacteraemia	serious				2213
14890	14 pts		Infection staphylococcal	serious				2213
14891	2 pts		Staphylococcal osteomyelitis	serious				2213
14892	12 pts		Staphylococcal sepsis	serious				2213
14893	1 pts		Streptococcal sepsis	serious				2213
14894	6 pts		Subcutaneous abscess	serious				2213
14895	1 pts		Testicular abscess	serious				2213
14896	1 pts		Tooth abscess	serious				2213
14897	1 pts		Tooth infection	serious				2213
14898	7 pts		Upper respiratory tract infection	serious				2213
14899	1 pts		Vestibular neuronitis	serious				2213
14900	5 pts		Viral infection	serious				2213
14901	1 pts		Viral pharyngitis	serious				2213
14902	1 pts		Wound infection bacterial	serious				2213
14903	2 pts		Wound infection staphylococcal	serious				2213
14904	1 pts		Zygomycosis	serious				2213
14905	2 pts		Acetabulum fracture	serious				2213
14906	1 pts		Animal bite	serious				2213
14907	9 pts		Ankle fracture	serious				2213
14908	13 pts		Arteriovenous fistula occlusion	serious				2213
14909	3 pts		Arteriovenous fistula site haematoma	serious				2213
14910	49 pts		Arteriovenous fistula thrombosis	serious				2213
14911	2 pts		Arteriovenous graft aneurysm	serious				2213
14912	9 pts		Arteriovenous graft site haemorrhage	serious				2213
14913	1 pts		Brain herniation	serious				2213
14914	3 pts		Complications of transplanted kidney	serious				2213
14915	4 pts		Contusion	serious				2213
14916	1 pts		Cystitis radiation	serious				2213
14917	1 pts		Eye operation complication	serious				2213
14918	1 pts		Face injury	serious				2213
14919	3 pts		Forearm fracture	serious				2213
14920	1 pts		Foreign body	serious				2213
14921	3 pts		Fracture	serious				2213
14922	1 pts		Fractured coccyx	serious				2213
14923	1 pts		Graft complication	serious				2213
14924	1 pts		Graft haemorrhage	serious				2213
14925	7 pts		Graft thrombosis	serious				2213
14926	4 pts		Haemodialysis-induced symptom	serious				2213
14927	2 pts		In-stent coronary artery restenosis	serious				2213
14928	5 pts		Joint dislocation	serious				2213
14929	1 pts		Kidney rupture	serious				2213
14930	6 pts		Overdose	serious				2213
14931	3 pts		Pelvic fracture	serious				2213
14932	1 pts		Pneumothorax traumatic	serious				2213
14933	5 pts		Post procedural haemorrhage	serious				2213
14934	1 pts		Postoperative adhesion	serious				2213
14935	1 pts		Postoperative ileus	serious				2213
14936	1 pts		Postoperative thoracic procedure complication	serious				2213
14937	2 pts		Postoperative wound complication	serious				2213
14938	1 pts		Procedural complication	serious				2213
14939	10 pts		Procedural hypotension	serious				2213
14940	1 pts		Shunt aneurysm	serious				2213
14941	10 pts		Shunt occlusion	serious				2213
14942	6 pts		Shunt stenosis	serious				2213
14943	8 pts		Shunt thrombosis	serious				2213
14944	1 pts		Spinal column injury	serious				2213
14945	1 pts		Splenic rupture	serious				2213
14946	8 pts		Subdural haematoma	serious				2213
14947	1 pts		Suture rupture	serious				2213
14948	3 pts		Transplant failure	serious				2213
14949	15 pts		Vascular access complication	serious				2213
14950	13 pts		Vascular graft complication	serious				2213
14951	8 pts		Vascular graft occlusion	serious				2213
14952	8 pts		Vascular pseudoaneurysm	serious				2213
14953	4 pts		Wound dehiscence	serious				2213
14954	1 pts		Blood calcium decreased	serious				2213
14955	4 pts		Blood potassium increased	serious				2213
14956	2 pts		Blood pressure increased	serious				2213
14957	2 pts		C-reactive protein increased	serious				2213
14958	1 pts		Cardioactive drug level increased	serious				2213
14959	1 pts		Clostridium test positive	serious				2213
14960	1 pts		Electrocardiogram ST segment abnormal	serious				2213
14961	1 pts		Electrocardiogram ST-T segment abnormal	serious				2213
14962	2 pts		Electrocardiogram abnormal	serious				2213
14963	3 pts		Electrocardiogram change	serious				2213
14964	1 pts		Fibrin D dimer increased	serious				2213
14965	1 pts		Haematocrit decreased	serious				2213
14966	6 pts		Haemoglobin decreased	serious				2213
14967	1 pts		Heart rate irregular	serious				2213
14968	1 pts		Influenza virus test positive	serious				2213
14969	1 pts		International normalised ratio decreased	serious				2213
14970	1 pts		International normalised ratio fluctuation	serious				2213
14971	2 pts		International normalised ratio increased	serious				2213
14972	1 pts		Liver function test abnormal	serious				2213
14973	3 pts		Acidosis	serious				2213
14974	4 pts		Cachexia	serious				2213
14975	3 pts		Decreased appetite	serious				2213
14976	6 pts		Dehydration	serious				2213
14977	4 pts		Diabetic ketoacidosis	serious				2213
14978	6 pts		Failure to thrive	serious				2213
14979	3 pts		Hypercalcaemia	serious				2213
14980	97 pts		Hyperkalaemia	serious				2213
14981	1 pts		Hyperphosphataemia	serious				2213
14982	16 pts		Hypocalcaemia	serious				2213
14983	34 pts		Hypoglycaemia	serious				2213
14984	1 pts		Hyponatraemia	serious				2213
14985	1 pts		Lactic acidosis	serious				2213
14986	2 pts		Malnutrition	serious				2213
14987	1 pts		Hypoglycaemic shock	serious				2213
14988	1 pts		Type 1 diabetes mellitus	serious				2213
14989	11 pts		Arthralgia	serious				2213
14990	2 pts		Cervical spinal stenosis	serious				2213
14991	1 pts		Chondrocalcinosis pyrophosphate	serious				2213
14992	2 pts		Costochondritis	serious				2213
14993	1 pts		Intervertebral disc degeneration	serious				2213
14994	2 pts		Intervertebral disc disorder	serious				2213
14995	6 pts		Intervertebral disc protrusion	serious				2213
14996	1 pts		Destruction joint	serious				2213
14997	1 pts		Limb deformity	serious				2213
14998	1 pts		Mobility decreased	serious				2213
14999	9 pts		Muscular weakness	serious				2213
15000	1 pts		Musculoskeletal disorder	serious				2213
15001	1 pts		Musculoskeletal stiffness	serious				2213
15002	1 pts		Neuropathic arthropathy	serious				2213
15003	4 pts		Osteonecrosis	serious				2213
15004	1 pts		Osteopenia	serious				2213
15005	13 pts		Pain in extremity	serious				2213
15006	1 pts		Periarthritis	serious				2213
15007	1 pts		Pseudarthrosis	serious				2213
15008	1 pts		Arthropathy psoriatic	serious				2213
15009	2 pts		Rotator cuff syndrome	serious				2213
15010	1 pts		Scleroderma	serious				2213
15011	1 pts		Spinal column stenosis	serious				2213
15012	1 pts		Spondylolisthesis	serious				2213
15013	1 pts		Acute myeloid leukaemia	serious				2213
15014	1 pts		Adenocarcinoma	serious				2213
15015	1 pts		Adenoma benign	serious				2213
15016	1 pts		B-cell lymphoma	serious				2213
15017	4 pts		Bladder cancer	serious				2213
15018	1 pts		Bladder cancer recurrent	serious				2213
15019	3 pts		Bladder neoplasm	serious				2213
15020	1 pts		Brain cancer metastatic	serious				2213
15021	1 pts		Brain neoplasm	serious				2213
15022	7 pts		Breast cancer	serious				2213
15023	2 pts		Breast cancer metastatic	serious				2213
15024	1 pts		Chronic lymphocytic leukaemia	serious				2213
15025	1 pts		Chronic myeloid leukaemia	serious				2213
15026	1 pts		Colon neoplasm	serious				2213
15027	1 pts		Hepatic neoplasm malignant	serious				2213
15028	1 pts		Intraocular melanoma	serious				2213
15029	1 pts		Lentigo maligna stage unspecified	serious				2213
15030	2 pts		Adenocarcinoma lung	serious				2213
15031	4 pts		Lung neoplasm malignant	serious				2213
15032	1 pts		Lymphoma	serious				2213
15033	2 pts		Malignant melanoma	serious				2213
15034	1 pts		Malignant pleural effusion	serious				2213
15035	1 pts		Malignant urinary tract neoplasm	serious				2213
15036	1 pts		Metastases to central nervous system	serious				2213
15037	1 pts		Metastases to lung	serious				2213
15038	1 pts		Metastases to peritoneum	serious				2213
15039	1 pts		Metastatic malignant melanoma	serious				2213
15040	4 pts		Metastatic neoplasm	serious				2213
15041	1 pts		Neoplasm malignant	serious				2213
15042	2 pts		Neoplasm skin	serious				2213
15043	1 pts		Non-Hodgkin's lymphoma	serious				2213
15044	2 pts		Pancreatic carcinoma	serious				2213
15045	8 pts		Prostate cancer	serious				2213
15046	1 pts		Prostate cancer metastatic	serious				2213
15047	6 pts		Renal cell carcinoma	serious				2213
15048	1 pts		Renal oncocytoma	serious				2213
15049	1 pts		Small cell lung cancer stage unspecified	serious				2213
15050	3 pts		Neoplasm thyroid	serious				2213
15051	1 pts		Transitional cell carcinoma	serious				2213
15052	1 pts		Tumour haemorrhage	serious				2213
15053	1 pts		Vaginal cancer	serious				2213
15054	1 pts		Aphasia	serious				2213
15055	2 pts		Autonomic neuropathy	serious				2213
15056	3 pts		Balance disorder	serious				2213
15057	1 pts		Basal ganglia haemorrhage	serious				2213
15058	1 pts		Brain stem infarction	serious				2213
15059	1 pts		Cerebral atrophy	serious				2213
15060	10 pts		Cerebral haemorrhage	serious				2213
15061	5 pts		Cerebral infarction	serious				2213
15062	1 pts		Clonus	serious				2213
15063	3 pts		Coma	serious				2213
15064	30 pts		Convulsion	serious				2213
15065	9 pts		Dizziness	serious				2213
15066	1 pts		Dyskinesia	serious				2213
15067	1 pts		Encephalitis	serious				2213
15068	1 pts		Encephalitis post varicella	serious				2213
15069	1 pts		Encephalomalacia	serious				2213
15070	3 pts		Epilepsy	serious				2213
15071	2 pts		Extrapyramidal disorder	serious				2213
15072	1 pts		Guillain Barre syndrome	serious				2213
15073	7 pts		Haemorrhage intracranial	serious				2213
15074	6 pts		Headache	serious				2213
15075	1 pts		Hemianopia	serious				2213
15076	1 pts		Hypogeusia	serious				2213
15077	1 pts		Hypoglycaemic encephalopathy	serious				2213
15078	1 pts		Hypotonia	serious				2213
15079	4 pts		Hypoxic-ischaemic encephalopathy	serious				2213
15080	8 pts		Ischaemic stroke	serious				2213
15081	2 pts		Migraine	serious				2213
15082	1 pts		Myelitis transverse	serious				2213
15083	2 pts		Nerve compression	serious				2213
15084	1 pts		Neuralgia	serious				2213
15085	1 pts		Optic neuritis	serious				2213
15086	2 pts		Paraesthesia	serious				2213
15087	1 pts		Partial seizures	serious				2213
15088	1 pts		Post herpetic neuralgia	serious				2213
15089	3 pts		Presyncope	serious				2213
15090	2 pts		Somnolence	serious				2213
15091	3 pts		Status epilepticus	serious				2213
15092	1 pts		Stupor	serious				2213
15093	5 pts		Haemorrhage subarachnoid	serious				2213
15094	15 pts		Transient ischaemic attack	serious				2213
15095	2 pts		Tremor	serious				2213
15096	2 pts		Uraemic encephalopathy	serious				2213
15097	1 pts		Uraemic neuropathy	serious				2213
15098	2 pts		Dementia vascular	serious				2213
15099	1 pts		Bipolar disorder	serious				2213
15100	8 pts		Confusional state	serious				2213
15101	1 pts		Conversion disorder	serious				2213
15102	2 pts		Disorientation	serious				2213
15103	2 pts		Drug abuse	serious				2213
15104	1 pts		Hallucination	serious				2213
15105	2 pts		Major depression	serious				2213
15106	2 pts		Psychotic disorder	serious				2213
15107	1 pts		Restlessness	serious				2213
15108	1 pts		Schizophrenia	serious				2213
15109	1 pts		Substance abuse	serious				2213
15110	2 pts		Suicidal ideation	serious				2213
15111	1 pts		Calculus ureteric	serious				2213
15112	2 pts		Cystitis haemorrhagic	serious				2213
15113	2 pts		Nephrolithiasis	serious				2213
15114	2 pts		Colic renal	serious				2213
15115	1 pts		Renal cyst haemorrhage	serious				2213
15116	4 pts		Renal haemorrhage	serious				2213
15117	1 pts		Renal injury	serious				2213
15118	2 pts		Renal tubular necrosis	serious				2213
15119	1 pts		Urethral prolapse	serious				2213
15120	2 pts		Urethral stenosis	serious				2213
15121	1 pts		Haemorrhage urinary bladder	serious				2213
15122	1 pts		Breast inflammation	serious				2213
15123	1 pts		Epididymitis	serious				2213
15124	1 pts		Female genital tract fistula	serious				2213
15125	1 pts		Disease fibrocystic breast	serious				2213
15126	1 pts		Menometrorrhagia	serious				2213
15127	1 pts		Menorrhagia	serious				2213
15128	1 pts		Pelvic adhesions	serious				2213
15129	1 pts		Priapism	serious				2213
15130	1 pts		Scrotal haematocoele	serious				2213
15131	1 pts		Scrotal pain	serious				2213
15132	1 pts		Scrotal swelling	serious				2213
15133	1 pts		Testicular haemorrhage	serious				2213
15134	2 pts		Uterine polyp	serious				2213
15135	1 pts		Vaginal laceration	serious				2213
15136	1 pts		Prolapse vaginal	serious				2213
15137	4 pts		Atelectasis	serious				2213
15138	20 pts		Chronic obstructive pulmonary disease	serious				2213
15139	47 pts		Dyspnoea	serious				2213
15140	1 pts		Dyspnoea exertional	serious				2213
15141	10 pts		Epistaxis	serious				2213
15142	3 pts		Haemothorax	serious				2213
15143	2 pts		Hypercapnia	serious				2213
15144	1 pts		Hypoventilation	serious				2213
15145	3 pts		Interstitial lung disease	serious				2213
15146	1 pts		Laryngeal cyst	serious				2213
15147	2 pts		Lung consolidation	serious				2213
15148	2 pts		Lung infiltration	serious				2213
15149	1 pts		Nasal septum deviation	serious				2213
15150	1 pts		Pleural disorder	serious				2213
15151	32 pts		Pleural effusion	serious				2213
15152	4 pts		Aspiration pneumonia	serious				2213
15153	5 pts		Pneumonitis	serious				2213
15154	1 pts		Pulmonary alveolar haemorrhage	serious				2213
15155	1 pts		Pulmonary arterial hypertension	serious				2213
15156	1 pts		Pulmonary fibrosis	serious				2213
15157	1 pts		Pulmonary necrosis	serious				2213
15158	8 pts		Respiratory arrest	serious				2213
15159	1 pts		Respiratory disorder	serious				2213
15160	5 pts		Respiratory distress	serious				2213
15161	1 pts		Status asthmaticus	serious				2213
15162	1 pts		Stridor	serious				2213
15163	1 pts		Tachypnoea	serious				2213
15164	1 pts		Vocal cord polyp	serious				2213
15165	3 pts		Angioedema	serious				2213
15166	2 pts		Dermal cyst	serious				2213
15167	1 pts		Dermatitis acneiform	serious				2213
15168	9 pts		Diabetic foot	serious				2213
15169	1 pts		Erythema nodosum	serious				2213
15170	1 pts		Abnormal hair growth	serious				2213
15171	1 pts		Hidradenitis	serious				2213
15172	1 pts		Hyperkeratosis	serious				2213
15173	4 pts		Necrosis skin	serious				2213
15174	1 pts		Subcutaneous emphysema	serious				2213
15175	1 pts		Activities of daily living impaired	serious				2213
15176	1 pts		Treatment noncompliance	serious				2213
15177	1 pts		Incisional drainage	serious				2213
15178	5 pts		Therapy cessation	serious				2213
15179	1 pts		Aneurysm	serious				2213
15180	1 pts		Angiopathy	serious				2213
15181	2 pts		Aortic aneurysm rupture	serious				2213
15182	1 pts		Arterial haemorrhage	serious				2213
15183	1 pts		Arterial insufficiency	serious				2213
15184	3 pts		Arterial stenosis	serious				2213
15185	5 pts		Arteritis	serious				2213
15186	10 pts		Deep vein thrombosis	serious				2213
15187	1 pts		Diabetic macroangiopathy	serious				2213
15188	3 pts		Diabetic vascular disorder	serious				2213
15189	8 pts		Femoral arterial stenosis	serious				2213
15190	1 pts		Femoral artery occlusion	serious				2213
15191	5 pts		Haemorrhage	serious				2213
15192	49 pts		Hypertension	serious				2213
15193	29 pts		Hypertensive crisis	serious				2213
15194	12 pts		Hypertensive emergency	serious				2213
15195	54 pts		Hypotension	serious				2213
15196	1 pts		Iliac artery occlusion	serious				2213
15197	4 pts		Iliac artery stenosis	serious				2213
15198	2 pts		Intra-abdominal haematoma	serious				2213
15199	2 pts		Ischaemic limb pain	serious				2213
15200	6 pts		Hypertension malignant	serious				2213
15201	5 pts		Orthostatic hypotension	serious				2213
15202	13 pts		Peripheral arterial occlusive disease	serious				2213
15203	1 pts		Peripheral artery aneurysm	serious				2213
15204	30 pts		Disorder peripheral vascular	serious				2213
15205	2 pts		Phlebitis	serious				2213
15206	7 pts		Steal syndrome	serious				2213
15207	1 pts		Subclavian artery aneurysm	serious				2213
15208	1 pts		Subclavian artery stenosis	serious				2213
15209	7 pts		Superior vena cava syndrome	serious				2213
15210	1 pts		Systolic hypertension	serious				2213
15211	1 pts		Superficial thrombophlebitis	serious				2213
15212	4 pts		Thrombosis	serious				2213
15213	2 pts		Varicose ulceration	serious				2213
15214	2 pts		Vascular calcification	serious				2213
15215	1 pts		Vascular occlusion	serious				2213
15216	1 pts		Vena cava thrombosis	serious				2213
15217	1 pts		Venous aneurysm	serious				2213
15218	4 pts		Venous occlusion	serious				2213
15219	9 pts		Venous stenosis	serious				2213
15220	109 pts		Anaemia	below serious				2213
15221	187 pts		Abdominal pain	below serious				2213
15222	153 pts		Abdominal pain upper	below serious				2213
15223	376 pts		Diarrhoea	below serious				2213
15224	140 pts		Dyspepsia	below serious				2213
15225	552 pts		Nausea	below serious				2213
15226	482 pts		Vomiting	below serious				2213
15227	134 pts		Chest pain	below serious				2213
15228	117 pts		Oedema peripheral	below serious				2213
15229	138 pts		Bronchitis	below serious				2213
15230	157 pts		Nasopharyngitis	below serious				2213
15231	144 pts		Upper respiratory tract infection	below serious				2213
15232	114 pts		Urinary tract infection	below serious				2213
15233	124 pts		Arteriovenous fistula site complication	below serious				2213
15234	112 pts		Decreased appetite	below serious				2213
15235	206 pts		Hypocalcaemia	below serious				2213
15236	159 pts		Back pain	below serious				2213
15237	213 pts		Muscle spasms	below serious				2213
15238	201 pts		Pain in extremity	below serious				2213
15239	135 pts		Dizziness	below serious				2213
15240	219 pts		Headache	below serious				2213
15241	225 pts		Cough	below serious				2213
15242	226 pts		Dyspnoea	below serious				2213
15243	176 pts		Hypertension	below serious				2213
15244	183 pts		Hypotension	below serious				2213
15245	1 pts		Anaemia	serious				2214
15246	1 pts		Glaucoma	serious				2214
15247	1 pts		Abdominal hernia	serious				2214
15248	1 pts		Abdominal pain upper	serious				2214
15249	1 pts		Diarrhoea	serious				2214
15250	1 pts		Hernia inguinal	serious				2214
15251	1 pts		Pancreatitis acute	serious				2214
15252	1 pts		Influenza like illness	serious				2214
15253	1 pts		Kidney transplant rejection	serious				2214
15254	1 pts		Cystitis	serious				2214
15255	2 pts		Cytomegalovirus infection	serious				2214
15256	1 pts		Gastroenteritis viral	serious				2214
15257	1 pts		Lung infection	serious				2214
15258	1 pts		Pneumonia	serious				2214
15259	1 pts		Foot fracture	serious				2214
15260	1 pts		Lung adenocarcinoma metastatic	serious				2214
15261	1 pts		Cerebrovascular accident	serious				2214
15262	1 pts		Renal impairment	serious				2214
15263	1 pts		Lung infiltration	serious				2214
15264	3 pts		Abdominal discomfort	below serious				2214
15265	8 pts		Diarrhoea	below serious				2214
15266	7 pts		Nausea	below serious				2214
15267	4 pts		Malaise	below serious				2214
15268	5 pts		Upper respiratory tract infection	below serious				2214
15269	8 pts		Urinary tract infection	below serious				2214
15270	3 pts		Gout	below serious				2214
15271	4 pts		Hypercholesterolaemia	below serious				2214
15272	3 pts		Hyperlipidaemia	below serious				2214
15273	4 pts		Hypokalaemia	below serious				2214
15274	5 pts		Hypomagnesaemia	below serious				2214
15275	3 pts		Arthralgia	below serious				2214
15276	5 pts		Back pain	below serious				2214
15277	5 pts		Headache	below serious				2214
15278	3 pts		Insomnia	below serious				2214
15279	8 pts		Cough	below serious				2214
15280	3 pts		Oropharyngeal pain	below serious				2214
15281	5 pts		Hypertension	below serious				2214
15282	1 pts		Nasal congestion					2211
15283	1 pts		Diarrhea					2211
15284	3 pts		Dyspepsia					2211
15285	1 pts		Peripheral sensory neuropathy					2211
15286	1 pts		Vomiting					2211
15287						No AEs are reported		2212
15288	19 pts		Taste metallic					2216
15289	4 pts		Gastrointestinal pain					2216
15290	5 pts		Nausea					2216
15291	3 pts		Vomiting					2216
15292	2 pts		Diarrhea					2216
15293	7 pts		Headache					2216
15294	7.5		Abdominal pain					2215
15295	9.4		Diarrhea					2215
15296	7.5		Flatulence					2215
15297	7.5		Headache					2215
15298	28.3		Nausea					2215
15299	9.4		Rash					2215
15300	18.9		Taste perversion					2215
15301	24.5		Vomiting					2215
15302	2 pts		Myelosuppression	grade 3			TRUE	2220
15303	3 pts		Nausea	grade 1-2				2221
15304	1 pts		Fatigue	grade 3				2221
15305	2 pts		Diarrhea	grade 1				2221
15306	1 pts		Cramp	grade 1				2221
15307	1 pts		Anorexia	grade 1				2221
15308	1 pts		Mucositis	grade 1				2221
15309	1 pts		Edema	grade 1				2221
15310	4 pts		Hepatotoxicity	grade 3-4				2221
15311	2 pts		Nausea	grade 1-2				2219
15312	3 pts		Diarrhea	grade 1				2219
15313	2 pts		Hepatotoxicity	grade 3				2219
15314	1 pts		Nausea	grade 1-2				2218
15315	1 pts		Hypoalbuminemia	grade 1-2				2218
15316	1 pts		Blood bilirubin decreased	grade 1-2				2218
15317			Lymphopenia	grade 3-4				2218
15318	2 pts		Hyperbilirubinemia	grade 4				2217
15319	2 pts		Vomiting	grade 2-3				2217
15320	2 pts		Maculopapular rash	grade 3				2217
15321	42.9		Dry mouth					2224
15322	25		Constipation					2224
15323	24.1		Somnolence					2224
15324	22.3		Tremor					2224
15325	17.9		Dizziness					2224
15326	16.1		Nausea					2224
15327	13.4		Sweating					2224
15328	9.8		Asthenia					2224
15329	8		Insomnia					2224
15330	3.6		Abdominal pain					2224
15331	54		Somnolence					2222
15332	54		Tremor					2222
15333	54		Dizziness					2222
15334	52		Headache					2222
15335	25		Insomnia					2222
15336	21		Influence on libido					2222
15337	18		Nervousness					2222
15338	13		Myoclonus					2222
15339	11		Increased appetite					2222
15340	9		Paresthesia					2222
15341	9		Memory impairment					2222
15342	9		Anxiety					2222
15343	7		Twitching					2222
15344	5		Concentration impaired					2222
15345	5		Depression					2222
15346	4		Hypertonia					2222
15347	4		Sleep disorder					2222
15348	3		Psychosomatic disease					2222
15349	3		Yawning					2222
15350	3		Confusion					2222
15351	3		Speech disorder					2222
15352	3		Dreaming abnormal					2222
15353	3		Agitation					2222
15354	3		Migraine					2222
15355	2		Depersonalization					2222
15356	2		Irritability					2222
15357	2		Emotional lability					2222
15358	1		Panic reaction					2222
15359	29		Sweating increased					2222
15360	8		Rash					2222
15361	6		Pruritus					2222
15362	2		Dermatitis					2222
15363	2		Acne					2222
15364	2		Dry skin					2222
15365	1		Urticaria					2222
15366	84		Dry mouth					2222
15367	47		Constipation					2222
15368	33		Nausea					2222
15369	22		Dyspepsia					2222
15370	13		Diarrhea					2222
15371	12		Anorexia					2222
15372	11		Abdominal pain					2222
15373	7		Vomiting					2222
15374	6		Flatulence					2222
15375	5		Tooth disorder					2222
15376	2		Gastrointestinal disorder					2222
15377	2		Dysphagia					2222
15378	1		Esophagitis					2222
15379	39		Fatigue					2222
15380	18		Weight increase					2222
15381	8		Flushing					2222
15382	5		Hot flushes					2222
15383	4		Chest pain					2222
15384	4		Fever					2222
15385	3		Allergy					2222
15386	3		Pain					2222
15387	2		Localised edema					2222
15388	2		Chills					2222
15389	6		Postural hypotension					2222
15390	4		Palpitation					2222
15391	4		Tachycardia					2222
15392	14		Pharyngitis					2222
15393	12		Rhinitis					2222
15394	6		Sinusitis					2222
15395	6		Coughing					2222
15396	2		Bronchospasm					2222
15397	2		Epistaxis					2222
15398	14		Micturition disorder					2222
15399	6		Urinary tract infection					2222
15400	5		Micturition frequency					2222
15401	2		Urinary retention					2222
15402	2		Dysuria					2222
15403	2		Cystitis					2222
15404	18		Abnormal vision					2222
15405	8		Taste perversion					2222
15406	6		Tinnitus					2222
15407	3		Lacrimation abnormal					2222
15408	2		Mydriasis					2222
15409	1		Conjunctivitis					2222
15410	13		Myalgia					2222
15411	6		Back pain					2222
15412	3		Arthralgia					2222
15413	1		Muscle weakness					2222
15414	3		Purpura					2222
15415	2		Thirst					2222
15416	46		Somnolence					2223
15417	33		Tremor					2223
15418	41		Dizziness					2223
15419	28		Headache					2223
15420	11		Insomnia					2223
15421	4		Nervousness					2223
15422	2		Myoclonus					2223
15423	2		Paresthesia					2223
15424	7		Memory impairment					2223
15425	2		Anxiety					2223
15426	4		Twitching					2223
15427	2		Hypertonia					2223
15428	9		Sleep disorder					2223
15429	2		Confusion					2223
15430	2		Depersonalization					2223
15431	2		Irritability					2223
15432	2		Panic reaction					2223
15433	2		Aggressive reaction					2223
15434	2		Paresis					2223
15435	9		Sweating increased					2223
15436	4		Rash					2223
15437	2		Pruritus					2223
15438	2		Skin odor abnormal					2223
15439	63		Dry mouth					2223
15440	22		Constipation					2223
15441	9		Nausea					2223
15442	13		Dyspepsia					2223
15443	7		Diarrhea					2223
15444	22		Anorexia					2223
15445	13		Abdominal pain					2223
15446	7		Vomiting					2223
15447	2		Eructation					2223
15448	2		Ulcerative stomatitis					2223
15449	35		Fatigue					2223
15450	2		Weight increase					2223
15451	7		Flushing					2223
15452	2		Hot flushes					2223
15453	7		Chest pain					2223
15454	2		Fever					2223
15455	7		Allergy					2223
15456	4		Pain					2223
15457	7		Weight decrease					2223
15458	4		Otitis media					2223
15459	2		Asthenia					2223
15460	2		Halitosis					2223
15461	4		Postural hypotension					2223
15462	4		Palpitation					2223
15463	2		Tachycardia					2223
15464	2		Syncope					2223
15465	7		Rhinitis					2223
15466	2		Sinusitis					2223
15467	4		Coughing					2223
15468	7		Bronchospasm					2223
15469	2		Dyspnea					2223
15470	2		Laryngitis					2223
15471	4		Micturition disorder					2223
15472	7		Urinary retention					2223
15473	7		Abnormal vision					2223
15474	4		Taste perversion					2223
15475	4		Tinnitus					2223
15476	2		Anisocoria					2223
15477	2		Blepharospasm					2223
15478	2		Eye allergy					2223
15479	2		Disorder vestibular					2223
15480	2		Muscle weakness					2223
15481	2		Anemia					2223
15482	2 pts		Nausea		discontinuation	leads to discontinuation		2228
15483	2 pts		Taste abnormality		discontinuation	leads to discontinuation		2228
15484	1 pts		Vulvovaginal pruritus		discontinuation	leads to discontinuation		2226
15485	1 pts		Vulvovaginal burning sensation		discontinuation	leads to discontinuation		2225
15486	1 pts		Vaginal irritation		discontinuation	leads to discontinuation		2227
15487	1 pts		Spotting vaginal		discontinuation	leads to discontinuation		2227
15488	2 pts		Neutropenia					2229
15489	4 pts		Rash					2229
15490	5 pts		Fever					2229
15491	1 pts		Agranulocytosis		discontinuation	leads to discontinuation		2231
15492	23 pts		Acute kidney injury		discontinuation	leads to discontinuation		2230
15493	1 pts		Arm fracture	below serious				2234
15494	1 pts		Tendonitis	below serious				2234
15495	9 pts		Headache	below serious				2236
15496	6 pts		Vomiting	below serious				2236
15497	16 pts		Irritability	below serious				2236
15498	5 pts		Feeling sad	below serious				2236
15499	4 pts		Anorexia	below serious				2235
15500	4 pts		Dizziness	below serious				2235
15501	7 pts		Restlessness	below serious				2235
15502	6 pts		Sore throat	below serious				2235
15503	4 pts		Stiffness	below serious				2235
15504	5 pts		Urticaria	below serious				2235
15505						No serious adverse events were reported, and none of subjects were withdrawn from the study.		2232
15506						No serious adverse events were reported, and none of subjects were withdrawn from the study.		2233
15507	1 pts		Pancytopenia					2239
15508	1 pts		Mucositis	severe				2239
15509	1 pts		Hepatic insufficiency					2239
15510	1 pts		Pancreatitis					2239
15511	1 pts		Hyponatremia					2239
15512	1 pts		Hypocalcemia					2239
15513	1 pts		Respiratory distress					2239
15514	1 pts		Melena					2239
15515						No information on AE is provided		2238
15516						No information on AE is provided		2237
15517	2 pts		Neurological status deterioration	serious				2240
15518	1 pts		Hepatotoxicity	serious				2240
15519	2 pts		Acute respiratory failure	serious				2240
15520	3 pts		Nausea and vomiting	below serious				2240
15521	2 pts		Headache	below serious				2240
15522	1 pts		Urinary tract infection	below serious				2240
15523	1 pts		Myocardial infarction	below serious				2240
15524	1 pts		Constipation	below serious				2240
15525			Hepatitis		discontinuation	WARNING		2241
15526			Diarrhea		discontinuation	leads to discontinuation		2241
15527			Cyanosis	acute	discontinuation			2244
15528			Methaemoglobinaemia		discontinuation			2244
15529			Haemolysis		discontinuation			2244
15530	14.3		Vomiting		discontinuation			2243
15531	14.3		Fever		discontinuation			2243
15532	11.1		Anemia		discontinuation			2242
15533	11.1		Rash		discontinuation			2242
15534	11.1		Fever		discontinuation			2242
15535	0.3		Heart block AV second degree		discontinuation			2246
15536	1		Constipation		discontinuation			2245
15537	1		Dry mouth		discontinuation			2245
15538	0.6		Nervous system disorder NOS		discontinuation			2245
15539						No information on AEs is available		2254
15540	2 pts		Hyperbilirubinemia	grade 3			TRUE	2252
15541	2 pts		Febrile neutropenia	grade 3-4			TRUE	2253
15542	2 pts		Thrombocytopenia				TRUE	2252
15543	17		Anaemia	grade 1				2251
15544	17		Lymphopenia	grade 2				2251
15545	17		Neutropenia	grade 2				2251
15546	17		Leucopenia	grade 1				2251
15547	17		Thrombocytopaenia	grade 1				2251
15548						information for AEs exists but without the dose relation		2248
15549						information for AEs exists but without the dose relation		2247
15550	87		Neutropenia	grade 3-4				2249
15551	85		Thrombocytopenia	grade 3-4				2249
15552	23		Febrile neutropenia	grade 3-4				2249
15553	22		Leukopenia	grade 3-4				2249
15554	6 pts		Anemia	grade 5	discontinuation	leads to discontinuation		2249
15555	6 pts		Neutropenia	grade 5	discontinuation	leads to discontinuation		2249
15556	6 pts		Thrombocytopenia	grade 5	discontinuation	leads to discontinuation		2249
15557	83		Neutropenia	all grades				2250
15558	81		Thrombocytopenia	all grades				2250
15559	54		Anemia	all grades				2250
15560	2		Splenomegaly	all grades				2250
15561	4		Thrombocythaemia	all grades				2250
15562	1		Tachycardia	all grades				2250
15563	1		Pulmonary edema	all grades				2250
15564	22		Nausea	all grades				2250
15565	8		Constipation	all grades				2250
15566	16		Diarrhea	all grades				2250
15567	8		Vomiting	all grades				2250
15568	4		Abdominal pain	all grades				2250
15569	5		Oral mucosal petechiae	all grades				2250
15570	7		Stomatitis	all grades				2250
15571	2		Loose stools	all grades				2250
15572	5		Tongue ulceration	all grades				2250
15573	2		Dysphagia	all grades				2250
15574	16		Pyrexia	all grades				2250
15575	18		Fatigue	all grades				2250
15576	4		Asthenia	all grades				2250
15577	1		Fall	all grades				2250
15578	4		Hyperbilirubinaemia	all grades				2250
15579	1		Hepatomegaly	all grades				2250
15580	2		Cellulitis	all grades				2250
15581	1		Urinary tract infection	all grades				2250
15582	1		Alanine aminotransferase increased	all grades				2250
15583	1		Aspartate aminotransferase increased	all grades				2250
15584	1		Alkaline phosphatase increased	all grades				2250
15585	7		Hypocalcemia	all grades				2250
15586	7		Hypoalbuminemia	all grades				2250
15587	2		Hypomagnesaemia	all grades				2250
15588	4		Hypokalemia	all grades				2250
15589	4		Decreased appetite	all grades				2250
15590	6		Anorexia	all grades				2250
15591	1		Dehydration	all grades				2250
15592	1		Arthralgia	all grades				2250
15593	1		Back pain	all grades				2250
15594	10		Headache	all grades				2250
15595	2		Dizziness	all grades				2250
15596	1		Hypoaesthesia	all grades				2250
15597	5		Insomnia	all grades				2250
15598	2		Depression	all grades				2250
15599	6		Cough	all grades				2250
15600	2		Dyspnea	all grades				2250
15601	4		Pharyngitis	all grades				2250
15602	4		Epistaxis	all grades				2250
15603	3 pts		Nasopharyngitis	below serious				2256
15604	5 pts		Somnolence	below serious				2256
15605						No AEs are reported		2255
15606	1 pts		Somnolence		discontinuation	leads to discontinuation		2257
15607	1 pts		Abdominal pain		discontinuation	leads to discontinuation		2257
15608	> 0.45		Headache		discontinuation	leads to discontinuation		2258
15609	> 0.45		Depression		discontinuation	leads to discontinuation		2258
15610	> 0.45		Menorrhagia		discontinuation	leads to discontinuation		2258
15611	> 0.45		Skin disorder		discontinuation	leads to discontinuation		2258
15612	> 0.45		Emotional lability		discontinuation	leads to discontinuation		2258
15613			Cushing's syndrome		discontinuation	WARNING		2260
15614			Hypothalamic pituitary adrenal axis suppression		discontinuation	WARNING		2260
15615			Atrophy		discontinuation	WARNING		2260
15616			Striae		discontinuation	WARNING		2260
15617			Irritation skin		discontinuation	WARNING		2260
15618			Acneiform eruption		discontinuation	WARNING		2260
15619			Skin hypopigmentation		discontinuation	WARNING		2260
15620			Allergic contact dermatitis		discontinuation	WARNING		2260
15621			Telangiectasia		discontinuation	WARNING		2259
15622			Bradypnoea			Overdosage		2265
15623			Bradycardia			Overdosage		2265
15624			Hypotension			Overdosage		2265
15625			Miosis			Overdosage		2265
15626			Hypertension	grade 1-3				2261
15627			Fatigue					2261
15628			Proteinuria	grade 1-3				2261
15629			Hypertriglyceridemia					2261
15630			Constipation					2261
15631			Edema peripheral					2261
15632			Hypertension	grade 2-3			TRUE	2264
15633			Proteinuria	grade 2			TRUE	2264
15634	1.2		Hypotension		discontinuation			2262
15635	2.6		Hypotension		discontinuation			2263
15636	2.6		Hemorrhage		discontinuation			2263
15637	2.6		Atrioventricular block		discontinuation			2263
15638	2 pts		Thrombocytopenia	grade 4	dose reduction	toxicity observed during the first cycle of dexrazoxane		2270
15639	4 pts		Neutropenia				TRUE	2269
15640	4 pts		Neutropenia				TRUE	2266
15641	94		Alopecia			Adverse experiences occurring during courses 1 through 6		2268
15642	77		Nausea			Adverse experiences occurring during courses 1 through 6		2268
15643	59		Vomiting			Adverse experiences occurring during courses 1 through 6		2268
15644	61		Malaise and fatigue			Adverse experiences occurring during courses 1 through 6		2268
15645	42		Anorexia			Adverse experiences occurring during courses 1 through 6		2268
15646	34		Stomatitis			Adverse experiences occurring during courses 1 through 6		2268
15647	34		Fever			Adverse experiences occurring during courses 1 through 6		2268
15648	23		Infection			Adverse experiences occurring during courses 1 through 6		2268
15649	21		Diarrhea			Adverse experiences occurring during courses 1 through 6		2268
15650	12		Injection site pain			Adverse experiences occurring during courses 1 through 6		2268
15651	17		Sepsis			Adverse experiences occurring during courses 1 through 6		2268
15652	17		Neurotoxicity			Adverse experiences occurring during courses 1 through 6		2268
15653	5		Erythema			Adverse experiences occurring during courses 1 through 6		2268
15654	6		Phlebitis			Adverse experiences occurring during courses 1 through 6		2268
15655	6		Esophagitis			Adverse experiences occurring during courses 1 through 6		2268
15656	8		Dysphagia			Adverse experiences occurring during courses 1 through 6		2268
15657	2		Hemorrhage			Adverse experiences occurring during courses 1 through 6		2268
15658	1		Extravasation			Adverse experiences occurring during courses 1 through 6		2268
15659	2		Urticaria			Adverse experiences occurring during courses 1 through 6		2268
15660	1		Administration site recall reaction			Adverse experiences occurring during courses 1 through 6		2268
15661	100		Alopecia			Adverse experiences occurring at course 7 and beyond		2267
15662	51		Nausea			Adverse experiences occurring at course 7 and beyond		2267
15663	42		Vomiting			Adverse experiences occurring at course 7 and beyond		2267
15664	48		Malaise and fatigue			Adverse experiences occurring at course 7 and beyond		2267
15665	27		Anorexia			Adverse experiences occurring at course 7 and beyond		2267
15666	26		Stomatitis			Adverse experiences occurring at course 7 and beyond		2267
15667	22		Fever			Adverse experiences occurring at course 7 and beyond		2267
15668	19		Infection			Adverse experiences occurring at course 7 and beyond		2267
15669	14		Diarrhea			Adverse experiences occurring at course 7 and beyond		2267
15670	13		Injection site pain			Adverse experiences occurring at course 7 and beyond		2267
15671	12		Sepsis			Adverse experiences occurring at course 7 and beyond		2267
15672	10		Neurotoxicity			Adverse experiences occurring at course 7 and beyond		2267
15673	4		Erythema			Adverse experiences occurring at course 7 and beyond		2267
15674	3		Phlebitis			Adverse experiences occurring at course 7 and beyond		2267
15675	3		Esophagitis			Adverse experiences occurring at course 7 and beyond		2267
15676	3		Hemorrhage			Adverse experiences occurring at course 7 and beyond		2267
15677	3		Extravasation			Adverse experiences occurring at course 7 and beyond		2267
15678	2		Urticaria			Adverse experiences occurring at course 7 and beyond		2267
15679	1		Administration site recall reaction			Adverse experiences occurring at course 7 and beyond		2267
15680						attempt to suicide		2275
15681						attempt to suicide		2274
15682			Respiratory depression	serious|grade 5		WARNING		2273
15683			Respiratory depression	serious|grade 5		WARNING		2271
15684			Respiratory depression	serious|grade 5		WARNING		2272
15685			Abuse	serious|grade 5		WARNING		2272
15686			Respiratory depression	serious|grade 5		WARNING		2277
15687			Abuse	serious|grade 5		WARNING		2277
15688	3 pts		Somnolence		discontinuation	leads to discontinuation		2276
15689	2 pts		Hypoventilation		discontinuation	leads to discontinuation		2276
15690	2 pts		Rash		discontinuation	leads to discontinuation		2276
15691	1 pts		Asthenia		discontinuation	leads to discontinuation		2276
15692	1 pts		Hyperkinesia		discontinuation	leads to discontinuation		2276
15693	1 pts		Incoordination		discontinuation	leads to discontinuation		2276
15694	1 pts		Vasodilatation		discontinuation	leads to discontinuation		2276
15695	1 pts		Urticaria		discontinuation	leads to discontinuation		2276
15696	1 pts		Chest pain	below serious				2278
15697	1 pts		Constipation	below serious				2278
15698	1 pts		Diarrhoea	below serious				2278
15699	1 pts		Discomfort	below serious				2278
15700	2 pts		Weight increased	below serious				2278
15701	3 pts		Oedema	below serious				2278
15702	1 pts		Muscle spasms	below serious				2278
15703	1 pts		Akathisia	below serious				2278
15704	4 pts		Headache	below serious				2278
15705	1 pts		Sedation	below serious				2278
15706	1 pts		Anxiety	below serious				2278
15707	1 pts		Irregular breathing	below serious				2278
15708	1 pts		Hyperhidrosis	below serious				2278
15709	1 pts		Skin irritation	below serious				2278
15710	4 pts		Musculoskeletal and connective tissue deformities of skull, face and buccal cavity		discontinuation	WARNING		2281
15711			Diabetic hyperosmolar coma		discontinuation	WARNING		2279
15712			Hyperosmolar (non-ketotic) coma		discontinuation	WARNING		2280
15713			Cataracts		discontinuation	WARNING		2282
15714			Pulmonary hypertension		discontinuation	leads to discontinuation		2283
15715			Hypersensitivity		discontinuation	WARNING		2285
15716			Hypokalemia		discontinuation	WARNING		2285
15717			Metabolic acidosis		discontinuation	WARNING		2285
15718			Fall		discontinuation	WARNING		2285
15719	83.3		Hypokalemia	mild	discontinuation			2284
15720	16.7		Weight loss		discontinuation			2284
15721	16.7		Itchy throat		discontinuation			2284
15722	16.7		Tachycardia		discontinuation			2284
15723	16.7		Gait instability	moderate	discontinuation			2284
15724	16.7		Toothache	moderate	discontinuation			2284
15725	5 pts		Neuropathy		discontinuation	leads to discontinuation	TRUE	2288
15726	1 pts		Pancreatitis		discontinuation	leads to discontinuation	TRUE	2288
15727	8 pts		Neuropathy		discontinuation	leads to discontinuation	TRUE	2290
15728	10 pts		Pancreatitis		discontinuation	leads to discontinuation	TRUE	2290
15729	13 pts		Neuropathy		discontinuation	leads to discontinuation	TRUE	2287
15730	6 pts		Pancreatitis		discontinuation	leads to discontinuation	TRUE	2287
15731	0.35		Pancreatitis	grade 5	discontinuation	leads to discontinuation	TRUE	2289
15732	3 pts		Neutropenia	grade 4	discontinuation	leads to discontinuation	TRUE	2286
15733	9 pts		Neutropenia	grade 3	discontinuation	leads to discontinuation	TRUE	2286
15734	6 pts		Hematotoxicity		discontinuation	leads to discontinuation, need to red blood cell transfusions		2286
15735	4 pts		Anemia	grade 3	discontinuation	leads to discontinuation		2286
15736	1 pts		Thrombocytopenia	grade 3	discontinuation	leads to discontinuation		2286
15737	5 pts		Neuropathy		discontinuation	leads to discontinuation	TRUE	2286
15738	3 pts		Diarrhea		discontinuation	leads to discontinuation	TRUE	2286
15739	2 pts		Pancreatitis		discontinuation	leads to discontinuation	TRUE	2286
15740	2 pts		Serum alkaline phosphatase elevated		discontinuation	leads to discontinuation	TRUE	2286
15741	1 pts		Abdominal pain		discontinuation	leads to discontinuation	TRUE	2286
15742	69		Fever					2296
15743	65		Headache					2296
15744	57		Vertigo					2296
15745	49		Malaise					2296
15746	45		Chills					2296
15747	40		Joint pain					2296
15748	37		Abdominal pain					2296
15749	33		Chest pain					2296
15750	28		Nausea					2296
15751	24		Neck pain					2296
15752	16		Vomiting					2296
15753	14		Muscular pain					2296
15754	38		Lymph node tenderness					2296
15755	34		Epididymal tenderness					2296
15756	15		Nodule					2296
15757	8		Tinnitus					2296
15758	2		Convulsion					2296
15759	<1		Eruption					2296
15760	<1		Shock					2296
15761	5		Fatigue	grade 2				2295
15762	2		Nausea	grade 2				2295
15763	2		Vomiting	grade 2				2295
15764	2		Joint pain	grade 2				2295
15765	2		Eye swelling	grade 2				2295
15766	2		Rash	grade 2				2295
15767	2		Dyspnea	grade 2				2295
15768	100		Lymphadenopathy					2292
15769	30		Papular urticarial eruption					2292
15770	10		Pustular skin eruption					2292
15771	10		Proteinuria					2292
15772	20		Visual field constriction					2292
15773	10		Optic nerve pallor					2292
15774	90		Corneal opacity					2292
15775	10		Anterior uveitis					2292
15776	10		Chorioretinitis					2292
15777	100		Lymphadenopathy					2291
15778	70		Papular urticarial eruption					2291
15779	40		Pustular skin eruption					2291
15780	30		Proteinuria					2291
15781	10		Visual field constriction					2291
15782	20		Optic nerve pallor					2291
15783	80		Corneal opacity					2291
15784	30		Anterior uveitis					2291
15785	30		Chorioretinitis					2291
15786			Fever					2293
15787	27.3		Nausea					2293
15788	18.2		Vomiting					2293
15789	9.1		Abdominal discomfort					2293
15790	63.6		Fever					2294
15791	9.1		Pruritus					2294
15792	9.1		Giddiness					2294
15793	9.1		Joint ache					2294
15794						No AEs reported		2297
15795	18.2		Intraocular pressure increased		discontinuation	difluprednate was switched to a different topical steroid in 6 eyes		2298
15796	21.2		Toxic epitheliolysis	grade 1-2	discontinuation	Seven eyes (21.2%) developed toxic epitheliopathy during difluprednate treatment. Epitheliopathy was mild in 4 eyes (superficial punctate keratitis) and moderate in 3 eyes (small epithelial defect). Epitheliopathy resolved completely in 6 eyes after discontinuation of difluprednate.		2298
15797			IOP increased					2299
15798			Cataract					2299
15799			Healing delayed					2299
15800			Bacterial infection					2299
15801			Infection viral					2299
15802			Fungal infection					2299
15803			Vomiting		discontinuation			2301
15804			Lethargy		discontinuation			2301
15805			Tachycardia		discontinuation			2301
15806			AV block		discontinuation			2301
15807			Hyperkalemia		discontinuation			2300
15808			Nausea		discontinuation			2300
15809			Vomiting		discontinuation			2300
15810			Lethargy		discontinuation			2300
15811			Atrioventricular block		discontinuation			2300
15812			Blurred vision		discontinuation			2302
15813			Sinus bradycardia		discontinuation			2302
15814			Electrocardiogram ST segment depression		discontinuation			2302
15815			Heart block		discontinuation			2302
15816			Ventricular tachycardia		discontinuation			2302
15817			Ventricular fibrillation		discontinuation			2302
15818						No adverse effects leading to discontinuation were observed		2303
15819	9.1		Headache		discontinuation			2307
15820	3.5		Diarrhoea		discontinuation			2307
15821	1.5		Nausea		discontinuation			2307
15822	2		Vomiting		discontinuation			2307
15823	1.5		Dyspepsia		discontinuation			2307
15824			Myocardial infarction		discontinuation			2304
15825			Mesenteric ischemia		discontinuation			2305
15826			Tachycardia		discontinuation			2305
15827			Hypotension		discontinuation			2305
15828			Multi-organ failure		discontinuation			2305
15829			Delirium		discontinuation			2305
15830			Anuria		discontinuation			2305
15831			Renal failure		discontinuation			2305
15832			Loss of consciousness		discontinuation			2306
15833			Respiratory distress		discontinuation			2306
15834			Apnea		discontinuation			2306
15835			Coma		discontinuation			2306
15836	7		Dry mouth		discontinuation	leads to discontinuation		2308
15837	7		Prostatism		discontinuation	leads to discontinuation		2308
15838	5 pts		Drowsiness	below serious				2309
15839	3 pts		Fatigue	below serious				2309
15840	4 pts		Restlessness	below serious				2309
15841	5 pts		Headache	below serious				2309
15842	1 pts		Optic neuritis	below serious				2309
15843	5 pts		Nausea and vomiting	below serious				2309
15844	2 pts		Rash	below serious				2309
15845	7 pts		After taste	below serious				2309
15846			Somnolence		discontinuation			2312
15847			Nightmares		discontinuation			2312
15848			Auditory hallucinations		discontinuation			2312
15849			Paranoid delusions		discontinuation			2312
15850			Tremor		discontinuation	generalised tremor of the extremities		2312
15851			Dysphagia		discontinuation			2312
15852			Dysarthria		discontinuation			2312
15853			Polyneuropathy		discontinuation			2312
15854			Axonal neuropathy	acute	discontinuation			2312
15855	14.3		Delirium	grade 3	discontinuation			2311
15856	14.3		Peripheral motor neuropathy	grade 3	discontinuation			2311
15857	40		Delirium	grade 3	discontinuation		TRUE	2310
15858	40		Ataxia	grade 2-3	discontinuation			2310
15859			Drowsiness		discontinuation			2313
15860			Flushing		discontinuation			2313
15861			Vomiting		discontinuation			2313
15862			Coma		discontinuation			2313
15863			Consciousness loss of		discontinuation			2313
15864			Bronchospasm		discontinuation			2313
15865			Hypotension		discontinuation			2313
15866			Sinus tachycardia		discontinuation			2313
15867			Arrhythmia		discontinuation			2313
15868			Confusion		discontinuation			2314
15869			Lethargy		discontinuation			2314
15870			Coma		discontinuation			2314
15871			Intellectual disability		discontinuation			2314
15872			Cognitive impairment		discontinuation			2314
15873						No information on AE is provided		2315
15874	2 pts		Dizziness	below serious				2318
15875	2 pts		Nausea	below serious				2318
15876	1 pts		Vomiting	below serious				2317
15877	11.1		Abnormal ECG		discontinuation			2319
15878	11.1		Headache		discontinuation			2319
15879	11.1		Syncope		discontinuation			2319
15880	11.1		Vasodilation		discontinuation			2319
15881			Electrocardiogram QTc interval prolonged			Overdosage		2321
15882			Ventricular tachycardia			Overdosage		2316
15883			Ventricular bigeminy			Overdosage		2316
15884			Premature ventricular contractions			Overdosage		2316
15885	0.5		Asthenia		discontinuation			2320
15886	0.5		Headache		discontinuation			2320
15887	0.5		Dizziness		discontinuation			2320
15888	0.5		Fatigue		discontinuation			2320
15889	0.5		Hyperthyroidism		discontinuation			2320
15890	0.5		Bradycardia sinus		discontinuation			2320
15891						No AEs reported		2322
15892	1 pts		Retinal detachment	serious				2324
15893	1 pts		Endometriosis	serious				2324
15894	1 pts		Menorrhagia	serious				2324
15895	5 pts		Nasopharyngitis	below serious				2324
15896	2 pts		Pharyngitis	below serious				2324
15897	1 pts		Urine uric acid increased	below serious				2324
15898	2 pts		Back pain	below serious				2324
15899	1 pts		Headache	below serious				2324
15900	3 pts		Cough	below serious				2324
15901	3 pts		Nasal congestion	below serious				2324
15902	1 pts		Oropharyngeal pain	below serious				2324
15903	2 pts		Sinus congestion	below serious				2324
15904	2 pts		Pruritus	below serious				2324
15905	1 pts		Atrial fibrillation	serious				2325
15906	2 pts		Nausea	below serious				2325
15907	3 pts		Sinusitis	below serious				2325
15908	2 pts		Upper respiratory tract infection	below serious				2325
15909	2 pts		Citric acid urine decreased	below serious				2325
15910	2 pts		Urine electrolytes increased	below serious				2325
15911	2 pts		Urine uric acid increased	below serious				2325
15912	2 pts		Hypercalcaemia	below serious				2325
15913	2 pts		Muscle spasms	below serious				2325
15914	2 pts		Headache	below serious				2325
15915	2 pts		Cough	below serious				2325
15916	2 pts		Oropharyngeal pain	below serious				2325
15917	2 pts		Dermatitis contact	below serious				2325
15918	1 pts		Blood creatinine increased	serious				2326
15919	1 pts		Blood urea increased	serious				2326
15920	1 pts		Glomerular filtration rate decreased	serious				2326
15921	1 pts		Hypercalcaemia	serious				2326
15922	1 pts		Pharyngitis	below serious				2326
15923	1 pts		Headache	below serious				2326
15924	8.3		Hypercalcemia	grade 3	discontinuation		TRUE	2323
15925	8.3		Creatinine increased	grade 3	discontinuation		TRUE	2323
15926	50		Somnolence					2334
15927			Agitation					2328
15928			Dilated pupils					2328
15929			Rhabdomyolysis					2329
15930						No AEs leading to discontinuation reported		2327
15931			Somnolence			WARNING		2331
15932			Drowsiness	grade 3		WARNING BONJESTA (doxylamine succinate + pyridoxine hydrochloride) use is not recommended if a woman is concurrently using central nervous system (CNS) depressants including alcohol. The combination may result in severe drowsiness leading to falls or accidents		2330
15933			Vomiting		discontinuation	1 patient		2332
15934			Vomiting		discontinuation	1 patient		2333
15935			Decreased hemoglobin		discontinuation	1 patient		2333
15936			Visual impairment		discontinuation	1 patient		2333
15937			QT interval prolonged		discontinuation	WARNING		2337
15938			Torsades de pointes		discontinuation	WARNING		2336
15939	24.6		Asthenia					2335
15940	3.3		Chills					2335
15941	3.3		Anorexia					2335
15942	16.4		Akathisia					2335
15943	27.9		Anxiety					2335
15944	3.3		Confusion					2335
15945	9.8		Dizziness					2335
15946	9.8		Dry mouth					2335
15947	4.9		Nervousness					2335
15948	3.3		Paresthesia					2335
15949	24.6		Somnolence					2335
15950	1.6		Tremor					2335
15951	4.9		Pharyngitis					2335
15952	4.9		Rhinitis					2335
15953	8.2		Sweaty					2335
15954	1 pts		Arrhythmia	serious				2358
15955	1 pts		Atrial flutter	serious				2358
15956	1 pts		Coronary artery occlusion	serious				2358
15957	1 pts		Pneumoperitoneum	serious				2358
15958	2 pts		Chest pain	serious				2358
15959	1 pts		Abscess intestinal	serious				2358
15960	1 pts		Ankle fracture	serious				2358
15961	1 pts		Head injury	serious				2358
15962	1 pts		Hip fracture	serious				2358
15963	1 pts		Diabetes mellitus	serious				2358
15964	1 pts		Osteoarthritis spinal	serious				2358
15965	1 pts		Oesophageal adenocarcinoma metastatic	serious				2358
15966	1 pts		Intracranial aneurysm	serious				2358
15967	1 pts		Renal failure acute	serious				2358
15968	1 pts		Prostatitis	serious				2358
15969	1 pts		Dyspnoea	serious				2358
15970	1 pts		Interstitial lung disease	serious				2358
15971	1 pts		Orthostatic hypotension	serious				2358
15972	37 pts		Constipation	below serious				2358
15973	31 pts		Diarrhoea	below serious				2358
15974	34 pts		Dry mouth	below serious				2358
15975	28 pts		Nausea	below serious				2358
15976	14 pts		Fatigue	below serious				2358
15977	13 pts		Upper respiratory tract infection	below serious				2358
15978	12 pts		Contusion	below serious				2358
15979	59 pts		Fall	below serious				2358
15980	10 pts		Pain in extremity	below serious				2358
15981	26 pts		Dizziness	below serious				2358
15982	32 pts		Headache	below serious				2358
15983	15 pts		Hyperhidrosis	below serious				2358
15984	5 pts		Orthostatic hypotension	below serious				2358
15985	1 pts		Non-cardiac chest pain	serious				2357
15986	2 pts		Conjunctivitis	below serious				2357
15987	1 pts		Vision blurred	below serious				2357
15988	1 pts		Abdominal pain	below serious				2357
15989	1 pts		Colonic polyp	below serious				2357
15990	2 pts		Constipation	below serious				2357
15991	3 pts		Dry mouth	below serious				2357
15992	1 pts		Gastritis	below serious				2357
15993	11 pts		Nausea	below serious				2357
15994	1 pts		Stomach discomfort	below serious				2357
15995	2 pts		Vomiting	below serious				2357
15996	2 pts		Irritability	below serious				2357
15997	1 pts		Non-cardiac chest pain	below serious				2357
15998	1 pts		Therapeutic response unexpected	below serious				2357
15999	1 pts		Drug hypersensitivity	below serious				2357
16000	1 pts		Cystitis	below serious				2357
16001	1 pts		Folliculitis	below serious				2357
16002	1 pts		Gastroenteritis	below serious				2357
16003	1 pts		Kidney infection	below serious				2357
16004	4 pts		Pharyngitis	below serious				2357
16005	1 pts		Tooth abscess	below serious				2357
16006	2 pts		Urinary tract infection	below serious				2357
16007	1 pts		Joint injury	below serious				2357
16008	1 pts		Muscle strain	below serious				2357
16009	1 pts		Neurological examination abnormal	below serious				2357
16010	1 pts		Anorexia	below serious				2357
16011	1 pts		Dehydration	below serious				2357
16012	1 pts		Hyperglycaemia	below serious				2357
16013	2 pts		Arthralgia	below serious				2357
16014	1 pts		Back pain	below serious				2357
16015	1 pts		Groin pain	below serious				2357
16016	1 pts		Haemarthrosis	below serious				2357
16017	1 pts		Muscle spasms	below serious				2357
16018	1 pts		Musculoskeletal pain	below serious				2357
16019	1 pts		Myalgia	below serious				2357
16020	1 pts		Osteoarthritis	below serious				2357
16021	1 pts		Aphonia	below serious				2357
16022	3 pts		Dizziness	below serious				2357
16023	1 pts		Hypersomnia	below serious				2357
16024	3 pts		Somnolence	below serious				2357
16025	1 pts		Confusional state	below serious				2357
16026	1 pts		Dysphoria	below serious				2357
16027	6 pts		Insomnia	below serious				2357
16028	2 pts		Libido decreased	below serious				2357
16029	1 pts		Breast cyst	below serious				2357
16030	1 pts		Erectile dysfunction	below serious				2357
16031	1 pts		Haemorrhage vaginal	below serious				2357
16032	1 pts		Vulvovaginal pruritus	below serious				2357
16033	2 pts		Asthma	below serious				2357
16034	1 pts		Epistaxis	below serious				2357
16035	1 pts		Nasal congestion	below serious				2357
16036	1 pts		Acne	below serious				2357
16037	1 pts		Generalised pruritus	below serious				2357
16038	1 pts		Psoriasis	below serious				2357
16039	1 pts		Cardiac ablation	below serious				2357
16040	1 pts		Muscular weakness	serious				2359
16041	1 pts		Dizziness	serious				2359
16042	1 pts		Dyspnoea	serious				2359
16043	3 pts		Palpitations	below serious				2359
16044	1 pts		Vision blurred	below serious				2359
16045	2 pts		Abdominal pain	below serious				2359
16046	10 pts		Constipation	below serious				2359
16047	10 pts		Diarrhoea	below serious				2359
16048	12 pts		Dry mouth	below serious				2359
16049	3 pts		Dyspepsia	below serious				2359
16050	24 pts		Nausea	below serious				2359
16051	2 pts		Vomiting	below serious				2359
16052	7 pts		Fatigue	below serious				2359
16053	2 pts		Feeling abnormal	below serious				2359
16054	3 pts		Gastroenteritis	below serious				2359
16055	6 pts		Influenza	below serious				2359
16056	1 pts		Pharyngitis	below serious				2359
16057	2 pts		Pharyngotonsillitis	below serious				2359
16058	3 pts		Anorexia	below serious				2359
16059	5 pts		Decreased appetite	below serious				2359
16060	5 pts		Arthralgia	below serious				2359
16061	1 pts		Muscle spasms	below serious				2359
16062	2 pts		Myalgia	below serious				2359
16063	3 pts		Pain in extremity	below serious				2359
16064	9 pts		Dizziness	below serious				2359
16065	12 pts		Headache	below serious				2359
16066	4 pts		Hypoaesthesia	below serious				2359
16067	1 pts		Lethargy	below serious				2359
16068	2 pts		Paraesthesia	below serious				2359
16069	3 pts		Sedation	below serious				2359
16070	5 pts		Somnolence	below serious				2359
16071	2 pts		Tremor	below serious				2359
16072	1 pts		Confusional state	below serious				2359
16073	10 pts		Insomnia	below serious				2359
16074	2 pts		Libido decreased	below serious				2359
16075	2 pts		Sleep disorder	below serious				2359
16076	1 pts		Nocturia	below serious				2359
16077	1 pts		Pollakiuria	below serious				2359
16078	3 pts		Erectile dysfunction	below serious				2359
16079	2 pts		Pharyngolaryngeal pain	below serious				2359
16080	2 pts		Yawning	below serious				2359
16081	5 pts		Hot flush	below serious				2359
16082	3 pts		Hypertension	below serious				2359
16083	1 pts		Myocardial infarction	serious				2350
16084	1 pts		Diarrhoea	serious				2350
16085	1 pts		Hypoaesthesia oral	serious				2350
16086	1 pts		Hypoaesthesia	serious				2350
16087	1 pts		Transient ischaemic attack	serious				2350
16088	3 pts		Palpitations	below serious				2350
16089	2 pts		Vision blurred	below serious				2350
16090	2 pts		Abdominal distension	below serious				2350
16091	1 pts		Abdominal pain	below serious				2350
16092	2 pts		Abdominal pain upper	below serious				2350
16093	14 pts		Constipation	below serious				2350
16094	7 pts		Diarrhoea	below serious				2350
16095	12 pts		Dry mouth	below serious				2350
16096	3 pts		Dyspepsia	below serious				2350
16097	2 pts		Gastrooesophageal reflux disease	below serious				2350
16098	14 pts		Nausea	below serious				2350
16099	2 pts		Stomach discomfort	below serious				2350
16100	3 pts		Vomiting	below serious				2350
16101	3 pts		Asthenia	below serious				2350
16102	10 pts		Fatigue	below serious				2350
16103	2 pts		Irritability	below serious				2350
16104	1 pts		Therapeutic response unexpected	below serious				2350
16105	2 pts		Urinary tract infection	below serious				2350
16106	3 pts		Anorexia	below serious				2350
16107	5 pts		Decreased appetite	below serious				2350
16108	1 pts		Hyperglycaemia	below serious				2350
16109	2 pts		Hypokalaemia	below serious				2350
16110	1 pts		Muscle spasms	below serious				2350
16111	2 pts		Musculoskeletal pain	below serious				2350
16112	2 pts		Pain in extremity	below serious				2350
16113	9 pts		Dizziness	below serious				2350
16114	10 pts		Headache	below serious				2350
16115	1 pts		Hypersomnia	below serious				2350
16116	1 pts		Hypoaesthesia	below serious				2350
16117	2 pts		Lethargy	below serious				2350
16118	2 pts		Paraesthesia	below serious				2350
16119	3 pts		Sedation	below serious				2350
16120	14 pts		Somnolence	below serious				2350
16121	3 pts		Anorgasmia	below serious				2350
16122	21 pts		Insomnia	below serious				2350
16123	4 pts		Libido decreased	below serious				2350
16124	2 pts		Loss of libido	below serious				2350
16125	4 pts		Sleep disorder	below serious				2350
16126	4 pts		Nocturia	below serious				2350
16127	2 pts		Pollakiuria	below serious				2350
16128	2 pts		Ejaculation delayed	below serious				2350
16129	2 pts		Ejaculation disorder	below serious				2350
16130	3 pts		Erectile dysfunction	below serious				2350
16131	2 pts		Testicular pain	below serious				2350
16132	2 pts		Pharyngolaryngeal pain	below serious				2350
16133	1 pts		Yawning	below serious				2350
16134	5 pts		Hyperhidrosis	below serious				2350
16135	3 pts		Pruritus	below serious				2350
16136	1 pts		Hot flush	below serious				2350
16137	5 pts		Hypertension	below serious				2350
16138	1 pts		Wrist fracture	serious				2351
16139	2 pts		Osteoarthritis	serious				2351
16140	1 pts		Encephalopathy hypertensive	serious				2351
16141	1 pts		Transient ischaemic attack	serious				2351
16142	3 pts		Tachycardia	below serious				2351
16143	3 pts		Vertigo	below serious				2351
16144	3 pts		Abdominal distension	below serious				2351
16145	2 pts		Abdominal pain upper	below serious				2351
16146	6 pts		Constipation	below serious				2351
16147	8 pts		Diarrhoea	below serious				2351
16148	11 pts		Dry mouth	below serious				2351
16149	2 pts		Dyspepsia	below serious				2351
16150	14 pts		Nausea	below serious				2351
16151	2 pts		Vomiting	below serious				2351
16152	2 pts		Asthenia	below serious				2351
16153	8 pts		Fatigue	below serious				2351
16154	4 pts		Influenza	below serious				2351
16155	2 pts		Sinusitis	below serious				2351
16156	2 pts		Weight increased	below serious				2351
16157	2 pts		Anorexia	below serious				2351
16158	3 pts		Neck pain	below serious				2351
16159	7 pts		Dizziness	below serious				2351
16160	2 pts		Dysgeusia	below serious				2351
16161	3 pts		Migraine	below serious				2351
16162	6 pts		Somnolence	below serious				2351
16163	3 pts		Erectile dysfunction	below serious				2351
16164	8 pts		Hyperhidrosis	below serious				2351
16165	1 pts		Gastrointestinal disorder (NOS)	serious				2352
16166	1 pts		Sinus infection	serious				2352
16167	9 pts		Nausea	below serious				2352
16168	7 pts		Dry mouth	below serious				2352
16169	5 pts		Constipation	below serious				2352
16170	5 pts		Hyperhidrosis	below serious				2352
16171	1 pts		Acute myocardial infarction	serious				2360
16172	1 pts		Panic attack	serious				2360
16173	4 pts		Vision blurred	below serious				2360
16174	63 pts		Nausea	below serious				2360
16175	40 pts		Dry mouth	below serious				2360
16176	19 pts		Diarrhoea	below serious				2360
16177	18 pts		Constipation	below serious				2360
16178	5 pts		Vomiting	below serious				2360
16179	5 pts		Abdominal pain	below serious				2360
16180	13 pts		Fatigue	below serious				2360
16181	4 pts		Feeling jittery	below serious				2360
16182	6 pts		Viral upper respiratory tract infection	below serious				2360
16183	2 pts		Accidental overdose	below serious				2360
16184	4 pts		Weight decreased	below serious				2360
16185	3 pts		Blood pressure increased	below serious				2360
16186	8 pts		Decreased appetite	below serious				2360
16187	5 pts		Anorexia	below serious				2360
16188	21 pts		Headache	below serious				2360
16189	22 pts		Dizziness	below serious				2360
16190	20 pts		Somnolence	below serious				2360
16191	4 pts		Tension headache	below serious				2360
16192	4 pts		Tremor	below serious				2360
16193	11 pts		Insomnia	below serious				2360
16194	5 pts		Restlessness	below serious				2360
16195	4 pts		Libido decreased	below serious				2360
16196	3 pts		Orgasm abnormal	below serious				2360
16197	3 pts		Yawning	below serious				2360
16198	11 pts		Hyperhidrosis	below serious				2360
16199	1 pts		Intervertebral disc protrusion	serious				2353
16200	35 pts		Constipation	below serious				2353
16201	27 pts		Diarrhoea	below serious				2353
16202	31 pts		Dry mouth	below serious				2353
16203	83 pts		Nausea	below serious				2353
16204	12 pts		Vomiting	below serious				2353
16205	25 pts		Fatigue	below serious				2353
16206	13 pts		Decreased appetite	below serious				2353
16207	26 pts		Dizziness	below serious				2353
16208	45 pts		Headache	below serious				2353
16209	15 pts		Somnolence	below serious				2353
16210	24 pts		Insomnia	below serious				2353
16211	23 pts		Hyperhidrosis	below serious				2353
16212	13 pts		Hot flush	below serious				2353
16213	1 pts		Angina pectoris	serious				2361
16214	1 pts		Somnolence	serious				2361
16215	1 pts		Sexual abuse	serious				2361
16216	57 pts		Nausea	below serious				2361
16217	25 pts		Dry mouth	below serious				2361
16218	8 pts		Constipation	below serious				2361
16219	3 pts		Dyspepsia	below serious				2361
16220	10 pts		Vomiting	below serious				2361
16221	2 pts		Abdominal pain upper	below serious				2361
16222	2 pts		Stomach discomfort	below serious				2361
16223	15 pts		Fatigue	below serious				2361
16224	4 pts		Feeling jittery	below serious				2361
16225	2 pts		Influenza	below serious				2361
16226	1 pts		Blood creatine phosphokinase increased	below serious				2361
16227	11 pts		Decreased appetite	below serious				2361
16228	26 pts		Headache	below serious				2361
16229	18 pts		Somnolence	below serious				2361
16230	17 pts		Dizziness	below serious				2361
16231	2 pts		Tension headache	below serious				2361
16232	7 pts		Libido decreased	below serious				2361
16233	6 pts		Anorgasmia	below serious				2361
16234	6 pts		Insomnia	below serious				2361
16235	5 pts		Anxiety	below serious				2361
16236	4 pts		Abnormal dreams	below serious				2361
16237	8 pts		Hyperhidrosis	below serious				2361
16238	2 pts		Fatigue	below serious				2338
16239	2 pts		Nausea	below serious				2338
16240	1 pts		Libido decreased	below serious				2338
16241	4 pts		Stomach discomfort	below serious				2338
16242	1 pts		Acute myocardial infarction	serious				2354
16243	1 pts		Vertigo	serious				2354
16244	1 pts		Alcohol poisoning	serious				2354
16245	1 pts		Myopathy toxic	serious				2354
16246	1 pts		Asthma	serious				2354
16247	2 pts		Tinnitus	below serious				2354
16248	5 pts		Vertigo	below serious				2354
16249	2 pts		Vision blurred	below serious				2354
16250	12 pts		Constipation	below serious				2354
16251	9 pts		Diarrhoea	below serious				2354
16252	13 pts		Dry mouth	below serious				2354
16253	3 pts		Flatulence	below serious				2354
16254	35 pts		Nausea	below serious				2354
16255	2 pts		Toothache	below serious				2354
16256	2 pts		Asthenia	below serious				2354
16257	7 pts		Fatigue	below serious				2354
16258	2 pts		Hypertransaminasaemia	below serious				2354
16259	5 pts		Nasopharyngitis	below serious				2354
16260	2 pts		Viral infection	below serious				2354
16261	2 pts		Joint sprain	below serious				2354
16262	4 pts		Anorexia	below serious				2354
16263	2 pts		Decreased appetite	below serious				2354
16264	2 pts		Increased appetite	below serious				2354
16265	2 pts		Muscle spasms	below serious				2354
16266	2 pts		Neck pain	below serious				2354
16267	10 pts		Dizziness	below serious				2354
16268	27 pts		Headache	below serious				2354
16269	2 pts		Migraine	below serious				2354
16270	10 pts		Somnolence	below serious				2354
16271	2 pts		Confusional state	below serious				2354
16272	4 pts		Libido decreased	below serious				2354
16273	2 pts		Urinary retention	below serious				2354
16274	2 pts		Urine flow decreased	below serious				2354
16275	2 pts		Ejaculation disorder	below serious				2354
16276	2 pts		Sexual dysfunction	below serious				2354
16277	4 pts		Yawning	below serious				2354
16278	5 pts		Hyperhidrosis	below serious				2354
16279	2 pts		Pruritus	below serious				2354
16280	3 pts		Palpitations	below serious				2355
16281	3 pts		Vision blurred	below serious				2355
16282	7 pts		Abdominal discomfort	below serious				2355
16283	10 pts		Constipation	below serious				2355
16284	10 pts		Dry mouth	below serious				2355
16285	30 pts		Nausea	below serious				2355
16286	6 pts		Vomiting	below serious				2355
16287	5 pts		Asthenia	below serious				2355
16288	4 pts		Fatigue	below serious				2355
16289	6 pts		Anorexia	below serious				2355
16290	3 pts		Decreased appetite	below serious				2355
16291	15 pts		Dizziness	below serious				2355
16292	12 pts		Somnolence	below serious				2355
16293	4 pts		Tremor	below serious				2355
16294	7 pts		Hyperhidrosis	below serious				2355
16295	1 pts		Prostate cancer	serious				2341
16296	21 pts		Constipation	below serious				2340
16297	14 pts		Diarrhoea	below serious				2340
16298	33 pts		Dry mouth	below serious				2340
16299	50 pts		Nausea	below serious				2340
16300	16 pts		Fatigue	below serious				2340
16301	8 pts		Decreased appetite	below serious				2340
16302	14 pts		Dizziness	below serious				2340
16303	16 pts		Somnolence	below serious				2340
16304	3 pts		Ejaculation delayed	below serious				2341
16305	3 pts		Erectile dysfunction	below serious				2341
16306	16 pts		Hyperhidrosis	below serious				2340
16307	1 pts		Syncope	serious				2339
16308	1 pts		Drug abuse	serious				2339
16309	1 pts		Panic attack	serious				2339
16310	1 pts		Social phobia	serious				2339
16311	6 pts		Diarrhoea	below serious				2339
16312	20 pts		Nausea	below serious				2339
16313	7 pts		Vomiting	below serious				2339
16314	8 pts		Fatigue	below serious				2339
16315	7 pts		Influenza	below serious				2339
16316	4 pts		Upper respiratory tract infection	below serious				2339
16317	10 pts		Decreased appetite	below serious				2339
16318	10 pts		Dizziness	below serious				2339
16319	19 pts		Headache	below serious				2339
16320	7 pts		Somnolence	below serious				2339
16321	6 pts		Insomnia	below serious				2339
16322	1 pts		Hernia inguinal	serious				2362
16323	1 pts		Clostridial infection	serious				2362
16324	1 pts		Diverticulitis	serious				2362
16325	1 pts		Respiratory tract infection	serious				2362
16326	1 pts		Syncope	serious				2362
16327	1 pts		Suicide attempt	serious				2362
16328	7 pts		Vision blurred	below serious				2362
16329	7 pts		Abdominal discomfort	below serious				2362
16330	17 pts		Constipation	below serious				2362
16331	15 pts		Diarrhoea	below serious				2362
16332	22 pts		Dry mouth	below serious				2362
16333	8 pts		Dyspepsia	below serious				2362
16334	51 pts		Nausea	below serious				2362
16335	7 pts		Vomiting	below serious				2362
16336	11 pts		Fatigue	below serious				2362
16337	13 pts		Decreased appetite	below serious				2362
16338	13 pts		Dizziness	below serious				2362
16339	30 pts		Headache	below serious				2362
16340	24 pts		Somnolence	below serious				2362
16341	8 pts		Anxiety	below serious				2362
16342	11 pts		Insomnia	below serious				2362
16343	9 pts		Yawning	below serious				2362
16344	14 pts		Hyperhidrosis	below serious				2362
16345	1 pts		Coronary artery disease	serious				2356
16346	1 pts		Urosepsis	serious				2356
16347	1 pts		Fall	serious				2356
16348	1 pts		Metastases to central nervous system	serious				2356
16349	1 pts		Syncope	serious				2356
16350	4 pts		Palpitations	below serious				2356
16351	5 pts		Vision blurred	below serious				2356
16352	5 pts		Abdominal discomfort	below serious				2356
16353	4 pts		Abdominal pain	below serious				2356
16354	7 pts		Abdominal pain upper	below serious				2356
16355	23 pts		Constipation	below serious				2356
16356	18 pts		Diarrhoea	below serious				2356
16357	25 pts		Dry mouth	below serious				2356
16358	3 pts		Dyspepsia	below serious				2356
16359	6 pts		Flatulence	below serious				2356
16360	41 pts		Nausea	below serious				2356
16361	11 pts		Vomiting	below serious				2356
16362	18 pts		Fatigue	below serious				2356
16363	3 pts		Feeling jittery	below serious				2356
16364	3 pts		Thirst	below serious				2356
16365	3 pts		Liver function test abnormal	below serious				2356
16366	3 pts		Weight increased	below serious				2356
16367	15 pts		Decreased appetite	below serious				2356
16368	6 pts		Arthralgia	below serious				2356
16369	17 pts		Dizziness	below serious				2356
16370	4 pts		Dysgeusia	below serious				2356
16371	16 pts		Headache	below serious				2356
16372	14 pts		Somnolence	below serious				2356
16373	3 pts		Tremor	below serious				2356
16374	13 pts		Insomnia	below serious				2356
16375	5 pts		Libido decreased	below serious				2356
16376	3 pts		Dysuria	below serious				2356
16377	6 pts		Pollakiuria	below serious				2356
16378	3 pts		Urine flow decreased	below serious				2356
16379	5 pts		Erectile dysfunction	below serious				2356
16380	6 pts		Cough	below serious				2356
16381	3 pts		Dermatitis contact	below serious				2356
16382	10 pts		Hyperhidrosis	below serious				2356
16383	4 pts		Night sweats	below serious				2356
16384	3 pts		Rash	below serious				2356
16385	4 pts		Hot flush	below serious				2356
16386	3 pts		Hypertension	below serious				2356
16387	1 pts		Non-cardiac chest pain	serious				2363
16388	12 pts		Constipation	below serious				2363
16389	18 pts		Diarrhoea	below serious				2363
16390	30 pts		Dry mouth	below serious				2363
16391	46 pts		Nausea	below serious				2363
16392	7 pts		Fatigue	below serious				2363
16393	10 pts		Decreased appetite	below serious				2363
16394	17 pts		Dizziness	below serious				2363
16395	22 pts		Somnolence	below serious				2363
16396	14 pts		Insomnia	below serious				2363
16397	8 pts		Hyperhidrosis	below serious				2363
16398	12 pts		Nausea	below serious				2364
16399	10 pts		Diarrhoea	below serious				2364
16400	7 pts		Dry mouth	below serious				2364
16401	3 pts		Upper respiratory tract infection	below serious				2364
16402	7 pts		Headache	below serious				2364
16403	5 pts		Somnolence	below serious				2364
16404	3 pts		Dizziness	below serious				2364
16405	2 pts		Insomnia	below serious				2364
16406	5 pts		Erectile dysfunction	below serious				2364
16407	1 pts		Rash	below serious				2364
16408	5 pts		Palpitations	below serious				2365
16409	6 pts		Vision blurred	below serious				2365
16410	55 pts		Nausea	below serious				2365
16411	26 pts		Dry mouth	below serious				2365
16412	19 pts		Diarrhoea	below serious				2365
16413	18 pts		Constipation	below serious				2365
16414	12 pts		Vomiting	below serious				2365
16415	7 pts		Dyspepsia	below serious				2365
16416	4 pts		Abdominal pain upper	below serious				2365
16417	17 pts		Fatigue	below serious				2365
16418	5 pts		Feeling jittery	below serious				2365
16419	4 pts		Irritability	below serious				2365
16420	5 pts		Viral upper respiratory tract infection	below serious				2365
16421	4 pts		Urinary tract infection bacterial	below serious				2365
16422	3 pts		Muscle strain	below serious				2365
16423	15 pts		Decreased appetite	below serious				2365
16424	2 pts		Muscle spasms	below serious				2365
16425	28 pts		Headache	below serious				2365
16426	24 pts		Dizziness	below serious				2365
16427	12 pts		Somnolence	below serious				2365
16428	5 pts		Dysgeusia	below serious				2365
16429	3 pts		Sedation	below serious				2365
16430	14 pts		Insomnia	below serious				2365
16431	4 pts		Nightmare	below serious				2365
16432	4 pts		Restlessness	below serious				2365
16433	3 pts		Middle insomnia	below serious				2365
16434	3 pts		Nervousness	below serious				2365
16435	3 pts		Erectile dysfunction	below serious				2365
16436	4 pts		Yawning	below serious				2365
16437	3 pts		Rhinorrhoea	below serious				2365
16438	8 pts		Hyperhidrosis	below serious				2365
16439	2 pts		Hot flush	below serious				2365
16440	1 pts		Liver disorder	serious				2367
16441	1 pts		Anaemia	below serious				2367
16442	5 pts		Palpitations	below serious				2367
16443	4 pts		Vertigo	below serious				2367
16444	1 pts		Vitreous floaters	below serious				2367
16445	5 pts		Abdominal discomfort	below serious				2367
16446	4 pts		Abdominal distension	below serious				2367
16447	1 pts		Abdominal pain	below serious				2367
16448	6 pts		Abdominal pain upper	below serious				2367
16449	29 pts		Constipation	below serious				2367
16450	8 pts		Diarrhoea	below serious				2367
16451	2 pts		Dyspepsia	below serious				2367
16452	1 pts		Food poisoning	below serious				2367
16453	2 pts		Gastritis	below serious				2367
16454	42 pts		Nausea	below serious				2367
16455	4 pts		Stomatitis	below serious				2367
16456	7 pts		Vomiting	below serious				2367
16457	4 pts		Asthenia	below serious				2367
16458	1 pts		Chest discomfort	below serious				2367
16459	1 pts		Fatigue	below serious				2367
16460	2 pts		Feeling abnormal	below serious				2367
16461	9 pts		Malaise	below serious				2367
16462	2 pts		Pyrexia	below serious				2367
16463	14 pts		Thirst	below serious				2367
16464	5 pts		Hepatic function abnormal	below serious				2367
16465	2 pts		Bronchitis	below serious				2367
16466	3 pts		Cystitis	below serious				2367
16467	1 pts		Folliculitis	below serious				2367
16468	1 pts		Hand-foot-and-mouth disease	below serious				2367
16469	2 pts		Herpes zoster	below serious				2367
16470	1 pts		Hordeolum	below serious				2367
16471	3 pts		Influenza	below serious				2367
16472	1 pts		Keratitis bacterial	below serious				2367
16473	26 pts		Nasopharyngitis	below serious				2367
16474	1 pts		Paronychia	below serious				2367
16475	1 pts		Pertussis	below serious				2367
16476	2 pts		Upper respiratory tract infection	below serious				2367
16477	3 pts		Contusion	below serious				2367
16478	1 pts		Heat illness	below serious				2367
16479	2 pts		Alanine aminotransferase increased	below serious				2367
16480	2 pts		Blood alkaline phosphatase increased	below serious				2367
16481	5 pts		Blood bilirubin increased	below serious				2367
16482	2 pts		Blood cholesterol increased	below serious				2367
16483	1 pts		Blood uric acid increased	below serious				2367
16484	1 pts		Haematocrit increased	below serious				2367
16485	1 pts		Haemoglobin increased	below serious				2367
16486	1 pts		Heart rate increased	below serious				2367
16487	1 pts		Red blood cell count increased	below serious				2367
16488	2 pts		Weight decreased	below serious				2367
16489	13 pts		Decreased appetite	below serious				2367
16490	1 pts		Arthritis	below serious				2367
16491	1 pts		Musculoskeletal stiffness	below serious				2367
16492	1 pts		Myalgia	below serious				2367
16493	1 pts		Neck mass	below serious				2367
16494	1 pts		Nodal osteoarthritis	below serious				2367
16495	1 pts		Periarthritis	below serious				2367
16496	1 pts		Fasciitis plantar	below serious				2367
16497	1 pts		Synovial cyst	below serious				2367
16498	1 pts		Tenosynovitis	below serious				2367
16499	2 pts		Trigger finger	below serious				2367
16500	1 pts		Autonomic nervous system imbalance	below serious				2367
16501	11 pts		Dizziness	below serious				2367
16502	2 pts		Dizziness postural	below serious				2367
16503	1 pts		Dysgeusia	below serious				2367
16504	1 pts		Dyskinesia	below serious				2367
16505	1 pts		Head discomfort	below serious				2367
16506	9 pts		Headache	below serious				2367
16507	1 pts		Hypoaesthesia	below serious				2367
16508	1 pts		Sensory disturbance	below serious				2367
16509	1 pts		Sleep paralysis	below serious				2367
16510	51 pts		Somnolence	below serious				2367
16511	1 pts		Syncope	below serious				2367
16512	1 pts		Tremor	below serious				2367
16513	2 pts		Middle insomnia	below serious				2367
16514	1 pts		Nightmare	below serious				2367
16515	3 pts		Dysuria	below serious				2367
16516	1 pts		Hypertonic bladder	below serious				2367
16517	2 pts		Pollakiuria	below serious				2367
16518	1 pts		Menopausal symptoms	below serious				2366
16519	1 pts		Metrorrhagia	below serious				2366
16520	1 pts		Epistaxis	below serious				2367
16521	1 pts		Hyperventilation	below serious				2367
16522	1 pts		Oropharyngeal discomfort	below serious				2367
16523	1 pts		Oropharyngeal pain	below serious				2367
16524	1 pts		Allergic rhinitis	below serious				2367
16525	1 pts		Yawning	below serious				2367
16526	1 pts		Dermatitis atopic	below serious				2367
16527	1 pts		Drug eruption	below serious				2367
16528	2 pts		Hyperhidrosis	below serious				2367
16529	1 pts		Miliaria	below serious				2367
16530	5 pts		Pruritus	below serious				2367
16531	1 pts		Purpura	below serious				2367
16532	4 pts		Rash	below serious				2367
16533	1 pts		Rash papular	below serious				2367
16534	1 pts		Hot flush	below serious				2367
16535	1 pts		Craniocerebral injury	serious				2368
16536	1 pts		Subdural haematoma	serious				2368
16537	43 pts		Nausea	below serious				2368
16538	6 pts		Diarrhoea	below serious				2368
16539	16 pts		Dry mouth	below serious				2368
16540	12 pts		Decreased appetite	below serious				2368
16541	24 pts		Headache	below serious				2368
16542	11 pts		Dizziness	below serious				2368
16543	1 pts		Gastric polyps	serious				2371
16544	1 pts		Intervertebral disc protrusion	serious				2371
16545	1 pts		Cerebral haemorrhage	serious				2371
16546	1 pts		Calculus urethral	serious				2371
16547	1 pts		Idiopathic thrombocytopenic purpura	below serious				2371
16548	1 pts		Bundle branch block right	below serious				2371
16549	2 pts		Tachycardia	below serious				2371
16550	1 pts		Motion sickness	below serious				2371
16551	2 pts		Tinnitus	below serious				2371
16552	5 pts		Vertigo	below serious				2371
16553	1 pts		Vertigo positional	below serious				2371
16554	1 pts		Autoimmune thyroiditis	below serious				2371
16555	2 pts		Conjunctivitis	below serious				2371
16556	2 pts		Conjunctivitis allergic	below serious				2371
16557	1 pts		Eye pain	below serious				2371
16558	1 pts		Photophobia	below serious				2371
16559	8 pts		Abdominal discomfort	below serious				2371
16560	3 pts		Abdominal distension	below serious				2371
16561	1 pts		Abdominal pain	below serious				2371
16562	25 pts		Constipation	below serious				2371
16563	4 pts		Dental caries	below serious				2371
16564	9 pts		Diarrhoea	below serious				2371
16565	4 pts		Dyspepsia	below serious				2371
16566	2 pts		Gastritis	below serious				2371
16567	1 pts		Atrophic gastritis	below serious				2371
16568	1 pts		Gastrointestinal motility disorder	below serious				2371
16569	1 pts		Gastrooesophageal reflux disease	below serious				2371
16570	1 pts		Infrequent bowel movements	below serious				2371
16571	2 pts		Large intestine polyp	below serious				2371
16572	21 pts		Nausea	below serious				2371
16573	1 pts		Altered saliva	below serious				2371
16574	2 pts		Stomatitis	below serious				2371
16575	1 pts		Vomiting	below serious				2371
16576	1 pts		Face oedema	below serious				2371
16577	2 pts		Feeling abnormal	below serious				2371
16578	8 pts		Malaise	below serious				2371
16579	1 pts		Oedema peripheral	below serious				2371
16580	14 pts		Thirst	below serious				2371
16581	2 pts		Hepatic function abnormal	below serious				2371
16582	7 pts		Bronchitis	below serious				2371
16583	3 pts		Gastroenteritis	below serious				2371
16584	1 pts		Gingival abscess	below serious				2371
16585	1 pts		Gingival infection	below serious				2371
16586	1 pts		Pertussis	below serious				2371
16587	3 pts		Pharyngitis	below serious				2371
16588	1 pts		Bone contusion	below serious				2371
16589	1 pts		Chillblains	below serious				2371
16590	16 pts		Contusion	below serious				2371
16591	1 pts		Excoriation	below serious				2371
16592	1 pts		Fall	below serious				2371
16593	5 pts		Ligament sprain	below serious				2371
16594	2 pts		Nerve root injury cervical	below serious				2371
16595	4 pts		Procedural pain	below serious				2371
16596	1 pts		Spinal compression fracture	below serious				2371
16597	1 pts		Thermal burn	below serious				2371
16598	4 pts		Alanine aminotransferase increased	below serious				2371
16599	3 pts		Aspartate aminotransferase increased	below serious				2371
16600	4 pts		Blood creatine phosphokinase increased	below serious				2371
16601	1 pts		Blood lactate dehydrogenase increased	below serious				2371
16602	1 pts		Blood urea increased	below serious				2371
16603	2 pts		Gamma-glutamyltransferase increased	below serious				2371
16604	6 pts		Liver function test abnormal	below serious				2371
16605	1 pts		White blood cell count increased	below serious				2371
16606	10 pts		Decreased appetite	below serious				2371
16607	7 pts		Arthralgia	below serious				2371
16608	2 pts		Arthritis	below serious				2371
16609	4 pts		Back pain	below serious				2371
16610	1 pts		Fasciitis	below serious				2371
16611	1 pts		Muscle spasms	below serious				2371
16612	1 pts		Trigger finger	below serious				2371
16613	1 pts		Carpal tunnel syndrome	below serious				2371
16614	15 pts		Dizziness	below serious				2371
16615	4 pts		Dizziness postural	below serious				2371
16616	1 pts		Dysarthria	below serious				2371
16617	9 pts		Headache	below serious				2371
16618	1 pts		Hypoaesthesia	below serious				2371
16619	2 pts		Migraine	below serious				2371
16620	1 pts		Sciatica	below serious				2371
16621	45 pts		Somnolence	below serious				2371
16622	1 pts		Tension headache	below serious				2371
16623	4 pts		Tremor	below serious				2371
16624	1 pts		Anxiety	below serious				2371
16625	1 pts		Dysphoria	below serious				2371
16626	1 pts		Sleep talking	below serious				2371
16627	1 pts		Chromaturia	below serious				2371
16628	5 pts		Dysuria	below serious				2371
16629	1 pts		Haematuria	below serious				2371
16630	1 pts		Pollakiuria	below serious				2371
16631	1 pts		Urinary retention	below serious				2371
16632	1 pts		Urine flow decreased	below serious				2371
16633	1 pts		Atrophic vulvovaginitis	below serious				2370
16634	1 pts		Benign prostatic hyperplasia	below serious				2369
16635	2 pts		Sexual dysfunction	below serious				2371
16636	3 pts		Cough	below serious				2371
16637	1 pts		Hyperventilation	below serious				2371
16638	1 pts		Oropharyngeal pain	below serious				2371
16639	2 pts		Allergic rhinitis	below serious				2371
16640	3 pts		Eczema	below serious				2371
16641	1 pts		Erythema	below serious				2371
16642	1 pts		Hyperhidrosis	below serious				2371
16643	3 pts		Pruritus	below serious				2371
16644	1 pts		Rash macular	below serious				2371
16645	1 pts		Swelling face	below serious				2371
16646	1 pts		Hot flush	below serious				2371
16647	2 pts		Nausea	below serious				2372
16648	1 pts		Somnolence	below serious				2372
16649	1 pts		SIADH	below serious				2372
16650	1 pts		Malignant ascites	serious				2373
16651	1 pts		Palpitations	below serious				2373
16652	1 pts		Ear congestion	below serious				2373
16653	1 pts		Tinnitus	below serious				2373
16654	1 pts		Vertigo positional	below serious				2373
16655	1 pts		Basedow's disease	below serious				2373
16656	1 pts		Blepharitis	below serious				2373
16657	2 pts		Abdominal distension	below serious				2373
16658	2 pts		Abdominal pain upper	below serious				2373
16659	1 pts		Anal fissure	below serious				2373
16660	1 pts		Cheilitis	below serious				2373
16661	19 pts		Constipation	below serious				2373
16662	1 pts		Dental caries	below serious				2373
16663	6 pts		Diarrhoea	below serious				2373
16664	1 pts		Dyspepsia	below serious				2373
16665	1 pts		Faeces hard	below serious				2373
16666	3 pts		Gastritis	below serious				2373
16667	18 pts		Nausea	below serious				2373
16668	3 pts		Stomatitis	below serious				2373
16669	3 pts		Vomiting	below serious				2373
16670	1 pts		Asthenia	below serious				2373
16671	12 pts		Malaise	below serious				2373
16672	1 pts		Peripheral swelling	below serious				2373
16673	19 pts		Thirst	below serious				2373
16674	1 pts		Hepatic function abnormal	below serious				2373
16675	1 pts		Gingival abscess	below serious				2373
16676	1 pts		Gingivitis	below serious				2373
16677	1 pts		Hordeolum	below serious				2373
16678	1 pts		Oral herpes	below serious				2373
16679	1 pts		Paronychia	below serious				2373
16680	1 pts		Tonsillitis	below serious				2373
16681	1 pts		Chillblains	below serious				2373
16682	9 pts		Contusion	below serious				2373
16683	1 pts		Excoriation	below serious				2373
16684	2 pts		Ligament sprain	below serious				2373
16685	1 pts		Limb crushing injury	below serious				2373
16686	1 pts		Muscle injury	below serious				2373
16687	1 pts		Muscle rupture	below serious				2373
16688	1 pts		Procedural pain	below serious				2373
16689	8 pts		Alanine aminotransferase increased	below serious				2373
16690	7 pts		Aspartate aminotransferase increased	below serious				2373
16691	1 pts		Blood potassium decreased	below serious				2373
16692	3 pts		Blood urine present	below serious				2373
16693	1 pts		Liver function test abnormal	below serious				2373
16694	9 pts		Decreased appetite	below serious				2373
16695	1 pts		Diabetes mellitus	below serious				2373
16696	2 pts		Intervertebral disc protrusion	below serious				2373
16697	2 pts		Muscle spasms	below serious				2373
16698	1 pts		Osteoporosis	below serious				2373
16699	2 pts		Dizziness	below serious				2373
16700	1 pts		Dizziness postural	below serious				2373
16701	1 pts		Dysgeusia	below serious				2373
16702	1 pts		Loss of consciousness	below serious				2373
16703	1 pts		Migraine	below serious				2373
16704	24 pts		Somnolence	below serious				2373
16705	1 pts		Abulia	below serious				2373
16706	1 pts		Depression	below serious				2373
16707	3 pts		Insomnia	below serious				2373
16708	2 pts		Dysuria	below serious				2373
16709	1 pts		Hypertonic bladder	below serious				2373
16710	1 pts		Stress urinary incontinence	below serious				2373
16711	1 pts		Urethral haemorrhage	below serious				2373
16712	1 pts		Urinary incontinence	below serious				2373
16713	1 pts		Urine flow decreased	below serious				2373
16714	1 pts		Cough	below serious				2373
16715	3 pts		Upper respiratory tract inflammation	below serious				2373
16716	1 pts		Dermatitis	below serious				2373
16717	2 pts		Dermatitis contact	below serious				2373
16718	1 pts		Eczema	below serious				2373
16719	1 pts		Ingrowing nail	below serious				2373
16720	1 pts		Dermatitis seborrhoeic	below serious				2373
16721	1 pts		Hot flush	below serious				2373
16722	1 pts		Hypertension	below serious				2373
16723			Suicidal ideation		discontinuation	WARNING		2349
16724			Suicidal behavior		discontinuation	WARNING		2349
16725			Hepatic failure		discontinuation	WARNING. Sometimes fatal		2349
16726			Orthostatic hypotension		discontinuation	WARNING		2349
16727			Syncope		discontinuation	WARNING		2349
16728			Serotonin syndrome		discontinuation	WARNING		2349
16729			Neuroleptic malignant syndrome		discontinuation	WARNING		2349
16730			Bleeding		discontinuation	WARNING		2349
16731			Mania		discontinuation	WARNING		2349
16732			Hypomania		discontinuation	WARNING		2349
16733			Seizures		discontinuation	WARNING		2349
16734			Hyponatremia		discontinuation	WARNING		2349
16735			Urinary hesitation		discontinuation	WARNING		2349
16736			Urinary retention		discontinuation	WARNING		2349
16737	1.3		Nausea		discontinuation			2345
16738	3.7		Nausea		discontinuation			2347
16739	1.3		Vomiting		discontinuation			2347
16740	1		Dizziness		discontinuation			2347
16741	3.5		Nausea		discontinuation			2346
16742	1.6		Dizziness		discontinuation			2346
16743	1.6		Somnolence		discontinuation			2346
16744	1.1		Fatigue		discontinuation			2346
16745	1.9		Nausea		discontinuation			2348
16746	1.5		Somnolence		discontinuation			2348
16747	1.3		Fatigue		discontinuation			2348
16748	4		Fatigue		discontinuation			2344
16749	4		Insomnia		discontinuation			2344
16750	3		Dizziness		discontinuation			2343
16751	3		Pain		discontinuation			2343
16752			Generalized tonic-clonic seizure		discontinuation			2342
16753			Blurred vision		discontinuation			2342
16754			Irritability		discontinuation			2342
16755			Anxiety		discontinuation			2342
16756	1 pts		Cardiac failure	serious				2377
16757	1 pts		Gastroenteritis	serious				2377
16758	1 pts		Respiratory failure	serious				2377
16759	6 pts		Constitutional syndrome	below serious				2377
16760	10 pts		Ear, nose and throat infection	below serious				2377
16761	7 pts		Gastrointestinal disorder	below serious				2377
16762	2 pts		Hepatic and hepatobiliary disorders NEC	below serious				2377
16763	14 pts		Infection	below serious				2377
16764	15 pts		Neurologic disorder NOS	below serious				2377
16765	3 pts		Colonic polyp	serious				2378
16766	1 pts		Enterocolitis	serious				2378
16767	1 pts		Intestinal obstruction	serious				2378
16768	1 pts		Lymph node cancer metastatic	serious				2378
16769	1 pts		Meningioma	serious				2378
16770	1 pts		Pancreatic carcinoma	serious				2378
16771	1 pts		Dementia Alzheimer's type	serious				2378
16772	1 pts		Thrombotic stroke	serious				2378
16773	1 pts		Intervertebral disc protrusion	serious				2378
16774	1 pts		Synovitis	serious				2378
16775	1 pts		Acute myocardial infarction	serious				2378
16776	1 pts		Pneumonia	serious				2378
16777	1 pts		Urinary tract infection	serious				2378
16778	1 pts		Aortic dissection	serious				2378
16779	1 pts		Macular degeneration	serious				2378
16780	1 pts		Cholangitis	serious				2378
16781	19 pts		Diarrhoea	below serious				2378
16782	19 pts		Upper respiratory tract inflammation	below serious				2378
16783	13 pts		Constipation	below serious				2378
16784	14 pts		Eczema	below serious				2378
16785	10 pts		Arthralgia	below serious				2378
16786	10 pts		Gastritis	below serious				2378
16787						No information on AE is provided		2374
16788	1		Sexual dysfunction		discontinuation			2376
16789	1		Impotence		discontinuation			2376
16790	<1		Ejaculation disorder		discontinuation			2376
16791	<1		Sexual function and fertility disorders		discontinuation			2376
16792	<1		Gynecomastia		discontinuation			2376
16793	<1		Prostate cancer		discontinuation			2376
16794	3		Impotence		discontinuation			2375
16795	3		Libido decreased		discontinuation			2375
16796						No SAEs were observed		2379
16797	1 pts		Mania		discontinuation			2383
16798						No AEs are reported		2382
16799						No AEs are reported		2381
16800	1 pts		Hallucination		discontinuation	leads to discontinuation		2380
16801	1 pts		Dizziness		discontinuation	leads to discontinuation		2380
16802	1 pts		Insomnia		discontinuation	leads to discontinuation		2380
16803	1 pts		Hepatotoxicity		discontinuation	leads to discontinuation		2380
16804	1 pts		Skin rash		discontinuation	leads to discontinuation		2380
16805	1 pts		Pruritus		discontinuation	leads to discontinuation		2380
16806	1 pts		Rash		discontinuation	leads to discontinuation		2380
16807						No AEs are reported		2388
16808	2		Psychiatric symptom		discontinuation	leads to discontinuation		2387
16809	2		Diarrhea		discontinuation	leads to discontinuation		2387
16810	2		Dyskinesia		discontinuation	leads to discontinuation		2387
16811	2		Nausea		discontinuation	leads to discontinuation		2387
16812	1		Abdominal pain		discontinuation	leads to discontinuation		2387
16813	2		Hyperkinesia		discontinuation	leads to discontinuation		2387
16814						No AEs are reported		2386
16815			Abdominal pain					2385
16816			Loose stools					2385
16817			Abdominal pain					2384
16818			Loose stools					2384
16819	1 pts		Palpitations	below serious				2391
16820	1 pts		Diarrhoea	below serious				2391
16821	2 pts		Fatigue	below serious				2391
16822	1 pts		Vessel puncture site reaction	below serious				2391
16823	1 pts		Fungal skin infection	below serious				2391
16824	3 pts		Nasopharyngitis	below serious				2391
16825	2 pts		Dizziness	below serious				2391
16826	5 pts		Headache	below serious				2391
16827	1 pts		Pollakiuria	below serious				2391
16828	2		Dizziness					2390
16829	5		Nausea					2390
16830	6		Arthralgia					2389
16831	6		Dizziness					2389
16832	6		Leg cramps					2389
16833	13		Infection respiratory					2389
16834	2		Sinusitis					2389
16835	4		Nausea					2389
16836	1 pts		Renal failure					2393
16837						No information on AE is provided		2392
16838	1 pts		Rash acneiform	serious				2395
16839	1 pts		Dehydration	serious				2395
16840	1 pts		Speech impairment NOS	serious				2395
16841	1 pts		Confusion	serious				2395
16842	1 pts		Dizziness	serious				2395
16843	1 pts		Blurred vision	serious				2395
16844	2 pts		Pain	serious				2395
16845	1 pts		Sexual function abnormal	serious				2395
16846	10 pts		Leukocyte count decreased	below serious				2395
16847	46 pts		Fatigue	below serious				2395
16848	9 pts		Fever	below serious				2395
16849	9 pts		Insomnia	below serious				2395
16850	5 pts		Weight loss	below serious				2395
16851	14 pts		Alopecia	below serious				2395
16852	30 pts		Dry skin	below serious				2395
16853	49 pts		Pruritis	below serious				2395
16854	38 pts		Rash	below serious				2395
16855	65 pts		Rash acneiform	below serious				2395
16856	68 pts		Diarrhea	below serious				2395
16857	5 pts		Distension NOS	below serious				2395
16858	9 pts		Dry mouth	below serious				2395
16859	4 pts		Dysphagia	below serious				2395
16860	5 pts		Flatulence	below serious				2395
16861	14 pts		Dyspepsia	below serious				2395
16862	15 pts		Mucositis	below serious				2395
16863	4 pts		Epistaxis	below serious				2395
16864	4 pts		Bleeding rectal	below serious				2395
16865	6 pts		ALP increased	below serious				2395
16866	9 pts		Creatinine increased	below serious				2395
16867	24 pts		Aspartate aminotransferase increased	below serious				2395
16868	11 pts		Hyperkalemia	below serious				2395
16869	17 pts		Hypomagnesemia	below serious				2395
16870	6 pts		Hyponatremia	below serious				2395
16871	9 pts		Dizziness	below serious				2395
16872	7 pts		Depression	below serious				2395
16873	19 pts		Pain	below serious				2395
16874	25 pts		Pain	below serious				2395
16875	6 pts		Pain	below serious				2395
16876	14 pts		Cough	below serious				2395
16877	4 pts		Dyspnea	below serious				2395
16878	2 pts		Pyrexia	serious				2396
16879	1 pts		Device occlusion	serious				2396
16880	1 pts		Drug intolerance	serious				2396
16881	1 pts		Fatigue	serious				2396
16882	1 pts		Bile duct obstruction	serious				2396
16883	1 pts		Biliary dilatation	serious				2396
16884	1 pts		Cholangitis acute	serious				2396
16885	1 pts		Hepatic failure	serious				2396
16886	2 pts		Pleural effusion	serious				2396
16887	1 pts		Pulmonary embolism	serious				2396
16888	1 pts		Dysphagia	serious				2396
16889	1 pts		Gastrointestinal haemorrhage	serious				2396
16890	1 pts		Lower gastrointestinal haemorrhage	serious				2396
16891	1 pts		Upper gastrointestinal haemorrhage	serious				2396
16892	2 pts		Biliary sepsis	serious				2396
16893	1 pts		Morganella infection	serious				2396
16894	1 pts		Sepsis	serious				2396
16895	1 pts		Septic shock	serious				2396
16896	1 pts		Decreased appetite	serious				2396
16897	1 pts		Hypercalcaemia	serious				2396
16898	2 pts		Anaemia	serious				2396
16899	1 pts		Haemorrhagic anaemia	serious				2396
16900	1 pts		Anastomotic ulcer	serious				2396
16901	1 pts		Procedural pain	serious				2396
16902	1 pts		Cerebrovascular accident	serious				2396
16903	1 pts		Ischaemic stroke	serious				2396
16904	25 pts		Diarrhoea	below serious				2396
16905	22 pts		Nausea	below serious				2396
16906	16 pts		Abdominal pain	below serious				2396
16907	48 pts		Rash	below serious				2396
16908	7 pts		Dermatitis acneiform	below serious				2396
16909	15 pts		Fatigue	below serious				2396
16910	12 pts		Asthenia	below serious				2396
16911	12 pts		Pyrexia	below serious				2396
16912	6 pts		Mucosal inflammation	below serious				2396
16913	18 pts		Decreased appetite	below serious				2396
16914	11 pts		Anaemia	below serious				2396
16915	11 pts		Weight decreased	below serious				2396
16916	66.7		Diarrhea	grade 1-2				2407
16917	33.3		Hyperbilirubinemia	grade 1-2				2407
16918	83.3		Skin toxicity	grade 1-2				2407
16919	33.3		Headache	grade 1-2				2407
16920	33.3		Diarrhea	grade 4				2407
16921	28.6		Mucositis	grade 1-2				2406
16922	85.7		Diarrhea	grade 1-2				2406
16923	14.3		Hyperbilirubinemia	grade 1-2				2406
16924	28.6		Skin toxicity	grade 1-2				2406
16925	5.3		Fatigue	grade 3				2400
16926	5.3		Dehydration	grade 3				2400
16927	5.3		Pneumonitis	grade 3				2400
16928						AEs not reported		2397
16929	33.3		Leukopenia	grade 3	discontinuation			2403
16930	33.3		Erysipelas	grade 3				2403
16931	33.3		Leukopenia	grade 4				2403
16932	33.3		Neutropenia	grade 3				2403
16933	33.3		Neutropenia	grade 4				2403
16934	33.3		Neutropenia	grade 3				2402
16935	66.7		Neutropenia	grade 4				2402
16936	33.3		Leukopenia	grade 3				2402
16937	33.3		Leukopenia	grade 4				2402
16938	33.3		Neutropenia	grade 3				2401
16939			Diarrhea					2399
16940	100		Rash	grade 3	discontinuation			2394
16941			Transaminases increased					2399
16942	10		Rash		dose reduction			2404
16943	4		Diarrhea		dose reduction			2404
16944	7		Rash		dose interruption			2404
16945	2		Diarrhea		dose interruption			2404
16946	8		Rash	grade 3				2404
16947	<1		Pruritus	grade 3				2404
16948	6		Diarrhea	grade 3				2404
16949	3		Nausea	grade 3				2404
16950	2		Vomiting	grade 3				2404
16951	<1		Stomatitis	grade 3				2404
16952	1		Constipation	grade 3				2404
16953	2		Abdominal pain	grade 3				2404
16954	14		Fatigue	grade 3				2404
16955	4		Chest pain	grade 3				2404
16956	17		Dyspnea	grade 3				2404
16957	4		Cough	grade 3				2404
16958	1		Hemoptysis	grade 3				2404
16959	8		Anorexia	grade 3				2404
16960	1		Headache	grade 3				2404
16961	3		Neuropathy	grade 3				2404
16962	3		Bone pain	grade 3				2404
16963	4		Infection	grade 3				2404
16964	<1		Conjunctivitis	grade 3				2404
16965	<1		Insomnia	grade 3				2404
16966	<1		Rash	grade 4				2404
16967	<1		Diarrhea	grade 4				2404
16968	1		Anorexia	grade 4				2404
16969	4		Fatigue	grade 4				2404
16970	11		Dyspnea	grade 4				2404
16971	<1		Vomiting	grade 4				2404
16972	<1		Abdominal pain	grade 4				2404
16973	1		Diarrhoea		discontinuation			2405
16974	1		Rash		discontinuation			2405
16975			Erythematous rash	grade 1				2398
16976			Illness		discontinuation			2410
16977			Somnolence	grade 1-2	discontinuation			2410
16978			Dizziness	grade 1-2	discontinuation			2410
16979						No SAEs were observed		2409
16980			Somnolence		discontinuation			2408
16981			Respiratory depression		discontinuation			2408
16982			Confusion		discontinuation			2408
16983			Coordination impaired		discontinuation			2408
16984			Slurred speech		discontinuation			2408
16985			Coma		discontinuation			2408
16986	1 pts		Restlessness	below serious				2417
16987	1 pts		Fatigue	serious				2418
16988	8 pts		Drowsiness	below serious				2418
16989	2 pts		Weakness	below serious				2418
16990	2 pts		Irritability	below serious				2418
16991	4 pts		Headache	below serious				2418
16992	1 pts		Nervousness	below serious				2418
16993	3 pts		Malaise	below serious				2418
16994	1 pts		Delusions	below serious				2418
16995	2 pts		Dizziness	below serious				2418
16996	1 pts		Vision blurred	below serious				2418
16997	2 pts		Nasal congestion	below serious				2418
16998	5 pts		Dry mouth	below serious				2418
16999	7 pts		Bad taste	below serious				2418
17000	1 pts		Tremor	below serious				2418
17001	1 pts		Ataxia	below serious				2418
17002	2 pts		Nausea and vomiting	below serious				2418
17003	1 pts		Abdominal discomfort	below serious				2418
17004	1 pts		Diarrhea	below serious				2418
17005	1 pts		Sweating	below serious				2418
17006	1 pts		Decreased appetite	below serious				2418
17007	2 pts		Increased appetite	below serious				2418
17008	2 pts		Weight loss	below serious				2418
17009	8 pts		Dysgeusia	below serious				2416
17010	6 pts		Dizziness	below serious				2416
17011	4 pts		Somnolence	below serious				2416
17012	6 pts		Abdominal pain upper	below serious				2416
17013	10 pts		Vomiting	below serious				2416
17014	4 pts		Abdominal discomfort	below serious				2416
17015	4 pts		Toothache	below serious				2416
17016	13 pts		Upper respiratory tract infection	below serious				2416
17017	9 pts		Nasopharyngitis	below serious				2416
17018	6 pts		Oropharyngeal pain	below serious				2416
17019	4 pts		Irritability	below serious				2416
17020	1 pts		Nasal congestion	below serious				2416
17021	1 pts		Sedation	serious				2419
17022	1 pts		Respiratory distress	serious				2419
17023	22 pts		Headache	below serious				2419
17024	22 pts		Dysgeusia	below serious				2419
17025	13 pts		Dizziness	below serious				2419
17026	6 pts		Somnolence	below serious				2419
17027	8 pts		Abdominal pain upper	below serious				2419
17028	5 pts		Vomiting	below serious				2419
17029	7 pts		Nausea	below serious				2419
17030	8 pts		Abdominal discomfort	below serious				2419
17031	2 pts		Toothache	below serious				2419
17032	4 pts		Urinary tract infection	below serious				2419
17033	8 pts		Pyrexia	below serious				2419
17034	4 pts		Nasal congestion	below serious				2419
17035			Coma		discontinuation			2413
17036						There were no serious adverse events or discontinuations due to adverse events		2411
17037						There were no serious adverse events or discontinuations due to adverse events		2414
17038			CNS depression		discontinuation	WARNING		2415
17039			Alertness decreased		discontinuation	WARNING		2415
17040			Coordination impaired		discontinuation	WARNING		2415
17041			Anaphylactic reaction	severe	discontinuation	WARNING		2415
17042			Anaphylactoid reaction	severe	discontinuation	WARNING		2415
17043			Angioedema		discontinuation	WARNING		2415
17044			Anaphylaxis		discontinuation	WARNING		2415
17045			Abnormal thinking		discontinuation	WARNING		2415
17046			Abnormal behaviour NOS		discontinuation	WARNING		2415
17047			Hallucinations		discontinuation	WARNING		2415
17048			Abnormal behaviour NOS		discontinuation	WARNING		2415
17049			Depression worsened		discontinuation	WARNING		2415
17050			Suicidal ideation		discontinuation	WARNING		2415
17051						Since commercial marketing began, spontaneous cases of eszopiclone overdoses up to 270 mg (90 times the maximum recommended dose of eszopiclone) have been reported, in which patients have recovered.		2412
17052			Pulmonary embolism		discontinuation			2423
17053	23		Vomiting			No adverse reactions leading to discontinuation were reported		2421
17054	48		Nausea			No adverse reactions leading to discontinuation were reported		2420
17055	32		Mastalgia			No adverse reactions leading to discontinuation were reported		2422
17056			Thromboembolic event		discontinuation	WARNING		2425
17057			Hepatic disease		discontinuation	WARNING		2425
17058			Headache		discontinuation	WARNING		2425
17059			Hypertension		discontinuation	WARNING		2425
17060			Uterine bleeding		discontinuation	WARNING		2425
17061			Dysfunctional uterine bleeding		discontinuation	11% of the women discontinued from the clinical trial due to an adverse reaction; the most common adverse reactions leading to discontinuation were irregular and/or heavy uterine bleeding, headache, mood changes, nausea, acne, and weight gain.		2424
17062			Uterine bleeding		discontinuation	11% of the women discontinued from the clinical trial due to an adverse reaction; the most common adverse reactions leading to discontinuation were irregular and/or heavy uterine bleeding, headache, mood changes, nausea, acne, and weight gain.		2424
17063			Headache		discontinuation	11% of the women discontinued from the clinical trial due to an adverse reaction; the most common adverse reactions leading to discontinuation were irregular and/or heavy uterine bleeding, headache, mood changes, nausea, acne, and weight gain.		2424
17064			Mood change		discontinuation	11% of the women discontinued from the clinical trial due to an adverse reaction; the most common adverse reactions leading to discontinuation were irregular and/or heavy uterine bleeding, headache, mood changes, nausea, acne, and weight gain.		2424
17065			Nausea		discontinuation	11% of the women discontinued from the clinical trial due to an adverse reaction; the most common adverse reactions leading to discontinuation were irregular and/or heavy uterine bleeding, headache, mood changes, nausea, acne, and weight gain.		2424
17066			Acne		discontinuation	11% of the women discontinued from the clinical trial due to an adverse reaction; the most common adverse reactions leading to discontinuation were irregular and/or heavy uterine bleeding, headache, mood changes, nausea, acne, and weight gain.		2424
17067			Weight gain		discontinuation	11% of the women discontinued from the clinical trial due to an adverse reaction; the most common adverse reactions leading to discontinuation were irregular and/or heavy uterine bleeding, headache, mood changes, nausea, acne, and weight gain.		2424
17068	8.4		Nervous system disorder		discontinuation			2426
17069	5.8		Digestion impaired		discontinuation			2426
17070	3.9		Rash		discontinuation			2426
17071	1.9		Fatigue		discontinuation			2426
17072	1.9		Headache		discontinuation			2426
17073	16.7		Drowsiness				TRUE	2427
17074			Blood dyscrasia		discontinuation	WARNING		2428
17075			Lupus erythematosus systemic		discontinuation	WARNING		2428
17076			Suicidal behavior		discontinuation	WARNING		2428
17077			Suicidal ideation		discontinuation	WARNING		2428
17078	2		Abdominal pain		discontinuation			2430
17079	2		Diarrhea		discontinuation			2430
17080	1		Flatulence		discontinuation			2430
17081	<1		Insomnia		discontinuation			2429
17082	24.9		Headache					2432
17083	14.5		Vaginitis					2432
17084	13.7		Weight increase					2432
17085	13.5		Acne					2432
17086	12.8		Breast pain					2432
17087	10.9		Abdominal pain					2432
17088	10.5		Pharyngitis					2432
17089	9.6		Leukorrhea					2432
17090	7.6		Influenza-like symptoms					2432
17091	7.2		Dizziness					2432
17092	7.2		Dysmenorrhea					2432
17093	6.8		Back pain					2432
17094	6.5		Emotional lability					2432
17095	6.4		Nausea					2432
17096	5.6		Pain					2432
17097	5.6		Nervousness					2432
17098	5.5		Depression					2432
17099	5.4		Hypersensitivity					2432
17100	5.2		Injection site pain					2432
17101	11.1		Menstrual irregularity		discontinuation	leads to discontinuation		2431
17102	2.3		Emotional lability		discontinuation	leads to discontinuation		2431
17103	2.3		Weight increase		discontinuation	leads to discontinuation		2431
17104	1.6		Headache		discontinuation	leads to discontinuation		2431
17105	1.3		Acne		discontinuation	leads to discontinuation		2431
17106	1		Depression		discontinuation	leads to discontinuation		2431
17107						AEs not reported		2439
17108	2 pts		Anaemia	serious				2433
17109	1 pts		Anaemia iron deficiency	serious				2433
17110	1 pts		Leukocytosis	serious				2433
17111	1 pts		Lymph node pain	serious				2433
17112	1 pts		Lymphadenopathy	serious				2433
17113	1 pts		Neutropenia	serious				2433
17114	2 pts		Atrial fibrillation	serious				2433
17115	1 pts		Atrial flutter	serious				2433
17116	1 pts		Bradycardia	serious				2433
17117	1 pts		Cardiac failure	serious				2433
17118	1 pts		Cardiogenic shock	serious				2433
17119	1 pts		Left ventricular failure	serious				2433
17120	1 pts		Mitral valve incompetence	serious				2433
17121	1 pts		Myopericarditis	serious				2433
17122	2 pts		Pericardial effusion	serious				2433
17123	1 pts		Retinal detachment	serious				2433
17124	2 pts		Abdominal pain	serious				2433
17125	2 pts		Abdominal pain upper	serious				2433
17126	1 pts		Abdominal tenderness	serious				2433
17127	2 pts		Aphthous stomatitis	serious				2433
17128	1 pts		Ascites	serious				2433
17129	1 pts		Colonic polyp	serious				2433
17130	3 pts		Diarrhoea	serious				2433
17131	1 pts		Gastric haemorrhage	serious				2433
17132	1 pts		Gastritis	serious				2433
17133	1 pts		Haemorrhoidal haemorrhage	serious				2433
17134	1 pts		Oesophagitis	serious				2433
17135	1 pts		Rectal haemorrhage	serious				2433
17136	1 pts		Subileus	serious				2433
17137	3 pts		Umbilical hernia	serious				2433
17138	1 pts		Vomiting	serious				2433
17139	4 pts		Disease progression	serious				2433
17140	1 pts		Oedema	serious				2433
17141	1 pts		Oedema peripheral	serious				2433
17142	1 pts		Cholecystitis	serious				2433
17143	1 pts		Hepatomegaly	serious				2433
17144	1 pts		Portal vein thrombosis	serious				2433
17145	1 pts		Anaphylactic shock	serious				2433
17146	1 pts		House dust allergy	serious				2433
17147	1 pts		Hypersensitivity	serious				2433
17148	1 pts		Acute tonsillitis	serious				2433
17149	1 pts		Appendicitis	serious				2433
17150	1 pts		Bronchitis	serious				2433
17151	1 pts		Enterocolitis infectious	serious				2433
17152	3 pts		Gastroenteritis	serious				2433
17153	1 pts		Herpes simplex	serious				2433
17154	2 pts		Herpes zoster	serious				2433
17155	1 pts		Herpes zoster ophthalmic	serious				2433
17156	2 pts		Infection	serious				2433
17157	1 pts		Lymph node tuberculosis	serious				2433
17158	1 pts		Lymphadenitis bacterial	serious				2433
17159	1 pts		Otitis media chronic	serious				2433
17160	5 pts		Pneumonia	serious				2433
17161	2 pts		Sinusitis	serious				2433
17162	1 pts		Urosepsis	serious				2433
17163	1 pts		Vestibular neuronitis	serious				2433
17164	1 pts		Arthropod sting	serious				2433
17165	1 pts		Foot fracture	serious				2433
17166	1 pts		Post procedural haemorrhage	serious				2433
17167	2 pts		Blood creatinine increased	serious				2433
17168	3 pts		C-reactive protein increased	serious				2433
17169	4 pts		Weight decreased	serious				2433
17170	1 pts		Diabetes mellitus	serious				2433
17171	1 pts		Gout	serious				2433
17172	1 pts		Hypokalaemia	serious				2433
17173	2 pts		Arthralgia	serious				2433
17174	1 pts		Arthritis reactive	serious				2433
17175	1 pts		Back pain	serious				2433
17176	2 pts		Flank pain	serious				2433
17177	1 pts		Foot deformity	serious				2433
17178	1 pts		Intervertebral disc protrusion	serious				2433
17179	1 pts		Muscular weakness	serious				2433
17180	4 pts		Myalgia	serious				2433
17181	1 pts		Myositis	serious				2433
17182	1 pts		Polyarthritis	serious				2433
17183	1 pts		Adenocarcinoma pancreas	serious				2433
17184	1 pts		Benign ovarian tumour	serious				2433
17185	1 pts		Cholesteatoma	serious				2433
17186	1 pts		Plasmacytoma	serious				2433
17187	1 pts		Cerebral atrophy	serious				2433
17188	1 pts		Cerebral haemorrhage	serious				2433
17189	1 pts		Ruptured cerebral aneurysm	serious				2433
17190	1 pts		Pregnancy	serious				2433
17191	1 pts		Acute psychosis	serious				2433
17192	1 pts		Depressed mood	serious				2433
17193	1 pts		Paranoia	serious				2433
17194	1 pts		Suicide attempt	serious				2433
17195	1 pts		Calculus ureteric	serious				2433
17196	2 pts		Haematuria	serious				2433
17197	1 pts		Nephrotic syndrome	serious				2433
17198	2 pts		Colic renal	serious				2433
17199	1 pts		Renal failure	serious				2433
17200	5 pts		Renal failure acute	serious				2433
17201	3 pts		Renal haemorrhage	serious				2433
17202	2 pts		Renal impairment	serious				2433
17203	1 pts		Dysmenorrhoea	serious				2433
17204	1 pts		Menorrhagia	serious				2433
17205	1 pts		Irregular menstruation	serious				2433
17206	1 pts		Menstruation irregular	serious				2433
17207	7 pts		Ovarian cyst	serious				2433
17208	1 pts		Pelvic fluid collection	serious				2433
17209	1 pts		Polycystic ovaries	serious				2433
17210	2 pts		Haemorrhage vaginal	serious				2433
17211	1 pts		Chronic obstructive pulmonary disease	serious				2433
17212	1 pts		Dyspnoea	serious				2433
17213	1 pts		Dyspnoea exertional	serious				2433
17214	1 pts		Lung disorder	serious				2433
17215	1 pts		Painful respiration	serious				2433
17216	1 pts		Pleural effusion	serious				2433
17217	1 pts		Pleurisy	serious				2433
17218	2 pts		Pneumonitis	serious				2433
17219	1 pts		Pulmonary oedema	serious				2433
17220	8 pts		Angioedema	serious				2433
17221	1 pts		Angiodysplasia	serious				2433
17222	1 pts		Hypotension	serious				2433
17223	1 pts		Thrombosis	serious				2433
17224	1 pts		Venous thrombosis limb	serious				2433
17225	35 pts		Anaemia	below serious				2433
17226	38 pts		Leukopenia	below serious				2433
17227	30 pts		Thrombocytopenia	below serious				2433
17228	12 pts		Abdominal discomfort	below serious				2433
17229	24 pts		Abdominal pain	below serious				2433
17230	14 pts		Abdominal pain upper	below serious				2433
17231	83 pts		Aphthous stomatitis	below serious				2433
17232	48 pts		Diarrhoea	below serious				2433
17233	20 pts		Nausea	below serious				2433
17234	11 pts		Asthenia	below serious				2433
17235	20 pts		Fatigue	below serious				2433
17236	25 pts		Oedema	below serious				2433
17237	42 pts		Oedema peripheral	below serious				2433
17238	12 pts		Pyrexia	below serious				2433
17239	11 pts		Gastroenteritis	below serious				2433
17240	15 pts		Oral herpes	below serious				2433
17241	14 pts		Sinusitis	below serious				2433
17242	22 pts		Urinary tract infection	below serious				2433
17243	32 pts		Blood creatine phosphokinase increased	below serious				2433
17244	38 pts		Blood creatinine increased	below serious				2433
17245	46 pts		Hypercholesterolaemia	below serious				2433
17246	28 pts		Hyperlipidaemia	below serious				2433
17247	15 pts		Hypertriglyceridaemia	below serious				2433
17248	12 pts		Iron deficiency	below serious				2433
17249	13 pts		Arthralgia	below serious				2433
17250	14 pts		Myalgia	below serious				2433
17251	37 pts		Headache	below serious				2433
17252	13 pts		Haematuria	below serious				2433
17253	28 pts		Proteinuria	below serious				2433
17254	24 pts		Cough	below serious				2433
17255	12 pts		Oropharyngeal pain	below serious				2433
17256	30 pts		Acne	below serious				2433
17257	18 pts		Rash	below serious				2433
17258	33 pts		Hypertension	below serious				2433
17259	1 pts		Septicemia	serious				2435
17260	1 pts		Pyelonephritis	serious				2435
17261	2 pts		Conjunctivitis	below serious				2435
17262	2 pts		Constipation	below serious				2435
17263	11 pts		Diarrhea	below serious				2435
17264	4 pts		Nausea	below serious				2435
17265	8 pts		Cold	below serious				2435
17266	7 pts		Fatigue	below serious				2435
17267	10 pts		Fever	below serious				2435
17268	3 pts		Irritability	below serious				2435
17269	2 pts		Cellulitis	below serious				2435
17270	3 pts		Ear infection	below serious				2435
17271	13 pts		Sore mouth	below serious				2435
17272	8 pts		Mouth ulcer	below serious				2435
17273	4 pts		Mouth irritation	below serious				2435
17274	8 pts		Sore throat	below serious				2435
17275	2 pts		Gastric infection	below serious				2435
17276	3 pts		Streptococcal sore throat	below serious				2435
17277	2 pts		Appetite lost	below serious				2435
17278	13 pts		Headache	below serious				2435
17279	5 pts		Seizures	below serious				2435
17280	2 pts		Abscess	below serious				2435
17281	2 pts		Dermatitis	below serious				2435
17282	10 pts		Hives	below serious				2435
17283	1 pts		Acute myocardial infarction	serious				2434
17284	1 pts		Cardiac failure congestive	serious				2434
17285	1 pts		Oesophageal haemorrhage	serious				2434
17286	1 pts		Upper gastrointestinal haemorrhage	serious				2434
17287	1 pts		Multi-organ failure	serious				2434
17288	2 pts		Pyrexia	serious				2434
17289	1 pts		Septic shock	serious				2434
17290	1 pts		Post embolisation syndrome	serious				2434
17291	1 pts		Renal haematoma	serious				2434
17292	1 pts		Hepatic enzyme increased	serious				2434
17293	1 pts		Hyperkalaemia	serious				2434
17294	1 pts		Hypoalbuminaemia	serious				2434
17295	1 pts		Renal failure acute	serious				2434
17296	1 pts		Aspiration pneumonia	serious				2434
17297	1 pts		Hypertension	serious				2434
17298	6 pts		Anaemia	below serious				2434
17299	6 pts		Thrombocytopenia	below serious				2434
17300	8 pts		Abdominal pain upper	below serious				2434
17301	5 pts		Ascites	below serious				2434
17302	4 pts		Diarrhoea	below serious				2434
17303	2 pts		Gastritis	below serious				2434
17304	2 pts		Gingival bleeding	below serious				2434
17305	2 pts		Irritable bowel syndrome	below serious				2434
17306	9 pts		Mouth ulceration	below serious				2434
17307	7 pts		Stomatitis	below serious				2434
17308	2 pts		Mucosal inflammation	below serious				2434
17309	5 pts		Oedema peripheral	below serious				2434
17310	2 pts		Hepatitis B	below serious				2434
17311	3 pts		Herpes zoster	below serious				2434
17312	2 pts		Nasopharyngitis	below serious				2434
17313	2 pts		Pneumonia	below serious				2434
17314	2 pts		Skin infection	below serious				2434
17315	2 pts		Upper respiratory tract infection	below serious				2434
17316	2 pts		Alanine aminotransferase increased	below serious				2434
17317	3 pts		Aspartate aminotransferase increased	below serious				2434
17318	3 pts		Platelet count decreased	below serious				2434
17319	3 pts		Weight decreased	below serious				2434
17320	11 pts		Decreased appetite	below serious				2434
17321	3 pts		Dyslipidaemia	below serious				2434
17322	4 pts		Hyperglycaemia	below serious				2434
17323	2 pts		Hypoalbuminaemia	below serious				2434
17324	5 pts		Hypokalaemia	below serious				2434
17325	2 pts		Hypomagnesaemia	below serious				2434
17326	2 pts		Arthralgia	below serious				2434
17327	4 pts		Back pain	below serious				2434
17328	2 pts		Flank pain	below serious				2434
17329	4 pts		Musculoskeletal pain	below serious				2434
17330	2 pts		Dizziness	below serious				2434
17331	4 pts		Headache	below serious				2434
17332	7 pts		Insomnia	below serious				2434
17333	2 pts		Benign prostatic hyperplasia	below serious				2434
17334	4 pts		Epistaxis	below serious				2434
17335	4 pts		Rash	below serious				2434
17336	4 pts		Hypertension	below serious				2434
17337	25		Neutropenia	grade 3			TRUE	2444
17338	17		Neutropenia	grade 3			TRUE	2443
17339	15		Neutropenia	grade 3			TRUE	2447
17340	7		Neutropenia	grade 4			TRUE	2447
17341	25		Febrile neutropenia	grade 4			TRUE	2444
17342	17		Febrile neutropenia	grade 4			TRUE	2443
17343	7		Febrile neutropenia	grade 4			TRUE	2447
17344	17		Thrombocytopenia	grade 4			TRUE	2443
17345	50		Neutropenia	grade 3				2444
17346	67		Neutropenia	grade 3				2443
17347	80		Neutropenia	grade 3				2442
17348	62		Neutropenia	grade 3				2447
17349	50		Leukopenia	grade 3				2444
17350	50		Leukopenia	grade 3				2443
17351	20		Leukopenia	grade 3				2442
17352	15		Leukopenia	grade 3				2447
17353	67		Thrombocytopenia	grade 3				2443
17354	23		Thrombocytopenia	grade 3				2447
17355	25		Anemia	grade 3				2444
17356	17		Anemia	grade 3				2443
17357	20		Anemia	grade 3				2442
17358	23		Anemia	grade 3				2447
17359	50		Febrile neutropenia	grade 3				2443
17360	15		Febrile neutropenia	grade 3				2447
17361	33		Lymphopenia	grade 3				2443
17362	33		Pneumonia	grade 3				2443
17363	40		Hypokalemia	grade 3				2442
17364	23		Hypokalemia	grade 3				2447
17365						AEs not reported		2438
17366	14.3		Interstitial pneumonitis	grade 2	discontinuation		TRUE	2446
17367	16.7		Interstitial pneumonitis	grade 2	discontinuation		TRUE	2445
17368	20		Oesophagitis	grade 3			TRUE	2450
17369	20		Interstitial pneumonitis	grade 3			TRUE	2450
17370	20		Dyspnoea	grade 4			TRUE	2450
17371			Dysphagia	grade 3				2450
17372	20		Dermatitis	grade 3				2449
17373	10		Oesophagitis	grade 3				2449
17374	10		Asthenia	grade 3				2449
17375	2.9		Rash	grade 3			TRUE	2440
17376	1.4		Mucositis	grade 3			TRUE	2440
17377	2		Hypokalemia	grade 3			TRUE	2451
17378	1.4		Fatigue	grade 3				2440
17379	1.4		Phosphatase alkaline increased	grade 3				2440
17380	1.4		Hypoalbuminemia	grade 3				2440
17381	2.9		Hypersensitivity	grade 3				2440
17382	2.9		Thrombocytopenia	grade 3				2440
17383	1.4		AST increased	grade 3				2440
17384	1.4		Hyperbilirubinemia	grade 3				2440
17385	1.4		Anorexia	grade 3				2440
17386	1.4		Dehydration	grade 3				2440
17387	2.9		Dyspnea	grade 3				2440
17388	2		Anemia	grade 3				2451
17389	2		Hypersensitivity	grade 3				2451
17390	2		Hyperbilirubinemia	grade 3				2451
17391	16.7		Hypersensitivity	grade 3				2448
17392	2.6		Pneumonitis		discontinuation	treatment termination		2441
17393	1.9		Dyspnea		discontinuation	treatment termination		2441
17394	1.5		Lung disorder		discontinuation	treatment termination		2441
17395	1.1		Fatigue		discontinuation	treatment termination		2441
17396	0.4		Renal failure		discontinuation	treatment termination		2441
17397	4.5		Stomatitis		dose reduction			2441
17398	3.3		Pneumonitis		dose reduction			2441
17399	3		Dyspnea		dose reduction			2441
17400	3		Mucosal inflammation		dose reduction			2441
17401	2.2		Asthenia		dose reduction			2441
17402	2.2		Pneumonia		dose reduction			2441
17403	2.2		Thrombocytopenia		dose reduction			2441
17404	1.9		Anemia		dose reduction			2441
17405	1.9		Diarrhea		dose reduction			2441
17406	1.5		Rash		dose reduction			2441
17407	1.5		Pyrexia		dose reduction			2441
17408	1.1		Vomiting		dose reduction			2441
17409	1.1		Dehydration		dose reduction			2441
17410	1.1		Blood creatinine increased		dose reduction			2441
17411	1.1		Constipation		dose reduction			2441
17412	1.1		Fatigue		dose reduction			2441
17413	1.1		Interstitial lung disease		dose reduction			2441
17414	1.1		Nausea		dose reduction			2441
17415	0.7		Abdominal pain		dose reduction			2441
17416	0.7		Anorexia		dose reduction			2441
17417	0.7		Arthralgia		dose reduction			2441
17418	0.7		Edema peripheral		dose reduction			2441
17419	0.7		Pruritus		dose reduction			2441
17420	0.4		Pleural effusion		dose reduction			2441
17421	3.3		Stomatitis	grade 3				2441
17422	4.5		Anemia	grade 3				2441
17423	1.1		Thrombocytopenia	grade 3				2441
17424	1.5		Lymphopenia	grade 3				2441
17425	0.4		Platelet count decreased	grade 3				2441
17426	0.7		Rash	grade 3				2441
17427	0.7		Erythema	grade 3				2441
17428	1.9		Hypercholesterolemia	grade 3				2441
17429	0.7		Hypertriglyceridemia	grade 3				2441
17430	2.2		Hyperglycemia	grade 3				2441
17431	0.4		Hyperlipidemia	grade 3				2441
17432	0.7		Blood glucose increased	grade 3				2441
17433	0.7		Blood triglycerides increased	grade 3				2441
17434	1.1		Diabetes mellitus	grade 3				2441
17435	0.4		Pancreatitis acute	grade 4				2441
17436	0.4		Blood creatinine increased	grade 3				2441
17437	0.7		Renal failure	grade 3				2441
17438	0.4		Renal failure acute	grade 4				2441
17439	2.6		Pneumonitis	grade 3				2441
17440	0.4		Interstitial lung disease	grade 3				2441
17441	0.7		Lung infiltration	grade 3				2441
17442	0.4		Pulmonary alveolar hemorrhage	grade 3				2441
17443	0.4		Deep vein thrombosis	grade 3				2441
17444	0.7		AST increased	grade 3				2441
17445	0.4		ALT increased	grade 3				2441
17446	0.4		Hepatic failure	grade 3				2441
17447	1.5		Diarrhea	grade 3				2441
17448	0.4		Dry skin	grade 3				2441
17449	0.4		Pruritus	grade 3				2441
17450	0.4		Palmar-plantar erythrodysaesthesia syndrome	grade 3				2441
17451	3		Fatigue	grade 3				2441
17452	1.5		Asthenia	grade 3				2441
17453	1.1		Mucosal inflammation	grade 3				2441
17454	0.4		Anorexia	grade 3				2441
17455	1.5		Dyspnea	grade 3				2441
17456	2.2		Infection	grade 3				2441
17457	1.1		Infection	grade 4				2441
17458	8.9		Hemoglobin decreased	grade 3				2441
17459	0.4		Hemoglobin decreased	grade 4				2441
17460	0.7		Alkaline phosphatase increased	grade 3				2441
17461	4.5		Phosphate decreased	grade 3				2441
17462	0.4		Sodium decreased	grade 3				2441
17463	0.4		Calcium increased	grade 3				2441
17464	0.7		Bilirubin increased	grade 3				2441
17465	0.4		Bilirubin increased	grade 4				2441
17466	0.4		Sodium increased	grade 3				2441
17467						Information about AEs not found		2437
17468						Information about AEs not found		2436
17469						no serious adverse events were reported		2453
17470						No adverse reactions leading to discontinuation were reported		2452
17471			Bone density increased		discontinuation	WARNING		2455
17472			Fetal damage		discontinuation	WARNING		2455
17473			Myocardial infarction		discontinuation	The incidence of cardiac ischemic events (myocardial infarction, angina, and myocardial ischemia) was 1.6%		2454
17474			Angina		discontinuation	The incidence of cardiac ischemic events (myocardial infarction, angina, and myocardial ischemia) was 1.6%		2454
17475			Myocardial ischemia		discontinuation	The incidence of cardiac ischemic events (myocardial infarction, angina, and myocardial ischemia) was 1.6%		2454
17476	0.4		Cardiac failure		discontinuation			2454
17477	1 pts		Epilepsy congenital	serious				2456
17478	1 pts		Appendicitis	serious				2456
17479	7 pts		Upper respiratory tract infection	below serious				2456
17480	1 pts		Cataract	serious				2459
17481	1 pts		Abdominal pain upper	serious				2459
17482	7 pts		Type 2 diabetes mellitus	below serious				2459
17483			Liver injury		discontinuation	leads to discontinuation		2458
17484						No AEs are reported		2457
17485	2 pts		Coronary artery disorders NEC	serious				2468
17486	1 pts		Ischaemic coronary artery disorders	serious				2468
17487	1 pts		Gastrointestinal and abdominal pains (excl oral and throat)	serious				2468
17488	1 pts		Nausea and vomiting symptoms	serious				2468
17489	2 pts		Pain and discomfort NEC	serious				2468
17490	1 pts		Muscle weakness conditions	serious				2468
17491	1 pts		Prostatic neoplasms malignant	serious				2468
17492	1 pts		Transient cerebrovascular events	serious				2468
17493	1 pts		Bronchospasm and obstruction	serious				2468
17494	1 pts		Lower respiratory tract signs and symptoms	serious				2468
17495	11 pts		Nausea and vomiting symptoms	below serious				2468
17496	11 pts		Non-site specific injuries NEC	below serious				2468
17497	17 pts		Liver function analyses	below serious				2468
17498	17 pts		Joint related signs and symptoms	below serious				2468
17499	14 pts		Headaches NEC	below serious				2468
17500	5 pts		Neurological signs and symptoms NEC	below serious				2468
17501	1 pts		Anaemias NEC	serious				2463
17502	1 pts		Cardiomyopathies	serious				2463
17503	2 pts		Ischaemic coronary artery disorders	serious				2463
17504	1 pts		Supraventricular arrhythmias	serious				2463
17505	1 pts		Pain and discomfort NEC	serious				2463
17506	1 pts		Hypoglycaemic conditions NEC	serious				2463
17507	1 pts		Malignant neoplasm of colon	serious				2463
17508	1 pts		Endocrine neoplasms malignant and unspecified NEC	serious				2463
17509	7 pts		Gastrointestinal and abdominal pains (excl oral and throat)	below serious				2463
17510	13 pts		Influenza viral infections	below serious				2463
17511	52 pts		Upper respiratory tract infections	below serious				2463
17512	9 pts		Non-site specific injuries NEC	below serious				2463
17513	10 pts		Liver function analyses	below serious				2463
17514	23 pts		Joint related signs and symptoms	below serious				2463
17515	5 pts		Neurological signs and symptoms NEC	below serious				2463
17516	1 pts		Supraventricular arrhythmias	serious				2465
17517	1 pts		Abdominal hernia	serious				2465
17518	1 pts		Duodenal and small intestinal stenosis and obstruction	serious				2465
17519	1 pts		Total fluid volume decreased	serious				2465
17520	1 pts		Seizures and seizure disorders NEC	serious				2465
17521	1 pts		Renal failure and impairment	serious				2465
17522	18 pts		Diarrhoea (excl infective)	below serious				2465
17523	8 pts		Gastrointestinal and abdominal pains (excl oral and throat)	below serious				2465
17524	8 pts		Nausea and vomiting symptoms	below serious				2465
17525	7 pts		Influenza viral infections	below serious				2465
17526	27 pts		Upper respiratory tract infections	below serious				2465
17527	9 pts		Non-site specific injuries NEC	below serious				2465
17528	6 pts		Liver function analyses	below serious				2465
17529	14 pts		Musculoskeletal and connective tissue conditions NEC	below serious				2465
17530	12 pts		Headaches NEC	below serious				2465
17531	9 pts		Neurological signs and symptoms NEC	below serious				2465
17532	3 pts		Back pain	below serious				2467
17533	3 pts		Headache	below serious				2467
17534	6 pts		Pain	below serious				2467
17535	1 pts		Dyspepsia	below serious				2467
17536	2 pts		Increased appetite	below serious				2467
17537	2 pts		Abnormal liver function tests	below serious				2467
17538	2 pts		Arthralgia	below serious				2467
17539	1 pts		Delirium	serious				2469
17540	1 pts		Guillain Barre syndrome	serious				2469
17541	1 pts		Pneumonia	serious				2469
17542	2 pts		Accidental injury	below serious				2469
17543	2 pts		Back pain	below serious				2469
17544	2 pts		Headache	below serious				2469
17545	8 pts		Diarrhoea	below serious				2469
17546	2 pts		Dyspepsia	below serious				2469
17547	1 pts		Arthralgia	below serious				2469
17548	1 pts		Rash	below serious				2469
17549	1 pts		Suicide attempt	serious				2464
17550	1 pts		Back pain	serious				2464
17551	1 pts		Accidental injury	below serious				2464
17552	2 pts		Back pain	below serious				2464
17553	2 pts		Headache	below serious				2464
17554	2 pts		Arthralgia	below serious				2464
17555	3 pts		Rash	below serious				2464
17556	4 pts		Flank pain	below serious				2470
17557	1 pts		Muscle spasms	below serious				2470
17558	2 pts		Blood creatine phosphokinase increased	below serious				2470
17559	2 pts		Creatinine urine increased	below serious				2470
17560	2 pts		Urine calcium increased	below serious				2470
17561	2 pts		Haematuria	below serious				2470
17562	2 pts		Rash	below serious				2470
17563	1 pts		Acute myocardial infarction	serious				2471
17564	1 pts		Angina pectoris	serious				2471
17565	1 pts		Colitis	serious				2471
17566	1 pts		Oedema peripheral	serious				2471
17567	1 pts		Cholecystitis acute	serious				2471
17568	1 pts		Cholelithiasis	serious				2471
17569	1 pts		Bile duct obstruction	serious				2471
17570	1 pts		Appendicitis	serious				2471
17571	1 pts		Bursitis infective	serious				2471
17572	1 pts		Pneumonia	serious				2471
17573	1 pts		Chest wall abscess	serious				2471
17574	1 pts		Sepsis	serious				2471
17575	1 pts		Pneumonia streptococcal	serious				2471
17576	1 pts		Squamous cell carcinoma of lung	serious				2471
17577	1 pts		Malignant melanoma	serious				2471
17578	1 pts		Uterine leiomyoma	serious				2471
17579	1 pts		Nephropathy	serious				2471
17580	1 pts		Oliguria	serious				2471
17581	1 pts		Chronic obstructive pulmonary disease	serious				2471
17582	1 pts		Acute respiratory failure	serious				2471
17583	1 pts		Disorder peripheral vascular	serious				2471
17584	1 pts		Peripheral arterial occlusive disease	serious				2471
17585	9 pts		Diarrhoea	below serious				2471
17586	8 pts		Oedema peripheral	below serious				2471
17587	11 pts		Aspartate aminotransferase increased	below serious				2471
17588	10 pts		Alanine aminotransferase increased	below serious				2471
17589	14 pts		Arthralgia	below serious				2471
17590	9 pts		Back pain	below serious				2471
17591	8 pts		Hypertension	below serious				2471
17592	1 pts		Cardiac failure congestive	serious				2466
17593	1 pts		Gastrooesophageal reflux disease	serious				2466
17594	1 pts		Type 2 diabetes mellitus	serious				2466
17595	1 pts		Pain in extremity	serious				2466
17596	1 pts		Dyspnoea	serious				2466
17597	1 pts		Respiratory failure	serious				2466
17598	1 pts		Iliac artery occlusion	serious				2466
17599	5 pts		Blood creatinine increased	below serious				2466
17600	2 pts		Back pain	below serious				2466
17601	3 pts		Pain in extremity	below serious				2466
17602	2 pts		Hepatic enzyme increased	below serious				2466
17603	3 pts		Bronchitis	below serious				2466
17604	2 pts		Nasopharyngitis	below serious				2466
17605	2 pts		Drug hypersensitivity	below serious				2466
17606	2 pts		Depression	below serious				2466
17607	2 pts		Headache	below serious				2466
17608	2 pts		Dizziness	below serious				2466
17609	2 pts		Osteoarthritis	below serious				2466
17610	2 pts		Rash	below serious				2466
17611	2 pts		Tendonitis	below serious				2466
17612	1 pts		Aortic valve disease	serious				2472
17613	1.8		Function liver abnormal		discontinuation	leads to discontinuation		2461
17614	1.2		Function liver abnormal		discontinuation	leads to discontinuation		2462
17615						No AEs are reported		2460
17616	1 pts		Headache			subjects with newly diagnosed epilepsy		2474
17617	5 pts		Nausea			subjects with newly diagnosed epilepsy		2474
17618	3 pts		Anorexia			subjects with newly diagnosed epilepsy		2474
17619	1 pts		Dyspepsia			subjects with newly diagnosed epilepsy		2474
17620	1 pts		Insomnia			subjects with newly diagnosed epilepsy		2474
17621	6.9		Fatigue			Monotherapy		2473
17622	3.4		Weight decrease			Monotherapy		2473
17623	3.4		Face edema			Monotherapy		2473
17624	8.6		Insomnia			Monotherapy		2473
17625	6.9		Headache			Monotherapy		2473
17626	5.2		Anxiety			Monotherapy		2473
17627	3.4		Acne			Monotherapy		2473
17628	3.4		Rash			Monotherapy		2473
17629	8.6		Dyspepsia			Monotherapy		2473
17630	8.6		Vomiting			Monotherapy		2473
17631	6.9		Constipation			Monotherapy		2473
17632	5.2		Diarrhea			Monotherapy		2473
17633	5.2		SGPT increased			Monotherapy		2473
17634	3.4		Hypophosphatemia			Monotherapy		2473
17635	8.6		Upper respiratory tract infection			Monotherapy		2473
17636	6.9		Rhinitis			Monotherapy		2473
17637	3.4		Diplopia			Monotherapy		2473
17638	3.4		Otitis media			Monotherapy		2473
17639	3.4		Bleeding intermenstrual			Monotherapy		2473
17640	3.4		Urinary tract infection			Monotherapy		2473
17641	18		Headache		discontinuation			2475
17642	6		Ankle edema		discontinuation			2475
17643	6		Flushing		discontinuation			2475
17644	2		Nausea		discontinuation			2475
17645	2		Palpitation		discontinuation			2475
17646	2		Vertigo		discontinuation			2475
17647	10		Dyspepsia					2476
17648	7.7		Nausea					2476
17649	7		Constipation					2476
17650	2.6		Vomiting					2476
17651	2		Abdominal pain					2476
17652	1.8		Diarrhea					2476
17653	8.7		Headache					2476
17654	8.5		Somnolence					2476
17655	6.5		Dizziness					2476
17656	2.2		Tremor					2476
17657	1.4		Confusion					2476
17658	2		Reaction gastrointestinal		discontinuation	leads to discontinuation		2476
17659	4.6		Sweating increased					2476
17660	4.2		Pruritus					2476
17661	3.7		Rash					2476
17662	1		Reaction skin		discontinuation	leads to discontinuation		2476
17663	4.5		Tinnitus					2476
17664	2.2		Blurred vision					2476
17665	1.6		Hearing decreased					2476
17666	2.5		Palpitations					2476
17667	0.5		Cardiovascular disorder (NOS)		discontinuation	leads to discontinuation		2476
17668	5.7		Nervousness					2476
17669	5.4		Asthenia					2476
17670	5		Peripheral edema					2476
17671	2.8		Dyspnea					2476
17672	1.7		Fatigue					2476
17673	1.5		Upper respiratory infection					2476
17674	1.2		Nasopharyngitis					2476
17675	<1		Gastritis					2476
17676	<1		Ulcer peptic with perforation					2476
17677	<1		Ulcer peptic with perforation					2476
17678	<1		Gastrointestinal hemorrhage					2476
17679	<1		Anorexia					2476
17680	<1		Flatulence					2476
17681	<1		Dry mouth					2476
17682	<1		Blood in stool					2476
17683	<1		Alkaline phosphatase increased					2476
17684	<1		LDH increased					2476
17685	<1		SGOT increased					2476
17686	<1		Jaundice					2476
17687	<1		Cholestatic hepatitis					2476
17688	<1		Buccal mucosa aphthous ulceration					2476
17689	<1		Taste metallic					2476
17690	<1		Pancreatitis					2476
17691	<1		Atrial fibrillation					2476
17692	<1		Pulmonary edema					2476
17693	<1		Electrocardiogram change					2476
17694	<1		Supraventricular tachycardia					2476
17695	<1		Renal failure					2476
17696	<1		Dysuria					2476
17697	<1		Cystitis					2476
17698	<1		Hematuria					2476
17699	<1		Oliguria					2476
17700	<1		Azotemia					2476
17701	<1		Anuria					2476
17702	<1		Nephritis interstitial					2476
17703	<1		Nephrosis					2476
17704	<1		Acute papillary necrosis					2476
17705	<1		Angioedema					2476
17706	<1		Purpura					2476
17707	<1		Bruising					2476
17708	<1		Hemorrhage					2476
17709	<1		Thrombocytopenia					2476
17710	<1		Hemolytic anemia					2476
17711	<1		Aplastic anemia					2476
17712	<1		Agranulocytosis					2476
17713	<1		Pancytopenia					2476
17714	<1		Depression					2476
17715	<1		Disorientation					2476
17716	<1		Seizures					2476
17717	<1		Trigeminal neuralgia					2476
17718	<1		Burning tongue					2476
17719	<1		Diplopia					2476
17720	<1		Optic neuritis					2476
17721	<1		Exfoliative dermatitis					2476
17722	<1		Toxic epidermal necrolysis					2476
17723	<1		Stevens-Johnson syndrome					2476
17724	<1		Alopecia					2476
17725	<1		Anaphylaxis					2476
17726	<1		Urticaria					2476
17727	<1		Malaise					2476
17728	<1		Insomnia					2476
17729	<1		Tachycardia					2476
17730	<1		Personality change					2476
17731	<1		Lymphadenopathy					2476
17732	<1		Mastodynia					2476
17733	<1		Fever					2476
17734	1 pts		Knee pain	serious				2483
17735	1 pts		Stroke	serious				2483
17736	1 pts		Elevated prostate specific antigen [PSA]	below serious				2483
17737	1 pts		Palpitations	serious				2484
17738	1 pts		Dizziness	serious				2484
17739	1 pts		Abdominal pain	serious				2484
17740	4 pts		Rash	below serious				2484
17741	3 pts		Libido decreased	below serious				2484
17742	2 pts		Dizziness	below serious				2485
17743	1 pts		Headache	below serious				2485
17744	1 pts		Itchy eyes	below serious				2485
17745	1 pts		Ankle fracture	below serious				2485
17746	2 pts		Libido decreased	below serious				2482
17747	2 pts		Upper respiratory tract infection	below serious				2482
17748	1 pts		Agitation	below serious				2482
17749	1 pts		Arthralgia	below serious				2482
17750	1 pts		Aspartate aminotransferase increased	below serious				2482
17751	1 pts		Diarrhoea	below serious				2482
17752	1 pts		Dyspnoea	below serious				2482
17753	1 pts		Fatigue	below serious				2482
17754	1 pts		Oropharyngeal pain	below serious				2482
17755	1 pts		Pruritus	below serious				2482
17756	1 pts		Generalised rash	below serious				2482
17757	1 pts		Vomiting	below serious				2482
17758	1 pts		Skin abrasion	below serious				2482
17759	1 pts		Swelling face	below serious				2482
17760						No AEs were observed		2479
17761						No information on AE is provided		2480
17762	1.7		Impotence		discontinuation			2478
17763	0.8		Pharyngolaryngeal discomfort		discontinuation			2478
17764	0.8		Epididymitis		discontinuation			2478
17765	0.8		Urinary frequency		discontinuation			2478
17766	0.8		Goiter		discontinuation			2478
17767	2.6		Impotence		discontinuation			2477
17768	1.7		Libido decreased		discontinuation			2477
17769	0.9		Arrhythmia		discontinuation			2477
17770	0.2		Paresthesia		discontinuation			2481
17771	1.7		Impotence		discontinuation			2481
17772	0.6		Libido decreased		discontinuation			2481
17773	0.4		Ejaculation disorder		discontinuation			2481
17774	0.2		Abdominal pain		discontinuation			2481
17775	0.2		Seizures and seizure disorders NEC		discontinuation			2481
17776	0.2		Somnolence		discontinuation			2481
17777			Ventricular tachycardia		discontinuation	WARNING		2490
17778			Cardiac arrest		discontinuation	WARNING		2490
17779			Unconsciousness		discontinuation			2488
17780			Cyanosis		discontinuation			2488
17781			Bradycardia		discontinuation			2488
17782			Arrhythmia		discontinuation			2488
17783			Brugada syndrome		discontinuation			2486
17784			Mental status changes		discontinuation			2486
17785			Fatigue		discontinuation			2486
17786			Polymorphic ventricular tachycardia		discontinuation			2489
17787			Ventricular tachycardia		discontinuation			2487
17788			Hypotension		discontinuation			2487
17789			Cardiopulmonary arrest		discontinuation			2487
17790			Fetal damage		discontinuation	WARNING		2494
17791			Myocardial ischemia		discontinuation	WARNING		2494
17792			Stomatitis		discontinuation	WARNING		2494
17793			Esophagitis		discontinuation	WARNING		2494
17794			Leukopenia		discontinuation	WARNING		2494
17795			Vomiting		discontinuation	WARNING		2494
17796			Diarrhea		discontinuation	WARNING		2494
17797			Gastrointestinal ulcer		discontinuation	WARNING		2494
17798			Gastrointestinal bleeding		discontinuation	WARNING		2494
17799			Thrombocytopenia		discontinuation	WARNING		2494
17800			Hemorrhage		discontinuation	WARNING		2494
17801	72		Mucositis	grade 3-4			TRUE	2493
17802	33.3		Diarrhea	grade 3	discontinuation		TRUE	2492
17803	50		Diarrhea	grade 4	discontinuation		TRUE	2491
17804						No major adverse effects to flumazenil were noted on study days.		2496
17805	10.3		Injection site pain					2497
17806	8		Agitation					2497
17807	3.4		Anxiety					2497
17808	3.4		Crying abnormal					2497
17809	3.4		Headache					2497
17810	3.4		Vomiting					2497
17811	3.4		Tachycardia					2497
17812	3.4		Dizziness					2497
17813	2.3		Nausea					2497
17814	1.1		Convulsions					2497
17815						No side-effects occurred		2495
17816	9		Headache					2500
17817	6.9		Fever					2500
17818	4.2		Allergic reaction					2500
17819	2.6		Pain					2500
17820	3.7		Accidental injury					2500
17821	3.7		Infection					2500
17822	0.5		Back pain					2500
17823	4.2		Vomiting					2500
17824	2.1		Dyspepsia					2500
17825	17.5		Pharyngitis					2500
17826	9		Rhinitis					2500
17827	8.5		Cough increased					2500
17828	7.4		Sinusitis					2500
17829	3.2		Epistaxis					2500
17830	2.6		Rash					2500
17831	1.1		Urinary tract infection					2500
17832	13.8		Headache					2498
17833	3.7		Fever					2498
17834	4.6		Allergic reaction					2498
17835	4.6		Pain					2498
17836	3.7		Accidental injury					2498
17837	0.9		Infection					2498
17838	3.2		Back pain					2498
17839	4.6		Vomiting					2498
17840	3.2		Dyspepsia					2498
17841	16.6		Pharyngitis					2498
17842	15.7		Rhinitis					2498
17843	5.5		Cough increased					2498
17844	4.1		Sinusitis					2498
17845	0.9		Epistaxis					2498
17846	3.7		Rash					2498
17847	0.9		Urinary tract infection					2498
17848	8.8		Headache					2499
17849	0.9		Fever					2499
17850	4.4		Allergic reaction					2499
17851	1.8		Pain					2499
17852	3.5		Accidental injury					2499
17853	0.9		Infection					2499
17854	1.8		Back pain					2499
17855	3.5		Dyspepsia					2499
17856	16.8		Pharyngitis					2499
17857	3.5		Rhinitis					2499
17858	1.8		Cough increased					2499
17859	8.8		Sinusitis					2499
17860	1.8		Rash					2499
17861	3.5		Urinary tract infection					2499
17862	10		Asthma		discontinuation	leads to discontinuation		2501
17863	1.7		Pharyngitis		discontinuation	leads to discontinuation		2501
17864	12 pts		Abdominal pain		discontinuation	2 patients voluntary abandoned therapy		2503
17865	15 pts		Flatulence					2503
17866	8 pts		Vomiting		discontinuation	8 patients required a cessation of therapy, 3 patients voluntary abandoned therapy		2503
17867	5 pts		Diarrhea					2503
17868	9 pts		Headache		discontinuation	1 patient voluntary abandoned therapy		2503
17869	10 pts		Dry skin					2503
17870	1 pts		Nephrolithiasis					2503
17871	3 pts		Hypertransaminasemia		discontinuation			2503
17872	1 pts		Fatty liver		discontinuation			2503
17873	2 pts		Leg pain					2503
17874	4 pts		Dyslipidemia					2503
17875	4 pts		Fluid retention					2503
17876	5 pts		Weight gain		discontinuation	1 patient required a cessation of therapy, 2 patients voluntary abandoned therapy		2503
17877	3 pts		Epigastralgia			Epigastralgia/pyrosis		2503
17878	3 pts		Pyrosis			Epigastralgia/pyrosis		2503
17879	2 pts		Dyspepsia					2503
17880	9 pts		Nausea					2503
17881	1 pts		Vaginal infection					2503
17882	3 pts		Constipation					2503
17883	25		Hot flushes	all grades				2502
17884	49		Breast tenderness	all grades				2502
17885	22		Nausea and vomiting	all grades				2502
17886	17		Appetite lost	all grades				2502
17887	16		Diarrhea	all grades				2502
17888	4		Hot flushes	severe				2502
17889	7		Breast tenderness	severe				2502
17890	1.3		Nausea and vomiting	severe				2502
17891	1.3		Appetite lost	severe				2502
17892	1.3		Diarrhea	severe	discontinuation			2502
17893	4		Impaired liver function		discontinuation			2502
17894	1.3		Gynecomastia		discontinuation			2502
17895	5 pts		Esophageal candidiasis	below serious				2512
17896	7 pts		General system disorders NEC	below serious				2513
17897	2 pts		General system disorders NEC	below serious				2513
17898	1 pts		General system disorders NEC	below serious				2513
17899	5 pts		General system disorders NEC	below serious				2513
17900	4 pts		General system disorders NEC	below serious				2513
17901	1 pts		Thirst	below serious				2511
17902	1 pts		Gastrointestinal viral infection	below serious				2511
17903	2 pts		Headache	below serious				2511
17904	1 pts		Throat irritation	below serious				2511
17905	1 pts		Palpitations	below serious				2511
17906	1 pts		Laceration	below serious				2511
17907	1 pts		Hypertension	below serious				2511
17908	1 pts		Pneumonia mycoplasmal	serious				2509
17909	1 pts		Disruptive mood dysregulation disorder	serious				2510
17910						No AEs are reported		2508
17911						No AEs are reported		2507
17912						Adverse events reported with fluticasone propionate were similar to placebo, and no clinically significant abnormalities in laboratory safety tests were observed.		2505
17913						no acute toxic effects		2504
17914						No AEs are reported		2506
17915	2.6		Nausea		discontinuation			2518
17916			Status epilepticus		discontinuation			2516
17917			Cardiac arrest		discontinuation			2516
17918			Sinus bradycardia	grade 3	discontinuation			2514
17919			Fatigue	grade 3	discontinuation			2514
17920			Diarrhoea		discontinuation			2517
17921			Nausea		discontinuation			2517
17922			Abdominal pain		discontinuation			2517
17923			Drowsiness		discontinuation			2515
17924			Serotonin syndrome		discontinuation			2519
17925			Suicidal behavior		discontinuation			2519
17926						No AEs are reported		2520
17927	1 pts		Epidermal necrolysis		discontinuation	leads to discontinuation		2521
17928	23 pts		Congestive heart failure					2522
17929	19 pts		Cirrhosis liver					2523
17930	1 pts		Chronic kidney disease					2523
17931	2 pts		Interstitial lung disease	serious				2524
17932	2 pts		Lung infection	serious				2524
17933	2 pts		Pneumonia	serious				2524
17934	1 pts		Haemoptysis	serious				2524
17935	1 pts		Death	serious				2524
17936	1 pts		Sudden death	serious				2524
17937	1 pts		Paraplegia	serious				2524
17938	1 pts		Arterial thrombosis limb	serious				2524
17939	1 pts		Circulatory collapse	serious				2524
17940	73 pts		Rash	below serious				2524
17941	10 pts		Pruritus	below serious				2524
17942	9 pts		Dry skin	below serious				2524
17943	9 pts		Skin exfoliation	below serious				2524
17944	37 pts		Diarrhoea	below serious				2524
17945	31 pts		Alanine aminotransferase increased	below serious				2524
17946	21 pts		Aspartate aminotransferase increased	below serious				2524
17947	8 pts		Transaminases increased	below serious				2524
17948	1 pts		Toxic epidermal necrolysis	grade 4			TRUE	2526
17949						No information on AEs is available		2527
17950	1 pts		Asthenia	grade 4	discontinuation	leads to discontinuation		2525
17951	2 pts		Acne	grade 3	discontinuation	leads to discontinuation		2528
17952	2 pts		Rash	grade 2-3	discontinuation	leads to discontinuation		2528
17953	1 pts		Diarrhea		discontinuation	leads to discontinuation		2528
17954	1 pts		Abdominal pain		discontinuation	leads to discontinuation		2528
17955	1 pts		Headache		discontinuation	leads to discontinuation		2528
17956	1 pts		Epistaxis		discontinuation	leads to discontinuation		2528
17957	1 pts		Pruritus		discontinuation	leads to discontinuation		2528
17958	1 pts		Necrosis skin		discontinuation	leads to discontinuation		2532
17959	1 pts		Neutropenia	grade 2				2530
17960	1 pts		AST increased	grade 2				2530
17961	1 pts		ALT increased	grade 2				2530
17962	2 pts		Hepatotoxicity	grade 3			TRUE	2533
17963	1 pts		Neutropenic infection	grade 4			TRUE	2533
17964	2		Myocardial infarction		discontinuation	leads to discontinuation		2529
17965	2		Cerebrovascular accident		discontinuation	leads to discontinuation		2529
17966	2		Arrhythmia		discontinuation	leads to discontinuation		2529
17967	2		Hypertension		discontinuation	leads to discontinuation		2529
17968	<1		Anemia		discontinuation	leads to discontinuation		2529
17969	<1		Thrombocytopenia		discontinuation	leads to discontinuation		2529
17970	<1		Hepatic dysfunction NOS		discontinuation	leads to discontinuation		2529
17971	<1		Kidney dysfunction		discontinuation	leads to discontinuation		2529
17972	<1		Nausea		discontinuation	leads to discontinuation		2529
17973	<1		Vomiting		discontinuation	leads to discontinuation		2529
17974	<1		Fever		discontinuation	leads to discontinuation		2529
17975	<1		Rash		discontinuation	leads to discontinuation		2529
17976	<1		Dyspnea		discontinuation	leads to discontinuation		2529
17977	<1		Hemorrhage		discontinuation	leads to discontinuation		2529
17978	<1		Infection		discontinuation	leads to discontinuation		2529
17979	<1		Stomatitis		discontinuation	leads to discontinuation		2529
17980	<1		Somnolence		discontinuation	leads to discontinuation		2529
17981	<1		Flu syndrome		discontinuation	leads to discontinuation		2529
17982	<1		Edema		discontinuation	leads to discontinuation		2529
17983			Myelosuppression					2531
17984			Paresthesia					2531
17985			Rash	severe				2531
17986	1.1		Depression		discontinuation			2535
17987	1.1		Flushing		discontinuation			2535
17988	2.2		Nausea		discontinuation			2535
17989	1.1		Vomiting		discontinuation			2535
17990	1.1		Rash		discontinuation			2535
17991			Abdominal cramps		discontinuation			2534
17992			Abnormal liver function tests		discontinuation			2534
17993			Diarrhea		discontinuation			2534
17994			CPK increased		discontinuation			2534
17995			Joint pain		discontinuation			2534
17996			Muscle pain		discontinuation			2534
17997			Nausea		discontinuation			2534
17998			Vomiting		discontinuation			2534
17999	1 pts		Catheter site haematoma	below serious				2541
18000	1 pts		Influenza	below serious				2541
18001	1 pts		Nasopharyngitis	below serious				2541
18002	1 pts		Arthralgia	below serious				2541
18003	1 pts		Back pain	below serious				2541
18004	1 pts		Disorder muscle	below serious				2541
18005	1 pts		Syncope	below serious				2541
18006	1 pts		Rash maculo-papular	below serious				2541
18007	0.8		Hypoglycaemia		discontinuation			2537
18008	0.9		Tremor		discontinuation			2537
18009			Hypoglycemia			Overdosage		2540
18010	0.6		Hypoglycemia		discontinuation			2539
18011	0.6		Glomerular filtration rate decreased		discontinuation			2539
18012			Creatine kinase increased			Overdosage		2538
18013			Troponin I increased			Overdosage		2538
18014						No information on AE is provided		2536
18015			Hypoglycaemia		discontinuation			2543
18016			Hypoglycaemic encephalopathy	grade 5	discontinuation			2542
18017	0.17		Myocardial infarction	serious	discontinuation			2544
18018	0.17		Abortion spontaneous	serious	discontinuation			2544
18019	0.7		Hypoglycemia		discontinuation			2545
18020	0.25		Pyelonephritis		discontinuation			2545
18021			Cardiovascular disorder NOS	grade 5	discontinuation	WARNING		2546
18022						no adverse effects were reported		2547
18023						no adverse effects were reported		2548
18024	1 pts		Facial swelling	serious				2551
18025	5		Hypoglycemia		discontinuation	side effects attributed to hypoglycemia		2550
18026						No information on AE is provided		2549
18027	2 pts		Fatigue	grade 2				2554
18028	29 pts		Hot flashes	grade 2				2554
18029	5 pts		Menses irregular	grade 2				2554
18030	9 pts		Libido decreased	grade 2				2554
18031	6 pts		Agitation	grade 2				2554
18032	9 pts		Anxiety	grade 2				2554
18033	8 pts		Depression	grade 2				2554
18034	1 pts		Muscle pain	grade 2				2554
18035	12 pts		Headache	grade 2				2554
18036	10 pts		Sweating	grade 2				2554
18037	1 pts		Thromboembolism	grade 4				2554
18038	12 pts		Dryness vaginal	grade 2				2554
18039	4 pts		Hot flashes	grade 3				2554
18040	2 pts		Menses irregular	grade 3				2554
18041	1 pts		Depression	grade 3				2554
18042	80		Gastrointestinal disorder (NOS)					2553
18043	58		Bladder disorder NOS					2553
18044	37		Skin and subcutaneous conditions NEC					2553
18045	36		Diarrhea					2552
18046	16		Cystitis					2552
18047	14		Bleeding rectal					2552
18048	8		Proctitis					2552
18049	7		Hematuria					2552
18050	1 pts		Urinary incontinence		discontinuation	leads to discontinuation		2556
18051						impossible to link AEs with the definite dose		2555
18052	1 pts		Implant site infection		discontinuation	leads to discontinuation		2557
18053			Tachycardia		discontinuation			2558
18054			Lethargy		discontinuation			2559
18055			Hypotension		discontinuation			2559
18056			Tachycardia		discontinuation			2559
18057			Chest pain		discontinuation			2559
18058			Systemic lupus erythematosus synd		discontinuation	WARNING		2561
18059			Glomerulonephritis		discontinuation	WARNING		2561
18060			Angina pectoris		discontinuation	WARNING		2562
18061			Myocardial infarction		discontinuation	WARNING		2562
18062			Peripheral neuritis		discontinuation	WARNING		2562
18063			Systemic lupus erythematosus synd		discontinuation	WARNING		2563
18064			Glomerulonephritis		discontinuation	WARNING		2563
18065	rare		Skin rash		discontinuation	WARNING		2560
18066	rare		Febrile reaction		discontinuation	WARNING		2560
18067						No adverse reactions were reported		2564
18068						No AEs reported		2565
18069	2.6		Chest pain					2566
18070	1.4		Bradycardia					2566
18071	3.7		Extrasystoles ventricular		discontinuation	premature discontinuation of CORVERT treatment was the emergence of ventricular extrasystoles (6 of 776 patients; 0.8%)		2566
18072	2.6		Hypotension					2566
18073	3.4		Non-sustained ventricular tachycardia		discontinuation	premature discontinuation of CORVERT treatment was the emergence of non-sustained monomorphic ventricular tachycardia (7 of 776 patients; 0.9%)		2566
18074	3.5		Non-sustained ventricular tachycardia		discontinuation	premature discontinuation of CORVERT treatment was the emergence of non-sustained polymorphic ventricular tachycardia (14 of 776 patients; 1.8%)		2566
18075	1.2		Sinus bradycardia					2566
18076	1.8		Polymorphic ventricular tachycardia		discontinuation	premature discontinuation of CORVERT treatment was the emergence of sustained polymorphic ventricular tachycardia (7 of 776 patients; 0.9%)		2566
18077	1		Heart arrest					2566
18078	4.1		Headache					2566
18079	1.9		Procedural complication			procedural non-surgical event		2566
18080	4.8		Nausea					2566
18081	1.8		Dizziness					2566
18082	1.8		Diarrhea					2566
18083						AEs not specified		2568
18084						AEs associated with early withdrawal are not stratified by dose		2567
18085			QT interval prolonged					2581
18086			Neuroleptic malignant syndrome					2582
18087			Tardive dyskinesia					2583
18088			Hyperglycemia					2583
18089	18		Weight gain					2572
18090	0.1		Seizures					2575
18091	5		Orthostatic hypotension					2573
18092	0.4		Syncope					2574
18093			Leukopenia					2576
18094			Neutropenia					2576
18095			Agranulocytosis					2576
18096	26		Hyperprolactinemia					2580
18097	0.1		Gynecomastia			In pooled analysis from clinical studies including longer term trials, in 3210 adults treated with iloperidone, gynecomastia was reported in 2 male subjects (0.1%)		2579
18098	0.2		Galactorrhea			In pooled analysis from clinical studies including longer term trials, in 3210 adults treated with iloperidone, gynecomastia was reported in 8 female subjects (0.2%)		2579
18099			Temperature regulation disorder					2577
18100			Dysphagia					2577
18101			Suicide attempt					2578
18102			Priapism					2578
18103	11.9		Somnolence					2571
18104			Extrapyramidal symptoms					2569
18105			Electrocardiogram QTc interval prolonged					2569
18106						no adverse physical effects were noted for this patient		2570
18107	1.5		Localised skin reaction		discontinuation			2585
18108	2		Application site reaction		discontinuation			2584
18109	18.6		Thrombocytopenia		discontinuation			2591
18110			Death	grade 5				2588
18111			Cardiac arrest					2587
18112			Diarrhea		discontinuation			2586
18113			Thrombocytopenia		discontinuation			2586
18114			Pulmonary edema		discontinuation			2589
18115			Cardiac arrest		discontinuation			2589
18116			Respiratory distress syndrome		discontinuation			2589
18117			Chest pain		discontinuation			2589
18118			Palpitations		discontinuation			2589
18119			Ventricular ectopic beats		discontinuation			2589
18120						No SAEs were observed		2590
18121	1 pts		Hyperreflexia		discontinuation	leads to discontinuation		2592
18122	1 pts		Hyperexcitability		discontinuation	leads to discontinuation		2592
18123	1 pts		Agitation		discontinuation	leads to discontinuation		2592
18124	1 pts		Weakness		discontinuation	leads to discontinuation		2592
18125	50		Headache					2593
18126	32		Dizziness					2593
18127	14		Asthenia					2593
18128	10		Nausea					2593
18129	8		Bronchitis					2593
18130	8		Hypotension					2593
18131	4		Sinusitis					2593
18132	4		Ventricular tachycardia					2593
18133	4		Hyperglycemia					2593
18134	4		Rhinitis					2593
18135	4		Paresthesia					2593
18136	4		Vomiting					2593
18137	3		Amblyopia					2593
18138	3		Hyperlipidemia					2593
18139	2		Tachycardia					2593
18140	0.6		Chest pain		discontinuation			2594
18141	0.6		Heart arrest		discontinuation			2594
18142	0.6		Heart failure		discontinuation			2594
18143	0.6		Hypotension		discontinuation			2594
18144	0.6		Failure kidney		discontinuation			2594
18145	0.4		Infection		discontinuation			2594
18146	0.4		Ventricular fibrillation		discontinuation			2594
18147	0.4		Dizziness		discontinuation			2594
18148	0.2		Arrhythmia		discontinuation			2594
18149	0.2		Cerebrovascular accident		discontinuation			2594
18150	0.2		Syncope		discontinuation			2594
18151	0.2		Gastroenteritis		discontinuation			2594
18152	0.2		Myasthenia		discontinuation			2594
18153	0.2		Dyspnea		discontinuation			2594
18154	0.2		Edema lung		discontinuation			2594
18155	0.2		Angioedema		discontinuation			2594
18156	0.2		Breast carcinoma		discontinuation			2594
18157	0.2		Uremia		discontinuation			2594
18158	6.4		Chest pain					2595
18159	3.1		Heart failure					2595
18160	2.7		Ventricular tachycardia					2595
18161	2.3		Pneumonia					2595
18162	2.1		Syncope					2595
18163	1.9		Dyspnea					2595
18164	1.7		Arrhythmia					2595
18165	1.5		Hypotension					2595
18166	1.4		Heart arrest					2595
18167	1.4		Cerebrovascular accident					2595
18168	1.4		Dizziness					2595
18169	1.2		Cellulite					2595
18170	1		Cerebral ischemia					2595
18171	1		Coronary artery disease					2595
18172	1		Anemia					2595
18173	1		Bronchitis					2595
18174	1		Dehydration					2595
18175	1		Angina pectoris					2595
18176	1		Hyperglycemia					2595
18177	1		Hypoglycemia					2595
18178	1		Infection					2595
18179	1		Acute kidney failure					2595
18180	0.8		Neoplasm					2595
18181	0.8		Gout					2595
18182	0.8		Atrial fibrillation					2595
18183	0.8		Gastrointestinal hemorrhage					2595
18184	0.8		Failure kidney					2595
18185	0.8		Myocardial infarct					2595
18186	0.6		Sepsis					2595
18187	0.6		Asthma					2595
18188	0.6		Accidental injury					2595
18189	0.6		Cholecystitis					2595
18190	0.6		Cholelithiasis					2595
18191	0.6		Supraventricular tachycardia					2595
18192	0.4		Esophagitis					2595
18193	0.4		Edema lung					2595
18194	0.4		Headache					2595
18195	0.4		Osteomyelitis					2595
18196	0.4		Peripheral vascular disease					2595
18197	0.4		Bradycardia					2595
18198	0.4		Digitalis intoxication					2595
18199	0.4		Gastroenteritis					2595
18200	0.4		Hyperkalemia					2595
18201	0.4		Hemorrhage subarachnoid					2595
18202	0.4		Deep thrombophlebitis					2595
18203	0.4		Angioedema					2595
18204	0.4		Ascites					2595
18205	0.4		Infection					2595
18206	0.4		Fibrillation ventricular					2595
18207	0.2		Anomaly vascular					2595
18208	0.2		Coagulation disorder					2595
18209	0.2		Creatinine increased					2595
18210	0.2		Hyponatremia					2595
18211	0.2		Diarrhea					2595
18212	0.2		Failure liver					2595
18213	0.2		Neoplasm of the prostate					2595
18214	0.2		Myasthenia					2595
18215	0.2		Palpitations					2595
18216	0.2		Urinary tract infection					2595
18217	0.2		Dyspepsia					2595
18218	0.2		Function kidney abnormal					2595
18219	0.2		Anemia iron deficiency					2595
18220	0.2		Alkalosis					2595
18221	0.2		Arrhythmia nodal					2595
18222	0.2		Arthralgia					2595
18223	0.2		Breast carcinoma					2595
18224	0.2		Hypokalemia					2595
18225	0.2		Ketosis					2595
18226	0.2		Cerebral infarct					2595
18227	0.2		Emotional lability					2595
18228	0.2		Edema face					2595
18229	0.2		Gastritis hemorrhagic					2595
18230	0.2		Abnormal gait					2595
18231	0.2		Hematemesis					2595
18232	0.2		Herpes zoster					2595
18233	0.2		Uremia					2595
18234	0.2		Leucopenia					2595
18235	0.2		Thrombocytopenia					2595
18236	0.2		Neurolysis					2595
18237	0.2		Ophthalmitis					2595
18238	0.2		Disorder parathyroid					2595
18239	0.2		Disorder respiratory system					2595
18240	0.2		Skin ulcer					2595
18241	0.2		Abnormal thinking					2595
18242	0.2		Vascular disorder NOS					2595
18243	0.2		Wrist drop					2595
18244	0.2		Gastritis					2595
18245	2.3		Asthenia		discontinuation			2596
18246	7.4		Headache		discontinuation			2596
18247	3.7		Dizziness		discontinuation			2596
18248	0.8		Pain		discontinuation			2596
18249	1.5		Chest pain		discontinuation			2596
18250	1.5		Nausea		discontinuation			2596
18251	1.4		Hypotension		discontinuation			2596
18252	0.4		Abdominal pain		discontinuation			2596
18253	0.4		Chills		discontinuation			2596
18254	0.4		Failure kidney		discontinuation			2596
18255	0.4		Malaise		discontinuation			2596
18256	0.6		Heart arrest		discontinuation			2596
18257	0.4		Confusion		discontinuation			2596
18258	0.4		Diarrhea		discontinuation			2596
18259	0.2		Gastroenteritis		discontinuation			2596
18260	0.2		Back pain		discontinuation			2596
18261	0.2		Acute kidney failure		discontinuation			2596
18262	0.2		Myasthenia		discontinuation			2596
18263	0.2		Nervousness		discontinuation			2596
18264	0.2		Pruritus		discontinuation			2596
18265	0.6		Heart failure		discontinuation			2596
18266	0.2		Dyspepsia		discontinuation			2596
18267	0.2		Cerebrovascular accident		discontinuation			2596
18268	0.2		Constipation		discontinuation			2596
18269	0.2		Dyspnea		discontinuation			2596
18270	0.6		Vomiting		discontinuation			2596
18271	0.6		Paresthesia		discontinuation			2596
18272	0.4		Function kidney abnormal		discontinuation			2596
18273	0.4		Palpitations		discontinuation			2596
18274	0.4		Syncope		discontinuation			2596
18275	0.6		Rash		discontinuation			2596
18276	0.4		Rectal hemorrhage		discontinuation			2596
18277	0.4		Ventricular fibrillation		discontinuation			2596
18278	0.2		Angioedema		discontinuation			2596
18279	0.2		Amblyopia		discontinuation			2596
18280	0.2		Anorexia		discontinuation			2596
18281	0.2		Neck pain		discontinuation			2596
18282	0.2		Carcinoma		discontinuation			2596
18283	0.2		Breast carcinoma		discontinuation			2596
18284	0.2		Dehydration		discontinuation			2596
18285	0.2		Edema face		discontinuation			2596
18286	0.2		Edema peripheral		discontinuation			2596
18287	0.2		Edema lung		discontinuation			2596
18288	0.2		Fever		discontinuation			2596
18289	0.2		Hyperglycemia		discontinuation			2596
18290	0.2		Hypertension		discontinuation			2596
18291	0.2		Infection		discontinuation			2596
18292	0.2		Fungal infection		discontinuation			2596
18293	0.2		Impotence		discontinuation			2596
18294	0.2		Ketosis		discontinuation			2596
18295	0.2		Breast neoplasm		discontinuation			2596
18296	0.2		Lab test abnormal		discontinuation			2596
18297	0.2		Myalgia		discontinuation			2596
18298	0.2		Photophobia		discontinuation			2596
18299	0.2		Pleural effusion		discontinuation			2596
18300	0.2		Somnolence		discontinuation			2596
18301	0.2		Sweaty		discontinuation			2596
18302	0.2		Vasodilation		discontinuation			2596
18303	0.2		Weight decrease		discontinuation			2596
18304	0.2		Uremia		discontinuation			2596
18305	6 pts		Headache		discontinuation	leads to discontinuation		2598
18306	57		Headache					2597
18307	5		Headache		discontinuation	leads to discontinuation		2599
18308	2		Rash		discontinuation	leads to discontinuation		2600
18309	2		Nausea		discontinuation	leads to discontinuation		2599
18310	2		Pruritus		discontinuation	leads to discontinuation		2600
18311	3 pts		Flushing	below serious				2601
18312	4 pts		Headache	below serious				2601
18313	3 pts		Vomiting	below serious				2601
18314	2 pts		Paraesthesia upper limb	below serious				2601
18315	2 pts		Rash	below serious				2601
18316	2 pts		Bug bite	below serious				2601
18317	2 pts		Abdominal pain	below serious				2601
18318	4 pts		Swelling of limbs	below serious				2601
18319	2 pts		Urine colour abnormal	below serious				2601
18320	2 pts		Lightheadedness	below serious				2601
18321	2 pts		Constipation	below serious				2601
18322	3 pts		Osteoarthritis	serious				2602
18323	2 pts		Colon cancer	serious				2602
18324	2 pts		Prostate cancer	serious				2602
18325	2 pts		Sepsis	serious				2602
18326	2 pts		Stress fracture	serious				2602
18327	2 pts		Transient ischaemic attack	serious				2602
18328	1 pts		Appendiceal mucocoele	serious				2602
18329	1 pts		Bradycardia	serious				2602
18330	1 pts		Chest discomfort	serious				2602
18331	1 pts		Choroid melanoma	serious				2602
18332	1 pts		Dyspnoea	serious				2602
18333	1 pts		Gastroenteritis viral	serious				2602
18334	1 pts		Intraventricular haemorrhage	serious				2602
18335	1 pts		Ischaemic stroke	serious				2602
18336	1 pts		Nephrolithiasis	serious				2602
18337	1 pts		Pancreatic neoplasm	serious				2602
18338	1 pts		Aspiration pneumonia	serious				2602
18339	1 pts		Small intestinal obstruction	serious				2602
18340	1 pts		Spina bifida	serious				2602
18341	1 pts		Spinal fracture	serious				2602
18342	1 pts		Throat cancer	serious				2602
18343	1 pts		Urinary retention	serious				2602
18344	1 pts		Urinary tract infection	serious				2602
18345	42 pts		Dizziness	below serious				2602
18346	28 pts		Headache	below serious				2602
18347	31 pts		Oedema	below serious				2602
18348	23 pts		Nasopharyngitis	below serious				2602
18349	23 pts		Fatigue	below serious				2602
18350	23 pts		Constipation	below serious				2602
18351	19 pts		Insomnia	below serious				2602
18352	20 pts		Anxiety	below serious				2602
18353	20 pts		Depression	below serious				2602
18354	17 pts		Back pain	below serious				2602
18355	12 pts		Upper respiratory tract infection	below serious				2602
18356	11 pts		Pain in extremity	below serious				2602
18357	12 pts		Joint swelling	below serious				2602
18358	10 pts		Somnolence	below serious				2602
18359	8 pts		Hypoaesthesia	below serious				2602
18360	8 pts		Musculoskeletal stiffness	below serious				2602
18361	9 pts		Sleep disorder	below serious				2602
18362	7 pts		Diarrhoea	below serious				2602
18363	6 pts		Basal cell carcinoma	below serious				2602
18364	7 pts		Dysphagia	below serious				2602
18365	7 pts		Osteoarthritis	below serious				2602
18366	7 pts		Rapid eye movements sleep abnormal	below serious				2602
18367	9 pts		Dyspnoea	below serious				2602
18368	8 pts		Dystonia	below serious				2602
18369	7 pts		Tendonitis	below serious				2602
18370	5 pts		Nephrolithiasis	below serious				2602
18371	6 pts		Chest pain	below serious				2602
18372	6 pts		Abdominal pain upper	below serious				2602
18373	7 pts		Micturition urgency	below serious				2602
18374	5 pts		Diverticulitis	below serious				2602
18375	5 pts		Paraesthesia	below serious				2602
18376	7 pts		Vision blurred	below serious				2602
18377	6 pts		Blood creatine phosphokinase increased	below serious				2602
18378	7 pts		Blood creatinine increased	below serious				2602
18379	7 pts		Erectile dysfunction	below serious				2602
18380	6 pts		Muscle strain	below serious				2602
18381	4 pts		Sciatica	below serious				2602
18382	5 pts		Benign prostatic hyperplasia	below serious				2602
18383	6 pts		Palpitations	below serious				2602
18384	7 pts		Flushing	below serious				2602
18385	5 pts		Pain	below serious				2602
18386	3 pts		Abdominal pain	below serious				2602
18387	5 pts		Hot flush	below serious				2602
18388	4 pts		Tachycardia	below serious				2602
18389	4 pts		Syncope	below serious				2602
18390	4 pts		Tooth abscess	below serious				2602
18391	4 pts		Vitamin D deficiency	below serious				2602
18392	3 pts		Respiratory tract infection	below serious				2602
18393	5 pts		Rotator cuff syndrome	below serious				2602
18394	3 pts		Suicidal ideation	below serious				2602
18395	3 pts		Abnormal dreams	below serious				2602
18396	3 pts		Atrioventricular block first degree	below serious				2602
18397	5 pts		Confusional state	below serious				2602
18398	3 pts		Eye infection	below serious				2602
18399	3 pts		Lower respiratory tract infection	below serious				2602
18400	3 pts		Osteoporosis	below serious				2602
18401	3 pts		Rhinorrhoea	below serious				2602
18402	3 pts		Urinary incontinence	below serious				2602
18403	3 pts		Dry mouth	below serious				2602
18404	3 pts		Ear discomfort	below serious				2602
18405	3 pts		Muscular weakness	below serious				2602
18406	3 pts		Nasal congestion	below serious				2602
18407	3 pts		Salivary hypersecretion	below serious				2602
18408			Lethargy					2606
18409			Sinus tachycardia					2606
18410			Hypotension					2606
18411			Flushing					2607
18412			Tachycardia					2607
18413			Electrocardiogram ST segment depression					2607
18414			Hypotension					2607
18415						No adverse reactions were reported		2603
18416			Drop of blood pressure		discontinuation			2605
18417			Leg edema		discontinuation			2605
18418			Dizziness		discontinuation			2605
18419						No adverse reactions leading to discontinuation were reported		2604
18420	1 pts		Lumbar spinal stenosis	serious				2611
18421	3 pts		Acoustic stimulation tests abnormal	below serious				2611
18422	2 pts		Alanine aminotransferase increased	below serious				2611
18423	1 pts		Aspartate aminotransferase increased	below serious				2611
18424	2 pts		Constipation	below serious				2611
18425	3 pts		Cough	below serious				2611
18426	8 pts		Headache	below serious				2611
18427	2 pts		Nasal congestion	below serious				2611
18428	4 pts		Pain in extremity	below serious				2611
18429	3 pts		Upper respiratory tract infection	below serious				2611
18430						No AEs were reported		2610
18431						No AEs were reported		2612
18432	11		Nausea					2609
18433	11		Diarrhea					2609
18434	7		Vomiting					2609
18435	6		Abdominal pain					2609
18436	2		Constipation					2609
18437	7		Fever					2609
18438	3		Chest pain					2609
18439	2		Pain					2609
18440	2		Fatigue					2609
18441	4		Coughing					2609
18442	2		Dyspnea					2609
18443	2		Pneumonia					2609
18444	2		Sinusitis					2609
18445	2		Sputum increased					2609
18446	4		Rash					2609
18447	3		Sweating increased					2609
18448	2		Skin and subcutaneous tissue disorders					2609
18449	4		Headache					2609
18450	2		Dizziness					2609
18451	2		Pneumocystis carinii infection					2609
18452	2		Depression					2608
18453	30 pts		Mental deterioration	below serious				2619
18454	1 pts		Pericardial effusion	serious				2623
18455	1 pts		Ventricular tachycardia	serious				2623
18456	3 pts		Atrial fibrillation	below serious				2623
18457	1 pts		Delirium	below serious				2623
18458	1 pts		Saliva secretion excessive	below serious				2623
18459	8 pts		Feeling strange	below serious				2620
18460	7 pts		Memory loss	below serious				2620
18461	6 pts		Weakness	below serious				2620
18462	5 pts		Delayed orgasm	below serious				2620
18463	4 pts		Loss of libido	below serious				2620
18464	4 pts		Poor concentration	below serious				2620
18465	4 pts		Sexual arousal decreased	below serious				2620
18466	3 pts		Dizziness	below serious				2620
18467	3 pts		Dizziness on standing up	below serious				2620
18468	3 pts		Unsteadiness	below serious				2620
18469	3 pts		Word finding difficulty	below serious				2620
18470	2 pts		Paresthesia	below serious				2620
18471	2 pts		Numbness	below serious				2620
18472	2 pts		Taste altered	below serious				2620
18473	1 pts		Blurred vision	below serious				2620
18474	1 pts		Decreased appetite	below serious				2620
18475	1 pts		Irritable	below serious				2620
18476	2 pts		Headache	below serious				2621
18477	1 pts		Chest pain	below serious				2621
18478	1 pts		Feeling high	below serious				2621
18479	1 pts		Feeling floating	below serious				2621
18480	3 pts		Headache	below serious				2622
18481	3 pts		Nausea	below serious				2622
18482	1 pts		Vomiting	below serious				2622
18483	2 pts		Blood pressure increased	below serious				2622
18484	1 pts		Insomnia	below serious				2622
18485	1 pts		Poor quality sleep	below serious				2622
18486	1 pts		Tachycardia	below serious				2622
18487	1 pts		Dissociation	below serious				2622
18488	1 pts		Dizziness	below serious				2622
18489	1 pts		Hypertension	below serious				2622
18490	1 pts		Upper respiratory tract infection	below serious				2622
18491			Dissociation			WARNING		2618
18492	0.9		Depression		discontinuation	S(+) enantiomer of ketamine		2614
18493	0.9		Bursitis		discontinuation	S(+) enantiomer of ketamine		2617
18494	0.9		Disturbance in attention		discontinuation	S(+) enantiomer of ketamine		2617
18495	0.9		Dizziness		discontinuation	S(+) enantiomer of ketamine		2617
18496	0.9		Mania		discontinuation	S(+) enantiomer of ketamine		2617
18497	1.7		Nausea		discontinuation	S(+) enantiomer of ketamine		2617
18498	0.9		Panic attack		discontinuation	S(+) enantiomer of ketamine		2617
18499	0.9		Anxiety		discontinuation	S(+) enantiomer of ketamine		2616
18500	0.9		Bronchitis		discontinuation	S(+) enantiomer of ketamine		2616
18501	1.7		Depression		discontinuation	S(+) enantiomer of ketamine		2616
18502	0.9		Drug intolerance		discontinuation	S(+) enantiomer of ketamine		2616
18503	0.9		Insomnia		discontinuation	S(+) enantiomer of ketamine		2616
18504	0.9		Panic attack		discontinuation	S(+) enantiomer of ketamine		2616
18505	1.4		Anxiety		discontinuation	S(+) enantiomer of ketamine		2615
18506	2.8		Blood pressure increased		discontinuation	S(+) enantiomer of ketamine		2615
18507	1.4		Hip fracture		discontinuation	S(+) enantiomer of ketamine		2615
18508			Dizziness			S(+) enantiomer of ketamine		2613
18509			Hyperhidrosis			S(+) enantiomer of ketamine		2613
18510			Somnolence			S(+) enantiomer of ketamine		2613
18511			Hypoaesthesia			S(+) enantiomer of ketamine		2613
18512			Feeling abnormal			S(+) enantiomer of ketamine		2613
18513			Nausea			S(+) enantiomer of ketamine		2613
18514			Vomiting			S(+) enantiomer of ketamine		2613
18515	1 pts		Irritability		discontinuation	leads to discontinuation		2625
18516	1 pts		Drowsiness		discontinuation	leads to discontinuation		2625
18517	1 pts		Fragility fracture		discontinuation	leads to discontinuation		2625
18518	1 pts		Encephalopathy toxic		discontinuation	leads to discontinuation		2625
18519						No information on AE is provided		2624
18520	1 pts		Allergic contact dermatitis		discontinuation	leads to discontinuation		2627
18521	1 pts		Abdominal pain	mild				2626
18522	1 pts		Headache					2626
18523			Acute renal failure		discontinuation			2629
18524			Orthostatic hypotension		discontinuation			2628
18525	rare		Hepatocellular injury	severe		WARNINGS		2631
18526			Congestive heart failure			WARNINGS		2631
18527			Cardiac failure		discontinuation	WARNINGS		2631
18528						No adverse reactions leading to discontinuation were reported		2630
18529						No adverse reactions leading to discontinuation were reported		2632
18530	3 pts		Headache	below serious				2636
18531	2 pts		Papular skin eruption	below serious				2636
18532	2 pts		Nausea	below serious				2636
18533	1 pts		Cancer	serious				2637
18534	1 pts		Urinary tract infection	serious				2637
18535	1 pts		Bleeding vaginal	serious				2637
18536	1 pts		Gastroenteritis	serious				2637
18537	1 pts		Pneumonia	serious				2637
18538	1 pts		Influenza	serious				2637
18539	1 pts		Biopsy kidney	serious				2637
18540	1 pts		Fall	below serious				2637
18541	2 pts		Dizziness	below serious				2637
18542	1 pts		Keratoconus	below serious				2637
18543	1 pts		Hypotension	below serious				2637
18544	1 pts		Hypertension	below serious				2637
18545	1 pts		Hypoglycemia	below serious				2637
18546			Ataxia			Overdosage		2633
18547			Rotational nystagmus			Overdosage		2633
18548			Tonic-clonic seizures			Overdosage		2635
18549			Tremor limb			Overdosage		2635
18550			Muscle weakness			Overdosage		2635
18551			Ataxia			Overdosage		2635
18552			Hypertonia			Overdosage		2635
18553	3		Dizziness		discontinuation			2634
18554	3		Nausea		discontinuation			2634
18555	2		Headache		discontinuation			2634
18556	2		Coordination abnormal		discontinuation			2634
18557	2		Nystagmus		discontinuation			2634
18558	2		Asthenia		discontinuation			2634
18559	<1		Vertigo		discontinuation			2634
18560	<1		Rash		discontinuation			2634
18561	<1		Intention tremor		discontinuation			2634
18562	<1		Tremor		discontinuation			2634
18563	<1		Gait disturbance		discontinuation			2634
18564	<1		Pancreatitis		discontinuation			2634
18565	<1		Stomach discomfort		discontinuation			2634
18566	<1		Anxiety		discontinuation			2634
18567	<1		Depression		discontinuation			2634
18568	<1		Psychomotor retardation		discontinuation			2634
18569	<1		Diplopia		discontinuation			2634
18570	<1		Hot flush		discontinuation			2634
18571	3 pts		Upper respiratory tract infection	below serious				2644
18572	2 pts		Viral upper respiratory tract infection	below serious				2644
18573	1 pts		Urinary tract infection	below serious				2644
18574	1 pts		Diarrhoea	below serious				2644
18575	1 pts		Gastric polyps	below serious				2644
18576	1 pts		Nausea	below serious				2644
18577	3 pts		Dizziness	below serious				2644
18578	1 pts		Laryngeal discomfort	below serious				2644
18579	1 pts		Oropharyngeal pain	below serious				2644
18580	1 pts		Alanine aminotransferase increased	below serious				2644
18581	1 pts		Blood urea increased	below serious				2644
18582	1 pts		Nephrolithiasis	below serious				2644
18583	1 pts		Haematuria	below serious				2644
18584	1 pts		Ventricular extrasystoles	below serious				2644
18585	1 pts		Dry eye	below serious				2644
18586	1 pts		Hyperuricaemia	below serious				2644
18587	1 pts		Back pain	below serious				2644
18588	1.6		Dizziness		discontinuation			2643
18589	1.6		Vomiting		discontinuation			2643
18590	2.5		Diarrhoea		discontinuation	diarrhoea due to ulcerative colitis		2640
18591						No AEs were observed		2642
18592						Overdosage		2641
18593	1.5		Rash		discontinuation			2639
18594						No information on AE is provided		2638
18595			Hyperemia	grade 2				2646
18596	50		Hyperemia					2645
18597	50		Ocular discomfort	grade 1				2645
18598	0.2		Meibomianitis		discontinuation			2649
18599	0.2		Iritis		discontinuation			2649
18600	0.2		Cystoid macular edema		discontinuation			2649
18601	0.2		Ocular hyperemia		discontinuation	with eyelid rash, eye pain, eyelid erythema, ocular discharge		2649
18602			Asthenopia		discontinuation			2648
18603			Eye irritation		discontinuation			2648
18604			Eye pain		discontinuation			2648
18605			Headache		discontinuation			2648
18606	0.6		Visual field defect		discontinuation	with increased depression		2647
18607	0.6		Conjunctivitis		discontinuation			2647
18608	0.6		Eye pain		discontinuation			2647
18609	0.6		Ocular hyperemia		discontinuation			2647
18610	2 pts		Joint sprain	serious				2654
18611	1 pts		Foot fracture	serious				2654
18612	1 pts		Thrombosis	serious				2654
18613	1 pts		Blood human chorionic gonadotropin positive	serious				2654
18614	1 pts		Blood potassium decreased	serious				2654
18615	1 pts		Pregnancy test false positive	serious				2654
18616	1 pts		Sick sinus syndrome	serious				2654
18617	2 pts		Pregnancy NOS	serious				2654
18618	1 pts		Abortion spontaneous NOS	serious				2654
18619	1 pts		Pain NOS	serious				2654
18620	1 pts		Arthritis NOS	serious				2654
18621	1 pts		Angioneurotic edema	serious				2654
18622	24 pts		Rash NOS	below serious				2654
18623	8 pts		Pruritus	below serious				2654
18624	6 pts		Dry skin	below serious				2654
18625	11 pts		Diarrhoea NOS	below serious				2654
18626	8 pts		Constipation	below serious				2654
18627	5 pts		Vomiting NOS	below serious				2654
18628	9 pts		Dizziness	below serious				2654
18629	6 pts		Pyrexia	below serious				2654
18630	6 pts		Nasopharyngitis	below serious				2654
18631	6 pts		Pharyngitis	below serious				2654
18632	5 pts		Sinusitis NOS	below serious				2654
18633	5 pts		Alanine aminotransferase increased	below serious				2654
18634	5 pts		Cramp muscle	below serious				2654
18635	7 pts		Insomnia	below serious				2654
18636	5 pts		Pyrexia	serious				2658
18637	1 pts		Generalised oedema	serious				2658
18638	1 pts		Non-cardiac chest pain	serious				2658
18639	5 pts		Pneumonia	serious				2658
18640	1 pts		Erysipelas	serious				2658
18641	1 pts		Gastroenteritis	serious				2658
18642	1 pts		Infection	serious				2658
18643	1 pts		Lower respiratory tract infection	serious				2658
18644	1 pts		Respiratory tract infection	serious				2658
18645	1 pts		Staphylococcal sepsis	serious				2658
18646	3 pts		Urinary tract infection	serious				2658
18647	1 pts		Urosepsis	serious				2658
18648	1 pts		Chronic obstructive pulmonary disease	serious				2658
18649	1 pts		Hypoxia	serious				2658
18650	1 pts		Lung disorder	serious				2658
18651	1 pts		Aspiration pneumonia	serious				2658
18652	3 pts		Pulmonary embolism	serious				2658
18653	1 pts		Respiratory failure	serious				2658
18654	8 pts		Acute myeloid leukaemia	serious				2658
18655	1 pts		Leukaemia	serious				2658
18656	1 pts		Lung cancer metastatic	serious				2658
18657	1 pts		Myelodysplastic syndrome	serious				2658
18658	1 pts		Refractory anaemia with an excess of blasts	serious				2658
18659	1 pts		Anxiety disorder	serious				2658
18660	1 pts		Altered mood	serious				2658
18661	2 pts		Atrial fibrillation	serious				2658
18662	2 pts		Cardiac failure	serious				2658
18663	1 pts		Diarrhoea	serious				2658
18664	1 pts		Intussusception	serious				2658
18665	1 pts		Tooth disorder	serious				2658
18666	1 pts		Fall	serious				2658
18667	1 pts		Injury	serious				2658
18668	1 pts		Transfusion reaction	serious				2658
18669	1 pts		Diabetes mellitus inadequate control	serious				2658
18670	1 pts		Hyperglycaemia	serious				2658
18671	1 pts		Hypoglycaemia	serious				2658
18672	1 pts		Headache	serious				2658
18673	1 pts		Renal failure	serious				2658
18674	1 pts		Urinary incontinence	serious				2658
18675	1 pts		Phlebitis	serious				2658
18676	1 pts		Venous thrombosis	serious				2658
18677	4 pts		Anaemia	serious				2658
18678	2 pts		Febrile neutropenia	serious				2658
18679	5 pts		Neutropenia	serious				2658
18680	1 pts		Pancytopenia	serious				2658
18681	6 pts		Thrombocytopenia	serious				2658
18682	1 pts		International normalised ratio increased	serious				2658
18683	1 pts		Urine human chorionic gonadotropin abnormal	serious				2658
18684	1 pts		Fibromyalgia	serious				2658
18685	1 pts		Muscle spasms	serious				2658
18686	1 pts		Myalgia	serious				2658
18687	1 pts		Pyoderma gangrenosum	serious				2658
18688	1 pts		Cytogenetic abnormality	serious				2658
18689	32 pts		Diarrhoea	below serious				2658
18690	16 pts		Nausea	below serious				2658
18691	18 pts		Constipation	below serious				2658
18692	7 pts		Abdominal pain	below serious				2658
18693	8 pts		Vomiting	below serious				2658
18694	4 pts		Dry mouth	below serious				2658
18695	8 pts		Abdominal pain upper	below serious				2658
18696	4 pts		Dyspepsia	below serious				2658
18697	2 pts		Flatulence	below serious				2658
18698	17 pts		Fatigue	below serious				2658
18699	15 pts		Oedema peripheral	below serious				2658
18700	11 pts		Pyrexia	below serious				2658
18701	5 pts		Non-cardiac chest pain	below serious				2658
18702	5 pts		Influenza like illness	below serious				2658
18703	3 pts		Oedema	below serious				2658
18704	1 pts		Pain	below serious				2658
18705	55 pts		Neutropenia	below serious				2658
18706	10 pts		Anaemia	below serious				2658
18707	12 pts		Leukopenia	below serious				2658
18708	38 pts		Thrombocytopenia	below serious				2658
18709	15 pts		Nasopharyngitis	below serious				2658
18710	11 pts		Upper respiratory tract infection	below serious				2658
18711	6 pts		Urinary tract infection	below serious				2658
18712	7 pts		Bronchitis	below serious				2658
18713	2 pts		Cystitis	below serious				2658
18714	2 pts		Lower respiratory tract infection	below serious				2658
18715	9 pts		Respiratory tract infection	below serious				2658
18716	7 pts		Gastroenteritis	below serious				2658
18717	4 pts		Gastroenteritis viral	below serious				2658
18718	5 pts		Influenza	below serious				2658
18719	6 pts		Oral herpes	below serious				2658
18720	3 pts		Pharyngitis	below serious				2658
18721	4 pts		Rhinitis	below serious				2658
18722	12 pts		Headache	below serious				2658
18723	8 pts		Dizziness	below serious				2658
18724	8 pts		Paraesthesia	below serious				2658
18725	4 pts		Peripheral sensory neuropathy	below serious				2658
18726	12 pts		Muscle spasms	below serious				2658
18727	12 pts		Back pain	below serious				2658
18728	4 pts		Myalgia	below serious				2658
18729	6 pts		Arthralgia	below serious				2658
18730	5 pts		Pain in extremity	below serious				2658
18731	1 pts		Musculoskeletal chest pain	below serious				2658
18732	3 pts		Neck pain	below serious				2658
18733	8 pts		Decreased appetite	below serious				2658
18734	4 pts		Iron overload	below serious				2658
18735	4 pts		Hypoalbuminaemia	below serious				2658
18736	7 pts		Hypokalaemia	below serious				2658
18737	3 pts		Hypomagnesaemia	below serious				2658
18738	12 pts		Cough	below serious				2658
18739	12 pts		Dyspnoea	below serious				2658
18740	3 pts		Epistaxis	below serious				2658
18741	4 pts		Dyspnoea exertional	below serious				2658
18742	7 pts		Oropharyngeal pain	below serious				2658
18743	16 pts		Pruritus	below serious				2658
18744	10 pts		Dry skin	below serious				2658
18745	18 pts		Rash	below serious				2658
18746	2 pts		Hyperhidrosis	below serious				2658
18747	3 pts		Petechiae	below serious				2658
18748	6 pts		Insomnia	below serious				2658
18749	4 pts		Depression	below serious				2658
18750	3 pts		Anxiety	below serious				2658
18751	3 pts		Contusion	below serious				2658
18752	2 pts		Fall	below serious				2658
18753	2 pts		Wound	below serious				2658
18754	7 pts		Alanine aminotransferase increased	below serious				2658
18755	6 pts		Weight decreased	below serious				2658
18756	6 pts		Haematoma	below serious				2658
18757	7 pts		Hypertension	below serious				2658
18758	1 pts		Cataract	below serious				2658
18759	8 pts		Vertigo	below serious				2658
18760	5 pts		Musculoskeletal pain	below serious				2658
18761	1 pts		Fatigue	serious				2655
18762	2 pts		General physical health deterioration	serious				2655
18763	1 pts		Mucosal inflammation	serious				2655
18764	3 pts		Pneumonia	serious				2655
18765	1 pts		Anal abscess	serious				2655
18766	1 pts		Bacteraemia	serious				2655
18767	1 pts		Cellulitis	serious				2655
18768	1 pts		Erysipelas	serious				2655
18769	1 pts		Gastroenteritis	serious				2655
18770	1 pts		Pneumonia legionella	serious				2655
18771	1 pts		Pyelonephritis	serious				2655
18772	2 pts		Septic shock	serious				2655
18773	1 pts		Urinary tract infection	serious				2655
18774	1 pts		Epistaxis	serious				2655
18775	1 pts		Lung disorder	serious				2655
18776	2 pts		Pulmonary embolism	serious				2655
18777	8 pts		Acute myeloid leukaemia	serious				2655
18778	1 pts		Bladder cancer	serious				2655
18779	1 pts		Breast cancer	serious				2655
18780	1 pts		Colon cancer	serious				2655
18781	1 pts		Colorectal cancer	serious				2655
18782	1 pts		Histiocytosis haematophagic	serious				2655
18783	2 pts		Refractory anaemia with an excess of blasts	serious				2655
18784	1 pts		Confusional state	serious				2655
18785	1 pts		Delirium	serious				2655
18786	1 pts		Altered mood	serious				2655
18787	2 pts		Acute myocardial infarction	serious				2655
18788	1 pts		Cardiac failure	serious				2655
18789	1 pts		Myocardial infarction	serious				2655
18790	1 pts		Tachyarrhythmia	serious				2655
18791	1 pts		Abdominal pain	serious				2655
18792	1 pts		Abdominal pain upper	serious				2655
18793	1 pts		Colitis	serious				2655
18794	1 pts		Constipation	serious				2655
18795	3 pts		Diarrhoea	serious				2655
18796	1 pts		Intestinal obstruction	serious				2655
18797	1 pts		Femoral neck fracture	serious				2655
18798	1 pts		Humerus fracture	serious				2655
18799	1 pts		Spinal compression fracture	serious				2655
18800	1 pts		Subdural haematoma	serious				2655
18801	1 pts		Synovial rupture	serious				2655
18802	1 pts		Hyperglycaemia	serious				2655
18803	1 pts		Cerebral haemorrhage	serious				2655
18804	1 pts		Cerebrovascular accident	serious				2655
18805	1 pts		Coma	serious				2655
18806	1 pts		Headache	serious				2655
18807	1 pts		Colic renal	serious				2655
18808	1 pts		Renal failure	serious				2655
18809	1 pts		Stress urinary incontinence	serious				2655
18810	4 pts		Deep vein thrombosis	serious				2655
18811	1 pts		Arterial occlusive disease	serious				2655
18812	1 pts		Hypotension	serious				2655
18813	1 pts		Orthostatic hypotension	serious				2655
18814	1 pts		Anaemia	serious				2655
18815	1 pts		Autoimmune thrombocytopenia	serious				2655
18816	1 pts		Bone marrow failure	serious				2655
18817	2 pts		Febrile neutropenia	serious				2655
18818	1 pts		Haemolysis	serious				2655
18819	5 pts		Neutropenia	serious				2655
18820	1 pts		Pancytopenia	serious				2655
18821	1 pts		Splenomegaly	serious				2655
18822	3 pts		Thrombocytopenia	serious				2655
18823	1 pts		Arthritis	serious				2655
18824	2 pts		Back pain	serious				2655
18825	1 pts		Joint range of motion decreased	serious				2655
18826	1 pts		Musculoskeletal pain	serious				2655
18827	1 pts		Skin ulcer	serious				2655
18828	1 pts		Urticaria	serious				2655
18829	37 pts		Diarrhoea	below serious				2655
18830	21 pts		Nausea	below serious				2655
18831	19 pts		Constipation	below serious				2655
18832	14 pts		Abdominal pain	below serious				2655
18833	9 pts		Vomiting	below serious				2655
18834	5 pts		Dry mouth	below serious				2655
18835	8 pts		Abdominal pain upper	below serious				2655
18836	5 pts		Dyspepsia	below serious				2655
18837	1 pts		Flatulence	below serious				2655
18838	17 pts		Fatigue	below serious				2655
18839	13 pts		Oedema peripheral	below serious				2655
18840	16 pts		Pyrexia	below serious				2655
18841	5 pts		Influenza like illness	below serious				2655
18842	4 pts		Oedema	below serious				2655
18843	4 pts		Pain	below serious				2655
18844	57 pts		Neutropenia	below serious				2655
18845	8 pts		Leukopenia	below serious				2655
18846	36 pts		Thrombocytopenia	below serious				2655
18847	16 pts		Nasopharyngitis	below serious				2655
18848	12 pts		Upper respiratory tract infection	below serious				2655
18849	12 pts		Urinary tract infection	below serious				2655
18850	14 pts		Bronchitis	below serious				2655
18851	4 pts		Cystitis	below serious				2655
18852	5 pts		Lower respiratory tract infection	below serious				2655
18853	3 pts		Respiratory tract infection	below serious				2655
18854	6 pts		Sinusitis	below serious				2655
18855	6 pts		Gastroenteritis	below serious				2655
18856	5 pts		Influenza	below serious				2655
18857	4 pts		Pharyngitis	below serious				2655
18858	3 pts		Rhinitis	below serious				2655
18859	14 pts		Headache	below serious				2655
18860	10 pts		Dizziness	below serious				2655
18861	4 pts		Sciatica	below serious				2655
18862	4 pts		Balance disorder	below serious				2655
18863	1 pts		Peripheral sensory neuropathy	below serious				2655
18864	15 pts		Muscle spasms	below serious				2655
18865	8 pts		Back pain	below serious				2655
18866	6 pts		Myalgia	below serious				2655
18867	5 pts		Arthralgia	below serious				2655
18868	10 pts		Pain in extremity	below serious				2655
18869	5 pts		Musculoskeletal chest pain	below serious				2655
18870	3 pts		Neck pain	below serious				2655
18871	8 pts		Decreased appetite	below serious				2655
18872	5 pts		Iron overload	below serious				2655
18873	1 pts		Hypoalbuminaemia	below serious				2655
18874	3 pts		Hypokalaemia	below serious				2655
18875	3 pts		Hypomagnesaemia	below serious				2655
18876	10 pts		Cough	below serious				2655
18877	9 pts		Dyspnoea	below serious				2655
18878	4 pts		Epistaxis	below serious				2655
18879	3 pts		Dyspnoea exertional	below serious				2655
18880	6 pts		Oropharyngeal pain	below serious				2655
18881	20 pts		Pruritus	below serious				2655
18882	10 pts		Dry skin	below serious				2655
18883	12 pts		Rash	below serious				2655
18884	4 pts		Alopecia	below serious				2655
18885	4 pts		Hyperhidrosis	below serious				2655
18886	4 pts		Petechiae	below serious				2655
18887	9 pts		Insomnia	below serious				2655
18888	5 pts		Anxiety	below serious				2655
18889	4 pts		Contusion	below serious				2655
18890	4 pts		Fall	below serious				2655
18891	1 pts		Joint sprain	below serious				2655
18892	4 pts		Wound	below serious				2655
18893	5 pts		Alanine aminotransferase increased	below serious				2655
18894	5 pts		Weight decreased	below serious				2655
18895	6 pts		Haematoma	below serious				2655
18896	4 pts		Phlebitis	below serious				2655
18897	9 pts		Hypertension	below serious				2655
18898	5 pts		Cataract	below serious				2655
18899	5 pts		Conjunctivitis	below serious				2655
18900	3 pts		Dysuria	below serious				2655
18901	3 pts		Vertigo	below serious				2655
18902	11 pts		Musculoskeletal pain	below serious				2655
18903	1 pts		Squamous cell carcinoma	serious				2656
18904	1 pts		Herpes zoster	below serious				2656
18905	1 pts		Herpes zoster ophthalmic	below serious				2656
18906	1 pts		Viral rash	below serious				2656
18907	1 pts		Thrombocytopenia	below serious				2656
18908	1 pts		Neutropenia	below serious				2656
18909	1 pts		Constipation	below serious				2656
18910	1 pts		Abdominal pain upper	below serious				2656
18911	1 pts		Diarrhoea	below serious				2656
18912	1 pts		Dry mouth	below serious				2656
18913	1 pts		Flatulence	below serious				2656
18914	1 pts		Stomatitis	below serious				2656
18915	1 pts		Chills	below serious				2656
18916	1 pts		Oedema peripheral	below serious				2656
18917	1 pts		Dysgeusia	below serious				2656
18918	1 pts		Peripheral sensory neuropathy	below serious				2656
18919	1 pts		Eczema	below serious				2656
18920	1 pts		Rash	below serious				2656
18921	1 pts		Conjunctivitis	below serious				2656
18922	1 pts		Muscle spasms	below serious				2656
18923	1 pts		Neck pain	below serious				2656
18924	1 pts		Basal cell carcinoma	below serious				2656
18925	1 pts		Malignant melanoma	below serious				2656
18926	1 pts		Libido decreased	below serious				2656
18927	1 pts		Erectile dysfunction	below serious				2656
18928	1 pts		Bleeding	serious				2657
18929	1 pts		Ischemic colitis	serious				2657
18930						impossible to link AEs with the definite dose: When considering only patients who received at least 1 dose of lenalidomide, 15 of 26 patients (58%) experienced grade 3 to 4 hematologic toxicity, with 5 (19%) experiencing grade4 hematologic toxicity. Half of all patients experienced grade 3 neutropenia. The most frequent nonhematologic toxicities (any grade) were elevated transaminases (39%), fatigue (35%), hypokalemia (31%), infection (31%), and rash (27%). The only grade 3 nonhematologic toxicity seen in more than 1 patient was hypokalemia		2653
18931			Birth defects	serious		WARNING		2650
18932			Neutropenia			WARNING		2652
18933			Thrombocytopenia			WARNING		2652
18934			Thrombosis venous deep			WARNING		2652
18935			Pulmonary embolism			WARNING		2652
18936	6.1		Thrombocytopenia		discontinuation	leads to discontinuation		2651
18937	3.5		Neutropenia		discontinuation	leads to discontinuation		2651
18938	2		Rash		discontinuation	leads to discontinuation		2651
18939	1.5		Nausea		discontinuation	leads to discontinuation		2651
18940	1.3		Diarrhea		discontinuation	leads to discontinuation		2651
18941	1		Fatigue		discontinuation	leads to discontinuation		2651
18942	1		Anaemia NOS		discontinuation	leads to discontinuation		2651
18943	1		Abdominal distension		discontinuation	leads to discontinuation		2651
18944	0.8		Pyrexia		discontinuation	leads to discontinuation		2651
18945	0.8		Dyspnea		discontinuation	leads to discontinuation		2651
18946	0.5		Cough		discontinuation	leads to discontinuation		2651
18947	0.5		Abdominal pain NOS		discontinuation	leads to discontinuation		2651
18948	0.5		Face edema		discontinuation	leads to discontinuation		2651
18949	0.5		Pruritus		discontinuation	leads to discontinuation		2651
18950	0.5		Anemia hemolytic (NOS)		discontinuation	leads to discontinuation		2651
18951	1		Pneumonia NOS		discontinuation	leads to discontinuation		2651
18952	0.5		Arthralgia		discontinuation	leads to discontinuation		2651
18953	1 pts		Head pain	serious				2659
18954	1 pts		Urticaria	serious				2659
18955	1 pts		Pruritus	serious				2659
18956	1 pts		Arthritis	below serious				2659
18957	1 pts		Vaginitis	below serious				2659
18958	1 pts		Dizziness	below serious				2659
18959	1 pts		Weight gain	below serious				2659
18960	1 pts		Fatigue	below serious				2659
18961	1 pts		Hot flashes	below serious				2659
18962	1 pts		Thorax pain	below serious				2659
18963	1 pts		Shortness of breath	below serious				2659
18964	1 pts		Cataract	below serious				2660
18965	5 pts		Musculoskeletal pain	below serious				2660
18966	1 pts		Atrial tachycardia	below serious				2660
18967	1 pts		Wound complication	below serious				2660
18968	1 pts		Gallbladder necrosis	below serious				2660
18969	1 pts		Dizziness	below serious				2660
18970	1 pts		Nausea and vomiting	below serious				2660
18971	1 pts		Headache	below serious				2660
18972	1 pts		Skin infection	below serious				2660
18973	1 pts		Fatigue	serious				2661
18974	3 pts		Renal failure	serious				2661
18975	1 pts		Melena	serious				2661
18976	1 pts		Bleeding rectal	serious				2661
18977	1 pts		Liver failure	serious				2661
18978	4 pts		Sudden death	serious				2661
18979	1 pts		Edema	serious				2661
18980	1 pts		Supraventricular arrhythmias	serious				2661
18981	158 pts		Edema	below serious				2661
18982	157 pts		Hypertension	below serious				2661
18983	360 pts		Hot flashes	below serious				2661
18984	176 pts		Sweating	below serious				2661
18985	105 pts		Diarrhea	below serious				2661
18986	317 pts		Arthritis	below serious				2661
18987	203 pts		Hypercholesterolemia	below serious				2661
18988	145 pts		Dizziness	below serious				2661
18989	269 pts		Insomnia	below serious				2661
18990	152 pts		Depression	below serious				2661
18991	110 pts		Sensory neuropathy	below serious				2661
18992	51 pts		Abdominal pain	below serious				2661
18993	151 pts		Headache	below serious				2661
18994	513 pts		Arthralgia	below serious				2661
18995	268 pts		Myalgia	below serious				2661
18996	174 pts		Bone pain	below serious				2661
18997	102 pts		Dryness vaginal	below serious				2661
18998						OVERDOSAGE		2666
18999						AEs not reported		2662
19000						AEs not reported		2663
19001	5		Bilirubin abnormal	grade 3				2664
19002	3		Aspartate aminotransferase abnormal	grade 3				2664
19003	3		ALT increased	grade 3				2664
19004	6		Gamma-glutamyltransferase increased	grade 3				2664
19005			Hypercalcemia		discontinuation			2665
19006			Cerebrovascular accident		discontinuation			2665
19007	3		Bilirubin abnormal	grade 3				2665
19008	4		Aspartate aminotransferase abnormal	grade 3				2665
19009	1		ALT increased	grade 3				2665
19010	9		Gamma-glutamyltransferase increased	grade 3				2665
19011	1 pts		Pneumonia	serious				2673
19012	7 pts		Pyrexia	below serious				2673
19013	24 pts		Nasopharyngitis	below serious				2673
19014	7 pts		Platelet count decreased	below serious				2673
19015	10 pts		Protein urine present	below serious				2673
19016	44.7		Somnolence					2667
19017	13.2		Asthenia					2667
19018	13.2		Accidental injury					2667
19019	15.8		Infection					2667
19020	13.2		Nausea					2667
19021	10.5		Dizziness					2667
19022	10.5		Urinary tract infection					2667
19023			Blurred vision	grade 1		Overdosage		2672
19024			Ataxia	grade 1		Overdosage		2672
19025			Leucopenia	grade 1		Overdosage		2672
19026			Thrombocytopenia	grade 1		Overdosage		2672
19027	1		Ataxia		discontinuation			2670
19028	1		Convulsion		discontinuation			2670
19029	1		Depression		discontinuation			2670
19030	1		Hostility		discontinuation			2670
19031	1		Hyperkinesia		discontinuation			2670
19032	3		Asthenia				TRUE	2671
19033	1		Headache				TRUE	2671
19034	2		Agitation				TRUE	2671
19035	1		Ataxia				TRUE	2671
19036	2		Convulsion				TRUE	2671
19037	1		Depression				TRUE	2671
19038	1		Emotional lability				TRUE	2671
19039	7		Hostility				TRUE	2671
19040	2		Hyperkinesia				TRUE	2671
19041	1		Insomnia				TRUE	2671
19042	2		Personality disorder				TRUE	2671
19043	3		Somnolence				TRUE	2671
19044	2		Status epilepticus				TRUE	2671
19045	1		Abnormal thinking				TRUE	2671
19046	13.8		Asthenia					2669
19047	7.2		Infection					2669
19048	6.1		Somnolence					2669
19049	3.3		Headache					2669
19050	0.6		Rash				TRUE	2668
19051	1.2		Convulsion				TRUE	2668
19052	1 pts		Patent ductus arteriosus	serious				2678
19053	1 pts		Food poisoning	serious				2678
19054	1 pts		Vomiting	serious				2678
19055	1 pts		Acute tonsillitis	serious				2678
19056	1 pts		Bronchitis acute	serious				2678
19057	4 pts		Bronchopneumonia	serious				2678
19058	1 pts		Lower respiratory tract infection	serious				2678
19059	2 pts		Pneumonia	serious				2678
19060	1 pts		Pyelonephritis	serious				2678
19061	1 pts		Skin infection	serious				2678
19062	1 pts		Tonsillitis	serious				2678
19063	1 pts		Upper respiratory tract infection	serious				2678
19064	1 pts		Viral upper respiratory tract infection	serious				2678
19065	1 pts		Concussion	serious				2678
19066	1 pts		Head injury	serious				2678
19067	1 pts		Weight increased	serious				2678
19068	1 pts		Dehydration	serious				2678
19069	1 pts		Acute lymphocytic leukaemia	serious				2678
19070	1 pts		Convulsion	serious				2678
19071	4 pts		Febrile convulsion	serious				2678
19072	4 pts		Cough	serious				2678
19073	1 pts		Bronchitis	serious				2678
19074	49 pts		Conjunctivitis	below serious				2678
19075	14 pts		Constipation	below serious				2678
19076	48 pts		Diarrhoea	below serious				2678
19077	22 pts		Teething	below serious				2678
19078	31 pts		Vomiting	below serious				2678
19079	85 pts		Pyrexia	below serious				2678
19080	57 pts		Gastroenteritis	below serious				2678
19081	25 pts		Influenza	below serious				2678
19082	19 pts		Laryngitis	below serious				2678
19083	79 pts		Nasopharyngitis	below serious				2678
19084	58 pts		Pharyngitis	below serious				2678
19085	73 pts		Rhinitis	below serious				2678
19086	131 pts		Upper respiratory tract infection	below serious				2678
19087	25 pts		Viral infection	below serious				2678
19088	24 pts		Allergic rhinitis	below serious				2678
19089	1 pts		Ear pain	below serious				2674
19090	1 pts		Eye pruritus	below serious				2674
19091	1 pts		Ocular hyperaemia	below serious				2674
19092	1 pts		Nausea	below serious				2674
19093	2 pts		Fatigue	below serious				2674
19094	1 pts		Blood pressure increased	below serious				2674
19095	1 pts		Sinus headache	below serious				2674
19096	2 pts		Somnolence	below serious				2674
19097	1 pts		Anxiety	below serious				2674
19098	1 pts		Skin lesion	below serious				2674
19099	1 pts		Pyrexia	serious				2676
19100	1 pts		Tachycardia	below serious				2676
19101	1 pts		Eye swelling	below serious				2676
19102	4 pts		Diarrhoea	below serious				2676
19103	4 pts		Vomiting	below serious				2676
19104	1 pts		Eructation	below serious				2676
19105	1 pts		Constipation	below serious				2676
19106	5 pts		Pyrexia	below serious				2676
19107	1 pts		Pain	below serious				2676
19108	1 pts		Nasopharyngitis	below serious				2676
19109	3 pts		Otitis media	below serious				2676
19110	1 pts		Viral rash	below serious				2676
19111	2 pts		Gastroenteritis	below serious				2676
19112	1 pts		Folliculitis	below serious				2676
19113	1 pts		Hordeolum	below serious				2676
19114	1 pts		Head injury	below serious				2676
19115	1 pts		Skin laceration	below serious				2676
19116	1 pts		Alanine aminotransferase increased	below serious				2676
19117	2 pts		Sleep disorder	below serious				2676
19118	1 pts		Nervousness	below serious				2676
19119	1 pts		Asthma	below serious				2676
19120	2 pts		Epistaxis	below serious				2676
19121	1 pts		Nasal discomfort	below serious				2676
19122	1 pts		Rhinorrhoea	below serious				2676
19123	1 pts		Scab	below serious				2676
19124	1 pts		Swelling face	below serious				2676
19125	1 pts		Dermatitis diaper	below serious				2676
19126	1 pts		Skin irritation	below serious				2676
19127	1 pts		Rash	below serious				2676
19128	1 pts		Urticaria	below serious				2676
19129	9 pts		Fatigue	below serious				2675
19130	12 pts		Somnolence	below serious				2675
19131	1 pts		Otitis media acute	serious				2677
19132	1 pts		Acute sinusitis	serious				2677
19133	1 pts		Upper respiratory tract infection	serious				2677
19134	1 pts		Sinus bradycardia	below serious				2677
19135	1 pts		Discharge eye	below serious				2677
19136	6 pts		Diarrhoea	below serious				2677
19137	3 pts		Teething	below serious				2677
19138	3 pts		Constipation	below serious				2677
19139	2 pts		Vomiting	below serious				2677
19140	1 pts		Thirst	below serious				2677
19141	1 pts		Injection site pain	below serious				2677
19142	1 pts		Upper respiratory tract infection	below serious				2677
19143	1 pts		Viral upper respiratory tract infection	below serious				2677
19144	1 pts		Gastroenteritis	below serious				2677
19145	1 pts		Oral candidiasis	below serious				2677
19146	1 pts		Bronchitis acute	below serious				2677
19147	1 pts		Skin infection	below serious				2677
19148	1 pts		Increased appetite	below serious				2677
19149	2 pts		Somnolence	below serious				2677
19150	1 pts		Insomnia	below serious				2677
19151	2 pts		Rhinorrhoea	below serious				2677
19152	1 pts		Asthma	below serious				2677
19153	1 pts		Dermatitis atopic	below serious				2677
19154	1 pts		Dermatitis contact	below serious				2677
19155	1 pts		Hyperkeratosis	below serious				2677
19156	1 pts		Rash	below serious				2677
19157						No AEs are reported		2679
19158	2 pts		Hepatotoxicity		discontinuation	leads to discontinuation		2680
19159	2.3		Somnolence		discontinuation	leads to discontinuation		2681
19160	2.3		Fatigue		discontinuation	leads to discontinuation		2681
19161	2.3		Asthenia		discontinuation	leads to discontinuation		2681
19162						no adverse reactions were reported, only abstract is available		2682
19163	1 pts		Lupus-like syndrome		discontinuation	leads to discontinuation		2683
19164	8.7		Metrorrhagia		discontinuation			2686
19165	3.7		Bleeding vaginal		discontinuation			2686
19166	1.5		Bleeding		discontinuation			2684
19167	0.7		Heavy periods		discontinuation	Discontinuation for bleeding complaints occurred in 35 (2.1%, 95% CI 1.3–2.7%) levonorgestrel 52 mg IUS users. Reasons provided by women who primarily discontinued for bleeding-related complaints included heavy flow (12 women) and pattern-related issues including irregular bleeding (12 women), prolonged flow (7women) and increased frequency (3 women); only onesubject discontinued for amenorrhea.		2685
19168	0.7		Menstrual irregularity		discontinuation	Discontinuation for bleeding complaints occurred in 35 (2.1%, 95% CI 1.3–2.7%) levonorgestrel 52 mg IUS users. Reasons provided by women who primarily discontinued for bleeding-related complaints included heavy flow (12 women) and pattern-related issues including irregular bleeding (12 women), prolonged flow (7women) and increased frequency (3 women); only onesubject discontinued for amenorrhea.		2685
19169	0.4		Menstruation prolonged		discontinuation	Discontinuation for bleeding complaints occurred in 35 (2.1%, 95% CI 1.3–2.7%) levonorgestrel 52 mg IUS users. Reasons provided by women who primarily discontinued for bleeding-related complaints included heavy flow (12 women) and pattern-related issues including irregular bleeding (12 women), prolonged flow (7women) and increased frequency (3 women); only onesubject discontinued for amenorrhea.		2685
19170	0.18		Menstruation frequent		discontinuation	Discontinuation for bleeding complaints occurred in 35 (2.1%, 95% CI 1.3–2.7%) levonorgestrel 52 mg IUS users. Reasons provided by women who primarily discontinued for bleeding-related complaints included heavy flow (12 women) and pattern-related issues including irregular bleeding (12 women), prolonged flow (7women) and increased frequency (3 women); only onesubject discontinued for amenorrhea.		2685
19171	0.06		Amenorrhea		discontinuation	Discontinuation for bleeding complaints occurred in 35 (2.1%, 95% CI 1.3–2.7%) levonorgestrel 52 mg IUS users. Reasons provided by women who primarily discontinued for bleeding-related complaints included heavy flow (12 women) and pattern-related issues including irregular bleeding (12 women), prolonged flow (7women) and increased frequency (3 women); only onesubject discontinued for amenorrhea.		2685
19172	4.2		Headache					2687
19173	10		Somnolence					2688
19174	9		Headache					2688
19175	5		Fatigue					2688
19176	4		Dry mouth					2688
19177	2		Fatigue					2689
19178	7		Fever					2689
19179	5		Headache					2689
19180	2		Influenza-like symptoms					2689
19181	2		Constipation					2689
19182	3		Diarrhea					2689
19183	2		Dyspepsia					2689
19184	2		Loose stools					2689
19185	2		Stomatitis					2689
19186	2		Tooth disorder					2689
19187	5		Vomiting					2689
19188	2		Earache					2689
19189	7		Drowsiness					2689
19190	2		Infection viral					2689
19191	2		Allergic rhinitis					2689
19192	3		Coughing					2689
19193	3		Epistaxis					2689
19194	3		Pharyngitis					2689
19195	2		Rash					2689
19196	2 pts		Hypotension					2690
19197	1 pts		Abnormal liver function tests					2690
19198	1 pts		Nausea					2690
19199	1 pts		Vomiting					2690
19200	1 pts		Acidosis					2690
19201	1 pts		Brain edema					2690
19202	1 pts		Coma					2690
19203	1 pts		Convulsion					2690
19204	2 pts		Somnolence					2690
19205	1 pts		Abnormal thinking					2690
19206	1 pts		Hyperventilation					2690
19207	1 pts		Hypoventilation					2690
19208	2 pts		Respiratory failure					2690
19209	6		Nervousness					2691
19210	3		Anxiety					2691
19211	2		Insomnia					2691
19212	2		Agitation					2691
19213	16		Drowsiness					2691
19214	8		Dizziness					2691
19215	3		Tremor					2691
19216	22		Dry mouth					2691
19217	6		Constipation					2691
19218	4		Blurred vision					2691
19219	2		Nausea					2691
19220	4		Weakness					2691
19221	4		Headache					2691
19222	4		Fatigue					2691
19223	44.4		Asthenia	grade 1-2				2692
19224	22.2		Abdominal pain	grade 1-2				2692
19225	22.2		Headache	grade 1-2				2692
19226	66.7		Postural hypotension	grade 1-2				2692
19227	33.3		Dry mouth	grade 1-2				2692
19228	11.1		Flatulence	grade 1-2				2692
19229	22.2		Nausea	grade 1-2				2692
19230	22.2		Hyperlipidaemia	grade 1-2				2692
19231	33.3		Dizziness	grade 1-2				2692
19232	11.1		Epistaxis	grade 1-2				2692
19233	33.3		Rhinitis	grade 1-2				2692
19234	11.1		Rash	grade 1-2				2692
19235	55.5		Conjunctivitis	grade 1-2				2692
19236	11.1		Eye pain	grade 1-2				2692
19237	55.5		Asthenia	grade 1-2				2693
19238	33.3		Headache	grade 1-2				2693
19239	22.2		Hot flushes	grade 1-2				2693
19240	44.4		Postural hypotension	grade 1-2			TRUE	2693
19241	22.2		Dry mouth	grade 1-2				2693
19242	22.2		Dizziness	grade 1-2				2693
19243	22.2		Abnormal vision	grade 1-2				2693
19244	22.2		Postural hypotension	grade 3	discontinuation			2696
19245	20		Transaminases increased	grade 1-2	discontinuation			2695
19246	1		Vomiting	grade 1	discontinuation			2694
19247						impossible to link AEs with the definite dose: Toxicities that were not dose-limiting during that period included nausea (two, grade 1), diarrhoea (five, grade 1, and one grade 2), fatigue (five, grade 1). With continued dosing, two patients (of the 12 who completed >1 month of therapy) developed asymptomatic		2697
19248	4 pts		Contact dermatitis			WARNING		2698
19249	25		Neutropenia	grade 4			TRUE	2699
19250	25		Thrombocytopenia	grade 3			TRUE	2699
19251			Convulsions		discontinuation	WARNING		2701
19252			Neutropenia		discontinuation	WARNING		2701
19253			Agranulocytosis		discontinuation	WARNING		2701
19254			Stevens-Johnson syndrome	serious	discontinuation	WARNING. Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) have been reported with the concomitant use of mebendazole and metronidazole.		2700
19255			Toxic epidermal necrolysis	serious	discontinuation	WARNING. Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) have been reported with the concomitant use of mebendazole and metronidazole.		2700
19256			Diarrhoea					2702
19257			Gastrointestinal disorder NOS	severe	discontinuation	leads to discontinuation		2703
19258			Skin rash		discontinuation	leads to discontinuation		2703
19259			Reaction skin	serious	discontinuation	leads to discontinuation		2703
19260	2 pts		Osteoporosis		discontinuation	leads to discontinuation		2707
19261	1 pts		Deep vein thrombosis		discontinuation	leads to discontinuation		2708
19262	1 pts		Deep vein thrombosis		discontinuation	leads to discontinuation		2706
19263	1 pts		Adrenal insufficiency		discontinuation	leads to discontinuation		2705
19264						Impossible to link AEs with the dose:The main side effects were weight gain and appetite enhancement		2704
19265	6 pts		Nausea	below serious				2709
19266	3 pts		Dizziness	below serious				2709
19267	1 pts		Pruritus	below serious				2709
19268	3 pts		Vomiting	below serious				2709
19269	2 pts		Erythema	below serious				2709
19270	1 pts		Constipation	below serious				2709
19271	2 pts		Muscle spasms	below serious				2709
19272	1 pts		Somnolence	below serious				2709
19273	2 pts		Dizziness	below serious				2710
19274	2 pts		Pruritus	below serious				2710
19275	1 pts		Constipation	below serious				2710
19276	1 pts		Somnolence	below serious				2710
19277	0.7		Stomach pain		discontinuation			2712
19278	0.7		Osteoarthritis		discontinuation			2712
19279	0.8		Hypertension worsened		discontinuation			2711
19280	0.8		Liver function tests raised		discontinuation			2711
19281	0.8		Potassium low		discontinuation			2711
19282	0.8		Shortness of breath		discontinuation			2711
19283	1 pts		Cardiac arrhythmia	serious				2714
19284	1 pts		Lethargy	below serious				2714
19285	2 pts		Irritability	below serious				2714
19286	2 pts		Fatigue	below serious				2715
19287	2 pts		Sleepiness	below serious				2715
19288	1 pts		Hypomania	below serious				2715
19289	2 pts		Agitation	below serious				2715
19290	3 pts		Sleep excessive	below serious				2715
19291	3 pts		Dreaming excessive	below serious				2715
19292	2 pts		Dystonia	below serious				2715
19293	1 pts		Paresthesia	below serious				2715
19294	2 pts		Difficulty in micturition	below serious				2715
19295	1 pts		Tachycardia	below serious				2715
19296	1 pts		Rash	below serious				2715
19297	2 pts		Blurred vision	below serious				2723
19298	3 pts		Headache	below serious				2723
19299	1 pts		Hyperosmia	below serious				2723
19300	1 pts		Attention concentration difficulty	below serious				2723
19301	1 pts		Muscle twitching	below serious				2723
19302	1 pts		Sweating	below serious				2723
19303	1 pts		Abdominal pain	below serious				2723
19304	2 pts		Indigestion	below serious				2723
19305	1 pts		Constipation	below serious				2723
19306	2 pts		Diarrhea	below serious				2723
19307	1 pts		Vomiting	below serious				2723
19308	1 pts		Decreased appetite	below serious				2723
19309	1 pts		Increased libido	below serious				2723
19310	1 pts		Coughing	below serious				2723
19311	1 pts		Breast discharge	below serious				2723
19312	1 pts		Allergic cough	below serious				2716
19313	1 pts		Calf pain	below serious				2716
19314	1 pts		Constipation	below serious				2716
19315	1 pts		Shoulder injury	below serious				2716
19316	1 pts		Back pain	below serious				2716
19317	1 pts		Dizziness	below serious				2716
19318	1 pts		Hematuria	below serious				2716
19319	1 pts		Confusion	below serious				2716
19320	1 pts		Knee pain	below serious				2716
19321	1 pts		Musculoskeletal pain	below serious				2716
19322	1 pts		Fall	below serious				2716
19323	1 pts		Nervousness	below serious				2716
19324	1 pts		Dry mouth	below serious				2716
19325	1 pts		Nausea	below serious				2716
19326	1 pts		Vomiting	below serious				2716
19327	1 pts		Mouth cancer	serious				2717
19328	1 pts		Myocardial infarction	serious				2717
19329	2 pts		Dizziness	below serious				2717
19330	4 pts		Fatigue	below serious				2717
19331	2 pts		Headache	below serious				2717
19332	2 pts		Decreased appetite	below serious				2717
19333	2 pts		Insomnia	below serious				2717
19334	1 pts		Motor vehicle accident	serious				2718
19335	1 pts		Lung cancer	serious				2718
19336	6 pts		Constipation	below serious				2718
19337	1 pts		Atrial fibrillation	serious				2724
19338	1 pts		Bradyarrhythmia	serious				2724
19339	1 pts		Asthenia	serious				2724
19340	1 pts		Local swelling	serious				2724
19341	1 pts		Cholecystitis acute	serious				2724
19342	1 pts		Acute sinusitis	serious				2724
19343	1 pts		Respiratory tract infection bacterial	serious				2724
19344	1 pts		Urinary tract infection enterococcal	serious				2724
19345	2 pts		Urosepsis	serious				2724
19346	2 pts		Fall	serious				2724
19347	1 pts		Hip fracture	serious				2724
19348	1 pts		Intentional overdose	serious				2724
19349	1 pts		Post-traumatic pain	serious				2724
19350	1 pts		Road traffic accident	serious				2724
19351	1 pts		Fracture pathological	serious				2724
19352	1 pts		Lung neoplasm malignant	serious				2724
19353	1 pts		Ataxia	serious				2724
19354	1 pts		Aggression	serious				2724
19355	1 pts		Agitation	serious				2724
19356	1 pts		Confusional state	serious				2724
19357	1 pts		Hallucination, auditory	serious				2724
19358	1 pts		Major depression	serious				2724
19359	1 pts		Personality disorder	serious				2724
19360	1 pts		Acute respiratory failure	serious				2724
19361	1 pts		Dyspnoea	serious				2724
19362	1 pts		Haemoptysis	serious				2724
19363	1 pts		Swelling face	serious				2724
19364	1 pts		Hypertension	serious				2724
19365	19 pts		Fall	below serious				2724
19366	11 pts		Weight decreased	below serious				2724
19367	10 pts		Somnolence	below serious				2724
19368	15 pts		Agitation	below serious				2724
19369	1 pts		TIA	serious				2719
19370	2 pts		Anxiety	below serious				2720
19371	1 pts		Dizziness	below serious				2720
19372	1 pts		Echolalia	below serious				2720
19373	1 pts		Back pain	serious				2721
19374	1 pts		Fracture	serious				2721
19375	1 pts		Pain	serious				2721
19376	1 pts		Retinal tear	serious				2721
19377	14 pts		Back pain	below serious				2721
19378	10 pts		Confusion	below serious				2721
19379	15 pts		Constipation	below serious				2721
19380	16 pts		Dizziness	below serious				2721
19381	16 pts		Dyspnea	below serious				2721
19382	33 pts		Fatigue	below serious				2721
19383	13 pts		Somnolence	below serious				2721
19384	3 pts		Vomiting	below serious				2721
19385	2 pts		Abdominal discomfort	below serious				2725
19386	2 pts		Decreased appetite	below serious				2725
19387	1 pts		Diarrhea	below serious				2725
19388	4 pts		Headache	below serious				2725
19389	3 pts		Increased appetite	below serious				2725
19390	1 pts		Bed wetting	below serious				2725
19391	3 pts		Insomnia	below serious				2725
19392	2 pts		Sedation	below serious				2725
19393	1 pts		Deliberate self-harm	below serious				2725
19394	2 pts		Suicidal ideation	below serious				2725
19395	1 pts		Intracranial hypertension	below serious				2722
19396	1 pts		Conjunctivitis	below serious				2722
19397	1 pts		Constipation	below serious				2722
19398	1 pts		Diarrhea	below serious				2722
19399	1 pts		Anemia	below serious				2722
19400	2 pts		Emesis	below serious				2722
19401	3 pts		Nervous system disorder	below serious				2722
19402	2 pts		Agitation	below serious				2722
19403	2 pts		Headache	below serious				2722
19404	1 pts		Seizures	below serious				2722
19405	1 pts		Rash	below serious				2722
19406	1 pts		Fatigue	below serious				2722
19407	3 pts		Dehydration	below serious				2722
19408	2 pts		Pain	below serious				2722
19409	1 pts		Hyponatremia	below serious				2722
19410	1 pts		Restlessness					2713
19411	1 pts		Psychosis					2713
19412	1 pts		Visual hallucinations					2713
19413	1 pts		Somnolence					2713
19414	1 pts		Stupor					2713
19415	1 pts		Loss of consciousness					2713
19416	1 pts		Aplastic anemia	grade 5	discontinuation			2726
19417			Coma					2727
19418			Stupor					2728
19419	1 pts		Pancytopenia	grade 5	discontinuation			2729
19420	2		Syncope					2733
19421	28		Swelling & soreness of mouth					2730
19422	18		Incision site paraesthesia					2730
19423	2		Other and unspecified diseases of pulp and periapical tissues					2730
19424			Seizures			OVERDOSAGE		2734
19425			Pneumonia			OVERDOSAGE		2734
19426			Death	grade 5		OVERDOSAGE		2734
19427	16		Diplopia					2731
19428	26		Numbness of lip					2731
19429	3.2		Herpes lesion intra-oral					2732
19430	3.2		Oral mucosa hematoma					2732
19431	1 pts		Atrial fibrillation	serious				2738
19432	1 pts		Supraventricular tachycardia	serious				2738
19433	1 pts		Chest discomfort	serious				2738
19434	1 pts		Bronchitis	serious				2738
19435	1 pts		Peridiverticular abscess	serious				2738
19436	1 pts		Pharyngitis	serious				2738
19437	1 pts		Hip fracture	serious				2738
19438	1 pts		Transient ischemic attack	serious				2738
19439	1 pts		Uterovaginal prolapse	serious				2738
19440	19 pts		Abdominal pain	below serious				2738
19441	15 pts		Diarrhea	below serious				2738
19442	11 pts		Urinary tract infection	below serious				2738
19443	12 pts		Sinusitis	below serious				2738
19444	8 pts		Bronchitis	below serious				2738
19445	14 pts		Headache	below serious				2738
19446	9 pts		Cough	below serious				2738
19447	1 pts		Atrial fibrillation	serious				2739
19448	1 pts		Ventricular extrasystoles	serious				2739
19449	1 pts		Gastrointestinal hemorrhage	serious				2739
19450	1 pts		Hiatus hernia	serious				2739
19451	1 pts		Nausea	serious				2739
19452	1 pts		Esophagitis	serious				2739
19453	1 pts		Multi organ failure	serious				2739
19454	1 pts		Appendicitis	serious				2739
19455	1 pts		Ankle fracture	serious				2739
19456	1 pts		Patella fracture	serious				2739
19457	1 pts		Post procedural edema	serious				2739
19458	1 pts		Radius fracture	serious				2739
19459	1 pts		Intervertebral disc protrusion	serious				2739
19460	1 pts		Breast cancer	serious				2739
19461	1 pts		Cardiac neoplasm unspecified	serious				2739
19462	1 pts		Prostate cancer	serious				2739
19463	2 pts		Cerebrovascular accident	serious				2739
19464	1 pts		Hypotension	serious				2739
19465	1 pts		Intra-abdominal hemorrhage	serious				2739
19466	19 pts		Abdominal pain	below serious				2739
19467	15 pts		Diarrhea	below serious				2739
19468	11 pts		Dyspepsia	below serious				2739
19469	14 pts		Urinary tract infection	below serious				2739
19470	10 pts		Nasopharyngitis	below serious				2739
19471	3 pts		Cough	below serious				2739
19472	1 pts		Agranulocytosis	serious				2740
19473	1 pts		Cardiac failure	serious				2740
19474	1 pts		Gastroesophageal reflux disease	serious				2740
19475	1 pts		Small intestinal hemorrhage	serious				2740
19476	2 pts		Chest pain	serious				2740
19477	1 pts		Cholangitis acute	serious				2740
19478	1 pts		Subcutaneous abscess	serious				2740
19479	1 pts		Humerus fracture	serious				2740
19480	1 pts		Type 2 diabetes mellitus	serious				2740
19481	1 pts		Ovarian granulosa-theca cell tumor	serious				2740
19482	1 pts		Renal cell carcinoma	serious				2740
19483	1 pts		Squamous cell carcinoma	serious				2740
19484	1 pts		Syncope	serious				2740
19485	1 pts		Ovarian cyst	serious				2740
19486	15 pts		Abdominal pain	below serious				2740
19487	18 pts		Diarrhea	below serious				2740
19488	10 pts		Abdominal pain lower	below serious				2740
19489	10 pts		Urinary tract infection	below serious				2740
19490	9 pts		Bronchitis	below serious				2740
19491	14 pts		Headache	below serious				2740
19492	4 pts		Cough	below serious				2740
19493	1 pts		Lymphadenopathy	below serious				2737
19494	1 pts		Gastrointestinal hypermotility	below serious				2737
19495	1 pts		Haemorrhoidal haemorrhage	below serious				2737
19496	1 pts		Nausea	below serious				2737
19497	1 pts		Sinusitis	below serious				2737
19498	1 pts		Urinary tract infection	below serious				2737
19499	1 pts		Bursitis	below serious				2737
19500	1 pts		Pollakiuria	below serious				2737
19501	1 pts		Hypersensitivity		discontinuation	leads to discontinuation		2742
19502	1 pts		Intoxication		discontinuation	leads to discontinuation		2741
19503						No AEs were reported		2743
19504						No AEs were reported		2744
19505	1 pts		Diarrhea		discontinuation	leads to discontinuation		2736
19506	1 pts		Colitis		discontinuation	leads to discontinuation		2736
19507	1 pts		Dizziness		discontinuation	leads to discontinuation		2736
19508	1 pts		Nausea		discontinuation	leads to discontinuation		2736
19509	1 pts		Joint pain		discontinuation	leads to discontinuation		2736
19510	2 pts		Headache		discontinuation	leads to discontinuation		2736
19511	1 pts		Rash		discontinuation	leads to discontinuation		2736
19512	1 pts		Lethargy		discontinuation	leads to discontinuation		2736
19513	1 pts		Constipation		discontinuation	leads to discontinuation		2736
19514	1 pts		Dry mouth		discontinuation	leads to discontinuation		2736
19515	1 pts		Malaise		discontinuation	leads to discontinuation		2736
19516	1 pts		Back discomfort		discontinuation	leads to discontinuation		2736
19517	1 pts		Disorientation		discontinuation	leads to discontinuation		2736
19518	1 pts		Indigestion		discontinuation	leads to discontinuation		2736
19519	1 pts		Nausea		discontinuation	leads to discontinuation		2736
19520	1 pts		Generalised aching		discontinuation	leads to discontinuation		2736
19521	1 pts		Vomiting		discontinuation	leads to discontinuation		2736
19522	1 pts		Muscle cramps		discontinuation	leads to discontinuation		2736
19523	1 pts		Nasal congestion		discontinuation	leads to discontinuation		2736
19524	1 pts		Eustachian tube obstruction		discontinuation	leads to discontinuation		2736
19525	1 pts		Fever		discontinuation	leads to discontinuation		2736
19526	1 pts		Anxiety		discontinuation	leads to discontinuation		2735
19527	1 pts		Headache		discontinuation	leads to discontinuation		2735
19528	1 pts		Pruritus		discontinuation	leads to discontinuation		2735
19529	1 pts		Libido decreased		discontinuation	leads to discontinuation		2735
19530	1 pts		Rheumatoid arthritis		discontinuation	leads to discontinuation		2735
19531	1 pts		Asthenia		discontinuation	leads to discontinuation		2735
19532	1 pts		Double vision	below serious				2745
19533			Anorexia		discontinuation	WARNING		2747
19534			Tachypnea		discontinuation	WARNING		2747
19535			Lethargy		discontinuation	WARNING		2747
19536			Coma		discontinuation	WARNING		2747
19537	2 pts		Loss of energy		discontinuation	leads to discontinuation		2746
19538	2 pts		Fatigue		discontinuation	leads to discontinuation		2746
19539	2 pts		Lethargy		discontinuation	leads to discontinuation		2746
19540			Fetal damage	grade 5	discontinuation	WARNING		2750
19541			Fetal damage	grade 5	discontinuation	WARNING		2749
19542			Fetal damage	grade 5	discontinuation	WARNING		2748
19543			Adverse event	grade 5				2753
19544			Adverse event	grade 5				2751
19545			Adverse event	grade 5				2752
19546	2 pts		Mucosal ulceration			poisoning		2765
19547						suicide attempt		2764
19548	1 pts		Nausea			suicide attempt		2767
19549	1 pts		Vomiting			suicide attempt		2767
19550	1 pts		Nausea			suicide attempt		2766
19551	1 pts		Vomiting			suicide attempt		2766
19552	1 pts		Skin lesion			poisoning		2763
19553	1 pts		Mucosal ulceration			poisoning		2763
19554	1 pts		Abdominal pain			poisoning		2763
19555	1 pts		Mucosal ulceration			poisoning		2762
19556	1 pts		Nausea			poisoning		2762
19557	1 pts		Vomiting			poisoning		2762
19558	1 pts		Diarrhea			poisoning		2762
19559	1 pts		Abdominal pain			poisoning		2762
19560	2 pts		Toxicity renal	grade 1-2	discontinuation	leads to discontinuation		2760
19561	2 pts		Cytolysis	grade 2-3	discontinuation	leads to discontinuation		2761
19562	1 pts		Neutropenia	grade 3	discontinuation	leads to discontinuation		2761
19563	1 pts		Digestion impaired	grade 3	discontinuation	leads to discontinuation		2761
19564	1 pts		Lymphoproliferative disorder		discontinuation	leads to discontinuation		2768
19565			Fetal damage	severe|grade 5		WARNING		2756
19566			Hepatic and hepatobiliary disorders	serious		WARNING		2757
19567			Respiratory tract disorders NEC	serious		WARNING		2757
19568			Skin and subcutaneous conditions NEC	serious		WARNING		2757
19569			Kidney disorder	serious		WARNING		2757
19570			Bone marrow depression	severe|grade 5		WARNING		2759
19571			Aplastic anemia	severe|grade 5		WARNING		2759
19572			Gastrointestinal toxicity	severe|grade 5		WARNING		2759
19573			Interstitial pneumonitis	serious	discontinuation	WARNING		2757
19574			Skin and subcutaneous conditions NEC	severe|grade 5		WARNING		2758
19575			Fetal damage	severe|grade 5		WARNING		2754
19576			Gastrointestinal disorder (NOS)			WARNING		2755
19577			Hepatic and hepatobiliary disorders	serious		WARNING		2755
19578			Respiratory tract disorders NEC	serious		WARNING		2755
19579			Skin and subcutaneous conditions NEC	serious		WARNING		2755
19580			Kidney disorder	serious		WARNING		2755
19581						No SAEs were observed		2769
19582	1		Pain localised		discontinuation	leads to discontinuation		2770
19583			Hypertension					2773
19584			Cerebrovascular accident					2773
19585			Respiratory depression					2771
19586			Hypothermia					2771
19587			Hypertonicity					2771
19588			Jerky movement NOS					2771
19589			Convulsions					2771
19590						no AEs reported		2772
19591	1 pts		Bradycardia	grade 5	discontinuation	leads to discontinuation		2781
19592	1 pts		Hypotension	grade 5	discontinuation	leads to discontinuation		2781
19593	1 pts		Heart block	grade 5	discontinuation	leads to discontinuation		2781
19594	2 pts		Nausea and vomiting					2777
19595	4 pts		Extrapyramidal disorder					2777
19596	4 pts		Agitation					2777
19597	3 pts		Fatigue					2777
19598	2 pts		Appetite lost					2777
19599	1 pts		Diarrhea					2777
19600	1 pts		Nausea and vomiting					2776
19601	1 pts		Extrapyramidal disorder					2776
19602	4 pts		Agitation					2776
19603	1 pts		Depression					2776
19604	5 pts		Fatigue					2776
19605	1 pts		Appetite lost					2776
19606	1 pts		Diarrhea					2776
19607	1 pts		Nausea and vomiting					2775
19608	2 pts		Extrapyramidal disorder					2775
19609	2 pts		Agitation					2775
19610	2 pts		Depression					2775
19611	3 pts		Fatigue					2775
19612	2 pts		Appetite lost					2775
19613	1 pts		Diarrhea					2775
19614	3 pts		Nausea and vomiting					2778
19615	1 pts		Agitation					2778
19616	1 pts		Depression					2778
19617	4 pts		Fatigue					2778
19618	2 pts		Appetite lost					2778
19619	1 pts		Diarrhea					2778
19620	2 pts		Nausea and vomiting					2779
19621	4 pts		Agitation					2779
19622	2 pts		Depression					2779
19623	3 pts		Fatigue					2779
19624	2 pts		Appetite lost					2779
19625	1 pts		Diarrhea					2779
19626	1 pts		Nausea and vomiting					2774
19627	3 pts		Extrapyramidal disorder					2774
19628	5 pts		Agitation					2774
19629	4 pts		Depression					2774
19630	5 pts		Fatigue					2774
19631	5 pts		Appetite lost					2774
19632	2 pts		Diarrhea					2774
19633	1 pts		Cyanosis		discontinuation	leads to discontinuation		2780
19634	1 pts		Lethargic		discontinuation	leads to discontinuation		2780
19635	1 pts		Irritable		discontinuation	leads to discontinuation		2780
19636	1 pts		Diarrhea		discontinuation	leads to discontinuation		2780
19637	1 pts		Respiratory distress		discontinuation	leads to discontinuation		2780
19638	1 pts		Appetite lost		discontinuation	leads to discontinuation		2780
19639	1 pts		Methemoglobinemia		discontinuation	leads to discontinuation		2780
19640	1 pts		Hypoxemia		discontinuation	leads to discontinuation		2780
19641			Arthralgia	grade 3				2782
19642			Fatigue	grade 3				2782
19643			Asthenia	grade 3				2782
19644			Rash					2782
19645			Hypotension					2782
19646	2 pts		Pancytopenia					2789
19647	1 pts		Hypertension	severe				2787
19648	1 pts		Bradycardia					2787
19649						No AEs are reported		2784
19650						No AEs are reported		2783
19651			Supine hypertension		discontinuation	WARNING		2788
19652	1 pts		Blood pressure systolic increased					2786
19653	1 pts		Lethargic					2785
19654	1 pts		Pharyngolaryngeal pain	serious				2798
19655	1 pts		Pyrexia	serious				2798
19656	1 pts		Eosinophilia	below serious				2798
19657	3 pts		Gastrointestinal disorders	below serious				2798
19658	1 pts		Abdominal pain	below serious				2798
19659	1 pts		Constipation	below serious				2798
19660	1 pts		Diarrhoea	below serious				2798
19661	2 pts		Nausea	below serious				2798
19662	1 pts		Odynophagia	below serious				2798
19663	1 pts		Vomiting	below serious				2798
19664	1 pts		Food allergy	below serious				2798
19665	1 pts		Hypokalaemia	below serious				2798
19666	1 pts		Increased libido	below serious				2798
19667	1 pts		Libido increased	below serious				2798
19668	1 pts		Stress	below serious				2798
19669	2 pts		Metrorrhagia	below serious				2798
19670	1 pts		Sinus congestion	below serious				2798
19671	1 pts		Pruritis	below serious				2798
19672	1 pts		Rash papular	below serious				2798
19673	2 pts		Hot flush	below serious				2798
19674	3 pts		Hypertension	below serious				2798
19675	2 pts		Electrocardiogram abnormal	below serious				2799
19676	1 pts		Anxiety	below serious				2799
19677	2 pts		Blurry vision	below serious				2799
19678	1 pts		Bug bite	below serious				2799
19679	1 pts		Constipation	below serious				2799
19680	1 pts		Costochondritis	below serious				2799
19681	1 pts		Dizziness	below serious				2799
19682	1 pts		Infected bite	below serious				2799
19683	1 pts		Dry eyes	below serious				2799
19684	1 pts		Dysmenorrhea	below serious				2799
19685	1 pts		Exhaustion	below serious				2799
19686	1 pts		Fibromyalgia	below serious				2799
19687	1 pts		Tremor of hands	below serious				2799
19688	1 pts		Hemorrhoids	below serious				2799
19689	2 pts		Hypokalemia	below serious				2799
19690	1 pts		Insomnia	below serious				2799
19691	1 pts		Lump feeling in throat	below serious				2799
19692	1 pts		Menorrhagia	below serious				2799
19693	1 pts		Sores mouth	below serious				2799
19694	5 pts		Nausea	below serious				2799
19695	3 pts		Pain	below serious				2799
19696	1 pts		Restless leg syndrome	below serious				2799
19697	2 pts		Pruritus	below serious				2799
19698	3 pts		Rash	below serious				2799
19699	1 pts		Rosacea	below serious				2799
19700	1 pts		Sinus congestion	below serious				2799
19701	3 pts		Somnolence	below serious				2799
19702			Adrenal insufficiency					2801
19703			Hypokalemia					2801
19704			Hypokalemia					2800
19705	2		Rash		discontinuation			2791
19706	13.3		Rash		discontinuation			2794
19707	3.3		Ache		discontinuation			2794
19708	1.9		Anxiety		discontinuation			2796
19709	8.3		Rash		discontinuation			2790
19710	1.2		Nausea		discontinuation			2793
19711	1.2		Fever		discontinuation			2793
19712	2		Fatigue		discontinuation			2792
19713	2		Respiratory failure		discontinuation			2795
19714	2		Nausea		discontinuation			2797
19715	2		Asthenia		discontinuation			2797
19716	1 pts		Diarrhea	severe	discontinuation			2804
19717	26.95		Abdominal discomfort					2803
19718	33.9		Diarrhea					2803
19719	33.9		Hypoglycemia					2803
19720	11.7		Abdominal pain			tended to diminish with continued treatment		2802
19721	28.7		Diarrhea			tended to diminish with continued treatment		2802
19722	41.5		Flatulence					2802
19723	4.3		Skin rash					2802
19724	9.2		Serum iron decreased			did not persist in the majority of cases and was not associated with reductions in hemoglobin or changes in other hematologic indices		2802
19725			Neuritis	grade 3-4	discontinuation			2805
19726			Neuropathy	grade 3-4	discontinuation			2805
19727	1 pts		Gastroduodenal bleeding	serious				2808
19728	1 pts		Urinary tract infection	below serious				2808
19729	11.1		Hypotension		discontinuation			2810
19730	7.1		Hypotension		discontinuation			2809
19731						No AEs were observed		2807
19732						No AEs were observed		2806
19733	1 pts		Strabismus correction	serious				2812
19734	5 pts		Hypertrichosis	below serious				2812
19735	1 pts		Headache		discontinuation	leads to discontinuation		2814
19736	1 pts		Nausea		discontinuation	leads to discontinuation		2814
19737						No AEs were reported		2811
19738	1 pts		Hypotension		discontinuation	leads to discontinuation		2813
19739	1 pts		Tachycardia		discontinuation	leads to discontinuation		2813
19740	1 pts		Myocardial infarction		discontinuation	leads to discontinuation		2813
19741	68.2		Bleeding					2819
19742	7.6		Vomiting					2819
19743	1 pts		Abdominal pain		discontinuation	leads to discontinuation		2816
19744	1 pts		Vomiting		discontinuation	leads to discontinuation		2816
19745	1 pts		Diarrhea		discontinuation	leads to discontinuation		2816
19746	1 pts		Multiorgan failure	grade 5	discontinuation	leads to discontinuation		2815
19747	9.6		Nausea					2818
19748	1.7		Diarrhea					2817
19749	17.4		Vomiting					2818
19750	9.3		Nausea					2817
19751	14		Vomiting					2817
19752			Anorexia	grade 1-2	discontinuation	transiently discontinued mitotane treatment; experienced grade 1 or 2 digestive toxicity		2820
19753			Nausea	grade 1-2	discontinuation	transiently discontinued mitotane treatment; experienced grade 1 or 2 digestive toxicity		2820
19754			Vomiting	grade 1-2	discontinuation	transiently discontinued mitotane treatment; experienced grade 1 or 2 digestive toxicity		2820
19755			Diarrhea	grade 1-2	discontinuation	transiently discontinued mitotane treatment; experienced grade 1 or 2 digestive toxicity		2820
19756			Abdominal pain	grade 1-2	discontinuation	transiently discontinued mitotane treatment; experienced grade 1 or 2 digestive toxicity		2820
19757			Central nervous system toxicity		discontinuation	WARNING		2821
19758			Fetal damage		discontinuation	WARNING		2821
19759			Ovarian cyst		discontinuation	WARNING		2821
19760			Adrenal insufficiency		discontinuation	WARNING		2821
19761	1.3		Diarrhea		discontinuation	leads to discontinuation		2822
19762	0.8		Dyspepsia		discontinuation	leads to discontinuation		2822
19763	1.1		Abdominal pain		discontinuation	leads to discontinuation		2822
19764						No SAEs were observed		2823
19765						No SAEs were observed		2824
19766			Application site fissure	grade 3-4	discontinuation			2825
19767			Hypersensitivity	grade 2-3	discontinuation			2825
19768	6.7		Burning sensation		discontinuation			2827
19769						no AEs reported		2826
19770						impossible to link AEs with the definite dose: Twenty-seven of 62 reported events were possibly related to study medication. Mild to moderate adverse events included diarrhea, nausea, abdominal pain, headache, dizziness, and light-headedness.		2828
19771			Hypoglycemia			suicide attempt		2829
19772	0.3		Hypoglycemia		discontinuation	leads to discontinuation		2830
19773	53		Headaches					2833
19774	42		Dry mouth					2833
19775	42		Diarrhea					2833
19776			Nausea and vomiting					2838
19777			Nausea and vomiting					2837
19778			Nausea and vomiting					2831
19779			Nausea and vomiting					2832
19780	3.5		Nausea		discontinuation	leads to discontinuation		2836
19781	2.9		Headache		discontinuation	leads to discontinuation		2836
19782	1.9		Dizziness		discontinuation	leads to discontinuation		2836
19783	1.5		Somnolence		discontinuation	leads to discontinuation		2836
19784	1.5		Insomnia		discontinuation	leads to discontinuation		2836
19785	1.3		Asthenia		discontinuation	leads to discontinuation		2836
19786	1.2		Agitation		discontinuation	leads to discontinuation		2836
19787	25		Somnolence					2835
19788	25		Dry mouth					2834
19789	22		Nausea					2834
19790	17		Dizziness					2834
19791	14		Constipation					2834
19792	11		Asthenia					2834
19793	10		Light headedness					2834
19794	9		Blurred vision					2834
19795	7		Confusion					2834
19796	7		Abnormal vision					2834
19797	1 pts		Esophagitis	grade 3	discontinuation	leads to discontinuation		2839
19798	2 pts		Leukopenia	grade 3				2839
19799	2 pts		Thrombocytopenia	grade 3				2839
19800	1 pts		Dyspnea	grade 3				2839
19801	1 pts		Nausea	grade 3	discontinuation	leads to discontinuation		2839
19802	1 pts		Fatigue	grade 3	discontinuation	leads to discontinuation		2839
19803	1 pts		Thrombocytopenia	grade 4				2841
19804	1 pts		Hyponatremia	grade 4	discontinuation	leads to discontinuation		2840
19805	1 pts		Thrombocytopenia	grade 3	discontinuation	leads to discontinuation		2840
19806	1 pts		Dizziness	grade 3	discontinuation	leads to discontinuation		2840
19807	2 pts		Elevated liver enzymes	grade 3	discontinuation	leads to discontinuation		2840
19808	0.12		Hypersensitivity		discontinuation	1 patient		2842
19809			Bleeding		discontinuation	WARNING		2843
19810			Healing delayed		discontinuation	WARNING		2843
19811			Corneal disorder (NOS)		discontinuation	WARNING		2843
19812			Keratitis		discontinuation	WARNING		2843
19813	50		Hypotension	severe			TRUE	2845
19814	50		Oliguria				TRUE	2845
19815	50		Nausea	severe	discontinuation			2845
19816	50		Vomiting	severe	discontinuation			2845
19817						no dose reduction was necessary in this group		2846
19818			Vomiting			Some side-effects were seen, but these were typically mild and transient, disappearing either within a few hours or at least by the following day. The most severe response was that of subject number 3 at the highest dose of 6 g, in which vomiting was observed at 1.5 and 3 h after taking the drug.		2844
19819	20		Nausea		discontinuation			2847
19820	2.5		Toxicity renal		discontinuation			2847
19821	17.5		Nausea	severe			TRUE	2847
19822	2 pts		Nausea	grade 3			TRUE	2848
19823	2 pts		Vomiting	grade 3			TRUE	2848
19824	2 pts		Diarrhea	grade 3			TRUE	2848
19825	2 pts		Colitis	grade 3			TRUE	2848
19826	1 pts		Tachycardia	grade 5	discontinuation	leads to discontinuation		2854
19827	1 pts		Hyperglycemia	grade 5	discontinuation	leads to discontinuation		2854
19828	1 pts		Hypotension		discontinuation	leads to discontinuation		2853
19829	1 pts		Tachycardia		discontinuation	leads to discontinuation		2853
19830	1 pts		Flushing		discontinuation	leads to discontinuation		2853
19831	1 pts		Hypotension		discontinuation	leads to discontinuation		2850
19832	1 pts		Acidosis		discontinuation	leads to discontinuation		2850
19833	1 pts		Hyperglycemia		discontinuation	leads to discontinuation		2850
19834	1 pts		Conduction defects (SMQ)		discontinuation	leads to discontinuation		2850
19835	1 pts		Nausea		discontinuation	leads to discontinuation		2856
19836	1 pts		Vomiting		discontinuation	leads to discontinuation		2856
19837	1 pts		Headache		discontinuation	leads to discontinuation		2856
19838	1 pts		Reflex tachycardia		discontinuation	leads to discontinuation		2852
19839	1 pts		Hypotension	grade 4	discontinuation	leads to discontinuation		2855
19840	1 pts		Sinus node dysfunction		discontinuation	leads to discontinuation		2855
19841	1 pts		Atrioventricular node dysfunction		discontinuation	leads to discontinuation		2855
19842	1 pts		Hyperglycemia		discontinuation	leads to discontinuation		2855
19843	1 pts		Intestinal infarction		discontinuation	leads to discontinuation		2851
19844	30		Edema				TRUE	2849
19845	7.5		Nausea				TRUE	2859
19846	7.5		Vomiting				TRUE	2859
19847	5.7		Hot flashes		discontinuation			2859
19848	3.8		Interstitial lung disease		discontinuation			2859
19849	1.9		Visual disturbance NOS		discontinuation			2859
19850	1.9		Pruritus		discontinuation			2859
19851	1.9		Dizziness		discontinuation			2859
19852	1.9		Headache		discontinuation			2859
19853	1.9		Hepatic enzyme increased		discontinuation			2859
19854	2		Interstitial pneumonitis		discontinuation	WARNING		2861
19855	rare		Pulmonary fibrosis	grade 5	discontinuation	WARNING		2861
19856	rare		Liver injury	severe	discontinuation	WARNING		2862
19857	1 - 2		Visual disturbances		discontinuation	WARNING. Impaired adaptation to darkness, abnormal vision, and colored vision		2860
19858			Vomiting	moderate	discontinuation	There were no clinical signs or symptoms or changes in parameters such as transaminases or chest X-ray. Maintenance treatment (150 mg/day) was resumed 30 days later.		2858
19859			Diarrhoea	moderate	discontinuation	There were no clinical signs or symptoms or changes in parameters such as transaminases or chest X-ray. Maintenance treatment (150 mg/day) was resumed 30 days later.		2858
19860			Gastrointestinal disorders		discontinuation			2857
19861			Nausea		discontinuation			2857
19862			Vomiting		discontinuation			2857
19863			Malaise		discontinuation			2857
19864			Headache		discontinuation			2857
19865			Dizziness		discontinuation			2857
19866	4 pts		Death	grade 5				2865
19867	7 pts		Death	grade 5				2864
19868	50		Blood pressure decreased			No SAEs were observed		2863
19869	13.6		Ischemia		discontinuation	leads to discontinuation		2866
19870	2 pts		Myocardial infarction	grade 5	discontinuation	leads to discontinuation		2866
19871			Gastrointestinal disorders NEC					2867
19872						impossible to link AEs with the definite dose		2868
19873			Peptic ulcer disease		discontinuation			2869
19874			Cough		discontinuation			2869
19875	1 pts		Psychiatric symptom NOS			leads to dose reduction		2873
19876	1 pts		Orofacial dyskinesia		discontinuation	leads to discontinuation		2874
19877	1 pts		CNS disorder (NOS)		discontinuation	leads to discontinuation		2872
19878	1 pts		Traumatic injury	grade 1				2875
19879	1 pts		Headache	grade 1				2875
19880	2 pts		Insomnia	grade 2				2875
19881	1 pts		Malaise and fatigue	grade 1				2875
19882	2 pts		Nausea	grade 1				2875
19883	4 pts		Vomiting	grade 1				2875
19884	1 pts		Reaction skin	grade 1				2875
19885	4 pts		Pruritus	grade 1				2875
19886	4 pts		ALT	grade 1				2875
19887	1pts		ALT	grade 2				2875
19888						No AEs were reported		2870
19889						No AEs were reported		2871
19890	1 pts		Cardiac arrest	serious				2876
19891	1 pts		Hypertensive heart disease	serious				2876
19892	5 pts		Headache	below serious				2876
19893	1 pts		Hernia inguinal	serious				2877
19894	1 pts		Cholecystitis chronic	serious				2877
19895	10 pts		Dyslipidemia	below serious				2877
19896	1 pts		Cellulitis	serious				2878
19897	1 pts		Infected bites	serious				2878
19898	1 pts		Subdural haematoma	serious				2878
19899	1 pts		Breast cancer	serious				2878
19900	1 pts		Partial seizures	serious				2878
19901						No AEs are reported		2880
19902						No AEs are reported		2879
19903	18 pts		Bloating	below serious				2883
19904	6 pts		Borborygmi	below serious				2883
19905	25 pts		Infrequent bowel movements	below serious				2883
19906	21 pts		Diarrhea	below serious				2883
19907	61 pts		Fatty stools	below serious				2883
19908	60 pts		Flatulence	below serious				2883
19909	43 pts		Flatus	below serious				2883
19910	19 pts		Frequent bowel movements	below serious				2883
19911	68 pts		Increased bowel frequency	below serious				2883
19912	10 pts		Nausea	below serious				2883
19913	6 pts		Rectal oily spotting	below serious				2883
19914	4 pts		Hemorrhoidal bleeding	below serious				2883
19915	68 pts		Soft stools	below serious				2883
19916	64 pts		Abnormal feces	below serious				2883
19917	11 pts		Feces hard	below serious				2883
19918	83 pts		Abnormal feces	below serious				2883
19919	60 pts		Incontinence of faeces	below serious				2883
19920	44 pts		Incontinence of feces	below serious				2883
19921	5 pts		Epistaxis	below serious				2883
19922	5 pts		Feeling cold	below serious				2883
19923	5 pts		Increased thirst	below serious				2883
19924	11 pts		Decreased appetite	below serious				2883
19925	3 pts		Migraine headaches	below serious				2883
19926	5 pts		Asthma	below serious				2883
19927	5 pts		Skin rash	below serious				2883
19928	1 pts		Abdominal pain	serious				2882
19929	1 pts		Cholelithiasis	serious				2882
19930	1 pts		Appendicitis	serious				2882
19931	1 pts		Multiple injuries	serious				2882
19932	1 pts		Ovarian cyst ruptured	serious				2882
19933	1 pts		Hypertension	serious				2882
19934	5 pts		Vertigo	below serious				2882
19935	7 pts		Abdominal pain	below serious				2882
19936	8 pts		Abdominal pain upper	below serious				2882
19937	33 pts		Diarrhoea	below serious				2882
19938	12 pts		Flatulence	below serious				2882
19939	5 pts		Steatorrhoea	below serious				2882
19940	6 pts		Bronchitis	below serious				2882
19941	20 pts		Gastroenteritis	below serious				2882
19942	25 pts		Influenza	below serious				2882
19943	6 pts		Sinusitis	below serious				2882
19944	5 pts		Tooth infection	below serious				2882
19945	13 pts		Upper respiratory tract infection	below serious				2882
19946	7 pts		Joint sprain	below serious				2882
19947	16 pts		Back pain	below serious				2882
19948	5 pts		Muscle spasms	below serious				2882
19949	9 pts		Oropharyngeal pain	below serious				2882
19950						No AEs are reported		2884
19951			Fatigue		discontinuation	leads to discontinuation		2886
19952			Weakness generalized		discontinuation	leads to discontinuation		2886
19953			Nausea		discontinuation	leads to discontinuation		2886
19954			Jaundice		discontinuation	leads to discontinuation		2886
19955			Pruritus		discontinuation	leads to discontinuation		2886
19956			Hepatic failure		discontinuation	leads to discontinuation		2886
19957	2 pts		Loose stools		discontinuation	leads to discontinuation		2889
19958	2 pts		Loose stools		discontinuation	leads to discontinuation		2887
19959	1 pts		Rectal oily spotting		discontinuation	leads to discontinuation		2885
19960	1 pts		Flatus		discontinuation	leads to discontinuation		2885
19961	1 pts		Abdominal pain		discontinuation	leads to discontinuation		2885
19962	1 pts		Painful defaecation		discontinuation	leads to discontinuation		2885
19963	1 pts		Fatigue		discontinuation	leads to discontinuation		2888
19964	1 pts		Myocardial infarction		discontinuation	leads to discontinuation		2887
19965	8.8		Gastrointestinal symptom NOS		discontinuation	leads to discontinuation		2881
19966	4 pts		Gastroenteritis	serious				2893
19967	1 pts		Abdominal wall abscess	serious				2893
19968	1 pts		Atrial flutter	serious				2893
19969	1 pts		Oesophageal adenocarcinoma	serious				2893
19970	1 pts		Amnesia	serious				2893
19971	1 pts		Syncope	serious				2893
19972	1 pts		Thalamus haemorrhage	serious				2893
19973	2 pts		Renal impairment	serious				2893
19974	1 pts		Drug interaction	serious				2893
19975	1 pts		Cholecystitis	serious				2893
19976	1 pts		Abnormal sensation in eye	serious				2893
19977	1 pts		Weight decreased	serious				2893
19978	1 pts		Deep vein thrombosis	serious				2893
19979	13 pts		Nausea	below serious				2893
19980	12 pts		Fatigue	below serious				2893
19981	2 pts		Influenza	serious				2892
19982	1 pts		Sinusitis	serious				2892
19983	1 pts		Vomiting	serious				2892
19984	1 pts		Abortion spontaneous	serious				2892
19985	65 pts		Nausea	below serious				2892
19986	26 pts		Rhinorrhoea	below serious				2892
19987	20 pts		Nasal congestion	below serious				2892
19988	31 pts		Pyrexia	below serious				2892
19989	28 pts		Headache	below serious				2892
19990	22 pts		Dizziness	below serious				2892
19991	15 pts		Infusion site pain	below serious				2890
19992	6 pts		Infusion site erythema	below serious				2890
19993	4 pts		Infusion site induration	below serious				2890
19994	2 pts		Vessel puncture site pain	below serious				2890
19995	1 pts		Feeling hot	below serious				2890
19996	1 pts		Infusion site extravasation	below serious				2890
19997	2 pts		Dizziness	below serious				2890
19998	1 pts		Headache	below serious				2890
19999	1 pts		Ecchymosis	below serious				2890
20000	1 pts		Dermatitis seborrhoeic	below serious				2890
20001	1 pts		Constipation	below serious				2890
20002	1 pts		Tinnitus	below serious				2890
20003	1 pts		Visual impairment	below serious				2890
20004	15 pts		Infusion site pain	below serious				2891
20005	10 pts		Infusion site erythema	below serious				2891
20006	2 pts		Infusion site induration	below serious				2891
20007	2 pts		Vessel puncture site pain	below serious				2891
20008	1 pts		Infusion site warmth	below serious				2891
20009	1 pts		Vessel puncture site reaction	below serious				2891
20010	2 pts		Headache	below serious				2891
20011	1 pts		Paraesthesia	below serious				2891
20012	1 pts		Dry skin	below serious				2891
20013	1 pts		Abdominal pain	below serious				2891
20014	1 pts		Diarrhoea	below serious				2891
20015	1 pts		Musculoskeletal chest pain	below serious				2891
20016	1 pts		Musculoskeletal discomfort	below serious				2891
20017	1 pts		Musculoskeletal pain	below serious				2891
20018	1 pts		Nasopharyngitis	below serious				2891
20019						No adverse effects leading to discontinuation were reported		2896
20020						No serious adverse events were reported		2895
20021						No volunteers withdrew prematurely from the 450 mg group		2894
20022	rare		Nausea		discontinuation	Less than 1% of subjects discontinued prematurely from clinical trials due to nausea and vomiting		2897
20023	rare		Vomiting		discontinuation	Less than 1% of subjects discontinued prematurely from clinical trials due to nausea and vomiting		2897
20024			Coma					2900
20025			Drowsiness					2899
20026			Obtundation					2899
20027			Coma			Following an i.v. injection of 1 mg flumazenil, a benzodiazepine antidote, the patient regained consciousness for several minutes. A spontaneous recovery was observed 24 hours later.		2898
20028			Blisters			Skin blisters, attributed to oxazepam toxicity, appeared on the left forearm the following day and regressed spontaneously nine days later.		2898
20029						No AEs are reported		2905
20030	1 pts		Vomiting			POISONING		2904
20031			Dizziness					2903
20032			Tremor					2903
20033			Somnolence					2903
20034			Headache					2903
20035	1 pts		Stevens Johnson syndrome		discontinuation	leads to discontinuation		2908
20036	2.5		Hyponatremia		discontinuation	WARNING		2901
20037	6.4		Dizziness		discontinuation	leads to discontinuation		2902
20038	5.9		Diplopia		discontinuation	leads to discontinuation		2902
20039	5.2		Ataxia		discontinuation	leads to discontinuation		2902
20040	5.1		Vomiting		discontinuation	leads to discontinuation		2902
20041	4.9		Nausea		discontinuation	leads to discontinuation		2902
20042	3.8		Somnolence		discontinuation	leads to discontinuation		2902
20043	2.9		Headache		discontinuation	leads to discontinuation		2902
20044	2.1		Fatigue		discontinuation	leads to discontinuation		2902
20045	2.1		Abnormal vision		discontinuation	leads to discontinuation		2902
20046	1.8		Tremor		discontinuation	leads to discontinuation		2902
20047	1.7		Abnormal gait		discontinuation	leads to discontinuation		2902
20048	1.4		Rash		discontinuation	leads to discontinuation		2902
20049	1		Hyponatremia		discontinuation	leads to discontinuation		2902
20050	2.4		Somnolence		discontinuation	leads to discontinuation		2906
20051	2		Vomiting		discontinuation	leads to discontinuation		2906
20052	1.8		Ataxia		discontinuation	leads to discontinuation		2906
20053	1.3		Diplopia		discontinuation	leads to discontinuation		2906
20054	1.3		Dizziness		discontinuation	leads to discontinuation		2906
20055	1.1		Fatigue		discontinuation	leads to discontinuation		2906
20056	1.1		Nystagmus		discontinuation	leads to discontinuation		2906
20057	3.7		Convulsions		discontinuation	leads to discontinuation		2907
20058	1.2		Status epilepticus		discontinuation	leads to discontinuation		2907
20059	1.2		Ataxia		discontinuation	leads to discontinuation		2907
20060						No information on AE is provided		2909
20061						No AEs are reported		2910
20062	6 pts		Weakness		discontinuation	leads to discontinuation		2913
20063	6 pts		Headache		discontinuation	leads to discontinuation		2913
20064	6 pts		Malaise		discontinuation	leads to discontinuation		2913
20065	6 pts		Fatigue		discontinuation	leads to discontinuation		2913
20066	6 pts		Bad dreams		discontinuation	leads to discontinuation		2913
20067	1 pts		Fluid retention		discontinuation	leads to discontinuation		2913
20068	2 pts		Weakness		discontinuation	leads to discontinuation		2914
20069	2 pts		Headache		discontinuation	leads to discontinuation		2914
20070	2 pts		Malaise		discontinuation	leads to discontinuation		2914
20071	2 pts		Fatigue		discontinuation	leads to discontinuation		2914
20072	2 pts		Bad dreams		discontinuation	leads to discontinuation		2914
20073	1 pts		Fluid retention		discontinuation	leads to discontinuation		2914
20074	1 pts		Headache	severe	discontinuation	leads to discontinuation		2912
20075						impossible to link AEs with the definite dose		2911
20076	40		Hyperphosphatemia		discontinuation	leads to discontinuation		2917
20077	15		Hypercalcemia		discontinuation	leads to discontinuation		2917
20078	25		Plasma parathyroid hormone decreased		discontinuation	leads to discontinuation		2917
20079	29		Hypercalcemia		discontinuation	leads to discontinuation		2915
20080	29		Hypercalciuria		discontinuation	leads to discontinuation		2915
20081	2 pts		Hyperphosphatemia					2916
20082	3 pts		Hypercalcemia					2916
20083	2 pts		Lymphopenia	grade 4			TRUE	2918
20084			Neutropenia	grade 3-4				2918
20085			Fatigue	grade 3-4				2918
20086	1 pts		Neutropenia	grade 4	discontinuation	leads to dose reduction	TRUE	2920
20087	1 pts		Transaminases increased		discontinuation	leads to dose reduction		2919
20088	36		Granulocytopenia	all grades				2923
20089	21		Emesis	all grades				2923
20090	26		Fever	all grades				2923
20091	21		Clinical flare reaction	all grades		transient flare		2923
20092	19		Renal insufficiency	all grades				2923
20093	21		Thrombocytopenia	all grades				2923
20094	7		Diarrhea	all grades				2923
20095	17		Fatigue	all grades				2923
20096	12		Fungal infection	all grades				2923
20097	12		Systemic herpes zoster infection	all grades				2923
20098	24		Infection	all grades				2923
20099	7		Pancreatitis	all grades				2923
20100	2		Bronchospasm	all grades				2923
20101	1		Anaemia	grade 3-4				2922
20102	5		Neutropenia	grade 3-4				2922
20103	3		Thrombocytopenia	grade 3-4				2922
20104	1		Hepatic and hepatobiliary disorders NEC	grade 4				2922
20105	2		Alopecia	grade 1				2922
20106	12		Nausea and vomiting	grade 2-3				2922
20107	4		Diarrhoea	grade 1-2				2922
20108	2		Rash	grade 1-2				2922
20109	3		Conjunctivitis	grade 1-2				2922
20110	9		Infection	grade 2-4				2922
20111	63		Nausea and vomiting			Frontline treatment		2921
20112	46		Fever					2921
20113	43		Rash					2921
20114	42		Fatigue					2921
20115	22		Leukopenia					2921
20116	21		Pruritus					2921
20117	20		Cough increased					2921
20118	19		Myalgia					2921
20119	19		Chills					2921
20120	17		Headache					2921
20121	17		Diarrhea					2921
20122	16		Abdominal pain					2921
20123	13		Anorexia					2921
20124	12		Asthenia					2921
20125	12		Stomatitis					2921
20126	11		Dyspnea					2921
20127	8		Anemia					2921
20128	8		Pain					2921
20129	8		Pharyngitis					2921
20130	8		Sweating increased					2921
20131	8		Viral infection					2921
20132	6		Arthralgia					2921
20133	6		Thrombocytopenia					2921
20134	4		Skin disorder					2921
20135	2		Allergic reaction					2921
20136	2		Hepatic function disorder					2921
20137	1		Neurologic disorder NOS					2921
20138	13		Upper respiratory infection					2921
20139	11		Rhinitis					2921
20140	8		Herpes zoster					2921
20141	8		Pharyngitis					2921
20142	8		Viral infection					2921
20143	7		Infection NOS					2921
20144	6		Sinusitis					2921
20145	6		Cellulitis					2921
20146	5		Bacterial infection					2921
20147	5		Pneumonia					2921
20148	4		Conjunctivitis					2921
20149	4		Furunculosis					2921
20150	4		Herpes simplex					2921
20151	3		Bronchitis					2921
20152	3		Sepsis					2921
20153	3		Urinary tract infection					2921
20154	2		Abscesses of skin					2921
20155	2		Moniliasis oral					2921
20156	<1		Infection mycotic					2921
20157	1		Osteomyelitis					2921
20158	11 pts		Nausea and vomiting	below serious				2925
20159	7 pts		Dyspepsia	below serious				2926
20160	5 pts		Nausea	below serious				2926
20161	5 pts		Reflux gastritis	below serious				2926
20162	3 pts		Headache	below serious				2926
20163	2 pts		Sepsis	below serious				2924
20164	2 pts		Angina	below serious				2924
20165	1 pts		Pneumonia	below serious				2924
20166	1 pts		Bladder infections and inflammations	below serious				2924
20167	1 pts		Upper respiratory infection	below serious				2924
20168	2 pts		Nausea	below serious				2924
20169	1 pts		Refractory shock	grade 5	discontinuation	leads to discontinuation		2928
20170	44 pts		Flushing		discontinuation	leads to discontinuation		2927
20171	44 pts		Hypotension		discontinuation	leads to discontinuation		2927
20172	44 pts		Convulsions		discontinuation	leads to discontinuation		2927
20173	44 pts		Somnolence		discontinuation	leads to discontinuation		2927
20174	44 pts		Loss of consciousness		discontinuation	leads to discontinuation		2927
20175	44 pts		Fever		discontinuation	leads to discontinuation		2927
20176	44 pts		Agitation		discontinuation	leads to discontinuation		2927
20177			Hypotension			WARNING		2929
20178			Tachycardia			WARNING		2929
20179						No AEs were reported		2931
20180						No AEs were reported		2930
20181	2.3		Hypersensitivity		discontinuation	leads to discontinuation		2932
20182			Tremor					2935
20183			Tongue thrust					2935
20184			Drooling					2935
20185			Drowsiness					2935
20186			Slow response to stimuli					2935
20187			Blood pressure decreased					2935
20188			Torsades de pointes					2936
20189			Electrocardiogram QTc interval prolonged					2936
20190						No SAEs were observed		2933
20191			Akathisia		discontinuation			2937
20192			Akinesia		discontinuation			2937
20193			Tremor					2934
20194	1 pts		Chest pain	serious				2944
20195	1 pts		Pancreatic cancer	serious				2944
20196	0.3		Fatigue		discontinuation	leads to discontinuation		2939
20197	0.3		Fatigue		discontinuation	leads to discontinuation		2940
20198	0.1		ALT increased		discontinuation	leads to discontinuation		2940
20199	0.7		Myalgia		discontinuation	leads to discontinuation		2940
20200	0.1		Urinary retention		discontinuation	leads to discontinuation		2940
20201	0.1		Fatigue		discontinuation	leads to discontinuation		2941
20202	0.1		CPK increased		discontinuation	leads to discontinuation		2941
20203	0.1		Pollakiuria		discontinuation	leads to discontinuation		2941
20204	0.2		Fatigue		discontinuation	leads to discontinuation		2945
20205	0.4		CPK increased		discontinuation	leads to discontinuation		2945
20206	0.4		Rhabdomyolysis		discontinuation	leads to discontinuation		2945
20207	2.9		Fatigue		discontinuation	leads to discontinuation		2942
20208	2		Pyrexia		discontinuation	leads to discontinuation		2942
20209	10.8		CPK increased		discontinuation	leads to discontinuation		2942
20210	5.9		ALT increased		discontinuation	leads to discontinuation		2942
20211	4.9		AST increased		discontinuation	leads to discontinuation		2942
20212	2		Back pain		discontinuation	leads to discontinuation		2942
20213	5.9		Myalgia		discontinuation	leads to discontinuation		2942
20214	1		Myopathy		discontinuation	leads to discontinuation		2942
20215	1		Rhabdomyolysis		discontinuation	leads to discontinuation		2942
20216	1		Myoglobinuria		discontinuation	leads to discontinuation		2942
20217	1		Proteinuria		discontinuation	leads to discontinuation		2942
20218	2.9		Gastrointestinal disorders		discontinuation	leads to discontinuation		2943
20219	11.8		ALT increased		discontinuation	leads to discontinuation		2943
20220	11.8		AST increased		discontinuation	leads to discontinuation		2943
20221	2.9		Blood creatine phosphokinase abnormal		discontinuation	leads to discontinuation		2943
20222	5.9		CPK increased		discontinuation	leads to discontinuation		2943
20223	8.8		Myalgia		discontinuation	leads to discontinuation		2943
20224	5.9		Rhabdomyolysis		discontinuation	leads to discontinuation		2943
20225	2.9		Myoglobinuria		discontinuation	leads to discontinuation		2943
20226	2.9		Renal and urinary disorders		discontinuation	leads to discontinuation		2943
20227	3		Gastrointestinal disorders		discontinuation	leads to discontinuation		2938
20228	9.1		Fatigue		discontinuation	leads to discontinuation		2938
20229	9.1		ALT increased		discontinuation	leads to discontinuation		2938
20230	9.1		AST increased		discontinuation	leads to discontinuation		2938
20231	6.1		Aspartate aminotransferase abnormal NOS		discontinuation	leads to discontinuation		2938
20232	12.1		CPK increased		discontinuation	leads to discontinuation		2938
20233	6.1		Blood creatine phosphokinase abnormal		discontinuation	leads to discontinuation		2938
20234	18.2		Myalgia		discontinuation	leads to discontinuation		2938
20235	6.1		Myopathy		discontinuation	leads to discontinuation		2938
20236	3		Pain in extremity		discontinuation	leads to discontinuation		2938
20237	9.1		Rhabdomyolysis		discontinuation	leads to discontinuation		2938
20238	6.1		Renal and urinary disorders		discontinuation	leads to discontinuation		2938
20239	3		Proteinuria		discontinuation	leads to discontinuation		2938
20240	3		Renal failure		discontinuation	leads to discontinuation		2938
20241	49.4		Inflammation					2947
20242	38.3		Skin erosion					2947
20243	54.3		Pain					2947
20244	75.3		Burn					2947
20245	59.3		Itching					2947
20246	29.6		Bleeding					2947
20247	83.2		Inflammation					2949
20248	63		Skin erosion					2949
20249	49.6		Pain					2949
20250	72.3		Burn					2949
20251	52.9		Itching					2949
20252	28.6		Bleeding					2949
20253	79.2		Inflammation					2946
20254	58.3		Skin erosion					2946
20255	79.2		Pain					2946
20256	91.7		Burn					2946
20257	83.3		Itching					2946
20258	45.8		Bleeding					2946
20259	71.4		Inflammation					2951
20260	50		Skin erosion					2951
20261	71.4		Pain					2951
20262	64.3		Burn					2951
20263	57.1		Itching					2951
20264	52.3		Inflammation					2948
20265	40.7		Skin erosion					2948
20266	55.8		Pain					2948
20267	76.7		Burn					2948
20268	60.5		Itching					2948
20269	32.6		Bleeding					2948
20270	81.9		Inflammation					2950
20271	61.4		Skin erosion					2950
20272	50.4		Pain					2950
20273	70.9		Burn					2950
20274	52.8		Itching					2950
20275	26.8		Bleeding					2950
20276	32.2		Inflammation	mild				2952
20277	37.1		Burn	mild				2952
20278	27		Skin erosion	mild				2952
20279	23.7		Pain	mild				2952
20280	32.2		Itching	mild				2952
20281	19.2		Bleeding	mild				2952
20282	30.4		Inflammation	moderate				2952
20283	25.9		Burn	moderate				2952
20284	20.8		Skin erosion	moderate				2952
20285	20.4		Pain	moderate				2952
20286	16		Itching	moderate				2952
20287	3		Bleeding	moderate				2952
20288	9.3		Inflammation	severe				2952
20289	11.5		Burn	severe				2952
20290	8.9		Skin erosion	severe				2952
20291	11.5		Pain	severe				2952
20292	7.8		Itching	severe				2952
20293	0.7		Bleeding	severe				2952
20294	1 pts		Diarrhoea	serious				2953
20295	3 pts		Gastritis	below serious				2953
20296	3 pts		Nausea	below serious				2953
20297	1 pts		Vomiting	below serious				2953
20298	2 pts		Asthenia	below serious				2953
20299	2 pts		Nasopharyngitis	below serious				2953
20300	1 pts		Transaminases increased	below serious				2953
20301	3 pts		Headache	below serious				2953
20302	1 pts		Rash	below serious				2953
20303	67		Hepatic enzyme increased		discontinuation			2954
20304	67		Nausea					2954
20305	67		Vomiting					2954
20306	67		Diarrhea					2954
20307	67		Somnolence					2954
20308	0.84		Rash		discontinuation			2956
20309			Arrhythmia		discontinuation	WARNING		2957
20310			Electrocardiogram QTc interval prolonged		discontinuation	WARNING		2957
20311			Hepatotoxicity		discontinuation	WARNING		2957
20312	2		Nausea		discontinuation			2955
20313	2		Vomiting		discontinuation			2955
20314	2		Hepatic enzymes increased		discontinuation			2955
20315	3		Pulmonary function impairment		discontinuation			2959
20316	7		AIDS		discontinuation			2959
20317	1		Pneumonia		discontinuation			2958
20318						No AEs are reported		2960
20319						No SAEs were observed		2961
20320	1 pts		Thrombosis venous deep	serious				2964
20321	1 pts		Appendectomy	serious				2964
20322	1 pts		Suicide attempt	serious				2964
20323	3 pts		Cardiovascular insufficiency	below serious				2964
20324	18 pts		Skin disorder	below serious				2964
20325	41 pts		Gastrointestinal disturbance	below serious				2964
20326	47 pts		Psychiatric disorders	below serious				2964
20327	1 pts		Lung disorder	below serious				2964
20328						No AEs are reported		2962
20329	1		Vertigo		discontinuation	leads to discontinuation		2963
20330	1		Abdominal pain upper		discontinuation	leads to discontinuation		2963
20331	1		Gastroesophageal reflux disease		discontinuation	leads to discontinuation		2963
20332	1		Intestinal functional disorder		discontinuation	leads to discontinuation		2963
20333	1		Nausea		discontinuation	leads to discontinuation		2963
20334	1		Dizziness		discontinuation	leads to discontinuation		2963
20335	1		Aphasia		discontinuation	leads to discontinuation		2963
20336	1		Headache		discontinuation	leads to discontinuation		2963
20337	1		Renal pain		discontinuation	leads to discontinuation		2963
20338	35 pts		Sedation	below serious				2966
20339	15 pts		Confusion	below serious				2966
20340	25 pts		Dizziness	below serious				2966
20341	3 pts		Headache	below serious				2966
20342	9 pts		Dry mouth	below serious				2966
20343	2 pts		Dizziness	below serious				2977
20344	1 pts		Swelling of legs	below serious				2977
20345	3 pts		Diplopia	below serious				2979
20346	10 pts		Vision blurred	below serious				2979
20347	19 pts		Constipation	below serious				2979
20348	1 pts		Diarrhea	below serious				2979
20349	3 pts		Fatigue	below serious				2979
20350	26 pts		Dizziness	below serious				2979
20351	1 pts		Speech disorder	below serious				2979
20352	1 pts		Agitation	below serious				2979
20353	1 pts		Insomnia	below serious				2979
20354	1 pts		Orgasm abnormal	below serious				2979
20355	1 pts		Hearing loss	below serious				2971
20356	3 pts		Diplopia	below serious				2971
20357	17 pts		Vision blurred	below serious				2971
20358	28 pts		Constipation	below serious				2971
20359	24 pts		Edema limbs	below serious				2971
20360	3 pts		Fatigue	below serious				2971
20361	1 pts		Pain in extremity	below serious				2971
20362	25 pts		Cognitive disturbance	below serious				2971
20363	1 pts		Depressed level of consciousness	below serious				2971
20364	35 pts		Dizziness	below serious				2971
20365	1 pts		Anxiety	below serious				2971
20366	2 pts		Insomnia	below serious				2971
20367	1 pts		Leukopenia	below serious				2965
20368	1 pts		Left ventricular hypertrophy	below serious				2965
20369	1 pts		Uveitis	below serious				2965
20370	3 pts		Vision blurred	below serious				2965
20371	1 pts		Constipation	below serious				2965
20372	1 pts		Dry mouth	below serious				2965
20373	1 pts		Flatulence	below serious				2965
20374	2 pts		Gastritis	below serious				2965
20375	1 pts		Paraesthesia oral	below serious				2965
20376	1 pts		Asthenia	below serious				2965
20377	1 pts		Chills	below serious				2965
20378	1 pts		Gait disturbance	below serious				2965
20379	6 pts		Oedema peripheral	below serious				2965
20380	1 pts		Tinea cruris	below serious				2965
20381	1 pts		Ligament sprain	below serious				2965
20382	1 pts		Meniscus lesion	below serious				2965
20383	1 pts		Tooth fracture	below serious				2965
20384	1 pts		Blood creatinine increased	below serious				2965
20385	1 pts		Blood glucose decreased	below serious				2965
20386	1 pts		Blood pressure diastolic decreased	below serious				2965
20387	1 pts		Blood pressure systolic decreased	below serious				2965
20388	4 pts		Weight increased	below serious				2965
20389	1 pts		Fluid retention	below serious				2965
20390	1 pts		Hypoglycaemia	below serious				2965
20391	4 pts		Increased appetite	below serious				2965
20392	1 pts		Salt craving	below serious				2965
20393	1 pts		Flank pain	below serious				2965
20394	1 pts		Muscle spasms	below serious				2965
20395	1 pts		Muscular weakness	below serious				2965
20396	2 pts		Osteoarthritis	below serious				2965
20397	1 pts		Synovial cyst	below serious				2965
20398	3 pts		Balance disorder	below serious				2965
20399	3 pts		Disturbance in attention	below serious				2965
20400	4 pts		Dizziness	below serious				2965
20401	1 pts		Dizziness postural	below serious				2965
20402	1 pts		Hypersomnia	below serious				2965
20403	1 pts		Muscle contractions involuntary	below serious				2965
20404	1 pts		Neuralgia	below serious				2965
20405	1 pts		Sensory disturbance	below serious				2965
20406	9 pts		Somnolence	below serious				2965
20407	1 pts		Speech disorder	below serious				2965
20408	1 pts		Tremor	below serious				2965
20409	1 pts		Visual field defect	below serious				2965
20410	1 pts		Dysthymic disorder	below serious				2965
20411	1 pts		Euphoric mood	below serious				2965
20412	1 pts		Insomnia	below serious				2965
20413	1 pts		Urinary incontinence	below serious				2965
20414	1 pts		Dysmenorrhoea	below serious				2965
20415	1 pts		Erectile dysfunction	below serious				2965
20416	1 pts		Blister	below serious				2965
20417	1 pts		Photosensitivity reaction	below serious				2965
20418	1 pts		Rash	below serious				2965
20419	1 pts		Debridement	below serious				2965
20420	1 pts		Skin graft	below serious				2965
20421	1 pts		Breast cancer	serious				2972
20422	13 pts		Vision blurred	below serious				2972
20423	36 pts		Constipation	below serious				2972
20424	20 pts		Feeling abnormal	below serious				2972
20425	18 pts		Oedema peripheral	below serious				2972
20426	39 pts		Weight increased	below serious				2972
20427	74 pts		Dizziness	below serious				2972
20428	116 pts		Somnolence	below serious				2972
20429	1 pts		Oxygen saturation decreased	serious				2978
20430	1 pts		Asthma	serious				2978
20431	1 pts		Hypotension	serious				2978
20432	1 pts		Dry mouth	below serious				2978
20433	16 pts		Pyrexia	below serious				2978
20434	2 pts		Headache	below serious				2978
20435	1 pts		Somnolence	below serious				2978
20436	1 pts		Bladder disorder	below serious				2978
20437	3 pts		Cough	below serious				2978
20438	1 pts		Decubitus ulcer	below serious				2978
20439	6 pts		Sedation	below serious				2967
20440	14 pts		Dizziness	below serious				2967
20441	3 pts		Blurred vision	below serious				2967
20442	1 pts		Trauma	serious				2973
20443	6 pts		Tiredness	below serious				2973
20444	4 pts		Chest pain	below serious				2973
20445	1 pts		Cramp	below serious				2973
20446	6 pts		Headache	below serious				2973
20447	13 pts		Dizzy	below serious				2973
20448	6 pts		Blurred vision	below serious				2973
20449	2 pts		Migraine	below serious				2973
20450	4 pts		Upset stomach	below serious				2973
20451	1 pts		Heart racing	below serious				2973
20452	9 pts		Constipation	below serious				2973
20453	2 pts		Mucus stools	below serious				2973
20454	1 pts		Weight gain	below serious				2973
20455	1 pts		Sleep restless	below serious				2973
20456	2 pts		Hemorrhoids	below serious				2973
20457	6 pts		Nausea	below serious				2973
20458	1 pts		General body pain	below serious				2973
20459	1 pts		Chills	below serious				2973
20460	4 pts		Feeling high	below serious				2973
20461	1 pts		Paresthesia of fingers	below serious				2973
20462	2 pts		Feeling of fullness in abdomen	below serious				2973
20463	2 pts		Rash	below serious				2973
20464	1 pts		Itch	below serious				2973
20465	1 pts		Fever	below serious				2973
20466	1 pts		Respiratory symptom	below serious				2973
20467	1 pts		Leg cramps	below serious				2973
20468	1 pts		Dry eyes	below serious				2973
20469	1 pts		Palpitations	below serious				2968
20470	1 pts		Diarrhoea	below serious				2968
20471	2 pts		Dry mouth	below serious				2968
20472	1 pts		Dyspepsia	below serious				2968
20473	1 pts		Vomiting	below serious				2968
20474	1 pts		Chest pain	below serious				2968
20475	1 pts		Chills	below serious				2968
20476	1 pts		Fatigue	below serious				2968
20477	2 pts		Feeling drunk	below serious				2968
20478	1 pts		Oedema peripheral	below serious				2968
20479	2 pts		Pyrexia	below serious				2968
20480	4 pts		Urinary tract infection	below serious				2968
20481	1 pts		Alanine aminotransferase increased	below serious				2968
20482	1 pts		Aspartate aminotransferase increased	below serious				2968
20483	4 pts		Dizziness	below serious				2968
20484	1 pts		Dizziness postural	below serious				2968
20485	3 pts		Headache	below serious				2968
20486	1 pts		Hypoaesthesia	below serious				2968
20487	1 pts		Muscle spasticity	below serious				2968
20488	2 pts		Neuralgia	below serious				2968
20489	5 pts		Somnolence	below serious				2968
20490	1 pts		Tension headache	below serious				2968
20491	1 pts		Euphoric mood	below serious				2968
20492	1 pts		Stress urinary incontinence	below serious				2968
20493	10 pts		Upper respiratory tract infection	below serious				2974
20494	71 pts		Dizziness	below serious				2974
20495	30 pts		Somnolence	below serious				2974
20496	1 pts		Diverticulum intestinal haemorrhagic	serious				2975
20497	6 pts		Constipation	below serious				2975
20498	5 pts		Fatigue	below serious				2975
20499	6 pts		Oedema peripheral	below serious				2975
20500	5 pts		Weight increased	below serious				2975
20501	12 pts		Dizziness	below serious				2975
20502	4 pts		Headache	below serious				2975
20503	3 pts		Somnolence	below serious				2975
20504	4 pts		Tremor	below serious				2975
20505	8 pts		Tiredness	below serious				2969
20506	6 pts		Dizziness	below serious				2969
20507	3 pts		Dry mouth	below serious				2969
20508	3 pts		Constipation	below serious				2969
20509	4 pts		Elevated mood	below serious				2969
20510	1 pts		Death	serious				2976
20511						No AEs are reported		2980
20512	1 pts		Vision blurred	moderate				2981
20513	1 pts		Nausea	moderate				2981
20514	4 pts		Dizziness	mild				2981
20515	1 pts		Dysarthria	moderate				2981
20516	2 pts		Headache	mild				2981
20517	3.47		Dizziness		discontinuation	leads to discontinuation		2970
20518	2.76		Somnolence		discontinuation	leads to discontinuation		2970
20519	0.82		Asthenia		discontinuation	leads to discontinuation		2970
20520	0.72		Confusion		discontinuation	leads to discontinuation		2970
20521	0.61		Peripheral edema		discontinuation	leads to discontinuation		2970
20522	1.12		Headache		discontinuation	leads to discontinuation		2970
20523	0.82		Amblyopia		discontinuation	leads to discontinuation		2970
20524	0.72		Dry mouth		discontinuation	leads to discontinuation		2970
20525	0.72		Nausea		discontinuation	leads to discontinuation		2970
20526	0.41		Infection		discontinuation	leads to discontinuation		2970
20527	0.41		Ataxia		discontinuation	leads to discontinuation		2970
20528	0.41		Neuropathy		discontinuation	leads to discontinuation		2970
20529	0.41		Tremor		discontinuation	leads to discontinuation		2970
20530	0.31		Constipation		discontinuation	leads to discontinuation		2970
20531	0.31		Diarrhea		discontinuation	leads to discontinuation		2970
20532	0.31		Incoordination		discontinuation	leads to discontinuation		2970
20533	0.31		Abnormal thinking		discontinuation	leads to discontinuation		2970
20534			Nausea	acute	discontinuation	Forty-two percent (n = 8) of the patients developed acute side effects including nausea, ataxia, dizziness, confusion with the initial dose of primidone (62.5 mg), and these patients discontinued the therapy.		2984
20535			Ataxia	acute	discontinuation	Forty-two percent (n = 8) of the patients developed acute side effects including nausea, ataxia, dizziness, confusion with the initial dose of primidone (62.5 mg), and these patients discontinued the therapy.		2984
20536			Dizziness	acute	discontinuation	Forty-two percent (n = 8) of the patients developed acute side effects including nausea, ataxia, dizziness, confusion with the initial dose of primidone (62.5 mg), and these patients discontinued the therapy.		2984
20537			Confusion	acute	discontinuation	Forty-two percent (n = 8) of the patients developed acute side effects including nausea, ataxia, dizziness, confusion with the initial dose of primidone (62.5 mg), and these patients discontinued the therapy.		2984
20538			Coma		discontinuation			2982
20539			Crystalluria		discontinuation			2982
20540			Suicidal behavior		discontinuation	WARNING		2983
20541			Suicidal ideation		discontinuation	WARNING		2983
20542	1 pts		Blurred vision		discontinuation	leads to discontinuation		2986
20543	1 pts		QT interval prolonged		discontinuation	leads to discontinuation		2985
20544	0.5		Agranulocytosis	grade 4	discontinuation	Agranulocytosis, bone marrow depression, neutropenia, hypoplastic anemia and thrombocytopenia in patients receiving procainamide hydrochloride have been reported at a rate of approximately 0.5%. Most of these patients received procainamide within the recommended dosage range. Fatalities have occurred (with approximately 20–25 percent mortality in reported cases of agranulocytosis).		2988
20545	0.5		Bone marrow depression			Agranulocytosis, bone marrow depression, neutropenia, hypoplastic anemia and thrombocytopenia in patients receiving procainamide hydrochloride have been reported at a rate of approximately 0.5%. Most of these patients received procainamide within the recommended dosage range. Fatalities have occurred (with approximately 20–25 percent mortality in reported cases of agranulocytosis).		2988
20546	0.5		Neutropenia			Agranulocytosis, bone marrow depression, neutropenia, hypoplastic anemia and thrombocytopenia in patients receiving procainamide hydrochloride have been reported at a rate of approximately 0.5%. Most of these patients received procainamide within the recommended dosage range. Fatalities have occurred (with approximately 20–25 percent mortality in reported cases of agranulocytosis).		2988
20547	0.5		Hypoplastic anemia			Agranulocytosis, bone marrow depression, neutropenia, hypoplastic anemia and thrombocytopenia in patients receiving procainamide hydrochloride have been reported at a rate of approximately 0.5%. Most of these patients received procainamide within the recommended dosage range. Fatalities have occurred (with approximately 20–25 percent mortality in reported cases of agranulocytosis).		2988
20548	0.5		Thrombocytopenia			Agranulocytosis, bone marrow depression, neutropenia, hypoplastic anemia and thrombocytopenia in patients receiving procainamide hydrochloride have been reported at a rate of approximately 0.5%. Most of these patients received procainamide within the recommended dosage range. Fatalities have occurred (with approximately 20–25 percent mortality in reported cases of agranulocytosis).		2988
20549			Nausea		discontinuation	Reduction of the initial dose (4000 mg/day) was necessary in 5 patients because of nausea and vomiting, epigastric pain or insomnia.		2987
20550			Vomiting		discontinuation	Reduction of the initial dose (4000 mg/day) was necessary in 5 patients because of nausea and vomiting, epigastric pain or insomnia.		2987
20551			Insomnia		discontinuation	Reduction of the initial dose (4000 mg/day) was necessary in 5 patients because of nausea and vomiting, epigastric pain or insomnia.		2987
20552			Epigastric pain		discontinuation	Reduction of the initial dose (4000 mg/day) was necessary in 5 patients because of nausea and vomiting, epigastric pain or insomnia.		2987
20553						No AEs are reported		2989
20554						No AEs are reported		2991
20555	1 pts		Pancreatitis					2990
20556	1 pts		Seizure	serious				2995
20557	7 pts		Headache	below serious				2995
20558	7 pts		GI upset	below serious				2995
20559	12 pts		Premature rupture of membranes	serious				2993
20560	21 pts		Cervix disorder	serious				2993
20561	6 pts		Foetal distress	serious				2993
20562	4 pts		Cervical incompetence	serious				2993
20563	4 pts		Pregnancy induced hypertension	serious				2993
20564	2 pts		Oligohydramnios	serious				2993
20565	1 pts		Cholestasis of pregnancy	serious				2993
20566	1 pts		Obstructed labour	serious				2993
20567	1 pts		Placenta accreta	serious				2993
20568	1 pts		Vaginal discharge	serious				2993
20569	9 pts		Cervix cerclage procedure	serious				2993
20570	2 pts		Abdominal pain	serious				2993
20571	1 pts		Gastritis	serious				2993
20572	1 pts		Vomiting	serious				2993
20573	1 pts		Pneumonia	serious				2993
20574	1 pts		Ureaplasma infection	serious				2993
20575	2 pts		Fall	serious				2993
20576	1 pts		Abdominal injury	serious				2993
20577	1 pts		Acute cholecystitis	serious				2993
20578	1 pts		Fetal monitoring	serious				2993
20579	1 pts		Physical assault	serious				2993
20580	13 pts		Abdominal pain	below serious				2993
20581	15 pts		Dyspepsia	below serious				2993
20582	12 pts		Vaginitis bacterial	below serious				2993
20583	17 pts		Vulvovaginal mycotic infection	below serious				2993
20584	15 pts		Vaginal infection	below serious				2993
20585	23 pts		Cervix disorder	below serious				2993
20586	15 pts		Anaemia	below serious				2993
20587	12 pts		Back pain	below serious				2993
20588	14 pts		Gestational diabetes	below serious				2993
20589	13 pts		Premature rupture of membranes	below serious				2993
20590	11 pts		Urinary tract infection	below serious				2993
20591	6 pts		Headache	below serious				2994
20592	3 pts		Dizziness	below serious				2994
20593	2 pts		Nausea	below serious				2994
20594	1 pts		Drowsiness			Side effects were maximal at 1 hour		2997
20595	1 pts		Tiredness			Side effects were maximal at 1 hour		2997
20596	1 pts		Headaches			Side effects were maximal at 1 hour		2997
20597	1 pts		Faint			Side effects were maximal at 1 hour		2997
20598	1 pts		Urinary frequency			Side effects were maximal at 1 hour		2997
20599	8		Fatigue					2992
20600	16		Headache					2992
20601	24		Dizziness					2992
20602	8		Abdominal bloating					2992
20603	20		Abdominal crampy pains					2992
20604	8		Diarrhea					2992
20605	8		Nausea					2992
20606	8		Back pain					2992
20607	12		Musculoskeletal pain					2992
20608	8		Irritability					2992
20609	16		Breast pain					2992
20610	12		Infection viral					2992
20611	8		Coughing					2992
20612			Deep vein thrombosis			WARNING		2996
20613			Pulmonary embolism			WARNING		2996
20614			Stroke			WARNING		2996
20615			Myocardial infarction			WARNING		2996
20616			Dementia			WARNING		2996
20617			Breast cancer			WARNING		2996
20618	6 pts		Bradycardia	below serious				2999
20619	1 pts		Dog bite	below serious				3000
20620	1 pts		Fetal bradycardia	serious				2998
20621	1 pts		Maternal hypotension syndrome	below serious				2998
20622	15 pts		Fetal heart rate deceleration	below serious				2998
20623	22.6		Pyrexia					3001
20624	22.6		Diarrhea					3001
20625	11.1		Vomiting					3001
20626	6.4		Peripheral coldness					3001
20627	6.4		Constipation					3001
20628	3.8		Sleep disorder					3001
20629	7.7		Gastroenteritis					3001
20630	8.6		Insomnia					3001
20631	6.4		Nightmare					3001
20632	3.8		Decreased appetite					3001
20633	1.3		Irritability					3001
20634	3.4		Rhinorrhea					3001
20635	2.1		Flatulence					3001
20636	3		Rash					3001
20637	0.9		Somnolence					3001
20638	1.3		Restlessness					3001
20639	2.1		Hypersomnia					3001
20640	2.1		Abdominal pain					3001
20641	1.3		Agitation					3001
20642	2.6		Insomnia					3001
20643	2.1		Frequent bowel movements					3001
20644	2.1		Erythema					3001
20645	1.3		Hypotension					3001
20646	0.4		Bradycardia					3001
20647	0.4		Bundle branch block right					3001
20648	0.9		Bronchospasm					3001
20649	0.4		Bronchial hyperreactivity					3001
20650	0.4		Hypoglycemia					3001
20651	33.3		Bradycardia	grade 1-2				3003
20652	6.7		Light-headed feeling	grade 1-2				3003
20653	26.7		Weakness	grade 1-2				3003
20654	33.3		Fatigue	grade 1-2				3003
20655	6.7		Nausea	grade 1-2				3003
20656	20		Abdominal pain	grade 1-2				3003
20657	6.7		Vomiting	grade 1-2				3003
20658	6.7		Diarrhoea	grade 1-2				3003
20659	1 pts		Cardiotoxicity		discontinuation	leads to discontinuation		3002
20660	1 pts		Shock		discontinuation	leads to discontinuation		3002
20661						Adverse effects leading to discontinuation are not specified..		3004
20662						No adverse effects were recorded.		3005
20663	3 pts		Muscle twitching	below serious				3008
20664	1 pts		Pruritis	below serious				3008
20665	1 pts		Discoloration urine	below serious				3008
20666	1 pts		Cellulitis	below serious				3008
20667			Abdominal cramps			Overdosage		3007
20668			Diarrhea			Overdosage		3007
20669			Emesis			Overdosage		3007
20670			Nausea			Overdosage		3007
20671			Hypersalivation			Overdosage		3007
20672			Urinary incontinence			Overdosage		3007
20673			Fasciculation			Overdosage		3007
20674			Muscle weakness			Overdosage		3007
20675			Blurred vision			Overdosage		3007
20676						No information on AE is provided		3009
20677	10		Diaphoresis				TRUE	3010
20678	10		Sweating				TRUE	3010
20679	10		Abdominal cramps				TRUE	3010
20680	0.002		Gastrointestinal disturbance		discontinuation			3006
20681	0.002		Headache		discontinuation			3006
20682	0.005		Hypertension		discontinuation			3006
20683	0.005		Allergic reaction		discontinuation			3006
20684	0.007		Bronchitis		discontinuation			3006
20685	0.05		Nausea		discontinuation			3006
20686	0.05		Diarrhea		discontinuation			3006
20687			Convulsions	grade 5	discontinuation	died		3015
20688			Unconsciousness	grade 5	discontinuation	died		3015
20689			Convulsions	severe	discontinuation	died		3014
20690			Vomiting		discontinuation	died		3014
20691			Cyanosis		discontinuation	died		3014
20692			Collapse		discontinuation	died		3014
20693			Convulsions		discontinuation	died		3016
20694			Respiratory failure	grade 5	discontinuation	died		3016
20695			Vomiting		discontinuation	died		3012
20696			Convulsions	severe	discontinuation	died		3012
20697			Cyanosis		discontinuation	died		3012
20698			Cyanosis		discontinuation	died		3011
20699			Vomiting	severe	discontinuation	died		3011
20700			Convulsions		discontinuation	died		3011
20701			Apnoea		discontinuation	died		3011
20702			Haematemesis		discontinuation	died		3011
20703			Cardiac failure	grade 5	discontinuation	died		3011
20704			Folate deficiency		discontinuation	WARNING		3017
20705			Convulsions		discontinuation	WARNING		3013
20706			Abdominal pain		discontinuation	WARNING		3013
20707			Nausea		discontinuation	WARNING		3013
20708			Vomiting	severe	discontinuation	WARNING		3013
20709			Excitability		discontinuation	WARNING		3013
20710			Respiratory depression	grade 5	discontinuation	WARNING		3013
20711			Circulatory collapse	grade 5	discontinuation	WARNING		3013
20712	1 pts		Myocardial infarction	serious				3020
20713	1 pts		Sexual assault victim	serious				3020
20714	1 pts		Panic attack	serious				3020
20715	1 pts		Exacerbation of asthma	serious				3020
20716	1 pts		Weight loss	serious				3019
20717	76		Drowsiness		discontinuation	leads to discontinuation		3026
20718	56		Tachycardia		discontinuation	leads to discontinuation		3026
20719	18		Hypotension		discontinuation	leads to discontinuation		3026
20720	10		Coma		discontinuation	leads to discontinuation		3026
20721	6		Agitation		discontinuation	leads to discontinuation		3026
20722	5		Respiratory depression		discontinuation	leads to discontinuation		3026
20723	2		Seizures		discontinuation	leads to discontinuation		3026
20724	4		Electrocardiogram QTc interval prolonged		discontinuation	leads to discontinuation		3026
20725	3 pts		Death	grade 5	discontinuation	leads to discontinuation		3026
20726	1 pts		Bladder distension		discontinuation	leads to discontinuation		3021
20727	1 pts		Unconscious		discontinuation	leads to discontinuation		3025
20728	1 pts		Incontinent		discontinuation	leads to discontinuation		3025
20729	1 pts		Postural hypotension		discontinuation	leads to discontinuation		3025
20730	1 pts		Sinus tachycardia		discontinuation	leads to discontinuation		3025
20731	9 pts		Somnolence		discontinuation	leads to discontinuation		3027
20732	9 pts		Tachycardia		discontinuation	leads to discontinuation		3027
20733	9 pts		Respiratory depression		discontinuation	leads to discontinuation		3027
20734	13 pts		Somnolence					3023
20735	10 pts		Dizziness					3023
20736	4 pts		Constipation					3023
20737	1 pts		Tongue paralysis					3023
20738	1 pts		Dry mouth					3023
20739	80		Fatigue					3018
20740	47		Somnolence					3018
20741	1 pts		LBBB		discontinuation	leads to discontinuation		3024
20742	26 pts		Agitation					3022
20743	24 pts		Somnolence					3022
20744	18 pts		Headache					3022
20745	11 pts		Dizziness					3022
20746	11 pts		Constipation					3022
20747	10 pts		Insomnia					3022
20748	7 pts		Tachycardia					3022
20749	7 pts		Pain					3022
20750	7 pts		Pharyngitis					3022
20751	7 pts		Rash					3022
20752	6 pts		Alanine aminotransferase increased					3022
20753	6 pts		Dry mouth					3022
20754	6 pts		Dyspepsia					3022
20755	6 pts		Nausea					3022
20756	5 pts		Asthenia					3022
20757	1 pts		Vomiting					3022
20758						No adverse effects leading to discontinuation were reported		3028
20759						There were no deaths or serious adverse events reported during the study, and all patients completed the study.		3029
20760						There were no clinically significant effects on patient laboratory tests or serious adverse events.		3030
20761	1 pts		Dry mouth	below serious				3037
20762	1 pts		Hematochezia	below serious				3037
20763	1 pts		Fatigue	below serious				3037
20764	1 pts		Sinus infection	below serious				3037
20765	1 pts		Dizziness	below serious				3037
20766	2 pts		Headache	below serious				3037
20767	2 pts		Sore throat	below serious				3037
20768	1 pts		Constipation	below serious				3037
20769	1 pts		Nausea	below serious				3037
20770	1 pts		Urinary tract infection	below serious				3037
20771	1 pts		Rhinorrhea	below serious				3037
20772	1 pts		Depression	serious				3038
20773	1 pts		Anxiety	below serious				3038
20774	1 pts		Nightmares	below serious				3038
20775	1 pts		Diarrhea NOS	below serious				3039
20776	1 pts		Dizziness	below serious				3039
20777	1 pts		Insomnia exacerbated	below serious				3039
20778	3 pts		Somnolence	below serious				3039
20779	3 pts		Vivid dreams	below serious				3039
20780	4 pts		Headache	below serious				3032
20781	2 pts		Pain in extremity	below serious				3033
20782	2 pts		Blood creatine phosphokinase increased	below serious				3035
20783	3 pts		Headache	below serious				3035
20784	1 pts		Eosinophilia	below serious				3034
20785	1 pts		Leukopenia	below serious				3034
20786	1 pts		Eye pain	below serious				3034
20787	1 pts		Abdominal pain	below serious				3034
20788	2 pts		Fatigue	below serious				3034
20789	1 pts		Inflammation	below serious				3034
20790	1 pts		Irritability	below serious				3034
20791	1 pts		Malaise	below serious				3034
20792	1 pts		Oedema peripheral	below serious				3034
20793	1 pts		Herpes zoster	below serious				3034
20794	1 pts		Influenza	below serious				3034
20795	1 pts		Respiratory tract infection viral	below serious				3034
20796	1 pts		Rhinitis	below serious				3034
20797	1 pts		Excoriation	below serious				3034
20798	1 pts		Hand fracture	below serious				3034
20799	3 pts		Blood creatine phosphokinase increased	below serious				3034
20800	1 pts		Transaminases increased	below serious				3034
20801	1 pts		Back pain	below serious				3034
20802	6 pts		Somnolence	below serious				3034
20803	1 pts		Abnormal dreams	below serious				3034
20804	1 pts		Early morning awakening	below serious				3034
20805	1 pts		Night sweats	below serious				3034
20806	1 pts		Photosensitivity reaction	below serious				3034
20807	1 pts		Pruritus	below serious				3034
20808	1 pts		Skin ulcer	below serious				3040
20809	1 pts		Paranasal sinus infection	below serious				3040
20810	1 pts		Diarrhea	below serious				3040
20811	1 pts		Fracture	below serious				3040
20812	11 pts		Headache	below serious				3036
20813	12 pts		Insomnia	below serious				3036
20814	12.7		Somnolence					3042
20815	1.6		Malaise					3042
20816	3.2		Dizziness					3042
20817	4.8		Nasopharyngitis					3042
20818						drug-abuse		3043
20819						No AEs are reported		3041
20820	0.8		Somnolence		discontinuation	leads to discontinuation		3031
20821	0.5		Dizziness		discontinuation	leads to discontinuation		3031
20822	0.3		Nausea		discontinuation	leads to discontinuation		3031
20823	0.3		Fatigue		discontinuation	leads to discontinuation		3031
20824	0.3		Headache		discontinuation	leads to discontinuation		3031
20825	0.3		Insomnia		discontinuation	leads to discontinuation		3031
20826	6		Dizziness			Dizziness/vertigo		3045
20827	6		Vertigo			Dizziness/vertigo		3045
20828	4		Asthenia					3045
20829	3		Nausea					3045
20830	2		Headache					3045
20831	1		Abdominal pain					3045
20832	1		Gastrointestinal disorder					3045
20833	1		Rash					3045
20834	1		Cough increased					3045
20835	13		Headache					3044
20836	33		Cough					3044
20837	13		Dizziness					3044
20838	19		Asthenia					3044
20839	4		Cramps					3044
20840	4		Diarrhea					3044
20841	8		Nausea					3044
20842	1		Palpitations					3044
20843	1		Dyspnea					3044
20844	1		Tinnitus					3044
20845	3		Malaise					3044
20846	1		Pruritus					3044
20847	1		Dry mouth					3044
20848	3		Polyuria					3044
20849	1 pts		Myocardial infarction	serious				3049
20850	4 pts		Hypoglycaemia	below serious				3050
20851	3 pts		Nausea	below serious				3050
20852	2 pts		Abdominal pain	below serious				3050
20853	3 pts		Dizziness	below serious				3050
20854	2 pts		Insomnia	below serious				3050
20855	2 pts		Asthenia	below serious				3050
20856	1 pts		Non STEMI	serious				3048
20857	1 pts		Bronchospasm	serious				3047
20858	1 pts		Syncope	serious				3048
20859	1 pts		Chest pain	serious				3048
20860	1 pts		Shaking of hands	below serious				3048
20861	1 pts		Back pain	below serious				3048
20862	1 pts		Kidney disorder	below serious				3048
20863	1 pts		Excess sweating	below serious				3048
20864	1 pts		Heart failure	serious				3051
20865	1 pts		Stroke	serious				3051
20866	2 pts		Nausea	below serious				3051
20867	3 pts		Dizziness	below serious				3051
20868	2 pts		Constipation	below serious				3051
20869	3 pts		Nausea	below serious				3052
20870	1 pts		Dizziness	below serious				3052
20871	1 pts		Hypoglycemia	below serious				3053
20872	1 pts		Function kidney abnormal	below serious				3053
20873	1 pts		Transaminitis	below serious				3053
20874	1 pts		Nephrolithiasis	below serious				3053
20875	2 pts		Nausea	below serious				3054
20876	1 pts		Hyponatremia	below serious				3054
20877	1 pts		Fatigue	below serious				3054
20878	1 pts		Face edema	below serious				3054
20879	3 pts		Dizziness	below serious				3057
20880	2 pts		Nausea	below serious				3057
20881	2 pts		Nausea	below serious				3055
20882	1 pts		Urine discoloration	below serious				3055
20883	1 pts		Weakness in extremity	below serious				3055
20884	1 pts		Appetite lost	below serious				3055
20885	1 pts		Muscle spasm	below serious				3055
20886	1 pts		Sleep restless	below serious				3055
20887	1 pts		Tenosynovitis	below serious				3055
20888	1 pts		Fatigue	below serious				3055
20889	1 pts		Bloating	below serious				3055
20890	1 pts		Dry mouth	below serious				3055
20891	1 pts		Cold sweat	below serious				3056
20892	1 pts		Dissociation	below serious				3056
20893	1 pts		Palpitations	below serious				3056
20894	1 pts		Pharyngitis	below serious				3056
20895	1 pts		Somnolence	below serious				3056
20896	12.3		Dizziness					3058
20897	8.6		Nausea					3058
20898	6.4		Asthenia					3058
20899	4.3		Constipation					3058
20900	3.2		Angina pectoris					3058
20901	2.7		Headache					3058
20902	2.7		Sweating					3058
20903						No AEs are reported		3059
20904			Electrocardiogram QTc interval prolonged	grade 5				3060
20905	1.3		Dizziness		discontinuation	leads to discontinuation		3046
20906	1		Nausea		discontinuation	leads to discontinuation		3046
20907	0.5		Asthenia		discontinuation	leads to discontinuation		3046
20908	0.5		Constipation		discontinuation	leads to discontinuation		3046
20909	0.5		Headache		discontinuation	leads to discontinuation		3046
20910			Hypoglycemia		discontinuation	WARNING		3061
20911	1 pts		Nonprotein nitrogen blood increased		discontinuation	leads to discontinuation		3063
20912	1 pts		Abdominal pain		discontinuation	leads to discontinuation		3063
20913	1 pts		Tenderness		discontinuation	leads to discontinuation		3063
20914	1 pts		Anorexia		discontinuation	leads to discontinuation		3063
20915	1 pts		Pancreatic enzymes increased		discontinuation	leads to discontinuation		3063
20916	1 pts		Pancreatitis		discontinuation	leads to discontinuation		3063
20917	3 pts		CNS disorder (NOS)	severe				3062
20918	3 pts		Fatigue					3062
20919	1 pts		Nausea		discontinuation	leads to discontinuation		3062
20920	1 pts		Vomiting		discontinuation	leads to discontinuation		3062
20921	1 pts		Headache	severe	discontinuation	leads to discontinuation		3062
20922	1 pts		Hematocrit low		discontinuation	leads to discontinuation		3062
20923	1 pts		Hyperuricemia	severe	discontinuation	leads to discontinuation		3066
20924	1 pts		Injury to kidney	acute	discontinuation	leads to discontinuation		3066
20925						WARNING		3065
20926			Fetal death	grade 5		WARNING		3064
20927	4		Abdominal pain					3067
20928	1		Asthenia					3067
20929	1		Chest pain					3067
20930	2		Fever					3067
20931	3		Headache					3067
20932	1		Pain					3067
20933	2		Anorexia					3067
20934	3		Diarrhea					3067
20935	3		Dyspepsia					3067
20936	3		Eructation					3067
20937	2		Flatulence					3067
20938	6		Nausea					3067
20939	3		Nausea and vomiting					3067
20940	1		Vomiting					3067
20941	2		Myalgia					3067
20942	1		Insomnia					3067
20943	11		Rash					3067
20944	3		Taste perversion					3067
20945	30		Urine discoloration					3067
20946	<1		Alkaline phosphatase increased					3067
20947	7		SGOT increased					3067
20948	9		SGPT increased					3067
20949	6		Anemia					3067
20950	1		Eosinophilia					3067
20951	17		Leukopenia					3067
20952	25		Neutropenia					3067
20953	5		Thrombocytopenia					3067
20954						impossible to link dose with AEs: Alkaline phosphatase increased modestly in 7 patients. One patient developed an acute, drug induced, flu-like syndrome with marked elevation of liver enzymes which resolved promptly with drug withdrawal.		3068
20955	1 pts		Skin red			attempt to suicide		3070
20956						No information on AE is provided		3069
20957	1 pts		Skin red	grade 5		attempt to suicide		3071
20958	1 pts		Hyperemesis	grade 5		attempt to suicide		3071
20959	1 pts		Pruritus	grade 5		attempt to suicide		3071
20960	4 pts		Anaemia	serious				3072
20961	1 pts		Disseminated intravascular coagulation	serious				3072
20962	1 pts		Acute myocardial infarction	serious				3072
20963	1 pts		Cardiac arrest	serious				3072
20964	1 pts		Endophthalmitis	serious				3072
20965	1 pts		Abdominal hernia	serious				3072
20966	2 pts		Abdominal pain	serious				3072
20967	1 pts		Gastritis	serious				3072
20968	1 pts		Lower gastrointestinal haemorrhage	serious				3072
20969	1 pts		Nausea	serious				3072
20970	4 pts		Oesophageal varices haemorrhage	serious				3072
20971	3 pts		Vomiting	serious				3072
20972	1 pts		Chest pain	serious				3072
20973	3 pts		Generalised oedema	serious				3072
20974	1 pts		Pyrexia	serious				3072
20975	1 pts		Biliary cirrhosis primary	serious				3072
20976	1 pts		Cirrhosis alcoholic	serious				3072
20977	1 pts		Portal vein thrombosis	serious				3072
20978	1 pts		Liver transplant rejection	serious				3072
20979	3 pts		Cellulitis	serious				3072
20980	2 pts		Clostridium colitis	serious				3072
20981	1 pts		Gastroenteritis	serious				3072
20982	4 pts		Pneumonia	serious				3072
20983	2 pts		Urinary tract infection	serious				3072
20984	1 pts		Decreased appetite	serious				3072
20985	1 pts		Fluid overload	serious				3072
20986	2 pts		Hyperkalaemia	serious				3072
20987	2 pts		Syncope	serious				3072
20988	1 pts		Suicidal ideation	serious				3072
20989	1 pts		Chronic obstructive pulmonary disease	serious				3072
20990	1 pts		Hydrothorax	serious				3072
20991	2 pts		Pleural effusion	serious				3072
20992	1 pts		Respite care	serious				3072
20993	7 pts		Anaemia	below serious				3072
20994	15 pts		Ascites	below serious				3072
20995	9 pts		Abdominal pain upper	below serious				3072
20996	8 pts		Pyrexia	below serious				3072
20997	21 pts		Oedema peripheral	below serious				3072
20998	13 pts		Muscle spasms	below serious				3072
20999	9 pts		Arthralgia	below serious				3072
21000	18 pts		Dizziness	below serious				3072
21001	10 pts		Depression	below serious				3072
21002	9 pts		Dyspnoea	below serious				3072
21003	13 pts		Pruritus	below serious				3072
21004	7 pts		Rash	below serious				3072
21005	1 pts		Meningitis	serious				3073
21006	1 pts		Atrial fibrillation	serious				3073
21007	1 pts		Non-cardiac chest pain	serious				3073
21008	1 pts		Intervertebral disc displacement	serious				3073
21009	1 pts		Hypoaesthesia	serious				3073
21010	1 pts		Hypertension	serious				3073
21011	13 pts		Diarrhoea	below serious				3073
21012	10 pts		Sinusitis	below serious				3073
21013	1 pts		Road traffic accident	serious				3074
21014	1 pts		Costochondritis	serious				3074
21015	1 pts		Alcohol withdrawal syndrome	serious				3074
21016	22 pts		Nausea	below serious				3074
21017	11 pts		Vomiting	below serious				3074
21018	7 pts		Urinary tract infection	below serious				3074
21019	18 pts		Headache	below serious				3074
21020	9 pts		Cough	below serious				3074
21021	7 pts		Nasal congestion	below serious				3074
21022						No adverse reactions leading to discontinuation were reported		3076
21023						Drug-related AEs leading to discontinuation - 10%, but they are not indicated		3075
21024						No adverse reactions leading to discontinuation were reported		3078
21025			Taste loss		discontinuation			3077
21026			Dysentery		discontinuation			3077
21027			Weight decrease		discontinuation			3077
21028			Anorexia		discontinuation			3077
21029			Nausea		discontinuation			3077
21030			Nasal passage irritation		discontinuation			3077
21031	5 pts		Gastrointestinal disorder (NOS)	below serious				3080
21032	3 pts		Dizziness	below serious				3080
21033	1 pts		Dry mouth	below serious				3080
21034	5 pts		Sleep problem	below serious				3080
21035	2 pts		Memory loss of	below serious				3080
21036	2 pts		Suicidal ideation	below serious				3080
21037	3 pts		Mental concentration difficulty	below serious				3080
21038	3 pts		Fatigue	below serious				3080
21039	1 pts		Skin irritation	below serious				3080
21040	2 pts		Gastrointestinal symptom NOS	below serious				3079
21041	2		Ocular pain		discontinuation	leads to discontinuation		3081
21042	1 pts		Atrioventricular block third degree	serious				3083
21043	1 pts		Cystitis	serious				3083
21044	2 pts		Dehydration	serious				3083
21045	1 pts		Immune hemolytic anemia drug-induced	serious				3083
21046	1 pts		Pain NOS	serious				3083
21047	1 pts		Fibrosis pulmonary	serious				3083
21048	1 pts		Hyponatremia	serious				3083
21049	3 pts		Anorexia	below serious				3083
21050	2 pts		Arthritis	below serious				3083
21051	1 pts		Bruising	below serious				3083
21052	1 pts		Cataract	below serious				3083
21053	8 pts		Constipation	below serious				3083
21054	4 pts		Constitutional syndrome	below serious				3083
21055	5 pts		Diarrhea	below serious				3083
21056	3 pts		Dry skin	below serious				3083
21057	1 pts		Swallowing difficult	below serious				3083
21058	1 pts		Gastritis	below serious				3083
21059	2 pts		Hair loss	below serious				3083
21060	6 pts		Heartburn-like dyspepsia	below serious				3083
21061	16 pts		Hot flashes	below serious				3083
21062	1 pts		Hypotension	below serious				3083
21063	1 pts		Incontinence urinary	below serious				3083
21064	2 pts		Infection	below serious				3083
21065	1 pts		Urinary tract infection NOS	below serious				3083
21066	1 pts		Urethral anastomotic leak	below serious				3083
21067	1 pts		Muscle weakness	below serious				3083
21068	1 pts		Muscle weakness	below serious				3083
21069	2 pts		Nail changes	below serious				3083
21070	5 pts		Nausea	below serious				3083
21071	1 pts		Motor polyneuropathy	below serious				3083
21072	1 pts		Otitis media serous	below serious				3083
21073	10 pts		Back pain	below serious				3083
21074	1 pts		Breast pain	below serious				3083
21075	5 pts		Pain in extremity	below serious				3083
21076	2 pts		Head pain	below serious				3083
21077	5 pts		Joint pain	below serious				3083
21078	2 pts		Muscle pain	below serious				3083
21079	3 pts		Neck pain	below serious				3083
21080	2 pts		Pain NOS	below serious				3083
21081	1 pts		Penile pain	below serious				3083
21082	3 pts		Pain	below serious				3083
21083	2 pts		Rash acneiform	below serious				3083
21084	1 pts		Restrictive cardiomyopathy	below serious				3083
21085	2 pts		Embolism and thrombosis	below serious				3083
21086	1 pts		Dysarthria	below serious				3083
21087	1 pts		Watering eyes	below serious				3083
21088	2 pts		Weight loss	below serious				3083
21089	1 pts		Radius fracture	serious				3084
21090	1 pts		Skeletal injury	serious				3084
21091	1 pts		Gastrointestinal disorder	serious				3084
21092	1 pts		Appendicitis	serious				3084
21093	1 pts		Cervical root pain	serious				3084
21094	1 pts		Depression	serious				3084
21095	1 pts		Panic reaction	serious				3084
21096	1 pts		Urinary bladder polyp	serious				3084
21097	7 pts		Bronchitis	below serious				3084
21098	4 pts		Abdominal pain upper	below serious				3084
21099	4 pts		Periodontitis	below serious				3084
21100	3 pts		Constipation	below serious				3084
21101	3 pts		Dental caries	below serious				3084
21102	3 pts		Dyspepsia	below serious				3084
21103	8 pts		Arthralgia	below serious				3084
21104	3 pts		Bone pain	below serious				3084
21105	3 pts		Neck pain	below serious				3084
21106	4 pts		Fall	below serious				3084
21107	3 pts		Contusion	below serious				3084
21108	5 pts		Hypertension	below serious				3084
21109	3 pts		Hot flush	below serious				3084
21110	3 pts		Anaemia	below serious				3084
21111	1 pts		Blood pressure increased	below serious				3082
21112	1 pts		Ear infection	below serious				3082
21113	4 pts		Back pain	below serious				3086
21114	1 pts		Abscess	below serious				3086
21115	1 pts		Asthenia	below serious				3086
21116	1 pts		Insomnia	below serious				3086
21117	1 pts		Neurosis	below serious				3086
21118	1 pts		Sleep disorder	below serious				3086
21119	2 pts		Dyspnea	below serious				3086
21120	1 pts		Bronchitis	below serious				3086
21121	1 pts		Epistaxis	below serious				3086
21122	1 pts		Pharyngitis	below serious				3086
21123	1 pts		Atrial fibrillation	below serious				3086
21124	1 pts		Peripheral vascular disease	below serious				3086
21125	2 pts		Leg cramps	below serious				3086
21126	1 pts		Bone fracture (not spontaneous)	below serious				3086
21127	1 pts		Eczema	below serious				3086
21128	2 pts		Conjunctivitis	below serious				3086
21129	1 pts		Glaucoma	below serious				3086
21130	1 pts		Flatulence	below serious				3086
21131	1 pts		Anemia iron deficiency	below serious				3086
21132	5 pts		Nausea	below serious				3085
21133	1 pts		Upset stomach	below serious				3085
21134	2 pts		Diarrhea	below serious				3085
21135	4 pts		Pain	below serious				3085
21136	3 pts		Constipation	below serious				3085
21137	1.7		Skin rash		discontinuation			3091
21138	1.7		Gastrointestinal upset		discontinuation			3091
21139	1		Vomiting		discontinuation			3092
21140	1		Diarrhea		discontinuation			3092
21141	0.2		Vomiting		discontinuation			3089
21142	0.3		Diarrhea		discontinuation			3088
21143	2.5		Abdominal pain upper		discontinuation			3087
21144	0.8		Diarrhea		discontinuation			3087
21145	0.3		Vomiting		discontinuation			3087
21146	1.4		Abdominal pain upper		discontinuation			3090
21147	0.3		Vomiting		discontinuation			3090
21148	8 pts		Suicidal ideation	serious				3098
21149	1 pts		Oedema peripheral	serious				3098
21150	3 pts		Appendicitis	serious				3098
21151	3 pts		Infection	serious				3098
21152	3 pts		Increased appetite	below serious				3096
21153	4 pts		Common cold	below serious				3096
21154	4 pts		Sexual dysfunction	below serious				3096
21155	2 pts		Insomnia	below serious				3096
21156	3 pts		Dizziness	below serious				3096
21157	6 pts		Dry mouth	below serious				3096
21158	2 pts		Rhinorrhea	below serious				3096
21159	2 pts		Sore throat	below serious				3096
21160	9 pts		Fatigue	below serious				3096
21161	9 pts		Somnolence	below serious				3096
21162	2 pts		Urination abnormal NOS	below serious				3096
21163	2 pts		Fever	below serious				3096
21164	2 pts		Akathisia	below serious				3096
21165	1 pts		Tardive dyskinesia	below serious				3096
21166	1 pts		Chest pain	serious				3099
21167	9 pts		Nausea	below serious				3099
21168	13 pts		Constipation	below serious				3099
21169	7 pts		Weight increased	below serious				3099
21170	21 pts		Extrapyramidal disorder	below serious				3099
21171	12 pts		Akathisia	below serious				3099
21172	16 pts		Sedation	below serious				3099
21173	8 pts		Dizziness	below serious				3099
21174	10 pts		Tremor	below serious				3099
21175	21 pts		Insomnia	below serious				3099
21176	1 pts		Homicidal ideation	serious				3097
21177	1 pts		Schizophrenia	serious				3097
21178	1 pts		Suicidal ideation	serious				3097
21179	1 pts		Tachycardia	below serious				3097
21180	1 pts		Cerumen impaction	below serious				3097
21181	2 pts		Ear pain	below serious				3097
21182	2 pts		Abdominal pain	below serious				3097
21183	1 pts		Abdominal pain upper	below serious				3097
21184	3 pts		Nausea	below serious				3097
21185	1 pts		Feeling jittery	below serious				3097
21186	1 pts		Nasopharyngitis	below serious				3097
21187	1 pts		Rhinitis	below serious				3097
21188	1 pts		Sinusitis	below serious				3097
21189	2 pts		Upper respiratory tract infection	below serious				3097
21190	1 pts		Blood insulin increased	below serious				3097
21191	2 pts		Back pain	below serious				3097
21192	1 pts		Joint swelling	below serious				3097
21193	1 pts		Musculoskeletal stiffness	below serious				3097
21194	1 pts		Pain in extremity	below serious				3097
21195	1 pts		Akathisia	below serious				3097
21196	9 pts		Headache	below serious				3097
21197	1 pts		Anxiety	below serious				3097
21198	1 pts		Suicidal ideation	below serious				3097
21199	1 pts		Nocturia	below serious				3097
21200	1 pts		Pollakiuria	below serious				3097
21201	1 pts		Polyuria	below serious				3097
21202	1 pts		Galactorrhoea	below serious				3097
21203	1 pts		Nasal congestion	below serious				3097
21204	1 pts		Swelling face	below serious				3097
21205	1.4		Dizziness		discontinuation			3095
21206	1.4		Nausea		discontinuation			3095
21207	1.1		Agitation		discontinuation			3095
21208	0.8		Parkinsonism		discontinuation			3095
21209	0.8		Somnolence		discontinuation			3095
21210	0.5		Dystonia		discontinuation			3095
21211	0.5		Abdominal pain		discontinuation			3095
21212	0.3		Hypotension postural		discontinuation			3095
21213	0.3		Tachycardia		discontinuation			3095
21214	1		Dizziness		discontinuation			3093
21215	1		Agitation		discontinuation			3093
21216	0.5		Somnolence		discontinuation			3093
21217	0.5		Hypotension postural		discontinuation			3093
21218	0.5		Tachycardia		discontinuation			3093
21219	1		Akathisia		discontinuation			3093
21220	0.4		Parkinsonism		discontinuation			3094
21221	0.2		Somnolence		discontinuation			3094
21222	0.2		Dizziness		discontinuation			3094
21223	0.2		Dystonia		discontinuation			3094
21224	0.2		SGOT increased		discontinuation			3094
21225	0.2		SGPT increased		discontinuation			3094
21226	2		Somnolence		discontinuation			3100
21227	2		Dizziness		discontinuation			3100
21228	1		Anorexia		discontinuation			3100
21229	1		Anxiety		discontinuation			3100
21230	1		Ataxia		discontinuation			3100
21231	1		Hypotension		discontinuation			3100
21232	1		Palpitation		discontinuation			3100
21233	5		Somnolence		discontinuation			3101
21234	3		Nausea		discontinuation			3101
21235	2		Abdominal pain		discontinuation			3101
21236	2		Vomiting		discontinuation			3101
21237			Gastrointestinal disorder NOS					3102
21238			Lipids abnormal					3102
21239			Insulin resistance					3102
21240			Lipoatrophy					3102
21241	1 pts		Hypertension	grade 2	discontinuation	leads to discontinuation		3104
21242	1 pts		Death fetal		discontinuation	leads to discontinuation		3103
21243	3.1		Headache				TRUE	3106
21244	3.1		Malaise				TRUE	3106
21245	9.4		Oedema legs				TRUE	3106
21246	3.1		Pain in leg		discontinuation			3106
21247			Macular edema		discontinuation			3105
21248			Congestive heart failure		discontinuation	WARNING		3107
21249	2		Myocardial ischemia		discontinuation	WARNING		3107
21250			Fluid retention		discontinuation	WARNING		3107
21251			Edema		discontinuation	WARNING		3107
21252			Weight gain		discontinuation	WARNING		3107
21253			Anemia		discontinuation	WARNING		3107
21254			Macular edema		discontinuation	WARNING		3107
21255			Fracture bone		discontinuation	WARNING. Increased incidence of bone fracture in female patients		3107
21256	1 pts		Chest pain	serious				3116
21257	5 pts		Dry mouth	below serious				3116
21258	34 pts		Nausea	below serious				3116
21259	13 pts		Vomiting	below serious				3116
21260	6 pts		Application site irritation	below serious				3116
21261	5 pts		Fatigue	below serious				3116
21262	7 pts		Upper respiratory tract infection	below serious				3116
21263	10 pts		Dizziness	below serious				3116
21264	13 pts		Headache	below serious				3116
21265	8 pts		Somnolence	below serious				3116
21266	6 pts		Insomnia	below serious				3116
21267	3 pts		Hiccups	below serious				3116
21268	4 pts		Pruritus	below serious				3116
21269	1 pts		Cholelithiasis	serious				3115
21270	4 pts		Abdominal pain upper	below serious				3115
21271	8 pts		Diarrhoea	below serious				3115
21272	7 pts		Dry mouth	below serious				3115
21273	48 pts		Nausea	below serious				3115
21274	18 pts		Vomiting	below serious				3115
21275	5 pts		Application site irritation	below serious				3115
21276	11 pts		Application site pruritus	below serious				3115
21277	2 pts		Upper respiratory tract infection	below serious				3115
21278	8 pts		Dizziness	below serious				3115
21279	7 pts		Somnolence	below serious				3115
21280	4 pts		Anxiety	below serious				3115
21281	7 pts		Insomnia	below serious				3115
21282	4 pts		Hiccups	below serious				3115
21283	4 pts		Pruritus	below serious				3115
21284	1 pts		Diarrhoea	serious				3108
21285	1 pts		Cholecystitis	serious				3108
21286	1 pts		Urosepsis	serious				3108
21287	1 pts		Ankle fracture	serious				3108
21288	1 pts		Intervertebral disc protrusion	serious				3108
21289	1 pts		Syncope	serious				3108
21290	1 pts		Abortion	serious				3108
21291	1 pts		Hallucination, visual	serious				3108
21292	1 pts		Sleep attacks	serious				3108
21293	1 pts		Benign prostatic hyperplasia	serious				3108
21294	41 pts		Nausea	below serious				3108
21295	20 pts		Dizziness	below serious				3108
21296	13 pts		Headache	below serious				3108
21297	15 pts		Dyskinesia	below serious				3108
21298	1 pts		Bundle branch block left	serious				3111
21299	1 pts		Gastrointestinal haemorrhage	serious				3111
21300	1 pts		Orchitis	serious				3111
21301	1 pts		Mental status changes	serious				3111
21302	1 pts		Aspiration pneumonia	serious				3111
21303	1 pts		Acetabulum fracture	serious				3111
21304	1 pts		Pubic rami fracture	serious				3111
21305	13 pts		Nausea	below serious				3111
21306	3 pts		Dry mouth	below serious				3111
21307	7 pts		Fatigue	below serious				3111
21308	4 pts		Application site pruritus	below serious				3111
21309	4 pts		Application site erythema	below serious				3111
21310	7 pts		Urinary tract infection	below serious				3111
21311	5 pts		Dyskinesia	below serious				3111
21312	5 pts		Confusional state	below serious				3111
21313	1 pts		Fall	serious				3117
21314	1 pts		Joint injury	serious				3117
21315	1 pts		Lumbar vertebral fracture	serious				3117
21316	1 pts		Rotator cuff syndrome	serious				3117
21317	1 pts		Mallory-Weiss syndrome	serious				3117
21318	11 pts		Nausea	below serious				3117
21319	7 pts		Dry mouth	below serious				3117
21320	6 pts		Application site pruritus	below serious				3117
21321	5 pts		Application site erythema	below serious				3117
21322	6 pts		Upper respiratory tract infection	below serious				3117
21323	3 pts		Arthralgia	below serious				3117
21324	11 pts		Dizziness	below serious				3117
21325	4 pts		Dyskinesia	below serious				3117
21326	8 pts		Insomnia	below serious				3117
21327	1 pts		Fall	serious				3118
21328	1 pts		Brain herniation	serious				3118
21329	1 pts		Head injury	serious				3118
21330	1 pts		Skull fracture	serious				3118
21331	1 pts		Haemorrhage intracranial	serious				3118
21332	1 pts		Transient ischaemic attack	serious				3118
21333	15 pts		Nausea	below serious				3118
21334	7 pts		Dry mouth	below serious				3118
21335	8 pts		Application site pruritus	below serious				3118
21336	7 pts		Application site erythema	below serious				3118
21337	4 pts		Fall	below serious				3118
21338	8 pts		Somnolence	below serious				3118
21339	11 pts		Dyskinesia	below serious				3118
21340	6 pts		Confusional state	below serious				3118
21341	11 pts		Nausea	below serious				3119
21342	5 pts		Dry mouth	below serious				3119
21343	7 pts		Application site pruritus	below serious				3119
21344	5 pts		Application site erythema	below serious				3119
21345	5 pts		Back pain	below serious				3119
21346	5 pts		Arthralgia	below serious				3119
21347	14 pts		Dyskinesia	below serious				3119
21348	5 pts		Tremor	below serious				3119
21349	1 pts		Heart failure	serious				3109
21350	1 pts		Tachycardia paroxysmal	serious				3109
21351	1 pts		Gastric ulcer	serious				3109
21352	1 pts		Deep vein thrombosis	serious				3109
21353	1 pts		Femur fracture	serious				3109
21354	1 pts		Coma diabetic	serious				3109
21355	1 pts		Breast cancer	serious				3109
21356	1 pts		Traumatic brain injury	serious				3109
21357	1 pts		Disease Parkinson's	serious				3109
21358	27 pts		Nausea	below serious				3109
21359	15 pts		Application site pruritus	below serious				3109
21360	18 pts		Somnolence	below serious				3109
21361	12 pts		Headache	below serious				3109
21362	9 pts		Nausea	below serious				3112
21363	2 pts		Application site pruritus	below serious				3112
21364	7 pts		Nasopharyngitis	below serious				3112
21365	4 pts		Dizziness	below serious				3112
21366	2 pts		Restlessness	below serious				3112
21367	4 pts		Pruritus	below serious				3112
21368	2 pts		Erythema	below serious				3112
21369	1 pts		Spondylolisthesis	serious				3120
21370	1 pts		Hepatitis	serious				3120
21371	1 pts		Jaundice	serious				3120
21372	1 pts		Kidney transplant rejection	serious				3120
21373	1 pts		Intervertebral disc protrusion	serious				3120
21374	1 pts		Myalgia	serious				3120
21375	1 pts		Osteoarthritis	serious				3120
21376	1 pts		Dizziness	serious				3120
21377	1 pts		Tremor	serious				3120
21378	42 pts		Nausea	below serious				3120
21379	13 pts		Vomiting	below serious				3120
21380	10 pts		Constipation	below serious				3120
21381	19 pts		Application site pruritus	below serious				3120
21382	11 pts		Application site erythema	below serious				3120
21383	28 pts		Dizziness	below serious				3120
21384	13 pts		Insomnia	below serious				3120
21385	12 pts		Pruritus	below serious				3120
21386	1 pts		Ankle fracture	serious				3121
21387	1 pts		Skin laceration	serious				3121
21388	1 pts		Decubitus ulcer	serious				3121
21389	1 pts		Dyspepsia	below serious				3121
21390	1 pts		Wound infection staphylococcal	below serious				3121
21391	1 pts		Brain contusion	below serious				3121
21392	1 pts		Traumatic brain injury	below serious				3121
21393	1 pts		Fall	below serious				3121
21394	1 pts		Pain in extremity	below serious				3121
21395	2 pts		Dyskinesia	below serious				3121
21396	1 pts		Dizziness	below serious				3121
21397	1 pts		Psychotic disorder	below serious				3121
21398	1 pts		Suicidal ideation	below serious				3121
21399	1 pts		Cough	below serious				3121
21400	1 pts		Nasal congestion	below serious				3121
21401	1 pts		Abdominal pain	serious				3113
21402	1 pts		Chest pain	serious				3113
21403	1 pts		Foot fracture	serious				3113
21404	1 pts		Anxiety	serious				3113
21405	1 pts		Dyspnoea	serious				3113
21406	1 pts		Eye haemorrhage	below serious				3113
21407	1 pts		Constipation	below serious				3113
21408	1 pts		Gastrooesophageal reflux disease	below serious				3113
21409	4 pts		Nausea	below serious				3113
21410	3 pts		Vomiting	below serious				3113
21411	1 pts		Application site pruritus	below serious				3113
21412	1 pts		Dialysis device complication	below serious				3113
21413	1 pts		Back injury	below serious				3113
21414	1 pts		Electrocardiogram PR prolongation	below serious				3113
21415	1 pts		Electrocardiogram ST segment abnormal	below serious				3113
21416	1 pts		Anorexia	below serious				3113
21417	1 pts		Diabetic ketoacidosis	below serious				3113
21418	1 pts		Hyperglycaemia	below serious				3113
21419	1 pts		Fluid overload	below serious				3113
21420	1 pts		Muscle spasms	below serious				3113
21421	1 pts		Pain in extremity	below serious				3113
21422	1 pts		Somnolence	below serious				3113
21423	2 pts		Headache	below serious				3113
21424	1 pts		Paraesthesia	below serious				3113
21425	1 pts		Confusional state	below serious				3113
21426	1 pts		Depression	below serious				3113
21427	1 pts		Dysphoria	below serious				3113
21428	2 pts		Dyspnoea	below serious				3113
21429	1 pts		Sleep apnoea syndrome	below serious				3113
21430	2 pts		Hypertension	below serious				3113
21431	1 pts		Pneumonia	serious				3114
21432	1 pts		Hypokalaemia	serious				3114
21433	16 pts		Nausea	below serious				3114
21434	6 pts		Vomiting	below serious				3114
21435	12 pts		Application site pruritus	below serious				3114
21436	8 pts		Somnolence	below serious				3114
21437	8 pts		Dizziness	below serious				3114
21438	1 pts		Atrial fibrillation	serious				3122
21439	1 pts		Myocardial bridging	serious				3122
21440	1 pts		Gastric polyps	serious				3122
21441	1 pts		Large intestine polyp	serious				3122
21442	1 pts		Intervertebral disc protrusion	serious				3122
21443	1 pts		Parathyroid tumour benign	serious				3122
21444	1 pts		Transient ischaemic attack	serious				3122
21445	11 pts		Nausea	below serious				3122
21446	7 pts		Vomiting	below serious				3122
21447	10 pts		Somnolence	below serious				3122
21448	10 pts		Dizziness	below serious				3122
21449	8 pts		Erythema	below serious				3122
21450	10 pts		Pruritus	below serious				3122
21451	1 pts		Oedema peripheral	serious				3110
21452	1 pts		Cerebrovascular accident	serious				3110
21453	8 pts		Nausea	below serious				3110
21454	3 pts		Application site erythema	below serious				3110
21455	2 pts		Fatigue	below serious				3110
21456	2 pts		Urinary tract infection	below serious				3110
21457	2 pts		Fall	below serious				3110
21458	6 pts		Headache	below serious				3110
21459	3 pts		Insomnia	below serious				3110
21460	3.85		Abnormal ECG	mild	discontinuation	1 patient		3126
21461	3.85		Hypertension	mild	discontinuation	1 patient		3126
21462	3.85		Sensory hallucinations	moderate	discontinuation			3126
21463	7.7		Application site reaction	moderate	discontinuation			3126
21464			Allergic reaction		discontinuation	WARNING		3124
21465			Somnolence		discontinuation	WARNING		3124
21466			Hallucinations		discontinuation	WARNING		3124
21467			Psychotic behavior		discontinuation	WARNING		3124
21468			Dyskinesia		discontinuation	WARNING		3124
21469			Hypotension symptomatic		discontinuation	WARNING		3124
21470			Syncope		discontinuation	WARNING		3124
21471	2		Application site reaction		discontinuation	WARNING		3125
21472			Blood pressure increased		discontinuation	WARNING		3124
21473			Tachycardia		discontinuation	WARNING		3124
21474			Impulse-control disorder		discontinuation	WARNING		3124
21475			Compulsive personality disorder		discontinuation	WARNING		3124
21476			Daytime sleepiness		discontinuation	WARNING		3124
21477						No adverse reactions leading to discontinuation were mentioned		3123
21478	1 pts		Nausea	serious				3128
21479	1 pts		Vomiting	serious				3128
21480	1 pts		Road traffic accident	serious				3128
21481	1 pts		Weight decreased	serious				3128
21482	1 pts		Coordination abnormal	serious				3128
21483	1 pts		Lethargy	serious				3128
21484	1 pts		Transient ischaemic attack	serious				3128
21485	1 pts		Contusion	serious				3128
21486	14 pts		Diplopia	below serious				3128
21487	22 pts		Nausea	below serious				3128
21488	13 pts		Vomiting	below serious				3128
21489	27 pts		Fatigue	below serious				3128
21490	9 pts		Contusion	below serious				3128
21491	47 pts		Dizziness	below serious				3128
21492	29 pts		Headache	below serious				3128
21493	22 pts		Somnolence	below serious				3128
21494	1 pts		Acute bronchitis	serious				3127
21495	3 pts		Vision blurred	below serious				3127
21496	8 pts		Constipation	below serious				3127
21497	3 pts		Diarrhoea	below serious				3127
21498	6 pts		Dry mouth	below serious				3127
21499	3 pts		Dyspepsia	below serious				3127
21500	3 pts		Sedation	below serious				3127
21501	12 pts		Somnolence	below serious				3127
21502	3 pts		Dermatitis contact	below serious				3127
21503	5 pts		Rash	below serious				3127
21504	1 pts		Hypothyroidism	below serious				3129
21505	5 pts		Vomiting	below serious				3129
21506	2 pts		Dental caries	below serious				3129
21507	2 pts		Nausea	below serious				3129
21508	1 pts		Pyrexia	below serious				3129
21509	1 pts		Bronchitis	below serious				3129
21510	1 pts		Otitis media	below serious				3129
21511	1 pts		Contusion	below serious				3129
21512	1 pts		Gamma-glutamyltransferase increased	below serious				3129
21513	6 pts		Decreased appetite	below serious				3129
21514	2 pts		Dehydration	below serious				3129
21515	1 pts		Joint swelling	below serious				3129
21516	8 pts		Status epilepticus	below serious				3129
21517	6 pts		Somnolence	below serious				3129
21518	1 pts		Autism	below serious				3129
21519	1 pts		Complex partial seizures	below serious				3129
21520	1 pts		Dizziness	below serious				3129
21521	1 pts		Headache	below serious				3129
21522	1 pts		Psychomotor hyperactivity	below serious				3129
21523	1 pts		Tonic convulsion	below serious				3129
21524	1 pts		Agitation	below serious				3129
21525	1 pts		Stereotypy	below serious				3129
21526	1 pts		Dysmenorrhea	below serious				3129
21527	1 pts		Drug eruption	below serious				3129
21528	1 pts		Dry skin	below serious				3129
21529	1 pts		Eczema	below serious				3129
21530	1 pts		Purpura	below serious				3129
21531	1 pts		Chapped skin	below serious				3129
21532	1 pts		Subcutaneous haematoma	below serious				3129
21533						none of the subjects in the maximal tolerated dose study withdrew due to adverse effects		3130
21534			Depression worsened			WARNINGS		3131
21535			Suicidal behavior	serious		WARNINGS		3131
21536			QT shortened	serious		WARNINGS		3132
21537			Leukopenia	serious		WARNINGS		3131
21538			Mood change			WARNINGS		3131
21539			Central nervous system disorder NOS			WARNINGS		3131
21540			Hypersensitivity reaction			WARNINGS		3131
21541	1-2		Fatigue		discontinuation	Fatigue was reported in 10% of BANZEL-treated patients compared to 8% of patients on placebo patients. It led to study discontinuation in 1% of BANZEL-treated patients and 0% of patients on placebo patients.		3132
21542	2		Convulsion		discontinuation			3133
21543	2		Rash		discontinuation			3133
21544	1		Vomiting		discontinuation			3134
21545	3		Dizziness		discontinuation			3134
21546	2		Headache		discontinuation			3134
21547	1		Nausea		discontinuation			3134
21548	1		Ataxia		discontinuation			3134
21549	5 pts		Headache					3138
21550	5 pts		Tremor					3138
21551	3 pts		Palpitations					3138
21552	5 pts		Headache					3139
21553	2 pts		Dizziness					3139
21554	5 pts		Tremor					3139
21555	1 pts		Palpitations					3139
21556	1 pts		Muscle cramps					3139
21557	9		Nasal sinus congestion			considered drug-related or nondrug-related by the investigator		3136
21558	5		Rhinitis			considered drug-related or nondrug-related by the investigator		3136
21559	13		Headache			considered drug-related or nondrug-related by the investigator		3136
21560	3		Asthma			considered drug-related or nondrug-related by the investigator		3136
21561	7		Tracheobronchitis			considered drug-related or nondrug-related by the investigator		3136
21562	5		Influenza			considered drug-related or nondrug-related by the investigator		3136
21563	4		Ear disorder					3135
21564	6		Pharyngitis					3135
21565	17		Headache					3135
21566	4		Asthma					3135
21567	4		Skin rash					3135
21568	3		Urticaria					3135
21569	4		Hypertension			considered drug-related or nondrug-related by the investigator		3137
21570	7		Throat irritation			considered drug-related or nondrug-related by the investigator		3137
21571	4		Congestion nasal			considered drug-related or nondrug-related by the investigator		3137
21572	4		Sinusitis			considered drug-related or nondrug-related by the investigator		3137
21573	3		Ear disorder			considered drug-related or nondrug-related by the investigator		3137
21574	3		Nausea and vomiting			considered drug-related or nondrug-related by the investigator		3137
21575	5		Cough			considered drug-related or nondrug-related by the investigator		3137
21576	4		Rhinitis			considered drug-related or nondrug-related by the investigator		3137
21577	5		Respiratory tract infection viral			considered drug-related or nondrug-related by the investigator		3137
21578	12		Musculoskeletal pain			considered drug-related or nondrug-related by the investigator		3137
21579	3		Muscle cramps			considered drug-related or nondrug-related by the investigator		3137
21580	14		Headache			considered drug-related or nondrug-related by the investigator		3137
21581	4		Dizziness			considered drug-related or nondrug-related by the investigator		3137
21582	1 pts		Scintillating scotoma					3140
21583	1 pts		Epileptic fit					3140
21584						No information on AE is provided		3141
21585	5		Bradycardia			Adverse event during the induction period (from onset of anesthesia by mask induction to surgical incision)		3142
21586	4		Hypotension			Adverse event during the induction period (from onset of anesthesia by mask induction to surgical incision)		3142
21587	2		Tachycardia			Adverse event during the induction period (from onset of anesthesia by mask induction to surgical incision)		3142
21588	7		Agitation			Adverse event during the induction period (from onset of anesthesia by mask induction to surgical incision)		3142
21589	8		Laryngospasm			Adverse event during the induction period (from onset of anesthesia by mask induction to surgical incision)		3142
21590	8		Airways obstruction			Adverse event during the induction period (from onset of anesthesia by mask induction to surgical incision)		3142
21591	5		Breath holding			Adverse event during the induction period (from onset of anesthesia by mask induction to surgical incision)		3142
21592	5		Cough increased			Adverse event during the induction period (from onset of anesthesia by mask induction to surgical incision)		3142
21593	6		Tachycardia			Adverse event during the induction period (from onset of anesthesia by mask induction to surgical incision)		3144
21594	4		Hypotension			Adverse event during the induction period (from onset of anesthesia by mask induction to surgical incision)		3144
21595	15		Agitation			Adverse event during the induction period (from onset of anesthesia by mask induction to surgical incision)		3144
21596	5		Breath holding			Adverse event during the induction period (from onset of anesthesia by mask induction to surgical incision)		3144
21597	5		Cough increased			Adverse event during the induction period (from onset of anesthesia by mask induction to surgical incision)		3144
21598	3		Laryngospasm			Adverse event during the induction period (from onset of anesthesia by mask induction to surgical incision)		3144
21599	2		Apnea			Adverse event during the induction period (from onset of anesthesia by mask induction to surgical incision)		3144
21600	2		Increased salivation			Adverse event during the induction period (from onset of anesthesia by mask induction to surgical incision)		3144
21601	1		Fever			Adverse event during maintenance and emergence periods		3143
21602	6		Shivering			Adverse event during maintenance and emergence periods		3143
21603	1		Hypothermia			Adverse event during maintenance and emergence periods		3143
21604	1		Movements involuntary			Adverse event during maintenance and emergence periods		3143
21605	1		Headache			Adverse event during maintenance and emergence periods		3143
21606	11		Hypotension			Adverse event during maintenance and emergence periods		3143
21607	2		Hypertension			Adverse event during maintenance and emergence periods		3143
21608	5		Bradycardia			Adverse event during maintenance and emergence periods		3143
21609	2		Tachycardia			Adverse event during maintenance and emergence periods		3143
21610	9		Somnolence			Adverse event during maintenance and emergence periods		3143
21611	9		Agitation			Adverse event during maintenance and emergence periods		3143
21612	4		Dizziness			Adverse event during maintenance and emergence periods		3143
21613	4		Increased salivation			Adverse event during maintenance and emergence periods		3143
21614	2		Nausea			Adverse event during maintenance and emergence periods		3143
21615	18		Vomiting			Adverse event during maintenance and emergence periods		3143
21616	11		Cough increased			Adverse event during maintenance and emergence periods		3143
21617	2		Breath holding			Adverse event during maintenance and emergence periods		3143
21618	2		Laryngospasm			Adverse event during maintenance and emergence periods		3143
21619						No AEs were observed		3151
21620	2 pts		Creatine kinase increased	below serious				3147
21621	4 pts		UTI	serious				3146
21622	3 pts		Penile pain	serious				3146
21623	1 pts		Wound infection	serious				3146
21624	1 pts		Wound drainage	serious				3146
21625	3 pts		Nausea	below serious				3145
21626	5 pts		Diarrhea	below serious				3145
21627	3 pts		Constipation	below serious				3145
21628	14 pts		Upper respiratory infection	below serious				3145
21629	7 pts		Insomnia	below serious				3145
21630	2 pts		Muscle weakness	below serious				3145
21631	6 pts		ALT increased	below serious				3145
21632	7 pts		CPK increased	below serious				3145
21633			Rhabdomyolysis	grade 3				3150
21634			Rhabdomyolysis					3149
21635	0.6		Esophageal acid reflux					3148
21636	1.3		Constipation					3148
21637	0.6		Diarrhea					3148
21638	0.6		Flatulence					3148
21639	1.3		Abdominal pain		discontinuation			3148
21640	1.3		Back pain					3148
21641	1.3		Myalgia					3148
21642	1.4		ALT increased	grade 2				3148
21643	2.1		AST increased	grade 2				3148
21644	1.4		Creatine kinase increased	grade 3	discontinuation			3148
21645	0.6		Myopathy		discontinuation			3148
21646	1.9		Fatigue		discontinuation			3153
21647	0.6		Pruritus		discontinuation			3153
21648	0.6		Creatine kinase increased		discontinuation			3153
21649	0.6		General body pain		discontinuation			3152
21650	1 pts		Rash face	below serious				3154
21651	1 pts		Diarrhea	below serious				3154
21652	1 pts		Mouth ulceration	moderate				3155
21653	1 pts		Headache					3155
21654	1 pts		Alanine aminotransferase increase					3155
21655			Immunosuppression			WARNING		3156
21656			Hepatic artery thrombosis			WARNING		3156
21657			Dehiscence			WARNING		3156
21658	1 pts		Dry eye	below serious				3157
21659	2 pts		Abdominal discomfort	below serious				3157
21660	3 pts		Abdominal distension	below serious				3157
21661	2 pts		Abdominal pain	below serious				3157
21662	1 pts		Constipation	below serious				3157
21663	7 pts		Dry mouth	below serious				3157
21664	1 pts		Nausea	below serious				3157
21665	1 pts		Vomiting	below serious				3157
21666	2 pts		Decreased appetite	below serious				3157
21667	3 pts		Back pain	below serious				3157
21668	1 pts		Dizziness	below serious				3157
21669	3 pts		Dysmenorrhoea	below serious				3157
21670	3 pts		Oropharyngeal pain	below serious				3157
21671	1 pts		Dry skin	below serious				3157
21672	1 pts		Hot flush	below serious				3157
21673	1 pts		Mouth haemorrhage	serious				3161
21674	1 pts		Pyelonephritis	serious				3161
21675	1 pts		Gastric neoplasm	serious				3161
21676	1 pts		Sciatica	serious				3161
21677	30 pts		Dry mouth	below serious				3161
21678	9 pts		Constipation	below serious				3161
21679	1 pts		Vitreous detachment	serious				3163
21680	4 pts		Dry mouth	below serious				3163
21681	2 pts		Balance disorder	below serious				3163
21682	1 pts		Muscular weakness	serious				3160
21683	6 pts		Dry mouth	below serious				3160
21684	1 pts		Constipation	below serious				3160
21685	5 pts		Nasopharyngitis	below serious				3160
21686	8 pts		Hypertension	below serious				3160
21687	18 pts		Dry mouth	below serious				3162
21688	3 pts		Constipation	below serious				3162
21689	6 pts		Nasopharyngitis	below serious				3162
21690	6 pts		Escherichia urinary tract infection	below serious				3162
21691	18 pts		Hypertension	below serious				3162
21692	1 pts		Confusional state	serious				3158
21693	23 pts		Dry mouth	below serious				3158
21694	4 pts		Constipation	below serious				3158
21695	5 pts		Escherichia urinary tract infection	below serious				3158
21696	5 pts		Urinary tract infection	below serious				3158
21697	1 pts		Dry mouth	serious				3159
21698	1 pts		Cholecystitis	serious				3159
21699	1 pts		Arthritis bacterial	serious				3159
21700	1 pts		Infected lymphocele	serious				3159
21701	1 pts		Bladder cancer recurrent	serious				3159
21702	1 pts		Pulmonary embolism	serious				3159
21703	1 pts		Angioedema	serious				3159
21704	2 pts		Lymphocele	serious				3159
21705	19 pts		Dry mouth	below serious				3159
21706						no serious treatment-related AEs were observed		3164
21707						No adverse reactions leading to discontinuation were reported		3165
21708			Angioedema		discontinuation	WARNING		3167
21709	rare		Anaphylactic reaction		discontinuation	WARNING		3167
21710	1.5		Dry mouth		discontinuation			3166
21711	5 pts		Skin and subcutaneous tissue disorders	below serious				3169
21712	4 pts		Nervous system disorders	below serious				3169
21713	1 pts		Weight gain	below serious				3169
21714	2 pts		Encephalopathy	serious				3168
21715	1 pts		Diagnostic procedure	serious				3168
21716	1 pts		Hypoxia	serious				3168
21717	1 pts		Fournier's gangrene	serious				3168
21718	5 pts		Weight loss	below serious				3168
21719	3 pts		Hypertension	below serious				3168
21720	4 pts		Maculo-papular rash	below serious				3168
21721	4 pts		Headache	below serious				3168
21722	2 pts		Alopecia	below serious				3168
21723	3 pts		Dry skin	below serious				3168
21724	2 pts		Edema	below serious				3168
21725	3 pts		Mucositis oral	below serious				3168
21726	2 pts		Pain in extremity	below serious				3168
21727	20		Diarrhea	grade 3			TRUE	3170
21728	6.7		Pancreatitis	grade 3	dose interruption			3174
21729	33		Ascites	grade 3				3175
21730	17		Constipation	grade 3				3175
21731	17		Obstruction ureter	grade 3				3175
21732	17		Hypoalbuminemia	grade 3				3175
21733	33		Alkaline phosphatase	grade 3				3175
21734	17		Muscle weakness	grade 3				3175
21735	17		Depressed level of consciousness	grade 3				3175
21736	17		Pleural effusion	grade 3				3175
21737	17		Hypoxia	grade 3				3175
21738	17		Pruritis	grade 1				3175
21739	17		Rash	grade 1				3175
21740	17		Hypocalcemia	grade 1				3175
21741	33		Hypertension	grade 3	discontinuation		TRUE	3171
21742	33		Dyspnea	grade 3				3171
21743	67		Rash	grade 3				3171
21744	67		Fatigue	grade 1				3171
21745	33		Anorexia	grade 1				3171
21746	33		Nausea	grade 1				3171
21747	33		Pharyngitis	grade 1				3171
21748	33		Dyspnea	grade 3				3171
21749	67		Pruritis	grade 1				3171
21750	33		Rash	grade 2	discontinuation		TRUE	3171
21751	67		Rash	grade 3	discontinuation		TRUE	3171
21752	22.5		Diarrhea			OVERDOSAGE		3172
21753	10		Hand and foot skin reaction			OVERDOSAGE		3173
21754	5		Desquamation					3173
21755	12.5		Fatigue					3173
21756	5		Hypertension					3173
21757	2.5		Mucositis oral					3173
21758	12.5		Alopecia					3173
21759	12.5		Dry skin					3173
21760	12.5		Nausea					3173
21761	12.5		Vomiting					3173
21762	15		Anorexia					3173
21763	17.5		Weight loss					3173
21764	12.5		Hypocalcaemia					3173
21765	2		Hypertension	grade 3				3176
21766	2		Fatigue	grade 3				3176
21767	<1		Fever	grade 3				3176
21768	<1		Weight loss	grade 3				3176
21769	1		Rash	grade 3				3176
21770	5		Hand and foot skin reaction	grade 3				3176
21771	<1		Pruritus	grade 3				3176
21772	<1		Flushing	grade 3				3176
21773	2		Diarrhea	grade 3				3176
21774	1		Nausea	grade 3				3176
21775	1		Anorexia	grade 3				3176
21776	1		Constipation	grade 3				3176
21777	<1		Vomiting	grade 3				3176
21778	<1		Mucositis	grade 3				3176
21779	1		Infection	grade 3				3176
21780	<1		Cough	grade 3				3176
21781	2		Dyspnea	grade 3				3176
21782	<1		Dyspnea	grade 4				3176
21783	<1		Hypertension	grade 4				3176
21784	<1		Fatigue	grade 4				3176
21785	5.1		Lymphopenia	grade 3				3176
21786	2.4		Amylase increased	grade 3				3176
21787	4.1		Hyperglycemia	grade 3				3176
21788	2.1		Hyperkalemia	grade 3				3176
21789	3.5		Lipase increased	grade 3				3176
21790	3.5		Hyponatremia	grade 3				3176
21791	1.8		Hypophosphatemia	grade 3				3176
21792	0.6		Lymphopenia	grade 4				3176
21793	0.6		Amylase increased	grade 4				3176
21794	0.3		Hyperglycemia	grade 4				3176
21795	0.6		Hyperkalemia	grade 4				3176
21796	1.8		Lipase increased	grade 4				3176
21797	13 pts		Lethargy		discontinuation	Discontinue: 6/13; Dose reduce: 3/13; Continue at same dose: 4/13		3181
21798	11 pts		Bradycardia		discontinuation	Discontinue: 2/11; Dose reduce: 5/11; Pacemaker + continue: 4/11		3181
21799	6 pts		Bronchospasm		discontinuation			3181
21800	2 pts		Nausea and vomiting		discontinuation			3181
21801	2 pts		Erectile dysfunction		discontinuation	Discontinue: 1/2; Dose reduce: 1/2		3181
21802	1 pts		Visual disturbance		discontinuation			3181
21803	1 pts		Hypotension					3181
21804	1 pts		Loss of taste					3181
21805	1 pts		Depression		discontinuation			3181
21806	7.9		Chest pain					3180
21807	18.4		Dyspnea					3180
21808	7.9		Palpitation					3180
21809	10.5		Asthenia					3180
21810	13.2		Dizziness					3180
21811	26.3		Fatigue					3180
21812	5.3		Headache					3180
21813	15.8		Light-headed					3180
21814	2.6		Sleep problem					3180
21815	2.6		Upper respiratory tract signs and symptoms					3180
21816	5.3		Visual disturbance NOS					3180
21817	15.4		Chest pain					3177
21818	20.5		Dyspnea					3177
21819	5.1		Palpitation					3177
21820	5.1		Vasodilation					3177
21821	20.5		Asthenia					3177
21822	17.9		Dizziness					3177
21823	25.6		Fatigue					3177
21824	7.7		Headache					3177
21825	5.1		Light-headed					3177
21826	7.7		Sleep problem					3177
21827	12.8		Upper respiratory tract signs and symptoms					3177
21828	13.1		Bradycardia					3178
21829	5.2		Diarrhea					3178
21830	7.8		Nausea and vomiting					3178
21831	3.9		Abdominal pain NOS					3178
21832	19.6		Fatigue					3178
21833	5.2		Hyperhidrosis					3178
21834	5.2		Weakness					3178
21835	2.6		Musculoskeletal pain					3178
21836	16.3		Dizziness					3178
21837	3.3		Headache					3178
21838	3.3		Cough					3178
21839	9.2		Dyspnea					3178
21840	12.3		Bradycardia					3179
21841	5.7		Diarrhea					3179
21842	5.7		Nausea and vomiting					3179
21843	2.5		Abdominal pain NOS					3179
21844	18.9		Fatigue					3179
21845	4.9		Hyperhidrosis					3179
21846	4.9		Weakness					3179
21847	4.1		Musculoskeletal pain					3179
21848	13.1		Dizziness					3179
21849	11.5		Headache					3179
21850	2.5		Cough					3179
21851	9.8		Dyspnea					3179
21852	11 pts		Photosensitivity reaction		discontinuation	leads to discontinuation		3183
21853	4 pts		Nausea					3182
21854	3 pts		Vomiting					3182
21855	1 pts		Headache					3182
21856	4 pts		Dizziness					3182
21857	10 pts		Abdominal pain	serious				3186
21858	1 pts		Abdominal pain	serious				3186
21859	1 pts		Abdominal pain	serious				3186
21860	1 pts		Abdominal pain	serious				3186
21861	1 pts		Intestinal perforation	serious				3186
21862	1 pts		Bleeding vaginal	serious				3186
21863	1 pts		Abscess	serious				3186
21864	1 pts		Abscess	serious				3186
21865	1 pts		Acid reflux (esophageal)	serious				3186
21866	11 pts		Acute coronary syndrome	serious				3186
21867	2 pts		Distress respiratory	serious				3186
21868	1 pts		Alcoholic withdrawal symptoms	serious				3186
21869	2 pts		Alzheimer's disease	serious				3186
21870	1 pts		Amyloidosis	serious				3186
21871	1 pts		Aneurysm	serious				3186
21872	1 pts		Angioedema	serious				3186
21873	1 pts		Angiography	serious				3186
21874	2 pts		Angioplasty	serious				3186
21875	1 pts		Aortic aneurysm	serious				3186
21876	1 pts		Aortic regurgitation	serious				3186
21877	5 pts		Aortic stenosis	serious				3186
21878	2 pts		Appendectomy	serious				3186
21879	2 pts		Arm injury	serious				3186
21880	1 pts		Arm injury	serious				3186
21881	2 pts		Arterial occlusive disease	serious				3186
21882	2 pts		Arterial stenosis	serious				3186
21883	1 pts		Arterial stenosis	serious				3186
21884	1 pts		Arthroplasty NOS	serious				3186
21885	1 pts		Ascites	serious				3186
21886	1 pts		Ascites	serious				3186
21887	1 pts		Ascites	serious				3186
21888	73 pts		Atrial fibrillation	serious				3186
21889	1 pts		Atrial fibrillation	serious				3186
21890	8 pts		Atrial flutter	serious				3186
21891	3 pts		AV block	serious				3186
21892	1 pts		Azotemia	serious				3186
21893	10 pts		Back pain	serious				3186
21894	2 pts		Bacterial infection	serious				3186
21895	1 pts		GI bleed	serious				3186
21896	1 pts		Bile duct cancer	serious				3186
21897	1 pts		Binodal disease	serious				3186
21898	1 pts		Bipolar disorder	serious				3186
21899	1 pts		Eye bleeding	serious				3186
21900	1 pts		Blisters	serious				3186
21901	2 pts		Blood in stool	serious				3186
21902	1 pts		General body pain	serious				3186
21903	5 pts		Bowel cancer	serious				3186
21904	7 pts		Bowel obstruction	serious				3186
21905	1 pts		Bowel perforation	serious				3186
21906	1 pts		Bruise	serious				3186
21907	1 pts		Buttock pain	serious				3186
21908	2 pts		CABG	serious				3186
21909	2 pts		CABG	serious				3186
21910	5 pts		Cardiopulmonary arrest	serious				3186
21911	143 pts		Chest pain	serious				3186
21912	1 pts		Chest pain	serious				3186
21913	6 pts		Chest pain	serious				3186
21914	1 pts		Chest pain	serious				3186
21915	1 pts		Cholangiocarcinoma	serious				3186
21916	2 pts		Cholecystectomy	serious				3186
21917	1 pts		Cholestasis	serious				3186
21918	1 pts		Cholestasis	serious				3186
21919	1 pts		Chorioretinopathy	serious				3186
21920	1 pts		Chronic obstructive pulmonary disease	serious				3186
21921	23 pts		Chronic obstructive pulmonary disease	serious				3186
21922	1 pts		Cold extremities	serious				3186
21923	2 pts		Colon cancer	serious				3186
21924	2 pts		Congestive heart failure	serious				3186
21925	2 pts		Constipation	serious				3186
21926	1 pts		Angiograph coronary	serious				3186
21927	1 pts		Coronary revascularization	serious				3186
21928	1 pts		Coronary vasospasm	serious				3186
21929	1 pts		Drug toxicity	serious				3186
21930	4 pts		Death	serious				3186
21931	1 pts		Death	serious				3186
21932	3 pts		Depression	serious				3186
21933	1 pts		Blood pressure abnormal	serious				3186
21934	14 pts		Diabetes	serious				3186
21935	1 pts		Dilatation of esophagus	serious				3186
21936	1 pts		Intervertebral discitis	serious				3186
21937	1 pts		Disseminated intravascular coagulation	serious				3186
21938	2 pts		Diverticulosis	serious				3186
21939	5 pts		Dizziness	serious				3186
21940	3 pts		Dizziness	serious				3186
21941	1 pts		Drug overdose	serious				3186
21942	1 pts		Drug toxicity	serious				3186
21943	1 pts		Dysphagia	serious				3186
21944	11 pts		Dyspnea	serious				3186
21945	1 pts		Dyspnea	serious				3186
21946	3 pts		Dyspnea	serious				3186
21947	1 pts		Electrolyte imbalance	serious				3186
21948	5 pts		Creatinine increased	serious				3186
21949	2 pts		International normalized ratio increased	serious				3186
21950	1 pts		Prothrombin time increased	serious				3186
21951	1 pts		Encephalitis	serious				3186
21952	8 pts		Encephalopathy	serious				3186
21953	3 pts		Endocarditis	serious				3186
21954	3 pts		Epididymitis	serious				3186
21955	1 pts		Epigastric pain	serious				3186
21956	2 pts		Epistaxis	serious				3186
21957	1 pts		Device malfunction	serious				3186
21958	1 pts		Erectile dysfunction	serious				3186
21959	1 pts		Pocket erosion	serious				3186
21960	2 pts		Esophageal cancer	serious				3186
21961	1 pts		Chronic calculous cholecystitis	serious				3186
21962	1 pts		Eye disorders	serious				3186
21963	1 pts		Failure to thrive	serious				3186
21964	7 pts		Fall	serious				3186
21965	2 pts		Fatigue	serious				3186
21966	2 pts		Fever	serious				3186
21967	1 pts		Fistula	serious				3186
21968	1 pts		Foot injury	serious				3186
21969	4 pts		Gangrene	serious				3186
21970	3 pts		Gastritis	serious				3186
21971	7 pts		Gastroenteritis	serious				3186
21972	1 pts		Gastritis	serious				3186
21973	3 pts		General physical health deterioration	serious				3186
21974	1 pts		GERD	serious				3186
21975	25 pts		GI bleed	serious				3186
21976	1 pts		Groin pain	serious				3186
21977	1 pts		Gynecomastia	serious				3186
21978	1 pts		Gynecomastia	serious				3186
21979	1 pts		Head injury	serious				3186
21980	5 pts		Headache	serious				3186
21981	1 pts		Hearing loss	serious				3186
21982	1 pts		Heart failure	serious				3186
21983	1 pts		Heart failure	serious				3186
21984	1 pts		Hematoma	serious				3186
21985	5 pts		Hematuria	serious				3186
21986	3 pts		Hemorrhage	serious				3186
21987	1 pts		Hemorrhage	serious				3186
21988	1 pts		Hepatomegaly	serious				3186
21989	8 pts		Hernia	serious				3186
21990	1 pts		Herniated disc	serious				3186
21991	2 pts		Hospitalization	serious				3186
21992	1 pts		Hydronephrosis	serious				3186
21993	2 pts		Hypercalcemia	serious				3186
21994	9 pts		Hyperglycemia	serious				3186
21995	1 pts		Hyperkalemia	serious				3186
21996	20 pts		Hyperkalemia	serious				3186
21997	1 pts		Hyperplasia	serious				3186
21998	27 pts		Hypertension	serious				3186
21999	1 pts		Hypertension	serious				3186
22000	7 pts		Hypoglycemia	serious				3186
22001	1 pts		Hyponatremia	serious				3186
22002	1 pts		Hyponatremia	serious				3186
22003	2 pts		Hyponatremia	serious				3186
22004	2 pts		Hypovolemia	serious				3186
22005	1 pts		Hypoxemia	serious				3186
22006	1 pts		Hysterectomy	serious				3186
22007	2 pts		Device malfunction	serious				3186
22008	1 pts		Ileitis	serious				3186
22009	3 pts		Infection	serious				3186
22010	2 pts		Infection	serious				3186
22011	2 pts		Intestinal carcinoma	serious				3186
22012	1 pts		Bleeding intracranial	serious				3186
22013	1 pts		Renal disease	serious				3186
22014	1 pts		Renal disease	serious				3186
22015	63 pts		Renal disease	serious				3186
22016	1 pts		Failure kidney	serious				3186
22017	3 pts		Kidney stone	serious				3186
22018	1 pts		Above knee amputation	serious				3186
22019	1 pts		Knee arthroplasty	serious				3186
22020	1 pts		Laryngeal edema	serious				3186
22021	1 pts		Leg amputation	serious				3186
22022	2 pts		Leg pain	serious				3186
22023	2 pts		Leukemia	serious				3186
22024	1 pts		Leukocytosis	serious				3186
22025	1 pts		Liver laceration	serious				3186
22026	1 pts		Leg ischemia	serious				3186
22027	9 pts		Lung cancer	serious				3186
22028	1 pts		Pulmonary contusion	serious				3186
22029	1 pts		Mallory-Weiss syndrome	serious				3186
22030	1 pts		Mitral regurgitation	serious				3186
22031	1 pts		Myasthenia gravis	serious				3186
22032	1 pts		Myelopathy	serious				3186
22033	66 pts		Myocardial infarction	serious				3186
22034	1 pts		Myoclonus	serious				3186
22035	1 pts		Myopathy	serious				3186
22036	1 pts		Head and neck cancer	serious				3186
22037	1 pts		Nephrectomy	serious				3186
22038	1 pts		Neuronitis	serious				3186
22039	1 pts		Neuropathy	serious				3186
22040	1 pts		Obstructive uropathy	serious				3186
22041	1 pts		Opisthorchiasis	serious				3186
22042	1 pts		Opisthorchiasis	serious				3186
22043	1 pts		Atrophy optic	serious				3186
22044	1 pts		Orthopnea	serious				3186
22045	10 pts		Osteoarthritis	serious				3186
22046	3 pts		Osteochondrosis	serious				3186
22047	1 pts		Osteomyelitis	serious				3186
22048	5 pts		Osteomyelitis	serious				3186
22049	4 pts		Pancreatic cancer	serious				3186
22050	2 pts		Pancreatitis	serious				3186
22051	7 pts		Pancreatitis	serious				3186
22052	1 pts		Penile bleeding	serious				3186
22053	2 pts		Pericarditis	serious				3186
22054	1 pts		Peripheral vascular disease	serious				3186
22055	1 pts		Peritonitis	serious				3186
22056	9 pts		Pleural effusion	serious				3186
22057	2 pts		Pneumonia	serious				3186
22058	76 pts		Pneumonia	serious				3186
22059	1 pts		Cancer surgery	serious				3186
22060	1 pts		Proctitis	serious				3186
22061	1 pts		Prostate cancer	serious				3186
22062	1 pts		Prostatitis	serious				3186
22063	1 pts		Congestion pulmonary	serious				3186
22064	1 pts		Pulmonary congestion	serious				3186
22065	3 pts		Pulmonary edema	serious				3186
22066	10 pts		Pulmonary edema	serious				3186
22067	1 pts		Purpura	serious				3186
22068	2 pts		Pyelocystitis	serious				3186
22069	1 pts		Pyelonephritis	serious				3186
22070	2 pts		Pyelonephritis	serious				3186
22071	2 pts		Radiofrequency ablation	serious				3186
22072	1 pts		Rectal cancer	serious				3186
22073	1 pts		Intestinal haematoma	serious				3186
22074	2 pts		Respiratory failure	serious				3186
22075	1 pts		Retinal angiopathy	serious				3186
22076	1 pts		Retinal detachment	serious				3186
22077	1 pts		Retinopathy	serious				3186
22078	1 pts		Esophageal rupture	serious				3186
22079	1 pts		Scleroderma	serious				3186
22080	1 pts		Sepsis	serious				3186
22081	16 pts		Sepsis	serious				3186
22082	2 pts		Shortness of breath	serious				3186
22083	22 pts		Shortness of breath	serious				3186
22084	2 pts		Shoulder injury	serious				3186
22085	2 pts		Shoulder pain	serious				3186
22086	2 pts		Sick sinus syndrome	serious				3186
22087	1 pts		Nasal sinus cancer	serious				3186
22088	1 pts		Sinus node dysfunction	serious				3186
22089	1 pts		Sinusitis	serious				3186
22090	5 pts		Skin cancer	serious				3186
22091	1 pts		Skin laceration	serious				3186
22092	1 pts		Skin lesion	serious				3186
22093	1 pts		Skull fracture	serious				3186
22094	1 pts		Small bowel obstruction	serious				3186
22095	1 pts		Dislocated sternum	serious				3186
22096	3 pts		Stroke	serious				3186
22097	71 pts		Stroke	serious				3186
22098	1 pts		Supratherapeutic INR	serious				3186
22099	1 pts		Toe amputation	serious				3186
22100	1 pts		Toe amputation	serious				3186
22101	1 pts		Toothache	serious				3186
22102	1 pts		Alveolitis allergic	serious				3186
22103	2 pts		Transient ischemic attack	serious				3186
22104	8 pts		Transient ischemic attack	serious				3186
22105	3 pts		Tremor	serious				3186
22106	1 pts		Tricuspid regurgitation	serious				3186
22107	1 pts		Ulcer	serious				3186
22108	1 pts		Upper respiratory infection	serious				3186
22109	4 pts		Upper respiratory infection	serious				3186
22110	1 pts		Urethritis	serious				3186
22111	1 pts		Urinary incontinence	serious				3186
22112	18 pts		Urinary tract infection	serious				3186
22113	2 pts		Urinary tract stone	serious				3186
22114	2 pts		Uterine cancer	serious				3186
22115	1 pts		Uterine prolapse	serious				3186
22116	1 pts		Uterine cancer	serious				3186
22117	2 pts		Heart valve replacement	serious				3186
22118	2 pts		Venous insufficiency	serious				3186
22119	3 pts		Ventricular fibrillation	serious				3186
22120	1 pts		Vertebrobasilar insufficiency	serious				3186
22121	1 pts		Vision abnormal	serious				3186
22122	1 pts		Volume overload	serious				3186
22123	1 pts		Drug-induced hypersensitivity syndrome	serious				3186
22124	1 pts		Weakness	serious				3186
22125	7 pts		Weakness	serious				3186
22126	1 pts		Heart failure	serious				3186
22127	3 pts		Wound infection	serious				3186
22128	2 pts		Abdominal pain	below serious				3186
22129	31 pts		Abdominal pain	below serious				3186
22130	2 pts		Abdominal pain	below serious				3186
22131	6 pts		Abdominal pain	below serious				3186
22132	3 pts		Bleeding vaginal	below serious				3186
22133	2 pts		Actinic keratosis	below serious				3186
22134	12 pts		Mental status changes	below serious				3186
22135	4 pts		Ankle injury	below serious				3186
22136	4 pts		Anxiety	below serious				3186
22137	8 pts		Arthralgia	below serious				3186
22138	3 pts		Asthenia	below serious				3186
22139	9 pts		Asthma	below serious				3186
22140	2 pts		Ataxia	below serious				3186
22141	5 pts		Ataxia	below serious				3186
22142	3 pts		Atherosclerosis	below serious				3186
22143	2 pts		Atherosclerosis	below serious				3186
22144	4 pts		Atherosclerosis	below serious				3186
22145	7 pts		Atrial flutter	below serious				3186
22146	2 pts		AV block	below serious				3186
22147	67 pts		Back pain	below serious				3186
22148	7 pts		Eye bleeding	below serious				3186
22149	20 pts		Bradycardia	below serious				3186
22150	18 pts		Breast pain	below serious				3186
22151	2 pts		Breast tenderness	below serious				3186
22152	63 pts		Bronchitis	below serious				3186
22153	2 pts		Bruise	below serious				3186
22154	11 pts		Bruise	below serious				3186
22155	2 pts		Block bundle branch	below serious				3186
22156	4 pts		Buttock pain	below serious				3186
22157	2 pts		Tumor resection	below serious				3186
22158	18 pts		Cataracts	below serious				3186
22159	18 pts		Cellulitis	below serious				3186
22160	11 pts		Chest pain	below serious				3186
22161	2 pts		Chills	below serious				3186
22162	5 pts		Cholecystitis	below serious				3186
22163	4 pts		Colitis	below serious				3186
22164	2 pts		Concussion	below serious				3186
22165	8 pts		Conjunctivitis	below serious				3186
22166	28 pts		Constipation	below serious				3186
22167	18 pts		Cyst	below serious				3186
22168	10 pts		Decreased appetite	below serious				3186
22169	13 pts		Dehydration	below serious				3186
22170	20 pts		Depression	below serious				3186
22171	4 pts		Medical device change	below serious				3186
22172	38 pts		Diabetes	below serious				3186
22173	2 pts		Diabetes	below serious				3186
22174	79 pts		Diarrhea	below serious				3186
22175	64 pts		Dizziness	below serious				3186
22176	3 pts		Drowsiness	below serious				3186
22177	2 pts		Dry eyes	below serious				3186
22178	2 pts		Duodenitis	below serious				3186
22179	3 pts		Dyspnea	below serious				3186
22180	3 pts		Ear pain	below serious				3186
22181	4 pts		Edema	below serious				3186
22182	2 pts		Bilirubin elevated	below serious				3186
22183	4 pts		Blood urea nitrogen increased	below serious				3186
22184	9 pts		Cardiac enzymes increased	below serious				3186
22185	60 pts		Creatinine increased	below serious				3186
22186	4 pts		International normalized ratio increased	below serious				3186
22187	5 pts		Elevated liver enzymes	below serious				3186
22188	2 pts		PSA increased	below serious				3186
22189	4 pts		Emotional lability	below serious				3186
22190	19 pts		Epistaxis	below serious				3186
22191	7 pts		Extrasystoles	below serious				3186
22192	3 pts		Eye pain	below serious				3186
22193	2 pts		Eyelid cyst	below serious				3186
22194	15 pts		Fall	below serious				3186
22195	5 pts		Fever	below serious				3186
22196	2 pts		Fluid retention	below serious				3186
22197	2 pts		Foot injury	below serious				3186
22198	7 pts		Foot pain	below serious				3186
22199	7 pts		Gallstones	below serious				3186
22200	11 pts		GI bleed	below serious				3186
22201	7 pts		Distress gastrointestinal	below serious				3186
22202	3 pts		Glaucoma	below serious				3186
22203	7 pts		Goiter	below serious				3186
22204	3 pts		Gonitis	below serious				3186
22205	6 pts		Gynecomastia	below serious				3186
22206	44 pts		Gynecomastia	below serious				3186
22207	3 pts		Hair loss	below serious				3186
22208	3 pts		Hand injury	below serious				3186
22209	3 pts		Hand pain	below serious				3186
22210	2 pts		Hay fever	below serious				3186
22211	2 pts		Heartburn	below serious				3186
22212	2 pts		Hematemesis	below serious				3186
22213	3 pts		Hematoma	below serious				3186
22214	11 pts		Hematuria	below serious				3186
22215	5 pts		Hemoptysis	below serious				3186
22216	3 pts		Hemorrhoids	below serious				3186
22217	2 pts		Hemorrhoids	below serious				3186
22218	2 pts		Herpes simplex	below serious				3186
22219	17 pts		Pain in hip	below serious				3186
22220	2 pts		Hoarseness	below serious				3186
22221	2 pts		Hypercalcemia	below serious				3186
22222	2 pts		Hyperkalemia	below serious				3186
22223	5 pts		Hyperkalemia	below serious				3186
22224	226 pts		Hyperkalemia	below serious				3186
22225	2 pts		Hyperthermia	below serious				3186
22226	3 pts		Hyperthyroidism	below serious				3186
22227	4 pts		Hyperuricemia	below serious				3186
22228	7 pts		Hypervolemia	below serious				3186
22229	3 pts		Hyponatremia	below serious				3186
22230	10 pts		Hyponatremia	below serious				3186
22231	71 pts		Hypotension	below serious				3186
22232	15 pts		Hypothyroidism	below serious				3186
22233	2 pts		Hypoxia	below serious				3186
22234	8 pts		Infection	below serious				3186
22235	2 pts		Influenza	below serious				3186
22236	2 pts		Ingrown toe nail	below serious				3186
22237	135 pts		Renal disease	below serious				3186
22238	4 pts		Knee injury	below serious				3186
22239	20 pts		Knee pain	below serious				3186
22240	3 pts		Labyrinthitis	below serious				3186
22241	2 pts		Lipoma	below serious				3186
22242	2 pts		Edema of lower extremities	below serious				3186
22243	2 pts		Lung cancer	below serious				3186
22244	2 pts		Lung mass	below serious				3186
22245	7 pts		Memory loss	below serious				3186
22246	54 pts		Nausea	below serious				3186
22247	7 pts		Neck pain	below serious				3186
22248	2 pts		Neuralgia	below serious				3186
22249	2 pts		Onychomycosis	below serious				3186
22250	26 pts		Osteoarthritis	below serious				3186
22251	14 pts		Osteochondrosis	below serious				3186
22252	2 pts		Otitis	below serious				3186
22253	23 pts		Parasthesia	below serious				3186
22254	2 pts		Parkinson's disease	below serious				3186
22255	2 pts		Pericarditis	below serious				3186
22256	3 pts		Peripheral arterial disease	below serious				3186
22257	6 pts		Pleural effusion	below serious				3186
22258	44 pts		Pneumonia	below serious				3186
22259	9 pts		Polyps	below serious				3186
22260	3 pts		Prostate cancer	below serious				3186
22261	4 pts		Proteinuria	below serious				3186
22262	14 pts		Pruritis	below serious				3186
22263	3 pts		Congestion pulmonary	below serious				3186
22264	3 pts		Pulmonary congestion	below serious				3186
22265	4 pts		Pulmonary embolism	below serious				3186
22266	3 pts		Pulmonary edema	below serious				3186
22267	9 pts		Pyelonephritis	below serious				3186
22268	8 pts		Radiculitis	below serious				3186
22269	2 pts		Respiratory failure	below serious				3186
22270	2 pts		Retinopathy	below serious				3186
22271	10 pts		Rhinitis	below serious				3186
22272	7 pts		Sciatica	below serious				3186
22273	2 pts		Seasonal allergy	below serious				3186
22274	10 pts		Shingles	below serious				3186
22275	3 pts		Shortness of breath	below serious				3186
22276	2 pts		Shoulder injury	below serious				3186
22277	4 pts		Shoulder injury	below serious				3186
22278	4 pts		Sick sinus syndrome	below serious				3186
22279	6 pts		Skin laceration	below serious				3186
22280	2 pts		Sleep disturbance	below serious				3186
22281	2 pts		Sore throat	below serious				3186
22282	3 pts		Sore throat	below serious				3186
22283	2 pts		Spinal stenosis	below serious				3186
22284	3 pts		Sweating	below serious				3186
22285	28 pts		Syncope	below serious				3186
22286	22 pts		Tachycardia	below serious				3186
22287	3 pts		Tendonitis	below serious				3186
22288	2 pts		Thrombocytopenia	below serious				3186
22289	2 pts		Thyroid nodule	below serious				3186
22290	5 pts		Tinnitus	below serious				3186
22291	2 pts		Temporomandibular joint disorder	below serious				3186
22292	2 pts		Tonsillitis	below serious				3186
22293	3 pts		Tooth extraction	below serious				3186
22294	8 pts		Ulcer	below serious				3186
22295	86 pts		Upper respiratory infection	below serious				3186
22296	2 pts		Urethritis	below serious				3186
22297	2 pts		Urethritis	below serious				3186
22298	7 pts		Urinary incontinence	below serious				3186
22299	10 pts		Urinary retention	below serious				3186
22300	2 pts		Urinary tract stone	below serious				3186
22301	8 pts		Urticaria	below serious				3186
22302	8 pts		Varicose veins	below serious				3186
22303	10 pts		Venous insufficiency	below serious				3186
22304	5 pts		Vision loss	below serious				3186
22305	3 pts		Vitamin D deficiency	below serious				3186
22306	20 pts		Vomiting	below serious				3186
22307	45 pts		Weakness	below serious				3186
22308	5 pts		Weakness	below serious				3186
22309	2 pts		Weight loss	below serious				3186
22310	15 pts		Hypotension	below serious				3185
22311	1 pts		Ventricular extrasystoles	below serious				3188
22312	1 pts		Vertigo	below serious				3188
22313	1 pts		Dental caries	below serious				3188
22314	1 pts		Diarrhoea	below serious				3188
22315	2 pts		Nausea	below serious				3188
22316	1 pts		Toothache	below serious				3188
22317	1 pts		Bronchitis viral	below serious				3188
22318	1 pts		Ankle fracture	below serious				3188
22319	1 pts		Blood potassium increased	below serious				3188
22320	1 pts		Hyperglycaemia	below serious				3188
22321	1 pts		Balance disorder	below serious				3188
22322	1 pts		Gynaecomastia	below serious				3187
22323	1 pts		Cough	below serious				3188
22324	1 pts		Respiratory tract congestion	below serious				3188
22325	1 pts		Wheezing	below serious				3188
22326	1 pts		Anaemia	serious				3184
22327	1 pts		Aortic valve stenosis	serious				3184
22328	1 pts		Cardiogenic shock	serious				3184
22329	1 pts		Gastrointestinal haemorrhage	serious				3184
22330	1 pts		Proctalgia	serious				3184
22331	1 pts		Multi-organ failure	serious				3184
22332	1 pts		Non-cardiac chest pain	serious				3184
22333	1 pts		Systemic inflammatory response syndrome	serious				3184
22334	1 pts		H1N1 influenza	serious				3184
22335	3 pts		Pneumonia	serious				3184
22336	1 pts		Urinary tract infection	serious				3184
22337	1 pts		Haematoma traumatic	serious				3184
22338	1 pts		International normalised ratio increased	serious				3184
22339	1 pts		Hyperglycaemia	serious				3184
22340	1 pts		Hypokalaemia	serious				3184
22341	1 pts		Lactic acidosis	serious				3184
22342	1 pts		Adenocarcinoma of colon	serious				3184
22343	1 pts		Delirium	serious				3184
22344	4 pts		Respiratory failure	serious				3184
22345	1 pts		Aspiration pneumonia	serious				3184
22346	1 pts		Aortic dissection	serious				3184
22347	1 pts		Distributive shock	serious				3184
22348	1 pts		Hypertensive crisis	serious				3184
22349	2 pts		Hypertensive emergency	serious				3184
22350	1 pts		Hypotension	serious				3184
22351	1 pts		Hypovolaemic shock	serious				3184
22352	1 pts		Hypoglycemia	below serious				3189
22353	1 pts		Gastrointestinal upset	below serious				3189
22354	1 pts		Nausea	below serious				3189
22355	1 pts		Tachycardia	below serious				3189
22356	6.4		Gynecomastia					3192
22357	2.9		Gynecomastia		discontinuation			3192
22358	2		Hyperkalemia					3192
22359	1		Hyperkalemia		discontinuation			3192
22360	5.5		Gastric pain		discontinuation			3191
22361	5.5		Dizziness		discontinuation			3191
22362	5.5		Arterial hypotension		discontinuation			3191
22363	66.7		Gynecomastia					3193
22364	22.2		Semen abnormal					3193
22365			Altered mood		discontinuation			3190
22366			Dizziness		discontinuation			3190
22367	19		Abdominal pain					3197
22368	18		Asthenia					3197
22369	25		Headache					3197
22370	34		Diarrhea					3197
22371	12		Dyspepsia					3197
22372	24		Nausea					3197
22373	12		Vomiting					3197
22374	6		Lipodystrophy					3197
22375	6		Arthralgia					3197
22376	4		Myalgia					3197
22377	19		Abnormal dreams					3197
22378	13		Depressive disorders					3197
22379	26		Dizziness					3197
22380	22		Insomnia					3197
22381	13		Neuropathy					3197
22382	12		Paresthesia					3197
22383	9		Cough increased					3197
22384	11		Rhinitis					3197
22385	35		Rash					3197
22386	<1		Skin discoloration					3197
22387	54 pts		Headache					3196
22388	50 pts		Diarrhea					3196
22389	52 pts		Neuropathy peripheral					3196
22390	40 pts		Rash					3196
22391	39 pts		Nausea and vomiting					3196
22392	43 pts		Nausea					3194
22393	34 pts		Diarrhea					3194
22394	25 pts		Headache					3194
22395	18 pts		Rash					3194
22396	18 pts		Vomiting					3194
22397	8 pts		Neuropathy peripheral					3194
22398	53 pts		Nausea					3195
22399	45 pts		Diarrhea					3195
22400	46 pts		Headache					3195
22401	30 pts		Rash					3195
22402	30 pts		Vomiting					3195
22403	21 pts		Neuropathy peripheral					3195
22404	1 pts		Swallowing difficult		discontinuation	leads to discontinuation		3198
22405	1 pts		Pruritus		discontinuation	leads to discontinuation		3198
22406	2 pts		Oxygen saturation decreased		discontinuation	leads to discontinuation		3199
22407	1 pts		Pruritus		discontinuation	leads to discontinuation		3199
22408	1 pts		Dizziness		discontinuation	leads to discontinuation		3199
22409			Nausea					3201
22410			Vomiting					3201
22411			Hypotension					3201
22412	1 pts		Oxygen saturation decreased		discontinuation	leads to discontinuation		3200
22413	1 pts		Abdominal pain	serious				3202
22414	1 pts		Sick sinus syndrome	below serious				3202
22415	1 pts		Anal pain	below serious				3202
22416	33 pts		Diarrhea	below serious				3202
22417	1 pts		Dyspepsia	below serious				3202
22418	17 pts		Lower gastrointestinal hemorrhage	below serious				3202
22419	1 pts		Mucositis oral	below serious				3202
22420	2 pts		Nausea	below serious				3202
22421	2 pts		Rectal pain	below serious				3202
22422	17 pts		Tenesmus	below serious				3202
22423	3 pts		Fatigue	below serious				3202
22424	1 pts		Abdominal infection	below serious				3202
22425	1 pts		Rash pustular	below serious				3202
22426	1 pts		Headache	below serious				3202
22427	1 pts		Syncope	below serious				3202
22428	1 pts		Cystitis noninfective	below serious				3202
22429	1 pts		Hematuria	below serious				3202
22430	1 pts		Urinary frequency	below serious				3202
22431	16.7		Headache	severe	discontinuation			3206
22432	8.3		Headache		discontinuation			3206
22433	12.5		Nausea		discontinuation			3206
22434	8.3		Nausea	severe	discontinuation			3206
22435	4.2		Acute pancreatitis		discontinuation			3206
22436	4.2		Abdominal pain		discontinuation			3206
22437	4.2		Lethargy		discontinuation			3206
22438	8.3		Depression		discontinuation			3206
22439	4.2		Dizziness	severe	discontinuation			3206
22440	4.2		Rash		discontinuation			3206
22441	4.2		Light headedness		discontinuation			3206
22442			Headache		discontinuation			3203
22443			Dizziness		discontinuation			3203
22444	2.9		Toxic reaction (NOS)	serious	discontinuation			3205
22445	2.9		Anorexia	serious	discontinuation			3205
22446	2.9		Nausea	serious	discontinuation			3205
22447	2.9		Abdominal discomfort	serious	discontinuation			3205
22448	2.9		General malaise	serious	discontinuation			3205
22449	2.9		Headache	serious	discontinuation			3205
22450	2.9		Fever	serious	discontinuation			3205
22451	2.9		Rash	serious	discontinuation			3205
22452	2.9		Lymphadenopathy cervical	serious	discontinuation			3205
22453	2.9		Transaminase value increased	serious	discontinuation	increased liver transaminase levels		3205
22454	5.7		Leukopenia		discontinuation			3205
22455	5.7		Transaminase value increased	grade 2-4	discontinuation	liver transaminases elevated more than 3 times over the baseline value		3205
22456	8.6		IgA decreased		discontinuation			3205
22457			Lactic acidosis	severe	discontinuation			3204
22458			Seizures		discontinuation			3204
22459			Coagulopathy		discontinuation			3204
22460			Hyperglycemia		discontinuation			3204
22461			Ketosis		discontinuation			3204
22462			Methemoglobinemia		discontinuation			3204
22463			Acute renal failure					3207
22464	rare		Skin rash		discontinuation			3209
22465	low incidence		Acute renal failure			WARNINGS		3208
22466	1 pts		Haematemesis		discontinuation	leads to discontinuation		3212
22467	1 pts		Leucocytosis NOS		discontinuation	leads to discontinuation		3212
22468	1 pts		Acute kidney injury		discontinuation	leads to discontinuation		3213
22469	1 pts		Hyperbilirubinemia		discontinuation	leads to discontinuation		3213
22470	1 pts		Ischemic skin necrosis		discontinuation	leads to discontinuation		3213
22471	1 pts		Hematemesis		discontinuation	leads to discontinuation		3211
22472	1 pts		Granulocytosis		discontinuation	leads to discontinuation		3211
22473	1 pts		Spasms		discontinuation	leads to discontinuation		3214
22474	1 pts		Anorexia		discontinuation	leads to discontinuation		3214
22475	1 pts		Vomiting		discontinuation	leads to discontinuation		3214
22476	1 pts		Anuria		discontinuation	leads to discontinuation		3214
22477	1 pts		Arrhythmia atrial		discontinuation	leads to discontinuation		3214
22478	1 pts		Hypotension		discontinuation	leads to discontinuation		3214
22479	1 pts		Bone marrow depression		discontinuation	leads to discontinuation		3214
22480	1 pts		Abdominal pain		discontinuation	leads to discontinuation		3215
22481	1 pts		Hematemesis		discontinuation	leads to discontinuation		3215
22482	1 pts		Melena		discontinuation	leads to discontinuation		3215
22483	1 pts		Hematuria		discontinuation	leads to discontinuation		3215
22484	1 pts		Abdominal pain		discontinuation	leads to discontinuation		3216
22485	1 pts		Anorexia		discontinuation	leads to discontinuation		3216
22486	1 pts		Diarrhea		discontinuation	leads to discontinuation		3216
22487	1 pts		Chills		discontinuation	leads to discontinuation		3216
22488	1 pts		Lumbar pain		discontinuation	leads to discontinuation		3216
22489	1 pts		Polydypsia		discontinuation	leads to discontinuation		3216
22490	1 pts		Polyuria		discontinuation	leads to discontinuation		3216
22491	1 pts		Hematuria		discontinuation	leads to discontinuation		3216
22492	1 pts		Abdominal pain		discontinuation	leads to discontinuation		3210
22493	1 pts		Headache		discontinuation	leads to discontinuation		3210
22494	1 pts		Hematuria		discontinuation	leads to discontinuation		3210
22495	1 pts		Proteinuria		discontinuation	leads to discontinuation		3210
22496	1 pts		Proteinuria		discontinuation	leads to discontinuation		3217
22497	21 pts		Nausea		discontinuation	leads to discontinuation		3220
22498	21 pts		Vomiting		discontinuation	leads to discontinuation		3220
22499	21 pts		Anorexia		discontinuation	leads to discontinuation		3220
22500	21 pts		Dyspepsia		discontinuation	leads to discontinuation		3220
22501	21 pts		Diarrhea		discontinuation	leads to discontinuation		3220
22502	21 pts		Abdominal pain		discontinuation	leads to discontinuation		3220
22503	1 pts		Transaminases increased		discontinuation	leads to discontinuation		3218
22504	1 pts		Atrial fibrillation		discontinuation	leads to discontinuation		3218
22505	1 pts		Dyspnea		discontinuation	leads to discontinuation		3218
22506	1 pts		Chest pain		discontinuation	leads to discontinuation		3218
22507	1 pts		Transaminases increased		discontinuation	leads to discontinuation		3219
22508	1 pts		Nausea		discontinuation	leads to discontinuation		3219
22509	1 pts		Vomiting		discontinuation	leads to discontinuation		3219
22510	1 pts		Pallor		discontinuation	leads to discontinuation		3219
22511	1 pts		Vasodilatation		discontinuation	leads to discontinuation		3219
22512	1 pts		Sweating increased		discontinuation	leads to discontinuation		3219
22513	1 pts		Acute myocardial infarction	serious				3230
22514	1 pts		Endocarditis	serious				3230
22515	1 pts		Deafness	below serious				3230
22516	1 pts		Ear pain	below serious				3230
22517	2 pts		Gastrooesophageal reflux disease	below serious				3230
22518	1 pts		Haemorrhoidal haemorrhage	below serious				3230
22519	1 pts		Biliary colic	below serious				3230
22520	1 pts		Bronchitis	below serious				3230
22521	1 pts		Gastroenteritis	below serious				3230
22522	2 pts		Sinusitis	below serious				3230
22523	1 pts		Wound infection	below serious				3230
22524	1 pts		Fall	below serious				3230
22525	1 pts		Joint sprain	below serious				3230
22526	1 pts		Muscle strain	below serious				3230
22527	1 pts		Vertebral injury	below serious				3230
22528	1 pts		Hepatic enzyme increased	below serious				3230
22529	1 pts		Prostatic specific antigen increased	below serious				3230
22530	1 pts		Dyslipidaemia	below serious				3230
22531	1 pts		Hypertriglyceridaemia	below serious				3230
22532	3 pts		Arthralgia	below serious				3230
22533	5 pts		Back pain	below serious				3230
22534	1 pts		Intervertebral disc protrusion	below serious				3230
22535	2 pts		Myalgia	below serious				3230
22536	2 pts		Pain in extremity	below serious				3230
22537	3 pts		Dizziness	below serious				3230
22538	6 pts		Headache	below serious				3230
22539	1 pts		Anxiety	below serious				3230
22540	2 pts		Insomnia	below serious				3230
22541	1 pts		Micturition urgency	below serious				3230
22542	1 pts		Nocturia	below serious				3230
22543	1 pts		Night sweats	below serious				3230
22544	1 pts		Fracture rib	serious				3231
22545	1 pts		Intervertebral disc protrusion	serious				3231
22546	1 pts		Haemothorax	serious				3231
22547	1 pts		Arrhythmia	below serious				3231
22548	2 pts		Abdominal pain upper	below serious				3231
22549	4 pts		Dyspepsia	below serious				3231
22550	1 pts		Chest pain	below serious				3231
22551	1 pts		Influenza like illness	below serious				3231
22552	1 pts		Infective tenosynovitis	below serious				3231
22553	1 pts		Tonsillitis	below serious				3231
22554	1 pts		Multiple fractures	below serious				3231
22555	1 pts		Procedural headache	below serious				3231
22556	5 pts		Back pain	below serious				3231
22557	4 pts		Myalgia	below serious				3231
22558	1 pts		Pain in extremity	below serious				3231
22559	1 pts		Burning sensation	below serious				3231
22560	1 pts		Dizziness	below serious				3231
22561	4 pts		Headache	below serious				3231
22562	2 pts		Colic renal	below serious				3231
22563	1 pts		Urinary retention	below serious				3231
22564	1 pts		Erythema	below serious				3231
22565	1 pts		Tooth extraction	below serious				3231
22566	1 pts		Ear, nose and throat examination abnormal	below serious				3223
22567	1 pts		Myocardial infarction	serious				3224
22568	1 pts		Intervertebral disc protrusion	serious				3224
22569	1 pts		Anaemia	below serious				3224
22570	1 pts		Palpitations	below serious				3224
22571	1 pts		Cataract nuclear	below serious				3224
22572	1 pts		Conjunctivitis	below serious				3224
22573	1 pts		Dacryostenosis acquired	below serious				3224
22574	1 pts		Photopsia	below serious				3224
22575	1 pts		Retinal tear	below serious				3224
22576	1 pts		Vitreous detachment	below serious				3224
22577	1 pts		Vitreous floaters	below serious				3224
22578	2 pts		Diarrhoea	below serious				3224
22579	1 pts		Dyspepsia	below serious				3224
22580	1 pts		Food poisoning	below serious				3224
22581	1 pts		Hyperchlorhydria	below serious				3224
22582	1 pts		Irritability	below serious				3224
22583	1 pts		Pain	below serious				3224
22584	1 pts		Allergy to arthropod sting	below serious				3224
22585	1 pts		Drug hypersensitivity	below serious				3224
22586	2 pts		Bronchitis	below serious				3224
22587	1 pts		Gastroenteritis viral	below serious				3224
22588	6 pts		Nasopharyngitis	below serious				3224
22589	1 pts		Pharyngotonsillitis	below serious				3224
22590	1 pts		Pneumonia	below serious				3224
22591	1 pts		Tonsillitis	below serious				3224
22592	2 pts		Tooth infection	below serious				3224
22593	1 pts		Arthropod bite	below serious				3224
22594	1 pts		Arthropod sting	below serious				3224
22595	1 pts		Fall	below serious				3224
22596	1 pts		Joint injury	below serious				3224
22597	1 pts		Road traffic accident	below serious				3224
22598	1 pts		Blood cholesterol increased	below serious				3224
22599	2 pts		Blood creatine phosphokinase increased	below serious				3224
22600	1 pts		Blood creatinine increased	below serious				3224
22601	1 pts		Blood testosterone decreased	below serious				3224
22602	1 pts		Blood urea increased	below serious				3224
22603	1 pts		Hypercholesterolaemia	below serious				3224
22604	1 pts		Hyperlipidaemia	below serious				3224
22605	1 pts		Bone pain	below serious				3224
22606	1 pts		Coccydynia	below serious				3224
22607	1 pts		Groin pain	below serious				3224
22608	1 pts		Musculoskeletal pain	below serious				3224
22609	2 pts		Dizziness	below serious				3224
22610	1 pts		Libido decreased	below serious				3224
22611	1 pts		Pollakiuria	below serious				3224
22612	1 pts		Terminal dribbling	below serious				3224
22613	1 pts		Epididymitis	below serious				3224
22614	1 pts		Penile pain	below serious				3224
22615	1 pts		Prostatitis	below serious				3224
22616	1 pts		Testicular pain	below serious				3224
22617	1 pts		Cough	below serious				3224
22618	1 pts		Dry throat	below serious				3224
22619	1 pts		Intervertebral disc operation	below serious				3224
22620	1 pts		Nasal septal operation	below serious				3224
22621	1 pts		Pancreatitis haemorrhagic	serious				3232
22622	1 pts		Cerumen impaction	below serious				3232
22623	2 pts		Vision blurred	below serious				3232
22624	1 pts		Abdominal pain upper	below serious				3232
22625	3 pts		Dyspepsia	below serious				3232
22626	1 pts		Gastrooesophageal reflux disease	below serious				3232
22627	1 pts		Hernia inguinal	below serious				3232
22628	1 pts		Toothache	below serious				3232
22629	1 pts		Non-cardiac chest pain	below serious				3232
22630	1 pts		Seasonal allergy	below serious				3232
22631	1 pts		Ear infection	below serious				3232
22632	1 pts		Infected bites	below serious				3232
22633	5 pts		Nasopharyngitis	below serious				3232
22634	2 pts		Pharyngitis	below serious				3232
22635	3 pts		Upper respiratory tract infection	below serious				3232
22636	1 pts		Viral infection	below serious				3232
22637	1 pts		Blood calcium increased	below serious				3232
22638	1 pts		Blood uric acid increased	below serious				3232
22639	1 pts		Gamma-glutamyltransferase increased	below serious				3232
22640	1 pts		Haemoglobin decreased	below serious				3232
22641	1 pts		Heart rate decreased	below serious				3232
22642	1 pts		Scan myocardial perfusion abnormal	below serious				3232
22643	6 pts		Back pain	below serious				3232
22644	2 pts		Muscle spasms	below serious				3232
22645	1 pts		Pain in extremity	below serious				3232
22646	1 pts		Rheumatoid arthritis	below serious				3232
22647	1 pts		Drooling	below serious				3232
22648	12 pts		Headache	below serious				3232
22649	1 pts		Lethargy	below serious				3232
22650	1 pts		Syncope	below serious				3232
22651	1 pts		Post-traumatic stress disorder	below serious				3232
22652	1 pts		Micturition urgency	below serious				3232
22653	1 pts		Pollakiuria	below serious				3232
22654	1 pts		Renal impairment	below serious				3232
22655	1 pts		Priapism	below serious				3232
22656	1 pts		Bronchial hyperreactivity	below serious				3232
22657	1 pts		Epistaxis	below serious				3232
22658	2 pts		Oropharyngeal pain	below serious				3232
22659	1 pts		Sinus congestion	below serious				3232
22660	1 pts		Acne	below serious				3232
22661	1 pts		Dermatitis contact	below serious				3232
22662	2 pts		Rash	below serious				3232
22663	1 pts		Skin neoplasm excision	below serious				3232
22664	1 pts		Hot flush	below serious				3232
22665	3 pts		Hypertension	below serious				3232
22666	1 pts		Injury	serious				3225
22667	1 pts		Lumbar spinal stenosis	serious				3225
22668	1 pts		Colon cancer	serious				3225
22669	1 pts		Hepatic cancer metastatic	serious				3225
22670	1 pts		Hypertension	serious				3225
22671	1 pts		Abnormal sensation in eye	below serious				3225
22672	1 pts		Abdominal pain upper	below serious				3225
22673	1 pts		Dental caries	below serious				3225
22674	2 pts		Diarrhoea	below serious				3225
22675	1 pts		Onychomycosis	below serious				3225
22676	1 pts		Oral herpes	below serious				3225
22677	1 pts		Tinea cruris	below serious				3225
22678	1 pts		Tonsillitis	below serious				3225
22679	1 pts		Upper respiratory tract infection	below serious				3225
22680	1 pts		Fracture rib	below serious				3225
22681	1 pts		Blood pressure increased	below serious				3225
22682	1 pts		Blood uric acid increased	below serious				3225
22683	1 pts		Transaminases abnormal	below serious				3225
22684	2 pts		Arthralgia	below serious				3225
22685	1 pts		Arthritis	below serious				3225
22686	2 pts		Muscle spasms	below serious				3225
22687	3 pts		Myalgia	below serious				3225
22688	1 pts		Pyogenic granuloma	below serious				3225
22689	3 pts		Dizziness	below serious				3225
22690	3 pts		Headache	below serious				3225
22691	1 pts		Neuralgia	below serious				3225
22692	1 pts		Insomnia	below serious				3225
22693	1 pts		Calculus ureteric	below serious				3225
22694	1 pts		Perineal pain	below serious				3225
22695	1 pts		Prostatitis	below serious				3225
22696	2 pts		Allergic rhinitis	below serious				3225
22697	1 pts		Dermatitis	below serious				3225
22698	1 pts		Ingrowing nail	below serious				3225
22699	1 pts		Pain of skin	below serious				3225
22700	1 pts		Urticaria	below serious				3225
22701	1 pts		Orthostatic hypotension	below serious				3225
22702	1 pts		Tinnitus	below serious				3233
22703	1 pts		Ocular hyperaemia	below serious				3233
22704	1 pts		Abdominal discomfort	below serious				3233
22705	2 pts		Diarrhoea	below serious				3233
22706	2 pts		Dyspepsia	below serious				3233
22707	1 pts		Irritable bowel syndrome	below serious				3233
22708	3 pts		Nausea	below serious				3233
22709	1 pts		Peptic ulcer	below serious				3233
22710	1 pts		Reflux oesophagitis	below serious				3233
22711	1 pts		Oedema peripheral	below serious				3233
22712	1 pts		Adenoiditis	below serious				3233
22713	1 pts		Bronchitis	below serious				3233
22714	1 pts		Otitis media chronic	below serious				3233
22715	1 pts		Tinea pedis	below serious				3233
22716	2 pts		Prostatic specific antigen increased	below serious				3233
22717	4 pts		Back pain	below serious				3233
22718	1 pts		Joint range of motion decreased	below serious				3233
22719	2 pts		Muscle tightness	below serious				3233
22720	1 pts		Musculoskeletal pain	below serious				3233
22721	6 pts		Myalgia	below serious				3233
22722	1 pts		Myositis	below serious				3233
22723	3 pts		Headache	below serious				3233
22724	1 pts		Calculus ureteric	below serious				3233
22725	1 pts		Nephrolithiasis	below serious				3233
22726	1 pts		Spontaneous penile erection	below serious				3233
22727	1 pts		Asthma	below serious				3233
22728	1 pts		Cough	below serious				3233
22729	2 pts		Allergic rhinitis	below serious				3233
22730	1 pts		Rhinorrhoea	below serious				3233
22731	1 pts		Colon polypectomy	below serious				3233
22732	1 pts		Tooth extraction	below serious				3233
22733	2 pts		Hot flush	below serious				3233
22734	1 pts		Gastritis	serious				3234
22735	1 pts		Nausea	serious				3234
22736	1 pts		Vomiting	serious				3234
22737	1 pts		Chills	serious				3234
22738	1 pts		Sepsis	serious				3234
22739	1 pts		Lymphocyte count decreased	serious				3234
22740	1 pts		Platelet count decreased	serious				3234
22741	1 pts		Weight loss	serious				3234
22742	1 pts		Dehydration	serious				3234
22743	1 pts		Hyperglycemia	serious				3234
22744	1 pts		Hyponatremia	serious				3234
22745	1 pts		Urinary retention	serious				3234
22746	18 pts		Diarrhea	below serious				3234
22747	7 pts		Gastrointestinal disorders	below serious				3234
22748	30 pts		Fatigue	below serious				3234
22749	6 pts		Back pain	below serious				3234
22750	9 pts		Headache	below serious				3234
22751	22 pts		Renal and urinary disorders	below serious				3234
22752	55 pts		Urinary frequency	below serious				3234
22753	15 pts		Urinary tract pain	below serious				3234
22754	36 pts		Urinary urgency	below serious				3234
22755	7 pts		Ejaculation disorder	below serious				3234
22756	34 pts		Erectile dysfunction	below serious				3234
22757	6 pts		Reproductive system and breast disorders	below serious				3234
22758	6 pts		Hypertension	below serious				3234
22759	1 pts		Small intestinal obstruction	serious				3235
22760	1 pts		Anaemia	below serious				3235
22761	1 pts		Palpitations	below serious				3235
22762	1 pts		Cataract	below serious				3235
22763	1 pts		Ocular hyperaemia	below serious				3235
22764	1 pts		Vision blurred	below serious				3235
22765	1 pts		Abdominal pain upper	below serious				3235
22766	1 pts		Dry mouth	below serious				3235
22767	6 pts		Dyspepsia	below serious				3235
22768	2 pts		Gastrooesophageal reflux disease	below serious				3235
22769	1 pts		Oesophageal ulcer	below serious				3235
22770	1 pts		Retching	below serious				3235
22771	1 pts		Toothache	below serious				3235
22772	1 pts		Hernia	below serious				3235
22773	1 pts		Irritability	below serious				3235
22774	1 pts		Non-cardiac chest pain	below serious				3235
22775	1 pts		Oedema peripheral	below serious				3235
22776	1 pts		Suprapubic pain	below serious				3235
22777	1 pts		Seasonal allergy	below serious				3235
22778	1 pts		Abdominal abscess	below serious				3235
22779	1 pts		Acute tonsillitis	below serious				3235
22780	2 pts		Bronchitis	below serious				3235
22781	1 pts		Cellulitis	below serious				3235
22782	1 pts		Device related infection	below serious				3235
22783	3 pts		Nasopharyngitis	below serious				3235
22784	1 pts		Otitis externa	below serious				3235
22785	1 pts		Perirectal abscess	below serious				3235
22786	1 pts		Pharyngitis streptococcal	below serious				3235
22787	3 pts		Sinusitis	below serious				3235
22788	1 pts		Tonsillitis	below serious				3235
22789	1 pts		Wound infection	below serious				3235
22790	1 pts		Arthropod bite	below serious				3235
22791	2 pts		Contusion	below serious				3235
22792	1 pts		Excoriation	below serious				3235
22793	2 pts		Foot fracture	below serious				3235
22794	1 pts		Limb injury	below serious				3235
22795	1 pts		Fracture rib	below serious				3235
22796	1 pts		Heart rate increased	below serious				3235
22797	1 pts		Prostatic specific antigen increased	below serious				3235
22798	1 pts		Weight increased	below serious				3235
22799	1 pts		Gout	below serious				3235
22800	1 pts		Hyperkalaemia	below serious				3235
22801	6 pts		Back pain	below serious				3235
22802	1 pts		Groin pain	below serious				3235
22803	1 pts		Musculoskeletal chest pain	below serious				3235
22804	2 pts		Musculoskeletal discomfort	below serious				3235
22805	3 pts		Pain in extremity	below serious				3235
22806	2 pts		Tendonitis	below serious				3235
22807	1 pts		Prostate cancer	below serious				3235
22808	1 pts		Skin papilloma	below serious				3235
22809	3 pts		Dizziness	below serious				3235
22810	9 pts		Headache	below serious				3235
22811	1 pts		Radiculopathy	below serious				3235
22812	1 pts		Restless legs syndrome	below serious				3235
22813	1 pts		Sinus headache	below serious				3235
22814	1 pts		Abnormal dreams	below serious				3235
22815	1 pts		Chromaturia	below serious				3235
22816	1 pts		Dysuria	below serious				3235
22817	1 pts		Spermatocele	below serious				3235
22818	1 pts		Testicular pain	below serious				3235
22819	1 pts		Dyspnoea	below serious				3235
22820	1 pts		Upper-airway cough syndrome	below serious				3235
22821	1 pts		Dermatitis allergic	below serious				3235
22822	1 pts		Hyperhidrosis	below serious				3235
22823	1 pts		Pruritus	below serious				3235
22824	1 pts		Endodontic procedure	below serious				3235
22825	1 pts		Medical device removal	below serious				3235
22826	3 pts		Flushing	below serious				3235
22827	4 pts		Headache	below serious				3226
22828	1 pts		Congestive heart failure	serious				3229
22829	1 pts		Decompensated heart failure	serious				3229
22830	1 pts		Nosebleed	serious				3229
22831	1 pts		Sepsis	serious				3229
22832	1 pts		Diarrhea	below serious				3229
22833	1 pts		Flushing	below serious				3229
22834	2 pts		Headache	below serious				3229
22835	1 pts		Hypoglycemia	below serious				3229
22836	1 pts		Insomnia	below serious				3229
22837	1 pts		Taste metallic	below serious				3229
22838	1 pts		Palpitations	below serious				3229
22839	1 pts		Stomach upset	below serious				3229
22840	2 pts		Indigestion	below serious				3227
22841	3 pts		Diarrhea	below serious				3227
22842	1 pts		Headache	below serious				3227
22843	1 pts		Back pain	below serious				3227
22844	1 pts		Syncope	below serious				3227
22845	1 pts		Myocardial infarction	serious				3228
22846	1 pts		Lightheadedness	below serious				3228
22847	1 pts		Hematuria	below serious				3228
22848	1 pts		Diarrhea	below serious				3228
22849	1 pts		Urinary retention	below serious				3228
22850	1 pts		Small bowel obstruction	below serious				3228
22851	1 pts		Nasal sinus drainage	below serious				3228
22852	1 pts		Chest pain	below serious				3228
22853	1 pts		Hypertension	below serious				3228
22854	1 pts		Leg pain	below serious				3228
22855	1 pts		Fever	below serious				3228
22856	1 pts		Chills	below serious				3236
22857	1 pts		Muscle pain	below serious				3236
22858	1 pts		Edema	below serious				3236
22859	7.7		Headache					3238
22860	7		Dyspepsia					3238
22861	2.9		Back pain					3238
22862	2.9		Flushing					3238
22863	3		Myalgia					3238
22864	1.7		Abdominal pain upper					3238
22865	2 pts		Facial flushing	grade 1				3237
22866	1 pts		Anorexia	grade 1				3237
22867						Adverse reactions were similar to those seen at lower doses		3222
22868						Adverse reactions were similar to those seen at lower doses		3221
22869	17		Musculoskeletal pain	grade 3			TRUE	3240
22870	17		Hypercalcaemia	grade 3			TRUE	3239
22871	17		Hypertriglyceridaemia	grade 4			TRUE	3239
22872			Disorder fetal		discontinuation	WARNING		3241
22873			Skin irritation		discontinuation	WARNING		3241
22874			Pruritus		discontinuation	WARNING		3241
22875			Burning skin		discontinuation	WARNING		3241
22876			Skin red		discontinuation	WARNING		3241
22877			Skin peeling		discontinuation	WARNING		3241
22878			Photosensitivity		discontinuation	WARNING		3241
22879			Sunburn		discontinuation	WARNING		3241
22880						In healthy young subjects receiving single doses, there were no serious adverse events and no discontinuations occurred as a result of adverse events.		3242
22881						The high plasma concentrations of telmisartan attained with multiple doses of 320 mg were well tolerated.		3243
22882			Disorder fetal		discontinuation	WARNING		3244
22883			Hypotension		discontinuation	WARNING		3244
22884						No AEs reported		3246
22885						No AEs were observed		3245
22886	1 pts		Dizziness	serious				3247
22887	2 pts		Infection	serious				3247
22888	20		Somnolence				TRUE	3250
22889	16.7		Ataxia				TRUE	3251
22890						After two patients experienced DLT at the level of 200 mg b.i.d., three additional patients were treated with 150 mg b.i.d. without experiencing significant toxicity.		3249
22891	50		Cutaneous mucormycosis				TRUE	3253
22892	50		Dyspnea				TRUE	3253
22893			Dyspnea	grade 3-4		1 patient	TRUE	3248
22894			Fetal damage		discontinuation	WARNING		3252
22895			Deep vein thrombosis		discontinuation	WARNING		3252
22896			Pulmonary embolism		discontinuation	WARNING		3252
22897	45.9		Headache					3257
22898	27		Nausea					3257
22899	5.4		Vomiting					3257
22900	8.1		Pruritus					3257
22901	8.1		Arthralgia					3257
22902	8.1		Alopecia					3257
22903	2.7		Dysaesthesia					3257
22904	10.8		Eczema					3257
22905	5.4		Exanthema					3257
22906	5.4		Photosensitivity allergic reac					3257
22907	2.7		Erythema nodosum					3257
22908	2.7		Rotavirus infection					3257
22909	29.7		Respiratory tract infections					3257
22910	10.8		Urinary tract infections					3257
22911	5.4		Genital candidiasis					3257
22912	2.7		Herpes labialis					3257
22913	5.4		Transaminases increased					3257
22914	8.1		Leucopenia					3257
22915	2.7		Anaemia					3257
22916	2.7		Thrombopenia					3257
22917	2.7		Pancreatitis		discontinuation			3257
22918	5.4		Headache		discontinuation			3257
22919	2.7		Pneumonia		discontinuation			3257
22920	5.4		Leucopenia		discontinuation			3257
22921	9.6		Pain	grade 1-2				3256
22922	20		Nausea and vomiting	grade 1-2				3256
22923	11.8		Leukopenia	grade 1-2				3256
22924	3.7		Thrombocytopenia	grade 1-3				3256
22925	24.4		Hepatotoxicity	grade 1-2				3256
22926	8.9		Headache	grade 1-2				3256
22927	8.9		Anemia	grade 1-3				3256
22928	16.3		Gamma-glutamyltransferase increased	grade 1-4				3256
22929	1.4		Diarrhea	grade 2				3256
22930	11.8		Skin toxicity	grade 1-2				3256
22931	5.2		Hair loss	grade 1				3256
22932	26.7		Infection	grade 1-3				3256
22933	1.4		Blood urea nitrogen increased	grade 1				3256
22934	1.4		Neurotoxicity	grade 1-2				3256
22935	0.7		Hemorrhage	grade 3				3256
22936	0.7		Stomatitis	grade 1				3256
22937	0.7		Creatinine increased	grade 2				3256
22938	0.7		Cardiac arrhythmias	grade 1				3256
22939	0.7		Constipation	grade 1				3256
22940	6.1		Pain	grade 1-3	discontinuation			3258
22941	4.4		Nausea and vomiting	grade 1-2	discontinuation			3258
22942	2.7		Leukopenia	grade 1-3	discontinuation			3258
22943	2.7		Thrombocytopenia	grade 1-3	discontinuation			3258
22944	2.4		Hepatotoxicity	grade 1-2	discontinuation			3258
22945	1.7		Headache	grade 1-2	discontinuation			3258
22946	0.7		Anemia	grade 1-4	discontinuation			3258
22947	1		Gamma-glutamyltransferase increased	grade 2-3	discontinuation			3258
22948	1		Diarrhea	grade 2-4	discontinuation			3258
22949	0.7		Skin toxicity	grade 1	discontinuation			3258
22950	0.7		Hair loss	grade 1	discontinuation			3258
22951	0.3		Cardiac dysfunction	grade 3	discontinuation			3258
22952	0.3		Pericarditis	grade 2	discontinuation			3258
22953	25		Leukopenia					3254
22954	25		Creatinine increased		dose reduction			3254
22955	16.1		Neutropenia	grade 3				3255
22956	16.1		Anemia	grade 3				3255
22957	16.1		Thrombocytopenia	grade 3				3255
22958	2 pts		Headache	below serious				3259
22959	1 pts		Cardiovascular insufficiency	serious				3260
22960	1 pts		Myocardial infarction	serious				3260
22961	2 pts		Intestinal obstruction	serious				3260
22962	1 pts		Pancreatitis acute	serious				3260
22963	3 pts		Non-cardiac chest pain	serious				3260
22964	1 pts		Cholecystitis	serious				3260
22965	1 pts		Cholelithiasis	serious				3260
22966	1 pts		Diverticulitis	serious				3260
22967	2 pts		Lobar pneumonia	serious				3260
22968	1 pts		Pseudomonas infection	serious				3260
22969	1 pts		Sinusitis	serious				3260
22970	1 pts		Upper respiratory tract infection	serious				3260
22971	2 pts		Viral upper respiratory tract infection	serious				3260
22972	1 pts		Contusion	serious				3260
22973	1 pts		Fall	serious				3260
22974	1 pts		Limb crushing injury	serious				3260
22975	1 pts		Radius fracture	serious				3260
22976	1 pts		Spinal compression fracture	serious				3260
22977	1 pts		Wrist fracture	serious				3260
22978	1 pts		Fluid overload	serious				3260
22979	1 pts		Myositis	serious				3260
22980	1 pts		Bladder transitional cell carcinoma	serious				3260
22981	1 pts		Cerebrovascular accident	serious				3260
22982	1 pts		Haemorrhagic stroke	serious				3260
22983	1 pts		Renal failure acute	serious				3260
22984	1 pts		Benign prostatic hyperplasia	serious				3260
22985	1 pts		Acute respiratory failure	serious				3260
22986	1 pts		Pneumothorax	serious				3260
22987	1 pts		Pulmonary embolism	serious				3260
22988	1 pts		Angioedema	serious				3260
22989	8 pts		Oedema peripheral	below serious				3260
22990	12 pts		Bronchitis	below serious				3260
22991	10 pts		Lower respiratory tract infection	below serious				3260
22992	21 pts		Nasopharyngitis	below serious				3260
22993	16 pts		Urinary tract infection	below serious				3260
22994	12 pts		Back pain	below serious				3260
22995	14 pts		Hypertension	below serious				3260
22996	1 pts		Lymphadenopathy	serious				3261
22997	1 pts		Angina pectoris	serious				3261
22998	1 pts		Cardiac failure congestive	serious				3261
22999	1 pts		Coronary artery insufficiency	serious				3261
23000	1 pts		Abdominal hernia	serious				3261
23001	1 pts		Gastrointestinal haemorrhage	serious				3261
23002	2 pts		Hernia inguinal	serious				3261
23003	1 pts		Non-cardiac chest pain	serious				3261
23004	1 pts		Cholecystitis	serious				3261
23005	2 pts		Cholelithiasis	serious				3261
23006	1 pts		Bronchitis	serious				3261
23007	1 pts		Dengue fever	serious				3261
23008	1 pts		Gastroenteritis viral	serious				3261
23009	1 pts		Cerebrovascular accident	serious				3261
23010	1 pts		Dizziness	serious				3261
23011	1 pts		Hydrothorax	serious				3261
23012	1 pts		Respiratory failure	serious				3261
23013	21 pts		Cough	below serious				3261
23014	1 pts		Acute myocardial infarction	serious				3262
23015	5 pts		Chronic obstructive pulmonary disease	below serious				3262
23016			Tachycardia		discontinuation			3264
23017			Immediate hypersensitivity reaction		discontinuation	WARNING		3265
23018			Angioedema		discontinuation	WARNING		3265
23019			Bronchospasm		discontinuation	WARNING		3265
23020			Anaphylaxis		discontinuation	WARNING		3265
23021			Bronchospasm paradoxical		discontinuation	WARNING		3265
23022						there were no systemic anticholinergic adverse effects following a single inhaled dose of up to 282 mcg tiotropium dry powder		3263
23023			Dizziness					3268
23024			Dizziness					3266
23025			Shakiness					3267
23026						No SAEs were observed		3269
23027			Dizziness		discontinuation			3271
23028			Acute liver failure	grade 3-5	discontinuation	WARNINGS. 3/1000000 patients per year in the United States		3273
23029			Hepatocellular injury	grade 3-5	discontinuation	WARNINGS		3273
23030	6		Diarrhea		discontinuation	Diarrhea resulted in withdrawal in approximately 8%, 40% and 70% of patients with mild, moderate and severe diarrhea, respectively.		3272
23031	1.7		ALT increased		discontinuation			3274
23032	1.7		Aspartate aminotransferase increased		discontinuation			3274
23033	1		Somnolence		discontinuation			3275
23034	1		Hallucinations		discontinuation			3276
23035	33		Nausea	severe	discontinuation			3270
23036	33		Vomiting	severe	discontinuation			3270
23037	2 pts		Angina pectoris	serious				3282
23038	3 pts		Atrial fibrillation	serious				3282
23039	1 pts		Coronary artery disease	serious				3282
23040	1 pts		Mitral valve prolapse	serious				3282
23041	1 pts		Myocardial infarction	serious				3282
23042	1 pts		Myocardial ischaemia	serious				3282
23043	2 pts		Palpitations	serious				3282
23044	1 pts		Pericardial effusion	serious				3282
23045	1 pts		Pericarditis	serious				3282
23046	1 pts		Sick sinus syndrome	serious				3282
23047	1 pts		Ventricular extrasystoles	serious				3282
23048	1 pts		Deafness	serious				3282
23049	2 pts		Vertigo	serious				3282
23050	1 pts		Glaucoma	serious				3282
23051	2 pts		Retinal detachment	serious				3282
23052	1 pts		Abdominal distension	serious				3282
23053	1 pts		Anal fissure	serious				3282
23054	1 pts		Anal fistula	serious				3282
23055	1 pts		Colonic polyp	serious				3282
23056	1 pts		Diverticulum intestinal	serious				3282
23057	1 pts		Gastrooesophageal reflux disease	serious				3282
23058	1 pts		Hiatus hernia	serious				3282
23059	1 pts		Ileus	serious				3282
23060	2 pts		Hernia inguinal	serious				3282
23061	1 pts		Periodontitis	serious				3282
23062	1 pts		Rectal haemorrhage	serious				3282
23063	2 pts		Umbilical hernia	serious				3282
23064	8 pts		Chest pain	serious				3282
23065	1 pts		Exercise tolerance decreased	serious				3282
23066	3 pts		Fatigue	serious				3282
23067	1 pts		Thirst	serious				3282
23068	1 pts		Cholangitis	serious				3282
23069	3 pts		Hepatic function abnormal	serious				3282
23070	2 pts		Hepatic pain	serious				3282
23071	1 pts		Hepatitis	serious				3282
23072	1 pts		Liver disorder	serious				3282
23073	1 pts		Anaphylactic shock	serious				3282
23074	1 pts		Abscess limb	serious				3282
23075	1 pts		Bartholin's abscess	serious				3282
23076	1 pts		Cellulitis	serious				3282
23077	2 pts		Diverticulitis	serious				3282
23078	1 pts		Gastroenteritis	serious				3282
23079	1 pts		Hepatitis B	serious				3282
23080	2 pts		Kidney infection	serious				3282
23081	1 pts		Liver abscess	serious				3282
23082	1 pts		Malaria	serious				3282
23083	1 pts		Mycoplasma infection	serious				3282
23084	1 pts		Perineal abscess	serious				3282
23085	3 pts		Pneumonia	serious				3282
23086	1 pts		Respiratory tract infection viral	serious				3282
23087	1 pts		Syphilis	serious				3282
23088	1 pts		Urogenital infection bacterial	serious				3282
23089	2 pts		Cartilage injury	serious				3282
23090	1 pts		Clavicle fracture	serious				3282
23091	1 pts		Fall	serious				3282
23092	1 pts		Hand fracture	serious				3282
23093	1 pts		Induced abortion haemorrhage	serious				3282
23094	1 pts		Lumbar vertebral fracture	serious				3282
23095	1 pts		Multiple fractures	serious				3282
23096	1 pts		Post procedural haemorrhage	serious				3282
23097	1 pts		Spinal compression fracture	serious				3282
23098	1 pts		Spinal fracture	serious				3282
23099	1 pts		Ulna fracture	serious				3282
23100	1 pts		Wrist fracture	serious				3282
23101	9 pts		Alanine aminotransferase increased	serious				3282
23102	9 pts		Aspartate aminotransferase increased	serious				3282
23103	1 pts		Blood bilirubin increased	serious				3282
23104	2 pts		Liver function test abnormal	serious				3282
23105	4 pts		Transaminases increased	serious				3282
23106	1 pts		Hyperglycaemia	serious				3282
23107	1 pts		Hypovolaemia	serious				3282
23108	1 pts		Cervical spinal stenosis	serious				3282
23109	1 pts		Fistula	serious				3282
23110	1 pts		Foot deformity	serious				3282
23111	2 pts		Intervertebral disc protrusion	serious				3282
23112	1 pts		Ligament pain	serious				3282
23113	1 pts		Musculoskeletal pain	serious				3282
23114	1 pts		Osteoarthropathy	serious				3282
23115	1 pts		Rotator cuff syndrome	serious				3282
23116	3 pts		Breast cancer	serious				3282
23117	1 pts		Cervix carcinoma stage 0	serious				3282
23118	1 pts		Chronic myeloid leukaemia	serious				3282
23119	2 pts		Malignant melanoma	serious				3282
23120	1 pts		Malignant melanoma in situ	serious				3282
23121	1 pts		Pituitary tumour benign	serious				3282
23122	1 pts		Cerebral haemorrhage	serious				3282
23123	1 pts		Dizziness	serious				3282
23124	5 pts		Headache	serious				3282
23125	3 pts		Intracranial aneurysm	serious				3282
23126	2 pts		Loss of consciousness	serious				3282
23127	1 pts		Migraine with aura	serious				3282
23128	1 pts		Nerve root compression	serious				3282
23129	2 pts		Paraesthesia	serious				3282
23130	1 pts		Parkinsonism	serious				3282
23131	1 pts		Presyncope	serious				3282
23132	1 pts		Sciatica	serious				3282
23133	1 pts		Syncope	serious				3282
23134	1 pts		Vertebral artery dissection	serious				3282
23135	1 pts		VIIth nerve paralysis	serious				3282
23136	1 pts		Major depression	serious				3282
23137	1 pts		Bladder prolapse	serious				3282
23138	4 pts		Haematuria	serious				3282
23139	2 pts		Pollakiuria	serious				3282
23140	1 pts		Polyuria	serious				3282
23141	1 pts		Renal cyst	serious				3282
23142	1 pts		Renal failure chronic	serious				3282
23143	1 pts		Renal impairment	serious				3282
23144	1 pts		Urinary incontinence	serious				3282
23145	1 pts		Cervical dysplasia	serious				3282
23146	3 pts		Menorrhagia	serious				3282
23147	2 pts		Ovarian cyst	serious				3282
23148	1 pts		Ovarian torsion	serious				3282
23149	1 pts		Pelvic prolapse	serious				3282
23150	3 pts		Uterine prolapse	serious				3282
23151	1 pts		Uterovaginal prolapse	serious				3282
23152	2 pts		Dyspnoea	serious				3282
23153	1 pts		Laryngeal oedema	serious				3282
23154	1 pts		Nasal septum deviation	serious				3282
23155	1 pts		Productive cough	serious				3282
23156	1 pts		Pulmonary embolism	serious				3282
23157	1 pts		Respiratory failure	serious				3282
23158	1 pts		Angioedema	serious				3282
23159	1 pts		Hidradenitis	serious				3282
23160	1 pts		Urticaria	serious				3282
23161	1 pts		Haematoma	serious				3282
23162	3 pts		Hypotension	serious				3282
23163	1 pts		Orthostatic hypotension	serious				3282
23164	1 pts		Superficial thrombophlebitis	serious				3282
23165	1 pts		Varicose vein	serious				3282
23166	49 pts		Abdominal distension	below serious				3282
23167	81 pts		Constipation	below serious				3282
23168	133 pts		Diarrhoea	below serious				3282
23169	154 pts		Dry mouth	below serious				3282
23170	78 pts		Dyspepsia	below serious				3282
23171	81 pts		Vomiting	below serious				3282
23172	58 pts		Asthenia	below serious				3282
23173	132 pts		Fatigue	below serious				3282
23174	532 pts		Thirst	below serious				3282
23175	55 pts		Gastroenteritis	below serious				3282
23176	78 pts		Influenza	below serious				3282
23177	221 pts		Nasopharyngitis	below serious				3282
23178	56 pts		Sinusitis	below serious				3282
23179	87 pts		Upper respiratory tract infection	below serious				3282
23180	69 pts		Decreased appetite	below serious				3282
23181	100 pts		Polydipsia	below serious				3282
23182	70 pts		Arthralgia	below serious				3282
23183	52 pts		Myalgia	below serious				3282
23184	108 pts		Dizziness	below serious				3282
23185	55 pts		Insomnia	below serious				3282
23186	281 pts		Nocturia	below serious				3282
23187	222 pts		Pollakiuria	below serious				3282
23188	78 pts		Cough	below serious				3282
23189	50 pts		Oropharyngeal pain	below serious				3282
23190	49 pts		Dry skin	below serious				3282
23191	369 pts		Polyuria	below serious				3282
23192	1 pts		Disseminated intravascular coagulation	serious				3281
23193	1 pts		Hepatic cirrhosis	serious				3281
23194	1 pts		Pylethrombosis	serious				3281
23195	1 pts		Omphalitis	serious				3281
23196	1 pts		Bile duct cancer	serious				3281
23197	1 pts		Hepatic neoplasm malignant	serious				3281
23198	1 pts		Respiration failure	serious				3281
23199	1 pts		Intra-abdominal haemorrhage	serious				3281
23200	6 pts		Diarrhoea	below serious				3281
23201	4 pts		Vomiting	below serious				3281
23202	3 pts		Stomatitis	below serious				3281
23203	11 pts		Thirst	below serious				3281
23204	3 pts		Encephalopathy hepatic	below serious				3281
23205	4 pts		Insomnia	below serious				3281
23206	6 pts		Pollakiuria	below serious				3281
23207	3 pts		Pruritus	below serious				3281
23208	17 pts		Pain	serious				3280
23209	2 pts		Nausea	serious				3280
23210	17 pts		Edema	serious				3280
23211	13 pts		Infection	serious				3280
23212	8 pts		Hypotension	serious				3280
23213	3 pts		Edema	serious				3280
23214	1 pts		Congestive cardiac failure	serious				3279
23215	1 pts		Cataract	serious				3279
23216	1 pts		Diabetic retinal edema	serious				3279
23217	1 pts		Hernia inguinal	serious				3279
23218	1 pts		Nausea	serious				3279
23219	1 pts		Large intestine polyp	serious				3279
23220	1 pts		Fever	serious				3279
23221	1 pts		C-reactive protein increased	serious				3279
23222	1 pts		Occult blood positive	serious				3279
23223	1 pts		Osteoarthritis	serious				3279
23224	1 pts		Embolic stroke	serious				3279
23225	1 pts		Renal failure acute	serious				3279
23226	1 pts		Epistaxis	serious				3279
23227	6 pts		Constipation	below serious				3279
23228	10 pts		Thirst	below serious				3279
23229	3 pts		Blood potassium increased	below serious				3279
23230	8 pts		Blood sodium increased	below serious				3279
23231	3 pts		Hypokalaemia	below serious				3279
23232						No AEs are reported		3278
23233			Liver injury	serious		WARNING		3284
23234	6.6		Pollakiuria		discontinuation	leads to discontinuation		3285
23235	6.6		Polyuria		discontinuation	leads to discontinuation		3285
23236	6.6		Nocturia		discontinuation	leads to discontinuation		3285
23237						No AEs are reported		3277
23238	6 pts		Thirst					3283
23239	6 pts		Urinary frequency					3283
23240	2 pts		Dry mouth					3283
23241	2 pts		Headache NOS					3283
23242	17 pts		Sedation	below serious				3288
23243	17 pts		Paresthesia	below serious				3288
23244	6 pts		Headache	below serious				3288
23245	6 pts		Dry mouth	below serious				3288
23246	1 pts		Anemia	serious				3287
23247	1 pts		Diverticulitis	serious				3287
23248	1 pts		Furuncle	serious				3287
23249	33 pts		Headache	below serious				3287
23250	20 pts		Fatigue	below serious				3287
23251	16 pts		Cough	below serious				3287
23252	11 pts		Diarrhea	below serious				3287
23253	9 pts		Dizziness	below serious				3287
23254	1 pts		Alcoholic relapse	serious				3286
23255	12 pts		Headache	below serious				3286
23256	9 pts		Appetite lost	below serious				3286
23257	8 pts		Concentration impaired	below serious				3286
23258	7 pts		Dysgeusia	below serious				3286
23259	6 pts		Somnolence	below serious				3286
23260	6 pts		Depression	below serious				3286
23261	1 pts		Anorexia	serious				3290
23262	1 pts		Migraine	serious				3290
23263	1 pts		Angle glaucoma closed	serious				3290
23264	1 pts		Joint dislocation	serious				3290
23265	39 pts		Nasopharyngitis	below serious				3290
23266	11 pts		Decreased appetite	below serious				3290
23267	50 pts		Paraesthesia	below serious				3290
23268	26 pts		Dysaesthesia	below serious				3290
23269	16 pts		Somnolence	below serious				3290
23270	4 pts		Disturbance in attention	below serious				3290
23271	16 pts		Upper respiratory tract inflammation	below serious				3290
23272	6 pts		Nausea	below serious				3290
23273	8 pts		Malaise	below serious				3290
23274	51 pts		Weight decreased	below serious				3290
23275	15 pts		Blood bicarbonate decreased	below serious				3290
23276	3 pts		Numbness	below serious				3289
23277	2 pts		Attention concentration difficulty	below serious				3289
23278	3 pts		Fatigue	below serious				3289
23279	3 pts		Itching	below serious				3289
23280	5 pts		Sleepiness	below serious				3289
23281	4 pts		Diarrhea	below serious				3289
23282	1 pts		Intussusception	serious				3291
23283	1 pts		Contusion	serious				3291
23284	1 pts		Traumatic liver injury	serious				3291
23285	1 pts		Suicide attempt	serious				3291
23286	23 pts		Aphasia	below serious				3291
23287	23 pts		Cognitive disorder	below serious				3291
23288	9 pts		Dizziness	below serious				3291
23289	24 pts		Memory impairment	below serious				3291
23290	45 pts		Paresthesia	below serious				3291
23291	36 pts		Fatigue	below serious				3291
23292	26 pts		Dry mouth	below serious				3291
23293	14 pts		Altered mood	below serious				3291
23294	11 pts		Weight decreased	below serious				3291
23295	12 pts		Thinking slow	below serious				3292
23296	4 pts		Nervousness	below serious				3292
23297	14 pts		Anxiety	below serious				3292
23298	12 pts		Memory impairment	below serious				3292
23299	13 pts		Word finding difficulty	below serious				3292
23300	12 pts		Fatigue	below serious				3292
23301	13 pts		Attention concentration difficulty	below serious				3292
23302	4 pts		Depression	below serious				3292
23303	5 pts		Confusion	below serious				3292
23304	13 pts		Weight loss	below serious				3292
23305	13 pts		Decreased appetite	below serious				3292
23306	22 pts		Paresthesia	below serious				3292
23307	6 pts		Eye symptom	below serious				3292
23308	6 pts		Vision abnormal	below serious				3292
23309	10 pts		Sore throat	below serious				3292
23310	3 pts		Diarrhea	below serious				3292
23311	4 pts		Heart rate increased	below serious				3292
23312	4 pts		Stomach discomfort	below serious				3292
23313	3 pts		Fever	below serious				3292
23314	12 pts		Dizziness	below serious				3292
23315	6 pts		Balance difficulty	below serious				3292
23316	16 pts		Drowsiness	below serious				3292
23317						suicide attempt		3296
23318						impossible to link AEs with the definite dose		3294
23319	2.3		Convulsions aggravated		discontinuation	leads to discontinuation		3299
23320	1.6		Attention concentration difficulty		discontinuation	leads to discontinuation		3299
23321	1.3		Language disorder		discontinuation	leads to discontinuation		3299
23322	1.3		Personality disorder		discontinuation	leads to discontinuation		3299
23323	1.3		Somnolence		discontinuation	leads to discontinuation		3299
23324	4		Psychomotor retardation		discontinuation	leads to discontinuation		3293
23325	3.2		Memory impairment		discontinuation	leads to discontinuation		3293
23326	3.2		Fatigue		discontinuation	leads to discontinuation		3293
23327	3.1		Confusion		discontinuation	leads to discontinuation		3293
23328	3.2		Somnolence		discontinuation	leads to discontinuation		3293
23329	2.9		Attention concentration difficulty		discontinuation	leads to discontinuation		3293
23330	2.7		Anorexia		discontinuation	leads to discontinuation		3293
23331	2.6		Depression		discontinuation	leads to discontinuation		3293
23332	2.5		Dizziness		discontinuation	leads to discontinuation		3293
23333	2.5		Weight decrease		discontinuation	leads to discontinuation		3293
23334	2.3		Nervousness		discontinuation	leads to discontinuation		3293
23335	2.1		Ataxia		discontinuation	leads to discontinuation		3293
23336	2		Paresthesia		discontinuation	leads to discontinuation		3293
23337	>=2		Memory impairment		discontinuation	leads to discontinuation		3298
23338	>=2		Fatigue		discontinuation	leads to discontinuation		3298
23339	>=2		Asthenia		discontinuation	leads to discontinuation		3298
23340	>=2		Insomnia		discontinuation	leads to discontinuation		3298
23341	>=2		Somnolence		discontinuation	leads to discontinuation		3298
23342	>=2		Paresthesia		discontinuation	leads to discontinuation		3298
23343	>=2		Attention concentration difficulty		discontinuation	leads to discontinuation		3297
23344	>=2		Fever		discontinuation	leads to discontinuation		3297
23345	>=2		Flushing		discontinuation	leads to discontinuation		3297
23346	>=2		Confusion		discontinuation	leads to discontinuation		3297
23347	1 pts		Coma					3295
23348	40.7		Leukopenia	grade 3				3303
23349	15.9		Leukopenia	grade 4				3303
23350	31		Neutropenia	grade 3				3303
23351	50.4		Neutropenia	grade 4				3303
23352	17.7		Thrombocytopenia	grade 3				3303
23353	22.1		Thrombocytopenia	grade 4				3303
23354	26.5		Anemia	grade 3				3303
23355	2.7		Anemia	grade 4				3303
23356	31.9		Nausea	grade 1				3303
23357	25		Nausea	grade 2				3303
23358	5.2		Nausea	grade 3				3303
23359	19.8		Alopecia	grade 1				3303
23360	22.4		Alopecia	grade 2				3303
23361	4.3		Alopecia	grade 3				3303
23362	22.4		Fatigue	grade 1				3303
23363	10.3		Fatigue	grade 2				3303
23364	5.2		Fatigue	grade 3				3303
23365	12.1		Vomiting	grade 1				3303
23366	19.8		Vomiting	grade 2				3303
23367	4.3		Vomiting	grade 3				3303
23368	0.9		Vomiting	grade 4				3303
23369	19		Diarrhea	grade 1				3303
23370	13.8		Diarrhea	grade 2				3303
23371	1.7		Diarrhea	grade 3				3303
23372	0.9		Diarrhea	grade 4				3303
23373	58		Neutropenia	grade 4		Toxicity after the first course of therapy.		3300
23374	20		Thrombocytopenia	grade 4		Toxicity after the first course of therapy.		3301
23375	11		Anemia	grade 3-4		Toxicity after the first course of therapy.		3301
23376	1 pts		Leukopenia	grade 1				3302
23377	1 pts		Leukopenia	grade 2				3302
23378	7 pts		Leukopenia	grade 3				3302
23379	2 pts		Leukopenia	grade 4				3302
23380	6 pts		Neutropenia	grade 2				3302
23381	2 pts		Neutropenia	grade 3				3302
23382	1 pts		Neutropenia	grade 4				3302
23383	2 pts		Thrombocytopenia	grade 1				3302
23384	1 pts		Thrombocytopenia	grade 2				3302
23385	1 pts		Thrombocytopenia	grade 3				3302
23386	2 pts		Thrombocytopenia	grade 4				3302
23387	3 pts		Anemia	grade 1				3302
23388	3 pts		Anemia	grade 2				3302
23389	1 pts		Anemia			Grade 9: preexisting abnormality, getting worse while on study.		3302
23390	4 pts		Leukopenia	grade 1				3304
23391	4 pts		Leukopenia	grade 2				3304
23392	3 pts		Leukopenia	grade 3				3304
23393	1 pts		Leukopenia	grade 4				3304
23394	1 pts		Neutropenia	grade 1				3304
23395	2 pts		Neutropenia	grade 2				3304
23396	1 pts		Neutropenia	grade 3				3304
23397	1 pts		Neutropenia	grade 4				3304
23398	3 pts		Thrombocytopenia	grade 2				3304
23399	2 pts		Thrombocytopenia	grade 3				3304
23400	4 pts		Anemia	grade 1				3304
23401	1 pts		Anemia	grade 2				3304
23402	1 pts		Anemia	grade 3				3304
23403	3 pts		Anemia			Grade 9: preexisting abnormality, getting worse while on study.		3304
23404	7 pts		Nausea and vomiting	grade 1-4				3306
23405	6 pts		Nausea and vomiting	grade 1-4				3307
23406	5 pts		Nausea and vomiting	grade 1-4			TRUE	3305
23407	2 pts		Dizziness	grade 1-4				3306
23408	4 pts		Dizziness	grade 1-4				3307
23409	4 pts		Dizziness	grade 1-4			TRUE	3305
23410	2 pts		Sweating	grade 1-4				3306
23411	3 pts		Sweating	grade 1-4				3307
23412	3 pts		Sweating	grade 1-4				3305
23413	2 pts		Peripheral edema	grade 1-4				3306
23414	4 pts		Peripheral edema	grade 1-4				3307
23415	3 pts		Peripheral edema	grade 1-4				3305
23416	2 pts		Vaginal discharge	grade 1-4				3306
23417	3 pts		Vaginal discharge	grade 1-4				3307
23418	0		Vaginal discharge	grade 1-4				3305
23419	1 pts		Hot flushes	grade 1-4				3306
23420	4 pts		Hot flushes	grade 1-4				3307
23421	2 pts		Hot flushes	grade 1-4				3305
23422	1 pts		Lactation decreased	below serious				3308
23423						No adverse reactions leading to discontinuation were reported		3310
23424						No adverse reactions leading to discontinuation were reported		3309
23425						There was no serious adverse events related to the administration of torasemide.		3313
23426			Hepatic coma			WARNINGS		3312
23427			Tinnitus			WARNINGS		3312
23428			Hearing loss			WARNINGS		3312
23429			Electrolyte depletion		discontinuation	WARNINGS		3312
23430			Electrolyte depletion		discontinuation	WARNINGS		3312
23431			Hypokalemia		discontinuation	WARNINGS		3312
23432	0.1 - 0.5		Dizziness		discontinuation			3311
23433	0.1 - 0.5		Headache		discontinuation			3311
23434	0.1 - 0.5		Nausea		discontinuation			3311
23435	0.1 - 0.5		Weakness		discontinuation			3311
23436	0.1 - 0.5		Vomiting		discontinuation			3311
23437	0.1 - 0.5		Hyperglycemia		discontinuation			3311
23438	0.1 - 0.5		Urination abnormal NOS		discontinuation			3311
23439	0.1 - 0.5		Hyperuricemia		discontinuation			3311
23440	0.1 - 0.5		Hypokalemia		discontinuation			3311
23441	0.1 - 0.5		Excessive thirst		discontinuation			3311
23442	0.1 - 0.5		Hypovolemia		discontinuation			3311
23443	0.1 - 0.5		Impotence		discontinuation			3311
23444	0.1 - 0.5		Esophageal hemorrhage		discontinuation			3311
23445	0.1 - 0.5		Dyspepsia		discontinuation			3311
23446			Diarrhea		discontinuation			3314
23447			Dizziness		discontinuation			3314
23448			Elevated liver enzymes		discontinuation			3314
23449	1 pts		Venous thromboembolism	serious				3316
23450	1 pts		Gangrene	serious				3315
23451	1 pts		Cardiac arrest	serious				3315
23452	1 pts		Septic shock	serious				3315
23453	1 pts		Anemia	below serious				3315
23454	1 pts		Constipation	below serious				3315
23455	2 pts		Diarrhea	below serious				3315
23456	1 pts		Aspartate aminotransferase increased	below serious				3315
23457	1 pts		Fluid overload	below serious				3315
23458	1 pts		Fungal rash	below serious				3315
23459	1 pts		Hypothermia	below serious				3315
23460	1 pts		Abrasion	below serious				3315
23461	1 pts		Pedal edema	below serious				3315
23462	1 pts		Pressure ulcer	below serious				3315
23463	1 pts		Palmar erythema	below serious				3315
23464	1 pts		Thrombocytopenia	below serious				3315
23465	1 pts		Ventricular tachycardia	below serious				3315
23466	1 pts		Anemia	below serious				3315
23467	1 pts		Pneumonia	below serious				3315
23468	1 pts		Renal failure	below serious				3315
23469	1 pts		Blindness		discontinuation	leads to discontinuation		3319
23470	1 pts		Convulsions generalized		discontinuation	leads to discontinuation		3317
23471	1 pts		Deep vein thrombosis leg		discontinuation	leads to discontinuation		3320
23472	50.4		Headache					3318
23473	25.4		Nasal disorder NOS					3318
23474	20.7		Back pain					3318
23475	19.8		Abdominal pain					3318
23476	11.2		Musculoskeletal pain					3318
23477	6.9		Arthralgia					3318
23478	6.5		Muscle cramps					3318
23479	6		Migraine					3318
23480	5.6		Anemia					3318
23481	5.2		Fatigue					3318
23482	1 pts		Abdominal cramps	severe	discontinuation	leads to discontinuation		3321
23483	1 pts		Bleeding menstrual heavy	severe	discontinuation	leads to discontinuation		3321
23484	3		Conjunctival hyperemia		discontinuation	leads to discontinuation		3322
23485	2 pts		Hyperemia eye		discontinuation	leads to discontinuation		3323
23486	1 pts		Iritis		discontinuation	leads to discontinuation		3323
23487	1 pts		Dermatitis		discontinuation	leads to discontinuation		3323
23488	1 pts		Upper respiratory infection		discontinuation	leads to discontinuation		3323
23489			Diarrhea		discontinuation			3327
23490	4.3		Hypercalcemia	grade 4			TRUE	3325
23491	17.4		Skin toxicity	grade 3			TRUE	3325
23492	4.3		Emesis	grade 3			TRUE	3325
23493	4.3		AST/ALT ratio abnormal	grade 3			TRUE	3325
23494	22.2		Hypercalcemia	grade 4			TRUE	3324
23495	33.3		Skin toxicity	grade 3			TRUE	3324
23496	11.1		Anemia	grade 3			TRUE	3324
23497	11.1		Thrombocytopenia	grade 3			TRUE	3324
23498	11.1		Emesis	grade 3			TRUE	3324
23499	11.1		Hypercalcemia	grade 3			TRUE	3324
23500			Cheilitis		discontinuation			3328
23501			Skin xerosis		discontinuation			3328
23502			Facial desquamation		discontinuation	desquamation of the forehead		3328
23503			Desquamation		discontinuation	desquamation of the external auditory meatus		3328
23504			Headache		discontinuation			3328
23505			Skin xerosis		discontinuation			3328
23506						AEs not specified		3326
23507			Fetal damage	grade 4	discontinuation	WARNING		3329
23508			Kidney failure	acute				3330
23509			Hyperkalemia		discontinuation	WARNING		3331
23510	1 pts		Ataxia		discontinuation	leads to dose reduction		3332
23511	1 pts		Drowsiness		discontinuation	leads to dose reduction		3332
23512			Coordination abnormal		discontinuation	leads to discontinuation		3333
23513			Drowsiness		discontinuation	leads to discontinuation		3333
23514			Groggy		discontinuation	leads to discontinuation		3333
23515			Somnolence		discontinuation	leads to discontinuation		3333
23516			Depression		discontinuation	leads to discontinuation		3333
23517			Restlessness		discontinuation	leads to discontinuation		3333
23518			Dizziness		discontinuation	leads to discontinuation		3333
23519			Lightheadedness		discontinuation	leads to discontinuation		3333
23520			Headache		discontinuation	leads to discontinuation		3333
23521			Nausea		discontinuation	leads to discontinuation		3333
23522			Visual disturbance		discontinuation	leads to discontinuation		3333
23523			Nervousness		discontinuation	leads to discontinuation		3333
23524			Abdominal distress		discontinuation	leads to discontinuation		3333
23525			Bladder disorders NEC		discontinuation	leads to discontinuation		3333
23526			Aching in limb		discontinuation	leads to discontinuation		3333
23527			Backache		discontinuation	leads to discontinuation		3333
23528			Blepharitis		discontinuation	leads to discontinuation		3333
23529						No information on AE is provided		3334
23530	1 pts		Chorea		discontinuation	leads to discontinuation		3340
23531	1 pts		Rash		discontinuation	leads to discontinuation		3340
23532	1 pts		Hyperactivity		discontinuation	leads to discontinuation		3340
23533	2 pts		Constipation		discontinuation	leads to discontinuation		3339
23534	4 pts		Gastrointestinal disorders		discontinuation	leads to discontinuation		3339
23535	2 pts		Behaviour disorder		discontinuation	leads to discontinuation		3339
23536	1 pts		Movements involuntary		discontinuation	leads to discontinuation		3339
23537	1 pts		Drowsiness		discontinuation	leads to discontinuation		3339
23538	1 pts		Skin rash		discontinuation	leads to discontinuation		3339
23539	77		Extrapyramidal symptoms					3341
23540						only abstract is available		3335
23541						only abstract is available		3336
23542	1 pts		Dependence					3337
23543	1 pts		Dependence					3338
23544						No adverse effects leading to discontinuation were observed		3343
23545						No adverse effects leading to discontinuation were observed		3344
23546	11		Vaginitis			No adverse effects leading to discontinuation were observed		3342
23547	11		Skin irritation			No adverse effects leading to discontinuation were observed		3342
23548	0.34		Acute renal failure		discontinuation			3346
23549	0.17		Infection staphylococcal		discontinuation			3346
23550	0.17		Respiratory failure		discontinuation			3346
23551	0.17		Sepsis		discontinuation			3346
23552	0.17		Intracranial hemorrhage		discontinuation			3346
23553	0.17		Hypersensitivity		discontinuation			3346
23554	0.17		Renal failure		discontinuation			3346
23555			Acute renal failure		discontinuation			3345
23556	4 pts		Cold	below serious				3349
23557	1 pts		Drowsiness	below serious				3349
23558	2 pts		Cough	below serious				3349
23559	1 pts		Constipation	below serious				3349
23560	3 pts		Nausea	below serious				3349
23561	2 pts		Insomnia	below serious				3349
23562	1 pts		Anxiety	below serious				3349
23563	4 pts		Chest pain - cardiac	below serious				3359
23564	7 pts		Constipation	below serious				3359
23565	6 pts		Diarrhea	below serious				3359
23566	10 pts		Flatulence	below serious				3359
23567	14 pts		Nausea	below serious				3359
23568	6 pts		Stomach pain	below serious				3359
23569	6 pts		Irritability	below serious				3359
23570	6 pts		Anorexia	below serious				3359
23571	11 pts		Back pain	below serious				3359
23572	11 pts		Headache	below serious				3359
23573	13 pts		Lethargy	below serious				3359
23574	11 pts		Memory impairment	below serious				3359
23575	7 pts		Somnolence	below serious				3359
23576	8 pts		Anxiety	below serious				3359
23577	17 pts		Psychiatric disorders	below serious				3359
23578	3 pts		Uterine pain	below serious				3359
23579	11 pts		Cough	below serious				3359
23580	4 pts		Pruritus	below serious				3359
23581	1 pts		Asthenia	serious				3350
23582	1 pts		Fracture	serious				3350
23583	1 pts		Prostate cancer	serious				3350
23584	1 pts		Conjunctival haemorrhage	below serious				3350
23585	1 pts		Eye disorder	below serious				3350
23586	2 pts		Abdominal discomfort	below serious				3350
23587	1 pts		Abdominal pain	below serious				3350
23588	3 pts		Constipation	below serious				3350
23589	2 pts		Diarrhoea	below serious				3350
23590	2 pts		Dry mouth	below serious				3350
23591	4 pts		Dyspepsia	below serious				3350
23592	1 pts		Gastric disorder	below serious				3350
23593	17 pts		Nausea	below serious				3350
23594	12 pts		Vomiting	below serious				3350
23595	2 pts		Asthenia	below serious				3350
23596	2 pts		Fatigue	below serious				3350
23597	1 pts		Malaise	below serious				3350
23598	1 pts		Pyrexia	below serious				3350
23599	2 pts		Bronchitis	below serious				3350
23600	1 pts		Upper respiratory tract infection	below serious				3350
23601	1 pts		Skin laceration	below serious				3350
23602	1 pts		Urine analysis abnormal	below serious				3350
23603	13 pts		Decreased appetite	below serious				3350
23604	2 pts		Hypokalaemia	below serious				3350
23605	1 pts		Muscle spasms	below serious				3350
23606	1 pts		Myalgia	below serious				3350
23607	1 pts		Metastases to spine	below serious				3350
23608	1 pts		Dementia Alzheimer's type	below serious				3350
23609	8 pts		Dizziness	below serious				3350
23610	7 pts		Headache	below serious				3350
23611	1 pts		Lethargy	below serious				3350
23612	1 pts		Paraesthesia	below serious				3350
23613	2 pts		Anxiety	below serious				3350
23614	2 pts		Insomnia	below serious				3350
23615	2 pts		Cough	below serious				3350
23616	1 pts		Hiccups	below serious				3350
23617	1 pts		Oropharyngeal discomfort	below serious				3350
23618	1 pts		Productive cough	below serious				3350
23619	1 pts		Erythema nodosum	below serious				3350
23620	1 pts		Hyperhidrosis	below serious				3350
23621	2 pts		Hypertension	below serious				3350
23622	2 pts		Skin rash	serious				3351
23623	1 pts		Transient ischemic attack	serious				3352
23624	1 pts		Arrhythmia	serious				3352
23625	1 pts		Pulmonary embolism	serious				3352
23626	1 pts		Sick sinus syndrome	serious				3352
23627	1 pts		Depression	serious				3352
23628	2 pts		Gastrointestinal bleed	serious				3352
23629	2 pts		Unstable angina	serious				3352
23630	1 pts		Cellulitis	serious				3352
23631	1 pts		Surgical procedure	serious				3352
23632	1 pts		Dehydration	serious				3352
23633	1 pts		Syncope	serious				3352
23634	1 pts		Wound infection	serious				3352
23635	2 pts		Death	serious				3352
23636	27 pts		Insomnia	below serious				3352
23637	21 pts		Nausea	below serious				3352
23638	23 pts		Abnormal dreams	below serious				3352
23639	14 pts		Nightmares	below serious				3352
23640	9 pts		Constipation	below serious				3352
23641	1 pts		Psychiatric decompensation	serious				3360
23642	1 pts		Hallucination auditory	serious				3360
23643	1 pts		Rash	serious				3347
23644	1 pts		Exacerbation of anxiety	serious				3347
23645	1 pts		Weakness of arms	serious				3347
23646	1 pts		Pneumonia	serious				3347
23647	7 pts		Constipation	below serious				3347
23648	13 pts		Nausea	below serious				3347
23649	7 pts		Heartburn	below serious				3347
23650	7 pts		Gastroesophageal reflux	below serious				3347
23651	8 pts		Depressed mood	below serious				3347
23652	2 pts		Anxiety	below serious				3347
23653	2 pts		Mood swings	below serious				3347
23654	14 pts		Insomnia	below serious				3347
23655	18 pts		Abnormal dreams	below serious				3347
23656	2 pts		Suicidal ideation	below serious				3347
23657	2 pts		Somnolence	below serious				3347
23658	2 pts		Dizziness	below serious				3347
23659	4 pts		Bad taste	below serious				3347
23660	8 pts		Lethargy	below serious				3347
23661	4 pts		Shortness of breath	below serious				3347
23662	3 pts		Rash	below serious				3347
23663	7 pts		Increased appetite	below serious				3347
23664	8 pts		Decreased appetite	below serious				3347
23665	2 pts		Weight loss	below serious				3347
23666	2 pts		Urinary tract infection	below serious				3347
23667	3 pts		Insomnia	below serious				3353
23668	4 pts		Nausea	below serious				3353
23669	1 pts		Conjunctivitis	below serious				3353
23670	1 pts		Constipation	below serious				3353
23671	1 pts		Coughing	below serious				3353
23672	1 pts		Depression mental	below serious				3353
23673	1 pts		Sexual dysfunction	below serious				3353
23674	1 pts		Fatigue	below serious				3353
23675	1 pts		Flushing	below serious				3353
23676	1 pts		Headache	below serious				3353
23677	1 pts		Sex inhibition	below serious				3353
23678	1 pts		Postnasal drip	below serious				3353
23679	2 pts		Mental distress	below serious				3353
23680	1 pts		Drug withdrawal syndrome	below serious				3353
23681	1 pts		Hypoglycemic episode	serious				3354
23682	1 pts		Knee replacement	serious				3354
23683	2 pts		Major depressive disorder	below serious				3354
23684	18 pts		Taste changed	below serious				3354
23685	27 pts		Dry mouth	below serious				3354
23686	29 pts		Appetite disorder	below serious				3354
23687	29 pts		Nausea	below serious				3354
23688	11 pts		Vomiting	below serious				3354
23689	19 pts		Gas	below serious				3354
23690	23 pts		Constipation	below serious				3354
23691	15 pts		Fatigue	below serious				3354
23692	15 pts		Insomnia	below serious				3354
23693	9 pts		Dizziness	below serious				3354
23694	10 pts		Irritability	below serious				3354
23695	1 pts		Back surgery	serious				3355
23696	1 pts		Death	serious				3355
23697	9 pts		Constipation	below serious				3355
23698	11 pts		Diarrhoea	below serious				3355
23699	36 pts		Nausea	below serious				3355
23700	12 pts		Vomiting	below serious				3355
23701	14 pts		Fatigue	below serious				3355
23702	11 pts		Irritability	below serious				3355
23703	5 pts		Upper respiratory tract infection	below serious				3355
23704	9 pts		Arthralgia	below serious				3355
23705	11 pts		Dizziness	below serious				3355
23706	6 pts		Dysgeusia	below serious				3355
23707	27 pts		Abnormal dreams	below serious				3355
23708	9 pts		Anxiety	below serious				3355
23709	7 pts		Depression	below serious				3355
23710	6 pts		Hostility	below serious				3355
23711	15 pts		Insomnia	below serious				3355
23712	3 pts		Flatulence	below serious				3348
23713	1 pts		Chest pain	serious				3356
23714	1 pts		Allergy to chemicals	serious				3356
23715	1 pts		Pyelonephritis	serious				3356
23716	1 pts		Ankle fracture	serious				3356
23717	1 pts		Intervertebral disc protrusion	serious				3356
23718	1 pts		Knee arthroplasty	serious				3356
23719	13 pts		Constipation	below serious				3356
23720	15 pts		Diarrhoea	below serious				3356
23721	66 pts		Nausea	below serious				3356
23722	13 pts		Fatigue	below serious				3356
23723	19 pts		Nasopharyngitis	below serious				3356
23724	19 pts		Upper respiratory tract infection	below serious				3356
23725	26 pts		Headache	below serious				3356
23726	36 pts		Abnormal dreams	below serious				3356
23727	17 pts		Insomnia	below serious				3356
23728	13 pts		Sleep disorder	below serious				3356
23729	4 pts		Nausea	below serious				3357
23730	2 pts		Sleep disturbance	below serious				3357
23731	1 pts		Abdominal mass	serious				3358
23732	1 pts		Cocaine addiction	serious				3358
23733	1 pts		Chest pain	serious				3358
23734	1 pts		Chest pain	serious				3358
23735	1 pts		Nausea	serious				3358
23736	15 pts		Headache	below serious				3358
23737	14 pts		Blood pressure increased	below serious				3358
23738	11 pts		Abdominal pain	below serious				3358
23739	19 pts		Nausea	below serious				3358
23740	8 pts		Toothache	below serious				3358
23741	11 pts		Vivid dreams	below serious				3358
23742	6 pts		Flatulence	below serious				3358
23743	1 pts		Cellulitis	serious				3361
23744	15 pts		Dreaming abnormal	below serious				3361
23745	4 pts		Fatigue	below serious				3361
23746	16 pts		Nausea	below serious				3361
23747	6 pts		Vomiting	below serious				3361
23748	3 pts		Dizziness	below serious				3361
23749			Vomiting		discontinuation			3362
23750			Tachycardia		discontinuation			3362
23751	4		Nausea		discontinuation			3363
23752	1		Anger		discontinuation			3363
23753	1		Insomnia		discontinuation			3363
23754			Psychiatric disorder NOS	serious	discontinuation	WARNING		3364
23755			Suicidal ideation	serious	discontinuation	WARNING		3364
23756			Suicidal behavior	serious	discontinuation	WARNING		3364
23757			Agitation		discontinuation	WARNING		3364
23758			Hostility		discontinuation	WARNING		3364
23759			Depressed mood		discontinuation	WARNING		3364
23760			Angioedema		discontinuation	WARNING		3364
23761			Hypersensitivity reaction		discontinuation	WARNING		3364
23762	rare		Reaction skin	grade 3-4	discontinuation	WARNING		3364
23763			Accidental injury		discontinuation	WARNING		3364
23764	3		Nausea		discontinuation	WARNING. Nausea is the most common adverse reaction (up to 30% incidence rate). Approximately 3% of patients treated with CHANTIX 1 mg twice daily in studies involving 12 weeks of treatment discontinued treatment prematurely because of nausea.		3365
23765	1 pts		Paralysis		discontinuation	leads to discontinuation		3369
23766	1 pts		Sepsis	grade 5	discontinuation	leads to discontinuation		3368
23767						No AEs were reported		3370
23768	2 pts		Drug intolerance					3366
23769			Bradycardia					3367
23770	4 pts		Dizziness	below serious				3374
23771	2 pts		Nausea	below serious				3374
23772	5 pts		Constipation	below serious				3375
23773	1 pts		Dizziness	below serious				3375
23774	1 pts		Nausea	below serious				3375
23775	4 pts		Dizziness	below serious				3376
23776	2 pts		Heart rate abnormal	below serious				3376
23777	6 pts		Constipation	below serious				3376
23778	5 pts		Lightheadedness	below serious				3376
23779	3 pts		Headache	below serious				3376
23780	2 pts		Blurred vision	below serious				3376
23781	3 pts		Nausea	below serious				3376
23782	5 pts		Tiredness	below serious				3376
23783	1 pts		Rash	below serious				3376
23784	2 pts		Heart rate abnormal	below serious				3377
23785	8 pts		Constipation	below serious				3377
23786	5 pts		Heartburn	below serious				3377
23787	6 pts		Headache	below serious				3377
23788	3 pts		Nausea	below serious				3377
23789	6 pts		Tiredness	below serious				3377
23790	1 pts		Rash	below serious				3377
23791	2 pts		Abdominal pain	below serious				3377
23792	1 pts		Back pain	below serious				3373
23793	1 pts		Dry mouth	below serious				3373
23794	2 pts		Headache	below serious				3373
23795	1 pts		Vomiting		discontinuation	leads to discontinuation		3381
23796	1 pts		Seizure		discontinuation	leads to discontinuation		3381
23797	1 pts		Light-headed		discontinuation	leads to discontinuation		3378
23798	1 pts		Dissociation		discontinuation	leads to discontinuation		3378
23799	1 pts		Bradycardia		discontinuation	leads to discontinuation		3378
23800	1 pts		Tachycardia		discontinuation	leads to discontinuation		3380
23801	1 pts		Hypotension		discontinuation	leads to discontinuation		3380
23802	1 pts		Heart rate abnormal		discontinuation	leads to discontinuation		3380
23803	1 pts		Heart block first degree		discontinuation	leads to discontinuation		3379
23804	1 pts		Bundle branch block right		discontinuation	leads to discontinuation		3379
23805	12.1		Headache					3371
23806	8.8		Constipation					3371
23807	3.7		Peripheral edema					3371
23808	3		Dizziness					3371
23809	3		Pharyngitis					3371
23810	3		Sinusitis					3371
23811	2.7		Dyspepsia					3371
23812	2.7		Rhinitis					3371
23813	2.4		Diarrhea					3371
23814	2.4		Pain					3371
23815	1.7		Edema					3371
23816	1.7		Nausea					3371
23817	1.5		Accidental injury					3371
23818	7.3		Constipation					3372
23819	3.3		Dizziness					3372
23820	2.7		Nausea					3372
23821	2.5		Hypotension					3372
23822	2.2		Headache					3372
23823	1.9		Edema					3372
23824	1.8		Pulmonary edema					3372
23825	1.7		Fatigue					3372
23826	1.4		Bradycardia					3372
23827	1.2		Rash					3372
23828	1.2		AV block					3372
23829	0.6		Flushing					3372
23830	2 pts		Chest pain	serious				3383
23831	1 pts		Psychiatric symptom	serious				3383
23832	1 pts		Blood pressure increased	serious				3383
23833	1 pts		Loss of consciousness	serious				3383
23834	1 pts		Eczema	serious				3383
23835	11 pts		Pain in extremity	below serious				3383
23836	16 pts		Fatigue	below serious				3383
23837	9 pts		Nasopharyngitis	below serious				3383
23838	11 pts		Photopsia	below serious				3383
23839	8 pts		Blood pressure increased	below serious				3383
23840	5 pts		Pruritus	below serious				3383
23841	4 pts		Increased appetite	below serious				3383
23842	4 pts		Immune system disorders	below serious				3383
23843	2 pts		Nausea	below serious				3382
23844	2 pts		Headache	below serious				3382
23845	2 pts		Dry mouth	below serious				3382
23846	2 pts		Back pain	below serious				3382
23847	9		Sedation		discontinuation	9 patients, 1 discontinued		3384
23848	2		Seizures		discontinuation			3384
23849	1		Status epilepticus		discontinuation	1 patient		3384
23850	6		Weight gain					3384
23851	1		Depression			1 patient		3384
23852	1		Excitability			1 patient		3384
23853	1		Itching			1 patient		3384
23854	1		Headache			1 patient		3384
23855	1		Irritability			1 patient		3384
23856	1		Muscle pain			1 patient		3384
23857	1		Libido decreased			1 patient		3384
23858						no AEs reported		3387
23859						no AEs reported		3385
23860						The 3- and 6-g doses were not statistically different with respect to efficacy measures; however, use of 6 g/day was accompanied by a increased incidence of serious adverse effects (11 and 16% for 3- and 6-g doses, respectively) and an increased incidence of dropouts resulting from adverse events (11 and 18%, respectively). AEs not specified.		3386
23861			Vision loss					3389
23862			Brain MRI signal changes			Abnormal MRI signal changes have been reported in some infants with IS receiving SABRIL		3389
23863			Suicidal behavior					3389
23864			Suicidal ideation					3389
23865			Anemia					3389
23866			Somnolence					3389
23867			Fatigue					3389
23868	common		Coma					3388
23869	common		Unconsciousness					3388
23870	common		Drowsiness					3388
23871	uncommon		Vertigo					3388
23872	uncommon		Psychosis					3388
23873	uncommon		Apnea					3388
23874	uncommon		Respiratory depression					3388
23875	uncommon		Bradycardia					3388
23876	uncommon		Agitation					3388
23877	uncommon		Irritability					3388
23878	uncommon		Confusion					3388
23879	uncommon		Headache					3388
23880	uncommon		Hypotension					3388
23881	uncommon		Abnormal behavior					3388
23882	uncommon		Seizures					3388
23883	uncommon		Status epilepticus					3388
23884	uncommon		Speech disorder					3388
23885	7		Headache					3390
23886	1		Gastritis					3390
23887	20		Pharyngitis					3390
23888	7		Rhinitis					3390
23889	24.7		Pharyngitis					3391
23890	13.8		Headache					3391
23891	3.7		Myalgia					3391
23892	3.5		Sinusitis					3391
23893	3.3		Flu syndrome					3391
23894	3.1		Cough increased					3391
23895	3.1		Rash					3391
23896	3.1		Rhinitis					3391
23897	3.1		Accidental injury					3391
23898	3.1		Nausea					3391
23899	2.9		Back pain					3391
23900	2.9		Hypertonia					3391
23901	2.7		Diarrhea					3391
23902	2.7		Exacerbation of asthma					3391
23903						no AEs reported		3392
23904			Loss of consciousness					3393
23905			Sleep driving		discontinuation	WARNINGS. Complex behaviors such as “sleep-driving” (i.e., driving while not fully awake after ingestion of a sedative-hypnotic, with amnesia for the event) have been reported.		3394
23906			Abnormal thinking			WARNINGS		3394
23907			Abnormal behavior			WARNINGS		3394
23908			Amnesia			WARNINGS		3394
23909			Depression worsened			WARNINGS		3394
23910			Suicidal tendency			WARNINGS		3394
23911			Suicide		discontinuation	WARNINGS		3394
23912			Anaphylactic reaction	severe	discontinuation	WARNINGS		3394
23913			Anaphylactoid reaction	severe	discontinuation	WARNINGS		3394
23914			Angioedema	grade 3-5	discontinuation	WARNINGS		3394
23915	1 pts		Respiratory obstruction unspecified	grade 5				3396
23916	1 pts		Hypoxemia	severe				3396
23917	1 pts		Pneumothorax	grade 5				3396
23918	1 pts		Abdominal pain	mild		subject with normal renal function		3397
23919	1 pts		Headache	moderate		subject with mild renal impairment		3397
23920	1 pts		Diarrhea	mild		subject with moderate renal impairment		3397
23921	1 pts		Weakness			subject with severe renal impairment		3397
23922	1 pts		Lightheadedness			subject with severe renal impairment		3397
23923	1 pts		Heart pounding			subject with severe renal impairment		3397
23924	1 pts		Rash	mild		subject with severe renal impairment		3397
23925	10		Liver injury	acute				3395
23926	3		Rash					3395
23927	3		Venous thrombophlebitis					3395
23928	2 pts		Ventricular arrhythmia	grade 3-4				3395
23929	2 pts		Liver injury	grade 3-4				3395
23930	2 pts		Encephalopathy	grade 3-4				3395
23931	1 pts		Renal failure	grade 3-4				3395
23932	3		Neutropenia					3398
23933	1		Aspartate aminotransferase increased					3398
23934	1		Delirium					3398
23935	1		Eosinophilia					3398
23936	1		Insomnia					3398
23937	1		Left ventricular hypertrophy					3398
23938	1		Troponin I increased					3398
23939	1		Vomiting					3398
23940	1 pts		Depression					3403
23941	1 pts		Muscle ache		discontinuation	leads to discontinuation		3404
23942	1 pts		Dizziness		discontinuation	leads to discontinuation		3404
23943	1 pts		Excess sweating		discontinuation	leads to discontinuation		3404
23944	1 pts		Diarrhoea		discontinuation	leads to discontinuation		3404
23945	1 pts		Metabolic acidosis exacerbated		discontinuation	leads to discontinuation		3406
23946	1 pts		Nystagmus		discontinuation	leads to discontinuation		3400
23947	1 pts		Seizure		discontinuation	leads to discontinuation		3405
23948	1 pts		Drowsiness		discontinuation	leads to discontinuation		3407
23949	1 pts		Anemia	grade 1	discontinuation	leads to discontinuation		3408
23950	17		Diarrhea	grade 3-4				3399
23951	1 pts		Cardiac arrhythmia	grade 5	discontinuation	consequence of grade 4 diarrhea		3399
23952	9		Asthenia					3401
23953	63		Headache					3401
23954	53		Malaise					3401
23955	20		Anorexia					3401
23956	6		Constipation					3401
23957	51		Nausea					3401
23958	17		Vomiting					3401
23959	1		Anemia					3401
23960	2		Granulocytopenia					3401
23961	3		ALT increased	grade 2-3				3401
23962	1		AST increased	grade 2-3				3401
23963	25		Fever					3402
23964	11		Hepatomegaly					3402
23965	8		Nausea and vomiting					3402
23966	8		Diarrhea					3402
23967	6		Stomatitis					3402
23968	5		Splenomegaly					3402
23969	15		Cough					3402
23970	7		Breath sounds abnormal					3402
23971	7		Ear disorders NEC					3402
23972	8		Congestion nasal					3402
23973	12		Skin rash					3402
23974	9		Lymphadenopathy					3402
23975	8		Neutropenia					3402
23976	4		Anemia					3402
23977	1		Thrombocytopenia					3402
23978	1		ALT increased	grade 3				3402
23979	2		AST increased	grade 3				3402
23980	3		Lipase increased					3402
23981	3		Amylase increased	grade 2-3				3402
23982	1 pts		Allergic reaction to drug	serious				3409
23983	1 pts		Colitis	serious				3409
23984	1 pts		Congestive heart failure	serious				3409
23985	1 pts		Lung cancer	serious				3409
23986	1 pts		Myocardial infarction	serious				3409
23987	1 pts		Respiratory failure	serious				3409
23988	9 pts		Dyspnea	below serious				3409
23989	0.4		Taste abnormality		discontinuation	The most frequently reported adverse event was unusual taste (11.0% of attacks overall), as a result of which three (0.4%) patients who were administered zolmitriptan nasal spray 5mg withdrew from the study.		3410
23990	0.4		Migraine aggravated		discontinuation			3410
23991			Arrhythmia		discontinuation	WARNINGS		3412
23992			Cerebral hemorrhage		discontinuation	WARNINGS		3412
23993			Subarachnoid hemorrhage		discontinuation	WARNINGS		3412
23994			Stroke		discontinuation	WARNINGS		3412
23995			Gastrointestinal ischemia		discontinuation	WARNINGS		3412
23996			Peripheral vasoconstriction		discontinuation	WARNINGS		3412
23997			Serotonin syndrome		discontinuation	WARNINGS		3412
23998			Sedation					3411
23999	1 pts		Status epilepticus	serious				3416
24000	1 pts		Abdominal pain	serious				3416
24001	1 pts		Cholelithiasis	serious				3416
24002	1 pts		Blood glucose decreased	serious				3416
24003	1 pts		Weight decreased	serious				3416
24004	1 pts		Dehydration	serious				3416
24005	7 pts		Decreased appetite	below serious				3416
24006	1 pts		Fatigue	below serious				3417
24007	1 pts		Gait disturbance	below serious				3417
24008	1 pts		Nasopharyngitis	below serious				3417
24009	1 pts		Urinary tract infection	below serious				3417
24010	1 pts		Dizziness	below serious				3417
24011	1 pts		Postictal headache	below serious				3417
24012	1 pts		Vomiting	below serious				3418
24013	1 pts		Dizziness	below serious				3418
24014	1 pts		Somnolence	below serious				3418
24015	2 pts		Depressed mood	below serious				3414
24016	1 pts		Rash	below serious				3414
24017	1 pts		Itching	below serious				3414
24018	2 pts		Libido decreased	below serious				3414
24019	2 pts		Mood swings	below serious				3414
24020	1 pts		Restlessness	below serious				3414
24021	2 pts		Irritability	below serious				3414
24022	2 pts		Confusion	below serious				3414
24023	1 pts		Memory loss of	below serious				3414
24024	1 pts		Attention concentration difficulty	below serious				3414
24025	1 pts		Slow movement	below serious				3414
24026	1 pts		Sweating decreased	below serious				3414
24027	1 pts		Thirst excessive	below serious				3414
24028	1 pts		Appetite lost	below serious				3414
24029	1 pts		Aggressive behavior	below serious				3414
24030	1 pts		Difficulty sleeping	below serious				3414
24031	1 pts		Impotence	below serious				3414
24032	3 pts		Suicidal ideation	serious				3415
24033	1 pts		Homicidal ideation	serious				3415
24034						impossible to link AEs with the definite dose		3419
24035	1		Vomiting			suicide attempt		3420
24036	1		Somnolence					3420
24037	1		Emesis			suicide attempt		3422
24038	1		Coma			suicide attempt		3421
24039	6		Somnolence		discontinuation	leads to discontinuation		3413
24040	6		Fatigue		discontinuation	leads to discontinuation		3413
24041	6		Ataxia		discontinuation	leads to discontinuation		3413
24042	3		Anorexia		discontinuation	leads to discontinuation		3413
24043	2		Attention concentration difficulty		discontinuation	leads to discontinuation		3413
24044	2		Memory impairment		discontinuation	leads to discontinuation		3413
24045	2		Mental retardation		discontinuation	leads to discontinuation		3413
24046	2		Nausea		discontinuation	leads to discontinuation		3413
24047	2		Vomiting		discontinuation	leads to discontinuation		3413
24048	1		Weight loss		discontinuation	leads to discontinuation		3413
24049	2 pts		Libido decreased					3424
24050	11 pts		Libido decreased					3423
24051	1 pts		Ascites	serious				3428
24052	1 pts		Ileus	serious				3428
24053	1 pts		Electrolyte imbalance	serious				3428
24054	1 pts		Failure to thrive	serious				3428
24055	1 pts		Syncope	serious				3428
24056	2 pts		Wound infection	serious				3428
24057	1 pts		Wound complication	serious				3428
24058	1 pts		Mania	serious				3428
24059	3 pts		Hypertension	below serious				3428
24060	18 pts		Constipation	below serious				3428
24061	6 pts		Diarrhea	below serious				3428
24062	1 pts		Dyspepsia	below serious				3428
24063	20 pts		Nausea	below serious				3428
24064	9 pts		Vomiting	below serious				3428
24065	4 pts		Anorexia	below serious				3428
24066	1 pts		Esophagitis	below serious				3428
24067	1 pts		Gastroparesis	below serious				3428
24068	3 pts		Weight loss	below serious				3428
24069	4 pts		Leukocytosis	below serious				3428
24070	1 pts		International normalized ratio increased	below serious				3428
24071	8 pts		Electrolyte imbalance	below serious				3428
24072	2 pts		Hypomagnesemia	below serious				3428
24073	2 pts		Elevated liver enzymes	below serious				3428
24074	3 pts		Delirium	below serious				3428
24075	1 pts		Insomnia	below serious				3428
24076	3 pts		Sensory neuropathy	below serious				3428
24077	1 pts		Cystostomy	below serious				3428
24078	1 pts		Pelvic abscess	below serious				3428
24079	1 pts		Urinary tract obstruction	below serious				3428
24080	6 pts		Bladder and urethral symptoms	below serious				3428
24081	1 pts		Allergic reaction to chemotherapy	below serious				3428
24082	2 pts		Pneumonitis	below serious				3428
24083	2 pts		Pneumothorax	below serious				3428
24084	7 pts		Wound infection	below serious				3428
24085	2 pts		Skin infection	below serious				3428
24086						WARNING: FOR SHORT-TERM HOSPITAL USE ONLY		3427
24087						No AEs are reported		3425
24088						No AEs are reported		3426
24089	2.3		Drug hypersensitivity		discontinuation			3430
24090	2.3		Skin rash		discontinuation			3430
24091			Abnormal liver function tests		discontinuation	WARNING		3432
24092			Hepatitis		discontinuation	WARNING		3432
24093			Hepatic failure		discontinuation	WARNING		3432
24094			Hypersensitivity		discontinuation	WARNING		3432
24095			Anaphylaxis		discontinuation	WARNING		3432
24096			Rash		discontinuation	WARNING		3432
24097			Urticaria		discontinuation	WARNING		3432
24098			Flushing		discontinuation	WARNING		3432
24099			Pruritus		discontinuation	WARNING		3432
24100			Bronchospasm		discontinuation	WARNING		3432
24101			Dyspnea		discontinuation	WARNING		3432
24102			Hypotension		discontinuation	WARNING		3432
24103			Multi-organ failure		discontinuation			3431
24104						No clinical adverse events were reported		3429
24105	10 pts		Pharyngitis	below serious				3433
24106						No adverse reactions leading to discontinuation were reported		3434
24107						No AEs reported		3435
24108						Adverse event rates were similar between drugs and placebo groups		3436
24109			Hypotension		discontinuation			3437
24110			Hypertension		discontinuation			3437
24111			Haemorrhage		discontinuation			3437
24112			Flushing		discontinuation			3437
24113			Pallor		discontinuation			3437
24114			Atrial fibrillation		discontinuation			3437
24115			Ventricular fibrillation		discontinuation			3437
24116			Bradycardia		discontinuation			3437
24117			Myocardial infarction		discontinuation			3437
24118			Tachycardia		discontinuation			3437
24119			Supraventricular tachycardia		discontinuation			3437
24120			Atrial flutter		discontinuation			3437
24121			Atrioventricular block complete		discontinuation			3437
24122			Atrioventricular block second degree		discontinuation			3437
24123			Cardiac failure congestive		discontinuation			3437
24124			Cardio-respiratory arrest		discontinuation			3437
24125			Low cardiac output syndrome		discontinuation			3437
24126			Myocardial ischaemia		discontinuation			3437
24127			Supraventricular extrasystoles		discontinuation			3437
24128			Ventricular tachycardia		discontinuation			3437
24129			Hypoxia		discontinuation			3437
24130			Acute respiratory failure		discontinuation			3437
24131			Pulmonary hypertension		discontinuation			3437
24132			Respiratory arrest		discontinuation			3437
24133			Incision site complication		discontinuation			3437
24134			Thrombocytopenia		discontinuation			3437
24135						No AEs are reported		3442
24136						No AEs are reported		3441
24137						No AEs are reported		3440
24138						AEs hardly any were severe		3439
24139	7		Somnolence		discontinuation	leads to discontinuation		3438
24140	4		Depression		discontinuation	leads to discontinuation		3438
24141	1		Nervousness		discontinuation	leads to discontinuation		3438
24142	1		Dizziness		discontinuation	leads to discontinuation		3438
24143	1		Ataxia		discontinuation	leads to discontinuation		3438
24144	1		Intellectual disability		discontinuation	leads to discontinuation		3438
24145						No information on AE is provided		3444
24146	1 pts		Headache					3445
24147	1 pts		Nausea					3445
24148	1 pts		Rhinitis					3445
24149	1 pts		Anxiety					3443
24150	1 pts		Incoordination					3443
24151	1 pts		Nervousness					3443
24152	1 pts		Breast mass	serious				3450
24153	12 pts		Abdominal pain upper	below serious				3450
24154	8 pts		Hypertriglyceridaemia	below serious				3450
24155	4 pts		Renal insufficiency	below serious				3448
24156	4 pts		Gastrointestinal upset	below serious				3448
24157	2 pts		Hyperkalemia	below serious				3448
24158	1 pts		Hypertension	below serious				3448
24159	1 pts		Tremor	below serious				3448
24160	1 pts		Cramp muscle	below serious				3448
24161	1 pts		Hypertension					3449
24162	1 pts		Superficial thrombophlebitis					3449
24163	2 pts		Headache					3449
24164	1 pts		Vomiting					3449
24165	4 pts		Hypokalemia					3449
24166	2 pts		Hypomagnesemia					3449
24167	2 pts		Myalgia					3449
24168			Vomiting					3446
24169			Drowsiness					3446
24170			Headache					3446
24171			Tachycardia					3446
24172			Impaired renal function	grade 2				3446
24173	1 pts		Musculoskeletal disorder	moderate	discontinuation	leads to discontinuation		3447
24174	1 pts		Connective tissue disorders	moderate	discontinuation	leads to discontinuation		3447
24175	11 pts		General system disorders NEC	grade 1-2	discontinuation	leads to discontinuation		3447
24176	11 pts		Instillation site pain	mild	discontinuation	leads to discontinuation		3447
24177	1 pts		Instillation site pruritus	mild	discontinuation	leads to discontinuation		3447
24178	1 pts		Candida infection	moderate	discontinuation	leads to discontinuation		3447
24179	1 pts		Macular fibrosis	mild	discontinuation	leads to discontinuation		3447
24180	1 pts		Sinusitis	mild	discontinuation	leads to discontinuation		3447
24181	1 pts		Vision blurred	mild	discontinuation	leads to discontinuation		3447
24182	1 pts		Eye irritation	mild	discontinuation	leads to discontinuation		3447
24183	1 pts		Conjunctival hyperemia	moderate	discontinuation	leads to discontinuation		3447
24184	1 pts		Foreign body sensation in eyes	severe	discontinuation	leads to discontinuation		3447
24185	2 pts		Headache	grade 1-2	discontinuation	leads to discontinuation		3447
24186	2 pts		Eye pain	mild	discontinuation	leads to discontinuation		3447
24187	1 pts		Throat irritation	mild				3447
24188	1 pts		Nausea					3452
24189	1 pts		Vomiting					3455
24190	1 pts		Dry mouth					3455
24191	1 pts		Epigastric distress					3451
24192	1 pts		Constipation					3453
24193	1 pts		Dizziness					3453
24194	1 pts		Light headedness					3454
24195	1 pts		Drowsiness					3456
24196	1 pts		Headache					3456
24197	1 pts		Diabetes	serious				3460
24198	1 pts		Concussion	serious				3460
24199	1 pts		Stomach flu	serious				3460
24200	5 pts		Nausea	below serious				3460
24201	4 pts		GI upset	below serious				3460
24202	3 pts		Headache	below serious				3458
24203	2 pts		Lightheadedness	below serious				3458
24204	4 pts		Drowsiness	below serious				3458
24205	4 pts		Lightheadedness	below serious				3461
24206	5 pts		Drowsiness	below serious				3461
24207	6 pts		Flushing	below serious				3459
24208	2 pts		Light-headed	below serious				3459
24209	2 pts		Thinking slow	below serious				3459
24210	7 pts		Dizziness	below serious				3462
24211	5 pts		Light-headed	below serious				3462
24212	6 pts		Thinking slow	below serious				3462
24213	2.5		Tachycardia					3457
24214	2.5		Palpitations					3457
24215	7.5		Asthenopia					3457
24216	2.5		Photophobia					3457
24217	5		Conjunctival hyperaemia					3457
24218	2.5		Vision blurred					3457
24219	2.5		Eye irritation					3457
24220	40		Dry mouth					3457
24221	30		Fatigue					3457
24222	5		Feeling of relaxation					3457
24223	10		Hunger					3457
24224	5		Feeling hot					3457
24225	5		Thirst					3457
24226	2.5		Chills					3457
24227	2.5		Upper respiratory tract infection					3457
24228	2.5		Hordeolum					3457
24229	7.5		Increased appetite					3457
24230	2.5		Polydipsia					3457
24231	2.5		Sensation of heaviness					3457
24232	2.5		Muscle spasms					3457
24233	37.5		Somnolence					3457
24234	10		Headache					3457
24235	5		Dizziness					3457
24236	2.5		Paraesthesia					3457
24237	5		Dysgeusia					3457
24238	2.5		Hypoaesthesia					3457
24239	2.5		Hypotonia					3457
24240						No AEs are reported		3464
24241	1 pts		Hallucinations		discontinuation	leads to discontinuation		3466
24242	1 pts		Delirium		discontinuation	leads to discontinuation		3466
24243	1 pts		Encephalopathy		discontinuation	leads to discontinuation		3467
24244	1 pts		Diarrhea					3465
24245	1 pts		Dizziness					3465
24246	1 pts		Rash		discontinuation	leads to discontinuation		3463
24247	1 pts		Confusion		discontinuation	leads to discontinuation		3463
24248	1 pts		Seizure		discontinuation	leads to discontinuation		3463
24249	1 pts		Thrombocytopenia		discontinuation	leads to discontinuation		3463
24250	2 pts		Unconsciousness		discontinuation	leads to discontinuation		3472
24251	1 pts		Headache	severe				3473
24252	1 pts		Headache	severe				3473
24253	1 pts		Stuttering					3473
24254	1 pts		Confusion					3473
24255	1 pts		Pneumonia					3469
24256	1 pts		Anemia					3468
24257	1 pts		Hypocalcemia					3468
24258	1 pts		Pancreatitis					3470
24259	1 pts		Pneumonia					3470
24260	1 pts		Pancreatitis	acute				3470
24261	1 pts		Anemia					3470
24262	2 pts		Pulmonary edema					3471
24263						No adverse reactions leading to discontinuation were reported		3474
24264			Reaction skin	severe|grade 4|grade 5	discontinuation	WARNING		3476
24265			Stevens-Johnson syndrome	severe|grade 4|grade 5	discontinuation	WARNING		3476
24266			Hypersensitivity reaction	severe|grade 4|grade 5	discontinuation	WARNING		3476
24267			Toxic epidermal necrolysis	severe|grade 4|grade 5	discontinuation	WARNING		3476
24268			Erythema multiforme	severe|grade 4|grade 5	discontinuation	WARNING		3476
24269	2.2		Rash		discontinuation			3475
24270	48 pts		Headache					3477
24271	26 pts		Catheter site pain					3477
24272	68 pts		Headache					3478
24273	11 pts		Excoriation					3478
24274	10 pts		Lethargy					3478
24275	10 pts		Diarrhoea					3478
24276	42 pts		Oropharyngeal pain					3478
24277	2 pts		Headache	mild				3479
24278	4 pts		Fatigue	grade 3				3483
24279	1 pts		Anorexia	grade 3				3483
24280	1 pts		Mucositis	grade 3				3483
24281	13 pts		Neutropenia	grade 3				3483
24282	3 pts		Neutropenia	grade 4			TRUE	3489
24283	1 pts		Neuropathic pain	grade 3	discontinuation	leads to dose reduction		3485
24284	1 pts		Anorexia	grade 3		leads to dose reduction		3485
24285	1 pts		Stomatitis	grade 3		leads to dose reduction		3485
24286	1 pts		Neutropenia	grade 4		leads to dose reduction		3485
24287	1 pts		Fever	grade 3		leads to dose reduction		3485
24288	1 pts		Dehydration	grade 3		leads to dose reduction		3485
24289	1 pts		Nausea	grade 3				3485
24290	1 pts		Vomiting	grade 3				3485
24291	1 pts		Dizziness	grade 3				3485
24292	1 pts		Sensory neuropathy	grade 3				3485
24293	1 pts		Myalgia	grade 3				3485
24294	2 pts		Alopecia	grade 2				3485
24295	1 pts		Bilirubin increased	grade 2				3485
24296	2 pts		Neutropenia	grade 4			TRUE	3487
24297	2 pts		Fatigue	grade 3			TRUE	3487
24298	1 pts		Low platelets	grade 3			TRUE	3484
24299	1 pts		Arthralgia	grade 3			TRUE	3484
24300	2 pts		Absolute neutrophil count increased	grade 4			TRUE	3488
24301	2 pts		Febrile neutropenia	grade 3			TRUE	3488
24302	1 pts		Febrile neutropenia	grade 4			TRUE	3482
24303	2 pts		Mucosal inflammation	grade 3-4				3482
24304	1 pts		Neutropenic sepsis	grade 4			TRUE	3486
24305			Neutropenia	grade 5		WARNING		3481
24306	1 pts		Myalgia	grade 1				3480
24307	1 pts		Fatigue	grade 1				3480
24308	4 pts		Vision blurred	below serious				3498
24309	5 pts		Constipation	below serious				3498
24310	4 pts		Hypoaesthesia oral	below serious				3498
24311	13 pts		Nausea	below serious				3498
24312	5 pts		Vomiting	below serious				3498
24313	4 pts		Back pain	below serious				3498
24314	4 pts		Pain in extremity	below serious				3498
24315	4 pts		Balance disorder	below serious				3498
24316	18 pts		Dizziness	below serious				3498
24317	5 pts		Somnolence	below serious				3498
24318	7 pts		Pruritus	below serious				3498
24319	1 pts		Myocardial infarction	serious				3497
24320	1 pts		Knee operation	serious				3497
24321	4 pts		Diarrhoea	below serious				3497
24322	5 pts		Fatigue	below serious				3497
24323	12 pts		Nasopharyngitis	below serious				3497
24324	2 pts		Bronchitis	below serious				3497
24325	4 pts		Sinusitis	below serious				3497
24326	7 pts		Upper respiratory tract infection	below serious				3497
24327	5 pts		Dizziness	below serious				3497
24328	3 pts		Oropharyngeal pain	below serious				3497
24329	1 pts		Coronary artery dissection	serious				3499
24330	1 pts		Vaginal infection	serious				3499
24331	11 pts		Fatigue	below serious				3499
24332	11 pts		Nasopharyngitis	below serious				3499
24333	4 pts		Bronchitis	below serious				3499
24334	3 pts		Sinusitis	below serious				3499
24335	4 pts		Oropharyngeal pain	below serious				3499
24336	1 pts		Angina pectoris	serious				3500
24337	1 pts		Sick sinus syndrome	serious				3500
24338	1 pts		Liver disorder	serious				3500
24339	1 pts		Hypoglycaemic shock	serious				3500
24340	1 pts		Breast cancer in situ	serious				3500
24341	8 pts		Vertigo	below serious				3500
24342	4 pts		Fatigue	below serious				3500
24343	1 pts		Dysarthria	severe				3495
24344	1 pts		Dysphemia	severe				3495
24345	1 pts		Aphasia	severe				3495
24346	1 pts		Negative thoughts	severe				3495
24347	1 pts		Coordination abnormal	severe				3495
24348	2 pts		Muscle weakness	severe				3495
24349	2 pts		Nausea	severe				3495
24350	2 pts		Vomiting	severe				3495
24351	8.5		Vomiting		discontinuation	leads to discontinuation		3501
24352	6.4		Gait disturbance		discontinuation	leads to discontinuation		3501
24353	6.4		Dizziness		discontinuation	leads to discontinuation		3501
24354	6.4		Somnolence		discontinuation	leads to discontinuation		3501
24355	4.8		Vomiting					3496
24356	4.8		Dizziness					3496
24357	>1		Dizziness		discontinuation	leads to discontinuation		3490
24358	>1		Ataxia		discontinuation	leads to discontinuation		3490
24359	>1		Vomiting		discontinuation	leads to discontinuation		3490
24360	>1		Diplopia		discontinuation	leads to discontinuation		3490
24361	>1		Nausea		discontinuation	leads to discontinuation		3490
24362	>1		Vertigo		discontinuation	leads to discontinuation		3490
24363	>1		Vision blurred		discontinuation	leads to discontinuation		3490
24364	>1		Dizziness		discontinuation	leads to discontinuation		3491
24365	>1		Ataxia		discontinuation	leads to discontinuation		3491
24366	>1		Vomiting		discontinuation	leads to discontinuation		3491
24367	>1		Diplopia		discontinuation	leads to discontinuation		3491
24368	>1		Nausea		discontinuation	leads to discontinuation		3491
24369	>1		Vertigo		discontinuation	leads to discontinuation		3491
24370	>1		Vision blurred		discontinuation	leads to discontinuation		3491
24371	>1		Dizziness		discontinuation	leads to discontinuation		3492
24372	>1		Ataxia		discontinuation	leads to discontinuation		3492
24373	>1		Vomiting		discontinuation	leads to discontinuation		3492
24374	>1		Diplopia		discontinuation	leads to discontinuation		3492
24375	>1		Nausea		discontinuation	leads to discontinuation		3492
24376	>1		Vertigo		discontinuation	leads to discontinuation		3492
24377	>1		Vision blurred		discontinuation	leads to discontinuation		3492
24378						The types of adverse events were not clinically different from those of patients administered recommended doses of the drug		3494
24379			Coma					3493
24380	3 pts		Muscle twitch					3511
24381	3 pts		Jitteriness					3511
24382	3 pts		Hallucinations					3511
24383	3 pts		Agitation					3511
24384	3 pts		Seizures					3511
24385	1 pts		Respiratory depression					3512
24386	1 pts		Hypotension					3512
24387	1 pts		Tremor					3512
24388	1 pts		Hyperreflexia					3512
24389	1 pts		Myoclonus					3512
24390	1 pts		Muscle twitching		discontinuation	leads to discontinuation		3510
24391	1 pts		Tremor		discontinuation	leads to discontinuation		3510
24392	2 pts		Respiratory depression					3513
24393			Addiction			WARNING		3505
24394			Addiction			WARNING		3507
24395			Addiction			WARNING		3509
24396			Respiratory depression	serious|grade 5		WARNING		3505
24397			Respiratory depression	serious|grade 5		WARNING		3507
24398			Respiratory depression	serious|grade 5		WARNING		3509
24399			Withdrawal syndrome neonatal			WARNING		3502
24400			Withdrawal syndrome neonatal			WARNING		3504
24401			Withdrawal syndrome neonatal			WARNING		3508
24402			Addiction			WARNING		3506
24403			Respiratory depression	serious|grade 5		WARNING		3506
24404			Withdrawal syndrome neonatal			WARNING		3503
24405			Cerebral ischemia			drug addiction		3517
24406			Encephalopathy			intoxication		3518
24407			Cognitive impairment			intoxication		3518
24408			Respiratory depression	grade 5		WARNING		3516
24409			QT interval prolonged			WARNING		3516
24410			Arrhythmia	serious		WARNING		3516
24411			Respiratory depression	grade 5		WARNING		3515
24412			Addiction			WARNING		3515
24413			QT interval prolonged	grade 5		WARNING		3515
24414			Withdrawal syndrome neonatal			WARNING		3514
24415						No patient, in the 3.0, 4.0, 6.0 or 8.0 mg/kg dosage group, had a Grade 3 or 4 adverse event that was assessed by the investigator as causally related. Criterion for MTD (i.e. the occurrence of the same, Grade 3 or 4, causally relatedadverse event in at least three patients in the same dosage group) was not met.		3520
24416			Anaphylaxis		discontinuation	WARNINGS		3522
24417			Anaphylactoid reaction		discontinuation	WARNINGS		3522
24418			Intravascular hemolysis	acute	discontinuation	WARNINGS		3519
24419			Hemolysis	significant	discontinuation	WARNINGS		3523
24420			Hemolytic anemia		discontinuation	WARNINGS		3523
24421			Abnormal liver function tests		discontinuation	WARNINGS		3523
24422			Hepatic impairment		discontinuation	WARNINGS		3523
24423			Hepatitis		discontinuation	WARNINGS		3523
24424			Hepatic failure		discontinuation	WARNINGS		3523
24425			Blood urea increased		discontinuation	WARNINGS. In fluconazole-controlled trials, the incidence of drug-related renal adverse events was 0.4%		3523
24426			Creatinine increased		discontinuation	WARNINGS. In fluconazole-controlled trials, the incidence of drug-related renal adverse events was 0.4%		3523
24427			Renal impairment		discontinuation	WARNINGS. In fluconazole-controlled trials, the incidence of drug-related renal adverse events was 0.4%		3523
24428			Renal failure	acute	discontinuation	WARNINGS. In fluconazole-controlled trials, the incidence of drug-related renal adverse events was 0.4%		3523
24429						No adverse reactions associated with this high dose were noted		3521
24430			Exfoliative conditions		discontinuation	WARNINGS		3524
24431			Stevens-Johnson syndrome		discontinuation	WARNINGS		3524
24432			Toxic epidermal necrolysis		discontinuation	WARNINGS		3524
24433			Rash		discontinuation	WARNINGS. If patients develop a rash they should be monitored closely and micafungin discontinued if lesions progress.		3524
24434	1.1		Hepatic and hepatobiliary disorders		discontinuation			3525
24435	0.4		Hepatic and hepatobiliary disorders	serious	discontinuation			3525
24436			Aspartate aminotransferase increased	grade 3-4	discontinuation	4 subjects receiving the 80-mg dose were discontinued from the drug because of laboratory abnormalities.		3526
24437			ALT increased	grade 3-4	discontinuation	4 subjects receiving the 80-mg dose were discontinued from the drug because of laboratory abnormalities.		3526
24438	14.8		Aspartate aminotransferase increased	grade 3-4				3526
24439	14.8		ALT increased	grade 3-4				3526
24440			Peliosis hepatis		discontinuation	WARNING		3527
24441			Liver failure		discontinuation	WARNING		3527
24442			Hepatocellular carcinoma		discontinuation	WARNING		3527
24443			High density lipoprotein decreased		discontinuation	WARNING		3527
24444			Low density lipoprotein increased		discontinuation	WARNING		3527
24445			Atherosclerosis		discontinuation	WARNING		3527
24446			Coronary artery disease		discontinuation	WARNING		3527
24447	1.4		Abdominal pain		discontinuation	patient 1		3528
24448	1.4		Chest pain		discontinuation	patient 1		3528
24449	1.4		Serum creatine phosphokinase increased		discontinuation	patient 1		3528
24450	1.4		Serum creatine phosphokinase MB increased		discontinuation	patient 1		3528
24451	1.4		Back pain		discontinuation	patient 2		3528
24452	4.3		Vomiting	mild	discontinuation	patient 1		3531
24453	4.3		Nausea		discontinuation	patient 1		3531
24454	4.3		Dizziness		discontinuation	patient 1		3531
24455			Opioid abuse		discontinuation	WARNING		3530
24456			Respiratory depression		discontinuation	WARNING		3530
24457			Intentional drug misuse		discontinuation	WARNING		3530
24458			Addiction		discontinuation	WARNING		3530
24459			Hypotension	severe	discontinuation	WARNING		3530
24460			Opioid abuse		discontinuation	WARNING		3529
24461			Respiratory depression		discontinuation	WARNING		3529
24462			Intentional drug misuse		discontinuation	WARNING		3529
24463			Addiction		discontinuation	WARNING		3529
24464			Hypotension	severe	discontinuation	WARNING		3529
24465			Opioid abuse		discontinuation	WARNING		3532
24466			Addiction		discontinuation	WARNING		3532
24467			Respiratory depression	grade 3-5	discontinuation	WARNING		3532
24468			Withdrawal syndrome neonatal		discontinuation	WARNING		3532
24469			Anaphylaxis		discontinuation	WARNING		3532
24470			Hypotension	severe	discontinuation	WARNING		3532
24471			Intentional drug misuse		discontinuation	WARNING		3532
24472			Angioedema		discontinuation	WARNING		3532
24473			Hypersensitivity reaction		discontinuation	WARNING		3532
24474			Adrenal insufficiency		discontinuation	WARNING		3532
24475			Pulmonary hypertension		discontinuation	WARNING		3533
24476			Valvular heart disease NOS		discontinuation	WARNING		3535
24477			Valvular heart disease NOS		discontinuation	WARNING		3534
24478						No AEs were reported		3539
24479						No AEs were reported		3537
24480						No AEs were reported		3538
24481	12		Drowsiness					3536
24482	5		Headache					3536
24483	2		Fatigue					3536
24484	2		Dizziness					3536
24485	2		Dry mouth					3536
24486	1		Dyspepsia					3536
24487	83 pts		Headache	below serious				3540
24488	32 pts		Dizziness	below serious				3540
24489	18 pts		Dysgeusia	below serious				3540
24490	64 pts		Dyspnoea	below serious				3540
24491	49 pts		Nausea	below serious				3540
24492	49 pts		Chest discomfort	below serious				3540
24493	40 pts		Flushing	below serious				3540
24494	1 pts		Abdominal pain	serious				3541
24495	2 pts		Anemia	serious				3541
24496	1 pts		Arthralgia	serious				3541
24497	1 pts		Chest pain - cardiac	serious				3541
24498	1 pts		Diarrhea	serious				3541
24499	2 pts		General disorders and administration site conditions	serious				3541
24500	1 pts		Hemoglobin increased	serious				3541
24501	1 pts		Neutrophil count decreased	serious				3541
24502	1 pts		Pneumonitis	serious				3541
24503	1 pts		Tooth infection	serious				3541
24504	2 pts		Anorexia	below serious				3541
24505	1 pts		Arthritis	below serious				3541
24506	1 pts		Atelectasis	below serious				3541
24507	5 pts		Back pain	below serious				3541
24508	2 pts		Blood and lymphatic system disorders	below serious				3541
24509	1 pts		Bullous dermatitis	below serious				3541
24510	3 pts		Cough	below serious				3541
24511	4 pts		Diarrhea	below serious				3541
24512	3 pts		Dizziness	below serious				3541
24513	1 pts		Dry skin	below serious				3541
24514	1 pts		Dyspnea	below serious				3541
24515	2 pts		Edema limbs	below serious				3541
24516	1 pts		Other disorders of eye	below serious				3541
24517	3 pts		Fatigue	below serious				3541
24518	1 pts		Generalized muscle weakness	below serious				3541
24519	1 pts		Hallucinations	below serious				3541
24520	1 pts		Hoarseness	below serious				3541
24521	2 pts		Hypomagnesemia	below serious				3541
24522	1 pts		Infusion related reaction	below serious				3541
24523	1 pts		Infusion site extravasation	below serious				3541
24524	2 pts		Lethargy	below serious				3541
24525	1 pts		Localized edema	below serious				3541
24526	3 pts		Nasal congestion	below serious				3541
24527	3 pts		Pain	below serious				3541
24528	10 pts		Pain in extremity	below serious				3541
24529	1 pts		Platelet count decreased	below serious				3541
24530	1 pts		Pleural effusion	below serious				3541
24531	1 pts		Productive cough	below serious				3541
24532	8 pts		Pruritus	below serious				3541
24533	1 pts		Rash maculo-papular	below serious				3541
24534	5 pts		Respiratory, thoracic and mediastinal disorders	below serious				3541
24535	1 pts		Retinoic acid syndrome	below serious				3541
24536	2 pts		Scleral disorder	below serious				3541
24537	1 pts		Other disorders of skin and subcutaneous tissue	below serious				3541
24538	1 pts		Skin ulceration	below serious				3541
24539	1 pts		Sore throat	below serious				3541
24540	1 pts		Stomach pain	below serious				3541
24541	2 pts		Urinary tract infection	below serious				3541
24542	1 pts		Vaginal infection	below serious				3541
24543	1 pts		Ventricular tachycardia	below serious				3541
24544	1 pts		Chest pain					3548
24545	2 pts		Palpitation					3548
24546	2 pts		Palpitation					3547
24547	1 pts		Dizziness					3548
24548	1 pts		Dizziness					3547
24549	3 pts		Flushing					3548
24550	1 pts		Flushing					3547
24551	1 pts		Shortness of breath					3548
24552	1 pts		Change in ECG					3548
24553	3 pts		Change in ECG					3547
24554	1 pts		Chest pain					3543
24555	4 pts		Palpitation					3544
24556	3 pts		Palpitation					3543
24557	2 pts		Dizziness					3544
24558	3 pts		Dizziness					3543
24559	4 pts		Flushing					3544
24560	2 pts		Shortness of breath					3544
24561	1 pts		Shortness of breath					3543
24562	2 pts		Nausea and vomiting					3543
24563	1 pts		Change in ECG					3544
24564	1 pts		Headache					3544
24565	3 pts		Headache					3543
24566	1 pts		Chest pain					3546
24567	2 pts		Chest pain					3545
24568	4 pts		Palpitation					3546
24569	2 pts		Palpitation					3545
24570	3 pts		Dizziness					3546
24571	3 pts		Dizziness					3545
24572	8 pts		Flushing					3546
24573	1 pts		Flushing					3545
24574	3 pts		Shortness of breath					3546
24575	3 pts		Nausea and vomiting					3546
24576	4 pts		Nausea and vomiting					3545
24577	7 pts		Change in ECG					3546
24578	7 pts		Headache					3546
24579	3 pts		Headache					3545
24580	1 pts		Chest pain					3542
24581	3 pts		Palpitation					3542
24582	3 pts		Flushing					3542
24583	4 pts		Shortness of breath					3542
24584	5 pts		Nausea and vomiting					3542
24585	1 pts		Change in ECG					3542
24586	4 pts		Headache					3542
24587	14 pts		Application site irritation	below serious				3549
24588			Skin irritation	severe	discontinuation	WARNINGS		3550
24589			Sensitization		discontinuation	WARNINGS		3550
24590	2.8		Retrograde ejaculation		discontinuation			3556
24591	1 pts		Atrioventricular block third degree	serious				3552
24592	1 pts		Carotid artery stenosis	serious				3552
24593	1 pts		Syncope	serious				3552
24594	63 pts		Retrograde ejaculation	below serious				3552
24595	9 pts		Dizziness	below serious				3552
24596	6 pts		Nasopharyngitis	below serious				3552
24597	6 pts		Orthostatic hypotension	below serious				3552
24598	5 pts		Abdominal pain	below serious				3552
24599	5 pts		Diarrhoea	below serious				3552
24600	5 pts		Prostatic specific antigen increased	below serious				3552
24601	1 pts		Urosepsis	serious				3551
24602	1 pts		Syncope	serious				3551
24603	14 pts		Retrograde ejaculation	below serious				3551
24604	2 pts		Nasal congestion	below serious				3551
24605	3 pts		Sinusitis	below serious				3551
24606	2 pts		Diarrhoea	below serious				3551
24607	2 pts		Bladder neurogenic	below serious				3551
24608	3 pts		Rash	below serious				3551
24609	18 pts		Retrograde ejaculation	below serious				3553
24610	5 pts		Dizziness	below serious				3553
24611	2 pts		Headache	below serious				3553
24612	3 pts		Nasal congestion	below serious				3553
24613	2 pts		Sinusitis	below serious				3553
24614	2 pts		Libido decreased	below serious				3553
24615			Postural hypotension				TRUE	3555
24616	13		Nervous system disorder NOS			1 patient		3554
24617	13		Fatigue			1 patient		3554
24618	13		Dizziness			1 patient		3554
24619	13		Hematuria			1 patient		3554
24620	13		Leukocyturia			1 patient		3554
24621			Intraoperative floppy iris syndrome					3557
24622	1 pts		Erythema		discontinuation			3558
24623	1 pts		Oedema		discontinuation			3558
24624	1 pts		Pruritus		discontinuation			3558
24625	59		Allergic contact dermatitis	severe	discontinuation			3559
24626	2 pts		Allergy		discontinuation			3560
24627	16.4		Peri-nipple pigmentation	grade 1-3		total cases reviewed		3561
24628	24.1		Vomiting	grade 1-3		total cases reviewed		3561
24629	5.2		Hypercalcemia	grade 1-3		total cases reviewed		3561
24630	4.3		Uterine bleeding	grade 1-3		total cases reviewed		3561
24631	21.6		Anorexia	grade 1-3		total cases reviewed		3561
24632	6.9		Diarrhea	grade 1-3		total cases reviewed		3561
24633	3.4		Withdrawal bleeding	grade 1-3		total cases reviewed		3561
24634	18.1		Edema	grade 1-3		total cases reviewed		3561
24635	44		Nausea	grade 1-3		total cases reviewed		3561
24636	5.2		Congestive heart failure	grade 1-3		total cases reviewed		3561
24637						No adverse reactions were reported		3562
24638	4.8		Acne			treatment related AEs		3563
24639	2.8		Dermatitis			treatment related AEs		3563
24640	1.2		Dry skin			treatment related AEs		3563
24641	1.2		Eczema			treatment related AEs		3563
24642	1.2		Erythema			treatment related AEs		3563
24643	2		Pruritus			treatment related AEs		3563
24644	0.4		Rosacea			treatment related AEs		3563
24645	0.8		Seborrhea			treatment related AEs		3563
24646	1.2		Skin discomfort			treatment related AEs		3563
24647	0.8		Sunburn			treatment related AEs		3563
24648	0.8		Conjunctivitis			treatment related AEs		3563
24649	0.4		Taste perversion			treatment related AEs		3563
24650	2.8		Dermatitis			treatment related AEs		3564
24651	0.4		Eczema			treatment related AEs		3564
24652	0.8		Erythema			treatment related AEs		3564
24653	0.8		Skin discomfort			treatment related AEs		3564
24654	1.6		Sunburn			treatment related AEs		3564
24655	0.4		Conjunctivitis			treatment related AEs		3564
24656	2.5		Dermatitis			treatment related AEs		3565
24657	1.3		Eczema			treatment related AEs		3565
24658						No AEs are reported		3566
24659						AEs are not specified: """"""""""""""""Symptoms from the upper or lower gastrointestinal tractwere recorded in four subjects after the 3000 mg amoxycillin dose and in seven subjects fter the 3200 mg acampicillin dose.""""""""""""""""		3567
24660			Nausea					3568
24661			Vomiting					3568
24662			Diarrhea					3568
24663			Consciousness loss		discontinuation			3569
24664			Cyanosis		discontinuation			3569
24665			Polymorphic ventricular tachycardia		discontinuation			3569
24666			Torsades de pointes		discontinuation			3569
24667			Cardiac arrest		discontinuation			3569
24668			Cardiac arrest		discontinuation			3570
24669			Encephalopathy		discontinuation			3570
24670			Tachycardia		discontinuation			3570
24671			Brain injury		discontinuation			3570
24672			Hypotension		discontinuation			3570
24673			Status epilepticus		discontinuation			3570
24674			Brain death		discontinuation			3570
24675			Seizure		discontinuation			3571
24676			Cardiac arrest		discontinuation			3571
24677			Tachycardia		discontinuation			3571
24678			Grand mal seizure		discontinuation			3573
24679			Ventricular tachycardia		discontinuation			3573
24680			Sinus tachycardia		discontinuation			3573
24681			Mental confusion		discontinuation			3573
24682			Hypersensitivity reaction		discontinuation			3572
24683			Mental confusion		discontinuation			3572
24684			Visual hallucinations		discontinuation			3572
24685	1 pts		Faintness			leads to discontinuation		3574
24686	1 pts		Skin rash	grade 4	discontinuation	leads to discontinuation		3574
24687	0.67		Nausea		discontinuation			3577
24688	0.67		Hot flashes		discontinuation			3577
24689	0.67		Migraine					3577
24690						No adverse effects leading to discontinuation were reported		3576
24691	0.9		Nausea		discontinuation			3575
24692	2.2		Gastrointestinal disorder		discontinuation			3578
24693			Diarrhea, Clostridium difficile		discontinuation			3579
24694			Allergy		discontinuation			3579
24695			Hypersensitivity reaction		discontinuation			3579
24696	2 pts		CPK increased		discontinuation	leads to discontinuation		3583
24697	2 pts		Elevated liver enzymes		discontinuation	leads to discontinuation		3583
24698	1 pts		Ulcerative colitis		discontinuation	leads to discontinuation		3583
24699	1 pts		Headache		discontinuation	leads to discontinuation		3583
24700	2 pts		Rash		discontinuation	leads to discontinuation		3583
24701	2 pts		Exfoliative dermatitis		discontinuation	leads to discontinuation		3583
24702	1 pts		Leg cramps		discontinuation	leads to discontinuation		3583
24703	2 pts		Myalgia		discontinuation	leads to discontinuation		3583
24704	10 pts		CPK increased		discontinuation	leads to discontinuation		3582
24705	7 pts		Elevated liver enzymes		discontinuation	leads to discontinuation		3582
24706	1 pts		Constipation		discontinuation	leads to discontinuation		3582
24707	1 pts		Dyspepsia		discontinuation	leads to discontinuation		3582
24708	2 pts		Flatulence		discontinuation	leads to discontinuation		3582
24709	2 pts		Nausea		discontinuation	leads to discontinuation		3582
24710	2 pts		Vomiting		discontinuation	leads to discontinuation		3582
24711	1 pts		Chest pain		discontinuation	leads to discontinuation		3582
24712	1 pts		Eye pain		discontinuation	leads to discontinuation		3582
24713	1 pts		Head pain		discontinuation	leads to discontinuation		3582
24714	1 pts		Leg pain		discontinuation	leads to discontinuation		3582
24715	3 pts		Skin disorder		discontinuation	leads to discontinuation		3582
24716	2 pts		Dizziness		discontinuation	leads to discontinuation		3582
24717	1 pts		Insomnia		discontinuation	leads to discontinuation		3582
24718	1 pts		Arthralgia		discontinuation	leads to discontinuation		3582
24719	1 pts		Leg cramps		discontinuation	leads to discontinuation		3582
24720	3 pts		Myalgia		discontinuation	leads to discontinuation		3582
24721	1 pts		Myasthenia		discontinuation	leads to discontinuation		3582
24722	2.8		Pharyngitis		discontinuation	leads to discontinuation		3580
24723	2.8		Rhinitis		discontinuation	leads to discontinuation		3580
24724	3		Headache		discontinuation	leads to discontinuation		3580
24725	3		Gastrointestinal disorders		discontinuation	leads to discontinuation		3581
24726	1 pts		Allergic rash		discontinuation	leads to discontinuation		3584
24727			Muscular weakness		discontinuation	7 patients of group 3 complained about increasing muscular weakness, ataxia, stumbling and tachycardia inducible by physiotherapeutic exercise on the fifth day. The adverse effects disappeared within 2 days after discontinuation of the drug in these patients		3586
24728			Ataxia		discontinuation	7 patients of group 3 complained about increasing muscular weakness, ataxia, stumbling and tachycardia inducible by physiotherapeutic exercise on the fifth day. The adverse effects disappeared within 2 days after discontinuation of the drug in these patients		3586
24729			Stumbling		discontinuation	7 patients of group 3 complained about increasing muscular weakness, ataxia, stumbling and tachycardia inducible by physiotherapeutic exercise on the fifth day. The adverse effects disappeared within 2 days after discontinuation of the drug in these patients		3586
24730			Tachycardia		discontinuation	7 patients of group 3 complained about increasing muscular weakness, ataxia, stumbling and tachycardia inducible by physiotherapeutic exercise on the fifth day. The adverse effects disappeared within 2 days after discontinuation of the drug in these patients		3586
24731						No adverse reactions were reported		3587
24732			Coma	grade 5	discontinuation			3585
24733						No information on AE is provided		3588
24734			Erythema multiforme		discontinuation			3589
24735			Proctocolitis ulcerative		discontinuation			3589
24736			Hepatitis toxic obstructive		discontinuation			3589
24737			Exfoliative dermatitis		discontinuation			3589
24738	0.57		Jaundice					3590
24739	0.18		Leukopenia					3590
24740	1.5		Hypoglycemia					3590
24741	0.8		Drowsiness					3590
24742	1.3		Dizziness					3590
24743	0.5		Headache					3590
24744	0.2		Paresthesia					3590
24745	0.2		Ataxia					3590
24746	0.2		Blurring of vision					3590
24747	2.3		Anorexia					3590
24748	1		Abdominal pain					3590
24749	0.5		Diarrhea					3590
24750	1		Vomiting					3590
24751	0.2		Pruritus					3590
24752	0.2		Alcohol intolerance					3590
24753	0.8		Acidosis					3590
24754	6		Diarrhoea			PRIMAXIN (imipenem and cilastatin)		3591
24755	5		Hypertension			PRIMAXIN (imipenem and cilastatin)		3591
24756	4		Constipation			PRIMAXIN (imipenem and cilastatin)		3591
24757	3		Infusion site pain			PRIMAXIN (imipenem and cilastatin)		3591
24758	5		Headache			PRIMAXIN (imipenem and cilastatin)		3591
24759	4		Nausea			PRIMAXIN (imipenem and cilastatin)		3591
24760	1		Cough			PRIMAXIN (imipenem and cilastatin)		3591
24761	1		Vomiting			PRIMAXIN (imipenem and cilastatin)		3591
24762	3		Hypokalaemia			PRIMAXIN (imipenem and cilastatin)		3591
24763	2		Insomnia			PRIMAXIN (imipenem and cilastatin)		3591
24764	3		Renal cyst			PRIMAXIN (imipenem and cilastatin)		3591
24765	2		Infusion site erythema			PRIMAXIN (imipenem and cilastatin)		3591
24766	3		Abdominal pain upper			PRIMAXIN (imipenem and cilastatin)		3591
24767	2		Cardiac failure			PRIMAXIN (imipenem and cilastatin)		3591
24768	3		Clostridium difficile colitis			PRIMAXIN (imipenem and cilastatin)		3591
24769	2		Vaginal infection			PRIMAXIN (imipenem and cilastatin)		3591
24770						no AEs reported		3592
24771			Gastrointestinal obstruction	grade 3-5				3593
24772			Gastrointestinal bleeding	grade 3-5				3593
24773			Splenic infarction	grade 3-5				3593
24774			QT interval prolonged					3593
24775			Torsade de pointes					3593
24776	75-100		Skin discoloration					3594
24777			Tear discoloration					3593
24778			Discoloration urine					3593
24779			Discoloration fecal					3593
24780			Depression			Depression and suicide due to skin discoloration		3593
24781			Suicidal ideation			Depression and suicide due to skin discoloration		3593
24782			Ichthyosis					3595
24783			Dry skin					3595
24784			Pruritus					3595
24785						no AEs reported		3596
24786			Ataxia			Use of cyclopentolate has been associated with psychotic reactions and behavioral disturbances, usually in children, especially with 2% concentration.		3598
24787			Disorder speech			Use of cyclopentolate has been associated with psychotic reactions and behavioral disturbances, usually in children, especially with 2% concentration.		3598
24788			Restlessness			Use of cyclopentolate has been associated with psychotic reactions and behavioral disturbances, usually in children, especially with 2% concentration.		3598
24789			Hallucinations			Use of cyclopentolate has been associated with psychotic reactions and behavioral disturbances, usually in children, especially with 2% concentration.		3598
24790			Hyperactivity			Use of cyclopentolate has been associated with psychotic reactions and behavioral disturbances, usually in children, especially with 2% concentration.		3598
24791			Seizures			Use of cyclopentolate has been associated with psychotic reactions and behavioral disturbances, usually in children, especially with 2% concentration.		3598
24792			Confusion and disorientation			Use of cyclopentolate has been associated with psychotic reactions and behavioral disturbances, usually in children, especially with 2% concentration.		3598
24793			Other specified visual disturbances			Use of cyclopentolate has been associated with psychotic reactions and behavioral disturbances, usually in children, especially with 2% concentration.		3598
24794			Vomiting					3597
24795			Cyanosis					3597
24796			Respiratory distress					3597
24797						No adverse reactions leading to discontinuation were reported		3599
24798			Embolism pulmonary		discontinuation	WARNING		3600
24799			Vein disorder NOS		discontinuation	WARNING		3600
24800			Thrombosis		discontinuation	WARNING		3600
24801			Blood urea nitrogen increased		discontinuation	WARNING		3600
24802			Acid base balance abnormal		discontinuation	WARNING		3600
24803			Hyperammonemia		discontinuation	WARNING		3600
24804			Aluminium abnormal NOS		discontinuation	WARNING		3600
24805						No adverse reactions leading to discontinuation were indicated, though dose reductions occured		3601
24806	18 pts		Blood cholesterol decreased					3602
24807	8 pts		Loss of control of diabetes		discontinuation	leads to discontinuation		3602
24808	1 pts		Acidosis		discontinuation	leads to discontinuation		3602
24809	2 pts		Hypoglycemic reaction		discontinuation	leads to discontinuation		3602
24810	1 pts		Distended blood vessels		discontinuation			3604
24811						No AEs are reported		3603
24812	> 0.45		Weight gain		discontinuation	leads to discontinuation		3605
24813	> 0.45		Headache		discontinuation	leads to discontinuation		3605
24814	> 0.45		Depression		discontinuation	leads to discontinuation		3605
24815	> 0.45		Menorrhagia		discontinuation	leads to discontinuation		3605
24816	> 0.45		Skin disorder		discontinuation	leads to discontinuation		3605
24817	> 0.45		Emotional lability		discontinuation	leads to discontinuation		3605
24818	13.2		Premenstrual syndrome					3606
24819	10.7		Migraine headache					3606
24820	8.3		Breast discomfort					3606
24821	4.5		Nausea and vomiting					3606
24822	2.3		Abdominal discomfort					3606
24823	2.3		Mood change					3606
24824	6.7		Premenstrual syndrome		discontinuation	leads to discontinuation		3606
24825	1.5		Migraine headache		discontinuation	leads to discontinuation		3606
24826	2 pts		Bronchospasm					3607
24827	2 pts		Bronchospasm					3608
24828						No AEs were reported		3609
24829			Malignant hyperthermia		discontinuation	WARNING		3610
24830						No serious adverse events		3612
24831						No serious adverse events		3613
24832	1.3		Gastrointestinal disorders					3611
24833	0.4		Epidermal and dermal conditions					3611
24834	0.3		Central nervous system disorder					3611
24835						No adverse effects leading to discontinuation were reported.		3614
24836						No adverse effects leading to discontinuation were reported.		3615
24837						No adverse effects were recorded.		3616
24838	2 pts		Palpitations		discontinuation	leads to discontinuation		3617
24839	2 pts		Edema face		discontinuation	leads to discontinuation		3617
24840	3 pts		Transaminases increased		discontinuation	leads to discontinuation		3617
24841	1 pts		Hypertriglyceridemia		discontinuation	leads to discontinuation		3617
24842	1 pts		Hyperglycaemia		discontinuation	leads to discontinuation		3617
24843	1 pts		Ectropion		discontinuation	leads to discontinuation		3619
24844	1 pts		Headache	mild				3618
24845			Peliosis hepatis	grade 4-5	discontinuation			3620
24846						No adverse effects leading to discontinuation were reported		3622
24847						No SAEs were observed		3621
24848	29 pts		Prematurity	serious				3625
24849	31 pts		Hypertension	serious				3625
24850	6.8		Autism spectrum disorder					3623
24851	7.2					No AEs were reported		3624
24852			Unconsciousness	grade 4	discontinuation			3628
24853			Uremia	severe	discontinuation			3628
24854			Multiorgan failure	severe	discontinuation			3628
24855			Multiple congenital abnormalities	severe	discontinuation	Inner epicanthal folds, high arched palate, protruding ear		3628
24856			Coma	grade 4-5	discontinuation			3626
24857			Cerebellar ataxia	severe	discontinuation			3627
24858	1.2		Nausea		discontinuation	leads to discontinuation		3629
24859	1.2		Vomiting		discontinuation	leads to discontinuation		3629
24860	0.3		Bad taste		discontinuation	leads to discontinuation		3630
24861	0.8		Nausea		discontinuation	leads to discontinuation		3630
24862	0.6		Vomiting		discontinuation	leads to discontinuation		3630
24863	0.3		Headache		discontinuation	leads to discontinuation		3630
24864	0.5		Dizziness		discontinuation	leads to discontinuation		3630
24865	0.2		Rash		discontinuation	leads to discontinuation		3630
24866	<0.1		Tachycardia		discontinuation	leads to discontinuation		3630
24867	1		Bad taste		discontinuation	leads to discontinuation		3631
24868	2.6		Nausea		discontinuation	leads to discontinuation		3631
24869	1.4		Vomiting		discontinuation	leads to discontinuation		3631
24870	0.6		Headache		discontinuation	leads to discontinuation		3631
24871	0.6		Dizziness		discontinuation	leads to discontinuation		3631
24872	0.6		Rash		discontinuation	leads to discontinuation		3631
24873	0.14		Tachycardia		discontinuation	leads to discontinuation		3631
24874	3 pts		Nausea		discontinuation	leads to discontinuation		3632
24875	8 pts		Nausea		discontinuation	leads to discontinuation		3633
24876	1 pts		Vomiting		discontinuation	leads to discontinuation		3632
24877	4 pts		Vomiting		discontinuation	leads to discontinuation		3633
24878	2 pts		Taste perversion		discontinuation	leads to discontinuation		3632
24879	5 pts		Taste perversion		discontinuation	leads to discontinuation		3633
24880	3 pts		Dizziness		discontinuation	leads to discontinuation		3632
24881	3 pts		Dizziness		discontinuation	leads to discontinuation		3633
24882	2 pts		Diarrhea		discontinuation	leads to discontinuation		3632
24883	1 pts		Diarrhea		discontinuation	leads to discontinuation		3633
24884			Sinus bradycardia					3635
24885			Somnolence			Three cases involved children who ingested 28 to 480 mg		3636
24886			Coma			Three cases involved children who ingested 28 to 480 mg		3636
24887			Hypotension			Three cases involved children who ingested 28 to 480 mg		3636
24888			Bradycardia			Three cases involved children who ingested 28 to 480 mg		3636
24889	50		Drowsiness					3638
24890	8.35		Hypotension		discontinuation	1 patient		3638
24891	8.35		Hypotension		discontinuation	1 patient		3639
24892						AEs not specified		3634
24893						no AEs reported		3637
24894			Change in ECG		discontinuation			3640
24895			Blood pressure systolic decreased		discontinuation			3640
24896						AEs not mentioned		3641
24897						No information on AE is provided		3642
24898						No information on AE is provided		3643
24899						No information on AE is provided		3644
24900			Seizures			Seizures and deaths have been reported following Lindane Lotion’s use with repeat or prolonged application, but also in rare cases following a single application reportedly used according to directions.		3645
24901	rare		Seizures			Seizures and deaths have been reported following Lindane Lotion’s use with repeat or prolonged application, but also in rare cases following a single application reportedly used according to directions.		3646
24902	1 pts		Redness of eyelid		discontinuation	leads to discontinuation		3647
24903	1 pts		Swelling of eyelid		discontinuation	leads to discontinuation		3647
24904	1 pts		Itching eyes	severe	discontinuation	leads to discontinuation		3647
24905						no AEs reported		3648
24906			Osteoporosis					3649
24907	3.5		Dermal and epidermal conditions NEC		discontinuation	leads to discontinuation		3650
24908	5.8		Skin and subcutaneous tissue disorders		discontinuation	leads to discontinuation, but remained in the study and continued undergoing treatment in the nonaffected area		3650
24909	3.5		Hematuria					3650
24910						No information on AE is provided		3652
24911						No information on AE is provided		3651
24912			Bronchoconstriction	severe	discontinuation	WARNING		3653
24913	15		Acute kidney injury		discontinuation	leads to discontinuation		3655
24914	15		Hypokalemia		discontinuation	leads to discontinuation		3656
24915	1		Leukopenia		discontinuation	leads to discontinuation		3656
24916	1		Hypernatremia		discontinuation	leads to discontinuation		3656
24917	3		Hypersensitivity		discontinuation	leads to discontinuation		3656
24918						No AEs are reported		3654
24919	1.9		Application site reaction		discontinuation			3658
24920	1.8		Nausea		discontinuation			3658
24921	1.5		Emotional lability		discontinuation			3658
24922	1.1		Headache		discontinuation			3658
24923	1		Breast discomfort		discontinuation			3658
24924	0.06		Adenocarcinoma of the cervix	serious	discontinuation	possibly related, adenocarcinoma in situ of the cervix		3658
24925	0.06		Menorrhagia	serious	discontinuation	possibly related		3658
24926			Cardiovascular risk	serious	discontinuation	WARNING		3657
24927			Venous thromboembolism		discontinuation	WARNING		3657
24928			Thromboembolic event		discontinuation			3659
24929	4 pts		Vomiting					3661
24930	4 pts		Abdominal pain					3661
24931	20 pts		Nausea					3661
24932	16 pts		URTI					3661
24933	4 pts		Breast pain					3661
24934	12 pts		Dysmenorrhea					3661
24935	27 pts		Headache					3661
24936	11 pts		Vomiting					3662
24937	13 pts		Abdominal pain					3662
24938	21 pts		Nausea					3662
24939	6 pts		Sinusitis					3662
24940	13 pts		URTI					3662
24941	9 pts		Breast pain					3662
24942	15 pts		Dysmenorrhea					3662
24943	26 pts		Headache					3662
24944	4 pts		Vomiting					3660
24945	15 pts		Abdominal pain					3660
24946	27 pts		Nausea					3660
24947	8 pts		Sinusitis					3660
24948	8 pts		URTI					3660
24949	13 pts		Breast pain					3660
24950	13 pts		Dysmenorrhea					3660
24951	38 pts		Headache					3660
24952	5.7		Nausea	grade 1-2				3663
24953	3.8		Headache	grade 1-2				3663
24954	1.9		Vomiting	grade 1-2				3663
24955	0.2		Hypertension	grade 1-2				3663
24956	2.9		Diarrhea	grade 1-2				3663
24957	0.7		Pain localized	grade 1-2				3663
24958	1.7		Dyspepsia	grade 1-2				3663
24959	2.1		Insomnia	grade 1-2				3663
24960	0.7		Dizziness	grade 1-2				3663
24961	1.2		Abdominal pain	grade 1-2				3663
24962	3.1		Constipation	grade 1-2				3663
24963	2.1		Pruritus	grade 1-2				3663
24964	2.6		Fever	grade 1-2				3663
24965	3		Rash					3664
24966	18		Transaminases increased					3664
24967	3		Creatinine serum increased					3664
24968	3		Leukopenia					3664
24969	11.8		Transaminases increased		discontinuation			3664
24970	3		Leukopenia		discontinuation			3664
24971	3		Blood sodium decreased		discontinuation			3664
24972	3		Rash		discontinuation			3664
24973	12.5		Neutropenia					3666
24974	12.5		Elevated liver enzymes					3665
24975	12		Increased intraocular pressure					3667
24976	3		Headache					3667
24977	5		Ocular discomfort					3667
24978	4		Macular edema					3667
24979	4		Conjunctival hyperemia					3667
24980	3		Dry eye					3667
24981	3		Iritis					3667
24982	3		Retinal hemorrhage					3667
24983	2		Vision blurred					3667
24984	2		Posterior capsule opacification					3667
24985	11		Cataract					3667
24986						No adverse reactions were reported		3668
24987						No adverse reactions were reported		3670
24988						No adverse reactions leading to discontinuation were reported		3669
24989						No AEs were reported		3672
24990			Teratogenicity					3671
24991						No AEs were reported		3673
24992	1 pts		Creatinine serum increased			leads to dose reduction		3674
24993	1 pts		Creatinine serum increased					3675
24994	1 pts		Creatinine serum increased			leads to dose reduction		3677
24995	1 pts		Creatinine increased					3679
24996	1 pts		Creatinine increased					3678
24997	1 pts		Creatinine increased					3676
24998	1 pts		Jaundice		discontinuation			3680
24999	1 pts		Jaundice		discontinuation			3681
25000			Nausea	severe	discontinuation			3682
25001			Vomiting	severe	discontinuation			3682
25002			Henoch-Schonlein purpura		discontinuation			3682
25003			Henoch Shonlein purpura		discontinuation			3682
25004			Acute liver failure		discontinuation			3683
25005			Acute liver failure		discontinuation			3684
25006			Liver injury	severe	discontinuation	WARNING		3685
25007			Acute liver failure	grade 5	discontinuation	WARNING		3685
25008			Agranulocytosis	grade 4	discontinuation	WARNING		3686
25009			Leukopenia		discontinuation	WARNING		3686
25010			Thrombocytopenia		discontinuation	WARNING		3686
25011			Aplastic anemia		discontinuation	WARNING		3686
25012			Anti-neutrophil cytoplasmic antibody positive vasculitis		discontinuation	WARNING		3686
25013			Hepatitis		discontinuation	WARNING		3686
25014			Interstitial pneumonitis		discontinuation	WARNING		3686
25015			Fever		discontinuation	WARNING		3686
25016			Exfoliative dermatitis		discontinuation	WARNING		3686
25017			Hypothyroidism		discontinuation	WARNING		3686
25018			Goiter congenital		discontinuation	WARNING		3686
25019			Congenital hypothyroidism		discontinuation	WARNING		3686
25020			Weakness					3687
25021			Dizziness					3687
25022			Nasal congestion					3687
25023						impossible to link AEs with the definite dose		3688
25024	1 pts		Drowsiness		discontinuation	leads to dose reduction		3689
25025	1 pts		Light headedness	light	discontinuation	leads to dose reduction		3689
25026	1 pts		Upper abdominal pain		discontinuation	leads to discontinuation		3690
25027	1 pts		Postural hypotension		discontinuation	leads to discontinuation		3690
25028	1 pts		Electrocardiogram abnormal		discontinuation	leads to discontinuation		3690
25029	4.4		Dyspepsia		discontinuation	leads to discontinuation		3694
25030	2.4		Nausea		discontinuation	leads to discontinuation		3694
25031	2.1		Dizziness		discontinuation	leads to discontinuation		3694
25032	16 pts		Cardiac thrombosis					3695
25033	4 pts		Cardiac thrombosis	grade 5	discontinuation	leads to discontinuation		3695
25034	1 pts					led to treatment interruptions		3692
25035	1 pts		Renal impairment	grade 1	discontinuation	leads to discontinuation		3693
25036	3915 pts		Hemorrhage					3691
25037	3677 pts		Edema					3691
25038	1653 pts		Death	grade 5	discontinuation	leads to discontinuation		3691
25039	1917 pts		Thrombosis					3691
25040	233 pts		Embolism					3691
25041			Stevens-Johnson syndrome		discontinuation	leads to discontinuation		3696
25042			Toxic epidermal necrolysis		discontinuation	leads to discontinuation		3697
25043			Stevens-Johnson syndrome	grade 5	discontinuation	leads to discontinuation		3697
25044			Toxic epidermal necrolysis	grade 5	discontinuation	leads to discontinuation		3697
25045	4 pts		Renal calculus					3698
25046	2 pts		Rash					3698
25047	2 pts		Conjunctivitis					3698
25048	2 pts		Fever					3698
25049	9.9		Agranulocytosis					3704
25050			Insomnia		discontinuation			3702
25051			Fear					3702
25052			Behaviour abnormal					3702
25053			Visual hallucinations					3702
25054			Disorientation					3702
25055			Auditory hallucinations					3702
25056	4.9		Skin rash		discontinuation			3703
25057			Leucopenia					3699
25058						Information about AEs not found		3700
25059	3.8		Allergic reaction		discontinuation			3701
25060			Granulocytopenia					3701
25061	0.2		Local reaction					3705
25062	2 pts		Nausea					3707
25063	2 pts		Vomiting					3707
25064						No AEs are reported		3706
25065						No AEs are reported		3708
25066	25		Infusion site irritation					3712
25067	25		Sensation of heaviness					3712
25068	12.5		Nausea					3713
25069	12.5		Vomiting		discontinuation	The single participant who discontinued due to an AE experienced mild intermittent vomiting about 1 hour after dose 2; this AE was considered treatment-related and resolved on the same day (day 1) after discontinuation of study treatment.		3713
25070	12.5		Infusion site inflammation					3713
25071	25		Infusion site irritation					3713
25072	12.5		Pain in extremity					3713
25073	12.5		Flushing					3713
25074	7.9		Nausea					3710
25075	2.5		Headache					3710
25076	6.2		Diarrhea					3710
25077	5.6		Pyrexia					3710
25078	1.9		Constipation					3710
25079	3.5		Insomnia					3710
25080	3.3		Vomiting					3710
25081	3.3		Hypokalemia					3710
25082	1.5		ALT increased					3710
25083	1		AST increased					3710
25084	1.5		Anemia					3710
25085	1.9		Thrombocytosis					3710
25086	1.2		Abdominal pain					3710
25087	1.9		Anxiety					3710
25088	0.8		Dizziness					3710
25089	1.7		Hypotension					3710
25090	1.2		Atrial fibrillation					3710
25091	1.7		Rash					3710
25092	2.8		Nausea					3711
25093	5.8		Headache					3711
25094	1.9		Diarrhea					3711
25095	1.7		Pyrexia					3711
25096	3.9		Constipation					3711
25097	1.3		Insomnia					3711
25098	1.1		Vomiting					3711
25099	0.8		Hypokalemia					3711
25100	1.7		ALT increased					3711
25101	1.7		AST increased					3711
25102	0.4		Anemia					3711
25103	0.4		Thrombocytosis					3711
25104	0.8		Abdominal pain					3711
25105	0.2		Anxiety					3711
25106	1.1		Dizziness					3711
25107	0.4		Hypotension					3711
25108	0.2		Atrial fibrillation					3711
25109	0.9		Rash					3711
25110	0.5		Renal impairment		discontinuation			3709
25111	1 pts		Infection	grade 5				3715
25112	15 pts		Neutropenia	grade 4				3715
25113	8 pts		Neutropenia	grade 3				3715
25114	6 pts		Neutropenia	grade 1-2				3715
25115	4 pts		Anemia	grade 3				3715
25116	20 pts		Anemia	grade 1-2				3715
25117	3 pts		Thrombocytopenia	grade 3				3715
25118	8 pts		Thrombocytopenia	grade 1-2				3715
25119	4 pts		Infection	grade 3				3715
25120	1 pts		Infection	grade 1-2				3715
25121	2 pts		Fever	grade 1-2				3715
25122	1 pts		Nausea	grade 3				3715
25123	19 pts		Nausea	grade 1-2				3715
25124	1 pts		Vomiting	grade 3				3715
25125	8 pts		Vomiting	grade 1-2				3715
25126	1 pts		Hyponatremia	grade 4				3715
25127			Myelosuppression	severe		WARNING		3714
25128			Anaphylactic reaction			WARNING		3714
25129	1 pts		Sinoatrial node dysfunction			intoxication		3720
25130	1 pts		Hypotonia			intoxication		3719
25131	1 pts		Apnea			intoxication		3718
25132	2 pts		Bradycardia					3716
25133	1 pts		Hypertension					3716
25134	2 pts		Gasping					3716
25135	1 pts		Hypothermia			suicide attempt		3717
25136	1 pts		Bradycardia			suicide attempt		3717
25137	1 pts		Hypotension			suicide attempt		3717
25138	1 pts		Miosis			suicide attempt		3717
25139	1 pts		Lethargy			suicide attempt		3717
25140	1 pts		Mucous membrane disorder (NOS)			suicide attempt		3717
25141	1 pts		Bowel sounds decreased			suicide attempt		3717
25142	1 pts		Chest pain			suicide attempt		3717
25143	3 pts		Asthenia					3721
25144	1 pts		Epigastralgia					3721
25145	1 pts		Disorientation					3721
25146	5 pts		Hypotension					3723
25147	1 pts		Bullous eruption					3723
25148	1 pts		Hypothermia					3723
25149						No information on AE is provided		3722
25150						no AEs reported		3724
25151	2.7		Rash	grade 1	discontinuation	1 patient. In one patient in the ticarciilin plus ciavuianate potassium-treated group, a mild rash and moderate nausea developed, which were thought to be drug related, and treatment was discontinued.		3726
25152	2.7		Nausea	grade 2	discontinuation	2 patient. In one patient in the ticarciilin plus ciavuianate potassium-treated group, a mild rash and moderate nausea developed, which were thought to be drug related, and treatment was discontinued.		3726
25153			Elevated liver enzymes					3726
25154			Eosinophilia					3726
25155			Hypersensitivity reaction	grade 3-5				3727
25156			Diarrhea, Clostridium difficile					3727
25157			Convulsions					3725
25158	60		Erythema					3728
25159	45		Thrombocytopenia					3728
25160	40		Hyponatremia					3728
25161	36		Gastric acid increased					3728
25162	30		Seizures					3728
25163	23		Hematuria					3728
25164	19		Hypotension					3728
25165	11		Oliguria					3728
25166	9		Abdominal distension					3728
25167	6		Activity motor exaggerated					3728
25168	6		Tracheal bleeding					3728
25169	1 pts		Hepatitis		discontinuation			3732
25170						No AEs are reported		3729
25171	1 pts		Aplastic anemia	grade 5	discontinuation			3730
25172	1 pts		Agranulocytosis	grade 5	discontinuation			3731
25173	1 pts		Thrombocytopenia	grade 5	discontinuation			3731
25174	9		Transaminases increased	grade 1-2				3733
25175	9		Anxiety	grade 2				3733
25176	9		Hemoglobin abnormal	grade 1				3733
25177	9		Anorexia	grade 1				3733
25178	32		Pain	grade 1-2				3733
25179	4.5		Cranial neuropathy	grade 2				3733
25180	41		Nausea	grade 1-2				3733
25181	9		Diarrhea	grade 1				3733
25182	14		Alkaline phosphatase increased	grade 1-3				3733
25183	14		Fatigue	grade 1-2				3733
25184	18		Dyspepsia	grade 1-2				3733
25185	9		Vomiting	grade 2	discontinuation			3733
25186	4.5		Mental status changes	grade 4				3733
25187	4.5		Constipation	grade 1				3733
25188	4.5		Wound infection	grade 3				3733
25189	18		Bone pain	grade 1-3				3733
25190	4.5		Insomnia	grade 2				3733
25191	4.5		Hyperglycemia	grade 1				3733
25192			Hepatitis drug-induced	grade 3	discontinuation			3734
25193			Hepatic failure		discontinuation			3735
25194			Hepatitis		discontinuation			3736
25195			Anicteric cholestasis		discontinuation	prolonged anicteric cholestasis marked by pruritus and high levels of alkaline phosphatase and gammaglutamyitransferase activities		3736
25196			Gastrointestinal perforation	grade 3-5	discontinuation	Upper gastrointestinal complications [perforations, ulcers or bleedings (PUBs)], some of them resulting in fatal outcome, have occurred in patients treated with valdecoxib		3739
25197			Gastrointestinal ulcer	grade 3-5	discontinuation	Upper gastrointestinal complications [perforations, ulcers or bleedings (PUBs)], some of them resulting in fatal outcome, have occurred in patients treated with valdecoxib		3739
25198			Gastrointestinal bleeding	grade 3-5	discontinuation	Upper gastrointestinal complications [perforations, ulcers or bleedings (PUBs)], some of them resulting in fatal outcome, have occurred in patients treated with valdecoxib		3739
25199			Exfoliative dermatitis					3739
25200	2		Dyspepsia					3744
25201	5.9		Gastritis					3744
25202	1		Allergic rash	grade 2	discontinuation			3744
25203	1		Dizziness	grade 2	discontinuation			3744
25204			Toxic epidermal necrolysis	grade 3-5	discontinuation	Serious skin reactions (e.g., toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme) have been reported in patients receiving BEXTRA. Some of these reactions have resulted in death.		3740
25205			Stevens-Johnson syndrome	grade 3-5	discontinuation	Serious skin reactions (e.g., toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme) have been reported in patients receiving BEXTRA. Some of these reactions have resulted in death.		3740
25206			Erythema multiforme	grade 3-5		Serious skin reactions (e.g., toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme) have been reported in patients receiving BEXTRA. Some of these reactions have resulted in death.		3741
25207			Anaphylactic reaction					3742
25208			Angioedema					3742
25209	0.48		Gastrointestinal ulcer haemorrhage	significant				3738
25210	1.6		Abdominal pain		discontinuation			3745
25211	0.7		Diarrhea		discontinuation			3745
25212	1.4		Dyspepsia		discontinuation			3745
25213	0.9		Nausea		discontinuation			3745
25214	2.2		Peripheral edema		discontinuation			3743
25215	0.3		Halitosis		discontinuation			3743
25216	5.5		Abdominal pain		discontinuation			3743
25217	6.2		Dyspepsia		discontinuation			3743
25218	1.2		Gastroenteritis		discontinuation			3743
25219	1.7		Hypertension		discontinuation			3737
25220	1.7		Peripheral edema		discontinuation			3737
25221	2.7		Abdominal pain		discontinuation			3737
25222	0.2		Duodenal ulcer		discontinuation			3737
25223	2.2		Dyspepsia		discontinuation			3737
25224	1.5		Gastric ulcer		discontinuation			3737
25225	0.5		Nausea		discontinuation			3737
25226	0.2		Vomiting		discontinuation			3737
25227	1		Rash		discontinuation			3737
25228	100		Peripheral neuropathy	grade 3	discontinuation			3746
25229	100		Peripheral neuropathy	grade 3	discontinuation			3753
25230	40		Peripheral neuropathy		discontinuation			3754
25231	20		Leukopenia		discontinuation	1 patient		3754
25232	40		Thrombocytopenia		discontinuation			3754
25233			Rash		discontinuation	1 patient		3749
25234			Fever		discontinuation	1 patient		3749
25235	100		Peripheral neuropathy			Phase 1 studies, all patients receiving zalcitabine at approximately 6 times the current total daily recommended dose experienced peripheral neuropathy by week 10.		3748
25236	80		Peripheral neuropathy			Eighty percent of patients who received approximately 2 times the current total daily recommended dose experienced peripheral neuropathy by week 12		3747
25237			Peripheral neuropathy	grade 3-5		THE MAJOR CLINICAL TOXICITY OF HIVID (Zalcitabine ) IS PERIPHERAL NEUROPATHY, WHICH MAY OCCUR IN UP TO 1/3 OF PATIENTS WITH ADVANCED DISEASE TREATED WITH HIVID		3750
25238	1.1		Pancreatitis	grade 3-5				3752
25239			Lactic acidosis	grade 3-5				3751
25240			Hepatic steatosis	grade 3-5				3751
25241			Hepatic failure	grade 3-5				3751
25242	3		Oral ulceration	grade 3				3752
25243			Esophageal ulcer	grade 3				3752
25244	infrequent		Cardiomyopathy	grade 3				3752
25245	infrequent		Congestive heart failure	grade 3				3752
25246			Anaphylactoid reaction	grade 3				3752
25247			Coma					3755
25248						no AEs mentioned		3756
25249						No AEs are reported		3759
25250						No AEs are reported		3757
25251						No AEs are reported		3758
25252	5 pts		Hypertriglyceridemia		discontinuation	leads to discontinuation		3760
25253	1 pts		Breathing slowed			POISONING		3761
25254	1 pts		Comatose			Suicide		3762
25255						No information on AE is provided		3764
25256						No information on AE is provided		3763
25257			Dizziness			leads to dose reduction		3765
25258			Constipation			leads to dose reduction		3765
25259			Vomiting			leads to dose reduction		3765
25260			Paralytic ileus	grade 5				3765
25261						AEs were not observed		3766
25262	18		Proctitis	grade 3-4	discontinuation		TRUE	3767
25263	27		Diarrhea	grade 4	discontinuation			3767
25264	27		Gastrointestinal haemorrhage	grade 1-2	discontinuation			3767
25265	9		Hematuria	grade 1				3767
25266	4.5		Gastritis					3767
25267	3 pts		Photosensitivity		discontinuation	leads to discontinuation		3768
25268						No AEs were observed		3769
25269						No SAEs were observed		3770
25270	1 pts		Tachycardia			attempt to suicide		3775
25271	1 pts		Seizure			attempt to suicide		3775
25272	1 pts		Fibrillation ventricular			attempt to suicide		3775
25273	1 pts		Rhabdomyolysis			attempt to suicide		3772
25274	1 pts		Acute renal failure					3772
25275	1 pts		Atrial fibrillation					3773
25276	1 pts		Malaise					3777
25277	1 pts		Anxiety					3777
25278	1 pts		Dizziness					3777
25279	1 pts		Nausea					3777
25280	1 pts		Nausea			attempt to suicide		3774
25281	1 pts		Vomiting			attempt to suicide		3774
25282	1 pts		Nausea			attempt to suicide		3776
25283	1 pts		Vomiting			attempt to suicide		3776
25284						No information on AE is provided		3771
25285	2 pts		Enterocolitis necrotizing	grade 5				3778
25286	1 pts		Acute pancreatitis		discontinuation	leads to discontinuation		3783
25287	1 pts		Epigastric pain	severe	discontinuation	leads to discontinuation		3783
25288	1 pts		Nausea		discontinuation	leads to discontinuation		3783
25289	1 pts		Vomiting		discontinuation	leads to discontinuation		3783
25290	27		Nausea			No information on AE is provided		3784
25291	13		Vomiting					3784
25292	20		Diarrhea					3784
25293	20		Injection site reactions					3784
25294	27		Myalgia					3784
25295	7		Arthralgia					3784
25296	7		Allergic reaction					3784
25297						No information on AE is provided		3779
25298	1 pts		Gastrointestinal disorder	grade 5		attempt to suicide		3780
25299	1 pts		Bone marrow depression	grade 5		attempt to suicide		3780
25300	1 pts		Rhabdomyolysis	grade 5		attempt to suicide		3780
25301	1 pts		Heart injury	grade 5		attempt to suicide		3780
25302	1 pts		Hepatic damage	grade 5		attempt to suicide		3780
25303	1 pts		Multi-organ failure			attempt to suicide		3782
25304	1 pts		Gastrointestinal disturbance			attempt to suicide		3781
25305	1 pts		Myelosuppression	grade 4		attempt to suicide		3781
25306	1 pts		Restrictive respiratory insufficiency			attempt to suicide		3781
25307			Anaphylactoid reaction			Immediately after the injection the patient felt warm, nauseated, short of breath with audible wheezes, and developed a headache. He developed urticaria across his back. There was no evidence of hypotension or laryngospasm. Treatment with diphenhydramine 25 mg IV, metaproterenol nebulizer, and methylprednisolone 125 mg IV successfully reversed the patient’s anaphylactoid reaction.		3786
25308			Anaphylactoid reaction			Within five minutes after the administration of 0.5 mg/kg of indocyanine green intravenously (IV) as a liver function test, a generalized urticarial reaction developed, with erythema over the arms and legs and generalized itching.		3789
25309			Anaphylactoid reaction			Shortly after administration of indocyanine green (1 ml containing 5 mg, IV) to determine cardiac output, the patient became nauseated, and dyspnea, wheezing, and peripheral vasodilation developed, which responded appropriately to epinephrine, IV corticosteroids, and IM antihistamines.		3788
25310			Anaphylactoid reaction			After injection of indocyanine green into the superior vena cava (1 ml containing 5 mg), nausea, heat sensation, choking, tachycardia, and hypotension developed, and the patient could not be resuscitated. The provisional summary of autopsy findings stated the immediate cause of death as bilateral pulmonary congestion and hemorrhagic edema secondary to anaphylactic shock (clinical), with contributory factors listed as the following: severe coronary artery atherosclerosis, with occlusion of left anterior coronary artery (4 cm away from origin) by mural thrombus; acute passive congestion of liver; severe congestive splenomegaly; cardiomegaly; and left ventricular hypertrophy and dilation.		3787
25311			Anaphylactoid reaction			After IV administration of 27 mg of indocyanine green, the patient immediately sustained a severe anaphylaxis consisting of cough, extreme dyspnea, cyanosis, laryngospasm, pulmonary congestion and edema, urticaria, and shock.		3785
25312			Headache			suicide	TRUE	3793
25313			Nausea			suicide	TRUE	3793
25314			Urination abnormal NOS			suicide	TRUE	3793
25315						No AEs reported		3790
25316						No AEs reported		3791
25317			Death			suicidal or accidental ingestion	TRUE	3792
25318	2 pts		Pruritic rash		discontinuation	leads to discontinuation		3799
25319	2 pts		Erythema edematous		discontinuation	leads to discontinuation		3799
25320	2 pts		Vesicular eruption		discontinuation	leads to discontinuation		3799
25321	8 pts		Hemodynamic test abnormal		discontinuation	leads to discontinuation		3801
25322						No AEs are reported		3797
25323						No AEs are reported		3796
25324	4 pts		Hypotension		discontinuation	leads to discontinuation		3800
25325	1 pts		Nausea	severe	discontinuation	leads to discontinuation		3802
25326	1 pts		Vomiting	severe	discontinuation	leads to discontinuation		3802
25327	1 pts		Headache	severe	discontinuation	leads to discontinuation		3802
25328			Hypotension		discontinuation	leads to discontinuation		3795
25329	63		Headache					3794
25330	6		Lightheadedness					3794
25331	4		Hypotension					3794
25332	4		Syncope					3794
25333	1 pts		Methemoglobinemia	grade 5				3798
25334	15.4		Diarrhea		discontinuation	2 patients		3805
25335	7.7		Paresthesia		discontinuation	1 patient		3805
25336	7.7		Fatigue		discontinuation	1 patient		3805
25337	7.7		Weakness		discontinuation	1 patient		3805
25338	7.7		Leg cramps		discontinuation	1 patient		3805
25339	7.7		Abdominal cramps		discontinuation	2-nd patient		3805
25340						The incidence of side effects did not increase when the dose of cardrase was increased to 1,000 mg daily but the severity increased significantly. No precise indication is given.		3803
25341	5.5		Muscle cramps	severe	discontinuation	1 patient		3804
25342	5.5		Dizziness	severe	discontinuation	1 patient		3804
25343	5.5		Generalized eruption	severe	discontinuation	2-nd patient		3804
25344	4.2		ALT increased		discontinuation			3806
25345	2		Creatinine high		discontinuation			3806
25346			Headache		discontinuation	dose-limiting side-effects such as lethargy, headache, and dizziness were noted. Four subjects taking this dose withdrew from the study because of these AEs.	TRUE	3808
25347			Dizziness		discontinuation	dose-limiting side-effects such as lethargy, headache, and dizziness were noted. Four subjects taking this dose withdrew from the study because of these AEs.	TRUE	3808
25348	16.7		Lethargy		discontinuation	dose-limiting side-effects such as lethargy, headache, and dizziness were noted. Four subjects taking this dose withdrew from the study because of these AEs.	TRUE	3808
25349						No subject discontinued active treatment because of an AE.		3807
25350	2 pts		Hypercalcaemia					3809
25351	3 pts		Dizziness					3811
25352	1 pts		Headache					3811
25353	1 pts		Nausea					3811
25354	11 pts		Hypercalcaemia					3812
25355	10 pts		Hypercalcaemia					3810
25356	3 pts		Hypercalcaemia				TRUE	3814
25357	3 pts		Hypercalcaemia			leads to dose reduction	TRUE	3813
25358	1 pts		Thrombocytopenia	grade 3			TRUE	3818
25359			Rash	grade 3			TRUE	3824
25360	1 pts		Anemia	grade 4			TRUE	3818
25361	1 pts		Leukopenia	grade 2				3818
25362	1 pts		Neutropenia	grade 2				3818
25363	1 pts		Lymphopenia	grade 2				3818
25364	1 pts		Abdominal discomfort	grade 2				3818
25365	2 pts		Nausea	grade 2				3818
25366	2 pts		Vomiting	grade 2				3818
25367	1 pts		Diarrhea	grade 2				3818
25368	1 pts		Prothrombin time increased	grade 1				3818
25369	1 pts		Fibrinogen decreased	grade 1				3818
25370	1 pts		Anorexia	grade 1				3818
25371	1 pts		Mucositis	grade 1				3818
25372	1 pts		Gastroesophageal reflux	grade 1				3818
25373	1 pts		Alkaline phosphatase increased	grade 2				3818
25374	1 pts		Fatigue	grade 1				3818
25375	1 pts		Rigor	grade 1				3818
25376	1 pts		Fever	grade 1				3818
25377	1 pts		Rash	grade 1				3818
25378	2 pts		Pruritus	grade 1				3818
25379	1 pts		Dry skin	grade 2				3818
25380	1 pts		Muscle contractions involuntary	grade 2				3818
25381	1 pts		Sensory neuropathy	grade 1				3818
25382	1 pts		Abnormal gait	grade 2				3818
25383	1 pts		Triglyceride increased	grade 1				3818
25384	1 pts		Hypokalemia	grade 1				3818
25385	2 pts		Pain	grade 1				3818
25386	1 pts		Rhinitis	grade 1				3818
25387	1 pts		Neutropenia	grade 4			TRUE	3819
25388	2 pts		Neutropenia	grade 4			TRUE	3825
25389	2 pts		Thrombocytopenia	grade 3			TRUE	3825
25390	1 pts		Diarrhea	grade 3			TRUE	3825
25391	1 pts		Urinary tract infection	grade 3			TRUE	3825
25392	2 pts		Rash	grade 3-4			TRUE	3826
25393	1 pts		Nausea	grade 3			TRUE	3826
25394	1 pts		Vomiting	grade 3			TRUE	3826
25395	1 pts		Diarrhea	grade 3			TRUE	3826
25396	1 pts		Dehydration	grade 3			TRUE	3826
25397	1 pts		Neutropenia	grade 4			TRUE	3826
25398	1 pts		Hypofibrinogenemia	grade 3	discontinuation	leads to discontinuation	TRUE	3827
25399			Neutropenia	grade 4			TRUE	3822
25400			Rash	grade 3			TRUE	3822
25401			Pneumonitis	grade 3	discontinuation	leads to discontinuation	TRUE	3823
25402			Rash	grade 3			TRUE	3817
25403	1 pts		Skin rash	grade 3			TRUE	3820
25404	1 pts		Mucositis	grade 3			TRUE	3820
25405	1 pts		Nausea	grade 1				3820
25406	1 pts		Vomiting	grade 1				3820
25407	1 pts		Aspartate aminotransferase increased	grade 3			TRUE	3820
25408	1 pts		Anorexia	grade 3			TRUE	3820
25409	1 pts		Fatigue	grade 1				3820
25410	1 pts		Alanine aminotransferase increase	grade 1				3820
25411	1 pts		Hyperbilirubinemia	grade 3			TRUE	3820
25412	1 pts		Creatinine increased	grade 3				3816
25413	1 pts		Hypotension	grade 4				3821
25414	1 pts		Creatinine increased	grade 2	discontinuation	leads to discontinuation	TRUE	3821
25415	1 pts		Creatinine increased	grade 2	discontinuation	leads to discontinuation	TRUE	3815
25416	1 pts		Anorexia	grade 2				3816
25417	2 pts		Hyperglycemia	grade 2				3816
25418	3 pts		Fatigue	grade 2				3816
25419			Alopecia	grade 2				3816
25420			Hyperkalemia	grade 2				3816
25421			Sores mouth	grade 2				3816
25422			Shortness of breath	grade 2				3816
25423			Dizziness	grade 2				3816
25424			Nausea	grade 2				3816
25425			Vomiting	grade 2				3816
25426			Ataxia	grade 2				3816
25427			Abdominal pain	grade 2				3816
25428			Headache	grade 2				3816
25429			Dehydration	grade 2				3816
25430			Oxalosis					3829
25431	50		Diarrhea					3828
25432	1 pts		Toxic labyrinthitis		discontinuation	leads to discontinuation		3833
25433						No information on AE is provided		3832
25434						No information on AE is provided. The effective dose for the average adult patient seems to be 15 or 20 perles (10 Gm.), given three times daily for many weeks, without any harmful effect and without any disturbance of the gastrointestinal tract.		3830
25435						No information on AE is provided		3831
25436						No information on AE is provided		3834
25437	1 pts		Corneal ulceration	serious				3835
25438	1 pts		Abscesses of skin	serious				3835
25439	1 pts		Skin rash	serious				3835
25440	1 pts		Sinusitis	serious				3835
25441	1 pts		Decreased appetite	below serious				3836
25442	1 pts		Diarrhea	below serious				3836
25443	1 pts		Insomnia	below serious				3836
25444	1 pts		Death by homicide	serious				3837
25445	3 pts		Tachycardia	below serious				3837
25446	6 pts		Malaise	below serious				3837
25447	9 pts		Joint stiffness	below serious				3837
25448	2 pts		Increased activity	below serious				3837
25449	2 pts		Muscle twitching	below serious				3837
25450	1 pts		Muscle rigidity	below serious				3837
25451	1 pts		Tremor limb	below serious				3837
25452	16 pts		Insomnia	below serious				3837
25453	28 pts		Headache	below serious				3837
25454	3 pts		Tremor	below serious				3837
25455	5 pts		Vertigo	below serious				3837
25456	6 pts		Excitation	below serious				3837
25457	15 pts		Paresthesia	below serious				3837
25458	3 pts		Urinary retention	below serious				3837
25459	3 pts		Decreased activity	below serious				3837
25460	4 pts		Disorientation	below serious				3837
25461	1 pts		Flatulence	below serious				3837
25462	2 pts		Hypertension	below serious				3837
25463	7 pts		Myoclonus	below serious				3837
25464						Impossible to link AEs with the definite dose: Single episodes of tiredness (n = 1), diarrhea (n = 1), and depressive affect (n =1) that could possibly be related to pregnenolone were reported.		3838
25465			QT interval prolonged	serious				3839
25466			Arrhythmia ventricular	serious				3839
25467			Heart block atrioventricular	serious				3839
25468			Ventricular tachycardia	serious				3841
25469			Bundle branch block right	serious				3841
25470			QT interval prolonged	serious				3841
25471			Arrhythmia ventricular	serious				3840
25472	1 pts		Hypersensitivity reaction	grade 3			TRUE	3843
25473	1 pts		Neutropenic fever	grade 3			TRUE	3847
25474	1 pts		Nausea	grade 3			TRUE	3842
25475	1 pts		Vomiting	grade 3			TRUE	3842
25476	1 pts		ALT increased	grade 3-4			TRUE	3842
25477	1 pts		Neutropenic infection	grade 3-4			TRUE	3842
25478	45		Nausea	grade 1				3846
25479	52		Dizziness	grade 1				3846
25480	26		Vomiting	grade 1				3846
25481	3		Convulsions	grade 1				3846
25482	23		Bradycardia	grade 1				3846
25483	65		Anemia					3844
25484	27		Transaminases increased					3844
25485	18		Thrombocytopenia					3844
25486	14		Hyperbilirubinemia					3844
25487	10		Acute renal failure					3844
25488	10		Leukocytosis					3844
25489	8		Acute respiratory distress syndrome					3844
25490	7		Lymphopenia					3844
25491	5		Neutropenia					3844
25492	3		Disseminated intravascular coagulation					3844
25493	3		Creatinine increased					3844
25494	3		Pneumonia					3844
25495	3		Pulmonary edema					3844
25496	3		Diarrhea					3844
25497	8.9		Acute renal failure					3845
25498	6.7		Hemoglobinuria					3845
25499	2.3		Jaundice					3845
25500	2 pts		Methaemoglobinaemia					3848
25501						No information on AE is provided		3849
25502						No adverse reactions were reported		3850
25503	1 pts		Swelling of limbs					3851
25504	2 pts		Renal failure	grade 5		WARNING		3852
25505			Hepatitis		discontinuation	leads to discontinuation		3853
25506	14.3		Tinnitus		dose reduction			3854
25507	14.3		Headache		dose reduction			3854
25508	85.7		Tinnitus					3854
25509	37.5		Tinnitus		dose reduction			3855
25510	6.7		Tinnitus		discontinuation			3856
25511	1.7		Dizziness		discontinuation			3856
25512	13.2		Gastro-intestinal disorder NOS		discontinuation			3856
25513	7 pts		Eosinophilia myalgia syndrome		discontinuation	leads to discontinuation		3859
25514			Eosinophilia myalgia syndrome		discontinuation	withdrawn from markets | leads to discontinuation		3857
25515						No AEs are reported		3858
25516	1 pts		Hemolytic anemia		discontinuation	leads to discontinuation		3862
25517	1 pts		Hemolytic anemia		discontinuation	leads to discontinuation		3860
25518	1 pts		Methemoglobinemia		discontinuation	leads to discontinuation		3860
25519	1 pts		Hemolytic anemia		discontinuation	leads to discontinuation		3863
25520	6 pts		Methemoglobinemia		discontinuation	leads to discontinuation		3861
25521	15 pts		Drug intolerance		discontinuation	leads to discontinuation		3864
25522			Cerebral hypoperfusion		discontinuation			3866
25523			Convulsions		discontinuation			3866
25524			Delirium		discontinuation			3866
25525			Convulsions		discontinuation			3865
25526			Hypothermia		discontinuation			3865
25527			Coma	grade 5	discontinuation			3865
25528			Haematemesis		discontinuation			3865
25529			Supraventricular arrhythmias		discontinuation			3865
25530			Ventricular arrhythmia		discontinuation			3865
25531			Unconsciousness		discontinuation			3865
25532			Cardiac arrest	grade 5	discontinuation			3865
25533	1 pts		Dystonia			leads to discontinuation		3869
25534	1 pts		Coma		discontinuation	Protracted deep coma, leads to discontinuation		3867
25535	1 pts		Gastritis			Chemical gastritis, leads to discontinuation		3871
25536						No AEs were observed		3872
25537						No AEs were observed		3870
25538	1 pts		Cognitive impairment			leads to discontinuation		3868
25539	1 pts		Fall			leads to discontinuation		3868
25540	1 pts		Dependence			leads to discontinuation		3868
25541	1 pts		Tolerance			leads to discontinuation		3868
25542						No adverse effects leading to discontinuation were reported.		3874
25543						No serious clinical AEs were found in the single-dose study		3873
25544						The symptoms are predominantly gastrointestinal, variable from patient to patient, and in general too drastic in most individuals.		3876
25545			Cough					3875
25546						No adverse effects leading to discontinuation were reported.		3877
25547			Contact dermatitis					3878
25548	37.5		Abdominal pain aggravated					3879
25549			Adverse event	grade 5		poisoning. No AEs are reported		3880
25550						No AEs are reported		3883
25551						No AEs are reported		3884
25552						No AEs are reported		3885
25553			Drug abuse			WARNING		3881
25554	1.5		Headache					3882
25555	0.7		Epistaxis					3882
25556	0.7		Anxiety					3882
25557	0.4		Foreign body sensation in eyes					3882
25558	0.4		Facial pain					3882
25559	0.4		Neck pain					3882
25560	0.4		Dizziness					3882
25561	0.4		Nasal congestion					3882
25562			Hypercalcemia	severe	discontinuation			3887
25563			Renal failure		discontinuation			3887
25564			Anemia normocytic		discontinuation			3887
25565			Constipation		discontinuation			3889
25566			Polyuria		discontinuation			3889
25567			Confusion		discontinuation			3888
25568			Lethargy		discontinuation			3888
25569			Dysarthria		discontinuation			3888
25570			Fatigue		discontinuation			3888
25571			Weakness		discontinuation			3888
25572			Anorexia		discontinuation			3888
25573			Abdominal pain	mild	discontinuation			3888
25574			Hypertension		discontinuation			3888
25575			Hypercalcemia		discontinuation			3886
25576	1 pts		Fatigue	severe	discontinuation	leads to discontinuation		3891
25577						No AEs are reported		3890
25578			Heartburn					3892
25579			Nausea					3892
25580			Stomach ache					3892
25581						The source does not contain information about AEs or lack thereof		3893
25582	17.1		Dizziness					3897
25583	5.7		Numbness					3897
25584	2.8		Shortness of breath					3897
25585	2.8		Chills					3897
25586	2.8		Nausea					3897
25587	2.8		Drowsiness					3897
25588	40		Nausea					3894
25589	8		Vertigo					3894
25590	8		Lump feeling in throat					3894
25591	4		Drowsiness					3894
25592	4		Tachycardia					3894
25593	4		Itching					3894
25594	4		Dry mouth					3894
25595	4		Weakness of limbs					3894
25596	3.1		Abdominal pain					3895
25597	3.1		Nausea					3895
25598	6.1		Lightheadedness					3895
25599	3.1		Sleepiness					3895
25600	1.5		Dry mouth					3895
25601	1.5		Hot flashes					3895
25602	1.5		Palpitations					3895
25603	1.5		Enlarged thyroid					3895
25604	1.5		Confusion					3895
25605	1.3		Angioneurotic edema	grade 1				3896
25606	1.3		Epigastralgia	grade 1				3896
25607						No adverse effects led to the discontinuation		3899
25608						No adverse effects leading to discontinuation were mentioned		3898
25609	8.3		Gastrointestinal symptom NOS		discontinuation			3900
25610	2 pts		Gastrointestinal discomfort	grade 1				3901
25611	1 pts		Fatigue	grade 1				3901
25612	1 pts		Taste changed	grade 1				3901
25613			Nausea					3902
25614			Tachycardia	grade 1				3902
25615						The source does not contain information about AEs or lack thereof		3903
25616			Urothelial carcinoma					3908
25617	20		Nephritis NEC					3904
25618			Nephropathy					3907
25619			Nephropathy					3906
25620			Transitional cell carcinoma					3905
25621						No AEs are reported		3910
25622						No AEs are reported		3909
25623						no info regarding AEs		3911
25624	12.5		Electrocardiogram QTc interval prolonged			Three terfenadine subjects were sequestered for additional days of ECG monitoring because QTcB at day 7 increased >10%		3912
25625			Driving ability disturbed					3913
25626	8.3		Headache	grade 2-3	discontinuation	Severe in one (discontinued); Moderate in one		3915
25627	4.15		Somnolence	grade 1		1 patient		3915
25628						no AEs		3916
25629	2.4		Nausea		discontinuation	1 patient		3914
25630	2.4		Headache		discontinuation	1 patient		3914
25631						No adverse effects leading to discontinuation were reported.		3918
25632			Neuroleptic malignant syndrome		discontinuation			3917
25633	4.9		Skin irritation		discontinuation	Lesional irritation		3920
25634	5.9		Skin irritation		discontinuation			3920
25635						No adverse effects leading to discontinuation were reported.		3919
25636	0.5		Rash	grade 3	discontinuation			3922
25637	10		Skin rash					3921
25638						The source does not contain information about AEs or lack thereof		3924
25639	1.6		Hydronephrosis		discontinuation			3925
25640	27		Hypercalciuria		discontinuation			3925
25641	1.6		Ache stomach		discontinuation			3925
25642	1.6		Ureteral calculus		discontinuation			3925
25643						AEs were not observed		3923
25644	64		QT interval prolonged					3929
25645	23		Tachycardia					3929
25646	7		Torsades de pointes					3930
25647	24		Bradycardia					3928
25648	2 pts		Dystonic reaction					3928
25649						No AEs are reported		3927
25650						No AEs are reported		3926
25651	1 pts		Hyperthermia					3932
25652	1 pts		Mydriasis					3932
25653	1 pts		Coma					3932
25654	1 pts		Seizures					3932
25655			Extrapyramidal disorder					3931
25656						Adverse events were generally mild, short-lasting and did not require discontinuation of treatment.		3934
25657						No adverse effects leading to discontinuation were reported.		3933
25658						The source does not contain information about AEs or lack thereof		3936
25659						The source does not contain information about AEs or lack thereof		3935
25660	3		Nausea		discontinuation			3938
25661	2.7		Diarrhea					3937
25662	2		Hypertension					3937
25663	8.7		Headache					3937
25664						No SAEs were observed		3939
25665						No SAEs were observed		3940
25666	1 pts		Rhabdomyolysis		discontinuation	leads to discontinuation		3941
25667	1 pts		Hemoglobin decreased		discontinuation	leads to discontinuation		3941
25668	1 pts		Hemoglobin decreased		discontinuation	leads to discontinuation		3942
25669	1 pts		Rhabdomyolysis		discontinuation	leads to discontinuation		3942
25670						No adverse effects leading to discontinuation were reported		3943
25671						No subject dropped out from the study because of adverse effects and no clinically significant safety issues were identified during the course of the study.		3945
25672						No adverse effects leading to discontinuation were reported.		3944
25673						No patients discontinued treatment due to side effects.		3947
25674	3.3		Anxiety		discontinuation			3948
25675	7.7		Flatulence		discontinuation			3946
25676						No adverse effects leading to discontinuation were reported.		3949
25677						No adverse effects leading to discontinuation were reported		3950
25678						3 adverse effects leading to discontinuation are not specified.		3951
25679	1 pts		Peripheral neuropathy		discontinuation	leads to discontinuation		3953
25680						No AEs are reported		3952
25681	7		Skin eruption	grade 1				3954
25682	14		Flushing of face	grade 1				3954
25683	1 pts		Cholestasis		discontinuation			3957
25684			Weight gain			one patient discontinued treatment		3956
25685	1 pts		Convulsion					3955
25686	2 pts		Weight gain	severe	discontinuation			3958
25687	1.2		Alopecia		discontinuation			3959
25688	1.2		Somnolence		discontinuation			3959
25689	1.2		Fever		discontinuation			3959
25690	30		Hot flushes					3962
25691	19.5		Gynaecomastia					3962
25692	12.3		Headache					3962
25693	6.8		Skin and subcutaneous tissue disorders NEC					3962
25694			Depression		discontinuation			3960
25695			Weight increase		discontinuation			3960
25696			Headache		discontinuation			3960
25697			Libido decreased		discontinuation			3960
25698	6.7		Fatigue		discontinuation			3960
25699	32.6		Amenorrhea			first month		3960
25700			Weight gain					3960
25701						Information about AEs not found		3961
25702						AEs not reported		3963
25703						No adverse effects were observed.		3964
25704						No adverse effects leading to discontinuation were reported.		3966
25705						No adverse effects leading to discontinuation were reported.		3967
25706						No adverse effects leading to discontinuation were reported.		3965
25707						No adverse effects leading to discontinuation were reported		3968
25708	0.6		Diarrhea		discontinuation			3969
25709	0.03		Cerebral hemorrhage	grade 5	discontinuation	possibly related to treatment		3969
25710	1.4		Dyspepsia		discontinuation			3969
25711			ALT increased		discontinuation			3969
25712	0.9		Upper abdominal pain		discontinuation			3969
25713			AST increased		discontinuation			3969
25714	0.7		Abdominal pain		discontinuation			3969
25715	1.5		Hypertension		discontinuation			3969
25716						1 adverse effect leading to discontinuation is not specified.		3971
25717	2		AST increased					3970
25718	4		ALT increased					3970
25719	2		ALP increased					3970
25720	2		Gamma-glutamyltransferase increased					3970
25721						No adverse effects leading to discontinuation were reported		3972
25722	15.1		Thrombocytopenia	severe	discontinuation			3973
25723	3 pts		Skin rash		discontinuation	Four rashes were reported, but none was considered as serious, even though three led to fumagillin withdrawal.		3973
25724	4.8		Neutropenia		discontinuation			3973
25725	1 pts		Liver failure	serious	discontinuation			3973
25726	1 pts		Meningoencephalitis	serious	discontinuation			3973
25727	3 pts		Neurological impairment	serious	discontinuation			3973
25728	2 pts		Hepatitis	serious	discontinuation			3973
25729	4 pts		Anaemia	serious	discontinuation			3973
25730	1 pts		Haemorrhagic shock	grade 5	discontinuation			3973
25731	1 pts		Anaemia	severe	discontinuation			3974
25732	1 pts		Alanine aminotransferase increase	severe	discontinuation			3974
25733			Tonic-clonic convulsion		discontinuation			3976
25734			Consciousness abnormal		discontinuation			3976
25735			Stupor		discontinuation			3976
25736			Hemiplegia	grade 3	discontinuation			3976
25737			Hepatitis		discontinuation			3976
25738			Dysphasia		discontinuation			3976
25739			Lethargy		discontinuation			3976
25740	10.1		Hypoglycaemia					3977
25741	3.4		Diarrhoea					3977
25742	5.1		Nausea					3977
25743	4.5		Oedema					3977
25744	6.5		Dizziness					3977
25745	8.9		Headache					3977
25746	3.8		Hypertension					3977
25747			Acute kidney injury		discontinuation			3975
25748			Haemodynamic instability	grade 3	discontinuation			3975
25749			Distributive shock	grade 3	discontinuation			3975
25750			Metabolic acidosis	grade 3-4	discontinuation			3975
25751			Vomiting		discontinuation			3975
25752			Abdominal pain	grade 3	discontinuation			3975
25753			Hypoglycaemia		discontinuation			3975
25754			Encephalopathy		discontinuation			3975
25755						No adverse effects leading to discontinuation were reported.		3978
25756	14.3		Vomiting		discontinuation			3980
25757	4		Pain in leg					3979
25758	16		Diarrhea					3979
25759	4		Pain in arm					3979
25760	5		Abdominal pain					3979
25761	11		Fatigue					3979
25762	8		Back pain					3979
25763	27		Urinary tract infection					3979
25764	7		Vomiting					3979
25765	10		Upper respiratory tract infection					3979
25766	27		Nausea					3979
25767	11		Insomnia					3979
25768	9		Depression					3979
25769	1		Skin infection					3979
25770	18		Headache					3979
25771						The source does not contain information about AEs or lack thereof		3981
25772	1 pts		Lymphadenopathy mediastinal	serious				3983
25773	1 pts		Spleen disorder	serious				3983
25774	62 pts		Acute myocardial infarction	serious				3983
25775	1 pts		Adams-Stokes syndrome	serious				3983
25776	51 pts		Angina pectoris	serious				3983
25777	113 pts		Angina unstable	serious				3983
25778	126 pts		Atrial fibrillation	serious				3983
25779	22 pts		Atrial flutter	serious				3983
25780	9 pts		Atrioventricular block complete	serious				3983
25781	7 pts		Atrioventricular block second degree	serious				3983
25782	8 pts		Atrioventricular block third degree	serious				3983
25783	15 pts		Bradycardia	serious				3983
25784	2 pts		Cardiac arrest	serious				3983
25785	12 pts		Cardiac failure acute	serious				3983
25786	1 pts		Congestive cardiomyopathy	serious				3983
25787	1 pts		Cor pulmonale	serious				3983
25788	1 pts		Coronary artery insufficiency	serious				3983
25789	2 pts		Intracardiac thrombus	serious				3983
25790	3 pts		Left ventricular failure	serious				3983
25791	57 pts		Myocardial infarction	serious				3983
25792	1 pts		Arrhythmia nodal	serious				3983
25793	1 pts		Nodal arrhythmia	serious				3983
25794	1 pts		Pericardial effusion	serious				3983
25795	1 pts		Rhythm idioventricular	serious				3983
25796	5 pts		Sick sinus syndrome	serious				3983
25797	1 pts		Sinoatrial block	serious				3983
25798	2 pts		Supraventricular extrasystoles	serious				3983
25799	2 pts		Torsade de pointes	serious				3983
25800	1 pts		Tricuspid valve incompetence	serious				3983
25801	1 pts		Ventricular dysfunction	serious				3983
25802	15 pts		Ventricular extrasystoles	serious				3983
25803	20 pts		Ventricular fibrillation	serious				3983
25804	1 pts		Vertigo positional	serious				3983
25805	2 pts		Hyperthyroidism	serious				3983
25806	9 pts		Cataract	serious				3983
25807	1 pts		Cataract cortical	serious				3983
25808	1 pts		Diabetic retinopathy	serious				3983
25809	3 pts		Glaucoma	serious				3983
25810	1 pts		Lens dislocation	serious				3983
25811	1 pts		Retinal artery embolism	serious				3983
25812	1 pts		Ulcerative keratitis	serious				3983
25813	1 pts		Uveitis	serious				3983
25814	1 pts		Vitreous haemorrhage	serious				3983
25815	1 pts		Ascites	serious				3983
25816	2 pts		Colitis	serious				3983
25817	1 pts		Diverticulum duodenal	serious				3983
25818	1 pts		Diverticulum intestinal haemorrhagic	serious				3983
25819	4 pts		Duodenal ulcer haemorrhage	serious				3983
25820	1 pts		Duodenitis	serious				3983
25821	2 pts		Dyspepsia	serious				3983
25822	1 pts		Enteritis	serious				3983
25823	1 pts		Gastric haemorrhage	serious				3983
25824	3 pts		Gastric ulcer	serious				3983
25825	2 pts		Gastric ulcer perforation	serious				3983
25826	1 pts		Atrophic gastritis	serious				3983
25827	2 pts		Gastritis haemorrhagic	serious				3983
25828	2 pts		Gastroduodenitis	serious				3983
25829	1 pts		Gastrointestinal perforation	serious				3983
25830	1 pts		Haemorrhoids	serious				3983
25831	1 pts		Ileus	serious				3983
25832	1 pts		Mallory-Weiss syndrome	serious				3983
25833	1 pts		Mesenteric artery thrombosis	serious				3983
25834	3 pts		Pancreatitis	serious				3983
25835	1 pts		Chronic pancreatitis	serious				3983
25836	1 pts		Sigmoiditis	serious				3983
25837	1 pts		Umbilical hernia	serious				3983
25838	6 pts		Upper gastrointestinal haemorrhage	serious				3983
25839	1 pts		Volvulus	serious				3983
25840	1 pts		Vomiting	serious				3983
25841	5 pts		Chest pain	serious				3983
25842	4 pts		Death	serious				3983
25843	1 pts		Fatigue	serious				3983
25844	1 pts		Implant site inflammation	serious				3983
25845	1 pts		Implant site ulcer	serious				3983
25846	5 pts		Non-cardiac chest pain	serious				3983
25847	73 pts		Sudden cardiac death	serious				3983
25848	1 pts		Systemic inflammatory response syndrome	serious				3983
25849	2 pts		Biliary colic	serious				3983
25850	6 pts		Cholelithiasis	serious				3983
25851	1 pts		Cholestasis	serious				3983
25852	1 pts		Cytolytic hepatitis	serious				3983
25853	1 pts		Hepatitis cholestatic	serious				3983
25854	1 pts		Hepatorenal failure	serious				3983
25855	1 pts		Allergic oedema	serious				3983
25856	1 pts		Anaphylactic shock	serious				3983
25857	1 pts		Abdominal sepsis	serious				3983
25858	1 pts		Bacterial sepsis	serious				3983
25859	1 pts		Bronchitis acute viral	serious				3983
25860	1 pts		Bronchitis chronic	serious				3983
25861	1 pts		Candida sepsis	serious				3983
25862	1 pts		Clostridium colitis	serious				3983
25863	1 pts		Ear infection	serious				3983
25864	2 pts		Endocarditis	serious				3983
25865	1 pts		Epstein-Barr virus infection	serious				3983
25866	1 pts		Hepatitis C	serious				3983
25867	2 pts		Herpes zoster	serious				3983
25868	1 pts		Intervertebral discitis	serious				3983
25869	1 pts		Lower respiratory tract infection viral	serious				3983
25870	1 pts		Malaria	serious				3983
25871	1 pts		Orchitis	serious				3983
25872	3 pts		Osteomyelitis	serious				3983
25873	1 pts		Otitis media chronic	serious				3983
25874	1 pts		Perianal abscess	serious				3983
25875	70 pts		Pneumonia	serious				3983
25876	1 pts		Pneumonia bacterial	serious				3983
25877	1 pts		Pneumonia primary atypical	serious				3983
25878	1 pts		Postoperative infection	serious				3983
25879	2 pts		Postoperative wound infection	serious				3983
25880	3 pts		Pulmonary tuberculosis	serious				3983
25881	3 pts		Pyelonephritis	serious				3983
25882	4 pts		Pyelonephritis chronic	serious				3983
25883	4 pts		Chronic pyelonephritis	serious				3983
25884	1 pts		Salmonellosis	serious				3983
25885	1 pts		Sinusitis	serious				3983
25886	1 pts		Infection staphylococcal	serious				3983
25887	3 pts		Staphylococcal sepsis	serious				3983
25888	3 pts		Upper respiratory tract infection	serious				3983
25889	1 pts		Chest injury	serious				3983
25890	5 pts		Fall	serious				3983
25891	7 pts		Femur fracture	serious				3983
25892	1 pts		Haemothorax	serious				3983
25893	4 pts		Head injury	serious				3983
25894	6 pts		Implantable defibrillator malfunction	serious				3983
25895	2 pts		Lower limb fracture	serious				3983
25896	2 pts		Multiple fractures	serious				3983
25897	2 pts		Pacemaker complication	serious				3983
25898	1 pts		Post procedural complication	serious				3983
25899	1 pts		Scrotal haematoma	serious				3983
25900	1 pts		Skeletal injury	serious				3983
25901	1 pts		Stent occlusion	serious				3983
25902	5 pts		Therapeutic agent toxicity	serious				3983
25903	1 pts		Tracheostomy malfunction	serious				3983
25904	1 pts		Wrist fracture	serious				3983
25905	2 pts		Arteriogram	serious				3983
25906	24 pts		Arteriogram coronary	serious				3983
25907	1 pts		Blood potassium increased	serious				3983
25908	27 pts		Cardiovascular evaluation	serious				3983
25909	1 pts		Colonoscopy	serious				3983
25910	3 pts		Heart rate decreased	serious				3983
25911	1 pts		Hysteroscopy	serious				3983
25912	3 pts		Dehydration	serious				3983
25913	3 pts		Diabetes mellitus non-insulin-dependent	serious				3983
25914	1 pts		Diabetic ketoacidosis	serious				3983
25915	1 pts		Electrolyte imbalance	serious				3983
25916	2 pts		Hypokalaemia	serious				3983
25917	1 pts		Hypovolaemia	serious				3983
25918	1 pts		Malnutrition	serious				3983
25919	1 pts		Arthralgia	serious				3983
25920	1 pts		Dactylitis	serious				3983
25921	1 pts		Haemarthrosis	serious				3983
25922	6 pts		Intervertebral disc protrusion	serious				3983
25923	1 pts		Musculoskeletal pain	serious				3983
25924	1 pts		Osteoporosis	serious				3983
25925	1 pts		Osteoporotic fracture	serious				3983
25926	4 pts		Osteoarthritis spinal	serious				3983
25927	1 pts		Tenosynovitis stenosans	serious				3983
25928	1 pts		Basal cell carcinoma	serious				3983
25929	1 pts		Benign breast neoplasm	serious				3983
25930	3 pts		Bladder cancer	serious				3983
25931	1 pts		Bladder papilloma	serious				3983
25932	2 pts		Breast cancer	serious				3983
25933	2 pts		Bronchial carcinoma	serious				3983
25934	1 pts		Chronic lymphocytic leukaemia recurrent	serious				3983
25935	1 pts		Chronic myeloid leukaemia	serious				3983
25936	1 pts		Clear cell carcinoma of the kidney	serious				3983
25937	1 pts		Gallbladder cancer	serious				3983
25938	2 pts		Lung cancer metastatic	serious				3983
25939	1 pts		Lung carcinoma cell type unspecified stage IV	serious				3983
25940	5 pts		Lung neoplasm malignant	serious				3983
25941	1 pts		Meningioma	serious				3983
25942	1 pts		Metastases to bone	serious				3983
25943	1 pts		Non-small cell lung cancer	serious				3983
25944	2 pts		Oesophageal carcinoma	serious				3983
25945	1 pts		Oropharyngeal cancer stage unspecified	serious				3983
25946	3 pts		Prostatic adenoma	serious				3983
25947	4 pts		Rectal cancer	serious				3983
25948	1 pts		Rectal cancer metastatic	serious				3983
25949	1 pts		Renal cell carcinoma stage unspecified	serious				3983
25950	3 pts		Renal neoplasm	serious				3983
25951	1 pts		Salivary gland neoplasm	serious				3983
25952	1 pts		Squamous cell carcinoma of skin	serious				3983
25953	1 pts		Tongue carcinoma stage IV	serious				3983
25954	2 pts		Tongue neoplasm malignant stage unspecified	serious				3983
25955	1 pts		Uterine cancer	serious				3983
25956	2 pts		Uterine leiomyoma	serious				3983
25957	1 pts		Brain stem haemorrhage	serious				3983
25958	5 pts		Carotid artery stenosis	serious				3983
25959	1 pts		Cerebellar haemorrhage	serious				3983
25960	1 pts		Cognitive disorder	serious				3983
25961	1 pts		Dementia Alzheimer's type	serious				3983
25962	1 pts		Epilepsy	serious				3983
25963	1 pts		Facial palsy	serious				3983
25964	1 pts		Grand mal convulsion	serious				3983
25965	1 pts		Headache	serious				3983
25966	1 pts		Intracranial aneurysm	serious				3983
25967	2 pts		Ischaemic cerebral infarction	serious				3983
25968	1 pts		Metabolic encephalopathy	serious				3983
25969	1 pts		Spinal cord haemorrhage	serious				3983
25970	2 pts		Haemorrhage subarachnoid	serious				3983
25971	1 pts		Syncope vasovagal	serious				3983
25972	1 pts		Vascular encephalopathy	serious				3983
25973	3 pts		Alcoholism	serious				3983
25974	1 pts		Delirium	serious				3983
25975	3 pts		Depression	serious				3983
25976	2 pts		Suicide attempt	serious				3983
25977	1 pts		Anuria	serious				3983
25978	1 pts		Calculus urinary	serious				3983
25979	1 pts		Glomerulonephritis chronic	serious				3983
25980	2 pts		Nephrolithiasis	serious				3983
25981	1 pts		Nephrotic syndrome	serious				3983
25982	1 pts		Polyuria	serious				3983
25983	1 pts		Renal artery stenosis	serious				3983
25984	2 pts		Colic renal	serious				3983
25985	11 pts		Renal failure acute	serious				3983
25986	1 pts		Stress incontinence	serious				3983
25987	1 pts		Urinary retention	serious				3983
25988	5 pts		Benign prostatic hyperplasia	serious				3983
25989	1 pts		Haemorrhage postmenopausal	serious				3983
25990	1 pts		Postmenopausal haemorrhage	serious				3983
25991	1 pts		Alveolitis allergic	serious				3983
25992	1 pts		Bronchopneumopathy	serious				3983
25993	35 pts		Chronic obstructive pulmonary disease	serious				3983
25994	2 pts		Chronic respiratory failure	serious				3983
25995	2 pts		Epistaxis	serious				3983
25996	1 pts		Haemopneumothorax	serious				3983
25997	1 pts		Haemoptysis	serious				3983
25998	3 pts		Interstitial lung disease	serious				3983
25999	1 pts		Nasal cyst	serious				3983
26000	1 pts		Non-cardiogenic pulmonary oedema	serious				3983
26001	3 pts		Pleurisy	serious				3983
26002	1 pts		Pneumonitis	serious				3983
26003	1 pts		Pneumothorax	serious				3983
26004	1 pts		Respiratory arrest	serious				3983
26005	1 pts		Cutaneous lupus erythematosus	serious				3983
26006	1 pts		Decubitus ulcer	serious				3983
26007	1 pts		Psoriasis	serious				3983
26008	1 pts		Alcohol detoxification	serious				3983
26009	1 pts		Arrhythmia prophylaxis	serious				3983
26010	1 pts		Cardiac ablation	serious				3983
26011	1 pts		Cardiac aneurysm repair	serious				3983
26012	4 pts		Cardiac pacemaker insertion	serious				3983
26013	1 pts		Carotid endarterectomy	serious				3983
26014	12 pts		Coronary artery surgery	serious				3983
26015	1 pts		Coronary revascularisation	serious				3983
26016	1 pts		Eventration procedure	serious				3983
26017	1 pts		Gastric banding	serious				3983
26018	1 pts		Obesity surgery	serious				3983
26019	5 pts		Percutaneous coronary intervention	serious				3983
26020	2 pts		Tooth extraction	serious				3983
26021	1 pts		Transurethral prostatectomy	serious				3983
26022	1 pts		Ureteral stent removal	serious				3983
26023	1 pts		Arteriosclerosis	serious				3983
26024	17 pts		Blood pressure inadequately controlled	serious				3983
26025	1 pts		Femoral artery aneurysm	serious				3983
26026	2 pts		Femoral artery occlusion	serious				3983
26027	2 pts		Hypertensive emergency	serious				3983
26028	1 pts		Iliac artery embolism	serious				3983
26029	1 pts		Claudication intermittent	serious				3983
26030	4 pts		Orthostatic hypotension	serious				3983
26031	3 pts		Peripheral embolism	serious				3983
26032	1 pts		Subclavian artery stenosis	serious				3983
26033	1 pts		Thrombophlebitis	serious				3983
26034	2 pts		Venous thrombosis limb	serious				3983
26035	161 pts		Atrial fibrillation	below serious				3983
26036	134 pts		Bradycardia	below serious				3983
26037	129 pts		Ventricular extrasystoles	below serious				3983
26038	34 pts		Ventricular tachycardia	below serious				3983
26039	89 pts		Phosphenes	below serious				3983
26040	38 pts		Bronchitis	below serious				3983
26041	39 pts		Respiratory tract infection	below serious				3983
26042	55 pts		Blood creatinine increased	below serious				3983
26043	178 pts		Heart rate decreased	below serious				3983
26044	46 pts		Transaminases increased	below serious				3983
26045	116 pts		Diabetes mellitus inadequate control	below serious				3983
26046	55 pts		Dizziness	below serious				3983
26047	216 pts		Blood pressure inadequately controlled	below serious				3983
26048	2 pts		Anaemia megaloblastic	serious				3984
26049	2 pts		Febrile neutropenia	serious				3984
26050	1 pts		Haemorrhagic diathesis	serious				3984
26051	1 pts		Haemorrhagic disorder	serious				3984
26052	2 pts		Heparin-induced thrombocytopenia	serious				3984
26053	8 pts		Anaemia hypochromic	serious				3984
26054	1 pts		Idiopathic thrombocytopenic purpura	serious				3984
26055	2 pts		Leukopenia	serious				3984
26056	3 pts		Lymphadenopathy	serious				3984
26057	1 pts		Lymphopenia	serious				3984
26058	4 pts		Anaemia microcytic	serious				3984
26059	3 pts		Neutropenia	serious				3984
26060	4 pts		Normochromic normocytic anaemia	serious				3984
26061	4 pts		Pancytopenia	serious				3984
26062	1 pts		Sideroblastic anaemia	serious				3984
26063	15 pts		Thrombocytopenia	serious				3984
26064	1 pts		Thrombocytopenic purpura	serious				3984
26065	1 pts		Thrombocytosis	serious				3984
26066	3 pts		Aortic valve incompetence	serious				3984
26067	12 pts		Aortic valve stenosis	serious				3984
26068	2 pts		Arrhythmia	serious				3984
26069	2 pts		Arrhythmia supraventricular	serious				3984
26070	1 pts		Arteriosclerosis coronary artery	serious				3984
26071	336 pts		Atrial fibrillation	serious				3984
26072	49 pts		Atrial flutter	serious				3984
26073	1 pts		Atrioventricular block	serious				3984
26074	17 pts		Atrioventricular block complete	serious				3984
26075	4 pts		Atrioventricular block first degree	serious				3984
26076	22 pts		Atrioventricular block second degree	serious				3984
26077	101 pts		Bradycardia	serious				3984
26078	1 pts		Block bundle branch	serious				3984
26079	7 pts		Bundle branch block left	serious				3984
26080	15 pts		Cardiac arrest	serious				3984
26081	357 pts		Cardiac failure	serious				3984
26082	37 pts		Cardiac failure acute	serious				3984
26083	31 pts		Cardiac failure congestive	serious				3984
26084	3 pts		Cardio-respiratory arrest	serious				3984
26085	30 pts		Cardiogenic shock	serious				3984
26086	1 pts		Cardiomyopathy	serious				3984
26087	3 pts		Cardiopulmonary failure	serious				3984
26088	6 pts		Cor pulmonale	serious				3984
26089	1 pts		Coronary artery dissection	serious				3984
26090	14 pts		Coronary artery occlusion	serious				3984
26091	1 pts		Endocarditis noninfective	serious				3984
26092	1 pts		Hypertensive heart disease	serious				3984
26093	1 pts		Left atrial dilatation	serious				3984
26094	16 pts		Mitral valve incompetence	serious				3984
26095	1 pts		Mitral valve prolapse	serious				3984
26096	1 pts		Myocardial depression	serious				3984
26097	1 pts		Fibrosis myocardial	serious				3984
26098	98 pts		Myocardial infarction	serious				3984
26099	5 pts		Nodal rhythm	serious				3984
26100	8 pts		Right ventricular failure	serious				3984
26101	9 pts		Sick sinus syndrome	serious				3984
26102	5 pts		Silent myocardial infarction	serious				3984
26103	2 pts		Sinus arrhythmia	serious				3984
26104	48 pts		Sinus bradycardia	serious				3984
26105	1 pts		Tachyarrhythmia	serious				3984
26106	6 pts		Tricuspid valve incompetence	serious				3984
26107	32 pts		Ventricular extrasystoles	serious				3984
26108	35 pts		Ventricular tachycardia	serious				3984
26109	1 pts		Adenomatous polyposis coli	serious				3984
26110	1 pts		Metabolic myopathy	serious				3984
26111	1 pts		Pyloric stenosis	serious				3984
26112	4 pts		Acute vestibular syndrome	serious				3984
26113	2 pts		Deafness neurosensory	serious				3984
26114	2 pts		Deafness unilateral	serious				3984
26115	2 pts		Hearing impaired	serious				3984
26116	3 pts		Tinnitus	serious				3984
26117	1 pts		Tympanic membrane disorder	serious				3984
26118	9 pts		Vertigo	serious				3984
26119	1 pts		Cushing's syndrome	serious				3984
26120	1 pts		Empty sella syndrome	serious				3984
26121	4 pts		Goitre	serious				3984
26122	6 pts		Hyperthyroidism	serious				3984
26123	1 pts		Toxic nodular goitre	serious				3984
26124	39 pts		Cataract	serious				3984
26125	1 pts		Cataract nuclear	serious				3984
26126	1 pts		Cataract subcapsular	serious				3984
26127	1 pts		Choroidal effusion	serious				3984
26128	1 pts		Conjunctival haemorrhage	serious				3984
26129	1 pts		Dacryoadenitis acquired	serious				3984
26130	1 pts		Diabetic glaucoma	serious				3984
26131	2 pts		Diplopia	serious				3984
26132	20 pts		Glaucoma	serious				3984
26133	1 pts		Glaucomatous optic disc atrophy	serious				3984
26134	7 pts		Macular degeneration	serious				3984
26135	1 pts		Macular fibrosis	serious				3984
26136	2 pts		Macular oedema	serious				3984
26137	2 pts		Normal tension glaucoma	serious				3984
26138	1 pts		Ocular hypertension	serious				3984
26139	1 pts		Ocular icterus	serious				3984
26140	1 pts		Ischaemic optic neuropathy	serious				3984
26141	28 pts		Photopsia	serious				3984
26142	1 pts		Retinal artery thrombosis	serious				3984
26143	10 pts		Retinal haemorrhage	serious				3984
26144	10 pts		Haemorrhage retinal	serious				3984
26145	1 pts		Retinal tear	serious				3984
26146	1 pts		Retinal vascular thrombosis	serious				3984
26147	2 pts		Retinal vein thrombosis	serious				3984
26148	1 pts		Retinoschisis	serious				3984
26149	13 pts		Vision blurred	serious				3984
26150	3 pts		Vitreous detachment	serious				3984
26151	8 pts		Vitreous haemorrhage	serious				3984
26152	1 pts		Abdominal adhesions	serious				3984
26153	1 pts		Abdominal distension	serious				3984
26154	1 pts		Abdominal hernia obstructive	serious				3984
26155	2 pts		Abdominal strangulated hernia	serious				3984
26156	1 pts		Acute abdomen	serious				3984
26157	1 pts		Anal ulcer	serious				3984
26158	3 pts		Ascites	serious				3984
26159	2 pts		Barrett's oesophagus	serious				3984
26160	2 pts		Colitis	serious				3984
26161	2 pts		Colitis ischaemic	serious				3984
26162	3 pts		Colitis ulcerative	serious				3984
26163	1 pts		Colonic pseudo-obstruction	serious				3984
26164	1 pts		Colonic stenosis	serious				3984
26165	10 pts		Diarrhoea	serious				3984
26166	1 pts		Diverticular perforation	serious				3984
26167	2 pts		Diverticulitis intestinal haemorrhagic	serious				3984
26168	1 pts		Duodenal obstruction	serious				3984
26169	4 pts		Duodenal ulcer	serious				3984
26170	2 pts		Duodenal ulcer perforation	serious				3984
26171	2 pts		Duodenitis haemorrhagic	serious				3984
26172	1 pts		Enterocolitis haemorrhagic	serious				3984
26173	2 pts		Erosive duodenitis	serious				3984
26174	3 pts		Erosive oesophagitis	serious				3984
26175	1 pts		Faecal incontinence	serious				3984
26176	1 pts		Flatulence	serious				3984
26177	3 pts		Food poisoning	serious				3984
26178	1 pts		Gastric mucosa erythema	serious				3984
26179	2 pts		Gastric polyps	serious				3984
26180	2 pts		Gastric ulcer perforation	serious				3984
26181	14 pts		Gastritis	serious				3984
26182	5 pts		Atrophic gastritis	serious				3984
26183	1 pts		Gastroduodenal haemorrhage	serious				3984
26184	1 pts		Gastrointestinal angiodysplasia haemorrhagic	serious				3984
26185	13 pts		Gastrointestinal haemorrhage	serious				3984
26186	12 pts		Gastrooesophageal reflux disease	serious				3984
26187	1 pts		Gastrooesophagitis	serious				3984
26188	7 pts		Haemorrhagic erosive gastritis	serious				3984
26189	1 pts		Hernial eventration	serious				3984
26190	7 pts		Hiatus hernia	serious				3984
26191	1 pts		Ileus paralytic	serious				3984
26192	29 pts		Hernia inguinal	serious				3984
26193	1 pts		Inguinal hernia strangulated	serious				3984
26194	1 pts		Inguinal hernia, obstructive	serious				3984
26195	5 pts		Intestinal obstruction	serious				3984
26196	1 pts		Large intestine perforation	serious				3984
26197	11 pts		Large intestine polyp	serious				3984
26198	5 pts		Lower gastrointestinal haemorrhage	serious				3984
26199	1 pts		Mechanical ileus	serious				3984
26200	6 pts		Melaena	serious				3984
26201	12 pts		Nausea	serious				3984
26202	1 pts		Oesophageal ulcer haemorrhage	serious				3984
26203	2 pts		Oesophagitis	serious				3984
26204	2 pts		Oesophagitis haemorrhagic	serious				3984
26205	1 pts		Pancreatic pseudocyst	serious				3984
26206	4 pts		Pancreatitis	serious				3984
26207	11 pts		Chronic pancreatitis	serious				3984
26208	2 pts		Periproctitis	serious				3984
26209	3 pts		Rectal polyp	serious				3984
26210	3 pts		Rectal ulcer haemorrhage	serious				3984
26211	1 pts		Retching	serious				3984
26212	1 pts		Haemorrhage retroperitoneal	serious				3984
26213	1 pts		Small intestinal obstruction	serious				3984
26214	1 pts		Splenic artery aneurysm	serious				3984
26215	3 pts		Subileus	serious				3984
26216	1 pts		Thrombosis mesenteric vessel	serious				3984
26217	2 pts		Umbilical hernia, obstructive	serious				3984
26218	8 pts		Upper gastrointestinal haemorrhage	serious				3984
26219	4 pts		Oesophageal varices	serious				3984
26220	4 pts		Varices oesophageal	serious				3984
26221	10 pts		Death	serious				3984
26222	3 pts		Device dislocation	serious				3984
26223	1 pts		Device extrusion	serious				3984
26224	2 pts		Device failure	serious				3984
26225	1 pts		Exercise tolerance decreased	serious				3984
26226	1 pts		Face oedema	serious				3984
26227	7 pts		Fatigue	serious				3984
26228	1 pts		Feeling abnormal	serious				3984
26229	1 pts		Feeling cold	serious				3984
26230	1 pts		Foreign body reaction	serious				3984
26231	3 pts		General physical health deterioration	serious				3984
26232	3 pts		Generalised oedema	serious				3984
26233	1 pts		Hernia obstructive	serious				3984
26234	1 pts		Irritability	serious				3984
26235	1 pts		Medical device complication	serious				3984
26236	38 pts		Non-cardiac chest pain	serious				3984
26237	9 pts		Oedema peripheral	serious				3984
26238	5 pts		Pyrexia	serious				3984
26239	3 pts		Spinal pain	serious				3984
26240	75 pts		Sudden death	serious				3984
26241	1 pts		Systemic inflammatory response syndrome	serious				3984
26242	1 pts		Thrombosis in device	serious				3984
26243	1 pts		Acute hepatic failure	serious				3984
26244	1 pts		Alcoholic liver disease	serious				3984
26245	1 pts		Biliary cirrhosis primary	serious				3984
26246	19 pts		Cholecystitis acute	serious				3984
26247	7 pts		Cholecystitis chronic	serious				3984
26248	2 pts		Chronic hepatitis	serious				3984
26249	1 pts		Cirrhosis alcoholic	serious				3984
26250	1 pts		Gallbladder perforation	serious				3984
26251	7 pts		Hepatic cirrhosis	serious				3984
26252	1 pts		Hepatitis alcoholic	serious				3984
26253	1 pts		Hepatomegaly	serious				3984
26254	1 pts		Hyperbilirubinaemia	serious				3984
26255	2 pts		Jaundice cholestatic	serious				3984
26256	1 pts		Liver disorder	serious				3984
26257	3 pts		Liver injury	serious				3984
26258	1 pts		Allergy to arthropod sting	serious				3984
26259	1 pts		Acute hepatitis C	serious				3984
26260	1 pts		Anal candidiasis	serious				3984
26261	16 pts		Appendicitis	serious				3984
26262	1 pts		Appendicitis perforated	serious				3984
26263	1 pts		Arteriovenous graft site infection	serious				3984
26264	3 pts		Bacteraemia	serious				3984
26265	1 pts		Biliary tract infection	serious				3984
26266	1 pts		Brain abscess	serious				3984
26267	1 pts		Bronchiolitis	serious				3984
26268	4 pts		Bronchitis bacterial	serious				3984
26269	29 pts		Bronchopneumonia	serious				3984
26270	3 pts		Campylobacter gastroenteritis	serious				3984
26271	1 pts		Candidiasis	serious				3984
26272	23 pts		Cellulitis	serious				3984
26273	5 pts		Cholecystitis infective	serious				3984
26274	1 pts		Cystitis	serious				3984
26275	2 pts		Ear infection	serious				3984
26276	1 pts		Echinococciasis	serious				3984
26277	1 pts		Emphysematous cholecystitis	serious				3984
26278	2 pts		Empyema	serious				3984
26279	2 pts		Endocarditis	serious				3984
26280	2 pts		Endocarditis bacterial	serious				3984
26281	1 pts		Endocarditis staphylococcal	serious				3984
26282	1 pts		Enterobacter sepsis	serious				3984
26283	1 pts		Enterococcal sepsis	serious				3984
26284	20 pts		Erysipelas	serious				3984
26285	7 pts		Gangrene	serious				3984
26286	1 pts		Gastroenteritis clostridial	serious				3984
26287	1 pts		Gastroenteritis salmonella	serious				3984
26288	1 pts		Gastroenteritis shigella	serious				3984
26289	1 pts		Groin abscess	serious				3984
26290	1 pts		Haemophilus infection	serious				3984
26291	2 pts		Helicobacter gastritis	serious				3984
26292	1 pts		Hepatitis C	serious				3984
26293	1 pts		Herpes zoster infection neurological	serious				3984
26294	2 pts		Herpes zoster ophthalmic	serious				3984
26295	1 pts		Herpes zoster oticus	serious				3984
26296	1 pts		Infected cyst	serious				3984
26297	1 pts		Infected dermal cyst	serious				3984
26298	3 pts		Infective exacerbation of bronchiectasis	serious				3984
26299	3 pts		Influenza	serious				3984
26300	1 pts		Intervertebral discitis	serious				3984
26301	1 pts		Joint abscess	serious				3984
26302	2 pts		Keratitis herpetic	serious				3984
26303	2 pts		Laryngitis	serious				3984
26304	1 pts		Laryngitis fungal	serious				3984
26305	3 pts		Liver abscess	serious				3984
26306	4 pts		Lung abscess	serious				3984
26307	11 pts		Lung infection	serious				3984
26308	1 pts		Lyme disease	serious				3984
26309	1 pts		Malaria	serious				3984
26310	1 pts		Mediastinal abscess	serious				3984
26311	1 pts		Meningitis tuberculous	serious				3984
26312	1 pts		Muscle abscess	serious				3984
26313	2 pts		Peritoneal abscess	serious				3984
26314	1 pts		Peritonitis bacterial	serious				3984
26315	1 pts		Abscess peritonsillar	serious				3984
26316	1 pts		Pharyngitis	serious				3984
26317	1 pts		Pneumococcal sepsis	serious				3984
26318	122 pts		Pneumonia	serious				3984
26319	7 pts		Pneumonia bacterial	serious				3984
26320	1 pts		Pneumonia escherichia	serious				3984
26321	1 pts		Pneumonia klebsiella	serious				3984
26322	1 pts		Pneumonia mycoplasmal	serious				3984
26323	1 pts		Pneumonia viral	serious				3984
26324	1 pts		Pseudomonal bacteraemia	serious				3984
26325	1 pts		Pulmonary tuberculoma	serious				3984
26326	4 pts		Pulmonary tuberculosis	serious				3984
26327	3 pts		Pyelonephritis	serious				3984
26328	7 pts		Pyelonephritis chronic	serious				3984
26329	7 pts		Chronic pyelonephritis	serious				3984
26330	1 pts		Pyoderma	serious				3984
26331	1 pts		Renal tuberculosis	serious				3984
26332	1 pts		Respiratory tract infection bacterial	serious				3984
26333	1 pts		Respiratory tract infection viral	serious				3984
26334	1 pts		Scrotal abscess	serious				3984
26335	1 pts		Sputum purulent	serious				3984
26336	2 pts		Infection staphylococcal	serious				3984
26337	4 pts		Subcutaneous abscess	serious				3984
26338	1 pts		Tonsillitis bacterial	serious				3984
26339	3 pts		Tracheobronchitis	serious				3984
26340	1 pts		Tuberculosis gastrointestinal	serious				3984
26341	2 pts		Tuberculous pleurisy	serious				3984
26342	1 pts		Tubo-ovarian abscess	serious				3984
26343	1 pts		Typhoid fever	serious				3984
26344	6 pts		Upper respiratory tract infection	serious				3984
26345	26 pts		Urinary tract infection	serious				3984
26346	7 pts		Urinary tract infection bacterial	serious				3984
26347	2 pts		Urinary tract infection enterococcal	serious				3984
26348	3 pts		Viral infection	serious				3984
26349	1 pts		Viral pericarditis	serious				3984
26350	3 pts		Wound infection bacterial	serious				3984
26351	1 pts		Accident at home	serious				3984
26352	1 pts		Aortic injury	serious				3984
26353	1 pts		Arterial restenosis	serious				3984
26354	2 pts		Blindness traumatic	serious				3984
26355	4 pts		Brain contusion	serious				3984
26356	1 pts		Burns second degree	serious				3984
26357	1 pts		Cardiac contusion	serious				3984
26358	1 pts		Cardiac valve rupture	serious				3984
26359	1 pts		Cervical vertebral fracture	serious				3984
26360	6 pts		Concussion	serious				3984
26361	9 pts		Contusion	serious				3984
26362	1 pts		Corrosive gastritis	serious				3984
26363	1 pts		Crushing injury of trunk	serious				3984
26364	3 pts		Eye injury	serious				3984
26365	2 pts		Face injury	serious				3984
26366	1 pts		Febrile nonhaemolytic transfusion reaction	serious				3984
26367	13 pts		Femoral neck fracture	serious				3984
26368	15 pts		Femur fracture	serious				3984
26369	4 pts		Fibula fracture	serious				3984
26370	5 pts		Foot fracture	serious				3984
26371	1 pts		Forearm fracture	serious				3984
26372	1 pts		Foreign body	serious				3984
26373	1 pts		Foreign body in eye	serious				3984
26374	1 pts		Heat stroke	serious				3984
26375	1 pts		Injury	serious				3984
26376	1 pts		Intervertebral disc injury	serious				3984
26377	4 pts		Joint dislocation	serious				3984
26378	1 pts		Kidney rupture	serious				3984
26379	2 pts		Laceration	serious				3984
26380	1 pts		Ligament rupture	serious				3984
26381	1 pts		Limb crushing injury	serious				3984
26382	2 pts		Limb traumatic amputation	serious				3984
26383	1 pts		Lip injury	serious				3984
26384	4 pts		Lower limb fracture	serious				3984
26385	1 pts		Pancreatic injury	serious				3984
26386	1 pts		Periorbital haematoma	serious				3984
26387	1 pts		Pneumoconiosis	serious				3984
26388	1 pts		Post procedural contusion	serious				3984
26389	14 pts		Post procedural myocardial infarction	serious				3984
26390	2 pts		Procedural hypotension	serious				3984
26391	2 pts		Procedural pain	serious				3984
26392	1 pts		Procedural site reaction	serious				3984
26393	1 pts		Radiation oesophagitis	serious				3984
26394	1 pts		Renal haematoma	serious				3984
26395	1 pts		Spinal column injury	serious				3984
26396	5 pts		Spinal fracture	serious				3984
26397	2 pts		Sternal fracture	serious				3984
26398	1 pts		Subcutaneous haematoma	serious				3984
26399	8 pts		Subdural haematoma	serious				3984
26400	2 pts		Suture related complication	serious				3984
26401	1 pts		Tendon injury	serious				3984
26402	1 pts		Thoracic vertebral fracture	serious				3984
26403	6 pts		Tibia fracture	serious				3984
26404	1 pts		Transfusion reaction	serious				3984
26405	3 pts		Traumatic intracranial haemorrhage	serious				3984
26406	1 pts		Traumatic ulcer	serious				3984
26407	2 pts		Ulna fracture	serious				3984
26408	1 pts		Vascular graft occlusion	serious				3984
26409	1 pts		Vascular graft thrombosis	serious				3984
26410	4 pts		Vascular pseudoaneurysm	serious				3984
26411	1 pts		Vasoplegia syndrome	serious				3984
26412	1 pts		Wound complication	serious				3984
26413	1 pts		Arteriogram carotid	serious				3984
26414	12 pts		Aspartate aminotransferase increased	serious				3984
26415	1 pts		Blood alkaline phosphatase increased	serious				3984
26416	1 pts		Blood creatine phosphokinase increased	serious				3984
26417	3 pts		Blood creatinine increased	serious				3984
26418	1 pts		Blood glucose decreased	serious				3984
26419	1 pts		Blood lactate dehydrogenase increased	serious				3984
26420	4 pts		Blood potassium increased	serious				3984
26421	2 pts		Blood pressure decreased	serious				3984
26422	24 pts		Blood pressure increased	serious				3984
26423	1 pts		Body temperature increased	serious				3984
26424	1 pts		Cardiac stress test abnormal	serious				3984
26425	1 pts		Chest X-ray abnormal	serious				3984
26426	1 pts		ECG signs of myocardial ischaemia	serious				3984
26427	57 pts		Electrocardiogram QT prolonged	serious				3984
26428	2 pts		Gamma-glutamyltransferase increased	serious				3984
26429	1 pts		Gastrointestinal examination	serious				3984
26430	55 pts		Heart rate decreased	serious				3984
26431	2 pts		Hepatic enzyme increased	serious				3984
26432	7 pts		Investigation	serious				3984
26433	1 pts		Oxygen saturation decreased	serious				3984
26434	2 pts		Platelet count decreased	serious				3984
26435	1 pts		Pulmonary arterial pressure increased	serious				3984
26436	1 pts		Red blood cell sedimentation rate increased	serious				3984
26437	3 pts		Sleep study	serious				3984
26438	1 pts		Streptococcus test positive	serious				3984
26439	1 pts		Thyroid function test abnormal	serious				3984
26440	1 pts		Treponema test positive	serious				3984
26441	1 pts		Troponin increased	serious				3984
26442	1 pts		Acidosis	serious				3984
26443	1 pts		Cachexia	serious				3984
26444	4 pts		Decreased appetite	serious				3984
26445	19 pts		Dehydration	serious				3984
26446	1 pts		Diabetic complication	serious				3984
26447	4 pts		Gout	serious				3984
26448	10 pts		Hyperglycaemia	serious				3984
26449	13 pts		Hyperkalaemia	serious				3984
26450	1 pts		Hypocalcaemia	serious				3984
26451	19 pts		Hypoglycaemia	serious				3984
26452	1 pts		Hypomagnesaemia	serious				3984
26453	1 pts		Insulin-requiring type 2 diabetes mellitus	serious				3984
26454	1 pts		Type 1 diabetes mellitus	serious				3984
26455	1 pts		Type 3 diabetes mellitus	serious				3984
26456	1 pts		Amyotrophy	serious				3984
26457	2 pts		Ankylosing spondylitis	serious				3984
26458	3 pts		Costochondritis	serious				3984
26459	2 pts		Foot deformity	serious				3984
26460	1 pts		Intervertebral disc compression	serious				3984
26461	4 pts		Intervertebral disc disorder	serious				3984
26462	1 pts		Intervertebral disc displacement	serious				3984
26463	1 pts		Kyphosis	serious				3984
26464	9 pts		Lumbar spinal stenosis	serious				3984
26465	1 pts		Muscle tightness	serious				3984
26466	1 pts		Musculoskeletal stiffness	serious				3984
26467	1 pts		Myopathy	serious				3984
26468	1 pts		Neuropathic arthropathy	serious				3984
26469	1 pts		Osteitis	serious				3984
26470	46 pts		Osteoarthritis	serious				3984
26471	5 pts		Osteonecrosis	serious				3984
26472	1 pts		Osteoporotic fracture	serious				3984
26473	4 pts		Pain in extremity	serious				3984
26474	1 pts		Arthropathy psoriatic	serious				3984
26475	2 pts		Scoliosis	serious				3984
26476	18 pts		Osteoarthritis spinal	serious				3984
26477	1 pts		Sympathetic posterior cervical syndrome	serious				3984
26478	3 pts		Synovitis	serious				3984
26479	1 pts		Systemic sclerosis	serious				3984
26480	1 pts		Vertebral foraminal stenosis	serious				3984
26481	1 pts		Acute leukaemia	serious				3984
26482	6 pts		Adenocarcinoma gastric	serious				3984
26483	8 pts		Adenocarcinoma of colon	serious				3984
26484	1 pts		Adenocarcinoma pancreas	serious				3984
26485	1 pts		Anal squamous cell carcinoma	serious				3984
26486	1 pts		Angiofibroma	serious				3984
26487	24 pts		Basal cell carcinoma	serious				3984
26488	1 pts		Benign renal neoplasm	serious				3984
26489	2 pts		Bile duct cancer	serious				3984
26490	1 pts		Bladder cancer stage I, with cancer in situ	serious				3984
26491	5 pts		Bladder transitional cell carcinoma	serious				3984
26492	2 pts		Bladder transitional cell carcinoma recurrent	serious				3984
26493	1 pts		Bladder transitional cell carcinoma stage III	serious				3984
26494	3 pts		Bowen's disease	serious				3984
26495	1 pts		Brain cancer metastatic	serious				3984
26496	1 pts		Brain neoplasm	serious				3984
26497	1 pts		Breast cancer recurrent	serious				3984
26498	5 pts		Bronchial carcinoma	serious				3984
26499	1 pts		Bronchioloalveolar carcinoma	serious				3984
26500	1 pts		Carcinoid tumour of the stomach	serious				3984
26501	1 pts		Cerebral hygroma	serious				3984
26502	1 pts		Cholesteatoma	serious				3984
26503	3 pts		Chronic lymphocytic leukaemia	serious				3984
26504	4 pts		Colon adenoma	serious				3984
26505	6 pts		Colon cancer	serious				3984
26506	1 pts		Colon cancer stage 0	serious				3984
26507	1 pts		Colorectal cancer	serious				3984
26508	2 pts		Colorectal cancer metastatic	serious				3984
26509	1 pts		Diffuse large B-cell lymphoma stage III	serious				3984
26510	1 pts		Ear neoplasm malignant	serious				3984
26511	2 pts		Endometrial adenocarcinoma	serious				3984
26512	1 pts		Extranodal marginal zone B-cell lymphoma (MALT type)	serious				3984
26513	3 pts		Gastric cancer stage IV	serious				3984
26514	1 pts		Gastrointestinal stromal tumour	serious				3984
26515	1 pts		Gastrointestinal tract adenoma	serious				3984
26516	1 pts		Glioblastoma	serious				3984
26517	3 pts		Hepatic cancer	serious				3984
26518	2 pts		Hepatocellular carcinoma	serious				3984
26519	2 pts		Hodgkin's disease	serious				3984
26520	1 pts		Intestinal adenocarcinoma	serious				3984
26521	4 pts		Invasive ductal breast carcinoma	serious				3984
26522	1 pts		Large cell lung cancer	serious				3984
26523	2 pts		Large cell lung cancer metastatic	serious				3984
26524	1 pts		Large cell lung cancer stage II	serious				3984
26525	2 pts		Laryngeal cancer	serious				3984
26526	1 pts		Laryngeal cancer metastatic	serious				3984
26527	1 pts		Laryngeal cancer recurrent	serious				3984
26528	1 pts		Lip and/or oral cavity cancer stage IV	serious				3984
26529	2 pts		Lipoma	serious				3984
26530	4 pts		Adenocarcinoma lung	serious				3984
26531	3 pts		Lung carcinoma cell type unspecified stage IV	serious				3984
26532	1 pts		Lymphangiosis carcinomatosa	serious				3984
26533	1 pts		Malignant ascites	serious				3984
26534	1 pts		Malignant neoplasm of eyelid	serious				3984
26535	3 pts		Malignant pleural effusion	serious				3984
26536	1 pts		Metastases to abdominal cavity	serious				3984
26537	2 pts		Metastases to adrenals	serious				3984
26538	3 pts		Metastases to bone	serious				3984
26539	1 pts		Metastases to bone marrow	serious				3984
26540	1 pts		Metastases to eye	serious				3984
26541	2 pts		Metastases to lung	serious				3984
26542	1 pts		Metastases to the mediastinum	serious				3984
26543	3 pts		Metastatic gastric cancer	serious				3984
26544	2 pts		Metastatic renal cell carcinoma	serious				3984
26545	2 pts		Myelodysplastic syndrome	serious				3984
26546	1 pts		Myelofibrosis	serious				3984
26547	4 pts		Myeloproliferative disorder	serious				3984
26548	1 pts		Neuroendocrine tumour	serious				3984
26549	1 pts		Neuroma	serious				3984
26550	1 pts		Nodular melanoma	serious				3984
26551	3 pts		Non-small cell lung cancer	serious				3984
26552	1 pts		Non-small cell lung cancer metastatic	serious				3984
26553	1 pts		Oesophageal adenocarcinoma	serious				3984
26554	1 pts		Oesophageal adenocarcinoma metastatic	serious				3984
26555	1 pts		Oesophageal squamous cell carcinoma	serious				3984
26556	1 pts		Ovarian germ cell teratoma benign	serious				3984
26557	1 pts		Pharyngeal cancer recurrent	serious				3984
26558	1 pts		Pineal parenchymal neoplasm malignant	serious				3984
26559	1 pts		Pituitary tumour benign	serious				3984
26560	1 pts		Pituitary tumour recurrent	serious				3984
26561	1 pts		Plasma cell leukaemia	serious				3984
26562	2 pts		Pleural mesothelioma	serious				3984
26563	38 pts		Prostate cancer	serious				3984
26564	4 pts		Prostate cancer metastatic	serious				3984
26565	1 pts		Prostate cancer recurrent	serious				3984
26566	5 pts		Rectal cancer	serious				3984
26567	6 pts		Renal cancer	serious				3984
26568	4 pts		Renal cancer metastatic	serious				3984
26569	1 pts		Renal cancer stage I	serious				3984
26570	1 pts		Renal cell carcinoma	serious				3984
26571	1 pts		Renal oncocytoma	serious				3984
26572	1 pts		Salivary gland adenoma	serious				3984
26573	4 pts		Skin cancer	serious				3984
26574	2 pts		Small intestine carcinoma	serious				3984
26575	1 pts		Spinal meningioma benign	serious				3984
26576	1 pts		Squamous cell carcinoma of the cervix	serious				3984
26577	2 pts		Tongue neoplasm malignant stage unspecified	serious				3984
26578	1 pts		Uterine leiomyoma	serious				3984
26579	5 pts		Amnesia	serious				3984
26580	1 pts		Brain stem infarction	serious				3984
26581	4 pts		Carotid arteriosclerosis	serious				3984
26582	2 pts		Carotid artery disease	serious				3984
26583	1 pts		Carotid artery dissection	serious				3984
26584	51 pts		Carotid artery stenosis	serious				3984
26585	1 pts		Cerebellar atrophy	serious				3984
26586	1 pts		Cerebellar haemorrhage	serious				3984
26587	1 pts		Cerebellar syndrome	serious				3984
26588	4 pts		Cerebral atrophy	serious				3984
26589	2 pts		Cerebral haematoma	serious				3984
26590	3 pts		Cerebral haemorrhage	serious				3984
26591	15 pts		Cerebral infarction	serious				3984
26592	8 pts		Cerebral ischaemia	serious				3984
26593	1 pts		Cerebral microangiopathy	serious				3984
26594	5 pts		Cerebrovascular disorder	serious				3984
26595	1 pts		Cranial nerve disorder	serious				3984
26596	1 pts		Cubital tunnel syndrome	serious				3984
26597	2 pts		Dementia Alzheimer's type	serious				3984
26598	1 pts		Dementia of the Alzheimer's type, with delusions	serious				3984
26599	1 pts		Diabetic hyperglycaemic coma	serious				3984
26600	19 pts		Dizziness	serious				3984
26601	1 pts		Dizziness postural	serious				3984
26602	1 pts		Dystonic tremor	serious				3984
26603	1 pts		Encephalitis	serious				3984
26604	1 pts		Encephalomyelitis	serious				3984
26605	4 pts		Encephalopathy	serious				3984
26606	7 pts		Epilepsy	serious				3984
26607	1 pts		Essential tremor	serious				3984
26608	1 pts		Facial nerve disorder	serious				3984
26609	4 pts		Grand mal convulsion	serious				3984
26610	1 pts		Hemianopia homonymous	serious				3984
26611	6 pts		Hemiparesis	serious				3984
26612	2 pts		Hydrocephalus	serious				3984
26613	1 pts		Hypoxic-ischaemic encephalopathy	serious				3984
26614	1 pts		Intercostal neuralgia	serious				3984
26615	1 pts		Intracranial venous sinus thrombosis	serious				3984
26616	97 pts		Ischaemic stroke	serious				3984
26617	32 pts		Loss of consciousness	serious				3984
26618	4 pts		Memory impairment	serious				3984
26619	1 pts		Monoplegia	serious				3984
26620	1 pts		Multiple sclerosis	serious				3984
26621	1 pts		Nerve root lesion	serious				3984
26622	2 pts		Neuralgia	serious				3984
26623	1 pts		Neurodegenerative disorder	serious				3984
26624	1 pts		Normal pressure hydrocephalus	serious				3984
26625	1 pts		Paraplegia	serious				3984
26626	1 pts		Post-injection delirium sedation syndrome	serious				3984
26627	1 pts		Post-traumatic headache	serious				3984
26628	1 pts		Posterior reversible encephalopathy syndrome	serious				3984
26629	15 pts		Presyncope	serious				3984
26630	1 pts		Psychomotor hyperactivity	serious				3984
26631	2 pts		Radicular syndrome	serious				3984
26632	5 pts		Radiculopathy	serious				3984
26633	4 pts		Somnolence	serious				3984
26634	2 pts		Speech disorder	serious				3984
26635	2 pts		Spinal cord compression	serious				3984
26636	5 pts		Haemorrhage subarachnoid	serious				3984
26637	91 pts		Syncope	serious				3984
26638	1 pts		Thalamic infarction	serious				3984
26639	1 pts		Tonic convulsion	serious				3984
26640	2 pts		Transient global amnesia	serious				3984
26641	56 pts		Transient ischaemic attack	serious				3984
26642	1 pts		VIth nerve disorder	serious				3984
26643	11 pts		Vascular encephalopathy	serious				3984
26644	2 pts		Vertebral artery occlusion	serious				3984
26645	3 pts		Vertebral artery stenosis	serious				3984
26646	15 pts		Vertebrobasilar insufficiency	serious				3984
26647	2 pts		Vertigo CNS origin	serious				3984
26648	1 pts		Vocal cord paresis	serious				3984
26649	1 pts		Wernicke-Korsakoff syndrome	serious				3984
26650	3 pts		Aggression	serious				3984
26651	1 pts		Agitated depression	serious				3984
26652	2 pts		Agitation	serious				3984
26653	2 pts		Alcohol abuse	serious				3984
26654	1 pts		Alcohol withdrawal syndrome	serious				3984
26655	1 pts		Alcoholism	serious				3984
26656	4 pts		Anxiety	serious				3984
26657	8 pts		Delirium	serious				3984
26658	1 pts		Delusional disorder, unspecified type	serious				3984
26659	3 pts		Depressed mood	serious				3984
26660	57 pts		Depression	serious				3984
26661	2 pts		Hallucination	serious				3984
26662	2 pts		Insomnia	serious				3984
26663	1 pts		Mood disorder due to a general medical condition	serious				3984
26664	1 pts		Obsessive thoughts	serious				3984
26665	1 pts		Persecutory delusion	serious				3984
26666	1 pts		Psychomotor retardation	serious				3984
26667	2 pts		Sleep disorder	serious				3984
26668	1 pts		Stress	serious				3984
26669	7 pts		Calculus ureteric	serious				3984
26670	10 pts		Calculus urinary	serious				3984
26671	4 pts		Cystitis haemorrhagic	serious				3984
26672	1 pts		Cystitis noninfective	serious				3984
26673	11 pts		Diabetic nephropathy	serious				3984
26674	3 pts		Dysuria	serious				3984
26675	6 pts		Hydronephrosis	serious				3984
26676	1 pts		Hypertensive nephropathy	serious				3984
26677	1 pts		IgA nephropathy	serious				3984
26678	1 pts		Incontinence	serious				3984
26679	1 pts		Nephroangiosclerosis	serious				3984
26680	1 pts		Nephrotic syndrome	serious				3984
26681	1 pts		Obstructive uropathy	serious				3984
26682	1 pts		Pollakiuria	serious				3984
26683	1 pts		Renal artery occlusion	serious				3984
26684	6 pts		Renal artery stenosis	serious				3984
26685	3 pts		Colic renal	serious				3984
26686	38 pts		Renal failure	serious				3984
26687	34 pts		Renal failure chronic	serious				3984
26688	13 pts		Renal impairment	serious				3984
26689	1 pts		Renal tubular acidosis	serious				3984
26690	2 pts		Tubulointerstitial nephritis	serious				3984
26691	1 pts		Ureteric obstruction	serious				3984
26692	1 pts		Urethral disorder	serious				3984
26693	1 pts		Vesicoureteric reflux	serious				3984
26694	3 pts		Acquired phimosis	serious				3984
26695	2 pts		Cystocele	serious				3984
26696	1 pts		Pelvic adhesions	serious				3984
26697	1 pts		Varicocele	serious				3984
26698	1 pts		Vulval disorder	serious				3984
26699	31 pts		Acute pulmonary oedema	serious				3984
26700	13 pts		Acute respiratory failure	serious				3984
26701	1 pts		Aspiration	serious				3984
26702	21 pts		Asthma	serious				3984
26703	5 pts		Bronchiectasis	serious				3984
26704	5 pts		Bronchitis chronic	serious				3984
26705	5 pts		Bronchospasm	serious				3984
26706	64 pts		Chronic obstructive pulmonary disease	serious				3984
26707	4 pts		Chronic respiratory failure	serious				3984
26708	7 pts		Cough	serious				3984
26709	1 pts		Diaphragmatic paralysis	serious				3984
26710	1 pts		Dyspnoea at rest	serious				3984
26711	4 pts		Haemoptysis	serious				3984
26712	2 pts		Idiopathic pulmonary fibrosis	serious				3984
26713	6 pts		Interstitial lung disease	serious				3984
26714	1 pts		Laryngeal stenosis	serious				3984
26715	1 pts		Lung consolidation	serious				3984
26716	1 pts		Obstructive airways disorder	serious				3984
26717	1 pts		Pickwickian syndrome	serious				3984
26718	8 pts		Pleural effusion	serious				3984
26719	1 pts		Pleural fibrosis	serious				3984
26720	7 pts		Aspiration pneumonia	serious				3984
26721	2 pts		Pneumonitis	serious				3984
26722	1 pts		Pulmonary artery thrombosis	serious				3984
26723	1 pts		Pulmonary granuloma	serious				3984
26724	19 pts		Pulmonary hypertension	serious				3984
26725	2 pts		Pulmonary microemboli	serious				3984
26726	15 pts		Pulmonary oedema	serious				3984
26727	1 pts		Reflux laryngitis	serious				3984
26728	1 pts		Respiration abnormal	serious				3984
26729	1 pts		Respiratory disorder	serious				3984
26730	7 pts		Sleep apnoea syndrome	serious				3984
26731	1 pts		Snoring	serious				3984
26732	1 pts		Status asthmaticus	serious				3984
26733	1 pts		Wheezing	serious				3984
26734	1 pts		Cold sweat	serious				3984
26735	2 pts		Decubitus ulcer	serious				3984
26736	1 pts		Dermatitis	serious				3984
26737	1 pts		Dermatitis allergic	serious				3984
26738	2 pts		Dermatitis bullous	serious				3984
26739	1 pts		Dermatomyositis	serious				3984
26740	1 pts		Lichen planus	serious				3984
26741	1 pts		Panniculitis	serious				3984
26742	3 pts		Pruritus allergic	serious				3984
26743	3 pts		Psoriasis	serious				3984
26744	1 pts		Generalised rash	serious				3984
26745	11 pts		Activities of daily living impaired	serious				3984
26746	2 pts		Alcohol use	serious				3984
26747	1 pts		Immobile	serious				3984
26748	15 pts		Impaired driving ability	serious				3984
26749	1 pts		Alcohol detoxification	serious				3984
26750	2 pts		Aortic bypass	serious				3984
26751	1 pts		Arterial stent insertion	serious				3984
26752	1 pts		Blepharoplasty	serious				3984
26753	23 pts		Cardiac rehabilitation therapy	serious				3984
26754	2 pts		Carotid angioplasty	serious				3984
26755	2 pts		Carotid artery stent insertion	serious				3984
26756	6 pts		Cholecystectomy	serious				3984
26757	1 pts		Cholesteatoma removal	serious				3984
26758	1 pts		Circumcision	serious				3984
26759	5 pts		Coronary arterial stent insertion	serious				3984
26760	8 pts		Coronary revascularisation	serious				3984
26761	1 pts		Femoral hernia repair	serious				3984
26762	9 pts		Hip arthroplasty	serious				3984
26763	8 pts		Hospitalisation	serious				3984
26764	2 pts		Implantable defibrillator insertion	serious				3984
26765	1 pts		Incisional hernia repair	serious				3984
26766	1 pts		Internal fixation of fracture	serious				3984
26767	1 pts		Keratoplasty	serious				3984
26768	1 pts		Lens extraction	serious				3984
26769	2 pts		Medical device removal	serious				3984
26770	2 pts		Meniscus removal	serious				3984
26771	1 pts		Nasal polypectomy	serious				3984
26772	2 pts		Obesity surgery	serious				3984
26773	2 pts		Peripheral artery bypass	serious				3984
26774	1 pts		Peripheral artery stent insertion	serious				3984
26775	1 pts		Physiotherapy	serious				3984
26776	4 pts		Removal of internal fixation	serious				3984
26777	1 pts		Renal artery ablation	serious				3984
26778	1 pts		Renal stone removal	serious				3984
26779	1 pts		Retinal laser coagulation	serious				3984
26780	1 pts		Rotator cuff repair	serious				3984
26781	1 pts		Sinus operation	serious				3984
26782	2 pts		Skin neoplasm excision	serious				3984
26783	1 pts		Suture insertion	serious				3984
26784	1 pts		Thyroidectomy	serious				3984
26785	3 pts		Transurethral prostatectomy	serious				3984
26786	1 pts		Urethral dilation procedure	serious				3984
26787	1 pts		Uterine polypectomy	serious				3984
26788	2 pts		Aortic aneurysm rupture	serious				3984
26789	1 pts		Aortic arteriosclerosis	serious				3984
26790	1 pts		Aortic dilatation	serious				3984
26791	1 pts		Aortic dissection	serious				3984
26792	1 pts		Aortic occlusion	serious				3984
26793	5 pts		Aortic thrombosis	serious				3984
26794	2 pts		Blood pressure fluctuation	serious				3984
26795	7 pts		Blood pressure inadequately controlled	serious				3984
26796	19 pts		Deep vein thrombosis	serious				3984
26797	3 pts		Diabetic vascular disorder	serious				3984
26798	204 pts		Hypertension	serious				3984
26799	13 pts		Hypertensive emergency	serious				3984
26800	1 pts		Iliac artery rupture	serious				3984
26801	2 pts		Jugular vein thrombosis	serious				3984
26802	1 pts		Lymphoedema	serious				3984
26803	1 pts		Lymphostasis	serious				3984
26804	1 pts		Hypertension malignant	serious				3984
26805	12 pts		Orthostatic hypotension	serious				3984
26806	13 pts		Peripheral artery stenosis	serious				3984
26807	1 pts		Phlebitis	serious				3984
26808	2 pts		Subclavian artery stenosis	serious				3984
26809	1 pts		Vasculitis	serious				3984
26810	3 pts		Venous insufficiency	serious				3984
26811	1 pts		Withdrawal hypertension	serious				3984
26812	135 pts		Atrial fibrillation	below serious				3984
26813	247 pts		Atrioventricular block first degree	below serious				3984
26814	473 pts		Bradycardia	below serious				3984
26815	144 pts		Sinus bradycardia	below serious				3984
26816	176 pts		Supraventricular extrasystoles	below serious				3984
26817	310 pts		Ventricular extrasystoles	below serious				3984
26818	483 pts		Photopsia	below serious				3984
26819	102 pts		Vision blurred	below serious				3984
26820	117 pts		Diarrhoea	below serious				3984
26821	119 pts		Fatigue	below serious				3984
26822	205 pts		Oedema peripheral	below serious				3984
26823	214 pts		Bronchitis	below serious				3984
26824	105 pts		Urinary tract infection	below serious				3984
26825	111 pts		Blood creatinine increased	below serious				3984
26826	154 pts		C-reactive protein increased	below serious				3984
26827	106 pts		Electrocardiogram QT prolonged	below serious				3984
26828	985 pts		Heart rate decreased	below serious				3984
26829	140 pts		Hyperkalaemia	below serious				3984
26830	275 pts		Dizziness	below serious				3984
26831	165 pts		Headache	below serious				3984
26832	113 pts		Chronic obstructive pulmonary disease	below serious				3984
26833	147 pts		Cough	below serious				3984
26834	114 pts		Dyspnoea	below serious				3984
26835	968 pts		Hypertension	below serious				3984
26836	1 pts		Nausea					3986
26837	2 pts		Vision disorders					3986
26838	1 pts		Abdominal pain					3986
26839	1 pts		Leg pain					3986
26840	1 pts		Fatigue					3986
26841						No AEs are reported		3985
26842	1 pts		Drowsiness			suicide attempt		3989
26843						No AEs are reported		3988
26844	5 pts		Pulmonary capillary wedge pressure					3990
26845	1 pts		Bradyarrhythmia		discontinuation	leads to discontinuation		3990
26846	3 pts		Heart rate decreased		discontinuation	leads to discontinuation		3990
26847	1 pts		Sustained ventricular tachycardia					3990
26848	1 pts		Dizziness			suicide attempt		3987
26849	1 pts		Nausea			suicide attempt		3987
26850	1 pts		Vomiting			suicide attempt		3987
26851	2.5		Atrial fibrillation		discontinuation	leads to discontinuation		3982
26852	0.5		Heart rate increased		discontinuation	leads to discontinuation		3982
26853	0.4		Bradycardia		discontinuation	leads to discontinuation		3982
26854	1 pts		Hypotension			leads to discontinuation		3992
26855	1 pts		Drowsiness			leads to discontinuation		3992
26856	6 pts		Psychiatric disorder NOS				TRUE	3991
26857	0.9		Upper abdominal pain		discontinuation			3994
26858	0.16		Diarrhoea		discontinuation			3995
26859	0.16		Vomiting		discontinuation			3995
26860	0.1		Itching		discontinuation			3995
26861	0.1		Urticaria		discontinuation			3995
26862	0.05		Haematoma		discontinuation			3995
26863	0.16		Dizziness		discontinuation			3995
26864	0.05		Stridor		discontinuation			3995
26865						No adverse effects leading to discontinuation were reported.		3993
26866						There were no serious adverse events (AEs) re- ported during the trial and not any discontinuations as a result of AEs.		3996
26867	27.8		Dyspepsia					3997
26868	4.4		GI upset					3997
26869	1.8		Abdominal pain NOS					3997
26870	8.8		Nausea					3997
26871	10.6		Abdominal pain upper					3997
26872	16.3		Headache					3997
26873	7.9		Diarrhoea NOS					3997
26874	6		Hypocalcemia		dose interruption			3998
26875			Osteonecrosis of jaw					4001
26876			Acute kidney injury					3999
26877						AEs were not observed		4000
26878			Stupor		discontinuation			4002
26879			Agitation		discontinuation			4002
26880			Disorientation		discontinuation			4002
26881			Amnesia		discontinuation			4002
26882			Nausea		discontinuation			4003
26883						No adverse effects leading to discontinuation were reported.		4004
26884	0.65		Confusional state		discontinuation	possibly related		4005
26885	0.65		Syncopal attack		discontinuation	possibly related		4005
26886	0.65		Gastric pain	grade 2	discontinuation	possibly related		4005
26887	0.65		Hypertensive crisis		discontinuation	possibly related		4005
26888	0.65		Hot flushes	grade 2	discontinuation	possibly related		4005
26889	24		Blood pressure decreased		dose reduction			4006
26890	10		Headache		dose reduction			4006
26891			Oedema lower limb		discontinuation	14 withdrawals (16.9% of patients in the safety population); lower limbs oedema was the most frequent event leading to study withdrawal.		4007
26892	20		Oedema lower limb					4007
26893	18		Flushing					4007
26894	26		Headache					4007
26895	6		Dizziness					4007
26896						No drug-related adverse effects leading to discontinuation were recorded.		4008
26897			Hypotension		discontinuation			4011
26898			Hypothermia		discontinuation			4011
26899			Hypoglycaemia		discontinuation			4011
26900						No adverse effects leading to discontinuation were reported.		4009
26901						No adverse effects leading to discontinuation were reported.		4010
26902	2.4		Angina pectoris	grade 3				4013
26903	1.2		Dizziness	grade 3				4013
26904			Flushing		discontinuation	A relatively high number of patients were withdrawn from the nitrendipine treatment group because of particularly troublesome adverse effects especially on the 40 mg dose (5/ withdrawals), typically those associated with pronounced systemic vasodilatation, including flushing, palpitations and oedema.		4014
26905			Oedema		discontinuation	A relatively high number of patients were withdrawn from the nitrendipine treatment group because of particularly troublesome adverse effects especially on the 40 mg dose (5/ withdrawals), typically those associated with pronounced systemic vasodilatation, including flushing, palpitations and oedema.		4014
26906			Palpitations		discontinuation	A relatively high number of patients were withdrawn from the nitrendipine treatment group because of particularly troublesome adverse effects especially on the 40 mg dose (5/ withdrawals), typically those associated with pronounced systemic vasodilatation, including flushing, palpitations and oedema.		4014
26907						No patients discontinued treatment due to side effects.		4012
26908			Hypothermia		dose reduction			4018
26909			Death	grade 5				4017
26910			Death	grade 5				4015
26911	2		Urinary retention	grade 2				4016
26912	7		Xerostomia	grade 1				4016
26913	4		Agitation mental	grade 1-2				4016
26914	43		Somnolence	grade 1				4016
26915	9		Dystonic reaction	grade 1-2				4016
26916	13		Tachycardia	grade 1				4016
26917	2		AV block	grade 2				4016
26918	7		Gastrointestinal symptom NOS	grade 1				4016
26919	13		Hypotension	grade 1-2				4016
26920	20		Electrocardiogram QTc interval prolonged	grade 1-2				4016
26921	7		Coma	grade 2-3		after intake of 1200 mg in an adult		4016
26922	2		Seizures	grade 2				4016
26923	2		Disorientation	grade 2				4016
26924	0.4		Ulcer		discontinuation	Duodenal or gastric ulcer		4020
26925	0.4		Heartburn		discontinuation			4020
26926	0.4		Eczema		discontinuation	Eczema and allergy		4020
26927	0.4		Gastritis		discontinuation			4020
26928	0.4		Weight increase		discontinuation			4020
26929	0.4		Allergy		discontinuation	Eczema and allergy		4020
26930	0.4		Seizures cerebral		discontinuation			4020
26931	6.6		Stomach upset		discontinuation			4020
26932	0.4		Depression		discontinuation			4020
26933						No adverse effects leading to discontinuation were reported.		4019
26934						No AEs were observed		4021
26935						No AEs were observed		4023
26936						No AEs were observed		4022
26937	3.7		Confusion		discontinuation			4025
26938	3.7		Hunger abnormal		discontinuation			4025
26939	7.4		Depression		discontinuation			4025
26940	11.1		Weight gain		discontinuation			4025
26941			Weight gain		discontinuation			4024
26942			Sleepiness		discontinuation			4024
26943						No side-effects were reported in the patients receiving proglumide.		4026
26944	12.9		Leukocytopenia	grade 3-4			TRUE	4029
26945	10.1		Transaminases increased	grade 3-4			TRUE	4029
26946	33.3		Asthenia	grade 3			TRUE	4027
26947	11.1		Granulocyte count low	grade 4			TRUE	4027
26948	11.1		Granulocytopenia	grade 4			TRUE	4027
26949	11.1		Fatigue	grade 3			TRUE	4027
26950	7.7		Decreased hemoglobin	grade 3				4031
26951	11.1		Leukocytopenia	grade 3				4027
26952	11.1		Nausea	grade 3				4027
26953	11.1		Aspartate aminotransferase increased	grade 3				4027
26954	33.3		Alanine aminotransferase increase	grade 3				4027
26955	11.1		Bilirubin elevated	grade 3-4				4027
26956	16.7		Granulocytopenia	grade 4			TRUE	4032
26957	8.3		Bilirubin elevated	grade 4			TRUE	4032
26958	16.7		Granulocyte count low	grade 4			TRUE	4032
26959	7.7		Granulocyte count low	grade 4			TRUE	4031
26960	15.4		Asthenia	grade 3			TRUE	4031
26961	66.7		Neutropenia	grade 4		during the first treatment cycle	TRUE	4028
26962	11.6		Nausea and vomiting	grade 3-4				4030
26963	11.1		Diarrhea	grade 3-4				4030
26964	2		Constipation	grade 3-4				4030
26965	2.1		Oral soft tissue conditions	grade 3-4				4030
26966	7.3		Pain	grade 3-4				4030
26967	5		Infection	grade 3-4				4030
26968	6.5		Hemoglobin decreased	grade 3-4				4030
26969	3.5		Thrombocytopenia	grade 3-4				4030
26970	2.2		Blood bilirubin decreased	grade 3-4				4030
26971						No adverse effects leading to discontinuation were reported.		4033
26972						Treatment was well tolerated		4034
26973	1.7		Constipation	grade 1-2	discontinuation			4035
26974						No drug-related adverse effects leading to discontinuation were recorded.		4036
26975						No patients discontinued treatment due to side effects.		4038
26976	0.44		Dizziness	grade 1	discontinuation			4037
26977	3.3		Elevated liver enzymes					4039
26978	0.8		Upper gastrointestinal symptoms					4039
26979			Somnolence		discontinuation			4041
26980	4		Ejaculation failure		discontinuation			4040
26981	2		Suicidal ideation					4040
26982			QT prolonged		discontinuation			4042
26983	19		Itching					4043
26984	6		Fainting					4043
26985	19		Constipation					4043
26986	19		Hyperkinesia					4043
26987	6		Sweating increased					4043
26988	12.5		Dizziness					4043
26989	12.5		Parkinsonism					4043
26990	6		Palpitation					4043
26991	44		Akathisia					4043
26992	6		Tardive dyskinesia					4043
26993	12.5		Drowsiness					4043
26994	25		Dry mouth					4043
26995			Gastrointestinal disorder		discontinuation			4044
26996	0.6		Blood pressure increased		dose interruption			4044
26997			Gastrointestinal disorder		discontinuation			4044
26998			Coagulation abnormal		discontinuation			4045
26999			Hyperglyceridemia					4046
27000	12		Nausea		discontinuation			4048
27001	12		Dyspepsia					4048
27002	3.4		Vomiting		discontinuation			4048
27003	0.7		Gastric ulcer		discontinuation			4049
27004	0.7		Rash		dose interruption			4049
27005	1.4		Dizziness	grade 3	discontinuation			4049
27006	4		Gastrointestinal disorder		discontinuation			4049
27007	0.7		Blood in stool		discontinuation			4049
27008						No adverse effects leading to discontinuation were reported.		4047
27009	4.6		Dizziness		discontinuation			4050
27010	3.1		Constipation		discontinuation			4050
27011	12.3		Nausea		discontinuation			4050
27012	6.2		Vomiting		discontinuation			4050
27013						No significant side effects were observed		4051
27014						No adverse effects leading to discontinuation were reported.		4052
27015						No adverse effects leading to discontinuation were reported.		4053
27016			Chronic interstitial cystitis	grade 3	discontinuation			4056
27017			ALT increased		discontinuation			4057
27018			Lethargy					4057
27019			Anorexia		discontinuation			4057
27020			GGT increased		discontinuation			4057
27021			Alkaline phosphatase increased		discontinuation			4057
27022						The source does not contain information about AEs or lack thereof		4054
27023						The source does not contain information about AEs or lack thereof		4055
27024	4.3		Vomiting			Nausea, vomiting - 4.3%		4058
27025	8.5		Tachycardia					4058
27026	2.1		Allergy					4058
27027			Chest pain					4058
27028	8.5		Dysuria					4058
27029	8.5		Nervous system disorder					4058
27030	4.3		Muscle pain					4058
27031	4.3		Nausea					4058
27032	1 pts		Fatigue	grade 3			TRUE	4059
27033	1 pts		Neutropenia	grade 4			TRUE	4059
27034	1 pts		Thrombocytopenia	grade 4			TRUE	4059
27035	1 pts		Fatigue	grade 3			TRUE	4060
27036	1 pts		Thrombocytopenia	grade 4			TRUE	4060
27037	1 pts		Bilirubinaemia	grade 3			TRUE	4060
27038	1 pts		Thrombocytopenia	grade 3			TRUE	4062
27039	1 pts		Neutropenic infection	grade 3			TRUE	4062
27040	1 pts		Anaemia					4062
27041	50		Nausea					4060
27042	50		Vomiting	grade 3-4				4060
27043	3 pts		ALT increased	grade 3-4				4060
27044	1 pts		Alkaline phosphatase increased	grade 3-4				4060
27045	1 pts		Hyperbilirubinaemia	grade 3-4				4060
27046	4 pts		Anaemia	grade 1-2				4060
27047	50		Nausea	grade 3				4059
27048	50		Vomiting	grade 3				4059
27049	4 pts		ALT increased	grade 3-4				4059
27050	3 pts		Alkaline phosphatase increased	grade 1-2				4059
27051	1 pts		Hyperbilirubinaemia	grade 3-4				4059
27052	5 pts		Anaemia	grade 1-2				4059
27053	5.6		ALT increased		discontinuation	leads to discontinuation		4061
27054	5.6		AST increased		discontinuation	leads to discontinuation		4061
27055	5.6		Alkaline phosphatase increased		discontinuation	leads to discontinuation		4061
27056	5.6		Bilirubin increased		discontinuation	leads to discontinuation		4061
27057	3.4		Thrombocytopenia		discontinuation	leads to discontinuation		4061
27058	1.6		Fatigue		discontinuation	leads to discontinuation		4061
27059	1.1		Creatine phosphokinase increased		discontinuation	leads to discontinuation		4061
27060	1.1		Ejection fraction decreased		discontinuation	leads to discontinuation		4061
27061	24		Elevated liver enzyme levels		discontinuation	leads to dose reduction		4061
27062	8		Neutropenia		discontinuation	leads to dose reduction		4061
27063	8		Febrile neutropenia		discontinuation	leads to dose reduction		4061
27064	4.2		Thrombocytopenia		discontinuation	leads to dose reduction		4061
27065	3.7		Fatigue		discontinuation	leads to dose reduction		4061
27066	2.4		Creatine phosphokinase increased		discontinuation	leads to dose reduction		4061
27067	1.1		Nausea		discontinuation	leads to dose reduction or interruption		4061
27068	1.1		Vomiting		discontinuation	leads to dose reduction		4061
27069	31		Neutropenia		discontinuation	leads to dose interruption		4061
27070	15		Thrombocytopenia		discontinuation	leads to dose interruption		4061
27071	6		Elevated liver enzyme levels		discontinuation	leads to dose interruption		4061
27072	2.9		Fatigue		discontinuation	leads to dose interruption		4061
27073	2.6		Anemia		discontinuation	leads to dose interruption		4061
27074	1.1		Creatinine increased		discontinuation	leads to dose interruption		4061
27075	1.28		Gastrointestinal disturbance	grade 1-2	discontinuation			4064
27076	1.2		AST increased		discontinuation			4065
27077	1.2		Gamma-glutamyltransferase increased		discontinuation			4065
27078	1.2		ALT increased		discontinuation			4065
27079						No adverse effects leading to discontinuation were reported		4063
27080	1		Dizziness		discontinuation	leads to discontinuation		4066
27081	1		Headache		discontinuation	leads to discontinuation		4066
27082	1		Cough			leads to discontinuation		4066
27083	2.6		Retching		discontinuation			4068
27084	2.6		Psychosis	grade 3	discontinuation			4068
27085	2.6		Nausea		discontinuation			4068
27086	17.1		Psychotic behavior		discontinuation			4067
27087	2.9		Seizure		discontinuation			4067
27088	6.7		Drowsiness	grade 3	dose reduction			4069
27089	6.7		Drowsiness	grade 3	discontinuation			4069
27090	6.7		Gait disturbance	grade 3	dose reduction			4069
27091	6.7		Dysarthria	grade 3	dose reduction			4069
27092	6.7		Gait disturbance	grade 3	discontinuation			4069
27093						No adverse reactions were recorded		4070
27094			Rash		discontinuation			4071
27095	0.8		Diarrhea					4072
27096	19.7		Dry mouth			2 patients were discontinued		4072
27097	0.8		Weakness of limbs					4072
27098	13.1		Tiredness					4072
27099	0.8		Flushed face					4072
27100	0.8		Headache					4072
27101	0.8		Orthostatic dysregulation					4072
27102	0.8		Edema					4072
27103	0.8		Vertigo		discontinuation	1 patient was discontinued		4072
27104	1.6		Nervousness					4072
27105	1 pts		Blood urea increased					4074
27106	1 pts		Blood lactate dehydrogenase increased					4074
27107	1 pts		Malaise					4074
27108	5 pts		Dry mouth					4074
27109	1 pts		ALT increased					4074
27110	1 pts		AST increased					4074
27111	2 pts		Blood potassium increased					4074
27112	1 pts		Blood calcium decreased					4074
27113	1 pts		Decreased appetite					4074
27114	1 pts		Nocturia					4074
27115	1 pts		Anorexia			leads to discontinuation		4074
27116	1 pts		Metastasis			metastasis to the subcutis of the abdominal wall		4073
27117	2 pts		Decreased appetite			leads to dose reduction		4076
27118						No AEs reported		4075
27119	3.3		Somnolence		discontinuation	leads to discontinuation		4077
27120	11.1		Thrombocytopenia	grade 3				4080
27121	50		Thrombocytopenia	grade 4				4081
27122	50		Abdominal pain	grade 3			TRUE	4081
27123	50		Fatigue	grade 3			TRUE	4081
27124	50		Neutropenia	grade 4			TRUE	4081
27125	50		Anemia	grade 3				4081
27126	40		Diarrhea	grade 3			TRUE	4082
27127	40		Non-cardiac chest pain	grade 3			TRUE	4082
27128						No adverse effects leading to discontinuation were reported; no DLTs		4079
27129	66.7		Non-cardiac chest pain	grade 3			TRUE	4078
27130	1 pts		Diarrhea	grade 3-4				4088
27131	1 pts		Nausea	grade 3-4				4088
27132	1 pts		Vomiting	grade 3-4				4088
27133	1 pts		Diarrhea				TRUE	4088
27134	1 pts		Paresthesia				TRUE	4089
27135	1 pts		Diarrhea				TRUE	4092
27136	3 pts		Diarrhea				TRUE	4086
27137	3 pts		Diarrhea				TRUE	4087
27138	1 pts		Diarrhea				TRUE	4084
27139	2 pts		Diarrhea				TRUE	4085
27140	2 pts		Nausea				TRUE	4085
27141	5 pts		Diarrhea	all grades				4083
27142	2 pts		Fatigue	all grades				4083
27143	4 pts		Nausea	all grades				4083
27144	3 pts		Neuropathy	all grades				4083
27145	4 pts		Abdominal pain	all grades				4083
27146	1 pts		Vomiting	all grades				4083
27147	2 pts		Constipation	all grades				4083
27148	2 pts		Alopecia	all grades				4083
27149	1 pts		Myalgia	all grades				4083
27150	1 pts		Dyspnea	all grades				4083
27151	1 pts		Pain in limb	all grades				4083
27152	1 pts		Hypokalemia	all grades				4083
27153	2 pts		Neuropathy	grade 3		MTD was not reached	TRUE	4083
27154	1 pts		Diarrhea	grade 3		MTD was not reached	TRUE	4083
27155	1 pts		Uric acid increased	grade 4		MTD was not reached	TRUE	4083
27156	2 pts		Fatigue	grade 3		MTD was not reached	TRUE	4083
27157	15 pts		Diarrhea	grade 1				4090
27158	19 pts		Diarrhea	grade 2				4090
27159	14 pts		Diarrhea	grade 3				4090
27160	19 pts		Nausea	grade 1				4090
27161	11 pts		Nausea	grade 2				4090
27162	3 pts		Nausea	grade 3				4090
27163	19 pts		Vomiting	grade 1				4090
27164	11 pts		Vomiting	grade 2				4090
27165	3 pts		Vomiting	grade 3				4090
27166	12 pts		Anorexia	grade 1				4090
27167	6 pts		Anorexia	grade 2				4090
27168	1 pts		Anorexia	grade 3				4090
27169	8 pts		Abdominal pain	grade 1				4090
27170	3 pts		Abdominal pain	grade 2				4090
27171	3 pts		Abdominal pain	grade 3				4090
27172	9 pts		Weight loss	grade 1				4090
27173	2 pts		Weight loss	grade 2				4090
27174	4 pts		Heartburn	grade 1				4090
27175	4 pts		Heartburn	grade 2				4090
27176	4 pts		Dyspepsia	grade 1				4090
27177	4 pts		Dyspepsia	grade 2				4090
27178	7 pts		Constipation	grade 1				4090
27179	1 pts		Dehydration	grade 1				4090
27180	2 pts		Dehydration	grade 2				4090
27181	3 pts		Dehydration	grade 3				4090
27182	1 pts		GI bleed	grade 3				4090
27183	14 pts		Fatigue	grade 1				4090
27184	26 pts		Fatigue	grade 2				4090
27185	5 pts		Fatigue	grade 3				4090
27186	7 pts		Neuropathy	grade 1				4090
27187	3 pts		Neuropathy	grade 2				4090
27188	1 pts		Neuropathy	grade 3				4090
27189	7 pts		Alopecia	grade 1				4090
27190	1 pts		Alopecia	grade 2				4090
27191	4 pts		Joint pain	grade 1				4090
27192	4 pts		Joint pain	grade 2				4090
27193	7 pts		Mucositis	grade 1				4090
27194	2 pts		Anemia	grade 1				4090
27195	2 pts		Anemia	grade 2				4090
27196	1 pts		Anemia	grade 3				4090
27197	1 pts		Anemia	grade 4				4090
27198	3 pts		Hypokalemia	grade 1				4090
27199	2 pts		Hypokalemia	grade 3				4090
27200	1 pts		Hypokalemia	grade 4				4090
27201	1 pts		Neutropenia	grade 2				4090
27202	1 pts		Neutropenia	grade 4				4090
27203	12 pts		Diarrhea	grade 3-4				4091
27204	38 pts		Diarrhea	all grades				4091
27205	1 pts		Fatigue	grade 3-4				4091
27206	25 pts		Fatigue	all grades				4091
27207	2 pts		Neuropathy peripheral	grade 3-4				4091
27208	14 pts		Neuropathy peripheral	all grades				4091
27209	14 pts		Nausea	all grades				4091
27210	1 pts		Headache	grade 3-4				4091
27211	11 pts		Headache	all grades				4091
27212	9 pts		Constipation	all grades				4091
27213	8 pts		Muscular weakness	all grades				4091
27214	3 pts		Dehydration	grade 3-4				4091
27215	7 pts		Dehydration	all grades				4091
27216	7 pts		Insomnia	all grades				4091
27217	7 pts		Vomiting	all grades				4091
27218	2 pts		Convulsion	grade 3-4				4091
27219	6 pts		Convulsion	all grades				4091
27220	1 pts		Edema peripheral	grade 3-4				4091
27221	6 pts		Edema peripheral	all grades				4091
27222	6 pts		Dyspnea	all grades				4091
27223	6 pts		Rash	all grades				4091
27224						No adverse effects leading to discontinuation were reported		4094
27225	16.7		Gastroesophageal reflux		discontinuation			4093
27226	16.7		Balance disorder		discontinuation			4093
27227	16.7		Fatigue		discontinuation			4093
27228	16.7		Headache		dose reduction			4093
27229	16.7		Hypersensitivity		discontinuation			4093
27230	16.7		Insomnia	grade 3	discontinuation			4093
27231						The source does not contain information about AEs or lack thereof		4095
27232			Headache					4096
27233			Urinary tract infection					4096
27234			Constipation					4096
27235			Pyrexia					4096
27236			Bradycardia					4096
27237	4.2		Pruritic rash		discontinuation			4097
27238	4.2		Nausea		discontinuation			4097
27239	4.2		Vomiting		discontinuation			4097
27240	4.2		Bone pain	grade 3	discontinuation			4097
27241	4.2		Elevated liver enzyme levels		discontinuation			4097
27242	1.2		Bilirubin increased	grade 4	discontinuation			4098
27243	1.2		Hyperglycemia	grade 4	discontinuation			4098
27244	2.3		Lymphocytopenia	grade 4	discontinuation			4098
27245	1.2		Hyperglycemia	grade 4	discontinuation			4098
27246	20.9		Lymphocytopenia	grade 3				4098
27247	3.5		Hyperglycemia	grade 3				4098
27248	1.2		Neutropenia	grade 3	discontinuation			4098
27249	1.2		Thrombocytopenia	grade 4	discontinuation			4098
27250	7		AST increased	grade 3				4098
27251	5.8		Aspartate aminotransferase increase	grade 3				4098
27252	5.9		Palpitations	grade 3				4099
27253	5.9		Arthralgia	grade 3				4099
27254						No SAEs were observed		4101
27255						No SAEs were observed		4102
27256						No SAEs were observed		4100
27257						No serious adverse experience requiring treatment discontinuation occurred during the course of the study.		4103
27258	2.9		Cramps leg		discontinuation			4104
27259	2.9		Nausea		discontinuation			4104
27260	2.9		Headache		discontinuation			4104
27261						No adverse effects leading to discontinuation were reported.		4105
27262	1 pts		Weakness generalised		discontinuation			4107
27263			Allergic contact dermatitis		discontinuation			4106
27264						AEs were not observed		4108
27265						No patients discontinued treatment due to side effects, and there were no reported adverse events.		4110
27266			Leukopenia	grade 1	discontinuation			4109
27267			Agranulocytosis		discontinuation			4109
27268	0.6		Paraesthesia		discontinuation			4111
27269	0.6		Vomiting		discontinuation			4111
27270	0.6		Chest pain		discontinuation			4111
27271	0.6		Anxiety		discontinuation			4111
27272	3		Depressed mood disorders and disturbances		discontinuation			4111
27273	0.3		Fatigue		discontinuation	Asthenia/fatigue		4111
27274	0.3		Asthenia		discontinuation	Asthenia/fatigue		4111
27275	0.9		Dizziness		discontinuation			4111
27276	0.6		Headache		discontinuation			4111
27277	1.5		Nausea		discontinuation			4111
27278	3.6		Nervous system disorder		discontinuation			4112
27279	2.2		Paresthesia		discontinuation			4112
27280	1.4		Hyposmia		discontinuation			4112
27281	2.9		Gastrointestinal disorder		discontinuation			4112
27282	1.4		Dizziness		discontinuation			4112
27283	5.1		Psychiatric and behavioural symptoms NEC		discontinuation			4112
27284	1.4		Anorexia		discontinuation			4112
27285	2.2		Depressed mood		discontinuation			4112
27286						No adverse effects leading to discontinuation were reported.		4114
27287	2.9		Exanthema		discontinuation			4113
27288			QT interval prolonged		discontinuation			4117
27289			Tardive dyskinesia		discontinuation			4117
27290			Hypertonia	grade 3	discontinuation			4117
27291			Venous thromboembolism		discontinuation			4117
27292			Ventricular arrhythmia		discontinuation			4117
27293			Dysphagia		discontinuation			4117
27294			Neuroleptic malignant syndrome		discontinuation			4117
27295			Torsade de pointes		discontinuation			4117
27296			Autonomic dysfunction		discontinuation			4117
27297			Neurologic symptoms	grade 3	discontinuation			4117
27298			Stroke		discontinuation			4117
27299	1.8		Seizures		discontinuation			4118
27300	2.2		Excitement		discontinuation			4116
27301	2.2		Dysphagia		discontinuation			4116
27302						No adverse effects leading to discontinuation were reported		4115
27303						No AEs are reported		4119
27304	4 pts		Granulocytopenia	grade 4		curated AEs are unlikely relates to uracil	TRUE	4121
27305	3 pts		Diarrhea	grade 3-4		curated AEs are unlikely relates to uracil	TRUE	4120
27306	3 pts		Diarrhea	grade 3-4		curated AEs are unlikely relates to uracil	TRUE	4124
27307	1 pts		Granulocytopenia	grade 4		curated AEs are unlikely relates to uracil		4123
27308	1 pts		Nausea	grade 3		curated AEs are unlikely relates to uracil		4123
27309	1 pts		Thrombocytopenia	grade 3		curated AEs are unlikely relates to uracil		4123
27310	5 pts		Vomiting	grade 1-2		curated AEs are unlikely relates to uracil		4123
27311	4 pts		Fatigue	grade 1-2		curated AEs are unlikely relates to uracil		4123
27312	4 pts		Diarrhoea	grade 1-2		curated AEs are unlikely relates to uracil		4123
27313	3 pts		Fatigue	grade 1-2		curated AEs are unlikely relates to uracil		4122
27314	2 pts		Nausea	grade 1-2		curated AEs are unlikely relates to uracil		4122
27315	1 pts		Pulmonary embolism		discontinuation			4125
27316	1 pts		Lower extremities weakness of		discontinuation			4125
27317	1 pts		Rash		discontinuation			4126
27318						The source does not contain information about AEs or lack thereof		4127
27319			Hypotonia					4128
27320			Drowsiness					4128
27321			Respiratory depression					4129
27322	8.2		Gastrointestinal disturbance		discontinuation			4130
27323	0.8		Itching					4131
27324	10		Skin eruption		discontinuation			4132
27325			Lactic acidosis	grade 3	discontinuation			4135
27326			Hypokalemia		discontinuation			4135
27327			Coma	grade 5	discontinuation			4135
27328			Convulsions	grade 3	discontinuation			4135
27329			Vomiting	grade 3	discontinuation			4135
27330			Respiratory alkalosis	grade 5	discontinuation			4135
27331	4		Alkaline phosphatase increased		discontinuation			4133
27332	4		Eosinophilia		discontinuation			4133
27333	4		SGOT increased		discontinuation			4133
27334			Hyperglycemia	grade 1	discontinuation			4134
27335			Hypokalemia	grade 2	discontinuation			4134
27336			Pyruvate increased		discontinuation			4134
27337			Respiration abnormal		discontinuation	Hypernea		4134
27338			Consciousness decreased		discontinuation			4134
27339			Respiratory alkalosis		discontinuation			4134
27340			Metabolic acidosis		discontinuation			4134
27341			Sinus tachycardia		discontinuation			4134
27342			Nausea	severe		POISONING		4136
27343			Vomiting	severe		POISONING		4136
27344			Violent	severe		POISONING		4137
27345			Convulsions generalized	severe		POISONING		4137
27346						The source does not contain information about AEs or lack thereof		4138
27347	0.37		Function liver abnormal		discontinuation	abnormal liver function was assessed by serum bilirubin, ALP, ALT and AST levels	TRUE	4140
27348	57		Nausea		discontinuation	Although 7 g daily was stated to be the maximally tolerated dose, it was probably the maximal practical dose.	TRUE	4139
27349	6.5		Hepatotoxicity		discontinuation			4141
27350						No adverse effects leading to discontinuation were reported.		4142
27351			Diaphoresis		discontinuation			4143
27352			Consciousness loss		discontinuation			4143
27353			Hypotension		discontinuation	blood pressure was 40/0 mm		4143
27354						impossible to link AEs with the definite dose		4144
27355	4 pts		Insomnia	below serious				4146
27356	5 pts		Nausea	below serious				4146
27357	3 pts		Dizziness	below serious				4146
27358	1 pts		Coronary artery stenosis	serious				4147
27359	1 pts		Vertigo positional	serious				4147
27360	1 pts		Chest pain	serious				4147
27361	1 pts		Diverticulitis	serious				4147
27362	1 pts		Gallbladder empyema	serious				4147
27363	2 pts		Urinary tract infection	serious				4147
27364	1 pts		Humerus fracture	serious				4147
27365	1 pts		Joint dislocation	serious				4147
27366	1 pts		Bladder cancer	serious				4147
27367	1 pts		Breast cancer	serious				4147
27368	1 pts		Uterine leiomyoma	serious				4147
27369	14 pts		Multiple sclerosis relapse	serious				4147
27370	1 pts		Peripheral ischaemia	serious				4147
27371	40 pts		Urinary tract infection	below serious				4147
27372	22 pts		Fall	below serious				4147
27373	16 pts		Back pain	below serious				4147
27374	1 pts		Headache	below serious				4145
27375	1.1		Seizure		discontinuation			4151
27376	1.1		Myocardial infarction		discontinuation			4151
27377			Seizures		discontinuation	WARNINGS		4153
27378	0.5		Headache		discontinuation			4152
27379	0.5		Balance disorder		discontinuation			4152
27380	0.5		Dizziness		discontinuation			4152
27381	0.5		Confusional state		discontinuation			4152
27382			Mental state abnormal		discontinuation			4150
27383			Complex partial seizures		discontinuation			4149
27384			Confusion		discontinuation			4149
27385			Weakness		discontinuation	an MS patient who ingested 300 mg of 4-aminopyridine (dalfampridine) developed a condition that resembled limbic encephalitis		4148
27386			Consciousness decreased		discontinuation	an MS patient who ingested 300 mg of 4-aminopyridine (dalfampridine) developed a condition that resembled limbic encephalitis		4148
27387			Memory loss		discontinuation	an MS patient who ingested 300 mg of 4-aminopyridine (dalfampridine) developed a condition that resembled limbic encephalitis		4148
27388			Hypophonia		discontinuation	an MS patient who ingested 300 mg of 4-aminopyridine (dalfampridine) developed a condition that resembled limbic encephalitis		4148
27389			Structural brain disorders NEC		discontinuation	an MS patient who ingested 300 mg of 4-aminopyridine (dalfampridine) developed a condition that resembled limbic encephalitis		4148
27390						There were no deaths, no serious AEs, and no AEs leading to withdrawal during the study.		4155
27391						There were no deaths, no serious AEs, and no AEs leading to withdrawal during the study.		4154
27392	7.14		C-reactive protein increased		discontinuation	One subject		4159
27393	7.14		Alanine aminotransferase increase		discontinuation	One subject		4159
27394	7.14		Haematuria		discontinuation	One subject		4159
27395	7.14		Epistaxis		discontinuation	One subject		4159
27396	7.14		Haemorrhoidal haemorrhage		discontinuation	One subject		4159
27397			Spinal epidural hematoma		discontinuation	WARNINGS		4156
27398			Bleeding	grade 3-5	discontinuation	WARNINGS		4156
27399			Bleeding		discontinuation			4157
27400			Gastrointestinal disorder NOS		discontinuation	gastrointestinal events (i.e., dyspepsia, nausea, upper abdominal pain, gastrointestinal hemorrhage, and diarrhea)		4157
27401	0.07		Bleeding	grade 5	discontinuation	0.07% per year		4158
27402						No AEs were observed		4160
27403	1 pts		Nephrotoxicity					4161
27404						No AEs were observed		4164
27405						No AEs were observed		4163
27406						No AEs were observed		4162
27407	15 pts		Nausea	grade 1-2				4165
27408	13 pts		Diarrhoea	grade 1-2				4165
27409	1 pts		Rash	grade 1-2				4165
27410	1 pts		Lassitude	grade 1-2				4165
27411	10 pts		Nausea	grade 3				4165
27412	5 pts		Diarrhoea	grade 3				4165
27413	1 pts		Nausea	grade 4				4165
27414	1 pts		Diarrhoea	grade 4				4165
27415			Thromboembolic event	serious	discontinuation			4166
27416			Myocardial infarction	serious	discontinuation			4166
27417			Stroke	serious	discontinuation			4166
27418			Paralysis		discontinuation			4166
27419			Convulsions		discontinuation			4167
27420			Skin and subcutaneous conditions NEC	severe	discontinuation			4167
27421			Stevens-Johnson syndrome	severe	discontinuation			4168
27422			Toxic epidermal necrolysis	severe	discontinuation			4168
27423			Acute generalized exanthematous pustulosis	severe	discontinuation			4168
27424			Drug reaction with eosinophilia and systemic symptoms	severe	discontinuation			4168
27425			Leukopenia	grade 3-5	discontinuation	WARNING		4172
27426			Thrombocytopenia	grade 3-5	discontinuation	WARNING		4172
27427	sometimes		Anemia		discontinuation	WARNING		4172
27428			Hematopoiesis impaired		discontinuation	WARNING		4172
27429	0.01		Hepatotoxicity	grade 3-5	discontinuation	WARNING		4172
27430	0.01		Hepatic vein thrombosis	grade 3-5	discontinuation	WARNING		4172
27431	0.01		Necrosis hepatocellular	grade 3-5	discontinuation	WARNING		4172
27432			Anaphylaxis		discontinuation	WARNING		4172
27433	6.25		Thrombocytopenia	grade 2			TRUE	4171
27434	6.25		Thrombocytopenia	grade 1	discontinuation	patient required 1 week delay of cycle 6		4171
27435	33		Cerebral ischemia	grade 4	discontinuation			4169
27436	2.2		Neutropenia	grade 4				4170
27437	2.2		Fatigue	grade 4				4170
27438			Anemia	mild	discontinuation	WARNING		4173
27439			Leukopenia	grade 3-5	discontinuation	WARNING		4173
27440			Thrombocytopenia	grade 3-5	discontinuation	WARNING		4173
27441			Hepatotoxicity	grade 3-5	discontinuation	WARNING		4173
27442			Hepatic vein thrombosis	grade 3-5	discontinuation	WARNING		4173
27443			Renal failure			Overdosage		4178
27444			Respiratory distress syndrome	grade 5		Overdosage		4175
27445	16.7		Neurological decompensation					4174
27446	33.3		Hemorrhage intracerebral					4174
27447	33.3		Aspiration pneumonia				TRUE	4174
27448	16.7		Hypotension					4174
27449	16.7		Haematuria					4174
27450	16.7		Hyperglycaemia	grade 1				4174
27451	16.7		Vomiting	grade 1				4174
27452	16.7		Fatigue	grade 1				4174
27453	16.7		Injection site phlebitis	grade 1				4174
27454	16.7		Infection	grade 1				4174
27455	33.3		Urinary tract infection	grade 1				4174
27456	16.7		Blood pressure decreased	grade 1				4174
27457	16.7		Hyponatraemia	grade 1				4174
27458	16.7		Agitation	grade 1				4174
27459	16.7		Convulsion	grade 1				4174
27460	16.7		Headache	grade 1				4174
27461	16.7		Lethargy	grade 1				4174
27462	16.7		Delirium	grade 1				4174
27463	16.7		Depression	grade 1				4174
27464	33.3		Respiratory failure	grade 1				4174
27465	16.7		Rash	grade 1				4174
27466	16.7		Skin irritation	grade 1				4174
27467	16.7		Deep vein thrombosis	grade 1				4174
27468	16.7		Hypotension	grade 1				4174
27469			Visual disturbances		discontinuation			4176
27470			Lethargy				TRUE	4177
27471			Dizziness				TRUE	4177
27472			Blurred vision				TRUE	4177
27473			Leg cramps				TRUE	4177
27474	67		Thrombocytopenia	grade 4	discontinuation		TRUE	4179
27475	67		Leukopenia	grade 4	discontinuation		TRUE	4179
27476	100		Myelosuppression	grade 4	discontinuation		TRUE	4179
27477	33		Stomatitis	grade 3	discontinuation		TRUE	4179
27478			Soft tissue necrosis	severe	discontinuation	WARNING		4183
27479			Toxic myocarditis	severe	discontinuation	WARNING		4182
27480			Congestive heart failure	grade 3-5	discontinuation	WARNING		4182
27481			Acute promyelocytic leukemia		discontinuation	WARNING		4182
27482			Myelosuppression	severe	discontinuation	WARNING		4182
27483			Leukopenia		discontinuation	WARNING	TRUE	4182
27484			Neutropenia		discontinuation	WARNING	TRUE	4182
27485			Hyperuricemia		discontinuation	WARNING		4182
27486			Thrombophlebitis		discontinuation	WARNING		4182
27487			Thromboembolic event		discontinuation	WARNING		4182
27488			Pulmonary embolism		discontinuation	WARNING		4182
27489			Aplasia bone marrow		discontinuation			4181
27490			Mucositis	grade 4	discontinuation			4181
27491			Gastrointestinal bleeding		discontinuation			4181
27492			Hyperthermia		discontinuation	patient died		4180
27493			Multiple organ failure		discontinuation	patient died		4180
27494			Lactic acidosis		discontinuation	patient died		4180
27495			Lactate dehydrogenase increased		discontinuation	patient died		4180
27496			Anuria		discontinuation	patient died		4180
27497	75		Contact dermatitis		discontinuation	adverse effects of mechlorethamine comprised pruritus (16 patients), erythema (14), oedema (eight) and vesiculation (five)		4185
27498	3.8		Thrombocytopenia	severe	discontinuation	patient died from generalized hemorrhage due to severe thrombocytopenia		4186
27499	3.8		Hemorrhage		discontinuation	patient died from generalized hemorrhage due to severe thrombocytopenia		4186
27500	5.6		Pancytopenia		discontinuation	patient died		4187
27501			Amyloidosis		discontinuation	WARNING		4188
27502			Mucosal disorder		discontinuation	WARNING. May be severe		4184
27503			Eye injury		discontinuation	WARNING. May be severe. Eye injury may lead to blindness.		4184
27504			Dermatitis		discontinuation	WARNING		4184
27505			Cancer of skin (excl melanoma)		discontinuation	WARNING		4184
27506			Disorder fetal		discontinuation	WARNING		4184
27507	3 pts		Allergic rash		discontinuation			4191
27508	1 pts		Thrombocytopenia	mild	dose reduction	mild thrombocytopenia at 1,750 mg/d Resolved on 1,000 mg/d		4190
27509						No SAEs were observed		4189
27510	<6.7		Nausea		discontinuation	leads to discontinuation		4192
27511	<6.7		Rash		discontinuation	leads to discontinuation		4192
27512	<6.7		Dizziness		discontinuation	leads to discontinuation		4192
27513						No SAEs were observed		4193
27514	1 pts		Pneumocystis carinii pneumonia	grade 5		complication of bendamustine monotherapy		4196
27515	2		Hypersensitivity		discontinuation	leads to discontinuation		4195
27516	1		Pyrexia		discontinuation	leads to discontinuation		4195
27517	1 pts		QT interval prolonged				TRUE	4194
27518	1 pts		Sinus tachycardia				TRUE	4194
27519	2 pts		ECG Nonspecific ST-T change				TRUE	4194
27520	1 pts		Left anterior fascicular block				TRUE	4194
27521			Vaginal pain or burning		discontinuation			4197
27522			Abdominal pain		discontinuation			4197
27523			Pelvic pain		discontinuation			4197
27524			Cramp		discontinuation			4197
27525						impossible to link AEs with the definite dose: the full text of the article is unavailable		4198
27526	2 pts		Thrombocytopenia					4200
27527						impossible to link AEs with the definite dose		4201
27528						No AEs are reported		4199
27529						No AEs were observed		4203
27530						No AEs were observed		4202
27531	1 pts		Abdominal pain	mild		Therapy was very well tolerated, and there were no withdrawals from treatment.		4204
27532	1 pts		Vomiting	mild		Therapy was very well tolerated, and there were no withdrawals from treatment.		4204
27533	1 pts		Death	serious				4205
27534	1 pts		Potassium	serious				4205
27535	2 pts		Fever	below serious				4205
27536	4 pts		Carbon dioxide	below serious				4205
27537	2 pts		Sodium	below serious				4205
27538	12 pts		Absolute neutrophil count	below serious				4205
27539	3 pts		SGOT	below serious				4205
27540	1 pts		Flu-like symptoms		discontinuation	leads to discontinuation		4206
27541	1 pts		Malaise		discontinuation	leads to discontinuation		4206
27542	1 pts		Arthralgia		discontinuation	leads to discontinuation		4206
27543	1 pts		Polyarteritis nodosa		discontinuation	leads to discontinuation		4206
27544						No AEs were reported		4207
27545	23		Headache					4208
27546	9		Fatigue					4208
27547	9		Dizziness					4208
27548	5		Pruritus					4208
27549	4		Malaise					4208
27550	3		Mood alteration NOS					4208
27551	2		Somnolence					4208
27552	2		Urticaria					4208
27553	2		Tinnitus					4208
27554	1		Arthralgia					4208
27555	1		Vertigo					4208
27556	1		Dry mouth					4208
27557	1		Myalgia					4208
27558	100		Neurotoxicity				TRUE	4216
27559	50		Neurotoxicity				TRUE	4212
27560	64		Neurotoxicity				TRUE	4213
27561	71		Neurotoxicity				TRUE	4215
27562	1 pts		Lhermitte's sign		discontinuation	leads to discontinuation		4210
27563	1 pts		Thrombocytopenia		discontinuation	leads to discontinuation		4217
27564	1 pts		Hypersensitivity reaction		discontinuation	leads to discontinuation		4211
27565	1 pts		Diarrhoea	grade 3	discontinuation	leads to discontinuation		4214
27566	1 pts		Peripheral sensory neuropathy		discontinuation	leads to discontinuation		4218
27567	1 pts		Peripheral sensory neuropathy		discontinuation	leads to discontinuation		4219
27568	1 pts		Peripheral sensory neuropathy		discontinuation	leads to discontinuation		4220
27569			Anaphylactic reaction			WARNING		4209
27570	1 pts		Eye allergy		discontinuation	leads to discontinuation		4221
27571	4 pts		Hematocrit decreased		discontinuation	leads to discontinuation		4223
27572	3 pts		Malaise					4225
27573	1 pts		Headache					4225
27574	2 pts		Nausea					4225
27575	1 pts		Pyrexia					4225
27576	1 pts		Vomiting					4225
27577	2 pts		Myalgia					4225
27578	4 pts		Malaise			primaquine sustained release		4224
27579	2 pts		Headache			primaquine sustained release		4224
27580	1 pts		Nausea			primaquine sustained release		4224
27581	3 pts		Decreased appetite			primaquine sustained release		4224
27582	1 pts		Pyrexia			primaquine sustained release		4224
27583	1 pts		Vomiting			primaquine sustained release		4224
27584	1 pts		Dizziness			primaquine sustained release		4224
27585	1 pts		Asthenia			primaquine sustained release		4224
27586	1 pts		Arthralgia			primaquine sustained release		4224
27587	1 pts		Muscle spasms			primaquine sustained release		4224
27588	1 pts		Dyspnoea exertional			primaquine sustained release		4224
27589	1 pts		Diarrhoea			primaquine sustained release		4224
27590	1 pts		Malaise			primaquine sustained release		4222
27591	2 pts		Headache			primaquine sustained release		4222
27592	1 pts		Nausea			primaquine sustained release		4222
27593	1 pts		Pyrexia			primaquine sustained release		4222
27594	1 pts		Vomiting			primaquine sustained release		4222
27595	1 pts		Dizziness			primaquine sustained release		4222
27596	1 pts		Asthenia			primaquine sustained release		4222
27597	1 pts		Pruritus			primaquine sustained release		4222
27598	1 pts		Haemoglobin decreased			primaquine sustained release		4222
27599	1 pts		Dyspepsia			primaquine sustained release		4222
27600	3		Nausea	grade 3-4		11 PCB patients dropped out, but AEs leading to discontinuation are not specified. The incidence of grade 3 or 4 treatment-related AEs was 25%.		4226
27601	5		Vomiting	grade 3-4		11 PCB patients dropped out, but AEs leading to discontinuation are not specified. The incidence of grade 3 or 4 treatment-related AEs was 25%.		4226
27602	2		Fatigue	grade 3-4		11 PCB patients dropped out, but AEs leading to discontinuation are not specified. The incidence of grade 3 or 4 treatment-related AEs was 25%.		4226
27603	1		Constipation	grade 3-4		11 PCB patients dropped out, but AEs leading to discontinuation are not specified. The incidence of grade 3 or 4 treatment-related AEs was 25%.		4226
27604	2		Anorexia	grade 3-4		11 PCB patients dropped out, but AEs leading to discontinuation are not specified. The incidence of grade 3 or 4 treatment-related AEs was 25%.		4226
27605	2		Headache	grade 3-4		11 PCB patients dropped out, but AEs leading to discontinuation are not specified. The incidence of grade 3 or 4 treatment-related AEs was 25%.		4226
27606	1		Rash	grade 3-4		11 PCB patients dropped out, but AEs leading to discontinuation are not specified. The incidence of grade 3 or 4 treatment-related AEs was 25%.		4226
27607	4		Thrombocytopenia	grade 3-4		11 PCB patients dropped out, but AEs leading to discontinuation are not specified. The incidence of grade 3 or 4 treatment-related AEs was 25%.		4226
27608	3		Neutropenia	grade 3-4		11 PCB patients dropped out, but AEs leading to discontinuation are not specified. The incidence of grade 3 or 4 treatment-related AEs was 25%.		4226
27609	2		Anemia	grade 3-4		11 PCB patients dropped out, but AEs leading to discontinuation are not specified. The incidence of grade 3 or 4 treatment-related AEs was 25%.		4226
27610	1		Diarrhea	grade 3-4		11 PCB patients dropped out, but AEs leading to discontinuation are not specified. The incidence of grade 3 or 4 treatment-related AEs was 25%.		4226
27611			Skin irritation		discontinuation			4227
27612			Contact dermatitis		discontinuation			4227
27613			Pruritus		discontinuation			4227
27614			Bladder discomfort					4228
27615			Restlessness					4228
27616			Muscle cramps					4228
27617			Dehydration					4228
27618	84		Weakness generalised			Day 3 after start of treatment		4230
27619	58		Dizziness			Day 3 after start of treatment		4230
27620	46		Vomiting			Day 3 after start of treatment		4230
27621	32		Itching			Day 3 after start of treatment		4230
27622	26		Nausea			Day 3 after start of treatment		4230
27623	14		Leucopenia	grade 1				4234
27624	14		Neutropenia	grade 1				4234
27625	12		Neutropenia	grade 2				4235
27626	12		Transaminitis	grade 3				4236
27627	6.7		Hypersensitivity reaction		discontinuation			4233
27628			Agranulocytosis					4232
27629			Hepatotoxicity					4231
27630	35		Nausea					4229
27631	35		Vomiting					4229
27632	60		Lassitude	grade 2				4229
27633	15		Diarrhoea					4229
27634	10		Constipation					4229
27635	15		Granulocytopenia					4229
27636			Swollen tongue		discontinuation			4237
27637			Oral mucosa pain		discontinuation			4237
27638			Keratoconjunctivitis			POISONING		4238
27639	1 pts		Anxiety	serious				4239
27640	49 pts		Headache	below serious				4239
27641	26 pts		Upper respiratory tract infection	below serious				4239
27642	29 pts		Myalgia	below serious				4239
27643	29 pts		Coughing	below serious				4239
27644	14 pts		Injury	below serious				4239
27645	14 pts		Pharyngitis	below serious				4239
27646	14 pts		Gastroenteritis	below serious				4239
27647	14 pts		Dizziness	below serious				4239
27648	10 pts		Arthralgia	below serious				4239
27649	11 pts		Viral infection	below serious				4239
27650						No adverse reactions leading to discontinuation were reported		4240
27651			Electrocardiogram QTc interval prolonged			WARNINGS. Halofantrine should not be administered with Lariam or within 15 weeks of the last dose of Lariam due to the risk of a potentially fatal prolongation of the QTc interval		4242
27652			Electrocardiogram QTc interval prolonged			WARNINGS. Ketoconazole should not be administered with Lariam or within 15 weeks of the last dose of Lariam due to the risk of a potentially fatal prolongation of the QTc interval.		4243
27653			Anxiety		discontinuation	WARNINGS		4245
27654			Paranoia		discontinuation	WARNINGS		4245
27655			Depression		discontinuation	WARNINGS		4245
27656			Hallucinations		discontinuation	WARNINGS		4245
27657			Psychotic behavior		discontinuation	WARNINGS		4245
27658			Electrocardiogram abnormal		discontinuation	WARNINGS. Concomitant administration of Lariam and quinine or quinidine may produce electrocardiographic abnormalities		4244
27659			Electrocardiogram abnormal		discontinuation	WARNINGS. Concomitant administration of Lariam and quinine or quinidine may produce electrocardiographic abnormalities		4241
27660	3 pts		Gastrointestinal disorders		discontinuation	leads to discontinuation		4246
27661	10.6		Proteinuria		discontinuation			4247
27662			Rash		discontinuation			4247
27663	1.5		Myasthenia gravis		discontinuation			4247
27664			Thrombocytopenia		discontinuation			4247
27665			Flu-like illness		discontinuation			4247
27666			Stomatitis		discontinuation			4247
27667	5		Leukopenia		discontinuation	WARNING		4248
27668	5		Thrombocytopenia		discontinuation	WARNING		4248
27669			Proteinuria		discontinuation	WARNING		4248
27670			Hematuria		discontinuation	WARNING		4248
27671			Glomerulonephritis membranous		discontinuation	WARNING		4248
27672			Nephrotic syndrome		discontinuation	WARNING		4248
27673	rare		Goodpasture's syndrome		discontinuation	WARNING		4248
27674	rare		Obliterative bronchiolitis		discontinuation	WARNING		4248
27675			Myasthenia gravis		discontinuation	WARNING		4248
27676			Pemphigus vulgaris		discontinuation	WARNING		4248
27677			Pemphigus foliaceus		discontinuation	WARNING		4248
27678	3.4		Bronchospasm					4249
27679	1.6		Tachycardia					4249
27680	1.1		Injection site reaction					4249
27681	0.9		Hypotension					4249
27682	0.6		Airway peak pressure increased					4249
27683	0.5		Erythematous rash					4249
27684	<0.1		Hypertension					4249
27685	<0.1		Fever					4249
27686	<0.1		Nausea and vomiting					4249
27687			Hypomagnesemia					4251
27688			Hypocalcemia					4251
27689			Hypokalemia					4251
27690			Hypocalcemia					4250
27691			Hypokalemia					4250
27692			Nausea	grade 1	discontinuation	1 patient had his dosing discontinued because of drug-related adverse events (mild nausea, vomiting, and pharyngitis and moderate pruritus)		4253
27693			Vomiting	grade 1	discontinuation	1 patient had his dosing discontinued because of drug-related adverse events (mild nausea, vomiting, and pharyngitis and moderate pruritus)		4253
27694			Pharyngitis	grade 1	discontinuation	1 patient had his dosing discontinued because of drug-related adverse events (mild nausea, vomiting, and pharyngitis and moderate pruritus)		4253
27695			Pruritus	grade 2	discontinuation	1 patient had his dosing discontinued because of drug-related adverse events (mild nausea, vomiting, and pharyngitis and moderate pruritus)		4253
27696	0.18		Nausea	grade 3	discontinuation	1 patient had his dosing discontinued because of drug-related adverse events (severe nausea and vomiting)		4253
27697	0.18		Vomiting	grade 3	discontinuation	1 patient had his dosing discontinued because of drug-related adverse events (severe nausea and vomiting)		4253
27698	rare		Hypersensitivity reaction					4252
27699	rare		Urticaria					4252
27700	rare		Anaphylactoid reaction					4252
27701						No AEs are reported		4254
27702						AEs were not observed		4256
27703	33		ALT increased					4255
27704	16.7		Fever	grade 4				4259
27705	33.3		Neutropenia	grade 4				4259
27706	33.3		Neutropenia	grade 4				4258
27707	16.7		Thrombocytopenia	grade 4				4258
27708	33		Neutropenia	grade 4				4260
27709	80		Neutropenia	grade 4	dose reduction			4261
27710	13		Thrombocytopenia	grade 3				4257
27711	19		Dehydration	grade 3				4257
27712	31		Intestinal obstruction	grade 3				4257
27713	19		Fatigue	grade 3-4				4257
27714	50		Neutropenia	grade 3-4				4257
27715	25		Nausea	grade 3				4257
27716	50		Leukopenia	grade 3-4				4257
27717	6		Neutropenic fever	grade 3				4257
27718	25		Anemia	grade 3				4257
27719	19		Vomiting	grade 3				4257
27720			Sedation			Every subject noted central effects from the dose of chlorbutol. The effects were variously described as sedation, light-headedness and euphoria and lasted from approximately 0.25 to 2 h after dosage.		4262
27721			Light headedness			Every subject noted central effects from the dose of chlorbutol. The effects were variously described as sedation, light-headedness and euphoria and lasted from approximately 0.25 to 2 h after dosage.		4262
27722			Euphoria			Every subject noted central effects from the dose of chlorbutol. The effects were variously described as sedation, light-headedness and euphoria and lasted from approximately 0.25 to 2 h after dosage.		4262
27723						No adverse effects leading to discontinuation were reported.		4263
27724	3 pts		Nausea					4264
27725	2 pts		Dizziness					4264
27726	37.5		Contact dermatitis					4265
27727						No adverse events were reported		4268
27728						No adverse effects were reported		4267
27729	1 pts		Asthma					4266
27730						No serious adverse effects were recorded.		4269
27731			Psychosis		discontinuation			4270
27732			Auditory hallucinations		discontinuation			4270
27733			Persecutory delusion		discontinuation			4270
27734			Dissociative states		discontinuation			4270
27735			Edema					4272
27736			Cardiac arrhythmia					4271
27737			Allergic contact dermatitis					4273
27738						No adverse effects leading to discontinuation were reported.		4274
27739			Syncopal attack		discontinuation			4275
27740			Hypertension		discontinuation			4277
27741			Bradycardia		discontinuation			4277
27742			Mental confusion		discontinuation			4277
27743			Stupor		discontinuation			4277
27744			Fatigue		discontinuation			4276
27745			Tremor		discontinuation			4276
27746			Lethargy		discontinuation			4276
27747			Vision blurred		discontinuation			4276
27748			Salivation		discontinuation			4276
27749			Chills		discontinuation			4276
27750						No AEs were observed		4279
27751						No AEs were observed		4278
27752	17		Fever					4280
27753	3		Somnolence					4280
27754	12		Headache					4280
27755	8		Hypertension					4280
27756	15.6		Somnolence		discontinuation	leads to discontinuation		4280
27757	53		Somnolence					4280
27758	7		Coughing					4280
27759	7		Yawning					4280
27760	19		Rhinitis					4280
27761	5		Sputum increased					4280
27762	5		Agitation					4280
27763	7.1		Faintness					4282
27764	7.1		Vomiting					4282
27765	14.2		Dizziness					4282
27766	1.7		Anorexia	grade 2				4281
27767	3.3		Headache	grade 1-2				4281
27768	1.7		Palpitation	grade 2				4281
27769	1.7		Alopecia	grade 1				4281
27770	3.3		Cystitis	grade 2				4281
27771	1.7		Menorrhagia	grade 2				4281
27772	1.7		Diarrhoea	grade 1				4281
27773			Vomiting		discontinuation			4283
27774			Diarrhea		discontinuation			4283
27775			Nausea					4283
27776			Epileptic seizure		discontinuation			4285
27777			Allergic contact dermatitis		discontinuation			4284
27778						AEs were not observed		4286
27779	2.2		Angioedema		discontinuation			4287
27780	2.2		Urticaria		discontinuation			4287
27781						No drug-related side effects were observed.		4289
27782			Pain burning		dose reduction			4288
27783			Stinging		dose reduction			4288
27784	3 pts		Liver injury	grade 1				4290
27785	1 pts		Insomnia					4290
27786	2 pts		Gingivitis					4290
27787						No AEs were observed		4291
27788						Carumonam was well tolerated by the volunteers.		4292
27789						No adverse effects leading to discontinuation were reported.		4293
27790						AEs were not observed		4294
27791	2		Blood eosinophils increased	grade 1-2				4295
27792	1		Epigastric pain	grade 1-2				4295
27793	5		Eosinophilia	grade 1-2				4295
27794	1		Transaminases increased	grade 1-2				4295
27795	1		Blood urea nitrogen increased	grade 1-2				4295
27796	1		Amylase increased	grade 1-2				4295
27797	1		Alkaline phosphatase increased	grade 1-2				4295
27798	1 pts		Facial flushing					4296
27799	1 pts		Dizziness					4296
27800	1 pts		Urticaria					4297
27801	1 pts		Hemoglobin decreased					4297
27802	1 pts		Leukocyte count decreased					4297
27803						Flutropium bromide did not cause significantly more side effects than placebo.		4298
27804	15 pts		Diarrhea		discontinuation		TRUE	4300
27805	4 pts		Gastrointestinal symptom NOS	severe	discontinuation		TRUE	4300
27806						No AEs reported		4299
27807	9		Upper respiratory tract infection					4302
27808	8		Flatulence					4302
27809	1		Flatulence		discontinuation			4302
27810	4		Diarrhea					4302
27811	1		Diarrhea		discontinuation			4302
27812	4		Blood creatine phosphokinase increased					4302
27813	1		Blood creatine phosphokinase increased		discontinuation			4302
27814	3		Abdominal distension					4302
27815	3		Increased blood pressure					4302
27816	1		Increased blood pressure		discontinuation			4302
27817	1		Diarrhea	grade 3				4302
27818	5		Urinary tract infection					4301
27819	3		Abdominal pain					4301
27820			Hypersensitivity reaction					4301
27821			Rash					4301
27822			Pruritus					4301
27823			Respiratory arrest		discontinuation			4304
27824						No serious adverse effects were recorded.		4303
27825	16.7		Thrombocytopenia	grade 4			TRUE	4306
27826	33.3		Leukopenia	grade 4			TRUE	4306
27827	33.3		Thrombocytopenia	grade 4			TRUE	4307
27828	33.3		Neutropenia	grade 4			TRUE	4307
27829						No adverse effects leading to discontinuation were reported; no DLTs		4308
27830	25		Febrile neutropenia	grade 3			TRUE	4305
27831	25		Neutropenia	grade 4			TRUE	4305
27832			Sweating		discontinuation			4312
27833			Drowsiness		discontinuation			4312
27834			Hyperreflexia		discontinuation			4312
27835			Tachycardia		discontinuation			4312
27836			Convulsions grand mal		discontinuation			4312
27837			Seizures	grade 5	discontinuation			4311
27838			Cardio-respiratory arrest	grade 5	discontinuation			4311
27839						No adverse effects leading to discontinuation were reported.		4310
27840						None of the subjects under study required discontinuation because of undesirable effects		4309
27841						No adverse effects leading to discontinuation were reported.		4313
27842	4.2		Myelosuppression		discontinuation			4318
27843						No adverse effects leading to discontinuation were reported.		4314
27844						No adverse effects leading to discontinuation were reported.		4315
27845	16.7		Neutropenia	grade 3			TRUE	4316
27846	33.3		Thrombocytopenia	grade 3			TRUE	4317
27847	66.7		Neutropenia	grade 3			TRUE	4317
27848						No SAEs were observed		4320
27849			Dermatitis		discontinuation			4319
27850			Throbbing headache		discontinuation			4319
27851			Hypersensitivity reaction		discontinuation			4319
27852						No SAEs were observed		4321
27853						No adverse effects leading to discontinuation were reported.		4322
27854						No adverse effects were recorded.		4324
27855			Nephritis interstitial		discontinuation			4323
27856			Convulsion		discontinuation			4323
27857			Anaphylactoid shock		discontinuation			4323
27858			Liver disorder		discontinuation			4323
27859			Toxic epidermal necrolysis		discontinuation			4323
27860			Consciousness abnormal		discontinuation			4323
27861			Acute renal failure		discontinuation			4323
27862			Oculomucocutaneous syndrome		discontinuation			4323
27863	2.4		Vomiting		discontinuation			4325
27864	15		Tiredness	grade 1				4325
27865	15		Sensation of cold	grade 1				4325
27866	15		Sensation of heat	grade 1				4325
27867						No adverse effects leading to discontinuation were reported.		4327
27868						No adverse reactions were reported during tulobuterol treatment.		4328
27869			Anaphylaxis		discontinuation			4329
27870			Serum potassium decreased		discontinuation			4329
27871			Serum potassium decreased		discontinuation			4326
27872	20		Difficulty voiding					4330
27873			Cholinergic crisis	grade 5				4332
27874			Psychotic disorder		discontinuation			4334
27875			Rhabdomyolysis		discontinuation			4331
27876			Parkinsonism		discontinuation			4333
27877	6.5		Diarrhoea		discontinuation			4335
27878	33.3		Neutropenia	grade 4			TRUE	4337
27879	33.3		Neutropenia	grade 3			TRUE	4337
27880	16.7		Thrombocytopenia	grade 4	dose reduction		TRUE	4338
27881	33.3		Neutropenia	grade 4	dose reduction		TRUE	4338
27882	100		Myelosuppression	grade 4	discontinuation		TRUE	4336
27883						No AEs were observed		4339
27884	13.1		Tiredness					4343
27885	10.7		Nausea					4343
27886	1.2		Headache					4343
27887	1.2		Vomiting					4343
27888	5.9		Mental confusion					4343
27889	1.2		Palpitation					4343
27890	1.2		Faintness					4343
27891	1.2		Loss of memory					4343
27892	1.2		Urticaria					4343
27893	1.2		Vertigo					4343
27894	5.5		Vomiting					4341
27895			Agranulocytosis					4340
27896			Contact urticaria					4342
27897	44		Marrow hypoplasia					4345
27898	37		Thrombocytopenia					4345
27899	37		Parotid pain					4345
27900	16		Dizziness					4345
27901	14.3		SGOT increased					4345
27902	27		Leukopenia					4345
27903	33.3		SGPT increased					4345
27904	19		Alkaline phosphatase increased					4345
27905			Thrombocytopenia					4344
27906			Orthostatic hypotension					4344
27907			Jaw pain					4344
27908						No AEs were reported		4346
27909						The source does not contain information about AEs or lack thereof		4347
27910						The source does not contain information about AEs or lack thereof		4348
27911	1 pts		Urticaria					4349
27912						No AEs were observed		4350
27913						No AEs were observed		4351
27914						No AEs were observed		4352
27915						No AEs were observed		4353
27916	18.8		Skin rash					4354
27917	12.5		Tachycardia					4354
27918	6.25		Drowsiness					4354
27919	6.25		Facial flushing					4354
27920			Parkinson's syndrome		discontinuation			4357
27921			Diarrhea					4355
27922			Extrapyramidal symptoms					4355
27923			Somnolence	grade 1-2				4355
27924			Dystonic reaction		discontinuation			4358
27925			Dyskinesia		discontinuation			4356
27926						The source does not contain information about AEs or lack thereof		4360
27927			Congestive cardiomyopathy		discontinuation			4359
27928						No adverse effects leading to discontinuation were reported.		4361
27929						No adverse reactions were reported		4362
27930						The source does not contain information about AEs or lack thereof		4364
27931						The source does not contain information about AEs or lack thereof		4365
27932						AEs were not observed		4363
27933	14.3		Nausea	grade 3				4367
27934	14.3		Dehydration	grade 3				4367
27935			Creatinine increased	grade 1-2				4367
27936	14.3		Dry mouth	grade 1				4367
27937			Headache					4366
27938			Constipation					4366
27939			Fatigue					4366
27940			Anorexia					4366
27941			Abdominal pain					4366
27942	11 pts		Cheilitis	grade 1-2				4368
27943	6 pts		Epistaxis	grade 1-2				4368
27944	4 pts		Skin fragility	grade 1-2				4368
27945	7 pts		Hair loss	grade 1-2				4368
27946	7 pts		Pruritus	grade 1-2				4368
27947	9 pts		Xerosis	grade 1-2				4368
27948	11 pts		Cheilitis	grade 3				4368
27949	1 pts		Skin fragility	grade 3				4368
27950	1 pts		Hair loss	grade 3				4368
27951	8 pts		Pruritus	grade 3				4368
27952	6 pts		Xerosis	grade 3				4368
27953	3 pts		Pruritus	grade 4				4368
27954	1 pts		Xerosis	grade 4				4368
27955	2 pts		Diarrhoea					4368
27956	2 pts		Fatigue					4368
27957	2 pts		Headache					4368
27958	1 pts		Musculoskeletal pain					4368
27959	1 pts		Arthralgia					4368
27960	4 pts		Rash					4368
27961	4 pts		Skin disorder					4368
27962	2 pts		Cheilitis	grade 1-2				4374
27963	3 pts		Xerosis	grade 1-2				4374
27964	6 pts		Pruritus	grade 1-2				4374
27965	2 pts		Epistaxis	grade 1-2				4374
27966	2 pts		Skin fragility	grade 1-2				4374
27967	1 pts		Hair loss	grade 1-2				4374
27968	2 pts		Cheilitis	grade 1-2				4374
27969	1 pts		Xerosis	grade 3				4374
27970	2 pts		Cheilitis	grade 4				4374
27971	3 pts		Rash					4369
27972	2 pts		Dry skin					4369
27973	2 pts		Anorexia					4369
27974	1 pts		Vomiting					4369
27975	1 pts		Postural hypotension					4369
27976	1 pts		Alopecia					4369
27977	1 pts		Melena					4369
27978	1 pts		Pain					4369
27979	1 pts		Nausea				TRUE	4372
27980	1 pts		Vomiting				TRUE	4372
27981	1 pts		Alk phos				TRUE	4373
27982	1 pts		SGPT increased				TRUE	4373
27983	1 pts		SGOT increased				TRUE	4373
27984	1 pts		Rash				TRUE	4371
27985	2 pts		Rash				TRUE	4370
27986	1 pts		Lethargy				TRUE	4370
27987	1 pts		Fatigue				TRUE	4370
27988	1 pts		Malaise				TRUE	4370
27989	1 pts		Leg cramps				TRUE	4370
27990	1 pts		Paresthesia				TRUE	4370
27991	13.3		Heartburn					4375
27992	13.3		Nausea					4375
27993	521 pts		Death fetal		discontinuation	leads to discontinuation		4376
27994	3 pts		Drowsiness					4377
27995	4.3		Taste loss		discontinuation			4379
27996	4.3		Myocardial infarction		discontinuation			4379
27997	3.3		Nausea		discontinuation			4378
27998	3.3		Vomiting		discontinuation			4378
27999						No adverse effects leading to discontinuation were reported.		4380
28000						No adverse effects leading to discontinuation were reported.		4381
28001						There were no serious adverse effects		4382
28002			Cholestatic hepatitis	grade 3	discontinuation			4384
28003						The source does not contain information about AEs or lack thereof		4383
28004	29		Visual disturbance	grade 1-2				4385
28005	14		Paralytic ileus		discontinuation			4385
28006	71		Tremor		discontinuation	one patient discontinued		4385
28007	57		Balance impaired NOS	grade 1-2				4385
28008	14		Dysuria	grade 1				4385
28009	57		Vertigo	grade 1				4385
28010						The source does not contain information about AEs or lack thereof		4386
28011			QT prolonged					4387
28012			Eosinophilic pustular folliculitis		discontinuation			4389
28013						AEs were not observed		4388
28014						There were no adverse events reported.		4390
28015						No drug-related adverse effects leading to discontinuation were reported.		4391
28016						No adverse effects leading to discontinuation were reported.		4392
28017			Death	grade 5	discontinuation	Malignant syndrome		4393
28018	2 pts		Nausea		discontinuation	leads to discontinuation		4394
28019	1 pts		Soreness breast		discontinuation	leads to discontinuation		4394
28020	1 pts		Bleeding menstrual heavy		discontinuation	leads to discontinuation		4394
28021						impossible to link AEs with the definite dose		4395
28022						No AEs were reported		4396
28023			Seizures					4397
28024			Loss of consciousness		dose interruption			4397
28025			Convulsion		discontinuation			4398
28026			Loss of consciousness					4398
28027						No adverse effects requiring discontinuation are mentioned.		4399
28028	33.3		Febrile neutropenia	grade 4			TRUE	4400
28029			Stomatitis	grade 3				4400
28030			Neutropenia	grade 3				4400
28031			Atrioventricular block					4403
28032			Hypotension	grade 3				4402
28033			Bronchospasm	grade 3				4402
28034			Urticaria	grade 3				4402
28035			Hypertension	grade 3				4401
28036			Contact urticaria		discontinuation			4404
28037						No adverse effects leading to discontinuation were reported.		4405
28038						No adverse effects leading to discontinuation were reported.		4406
28039			Vision decreased		discontinuation			4407
28040			Photophobia		discontinuation			4407
28041			Photopsia		discontinuation			4407
28042						No adverse effects leading to discontinuation were reported.		4408
28043						No adverse effect was observed in the phloroglucinol group.		4410
28044						It is safe to mother and baby and does not cause adverse foetal or maternal outcomes.		4409
28045						Adverse effects leading to discontinuation were not specified.		4411
28046	very rare		Circulatory failure	grade 5	discontinuation			4413
28047	very rare		Respiratory failure	grade 5	discontinuation			4413
28048						No adverse reactions leading to discontinuation were reported		4412
28049	19 pts		Drowsiness	below serious				4417
28050	3 pts		Dizziness	below serious				4417
28051	10 pts		Adverse drug reaction NOS	below serious				4417
28052	1 pts		Swelling of legs	serious				4414
28053	47 pts		Constipation	below serious				4421
28054	12 pts		Dyspepsia	below serious				4421
28055	9 pts		Vomiting	below serious				4421
28056	58 pts		Fatigue	below serious				4421
28057	8 pts		Cholesterol high	below serious				4421
28058	15 pts		Anorexia	below serious				4421
28059	11 pts		Anxiety	below serious				4421
28060	26 pts		Insomnia	below serious				4421
28061	9 pts		Cough	below serious				4421
28062	20 pts		Dyspnea	below serious				4421
28063	1 pts		Incision site bleeding	below serious				4422
28064	2 pts		Body temperature decrease	below serious				4422
28065	1 pts		Shivering	below serious				4422
28066	1 pts		Tachycardia	below serious				4422
28067	1 pts		Transfusion	below serious				4422
28068	1 pts		Wound dehiscence	below serious				4418
28069	1 pts		Dizziness	below serious				4420
28070	1 pts		Constipation	below serious				4415
28071	10		Corneal erosion					4416
28072						No AEs are reported		4423
28073						AEs are impossible to identify; the full text of the article is unavailable		4419
28074						No deaths or withdrawals due to clinical adverse events occurred.		4426
28075	12		Nausea		discontinuation			4424
28076	6		Vomiting		discontinuation			4424
28077	3		Loose stools		discontinuation			4424
28078	2		Abdominal pain		discontinuation			4424
28079	2		Abdominal discomfort		discontinuation			4424
28080	3		Rash		discontinuation			4424
28081			Reaction skin	grade 3-4	discontinuation	WARNING		4425
28082			Stevens-Johnson syndrome	grade 3-4	discontinuation	WARNING		4425
28083	1 pts		Anaemia	serious				4430
28084	3 pts		Cardiac failure	serious				4430
28085	2 pts		Angina pectoris	serious				4430
28086	2 pts		Atrial fibrillation	serious				4430
28087	1 pts		Atrioventricular block complete	serious				4430
28088	1 pts		Myocardial ischaemia	serious				4430
28089	1 pts		Duodenal ulcer	serious				4430
28090	1 pts		Gastric ulcer haemorrhage	serious				4430
28091	1 pts		Intestinal haemorrhage	serious				4430
28092	1 pts		Pancreatitis acute	serious				4430
28093	2 pts		Ischaemic ulcer	serious				4430
28094	2 pts		Necrosis	serious				4430
28095	2 pts		Sudden death	serious				4430
28096	1 pts		Death	serious				4430
28097	1 pts		Healing impaired	serious				4430
28098	1 pts		Multi-organ failure	serious				4430
28099	1 pts		Pyrexia	serious				4430
28100	1 pts		Cholelithiasis	serious				4430
28101	14 pts		Gangrene	serious				4430
28102	3 pts		Bronchopneumonia	serious				4430
28103	3 pts		Pneumonia	serious				4430
28104	2 pts		Infected skin ulcer	serious				4430
28105	2 pts		Purulent discharge	serious				4430
28106	2 pts		Sepsis	serious				4430
28107	1 pts		Osteomyelitis	serious				4430
28108	1 pts		Postoperative wound infection	serious				4430
28109	1 pts		Wound infection staphylococcal	serious				4430
28110	1 pts		Limb traumatic amputation	serious				4430
28111	1 pts		Shunt thrombosis	serious				4430
28112	1 pts		Dehydration	serious				4430
28113	1 pts		Hyperkalaemia	serious				4430
28114	2 pts		Pain in extremity	serious				4430
28115	1 pts		Bursitis	serious				4430
28116	1 pts		Tenosynovitis	serious				4430
28117	1 pts		Hypopharyngeal cancer stage III	serious				4430
28118	1 pts		Lung neoplasm	serious				4430
28119	1 pts		Coma diabetic	serious				4430
28120	1 pts		Syncope	serious				4430
28121	1 pts		Hydrothorax	serious				4430
28122	1 pts		Pulmonary artery thrombosis	serious				4430
28123	2 pts		Dry gangrene	serious				4430
28124	1 pts		Necrosis skin	serious				4430
28125	11 pts		Peripheral ischaemia	serious				4430
28126	10 pts		Extremity necrosis	serious				4430
28127	6 pts		Necrosis ischaemic	serious				4430
28128	2 pts		Circulatory collapse	serious				4430
28129	1 pts		Arterial thrombosis limb	serious				4430
28130	1 pts		Hypertension	serious				4430
28131	1 pts		Hypertensive crisis	serious				4430
28132	1 pts		Venous thrombosis limb	serious				4430
28133	24 pts		Skin ulcer	below serious				4430
28134	1 pts		Nausea	below serious				4431
28135	1 pts		Fatigue	below serious				4431
28136	1 pts		Phlebitis	below serious				4431
28137			Apnoea			Overdosage		4427
28138			Bradycardia			Overdosage		4427
28139			Hypotension			Overdosage		4427
28140	0.7		Penile pain		discontinuation			4429
28141	1.1		Penile pain	grade 1-2	discontinuation			4428
28142	1.1		Dizziness	grade 2	discontinuation			4428
28143	1.1		Rash	grade 2	discontinuation			4428
28144	6 pts		Nausea	below serious				4443
28145	1 pts		Schizoaffective disorder	serious				4440
28146	5 pts		Diarrhoea	below serious				4440
28147	2 pts		Headache	below serious				4440
28148	1 pts		Supraventricular tachycardia	serious				4434
28149	2 pts		Gastroenteritis	serious				4434
28150	2 pts		Chest pain	serious				4434
28151	1 pts		Traumatic fracture	serious				4434
28152	1 pts		Depression	serious				4434
28153	3 pts		Severe hypoglycemia	below serious				4434
28154	13 pts		Diarrhea	below serious				4434
28155	1 pts		Vitamin B12 deficiency	below serious				4439
28156	1 pts		Vitamin D deficiency	below serious				4439
28157	1 pts		Cut wound	below serious				4439
28158	3 pts		Diarrhea	below serious				4435
28159	8 pts		Myocardial reinfarction	serious				4441
28160	1 pts		Death	serious				4441
28161	5 pts		Target lesion revascularization	serious				4441
28162	40 pts		Non-target vessel revascularisation	below serious				4441
28163	10 pts		CABG	below serious				4441
28164	23 pts		Chest pain	below serious				4441
28165	7 pts		Nausea	below serious				4442
28166	8 pts		Diarrhea	below serious				4442
28167	4 pts		Hypoglycemia	below serious				4442
28168	1 pts		Ischaemic heart disease	serious				4448
28169	2 pts		Epigastric pain	serious				4450
28170	1 pts		Amnesia	serious				4436
28171	6 pts		Abdominal pain	below serious				4436
28172	1 pts		Bloating	below serious				4436
28173	10 pts		Diarrhea	below serious				4436
28174	1 pts		Dysphagia	below serious				4436
28175	1 pts		Gastric ulcer	below serious				4436
28176	2 pts		Gastroesophageal reflux disease	below serious				4436
28177	1 pts		Gastrointestinal pain	below serious				4436
28178	5 pts		Nausea	below serious				4436
28179	1 pts		Oral pain	below serious				4436
28180	1 pts		Periodontal disease	below serious				4436
28181	1 pts		Stomach pain	below serious				4436
28182	3 pts		Fatigue	below serious				4436
28183	1 pts		Tooth infection	below serious				4436
28184	1 pts		Creatinine increased	below serious				4436
28185	1 pts		Weight loss	below serious				4436
28186	1 pts		Dehydration	below serious				4436
28187	1 pts		Metabolism and nutrition disorders	below serious				4436
28188	1 pts		Back pain	below serious				4436
28189	1 pts		Myositis	below serious				4436
28190	1 pts		Dysarthria	below serious				4436
28191	1 pts		Dysgeusia	below serious				4436
28192	3 pts		Headache	below serious				4436
28193	1 pts		Lethargy	below serious				4436
28194	1 pts		Other specified disorders of nervous system	below serious				4436
28195	1 pts		Agitation	below serious				4436
28196	2 pts		Insomnia	below serious				4436
28197	1 pts		Hematuria	below serious				4436
28198	1 pts		Surgical and medical procedures	below serious				4436
28199	1 pts		Hypertension	below serious				4436
28200	7 pts		Infections and infestations	serious				4437
28201	6 pts		Neoplasm	serious				4437
28202	1 pts		Cerebral haemorrhage	serious				4437
28203	1 pts		Coronary artery bypass graft	serious				4437
28204	1 pts		Sudden death	serious				4437
28205	1 pts		Angiogram	serious				4437
28206	1 pts		Circulatory collapse	serious				4437
28207	1 pts		Immune system disorder	serious				4437
28208	2 pts		Transient ischaemic attack	serious				4437
28209	88 pts		Gastrointestinal disorder	below serious				4437
28210	5 pts		Drug hypersensitivity	below serious				4437
28211	1 pts		Abdominal pain	below serious				4444
28212	1 pts		Pain of extremities	below serious				4444
28213	1 pts		Anemia	below serious				4444
28214	1 pts		Nausea	below serious				4445
28215	1 pts		Constipation	below serious				4445
28216	1 pts		Dizziness	below serious				4445
28217	1 pts		Back pain	below serious				4445
28218	1 pts		Abdominal pain	below serious				4445
28219	1 pts		Effusion pleural	below serious				4445
28220	1 pts		Stomach pain	below serious				4445
28221	1 pts		Bloating	below serious				4445
28222	1 pts		Pancreatitis	serious				4446
28223	2 pts		Transient ischemic attack	serious				4446
28224	5 pts		Prostatectomy	serious				4446
28225	1 pts		Abscess	serious				4446
28226	1 pts		Appendicitis	serious				4446
28227	1 pts		Bleeding rectal	serious				4446
28228	2 pts		Syncope	serious				4446
28229	1 pts		Acute kidney injury	serious				4446
28230	2 pts		Myocardial infarction	serious				4446
28231	4 pts		Chest pain	serious				4446
28232	3 pts		Upper respiratory infection	serious				4446
28233	1 pts		Craniotomy	serious				4446
28234	1 pts		Leukemia	serious				4446
28235	1 pts		Paraesophageal hiatal hernia	serious				4446
28236	1 pts		Benign brain neoplasm NOS	serious				4446
28237	1 pts		Esophageal repair	serious				4446
28238	1 pts		Head injury	serious				4446
28239	1 pts		Eye infection	serious				4446
28240	1 pts		Pain in hip	serious				4446
28241	1 pts		Melanoma	serious				4446
28242	1 pts		Diabetes	serious				4446
28243	1 pts		Detached retina	serious				4446
28244	2 pts		Gastrointestinal infection	serious				4446
28245	1 pts		Ankle fracture	serious				4446
28246	1 pts		Hypotension	serious				4446
28247	1 pts		Pneumonia	serious				4446
28248	7 pts		Nausea	below serious				4446
28249	26 pts		Diarrhea	below serious				4446
28250	8 pts		Fatigue	below serious				4446
28251	4 pts		Memory impaired	below serious				4446
28252	9 pts		Weight loss	below serious				4446
28253	10 pts		Gastrointestinal disorders NEC	below serious				4452
28254	3 pts		Abnormal feces	below serious				4451
28255	17 pts		Diarrhea	below serious				4451
28256	8 pts		Vomiting	below serious				4451
28257	6 pts		Fatigue	below serious				4451
28258	7 pts		Irritability	below serious				4451
28259	3 pts		Product taste abnormal	below serious				4451
28260	3 pts		Pyrexia	below serious				4451
28261	2 pts		Ear infection	below serious				4451
28262	3 pts		Gastroenteritis	below serious				4451
28263	2 pts		Otitis media	below serious				4451
28264	8 pts		Decreased appetite	below serious				4451
28265	2 pts		Pain in extremity	below serious				4451
28266	2 pts		Dizziness	below serious				4451
28267	5 pts		Aggression	below serious				4451
28268	4 pts		Anger	below serious				4451
28269	3 pts		Initial insomnia	below serious				4451
28270	2 pts		Middle insomnia	below serious				4451
28271	3 pts		Nasal congestion	below serious				4451
28272	4 pts		Rash	below serious				4451
28273	5 pts		Vomiting	below serious				4449
28274	19 pts		Nausea	below serious				4449
28275	33 pts		Anorexia	below serious				4449
28276	16 pts		Diarrhoea	below serious				4449
28277	4 pts		Headache	below serious				4449
28278	7 pts		Abdominal pain	below serious				4449
28279	11 pts		Transient loss of consciousness	below serious				4449
28280	1 pts		Cramps calf	below serious				4449
28281	1 pts		Hematoma	serious				4438
28282	1 pts		Nausea and vomiting	serious				4438
28283	1 pts		Urinary retention	serious				4438
28284	1 pts		Diarrhea	below serious				4447
28285	1 pts		Nausea	below serious				4447
28286	1 pts		Headache	below serious				4447
28287			Lactic acidosis	grade 5	discontinuation	WARNING		4433
28288	6		Diarrhea		discontinuation	leads to discontinuation		4432
28289			Renal impairment			WARNINGS		4456
28290			Acute renal failure		discontinuation	WARNINGS		4456
28291			Neutropenia			WARNINGS		4456
28292						No adverse reactions leading to discontinuation were observed		4454
28293						No adverse reactions leading to discontinuation were observed		4455
28294	2		Ulceration		discontinuation			4453
28295	7 pts		Hemorrhage postpartum	serious				4458
28296	1 pts		Pre-eclampsia	serious				4458
28297	1 pts		Bowel obstruction	serious				4458
28298	1 pts		Thrombocytopenia neonatal	serious				4458
28299	2 pts		Death neonatal	serious				4458
28300						No information on AE is provided		4457
28301	1 pts		Akathisia	below serious				4464
28302	1 pts		Diarrhea	below serious				4464
28303	1 pts		Hematuria	below serious				4464
28304			Pancreatitis			Overdosage		4462
28305			Pancreatitis			Overdosage		4463
28306	2.5		Epigastralgia	grade 2-3	discontinuation			4459
28307	3.3		Nausea	grade 3	discontinuation			4459
28308	0.8		Vomiting	grade 2	discontinuation			4459
28309	14.6		Nausea		discontinuation			4461
28310	4.9		Abdominal pain		discontinuation			4461
28311	2.8		Vomiting		discontinuation			4460
28312	2.8		Nausea	grade 1	discontinuation			4460
28313	1 pts		Swollen eyelid					4466
28314	1 pts		Hyperlactatemia		discontinuation	leads to discontinuation; only abstract is available		4475
28315	1 pts		Aplastic anemia	grade 5	discontinuation	leads to discontinuation		4474
28316	1 pts		Aplastic anemia	grade 4	discontinuation	leads to discontinuation		4468
28317	1 pts		Aplastic anemia	grade 5	discontinuation	leads to discontinuation		4470
28318	1 pts		Aplastic anemia	grade 4	discontinuation	leads to discontinuation		4467
28319	1 pts		Aplastic anemia	grade 4	discontinuation	leads to discontinuation		4469
28320	1 pts		Aplastic anemia	grade 5	discontinuation	leads to discontinuation		4472
28321	1 pts		Aplastic anemia	grade 4	discontinuation	leads to discontinuation		4471
28322	1 pts		Aplastic anemia	grade 5	discontinuation	leads to discontinuation		4473
28323						No information on AE is provided		4465
28324			Generalized epileptic seizure	grade 4-5				4479
28325			Cardiac arrhythmias	grade 4-5				4479
28326			Calcium increased serum					4479
28327			Creatine kinase increased					4479
28328			Blood myoglobin increased					4479
28329			Leukocyte count increased					4479
28330			Serum phosphate decreased					4479
28331			Magnesium serum decreased					4479
28332			Acute myocardial infarction					4479
28333			Obstructive uropathy					4479
28334			Cardio-respiratory arrest	grade 5				4479
28335			Hypoxic encephalopathy	grade 5				4479
28336	30		Vomiting					4478
28337	44		Hypokalemia					4478
28338	18		Hyperglycemia					4478
28339	9		Acid-base balance abnoraml					4478
28340	100		Sinus tachycardia					4478
28341	12		Supraventricular tachycardia					4478
28342	10		Premature ventricular ectopic beats					4478
28343	12		Atrial flutter/ fibrillation					4478
28344	2		Multifocal atrial tachycardia					4478
28345	40		Hemodynamic instability					4478
28346	16		Tremor					4478
28347	14		Seizures					4478
28348	61		Vomiting					4477
28349	12		Abdominal pain					4477
28350	14		Diarrhea					4477
28351	2		Hematemesis					4477
28352	43		Hypokalemia					4477
28353	9		Acid-base balance abnoraml					4477
28354	62		Sinus tachycardia					4477
28355	14		Supraventricular tachycardia					4477
28356	19		Premature ventricular ectopic beats					4477
28357	8		Hypotension					4477
28358	21		Nervousness					4477
28359	14		Tremor					4477
28360	11		Disorientation					4477
28361	5		Seizures					4477
28362	73		Vomiting					4481
28363	85		Hypokalemia					4481
28364	98		Hyperglycemia					4481
28365	34		Acid-base balance abnoraml					4481
28366	100		Sinus tachycardia					4481
28367	2		Supraventricular tachycardia					4481
28368	3		Premature ventricular ectopic beats					4481
28369	1		Atrial flutter/ fibrillation					4481
28370	7		Hemodynamic instability					4481
28371	38		Tremor					4481
28372	5		Seizures					4481
28373	21		Abdominal pain					4480
28374	7		Rhabdomyolysis					4480
28375	21		Hypotension					4480
28376	64		Nervousness					4480
28377	7		Disorientation					4480
28378						no AEs		4483
28379						no AEs		4484
28380	16.7		Tremor			1 patient		4482
28381	16.7		Nervousness			1 patient		4482
28382	16.7		Dysrhythmias	grade 1		1 patient		4482
28383	16.7		Gastrointestinal discomfort	grade 3	discontinuation	1 patient: the study had been interrupted in I subject on the 1st day of 1200 mg Theo-1 because of severe gastrointestinal discomfort and a fast supraventricular tachycardia with a theophylline plasma concentration of 20.5 ug/ml		4482
28384	16.7		Supraventricular tachycardia	grade 3	discontinuation	1 patient: the study had been interrupted in I subject on the 1st day of 1200 mg Theo-1 because of severe gastrointestinal discomfort and a fast supraventricular tachycardia with a theophylline plasma concentration of 20.5 ug/ml		4482
28385	12.64		Vomiting					4476
28386	5.75		Vomiting	grade 3	discontinuation			4476
28387			Injection site pain					4486
28388	5		Chest pain					4488
28389	5		Flatulence					4488
28390	10		Diarrhea					4488
28391	5		Injection site pain					4488
28392	100		Injection site pain	grade 3-4				4487
28393	100		Creatine phosphokinase increased					4487
28394	25		Skin rash		discontinuation			4492
28395	0.8		Injection site pain					4489
28396	5.3		Phlebitis					4489
28397	0.8		Chest pain					4489
28398	6.8		Diarrhea					4489
28399	0.8		Vomiting					4489
28400	0.8		Retention of urine					4489
28401	0.8		Rash					4489
28402	0.8		Epistaxis					4489
28403	0.8		Edema					4489
28404						AEs not reported		4485
28405	1		Injection site pain					4491
28406	1		Rash					4491
28407	5		Diarrhea					4491
28408	3		Fatigue					4491
28409	1		Chills					4491
28410	1		Headache					4491
28411	3		AST increased					4491
28412	1		Bilirubin increased					4491
28413	1		Creatinine increased					4491
28414	6.7		Thrombophlebitis					4490
28415	6.7		Nausea					4490
28416	6.7		Diarrhea					4490
28417	6.7		Rash					4490
28418	6.7		Blood eosinophils increased					4490
28419	6.7		AST increased					4490
28420	13.3		ALT increased					4490
28421	13.3		GGT increased					4490
28422	6.7		Alkaline phosphatase increased					4490
28423						No AEs were reported		4495
28424			Nephrotoxicity			cause decrease in renal perfusion		4494
28425			Drowsiness		discontinuation	leads to discontinuation		4493
28426			Lethargy		discontinuation	leads to discontinuation		4493
28427			Nausea		discontinuation	leads to discontinuation		4493
28428			Vomiting		discontinuation	leads to discontinuation		4493
28429			Epigastric pain		discontinuation	leads to discontinuation		4493
28430						Overdosage. No AEs were observed		4502
28431			Inflammation at site of injection			Overdosage		4501
28432	14.3		Renal failure		discontinuation			4496
28433			Renal failure		discontinuation			4499
28434						No AEs were observed		4497
28435	37.5		Headache					4498
28436	25		Diarrhea					4498
28437	25		Nausea					4498
28438	25		White blood cell count decreased					4498
28439			Acute nonoliguric renal failure		discontinuation	Overdosage		4500
28440			Consciousness abnormal		discontinuation	Overdosage		4500
28441			Dysarthria		discontinuation	Overdosage		4500
28442			Myoclonus		discontinuation	Overdosage		4500
28443			Tendon reflex exaggerated		discontinuation	Overdosage		4500
28444			Sign Babinski present		discontinuation	Overdosage		4500
28445	1 pts		Tryptase increased			anaphylaxis		4504
28446	2 pts		Urticaria			anaphylaxis		4504
28447	1 pts		Abdominal cramp			anaphylaxis		4504
28448	1 pts		Nausea			anaphylaxis		4504
28449	1 pts		Diarrhea			anaphylaxis		4504
28450						No AEs are reported		4503
28451						No AEs are reported		4505
28452						No SAEs were observed		4514
28453	10 pts		Nausea	below serious				4510
28454	11 pts		Stomach pain	below serious				4510
28455	12 pts		Diarrhea	below serious				4510
28456	3 pts		Rash	below serious				4510
28457	2 pts		Swelling	below serious				4510
28458	4 pts		Vaginal candidiasis	below serious				4510
28459	8 pts		Nausea	below serious				4509
28460	2 pts		Vomiting	below serious				4509
28461	11 pts		Stomach pain	below serious				4509
28462	11 pts		Diarrhea	below serious				4509
28463	4 pts		Rash	below serious				4509
28464	2 pts		Swelling	below serious				4509
28465	1 pts		Abdominal pain upper	serious				4512
28466	1 pts		Vomiting	serious				4512
28467	1 pts		Implant site pain	serious				4512
28468	1 pts		Pyrexia	serious				4512
28469	1 pts		Burkholderia cepacia infection	serious				4512
28470	1 pts		Pseudomonas infection	serious				4512
28471	1 pts		Bronchial secretion retention	serious				4512
28472	1 pts		Gastrostomy tube insertion	serious				4512
28473	8 pts		Constipation	below serious				4512
28474	9 pts		Dyspnoea	below serious				4512
28475	45 pts		Nasal congestion	below serious				4512
28476	9 pts		Rales	below serious				4512
28477	10 pts		Wheezing	below serious				4512
28478	9 pts		Rash	below serious				4512
28479	2 pts		Wheezing	serious				4511
28480			Angioedema			WARNING		4508
28481			Anaphylaxis			WARNING		4508
28482			Stevens Johnson syndrome			WARNING		4508
28483			Toxic epidermal necrolysis			WARNING		4508
28484			Iritis		discontinuation			4507
28485			Conjunctivitis bacterial		discontinuation			4507
28486			Conjunctivitis		discontinuation			4507
28487			Irritability		discontinuation			4507
28488			Herpes zoster		discontinuation			4507
28489			Sinusitis		discontinuation			4506
28490			Throat infection		discontinuation			4506
28491			Upper respiratory tract infection		discontinuation			4506
28492						No SAEs were observed		4513
28493			Allergy		discontinuation	WARNINGS		4515
28494			Pseudomembranous colitis		discontinuation	WARNINGS		4515
28495			Hypersensitivity reaction	serious	discontinuation	WARNINGS		4516
28496			Diarrhea, Clostridium difficile		discontinuation	WARNINGS		4516
28497			Diarrhea		discontinuation			4517
28498			Nausea		discontinuation			4517
28499			Vomiting		discontinuation			4517
28500			Abdominal pain		discontinuation			4517
28501			Dissociative disorder		discontinuation			4518
28502			Pain	grade 3	discontinuation			4518
28503	3		Neuropsychiatric symptoms		discontinuation	leads to discontinuation		4520
28504	2.1		Gastrointestinal disturbance		discontinuation	leads to discontinuation		4520
28505	1.7		Neurological disorder NOS		discontinuation	leads to discontinuation		4520
28506	1.4		Skin and subcutaneous tissue disorders		discontinuation	leads to discontinuation		4520
28507			Neuropsychiatric symptoms			BOXED WARNING		4520
28508	2.8		Seizures					4519
28509	1 pts		Ischemic colitis		discontinuation	leads to discontinuation		4527
28510	1 pts		Abdominal pain	acute	discontinuation	leads to discontinuation		4527
28511	1 pts		Ischemic colitis		discontinuation	leads to discontinuation		4528
28512	1 pts		Abdominal pain	acute	discontinuation	leads to discontinuation		4528
28513	1 pts		Ischemic colitis		discontinuation	leads to discontinuation		4529
28514	1 pts		Abdominal pain	acute	discontinuation	leads to discontinuation		4529
28515	1 pts		Ischemic colitis		discontinuation	leads to discontinuation		4526
28516	1 pts		Abdominal pain	acute	discontinuation	leads to discontinuation		4526
28517	1 pts		Urinary retention	acute	discontinuation	leads to discontinuation		4525
28518	1 pts		Hypertension			accidentally		4524
28519	1 pts		Rhabdomyolysis			suicide attempt		4523
28520	1 pts		Creatine kinase increased			suicide attempt		4523
28521	1 pts		Blood myoglobin increased					4523
28522						No AEs are reported		4522
28523	10 pts		Tension					4521
28524	6 pts		Dry mouth					4521
28525	9 pts		Tachycardia					4521
28526	10 pts		Palpitations					4521
28527	13 pts		Anxiety					4521
28528	12 pts		Insomnia					4521
28529	7 pts		Anorexia					4521
28530	10 pts		Restlessness					4521
28531	1 pts		Neutropenia		discontinuation	leads to discontinuation		4531
28532	1 pts		Tendonitis		discontinuation	leads to discontinuation		4530
28533			Myocardial infarction		discontinuation			4535
28534			Headache	severe	discontinuation			4534
28535			Vomiting		discontinuation			4534
28536			Intracranial hemorrhage		discontinuation			4534
28537			Vomiting		discontinuation			4532
28538			Hypertension		discontinuation			4532
28539			Accelerated idioventricular rhythm		discontinuation			4532
28540			Heart injury		discontinuation			4532
28541			Cardiomyopathy		discontinuation			4533
28542						No information on AE is provided		4536
28543	33.3		Dyspepsia		discontinuation			4540
28544	20		Vasodilation		discontinuation			4539
28545	20		Nausea		discontinuation			4539
28546	50		Dyspepsia		discontinuation			4538
28547	25		Abdominal pain		discontinuation			4538
28548	25		Nausea		discontinuation			4538
28549	25		Gastrointestinal hemorrhage		discontinuation			4538
28550	25		Creatine phosphokinase increased	grade 1	discontinuation			4537
28551	1 pts		Pneumonia	serious				4542
28552	2 pts		Bipolar I disorder	serious				4542
28553	1 pts		Mania	serious				4542
28554	15 pts		Hypoaesthesia oral	below serious				4542
28555	5 pts		Akathisia	below serious				4542
28556	4 pts		Dysgeusia	below serious				4542
28557	12 pts		Sedation	below serious				4542
28558	12 pts		Somnolence	below serious				4542
28559	1 pts		Suicidal ideation	serious				4541
28560	1 pts		Suicide attempt	serious				4541
28561	27 pts		Hypoaesthesia oral	below serious				4541
28562	6 pts		Nausea	below serious				4541
28563	7 pts		Increased appetite	below serious				4541
28564	18 pts		Akathisia	below serious				4541
28565	11 pts		Dysgeusia	below serious				4541
28566	18 pts		Sedation	below serious				4541
28567	14 pts		Somnolence	below serious				4541
28568			Cerebrovascular disorder (NOS)		discontinuation	WARNING Increased incidence of cerebrovascular adverse reactions (e.g., stroke, transient ischemic attack) in elderly patients		4545
28569			Neuroleptic malignant syndrome		discontinuation	WARNING		4545
28570			Tardive dyskinesia		discontinuation	WARNING		4545
28571			Orthostatic hypotension		discontinuation	WARNING		4545
28572			Leukopenia		discontinuation	WARNING		4545
28573			Neutropenia		discontinuation	WARNING		4545
28574			Agranulocytosis		discontinuation	WARNING		4545
28575			QT interval prolonged		discontinuation	WARNING		4545
28576			Seizures		discontinuation	WARNING		4545
28577			Cognitive impairment		discontinuation	WARNING		4545
28578			Hyperglycemia		discontinuation	WARNING		4545
28579			Diabetes mellitus		discontinuation	WARNING		4545
28580			Dyslipidemia		discontinuation	WARNING		4545
28581			Weight gain		discontinuation	WARNING		4545
28582	0.6		Somnolence		discontinuation			4544
28583	2		Somnolence		discontinuation			4543
28584	2		Abdominal pain		discontinuation			4543
28585	2		Nausea		discontinuation			4543
28586	4.9		Anemia					4546
28587	4.9		Nasopharyngitis					4546
28588	4.9		Blood creatinine increased					4546
28589	4.2		Dyspnea					4546
28590	3.5		Cough					4546
28591	3.5		Cardiac failure congestive					4546
28592	3.2		Constipation					4546
28593	2.8		Bronchitis					4546
28594	2.5		Hyperkalemia					4546
28595	2.1		Osteoarthritis					4546
28596	1.8		Hyperuricemia					4546
28597	1.8		Contusion					4546
28598	1.4		Pneumonia					4546
28599	1.4		Chronic obstructive pulmonary disease					4546
28600	4.2		Calcium increased serum					4546
28601	1.5		Rash					4548
28602	1.5		Itching					4548
28603	1.5		Pruritus					4548
28604	7.5		Nausea					4548
28605	7.5		Vomiting					4548
28606	7.5		Diarrhoea					4548
28607	2 pts		Diarrhoea	severe	discontinuation	leads to dose interruption		4549
28608	9 pts		Vomiting					4547
28609			Erythema		discontinuation	leads to discontinuation		4551
28610			Edema hands		discontinuation	leads to discontinuation		4551
28611						No AEs reported		4550
28612	16 pts		Hypersensitivity		discontinuation	leads to discontinuation		4553
28613	12 pts		Diarrhea		discontinuation	leads to discontinuation		4553
28614	16 pts		Nausea and vomiting		discontinuation	leads to discontinuation		4553
28615	9 pts		Abdominal pain		discontinuation	leads to discontinuation		4553
28616	5 pts		Headache		discontinuation	leads to discontinuation		4553
28617	2 pts		Neurologic disorder NOS		discontinuation	leads to discontinuation		4553
28618	1 pts		Diarrhea		discontinuation	leads to discontinuation		4552
28619	1 pts		Allergic exanthema		discontinuation	leads to discontinuation		4552
28620	1 pts		Abdominal pain		discontinuation	leads to discontinuation		4552
28621	1 pts		Convulsion					4554
28622						No adverse effects led to the discontinuation		4555
28623	3.4		Migrainous headache		discontinuation			4556
28624	0.84		Systemic lupus erythematosus synd		discontinuation			4556
28625	1 pts		Osteoarthritis	serious				4557
28626	1 pts		Road traffic accident	serious				4557
28627	1 pts		Immunodeficiency common variable	serious				4557
28628	7 pts		Sinusitis	below serious				4557
28629	3 pts		Bronchitis	below serious				4557
28630	8 pts		Nausea	below serious				4557
28631	8 pts		Dyspepsia	below serious				4557
28632	4 pts		Diarrhea	below serious				4557
28633	3 pts		Abdominal pain upper	below serious				4557
28634	3 pts		Gastroesophageal reflux disease	below serious				4557
28635	3 pts		Cystoid macular oedema	below serious				4557
28636	7 pts		Ammonia increased	below serious				4557
28637	3 pts		Alanine aminotransferase increased	below serious				4557
28638	3 pts		Aspartate aminotransferase increased	below serious				4557
28639	4 pts		Weight increased	below serious				4557
28640	3 pts		Hepatic enzyme increased	below serious				4557
28641	8 pts		Headache	below serious				4557
28642	3 pts		Tremor	below serious				4557
28643	6 pts		Fatigue	below serious				4557
28644	1 pts		Hypoglycemia	below serious				4558
28645	3 pts		Fatigue	below serious				4558
28646	4 pts		Headache	below serious				4558
28647						No adverse effects leading to discontinuation were reported, no DLT		4562
28648	40		Somnolence				TRUE	4559
28649			Coma		discontinuation			4563
28650						No adverse effects leading to discontinuation were reported, no DLT		4561
28651			Headache				TRUE	4560
28652			Nausea				TRUE	4560
28653			Somnolence		discontinuation			4564
28654			Pancreatic pseudocyst		discontinuation			4564
28655			Hepatotoxicity		discontinuation	WARNING		4565
28656			Disorder fetal		discontinuation	WARNING		4565
28657			Pancreatitis		discontinuation	WARNING. Including fatal hemorrhagic cases.		4565
28658	33.3		Hypotension				TRUE	4566
28659	100		Restlessness				TRUE	4566
28660	100		Sedation	grade 2-3			TRUE	4566
28661	25		Sedation	grade 3			TRUE	4567
28662	25		Hypotension	grade 3			TRUE	4567
28663	50		Akathisia		discontinuation			4567
28664			Extrapyramidal symptoms		discontinuation	WARNING		4568
28665	11 pts		Neonatal disorder NOS					4573
28666	1 pts		Sinus tachycardia		discontinuation	leads to discontinuation		4574
28667	1 pts		Metabolic acidosis		discontinuation	leads to discontinuation		4574
28668	1 pts		Hypocalcemia		discontinuation	leads to discontinuation		4574
28669	1.8		Edema				TRUE	4571
28670	1.1		Dizziness				TRUE	4571
28671	0.7		Flushing				TRUE	4571
28672	0.7		Palpitation				TRUE	4571
28673	3		Edema				TRUE	4572
28674	3.4		Dizziness				TRUE	4572
28675	1.4		Flushing				TRUE	4572
28676	1.4		Palpitation				TRUE	4572
28677	10.8		Edema				TRUE	4570
28678	3.4		Dizziness				TRUE	4570
28679	2.6		Flushing				TRUE	4570
28680	4.5		Palpitation				TRUE	4570
28681	1.5		Headache		discontinuation	leads to discontinuation		4569
28682	3		Somnolence		discontinuation			4580
28683	3		Dizziness		discontinuation			4580
28684	1.5		Hallucinations		discontinuation			4580
28685	1.5		Body numbness		discontinuation			4580
28686	1.5		Dry mouth		discontinuation			4580
28687	1.5		Headache		discontinuation			4580
28688	1.5		Nausea		discontinuation			4580
28689	1.5		Vomiting		discontinuation			4580
28690			Apnea		discontinuation			4581
28691			Respiratory depression		discontinuation			4581
28692			Consciousness decreased		discontinuation			4581
28693			Bradypnea		discontinuation			4581
28694			Tachycardia		discontinuation			4581
28695			Diaphoresis		discontinuation			4581
28696			Syncope		discontinuation			4583
28697			Acute coronary syndrome		discontinuation			4583
28698						No adverse effects leading to discontinuation were reported		4576
28699						No adverse effects leading to discontinuation were reported		4585
28700	50		Hypoxia					4577
28701	75		Nausea					4577
28702	87.5		Somnolence					4578
28703	50		Vomiting					4579
28704			Confusion	acute	discontinuation			4575
28705			Restlessness	mild	discontinuation			4575
28706			Visual hallucinations		discontinuation			4575
28707			Tremor		discontinuation			4575
28708			Hyperalgesia		discontinuation			4575
28709			Myoclonus		discontinuation			4575
28710			Sweating		discontinuation			4575
28711			Miosis		discontinuation			4575
28712			Respiratory arrest	grade 5	discontinuation			4582
28713			Respiratory depression	grade 4	discontinuation			4584
28714			Opioid abuse		discontinuation			4584
28715	1 pts		Death	grade 5	discontinuation	leads to discontinuation		4586
28716	1 pts		Bradycardia		discontinuation	leads to discontinuation		4587
28717	1 pts		Atrioventricular block first degree		discontinuation	leads to discontinuation		4587
28718			Pleural disorder		discontinuation	leads to discontinuation		4588
28719			Discoloration skin					4592
28720						No AEs are reported		4589
28721						No AEs are reported		4591
28722	1 pts		Mucosal ulceration		discontinuation	leads to discontinuation		4590
28723	1.5		Ventricular extrasystoles	grade 1	discontinuation			4593
28724	1 pts		Tinnitus	below serious				4599
28725	1 pts		Ocular hyperaemia	below serious				4599
28726	3 pts		Abdominal pain upper	below serious				4599
28727	3 pts		Aphthous stomatitis	below serious				4599
28728	3 pts		Oral pain	below serious				4599
28729	2 pts		Stomatitis	below serious				4599
28730	1 pts		Cheilitis	below serious				4599
28731	1 pts		Gingivitis	below serious				4599
28732	1 pts		Oral discomfort	below serious				4599
28733	1 pts		Fatigue	below serious				4599
28734	4 pts		Tonsillitis	below serious				4599
28735	3 pts		Otitis media	below serious				4599
28736	1 pts		Joint stiffness	below serious				4599
28737	1 pts		Muscle twitching	below serious				4599
28738	4 pts		Paraesthesia	below serious				4599
28739	2 pts		Paraesthesia oral	below serious				4599
28740	3 pts		Throat irritation	below serious				4599
28741	2 pts		Epistaxis	below serious				4599
28742	1 pts		Nasal dryness	below serious				4599
28743	1 pts		Oropharyngeal swelling	below serious				4599
28744	1 pts		Rhinorrhoea	below serious				4599
28745	1 pts		Sneezing	below serious				4599
28746	1 pts		Cold sweat	below serious				4599
28747	1 pts		Urticaria	below serious				4599
28748			Myocardial infarction			WARNING		4596
28749	0.3		Vertigo		discontinuation			4598
28750	12.5		Abdominal pain		discontinuation			4597
28751	12.5		Vomiting		discontinuation			4597
28752	25		Stomach pain	grade 2	discontinuation			4595
28753	25		Headache	grade 1	discontinuation			4595
28754	4		Stomach pain	grade 2	discontinuation			4594
28755	4		Headache	grade 1	discontinuation			4594
28756	32		Stomach pain					4594
28757	12		Headache					4594
28758	4		Vertigo					4594
28759	12		Fatigue					4594
28760	70		Photophobia					4600
28761	25.9		Reading disorder					4600
28762	21.7		Headache					4600
28763	3.3		Hot flushes					4600
28764	1.7		Conjunctivitis					4600
28765	1.7		Blepharitis					4600
28766	1 pts		Kounis syndrome		discontinuation	leads to discontinuation		4602
28767	1 pts		Chest discomfort		discontinuation	leads to discontinuation		4602
28768	1 pts		Nausea		discontinuation	leads to discontinuation		4602
28769	1 pts		Vomiting		discontinuation	leads to discontinuation		4602
28770			Adverse event	severe				4601
28771	4 pts		Acne	below serious				4603
28772	1 pts		Bruising	below serious				4603
28773	1 pts		Bug bite	below serious				4603
28774	18 pts		Dry skin face	below serious				4603
28775	1 pts		Stomach flu	below serious				4603
28776	1 pts		Insomnia	below serious				4603
28777	5 pts		Irritation skin	below serious				4603
28778	7 pts		Redness	below serious				4603
28779	1 pts		Nausea					4604
28780	2 pts		Toothache					4604
28781	9 pts		Application site erythema		discontinuation			4604
28782	9 pts		Application site irritation		discontinuation			4604
28783	7 pts		Application site pruritus		discontinuation			4604
28784	7 pts		Nasopharyngitis					4604
28785	2 pts		Upper respiratory tract infection					4604
28786	3 pts		Headache					4604
28787	1 pts		Cough					4604
28788	2 pts		Hypertension					4604
28789	1 pts		Application site bleeding		discontinuation			4605
28790	6 pts		Application site erythema		discontinuation			4605
28791	1 pts		Application site exfoliation		discontinuation			4605
28792	5 pts		Application site irritation		discontinuation			4605
28793	6 pts		Application site pruritus		discontinuation			4605
28794	1 pts		Application site swelling		discontinuation			4605
28795	1 pts		Application site folliculitis		discontinuation			4605
28796	1 pts		Dental caries			Considered as severe adverse event		4605
28797	1 pts		Hypersensitivity			Considered as severe adverse event		4605
28798	1 pts		Musculoskeletal pain			Considered as severe adverse event		4605
28799	1 pts		Migraine			Considered as severe adverse event		4605
28800	1 pts		Atrial fibrillation			Considered as serious adverse event		4605
28801	1 pts		Cardiac failure congestive			Considered as serious adverse event		4605
28802			Adverse event	grade 5		WARNING		4606
28803			Adverse event	grade 5		WARNING		4607
28804						No AEs are reported		4608
28805	2 pts		Diarrhea	below serious				4621
28806	2 pts		Abdominal pain	below serious				4621
28807	2 pts		Headache	below serious				4621
28808	8 pts		Acute kidney injury	serious				4620
28809	1 pts		Clostridium difficile infection	serious				4620
28810	1 pts		Chest pain	serious				4620
28811	1 pts		Dysuria	serious				4620
28812	1 pts		Epistaxis	serious				4620
28813	1 pts		GI bleed	serious				4620
28814	1 pts		Hematuria	serious				4620
28815	1 pts		Hyperkalemia	serious				4620
28816	1 pts		Hypertension malignant	serious				4620
28817	1 pts		Myocardial infarction	serious				4620
28818	1 pts		Nausea	serious				4620
28819	1 pts		Nephrolithiasis	serious				4620
28820	1 pts		Neutropenia	serious				4620
28821	1 pts		Pain	serious				4620
28822	1 pts		Nephrostomy complication	serious				4620
28823	1 pts		Radial nerve palsy	serious				4620
28824	2 pts		Sepsis	serious				4620
28825	1 pts		Small bowel obstruction	serious				4620
28826	1 pts		Thrombocytopenia	serious				4620
28827	1 pts		Urinary incontinence	serious				4620
28828	3 pts		Urinary retention	serious				4620
28829	2 pts		Vomiting	serious				4620
28830	5 pts		Venous thromboembolism	serious				4620
28831	3 pts		Wound complication	serious				4620
28832	12 pts		Constipation	below serious				4620
28833	7 pts		Headache	below serious				4620
28834	8 pts		Hypomagnesemia	below serious				4620
28835	8 pts		Insomnia	below serious				4620
28836	19 pts		Osteopenia	below serious				4620
28837	12 pts		Proteinuria	below serious				4620
28838	1 pts		Rash	below serious				4622
28839	3 pts		Death	grade 5	discontinuation	leads to discontinuation		4610
28840	58		Vomiting					4619
28841	2 pts		Acute renal failure		discontinuation	leads to discontinuation		4611
28842	2 pts		Myalgia		discontinuation	leads to discontinuation		4617
28843	2 pts		Exanthema		discontinuation	leads to discontinuation		4616
28844	4.4		Infusion site reactions					4615
28845	4.1		Alanine aminotransferase increased					4615
28846	4.1		Aspartate aminotransferase increased					4615
28847	4.1		Alkaline phosphatase increased					4615
28848	3		Gastrointestinal disorder (NOS)					4615
28849	1.8		Central nervous system disorder NOS					4615
28850	1 pts		Nausea		discontinuation	leads to discontinuation		4612
28851	1 pts		Epigastric pain		discontinuation	leads to discontinuation		4612
28852	1 pts		Vomiting		discontinuation	leads to discontinuation		4612
28853	1 pts		Tremor		discontinuation	leads to discontinuation		4612
28854	1 pts		Vomiting		discontinuation	leads to discontinuation		4613
28855	1 pts		Renal failure		discontinuation	leads to discontinuation		4613
28856	2 pts		Nausea		discontinuation	leads to discontinuation		4609
28857	2 pts		Epigastric pain		discontinuation	leads to discontinuation		4609
28858	2 pts		Vomiting		discontinuation	leads to discontinuation		4609
28859	2 pts		Tremor		discontinuation	leads to discontinuation		4609
28860	1 pts		Renal tubular necrosis acute		discontinuation	leads to discontinuation		4614
28861	3		Reaction gastrointestinal		discontinuation	leads to discontinuation		4618
28862	9.3		Musculoskeletal disorder NOS					4618
28863	12 pts		Headache	below serious				4627
28864	3 pts		Pruritus	below serious				4627
28865	1 pts		Deep vein thrombosis	serious				4625
28866	13 pts		Headache	below serious				4625
28867	13 pts		Post procedural hemorrhage	below serious				4625
28868	1 pts		Pruritus	below serious				4625
28869	5 pts		Presyncope	below serious				4625
28870	11 pts		Headache	below serious				4623
28871	5 pts		Pruritus	below serious				4623
28872	17 pts		Headache	below serious				4628
28873	9 pts		Vomiting	below serious				4628
28874	36 pts		Nausea	below serious				4626
28875	12 pts		Vomiting	below serious				4626
28876	7 pts		Constipation	below serious				4626
28877	7 pts		Post procedural haemorrhage	below serious				4626
28878	34 pts		Nausea	below serious				4624
28879	11 pts		Vomiting	below serious				4624
28880	8 pts		Constipation	below serious				4624
28881			Vomiting		discontinuation			4629
28882			Nausea	mild	discontinuation			4629
28883			Anorexia	mild	discontinuation			4629
28884			Cardiac thrombosis	serious	discontinuation	WARNING		4630
28885			Myocardial infarction	grade 3-5	discontinuation	WARNING		4630
28886			Stroke	grade 3-5	discontinuation	WARNING		4630
28887			Gastrointestinal disorder NOS	serious	discontinuation	WARNING		4630
28888			Bleeding	grade 3-5	discontinuation	WARNING		4630
28889			Ulceration	grade 3-5	discontinuation	WARNING		4630
28890			Perforation stomach	grade 3-5	discontinuation	WARNING		4630
28891			Perforation of intestine	grade 3-5	discontinuation	WARNING		4630
28892	7		Nausea					4631
28893	6		Diarrhoea					4631
28894	3		Headache					4631
28895	6.9		Headache					4632
28896	5.2		Abdominal pain					4632
28897	4		Nausea					4632
28898	3.7		Diarrhea					4632
28899	3.2		Vomiting					4632
28900	2.7		Flatulence					4632
28901	1.9		Esophageal acid reflux					4632
28902	1.9		Upper respiratory infection					4632
28903	1.5		Constipation					4632
28904	1.5		Dizziness					4632
28905	1.5		Rash					4632
28906	1.3		Asthenia					4632
28907	1.1		Back pain					4632
28908	1.1		Cough					4632
28909	1 pts		Cardiac failure congestive	serious				4634
28910	1 pts		Diarrhoea	below serious				4634
28911	1 pts		Dyspepsia	below serious				4634
28912	1 pts		Gingival pain	below serious				4634
28913	1 pts		Oral pain	below serious				4634
28914	1 pts		Sensitivity of teeth	below serious				4634
28915	1 pts		Vomiting	below serious				4634
28916	1 pts		Pain in extremity	below serious				4634
28917	1 pts		Migraine	below serious				4634
28918	5 pts		Hiccups	below serious				4634
28919	14 pts		Localised itching	below serious				4635
28920	10 pts		Nausea	below serious				4635
28921	3 pts		Headache	below serious				4635
28922	1 pts		Sweating	below serious				4635
28923	1 pts		Allergic dermatitis		discontinuation	leads to discontinuation		4640
28924	1 pts		Bradycardia		discontinuation	leads to discontinuation		4636
28925	1 pts		Depression		discontinuation	leads to discontinuation		4638
28926	2 pts		Nausea	grade 2-3	discontinuation	leads to discontinuation		4638
28927	1 pts		Hypersensitivity		discontinuation	leads to discontinuation		4637
28928	1 pts		Nausea		discontinuation	leads to discontinuation		4637
28929			Nausea					4633
28930	1 pts		Death	grade 5	discontinuation	leads to discontinuation		4639
28931	1 pts		Burn					4641
28932	1 pts		Stinging					4641
28933			Vomiting		discontinuation			4642
28934			Loss of consciousness		discontinuation			4642
28935			Drowsiness		discontinuation			4643
28936						The patient was hemodynamically stable		4644
28937			Hemoptysis		discontinuation			4646
28938			Hematuria		discontinuation			4646
28939			Dyspnea		discontinuation			4646
28940			Cough		discontinuation			4646
28941			Pulmonary alveolar hemorrhage		discontinuation			4646
28942			Bleeding	grade 5	discontinuation	WARNING		4645
28943	50 pts		Oversedation	below serious				4647
28944	20 pts		Electrocardiogram QTc interval prolonged	below serious				4647
28945	1 pts		Somnolence					4649
28946	1 pts		Akathisia					4649
28947	1 pts					No AEs were reported		4650
28948	1 pts		Drowsiness		discontinuation	leads to discontinuation		4652
28949	1 pts		Tremor		discontinuation	leads to discontinuation		4652
28950	1 pts		Anxiety		discontinuation	leads to discontinuation		4652
28951	1 pts		Anxiety		discontinuation	leads to discontinuation		4652
28952	1 pts		Sedation		discontinuation	leads to discontinuation		4653
28953	1 pts		Hypotension		discontinuation	leads to discontinuation		4653
28954	1 pts		Drowsiness		discontinuation	leads to discontinuation		4654
28955	16 pts		Somnolence					4655
28956	2 pts		Syncope hypotensive					4655
28957	1 pts		Blurred vision					4648
28958	1 pts		Sedation					4648
28959	1 pts		Respiratory depression		discontinuation	leads to discontinuation		4651
28960	1 pts		Intestinal ulcers and perforation NEC	serious				4660
28961	1 pts		Pain and discomfort NEC	serious				4660
28962	1 pts		Cholecystitis and cholelithiasis	serious				4660
28963	1 pts		Abdominal and gastrointestinal infections	serious				4660
28964	1 pts		Osteoarthropathies	serious				4660
28965	1 pts		Endocrine neoplasms benign NEC	serious				4660
28966	1 pts		Hodgkin's disease NEC	serious				4660
28967	52 pts		Upper respiratory tract infections	below serious				4660
28968	8 pts		Non-site specific injuries NEC	below serious				4660
28969	15 pts		Liver function analyses	below serious				4660
28970	20 pts		Joint related signs and symptoms	below serious				4660
28971	27 pts		Musculoskeletal and connective tissue conditions NEC	below serious				4660
28972	19 pts		Headaches NEC	below serious				4660
28973	6 pts		Neurological signs and symptoms NEC	below serious				4660
28974	1		Hypertension		discontinuation			4656
28975	0.37		Muscle cramps		discontinuation			4656
28976	0.37		Diarrhea		discontinuation			4657
28977	2.4		Rash		discontinuation			4659
28978	1.9		Eosinophilia		discontinuation			4658
28979	1.9		GGT increased		discontinuation			4658
28980	1.9		Diarrhea		discontinuation			4658
28981	1.9		Vomiting		discontinuation			4658
28982	1.9		Calculus urinary	serious	discontinuation			4658
28983	1 pts		Angioedema	serious				4666
28984	68 pts		Nausea	below serious				4666
28985	59 pts		Vomiting	below serious				4666
28986	8 pts		Constipation	below serious				4666
28987	44 pts		Dizziness	below serious				4666
28988	13 pts		Headache	below serious				4666
28989	11 pts		Somnolence	below serious				4666
28990	11 pts		Pruritus	below serious				4666
28991	8 pts		Hyperhidrosis	below serious				4666
28992	7 pts		Oxygen saturation decreased	below serious				4666
28993	7 pts		Dehydration	below serious				4666
28994	5 pts		Hot flush	below serious				4666
28995	47 pts		Nausea	below serious				4665
28996	33 pts		Vomiting	below serious				4665
28997	6 pts		Constipation	below serious				4665
28998	26 pts		Dizziness	below serious				4665
28999	23 pts		Headache	below serious				4665
29000	6 pts		Somnolence	below serious				4665
29001	2 pts		Pruritus	below serious				4665
29002	1 pts		Hyperhidrosis	below serious				4665
29003	8 pts		Oxygen saturation decreased	below serious				4665
29004	2 pts		Hot flush	below serious				4665
29005	36 pts		Nausea	below serious				4664
29006	24 pts		Vomiting	below serious				4664
29007	9 pts		Constipation	below serious				4664
29008	18 pts		Dizziness	below serious				4664
29009	15 pts		Headache	below serious				4664
29010	6 pts		Somnolence	below serious				4664
29011	2 pts		Pruritus	below serious				4664
29012	2 pts		Hyperhidrosis	below serious				4664
29013	6 pts		Oxygen saturation decreased	below serious				4664
29014	2 pts		Hot flush	below serious				4664
29015						No information on AE is provided		4662
29016			Respiratory depression			Overdosage		4663
29017	4.4		Nausea		discontinuation			4661
29018	1.6		Vomiting		discontinuation			4661
29019	0.8		Constipation		discontinuation			4661
29020	1.4		Dizziness		discontinuation			4661
29021	1.1		Headache		discontinuation			4661
29022	1.1		Somnolence		discontinuation			4661
29023	0.8		Fatigue		discontinuation			4661
29024	0.7		Drug withdrawal syndrome		discontinuation			4661
29025	1.7		Liver function test abnormal		discontinuation			4661
29026	0.5		QT interval prolonged		discontinuation			4661
29027	0.5		Anxiety		discontinuation			4661
29028						No AEs reported		4668
29029			Sedation		discontinuation	WARNING		4667
29030			Coma		discontinuation	WARNING		4667
29031			Respiratory depression		discontinuation	WARNING		4667
29032	19		Dizziness					4669
29033	17		Vomiting					4669
29034	5		Palpitations					4669
29035	6		Headache					4669
29036	5		Nausea					4669
29037	2		Abdominal pain					4669
29038			Cardiac arrest			attempt to suicide		4670
29039	16 pts		Dry mouth	below serious				4677
29040	5 pts		Drowsiness	below serious				4677
29041	6 pts		Lightheadedness	below serious				4677
29042	8 pts		Fatigue	below serious				4677
29043	1 pts		Postoperative nausea	serious				4672
29044						No AEs were observed		4671
29045	3.9		Somnolence		discontinuation			4673
29046	2.6		Fatigue		discontinuation			4673
29047	6.4		Somnolence		discontinuation			4675
29048	5.1		Fatigue		discontinuation			4675
29049	1.3		Formication		discontinuation			4675
29050	1.3		Constipation		discontinuation			4675
29051	1.3		Vomiting		discontinuation			4675
29052	1.3		Electrocardiogram QT prolonged		discontinuation			4675
29053	1.3		Heart rate increased		discontinuation			4675
29054	1.3		Rash		discontinuation			4675
29055	1		Bradyphrenia		discontinuation			4674
29056			Ache stomach			Overdosage		4676
29057			Feeling anxious			Overdosage		4676
29058			Suicide attempt			Overdosage		4676
29059	6 pts		Shortness of breath	below serious				4678
29060	3 pts		Chest pain	below serious				4678
29061			Bradycardia			Overdosage		4682
29062			Hypotension			Overdosage		4682
29063	2.5		Nausea		discontinuation			4681
29064	2.5		Walking difficulty		discontinuation			4681
29065	2.5		Palpitation				TRUE	4681
29066	2.5		Insomnia				TRUE	4681
29067	2.5		Headache				TRUE	4681
29068	6.7		Urticaria		discontinuation			4679
29069			Bradycardia			Overdosage		4683
29070			Hypotension			Overdosage		4683
29071	1		Headache		discontinuation			4680
29072	0.7		Edema		discontinuation			4680
29073	0.5		Dermatitis		discontinuation			4680
29074	1 pts		Heart block first degree	below serious				4686
29075	4 pts		Acute blood loss anemia	serious				4687
29076	1 pts		Reaction anaphylactic anaphylactoid	serious				4687
29077	1 pts		Sepsis	serious				4687
29078	1 pts		Cardiac arrest	serious				4687
29079	1 pts		Cardiac tamponade	serious				4687
29080	7 pts		Complete heart block	serious				4687
29081	2 pts		Congestive heart failure	serious				4687
29082	1 pts		Coma	serious				4687
29083	1 pts		Diaphragmatic rupture	serious				4687
29084	2 pts		GI bleed	serious				4687
29085	1 pts		Hematuria	serious				4687
29086	2 pts		Hemorrhagic shock	serious				4687
29087	2 pts		Hemothorax	serious				4687
29088	1 pts		Haemophilus influenzae infection	serious				4687
29089	1 pts		Hyperkalemia	serious				4687
29090	6 pts		Hypertension	serious				4687
29091	1 pts		Hypokalemia	serious				4687
29092	8 pts		Hypotension	serious				4687
29093	1 pts		Hypovolemic shock	serious				4687
29094	3 pts		Hypoxemia	serious				4687
29095	2 pts		Infection	serious				4687
29096	1 pts		Irritable bowel syndrome	serious				4687
29097	5 pts		Junctional rhythm	serious				4687
29098	1 pts		Lactic acidosis	serious				4687
29099	1 pts		Embolectomy	serious				4687
29100	8 pts		Leukocytosis	serious				4687
29101	2 pts		MRSA	serious				4687
29102	1 pts		Pulseless electrical activity	serious				4687
29103	3 pts		Pulmonary contusion	serious				4687
29104	7 pts		Renal insufficiency	serious				4687
29105	3 pts		Sinus tachycardia	serious				4687
29106	1 pts		Wound infection	serious				4687
29107	1 pts		Subcutaneous emphysema	serious				4687
29108	3 pts		Urinary tract infection	serious				4687
29109	1 pts		Ventilator associated pneumonia	serious				4687
29110	1 pts		Ventricular ectopics	serious				4687
29111	1		Nausea and vomiting					4689
29112	8 pts		Hallucinations					4689
29113	4 pts		Tachycardia					4689
29114	3 pts		Tremor					4689
29115	2 pts		Hypotension					4689
29116	1 pts		Light-headed					4689
29117	1 pts		Phlebitis					4689
29118	1 pts		Hypertension					4689
29119	2 pts		Headache		discontinuation	leads to discontinuation		4685
29120	2 pts		Application site irritation		discontinuation	leads to discontinuation		4685
29121	1.3					no details about the AE		4684
29122	1.6		Death	grade 5	discontinuation	leads to discontinuation		4688
29123						No AEs were reported		4694
29124						No AEs were reported		4690
29125						No AEs were reported		4691
29126	1.7		Headache					4692
29127	1.1		Rash					4692
29128	1.1		Nausea					4692
29129	< 1		Abdominal pain					4692
29130	< 1		Application site burning					4692
29131	< 1		Cellulitis					4692
29132	< 1		Dermatitis					4692
29133	< 1		Dizziness					4692
29134	< 1		Pruritus					4692
29135	4.9		Nausea					4693
29136	3.6		Headache					4693
29137	3.6		Application site burning					4693
29138	2.4		Pruritus					4693
29139	1 pts		Abdominal pain					4693
29140	1 pts		Bleeding					4693
29141	1 pts		Pain					4693
29142	1 pts		Skin pain					4693
29143	1 pts		Hives					4693
29144	1 pts		Dry skin					4693
29145	1 pts		Rash					4693
29146	3 pts		Hypotension		discontinuation	leads to discontinuation		4696
29147	2 pts		Bradycardia		discontinuation	leads to discontinuation		4696
29148	1 pts		Myoclonus		discontinuation	leads to discontinuation		4696
29149	2 pts		Focal seizures		discontinuation	leads to discontinuation		4696
29150	1 pts		Hypertension		discontinuation	leads to discontinuation		4696
29151	32		Nausea					4696
29152	5		Emesis					4696
29153	5		Seizures					4696
29154	5		Headache					4696
29155	5		Confusion					4696
29156	3		Agitation					4696
29157						No information on AE is provided		4697
29158						No information on AE is provided		4695
29159	1 pts		Ileus paralytic	serious				4698
29160	1 pts		Chest pain	serious				4698
29161	1 pts		Fall	serious				4698
29162	1 pts		Dyspnoea	serious				4698
29163	2 pts		Constipation	below serious				4698
29164	3 pts		Nausea	below serious				4698
29165	1 pts		Cataract	below serious				4698
29166	1 pts		Eye haemorrhage	below serious				4698
29167	1 pts		Bronchitis	below serious				4698
29168	1 pts		Gastroenteritis	below serious				4698
29169	3 pts		Nasopharyngitis	below serious				4698
29170	1 pts		Pneumonia	below serious				4698
29171	2 pts		Sinusitis	below serious				4698
29172	1 pts		Tooth infection	below serious				4698
29173	2 pts		Fall	below serious				4698
29174	1 pts		Tooth fracture	below serious				4698
29175	1 pts		Electrocardiogram abnormal	below serious				4698
29176	1 pts		Arthralgia	below serious				4698
29177	2 pts		Back pain	below serious				4698
29178	1 pts		Abnormal dreams	below serious				4698
29179	1 pts		Agitation	below serious				4698
29180	1 pts		Insomnia	below serious				4698
29181	1 pts		Restlessness	below serious				4698
29182	1 pts		Nasal congestion	below serious				4698
29183	1 pts		Paranasal sinus discomfort	below serious				4698
29184	1 pts		Allergic rhinitis	below serious				4698
29185	2 pts		Rash	below serious				4698
29186	1 pts		Rosacea	below serious				4698
29187			Sinus tachycardia		discontinuation			4702
29188			Drowsiness		discontinuation			4702
29189			Metabolic acidosis		discontinuation			4702
29190			Seizures		discontinuation			4702
29191			Abdominal pain		discontinuation			4700
29192			Nausea		discontinuation			4700
29193			Dizziness		discontinuation			4700
29194			Seizures		discontinuation			4700
29195			Metabolic acidosis	severe	discontinuation			4700
29196			Cardiovascular symptom		discontinuation			4701
29197			Shock cardiogenic		discontinuation			4701
29198			Bleeding		discontinuation			4701
29199			Thrombopenia		discontinuation			4701
29200						There were no adverse effects.		4699
29201			Cardiac thrombosis	grade 3-5	discontinuation	WARNING		4703
29202			Myocardial infarction	grade 3-5	discontinuation	WARNING		4703
29203			Stroke	grade 3-5	discontinuation	WARNING		4703
29204			Gastrointestinal disorder NOS	grade 3-5	discontinuation	WARNING		4703
29205			Gastrointestinal bleeding	grade 3-5	discontinuation	WARNING		4703
29206			Gastrointestinal ulcer	grade 3-5	discontinuation	WARNING		4703
29207			Perforation stomach	grade 3-5	discontinuation	WARNING		4703
29208			Perforation of intestine	grade 3-5	discontinuation	WARNING		4703
29209						No SAEs were observed		4704
29210			Abdominal pain		discontinuation			4705
29211			Seizures					4708
29212			AST increased					4708
29213			ALT increased					4708
29214			Electrocardiogram QTc interval prolonged					4708
29215			Serotonin syndrome					4708
29216			Hypotension					4709
29217						No information on AE is provided		4706
29218			Amaurosis					4707
29219			Constipation	grade 3				4707
29220			Panic attack		discontinuation			4710
29221			Stomach pain		discontinuation			4711
29222						No SAEs were reported		4712
29223			Toxic reaction (NOS)	grade 5				4715
29224			Toxic reaction (NOS)	grade 5				4714
29225			Toxic reaction (NOS)	grade 5				4713
29226	4 pts		Nausea	below serious				4720
29227	1 pts		Vomiting	below serious				4720
29228			Pulmonary edema			Overdosage		4722
29229	2.5		Vomiting		discontinuation			4721
29230	11.4		Vomiting		discontinuation			4723
29231	6.3		Nausea	grade 1-2	discontinuation			4718
29232	4.8		Dizziness	grade 1-2	discontinuation			4718
29233	3.2		Confusion	grade 1-2	discontinuation			4718
29234	1.7		Nausea	grade 1-2	discontinuation			4716
29235	1.7		Dizziness	grade 1-2	discontinuation			4716
29236	0.8		Abdominal pain	grade 1-2	discontinuation			4716
29237	0.8		Vomiting	grade 1-2	discontinuation			4719
29238	0.8		Flu syndrome	grade 1-2	discontinuation			4719
29239	0.8		Confusion	grade 1-2	discontinuation			4719
29240	0.8		Fatigue	grade 1-2	discontinuation			4719
29241	0.8		Headache	grade 1-2	discontinuation			4717
29242	0.8		Vomiting	grade 1-2	discontinuation			4717
29243	0.8		Nausea	grade 1-2	discontinuation			4717
29244	0.8		Somnolence	grade 1-2	discontinuation			4717
29245			Respiratory depression		discontinuation	WARNING		4725
29246			Sedation		discontinuation	WARNING		4724
29247			Coma		discontinuation	WARNING		4724
29248			Hypotension	severe	discontinuation	WARNING		4725
29249	58		Nausea					4727
29250	38		Vomiting					4727
29251	27		Dizziness					4727
29252	18		Anorexia					4727
29253	16		Headache					4727
29254	1 pts		Respiratory depression			suicide attempt		4731
29255	1 pts		Dizziness			suicide attempt		4731
29256	1 pts		Nausea			suicide attempt		4731
29257	1 pts		Vomiting			suicide attempt		4731
29258	1 pts		Sweating			suicide attempt		4731
29259	1 pts		Cholinergic syndrome			suicide attempt		4729
29260			Nausea	grade 5				4730
29261			Vomiting	grade 5				4730
29262			Renal failure	grade 5				4730
29263	1 pts		Cholinergic syndrome			Poisoning		4728
29264	8		Nausea		discontinuation	leads to discontinuation		4732
29265	4		Vomiting		discontinuation	leads to discontinuation		4732
29266	2		Anorexia		discontinuation	leads to discontinuation		4732
29267	2		Dizziness		discontinuation	leads to discontinuation		4732
29268	1.7		Vomiting		discontinuation	leads to discontinuation		4726
29269	1.7		Nausea		discontinuation	leads to discontinuation		4726
29270	22.2		Nausea			Clinical adverse events considered to be at least possibly or probably related to treatment		4734
29271	6.2		Vomiting			Clinical adverse events considered to be at least possibly or probably related to treatment		4734
29272	4.9		Diarrhea			Clinical adverse events considered to be at least possibly or probably related to treatment		4734
29273	2.5		Abdominal pain			Clinical adverse events considered to be at least possibly or probably related to treatment		4734
29274	2.5		Diarrhea aggravated			Clinical adverse events considered to be at least possibly or probably related to treatment		4734
29275	2.5		Esophageal reflux			Clinical adverse events considered to be at least possibly or probably related to treatment		4734
29276	2.5		Fatigue			Clinical adverse events considered to be at least possibly or probably related to treatment		4734
29277	1.2		Dizziness (excl vertigo)			Clinical adverse events considered to be at least possibly or probably related to treatment		4734
29278	1.2		Dermatitis			Clinical adverse events considered to be at least possibly or probably related to treatment		4734
29279	3.7		Decreased appetite			Clinical adverse events considered to be at least possibly or probably related to treatment		4734
29280	2.5		Headache			Clinical adverse events considered to be at least possibly or probably related to treatment		4734
29281	1.2		Insomnia			Clinical adverse events considered to be at least possibly or probably related to treatment		4734
29282	2.5		Weakness			Clinical adverse events considered to be at least possibly or probably related to treatment		4734
29283	2.5		Depression			Clinical adverse events considered to be at least possibly or probably related to treatment		4734
29284	1.2		Anxiety			Clinical adverse events considered to be at least possibly or probably related to treatment		4734
29285	3		Diabetes mellitus			All causality (includes events with unknown relationship to study drug)		4733
29286	5		Lipodystrophy			All causality (includes events with unknown relationship to study drug)		4733
29287	11		Nausea			All causality (includes events with unknown relationship to study drug)		4733
29288	7		Vomiting			All causality (includes events with unknown relationship to study drug)		4733
29289	8		Diarrhea			All causality (includes events with unknown relationship to study drug)		4733
29290	6		Abdominal pain			All causality (includes events with unknown relationship to study drug)		4733
29291	2		Constipation			All causality (includes events with unknown relationship to study drug)		4733
29292	6		Fatigue			All causality (includes events with unknown relationship to study drug)		4733
29293	3		Fever			All causality (includes events with unknown relationship to study drug)		4733
29294	2		Back pain			All causality (includes events with unknown relationship to study drug)		4733
29295	5		Pneumonia			All causality (includes events with unknown relationship to study drug)		4733
29296	3		Bronchitis			All causality (includes events with unknown relationship to study drug)		4733
29297	3		Influenza			All causality (includes events with unknown relationship to study drug)		4733
29298	3		Sinusitis			All causality (includes events with unknown relationship to study drug)		4733
29299	3		Rash			All causality (includes events with unknown relationship to study drug)		4733
29300	3		Pruritus			All causality (includes events with unknown relationship to study drug)		4733
29301	2		Dry lips			All causality (includes events with unknown relationship to study drug)		4733
29302	2		Eczema			All causality (includes events with unknown relationship to study drug)		4733
29303	2 pts		Agitation	serious				4739
29304	1 pts		Anxiety	serious				4739
29305	1 pts		Hypotension orthostatic	serious				4739
29306	1 pts		Psychotic disorder	serious				4739
29307	1 pts		Screaming	serious				4739
29308	2 pts		Suicidal ideation	serious				4739
29309	1 pts		Syncope	serious				4739
29310	4 pts		Agitation	below serious				4739
29311	4 pts		Anxiety	below serious				4739
29312	37 pts		Application site reaction	below serious				4739
29313	5 pts		Decreased appetite	below serious				4739
29314	8 pts		Dizziness	below serious				4739
29315	9 pts		Insomnia	below serious				4739
29316	4 pts		Pharyngolaryngeal pain	below serious				4739
29317	7 pts		Somnolence	below serious				4739
29318	11 pts		Upper respiratory tract infection	below serious				4739
29319	7 pts		Vomiting	below serious				4739
29320	57 pts		Insomnia	below serious				4738
29321	30 pts		Skin rash	below serious				4738
29322	13 pts		Vivid dreams	below serious				4738
29323	18		Headache					4736
29324	9		Infection					4736
29325	3		Back pain					4736
29326	9		Diarrhea					4736
29327	5		Nausea					4736
29328	12		Insomnia					4736
29329	8		Dry mouth					4736
29330	5		Dizziness					4736
29331	4		Nervousness					4736
29332	3		Somnolence					4736
29333	3		Anxiety					4736
29334	2		Abnormal dreams					4736
29335	3		Pharyngitis					4736
29336	24		Application site reaction					4736
29337	16		Headache					4735
29338	15		Infection					4735
29339	6		Back pain					4735
29340	11		Diarrhea					4735
29341	7		Nausea					4735
29342	32		Insomnia					4735
29343	13		Dry mouth					4735
29344	14		Dizziness					4735
29345	10		Nervousness					4735
29346	5		Somnolence					4735
29347	5		Anxiety					4735
29348	5		Abnormal dreams					4735
29349	7		Pharyngitis					4735
29350	44		Application site reaction					4735
29351	5		Back pain					4737
29352	2		Chest pain					4737
29353	8		Pain					4737
29354	3		Hypertension					4737
29355	4		Constipation					4737
29356	2		Diarrhea					4737
29357	2		Dysphagia					4737
29358	5		Dyspepsia					4737
29359	2		Flatulence					4737
29360	11		Nausea					4737
29361	5		Stomatitis					4737
29362	2		Tooth disorder					4737
29363	3		Vomiting					4737
29364	2		Ecchymosis					4737
29365	2		Hypokalemia					4737
29366	3		Leg cramps					4737
29367	3		Myalgia					4737
29368	3		Ataxia					4737
29369	2		Depression					4737
29370	11		Dizziness					4737
29371	4		Dry mouth					4737
29372	6		Dyskinesia					4737
29373	4		Hallucinations					4737
29374	7		Headache					4737
29375	7		Insomnia					4737
29376	3		Somnolence					4737
29377	3		Tremor					4737
29378	3		Dyspnea					4737
29379	4		Pharyngitis					4737
29380	7		Rhinitis					4737
29381	4		Rash					4737
29382	6		Skin disorder					4737
29383	14 pts		Nausea	below serious				4741
29384	1 pts					No AEs were reported, without event		4743
29385						No AEs were reported		4744
29386	1 pts		Ischemic colitis		discontinuation	leads to discontinuation		4742
29387	6		Abnormal physical sensation					4740
29388	6		Abnormal physical sensation					4740
29389	6		Abnormal physical sensation					4740
29390	8		Sensation of pressure					4740
29391	2		Chest tightness of					4740
29392	3		Throat tightness					4740
29393	1		Pain					4740
29394	3		Pressure					4740
29395	2		Vertigo					4740
29396	3		Malaise and fatigue					4740
29397	7.4		Neutropenia		discontinuation			4745
29398	3.7		Neutropenia		discontinuation	1 patient		4745
29399	3.7		Glutamic-oxaloacetic transaminase increased		discontinuation	1 patient		4745
29400	3.7		Serum glutamic-pyruvic transaminase increased		discontinuation	1 patient		4745
29401						No adverse reactions leading to discontinuation were reported		4747
29402			Liver failure		discontinuation	WARNINGS		4750
29403			Taste disturbance	severe	discontinuation	WARNINGS		4750
29404			Smell alteration		discontinuation	WARNINGS		4750
29405			Depressive symptom		discontinuation	WARNINGS		4750
29406			Neutropenia	severe	discontinuation	WARNINGS		4750
29407			Stevens-Johnson syndrome		discontinuation	WARNINGS		4750
29408			Toxic epidermal necrolysis		discontinuation	WARNINGS		4750
29409			Erythema multiforme		discontinuation	WARNINGS		4750
29410			Exfoliative dermatitis		discontinuation	WARNINGS		4750
29411			Bullous dermatitis		discontinuation	WARNINGS		4750
29412			Drug reaction with eosinophilia and systemic symptoms		discontinuation	WARNINGS		4750
29413			Lupus erythematosus		discontinuation	WARNINGS		4751
29414			Thrombotic microangiopathy		discontinuation	WARNINGS		4751
29415			Thrombotic thrombocytopenic purpura		discontinuation	WARNINGS		4751
29416			Hemolytic uremic syndrome		discontinuation	WARNINGS		4751
29417	0.2		Headache		discontinuation			4748
29418	0.6		Diarrhea		discontinuation			4749
29419	0.4		Dyspepsia		discontinuation			4749
29420	0.4		Abdominal pain		discontinuation			4749
29421	0.2		Nausea		discontinuation			4749
29422	0.9		Rash		discontinuation			4749
29423	0.2		Pruritus		discontinuation			4749
29424	0.2		Liver enzyme abnormal		discontinuation			4749
29425	0.2		Taste disturbance		discontinuation			4749
29426	0.9		Visual disturbance		discontinuation			4749
29427			Nausea					4746
29428			Vomiting					4746
29429			Abdominal pain					4746
29430			Dizziness					4746
29431			Rash					4746
29432			Urination frequency of					4746
29433			Headache					4746
29434	1 pts		Torsade de pointes		discontinuation	leads to discontinuation		4752
29435	1 pts		Hyperthermia malignant		discontinuation	leads to discontinuation		4753
29436			Death		discontinuation	WARNING		4754
29437			Tardive dyskinesia		discontinuation	leads to discontinuation		4757
29438			Neutropenia	severe	discontinuation	leads to discontinuation		4757
29439			Hyperprolactinemia		discontinuation	leads to dose reduction/discontinuation		4756
29440			Menstrual irregularity		discontinuation	leads to dose reduction/discontinuation		4756
29441			Breast enlargement		discontinuation	leads to dose reduction/discontinuation		4756
29442			Amenorrhea		discontinuation	leads to dose reduction/discontinuation		4756
29443						No AEs reported		4755
29444	7 pts		Leukopenia	grade 3-4				4759
29445	10 pts		Neutropenia	grade 3-4			TRUE	4759
29446	2 pts		Vomiting	grade 3-4				4759
29447	1 pts		Constipation	grade 3-4				4759
29448	1 pts		Alopecia	grade 3-4				4759
29449	9 pts		Anaemia	all grades				4759
29450	12 pts		Leukopenia	all grades				4759
29451	11 pts		Neutropenia	all grades			TRUE	4759
29452	1 pts		Thrombocytopenia	all grades				4759
29453	13 pts		Nausea	all grades				4759
29454	11 pts		Vomiting	all grades				4759
29455	9 pts		Diarrhoea	all grades				4759
29456	2 pts		Stomatitis	all grades				4759
29457	8 pts		Constipation	all grades				4759
29458	7 pts		Sensory abnormalities NEC	all grades		neurosensory disorders which consisted of mild to moderate paresthesia and/or loss of deep tendon reflexes		4759
29459	9 pts		Alopecia	all grades				4759
29460	2 pts		Leukopenia	grade 3-4				4758
29461	3 pts		Neutropenia	grade 3-4			TRUE	4758
29462	2 pts		Vomiting	grade 3-4				4758
29463	3 pts		Diarrhoea	grade 1				4758
29464	1 pts		Stomatitis	grade 3-4				4758
29465	3 pts		Constipation	grade 3-4				4758
29466	2 pts		Alopecia	grade 1-2				4758
29467	80		Neutropenia	grade 1		< 2,000 cells/mm^3	TRUE	4761
29468	29		Neutropenia	grade 4		< 500 cells/mm^3	TRUE	4761
29469	81		Leukopenia	grade 1		< 4,000 cells/mm^3		4761
29470	12		Leukopenia	grade 4				4761
29471	4		Thrombocytopenia	grade 1		< 100,000 cells/mm^3		4761
29472	77		Anemia	grade 1		< 11 g/dl		4761
29473	1		Anemia	grade 3		< 8 g/dl		4761
29474	3		AST increased	grade 3-4				4761
29475	5		Bilirubin increased	grade 3-4				4761
29476	1		Nausea	grade 3-4				4761
29477	5		Asthenia	grade 3-4				4761
29478	2		Constipation	grade 3-4				4761
29479	5		Injection site reaction	grade 3-4				4761
29480	1		Injection site pain	grade 3-4				4761
29481	1		Neuropathy peripheral	grade 3-4				4761
29482	1		Vomiting	grade 3-4				4761
29483	1		Diarrhea	grade 3-4				4761
29484	1		Alopecia	grade 3-4				4761
29485	1		Phlebitis	grade 3-4				4761
29486	2		Dyspnea	grade 3-4				4761
29487	82		Neutropenia	grade 3-4		Four patients in the NAVELBINE plus cisplatin arm died of neutropenic sepsis	TRUE	4760
29488	24		Anemia	grade 3-4				4760
29489	58		Leukopenia	grade 3-4				4760
29490	5		Thrombocytopenia	grade 3-4				4760
29491	11		Febrile neutropenia	grade 3-4				4760
29492	4		Blood creatinine increased	grade 3-4				4760
29493	12		Malaise and fatigue	grade 3-4				4760
29494	13		Vomiting	grade 3-4				4760
29495	14		Nausea	grade 3-4				4760
29496	3		Constipation	grade 3-4				4760
29497	1		Weight decreased	grade 3-4				4760
29498	2		Fever	grade 3-4				4760
29499	4		Hearing impaired	grade 3-4				4760
29500	<1		Injection site reaction	grade 3-4				4760
29501	<3		Diarrhea	grade 3-4				4760
29502	<1		Paraesthesia	grade 3-4				4760
29503	2		Numbness	grade 3-4				4760
29504	<1		Arthralgia	grade 3-4				4760
29505	3		Embolism and thrombosis	grade 3-4				4760
29506	<3		Weakness	grade 3-4				4760
29507	<6		Infection	grade 3-4				4760
29508	<5		Respiratory tract infection	grade 3-4				4760
29509	11 pts		Lightheadedness	below serious				4768
29510	11 pts		Sickness/nausea	below serious				4768
29511	7 pts		Drowsiness	below serious				4768
29512	5 pts		Insomnia	below serious				4768
29513	6 pts		Decreased appetite	below serious				4768
29514	4 pts		Indigestion	below serious				4768
29515	5 pts		Soft stools	below serious				4768
29516	3 pts		Dry mouth	below serious				4768
29517	10 pts		Sleep decreased	below serious				4769
29518	9 pts		Daytime sleepiness	below serious				4769
29519	9 pts		Headache	below serious				4769
29520	9 pts		Nausea	below serious				4769
29521	7 pts		Dry mouth	below serious				4769
29522	5 pts		Agitation	below serious				4769
29523	5 pts		Dizziness	below serious				4769
29524	5 pts		Sweating	below serious				4769
29525			Serotonin syndrome		discontinuation			4766
29526			Suicidal ideation		discontinuation	WARNING		4767
29527			Serotonin syndrome		discontinuation	WARNING		4767
29528			Neuroleptic malignant syndrome		discontinuation	WARNING		4767
29529			Blood pressure increased		discontinuation	WARNING		4767
29530			Bleeding		discontinuation	WARNING		4767
29531			Glaucoma		discontinuation	WARNING		4767
29532			Mania		discontinuation	WARNING		4767
29533			Hypomania		discontinuation	WARNING		4767
29534			Cardiovascular disease, unspecified		discontinuation	WARNING		4767
29535			Unspecified cerebrovascular disease		discontinuation	WARNING		4767
29536			Elevated cholesterol		discontinuation	WARNING		4767
29537			Elevated triglycerides		discontinuation	WARNING		4767
29538			Seizure		discontinuation	WARNING		4767
29539			Hyponatremia		discontinuation	WARNING		4767
29540	33		Nausea	severe				4763
29541	67		Vomiting				TRUE	4763
29542	27		Vomiting			No adverse reactions leading to discontinuation were reported		4765
29543	67		Orthostatic hypotension				TRUE	4762
29544	67		Nausea			No adverse reactions leading to discontinuation were reported		4764
29545	5.3		Ejection fraction decreased		discontinuation			4776
29546	2.6		Prolonged neutropenia		discontinuation			4776
29547	21		Granulocytopenia	grade 4				4776
29548	8		Thrombocytopenia	grade 4				4776
29549	11		Febrile neutropenia	grade 4				4776
29550						No adverse effects leading to discontinuation were reported		4772
29551			Acute diverticular perforation		discontinuation		TRUE	4777
29552	100		Neutropenia	grade 4			TRUE	4771
29553	50		Leucopenia	grade 4			TRUE	4771
29554	16.7		Cardiac failure	grade 5	discontinuation			4771
29555	100		Neutropenia	grade 4			TRUE	4770
29556	100		Leucopenia	grade 4			TRUE	4770
29557	16.7		Thrombocytopenia	grade 4			TRUE	4770
29558	16.7		Anemia	grade 4			TRUE	4770
29559			Infusion related reaction	acute	discontinuation	WARNING		4775
29560			Myelosuppression	severe	discontinuation	WARNING		4775
29561			Cardiotoxicity		discontinuation	WARNING		4775
29562			Congestive heart failure		discontinuation	WARNING		4775
29563			Hepatic impairment		discontinuation	WARNING		4775
29564			Reaction anaphylactic anaphylactoid	grade 3-5	discontinuation	WARNING		4775
29565	4.2		Skin toxicity		discontinuation	Ten subjects (4.2%) discontinued treatment due to palmar-plantar skin eruptions or other skin toxicity.		4774
29566	0.9		Skin eruption		discontinuation			4773
29567	1 pts		Tremor			leads to discontinuation		4778
29568	2 pts		Tremor			leads to dose reduction		4778
29569	1 pts		Nervousness		discontinuation	leads to discontinuation		4779
29570	66.7		Tachycardia			All of the patients showed drug intolerance to isoproterenol hydrochloride. The dose at which intolerance developed ranged from 2.5 to 15 mg, with the most common level being 10 mg.		4782
29571	8.3		Premature ventricular contractions					4782
29572			Block heart		discontinuation	WARNING		4780
29573			Adams-Stokes syndrome		discontinuation	WARNING		4780
29574			Block heart		discontinuation	WARNING		4781
29575			Adams-Stokes syndrome		discontinuation	WARNING		4781
29576	5 pts		Irritability	below serious				4785
29577	1 pts		Urinary incontinence	below serious				4785
29578	1 pts		Double vision	below serious				4785
29579	1 pts		Nightmares	below serious				4785
29580	3 pts		Dyskinesia	below serious				4785
29581	2 pts		Sleep disturbance	below serious				4785
29582	5 pts		Strength loss of	below serious				4785
29583	2 pts		Visual hallucinations	below serious				4785
29584	1 pts		Crying	below serious				4785
29585	2 pts		Appetite suppressed	below serious				4785
29586	1 pts		Lightheadedness	below serious				4785
29587	1 pts		Wakefulness	below serious				4785
29588	2 pts		Anxiety	below serious				4785
29589	5 pts		Restless	below serious				4784
29590	5 pts		Insomnia	below serious				4784
29591	3 pts		Headache	below serious				4784
29592	3 pts		Anorexia	below serious				4784
29593	2 pts		Vivid dreams	below serious				4784
29594	2 pts		Nausea	below serious				4784
29595	1 pts		Syncope	serious				4787
29596	1 pts		Overdose	serious				4787
29597	9 pts		Abdominal pain upper	below serious				4787
29598	8 pts		Nausea	below serious				4787
29599	4 pts		Vomiting	below serious				4787
29600	4 pts		Irritability	below serious				4787
29601	5 pts		Pyrexia	below serious				4787
29602	3 pts		Gastroenteritis	below serious				4787
29603	3 pts		Influenza	below serious				4787
29604	14 pts		Nasopharyngitis	below serious				4787
29605	4 pts		Joint sprain	below serious				4787
29606	2 pts		Wrong drug administered	below serious				4787
29607	5 pts		Weight decreased	below serious				4787
29608	6 pts		Anorexia	below serious				4787
29609	17 pts		Decreased appetite	below serious				4787
29610	2 pts		Dizziness	below serious				4787
29611	22 pts		Headache	below serious				4787
29612	1 pts		Migraine	below serious				4787
29613	3 pts		Aggression	below serious				4787
29614	7 pts		Initial insomnia	below serious				4787
29615	9 pts		Insomnia	below serious				4787
29616	2 pts		Sleep disorder	below serious				4787
29617	3 pts		Tic	below serious				4787
29618	8 pts		Cough	below serious				4787
29619	1 pts		Tics	below serious				4786
29620	3 pts		Anxious mood	below serious				4786
29621	1 pts		Stomachache	below serious				4786
29622	3 pts		Trouble falling asleep	below serious				4786
29623	1 pts		Heart rate increased	below serious				4783
29624	1 pts		Chest tightness	below serious				4783
29625	6 pts		Insomnia	below serious				4783
29626	1 pts		Nightmares	below serious				4783
29627	2 pts		Fatigue	below serious				4783
29628	3 pts		Constipation	below serious				4783
29629	1 pts		Appetite impaired	below serious				4783
29630	2 pts		Agitation	below serious				4783
29631	1 pts		GI irritation	below serious				4783
29632	1 pts		Detachment emotional	below serious				4783
29633	1 pts		Spasms	below serious				4783
29634	3 pts		Back pain	below serious				4783
29635	2 pts		Muscle weakness	below serious				4783
29636	3 pts		Muscle pain	below serious				4783
29637	3 pts		Itching	below serious				4783
29638	2 pts		Rash	below serious				4783
29639	1 pts		Tingling sensation	below serious				4783
29640	2 pts		Dry mouth	below serious				4783
29641	1 pts		Shortness of breath	below serious				4783
29642	1 pts		Multiple sclerosis relapse	below serious				4783
29643			Abuse			WARNING		4791
29644			Hypertension	grade 1		Overdosage		4790
29645			Tachycardia	grade 1		Overdosage		4790
29646			Confusion			Overdosage		4790
29647			Irritability			Overdosage		4790
29648			Agitation			Overdosage		4790
29649			Hallucinations			Overdosage		4790
29650			Delusion			Overdosage		4790
29651	1.6		Headache		discontinuation			4789
29652	1.6		Nausea		discontinuation			4789
29653	1.6		Hot flushes		discontinuation			4789
29654	1.6		Panic attack		discontinuation			4789
29655	1.6		Nausea		discontinuation			4789
29656	1.6		Vomiting		discontinuation			4789
29657	1.6		Dizziness		discontinuation			4789
29658	1.5		Fatigue		discontinuation			4788
29659	1.5		Lethargy		discontinuation			4788
29660	1.5		Hypomania		discontinuation			4788
29661	1.5		Anger		discontinuation			4788
29662	1.5		Anxiety		discontinuation			4788
29663	1.5		Migraine		discontinuation			4788
29664	1.5		Depression		discontinuation			4788
29665	rare		Stevens-Johnson syndrome	grade 3-4				4793
29666	rare		Toxic epidermal necrolysis	grade 3-4				4793
29667	rare		Hepatic necrosis	grade 3-4				4793
29668	rare		Agranulocytosis	grade 3-4				4793
29669	rare		Aplastic anemia	grade 3-4				4793
29670	rare		Blood dyscrasia	grade 3-4				4793
29671	rare		Hypersensitivity reaction	grade 3-4				4793
29672	rare		Stevens-Johnson syndrome	grade 3-4				4792
29673	rare		Toxic epidermal necrolysis	grade 3-4				4792
29674	rare		Hepatic necrosis	grade 3-4				4792
29675	rare		Agranulocytosis	grade 3-4				4792
29676	rare		Aplastic anemia	grade 3-4				4792
29677	rare		Blood dyscrasia	grade 3-4				4792
29678	rare		Hypersensitivity reaction	grade 3-4				4792
29679						There may be an indication for its safe administration with doses up to 500 mg		4794
29680			Dystonia					4796
29681			Hyperreflexia					4796
29682						No SAEs were observed		4795
29683						No adverse reactions were reported		4797
29684						No adverse reactions were reported		4798
29685						No adverse reactions were reported		4799
29686			Delirium		discontinuation			4800
29687	1 pts		Pulmonary embolism	serious				4803
29688	1 pts		Respiratory failure	serious				4803
29689	61 pts		Nausea	below serious				4803
29690	44 pts		Vomiting	below serious				4803
29691	19 pts		Hypoxia	below serious				4803
29692	9 pts		Constipation	below serious				4803
29693	15 pts		Pruritus	below serious				4803
29694	13 pts		Dizziness	below serious				4803
29695	19 pts		Sedation	below serious				4803
29696	7 pts		Back pain	below serious				4803
29697	3 pts		Anxiety	below serious				4803
29698	4 pts		Restlessness	below serious				4803
29699	7 pts		Pruritus generalized	below serious				4803
29700	2 pts		Presyncope	below serious				4803
29701	6 pts		Somnolence	below serious				4803
29702	5.5					No AEs were reported		4801
29703	5.6					No deaths were reported. These outcomes were assessed as very low quality because of the limited number of participants and events.		4802
29704	1 pts		Rash	below serious				4808
29705	2 pts		Dyspepsia	below serious				4808
29706	1 pts		Pharyngitis	below serious				4808
29707	1 pts		Cystitis hemorrhagic	below serious				4808
29708	1 pts		Vomiting	below serious				4808
29709	1.5		Dyspepsia		discontinuation			4805
29710	1.5		Angioedema		discontinuation			4805
29711	3		Asthma		discontinuation			4805
29712	1.5		Ecchymosis		discontinuation			4805
29713	1.5		Myalgia		discontinuation			4805
29714	3		Dyspepsia				TRUE	4805
29715	3		Bleeding				TRUE	4805
29716	1.5		Asthma				TRUE	4805
29717	10		Dyspepsia		discontinuation			4804
29718	4.3		Urticaria		discontinuation			4804
29719	1.4		Asthma		discontinuation			4804
29720	1.4		Ecchymosis		discontinuation			4804
29721	1.4		Tinnitus		discontinuation			4804
29722	2.8		Dyspepsia				TRUE	4804
29723			Liver failure			Overdosage		4807
29724			Fever			Overdosage		4807
29725			Peptic ulcer			Overdosage		4807
29726			Upper gastrointestinal bleeding			Overdosage		4807
29727			Seizures			Overdosage		4806
29728	3 pts		Contusion	below serious				4811
29729	2 pts		Excoriation	below serious				4811
29730	7 pts		Rhinorrhea	below serious				4811
29731	5 pts		Cough	below serious				4811
29732	4 pts		Pharyngolaryngeal pain	below serious				4811
29733	3 pts		Nasal congestion	below serious				4811
29734	3 pts		Abdominal pain	below serious				4811
29735	4 pts		Diarrhoea	below serious				4811
29736	4 pts		Vomiting	below serious				4811
29737	2 pts		Toothache	below serious				4811
29738	7 pts		Headache	below serious				4811
29739	2 pts		Erythema	below serious				4811
29740	2 pts		Lymphadenopathy	below serious				4811
29741	2 pts		Decreased appetite	below serious				4811
29742	1 pts		Headache	below serious				4809
29743	1 pts		Abdominal pain	below serious				4809
29744	1 pts		Aphthous stomatitis	below serious				4809
29745	1 pts		Abdominal pain upper	below serious				4809
29746						No adverse reactions leading to discontinuation were mentioned		4812
29747			Hypersensitivity reaction		discontinuation	WARNING		4813
29748			Anaphylaxis		discontinuation	WARNING		4813
29749			Gastritis		discontinuation	WARNING		4813
29750			Hyperactivity		discontinuation	WARNING		4813
29751			Hyperactivity		discontinuation	The patient reported hyperactivity that began at an unspecified time after overdose and resolved after the Kuvan dose was reduced to 20 mg/kg per day		4810
29752						No AEs were observed		4814
29753	2.2		Myalgia		discontinuation			4815
29754	0.9		Diarrhea		discontinuation			4815
29755	0.8		Abdominal pain		discontinuation			4815
29756	0.5		Nausea		discontinuation			4815
29757	1.8		Myalgia		discontinuation			4816
29758	1.8		Diarrhoea	grade 3	discontinuation			4816
29759	1 pts		Transaminases increased		discontinuation	leads to discontinuation		4819
29760	1 pts		Fever		discontinuation	leads to discontinuation		4819
29761						suicide attempt		4818
29762	5 pts		Uric acid abnormal					4817
29763	33		Asthenia			There were no significant differences between groups in the type or frequency of adverse events		4820
29764	33		Abdominal pain			There were no significant differences between groups in the type or frequency of adverse events		4820
29765	25		Headache			There were no significant differences between groups in the type or frequency of adverse events		4820
29766	17		Diarrhea			There were no significant differences between groups in the type or frequency of adverse events		4820
29767	17		Dyspepsia			There were no significant differences between groups in the type or frequency of adverse events		4820
29768						No AEs are reported		4823
29769						impossible to link AEs with the definite dose: Five adverse events (headache, nausea, dizziness, vomiting, and rash) were selected for analysis on the basis of their incidence and potential for pharmacokinetic dependence during abacavir monotherapy		4821
29770	8		Hypersensitivity reaction	serious|grade 5		WARNING		4822
29771	2 pts		Hypoprothrombinemia		discontinuation	leads to discontinuation		4826
29772						No AEs are reported		4825
29773	20		Glutamic-oxaloacetic transaminase increased					4824
29774	20		Lactic dehydrogenase increased					4824
29775	20		Alkaline phosphatase increased					4824
29776	33		Blood bilirubin indirect					4827
29777	7		Jaundice		discontinuation	leads to discontinuation		4827
29778			Monomorphic ventricular tachycardia					4828
29779	15 pts		Infection	serious				4832
29780			Pseudomembranous colitis			WARNING		4830
29781						No information on AE is provided		4829
29782	14.3		Rash		discontinuation			4831
29783						No AEs are reported		4834
29784						impossible to link AEs with the definite dose		4835
29785						No AEs are reported		4833
29786	8 pts		Diarrhea	below serious				4838
29787	6 pts		Constipation	below serious				4838
29788	6 pts		Dry mouth	below serious				4838
29789	6 pts		Nausea and vomiting	below serious				4838
29790	5 pts		Dizziness on standing up	below serious				4838
29791	2 pts		Rash	below serious				4838
29792	4 pts		Perspiration excessive	below serious				4838
29793	2 pts		Dry skin	below serious				4838
29794	4 pts		Tremor	below serious				4838
29795	5 pts		Blurred vision	below serious				4838
29796	3 pts		Ringing in ears	below serious				4838
29797	2 pts		Urination frequency of	below serious				4838
29798	10 pts		Difficulty sleeping	below serious				4838
29799	7 pts		Sleep excessive	below serious				4838
29800	7 pts		Loss of libido	below serious				4838
29801	8 pts		Orgasm abnormal	below serious				4838
29802	5 pts		Erection decreased	below serious				4837
29803	7 pts		General malaise	below serious				4838
29804	10 pts		Fatigue	below serious				4838
29805	9 pts		Energy decreased	below serious				4838
29806	3 pts		Fatigue	below serious				4839
29807	1 pts		Insomnia	below serious				4839
29808	1 pts		Diarrhea	below serious				4839
29809	1 pts		Abdominal pain	below serious				4839
29810	1 pts		Sexual dysfunction	below serious				4839
29811	1 pts		Insomnia	below serious				4840
29812	11 pts		Itching	below serious				4841
29813	3 pts		Eye irritation	below serious				4841
29814	5 pts		Dry mouth	below serious				4841
29815	5 pts		Earache	below serious				4841
29816	5 pts		Hearing disability	below serious				4841
29817	11 pts		Throat pain	below serious				4841
29818	5 pts		Motor dysfunction	below serious				4841
29819	3 pts		Accidental injury	below serious				4841
29820	3 pts		Aggression	below serious				4841
29821	4 pts		Nightmares	below serious				4841
29822	3 pts		Mood variable	below serious				4841
29823	3 pts		Memory disturbance	below serious				4841
29824	2 pts		Hair loss	below serious				4841
29825						No AEs are reported		4836
29826	1 pts		Dizziness	mild		suicide attempt		4844
29827	1 pts		Drowsiness	mild		suicide attempt		4844
29828	1 pts		Seizures			suicide attempt		4843
29829	1 pts		Tachycardia			suicide attempt		4843
29830	1 pts		Neuromuscular disorders NEC			suicide attempt		4843
29831	1 pts		Hyperthermia	severe		suicide attempt		4843
29832	1		Asthenia		discontinuation	leads to discontinuation		4845
29833	4		Nausea		discontinuation	leads to discontinuation		4845
29834	1		Dry mouth		discontinuation	leads to discontinuation		4845
29835	1		Vomiting		discontinuation	leads to discontinuation		4845
29836	2		Dizziness		discontinuation	leads to discontinuation		4845
29837	3		Insomnia		discontinuation	leads to discontinuation		4845
29838	2		Somnolence		discontinuation	leads to discontinuation		4845
29839	1		Agitation		discontinuation	leads to discontinuation		4845
29840			Dizziness	grade 5				4842
29841			Sweating					4842
29842			Nausea					4842
29843			Vomiting					4842
29844			Tremor					4842
29845			Somnolence					4842
29846			Sinus tachycardia					4842
29847	1 pts		Tonsillitis	below serious				4847
29848	1 pts		Upper respiratory tract infection	below serious				4847
29849	1 pts		Headache	below serious				4847
29850	1 pts		Blepharitis	below serious				4847
29851	1 pts		Tonsillar hypertrophy	below serious				4847
29852	1 pts		Abdominal pain	below serious				4847
29853	1 pts		Enterocolitis	below serious				4847
29854	2 pts		Stomatitis	below serious				4847
29855	1 pts		Dermatitis atopic	below serious				4847
29856	1 pts		Dyshidrosis	below serious				4847
29857	1 pts		Skin papilloma	below serious				4847
29858	2 pts		Asthenia	below serious				4847
29859	1 pts		Malaise	below serious				4847
29860	1 pts		Arthropod bite	below serious				4847
29861	7 pts		Headache	below serious				4846
29862			Agitation			Overdosage		4851
29863			Vomiting			Overdosage		4851
29864	16.7		Hyponatremia			WARNING	TRUE	4848
29865	33.3		Hyponatremia	grade 3		WARNING	TRUE	4852
29866	100		Hyponatremia	grade 3		WARNING	TRUE	4853
29867	50		Hypertonia	grade 3		WARNING	TRUE	4853
29868	0.7		Nasal discomfort		discontinuation			4850
29869	0.7		Hyponatremia		discontinuation			4850
29870	0.2		Dizziness		discontinuation			4850
29871	0.2		Blood sodium decreased		discontinuation			4850
29872	0.2		Dysuria		discontinuation			4850
29873	0.4		Nasal congestion		discontinuation			4850
29874	0.2		Nasal discomfort		discontinuation			4849
29875	0.2		Hyponatremia		discontinuation	WARNING		4849
29876	0.4		Dizziness		discontinuation			4849
29877	0.4		Blood sodium decreased		discontinuation			4849
29878	0.4		Dysuria		discontinuation			4849
29879	0.2		Nasal congestion		discontinuation			4849
29880						No information on AE is provided, survived		4856
29881						No information on AE is provided, survived		4854
29882	33		Dry mouth					4855
29883	40		Dizziness					4855
29884	27		Vision blurred					4855
29885	14		Nausea					4855
29886	9		Somnolence					4855
29887	7		Asthenia					4855
29888	6		Nervousness					4855
29889			Defect conduction intraventricular					4857
29890			Defect conduction intraventricular					4858
29891			QT interval prolonged					4859
29892			Torsade de pointes					4859
29893			PR interval prolonged					4859
29894			QRS prolonged					4859
29895			Atrioventricular block	grade 3-5				4859
29896			Cardiac arrest	grade 3-5				4859
29897			Arrhythmia ventricular	grade 3-5				4859
29898						No adverse reactions leading to discontinuation observed		4861
29899						No adverse reactions leading to discontinuation observed		4860
29900						No adverse reactions leading to discontinuation observed		4862
29901			Myocardial ischemia			WARNINGS		4863
29902			Myocardial infarction			WARNINGS		4863
29903			Prinzmetal angina			WARNINGS		4863
29904			Arrhythmia		discontinuation	WARNINGS		4863
29905			Chest pain			WARNINGS		4863
29906			Throat pain			WARNINGS		4863
29907			Neck pain			WARNINGS		4863
29908			Jaw pain			WARNINGS		4863
29909			Chest tightness			WARNINGS		4863
29910			Throat tightness			WARNINGS		4863
29911			Neck tightness			WARNINGS		4863
29912			Pressure			WARNINGS		4863
29913			Chest heaviness			WARNINGS		4863
29914			Cerebral hemorrhage		discontinuation	WARNINGS		4863
29915			Subarachnoid hemorrhage		discontinuation	WARNINGS		4863
29916			Stroke		discontinuation	WARNINGS		4863
29917			Gastrointestinal ischemia		discontinuation	WARNINGS		4863
29918			Peripheral vasoconstriction		discontinuation	WARNINGS		4863
29919			Serotonin syndrome		discontinuation	WARNINGS		4863
29920			Splenic infarction		discontinuation	WARNINGS		4864
29921			Raynaud's syndrome		discontinuation	WARNINGS		4864
29922			Blood pressure high	grade 3	discontinuation	WARNINGS		4864
29923			Hypertensive crisis		discontinuation	WARNINGS		4864
29924			Anaphylactic reaction	grade 4-5	discontinuation	WARNINGS		4864
29925			Anaphylactoid reaction	grade 4-5	discontinuation	WARNINGS		4864
29926			Angioedema	grade 4-5	discontinuation	WARNINGS		4864
29927	15 pts		Vomiting		discontinuation	leads to discontinuation		4868
29928	3 pts		Diarrhea		discontinuation	leads to discontinuation		4868
29929	2 pts		Dehydration		discontinuation	leads to discontinuation		4868
29930	2 pts		Maculopapular rash		discontinuation	leads to discontinuation		4868
29931	1 pts		Hyperglycemia		discontinuation	leads to discontinuation		4865
29932	1 pts		Hyperglycemia		discontinuation	leads to discontinuation		4866
29933	1 pts		Hyperglycemia		discontinuation	leads to discontinuation		4867
29934						Side effects were minimal and well-tolerated, without any details		4869
29935	1 pts		Thrombophlebitis		discontinuation	leads to discontinuation		4870
29936	1 pts		Ischaemia	acute	discontinuation	leads to discontinuation		4870
29937	1 pts		Bradycardia	extreme	discontinuation	leads to discontinuation		4871
29938	1 pts		Death	serious				4877
29939	2 pts		Syncope	serious				4877
29940	1 pts		Pneumonia	serious				4877
29941	1 pts		Retinal detachment	serious				4877
29942	1 pts		Rectal haemorrhage	serious				4877
29943	1 pts		Pneumoconiosis	serious				4877
29944	7 pts		Nasopharyngitis	below serious				4877
29945	4 pts		Nausea	below serious				4877
29946	3 pts		Upper respiratory tract infection	below serious				4877
29947	1 pts		Agranulocytosis	serious				4876
29948	1 pts		Anemia	serious				4876
29949	1 pts		Acute pancreatitis	serious				4876
29950	1 pts		Acute pyelonephritis	serious				4876
29951	1 pts		Sepsis	serious				4876
29952	1 pts		Concussion	serious				4876
29953	1 pts		Poisoning	serious				4876
29954	1 pts		Follicle centre lymphoma diffuse small cell lymphoma	serious				4876
29955	1 pts		Malignant tongue neoplasm	serious				4876
29956	1 pts		Transient ischaemic attack	serious				4876
29957	1 pts		Pulmonary embolism	serious				4876
29958	2 pts		Deep vein thrombosis	serious				4876
29959	4 pts		Influenza	below serious				4876
29960	8 pts		Arthralgia	below serious				4876
29961	4 pts		Rheumatoid arthritis	below serious				4876
29962						No AEs are reported		4875
29963	4		Gastrointestinal disorder (NOS)		discontinuation	leads to discontinuation		4873
29964	2		Musculoskeletal disorder NOS		discontinuation	leads to discontinuation		4873
29965	4		Gastrointestinal disorder (NOS)		discontinuation	leads to discontinuation		4874
29966	2		Musculoskeletal disorder NOS		discontinuation	leads to discontinuation		4874
29967	4		Gastrointestinal disorder (NOS)		discontinuation	leads to discontinuation		4872
29968	1		Musculoskeletal disorder NOS		discontinuation	leads to discontinuation		4872
29969	7 pts		Anaemia	below serious				4882
29970	2 pts		Hypochloraemia	below serious				4882
29971	3 pts		Thrombocytopenia	below serious				4882
29972	3 pts		Hyponatraemia	below serious				4882
29973	2 pts		Hypokalaemia	below serious				4882
29974	2 pts		Blood urea nitrogen increased	below serious				4882
29975	1 pts		Nonprotein nitrogen increased	below serious				4882
29976	1 pts		Leucopenia	below serious				4882
29977	12 pts		Hypercapnia	below serious				4883
29978	12 pts		Thrombocytopenia	below serious				4883
29979	33 pts		NPN increased	below serious				4883
29980	38 pts		Leukocytosis	below serious				4883
29981	4 pts		Monocytosis	below serious				4883
29982	20 pts		Hypokalaemia	below serious				4883
29983	3 pts		Hyperkalaemia	below serious				4883
29984	4 pts		Blood urea decreased	below serious				4883
29985	10 pts		Hyponatraemia	below serious				4883
29986						No serious AEs reported		4878
29987						No serious AEs reported		4880
29988						No serious AEs reported		4879
29989	58		Nausea					4881
29990	44		Intermittent pyrexia					4881
29991	29		Constipation					4881
29992	28		Vomiting					4881
29993	24		Nasal passage irritation					4881
29994	24		Headache					4881
29995	23		Flatulence					4881
29996	19		Anemia					4881
29997	14		Tachycardia					4881
29998	12		Wound secretion					4881
29999	11		Pruritis					4881
30000	6		Dizziness					4881
30001	1.4		Gastrointestinal disorder		discontinuation	leads to discontinuation		4884
30002	1.4		Gastrointestinal disorder		discontinuation	leads to discontinuation		4885
30003	0.6		Nausea		discontinuation	leads to discontinuation		4884
30004	0.6		Nausea		discontinuation	leads to discontinuation		4885
30005	0.4		Vomiting		discontinuation	leads to discontinuation		4884
30006	0.4		Vomiting		discontinuation	leads to discontinuation		4885
30007	0.3		Dizziness		discontinuation	leads to discontinuation		4884
30008	0.3		Dizziness		discontinuation	leads to discontinuation		4885
30009	0.2		Headache		discontinuation	leads to discontinuation		4884
30010	0.2		Headache		discontinuation	leads to discontinuation		4885
30011	1.2		Gastrointestinal disorder		discontinuation	leads to discontinuation		4886
30012	0.6		Nausea		discontinuation	leads to discontinuation		4886
30013	0.5		Vomiting		discontinuation	leads to discontinuation		4886
30014	0.3		Dizziness		discontinuation	leads to discontinuation		4886
30015	0.3		Headache		discontinuation	leads to discontinuation		4886
30016	1 pts		Bigeminal rhythm		discontinuation	leads to discontinuation		4887
30017	1 pts		Cardiovascular insufficiency	serious				4891
30018	1 pts		Supraventricular tachycardia	serious				4891
30019	1 pts		Abdominal rigidity	serious				4891
30020	1 pts		Acute abdomen	serious				4891
30021	1 pts		Crohn's disease	serious				4891
30022	1 pts		Haematemesis	serious				4891
30023	1 pts		Chest pain	serious				4891
30024	1 pts		Pyrexia	serious				4891
30025	1 pts		Arthritis infective	serious				4891
30026	1 pts		Carbuncle	serious				4891
30027	1 pts		Cystitis	serious				4891
30028	1 pts		Lower respiratory tract infection	serious				4891
30029	1 pts		Lung infection	serious				4891
30030	1 pts		Nasopharyngitis	serious				4891
30031	4 pts		Urinary tract infection	serious				4891
30032	2 pts		Head injury	serious				4891
30033	1 pts		Laceration	serious				4891
30034	1 pts		Loss of consciousness	serious				4891
30035	1 pts		Transient ischaemic attack	serious				4891
30036	1 pts		Delirium	serious				4891
30037	1 pts		Prostatomegaly	serious				4891
30038	1 pts		Dysphonia	serious				4891
30039	2 pts		Dyspnoea	serious				4891
30040	1 pts		Respiratory distress	serious				4891
30041	3 pts		Respiratory failure	serious				4891
30042	1 pts		Gastrostomy	serious				4891
30043	1 pts		Hip arthroplasty	serious				4891
30044	1 pts		Inguinal hernia repair	serious				4891
30045	1 pts		Knee arthroplasty	serious				4891
30046	1 pts		Prostatectomy	serious				4891
30047	1 pts		Tracheostomy	serious				4891
30048	1 pts		Transurethral prostatectomy	serious				4891
30049	1 pts		Blood pressure labile	serious				4891
30050	3 pts		Orthostatic hypotension	serious				4891
30051	9 pts		Oedema peripheral	below serious				4891
30052	6 pts		Orthostatic hypotension	below serious				4891
30053	1 pts		Sick sinus syndrome	serious				4892
30054	1 pts		Appendicitis	serious				4892
30055	1 pts		Nerve injury, peripheral	serious				4892
30056	1 pts		Parkinson's disease	serious				4892
30057	1 pts		Transient ischaemic attack	serious				4892
30058	1 pts		Delusional perception	serious				4892
30059	1 pts		Venous stenosis	serious				4892
30060	1 pts		Transient ischaemic attack	serious				4893
30061	5 pts		Arthralgia	below serious				4893
30062	7 pts		Dizziness	below serious				4893
30063	5 pts		Headache	below serious				4893
30064	5 pts		Orthostatic hypotension	below serious				4893
30065	12 pts		General system disorders NEC	below serious				4896
30066	11 pts		Infection	below serious				4896
30067	11 pts		Injury, poisoning and procedural complications	below serious				4896
30068	6 pts		Laboratory test abnormality	below serious				4896
30069	1 pts		Leukoplakia oral	serious				4894
30070	1 pts		Spinal compression fracture	serious				4894
30071	1 pts		Intracranial aneurysm	serious				4894
30072	1 pts		Atrial fibrillation	serious				4895
30073	2 pts		Uric acid abnormal	below serious				4895
30074	3 pts		Blood pressure increased	below serious				4895
30075	2 pts		TSH increased	below serious				4895
30076	2 pts		Fall	below serious				4895
30077						No statistically significant differences were found between the incidence of adverse events by body system in each treatment arm and placebo, between the incidence of most commonly reported adverse events in rasagiline-treated patients (all doses together) and placebo or between adverse events commonly associated with dopaminergic medications in rasagilinetreated patients (all doses together) and placebo		4899
30078						No AEs are reported		4900
30079						No AEs are reported		4897
30080	1 pts		Ear discomfort					4898
30081	1 pts		Musculoskeletal pain					4898
30082			Hallucinations		discontinuation	leads to discontinuation		4890
30083	1 pts		Serotonin syndrome			suicide attempt		4888
30084	1 pts		Hypertension			dose error		4889
30085	1 pts		Orthostatic hypotension			dose error		4889
30086			Ototoxicity					4906
30087			Nephrotoxicity					4906
30088			Ototoxicity					4905
30089			Nephrotoxicity					4905
30090			Ototoxicity					4904
30091			Nephrotoxicity					4904
30092			Ototoxicity					4903
30093			Nephrotoxicity					4903
30094			Vestibular toxicity					4904
30095			Vestibular toxicity					4903
30096	1.7		Hypersensitivity		discontinuation			4902
30097	0.84		Disorder vestibular		discontinuation	1 patient		4902
30098	1.06		Heartburn		discontinuation	1 patient		4901
30099	1.06		Fatigue		discontinuation	1 patient		4901
30100	1 pts		Squamous cell carcinoma	serious				4910
30101	4 pts		Hyperkalaemia	below serious				4910
30102						No AEs are reported		4912
30103						No AEs are reported		4907
30104			Malignant or unspecified tumours (SMQ)			WARNING		4909
30105			Infection	serious		WARNING		4909
30106						No AEs are reported		4908
30107						No AEs are reported		4911
30108			Anemia		discontinuation	leads to discontinuation		4913
30109			Edema lung		discontinuation	leads to discontinuation		4913
30110			Allergic reaction		discontinuation	leads to discontinuation		4913
30111			Abnormal liver function tests		discontinuation	leads to discontinuation		4913
30112			Bilirubinemia		discontinuation	leads to discontinuation		4913
30113			Lymphoma like reaction		discontinuation	leads to discontinuation		4913
30114			Diarrhea		discontinuation	leads to discontinuation		4913
30115			Intestinal obstruction		discontinuation	leads to discontinuation		4913
30116	6.9		Urinary retention		discontinuation			4914
30117	0.2		Voiding difficulty	moderate	discontinuation			4915
30118	2.4		Dry mouth		discontinuation			4915
30119	1		Dry mouth		discontinuation			4916
30120	common		Dizziness		discontinuation	7% of patients treated with DETROL 2 mg bid discontinued treatment due to adverse events; the most common adverse events leading to discontinuation of DETROL were dizziness and headache.		4916
30121	common		Headache		discontinuation	7% of patients treated with DETROL 2 mg bid discontinued treatment due to adverse events; the most common adverse events leading to discontinuation of DETROL were dizziness and headache.		4916
30122	16.7		Dizziness	grade 2	discontinuation		TRUE	4918
30123	33.3		Asthenia	grade 2	discontinuation		TRUE	4917
30124	33.3		Weakness of limbs	grade 2	discontinuation		TRUE	4917
30125	33.3		Nausea	grade 2	discontinuation		TRUE	4917
30126	33.3		Vomiting	grade 2	discontinuation		TRUE	4917
30127			Sweating		discontinuation			4922
30128			Nystagmus		discontinuation			4922
30129			Generalised spasm		discontinuation			4922
30130			Tachycardia		discontinuation			4922
30131			Restlessness		discontinuation			4921
30132			Drowsiness		discontinuation			4921
30133			Sweating		discontinuation			4921
30134			Muscle contractions involuntary		discontinuation			4921
30135			Cyanosed		discontinuation			4921
30136			Cyanosis		discontinuation			4921
30137			Dyspnea		discontinuation			4921
30138			Spasms		discontinuation			4921
30139			Acute renal failure		discontinuation			4921
30140			Hyperpyrexia		discontinuation			4921
30141			Headache	severe	discontinuation			4919
30142			Obtundation		discontinuation			4919
30143			Hypertension		discontinuation			4919
30144			Electrocardiogram T wave peaked		discontinuation			4919
30145			Hyperthermia		discontinuation			4920
30146			Delirium		discontinuation			4920
30147			Thrombocytopenia		discontinuation			4920
30148			Suicidal tendency		discontinuation	WARNING		4923
30149			Suicidal behavior		discontinuation	WARNING		4923
30150			Hypertensive crisis		discontinuation	WARNING		4923
30151			Serotonin syndrome		discontinuation	WARNING		4923
30152			Mania		discontinuation	WARNING		4923
30153			Hypomania		discontinuation	WARNING		4923
30154			Hypotension		discontinuation	WARNING		4923
30155			Hepatotoxicity		discontinuation	WARNING		4923
30156			Administration site irritation		discontinuation	WARNING		4926
30157	16.7		Neutropenia	grade 4			TRUE	4924
30158	16.7		Ileus	grade 4			TRUE	4924
30159	50		Neutropenia	grade 4			TRUE	4928
30160	25		Fatigue	grade 3			TRUE	4928
30161	33.3		Neutropenia	grade 4			TRUE	4927
30162	33.3		Ileus	grade 4			TRUE	4927
30163	33.3		Neutropenic fever	grade 4			TRUE	4927
30164	66.7		Neutropenia	grade 4			TRUE	4925
30165	16.7		Sepsis	grade 5	discontinuation		TRUE	4925
30166	2 pts		Angina pectoris	serious				4931
30167	1 pts		Thyroid mass	serious				4931
30168	2 pts		Abdominal pain	serious				4931
30169	1 pts		Dyspepsia	serious				4931
30170	1 pts		Gastrooesophageal reflux disease	serious				4931
30171	1 pts		Nausea	serious				4931
30172	1 pts		Pancreatitis	serious				4931
30173	1 pts		Rectal haemorrhage	serious				4931
30174	1 pts		Rectal prolapse	serious				4931
30175	1 pts		Vomiting	serious				4931
30176	2 pts		Non-cardiac chest pain	serious				4931
30177	1 pts		Cholecystitis	serious				4931
30178	1 pts		Hypersensitivity	serious				4931
30179	1 pts		Pelvic abscess	serious				4931
30180	1 pts		Sepsis	serious				4931
30181	1 pts		Femur fracture	serious				4931
30182	1 pts		Dehydration	serious				4931
30183	1 pts		Hypocalcaemia	serious				4931
30184	1 pts		Arthritis	serious				4931
30185	1 pts		Osteoarthritis	serious				4931
30186	1 pts		Pain in extremity	serious				4931
30187	1 pts		Basal cell carcinoma	serious				4931
30188	1 pts		Malignant peritoneal neoplasm	serious				4931
30189	1 pts		Ovarian cancer	serious				4931
30190	1 pts		Global amnesia	serious				4931
30191	1 pts		Psychotic disorder	serious				4931
30192	1 pts		Bladder prolapse	serious				4931
30193	1 pts		Pollakiuria	serious				4931
30194	1 pts		Renal failure acute	serious				4931
30195	1 pts		Endometrial metaplasia	serious				4931
30196	1 pts		Arterial occlusive disease	serious				4931
30197	1 pts		Hypertension	serious				4931
30198	1 pts		Leriche syndrome	serious				4931
30199	1 pts		Varicose vein	serious				4931
30200	11 pts		Abdominal pain	below serious				4931
30201	13 pts		Dyspepsia	below serious				4931
30202	34 pts		Nausea	below serious				4931
30203	14 pts		Vomiting	below serious				4931
30204	12 pts		Asthenia	below serious				4931
30205	36 pts		Chills	below serious				4931
30206	29 pts		Fatigue	below serious				4931
30207	11 pts		Oedema peripheral	below serious				4931
30208	48 pts		Pain	below serious				4931
30209	43 pts		Pyrexia	below serious				4931
30210	27 pts		Nasopharyngitis	below serious				4931
30211	27 pts		Upper respiratory tract infection	below serious				4931
30212	7 pts		Hypercholesterolaemia	below serious				4931
30213	54 pts		Arthralgia	below serious				4931
30214	36 pts		Back pain	below serious				4931
30215	10 pts		Bone pain	below serious				4931
30216	11 pts		Muscle spasms	below serious				4931
30217	38 pts		Myalgia	below serious				4931
30218	22 pts		Pain in extremity	below serious				4931
30219	15 pts		Dizziness	below serious				4931
30220	29 pts		Headache	below serious				4931
30221	11 pts		Hypoaesthesia	below serious				4931
30222	17 pts		Cough	below serious				4931
30223	4 pts		Anaemia	serious				4933
30224	1 pts		Anaemia iron deficiency	serious				4933
30225	1 pts		Pancytopenia	serious				4933
30226	2 pts		Acute myocardial infarction	serious				4933
30227	3 pts		Angina pectoris	serious				4933
30228	1 pts		Arrhythmia	serious				4933
30229	12 pts		Atrial fibrillation	serious				4933
30230	1 pts		Atrioventricular block	serious				4933
30231	1 pts		Atrioventricular block complete	serious				4933
30232	2 pts		Bradycardia	serious				4933
30233	1 pts		Cardiac disorder	serious				4933
30234	4 pts		Cardiac failure	serious				4933
30235	3 pts		Cardiac failure congestive	serious				4933
30236	3 pts		Coronary artery disease	serious				4933
30237	5 pts		Myocardial infarction	serious				4933
30238	2 pts		Myocardial ischaemia	serious				4933
30239	1 pts		Palpitations	serious				4933
30240	1 pts		Tinnitus	serious				4933
30241	1 pts		Vertigo positional	serious				4933
30242	1 pts		Eye pain	serious				4933
30243	1 pts		Retinal artery embolism	serious				4933
30244	1 pts		Trichiasis	serious				4933
30245	1 pts		Abdominal distension	serious				4933
30246	3 pts		Abdominal pain	serious				4933
30247	2 pts		Colitis	serious				4933
30248	1 pts		Colitis ischaemic	serious				4933
30249	1 pts		Constipation	serious				4933
30250	1 pts		Diverticulum intestinal haemorrhagic	serious				4933
30251	1 pts		Duodenal ulcer haemorrhage	serious				4933
30252	1 pts		Femoral hernia, obstructive	serious				4933
30253	3 pts		Gastric ulcer	serious				4933
30254	1 pts		Gastric ulcer haemorrhage	serious				4933
30255	1 pts		Gastritis erosive	serious				4933
30256	2 pts		Ileus	serious				4933
30257	1 pts		Intestinal haemorrhage	serious				4933
30258	2 pts		Intestinal polyp	serious				4933
30259	1 pts		Pancreatitis acute	serious				4933
30260	1 pts		Small intestinal obstruction	serious				4933
30261	1 pts		Subileus	serious				4933
30262	3 pts		Vomiting	serious				4933
30263	1 pts		Accidental death	serious				4933
30264	1 pts		Asthenia	serious				4933
30265	1 pts		Fatigue	serious				4933
30266	1 pts		General physical health deterioration	serious				4933
30267	1 pts		Healing impaired	serious				4933
30268	1 pts		Malaise	serious				4933
30269	1 pts		Multi-organ failure	serious				4933
30270	1 pts		Necrosis	serious				4933
30271	1 pts		Acute hepatic failure	serious				4933
30272	1 pts		Hepatic failure	serious				4933
30273	1 pts		Bronchitis bacterial	serious				4933
30274	3 pts		Cellulitis	serious				4933
30275	1 pts		Clostridial infection	serious				4933
30276	2 pts		Erysipelas	serious				4933
30277	2 pts		Osteomyelitis	serious				4933
30278	1 pts		Chronic osteomyelitis	serious				4933
30279	1 pts		Pneumococcal sepsis	serious				4933
30280	10 pts		Pneumonia	serious				4933
30281	1 pts		Pneumonia influenzal	serious				4933
30282	1 pts		Pyelonephritis	serious				4933
30283	1 pts		Sepsis	serious				4933
30284	1 pts		Brain contusion	serious				4933
30285	1 pts		Comminuted fracture	serious				4933
30286	1 pts		Concussion	serious				4933
30287	2 pts		Excoriation	serious				4933
30288	2 pts		Femoral neck fracture	serious				4933
30289	3 pts		Femur fracture	serious				4933
30290	1 pts		Forearm fracture	serious				4933
30291	1 pts		Fracture	serious				4933
30292	2 pts		Fractured ischium	serious				4933
30293	1 pts		Hand fracture	serious				4933
30294	1 pts		Patella fracture	serious				4933
30295	1 pts		Post-traumatic pain	serious				4933
30296	1 pts		Procedural pain	serious				4933
30297	2 pts		Pubic rami fracture	serious				4933
30298	1 pts		Radius fracture	serious				4933
30299	2 pts		Fracture rib	serious				4933
30300	1 pts		Scapula fracture	serious				4933
30301	1 pts		Spinal fracture	serious				4933
30302	1 pts		Sternal fracture	serious				4933
30303	5 pts		Subdural haematoma	serious				4933
30304	1 pts		Haemorrhage subdural	serious				4933
30305	1 pts		Tibia fracture	serious				4933
30306	1 pts		Upper limb fracture	serious				4933
30307	1 pts		Blood glucose decreased	serious				4933
30308	1 pts		Cachexia	serious				4933
30309	1 pts		Diabetes mellitus	serious				4933
30310	1 pts		Failure to thrive	serious				4933
30311	1 pts		Hyperkalaemia	serious				4933
30312	7 pts		Back pain	serious				4933
30313	1 pts		Foot deformity	serious				4933
30314	1 pts		Joint swelling	serious				4933
30315	1 pts		Muscle haemorrhage	serious				4933
30316	6 pts		Osteoarthritis	serious				4933
30317	2 pts		Pain in extremity	serious				4933
30318	1 pts		Periarthritis	serious				4933
30319	1 pts		Polymyalgia rheumatica	serious				4933
30320	3 pts		Spinal column stenosis	serious				4933
30321	1 pts		Bowen's disease	serious				4933
30322	7 pts		Breast cancer	serious				4933
30323	1 pts		Chronic lymphocytic leukaemia	serious				4933
30324	1 pts		Colon neoplasm	serious				4933
30325	1 pts		Gastrointestinal carcinoma	serious				4933
30326	1 pts		Gastrointestinal neoplasm	serious				4933
30327	1 pts		Gastrointestinal tract adenoma	serious				4933
30328	1 pts		Haemangioma	serious				4933
30329	1 pts		Hodgkin's disease	serious				4933
30330	1 pts		Intestinal adenocarcinoma	serious				4933
30331	1 pts		Lipoma	serious				4933
30332	3 pts		Lung neoplasm malignant	serious				4933
30333	1 pts		Meningioma	serious				4933
30334	1 pts		Metastases to chest wall	serious				4933
30335	1 pts		Metastatic neoplasm	serious				4933
30336	1 pts		Morton's neuroma	serious				4933
30337	1 pts		Myelodysplastic syndrome	serious				4933
30338	1 pts		Seborrhoeic keratosis	serious				4933
30339	1 pts		Skin cancer	serious				4933
30340	3 pts		Squamous cell carcinoma	serious				4933
30341	1 pts		Anoxic encephalopathy	serious				4933
30342	1 pts		Aphasia	serious				4933
30343	1 pts		Brain injury	serious				4933
30344	2 pts		Cerebral haemorrhage	serious				4933
30345	6 pts		Cerebrovascular accident	serious				4933
30346	2 pts		Convulsion	serious				4933
30347	1 pts		Dementia	serious				4933
30348	4 pts		Dizziness	serious				4933
30349	2 pts		Hemiparesis	serious				4933
30350	1 pts		Lacunar infarction	serious				4933
30351	2 pts		Loss of consciousness	serious				4933
30352	1 pts		Myelopathy	serious				4933
30353	1 pts		Nerve compression	serious				4933
30354	1 pts		Somnolence	serious				4933
30355	1 pts		Haemorrhage subarachnoid	serious				4933
30356	1 pts		Syncope	serious				4933
30357	1 pts		Thalamic infarction	serious				4933
30358	7 pts		Transient ischaemic attack	serious				4933
30359	1 pts		Vertebrobasilar insufficiency	serious				4933
30360	2 pts		Anxiety	serious				4933
30361	1 pts		Confusional state	serious				4933
30362	2 pts		Delirium	serious				4933
30363	1 pts		Depression	serious				4933
30364	1 pts		Major depression	serious				4933
30365	1 pts		Nephrolithiasis	serious				4933
30366	1 pts		Renal cyst	serious				4933
30367	1 pts		Renal failure acute	serious				4933
30368	1 pts		Bartholin's cyst	serious				4933
30369	1 pts		Breast mass	serious				4933
30370	1 pts		Genital prolapse	serious				4933
30371	1 pts		Uterovaginal prolapse	serious				4933
30372	1 pts		Haemorrhage vaginal	serious				4933
30373	2 pts		Asthma	serious				4933
30374	1 pts		Bronchospasm	serious				4933
30375	1 pts		Dyspnoea	serious				4933
30376	1 pts		Emphysema	serious				4933
30377	1 pts		Mediastinal haemorrhage	serious				4933
30378	1 pts		Obstructive airways disorder	serious				4933
30379	1 pts		Pneumonitis	serious				4933
30380	2 pts		Pulmonary oedema	serious				4933
30381	1 pts		Dermatitis allergic	serious				4933
30382	1 pts		Social problem	serious				4933
30383	2 pts		Aortic stenosis	serious				4933
30384	1 pts		Arterial disorder	serious				4933
30385	1 pts		Arteriosclerosis	serious				4933
30386	3 pts		Deep vein thrombosis	serious				4933
30387	1 pts		Embolism	serious				4933
30388	1 pts		Femoral arterial stenosis	serious				4933
30389	2 pts		Hypertension	serious				4933
30390	1 pts		Hypotension	serious				4933
30391	1 pts		Orthostatic hypotension	serious				4933
30392	1 pts		Peripheral arterial occlusive disease	serious				4933
30393	2 pts		Varicose vein	serious				4933
30394	24 pts		Fatigue	below serious				4933
30395	30 pts		Pyrexia	below serious				4933
30396	32 pts		Influenza	below serious				4933
30397	119 pts		Arthralgia	below serious				4933
30398	113 pts		Back pain	below serious				4933
30399	30 pts		Bone pain	below serious				4933
30400	34 pts		Musculoskeletal pain	below serious				4933
30401	28 pts		Myalgia	below serious				4933
30402	55 pts		Osteoarthritis	below serious				4933
30403	5 pts		Anaemia	serious				4932
30404	1 pts		Coagulopathy	serious				4932
30405	2 pts		Anaemia iron deficiency	serious				4932
30406	1 pts		Pancytopenia	serious				4932
30407	2 pts		Acute coronary syndrome	serious				4932
30408	4 pts		Acute myocardial infarction	serious				4932
30409	6 pts		Angina pectoris	serious				4932
30410	1 pts		Aortic valve disease	serious				4932
30411	1 pts		Aortic valve stenosis	serious				4932
30412	1 pts		Arrhythmia	serious				4932
30413	1 pts		Atrioventricular block	serious				4932
30414	1 pts		Bradyarrhythmia	serious				4932
30415	4 pts		Bradycardia	serious				4932
30416	2 pts		Bundle branch block left	serious				4932
30417	1 pts		Cardiac disorder	serious				4932
30418	9 pts		Cardiac failure	serious				4932
30419	5 pts		Cardiac failure congestive	serious				4932
30420	2 pts		Cardio-respiratory arrest	serious				4932
30421	1 pts		Congestive cardiomyopathy	serious				4932
30422	4 pts		Coronary artery disease	serious				4932
30423	2 pts		Coronary artery occlusion	serious				4932
30424	1 pts		Fibrosis myocardial	serious				4932
30425	2 pts		Myocardial ischaemia	serious				4932
30426	1 pts		Palpitations	serious				4932
30427	2 pts		Supraventricular tachycardia	serious				4932
30428	1 pts		Tachyarrhythmia	serious				4932
30429	1 pts		Tachycardia	serious				4932
30430	1 pts		Ventricular extrasystoles	serious				4932
30431	1 pts		Dermoid cyst	serious				4932
30432	1 pts		Deafness bilateral	serious				4932
30433	1 pts		Meniere's disease	serious				4932
30434	1 pts		Ototoxicity	serious				4932
30435	1 pts		Amaurosis fugax	serious				4932
30436	13 pts		Cataract	serious				4932
30437	1 pts		Eye disorder	serious				4932
30438	2 pts		Retinal detachment	serious				4932
30439	1 pts		Abdominal hernia	serious				4932
30440	8 pts		Abdominal pain	serious				4932
30441	2 pts		Abdominal pain upper	serious				4932
30442	1 pts		Abdominal strangulated hernia	serious				4932
30443	1 pts		Anal polyp	serious				4932
30444	1 pts		Colitis	serious				4932
30445	5 pts		Colonic polyp	serious				4932
30446	1 pts		Colonic stenosis	serious				4932
30447	2 pts		Constipation	serious				4932
30448	4 pts		Diarrhoea	serious				4932
30449	2 pts		Diverticulum	serious				4932
30450	3 pts		Diverticulum intestinal	serious				4932
30451	1 pts		Dyspepsia	serious				4932
30452	1 pts		Enteritis	serious				4932
30453	2 pts		Gastric ulcer	serious				4932
30454	1 pts		Gastric ulcer haemorrhage	serious				4932
30455	1 pts		Gastritis erosive	serious				4932
30456	2 pts		Gastrointestinal haemorrhage	serious				4932
30457	1 pts		Gastrooesophageal reflux disease	serious				4932
30458	2 pts		Haematochezia	serious				4932
30459	1 pts		Ileal perforation	serious				4932
30460	1 pts		Ileus paralytic	serious				4932
30461	1 pts		Intestinal large ulcer	serious				4932
30462	1 pts		Mechanical ileus	serious				4932
30463	1 pts		Oesophagitis	serious				4932
30464	1 pts		Pancreatic duct dilatation	serious				4932
30465	1 pts		Pancreatitis acute	serious				4932
30466	1 pts		Proctalgia	serious				4932
30467	2 pts		Rectal haemorrhage	serious				4932
30468	1 pts		Rectal prolapse	serious				4932
30469	1 pts		Volvulus of small bowel	serious				4932
30470	3 pts		Vomiting	serious				4932
30471	3 pts		Asthenia	serious				4932
30472	3 pts		Chest pain	serious				4932
30473	1 pts		Chills	serious				4932
30474	3 pts		Death	serious				4932
30475	1 pts		Fatigue	serious				4932
30476	1 pts		Gait disturbance	serious				4932
30477	1 pts		General physical health deterioration	serious				4932
30478	2 pts		Malaise	serious				4932
30479	5 pts		Non-cardiac chest pain	serious				4932
30480	1 pts		Pain	serious				4932
30481	2 pts		Pyrexia	serious				4932
30482	1 pts		Sudden death	serious				4932
30483	1 pts		Systemic inflammatory response syndrome	serious				4932
30484	1 pts		Cholecystitis chronic	serious				4932
30485	1 pts		Cholestasis	serious				4932
30486	1 pts		Jaundice	serious				4932
30487	2 pts		Hypersensitivity	serious				4932
30488	2 pts		Appendicitis	serious				4932
30489	1 pts		Arthritis bacterial	serious				4932
30490	1 pts		Cystitis	serious				4932
30491	1 pts		Diarrhoea infectious	serious				4932
30492	5 pts		Diverticulitis	serious				4932
30493	1 pts		Endocarditis bacterial	serious				4932
30494	1 pts		Erysipelas	serious				4932
30495	1 pts		Furuncle	serious				4932
30496	1 pts		Intervertebral discitis	serious				4932
30497	1 pts		Labyrinthitis	serious				4932
30498	1 pts		Otitis externa	serious				4932
30499	13 pts		Pneumonia	serious				4932
30500	1 pts		Post procedural pneumonia	serious				4932
30501	1 pts		Pseudomembranous colitis	serious				4932
30502	1 pts		Pyelonephritis acute	serious				4932
30503	1 pts		Sepsis	serious				4932
30504	1 pts		Staphylococcal sepsis	serious				4932
30505	2 pts		Urinary tract infection	serious				4932
30506	1 pts		Viral infection	serious				4932
30507	1 pts		Wound infection	serious				4932
30508	1 pts		Accidental overdose	serious				4932
30509	1 pts		Avulsion fracture	serious				4932
30510	1 pts		Comminuted fracture	serious				4932
30511	2 pts		Concussion	serious				4932
30512	1 pts		Device breakage	serious				4932
30513	1 pts		Face injury	serious				4932
30514	5 pts		Femur fracture	serious				4932
30515	2 pts		Hand fracture	serious				4932
30516	1 pts		Joint injury	serious				4932
30517	1 pts		Lower limb fracture	serious				4932
30518	2 pts		Patella fracture	serious				4932
30519	5 pts		Radius fracture	serious				4932
30520	4 pts		Fracture rib	serious				4932
30521	2 pts		Spinal fracture	serious				4932
30522	2 pts		Subdural haematoma	serious				4932
30523	1 pts		Therapeutic agent toxicity	serious				4932
30524	1 pts		Ulna fracture	serious				4932
30525	1 pts		Upper limb fracture	serious				4932
30526	1 pts		Wound	serious				4932
30527	1 pts		Wound secretion	serious				4932
30528	1 pts		Barium enema	serious				4932
30529	1 pts		Blood osmolarity decreased	serious				4932
30530	3 pts		Blood pressure increased	serious				4932
30531	1 pts		International normalised ratio decreased	serious				4932
30532	2 pts		Weight decreased	serious				4932
30533	1 pts		Cachexia	serious				4932
30534	1 pts		Decreased appetite	serious				4932
30535	4 pts		Dehydration	serious				4932
30536	1 pts		Diabetes mellitus	serious				4932
30537	1 pts		Hypercalcaemia	serious				4932
30538	1 pts		Hyperglycaemia	serious				4932
30539	1 pts		Lipomatosis	serious				4932
30540	8 pts		Arthralgia	serious				4932
30541	3 pts		Arthritis	serious				4932
30542	1 pts		Arthrofibrosis	serious				4932
30543	2 pts		Foot deformity	serious				4932
30544	1 pts		Fracture delayed union	serious				4932
30545	1 pts		Intervertebral disc degeneration	serious				4932
30546	2 pts		Intervertebral disc protrusion	serious				4932
30547	1 pts		Joint swelling	serious				4932
30548	1 pts		Knee deformity	serious				4932
30549	1 pts		Myalgia	serious				4932
30550	1 pts		Myopathy	serious				4932
30551	1 pts		Osteitis	serious				4932
30552	13 pts		Osteoarthritis	serious				4932
30553	1 pts		Polymyalgia rheumatica	serious				4932
30554	2 pts		Spinal column stenosis	serious				4932
30555	2 pts		Osteoarthritis spinal	serious				4932
30556	1 pts		Spondylolisthesis	serious				4932
30557	1 pts		Abdominal neoplasm	serious				4932
30558	1 pts		Anal cancer	serious				4932
30559	1 pts		Anal canal cancer	serious				4932
30560	1 pts		B-cell lymphoma stage IV	serious				4932
30561	1 pts		Benign gastric neoplasm	serious				4932
30562	1 pts		Brain neoplasm	serious				4932
30563	6 pts		Breast cancer	serious				4932
30564	1 pts		Chronic lymphocytic leukaemia	serious				4932
30565	2 pts		Chronic myeloid leukaemia	serious				4932
30566	1 pts		Malignant melanoma	serious				4932
30567	1 pts		Multiple myeloma	serious				4932
30568	1 pts		Nasal cavity cancer	serious				4932
30569	1 pts		Neoplasm skin	serious				4932
30570	1 pts		Pancreatic neoplasm	serious				4932
30571	1 pts		Rectal cancer stage I	serious				4932
30572	1 pts		Rectal neoplasm	serious				4932
30573	2 pts		Squamous cell carcinoma	serious				4932
30574	2 pts		Squamous cell carcinoma of skin	serious				4932
30575	1 pts		Amnesia	serious				4932
30576	1 pts		Basal ganglia infarction	serious				4932
30577	2 pts		Cerebral artery occlusion	serious				4932
30578	2 pts		Cerebral haemorrhage	serious				4932
30579	4 pts		Cerebral infarction	serious				4932
30580	1 pts		Cerebrosclerosis	serious				4932
30581	8 pts		Cerebrovascular accident	serious				4932
30582	1 pts		Cerebrovascular disorder	serious				4932
30583	2 pts		Dementia	serious				4932
30584	1 pts		Dizziness	serious				4932
30585	1 pts		Embolic stroke	serious				4932
30586	1 pts		Encephalitis	serious				4932
30587	1 pts		Encephalomyelitis	serious				4932
30588	1 pts		Hemiplegia	serious				4932
30589	1 pts		Hydrocephalus	serious				4932
30590	2 pts		Ischaemic stroke	serious				4932
30591	1 pts		Loss of consciousness	serious				4932
30592	1 pts		Nerve root compression	serious				4932
30593	2 pts		Parkinson's disease	serious				4932
30594	1 pts		Parkinsonism	serious				4932
30595	1 pts		Post herpetic neuralgia	serious				4932
30596	1 pts		Sciatica	serious				4932
30597	1 pts		Spinal claudication	serious				4932
30598	5 pts		Syncope	serious				4932
30599	1 pts		Trigeminal neuralgia	serious				4932
30600	1 pts		Dementia vascular	serious				4932
30601	1 pts		Depression	serious				4932
30602	1 pts		Insomnia	serious				4932
30603	1 pts		Mental disorder	serious				4932
30604	1 pts		Suicide attempt	serious				4932
30605	1 pts		Bladder prolapse	serious				4932
30606	1 pts		Calculus urinary	serious				4932
30607	1 pts		Haematuria	serious				4932
30608	1 pts		Renal failure	serious				4932
30609	2 pts		Renal failure acute	serious				4932
30610	1 pts		Urinary incontinence	serious				4932
30611	1 pts		Breast fibrosis	serious				4932
30612	1 pts		Pelvic prolapse	serious				4932
30613	1 pts		Urogenital prolapse	serious				4932
30614	2 pts		Uterine polyp	serious				4932
30615	2 pts		Uterine prolapse	serious				4932
30616	1 pts		Asthmatic crisis	serious				4932
30617	1 pts		Diaphragmatic hernia	serious				4932
30618	2 pts		Dyspnoea	serious				4932
30619	1 pts		Epistaxis	serious				4932
30620	1 pts		Laryngeal oedema	serious				4932
30621	2 pts		Lung disorder	serious				4932
30622	1 pts		Nasal polyps	serious				4932
30623	1 pts		Orthopnoea	serious				4932
30624	1 pts		Pulmonary oedema	serious				4932
30625	1 pts		Pulmonary thrombosis	serious				4932
30626	1 pts		Acrodermatitis	serious				4932
30627	1 pts		Decubitus ulcer	serious				4932
30628	1 pts		Aortic dissection	serious				4932
30629	3 pts		Arteriosclerosis	serious				4932
30630	2 pts		Deep vein thrombosis	serious				4932
30631	1 pts		Femoral arterial stenosis	serious				4932
30632	1 pts		Femoral artery occlusion	serious				4932
30633	2 pts		Haematoma	serious				4932
30634	4 pts		Hypertension	serious				4932
30635	5 pts		Hypotension	serious				4932
30636	1 pts		Orthostatic hypotension	serious				4932
30637	1 pts		Shock	serious				4932
30638	2 pts		Thrombosis	serious				4932
30639	1 pts		Vasculitis	serious				4932
30640	1 pts		Vasoconstriction	serious				4932
30641	1 pts		Venous thrombosis	serious				4932
30642	94 pts		Nausea	below serious				4932
30643	64 pts		Fatigue	below serious				4932
30644	181 pts		Pyrexia	below serious				4932
30645	63 pts		Influenza	below serious				4932
30646	253 pts		Arthralgia	below serious				4932
30647	88 pts		Bone pain	below serious				4932
30648	76 pts		Musculoskeletal pain	below serious				4932
30649	147 pts		Myalgia	below serious				4932
30650	121 pts		Pain in extremity	below serious				4932
30651	69 pts		Dizziness	below serious				4932
30652	125 pts		Headache	below serious				4932
30653	1 pts		Benign breast neoplasm	serious				4929
30654	1 pts		Vertigo	below serious				4929
30655	1 pts		Dyspepsia	below serious				4929
30656	1 pts		Gastritis	below serious				4929
30657	1 pts		Chest pain	below serious				4929
30658	1 pts		Influenza like illness	below serious				4929
30659	1 pts		Furuncle	below serious				4929
30660	2 pts		Influenza	below serious				4929
30661	1 pts		Nasopharyngitis	below serious				4929
30662	1 pts		Oral herpes	below serious				4929
30663	1 pts		Hypokalaemia	below serious				4929
30664	3 pts		Bone pain	below serious				4929
30665	1 pts		Myosclerosis	below serious				4929
30666	1 pts		Pain in extremity	below serious				4929
30667	1 pts		Melanocytic naevus	below serious				4929
30668	1 pts		Neoplasm thyroid	below serious				4929
30669	1 pts		Headache	below serious				4929
30670	1 pts		Loss of consciousness	below serious				4929
30671	1 pts		Syncope	below serious				4929
30672	1 pts		Depression	below serious				4929
30673	1 pts		Haemorrhage postmenopausal	below serious				4929
30674	1 pts		Postmenopausal haemorrhage	below serious				4929
30675	1 pts		Uterine polyp	below serious				4929
30676	1 pts		Cough	below serious				4929
30677	1 pts		Oropharyngeal pain	below serious				4929
30678	1 pts		Drug reaction with eosinophilia and systemic symptoms	below serious				4929
30679	5 pts		Lymphoedema	below serious				4929
30680	1 pts		Vertigo	serious				4930
30681	1 pts		Haematochezia	serious				4930
30682	1 pts		Drug hypersensitivity	serious				4930
30683	1 pts		Febrile infection	serious				4930
30684	1 pts		Osteonecrosis	serious				4930
30685	1 pts		Ataxia	serious				4930
30686	1 pts		Cerebral haemorrhage	serious				4930
30687	2 pts		Abdominal pain upper	below serious				4930
30688	2 pts		Gastritis	below serious				4930
30689	8 pts		Nausea	below serious				4930
30690	7 pts		Chills	below serious				4930
30691	2 pts		Fatigue	below serious				4930
30692	11 pts		Influenza like illness	below serious				4930
30693	3 pts		Pyrexia	below serious				4930
30694	4 pts		Bronchitis	below serious				4930
30695	3 pts		Influenza	below serious				4930
30696	2 pts		Tooth abscess	below serious				4930
30697	2 pts		Radiation skin injury	below serious				4930
30698	3 pts		Hepatic enzyme increased	below serious				4930
30699	5 pts		Myalgia	below serious				4930
30700	2 pts		Pain in extremity	below serious				4930
30701	2 pts		Pain in jaw	below serious				4930
30702	6 pts		Headache	below serious				4930
30703	2 pts		Migraine	below serious				4930
30704	5 pts		Depression	below serious				4930
30705	2 pts		Urge incontinence	below serious				4930
30706	16 pts		Menopausal symptoms	below serious				4930
30707	2 pts		Cough	below serious				4930
30708	1 pts		Pernicious anaemia	serious				4934
30709	5 pts		Acute myocardial infarction	serious				4934
30710	2 pts		Angina unstable	serious				4934
30711	1 pts		Arteriosclerosis coronary artery	serious				4934
30712	7 pts		Atrial fibrillation	serious				4934
30713	1 pts		Atrial flutter	serious				4934
30714	1 pts		Cardiovascular insufficiency	serious				4934
30715	4 pts		Myocardial infarction	serious				4934
30716	3 pts		Myocardial ischaemia	serious				4934
30717	1 pts		Myocarditis	serious				4934
30718	1 pts		Exomphalos	serious				4934
30719	1 pts		Phimosis	serious				4934
30720	3 pts		Vertigo	serious				4934
30721	1 pts		Retinal degeneration	serious				4934
30722	1 pts		Diverticular perforation	serious				4934
30723	2 pts		Duodenal ulcer	serious				4934
30724	1 pts		Femoral hernia	serious				4934
30725	1 pts		Gastritis erosive	serious				4934
30726	1 pts		Haematemesis	serious				4934
30727	1 pts		Ileus	serious				4934
30728	3 pts		Hernia inguinal	serious				4934
30729	1 pts		Inguinal hernia, obstructive	serious				4934
30730	1 pts		Melaena	serious				4934
30731	2 pts		Oesophagitis	serious				4934
30732	2 pts		Pancreatitis acute	serious				4934
30733	1 pts		Chronic pancreatitis	serious				4934
30734	2 pts		Peritonitis	serious				4934
30735	1 pts		Adverse drug reaction	serious				4934
30736	1 pts		Device failure	serious				4934
30737	3 pts		Non-cardiac chest pain	serious				4934
30738	3 pts		Cholecystitis acute	serious				4934
30739	1 pts		Jaundice	serious				4934
30740	1 pts		Hypersensitivity	serious				4934
30741	1 pts		Abdominal abscess	serious				4934
30742	2 pts		Appendicitis	serious				4934
30743	1 pts		Chronic sinusitis	serious				4934
30744	1 pts		Device related infection	serious				4934
30745	1 pts		Infective exacerbation of chronic obstructive airways disease	serious				4934
30746	1 pts		Osteomyelitis	serious				4934
30747	1 pts		Sepsis	serious				4934
30748	1 pts		Vestibular neuronitis	serious				4934
30749	1 pts		Viral infection	serious				4934
30750	1 pts		Arterial injury	serious				4934
30751	3 pts		Fall	serious				4934
30752	1 pts		Incisional hernia	serious				4934
30753	1 pts		Injury	serious				4934
30754	2 pts		Joint dislocation	serious				4934
30755	1 pts		Meniscus lesion	serious				4934
30756	16 pts		Traumatic fracture	serious				4934
30757	1 pts		Traumatic lung injury	serious				4934
30758	1 pts		Vascular graft complication	serious				4934
30759	1 pts		Metabolic acidosis	serious				4934
30760	1 pts		Arthritis	serious				4934
30761	2 pts		Back pain	serious				4934
30762	1 pts		Neck pain	serious				4934
30763	7 pts		Osteoarthritis	serious				4934
30764	1 pts		Osteonecrosis	serious				4934
30765	1 pts		Pain in extremity	serious				4934
30766	1 pts		Rheumatoid arthritis	serious				4934
30767	2 pts		Rotator cuff syndrome	serious				4934
30768	2 pts		Sensation of heaviness	serious				4934
30769	1 pts		Osteoarthritis spinal	serious				4934
30770	4 pts		Bladder cancer	serious				4934
30771	1 pts		Colon cancer	serious				4934
30772	1 pts		Haemangioma	serious				4934
30773	2 pts		Hepatic neoplasm malignant	serious				4934
30774	1 pts		Lymph node cancer metastatic	serious				4934
30775	1 pts		Meningioma	serious				4934
30776	1 pts		Multiple myeloma	serious				4934
30777	6 pts		Prostate cancer	serious				4934
30778	1 pts		Prostate cancer metastatic	serious				4934
30779	1 pts		Rectal cancer	serious				4934
30780	1 pts		Squamous cell carcinoma	serious				4934
30781	2 pts		Carotid artery stenosis	serious				4934
30782	1 pts		Carpal tunnel syndrome	serious				4934
30783	1 pts		Cerebellar infarction	serious				4934
30784	1 pts		Cerebral ischaemia	serious				4934
30785	6 pts		Cerebrovascular accident	serious				4934
30786	1 pts		Cervical root pain	serious				4934
30787	1 pts		Coma	serious				4934
30788	2 pts		Headache	serious				4934
30789	1 pts		Intracranial aneurysm	serious				4934
30790	2 pts		Ischaemic stroke	serious				4934
30791	1 pts		Monoparesis	serious				4934
30792	1 pts		Radicular pain	serious				4934
30793	4 pts		Transient ischaemic attack	serious				4934
30794	1 pts		Depression	serious				4934
30795	1 pts		Encopresis	serious				4934
30796	1 pts		Panic attack	serious				4934
30797	1 pts		Bladder neck obstruction	serious				4934
30798	2 pts		Calculus ureteric	serious				4934
30799	3 pts		Nephrolithiasis	serious				4934
30800	1 pts		Renal failure	serious				4934
30801	1 pts		Renal failure acute	serious				4934
30802	1 pts		Urethral polyp	serious				4934
30803	1 pts		Urethral stenosis	serious				4934
30804	1 pts		Prostatomegaly	serious				4934
30805	1 pts		Atelectasis	serious				4934
30806	1 pts		Bronchitis chronic	serious				4934
30807	2 pts		Cough	serious				4934
30808	1 pts		Dyspnoea exertional	serious				4934
30809	1 pts		Haemothorax	serious				4934
30810	1 pts		Lung consolidation	serious				4934
30811	1 pts		Pleurisy	serious				4934
30812	1 pts		Aspiration pneumonia	serious				4934
30813	1 pts		Walking disability	serious				4934
30814	2 pts		Aortic aneurysm	serious				4934
30815	1 pts		Deep vein thrombosis	serious				4934
30816	40 pts		Chills	below serious				4934
30817	40 pts		Fatigue	below serious				4934
30818	30 pts		Influenza like illness	below serious				4934
30819	143 pts		Pyrexia	below serious				4934
30820	30 pts		Influenza	below serious				4934
30821	50 pts		Nasopharyngitis	below serious				4934
30822	123 pts		Arthralgia	below serious				4934
30823	82 pts		Back pain	below serious				4934
30824	30 pts		Musculoskeletal pain	below serious				4934
30825	129 pts		Myalgia	below serious				4934
30826	43 pts		Pain in extremity	below serious				4934
30827	80 pts		Headache	below serious				4934
30828	47 pts		Hypertension	below serious				4934
30829	1 pts		Liver, cancer of	serious				4935
30830	1 pts		Atrophy muscle	serious				4935
30831	2 pts		Flu-like symptoms	below serious				4935
30832	30		Skeletal pain					4937
30833	20		Fever					4937
30834	20		Anorexia					4937
30835	20		Diarrhea					4937
30836	10		Constipation					4937
30837	20		Nausea					4937
30838	20		Myalgia					4937
30839	10		Arthralgia					4937
30840	30		Anemia					4937
30841	20		Rigors					4937
30842	20		Coughing					4937
30843	10		Leg edema					4937
30844	10		Urinary tract infection					4937
30845	40		Fatigue					4937
30846						impossible to link AEs with the definite dose: Serious adverse events considered possibly attributable to study drug included pneumonia, bronchitis, hypokalemia, myalgia, or anemia (in 9 patients) and renal impairment (3 patients).		4936
30847						No adverse effects leading to discontinuation were reported.		4938
30848						No adverse effects leading to discontinuation were reported.		4939
30849						No adverse effects leading to discontinuation were reported		4941
30850						no adverse events were observed		4942
30851			Cardiopulmonary arrest		discontinuation	patient died		4940
30852			Seizures		discontinuation	patient died		4940
30853			Metabolic acidosis	acute	discontinuation	patient died		4940
30854			Hyponatremia	severe	discontinuation	patient died		4940
30855			Central pontine myelinolysis		discontinuation	patient died		4940
30856			Extrapontine myelinolysis		discontinuation	patient died		4940
30857			Brain death	grade 5	discontinuation	patient died		4940
30858	20		Gastrointestinal discomfort				TRUE	4943
30859	5		Infusion site reaction					4944
30860	4		Nausea and vomiting					4944
30861	3		Diarrhea					4944
30862	2.7		Drug fever					4944
30863	1.5		Seizures					4944
30864	3.1		Thrombophlebitis			PRIMAXIN (imipenem and cilastatin)		4945
30865	0.7		Injection site pain			PRIMAXIN (imipenem and cilastatin)		4945
30866	0.4		Injection site erythema			PRIMAXIN (imipenem and cilastatin)		4945
30867	0.2		Induration			PRIMAXIN (imipenem and cilastatin)		4945
30868	2		Nausea			PRIMAXIN (imipenem and cilastatin)		4945
30869	1.8		Diarrhea			PRIMAXIN (imipenem and cilastatin)		4945
30870	1.5		Vomiting			PRIMAXIN (imipenem and cilastatin)		4945
30871	0.9		Skin rash			PRIMAXIN (imipenem and cilastatin)		4945
30872	0.3		Pruritus			PRIMAXIN (imipenem and cilastatin)		4945
30873	0.2		Urticaria			PRIMAXIN (imipenem and cilastatin)		4945
30874	0.4		Hypotension			PRIMAXIN (imipenem and cilastatin)		4945
30875	0.5		Fever			PRIMAXIN (imipenem and cilastatin)		4945
30876	0.4		Seizures			PRIMAXIN (imipenem and cilastatin)		4945
30877	0.3		Dizziness			PRIMAXIN (imipenem and cilastatin)		4945
30878	0.2		Somnolence			PRIMAXIN (imipenem and cilastatin)		4945
30879	2.2		Phlebitis			PRIMAXIN (imipenem and cilastatin)		4947
30880	1.1		Infusion site irritation			PRIMAXIN (imipenem and cilastatin)		4947
30881	3.9		Diarrhea			PRIMAXIN (imipenem and cilastatin)		4947
30882	1.1		Gastroenteritis			PRIMAXIN (imipenem and cilastatin)		4947
30883	1.1		Vomiting			PRIMAXIN (imipenem and cilastatin)		4947
30884	2.2		Skin rash			PRIMAXIN (imipenem and cilastatin)		4947
30885	1.1		Discoloration urine			PRIMAXIN (imipenem and cilastatin)		4947
30886	3		Diarrhea			PRIMAXIN (imipenem and cilastatin)		4946
30887	5.9		Convulsions			PRIMAXIN (imipenem and cilastatin)		4946
30888	1.5		Tachycardia			PRIMAXIN (imipenem and cilastatin)		4946
30889	1.5		Skin rash			PRIMAXIN (imipenem and cilastatin)		4946
30890	1.5		Candidiasis			PRIMAXIN (imipenem and cilastatin)		4946
30891	2.2		Oliguria and anuria			PRIMAXIN (imipenem and cilastatin)		4946
30892	6.1		Tachycardia					4948
30893	1.1		Headache					4948
30894	4.8		Nervousness					4948
30895	1.3		Nausea					4948
30896	1.6		Tremor					4948
30897						No conjunctival or corneal toxicity		4949
30898						No information on AE is provided		4950
30899			Cardiac disorders	grade 3-5	discontinuation	WARNINGS. Serious Cardiovascular Events: Sudden death		4953
30900			Stroke	grade 3-5	discontinuation	WARNINGS		4953
30901			Myocardial infarction	grade 3-5	discontinuation	WARNINGS		4953
30902			Increased blood pressure			WARNINGS		4953
30903			Heart rate increased			WARNINGS		4953
30904			Psychotic symptom	grade 3-5		WARNINGS. In patients with psychotic disorders		4953
30905			Psychotic symptom			WARNINGS		4953
30906			Manic symptom			WARNINGS		4953
30907			Aggression			WARNINGS		4953
30908			Growth suppression			WARNINGS		4953
30909			Seizures		discontinuation	WARNINGS. The threshold for seizures may be lowered.		4953
30910			Priapism			WARNINGS		4953
30911			Erection prolonged			WARNINGS		4953
30912			Vascular disorders			WARNINGS		4953
30913			Raynaud's phenomenon		discontinuation	WARNINGS		4953
30914			Visual disturbance			WARNINGS		4953
30915	1		Twitching		discontinuation	50 of 684 children treated with Focalin immediate-release formulation (7.3%) experienced an adverse event that resulted in discontinuation		4952
30916	1		Anorexia		discontinuation	50 of 684 children treated with Focalin immediate-release formulation (7.3%) experienced an adverse event that resulted in discontinuation		4952
30917	1		Insomnia		discontinuation	50 of 684 children treated with Focalin immediate-release formulation (7.3%) experienced an adverse event that resulted in discontinuation		4952
30918	1		Tachycardia		discontinuation	50 of 684 children treated with Focalin immediate-release formulation (7.3%) experienced an adverse event that resulted in discontinuation		4952
30919	1.8		Insomnia		discontinuation			4952
30920	1.8		Feeling jittery		discontinuation			4954
30921	1.2		Anorexia		discontinuation			4954
30922	1.2		Anxiety		discontinuation			4954
30923			Vomiting					4951
30924			Agitation					4951
30925			Tremor					4951
30926			Hyperreflexia					4951
30927			Muscle twitching					4951
30928			Convulsions					4951
30929			Euphoria					4951
30930			Confusion					4951
30931			Hallucinations					4951
30932			Delirium					4951
30933			Sweating					4951
30934			Flushing					4951
30935			Headache					4951
30936			Hyperpyrexia					4951
30937			Tachycardia					4951
30938			Palpitations					4951
30939			Cardiac arrhythmias					4951
30940			Hypertension					4951
30941			Mydriasis					4951
30942			Mucosal dryness					4951
30943			Rhabdomyolysis					4951
30944			Diarrhea		discontinuation			4955
30945			Erythema		discontinuation			4955
30946			Vomiting		discontinuation			4955
30947			Rash		discontinuation			4955
30948			Dry mouth		discontinuation			4955
30949	11		Nausea					4956
30950	3-9		Dyspepsia					4956
30951	3-9		Distress gastrointestinal					4956
30952	3-9		Abdominal pain					4956
30953	3-9		Diarrhea					4956
30954	3-9		Flatulence					4956
30955	3-9		Vomiting					4956
30956	1-3		Constipation					4956
30957	1-3		Gastritis					4956
30958	1-3		Peptic ulcer					4956
30959	3-9		Headache					4956
30960	3-9		Asthenia					4956
30961	1-3		Chest pain					4956
30962	3-9		Blood pressure increased					4956
30963	3-9		Edema					4956
30964	3-9		Dizziness					4956
30965	3-9		Drowsiness					4956
30966	1-3		Depression					4956
30967	3-9		Weight gain					4956
30968	3-9		Weight loss					4956
30969	1-3		Skin irritation					4956
30970	1-3		Tinnitus					4956
30971	1-3		Visual disturbance					4956
30972	1-3		Blood urea nitrogen increased					4956
30973	1-3		Urinary tract infection					4956
30974	<1		Gastrointestinal ulcer bleeding					4956
30975	<1		Bleeding gastrointestinal					4956
30976	<1		Perforation					4956
30977	<1		Glossitis					4956
30978	<1		Stomatitis					4956
30979	<1		Hepatitis					4956
30980	<1		Function liver abnormal					4956
30981	<1		Anaphylactoid reaction					4956
30982	<1		Fever					4956
30983	<1		Lymphadenopathy					4956
30984	<1		Serum sickness					4956
30985	<1		Hemolytic anemia					4956
30986	<1		Thrombocytopenia					4956
30987	<1		Granulocytopenia					4956
30988	<1		Agranulocytosis					4956
30989	<1		Urticaria					4956
30990	<1		Purpura					4956
30991	<1		Erythema multiforme					4956
30992	<1		Toxic epidermal necrolysis					4956
30993	<1		Hematuria					4956
30994	<1		Proteinuria					4956
30995	<1		Dysuria					4956
30996	<1		Renal failure					4956
30997	1 pts		Myocardial infarction	serious				4957
30998	1 pts		Fatigue	below serious				4957
30999	1 pts		Hypertension	below serious				4957
31000	1 pts		Creatinine	below serious				4957
31001	1 pts		Hyperkalemia	below serious				4957
31002	1 pts		Back pain	serious				4958
31003	1 pts		Back pain	serious				4958
31004	1 pts		Dizziness	serious				4958
31005	1 pts		Dizziness	serious				4958
31006	1 pts		Myocardial infarction	serious				4958
31007	1 pts		Myocardial infarction	serious				4958
31008	1 pts		Myocardial infarction	serious				4958
31009	1 pts		Myocardial infarction	serious				4958
31010	1 pts		Myocardial infarction	serious				4958
31011	1 pts		Myocardial infarction	serious				4958
31012	1 pts		Back pain	serious				4958
31013	1 pts		Back pain	serious				4958
31014	1 pts		Dizziness	serious				4958
31015	1 pts		Dizziness	serious				4958
31016	2 pts		Fatigue	below serious				4958
31017	1 pts		Hypotension NOS	below serious				4958
31018			Oligohydramnios			WARNING		4960
31019			Pulmonary hypoplasia			WARNING		4960
31020			Skull hypoplasia			WARNING		4960
31021			Death fetal			WARNING		4960
31022						No information on AE is provided		4959
31023			Hypotension			Overdosage		4963
31024			Anuria			Overdosage		4962
31025			Renal failure			Overdosage		4962
31026			Hypotension			Overdosage		4962
31027			Respiratory failure			Overdosage		4962
31028	0.8		Failure heart		discontinuation			4961
31029	0.6		Hyperkalaemia		discontinuation			4961
31030	2.3		Hypotension		discontinuation			4961
31031	0.3		Arrhythmia		discontinuation			4961
31032	0.8		Myocardial infarction		discontinuation			4961
31033	1.4		Kidney dysfunction		discontinuation			4961
31034	1.1		Stroke		discontinuation			4961
31035	0.8		Angina		discontinuation			4961
31036						No SAEs were observed		4964
31037	1 pts		Anaphylactoid reaction	serious				4968
31038	2 pts		Diffuse pain	below serious				4968
31039	2 pts		Suicidal ideation	below serious				4968
31040	2 pts		Tremor	below serious				4968
31041	2		Diarrhea		discontinuation	leads to discontinuation		4965
31042	<1		Nausea		discontinuation	leads to discontinuation		4965
31043	<1		Depression		discontinuation	leads to discontinuation		4965
31044	<1		Anxiety		discontinuation	leads to discontinuation		4965
31045			Diarrhea					4967
31046	<1		Pain		discontinuation	leads to discontinuation		4966
31047	<1		Constipation		discontinuation	leads to discontinuation		4966
31048	<1		Somnolence		discontinuation	leads to discontinuation		4966
31049	<1		Insomnia		discontinuation	leads to discontinuation		4966
31050	<1		Impotence		discontinuation	leads to discontinuation		4966
31051			Breathing shallow					4971
31052			Nausea					4971
31053			Pulse thready					4971
31054			Tachycardia					4971
31055			Bradycardia					4971
31056			Asystole					4971
31057			Death	grade 5				4971
31058			Blood pressure low					4971
31059			Blood pressure low					4970
31060			Ventricular tachycardia					4970
31061			Death	grade 5				4970
31062			Blood pressure low					4972
31063			Heart rate low					4972
31064			Necrosis bowel					4972
31065			Muscle tone flaccid					4972
31066	3 pts		Antinuclear antibody		discontinuation			4969
31067	1 pts		Anaemia	serious				4977
31068	1 pts		Arrhythmia	serious				4977
31069	1 pts		Atrial fibrillation	serious				4977
31070	1 pts		Sick sinus syndrome	serious				4977
31071	1 pts		Pancreatitis	serious				4977
31072	2 pts		Non-cardiac chest pain	serious				4977
31073	1 pts		Cholecystitis	serious				4977
31074	1 pts		Femur fracture	serious				4977
31075	1 pts		Diabetes mellitus non-insulin-dependent	serious				4977
31076	1 pts		Hypoglycaemia	serious				4977
31077	2 pts		Osteoarthritis	serious				4977
31078	1 pts		Non-Hodgkin's lymphoma	serious				4977
31079	1 pts		Colostomy closure	serious				4977
31080	5 pts		Anaemia	below serious				4977
31081	1 pts		Palpitations	below serious				4977
31082	3 pts		Cataract	below serious				4977
31083	3 pts		Abdominal pain upper	below serious				4977
31084	6 pts		Constipation	below serious				4977
31085	3 pts		Diverticulum	below serious				4977
31086	12 pts		Dyspepsia	below serious				4977
31087	2 pts		Flatulence	below serious				4977
31088	2 pts		Gastritis	below serious				4977
31089	7 pts		Gastrooesophageal reflux disease	below serious				4977
31090	2 pts		Haemorrhoids	below serious				4977
31091	2 pts		Hiatus hernia	below serious				4977
31092	10 pts		Nausea	below serious				4977
31093	3 pts		Stomach discomfort	below serious				4977
31094	2 pts		Toothache	below serious				4977
31095	1 pts		Chills	below serious				4977
31096	7 pts		Influenza like illness	below serious				4977
31097	3 pts		Pain	below serious				4977
31098	3 pts		Gastroenteritis viral	below serious				4977
31099	2 pts		Tooth infection	below serious				4977
31100	14 pts		Upper respiratory tract infection	below serious				4977
31101	6 pts		Urinary tract infection	below serious				4977
31102	1 pts		Excoriation	below serious				4977
31103	3 pts		Fall	below serious				4977
31104	3 pts		Muscle strain	below serious				4977
31105	2 pts		Skin laceration	below serious				4977
31106	3 pts		Hypercholesterolaemia	below serious				4977
31107	7 pts		Back pain	below serious				4977
31108	4 pts		Musculoskeletal stiffness	below serious				4977
31109	4 pts		Myalgia	below serious				4977
31110	3 pts		Neck pain	below serious				4977
31111	5 pts		Osteoarthritis	below serious				4977
31112	3 pts		Anxiety	below serious				4977
31113	1 pts		Urinary incontinence	below serious				4977
31114	3 pts		Epistaxis	below serious				4977
31115	1 pts		Dermatitis contact	below serious				4977
31116	2 pts		Skin lesion	below serious				4977
31117	3 pts		Hot flush	below serious				4977
31118	5 pts		Hypertension	below serious				4977
31119	1 pts		Malignant melanoma	serious				4978
31120	1 pts		Diverticulitis	serious				4978
31121	1 pts		Anxiety attack	serious				4978
31122	1 pts		Tooth fracture	below serious				4978
31123	1 pts		Hyperthyroidism	below serious				4978
31124	2 pts		High cholesterol	below serious				4978
31125	1 pts		Hips osteoarthritis	below serious				4978
31126	1 pts		Blood phosphorus increased	below serious				4978
31127	1 pts		Vaginal odor	below serious				4978
31128	1 pts		Heartburn	below serious				4978
31129	1 pts		Ankle swelling	below serious				4978
31130	1 pts		Conjunctivitis	below serious				4978
31131	1 pts		Lower respiratory tract infection	below serious				4978
31132	1 pts		Absent bowel movement	below serious				4978
31133	1 pts		Eye blood shot	below serious				4978
31134	1 pts		Swollen tongue	below serious				4978
31135	1 pts		Ear pain	below serious				4978
31136	1 pts		Diarrhea	below serious				4978
31137	1 pts		Abdominal cramp	below serious				4978
31138	1 pts		Shingles	below serious				4978
31139	1 pts		Stomach flu	below serious				4978
31140	1 pts		Sleep apnea	below serious				4978
31141	1 pts		Red blood cell count abnormal	below serious				4978
31142	1 pts		ALT increased	below serious				4978
31143	1 pts		Eosinophil count high	below serious				4978
31144	1 pts		Common cold	below serious				4978
31145	1 pts		Creatinine high	below serious				4978
31146	1 pts		Myocarditis	serious				4979
31147	1 pts		Vertigo	serious				4979
31148	1 pts		Gastric ulcer	serious				4979
31149	1 pts		Gastrointestinal haemorrhage	serious				4979
31150	1 pts		Liver disorder	serious				4979
31151	1 pts		Facial bones fracture	serious				4979
31152	1 pts		Foot fracture	serious				4979
31153	2 pts		Fractured sacrum	serious				4979
31154	1 pts		Hand fracture	serious				4979
31155	1 pts		Fracture rib	serious				4979
31156	1 pts		Skull fracture	serious				4979
31157	2 pts		Sternal fracture	serious				4979
31158	1 pts		Hysteroscopy	serious				4979
31159	1 pts		Osteonecrosis of jaw	serious				4979
31160	1 pts		Pain in extremity	serious				4979
31161	2 pts		Transient ischaemic attack	serious				4979
31162	1 pts		Urinary incontinence	serious				4979
31163	1 pts		Endometrial hyperplasia	serious				4979
31164	1 pts		Chronic obstructive pulmonary disease	serious				4979
31165	1 pts		Rash	serious				4979
31166	2 pts		Salpingo-oophorectomy	serious				4979
31167	1 pts		Shoulder operation	serious				4979
31168	1 pts		Toe operation	serious				4979
31169	2 pts		Hypertension	serious				4979
31170	1 pts		Peripheral artery occlusion	serious				4979
31171	1 pts		Dizziness	serious				4979
31172	25 pts		Headache	below serious				4979
31173			Laryngeal ulceration			Overdosage		4975
31174			Headache					4973
31175	0.9		Cramp muscle	grade 3	discontinuation			4974
31176	0.9		Abdominal pain	grade 2	discontinuation			4974
31177	0.9		Melena	grade 1	discontinuation			4974
31178	2.4		Diarrhea	grade 2	discontinuation			4976
31179	2.4		Vomiting	grade 2	discontinuation			4976
31180	2.4		Abdominal pain	grade 2	discontinuation			4976
31181	1.1		Abdominal pain	grade 1-2	discontinuation			4982
31182	1.1		Diarrhoea	grade 1-2	discontinuation			4982
31183	3.2		Dizziness	grade 1-2	discontinuation			4982
31184	1.1		Headache	grade 1-2	discontinuation			4982
31185	1.1		Ventricular fibrillation	grade 1-2	discontinuation			4982
31186	1.35		Vertigo		discontinuation			4981
31187	0.55		Syncope		discontinuation			4981
31188	0.42		Postural hypotension		discontinuation			4981
31189	0.39		Headache		discontinuation			4981
31190	0.46		Nausea		discontinuation			4981
31191	0.35		Abdominal pain		discontinuation			4981
31192	0.16		Diarrhoea		discontinuation			4981
31193	0.19		Urinary tract disorder		discontinuation			4981
31194	0.14		CNS disorder (NOS)		discontinuation			4981
31195	0.19		Asthenia		discontinuation			4981
31196	22		Hypotension postural					4980
31197	8.9		Dizziness					4980
31198	6.7		Headache					4980
31199	2		Malaise					4980
31200	1 pts		Cellulitis	serious				4987
31201	1 pts		Pneumonia	serious				4987
31202	1 pts		Diabetic foot	serious				4987
31203	1 pts		Choroidal neovascularisation	below serious				4987
31204	1 pts		Foreign body sensation in eyes	below serious				4987
31205	1 pts		Asteroid hyalosis	below serious				4987
31206	1 pts		Retinal neovascularisation	below serious				4987
31207	1 pts		Vision blurred	below serious				4987
31208	1 pts		Vitreous detachment	below serious				4987
31209	1 pts		Diarrhoea	below serious				4987
31210	1 pts		Flatulence	below serious				4987
31211	1 pts		Fatigue	below serious				4987
31212	1 pts		Fungal skin infection	below serious				4987
31213	1 pts		Respiratory tract infection	below serious				4987
31214	1 pts		Sinusitis	below serious				4987
31215	1 pts		Tooth fracture	below serious				4987
31216	1 pts		Hypoglycaemia	below serious				4987
31217	1 pts		Arthritis	below serious				4987
31218	1 pts		Muscle spasms	below serious				4987
31219	1 pts		Myalgia	below serious				4987
31220	1 pts		Pain in extremity	below serious				4987
31221	1 pts		Pain in jaw	below serious				4987
31222	2 pts		Basal cell carcinoma	below serious				4987
31223	1 pts		Paraesthesia	below serious				4987
31224	1 pts		Epistaxis	below serious				4987
31225	2 pts		Hypotension	below serious				4987
31226	6 pts		Anaemia	serious				4988
31227	1 pts		Haemorrhagic disorder	serious				4988
31228	1 pts		Hilar lymphadenopathy	serious				4988
31229	1 pts		Lymphadenopathy	serious				4988
31230	1 pts		Splenic infarction	serious				4988
31231	7 pts		Angina unstable	serious				4988
31232	1 pts		Aortic valve incompetence	serious				4988
31233	1 pts		Arteriospasm coronary	serious				4988
31234	3 pts		Atrial flutter	serious				4988
31235	2 pts		Atrioventricular block complete	serious				4988
31236	7 pts		Cardio-respiratory arrest	serious				4988
31237	7 pts		Cardiogenic shock	serious				4988
31238	1 pts		Cardiomyopathy	serious				4988
31239	2 pts		Cardiopulmonary failure	serious				4988
31240	4 pts		Coronary artery disease	serious				4988
31241	1 pts		Left ventricular dysfunction	serious				4988
31242	1 pts		Low cardiac output syndrome	serious				4988
31243	1 pts		Fibrosis myocardial	serious				4988
31244	1 pts		Tachyarrhythmia	serious				4988
31245	3 pts		Tachycardia	serious				4988
31246	1 pts		Ventricular extrasystoles	serious				4988
31247	10 pts		Ventricular tachycardia	serious				4988
31248	4 pts		Vertigo	serious				4988
31249	3 pts		Cataract	serious				4988
31250	1 pts		Retinal detachment	serious				4988
31251	2 pts		Constipation	serious				4988
31252	1 pts		Duodenal ulcer haemorrhage	serious				4988
31253	1 pts		Enterocolitis	serious				4988
31254	1 pts		Gastritis	serious				4988
31255	1 pts		Hiatus hernia	serious				4988
31256	1 pts		Intestinal obstruction	serious				4988
31257	1 pts		Intestinal polyp	serious				4988
31258	8 pts		Nausea	serious				4988
31259	1 pts		Small intestinal obstruction	serious				4988
31260	1 pts		Umbilical hernia, obstructive	serious				4988
31261	1 pts		Upper gastrointestinal haemorrhage	serious				4988
31262	5 pts		Vomiting	serious				4988
31263	1 pts		Chest discomfort	serious				4988
31264	6 pts		Chest pain	serious				4988
31265	1 pts		Device lead issue	serious				4988
31266	1 pts		Drug intolerance	serious				4988
31267	1 pts		Necrosis	serious				4988
31268	7 pts		Non-cardiac chest pain	serious				4988
31269	1 pts		Soft tissue inflammation	serious				4988
31270	9 pts		Sudden death	serious				4988
31271	2 pts		Cholecystitis	serious				4988
31272	1 pts		Hepatic cirrhosis	serious				4988
31273	1 pts		Hepatic cyst	serious				4988
31274	1 pts		Hepatorenal syndrome	serious				4988
31275	1 pts		Heart transplant rejection	serious				4988
31276	1 pts		Anal abscess	serious				4988
31277	2 pts		Appendicitis	serious				4988
31278	1 pts		Bronchitis bacterial	serious				4988
31279	2 pts		Erysipelas	serious				4988
31280	1 pts		Gastrointestinal viral infection	serious				4988
31281	1 pts		Hepatitis B	serious				4988
31282	1 pts		Liver abscess	serious				4988
31283	1 pts		Infection localised	serious				4988
31284	3 pts		Lower respiratory tract infection	serious				4988
31285	1 pts		Orchitis	serious				4988
31286	1 pts		Osteomyelitis acute	serious				4988
31287	1 pts		Paronychia	serious				4988
31288	2 pts		Pseudomembranous colitis	serious				4988
31289	3 pts		Respiratory tract infection	serious				4988
31290	8 pts		Sepsis	serious				4988
31291	1 pts		Viral infection	serious				4988
31292	1 pts		Wound infection pseudomonas	serious				4988
31293	1 pts		Accidental overdose	serious				4988
31294	1 pts		Ankle fracture	serious				4988
31295	1 pts		Contusion	serious				4988
31296	1 pts		Dermatitis artefacta	serious				4988
31297	1 pts		Electric shock	serious				4988
31298	1 pts		Extradural haematoma	serious				4988
31299	1 pts		Femoral neck fracture	serious				4988
31300	4 pts		Femur fracture	serious				4988
31301	1 pts		Head injury	serious				4988
31302	2 pts		Humerus fracture	serious				4988
31303	1 pts		Laceration	serious				4988
31304	1 pts		Post procedural haematoma	serious				4988
31305	1 pts		Procedural haemorrhage	serious				4988
31306	1 pts		Pubis fracture	serious				4988
31307	1 pts		Spinal compression fracture	serious				4988
31308	1 pts		Splenic rupture	serious				4988
31309	2 pts		Subdural haematoma	serious				4988
31310	1 pts		Thermal burn	serious				4988
31311	2 pts		Toxicity to various agents	serious				4988
31312	3 pts		Blood creatinine increased	serious				4988
31313	1 pts		Haemoglobin decreased	serious				4988
31314	2 pts		International normalised ratio increased	serious				4988
31315	1 pts		Renal function test abnormal	serious				4988
31316	1 pts		Decreased appetite	serious				4988
31317	1 pts		Diabetic ketoacidosis	serious				4988
31318	1 pts		Failure to thrive	serious				4988
31319	1 pts		Fluid intake reduced	serious				4988
31320	7 pts		Hypoglycaemia	serious				4988
31321	1 pts		Arthralgia	serious				4988
31322	1 pts		Arthritis	serious				4988
31323	1 pts		Bursitis	serious				4988
31324	1 pts		Costochondritis	serious				4988
31325	1 pts		Joint effusion	serious				4988
31326	1 pts		Muscular weakness	serious				4988
31327	2 pts		Pain in extremity	serious				4988
31328	1 pts		Bladder neoplasm	serious				4988
31329	2 pts		Colon cancer	serious				4988
31330	1 pts		Colorectal cancer	serious				4988
31331	1 pts		Hepatic neoplasm	serious				4988
31332	1 pts		Hepatobiliary neoplasm	serious				4988
31333	1 pts		Adenocarcinoma lung	serious				4988
31334	1 pts		Lung neoplasm malignant	serious				4988
31335	1 pts		Lung squamous cell carcinoma stage unspecified	serious				4988
31336	1 pts		Multiple myeloma	serious				4988
31337	1 pts		Prostate cancer metastatic	serious				4988
31338	1 pts		Uterine leiomyoma	serious				4988
31339	1 pts		Anterior spinal artery syndrome	serious				4988
31340	1 pts		Burning sensation	serious				4988
31341	1 pts		Cerebral haematoma	serious				4988
31342	1 pts		Coma	serious				4988
31343	1 pts		Diabetic neuropathy	serious				4988
31344	4 pts		Dizziness	serious				4988
31345	1 pts		Dysarthria	serious				4988
31346	2 pts		Embolic stroke	serious				4988
31347	2 pts		Epilepsy	serious				4988
31348	1 pts		Haemorrhagic stroke	serious				4988
31349	1 pts		Intracranial haematoma	serious				4988
31350	1 pts		Loss of consciousness	serious				4988
31351	1 pts		Metabolic encephalopathy	serious				4988
31352	1 pts		Myasthenia gravis	serious				4988
31353	1 pts		Myasthenia gravis crisis	serious				4988
31354	1 pts		Neuropathy peripheral	serious				4988
31355	2 pts		Somnolence	serious				4988
31356	1 pts		Trigeminal neuralgia	serious				4988
31357	1 pts		Unresponsive to stimuli	serious				4988
31358	1 pts		Uraemic encephalopathy	serious				4988
31359	1 pts		Abnormal behaviour	serious				4988
31360	1 pts		Alcohol abuse	serious				4988
31361	1 pts		Anxiety	serious				4988
31362	2 pts		Confusional state	serious				4988
31363	1 pts		Depression suicidal	serious				4988
31364	1 pts		Screaming	serious				4988
31365	1 pts		Bladder tamponade	serious				4988
31366	1 pts		Haematuria	serious				4988
31367	1 pts		Nephropathy	serious				4988
31368	1 pts		Polyuria	serious				4988
31369	1 pts		Renal artery stenosis	serious				4988
31370	20 pts		Renal failure acute	serious				4988
31371	5 pts		Renal impairment	serious				4988
31372	2 pts		Benign prostatic hyperplasia	serious				4988
31373	1 pts		Menorrhagia	serious				4988
31374	7 pts		Acute pulmonary oedema	serious				4988
31375	1 pts		Acute respiratory distress syndrome	serious				4988
31376	2 pts		Acute respiratory failure	serious				4988
31377	1 pts		Asthma	serious				4988
31378	1 pts		Atelectasis	serious				4988
31379	1 pts		Bronchiectasis	serious				4988
31380	13 pts		Chronic obstructive pulmonary disease	serious				4988
31381	20 pts		Dyspnoea	serious				4988
31382	1 pts		Pneumonitis	serious				4988
31383	1 pts		Pneumothorax	serious				4988
31384	1 pts		Productive cough	serious				4988
31385	1 pts		Pulmonary artery thrombosis	serious				4988
31386	6 pts		Respiratory failure	serious				4988
31387	1 pts		Wheezing	serious				4988
31388	2 pts		Hyperhidrosis	serious				4988
31389	1 pts		Skin ulcer	serious				4988
31390	1 pts		Skin ulcer haemorrhage	serious				4988
31391	1 pts		Extremity necrosis	serious				4988
31392	24 pts		Hypotension	serious				4988
31393	4 pts		Peripheral arterial occlusive disease	serious				4988
31394	1 pts		Peripheral ischaemia	serious				4988
31395	2 pts		Disorder peripheral vascular	serious				4988
31396	1 pts		Phlebitis	serious				4988
31397	49 pts		Diarrhoea	below serious				4988
31398	155 pts		Hyperkalaemia	below serious				4988
31399	47 pts		Renal impairment	below serious				4988
31400	59 pts		Cough	below serious				4988
31401	117 pts		Hypotension	below serious				4988
31402	1 pts		Thrush NOS	below serious				4989
31403	1 pts		Hyperkalemia	below serious				4990
31404	1 pts		GI bleed	serious				4986
31405	1 pts		Knee hemarthrosis	serious				4986
31406	5 pts		Diarrhea	below serious				4986
31407	1 pts		Lower extremities weakness of	below serious				4986
31408	0.6		Diarrhea		discontinuation	1 patient		4983
31409						No adverse reactions leading to discontinuation were reported		4984
31410			Disorder fetal		discontinuation	WARNING		4985
31411			Angioedema		discontinuation	WARNING		4985
31412			Angioedema		discontinuation	WARNING		4985
31413			Hypotension		discontinuation	WARNING		4985
31414			Impaired renal function		discontinuation	WARNING		4985
31415			Hyperkalemia		discontinuation	WARNING		4985
31416						No AEs are reported		4993
31417	0.9		Chest pain		discontinuation	leads to discontinuation		4994
31418	0.7		Electrocardiogram QTc interval prolonged		discontinuation	leads to discontinuation		4994
31419						impossible to link AEs with the definite dose: Thirty-one events had a probable or possible causal relationship: headache (12), injection site reaction (8), hot flushes (4), dizziness (3), and pain at injection site, depersonalization, abnormal thinking, and nausea (1 each). Intravenous administration was associated with 15 adverse events in 10 subjects.		4995
31420						No AEs are reported		4992
31421						No AEs are reported		4991
31422	20		Constipation		discontinuation			4996
31423	3		Gastrointestinal discomfort		discontinuation			4996
31424	8		Abdominal pain		discontinuation			4996
31425	9		Nausea		discontinuation			4996
31426	3		Vomiting		discontinuation			4996
31427	5		Diarrhea		discontinuation			4996
31428	7		Headaches		discontinuation			4996
31429	3		Malaise and fatigue		discontinuation			4996
31430						No AEs are reported		4999
31431						No AEs are reported		5000
31432						No AEs are reported		5001
31433	6.6		Alanine aminotransferase increase	grade 3				4998
31434	1.6		Hypotension	grade 3		Hypotension and urticaria were severe AEs whose relationship to oral 5-ALA cannot be ruled out		4998
31435	1.6		Urticaria	grade 3		Hypotension and urticaria were severe AEs whose relationship to oral 5-ALA cannot be ruled out		4998
31436	1 pts		Application site burning		discontinuation	leads to discontinuation		4997
31437	1 pts		Application site pain		discontinuation	leads to discontinuation		4997
31438						No AEs were reported		5005
31439	1 pts		Testicular pain		discontinuation	leads to discontinuation		5004
31440	1 pts		Testicular swelling		discontinuation	leads to discontinuation		5004
31441	1 pts		Epididymo-orchitis		discontinuation	leads to discontinuation		5004
31442	22 pts		Ataxia			leads to dose reduction		5003
31443	22 pts		Intention tremor			leads to dose reduction		5003
31444	84 pts		Pulmonary toxicity			leads to dose reduction		5002
31445	84 pts		Arrhythmia			leads to dose reduction		5002
31446	18 pts		Pulmonary toxicity		discontinuation	leads to discontinuation		5002
31447	18 pts		Arrhythmia		discontinuation	leads to discontinuation		5002
31448	0.6		Pharyngolaryngeal pain	severe	discontinuation	leads to discontinuation		5006
31449	1.5		Nausea					5006
31450	0.9		Pharyngotonsillitis					5006
31451	0.9		Vulvovaginal candidiasis					5006
31452	0.7		Headache					5006
31453	0.5		Diarrhea					5006
31454	0.5		Abdominal pain					5006
31455	6.25		Dizziness postural		discontinuation			5008
31456	12.5		Palpitations		discontinuation			5008
31457	6.25		Chest pain		discontinuation			5008
31458	6.25		Sinus tachycardia		discontinuation			5008
31459	6.25		Abdominal pain		discontinuation			5008
31460			Cardiotoxicity		discontinuation	WARNING		5009
31461			QT interval prolonged		discontinuation	WARNING		5009
31462			Ventricular tachycardia		discontinuation	WARNING		5009
31463			Pulmonary hypertension		discontinuation	WARNING		5009
31464			Bleeding		discontinuation	WARNING		5009
31465			Headache		discontinuation			5007
31466			Diarrhea		discontinuation			5007
31467			Edema		discontinuation			5007
31468			Palpitations		discontinuation			5007
31469			Abdominal pain		discontinuation			5007
31470	1 pts		APTT increased	grade 4				5012
31471	1 pts		INR increased	grade 4				5012
31472						No information on AE is provided		5011
31473	57.3		Haemorrhage					5010
31474	1 pts		Atrial fibrillation	serious				5014
31475	1 pts		Supraventricular tachycardia	serious				5014
31476	1 pts		Appendicitis	serious				5014
31477	1 pts		Ovarian adenoma	serious				5014
31478	14 pts		Abdominal pain upper	below serious				5014
31479	17 pts		Constipation	below serious				5014
31480	69 pts		Dry mouth	below serious				5014
31481	91 pts		Nausea	below serious				5014
31482	15 pts		Vomiting	below serious				5014
31483	38 pts		Fatigue	below serious				5014
31484	25 pts		Irritability	below serious				5014
31485	14 pts		Sinusitis	below serious				5014
31486	53 pts		Decreased appetite	below serious				5014
31487	30 pts		Dizziness	below serious				5014
31488	19 pts		Paraesthesia	below serious				5014
31489	23 pts		Somnolence	below serious				5014
31490	35 pts		Insomnia	below serious				5014
31491	16 pts		Hyperhidrosis	below serious				5014
31492	1 pts		Suicidal ideation	serious				5017
31493	1 pts		Congestive heart failure	serious				5017
31494	7 pts		Constipation	below serious				5017
31495	4 pts		Abdominal pain	below serious				5022
31496	9 pts		Abdominal pain upper	below serious				5022
31497	14 pts		Nausea	below serious				5022
31498	7 pts		Vomiting	below serious				5022
31499	11 pts		Fatigue	below serious				5022
31500	3 pts		Influenza	below serious				5022
31501	13 pts		Decreased appetite	below serious				5022
31502	3 pts		Myalgia	below serious				5022
31503	3 pts		Dizziness	below serious				5022
31504	12 pts		Headache	below serious				5022
31505	5 pts		Early morning awakening	below serious				5022
31506	1 pts		Abdominal pain	serious				5024
31507	1 pts		Abdominal pain upper	serious				5024
31508	3 pts		Vertigo	below serious				5024
31509	7 pts		Mydriasis	below serious				5024
31510	5 pts		Abdominal pain	below serious				5024
31511	8 pts		Abdominal pain upper	below serious				5024
31512	13 pts		Nausea	below serious				5024
31513	9 pts		Vomiting	below serious				5024
31514	21 pts		Fatigue	below serious				5024
31515	5 pts		Pyrexia	below serious				5024
31516	6 pts		Nasopharyngitis	below serious				5024
31517	3 pts		Rhinitis	below serious				5024
31518	9 pts		Anorexia	below serious				5024
31519	3 pts		Decreased appetite	below serious				5024
31520	15 pts		Headache	below serious				5024
31521	3 pts		Sleep disorder	below serious				5024
31522	7 pts		Cough	below serious				5024
31523	5 pts		Pharyngolaryngeal pain	below serious				5024
31524	1 pts		Abdominal pain upper	serious				5023
31525	5 pts		Mydriasis	below serious				5023
31526	6 pts		Abdominal pain	below serious				5023
31527	7 pts		Abdominal pain upper	below serious				5023
31528	4 pts		Diarrhoea	below serious				5023
31529	12 pts		Nausea	below serious				5023
31530	11 pts		Vomiting	below serious				5023
31531	13 pts		Fatigue	below serious				5023
31532	7 pts		Anorexia	below serious				5023
31533	4 pts		Decreased appetite	below serious				5023
31534	1 pts		Sleep disorder	below serious				5023
31535	5 pts		Cough	below serious				5023
31536	2 pts		Pharyngolaryngeal pain	below serious				5023
31537	10 pts		Irritability	below serious				5027
31538	8 pts		Drowsiness	below serious				5027
31539	9 pts		Decreased appetite	below serious				5027
31540	6 pts		Difficulty sleeping	below serious				5027
31541	6 pts		Self injurious behavior	below serious				5027
31542	5 pts		Vomiting	below serious				5027
31543	5 pts		Emotional instability	below serious				5027
31544	4 pts		Congestion nasal	below serious				5027
31545	4 pts		Stomach discomfort	below serious				5027
31546	3 pts		Constipation	below serious				5027
31547	2 pts		Behavior disorder	below serious				5027
31548	2 pts		Flu	below serious				5027
31549	2 pts		Irregular sleep wake rhythm disorder	below serious				5027
31550	2 pts		Tiredness	below serious				5027
31551	2 pts		Flushing	below serious				5027
31552	7 pts		Abdominal pain	below serious				5025
31553	6 pts		Nausea	below serious				5025
31554	3 pts		Vomiting	below serious				5025
31555	4 pts		Fatigue	below serious				5025
31556	3 pts		Pyrexia	below serious				5025
31557	3 pts		Nasopharyngitis	below serious				5025
31558	4 pts		Upper respiratory tract infection	below serious				5025
31559	3 pts		Anorexia	below serious				5025
31560	4 pts		Pharyngolaryngeal pain	below serious				5025
31561	2 pts		Nausea	below serious				5016
31562	1 pts		Blood pressure increased	below serious				5016
31563	7 pts		Nausea	below serious				5026
31564	2 pts		Vomiting	below serious				5026
31565	15 pts		Fatigue	below serious				5026
31566	13 pts		Therapeutic response unexpected	below serious				5026
31567	3 pts		Influenza	below serious				5026
31568	8 pts		Weight decreased	below serious				5026
31569	8 pts		Decreased appetite	below serious				5026
31570	4 pts		Dizziness	below serious				5026
31571	12 pts		Headache	below serious				5026
31572	3 pts		Emotional disorder	below serious				5026
31573	3 pts		Irritability	below serious				5026
31574	1 pts		Mood swings	below serious				5026
31575	3 pts		Nasal congestion	below serious				5026
31576	1 pts		Diverticulitis	serious				5015
31577	17 pts		Constipation	below serious				5015
31578	21 pts		Dry mouth	below serious				5015
31579	81 pts		Nausea	below serious				5015
31580	13 pts		Vomiting	below serious				5015
31581	10 pts		Fatigue	below serious				5015
31582	21 pts		Thirst	below serious				5015
31583	13 pts		Weight decreased	below serious				5015
31584	45 pts		Decreased appetite	below serious				5015
31585	11 pts		Dizziness	below serious				5015
31586	24 pts		Headache	below serious				5015
31587	29 pts		Somnolence	below serious				5015
31588	10 pts		Dysuria	below serious				5015
31589	30 pts		Nausea	below serious				5021
31590	18 pts		Vomiting	below serious				5021
31591	24 pts		Fatigue	below serious				5021
31592	31 pts		Decreased appetite	below serious				5021
31593	17 pts		Dizziness	below serious				5021
31594	20 pts		Somnolence	below serious				5021
31595	7 pts		Anxiety	below serious				5021
31596	8 pts		Insomnia	below serious				5021
31597	1 pts		Anxiety	below serious				5018
31598	1 pts		Night sweats	below serious				5018
31599	1 pts		Constipation	below serious				5018
31600	2 pts		Insomnia	below serious				5018
31601	2 pts		Tachycardia	below serious				5018
31602	1 pts		Irritability	below serious				5018
31603	1 pts		Dry mouth	below serious				5018
31604	1 pts		Flash hot	below serious				5018
31605	1 pts		Chest pain	below serious				5018
31606	1 pts		Labored breathing	below serious				5018
31607	1 pts		Headache	below serious				5018
31608	1 pts		Nausea and vomiting	below serious				5018
31609	3 pts		Feeling jittery	below serious				5019
31610	1 pts		Syncopal attack	below serious				5019
31611	1 pts		Nausea	below serious				5019
31612	1 pts		Chest pain	below serious				5019
31613	1 pts		Diarrhea	below serious				5020
31614	1 pts		Dizziness	below serious				5020
31615	1 pts		Abnormal dreams	below serious				5020
31616	1 pts		Urinary hesitation	below serious				5020
31617	1 pts		Painful urination	below serious				5020
31618	1 pts		Depression central nervous system		discontinuation	leads to discontinuation		5031
31619	1 pts		Tachycardia		discontinuation	leads to discontinuation		5032
31620	10 pts		Drowsiness					5028
31621	6 pts		Tachycardia					5028
31622	3 pts		Nausea					5028
31623	2 pts		Hypertension					5028
31624	2 pts		Vomiting					5028
31625	1 pts		Seizure					5028
31626	1 pts		Hypertension		discontinuation	leads to discontinuation		5029
31627	1 pts		Sinus tachycardia		discontinuation	leads to discontinuation		5033
31628	1 pts		Nausea		discontinuation	leads to discontinuation		5013
31629	1 pts		Malaise		discontinuation	leads to discontinuation		5013
31630	1 pts		Anorexia		discontinuation	leads to discontinuation		5013
31631						no children discontinued atomoxetine because of adverse events		5030
31632	1 pts		ST segment elevation myocardial infarction		discontinuation	leads to discontinuation		5034
31633	2 pts		Taste perversion		discontinuation	leads to discontinuation		5037
31634	1 pts		Gastritis		discontinuation	leads to discontinuation		5037
31635	1 pts		Somnolence		discontinuation	leads to discontinuation		5037
31636	1 pts		Burning sensation		discontinuation	leads to discontinuation		5036
31637	1 pts		Taste bitter		discontinuation	leads to discontinuation		5036
31638	2 pts		Somnolence		discontinuation	leads to discontinuation		5035
31639	1 pts		Back pain		discontinuation	leads to discontinuation		5035
31640	1 pts		Taste perversion		discontinuation	leads to discontinuation		5035
31641	1 pts		Sinusitis		discontinuation	leads to discontinuation		5035
31642	1 pts		Abdominal pain		discontinuation	leads to discontinuation		5039
31643	1 pts		Urticaria		discontinuation	leads to discontinuation		5039
31644	2.4		Colitis ulcerative		discontinuation	leads to discontinuation		5038
31645	2		Nausea		discontinuation	leads to discontinuation		5038
31646	1		Vomiting		discontinuation	leads to discontinuation		5038
31647	1		Erythema nodosum		discontinuation	leads to discontinuation		5038
31648	1		Frequent bowel movements		discontinuation	leads to discontinuation		5038
31649	8.6		Headache					5040
31650	2.6		Back pain					5040
31651	0.9		Diarrhoea					5040
31652	3.4		Upper respiratory tract infection					5040
31653	1.7		Peripheral oedema					5040
31654	1.7		Sinusitis					5040
31655	0.9		Fatigue					5040
31656	1.7		Cough					5040
31657	0.9		Arthralgia					5040
31658	6		Headache					5044
31659	2		Dizziness					5044
31660	2		Dizziness postural					5044
31661	9		Headache					5041
31662	2		Fatigue					5041
31663	2		Nausea					5041
31664	2		Dizziness					5041
31665	2		Cough increased					5041
31666	3		Headache					5042
31667	2		Fatigue					5042
31668	1		Nausea					5042
31669	3		Dizziness					5042
31670	1		Dizziness postural					5042
31671	2		Cough increased					5042
31672	3		Headache					5043
31673	2		Fatigue					5043
31674	1		Nausea					5043
31675	2		Dizziness					5043
31676	1		Dizziness postural					5043
31677	1		Cough increased					5043
31678	2		Headache					5045
31679	5		Fatigue					5045
31680	1		Nausea					5045
31681	1		Cough increased					5045
31682	1 pts		Ventricular tachycardia		discontinuation	leads to discontinuation		5047
31683	1 pts		Bradycardia		discontinuation	leads to discontinuation		5047
31684	1 pts		Ventricular tachycardia	grade 5	discontinuation	leads to discontinuation		5048
31685	1 pts		Bradycardia		discontinuation	leads to discontinuation		5048
31686	4 pts		Electrocardiogram QTc interval prolonged		discontinuation	leads to discontinuation		5048
31687	1 pts		Electrocardiogram QTc interval prolonged		discontinuation	leads to discontinuation		5049
31688	1 pts		Nausea		discontinuation	leads to discontinuation		5050
31689	1 pts		Diarrhea		discontinuation	leads to discontinuation		5050
31690	1 pts		Anorexia		discontinuation	leads to discontinuation		5050
31691	1 pts		Bigeminy		discontinuation	leads to discontinuation		5050
31692	2 pts		Weakness		discontinuation	leads to discontinuation		5046
31693	1 pts		Lightheadedness		discontinuation	leads to discontinuation		5046
31694	1 pts		Syncopal attack		discontinuation	leads to discontinuation		5046
31695	1 pts		Drug intolerance		discontinuation	leads to discontinuation		5046
31696	1 pts		Stye	below serious				5051
31697	1 pts		Headache	below serious				5051
31698	1 pts		Sore throat	below serious				5051
31699	1 pts		Corneal epithelium defect	below serious				5051
31700	1 pts		Hepatitis fulminant	grade 5	discontinuation	leads to discontinuation		5055
31701	1 pts		Corneal melt		discontinuation	leads to discontinuation		5054
31702						No AEs are reported		5052
31703	1 pts		Headache					5053
31704	1 pts		Nausea					5053
31705	2 pts		Dizziness					5053
31706	1 pts		Drowsiness					5053
31707	1 pts		Vomiting					5053
31708	1 pts		Hypotension					5053
31709	4		Nausea		discontinuation			5058
31710	2.8		Dizziness		discontinuation			5058
31711	1.5		Asthenia		discontinuation			5058
31712	1.5		Rhinitis		discontinuation			5058
31713			Nausea		discontinuation			5059
31714						No adverse reactions leading to discontinuation were reported		5057
31715						No adverse reactions leading to discontinuation were reported		5056
31716			Nausea		discontinuation			5061
31717						No adverse reactions leading to discontinuation were reported		5060
31718						No SAEs were observed		5064
31719						No SAEs were observed		5062
31720						No SAEs were observed		5063
31721	1.5		Hypersensitivity					5070
31722	0.5		Reaction serum sickness-like					5071
31723	1 pts		Diarrhea					5069
31724	1 pts		Eosinophilia					5067
31725	1 pts		Pruritus genital					5067
31726	1 pts		Moniliasis					5067
31727	1 pts		Vaginitis					5067
31728	1 pts		Aspartate aminotransferase increased					5066
31729	1 pts		ALT increased					5066
31730	1 pts		Alkaline phosphatase increased					5068
31731	1 pts		Blood urea increased					5068
31732	1 pts		Creatinine serum increased					5065
31733			Allergic reaction		discontinuation	WARNINGS		5073
31734			Hypersensitivity reaction	serious	discontinuation	WARNINGS		5073
31735			Pseudomembranous colitis		discontinuation	WARNINGS		5073
31736			Diarrhea		discontinuation			5072
31737			Nausea		discontinuation			5072
31738	0.4		Rash		discontinuation			5072
31739						There were no severe or life-threatening AEs. No subject discontinued the study.		5074
31740	0.8		Increased urinary frequency		discontinuation			5075
31741	2.5		Diarrhea		discontinuation			5075
31742	0.8		Nausea					5075
31743	0.8		Vomiting		discontinuation			5075
31744			Diarrhea, Clostridium difficile		discontinuation			5076
31745			Hypersensitivity		discontinuation			5076
31746						impossible to link AEs with the definite dose: One patient developed a generalized urticarial rash that resolved within 24 h after cessation of cefmenoxime therapy.		5078
31747						impossible to link AEs with the definite dose		5077
31748						impossible to link AEs with the definite dose		5080
31749	1 pts		Localized rash		discontinuation	leads to discontinuation		5079
31750						impossible to link AEs with the definite dose		5081
31751			Vomiting		discontinuation			5082
31752			Diarrhea		discontinuation			5082
31753			Rash		discontinuation			5082
31754	13 pts		Death	grade 5	discontinuation	leads to discontinuation. maybe it is not drug related		5084
31755	1 pts		Urinary tract yeast infection		discontinuation	leads to discontinuation		5084
31756						No AEs were reported		5083
31757						No AEs are reported		5094
31758	1 pts		Metabolic acidosis	grade 5		suicide attempt		5087
31759	1 pts		Hypokalemia	grade 5		suicide attempt		5087
31760	1 pts		Insomnia		discontinuation	leads to discontinuation		5092
31761	1 pts		Delusions		discontinuation	leads to discontinuation		5089
31762	1 pts		Depression		discontinuation	leads to discontinuation		5089
31763	1 pts		Dystonic reaction		discontinuation	leads to discontinuation		5093
31764						accidentally		5086
31765	1 pts		Drowsiness	severe		accidentally		5088
31766	1 pts		Sedation			accidentally		5088
31767	2		Ocular hyperemia					5085
31768	0.6		Visual acuity reduced					5085
31769	5.3		Conjunctival hyperemia					5085
31770	1		Dyspepsia					5091
31771	1		Feeling hot					5091
31772	1		Dysgeusia					5091
31773	1		Headache					5091
31774	1		Paresthesia					5091
31775	1		Presyncope					5091
31776	1		Hyperhidrosis					5091
31777	13.7		Somnolence					5090
31778	5.9		Fatigue					5090
31779	5		Dry mouth					5090
31780	2		Dizziness					5090
31781	2		Pharyngitis					5090
31782			Abdominal pain	grade 3-4	discontinuation			5095
31783			Rash	grade 3-4	discontinuation			5095
31784			Depression	grade 3-4	discontinuation			5095
31785			Joint dislocation	grade 3-4	discontinuation			5095
31786			Granulocytopenia	grade 3-4	discontinuation			5095
31787			Vertigo	grade 3-4	discontinuation			5095
31788			LE syndrome	grade 3-4	discontinuation			5095
31789			Sweating increased	grade 3-4	discontinuation			5095
31790	12 pts		Diarrhea					5098
31791	2 pts		Arrhythmia			led to redution dose		5096
31792	1 pts		Arrhythmia					5097
31793						No AEs are reported		5100
31794						No AEs are reported		5101
31795						No AEs are reported		5099
31796	1 pts		Dystonic reaction					5104
31797	38 pts		Convulsions					5102
31798			Death	grade 5	discontinuation	leads to discontinuation		5103
31799	1 pts		Tachycardia	below serious				5109
31800	6 pts		Dry mouth	below serious				5109
31801	1 pts		Toothache	below serious				5109
31802	1 pts		Rhinitis	below serious				5109
31803	1 pts		Dizziness	below serious				5109
31804	1 pts		Dysgeusia	below serious				5109
31805	1 pts		Anxiety	below serious				5109
31806	1 pts		Disruptive mood dysregulation disorder	below serious				5109
31807	1 pts		Sleep disorder	below serious				5109
31808	18 pts		Somnolence	below serious				5109
31809	5.2		Somnolence		discontinuation			5107
31810			Lethargy		discontinuation			5106
31811			Slurred speech		discontinuation			5106
31812			Sinus tachycardia		discontinuation			5106
31813			Sinus tachycardia		discontinuation			5105
31814			Confusion		discontinuation			5105
31815			Drowsiness		discontinuation			5105
31816			Agitation		discontinuation			5105
31817			Visual hallucinations		discontinuation			5105
31818			Serotonin syndrome	grade 4	discontinuation	WARNING		5108
31819			Cardiovascular disorder NOS		discontinuation	WARNING		5108
31820			CNS depression		discontinuation	WARNING		5108
31821	0.79		Headache	grade 3	discontinuation			5111
31822	5.51		Gastrointestinal disorder NOS		discontinuation			5111
31823			Drug-induced hepatitis		discontinuation	WARNING		5112
31824			Hepatitis acute		discontinuation	WARNING		5112
31825			Cytolytic hepatitis		discontinuation	WARNING		5112
31826			Reaction skin	grade 1-3	discontinuation	WARNING		5112
31827			Stevens-Johnson syndrome		discontinuation	WARNING		5112
31828			Toxic epidermal necrolysis		discontinuation	WARNING		5112
31829			Diabetes mellitus		discontinuation	WARNING		5112
31830			Hyperglycemia		discontinuation	WARNING		5112
31831			Fat redistribution		discontinuation	WARNING		5112
31832			Fat tissue increased		discontinuation	WARNING		5112
31833			Immune reconstitution syndrome		discontinuation	WARNING		5112
31834	0.5		Rash	grade 1-2	discontinuation			5113
31835						no untoward symptomatic effects		5110
31836	36		Rash	grade 3-4	discontinuation	leads to discontinuation		5115
31837	1 pts		Oral lesion		discontinuation	leads to discontinuation		5115
31838	1 pts		Fever	grade 3				5115
31839	2 pts		Function liver abnormal		discontinuation	leads to discontinuation		5115
31840	1 pts		Thrombocytopenia					5115
31841	1 pts		Nausea					5115
31842	1 pts		Fatigue					5115
31843	1 pts		Headache	grade 4	discontinuation	leads to discontinuation		5115
31844	3.2		Rash		discontinuation	in Studies 21 Part II and 13C, discontinuations due to rash were reported in more patients who received RESCRIPTOR 400 mg 3 times daily (3% and 4%, respectively) than in those who did not receive RESCRIPTOR (0% and 1%, respectively)		5114
31845						impossible to link dose with AEs: 50% of patients had grade 2 neurocognitive AEs. There was one grade 3 AE; a large bowel obstruction likely related to anticholinergic effects of desipramine that occurred in the patient with high-grade neuroendocrine rectal tumor.		5116
31846	1 pts		Areflexia	grade 5		Intoxication		5118
31847	1 pts		Coma	grade 5		Intoxication		5118
31848	1 pts		Seizures	grade 5		Intoxication		5118
31849	1 pts		Hypotension	grade 5		Intoxication		5118
31850			Suicidal ideation			WARNING		5117
31851	2 pts		Cardiac disorders	serious				5119
31852	1 pts		Injury, poisoning and procedural complications	serious				5119
31853	23 pts		Nervous system disorders	below serious				5119
31854	19 pts		Musculoskeletal and connective tissue disorders	below serious				5119
31855	19 pts		General system disorders NEC	below serious				5119
31856	15 pts		Cardiac disorders	below serious				5119
31857	12 pts		Respiratory disorder	below serious				5119
31858	13 pts		Injury, poisoning and procedural complications	below serious				5119
31859	11 pts		Vascular disorders	below serious				5119
31860	5 pts		Surgical and medical procedures	below serious				5119
31861	2 pts		Neoplasm	below serious				5119
31862	1 pts		Endocrine disorders	below serious				5119
31863	1 pts		Hepatobiliary disorders	below serious				5119
31864	1 pts		Immune system disorders	below serious				5119
31865	1 pts		Reproductive system and breast disorders	below serious				5119
31866						No AEs reported		5120
31867	2 pts		Impaired renal function		discontinuation	leads to dose reduction		5121
31868	1 pts		Thrombocytopenia		discontinuation	leads to dose reduction		5121
31869	20 pts		Nausea		discontinuation	leads to discontinuation		5124
31870	8 pts		Pain in limb		discontinuation	leads to discontinuation		5124
31871	8 pts		Cramp		discontinuation	leads to discontinuation		5124
31872	4 pts		Chest tightness		discontinuation	leads to discontinuation		5124
31873	4 pts		Throat tightness		discontinuation	leads to discontinuation		5125
31874	3 pts		Vomiting		discontinuation	leads to discontinuation		5124
31875			Cerebrovascular event	grade 5	discontinuation	leads to discontinuation		5123
31876						The safety of doses greater than 4 mg in a 7-day period has not been established		5122
31877	2 pts		Rhinitis		discontinuation	leads to discontinuation		5126
31878	2 pts		Dizziness		discontinuation	leads to discontinuation		5126
31879	1 pts		Edema face		discontinuation	leads to discontinuation		5126
31880	1 pts		Cold sweat		discontinuation	leads to discontinuation		5126
31881	1 pts		Trauma		discontinuation	leads to discontinuation		5126
31882	1 pts		Depression		discontinuation	leads to discontinuation		5126
31883	1 pts		Somnolence		discontinuation	leads to discontinuation		5126
31884	1 pts		Allergy		discontinuation	leads to discontinuation		5126
31885	1 pts		Vomiting		discontinuation	leads to discontinuation		5126
31886	1 pts		Hypotension		discontinuation	leads to discontinuation		5126
31887	1 pts		Paraesthesia		discontinuation	leads to discontinuation		5126
31888	14 pts		Central nervous system disorder NOS		discontinuation	These adverse effects were of such severity that further studies with diphenidol as an antiarrhythmic are not warranted.		5127
31889	1 pts		Eosinophilia		discontinuation	leads to discontinuation		5129
31890			Adverse event			joined low- and high-dose groups are reported		5128
31891	5 pts		Angina		discontinuation	leads to discontinuation		5130
31892	5 pts		Arrhythmia		discontinuation	leads to discontinuation		5130
31893	5 pts		Hypertension	severe	discontinuation	leads to discontinuation		5130
31894	3 pts		Fatigue	serious				5133
31895	1 pts		Mood depression	serious				5133
31896	2 pts		Muscle weakness	serious				5133
31897	1 pts		Pain	serious				5133
31898	1 pts		Back pain	serious				5133
31899	1 pts		Seizure	serious				5133
31900	21 pts		Anorexia	below serious				5133
31901	24 pts		Diarrhea	below serious				5133
31902	42 pts		Headache	below serious				5133
31903	43 pts		Insomnia	below serious				5133
31904	32 pts		Muscle cramps	below serious				5133
31905	8 pts		Vomiting	below serious				5133
31906	1 pts		Concussion	serious				5137
31907	1 pts		Femoral neck fracture	serious				5137
31908	1 pts		Joint dislocation	serious				5137
31909	1 pts		Pelvic fracture	serious				5137
31910	1 pts		Upper limb fracture	serious				5137
31911	1 pts		Colitis	serious				5137
31912	1 pts		Gastritis erosive	serious				5137
31913	1 pts		Cardiac failure acute	serious				5137
31914	1 pts		Endocarditis	serious				5137
31915	1 pts		Lupus erythematosus systemic	serious				5137
31916	1 pts		Bladder prolapse	serious				5137
31917	1 pts		Anaemia	serious				5137
31918	4 pts		Nasopharyngitis	below serious				5137
31919	4 pts		Influenza	below serious				5137
31920	3 pts		Urinary tract infection	below serious				5137
31921	2 pts		Cystitis	below serious				5137
31922	2 pts		Erysipelas	below serious				5137
31923	2 pts		Gastroenteritis	below serious				5137
31924	2 pts		Viral infection	below serious				5137
31925	1 pts		Conjunctivitis bacterial	below serious				5137
31926	1 pts		Herpes zoster	below serious				5137
31927	1 pts		Otitis media	below serious				5137
31928	1 pts		Upper respiratory tract infection	below serious				5137
31929	1 pts		Viral rhinitis	below serious				5137
31930	5 pts		Dizziness	below serious				5137
31931	2 pts		Syncope	below serious				5137
31932	1 pts		Dementia Alzheimer's type	below serious				5137
31933	1 pts		Burning sensation	below serious				5137
31934	1 pts		Lethargy	below serious				5137
31935	5 pts		Nausea	below serious				5137
31936	2 pts		Abdominal pain upper	below serious				5137
31937	1 pts		Constipation	below serious				5137
31938	2 pts		Vomiting	below serious				5137
31939	1 pts		Flatulence	below serious				5137
31940	1 pts		Chronic pancreatitis	below serious				5137
31941	5 pts		Insomnia	below serious				5137
31942	3 pts		Nightmare	below serious				5137
31943	2 pts		Abnormal dreams	below serious				5137
31944	1 pts		Delirium	below serious				5137
31945	1 pts		Hallucination, visual	below serious				5137
31946	1 pts		Increased libido	below serious				5137
31947	1 pts		Libido increased	below serious				5137
31948	2 pts		Increased appetite	below serious				5137
31949	2 pts		Asthenia	below serious				5137
31950	1 pts		Fatigue	below serious				5137
31951	1 pts		Gait disturbance	below serious				5137
31952	1 pts		Malaise	below serious				5137
31953	1 pts		Animal bite	below serious				5137
31954	1 pts		Periorbital haematoma	below serious				5137
31955	3 pts		Back pain	below serious				5137
31956	2 pts		Muscle spasms	below serious				5137
31957	1 pts		Lupus erythematosus systemic	below serious				5137
31958	1 pts		Dermatitis contact	below serious				5137
31959	1 pts		Photodermatosis	below serious				5137
31960	4 pts		Hypertension	below serious				5137
31961	1 pts		Haematoma	below serious				5137
31962	1 pts		Orthostatic hypotension	below serious				5137
31963	1 pts		Blood glucose increased	below serious				5137
31964	1 pts		Red blood cells urine	below serious				5137
31965	1 pts		Sinus bradycardia	below serious				5137
31966	1 pts		Pollakiuria	below serious				5137
31967	1 pts		Cough	below serious				5137
31968	1 pts		Rhinorrhoea	below serious				5137
31969	1 pts		Breast mass	below serious				5137
31970	1 pts		Cystocele	below serious				5137
31971	1 pts		Hepatic steatosis	below serious				5137
31972	1 pts		Seasonal allergy	below serious				5137
31973	1 pts		Hyperparathyroidism	below serious				5137
31974	1 pts		Headache	below serious				5140
31975	3 pts		Nausea	below serious				5138
31976	4 pts		Diarrhea	below serious				5138
31977	1 pts		Vomiting	below serious				5138
31978	1 pts		Muscle cramps	below serious				5138
31979	6 pts		Decreased appetite	below serious				5138
31980	3 pts		General body pain	below serious				5138
31981	1 pts		Bruise	below serious				5138
31982	3 pts		Weight decrease	below serious				5138
31983	3 pts		Joint pain	below serious				5138
31984	1 pts		Depressed mood	below serious				5138
31985	8 pts		Abnormal dreams	below serious				5138
31986	4 pts		Urination frequency of	below serious				5138
31987	2 pts		Chest pain	below serious				5138
31988	1 pts		Hostility	below serious				5138
31989	2 pts		Confusion	below serious				5138
31990	2 pts		Itching	below serious				5138
31991	1 pts		Abnormal vision	below serious				5138
31992	4 pts		Eye irritation	below serious				5138
31993	5 pts		Sore throat	below serious				5138
31994	1 pts		Incontinence	below serious				5138
31995	2 pts		Abdominal bloating	below serious				5138
31996	2 pts		Flatulence	below serious				5138
31997	2 pts		Fever	below serious				5138
31998	1 pts		Hot flashes	below serious				5138
31999	1 pts		Stool black	below serious				5138
32000	1 pts		Urination difficulty	below serious				5138
32001	1 pts		Nausea	serious				5139
32002	1 pts		Pneumonia	serious				5139
32003	1 pts		Femur fracture	serious				5139
32004	1 pts		Hyponatraemia	serious				5139
32005	1 pts		Osteoarthritis	serious				5139
32006	1 pts		Decubitus ulcer	serious				5139
32007	3 pts		Pollakiuria	below serious				5139
32008	2 pts		Nausea	below serious				5139
32009	1 pts		Blood creatine phosphokinase increased	below serious				5139
32010	3 pts		Decreased appetite	below serious				5139
32011	1 pts		Muscle spasms	below serious				5139
32012	2 pts		Insomnia	below serious				5139
32013	1 pts		Rash	below serious				5139
32014	1 pts		Vomiting	serious				5136
32015	1 pts		Renal impairment	serious				5136
32016	3 pts		Pyrexia	below serious				5136
32017	1 pts		Glucose urine present	below serious				5136
32018	2 pts		Blood creatine phosphokinase increased	below serious				5136
32019	2 pts		Decreased appetite	below serious				5136
32020	2 pts		Muscle spasms	below serious				5136
32021	4 pts		Parkinsonism	below serious				5136
32022	1 pts		Rash	below serious				5136
32023	1 pts		Myocardial infarction	serious				5135
32024	1 pts		Cataract	serious				5135
32025	1 pts		Hernia inguinal	serious				5135
32026	1 pts		Femoral neck fracture	serious				5135
32027	2 pts		Spinal compression fracture	serious				5135
32028	1 pts		Gastric cancer	serious				5135
32029	1 pts		Loss of consciousness	serious				5135
32030	1 pts		Asphyxia	serious				5135
32031	18 pts		Nasopharyngitis	below serious				5135
32032	6 pts		Contusion	below serious				5135
32033	2 pts		Angina pectoris	below serious				5135
32034	2 pts		Conjunctivitis	below serious				5135
32035	4 pts		Diarrhoea	below serious				5135
32036	3 pts		Constipation	below serious				5135
32037	3 pts		Nausea	below serious				5135
32038	2 pts		Abdominal discomfort	below serious				5135
32039	2 pts		Gastritis	below serious				5135
32040	2 pts		Abdominal pain upper	below serious				5135
32041	2 pts		Dyspepsia	below serious				5135
32042	3 pts		Hepatic function abnormal	below serious				5135
32043	2 pts		Bronchitis	below serious				5135
32044	1 pts		Glucose urine present	below serious				5135
32045	2 pts		Weight decreased	below serious				5135
32046	2 pts		Lymphocyte count decreased	below serious				5135
32047	2 pts		Decreased appetite	below serious				5135
32048	2 pts		Diabetes mellitus	below serious				5135
32049	2 pts		Muscle spasms	below serious				5135
32050	5 pts		Parkinsonism	below serious				5135
32051	3 pts		Dizziness	below serious				5135
32052	2 pts		Somnolence	below serious				5135
32053	2 pts		Agitation	below serious				5135
32054	3 pts		Sleep disorder	below serious				5135
32055	4 pts		Eczema	below serious				5135
32056	2 pts		Rash	below serious				5135
32057	2 pts		Hypertension	below serious				5135
32058	2 pts		Irritability	below serious				5135
32059	2 pts		Oedema peripheral	below serious				5135
32060	2 pts		Osteoarthritis spinal	below serious				5135
32061	1 pts		Hypertension	serious				5134
32062	1 pts		Decreased appetite	serious				5134
32063	1 pts		Intestinal obstruction	serious				5134
32064	1 pts		Nausea	serious				5134
32065	1 pts		Vomiting	serious				5134
32066	1 pts		Pyrexia	serious				5134
32067	1 pts		Bronchitis	serious				5134
32068	2 pts		Pneumonia	serious				5134
32069	1 pts		Femur fracture	serious				5134
32070	1 pts		Hyponatraemia	serious				5134
32071	1 pts		Osteoarthritis	serious				5134
32072	1 pts		Loss of consciousness	serious				5134
32073	1 pts		Hallucination	serious				5134
32074	1 pts		Hallucination, visual	serious				5134
32075	1 pts		Insomnia	serious				5134
32076	1 pts		Paranoia	serious				5134
32077	1 pts		Renal impairment	serious				5134
32078	1 pts		Decubitus ulcer	serious				5134
32079	3 pts		Pyrexia	below serious				5134
32080	17 pts		Nasopharyngitis	below serious				5134
32081	3 pts		Pollakiuria	below serious				5134
32082	1 pts		Conjunctivitis	below serious				5134
32083	6 pts		Diarrhoea	below serious				5134
32084	5 pts		Constipation	below serious				5134
32085	4 pts		Nausea	below serious				5134
32086	1 pts		Gastritis	below serious				5134
32087	5 pts		Glucose urine present	below serious				5134
32088	5 pts		Blood creatine phosphokinase increased	below serious				5134
32089	5 pts		Decreased appetite	below serious				5134
32090	5 pts		Muscle spasms	below serious				5134
32091	12 pts		Parkinsonism	below serious				5134
32092	1 pts		Dizziness	below serious				5134
32093	5 pts		Insomnia	below serious				5134
32094	2 pts		Rash	below serious				5134
32095	1 pts		Hypertension	below serious				5134
32096	1 pts		Oedema peripheral	below serious				5134
32097	1 pts		Nausea					5141
32098	1 pts		Vomiting					5141
32099	1 pts		Bradycardia					5141
32100	1 pts		Myoclonus		discontinuation	leads to discontinuation		5145
32101						No AEs are reported		5142
32102						No AEs are reported		5143
32103	<1		Diarrhea		discontinuation	leads to discontinuation		5132
32104	3		Diarrhea					5131
32105	3		Nausea					5131
32106	2		Vomiting					5131
32107	0.7		Bradycardia		discontinuation	leads to discontinuation		5144
32108	1.7		Diarrhea		discontinuation	leads to discontinuation		5144
32109	1.9		Nausea		discontinuation	leads to discontinuation		5144
32110	2.9		Vomiting		discontinuation	leads to discontinuation		5144
32111	0.4		QT interval prolonged		discontinuation	leads to discontinuation		5144
32112	0.3		Anorexia		discontinuation	leads to discontinuation		5144
32113	1.1		Dizziness		discontinuation	leads to discontinuation		5144
32114	0.4		Headache		discontinuation	leads to discontinuation		5144
32115	0.6		Somnolence		discontinuation	leads to discontinuation		5144
32116	0.2		Syncope		discontinuation	leads to discontinuation		5144
32117	0.5		Aggression		discontinuation	leads to discontinuation		5144
32118	0.8		Agitation		discontinuation	leads to discontinuation		5144
32119	0.7		Confusional state		discontinuation	leads to discontinuation		5144
32120	8 pts		Application site irritation					5146
32121	1 pts		Lacrimation					5146
32122	1 pts		Foreign body sensation in eyes					5146
32123	1 pts		Conjunctival hyperemia					5146
32124	1 pts		Visual disturbance					5146
32125	1 pts		Throat pain					5146
32126	1 pts		Seborrheic dermatitis					5146
32127	1 pts		Sugar urinary					5146
32128	22		Ocular stinging					5147
32129	12		Conjunctival injection					5147
32130	3		Headache					5147
32131	2 pts		Nausea	below serious				5152
32132	1 pts		Constipation	below serious				5152
32133	1 pts		Allergy	below serious				5152
32134	1 pts		Dizziness	below serious				5152
32135	1 pts		Numbness	below serious				5152
32136	1 pts		Orthostatic dizziness		discontinuation	leads to discontinuation		5149
32137	1 pts		Sinus tachycardia		discontinuation	leads to discontinuation		5151
32138	3 pts		Fatigue		discontinuation	leads to discontinuation		5150
32139	2 pts		Urinary incontinence		discontinuation	leads to discontinuation		5150
32140	1 pts		Rhinitis			leads to dose reduction		5150
32141	2.7		Postural edema				TRUE	5148
32142	1 pts		Neuropathy peripheral	serious				5154
32143	1 pts		Presyncope	serious				5154
32144	1 pts		Ocular discomfort	serious				5154
32145	3 pts		Cardiac failure congestive	serious				5154
32146	1 pts		Cardiomyopathy	serious				5154
32147	1 pts		Muscle rupture	serious				5154
32148	3 pts		Dizziness	below serious				5154
32149	7 pts		Diarrhoea	below serious				5154
32150	7 pts		Nausea	below serious				5154
32151	3 pts		Fatigue	below serious				5154
32152	1 pts		Cardiac failure congestive	serious				5155
32153	1 pts		Pleural effusion	serious				5155
32154	1 pts		Gastrointestinal haemorrhage	serious				5155
32155	1 pts		Pancreatic cyst	serious				5155
32156	1 pts		Gouty arthritis	serious				5155
32157	1 pts		Renal failure acute	serious				5155
32158	1 pts		Asthenia	serious				5155
32159	1 pts		Femoral neck fracture	serious				5155
32160	2 pts		Pneumonia	below serious				5155
32161	2 pts		Sinusitis	below serious				5155
32162	3 pts		Insomnia	below serious				5155
32163	2 pts		Depression	below serious				5155
32164	3 pts		Dizziness	below serious				5155
32165	4 pts		Diarrhoea	below serious				5155
32166	3 pts		Nausea	below serious				5155
32167	2 pts		Constipation	below serious				5155
32168	2 pts		Flatulence	below serious				5155
32169	4 pts		Fatigue	below serious				5155
32170			Heart failure	grade 5		WARNING: contraindicated		5156
32171	3.2		Gastrointestinal disorders		discontinuation	leads to discontinuation		5160
32172	1.5		QT interval prolonged		discontinuation	leads to discontinuation		5160
32173						No AEs are reported		5159
32174	6.7		Diarrhea		discontinuation	leads to discontinuation		5153
32175	3.9		Nausea		discontinuation	leads to discontinuation		5153
32176	2		Abdominal pain upper		discontinuation	leads to discontinuation		5153
32177	1.9		Abdominal pain		discontinuation	leads to discontinuation		5153
32178	1.7		Vomiting		discontinuation	leads to discontinuation		5153
32179	1.3		Dyspepsia		discontinuation	leads to discontinuation		5153
32180	3.7		Nasopharyngitis		discontinuation	leads to discontinuation		5153
32181	2.9		Upper respiratory tract infection		discontinuation	leads to discontinuation		5153
32182	3.4		Dizziness		discontinuation	leads to discontinuation		5153
32183	2.5		Blood creatinine increased		discontinuation	leads to discontinuation		5153
32184	1.2		Hepatic enzyme increased		discontinuation	leads to discontinuation		5153
32185	0.4		Blood urea increased		discontinuation	leads to discontinuation		5153
32186	2.6		Bradycardia		discontinuation	leads to discontinuation		5153
32187	1.1		Palpitations		discontinuation	leads to discontinuation		5153
32188	1.3		Cardiac failure congestive		discontinuation	leads to discontinuation		5153
32189	0.8		Cardiac failure		discontinuation	leads to discontinuation		5153
32190	2.7		Fatigue		discontinuation	leads to discontinuation		5153
32191	4.2		Oedema peripheral		discontinuation	leads to discontinuation		5153
32192	3.3		Back pain		discontinuation	leads to discontinuation		5153
32193	3.1		Arthralgia		discontinuation	leads to discontinuation		5153
32194	2.1		Pain in extremity		discontinuation	leads to discontinuation		5153
32195	2.2		Cough		discontinuation	leads to discontinuation		5153
32196	2.3		Dyspnoea		discontinuation	leads to discontinuation		5153
32197	1.3		Vertigo		discontinuation	leads to discontinuation		5153
32198	7.6		Diarrhea		discontinuation	leads to discontinuation		5157
32199	1.5		Vomiting		discontinuation	leads to discontinuation		5157
32200	3		Dyspepsia		discontinuation	leads to discontinuation		5157
32201	1.5		Abdominal pain		discontinuation	leads to discontinuation		5157
32202	4.5		Nasopharyngitis		discontinuation	leads to discontinuation		5157
32203	1.5		Electrocardiogram QT prolonged		discontinuation	leads to discontinuation		5157
32204	1.5		Blood creatinine increased		discontinuation	leads to discontinuation		5157
32205	4.5		Hepatic enzyme increased		discontinuation	leads to discontinuation		5157
32206	3		Blood urea increased		discontinuation	leads to discontinuation		5157
32207	1.5		Bradycardia		discontinuation	leads to discontinuation		5157
32208	6.1		Palpitations		discontinuation	leads to discontinuation		5157
32209	4.5		Cardiac failure congestive		discontinuation	leads to discontinuation		5157
32210	4.5		Cardiac failure		discontinuation	leads to discontinuation		5157
32211	4.5		Fatigue		discontinuation	leads to discontinuation		5157
32212	1.5		Cough		discontinuation	leads to discontinuation		5157
32213	3		Hypokalemia		discontinuation	leads to discontinuation		5157
32214	4.5		Vertigo		discontinuation	leads to discontinuation		5157
32215	29		Diarrhea		discontinuation	leads to discontinuation		5158
32216	8.1		Nausea		discontinuation	leads to discontinuation		5158
32217	3.2		Vomiting		discontinuation	leads to discontinuation		5158
32218	3.2		Abdominal pain		discontinuation	leads to discontinuation		5158
32219	3.2		Influenza		discontinuation	leads to discontinuation		5158
32220	1.6		Upper respiratory tract infection		discontinuation	leads to discontinuation		5158
32221	4.8		Dizziness		discontinuation	leads to discontinuation		5158
32222	3.2		Electrocardiogram QT prolonged		discontinuation	leads to discontinuation		5158
32223	1.6		Hepatic enzyme increased		discontinuation	leads to discontinuation		5158
32224	3.2		Blood urea increased		discontinuation	leads to discontinuation		5158
32225	6.5		Bradycardia		discontinuation	leads to discontinuation		5158
32226	4.8		Palpitations		discontinuation	leads to discontinuation		5158
32227	1.6		Cardiac failure congestive		discontinuation	leads to discontinuation		5158
32228	1.6		Cardiac failure		discontinuation	leads to discontinuation		5158
32229	3.2		Fatigue		discontinuation	leads to discontinuation		5158
32230	4.8		Atrial tachycardia		discontinuation	leads to discontinuation		5158
32231	4.8		Cough		discontinuation	leads to discontinuation		5158
32232	3.2		Vertigo		discontinuation	leads to discontinuation		5158
32233						No AEs reported		5161
32234			Irritation skin			leads to discontinuation		5162
32235	0.4		Nausea		discontinuation			5163
32236	0.4		Dizziness		discontinuation			5163
32237	0.3		Asthenia		discontinuation			5163
32238	0.3		Chest pain		discontinuation			5163
32239	0.2		Headache		discontinuation			5163
32240	0.2		Vomiting		discontinuation			5163
32241	0.2		Hypertonia		discontinuation			5163
32242	0.2		Paresthesia		discontinuation			5163
32243	0.2		Somnolence		discontinuation			5163
32244	19 pts		Impaired driving ability					5165
32245						No adverse events were reported in this study.		5166
32246	7 pts		Sleepiness					5164
32247						No SAEs were observed		5167
32248						No AEs are reported		5168
32249	1 pts		Nausea		discontinuation	leads to discontinuation		5169
32250	1 pts		Vomiting		discontinuation	leads to discontinuation		5169
32251						No AEs are reported		5170
32252						No serious adverse events were recorded		5171
32253						No adverse reactions leading to discontinuation were reported		5172
32254			Tachycardia		discontinuation	WARNING		5173
32255			Hypokalemia		discontinuation	WARNING		5173
32256			Anaphylactic reaction		discontinuation	WARNING		5173
32257	1 pts		Upper respiratory tract infection	below serious				5174
32258	1 pts		Inflammation	below serious				5174
32259						impossible to link AEs with the definite dose		5175
32260	1 pts		Papular urticarial eruption		discontinuation	leads to discontinuation		5179
32261	3 pts		Headache					5177
32262	3 pts		Tiredness					5177
32263	3 pts		Dizziness					5177
32264	3 pts		Headache					5176
32265	3 pts		Tiredness					5176
32266	3 pts		Dizziness					5176
32267	2 pts		Headache		discontinuation	leads to discontinuation		5178
32268	1 pts		Suicidal behavior	serious				5181
32269	2 pts		Pain stomach	below serious				5181
32270	1 pts		Insomnia	below serious				5181
32271	1 pts		Fatigue	below serious				5181
32272	1 pts		Feeling happy inappropriately	below serious				5181
32273	1 pts		Suicide attempt	serious				5215
32274	1 pts		Lymphadenitis	serious				5191
32275	1 pts		Gastritis	serious				5191
32276	1 pts		Ulna fracture	serious				5191
32277	15 pts		Nausea	below serious				5191
32278	6 pts		Vomiting	below serious				5191
32279	3 pts		Upper respiratory tract infection	below serious				5191
32280	4 pts		Incorrect dose administered	below serious				5191
32281	10 pts		Decreased appetite	below serious				5191
32282	4 pts		Dizziness	below serious				5191
32283	18 pts		Headache	below serious				5191
32284	6 pts		Insomnia	below serious				5191
32285	1 pts		Suicidal ideation	serious				5190
32286	1 pts		Suicide attempt	serious				5190
32287	9 pts		Abdominal pain upper	below serious				5190
32288	13 pts		Nausea	below serious				5190
32289	7 pts		Vomiting	below serious				5190
32290	6 pts		Fatigue	below serious				5190
32291	2 pts		Influenza	below serious				5190
32292	1 pts		Blood triglycerides increased	below serious				5210
32293	2 pts		White blood cell count decreased	below serious				5213
32294	1 pts		Diarrhoea	below serious				5211
32295	1 pts		Stomatitis	below serious				5211
32296	2 pts		Alanine aminotransferase increased	below serious				5211
32297	1 pts		Aspartate aminotransferase increased	below serious				5211
32298	2 pts		Atrioventricular block first degree	below serious				5214
32299	1 pts		Conjunctivitis allergic	below serious				5214
32300	1 pts		Haemorrhoids	below serious				5214
32301	1 pts		Proctalgia	below serious				5214
32302	1 pts		Excoriation	below serious				5214
32303	1 pts		Alanine aminotransferase increased	below serious				5214
32304	1 pts		Aspartate aminotransferase increased	below serious				5214
32305	1 pts		Blood triglycerides increased	below serious				5214
32306	1 pts		White blood cell count decreased	below serious				5214
32307	1 pts		White blood cell count increased	below serious				5214
32308	1 pts		Dizziness	below serious				5214
32309	1 pts		Anxiety	below serious				5214
32310	6 pts		Headache	below serious				5212
32311	8 pts		Anxiety	below serious				5212
32312	5 pts		Dizziness	below serious				5212
32313	1 pts		Depressive symptom	serious				5189
32314	1 pts		Hallucination, auditory	serious				5189
32315	1 pts		Overdose	serious				5189
32316	3 pts		Suicidal ideation	serious				5189
32317	4 pts		Abdominal pain upper	below serious				5189
32318	5 pts		Upper respiratory tract infection	below serious				5189
32319	6 pts		Insomnia	below serious				5189
32320	1 pts		Intentional overdose	serious				5180
32321	1 pts		Suicide attempt	serious				5180
32322	1 pts		Suicidal ideation	serious				5180
32323	1 pts		Faecaloma	serious				5180
32324	5 pts		Tachycardia	below serious				5180
32325	4 pts		Vomiting	below serious				5180
32326	7 pts		Nasopharyngitis	below serious				5180
32327	10 pts		Decreased appetite	below serious				5180
32328	15 pts		Tachycardia		discontinuation	leads to discontinuation		5182
32329	14 pts		Drowsiness		discontinuation	leads to discontinuation		5182
32330	5 pts		Tremor		discontinuation	leads to discontinuation		5182
32331	4 pts		Vomited		discontinuation	leads to discontinuation		5182
32332	4 pts		Nausea		discontinuation	leads to discontinuation		5182
32333	22		Headache					5186
32334	18		Asthenia					5186
32335	18		Nausea					5186
32336	17		Rhinitis					5186
32337	15		Diarrhoea					5186
32338	13		Somnolence					5186
32339	12		Insomnia					5186
32340	10		Nervousness					5186
32341	9		Sweating					5186
32342	8		Flu syndrome					5186
32343	7		Pain					5186
32344	7		Anxiety					5186
32345	6		Dizziness					5186
32346	6		Tremor					5186
32347	5		Pharyngitis					5186
32348						No AEs were reported		5194
32349	1 pts		Sleepy		discontinuation	leads to discontinuation		5196
32350	1 pts		Insomnia		discontinuation	leads to discontinuation		5198
32351						No AEs were reported		5199
32352	1 pts		Sleepy		discontinuation	leads to discontinuation		5200
32353	1 pts		Sleepy		discontinuation	leads to discontinuation		5201
32354	1 pts		Tremor		discontinuation	leads to discontinuation		5201
32355						No AEs were reported		5202
32356	1 pts		Hypertension	grade 1	discontinuation	leads to discontinuation		5203
32357						No AEs were reported		5204
32358	1 pts		Sore throat		discontinuation	leads to discontinuation		5205
32359	1 pts		Hypertension	grade 3	discontinuation	leads to discontinuation		5206
32360	1 pts		Sleepy		discontinuation	leads to discontinuation		5206
32361	1 pts		Sleepy		discontinuation	leads to discontinuation		5207
32362	1 pts		GI pain		discontinuation	leads to discontinuation		5208
32363	1 pts		Hypertension	grade 2	discontinuation	leads to discontinuation		5209
32364						No AEs were reported		5192
32365	1 pts		Nausea		discontinuation	leads to discontinuation		5193
32366	1 pts		Ataxic		discontinuation	leads to discontinuation		5195
32367	1 pts		Sleepy		discontinuation	leads to discontinuation		5195
32368						No AEs were reported		5197
32369	9		Asthenia					5184
32370	3		Vasodilatation					5184
32371	21		Nausea					5184
32372	12		Diarrhea					5184
32373	11		Anorexia					5184
32374	10		Dry mouth					5184
32375	7		Dyspepsia					5184
32376	16		Insomnia					5184
32377	12		Anxiety					5184
32378	14		Nervousness					5184
32379	13		Somnolence					5184
32380	10		Tremor					5184
32381	3		Libido decreased					5184
32382	1		Abnormal dreams					5184
32383	8		Sweating					5184
32384	4		Rash					5184
32385	15		Asthenia					5185
32386	5		Vasodilatation					5185
32387	26		Nausea					5185
32388	18		Diarrhea					5185
32389	17		Anorexia					5185
32390	12		Dry mouth					5185
32391	10		Dyspepsia					5185
32392	28		Insomnia					5185
32393	14		Anxiety					5185
32394	14		Nervousness					5185
32395	17		Somnolence					5185
32396	9		Tremor					5185
32397	11		Libido decreased					5185
32398	5		Abnormal dreams					5185
32399	7		Yawn					5185
32400	7		Sweating					5185
32401	6		Rash					5185
32402	21		Asthenia					5187
32403	2		Vasodilatation					5187
32404	29		Nausea					5187
32405	8		Diarrhea					5187
32406	8		Anorexia					5187
32407	9		Dry mouth					5187
32408	10		Dyspepsia					5187
32409	33		Insomnia					5187
32410	15		Anxiety					5187
32411	11		Nervousness					5187
32412	13		Somnolence					5187
32413	13		Tremor					5187
32414	5		Libido decreased					5187
32415	5		Abnormal dreams					5187
32416	11		Yawn					5187
32417	8		Sweating					5187
32418	4		Rash					5187
32419	7		Asthenia					5183
32420	1		Vasodilatation					5183
32421	12		Nausea					5183
32422	9		Diarrhea					5183
32423	5		Anorexia					5183
32424	5		Dry mouth					5183
32425	6		Dyspepsia					5183
32426	10		Insomnia					5183
32427	6		Anxiety					5183
32428	8		Nervousness					5183
32429	5		Somnolence					5183
32430	3		Tremor					5183
32431	1		Libido decreased					5183
32432	1		Abnormal dreams					5183
32433	1		Yawn					5183
32434	2		Sweating					5183
32435	2		Rash					5183
32436	1.8		Hypomania			after discontinuation		5188
32437	5 pts		Somnolence					5216
32438	1 pts		Agitation					5216
32439	1 pts		Dizziness					5216
32440			Impaired renal function		discontinuation			5219
32441			Hematuria		discontinuation			5219
32442			Cerebral hemorrhage		discontinuation			5219
32443			Physical impairment		discontinuation			5219
32444						No SAEs were observed		5220
32445			Cardio-respiratory arrest	grade 5				5218
32446			Impaired renal function	grade 5				5217
32447	1 pts		Arteriosclerosis coronary artery	serious				5223
32448	1 pts		Bradyarrhythmia	serious				5223
32449	10 pts		Cardiac failure	serious				5223
32450	1 pts		Ischaemic cardiomyopathy	serious				5223
32451	6 pts		Myocardial infarction	serious				5223
32452	1 pts		Postinfarction angina	serious				5223
32453	1 pts		Vertigo	serious				5223
32454	2 pts		Cataract	serious				5223
32455	1 pts		Cataract subcapsular	serious				5223
32456	2 pts		Glaucoma	serious				5223
32457	1 pts		Lens disorder	serious				5223
32458	1 pts		Duodenal ulcer perforation	serious				5223
32459	1 pts		Dysphagia	serious				5223
32460	1 pts		Enterocolitis haemorrhagic	serious				5223
32461	1 pts		Faecal incontinence	serious				5223
32462	1 pts		Gastric ulcer	serious				5223
32463	1 pts		Gastric ulcer haemorrhage	serious				5223
32464	2 pts		Gastroduodenitis	serious				5223
32465	1 pts		Ileus	serious				5223
32466	2 pts		Hernia inguinal	serious				5223
32467	1 pts		Intestinal stenosis	serious				5223
32468	1 pts		Nausea	serious				5223
32469	1 pts		Achalasia oesophageal	serious				5223
32470	1 pts		Pancreatitis	serious				5223
32471	1 pts		Peritoneal haemorrhage	serious				5223
32472	1 pts		Haemorrhage peritoneal	serious				5223
32473	1 pts		Oesophageal varices	serious				5223
32474	1 pts		Varices oesophageal	serious				5223
32475	1 pts		Abasia	serious				5223
32476	1 pts		Oedema peripheral	serious				5223
32477	1 pts		Bile duct stone	serious				5223
32478	2 pts		Cholecystitis	serious				5223
32479	2 pts		Bronchitis	serious				5223
32480	1 pts		Ear infection	serious				5223
32481	1 pts		Gastrointestinal infection	serious				5223
32482	2 pts		Herpes zoster	serious				5223
32483	1 pts		Peritonitis	serious				5223
32484	8 pts		Pneumonia	serious				5223
32485	1 pts		Post procedural infection	serious				5223
32486	1 pts		Urosepsis	serious				5223
32487	1 pts		Chemical poisoning	serious				5223
32488	1 pts		Exposure to toxic agent	serious				5223
32489	1 pts		Hand fracture	serious				5223
32490	2 pts		Humerus fracture	serious				5223
32491	2 pts		Lower limb fracture	serious				5223
32492	1 pts		Lumbar vertebral fracture	serious				5223
32493	1 pts		Patella fracture	serious				5223
32494	1 pts		Fracture rib	serious				5223
32495	1 pts		Skeletal injury	serious				5223
32496	1 pts		Haemorrhage subdural	serious				5223
32497	1 pts		Urethral injury	serious				5223
32498	1 pts		Blood pressure increased	serious				5223
32499	1 pts		Weight decreased	serious				5223
32500	1 pts		Decreased appetite	serious				5223
32501	4 pts		Dehydration	serious				5223
32502	1 pts		Muscular weakness	serious				5223
32503	2 pts		Osteoarthritis	serious				5223
32504	1 pts		Spinal column stenosis	serious				5223
32505	1 pts		Osteoarthritis spinal	serious				5223
32506	1 pts		Rectal cancer	serious				5223
32507	1 pts		Cerebral arteriosclerosis	serious				5223
32508	4 pts		Cerebrovascular accident	serious				5223
32509	1 pts		Coma	serious				5223
32510	3 pts		Loss of consciousness	serious				5223
32511	1 pts		Presyncope	serious				5223
32512	1 pts		Speech disorder	serious				5223
32513	1 pts		Vertebrobasilar insufficiency	serious				5223
32514	1 pts		Adjustment disorder	serious				5223
32515	3 pts		Aggression	serious				5223
32516	1 pts		Catatonia	serious				5223
32517	1 pts		Confusional state	serious				5223
32518	1 pts		Depression	serious				5223
32519	1 pts		Disorientation	serious				5223
32520	2 pts		Psychotic disorder	serious				5223
32521	1 pts		Suicide attempt	serious				5223
32522	1 pts		Renal failure acute	serious				5223
32523	1 pts		Stress urinary incontinence	serious				5223
32524	1 pts		Urinary incontinence	serious				5223
32525	2 pts		Benign prostatic hyperplasia	serious				5223
32526	1 pts		Pelvic pain	serious				5223
32527	1 pts		Acute lung injury	serious				5223
32528	1 pts		Aspiration	serious				5223
32529	1 pts		Bronchitis chronic	serious				5223
32530	1 pts		Chronic obstructive pulmonary disease	serious				5223
32531	2 pts		Dyspnoea	serious				5223
32532	1 pts		Emphysema	serious				5223
32533	1 pts		Pneumothorax	serious				5223
32534	5 pts		Pulmonary embolism	serious				5223
32535	1 pts		Respiratory failure	serious				5223
32536	1 pts		Rash	serious				5223
32537	1 pts		Arteriosclerosis	serious				5223
32538	2 pts		Essential hypertension	serious				5223
32539	1 pts		Haemorrhagic infarction	serious				5223
32540	1 pts		Hypertensive crisis	serious				5223
32541	57 pts		Vertigo	below serious				5223
32542	85 pts		Nausea	below serious				5223
32543	4 pts		Difficulty sleeping	below serious				5222
32544	42		Nausea					5221
32545	21		Vomiting					5221
32546	16		Diarrhea					5221
32547	15		Anorexia					5221
32548	8		Weight loss					5221
32549	15		Dizziness					5221
32550	1 pts		Nightmares		discontinuation	leads to discontinuation, 4 to 8 mg		5224
32551	1.8		Hepatic enzymes increased	grade 3-4	discontinuation			5225
32552	0.6		Pneumonia	grade 3-4	discontinuation			5225
32553	0.6		Diarrhea	grade 3-4	discontinuation			5225
32554	0.6		Flatulence	grade 3-4	discontinuation			5225
32555	0.6		Intestinal obstruction	grade 3-4	discontinuation			5225
32556	0.6		Nausea	grade 3-4	discontinuation			5225
32557	0.6		Vomiting	grade 3-4	discontinuation			5225
32558	0.6		Aortic stenosis	grade 3-4	discontinuation			5225
32559	0.6		Myocardial infarction	grade 3-4	discontinuation			5225
32560	0.6		Somnolence	grade 3-4	discontinuation			5225
32561	0.6		Pleurisy	grade 3-4	discontinuation			5225
32562	0.6		Respiratory insufficiency	grade 3-4	discontinuation			5225
32563	0.6		Rash	grade 3-4	discontinuation			5225
32564	0.6		Leucocytosis NOS	grade 3-4	discontinuation			5225
32565	12.5		Xerostomia		discontinuation			5237
32566	4.2		Erectile dysfunction		discontinuation			5237
32567	4.2		Headaches		discontinuation			5237
32568	4.2		Urinary retention		discontinuation			5237
32569	50		Dry mouth					5237
32570	16.7		Dry mouth	grade 1				5238
32571	5.6		Headache	grade 1				5238
32572	11.1		Nocturia	grade 1				5238
32573	5.6		Chest pain	grade 1				5238
32574	5.6		Hypoesthesia	grade 1				5238
32575	5.6		Nasal dryness	grade 1				5238
32576	12.9		Headache	grade 1				5235
32577	3.2		Cough	grade 1				5235
32578	3.2		Laceration	grade 1				5235
32579	3.2		Rhinorrhea	grade 1				5235
32580	24.2		Dry mouth					5227
32581	6.8		Mydriasis					5227
32582	5.7		Oropharyngeal pain					5227
32583	5		Headache					5227
32584	3.5		Urinary hesitation					5227
32585	3.5		Vision blurred					5227
32586	2.6		Nasal dryness					5227
32587	2.6		Dry throat					5227
32588	2.4		Dry eye					5227
32589	2.2		Dry skin					5227
32590	2		Constipation					5227
32591	16.9		Dry mouth					5228
32592	6.7		Vision blurred					5228
32593	5.8		Nasopharyngitis					5228
32594	5.3		Mydriasis					5228
32595	4.2		Urinary hesitation					5228
32596	3.6		Nasal dryness					5228
32597	2.9		Dry eye					5228
32598	2.2		Pharyngitis					5228
32599	6.4		Application site pain	grade 1-2				5229
32600	3.8		Dermatitis	grade 1-2				5229
32601	3.8		Pruritus	grade 1-2				5229
32602	3.8		Rash	grade 1-2				5229
32603	2.4		Erythema	grade 1-2				5229
32604	17		Erythema	grade 1-2				5230
32605	14.1		Burning sensation	grade 1-2				5230
32606	8.1		Pruritus	grade 1-2				5230
32607	1.5		Urinary retention					5233
32608	1.3		Nausea					5233
32609	1.3		Pruritus					5233
32610	1.1		Epistaxis					5233
32611	1.1		Dry mouth	grade 1-2	discontinuation			5231
32612	0.9		Retention urinary	grade 1-2	discontinuation			5231
32613	0.7		Urinary hesitation	grade 1-2	discontinuation			5231
32614	0.4		Vision blurred	grade 1-2	discontinuation			5231
32615	1.8		Vision blurred	grade 1-2	discontinuation			5232
32616	1.6		Dry mouth	grade 1-2	discontinuation			5232
32617	0.9		Application site dermatitis	grade 1-2	discontinuation			5232
32618	0.9		Urinary hesitation	grade 1-2	discontinuation			5232
32619	4.9		Alanine aminotransferase increased					5233
32620	6.6		White blood cell count decreased					5233
32621	8.3		Neutrophils increased					5233
32622	0.6		Abnormal ECG	grade 1				5234
32623						No infromation about AE is provided		5226
32624			Urinary hesitation			OVERDOSAGE		5236
32625			Vision blurred			OVERDOSAGE		5236
32626			Dry mouth			OVERDOSAGE		5236
32627			Application site erythema			OVERDOSAGE		5236
32628			Dry throat			OVERDOSAGE		5236
32629			Dry eye			OVERDOSAGE		5236
32630			Nasal dryness			OVERDOSAGE		5236
32631	5 pts		Sedation	below serious				5239
32632	3 pts		Fatigue	below serious				5239
32633	1		Hypertensive		discontinuation	leads to discontinuation		5241
32634	1		Cardiogenic pulmonary edema		discontinuation	leads to discontinuation		5242
32635	6		Somnolence		discontinuation	leads to discontinuation		5240
32636	2		Fatigue		discontinuation	leads to discontinuation		5240
32637	1		Hypotension		discontinuation	leads to discontinuation		5240
32638	1		Headache		discontinuation	leads to discontinuation		5240
32639	1		Dizziness		discontinuation	leads to discontinuation		5240
32640						No information on AE is provided		5244
32641						No information on AE is provided		5243
32642	50		Nausea			Nausea/vomiting		5246
32643	50		Vomiting			Nausea/vomiting		5246
32644	20		Mucositis			Mucositis/diarrhea		5246
32645	20		Diarrhea			Mucositis/diarrhea		5246
32646	15		Alopecia					5246
32647	11		Anorexia					5246
32648	2		Sepsis					5246
32649	2		Hepatitis			fatal		5246
32650	3 pts		Neutropenia	all grades				5245
32651	3 pts		Thrombocytopenia	all grades				5245
32652	3 pts		Mucositis	all grades				5245
32653	3 pts		Anorexia	all grades				5245
32654	3 pts		Diarrhea	all grades				5245
32655	2 pts		Vomiting	all grades				5245
32656	2 pts		Left ventricular systolic dysfunction	all grades				5245
32657	1 pts		Cardiac arrhythmia	all grades				5245
32658	2 pts		Rash	all grades				5245
32659	3 pts		Infection	all grades		ANC <1.0x10^9/L		5245
32660	1 pts		Edema	serious				5247
32661	12 pts		Neutropenia	below serious				5247
32662	27 pts		Anemia	below serious				5247
32663	8 pts		Thrombocytopenia	below serious				5247
32664	18 pts		Edema	below serious				5247
32665	15 pts		Fatigue	below serious				5247
32666	14 pts		Anorexia	below serious				5247
32667	13 pts		Nausea	below serious				5247
32668	13 pts		Vomiting	below serious				5247
32669	6 pts		Constipation	below serious				5247
32670	5 pts		Diarrhea	below serious				5247
32671	10 pts		Hyperbilirubinemia	below serious				5247
32672	8 pts		Azotemia	below serious				5247
32673	2 pts		Hypoglycemia	serious				5248
32674	1 pts		Suicide attempt	serious				5248
32675	1 pts		Folliculitis	serious				5248
32676	1 pts		Wheezing	serious				5248
32677	1 pts		Anxiety	serious				5248
32678	1 pts		Myalgia	serious				5248
32679	1 pts		Pruritus	serious				5248
32680	1 pts		Wolff-Parkinson-White syndrome	serious				5248
32681	1 pts		Aspartate aminotransferase increased	serious				5248
32682	1 pts		Maculo-papular rash	serious				5248
32683	1 pts		Hypophosphatemia	serious				5248
32684	1 pts		Axillary abscess	serious				5248
32685	12 pts		Infections and infestations	below serious				5248
32686	2 pts		Eye disorders	below serious				5248
32687	3 pts		Musculoskeletal and connective tissue disorders	below serious				5248
32688	4 pts		Nervous system disorders	below serious				5248
32689	6 pts		Gastrointestinal disorders	below serious				5248
32690	5 pts		Metabolism and nutrition disorders	below serious				5248
32691	1 pts		Reproductive system and breast disorders	below serious				5248
32692	5 pts		Psychiatric disorders	below serious				5248
32693	6 pts		Respiratory, thoracic and mediastinal disorders	below serious				5248
32694	5 pts		Skin and subcutaneous tissue disorders	below serious				5248
32695	1 pts		Ear and labyrinth disorders	below serious				5248
32696	4 pts		Cardiac disorders	below serious				5248
32697	2 pts		General disorders and administration site conditions	below serious				5248
32698	10 pts		Investigations	below serious				5248
32699	2 pts		Injury, poisoning and procedural complications	below serious				5248
32700	3 pts		Hepatobiliary disorders	below serious				5248
32701	4 pts		Blood and lymphatic system disorders	below serious				5248
32702	4 pts		Endocrine disorders	below serious				5248
32703	1 pts		Renal and urinary disorders	below serious				5248
32704	3pts		Nausea	grade 2-3	discontinuation	leads to discontinuation		5255
32705	1 pts		Vomiting	grade 2	discontinuation	leads to discontinuation		5255
32706	1 pts		Dehydration	grade 2	discontinuation	leads to discontinuation		5255
32707	2 pts		Effusion pleural	grade 2-3	discontinuation	leads to discontinuation		5255
32708	1 pts		Diarrhea	grade 2	discontinuation	leads to discontinuation		5255
32709	2 pts		Fatigue	grade 2-3	discontinuation	leads to discontinuation		5255
32710	1 pts		Rash	grade 3	discontinuation	leads to discontinuation		5255
32711	1 pts		Fever	grade 3	discontinuation	leads to discontinuation		5255
32712	1 pts		Neutropenia	grade 4			TRUE	5252
32713	1 pts		Rash	grade 2			TRUE	5252
32714	1 pts		ALT increased	grade 3			TRUE	5252
32715	1 pts		Transaminases increased	grade 3			TRUE	5256
32716	2 pts		Neutropenia	grade 3			TRUE	5257
32717	2 pts		Hypocalcemia	grade 4			TRUE	5257
32718	2 pts		Hypophosphatemia	grade 4			TRUE	5257
32719	2 pts		Hypokalemia	grade 3			TRUE	5257
32720	2 pts		Nausea	grade 3			TRUE	5257
32721	2 pts		Emesis	grade 3			TRUE	5257
32722						No information on AEs is available		5251
32723	1.8		Fluid retention	grade 3-4				5253
32724			Edema	grade 3-4				5253
32725	0.9		Nausea	grade 3-4				5253
32726	1.5		Vomiting	grade 3-4				5253
32727	1.6		Muscle cramps	grade 3-4				5253
32728	3.4		Musculoskeletal pain	grade 3-4				5253
32729	2		Diarrhea	grade 3-4				5253
32730	2.4		Rash	grade 3-4				5253
32731	1.6		Fatigue	grade 3-4				5253
32732	0.5		Headache	grade 3-4				5253
32733	2.5		Joint pain	grade 3-4				5253
32734	2.5		Abdominal pain	grade 3-4				5253
32735	1.1		Hemorrhage	grade 3-4				5253
32736	1.5		Myalgia	grade 3-4				5253
32737	0.2		Cough	grade 3-4				5253
32738	0.2		Pharyngolaryngeal pain	grade 3-4				5253
32739	0.2		Upper respiratory tract infection	grade 3-4				5253
32740	0.9		Dizziness	grade 3-4				5253
32741	0.9		Pyrexia	grade 3-4				5253
32742	1.6		Weight increased	grade 3-4				5253
32743	0.5		Depression	grade 3-4				5253
32744	0.2		Influenza	grade 3-4				5253
32745	3.1		Neutropenia	grade 4	discontinuation	leads to dose interruption or dose reduction		5253
32746	0.2		Thrombocytopenia	grade 4	discontinuation	leads to dose interruption or dose reduction		5253
32747	0.9		Anemia	grade 4	discontinuation	leads to dose interruption or dose reduction		5253
32748	0.2		Bilirubin elevated	grade 4	discontinuation	leads to dose interruption or dose reduction		5253
32749	2.9		AST increased	grade 4	discontinuation	leads to dose interruption or dose reduction		5253
32750	0.4		ALT increased	grade 4	discontinuation	leads to dose interruption or dose reduction		5253
32751	6		Fluid retention	grade 3-4				5254
32752	3		Edema	grade 3-4				5254
32753	5		Nausea	grade 3-4				5254
32754	3		Vomiting	grade 3-4				5254
32755	0.4		Muscle cramps	grade 3-4				5254
32756	9		Musculoskeletal pain	grade 3-4				5254
32757	5		Diarrhea	grade 3-4				5254
32758	5		Skin rash					5254
32759	4		Fatigue	grade 3-4				5254
32760	2		Headache	grade 3-4				5254
32761	1		Night sweats	grade 3-4				5254
32762	4		Abdominal pain	grade 3-4				5254
32763	7		Dyspnea	grade 3-4				5254
32764	2		Myalgia	grade 3-4				5254
32765	0.9		Cough	grade 3-4				5254
32766	0.9		Constipation	grade 3-4				5254
32767	0.4		Upper respiratory tract infection	grade 3-4				5254
32768	2		Anorexia	grade 3-4				5254
32769	8		Pyrexia	grade 3-4				5254
32770	5		Weight increased	grade 3-4				5254
32771	5		Asthenia	grade 3-4				5254
32772	6		Arthralgia	grade 3-4				5254
32773	4		Fatigue	grade 3-4				5254
32774	0.9		Pruritus	grade 3-4				5254
32775	2		Hypokalemia	grade 3-4				5254
32776	7		Pneumonia	grade 3-4				5254
32777	6		Hepatotoxicity	grade 3-4				5254
32778	0.4		Chest pain	grade 3-4				5254
32779	0.4		Rigors	grade 3-4				5254
32780	0.4		Sinusitis	grade 3-4				5254
32781	36		Neutropenia	grade 4	discontinuation	leads to dose interruption or dose reduction		5254
32782	13		Thrombocytopenia	grade 4	discontinuation	leads to dose interruption or dose reduction		5254
32783	7		Anemia	grade 4	discontinuation	leads to dose interruption or dose reduction		5254
32784	0.4		Alkaline phosphatase increased	grade 4	discontinuation	leads to dose interruption or dose reduction		5254
32785	1 pts		Serum creatinine increased	grade 1	dose reduction	leads to dose reduction		5249
32786	1 pts		Ascites	grade 2	dose reduction	leads to dose reduction		5249
32787	1 pts		Transaminases increased	grade 2	dose reduction	leads to dose reduction		5249
32788	1 pts		Bilirubin elevated	grade 3	dose reduction	leads to dose reduction		5249
32789	1 pts		Muscle cramps	severe	dose interruption	leads to dose interruprion		5250
32790	1 pts		Epistaxis		discontinuation	leads to discontinuation		5258
32791	1 pts		Epistaxis		discontinuation	leads to discontinuation		5261
32792	1 pts		Upper respiratory tract infection		discontinuation	leads to discontinuation		5261
32793	1 pts		Bilateral otitis media		discontinuation	leads to discontinuation		5261
32794	1 pts		Ear infection		discontinuation	leads to discontinuation		5261
32795	1 pts		Exacerbation of asthma		discontinuation	leads to discontinuation		5261
32796	1 pts		Nausea and vomiting		discontinuation	leads to discontinuation		5260
32797	19 pts		Nasal disorder NOS					5262
32798	17		Nasal disorder NOS		discontinuation	leads to discontinuation		5259
32799	2		Nasal dryness		discontinuation	leads to discontinuation		5259
32800	2		Epistaxis		discontinuation	leads to discontinuation		5259
32801	28 pts		Urinary tract infection	serious				5263
32802	26 pts		Bronchitis	serious				5263
32803	10 pts		Appendicitis	serious				5263
32804	10 pts		Diverticulitis	serious				5263
32805	8 pts		Lower respiratory tract infection	serious				5263
32806	5 pts		Lung infection	serious				5263
32807	4 pts		Infection	serious				5263
32808	4 pts		Haematoma infection	serious				5263
32809	3 pts		Clostridium difficile colitis	serious				5263
32810	3 pts		Infection staphylococcal	serious				5263
32811	3 pts		Appendicitis perforated	serious				5263
32812	3 pts		Clostridial infection	serious				5263
32813	3 pts		Tracheobronchitis	serious				5263
32814	2 pts		Arthritis infective	serious				5263
32815	2 pts		Bacteraemia	serious				5263
32816	2 pts		Device related infection	serious				5263
32817	2 pts		Pulmonary sepsis	serious				5263
32818	2 pts		Endocarditis	serious				5263
32819	2 pts		Lung infection pseudomonal	serious				5263
32820	2 pts		Skin infection	serious				5263
32821	1 pts		Acarodermatitis	serious				5263
32822	1 pts		Acute sinusitis	serious				5263
32823	1 pts		Acute tonsillitis	serious				5263
32824	1 pts		Anogenital warts	serious				5263
32825	1 pts		Arthritis bacterial	serious				5263
32826	1 pts		Beta haemolytic streptococcal infection	serious				5263
32827	1 pts		Biliary tract infection	serious				5263
32828	1 pts		Bronchitis bacterial	serious				5263
32829	1 pts		Diarrhoea infectious	serious				5263
32830	1 pts		Encephalitis viral	serious				5263
32831	1 pts		Enterocolitis infectious	serious				5263
32832	1 pts		Escherichia infection	serious				5263
32833	1 pts		Escherichia urinary tract infection	serious				5263
32834	1 pts		Eye infection	serious				5263
32835	1 pts		Gastroenteritis viral	serious				5263
32836	1 pts		Gastrointestinal infection	serious				5263
32837	1 pts		Genitourinary tract infection	serious				5263
32838	1 pts		Hepatitis E	serious				5263
32839	1 pts		Infected skin ulcer	serious				5263
32840	1 pts		Injection site infection	serious				5263
32841	1 pts		Intervertebral discitis	serious				5263
32842	1 pts		Lower respiratory tract infection viral	serious				5263
32843	1 pts		Perirectal abscess	serious				5263
32844	1 pts		Peritoneal infection	serious				5263
32845	1 pts		Pneumonia escherichia	serious				5263
32846	1 pts		Pneumonia klebsiella	serious				5263
32847	1 pts		Pneumonia legionella	serious				5263
32848	1 pts		Pneumonia streptococcal	serious				5263
32849	1 pts		Pseudomembranous colitis	serious				5263
32850	1 pts		Skin bacterial infection	serious				5263
32851	1 pts		Staphylococcal sepsis	serious				5263
32852	1 pts		Staphylococcal toxaemia	serious				5263
32853	1 pts		Streptococcal bacteraemia	serious				5263
32854	1 pts		Tetanus	serious				5263
32855	1 pts		Tuberculosis	serious				5263
32856	1 pts		Vulval abscess	serious				5263
32857	1 pts		Wound infection staphylococcal	serious				5263
32858	20 pts		Gastric ulcer haemorrhage	serious				5263
32859	11 pts		Diarrhoea	serious				5263
32860	8 pts		Abdominal pain	serious				5263
32861	8 pts		Colonic polyp	serious				5263
32862	7 pts		Gastritis haemorrhagic	serious				5263
32863	7 pts		Ileus	serious				5263
32864	6 pts		Vomiting	serious				5263
32865	5 pts		Peptic ulcer haemorrhage	serious				5263
32866	4 pts		Peritonitis	serious				5263
32867	3 pts		Ascites	serious				5263
32868	3 pts		Diverticulum	serious				5263
32869	3 pts		Food poisoning	serious				5263
32870	3 pts		Rectal polyp	serious				5263
32871	3 pts		Gastrointestinal ulcer haemorrhage	serious				5263
32872	2 pts		Intestinal ischaemia	serious				5263
32873	2 pts		Intestinal perforation	serious				5263
32874	2 pts		Mechanical ileus	serious				5263
32875	2 pts		Abdominal discomfort	serious				5263
32876	2 pts		Femoral hernia, obstructive	serious				5263
32877	2 pts		Gastrooesophageal reflux disease	serious				5263
32878	2 pts		Intestinal haemorrhage	serious				5263
32879	2 pts		Volvulus	serious				5263
32880	1 pts		Acute abdomen	serious				5263
32881	1 pts		Anal haemorrhage	serious				5263
32882	1 pts		Barrett's oesophagus	serious				5263
32883	1 pts		Colitis ischaemic	serious				5263
32884	1 pts		Enteritis	serious				5263
32885	1 pts		Gastric mucosal lesion	serious				5263
32886	1 pts		Gastric perforation	serious				5263
32887	1 pts		Gastric polyps	serious				5263
32888	1 pts		Gastric ulcer perforation	serious				5263
32889	1 pts		Gastrointestinal necrosis	serious				5263
32890	1 pts		Gastrooesophagitis	serious				5263
32891	1 pts		Gingival bleeding	serious				5263
32892	1 pts		Haematochezia	serious				5263
32893	1 pts		Hernial eventration	serious				5263
32894	1 pts		Ileus paralytic	serious				5263
32895	1 pts		Intestinal infarction	serious				5263
32896	1 pts		Intestinal polyp	serious				5263
32897	1 pts		Large intestine perforation	serious				5263
32898	1 pts		Mallory-Weiss syndrome	serious				5263
32899	1 pts		Megacolon	serious				5263
32900	1 pts		Mesenteric occlusion	serious				5263
32901	1 pts		Oesophageal haemorrhage	serious				5263
32902	1 pts		Oesophageal perforation	serious				5263
32903	1 pts		Oesophageal ulcer	serious				5263
32904	1 pts		Oesophageal ulcer haemorrhage	serious				5263
32905	1 pts		Peritoneal adhesions	serious				5263
32906	1 pts		Peritoneal haemorrhage	serious				5263
32907	1 pts		Haemorrhage peritoneal	serious				5263
32908	1 pts		Polyp colorectal	serious				5263
32909	1 pts		Rectal prolapse	serious				5263
32910	1 pts		Rectal ulcer haemorrhage	serious				5263
32911	1 pts		Salivary gland calculus	serious				5263
32912	1 pts		Small intestinal haemorrhage	serious				5263
32913	1 pts		Swollen tongue	serious				5263
32914	1 pts		Tooth disorder	serious				5263
32915	1 pts		Tooth loss	serious				5263
32916	19 pts		Lung neoplasm malignant	serious				5263
32917	18 pts		Colon cancer	serious				5263
32918	15 pts		Breast cancer	serious				5263
32919	9 pts		Basal cell carcinoma	serious				5263
32920	9 pts		Gastric cancer	serious				5263
32921	6 pts		Rectal cancer	serious				5263
32922	6 pts		Non-Hodgkin's lymphoma	serious				5263
32923	6 pts		Bladder neoplasm	serious				5263
32924	5 pts		Myelodysplastic syndrome	serious				5263
32925	4 pts		Colon neoplasm	serious				5263
32926	3 pts		Brain neoplasm	serious				5263
32927	3 pts		Lung neoplasm	serious				5263
32928	3 pts		Renal cancer	serious				5263
32929	3 pts		Skin cancer	serious				5263
32930	3 pts		Metastases to central nervous system	serious				5263
32931	3 pts		Lung cancer metastatic	serious				5263
32932	3 pts		Uterine cancer	serious				5263
32933	2 pts		Bile duct cancer	serious				5263
32934	2 pts		Breast cancer metastatic	serious				5263
32935	2 pts		Non-small cell lung cancer	serious				5263
32936	2 pts		Rectosigmoid cancer	serious				5263
32937	2 pts		Acute leukaemia	serious				5263
32938	2 pts		Bladder papilloma	serious				5263
32939	2 pts		Colorectal cancer	serious				5263
32940	2 pts		Malignant pleural effusion	serious				5263
32941	2 pts		Metastatic gastric cancer	serious				5263
32942	2 pts		Metastatic neoplasm	serious				5263
32943	2 pts		Lung cancer non-small cell stage IV	serious				5263
32944	2 pts		Squamous cell carcinoma of skin	serious				5263
32945	1 pts		Abdominal neoplasm	serious				5263
32946	1 pts		Adrenal adenoma	serious				5263
32947	1 pts		B-cell lymphoma	serious				5263
32948	1 pts		Benign anorectal neoplasm	serious				5263
32949	1 pts		Benign renal neoplasm	serious				5263
32950	1 pts		Bladder cancer recurrent	serious				5263
32951	1 pts		Bone cancer metastatic	serious				5263
32952	1 pts		Bone neoplasm malignant	serious				5263
32953	1 pts		Breast cancer female	serious				5263
32954	1 pts		Carcinoid tumour of the stomach	serious				5263
32955	1 pts		Cerebellar tumour	serious				5263
32956	1 pts		Cervix carcinoma	serious				5263
32957	1 pts		Cholesteatoma	serious				5263
32958	1 pts		Colorectal cancer metastatic	serious				5263
32959	1 pts		Cystosarcoma phyllodes	serious				5263
32960	1 pts		Diaphragm neoplasm	serious				5263
32961	1 pts		Fibrosarcoma	serious				5263
32962	1 pts		Gastric cancer stage IV	serious				5263
32963	1 pts		Glioblastoma multiforme	serious				5263
32964	1 pts		Intestinal adenocarcinoma	serious				5263
32965	1 pts		Large intestine carcinoma	serious				5263
32966	1 pts		Leiomyosarcoma metastatic	serious				5263
32967	1 pts		Liposarcoma	serious				5263
32968	1 pts		Lymph node cancer metastatic	serious				5263
32969	1 pts		Mediastinum neoplasm	serious				5263
32970	1 pts		Melanocytic naevus	serious				5263
32971	1 pts		Mesothelioma	serious				5263
32972	1 pts		Mesothelioma malignant	serious				5263
32973	1 pts		Metastatic renal cell carcinoma	serious				5263
32974	1 pts		Nasal neoplasm	serious				5263
32975	1 pts		Neurofibroma	serious				5263
32976	1 pts		Ovarian fibroma	serious				5263
32977	1 pts		Pancreatic neoplasm	serious				5263
32978	1 pts		Pancreatic neuroendocrine tumour	serious				5263
32979	1 pts		Pleural mesothelioma	serious				5263
32980	1 pts		Rectal adenoma	serious				5263
32981	1 pts		Rectal cancer metastatic	serious				5263
32982	1 pts		Skin cancer metastatic	serious				5263
32983	1 pts		Tongue neoplasm malignant stage unspecified	serious				5263
32984	1 pts		Vulval cancer	serious				5263
32985	26 pts		Fall	serious				5263
32986	14 pts		Subdural haematoma	serious				5263
32987	8 pts		Therapeutic agent toxicity	serious				5263
32988	5 pts		Operative haemorrhage	serious				5263
32989	5 pts		Upper limb fracture	serious				5263
32990	5 pts		Facial bones fracture	serious				5263
32991	5 pts		Spinal compression fracture	serious				5263
32992	5 pts		Drug toxicity	serious				5263
32993	4 pts		Road traffic accident	serious				5263
32994	4 pts		Concussion	serious				5263
32995	4 pts		Dislocation of joint prosthesis	serious				5263
32996	4 pts		Pelvic fracture	serious				5263
32997	4 pts		Fracture	serious				5263
32998	3 pts		Anaemia postoperative	serious				5263
32999	3 pts		Alcohol poisoning	serious				5263
33000	3 pts		Multiple fractures	serious				5263
33001	3 pts		Post procedural haematoma	serious				5263
33002	3 pts		Accidental overdose	serious				5263
33003	2 pts		Chest injury	serious				5263
33004	2 pts		Extradural haematoma	serious				5263
33005	2 pts		Muscle rupture	serious				5263
33006	2 pts		Laceration	serious				5263
33007	2 pts		Open fracture	serious				5263
33008	2 pts		Traumatic brain injury	serious				5263
33009	1 pts		Abdominal wound dehiscence	serious				5263
33010	1 pts		Anastomotic leak	serious				5263
33011	1 pts		Back crushing	serious				5263
33012	1 pts		Cerebral haemorrhage traumatic	serious				5263
33013	1 pts		Device failure	serious				5263
33014	1 pts		Dural tear	serious				5263
33015	1 pts		Epiphyseal fracture	serious				5263
33016	1 pts		Fibula fracture	serious				5263
33017	1 pts		Forearm fracture	serious				5263
33018	1 pts		Hand fracture	serious				5263
33019	1 pts		Poisoning	serious				5263
33020	1 pts		Post procedural stroke	serious				5263
33021	1 pts		Tooth fracture	serious				5263
33022	1 pts		Transplant failure	serious				5263
33023	1 pts		Wound complication	serious				5263
33024	45 pts		Chronic obstructive pulmonary disease	serious				5263
33025	21 pts		Epistaxis	serious				5263
33026	14 pts		Pleural effusion	serious				5263
33027	10 pts		Asthma	serious				5263
33028	7 pts		Sleep apnoea syndrome	serious				5263
33029	3 pts		Pleurisy	serious				5263
33030	2 pts		Bronchospasm	serious				5263
33031	2 pts		Interstitial lung disease	serious				5263
33032	2 pts		Pulmonary embolism	serious				5263
33033	2 pts		Pulmonary fibrosis	serious				5263
33034	2 pts		Bronchial disorder	serious				5263
33035	1 pts		Emphysema	serious				5263
33036	1 pts		Foreign body aspiration	serious				5263
33037	1 pts		Haemothorax	serious				5263
33038	1 pts		Hypoxia	serious				5263
33039	1 pts		Lung infiltration	serious				5263
33040	1 pts		Nasal mucosa atrophy	serious				5263
33041	1 pts		Congestion pulmonary	serious				5263
33042	1 pts		Pulmonary congestion	serious				5263
33043	58 pts		Osteoarthritis	serious				5263
33044	11 pts		Back pain	serious				5263
33045	9 pts		Intervertebral disc protrusion	serious				5263
33046	5 pts		Spinal column stenosis	serious				5263
33047	4 pts		Pain in extremity	serious				5263
33048	3 pts		Gouty arthritis	serious				5263
33049	2 pts		Bursitis	serious				5263
33050	2 pts		Rhabdomyolysis	serious				5263
33051	1 pts		Cervical spinal stenosis	serious				5263
33052	1 pts		Costochondritis	serious				5263
33053	1 pts		Intervertebral disc disorder	serious				5263
33054	1 pts		Kyphoscoliosis	serious				5263
33055	1 pts		Muscle spasms	serious				5263
33056	1 pts		Osteitis	serious				5263
33057	1 pts		Osteochondrosis	serious				5263
33058	1 pts		Sympathetic posterior cervical syndrome	serious				5263
33059	35 pts		Renal failure acute	serious				5263
33060	26 pts		Renal failure	serious				5263
33061	7 pts		Renal failure chronic	serious				5263
33062	4 pts		Haemorrhage urinary tract	serious				5263
33063	4 pts		Calculus ureteric	serious				5263
33064	3 pts		Renal cyst	serious				5263
33065	2 pts		Urinary bladder polyp	serious				5263
33066	2 pts		Urinary incontinence	serious				5263
33067	2 pts		Urinary tract obstruction	serious				5263
33068	1 pts		Acute prerenal failure	serious				5263
33069	1 pts		Bladder neck obstruction	serious				5263
33070	1 pts		Calculus bladder	serious				5263
33071	1 pts		Bladder calculus	serious				5263
33072	1 pts		Cystitis noninfective	serious				5263
33073	1 pts		Diabetic nephropathy	serious				5263
33074	1 pts		Obstructive uropathy	serious				5263
33075	1 pts		Pollakiuria	serious				5263
33076	1 pts		Polyuria	serious				5263
33077	1 pts		Renal artery stenosis	serious				5263
33078	1 pts		Disorder renal	serious				5263
33079	1 pts		Haemorrhage urinary bladder	serious				5263
33080	1 pts		Urinary tract disorder	serious				5263
33081	5 pts		Dementia Alzheimer's type	serious				5263
33082	4 pts		Presyncope	serious				5263
33083	3 pts		Cervical root pain	serious				5263
33084	3 pts		Loss of consciousness	serious				5263
33085	2 pts		Cerebrovascular accident	serious				5263
33086	2 pts		Encephalopathy	serious				5263
33087	2 pts		Aphasia	serious				5263
33088	2 pts		Dementia vascular	serious				5263
33089	1 pts		Ageusia	serious				5263
33090	1 pts		Anosmia	serious				5263
33091	1 pts		Autonomic nervous system imbalance	serious				5263
33092	1 pts		Brachial plexopathy	serious				5263
33093	1 pts		Brain injury	serious				5263
33094	1 pts		Carotid artery occlusion	serious				5263
33095	1 pts		Cauda equina syndrome	serious				5263
33096	1 pts		Cerebellar syndrome	serious				5263
33097	1 pts		Cerebral haematoma	serious				5263
33098	1 pts		Depressed level of consciousness	serious				5263
33099	1 pts		Extrapyramidal disorder	serious				5263
33100	1 pts		Hypokinesia	serious				5263
33101	1 pts		Lumbar radiculopathy	serious				5263
33102	1 pts		Multiple sclerosis relapse	serious				5263
33103	1 pts		Neurological symptom	serious				5263
33104	1 pts		Neuropathy peripheral	serious				5263
33105	1 pts		Paraesthesia	serious				5263
33106	1 pts		Simple partial seizures	serious				5263
33107	1 pts		Thalamus haemorrhage	serious				5263
33108	1 pts		Trigeminal neuralgia	serious				5263
33109	29 pts		Cholelithiasis	serious				5263
33110	4 pts		Jaundice	serious				5263
33111	4 pts		Bile duct stone	serious				5263
33112	2 pts		Hepatic failure	serious				5263
33113	2 pts		Hepatic steatosis	serious				5263
33114	2 pts		Hepatitis	serious				5263
33115	2 pts		Jaundice cholestatic	serious				5263
33116	1 pts		Bile duct stenosis	serious				5263
33117	1 pts		Cholelithiasis obstructive	serious				5263
33118	1 pts		Cholestasis	serious				5263
33119	1 pts		Cirrhosis alcoholic	serious				5263
33120	1 pts		Gallbladder disorder	serious				5263
33121	1 pts		Hepatitis alcoholic	serious				5263
33122	1 pts		Hepatotoxicity	serious				5263
33123	1 pts		Liver disorder	serious				5263
33124	1 pts		Post cholecystectomy syndrome	serious				5263
33125	15 pts		Hypotension	serious				5263
33126	8 pts		Haemorrhage	serious				5263
33127	4 pts		Hypertension	serious				5263
33128	2 pts		Varicose vein	serious				5263
33129	2 pts		Peripheral ischaemia	serious				5263
33130	1 pts		Aneurysm	serious				5263
33131	1 pts		Circulatory collapse	serious				5263
33132	1 pts		Extremity necrosis	serious				5263
33133	1 pts		Hypoperfusion	serious				5263
33134	1 pts		Iliac vein occlusion	serious				5263
33135	1 pts		Orthostatic hypotension	serious				5263
33136	1 pts		Peripheral embolism	serious				5263
33137	1 pts		Disorder peripheral vascular	serious				5263
33138	1 pts		Temporal arteritis	serious				5263
33139	1 pts		Thrombosed varicose vein	serious				5263
33140	1 pts		Venous thrombosis	serious				5263
33141	1 pts		Wound haemorrhage	serious				5263
33142	15 pts		Dehydration	serious				5263
33143	9 pts		Gout	serious				5263
33144	5 pts		Hyperkalaemia	serious				5263
33145	2 pts		Cachexia	serious				5263
33146	1 pts		Diabetes mellitus inadequate control	serious				5263
33147	1 pts		Fluid overload	serious				5263
33148	1 pts		Haemosiderosis	serious				5263
33149	1 pts		Obesity	serious				5263
33150	24 pts		Benign prostatic hyperplasia	serious				5263
33151	5 pts		Prostatitis	serious				5263
33152	1 pts		Colpocele	serious				5263
33153	1 pts		Endometrial hyperplasia	serious				5263
33154	1 pts		Endometrial hypertrophy	serious				5263
33155	1 pts		Epididymitis	serious				5263
33156	1 pts		Disease fibrocystic breast	serious				5263
33157	1 pts		Genital prolapse	serious				5263
33158	1 pts		Uterine cervical erosion	serious				5263
33159	1 pts		Uterine prolapse	serious				5263
33160	17 pts		Anaemia	serious				5263
33161	2 pts		Haemorrhagic anaemia	serious				5263
33162	1 pts		Anaemia megaloblastic	serious				5263
33163	1 pts		Anaemia of chronic disease	serious				5263
33164	1 pts		Anaemia vitamin B12 deficiency	serious				5263
33165	1 pts		Haemorrhagic diathesis	serious				5263
33166	1 pts		Anaemia hypochromic	serious				5263
33167	1 pts		Hypoprothrombinaemia	serious				5263
33168	1 pts		Anaemia microcytic	serious				5263
33169	1 pts		Nephrogenic anaemia	serious				5263
33170	9 pts		Chest pain	serious				5263
33171	4 pts		General physical health deterioration	serious				5263
33172	3 pts		Asthenia	serious				5263
33173	3 pts		Hernia obstructive	serious				5263
33174	1 pts		Catheter site pain	serious				5263
33175	1 pts		Chest discomfort	serious				5263
33176	1 pts		Implant site effusion	serious				5263
33177	1 pts		Swelling	serious				5263
33178	2 pts		Retinal vein thrombosis	serious				5263
33179	2 pts		Vitreous haemorrhage	serious				5263
33180	1 pts		Diplopia	serious				5263
33181	1 pts		Episcleritis	serious				5263
33182	1 pts		Pupils unequal	serious				5263
33183	1 pts		Retinal artery occlusion	serious				5263
33184	1 pts		Retinal disorder	serious				5263
33185	1 pts		Retinal vascular thrombosis	serious				5263
33186	1 pts		Retinoschisis	serious				5263
33187	2 pts		Alcohol withdrawal syndrome	serious				5263
33188	2 pts		Mental status changes	serious				5263
33189	2 pts		Suicide attempt	serious				5263
33190	1 pts		Alcoholism	serious				5263
33191	1 pts		Delusion	serious				5263
33192	1 pts		Delusional disorder, persecutory type	serious				5263
33193	1 pts		Depression suicidal	serious				5263
33194	1 pts		Major depression	serious				5263
33195	1 pts		Mental disorder	serious				5263
33196	1 pts		Somatisation disorder	serious				5263
33197	2 pts		Psoriasis	serious				5263
33198	2 pts		Urticaria	serious				5263
33199	1 pts		Dermatitis	serious				5263
33200	1 pts		Dermatitis allergic	serious				5263
33201	1 pts		Dermatitis atopic	serious				5263
33202	1 pts		Haemorrhage subcutaneous	serious				5263
33203	1 pts		Pemphigoid	serious				5263
33204	1 pts		Purpura	serious				5263
33205	1 pts		Pustular psoriasis	serious				5263
33206	1 pts		Necrosis skin	serious				5263
33207	1 pts		Skin ulcer haemorrhage	serious				5263
33208	3 pts		Toxic nodular goitre	serious				5263
33209	1 pts		Autoimmune thyroiditis	serious				5263
33210	1 pts		Hyperaldosteronism	serious				5263
33211	2 pts		Sudden hearing loss	serious				5263
33212	2 pts		Disorder vestibular	serious				5263
33213	1 pts		Meniere's disease	serious				5263
33214	1 pts		Tinnitus	serious				5263
33215	2 pts		Atrial fibrillation	serious				5263
33216	2 pts		Atrioventricular block complete	serious				5263
33217	2 pts		Bradycardia	serious				5263
33218	2 pts		Sick sinus syndrome	serious				5263
33219	1 pts		Atrioventricular block	serious				5263
33220	1 pts		Left ventricular dysfunction	serious				5263
33221	1 pts		Mitral valve disease	serious				5263
33222	1 pts		Pericardial effusion	serious				5263
33223	1 pts		Right ventricular failure	serious				5263
33224	5 pts		Hydrocele	serious				5263
33225	2 pts		Gastrointestinal angiodysplasia	serious				5263
33226	1 pts		Dermoid cyst	serious				5263
33227	1 pts		Muscular dystrophy	serious				5263
33228	1 pts		Cholecystectomy	serious				5263
33229	1 pts		Colon operation	serious				5263
33230	1 pts		Haemorrhoid operation	serious				5263
33231	1 pts		Hip arthroplasty	serious				5263
33232	1 pts		Knee arthroplasty	serious				5263
33233	1 pts		Retinal operation	serious				5263
33234	1 pts		Wound drainage	serious				5263
33235	1 pts		Anticoagulation drug level above therapeutic	serious				5263
33236	1 pts		Aspiration bronchial	serious				5263
33237	1 pts		Blood glucose increased	serious				5263
33238	1 pts		Prostatic specific antigen increased	serious				5263
33239	1 pts		Allergy to arthropod sting	serious				5263
33240	255 pts		Bronchitis	below serious				5263
33241	1067 pts		Nervous system disorders	below serious				5263
33242	529 pts		Dizziness	below serious				5263
33243	784 pts		Vascular disorders	below serious				5263
33244	350 pts		Hypotension	below serious				5263
33245	333 pts		Dyspnoea	below serious				5263
33246	345 pts		Eye disorders	below serious				5263
33247	344 pts		Renal and urinary disorders	below serious				5263
33248	1 pts		Diarrhoea	below serious				5264
33249	3 pts		Fatigue	below serious				5264
33250	2 pts		Hyperlipidaemia	below serious				5264
33251	1 pts		Hypotension	below serious				5264
33252	1 pts		Nausea	below serious				5264
33253	2 pts		Oedema peripheral	below serious				5264
33254	2 pts		Sinusitis	below serious				5264
33255	1 pts		Tooth abscess	below serious				5264
33256	2 pts		Urticaria	below serious				5264
33257						No adverse reactions leading to discontinuation were observed		5265
33258			Disorder fetal		discontinuation	WARNINGS		5266
33259	2.1		Hyperkalemia		discontinuation			5267
33260	4 pts		Leukopenia	grade 1		no prior abdominal/pelvic radiotherapy.		5270
33261	1 pts		Leukopenia	grade 2		no prior abdominal/pelvic radiotherapy.		5270
33262	2 pts		Leukopenia	grade 3		no prior abdominal/pelvic radiotherapy.		5270
33263	2 pts		Neutropenia	grade 1		no prior abdominal/pelvic radiotherapy.		5270
33264	2 pts		Neutropenia	grade 2		no prior abdominal/pelvic radiotherapy.		5270
33265	2 pts		Neutropenia	grade 4		no prior abdominal/pelvic radiotherapy.		5270
33266	2 pts		Thrombocytopenia	grade 1		no prior abdominal/pelvic radiotherapy.		5270
33267	3 pts		Nausea	grade 1		no prior abdominal/pelvic radiotherapy.		5270
33268	3 pts		Nausea	grade 2		no prior abdominal/pelvic radiotherapy.		5270
33269	2 pts		Nausea	grade 3		no prior abdominal/pelvic radiotherapy.		5270
33270	2 pts		Vomiting	grade 1		no prior abdominal/pelvic radiotherapy.		5270
33271	2 pts		Vomiting	grade 2		no prior abdominal/pelvic radiotherapy.		5270
33272	1 pts		Vomiting	grade 3		no prior abdominal/pelvic radiotherapy.		5270
33273	1 pts		Vomiting	grade 4		no prior abdominal/pelvic radiotherapy.		5270
33274	3 pts		Diarrhea	grade 1		no prior abdominal/pelvic radiotherapy.		5270
33275	2 pts		Diarrhea	grade 2		no prior abdominal/pelvic radiotherapy.		5270
33276	1 pts		Diarrhea	grade 3		no prior abdominal/pelvic radiotherapy.		5270
33277	1 pts		Diarrhea	grade 4		no prior abdominal/pelvic radiotherapy.		5270
33278	3 pts		Anorexia	grade 1		no prior abdominal/pelvic radiotherapy.		5270
33279	2 pts		Anorexia	grade 2		no prior abdominal/pelvic radiotherapy.		5270
33280	1 pts		Leukopenia	grade 2		with prior abdominal/pelvic radiotherapy.		5269
33281	2 pts		Leukopenia	grade 3		with prior abdominal/pelvic radiotherapy.		5269
33282	1 pts		Leukopenia	grade 4		with prior abdominal/pelvic radiotherapy.		5269
33283	2 pts		Neutropenia	grade 2		with prior abdominal/pelvic radiotherapy.		5269
33284	2 pts		Neutropenia	grade 3		with prior abdominal/pelvic radiotherapy.		5269
33285	1 pts		Neutropenia	grade 4		with prior abdominal/pelvic radiotherapy.		5269
33286	4 pts		Nausea	grade 1		with prior abdominal/pelvic radiotherapy.		5269
33287	1 pts		Nausea	grade 3		with prior abdominal/pelvic radiotherapy.		5269
33288	1 pts		Vomiting	grade 4		with prior abdominal/pelvic radiotherapy.		5269
33289	2 pts		Diarrhea	grade 1		with prior abdominal/pelvic radiotherapy.		5269
33290	3 pts		Diarrhea	grade 2		with prior abdominal/pelvic radiotherapy.		5269
33291	1 pts		Diarrhea	grade 4		with prior abdominal/pelvic radiotherapy.		5269
33292	3 pts		Anorexia	grade 1		with prior abdominal/pelvic radiotherapy.		5269
33293	2 pts		Anorexia	grade 2		with prior abdominal/pelvic radiotherapy.		5269
33294	33.3		Fatigue	grade 1-2				5268
33295	33.3		Weight loss	grade 1-2				5268
33296	50		Diarrhea	grade 1-2				5268
33297	58.3		Nausea	grade 1-2				5268
33298	50		Vomiting	grade 1-2				5268
33299	33.3		Cholinergic syndrome	grade 1-2				5268
33300	33.3		Mucositis	grade 1-2				5268
33301	8.3		Dyspnea	grade 1-2				5268
33302	8.3		Fever	grade 1-2				5268
33303	8.3		Fatigue	grade 3				5268
33304	8.3		Diarrhea	grade 3				5268
33305	8.3		Nausea	grade 3				5268
33306	8.3		Vomiting	grade 3				5268
33307	33.3		Cholinergic syndrome	grade 3				5268
33308	2 pts		Diarrhea	grade 3	discontinuation	leads to discontinuation	TRUE	5272
33309	1 pts		Gamma GT increased	grade 3			TRUE	5272
33310	1 pts		Stomatitis	grade 1				5272
33311	2 pts		Rash	grade 2				5272
33312	1 pts		Seborrheic dermatitis	grade 1				5272
33313	1 pts		Paronychia	grade 1				5272
33314	3 pts		Anorexia	grade 1				5272
33315	1 pts		Lymphocyte count decreased	grade 1				5272
33316	2 pts		Rash	grade 3			TRUE	5271
33317	2 pts		Diarrhea	grade 3			TRUE	5271
33318	1 pts		Hypoxia	grade 3			TRUE	5271
33319	2 pts		Pulmonary embolus	grade 4			TRUE	5271
33320	2 pts		Mucositis	grade 3			TRUE	5275
33321	2 pts		Rash	grade 3			TRUE	5275
33322	65		Diarrhea	all grades				5273
33323	13		Diarrhea	grade 3				5273
33324	1		Diarrhea	grade 4	discontinuation	leads to discontinuation		5273
33325	44		Nausea	all grades				5273
33326	2		Nausea	grade 3				5273
33327	26		Vomiting	all grades				5273
33328	2		Vomiting	grade 3				5273
33329	14		Stomatitis	all grades				5273
33330	11		Dyspepsia	all grades				5273
33331	<1		Dyspepsia	grade 3				5273
33332	53		Palmar-plantar erythrodysesthesia syndrome	all grades				5273
33333	12		Palmar-plantar erythrodysesthesia syndrome	grade 3				5273
33334	28		Rash	all grades				5273
33335	2		Rash	grade 3				5273
33336	<1		Dermatitis acneiform	grade 3				5273
33337	10		Dry skin	all grades				5273
33338	15		Mucosal inflammation	all grades				5273
33339	12		Pain in extremity	all grades				5273
33340	1		Pain in extremity	grade 3				5273
33341	11		Back pain	all grades				5273
33342	1		Back pain	grade 3				5273
33343	12		Dyspnea	all grades				5273
33344	3		Dyspnea	grade 3				5273
33345	10		Insomnia	all grades				5273
33346	<1		Insomnia	grade 3				5273
33347			Hepatotoxicity	severe|grade 5		WARNING		5273
33348	4		Bilirubin total increased	grade 3				5273
33349	41		Bilirubin total increased	grade 1-2				5273
33350	2		AST increased	grade 3				5273
33351	<1		AST increased	grade 4				5273
33352	46		AST increased	grade 1-2				5273
33353	2		ALT increased	grade 3				5273
33354	35		ALT increased	grade 1-2				5273
33355			Hepatotoxicity	severe|grade 5		WARNING		5274
33356	<1		Bilirubin total increased	grade 3				5274
33357	<1		Bilirubin total increased	grade 4				5274
33358	20		Bilirubin total increased	grade 1-2				5274
33359	6		AST increased	grade 3				5274
33360	47		AST increased	grade 1-2				5274
33361	5		ALT increased	grade 3				5274
33362	<1		ALT increased	grade 4				5274
33363	40		ALT increased	grade 1-2				5274
33364	1 pts		Fever		discontinuation	leads to discontinuation		5276
33365	2 pts		Neutropenia		discontinuation	leads to discontinuation		5277
33366	13 pts		General body pain					5279
33367	32 pts		Hot flashes					5279
33368	8 pts		Gastrointestinal disorder (NOS)					5279
33369	8 pts		Edema					5279
33370	3 pts		Libido decreased					5279
33371	7 pts		Disorder urinary tract					5279
33372	3 pts		Impotence					5279
33373	3 pts		Atrophy testicular					5279
33374	6 pts		Asthenia					5278
33375	16 pts		General body pain					5278
33376	5 pts		Headache					5278
33377	4 pts		Injection site reaction					5278
33378	23 pts		Hot flashes					5278
33379	5 pts		Gastrointestinal disorder (NOS)					5278
33380	4 pts		Dehydration					5278
33381	4 pts		Edema					5278
33382	8 pts		Disorder joint					5278
33383	4 pts		Myalgia					5278
33384	3 pts		Vertigo					5278
33385	3 pts		Neuromuscular disorders					5278
33386	4 pts		Paresthesia					5278
33387	6 pts		Skin reaction					5278
33388	5 pts		Urinary tract disorder NOS					5278
33389	1 pts		Dizziness			No major AEs were observed		5289
33390	3		Diarrhoea			Only 3% of the patients developed diarrhea, which was not felt to be secondary to the drug. There were no cases of pseudomembranous colitis.		5280
33391	9 pts		Diarrhoea					5281
33392	4 pts		Abdominal pain					5282
33393	3 pts		Pharyngitis					5283
33394	2 pts		Upper respiratory infection					5284
33395	1 pts		Vomiting					5285
33396	1 pts		Rhinitis					5286
33397	1 pts		Cough					5287
33398	1 pts		Asthenia					5288
33399						No adverse effects leading to discontinuation were reported		5291
33400	50		Anxiety				TRUE	5290
33401	50		Tachycardia				TRUE	5290
33402	100		Loose stools				TRUE	5290
33403			Anxiety	severe	discontinuation			5292
33404			Palpitations		discontinuation			5292
33405			Agitation		discontinuation			5292
33406			Shortness of breath		discontinuation			5292
33407			Irritability		discontinuation			5292
33408			Tachycardia		discontinuation			5292
33409			Tremor		discontinuation			5292
33410			Nausea		discontinuation			5293
33411			Vomiting		discontinuation			5293
33412			Abdominal pain		discontinuation			5293
33413			Headache	severe	discontinuation			5293
33414			Confusion		discontinuation			5293
33415			Disorientation		discontinuation			5293
33416			Diplopia		discontinuation			5293
33417						No serious adverse events		5294
33418	14 pts		Neurological disorders NEC		discontinuation	leads to discontinuation		5295
33419	14 pts		Gastrointestinal disorders		discontinuation	leads to discontinuation		5295
33420	1 pts		Herpes labialis		discontinuation	leads to discontinuation		5295
33421			Syncope		discontinuation			5298
33422			Tachycardia		discontinuation			5298
33423			Electrocardiogram QTc interval prolonged		discontinuation			5298
33424			Cardiac arrest		discontinuation			5298
33425			Syncope		discontinuation			5296
33426			Cardiac arrest		discontinuation			5296
33427			Torsades de pointes		discontinuation			5296
33428			Cardiac arrest	grade 5	discontinuation			5297
33429			Torsades de pointes		discontinuation	WARNING		5299
33430			Cardiac arrest		discontinuation	WARNING		5299
33431			Ventricular tachycardia		discontinuation	WARNING		5300
33432			Syncope		discontinuation	WARNING		5300
33433	1 pts		Depression worsened	below serious				5301
33434	10.3		Nausea					5302
33435	34.5		Somnolence					5302
33436	17.2		Dizziness					5302
33437	24.1		Fatigue					5302
33438	27.6		Orthostatic hypotension					5302
33439	10.3		Headache					5302
33440	3.4		Application site pruritus					5302
33441	6.9		Ocular hyperaemia					5302
33442	17.2		Vision blurred					5302
33443	13.8		Constipation					5302
33444	3.4		Vomiting					5302
33445	3.4		Dizziness postural					5302
33446	10.3		Abdominal pain					5302
33447	3.4		Feeling abnormal					5302
33448	3.4		Abdominal distension					5302
33449	4.2		Abdominal pain				TRUE	5303
33450	4.2		Constipation				TRUE	5303
33451						No AEs are reported		5304
33452			Adverse event	grade 5		No AEs are reported		5305
33453			ALT increased	grade 3				5310
33454			AST increased	grade 3				5310
33455			Bilirubin increased	grade 3				5310
33456	30		Mucositis	grade 3			TRUE	5311
33457						AEs not reported		5306
33458	100		Pancytopenia					5309
33459	91		Neutropenic fever					5309
33460	65		Bacteremia					5309
33461	13		Candidemia					5309
33462	4		Cytomegalovirus infection					5309
33463	4		Bleeding					5309
33464	100		Nausea					5309
33465	52		Mucosal ulceration					5309
33466	26		Diarrhea					5309
33467	4		Typhlitis					5309
33468	100		Alopecia					5309
33469	52		Peeling of hands & feet on soles					5309
33470	30		Papular skin eruption					5309
33471	13		Conjunctivitis					5309
33472	8		Death					5309
33473	75		Neutropenia	grade 2				5307
33474	12.5		Neutropenia	grade 3			TRUE	5307
33475	12.5		Thrombocytopenia	grade 3			TRUE	5307
33476	50		Hyperbilirubinaemia					5307
33477			Anorexia			OVERDOSAGE		5308
33478			Nausea			OVERDOSAGE		5308
33479			Vomiting			OVERDOSAGE		5308
33480			Myelosuppression			OVERDOSAGE		5308
33481			Hepatic disease			OVERDOSAGE		5308
33482	3 pts		Blurred vision					5312
33483	1 pts		Sleepy					5312
33484	5 pts		Dry mouth					5312
33485	1 pts		Chest pain					5312
33486	1 pts		Sneezing					5312
33487			Vomiting		discontinuation	leads to discontinuation		5317
33488			Cramps		discontinuation	leads to discontinuation		5317
33489			Peripheral vasoconstriction	severe	discontinuation	leads to discontinuation		5317
33490						No AEs are reported		5314
33491						No AEs are reported		5313
33492						No AEs are reported		5315
33493						No AEs are reported		5316
33494			Hyponatremia	severe	discontinuation	WARNING		5319
33495			Hypokalemia	severe	discontinuation	WARNING		5319
33496			Azotemia		discontinuation	WARNING		5320
33497			Hyperuricemia		discontinuation	WARNING		5320
33498						There was no evidence of any major side effects and the oral dose of 20-150 mg was well tolerated.		5318
33499	23		Gastrointestinal upset		discontinuation	leads to discontinuation		5322
33500	23		Dizziness		discontinuation	leads to discontinuation		5322
33501			Toxic reaction (NOS)	acute				5321
33502	1 pts		Nausea		discontinuation	leads to discontinuation		5325
33503	1 pts		Cephalgia		discontinuation	leads to discontinuation		5325
33504	1 pts		Colicky		discontinuation	leads to discontinuation		5325
33505						No AEs are reported		5324
33506						No AEs are reported		5323
33507	63 pts		Hypotension	below serious				5334
33508	16 pts		Bradycardia	below serious				5334
33509	9 pts		Diastolic hypotension	below serious				5334
33510	13 pts		Tachycardia	below serious				5334
33511	19 pts		Hypertension	below serious				5335
33512	17 pts		Systolic hypertension	below serious				5335
33513	13 pts		Hypoxia	below serious				5335
33514	10 pts		Respiratory rate increased	below serious				5335
33515	1 pts		Anaemia	serious				5333
33516	13 pts		Hypertension	below serious				5333
33517	8 pts		Respiratory acidosis	below serious				5333
33518	4 pts		Bradycardia	below serious				5333
33519	2 pts		Respiratory rate decreased	below serious				5333
33520			Nausea					5337
33521			Vomiting					5337
33522			Hypotension					5337
33523	12.4		Nasal discomfort					5338
33524	9.3		Somnolence					5338
33525	1 pts		Nasal discomfort		discontinuation	leads to discontinuation		5338
33526	1 pts		Somnolence		discontinuation	leads to discontinuation		5338
33527	90 pts		Hypoxemia					5336
33528	5 pts		Hypotension					5336
33529						No AEs were reported		5327
33530						No AEs were reported		5328
33531						No AEs were reported		5330
33532						No AEs were reported		5329
33533						No AEs were reported		5332
33534	10		Somnolence					5331
33535	7		Headache					5331
33536	2		Dysarthria					5331
33537	5		Nasal discomfort					5331
33538	2		Throat irritation					5331
33539	3		Rhinorrhea					5331
33540	4		Product taste abnormal					5331
33541	1		Lacrimation increased					5331
33542	9		Somnolence					5326
33543	2		Headache					5326
33544	2		Dysarthria					5326
33545	16		Nasal discomfort					5326
33546	7		Throat irritation					5326
33547	5		Rhinorrhea					5326
33548	2		Lacrimation increased					5326
33549	11 pts		Granulocytopenia	grade 4			TRUE	5339
33550	11 pts		Thrombocytopenia	grade 3				5339
33551	9 pts		Nausea and vomiting	grade 1-2				5339
33552	6 pts		Stomatitis	grade 1-3				5339
33553	5 pts		Alopecia	grade 1-3				5339
33554	3 pts		Diarrhea	grade 1-2				5339
33555	76		Nausea					5340
33556	61		Alopecia					5340
33557	61		Menstrual disorder					5340
33558	43		Amenorrhea					5340
33559	53		Upper respiratory tract infection					5340
33560	32		Urinary tract infection		discontinuation	one discontinuation to prevent future complications from repeated urinary tract infections		5340
33561	19		Stomatitis					5340
33562	18		Arrhythmia					5340
33563	16		Diarrhea					5340
33564	11		Urine abnormal					5340
33565	11		ECG abnormal					5340
33566	10		Constipation					5340
33567	8		Back pain					5340
33568	6		Sinusitis					5340
33569	6		Headache					5340
33570	19		Leukopenia		discontinuation	1 patient discontinued treatment		5340
33571	15		Gamma-GT increased					5340
33572	8		SGOT increased					5340
33573	6		Granulocytopenia					5340
33574	6		Anemia					5340
33575	5		SGPT increased					5340
33576	1 pts		Depression		discontinuation			5340
33577	1 pts		Left ventricular dysfunction		discontinuation			5340
33578	1 pts		Bone pain		discontinuation			5340
33579	1 pts		Emesis		discontinuation			5340
33580	1 pts		Renal failure		discontinuation			5340
33581			Anaphylactic reaction	grade 3-5				5341
33582						No AEs reported		5342
33583	4 pts		Weight gain		discontinuation	leads to discontinuation		5343
33584	1 pts		Conjunctivitis	below serious				5347
33585	1 pts		Eye swelling	below serious				5347
33586	1 pts		Abdominal pain upper	below serious				5347
33587	1 pts		Diarrhoea	below serious				5347
33588	3 pts		Nausea	below serious				5347
33589	1 pts		Vomiting	below serious				5347
33590	1 pts		Feeling hot	below serious				5347
33591	1 pts		Conjunctivitis bacterial	below serious				5347
33592	5 pts		Headache	below serious				5347
33593	1 pts		Somnolence	below serious				5347
33594	1 pts		Pollakiuria	below serious				5347
33595	1 pts		Cough	below serious				5347
33596	1 pts		Dry throat	below serious				5347
33597	3 pts		Urticaria	below serious				5347
33598	1 pts		Urticaria localised	below serious				5347
33599	1 pts		Flushing	below serious				5347
33600	1 pts		Headache	below serious				5348
33601	1 pts		Gastrooesophageal reflux disease	below serious				5344
33602	1 pts		Dysgeusia	below serious				5344
33603	1 pts		Chest pain	below serious				5345
33604	1 pts		Laryngitis	below serious				5345
33605	2 pts		Rhinitis	below serious				5345
33606	1 pts		Dizziness	below serious				5345
33607	1 pts		Apnoea	below serious				5345
33608	1 pts		Cough	below serious				5345
33609	1 pts		Haemoptysis	below serious				5345
33610	1 pts		Abdominal pain	below serious				5346
33611	1 pts		Paraesthesia oral	below serious				5346
33612	1 pts		Chest pain	below serious				5346
33613	5 pts		Dysgeusia	below serious				5346
33614	1 pts		Dyspnoea	below serious				5346
33615	1 pts		Abdominal pain	below serious				5350
33616	1 pts		Dyspepsia	below serious				5350
33617	1 pts		Toothache	below serious				5350
33618	1 pts		Chest discomfort	below serious				5350
33619	1 pts		Chest pain	below serious				5350
33620	1 pts		Foot fracture	below serious				5350
33621	1 pts		Blood bilirubin increased	below serious				5350
33622	1 pts		Arthralgia	below serious				5350
33623	1 pts		Back pain	below serious				5350
33624	1 pts		Musculoskeletal chest pain	below serious				5350
33625	1 pts		Myalgia	below serious				5350
33626	1 pts		Pain in extremity	below serious				5350
33627	2 pts		Dizziness	below serious				5350
33628	3 pts		Dysgeusia	below serious				5350
33629	1 pts		Periorbital oedema	below serious				5350
33630	1 pts		Urticaria	below serious				5350
33631	1 pts		Vaginal infection	below serious				5349
33632	2 pts		Musculoskeletal chest pain	below serious				5349
33633	1 pts		Oropharyngeal pain	below serious				5349
33634	1 pts		Flushing	below serious				5349
33635	2		Headache					5357
33636						No AEs are reported		5354
33637						No AEs are reported		5353
33638	1 pts		Jaundice		discontinuation	leads to discontinuation		5355
33639	1 pts		Pruritus	severe	discontinuation	leads to discontinuation		5355
33640	1 pts		Nausea		discontinuation	leads to discontinuation		5355
33641						No AEs are reported		5358
33642						No AEs are reported		5352
33643	1 pts		Bilirubin total increased	mild				5351
33644	1 pts		Alanine aminotransferase increase	mild				5351
33645			Psychiatric disorder NOS	serious		WARNING		5356
33646	1 pts		Atypical pneumonia	serious				5359
33647	1 pts		Cholecystitis	serious				5359
33648	2 pts		Abdominal cramps	below serious				5359
33649	2 pts		Back pain	below serious				5359
33650	8 pts		Constipation	below serious				5359
33651	26 pts		Diarrhea	below serious				5359
33652	7 pts		Exanthema	below serious				5359
33653	10 pts		Headache	below serious				5359
33654	25 pts		Hypokalemia	below serious				5359
33655	3 pts		Hyponatremia	below serious				5359
33656	8 pts		CRP increased	below serious				5359
33657	3 pts		Bilirubin increased	below serious				5359
33658	31 pts		Nausea	below serious				5359
33659	24 pts		Vomiting	below serious				5359
33660	1 pts		Road traffic accident	serious				5360
33661	1 pts		Blood creatine phosphokinase increased	serious				5361
33662	2 pts		Nausea	below serious				5361
33663	1 pts		Vomiting	below serious				5361
33664	2 pts		Dysgeusia	below serious				5361
33665	1 pts		Diarrhoea	below serious				5361
33666	1 pts		Eyelid oedema	below serious				5362
33667	1 pts		Diarrhoea	below serious				5362
33668	2 pts		Dyspepsia	below serious				5362
33669	1 pts		Application site reaction	below serious				5362
33670	3 pts		Upper respiratory tract infection	below serious				5362
33671	2 pts		Back pain	below serious				5362
33672	1 pts		Muscle spasms	below serious				5362
33673	1 pts		Dizziness	below serious				5362
33674	1 pts		Pollakiuria	below serious				5362
33675	1 pts		Hangnail	below serious				5362
33676	1 pts		Pilonidal cyst	serious				5363
33677	4 pts		Nausea	below serious				5363
33678	3 pts		Nasopharyngitis	below serious				5363
33679	4 pts		Somnolence	below serious				5363
33680						No serious or severe adverse events were observed. No discontinuations.		5364
33681						None of the 5 patients who received moxifloxacin at above the recommended dose of 400 mg once daily experienced an adverse event.		5365
33682	0.37		Erythema		discontinuation			5369
33683	1		QT interval prolonged		discontinuation			5369
33684	0.37		Angioedema	serious	discontinuation			5369
33685						There were no serious adverse events, dropouts, or deaths in this study.		5366
33686			Tendinitis		discontinuation	WARNING		5370
33687			Tendon rupture		discontinuation	WARNING		5370
33688			Peripheral neuropathy		discontinuation	WARNING		5370
33689			Central nervous system disorder NOS		discontinuation	WARNING		5370
33690			Myasthenia gravis		discontinuation	WARNING		5370
33691	>0.3		Nausea		discontinuation	Discontinuation of AVELOX due to adverse reactions occurred in 4% of patients treated with 400 mg PO. The most common adverse reactions (>0.3%) leading to discontinuation with the 400 mg oral doses were nausea, diarrhea, dizziness, and vomiting.		5368
33692	>0.3		Diarrhea		discontinuation	The most common adverse reactions (>0.3%) leading to discontinuation with the 400 mg oral doses were nausea, diarrhea, dizziness, and vomiting.		5368
33693	>0.3		Dizziness		discontinuation	The most common adverse reactions (>0.3%) leading to discontinuation with the 400 mg oral doses were nausea, diarrhea, dizziness, and vomiting.		5368
33694	>0.3		Vomiting		discontinuation	The most common adverse reactions (>0.3%) leading to discontinuation with the 400 mg oral doses were nausea, diarrhea, dizziness, and vomiting.		5368
33695			Rash		discontinuation	Discontinuation of AVELOX due to adverse reactions occurred in 4% with 400 mg intravenous. The most common adverse reaction leading to discontinuation with the 400 mg intravenous dose was rash.		5367
33696	1 pts		Pulmonary edema					5378
33697	1 pts		Dizzy					5377
33698	4 pts		Sleepy					5377
33699	1 pts		Headache					5377
33700	1 pts		Head pressure					5377
33701			Respiratory depression	serious|grade 5		WARNING		5373
33702			Respiratory depression	serious|grade 5		WARNING		5371
33703			Respiratory depression	serious|grade 5		WARNING		5372
33704						No information on AE is provided		5375
33705						No information on AE is provided		5374
33706						No information on AE is provided		5376
33707	3 pts		Anesthesia reversal				TRUE	5382
33708	2 pts		Anesthesia reversal				TRUE	5381
33709	1 pts		Psychiatric decompensation		discontinuation	leads to discontinuation		5385
33710						no clinically significant adverse effects		5380
33711						no clinically significant adverse effects		5379
33712	1 pts		Dizziness		discontinuation	leads to discontinuation		5384
33713	1 pts		Rash		discontinuation	leads to discontinuation		5384
33714	1 pts		Dizziness		discontinuation	leads to discontinuation		5383
33715	1 pts		Toothache	below serious				5386
33716	1 pts		Upper respiratory tract infection	below serious				5386
33717	1 pts		Allergic rhinitis	below serious				5386
33718	2 pts		Wheezing	below serious				5386
33719			Eyeball itching		dose interruption			5387
33720			Soreness in eyes		dose interruption			5387
33721			Swelling		dose interruption			5387
33722			Hypotension	marked				5388
33723			Bradycardia					5388
33724			Palpitations					5388
33725			Flushing					5388
33726			Drowsiness					5388
33727			Confusion					5388
33728			Slurred speech					5388
33729			Hypotension		discontinuation			5390
33730			Headache		discontinuation			5390
33731			Tachycardia		discontinuation			5390
33732			Angina		discontinuation	WARNINGS		5393
33733	2.5		Headache		discontinuation			5392
33734	2.2		Palpitation		discontinuation			5392
33735	1.9		Dizziness		discontinuation			5392
33736	1.9		Asthenia		discontinuation			5392
33737	1.2		Pedal edema		discontinuation			5392
33738	1.2		Nausea		discontinuation			5392
33739	0.9		Rash		discontinuation			5391
33740	0.9		Diarrhea		discontinuation			5391
33741	0.9		Tachycardia		discontinuation			5391
33742	0.6		Blurred vision		discontinuation			5391
33743	0.6		Chest pain		discontinuation			5391
33744	0.6		Face edema		discontinuation			5391
33745	0.6		Myocardial infarct		discontinuation			5391
33746	0.6		Vasodilatation		discontinuation			5391
33747	0.6		Vomiting		discontinuation			5391
33748						No adverse reactions leading to discontinuation were reported		5389
33749	1 pts		Nausea		discontinuation	leads to discontinuation		5394
33750	2 pts		Rash		discontinuation	leads to discontinuation		5394
33751	1 pts		Abdominal cramps		discontinuation	leads to discontinuation		5395
33752						No AEs are reported		5396
33753	1 pts		Tako-Tsubo cardiomyopathy		discontinuation	leads to discontinuation		5399
33754	58		Dry mouth					5398
33755	12		Fatigue					5398
33756	2		Somnolence					5398
33757	4		Insomnia					5398
33758	4		Dizziness					5398
33759	4		Headache					5398
33760	2		Constipation					5398
33761	2		Ataxia					5398
33762	4		Hyperglycaemia					5398
33763	4		Oedema					5398
33764	6		Urinary retention					5398
33765	6		Emotional lability					5398
33766	6		Swallowing difficult					5398
33767	2		Pruritus					5398
33768	2		Excess sweating					5398
33769	2		Weight gain					5398
33770	60		Dry mouth					5397
33771	8		Fatigue					5397
33772	8		Somnolence					5397
33773	4		Insomnia					5397
33774	8		Dizziness					5397
33775	2		Headache					5397
33776	2		Constipation					5397
33777	10		Ataxia					5397
33778	4		Feeling drunk					5397
33779	4		Concentration impaired					5397
33780	6		Hyperglycaemia					5397
33781	8		Oedema					5397
33782	2		Abdominal cramp					5397
33783	4		Urinary retention					5397
33784	2		Swallowing difficult					5397
33785	2		Blurry vision					5397
33786	1 pts		Convulsions		discontinuation	leads to discontinuation		5400
33787	1 pts		Hypotension		discontinuation	leads to discontinuation		5400
33788	4 pts		Eye discharge					5404
33789	4 pts		Stinging					5404
33790	4 pts		Blurred vision					5404
33791	2 pts		Dry nose					5404
33792	2 pts		Taste perversion					5404
33793	1.1		Conjunctivitis viral			Unrelated to the study drug		5402
33794	2.3		Hyperemia			Both related and unrelated to the study drug		5402
33795	1.1		Eyes tearing			Unrelated to the study drug		5402
33796	1.1		Eye discomfort			Related to the study drug		5402
33797	1.1		Corneal staining			Unrelated to the study drug		5402
33798						No serious adverse events were reported during the trial.		5401
33799	4.8		Vision blurred					5403
33800	3.3		Dry eye					5403
33801	2.1		Abnormal sensation in eye					5403
33802	2.4		Corneal staining					5403
33803	1.8		Conjunctival staining					5403
33804	1.5		Eye pruritus					5403
33805	0.3		Eye irritation					5403
33806	1.5		Headache					5403
33807	2.4		Dysgeusia					5403
33808	1.8		Upper respiratory tract infection					5403
33809	1.8		Nasopharyngitis					5403
33810	0.3		Ligament sprain					5403
33811	0.3		Cough					5403
33812			Loose stools		dose interruption			5406
33813			Loose stools		dose interruption			5406
33814			Diarrhoea		discontinuation			5405
33815			Nausea		discontinuation			5405
33816			Headache		discontinuation			5405
33817			Loose stools		discontinuation			5405
33818			Abdominal pain		discontinuation			5405
33819			Rash		discontinuation			5405
33820			Alopecia		discontinuation			5405
33821			Dizziness		discontinuation			5405
33822			Light headedness		discontinuation			5405
33823						No SAEs were observed		5408
33824			Diarrhea			all five subjects in the 4-g study		5407
33825	1 pts		Hypertensive crisis					5410
33826	1.4		Application site dermatitis		discontinuation	leads to discontinuation		5411
33827	0.5		Application site erythema		discontinuation	leads to discontinuation		5411
33828	0.5		Application site pain		discontinuation	leads to discontinuation		5411
33829	0.2		Application site dryness		discontinuation	leads to discontinuation		5411
33830	0.2		Hypoesthesia		discontinuation	leads to discontinuation		5411
33831	0.2		Paresthesia		discontinuation	leads to discontinuation		5411
33832	0.2		Rash		discontinuation	leads to discontinuation		5411
33833	0.2		Urticaria		discontinuation	leads to discontinuation		5411
33834	0.2		Photosensitivity reaction		discontinuation	leads to discontinuation		5411
33835						No information on AE is provided. Impossible to open the full text		5409
33836	1 pts		Headache		discontinuation	leads to discontinuation		5412
33837			Hypocalcemia		discontinuation			5414
33838			Fever		discontinuation			5415
33839			Hypotension		discontinuation			5415
33840			Taste perversion		discontinuation			5415
33841			Interstitial pneumonitis		discontinuation			5416
33842			Malaise		discontinuation			5416
33843			Dyspnea		discontinuation			5416
33844			Hypocalcemia		discontinuation			5416
33845			Bone pain		discontinuation			5416
33846			Diarrhea		discontinuation			5413
33847						No AEs reported		5417
33848						No AEs are reported. None complained of adverse symptoms after any i.v. dose of penbutolol.		5420
33849						no serious AEs were reported		5419
33850	0.6		Asthenia		discontinuation	leads to discontinuation		5418
33851	0.8		Nausea		discontinuation	leads to discontinuation		5418
33852	0.6		Depression		discontinuation	leads to discontinuation		5418
33853	0.6		Dizziness		discontinuation	leads to discontinuation		5418
33854	0.6		Headache		discontinuation	leads to discontinuation		5418
33855	1		Diarrhea		discontinuation	1 patient		5433
33856	1		Dyskinesia		discontinuation	1 patient		5433
33857	1		Dystonia		discontinuation	1 patient		5433
33858	1		Headache		discontinuation	1 patient		5433
33859	1		Liver disorder		discontinuation	1 patient		5433
33860	2.9		Nausea and vomiting		discontinuation			5433
33861	1		Parkinsonism aggravated		discontinuation	1 patient		5433
33862	1		Sleep disorder		discontinuation	1 patient		5433
33863	1		Urinary incontinence		discontinuation	1 patient		5433
33864						no AEs leading to discontinuation reported		5432
33865			Rash	grade 2-3	discontinuation	1 patient, moderately severe allergic dermatitis with pruritus		5426
33866			Syncope	grade 3	discontinuation	1 patient, an episode of syncope (severe,occurring 2 hours after dosing and lasting about 2 hours)		5426
33867			Daytime sleepiness					5428
33868	common		Daytime sleepiness					5431
33869	10		Hypotension symptomatic					5428
33870	14		Drug-induced hallucinosis			In controlled trials, pergolide mesylate with l-dopa caused hallucinosis in about 14% of patients as opposed to 3% taking placebo with l-dopa. This was of sufficient severity to cause discontinuation of treatment in about 3% of those enrolled		5429
33871	3		Drug-induced hallucinosis	grade 3	discontinuation	In controlled trials, pergolide mesylate with l-dopa caused hallucinosis in about 14% of patients as opposed to 3% taking placebo with l-dopa. This was of sufficient severity to cause discontinuation of treatment in about 3% of those enrolled		5429
33872	rare		Pleuritis					5430
33873	rare		Pleural effusion					5430
33874	rare		Pleural fibrosis					5430
33875	rare		Pericarditis					5430
33876	rare		Pericardial effusion					5430
33877	rare		Cardiac valvulopathy					5430
33878	rare		Retroperitoneal fibrosis					5430
33879	7.8		Hallucinations			Twenty-seven percent (27%) of approximately 1200 patients receiving pergolide mesylate for treatment of Parkinson’s disease in premarketing clinical trials in the US and Canada discontinued treatment due to adverse events. The events most commonly causing discontinuation were related to the nervous system (15.5%), primarily hallucinations (7.8%) and confusion (1.8%).		5427
33880	1.8		Confusion			Twenty-seven percent (27%) of approximately 1200 patients receiving pergolide mesylate for treatment of Parkinson’s disease in premarketing clinical trials in the US and Canada discontinued treatment due to adverse events. The events most commonly causing discontinuation were related to the nervous system (15.5%), primarily hallucinations (7.8%) and confusion (1.8%).		5427
33881			Vomiting			The largest overdose involved a young hospitalized adult patient who was not being treated with pergolide mesylate but who intentionally took 60 mg of the drug. He experienced vomiting, hypotension, and agitation.		5423
33882			Hypotension			The largest overdose involved a young hospitalized adult patient who was not being treated with pergolide mesylate but who intentionally took 60 mg of the drug. He experienced vomiting, hypotension, and agitation.		5423
33883			Agitation			The largest overdose involved a young hospitalized adult patient who was not being treated with pergolide mesylate but who intentionally took 60 mg of the drug. He experienced vomiting, hypotension, and agitation.		5423
33884			Hallucinations	grade 3		1 patient		5422
33885			Movements involuntary	grade 3		1 patient		5421
33886			Tingling	grade 3		1 patient		5421
33887			Palpitations			1 patient		5424
33888			Hypotension			1 patient		5424
33889			Ventricular extrasystoles			1 patient		5425
33890			Coma		discontinuation			5435
33891			Hypothermia		discontinuation			5435
33892			Tachycardia		discontinuation			5435
33893			Miosis		discontinuation			5435
33894			QT interval prolonged		discontinuation			5434
33895			Hypothermia		discontinuation			5434
33896			Loss of consciousness		discontinuation			5434
33897			PR interval prolonged		discontinuation			5434
33898			QRS prolonged		discontinuation			5434
33899			Neuroleptic malignant syndrome		discontinuation			5440
33900			Tardive dyskinesia		discontinuation	WARNING		5438
33901			Neuroleptic malignant syndrome		discontinuation	WARNING. Potentially fatal		5439
33902			Tardive dyskinesia		discontinuation	WARNING		5436
33903			Neuroleptic malignant syndrome		discontinuation	WARNING. Potentially fatal		5437
33904			Myocardial infarction		discontinuation	WARNING		5442
33905			Cerebrovascular spasm		discontinuation	WARNING		5442
33906			Cerebral vascular occlusion		discontinuation	WARNING		5442
33907			Hypotension		discontinuation	WARNING		5442
33908			Rhinitis		discontinuation	Two hundred and ninety-eight (298, 15%) discontinued from the study because of adverse events, including 9% during the 40 mg, and 18% during the 80 mg treatment period. The most common adverse events resulting in discontinuation included rhinitis (4%), vomiting (4%), nausea (3%), diarrhea (2%),headache (2%), dizziness (2%), and tachycardia (2%).		5441
33909			Vomiting		discontinuation	Two hundred and ninety-eight (298, 15%) discontinued from the study because of adverse events, including 9% during the 40 mg, and 18% during the 80 mg treatment period. The most common adverse events resulting in discontinuation included rhinitis (4%), vomiting (4%), nausea (3%), diarrhea (2%),headache (2%), dizziness (2%), and tachycardia (2%).		5441
33910			Nausea		discontinuation	Two hundred and ninety-eight (298, 15%) discontinued from the study because of adverse events, including 9% during the 40 mg, and 18% during the 80 mg treatment period. The most common adverse events resulting in discontinuation included rhinitis (4%), vomiting (4%), nausea (3%), diarrhea (2%),headache (2%), dizziness (2%), and tachycardia (2%).		5441
33911			Diarrhea		discontinuation	Two hundred and ninety-eight (298, 15%) discontinued from the study because of adverse events, including 9% during the 40 mg, and 18% during the 80 mg treatment period. The most common adverse events resulting in discontinuation included rhinitis (4%), vomiting (4%), nausea (3%), diarrhea (2%),headache (2%), dizziness (2%), and tachycardia (2%).		5441
33912			Headache		discontinuation	Two hundred and ninety-eight (298, 15%) discontinued from the study because of adverse events, including 9% during the 40 mg, and 18% during the 80 mg treatment period. The most common adverse events resulting in discontinuation included rhinitis (4%), vomiting (4%), nausea (3%), diarrhea (2%),headache (2%), dizziness (2%), and tachycardia (2%).		5441
33913			Dizziness		discontinuation	Two hundred and ninety-eight (298, 15%) discontinued from the study because of adverse events, including 9% during the 40 mg, and 18% during the 80 mg treatment period. The most common adverse events resulting in discontinuation included rhinitis (4%), vomiting (4%), nausea (3%), diarrhea (2%),headache (2%), dizziness (2%), and tachycardia (2%).		5441
33914			Tachycardia		discontinuation	Two hundred and ninety-eight (298, 15%) discontinued from the study because of adverse events, including 9% during the 40 mg, and 18% during the 80 mg treatment period. The most common adverse events resulting in discontinuation included rhinitis (4%), vomiting (4%), nausea (3%), diarrhea (2%),headache (2%), dizziness (2%), and tachycardia (2%).		5441
33915	0.84		Dyspnea		discontinuation	patient 1		5443
33916	0.84		Tachycardia		discontinuation	patient 1		5443
33917	0.84		Epistaxis		discontinuation			5443
33918	0.84		Cephalgia		discontinuation			5443
33919	0.84		Flushing	serious	discontinuation	patient 2		5443
33920	0.84		Chest pain	serious	discontinuation	patient 2		5443
33921	0.84		Shortness of breath	serious	discontinuation	patient 2		5443
33922	0.84		Tachycardia	serious	discontinuation	patient 2		5443
33923	9.7		Headache					5444
33924	29		Edema					5444
33925	9.7		Dizziness					5444
33926	3.2		Asthenia					5444
33927	12.9		Tachycardia					5444
33928	3.2		Palpitation					5444
33929	5.9		Edema		discontinuation	leads to discontinuation		5445
33930	3.4		Tachycardia		discontinuation	leads to discontinuation		5445
33931	18.8		Edema		discontinuation	leads to discontinuation		5446
33932	3 pts		Death	serious				5449
33933	1 pts		Cardiac failure congestive	serious				5448
33934	1 pts		Diverticulitis	serious				5448
33935	1 pts		Peridiverticular abscess	serious				5448
33936	1 pts		Subdural haematoma	serious				5448
33937	1 pts		Migraine	serious				5448
33938	9 pts		Oedema peripheral	below serious				5448
33939	6 pts		Arthralgia	below serious				5448
33940	5 pts		Cough	below serious				5448
33941	4 pts		Blood parathyroid hormone increased	below serious				5448
33942	4 pts		Nausea	below serious				5448
33943	4 pts		Weight increased	below serious				5448
33944	1 pts		Paroxysmal supraventricular tachycardia	serious				5450
33945	1 pts		Atrial fibrillation	serious				5450
33946	1 pts		Dehydration	serious				5450
33947	5 pts		Gastrointestinal disorder	below serious				5450
33948	2 pts		Infection	below serious				5450
33949	2 pts		Weight gain	below serious				5451
33950	2 pts		Peripheral oedema	below serious				5452
33951	3 pts		Edema	below serious				5456
33952	2 pts		Upper respiratory tract infection	below serious				5453
33953	1 pts		Encephalopathy	serious				5447
33954	1 pts		Hypertension	serious				5447
33955	1 pts		Hypoxia	serious				5447
33956	1 pts		Bacteremia	serious				5447
33957	3 pts		Pneumonia	serious				5447
33958	1 pts		Small bowel obstruction	serious				5447
33959	1 pts		Abdominal pain NOS	serious				5447
33960	2 pts		Thorax pain	serious				5447
33961	1 pts		Pancreatitis	serious				5447
33962	1 pts		Respiratory failure	serious				5447
33963	1 pts		Vomiting	serious				5447
33964	4 pts		Volume overload	below serious				5447
33965	4 pts		Diarrhea	below serious				5447
33966	3 pts		Dizziness	below serious				5447
33967	3 pts		Dyspnea	below serious				5447
33968	3 pts		Hyperkalemia	below serious				5447
33969	3 pts		Hypoglycemia	below serious				5447
33970	8 pts		Nausea	below serious				5447
33971	8 pts		Vomiting	below serious				5447
33972	1 pts		Glucose abnormal	serious				5454
33973	1 pts		Creatine kinase increased	serious				5454
33974	1 pts		Bloating	below serious				5454
33975	1 pts		Fever	below serious				5454
33976	2 pts		Appetite lost	below serious				5454
33977	2 pts		Pain	below serious				5454
33978	1 pts		Sleep disturbance	below serious				5454
33979	1 pts		Platelet count abnormal	below serious				5454
33980	1 pts		Aspartate aminotransferase increased	below serious				5454
33981	4 pts		Creatine kinase increased	below serious				5454
33982	1 pts		Neck pain	below serious				5454
33983	1 pts		Pain in extremity	below serious				5454
33984	1 pts		Bone pain	below serious				5455
33985	1 pts		Hot flashes	below serious				5455
33986	1 pts		Increased urinary frequency	below serious				5455
33987	1 pts		Muscle pain	below serious				5455
33988	1 pts		Shortness of breath	below serious				5455
33989	1 pts		Urinary tract infection	below serious				5455
33990	1.67		Edema	mild	discontinuation	1 patient		5459
33991	1.67		ALT increased	grade 2-4	discontinuation	1 patient		5459
33992						No serious adverse events occurred at any of the three doses tested. None of the three participants with early termination dropped out due to adverse effects related to study drug		5457
33993			Congestive heart failure		discontinuation	WARNING		5460
33994			Edema		discontinuation	WARNING		5460
33995			Hepatic failure	grade 5	discontinuation	WARNING. Sometimes fatal		5460
33996			Fractures		discontinuation	WARNING. Increased incidence in female patients		5460
33997			Bladder cancer		discontinuation	WARNING		5460
33998			Hypoglycemia		discontinuation	WARNING		5460
33999			Macular edema		discontinuation	WARNING		5460
34000						The patient denied any clinical symptoms during this period.		5458
34001	4		Thrombophlebitis					5462
34002	2		Injection site pain					5462
34003	2		Injection site erythema					5462
34004	2		Injection site induration					5462
34005	2		Diarrhea					5462
34006	2		Loose stools					5462
34007	1		Rash					5462
34008	4		Thrombophlebitis					5461
34009	2		Injection site pain					5461
34010	2		Injection site erythema					5461
34011	2		Injection site induration					5461
34012	2		Diarrhea					5461
34013	2		Loose stools					5461
34014	1		Rash					5461
34015						No AEs are reported		5463
34016						No AEs are reported		5464
34017	16.7		Elevated liver enzymes			Elevations in SGOT and/or SGPT enzyme levels were observed in 1 of 6 normal volunteers given 1200 mg of pralidoxime chloride intramuscularly		5469
34018	66.7		Elevated liver enzymes			Elevations in SGOT and/or SGPT enzyme levels were observed in 4 of 6 volunteers given 1800 mg of pralidoxime chloride intramuscularly		5470
34019						No AEs were reported		5466
34020						No AEs were reported		5467
34021			Hypertension					5468
34022			Headache					5468
34023			Visual accommodation disturbance of					5468
34024			Epigastric discomfort					5468
34025			Vomiting					5468
34026	5 pts		Lymphocytosis					5465
34027	4 pts		SGOT increased			transient elevation of SGPT and SGOT		5465
34028	4 pts		SGPT increased			transient elevation of SGPT and SGOT		5465
34029	4 pts		Thymol turbidity test increased					5465
34030	11 pts		Urobilinogen urine positive					5465
34031	9 pts		Change in ECG			The ECG changes were observed in nine subjects: inverted T3 in three, retrograde changes in three, sinus tachycardia in two, and premature contractions in one.		5465
34032	5		Headache					5471
34033	7		Upper respiratory infection					5471
34034	6		Musculoskeletal pain					5471
34035	2		Muscle ache					5471
34036	1		Creatine kinase increased					5471
34037	2		Fatigue					5471
34038	2		Abdominal pain					5471
34039	2		Nausea					5471
34040	1		Cough					5471
34041	5		Pharyngitis					5471
34042	5		Sinus disorder					5471
34043	2		Dyspepsia					5471
34044	3		Diarrhea					5471
34045	2		Influenza					5471
34046			Liver function test increased		discontinuation			5472
34047			Nausea		discontinuation			5472
34048			Anxiety		discontinuation			5472
34049			Depression		discontinuation			5472
34050			Dizziness		discontinuation			5472
34051	1 pts		Myocardial infarction	serious				5474
34052	1 pts		Small intestinal obstruction	serious				5474
34053	1 pts		Chest pain	serious				5474
34054	1 pts		Drug withdrawal syndrome	serious				5474
34055	1 pts		Campylobacter infection	serious				5474
34056	1 pts		Ankle fracture	serious				5474
34057	1 pts		Delayed recovery from anaesthesia	serious				5474
34058	1 pts		Endotracheal intubation complication	serious				5474
34059	1 pts		Fracture malunion	serious				5474
34060	1 pts		Sudden onset of sleep	serious				5474
34061	1 pts		Alcoholic psychosis	serious				5474
34062	1 pts		Depression	serious				5474
34063	1 pts		Hip arthroplasty	serious				5474
34064	1 pts		Anaemia microcytic	below serious				5474
34065	1 pts		Arrhythmia	below serious				5474
34066	1 pts		Atrial fibrillation	below serious				5474
34067	1 pts		Myocardial infarction	below serious				5474
34068	32 pts		Palpitations	below serious				5474
34069	1 pts		Tachycardia	below serious				5474
34070	2 pts		Ear pain	below serious				5474
34071	3 pts		Tinnitus	below serious				5474
34072	1 pts		Vertigo positional	below serious				5474
34073	1 pts		Vision blurred	below serious				5474
34074	1 pts		Visual acuity reduced	below serious				5474
34075	4 pts		Abdominal discomfort	below serious				5474
34076	2 pts		Abdominal pain	below serious				5474
34077	1 pts		Abdominal pain lower	below serious				5474
34078	3 pts		Abdominal pain upper	below serious				5474
34079	1 pts		Aphthous stomatitis	below serious				5474
34080	2 pts		Constipation	below serious				5474
34081	2 pts		Food poisoning	below serious				5474
34082	1 pts		Glossodynia	below serious				5474
34083	47 pts		Nausea	below serious				5474
34084	1 pts		Peptic ulcer	below serious				5474
34085	1 pts		Small intestinal obstruction	below serious				5474
34086	1 pts		Toothache	below serious				5474
34087	55 pts		Asthenia	below serious				5474
34088	1 pts		Drug withdrawal syndrome	below serious				5474
34089	2 pts		Irritability	below serious				5474
34090	1 pts		Medical device complication	below serious				5474
34091	14 pts		Oedema	below serious				5474
34092	6 pts		Oedema peripheral	below serious				5474
34093	3 pts		Pain	below serious				5474
34094	2 pts		Swelling	below serious				5474
34095	2 pts		Thirst	below serious				5474
34096	1 pts		Hepatic steatosis	below serious				5474
34097	1 pts		Acarodermatitis	below serious				5474
34098	1 pts		Campylobacter infection	below serious				5474
34099	3 pts		Ear infection	below serious				5474
34100	1 pts		Enteritis infectious	below serious				5474
34101	1 pts		Furuncle	below serious				5474
34102	1 pts		Gastroenteritis	below serious				5474
34103	1 pts		Lyme disease	below serious				5474
34104	5 pts		Nasopharyngitis	below serious				5474
34105	1 pts		Respiratory tract infection	below serious				5474
34106	1 pts		Tooth abscess	below serious				5474
34107	1 pts		Tooth infection	below serious				5474
34108	4 pts		Upper respiratory tract infection	below serious				5474
34109	1 pts		Urinary tract infection	below serious				5474
34110	1 pts		Viral infection	below serious				5474
34111	1 pts		Accident at home	below serious				5474
34112	1 pts		Ankle fracture	below serious				5474
34113	1 pts		Arthropod bite	below serious				5474
34114	1 pts		Bite	below serious				5474
34115	1 pts		Cardiac procedure complication	below serious				5474
34116	1 pts		Corneal abrasion	below serious				5474
34117	1 pts		Delayed recovery from anaesthesia	below serious				5474
34118	1 pts		Endotracheal intubation complication	below serious				5474
34119	4 pts		Fall	below serious				5474
34120	1 pts		Laceration	below serious				5474
34121	1 pts		Poisoning	below serious				5474
34122	1 pts		Fracture rib	below serious				5474
34123	2 pts		Road traffic accident	below serious				5474
34124	1 pts		Tendon injury	below serious				5474
34125	1 pts		Tooth injury	below serious				5474
34126	1 pts		Blood glucose increased	below serious				5474
34127	1 pts		Blood thyroid stimulating hormone increased	below serious				5474
34128	1 pts		Endoscopy	below serious				5474
34129	1 pts		Glycosylated haemoglobin increased	below serious				5474
34130	1 pts		Helicobacter test positive	below serious				5474
34131	1 pts		Sputum culture positive	below serious				5474
34132	2 pts		Weight increased	below serious				5474
34133	1 pts		White blood cell count increased	below serious				5474
34134	4 pts		Decreased appetite	below serious				5474
34135	2 pts		Dehydration	below serious				5474
34136	1 pts		Hyponatraemia	below serious				5474
34137	5 pts		Back pain	below serious				5474
34138	2 pts		Flank pain	below serious				5474
34139	3 pts		Muscle spasms	below serious				5474
34140	1 pts		Musculoskeletal pain	below serious				5474
34141	2 pts		Musculoskeletal stiffness	below serious				5474
34142	2 pts		Pain in extremity	below serious				5474
34143	1 pts		Basal cell carcinoma	below serious				5474
34144	1 pts		Lipoma	below serious				5474
34145	1 pts		Melanocytic naevus	below serious				5474
34146	1 pts		Neuroma	below serious				5474
34147	1 pts		Squamous cell carcinoma of skin	below serious				5474
34148	1 pts		Disturbance in attention	below serious				5474
34149	73 pts		Dizziness	below serious				5474
34150	52 pts		Dizziness postural	below serious				5474
34151	1 pts		Drooling	below serious				5474
34152	2 pts		Hypoaesthesia	below serious				5474
34153	2 pts		Paraesthesia	below serious				5474
34154	1 pts		Periodic limb movement disorder	below serious				5474
34155	1 pts		Restless legs syndrome	below serious				5474
34156	51 pts		Somnolence	below serious				5474
34157	1 pts		Sudden onset of sleep	below serious				5474
34158	1 pts		Syncope	below serious				5474
34159	1 pts		Aggression	below serious				5474
34160	1 pts		Alcoholic psychosis	below serious				5474
34161	1 pts		Bruxism	below serious				5474
34162	14 pts		Depression	below serious				5474
34163	1 pts		Flashback	below serious				5474
34164	2 pts		Libido decreased	below serious				5474
34165	2 pts		Haematuria	below serious				5474
34166	12 pts		Incontinence	below serious				5474
34167	1 pts		Micturition urgency	below serious				5474
34168	2 pts		Nephrolithiasis	below serious				5474
34169	33 pts		Pollakiuria	below serious				5474
34170	1 pts		Stress urinary incontinence	below serious				5474
34171	2 pts		Urinary incontinence	below serious				5474
34172	1 pts		Epididymitis	below serious				5474
34173	7 pts		Cough	below serious				5474
34174	7 pts		Dyspnoea	below serious				5474
34175	57 pts		Nasal congestion	below serious				5474
34176	5 pts		Oropharyngeal pain	below serious				5474
34177	1 pts		Productive cough	below serious				5474
34178	3 pts		Sleep apnoea syndrome	below serious				5474
34179	1 pts		Dermatitis	below serious				5474
34180	1 pts		Dermatitis allergic	below serious				5474
34181	1 pts		Hyperhidrosis	below serious				5474
34182	1 pts		Hyperkeratosis	below serious				5474
34183	1 pts		Ingrowing nail	below serious				5474
34184	1 pts		Psoriasis	below serious				5474
34185	1 pts		Skin ulcer	below serious				5474
34186	1 pts		Substance use	below serious				5474
34187	1 pts		Chondroplasty	below serious				5474
34188	1 pts		Hip arthroplasty	below serious				5474
34189	1 pts		Nerve block	below serious				5474
34190	7 pts		Hypotension	below serious				5474
34191	10 pts		Orthostatic hypotension	below serious				5474
34192	1 pts		Thrombus	below serious				5476
34193	1 pts		Chest pain	below serious				5476
34194	1 pts		Appendicitis	below serious				5476
34195	1 pts		Fainting	below serious				5476
34196	2 pts		Falling	below serious				5476
34197	7 pts		Drowsiness	below serious				5475
34198	5 pts		Dizziness	below serious				5475
34199	3 pts		Edema of lower extremities	below serious				5475
34200	3 pts		Headache	below serious				5475
34201	2 pts		Decreased appetite	below serious				5475
34202	2 pts		Nausea	below serious				5475
34203	2 pts		Diarrhea	below serious				5475
34204	2 pts		Gastrointestinal discomfort	below serious				5475
34205	2 pts		Nocturnal enuresis	below serious				5475
34206	10 pts		Dizziness on standing up	below serious				5473
34207	2 pts		Palpitation				TRUE	5478
34208	1 pts		Orthostatic hypotension				TRUE	5478
34209	2 pts		Nausea				TRUE	5478
34210	2 pts		Tinnitus				TRUE	5478
34211	1 pts		Vomiting				TRUE	5478
34212	1 pts		Sleepiness				TRUE	5478
34213	1 pts		Diarrhea				TRUE	5478
34214	2 pts		Palpitation				TRUE	5478
34215	2 pts		Orthostatic hypotension					5477
34216	3 pts		Nausea					5477
34217	2 pts		Tinnitus					5477
34218	3 pts		Vomiting					5477
34219	2 pts		Sleepiness					5477
34220	2 pts		Diarrhea					5477
34221	1 pts		Painful erection		discontinuation	leads to discontinuation		5479
34222						No AEs are reported		5481
34223	1 pts		Drug eruption eczematous		discontinuation	leads to discontinuation		5480
34224	0.7		Monocyte count increased					5482
34225	0.7		Eosinophil count increased					5482
34226	0.7		Platelet count decreased					5482
34227	1.5		Cardiac failure congestive					5482
34228	0.7		Coronary artery disease NOS					5482
34229	0.7		Myocardial infarction					5482
34230	0.7		Abdominal pain NOS					5482
34231	0.7		Diarrhea NOS					5482
34232	1.5		Chest pain					5482
34233	0.7		Pneumonia NOS					5482
34234	0.7		Urinary tract infection NOS					5482
34235	0.7		Prothrombin level decreased					5482
34236	0.7		Headache					5482
34237	0.7		Syncope					5482
34238						No AEs reported		5483
34239	0.7		Headache		discontinuation	leads to discontinuation		5484
34240	0.8		Dizziness		discontinuation	leads to discontinuation		5484
34241	0.3		Fatigue		discontinuation	leads to discontinuation		5484
34242	0.5		Coughing		discontinuation	leads to discontinuation		5484
34243	0.3		Nausea and vomiting		discontinuation	leads to discontinuation		5484
34244	0.2		Abdominal pain		discontinuation	leads to discontinuation		5484
34245	0.7		Dizziness		discontinuation	leads to discontinuation		5485
34246	0.3		Coughing		discontinuation	leads to discontinuation		5485
34247	0.2		Fatigue		discontinuation	leads to discontinuation		5485
34248	0.2		Nausea and vomiting		discontinuation	leads to discontinuation		5485
34249	0.5		Hypotension		discontinuation	leads to discontinuation		5485
34250	0.2		Dyspnea		discontinuation	leads to discontinuation		5485
34251	0.2		Rash		discontinuation	leads to discontinuation		5485
34252	1 pts		Chest wall pain	below serious				5487
34253	1 pts		Pain in extremity	below serious				5487
34254			Hot flashes					5488
34255						OVERDOSAGE		5491
34256			Leg cramps			OVERDOSAGE		5486
34257			Dizziness			OVERDOSAGE		5486
34258			Ataxia			OVERDOSAGE		5492
34259			Dizziness			OVERDOSAGE		5492
34260			Vomiting			OVERDOSAGE		5492
34261			Rash			OVERDOSAGE		5492
34262			Diarrhea			OVERDOSAGE		5492
34263			Tremor			OVERDOSAGE		5492
34264			Flushing			OVERDOSAGE		5492
34265			Alkaline phosphatase increased			OVERDOSAGE		5492
34266			Deep vein thrombosis			WARNING		5489
34267			Pulmonary embolism			WARNING		5489
34268			Stroke			WARNING		5489
34269	0.3		Vomiting		discontinuation			5490
34270	0.6		Nausea		discontinuation			5490
34271	0.6		Oedema		discontinuation			5490
34272	0.7		Muscle spasms		discontinuation			5490
34273	1.6		Muscle related signs and symptoms NEC		discontinuation			5490
34274	0.3		Headache		discontinuation			5490
34275	0.1		Paralysis		discontinuation			5490
34276	1.4		Hot flush		discontinuation			5490
34277	1.6		Peripheral vascular disorder		discontinuation			5490
34278						No SAEs were observed		5493
34279						No AEs are reported		5494
34280	3 pts		Chest discomfort		discontinuation	leads to discontinuation		5496
34281	3 pts		Palpitation		discontinuation	leads to discontinuation		5496
34282	1 pts		Pulmonary edema		discontinuation	leads to discontinuation		5496
34283	3 pts		Pulmonary edema		discontinuation	leads to discontinuation		5498
34284	3 pts		Shortness of breath		discontinuation	leads to discontinuation		5498
34285	3 pts		Tachycardia		discontinuation	leads to discontinuation		5498
34286	3 pts		Fetal tachycardia		discontinuation	leads to discontinuation		5498
34287						No AEs are reported		5495
34288			Absolute neutrophil count decreased		discontinuation	leads to discontinuation		5497
34289	1 pts		Eye pain	below serious				5499
34290	2 pts		Fatigue	below serious				5499
34291	1 pts		Hyperaesthesia	below serious				5499
34292	2 pts		Paraesthesia	below serious				5499
34293	2 pts		Somnolence	below serious				5499
34294			Transient ischemic attack		discontinuation	leads to discontinuation		5503
34295			Jaundice			liver toxicity		5504
34296	1 pts		Vomiting					5500
34297	2 pts		Dizziness					5502
34298	1 pts		Bradycardia					5500
34299	1 pts		Syncope					5501
34300	1 pts		Incontinence					5501
34301	2 pts		Nausea and vomiting					5507
34302	14		Procedural pain					5506
34303	6		Vomiting					5506
34304	5		Procedural hypotension					5506
34305	17		Procedural pain					5508
34306	8		Vomiting					5508
34307	5		Procedural hypotension					5508
34308	5		Nausea					5508
34309	18		Procedural pain					5509
34310	12		Vomiting					5509
34311	4		Procedural hypotension					5509
34312	4		Nausea					5509
34313	14		Procedural pain					5505
34314	3		Vomiting					5505
34315	12		Procedural pain					5510
34316	3		Hypercapnia					5510
34317	3		Nausea					5510
34318						No AEs are reported		5514
34319						No AEs are reported		5511
34320	2		Nausea		discontinuation	leads to discontinuation		5513
34321	2		Dizziness		discontinuation	leads to discontinuation		5513
34322			Nausea					5512
34323			Dizziness					5512
34324			Claustrophobia					5512
34325			Chorea					5512
34326			Palpitations					5512
34327			Asthenia					5512
34328			Nightmares					5512
34329			Hyperhidrosis					5512
34330			Visual hallucinations					5512
34331	1 pts		Fatigue	below serious				5521
34332	1 pts		Fatigue	below serious				5519
34333	7 pts		Nasopharyngitis	below serious				5519
34334	1 pts		Fatigue	below serious				5520
34335	7 pts		Nasopharyngitis	below serious				5520
34336	3 pts		Tonsillitis	below serious				5520
34337	4 pts		Chronic obstructive pulmonary disease exacerbation	serious				5516
34338	1 pts		Flatulence	below serious				5516
34339	2 pts		Nausea	below serious				5516
34340	1 pts		Myalgia	below serious				5516
34341	1 pts		Vertigo positional	below serious				5516
34342	1 pts		Atrial fibrillation	below serious				5516
34343	1 pts		Cold	below serious				5516
34344	1 pts		Atrial flutter	below serious				5516
34345	2 pts		Hyperpyrexia	serious				5517
34346	1 pts		Neuroleptic malignant syndrome	serious				5517
34347	1 pts		Hemorrhage (NOS)	serious				5517
34348	1 pts		Thrombosis venous arm	serious				5517
34349	1 pts		Gastrointestinal bleeding	serious				5517
34350	1 pts		Necrosis bowel	serious				5517
34351	1 pts		Obstruction small intestine	serious				5517
34352	1 pts		Proctitis	serious				5517
34353	1 pts		Aspartate aminotransferase increased	serious				5517
34354	1 pts		AST increased	serious				5517
34355	1 pts		Rhabdomyolysis	serious				5517
34356	1 pts		Agitation	serious				5517
34357	1 pts		Delirium	serious				5517
34358	1 pts		Intracerebral hemorrhage	serious				5517
34359	2 pts		Stroke	serious				5517
34360	1 pts		Pneumothorax	serious				5517
34361	1 pts		Pleural effusion	serious				5517
34362	1 pts		Acute kidney failure	serious				5517
34363	2 pts		Low back pain	serious				5515
34364	1 pts		Depression	serious				5515
34365	1 pts		Stroke	serious				5518
34366	2 pts		Acute myocardial infarction	serious				5518
34367	1 pts		Creatine kinase increased	serious				5518
34368	2 pts		Type 2 diabetes mellitus	serious				5518
34369	1 pts		Heart failure	serious				5518
34370	1 pts		Hypertension	serious				5518
34371	4 pts		Creatine kinase increased	below serious				5518
34372	13 pts		Alanine aminotransferase increase	below serious				5518
34373	5 pts		Gastrointestinal disturbance	below serious				5518
34374	13 pts		Hypertension	below serious				5518
34375	0.3		Cardiovascular disorder	grade 5	discontinuation			5524
34376	1.6		Myocardial infarction		discontinuation			5524
34377	0.4		Stroke		discontinuation			5524
34378	2.3		Unstable angina		discontinuation			5524
34379	2.3		Angina unstable		discontinuation			5524
34380	6.1		Coronary revascularization		discontinuation			5524
34381	7.5		Cardiovascular disorder		discontinuation			5524
34382	0.4		Aspartate aminotransferase increased		discontinuation			5524
34383	0.7		Alanine aminotransferase increased		discontinuation			5524
34384	0.3		Creatine kinase increased	grade 3	discontinuation	Creatine kinase increased (>5× ULN)		5524
34385	0.1		Creatine kinase increased	grade 4	discontinuation	Creatine kinase increased (>10× ULN)		5524
34386	3.8		Proteinuria		discontinuation			5524
34387	3.3		Creatinine increased		discontinuation			5524
34388						No adverse effects leading to discontinuation were reported		5523
34389	12.5		Rhabdomyolysis	grade 5	discontinuation		TRUE	5522
34390	1 pts		Anxiety	below serious				5528
34391	19 pts		Headache	below serious				5525
34392	9 pts		Attention concentration difficulty	below serious				5525
34393	10 pts		Diaphoresis	below serious				5525
34394	15 pts		Diarrhea	below serious				5526
34395	12 pts		Dizziness	below serious				5526
34396	12 pts		Dry mouth	below serious				5526
34397	3 pts		Fatigue	below serious				5526
34398	8 pts		Lightheadedness	below serious				5526
34399	3 pts		Sweating	below serious				5526
34400	13 pts		Diarrhea	below serious				5529
34401	9 pts		Somnolence	below serious				5529
34402	3 pts		Tremor	below serious				5529
34403	6 pts		Headache	below serious				5529
34404	3 pts		Rash	below serious				5529
34405	3 pts		Erectile dysfunction	below serious				5529
34406	1 pts		Suicidal ideation	serious				5530
34407	1 pts		Panic attack	serious				5530
34408	1 pts		Pregnancy	serious				5530
34409	1 pts		Hospitalization	serious				5530
34410	34 pts		Diarrhea	below serious				5530
34411	12 pts		Dizziness	below serious				5530
34412	13 pts		Fatigue	below serious				5530
34413	33 pts		Dry mouth	below serious				5530
34414	30 pts		Insomnia	below serious				5530
34415	57 pts		Nausea	below serious				5530
34416	13 pts		Palpitations	below serious				5530
34417	1 pts		Irritability	below serious				5531
34418	1 pts		Falling	below serious				5531
34419	1 pts		Nervousness	below serious				5531
34420	1 pts		Bruxism	below serious				5531
34421	5 pts		Rash	below serious				5531
34422	1 pts		Dehydration	serious				5532
34423	12 pts		Hyperactivity	below serious				5532
34424	10 pts		Sleep disturbance	below serious				5532
34425	6 pts		Fever	below serious				5532
34426	7 pts		Vomiting	below serious				5532
34427	7 pts		Gastroenteritis	below serious				5532
34428	5 pts		Otitis media	below serious				5532
34429	2 pts		Tic	below serious				5532
34430	3 pts		Decreased appetite	below serious				5532
34431	2 pts		Encopresis	below serious				5532
34432	2 pts		Teeth grinding	below serious				5532
34433	1 pts		Burning feet syndrome	below serious				5532
34434	1 pts		Chickenpox	below serious				5532
34435	1 pts		Flu	below serious				5532
34436	1 pts		Gas	below serious				5532
34437	1 pts		Inappropriate laughter	below serious				5532
34438	1 pts		Attention impaired	below serious				5532
34439	1 pts		Increased bowel frequency	below serious				5532
34440	1 pts		Tooth pain	below serious				5532
34441	5 pts		Anxiety	below serious				5527
34442	4 pts		Anger	below serious				5527
34443	5 pts		Depression	below serious				5527
34444	7 pts		Diarrhea	below serious				5527
34445	6 pts		Insomnia	below serious				5527
34446	6 pts		Nausea	below serious				5527
34447	2 pts		Attention concentration difficulty	below serious				5527
34448	8 pts		Headache	below serious				5527
34449	2 pts		Irritability	below serious				5527
34450	3 pts		Muscle spasm	below serious				5527
34451	6 pts		Sexual dysfunction	below serious				5527
34452	10		Self mutilation		discontinuation			5534
34453	10		Restlessness		discontinuation			5534
34454	1.1		Panic attack	grade 3	discontinuation			5533
34455	1.1		Emotional lability	grade 3	discontinuation			5533
34456	1.1		Seizure		discontinuation			5533
34457	1.9		Nausea		discontinuation			5535
34458	1.3		Headache		discontinuation			5535
34459	2 pts		Anemia	serious				5542
34460	13 pts		Sickle cell anemia with crisis	serious				5542
34461	1 pts		Bronchitis	serious				5542
34462	1 pts		Lower respiratory tract infection	serious				5542
34463	1 pts		Hypotension	serious				5542
34464	1 pts		Atrial fibrillation	serious				5542
34465	1 pts		Congestive cardiac failure	serious				5542
34466	1 pts		Vitreous hemorrhage	serious				5542
34467	1 pts		Pyrexia	serious				5542
34468	1 pts		Traumatic brain injury	serious				5542
34469	1 pts		Suicide attempt	serious				5542
34470	1 pts		Acute pulmonary edema	serious				5542
34471	18 pts		Sickle cell anaemia with crisis	below serious				5542
34472	13 pts		Headache	below serious				5542
34473	5 pts		Eye disorders	below serious				5542
34474	5 pts		Blurred vision	below serious				5542
34475	6 pts		General disorders and administration site conditions	below serious				5542
34476	1 pts		Atrioventricular block second degree	serious				5540
34477	1 pts		Bradycardia	serious				5540
34478	9 pts		Cardiac failure	serious				5540
34479	1 pts		Palpitations	serious				5540
34480	1 pts		Sinus bradycardia	serious				5540
34481	1 pts		Supraventricular tachycardia	serious				5540
34482	1 pts		Ventricular tachycardia	serious				5540
34483	1 pts		Hypotension	serious				5540
34484	1 pts		Implant site infection	serious				5540
34485	4 pts		Pneumonia	serious				5540
34486	1 pts		Pyelonephritis	serious				5540
34487	5 pts		Cardiac failure	below serious				5540
34488	5 pts		Palpitations	below serious				5540
34489	1 pts		Sinus tachycardia	below serious				5540
34490	9 pts		Flushing	below serious				5540
34491	2 pts		Hot flush	below serious				5540
34492	1 pts		Hypotension	below serious				5540
34493	8 pts		Hypotension	below serious				5540
34494	8 pts		Hypotension	below serious				5540
34495	1 pts		Peripheral coldness	below serious				5540
34496	2 pts		Peripheral ischaemia	below serious				5540
34497	1 pts		Thrombosis	below serious				5540
34498	1 pts		Varicose vein	below serious				5540
34499	1 pts		Balance disorder	below serious				5540
34500	1 pts		Dysgeusia	below serious				5540
34501	27 pts		Headache	below serious				5540
34502	1 pts		Memory impairment	below serious				5540
34503	1 pts		Parosmia	below serious				5540
34504	2 pts		Presyncope	below serious				5540
34505	1 pts		Tremor	below serious				5540
34506	7 pts		Visual impairment	below serious				5540
34507	1 pts		Chest pain	below serious				5536
34508	1 pts		Pyrexia	below serious				5536
34509	1 pts		Urinary tract infection	below serious				5536
34510	1 pts		Alanine aminotransferase increased	below serious				5536
34511	1 pts		Aspartate aminotransferase increased	below serious				5536
34512	1 pts		Blood bilirubin increased	below serious				5536
34513	1 pts		Blood creatinine increased	below serious				5536
34514	1 pts		Blood glucose increased	below serious				5536
34515	1 pts		Blood urea increased	below serious				5536
34516	1 pts		Blood uric acid increased	below serious				5536
34517	1 pts		Syncope	below serious				5536
34518	1 pts		DIOS	serious				5538
34519	1 pts		Respiratory tract disorders NEC	serious				5538
34520	2 pts		Pain throat	below serious				5538
34521	5 pts		Head pain	below serious				5538
34522	2 pts		Myalgia	below serious				5538
34523	2 pts		Chest pain	below serious				5538
34524	2 pts		Cough	below serious				5538
34525	1 pts		ALT increased	below serious				5538
34526	1 pts		Aspartate aminotransferase increased	below serious				5538
34527	1 pts		Rash	below serious				5538
34528	1 pts		Fatigue	below serious				5538
34529	1 pts		Respiratory tract disorders NEC	below serious				5538
34530	1 pts		Sputum increased	below serious				5538
34531	12 pts		Headaches	below serious				5537
34532	5 pts		Dizziness	below serious				5537
34533	3 pts		Back ache	below serious				5537
34534	3 pts		Lightheadedness	below serious				5537
34535	2 pts		Edema	below serious				5537
34536	1 pts		Cardiac failure	serious				5541
34537	1 pts		Pseudoaneurysm	serious				5541
34538	1 pts		Medical device complication	serious				5541
34539	4 pts		Headache	below serious				5541
34540	9 pts		Respiratory tract infection	below serious				5541
34541	2 pts		Chest pain	below serious				5541
34542	2 pts		Respiratory tract disorders NEC	serious				5539
34543	6 pts		Sinus congestion	below serious				5539
34544	2 pts		Flushing	below serious				5539
34545	1 pts		Epistaxis	below serious				5539
34546	2 pts		Musculoskeletal pain	below serious				5539
34547	2 pts		Fever	below serious				5539
34548	2 pts		Stomach discomfort	below serious				5539
34549	1 pts		Diarrhea	below serious				5539
34550	1 pts		Dysuria	below serious				5539
34551	1 pts		Tooth pain	below serious				5539
34552	1 pts		Conjunctivitis	below serious				5539
34553	2 pts		Sputum increased	below serious				5539
34554	1 pts		Hemoptysis	below serious				5539
34555	1 pts		Wheeze	below serious				5539
34556	1 pts		Fatigue	below serious				5539
34557	1 pts		Chest pain	below serious				5539
34558	1 pts		Shingles	below serious				5539
34559	1 pts		Parasthesia	below serious				5539
34560						9 patients discontinued because of perceived sildenafil-related AEs (chest tightness, neck stiffness, myalgia, headache, visual fi eld con-striction, dyspnea, abdominal pain, diarrhea, nausea, vomiting, dizziness, worsening hypotension, and drug hypersensitivity). No segregation by dose and no indication of frequency.		5543
34561			Rhabdomyolysis		discontinuation			5547
34562			Visual disturbance NOS		discontinuation	visual perception changes		5547
34563			Vomiting	severe	discontinuation			5544
34564			Blurred vision		discontinuation			5544
34565			Sinus tachycardia		discontinuation			5544
34566			Defective color vision		discontinuation			5546
34567			Retinal vascular occlusion		discontinuation			5546
34568			Visual field defect		discontinuation			5546
34569			Papilledema		discontinuation			5546
34570			Scotoma annular		discontinuation			5546
34571			Flushing		discontinuation			5545
34572			Headache		discontinuation			5545
34573			Tachycardia	mild	discontinuation			5545
34574			Cardiomegaly	grade 5	discontinuation	Cardiomegaly with dilated cardiomyopathy		5549
34575			Dilated cardiomyopathy	grade 5	discontinuation	Cardiomegaly with dilated cardiomyopathy		5549
34576			Coronary atherosclerosis	grade 5	discontinuation			5549
34577			Fibrosis myocardial	grade 5	discontinuation			5549
34578			Acute kidney injury		discontinuation			5548
34579	0.32		Nausea		discontinuation			5550
34580	0.32		Vomiting		discontinuation			5550
34581	0.32		Leg pain		discontinuation			5550
34582	0.32		Backache		discontinuation			5550
34583	0.32		Intermittent headache		discontinuation			5550
34584	0.32		Dyspepsia		discontinuation			5550
34585	0.32		Headache		discontinuation			5550
34586	0.61		Headache		discontinuation			5551
34587	0.61		Flushing		discontinuation			5551
34588	0.9		Headache		discontinuation			5552
34589	0.44		Flushing		discontinuation	intermittent flushing		5552
34590	0.44		Blurred vision		discontinuation			5552
34591	1.3		Groin pain		discontinuation			5552
34592	3.8		Cough					5553
34593	5.3		Dizziness					5553
34594	6		Fatigue					5553
34595	9		Headache					5553
34596	3		Oedema					5553
34597						No information on AEs is available		5555
34598	1 pts		Thrombocytopenia		discontinuation	leads to discontinuation		5557
34599	1 pts		Fever		discontinuation	leads to discontinuation		5557
34600	1 pts		Fatigue		discontinuation	leads to discontinuation		5557
34601	1 pts		Nausea		discontinuation	leads to discontinuation		5557
34602	1 pts		Vomiting		discontinuation	leads to discontinuation		5557
34603	1 pts		Fever		discontinuation	leads to discontinuation		5556
34604	4 pts		Anemia		discontinuation	leads to discontinuation		5558
34605	2 pts		Liver failure		discontinuation	leads to discontinuation		5558
34606	3 pts		Metabolic disorder		discontinuation	leads to discontinuation		5558
34607						No information on AEs is available		5554
34608	0.8		Nausea	grade 3				5567
34609	0.8		Vomiting	grade 3				5567
34610	1.3		Nausea	grade 3				5566
34611	1.3		Vomiting	grade 3				5566
34612			Nausea	grade 1-4				5563
34613			Vomiting	grade 1-4				5563
34614			Dizziness	grade 1-4				5563
34615			Unsteadiness	grade 1-4				5563
34616			Malaise	grade 1-4				5563
34617						Information about AEs not found		5561
34618	33.3		Grand mal seizure				TRUE	5569
34619	33.3		Mental status changes	grade 3				5564
34620	16.7		Thrombocytopenia	grade 4			TRUE	5568
34621	16.7		QT interval prolonged					5568
34622	16.7		Thrombosis venous deep					5568
34623	25		Thrombosis venous deep	grade 3				5572
34624						Information about AEs not found		5560
34625	22.2		Neutropenia	grade 4	discontinuation		TRUE	5565
34626	22.2		Thrombocytopenia	grade 4	discontinuation		TRUE	5565
34627	11.1		Nausea		discontinuation			5565
34628	11.1		Vomiting		discontinuation			5565
34629	11.1		Anorexia		discontinuation			5565
34630	11.1		Serum creatinine increased					5565
34631	11.1		Septicemia		discontinuation			5565
34632	10		Neutropenia	grade 4				5562
34633	10		Thrombocytopenia	grade 2				5562
34634			Hemoglobin decreased					5562
34635			Serum creatinine increased					5562
34636			QT interval prolonged			OVERDOSAGE		5570
34637			Uterine neoplasms malignant NEC			WARNING		5559
34638			Stroke			WARNING		5559
34639			Pulmonary embolism			WARNING		5559
34640			Tremor			OVERDOSAGE		5571
34641			Hyperreflexia			OVERDOSAGE		5571
34642			Unsteady gait			OVERDOSAGE		5571
34643			Dizziness			OVERDOSAGE		5571
34644	1 pts		Arrhythmia	below serious				5573
34645	1 pts		Glaucoma	below serious				5573
34646	1 pts		Diarrhoea	below serious				5573
34647	2 pts		Gastritis	below serious				5573
34648	1 pts		Periodontitis	below serious				5573
34649	2 pts		Chest pain	below serious				5573
34650	1 pts		Malaise	below serious				5573
34651	1 pts		Hepatitis A	below serious				5573
34652	1 pts		Influenza	below serious				5573
34653	1 pts		Tinea infection	below serious				5573
34654	1 pts		Tinea pedis	below serious				5573
34655	2 pts		Upper respiratory tract infection	below serious				5573
34656	1 pts		Excoriation	below serious				5573
34657	1 pts		Head injury	below serious				5573
34658	2 pts		Muscle injury	below serious				5573
34659	1 pts		Liver function test abnormal	below serious				5573
34660	1 pts		Platelet count decreased	below serious				5573
34661	1 pts		Arthralgia	below serious				5573
34662	1 pts		Arthritis	below serious				5573
34663	1 pts		Coccydynia	below serious				5573
34664	1 pts		Pain in extremity	below serious				5573
34665	1 pts		Spinal column stenosis	below serious				5573
34666	2 pts		Dizziness	below serious				5573
34667	1 pts		Haematuria	below serious				5573
34668	1 pts		Pyuria	below serious				5573
34669	1 pts		Postnasal drip	below serious				5573
34670	1 pts		Erythema	below serious				5573
34671	1 pts		Arteriosclerosis	below serious				5573
34672	1 pts		Hot flush	below serious				5573
34673	1 pts		Orthostatic hypotension	below serious				5573
34674	1 pts		Upper gastrointestinal hemorrhage	serious				5574
34675	1 pts		Death NOS	serious				5574
34676	1 pts		Nausea	serious				5574
34677	1 pts		Gastrointestinal disorders	serious				5574
34678	1 pts		Blurred vision	below serious				5574
34679	6 pts		Dizziness	below serious				5574
34680	1 pts		Nasal congestion	below serious				5574
34681	1 pts		Other specified disorders of nervous system	below serious				5574
34682	1 pts		Drug eruption		discontinuation	leads to discontinuation		5575
34683	1.6		Abnormal ejaculation		discontinuation	leads to discontinuation		5576
34684			Allergic reaction		discontinuation			5577
34685			Vaginitis		discontinuation			5577
34686			Depression			WARNING		5579
34687			Suicidal tendency			WARNING		5579
34688			Acute dystonia					5578
34689			Crisis oculogyric					5578
34690			Nausea and vomiting					5578
34691			Sweating					5578
34692			Sedation					5578
34693			Hypotension					5578
34694			Confusion					5578
34695			Diarrhea					5578
34696			Hallucinations					5578
34697			Redness					5578
34698			Tremor					5578
34699			Grimacing		discontinuation			5581
34700			Rigidity of limbs		discontinuation	rigid flexure posturing of upper extremities		5581
34701			Stupor		discontinuation			5581
34702			Confusion		discontinuation			5581
34703			Generalized tonic-clonic seizure		discontinuation			5582
34704			Drowsiness		discontinuation			5580
34705			Coma	grade 3	discontinuation			5580
34706	1.1		Confusion		discontinuation			5583
34707	1.6		Somnolence		discontinuation			5583
34708	1.1		Asthenia		discontinuation			5583
34709	1.7		Dizziness		discontinuation			5583
34710	1.3		Depression		discontinuation			5583
34711	12.5		Diarrhea		discontinuation	6.3% patients discontinuing clinical trials due to event		5584
34712	7		Nausea		discontinuation	2.6% patients discontinuing clinical trials due to event		5584
34713	7		Dyspepsia		discontinuation	1.1% patients discontinuing clinical trials due to event		5584
34714	5.1		Rash		discontinuation	3.4% patients discontinuing clinical trials due to event		5584
34715	3.7		GI pain		discontinuation	1.9% patients discontinuing clinical trials due to event		5584
34716	2.4		Neutropenia		discontinuation	1.3% patients discontinuing clinical trials due to event		5584
34717	2.2		Purpura		discontinuation	0.2% patients discontinuing clinical trials due to event		5584
34718	1.9		Vomiting		discontinuation	1.4% patients discontinuing clinical trials due to event		5584
34719	1.5		Flatulence		discontinuation	0.1% patients discontinuing clinical trials due to event		5584
34720	1.3		Pruritus		discontinuation	0.8% patients discontinuing clinical trials due to event		5584
34721	1.1		Dizziness		discontinuation	0.4% patients discontinuing clinical trials due to event		5584
34722	1		Anorexia		discontinuation	0.4% patients discontinuing clinical trials due to event		5584
34723	4 pts		Leukopenia					5586
34724	14 pts		Neutropenia					5586
34725	13 pts		Aspartate aminotransferase increased					5586
34726	36 pts		ALT increased					5586
34727	54 pts		Gamma GT increased					5586
34728	2 pts		ALP increased					5586
34729	1 pts		Cerebral hemorrhage					5586
34730	1 pts		Gastric ulcer hemorrhage					5586
34731	1 pts		Melena					5586
34732	2 pts		Epistaxis					5586
34733	1 pts		Rash					5586
34734	1 pts		Agranulocytosis		discontinuation	case report		5585
34735	1 pts		AST increased		discontinuation	case report		5585
34736	1 pts		ALT increased		discontinuation	case report		5585
34737	1 pts		Gamma GT increased		discontinuation	case report		5585
34738	1 pts		ALP increased		discontinuation	case report		5585
34739						No information on AE is provided		5587
34740						No adverse reactions leading to discontinuation were reported		5588
34741	1		Gastrointestinal disorder NOS	grade 1	discontinuation			5589
34742	2.1		Gastrointestinal disorder NOS	moderate	discontinuation			5589
34743	1		Gastrointestinal disorder NOS	severe	discontinuation			5589
34744	1		Transaminases increased	grade 1	discontinuation			5589
34745	1.6		Transaminases increased	moderate	discontinuation			5589
34746	4.8		Transaminases increased	severe	discontinuation			5589
34747			Hepatitis		discontinuation	WARNING. Including some fatalities		5590
34748			Hepatic decompensation		discontinuation	WARNING. Including some fatalities		5590
34749			Intracranial hemorrhage		discontinuation	WARNING. Fatal and non-fatal		5590
34750			Platelet aggregation		discontinuation	WARNING		5590
34751			Coagulation abnormal		discontinuation	WARNING		5590
34752	0.5		Rash		discontinuation	WARNING		5591
34753			Diabetes mellitus		discontinuation	WARNING		5590
34754			Hyperglycemia		discontinuation	WARNING		5590
34755			Immune reconstitution syndrome		discontinuation	WARNING		5590
34756			Fat redistribution		discontinuation	WARNING		5590
34757			Lipids increased		discontinuation	WARNING		5590
34758	13.6		Bleeding	grade 1-2	discontinuation			5592
34759	5.9		Drowsiness		discontinuation			5594
34760	3.9		Fatigue		discontinuation			5594
34761	3.9		Muscular weakness		discontinuation			5594
34762	3.9		Affective disorder		discontinuation			5594
34763	2		Bradycardia		discontinuation	patient 1		5594
34764	2		Ventricular extrasystoles		discontinuation	patient 1		5594
34765	2		Anxiety		discontinuation			5594
34766	2		Sleep disturbance		discontinuation			5594
34767	2		Syncope		discontinuation			5594
34768			Hypotension		discontinuation	WARNING		5593
34769			Liver injury		discontinuation	WARNING		5593
34770			Sedation		discontinuation	WARNING		5593
34771			Hallucinations		discontinuation	WARNING		5593
34772			Renal impairment		discontinuation	WARNING		5593
34773	8 pts		Ataxia		discontinuation	leads to discontinuation		5596
34774	8 pts		Tremor		discontinuation	leads to discontinuation		5596
34775	8 pts		Dizzy		discontinuation	leads to discontinuation		5596
34776	4 pts		Rash		discontinuation	leads to discontinuation		5596
34777	1 pts		Diarrhea		discontinuation	leads to discontinuation		5596
34778	1 pts		Nausea		discontinuation	leads to discontinuation		5596
34779	1 pts		Vomiting		discontinuation	leads to discontinuation		5596
34780	1 pts		Anorexia		discontinuation	leads to discontinuation		5596
34781	1 pts		Congestive heart failure		discontinuation	leads to discontinuation		5596
34782	3 pts		Hypotension		discontinuation	leads to discontinuation		5595
34783	1 pts		Nausea					5595
34784	1 pts		Vomiting					5595
34785	1 pts		Junctional rhythm					5595
34786	75		Nausea					5599
34787	50		Vomiting					5599
34788	25		Headache					5599
34789	25		Dizziness postural					5599
34790	25		Vertigo					5599
34791	12.5		Dizziness					5599
34792	37.5		Pruritus					5599
34793	25		Decreased appetite					5599
34794	12.5		Hot flush					5599
34795	14.5		Seizure			Generalized tonic-clonic seizures. In 80.8% of cases, the seizures occurred less than 24 hours after tramadol ingestion.		5598
34796	53.5		Nausea and vomiting					5598
34797	4.8		Tachycardia					5598
34798	38.4		Hypertension	mild				5598
34799	5.3		Arrhythmia					5598
34800	19		Headache					5597
34801	25.1		Nausea					5597
34802	16.1		Somnolence					5597
34803	13.6		Dizziness					5597
34804	21.3		Constipation					5597
34805	9.3		Vomiting					5597
34806	5		Arthralgia					5597
34807	13.1		Dry mouth					5597
34808	6.7		Sweating					5597
34809	8.6		Asthenia					5597
34810	7.3		Pruritus					5597
34811	5.7		Anorexia					5597
34812	5		Insomnia					5597
34813	1 pts		Cerebral edema	grade 5	discontinuation	leads to discontinuation		5603
34814	1 pts		Seizures	grade 5	discontinuation	leads to discontinuation		5603
34815	1 pts		Hyponatremia	grade 5	discontinuation	leads to discontinuation		5603
34816	1 pts		Arrhythmia		discontinuation	leads to discontinuation		5600
34817	1 pts		Consciousness disturbed		discontinuation	leads to discontinuation		5600
34818	1 pts		Drowsiness		discontinuation	leads to discontinuation		5601
34819	1 pts		Hypertension		discontinuation	leads to discontinuation		5601
34820	1 pts		Vomiting		discontinuation	leads to discontinuation		5601
34821	1 pts		Dry mouth		discontinuation	leads to discontinuation		5602
34822	1 pts		Upset stomach		discontinuation	leads to discontinuation		5602
34823	1 pts		Mental function decreased		discontinuation	leads to discontinuation		5602
34824	1 pts		Drowsiness		discontinuation	leads to discontinuation		5602
34825			Insomnia		discontinuation			5604
34826	1 pts		Anaemia	serious				5605
34827	1 pts		Gastrooesophageal reflux disease	serious				5605
34828	1 pts		Gastroenteritis	serious				5605
34829	11 pts		Dry mouth	below serious				5605
34830	9 pts		Constipation	below serious				5605
34831	2 pts		Nausea	below serious				5607
34832	5 pts		Headache	below serious				5607
34833	1 pts		Lethargy	below serious				5607
34834	1 pts		Tinnitus	below serious				5607
34835	1 pts		Diarrhoea	below serious				5607
34836	1 pts		Application site pruritus	below serious				5607
34837	1 pts		Arthralgia	below serious				5607
34838	4 pts		Back pain	below serious				5607
34839	1 pts		Musculoskeletal stiffness	below serious				5607
34840	1 pts		Dizziness	below serious				5607
34841	1 pts		Respiratory tract congestion	below serious				5607
34842	1 pts		Distress respiratory	serious				5606
34843	1 pts		Clot blood	serious				5606
34844	4 pts		Constipation	below serious				5606
34845	4 pts		Dry mouth	below serious				5606
34846	1 pts		Depression	below serious				5606
34847	1 pts		UTI	below serious				5606
34848	1 pts		Dizziness	below serious				5606
34849	1 pts		Skin rash	below serious				5606
34850						vital signs were unchanged but subjects found the experience to be “quite unpleasant”		5608
34851			Face angioedema		discontinuation	WARNING		5610
34852			Lip angioedema		discontinuation	WARNING		5610
34853			Oedema tongue		discontinuation	WARNING		5610
34854			Angioedema of larynx		discontinuation	WARNING		5610
34855			Somnolence		discontinuation	WARNING		5610
34856	1.9		Dry mouth		discontinuation			5609
34857	1 pts		Kidney infection	serious				5613
34858	2 pts		Nausea	below serious				5614
34859	8		Asthenia					5611
34860	4		Vasodilatation					5611
34861	4		Hypertension					5611
34862	31		Nausea					5611
34863	8		Constipation					5611
34864	8		Anorexia					5611
34865	4		Vomiting					5611
34866	4		Flatulence					5611
34867	3		Weight loss					5611
34868	20		Dizziness					5611
34869	17		Somnolence					5611
34870	17		Insomnia					5611
34871	12		Dry mouth					5611
34872	10		Nervousness					5611
34873	7		Abnormal dreams					5611
34874	5		Tremor					5611
34875	3		Depression					5611
34876	3		Paresthesia					5611
34877	3		Libido decreased					5611
34878	3		Agitation					5611
34879	7		Pharyngitis					5611
34880	3		Yawn					5611
34881	14		Sweating					5611
34882	4		Abnormal vision					5611
34883	16		Abnormal ejaculation					5611
34884	4		Impotence					5611
34885	3		Inhibited female orgasm					5611
34886	34		Headache					5612
34887	17		Asthenia					5612
34888	6		Flu syndrome					5612
34889	5		Accidental injury					5612
34890	4		Abdominal pain					5612
34891	5		Hypertension					5612
34892	3		Vasodilatation					5612
34893	3		Palpitation					5612
34894	29		Nausea					5612
34895	20		Anorexia					5612
34896	8		Constipation					5612
34897	6		Diarrhea					5612
34898	3		Vomiting					5612
34899	2		Eructation					5612
34900	4		Weight loss					5612
34901	23		Insomnia					5612
34902	17		Dry mouth					5612
34903	16		Dizziness					5612
34904	16		Somnolence					5612
34905	11		Nervousness					5612
34906	9		Libido decreased					5612
34907	5		Anxiety					5612
34908	4		Agitation					5612
34909	4		Tremor					5612
34910	4		Abnormal dreams					5612
34911	3		Paresthesia					5612
34912	2		Twitching					5612
34913	5		Yawn					5612
34914	2		Sinusitis					5612
34915	13		Sweating					5612
34916	6		Abnormal vision					5612
34917	16		Abnormal ejaculation					5612
34918	10		Impotence					5612
34919	8		Orgasmic disorders and disturbances					5612
34920	10 pts		Death	grade 5	discontinuation	leads to discontinuation		5617
34921	6 pts		Psychiatric symptom					5619
34922	6 pts		Gastrointestinal disorder (NOS)					5619
34923	5 pts		Nervous system disorder NOS					5619
34924	1 pts		Death	grade 5	discontinuation	leads to discontinuation		5620
34925	100		Somnolence		discontinuation	leads to discontinuation		5618
34926	1 pts		Coma		discontinuation	leads to discontinuation		5618
34927	0.5		Drowsiness		discontinuation	leads to discontinuation		5616
34928	0.4		Dizziness		discontinuation	leads to discontinuation		5616
34929	0.5		Headache		discontinuation	leads to discontinuation		5616
34930	0.6		Nausea		discontinuation	leads to discontinuation		5616
34931	0.5		Vomiting		discontinuation	leads to discontinuation		5616
34932	1.1		Drowsiness		discontinuation	leads to discontinuation		5615
34933	0.8		Vertigo		discontinuation	leads to discontinuation		5615
34934	0.5		Amnesia		discontinuation	leads to discontinuation		5615
34935	0.5		Nausea		discontinuation	leads to discontinuation		5615
34936	0.4		Headache		discontinuation	leads to discontinuation		5615
34937	0.4		Fall		discontinuation	leads to discontinuation		5615
34938	12.9		Allergic reaction		discontinuation	leads to discontinuation		5621
34939	103 pts		Arrhythmia					5622
34940	29 pts		Arrhythmia					5623
34941	21		Angina		discontinuation	leads to discontinuation		5622
34942	4		Arrhythmia		discontinuation	leads to discontinuation		5622
34943	4		Hypotension		discontinuation	leads to discontinuation		5622
34944	4		Dyspnea		discontinuation	leads to discontinuation		5622
34945	2		Arrhythmia		discontinuation	leads to discontinuation		5623
34946	9		Hypotension		discontinuation	leads to discontinuation		5623
34947	5 pts		Gastrointestinal signs and symptoms					5624
34948	4 pts		Dizziness					5624
34949	2 pts		Constipation					5624
34950	5 pts		Nervousness					5624
34951	1 pts		Pruritus					5624
34952	3 pts		Dry mouth					5624
34953	1 pts		Chest pain					5624
34954	1 pts		Headache					5624
34955	1 pts		Malaise					5624
34956	1 pts		Fatigue					5624
34957	1 pts		Appetite disorder					5624
34958	1 pts		Cardiac arrest	serious				5626
34959	2 pts		Respiratory failure	serious				5626
34960	1 pts		Tracheostomy	serious				5626
34961	1 pts		Hypotension	serious				5626
34962	1 pts		Thrombocytopenia	below serious				5626
34963	1 pts		Hyperbilirubinaemia	below serious				5626
34964	1 pts		Chronic gastrointestinal bleeding	below serious				5626
34965	1 pts		Diarrhoea	below serious				5626
34966	1 pts		Hepatic lesion	below serious				5626
34967	1 pts		Vancomycin-resistant enterococcal infection	below serious				5626
34968	1 pts		Bilirubin elevated	below serious				5626
34969	1 pts		Clostridium difficile toxin test positive	below serious				5626
34970	1 pts		Late diastolic murmur	below serious				5626
34971	1 pts		Hypophosphataemia	below serious				5626
34972	1 pts		Lactic acidosis	below serious				5626
34973	1 pts		Bronchoconstriction	below serious				5626
34974	1 pts		Pneumonia	below serious				5626
34975	2 pts		Pneumonia due to pseudomonas	below serious				5626
34976	1 pts		Skin tear	below serious				5626
34977	1 pts		Abdominal aortic aneurysm	below serious				5626
34978	1 pts		Acute hypotension	below serious				5626
34979	1 pts		Hypotension		discontinuation	leads to discontinuation		5628
34980	1 pts		Rash		discontinuation	leads to discontinuation		5628
34981	1 pts		Toxic epidermal necrolysis	severe	discontinuation	leads to discontinuation		5629
34982	1 pts		Kounis syndrome	grade 5				5630
34983						No AEs are reported		5625
34984						No AEs are reported		5627
34985						No AEs reported		5631
34986						No AEs reported		5632
34987	1 pts		Coagulopathy	serious				5637
34988	2 pts		Cardiac failure congestive	serious				5637
34989	1 pts		Multi-organ failure	serious				5637
34990	1 pts		Hyponatraemia	serious				5637
34991	1 pts		Transient ischaemic attack	serious				5637
34992	1 pts		Renal failure	serious				5637
34993	1 pts		Respiratory distress	serious				5637
34994	1 pts		Hypocoagulable state	below serious				5637
34995	1 pts		Leukocytosis	below serious				5637
34996	1 pts		Arrhythmia ventricular	below serious				5637
34997	1 pts		Abdominal discomfort	below serious				5637
34998	2 pts		Abdominal distension	below serious				5637
34999	1 pts		Abnormal bowel sounds	below serious				5637
35000	2 pts		Constipation	below serious				5637
35001	2 pts		Nausea	below serious				5637
35002	1 pts		Fatigue	below serious				5637
35003	1 pts		Hypothermia	below serious				5637
35004	2 pts		Pain	below serious				5637
35005	1 pts		Procedural pain	below serious				5637
35006	1 pts		Breath sounds abnormal	below serious				5637
35007	1 pts		Chest X-ray abnormal	below serious				5637
35008	1 pts		Hypoalbuminaemia	below serious				5637
35009	2 pts		Hypomagnesaemia	below serious				5637
35010	1 pts		Hypophosphataemia	below serious				5637
35011	1 pts		Hypovolaemia	below serious				5637
35012	1 pts		Muscle spasms	below serious				5637
35013	1 pts		Headache	below serious				5637
35014	1 pts		Lethargy	below serious				5637
35015	1 pts		Anxiety	below serious				5637
35016	1 pts		Dysuria	below serious				5637
35017	1 pts		Cough	below serious				5637
35018	1 pts		Postnasal drip	below serious				5637
35019	1 pts		Rales	below serious				5637
35020	1 pts		Pruritus	below serious				5637
35021	3 pts		Hypotension	below serious				5637
35022	1 pts		Cardiac failure congestive	serious				5638
35023	1 pts		Pneumonia	serious				5638
35024	1 pts		Respiratory acidosis	serious				5638
35025	1 pts		Coronary artery bypass	serious				5638
35026	1 pts		Hypotension	serious				5638
35027	1 pts		Dry eye	below serious				5638
35028	2 pts		Constipation	below serious				5638
35029	1 pts		Nausea	below serious				5638
35030	2 pts		Vomiting	below serious				5638
35031	1 pts		Chest pain	below serious				5638
35032	1 pts		Fatigue	below serious				5638
35033	1 pts		Oedema peripheral	below serious				5638
35034	1 pts		Bronchitis chronic	below serious				5638
35035	1 pts		Contusion	below serious				5638
35036	1 pts		Blood pressure decreased	below serious				5638
35037	1 pts		Cardiac murmur	below serious				5638
35038	1 pts		Carotid bruit	below serious				5638
35039	1 pts		Heart sounds abnormal	below serious				5638
35040	1 pts		Dehydration	below serious				5638
35041	1 pts		Hypernatraemia	below serious				5638
35042	1 pts		Hypokalaemia	below serious				5638
35043	1 pts		Neck pain	below serious				5638
35044	1 pts		Headache	below serious				5638
35045	2 pts		Insomnia	below serious				5638
35046	1 pts		Psychotic disorder	below serious				5638
35047	1 pts		Haematuria	below serious				5638
35048	1 pts		Pruritus	below serious				5638
35049	1 pts		Haematoma	below serious				5638
35050	1 pts		Thrombophlebitis	below serious				5638
35051	1 pts		Dizziness	below serious				5636
35052	1 pts		Atrial tachycardia	serious				5639
35053	1 pts		Urinary tract infection	serious				5639
35054	1 pts		Encephalopathy hepatic	serious				5639
35055	1 pts		Atrial flutter	below serious				5639
35056	1 pts		Nausea	below serious				5639
35057	1 pts		Vomiting	below serious				5639
35058	1 pts		Polydipsia	below serious				5639
35059	1 pts		Back pain	below serious				5639
35060	1 pts		Productive cough	below serious				5639
35061	1 pts		Dry skin	below serious				5639
35062	2 pts		Phlebitis	below serious				5639
35063	1 pts		Cardiac arrest	serious				5640
35064	1 pts		Atrial flutter	below serious				5640
35065	1 pts		Ventricular tachycardia	below serious				5640
35066	1 pts		Constipation	below serious				5640
35067	3 pts		Infusion site erythema	below serious				5640
35068	1 pts		Infusion site pain	below serious				5640
35069	1 pts		Pyrexia	below serious				5640
35070	1 pts		Heart rate increased	below serious				5640
35071	1 pts		Muscle spasms	below serious				5640
35072	1 pts		Pain in extremity	below serious				5640
35073	1 pts		Headache	below serious				5640
35074						The incidence and types of AEs associated with 40 and 80 mg/d conivaptan were similar to those observed with placebo		5635
35075			Hypotension					5633
35076			Thirst					5633
35077	0.2		Hypopituitarism		discontinuation	leads to discontinuation		5634
35078	0.2		Infusion site reaction		discontinuation	leads to discontinuation		5634
35079	1.6		Infusion site phlebitis		discontinuation	leads to discontinuation		5634
35080	0.2		Infusion related reaction		discontinuation	leads to discontinuation		5634
35081	0.2		Sepsis NOS		discontinuation	leads to discontinuation		5634
35082	0.2		Pneumonia NOS		discontinuation	leads to discontinuation		5634
35083	0.2		Blood creatinine increased		discontinuation	leads to discontinuation		5634
35084	0.2		Blood sodium increased		discontinuation	leads to discontinuation		5634
35085	0.2		Blood urea increased		discontinuation	leads to discontinuation		5634
35086	0.2		Heart rate increased		discontinuation	leads to discontinuation		5634
35087	0.8		Hypernatremia		discontinuation	leads to discontinuation		5634
35088	0.2		Epilepsy NOS		discontinuation	leads to discontinuation		5634
35089	0.2		Agitation		discontinuation	leads to discontinuation		5634
35090	0.2		Renal failure acute		discontinuation	leads to discontinuation		5634
35091	0.2		Respiratory arrest		discontinuation	leads to discontinuation		5634
35092	0.2		Respiratory failure		discontinuation	leads to discontinuation		5634
35093	0.2		Cyanosis peripheral		discontinuation	leads to discontinuation		5634
35094	0.2		Phlebitis NOS		discontinuation	leads to discontinuation		5634
35095	0.2		Phlebitis superficial		discontinuation	leads to discontinuation		5634
35096	3 pts		Hemorrhage	serious				5643
35097	1 pts		Ataxia	serious				5643
35098	3 pts		Dyspnea	serious				5643
35099	1 pts		Colitis	serious				5643
35100	1 pts		Diarrhea	serious				5643
35101	1 pts		Graft versus host disease	serious				5643
35102	1 pts		Rash	serious				5643
35103	1 pts		Seizure	serious				5643
35104	1 pts		Cellulitis	serious				5643
35105	1 pts		Hypoxia	serious				5643
35106	5 pts		Infection	serious				5643
35107	12 pts		Nausea	below serious				5643
35108	1 pts		Abdominal pain	below serious				5643
35109	1 pts		Ascites	below serious				5643
35110	2 pts		Headache	below serious				5643
35111	10 pts		Bilirubin increased	below serious				5643
35112						No adverse reactions leading to discontinuation were reported		5641
35113			Hepatic decompensation		discontinuation	WARNING. In patients with chronic hepatitis C, PROMACTA in combination with interferon and ribavirin may increase the risk of hepatic decompensation		5642
35114			Hepatotoxicity		discontinuation	WARNING		5642
35115			Portal vein thrombosis		discontinuation	WARNING		5642
35116	5 pts		Abdominal pain	below serious				5645
35117	2 pts		Appetite disorder	below serious				5645
35118	2 pts		Constipation	below serious				5645
35119	1 pts		Function liver abnormal	below serious				5645
35120	9 pts		Nausea and vomiting	below serious				5645
35121	6 pts		Anxiety	below serious				5645
35122	11 pts		Dizziness	below serious				5645
35123	10 pts		Drowsiness	below serious				5645
35124	8 pts		Headache	below serious				5645
35125	5 pts		Insomnia	below serious				5645
35126	1 pts		Chest pain	below serious				5645
35127	3 pts		Libido decreased	below serious				5645
35128	1 pts		Enlarged thyroid	below serious				5645
35129	1 pts		Weight gain	below serious				5645
35130	5 pts		Back pain	below serious				5645
35131	1 pts		Cough	below serious				5645
35132	1 pts		Infection	below serious				5645
35133	3 pts		Fatigue	below serious				5652
35134	2 pts		Headache	below serious				5652
35135	1 pts		Nausea	below serious				5652
35136	1 pts		Insomnia	below serious				5652
35137	1 pts		Breast tenderness	below serious				5652
35138	1 pts		Dizziness	below serious				5652
35139	2 pts		Nausea and vomiting	serious				5649
35140	1 pts		Pneumonia	serious				5649
35141	2 pts		Hyponatremia	serious				5649
35142	4 pts		Dehydration	serious				5649
35143	2 pts		Atrial fibrillation	serious				5649
35144	2 pts		Pain	serious				5649
35145	1 pts		Leg fracture	serious				5649
35146	1 pts		GI bleed	serious				5649
35147	2 pts		Mental status changes	serious				5649
35148	6 pts		Diarrhea	below serious				5649
35149	16 pts		Nausea and vomiting	below serious				5649
35150	5 pts		Upper respiratory infection	below serious				5649
35151	1 pts		Death	serious				5650
35152	19 pts		Fatigue	below serious				5650
35153	1 pts		Burning sensation	below serious				5650
35154	18 pts		Constipation	below serious				5650
35155	3 pts		Cramps in legs	below serious				5650
35156	10 pts		Sexual dysfunction	below serious				5650
35157	1 pts		Sinusitis	below serious				5650
35158	1 pts		Exacerbation of asthma	serious				5651
35159	1 pts		Nausea	below serious				5647
35160	14 pts		Drowsiness	below serious				5648
35161	11 pts		Nausea and vomiting	below serious				5648
35162	6 pts		Appetite disorder	below serious				5648
35163	1 pts		Diarrhea	serious				5646
35164	1 pts		Upper respiratory infection	serious				5646
35165	1 pts		Diarrhea	below serious				5646
35166	8 pts		Dry mouth					5644
35167	21 pts		Sexual desire decreased					5644
35168	12 pts		Clonus		discontinuation	leads to discontinuation		5653
35169	2 pts		Clonus		discontinuation	leads to discontinuation		5653
35170	21 pts		Hyperreflexia		discontinuation	leads to discontinuation		5653
35171	3 pts		Myoclonus		discontinuation	leads to discontinuation		5653
35172	2 pts		Eyelid myoclonus		discontinuation	leads to discontinuation		5653
35173	7 pts		Hunter's syndrome		discontinuation	leads to discontinuation		5653
35174	3 pts		Clonus		discontinuation	leads to discontinuation		5654
35175	9 pts		Hyperreflexia		discontinuation	leads to discontinuation		5654
35176	2 pts		Eyelid myoclonus		discontinuation	leads to discontinuation		5654
35177	1 pts		Hunter's syndrome		discontinuation	leads to discontinuation		5654
35178	1 pts		Coma	grade 3-4	discontinuation	leads to discontinuation		5655
35179	2 pts		Dizziness	grade 1-2	discontinuation	leads to discontinuation		5655
35180	2 pts		Restlessness	grade 1-2	discontinuation	leads to discontinuation		5655
35181	4 pts		Agitation	grade 3-4	discontinuation	leads to discontinuation		5655
35182	1 pts		Convulsion	grade 3-4	discontinuation	leads to discontinuation		5655
35183	8 pts		Tremor	grade 1-2	discontinuation	leads to discontinuation		5655
35184	3 pts		Mydriasis	grade 1-2	discontinuation	leads to discontinuation		5655
35185	7 pts		Tachycardia	grade 1-2	discontinuation	leads to discontinuation		5655
35186	4 pts		Change in ECG	grade 1-2	discontinuation	leads to discontinuation		5655
35187	1 pts		Change in ECG	grade 3-4	discontinuation	leads to discontinuation		5655
35188	4 pts		Nausea	grade 1-2	discontinuation	leads to discontinuation		5655
35189	8 pts		Vomiting	grade 1-2	discontinuation	leads to discontinuation		5655
35190	1 pts		Vomiting	grade 3-4	discontinuation	leads to discontinuation		5655
35191	1 pts		Intestinal atony	grade 3-4	discontinuation	leads to discontinuation		5655
35192	1 pts		Urinary retention	grade 3-4	discontinuation	leads to discontinuation		5655
35193	25 pts		Somnolence	grade 1-2	discontinuation	leads to discontinuation		5655
35194	10.7		Coronary heart disease		discontinuation	leads to discontinuation		5656
35195	29 pts		Decreased appetite	below serious				5657
35196	7 pts		Insomnia	below serious				5657
35197	3 pts		Weight decreased	below serious				5657
35198	6 pts		Irritability	below serious				5657
35199	4 pts		Fatigue	below serious				5657
35200	2 pts		Nasopharyngitis	below serious				5657
35201	1 pts		Nausea	below serious				5658
35202	4 pts		Headache	below serious				5659
35203	1 pts		Nausea	below serious				5659
35204	2 pts		Vomiting	below serious				5659
35205	2 pts		Headache	below serious				5660
35206	2 pts		Nausea	below serious				5660
35207	6 pts		Diarrhea	below serious				5661
35208	25 pts		Dry mouth	below serious				5661
35209	6 pts		Fatigue	below serious				5661
35210	10 pts		Feeling jittery	below serious				5661
35211	8 pts		Irritability	below serious				5661
35212	5 pts		Upper respiratory tract infection	below serious				5661
35213	4 pts		Heart rate increased	below serious				5661
35214	8 pts		Weight decreased	below serious				5661
35215	4 pts		Anorexia	below serious				5661
35216	26 pts		Decreased appetite	below serious				5661
35217	20 pts		Headache	below serious				5661
35218	8 pts		Initial insomnia	below serious				5661
35219	10 pts		Insomnia	below serious				5661
35220	4 pts		Libido decreased	below serious				5661
35221	5 pts		Hyperhidrosis	below serious				5661
35222	8 pts		Decreased appetite	below serious				5667
35223	7 pts		Dry mouth	below serious				5667
35224	10 pts		Insomnia	below serious				5667
35225	3 pts		Irritability	below serious				5667
35226	2 pts		Diaphoresis	below serious				5667
35227	2 pts		Libido decreased	below serious				5667
35228	2 pts		Tinnitus	below serious				5667
35229	4 pts		Muscle tension	below serious				5667
35230	3 pts		Tachycardia	below serious				5667
35231	2 pts		Paresthesia	below serious				5667
35232			Delirium	acute	discontinuation			5662
35233			Tachycardia		discontinuation			5662
35234			Hypertension		discontinuation			5662
35235			Tachypnea		discontinuation			5662
35236			Creatine kinase increased	mild	discontinuation			5662
35237			Abuse		discontinuation	WARNING		5666
35238			Dependence		discontinuation	WARNING		5666
35239			Cardiovascular disorder (NOS)	grade 3-5	discontinuation	WARNING		5666
35240			Stroke	serious	discontinuation	WARNING		5666
35241			Myocardial infarction	serious	discontinuation	WARNING		5666
35242			Blood pressure increased		discontinuation	WARNING		5666
35243			Heart rate increased		discontinuation	WARNING		5666
35244			Psychiatric symptom NOS		discontinuation	WARNING		5666
35245			Psychotic symptom		discontinuation	WARNING		5666
35246			Manic symptom		discontinuation	WARNING		5666
35247			Growth suppression		discontinuation	WARNING		5666
35248			Vascular disorders		discontinuation	WARNING		5666
35249			Raynaud's phenomenon		discontinuation	WARNING		5666
35250			Serotonin syndrome		discontinuation	WARNING		5666
35251	1		Ventricular hypertrophy		discontinuation			5663
35252	1		Tic		discontinuation			5663
35253	1		Vomiting		discontinuation			5663
35254	1		Psychomotor hyperactivity		discontinuation			5663
35255	1		Insomnia		discontinuation			5663
35256	1		Rash		discontinuation			5663
35257	1.3		Irritability		discontinuation			5664
35258	0.86		Decreased appetite		discontinuation			5664
35259	0.86		Insomnia		discontinuation			5664
35260	2		Insomnia		discontinuation			5665
35261	1		Tachycardia		discontinuation			5665
35262	1		Irritability		discontinuation			5665
35263	1		Hypertension		discontinuation			5665
35264	1		Headache		discontinuation			5665
35265	1		Anxiety		discontinuation			5665
35266	1		Dyspnea		discontinuation			5665
35267	4		Airways obstruction					5669
35268	4		Transient nocturnal oxygen desaturation					5669
35269			Seizures		discontinuation	WARNING		5668
35270			Hepatic dysfunction NOS	severe	discontinuation	WARNING		5668
35271			Instability cardiovascular	severe	discontinuation	WARNING		5668
35272						No SAEs were observed		5670
35273			Intoxication		discontinuation			5671
35274			Orthostatic hypotension		discontinuation			5671
35275			Drowsiness		discontinuation			5671
35276			Dizziness		discontinuation			5671
35277			Hallucinations		discontinuation			5672
35278	1 pts		Aortic dissection	serious				5673
35279	1 pts		Vomiting	serious				5673
35280	1 pts		Hepatic function abnormal	serious				5673
35281	14 pts		Nasopharyngitis	below serious				5673
35282	3 pts		Cystitis	below serious				5673
35283	9 pts		Decreased appetite	below serious				5673
35284	7 pts		Insomnia	below serious				5673
35285	22 pts		Somnolence	below serious				5673
35286	5 pts		Dizziness	below serious				5673
35287	5 pts		Headache	below serious				5673
35288	20 pts		Nausea	below serious				5673
35289	13 pts		Constipation	below serious				5673
35290	11 pts		Vomiting	below serious				5673
35291	6 pts		Diarrhoea	below serious				5673
35292	4 pts		Pruritus	below serious				5673
35293	3 pts		Dermatitis contact	below serious				5673
35294	4 pts		Arthralgia	below serious				5673
35295	6 pts		Thirst	below serious				5673
35296	6 pts		Drug withdrawal syndrome	below serious				5673
35297	5 pts		Malaise	below serious				5673
35298	4 pts		Contusion	below serious				5673
35299	3 pts		Thermal burn	below serious				5673
35300	1 pts		Dry mouth	below serious				5673
35301	1 pts		Haemorrhoids	below serious				5673
35302	1 pts		Toothache	below serious				5673
35303	2 pts		Feeling abnormal	below serious				5673
35304	2 pts		Pyrexia	below serious				5673
35305	1 pts		Face oedema	below serious				5673
35306	1 pts		Feeling cold	below serious				5673
35307	2 pts		Pharyngitis	below serious				5673
35308	1 pts		Oral herpes	below serious				5673
35309	2 pts		Blood urea increased	below serious				5673
35310	2 pts		Blood lactate dehydrogenase increased	below serious				5673
35311	2 pts		White blood cell count increased	below serious				5673
35312	1 pts		Blood creatinine increased	below serious				5673
35313	1 pts		Eosinophil count increased	below serious				5673
35314	1 pts		Neutrophil count increased	below serious				5673
35315	1 pts		Electrocardiogram T wave abnormal	below serious				5673
35316	1 pts		Platelet count increased	below serious				5673
35317	1 pts		Protein urine present	below serious				5673
35318	1 pts		Blood alkaline phosphatase increased	below serious				5673
35319	1 pts		Muscular weakness	below serious				5673
35320	1 pts		Osteoarthritis	below serious				5673
35321	1 pts		Periarthritis	below serious				5673
35322	1 pts		Osteoarthritis spinal	below serious				5673
35323	1 pts		Tenosynovitis	below serious				5673
35324	1 pts		Musculoskeletal stiffness	below serious				5673
35325	1 pts		Foot deformity	below serious				5673
35326	2 pts		Hypoaesthesia	below serious				5673
35327	1 pts		Sciatica	below serious				5673
35328	1 pts		Tremor	below serious				5673
35329	1 pts		Abnormal dreams	below serious				5673
35330	1 pts		Anxiety	below serious				5673
35331	1 pts		Hallucination	below serious				5673
35332	1 pts		Oliguria	below serious				5673
35333	1 pts		Disorder renal	below serious				5673
35334	2 pts		Hyperhidrosis	below serious				5673
35335	2 pts		Urticaria	below serious				5673
35336	1 pts		Cold sweat	below serious				5673
35337	1 pts		Heat rash	below serious				5673
35338	1 pts		Contrast media allergy	below serious				5673
35339	1 pts		Visual impairment	below serious				5673
35340	1 pts		Vertigo	below serious				5673
35341	1 pts		Palpitations	below serious				5673
35342	2 pts		Hypertension	below serious				5673
35343	1 pts		Vascular insufficiency	below serious				5673
35344	1 pts		Bronchitis chronic	below serious				5673
35345	1 pts		Yawning	below serious				5673
35346	1 pts		Oropharyngeal discomfort	below serious				5673
35347	1 pts		Oropharyngeal pain	below serious				5673
35348	1 pts		Benign prostatic hyperplasia	below serious				5673
35349	1 pts		Delirium	serious				5674
35350	1 pts		Angina pectoris	serious				5674
35351	1 pts		Vomiting	serious				5674
35352	1 pts		Drug withdrawal syndrome	serious				5674
35353	3 pts		Gastroenteritis	below serious				5674
35354	1 pts		Herpes simplex	below serious				5674
35355	1 pts		Otitis media	below serious				5674
35356	1 pts		Upper respiratory tract infection	below serious				5674
35357	1 pts		Anaemia iron deficiency	below serious				5674
35358	9 pts		Decreased appetite	below serious				5674
35359	2 pts		Hypoglycaemia	below serious				5674
35360	1 pts		Hyperglycaemia	below serious				5674
35361	1 pts		Hyperlipidaemia	below serious				5674
35362	5 pts		Insomnia	below serious				5674
35363	1 pts		Anxiety	below serious				5674
35364	1 pts		Depression	below serious				5674
35365	1 pts		Listless	below serious				5674
35366	17 pts		Somnolence	below serious				5674
35367	5 pts		Dizziness	below serious				5674
35368	4 pts		Headache	below serious				5674
35369	1 pts		Autonomic nervous system imbalance	below serious				5674
35370	1 pts		Dizziness postural	below serious				5674
35371	1 pts		Radial nerve palsy	below serious				5674
35372	1 pts		Diabetic retinopathy	below serious				5674
35373	1 pts		Motion sickness	below serious				5674
35374	2 pts		Hypertension	below serious				5674
35375	1 pts		Hypotension	below serious				5674
35376	1 pts		Hot flush	below serious				5674
35377	2 pts		Oropharyngeal pain	below serious				5674
35378	1 pts		Dyspnoea	below serious				5674
35379	1 pts		Hypoventilation	below serious				5674
35380	1 pts		Allergic rhinitis	below serious				5674
35381	19 pts		Nausea	below serious				5674
35382	16 pts		Constipation	below serious				5674
35383	11 pts		Vomiting	below serious				5674
35384	4 pts		Diarrhoea	below serious				5674
35385	4 pts		Abdominal discomfort	below serious				5674
35386	1 pts		Dry mouth	below serious				5674
35387	1 pts		Gastritis	below serious				5674
35388	1 pts		Periodontitis	below serious				5674
35389	1 pts		Stomatitis	below serious				5674
35390	2 pts		Xeroderma	below serious				5674
35391	2 pts		Eczema	below serious				5674
35392	2 pts		Erythema	below serious				5674
35393	2 pts		Pruritus	below serious				5674
35394	2 pts		Rash	below serious				5674
35395	1 pts		Dermatitis	below serious				5674
35396	1 pts		Hyperhidrosis	below serious				5674
35397	1 pts		Ingrowing nail	below serious				5674
35398	1 pts		Prurigo	below serious				5674
35399	1 pts		Generalised pruritus	below serious				5674
35400	1 pts		Pain in extremity	below serious				5674
35401	1 pts		Osteoarthritis spinal	below serious				5674
35402	1 pts		Facet joint syndrome	below serious				5674
35403	1 pts		Dysuria	below serious				5674
35404	5 pts		Drug withdrawal syndrome	below serious				5674
35405	5 pts		Thirst	below serious				5674
35406	3 pts		Malaise	below serious				5674
35407	2 pts		Pyrexia	below serious				5674
35408	1 pts		Chest pain	below serious				5674
35409	1 pts		Feeling abnormal	below serious				5674
35410	1 pts		Feeling hot	below serious				5674
35411	1 pts		Irritability	below serious				5674
35412	1 pts		Oedema	below serious				5674
35413	3 pts		Blood urine present	below serious				5674
35414	2 pts		Liver function test abnormal	below serious				5674
35415	2 pts		Blood creatine phosphokinase increased	below serious				5674
35416	2 pts		Protein urine present	below serious				5674
35417	1 pts		Electrocardiogram ST segment depression	below serious				5674
35418	1 pts		Gamma-glutamyltransferase increased	below serious				5674
35419	1 pts		Neutrophil count increased	below serious				5674
35420	1 pts		White blood cell count increased	below serious				5674
35421	1 pts		Lymphocyte percentage decreased	below serious				5674
35422	1 pts		Blood alkaline phosphatase increased	below serious				5674
35423	1 pts		Fall	below serious				5674
35424	1 pts		Wound	below serious				5674
35425	5 pts		Nausea	below serious				5675
35426	3 pts		Vomiting	below serious				5675
35427	5 pts		Dizziness	below serious				5675
35428	2 pts		Light-headed	below serious				5675
35429	3.4		Nausea		discontinuation			5677
35430	1.6		Constipation		discontinuation			5677
35431	3		Dizziness		discontinuation			5677
35432	2.6		Vomiting		discontinuation			5677
35433	1.8		Fatigue		discontinuation			5677
35434	3.4		Somnolence		discontinuation			5677
35435	0.6		Pruritus		discontinuation			5677
35436			Respiratory depression		discontinuation	WARNING		5678
35437			CNS disorder (NOS)		discontinuation	WARNING. Additive CNS depressive effects when used in conjunction with alcohol, other opioids, or illicit drugs.		5678
35438			Intracranial pressure increased		discontinuation	WARNING		5678
35439			Abuse NOS		discontinuation	WARNING		5678
35440			Mental function decreased		discontinuation	WARNING		5678
35441			Physical impairment		discontinuation	WARNING		5678
35442			Seizures		discontinuation	WARNING		5678
35443			Serotonin syndrome	grade 4	discontinuation	WARNING		5678
35444			Dizziness		discontinuation			5676
35445			Nausea		discontinuation			5676
35446			Vomiting		discontinuation			5676
35447			Somnolence		discontinuation			5676
35448			Headache		discontinuation			5676
35449	9		Loose stools			AUGMENTIN (amoxicillin/clavulanate potassium)		5679
35450	3		Nausea			AUGMENTIN (amoxicillin/clavulanate potassium)		5679
35451	3		Rash urticarial			AUGMENTIN (amoxicillin/clavulanate potassium)		5679
35452	1		Vomiting			AUGMENTIN (amoxicillin/clavulanate potassium)		5679
35453	1		Vaginitis			AUGMENTIN (amoxicillin/clavulanate potassium)		5679
35454			Diarrhea			AUGMENTIN (amoxicillin/clavulanate potassium)		5680
35455			Rash urticarial			AUGMENTIN (amoxicillin/clavulanate potassium)		5680
35456			Diaper rash			AUGMENTIN (amoxicillin/clavulanate potassium)		5680
35457	1 pts		Muscle weakness		discontinuation	leads to discontinuation		5683
35458	1 pts		Fatigue		discontinuation	leads to discontinuation		5683
35459	1 pts		Chest pain		discontinuation	leads to discontinuation		5683
35460	1 pts		Muscle weakness		discontinuation	leads to discontinuation		5682
35461	1 pts		Nausea		discontinuation	leads to discontinuation		5682
35462	1 pts		Abdominal pain		discontinuation	leads to discontinuation		5682
35463						No AEs are reported		5681
35464	4 pts		Macular rash		discontinuation	leads to discontinuation		5684
35465	4 pts		Pruritic rash		discontinuation	leads to discontinuation		5684
35466			Corneal toxicity			Prolonged use or abuse may lead to corneal epithelial toxicity and manifest as epithelial defects which may progress to permanent corneal damage.		5685
35467			Injury corneal			Patients should not touch the eye for approximately 20 minutes after using anesthetic as accidental injuries can occur due to insensitivity of the eye		5686
35468						impossible to link AEs with the definite dose		5687
35469	32		Hypotension					5688
35470	4		Heart block					5688
35471	5		Congestive heart failure					5688
35472	3		Proarrhythmia					5688
35473	6		Nausea					5688
35474	4		Confusion					5688
35475	3		Thrombocytopenia					5688
35476	1		Fever					5688
35477	5		Diarrhea					5688
35478						No AEs are reported		5692
35479						No AEs are reported		5691
35480						No AEs are reported		5690
35481						No AEs are reported		5689
35482						No AEs are reported		5693
35483						No AEs are reported		5694
35484	1 pts		Neutropenia		discontinuation	leads to discontinuation		5696
35485						No AEs are reported		5695
35486			Nephrotoxicity		discontinuation	leads to dose reduction		5697
35487			Fetal damage	grade 5	discontinuation	WARNING		5698
35488			Diarrhea, Clostridium difficile	grade 5	discontinuation	WARNING		5699
35489	1 pts		Dry mouth					5702
35490	1 pts		Headache					5702
35491	2 pts		Dry mouth					5700
35492						No AEs are reported		5701
35493						No information on AE is provided		5703
35494	2.4		Nausea		discontinuation			5706
35495	2.4		Lightheadedness		discontinuation			5706
35496			Arteriospasm	severe	discontinuation			5704
35497			Depression		discontinuation			5707
35498			Vertigo		discontinuation			5707
35499			Blurred vision		discontinuation			5707
35500			Arrhythmia		discontinuation			5707
35501			Hypersensitivity		discontinuation			5707
35502			Migraine aggravated		discontinuation			5707
35503			Urticaria		discontinuation			5707
35504			Dyspnoea		discontinuation			5707
35505			Fatigue		discontinuation			5707
35506			Tachycardia		discontinuation			5707
35507			Vagal reaction		discontinuation			5707
35508			Dizziness		discontinuation			5707
35509			Tinnitus		discontinuation			5707
35510			Nausea		discontinuation			5705
35511			Vomiting	severe	discontinuation			5705
35512			Dizziness		discontinuation			5705
35513			Blood pressure decreased		discontinuation	decreased blood pressure without perceptible pulse		5705
35514			Peripheral vasoconstriction		discontinuation			5705
35515			Paresthesia		discontinuation			5705
35516			Cyanosis peripheral		discontinuation			5705
35517			Cold feet		discontinuation			5705
35518			Angina		discontinuation			5705
35519						No adverse reactions leading to discontinuation were reported		5708
35520						No adverse reactions leading to discontinuation were reported		5709
35521	4 pts		Gastrointestinal disorders	severe	discontinuation	leads to discontinuation		5713
35522	3 pts		Gastrointestinal disorders	severe	discontinuation	leads to dose reduction		5713
35523	3 pts		Itching					5713
35524	3 pts		Dry skin					5713
35525	4.2		Application site burning					5710
35526	1.1		Headache					5710
35527			Hepatotoxicity	serious|grade 5		WARNING		5712
35528			QT interval prolonged			WARNING		5711
35529	58		Pain	grade 3				5714
35530	12.5		Pain	grade 3				5715
35531	33		Pain	grade 2				5714
35532	33		Pain	grade 2				5715
35533	8		Pain	grade 1				5714
35534	46		Pain	grade 1				5715
35535			Suspiciousness					5716
35536			Aggressive behavior					5716
35537			Abusive behavior					5716
35538			Cardiomyopathy		discontinuation			5717
35539						no adverse reactions were reported		5720
35540	1 pts		Ventricular arrhythmias and cardiac arrest	grade 4	discontinuation	leads to discontinuation		5718
35541	1 pts		Death	grade 5	discontinuation	leads to discontinuation		5719
35542			Dry mouth					5721
35543			Headache					5721
35544			Nausea					5721
35545	12.2		Neutropenia					5722
35546	2.4		Neutropenia		discontinuation			5722
35547			Hematuria			Hematuria/urinary tract abnormalities - 12.2%		5722
35548			Urinary tract toxicity			Hematuria/urinary tract abnormalities - 12.2%		5722
35549	12.2		Leukopenia					5722
35550			Fever			Fever/Rash - 29.3%		5722
35551			Rash			Fever/Rash - 29.3%		5722
35552	10.7		Eosinophilia		discontinuation			5723
35553	1 pts		Dizziness	below serious				5724
35554	1 pts		Chest tightness	below serious				5724
35555	1 pts		Dry mouth	below serious				5724
35556	1 pts		Urination abnormal NOS	below serious				5724
35557	1 pts		Itching	below serious				5724
35558	1 pts		Nausea	below serious				5724
35559	1 pts		Diarrhea	below serious				5724
35560						No adverse reactions leading to discontinuation were reported		5725
35561						No adverse reactions leading to discontinuation were reported		5726
35562	1.7		Migraine		discontinuation			5729
35563	1.7		Gastrointestinal discomfort		discontinuation			5729
35564	2.6		Diarrhea		discontinuation			5727
35565	4		Tachycardia	severe	discontinuation			5728
35566	1 pts		Hypersensitivity	serious				5732
35567	1 pts		Suicidal ideation	serious				5732
35568	13 pts		Dizziness	below serious				5732
35569	10 pts		Headache	below serious				5732
35570	9 pts		Insomnia	below serious				5732
35571	7 pts		Hot flush	below serious				5732
35572	6 pts		Irritability	below serious				5732
35573	6 pts		Nasopharyngitis	below serious				5732
35574	5 pts		Anxiety	below serious				5732
35575	5 pts		Blood pressure increased	below serious				5732
35576	5 pts		Hyperhidrosis	below serious				5732
35577	1 pts		Herniated disc	serious				5731
35578	5 pts		Nausea	below serious				5731
35579	3 pts		Dry mouth	below serious				5731
35580	3 pts		Tachycardia	below serious				5731
35581	2 pts		Insomnia	below serious				5731
35582	1 pts		Photophobia	below serious				5731
35583	2 pts		Depression	below serious				5731
35584	1 pts		Raw tongue	below serious				5731
35585	1 pts		Palpitations	below serious				5731
35586	5 pts		Nausea	below serious				5733
35587	1 pts		Abdominal pain	below serious				5733
35588	1 pts		Fatigue	below serious				5733
35589	3 pts		Dry mouth	below serious				5733
35590	1 pts		Urinary frequency	below serious				5733
35591	1 pts		Erectile dysfunction	below serious				5735
35592	1 pts		Stomach pain	below serious				5735
35593	1 pts		Suicidal ideation	serious				5736
35594	1 pts		Tachycardia	below serious				5736
35595	1 pts		Abdominal discomfort	below serious				5736
35596	1 pts		Chest pain (non-cardiac)	below serious				5736
35597	1 pts		Anorectal infection	below serious				5736
35598	1 pts		Upper respiratory tract infection	below serious				5736
35599	1 pts		Blood pressure diastolic increased	below serious				5736
35600	2 pts		Decreased appetite	below serious				5736
35601	1 pts		Anxiety	below serious				5736
35602	1 pts		Suicidal ideation	below serious				5736
35603	2 pts		Fatigue	below serious				5730
35604	1 pts		Weight loss	below serious				5730
35605	1 pts		Abdominal cramp	below serious				5730
35606	1 pts		Anal fissure	below serious				5730
35607	1 pts		Dizziness	below serious				5730
35608	1 pts		Gastroenteritis	below serious				5730
35609	1 pts		Gum pain	below serious				5730
35610	1 pts		Hemorrhoids	below serious				5730
35611	1 pts		Insomnia	below serious				5730
35612	1 pts		Nausea	below serious				5730
35613	1 pts		Sleep disturbance	below serious				5730
35614	1 pts		Somnolence	below serious				5730
35615	3 pts		Upper respiratory infection	below serious				5730
35616	3 pts		Nausea	below serious				5734
35617	3 pts		Fatigue	below serious				5734
35618	2 pts		Sleep disturbance	below serious				5734
35619	2 pts		Constipation	below serious				5734
35620	2 pts		Headache	below serious				5734
35621	1 pts		Tachycardia	below serious				5734
35622	1 pts		Urinary retention	below serious				5734
35623	2.4		Nausea		discontinuation			5737
35624	1.4		Blood pressure increased		discontinuation			5737
35625	1		Heart rate increased		discontinuation			5737
35626			Suicidal ideation		discontinuation	WARNING		5738
35627			Serotonin syndrome		discontinuation	WARNING		5738
35628			Neuroleptic malignant syndrome		discontinuation	WARNING		5738
35629			Blood pressure increased		discontinuation	WARNING		5738
35630			Heart rate increased		discontinuation	WARNING		5738
35631			Seizures		discontinuation	WARNING		5738
35632			Hepatotoxicity		discontinuation	WARNING		5738
35633			ALT increased	mild	discontinuation	WARNING		5738
35634			Aspartate aminotransferase increase	mild	discontinuation	WARNING		5738
35635	rare		Hepatitis fulminant		discontinuation	WARNING		5738
35636			Bleeding		discontinuation	WARNING		5738
35637	1.3		Suicidal ideation		discontinuation			5740
35638	6		Nausea		discontinuation	Frequency is provided for combined group 100 mg/day and 200 mg/day. In placebo-controlled trials in patients with fibromyalgia, 23% of patients treated with Savella 100 mg/day, 26% of patients treated with Savella 200 mg/day discontinued prematurely due to adverse reactions, compared to 12% of patients treated with placebo. Discontinuation due to adverse reactions was generally more common among patients treated with Savella 200 mg/day compared to Savella 100 mg/day.		5739
35639	3		Palpitations		discontinuation	Frequency is provided for combined group 100 mg/day and 200 mg/day. In placebo-controlled trials in patients with fibromyalgia, 23% of patients treated with Savella 100 mg/day, 26% of patients treated with Savella 200 mg/day discontinued prematurely due to adverse reactions, compared to 12% of patients treated with placebo. Discontinuation due to adverse reactions was generally more common among patients treated with Savella 200 mg/day compared to Savella 100 mg/day.		5739
35640	2		Headache		discontinuation	Frequency is provided for combined group 100 mg/day and 200 mg/day. In placebo-controlled trials in patients with fibromyalgia, 23% of patients treated with Savella 100 mg/day, 26% of patients treated with Savella 200 mg/day discontinued prematurely due to adverse reactions, compared to 12% of patients treated with placebo. Discontinuation due to adverse reactions was generally more common among patients treated with Savella 200 mg/day compared to Savella 100 mg/day.		5739
35641	1		Constipation		discontinuation	Frequency is provided for combined group 100 mg/day and 200 mg/day. In placebo-controlled trials in patients with fibromyalgia, 23% of patients treated with Savella 100 mg/day, 26% of patients treated with Savella 200 mg/day discontinued prematurely due to adverse reactions, compared to 12% of patients treated with placebo. Discontinuation due to adverse reactions was generally more common among patients treated with Savella 200 mg/day compared to Savella 100 mg/day.		5739
35642	1		Heart rate increased		discontinuation	Frequency is provided for combined group 100 mg/day and 200 mg/day. In placebo-controlled trials in patients with fibromyalgia, 23% of patients treated with Savella 100 mg/day, 26% of patients treated with Savella 200 mg/day discontinued prematurely due to adverse reactions, compared to 12% of patients treated with placebo. Discontinuation due to adverse reactions was generally more common among patients treated with Savella 200 mg/day compared to Savella 100 mg/day.		5739
35643	1		Hyperhidrosis		discontinuation	Frequency is provided for combined group 100 mg/day and 200 mg/day. In placebo-controlled trials in patients with fibromyalgia, 23% of patients treated with Savella 100 mg/day, 26% of patients treated with Savella 200 mg/day discontinued prematurely due to adverse reactions, compared to 12% of patients treated with placebo. Discontinuation due to adverse reactions was generally more common among patients treated with Savella 200 mg/day compared to Savella 100 mg/day.		5739
35644	1		Vomiting		discontinuation	Frequency is provided for combined group 100 mg/day and 200 mg/day. In placebo-controlled trials in patients with fibromyalgia, 23% of patients treated with Savella 100 mg/day, 26% of patients treated with Savella 200 mg/day discontinued prematurely due to adverse reactions, compared to 12% of patients treated with placebo. Discontinuation due to adverse reactions was generally more common among patients treated with Savella 200 mg/day compared to Savella 100 mg/day.		5739
35645	1		Dizziness		discontinuation	Frequency is provided for combined group 100 mg/day and 200 mg/day. In placebo-controlled trials in patients with fibromyalgia, 23% of patients treated with Savella 100 mg/day, 26% of patients treated with Savella 200 mg/day discontinued prematurely due to adverse reactions, compared to 12% of patients treated with placebo. Discontinuation due to adverse reactions was generally more common among patients treated with Savella 200 mg/day compared to Savella 100 mg/day.		5739
35646	17 pts		Electrocardiogram change		discontinuation	leads to discontinuation		5741
35647	11 pts		Congestive heart failure		discontinuation	leads to discontinuation		5741
35648	4 pts		Atrial fibrillation		discontinuation	leads to discontinuation		5741
35649	34 pts		Nausea		discontinuation	leads to discontinuation		5741
35650	3 pts		Gastrointestinal upset		discontinuation	leads to discontinuation		5741
35651	3 pts		Anxiety		discontinuation	leads to discontinuation		5741
35652	2 pts		Hypoesthesia		discontinuation	leads to discontinuation		5741
35653	2 pts		Tremor of hands		discontinuation	leads to discontinuation		5741
35654	2 pts		Dyspnea		discontinuation	leads to discontinuation		5741
35655	4 pts		Urinary retention		discontinuation	leads to discontinuation		5741
35656	5 pts		Laboratory test abnormality		discontinuation	leads to discontinuation		5741
35657	3 pts		Drug fever		discontinuation	leads to discontinuation		5741
35658	3 pts		Blurred vision		discontinuation	leads to discontinuation		5741
35659	1 pts		Cellulitis	serious				5744
35660	1 pts		Hypersensitivity	serious				5743
35661	1 pts		Toxicity to various agents	serious				5743
35662	1 pts		Haemorrhage vaginal	serious				5743
35663	1 pts		Acute myocardial infarction	serious				5743
35664	23 pts		Upper respiratory tract infection	below serious				5743
35665	5 pts		Fatigue	below serious				5742
35666			Disorder fetal		discontinuation	WARNING		5747
35667	0.4		Headache		discontinuation			5746
35668	0.2		Nausea		discontinuation			5746
35669	0.2		Bradycardia		discontinuation			5746
35670			Hyperhidrosis		discontinuation			5745
35671			Pallor		discontinuation			5745
35672			Depressed level of consciousness		discontinuation			5745
35673			Hypokinesia		discontinuation			5745
35674			Hypotension		discontinuation			5745
35675			Sinus bradycardia		discontinuation			5745
35676			Hypoglycemia		discontinuation			5745
35677			Hypokalemia		discontinuation			5745
35678			Respiratory failure		discontinuation			5745
35679			Vomiting		discontinuation			5745
35680	1 pts		Thrombocytopenic purpura		discontinuation	leads to discontinuation		5749
35681						impossible to link AEs with the definite dose		5748
35682	1 pts		Bone marrow granuloma		discontinuation	leads to discontinuation		5750
35683	4 pts		Burn	severe	discontinuation			5751
35684	3 pts		Dry mouth					5752
35685	1 pts		Rash					5753
35686	1 pts		Dyspepsia					5753
35687	2 pts		Constipation					5753
35688	1 pts		Sleepiness					5753
35689	1 pts		Irritability					5753
35690			Jaundice					5754
35691			Renal disorder NOS					5754
35692	1.14		Headache		discontinuation			5757
35693	1.17		Nausea		discontinuation			5758
35694	0.98		Abdominal pain		discontinuation			5758
35695	0.78		Diarrhea		discontinuation			5758
35696	0.39		Vomiting		discontinuation			5758
35697	1.8		Abdominal pain	grade 1-2	discontinuation	2 chloroquine-proguanil recipients discontinued the regimen during the posttravel period because of drug-related gastrointestinal events (mild-to-moderate nausea, abdominal pain, and diarrhea in one subject and severe nausea with mild abdominal pain in the other).		5759
35698	1.8		Nausea	grade 1-3	discontinuation	2 chloroquine-proguanil recipients discontinued the regimen during the posttravel period because of drug-related gastrointestinal events (mild-to-moderate nausea, abdominal pain, and diarrhea in one subject and severe nausea with mild abdominal pain in the other).		5759
35699			Epigastric discomfort					5755
35700			Vomiting					5755
35701			Hair loss					5756
35702			Skin scaly					5756
35703			Scales					5756
35704			Aphthous ulcer					5756
35705			Hematologic disorder					5756
35706			Sinus tachycardia		discontinuation			5763
35707			Increased muscle tone		discontinuation			5763
35708			Consciousness decreased		discontinuation			5763
35709			Agitation		discontinuation			5763
35710			Confusion		discontinuation			5763
35711			Disorientation		discontinuation			5763
35712			Visual hallucinations		discontinuation			5763
35713			Delirium		discontinuation			5763
35714						no serious adverse events occurred during the study; AEs did not lead to the discontinuation of the study		5760
35715						no serious adverse events occurred during the study; AEs did not lead to the discontinuation of the study		5762
35716						no serious adverse events occurred during the study; AEs did not lead to the discontinuation of the study		5761
35717			Respiratory depression	grade 5	discontinuation	WARNING		5765
35718			Respiratory depression	grade 5	discontinuation	WARNING		5764
35719			Irritation skin	severe	discontinuation	WARNING		5764
35720			Tissue damage	severe	discontinuation	WARNING		5764
35721			Burning sensation skin		discontinuation	WARNING		5764
35722			Pain		discontinuation	WARNING		5764
35723			Thrombophlebitis		discontinuation	WARNING		5764
35724			Necrosis injection site		discontinuation	WARNING		5764
35725			Gangrene		discontinuation	WARNING		5764
35726						no adverse effects observed		5766
35727	rare		Rhabdomyolysis	acute	discontinuation	WARNING. Rhabdomyolysis with hyperkalemia		5767
35728	rare		Ventricular arrhythmia		discontinuation	WARNING		5767
35729	rare		Cardiac arrest	grade 5	discontinuation	WARNING		5767
35730						No information on AE is provided		5768
35731	1 pts		Anuria	grade 5	discontinuation	leads to discontinuation		5769
35732	1 pts		Purpura	grade 5				5770
35733	1 pts		Agranulocytosis	grade 5				5771
35734	3 pts		Skin rash		discontinuation	leads to discontinuation		5772
35735	2 pts		Nausea		discontinuation	leads to dose reduction		5772
35736	1 pts		Headache					5772
35737	1 pts		Urinary hesitancy					5772
35738	1 pts		Lymphopenia	grade 1				5772
35739			Erythema facial		discontinuation			5775
35740			Erythema		discontinuation			5775
35741			Furunculosis		discontinuation			5775
35742			Nausea					5774
35743			Weakness					5774
35744			Malaise					5773
35745			Hemolytic anemia		discontinuation			5776
35746			Methemoglobinemia		discontinuation			5776
35747			Ventricular tachycardia					5779
35748			Convulsions					5777
35749						No AEs are reported		5778
35750			Gastrointestinal signs and symptoms					5784
35751			Gastrointestinal signs and symptoms					5780
35752	2 pts		Hematotoxicity	grade 3		led to redution dose to 75 mg/m2		5781
35753	12 pts		Hematotoxicity	grade 2	discontinuation	leads to discontinuation		5785
35754	1 pts		Hematotoxicity	grade 2	discontinuation	leads to discontinuation		5789
35755	2 pts		Hematotoxicity	grade 2	discontinuation	leads to discontinuation		5783
35756			Myelosuppression				TRUE	5787
35757			Myelosuppression				TRUE	5781
35758			Myelosuppression				TRUE	5788
35759			Myelosuppression				TRUE	5789
35760			Myelosuppression				TRUE	5782
35761			Myelosuppression				TRUE	5783
35762			Myelosuppression				TRUE	5786
35763			Death	grade 5	discontinuation	leads to discontinuation		5791
35764			Death	grade 5	discontinuation	leads to discontinuation		5790
35765	1 pts		Drowsiness		discontinuation			5794
35766	10 pts		Sedation					5792
35767	14 pts		Sedation					5793
35768						no AEs reported		5796
35769	31.2		Abdominal cramps	grade 1-2	discontinuation	Five of the 16 patients did not receive all 17 injections because of side effects. The side effects of ceruletide for any patient were never severe, consisting of mild to moderate abdominal cramps and vomiting.		5797
35770	31.2		Vomiting	grade 1-2	discontinuation	Five of the 16 patients did not receive all 17 injections because of side effects. The side effects of ceruletide for any patient were never severe, consisting of mild to moderate abdominal cramps and vomiting.		5798
35771	12.5		Sickness	grade 1				5795
35772	12.5		Dizziness	grade 1				5795
35773	6.25		Headache	grade 1		1 patient		5795
35774	50		Injection site pain	grade 1				5795
35775						No AEs are reported. A relation between serum drug concentration and adverse effects was not demonstrated.		5800
35776	1 pts		Nausea					5799
35777	1 pts		Numbness of lip					5799
35778	1 pts		Numbness of tongue					5799
35779						No adverse reactions were reported		5801
35780						No adverse reactions were reported		5802
35781						No AEs are reported		5804
35782						No AEs are reported		5803
35783	58		Anal irritation					5805
35784	58		Discharge					5805
35785	14		Sleepiness					5805
35786	15		Nausea					5805
35787	15		Vomiting					5805
35788	13		Stumbling					5805
35789			Yawning					5806
35790			Sensation of warmth					5806
35791			Nausea					5806
35792			Vomiting					5806
35793			Pallor					5806
35794			Dizziness					5806
35795			Respiratory arrest		discontinuation			5807
35796	2 pts		Febrile neutropenia	serious				5809
35797	2 pts		Neutropenia	serious				5809
35798	4 pts		Thrombocytopenia	serious				5809
35799	1 pts		Angina pectoris	serious				5809
35800	1 pts		Bradycardia	serious				5809
35801	1 pts		Cardiac failure	serious				5809
35802	1 pts		Cardiomyopathy	serious				5809
35803	1 pts		Coronary artery disease	serious				5809
35804	2 pts		Myocardial infarction	serious				5809
35805	1 pts		Myocardial ischaemia	serious				5809
35806	1 pts		Sinus bradycardia	serious				5809
35807	1 pts		Ventricular tachycardia	serious				5809
35808	1 pts		Vertigo	serious				5809
35809	1 pts		Vitreous detachment	serious				5809
35810	1 pts		Vitreous floaters	serious				5809
35811	2 pts		Vitreous haemorrhage	serious				5809
35812	1 pts		Abdominal pain lower	serious				5809
35813	3 pts		Diarrhoea	serious				5809
35814	1 pts		Duodenitis	serious				5809
35815	1 pts		Enterocele	serious				5809
35816	2 pts		Gastric ulcer perforation	serious				5809
35817	1 pts		Gastrointestinal haemorrhage	serious				5809
35818	2 pts		Ileus	serious				5809
35819	2 pts		Nausea	serious				5809
35820	1 pts		Pancreatitis acute	serious				5809
35821	1 pts		Rectal haemorrhage	serious				5809
35822	4 pts		Vomiting	serious				5809
35823	2 pts		Fatigue	serious				5809
35824	1 pts		Fibrosis	serious				5809
35825	4 pts		General physical health deterioration	serious				5809
35826	2 pts		Hernia	serious				5809
35827	9 pts		Pyrexia	serious				5809
35828	1 pts		Cholecystitis	serious				5809
35829	1 pts		Cholecystitis acute	serious				5809
35830	1 pts		Hepatocellular injury	serious				5809
35831	3 pts		Hepatotoxicity	serious				5809
35832	1 pts		Cytokine release syndrome	serious				5809
35833	1 pts		Drug hypersensitivity	serious				5809
35834	2 pts		Hypersensitivity	serious				5809
35835	1 pts		Gastroenteritis norovirus	serious				5809
35836	1 pts		Infectious pleural effusion	serious				5809
35837	1 pts		Pelvic abscess	serious				5809
35838	1 pts		Pharyngotonsillitis	serious				5809
35839	2 pts		Pneumonia	serious				5809
35840	1 pts		Pyelonephritis	serious				5809
35841	1 pts		Respiratory tract infection	serious				5809
35842	1 pts		Subcutaneous abscess	serious				5809
35843	1 pts		Procedural complication	serious				5809
35844	1 pts		Thermal burn	serious				5809
35845	1 pts		Wound dehiscence	serious				5809
35846	18 pts		Alanine aminotransferase increased	serious				5809
35847	7 pts		Aspartate aminotransferase increased	serious				5809
35848	2 pts		Blood bilirubin increased	serious				5809
35849	1 pts		Blood lactate dehydrogenase increased	serious				5809
35850	1 pts		Ejection fraction decreased	serious				5809
35851	1 pts		Electrocardiogram abnormal	serious				5809
35852	2 pts		Gamma-glutamyltransferase increased	serious				5809
35853	5 pts		Hepatic enzyme increased	serious				5809
35854	1 pts		Liver function test abnormal	serious				5809
35855	1 pts		Neutrophil count decreased	serious				5809
35856	1 pts		Platelet count decreased	serious				5809
35857	3 pts		Transaminases increased	serious				5809
35858	1 pts		Decreased appetite	serious				5809
35859	1 pts		Dehydration	serious				5809
35860	1 pts		Hypoglycaemia	serious				5809
35861	1 pts		Back pain	serious				5809
35862	1 pts		Intervertebral disc protrusion	serious				5809
35863	1 pts		Musculoskeletal chest pain	serious				5809
35864	1 pts		Myalgia intercostal	serious				5809
35865	1 pts		Malignant neoplasm of unknown primary site	serious				5809
35866	1 pts		Metastases to abdominal cavity	serious				5809
35867	1 pts		Thyroid adenoma	serious				5809
35868	1 pts		Ulcerated haemangioma	serious				5809
35869	2 pts		Headache	serious				5809
35870	1 pts		Intercostal neuralgia	serious				5809
35871	1 pts		Ischaemic stroke	serious				5809
35872	2 pts		Migraine	serious				5809
35873	1 pts		Paraesthesia	serious				5809
35874	1 pts		Posterior reversible encephalopathy syndrome	serious				5809
35875	1 pts		Presyncope	serious				5809
35876	1 pts		Seizure	serious				5809
35877	1 pts		Transverse sinus thrombosis	serious				5809
35878	1 pts		Haematuria	serious				5809
35879	1 pts		Urinary tract obstruction	serious				5809
35880	1 pts		Female genital tract fistula	serious				5809
35881	1 pts		Haemoptysis	serious				5809
35882	2 pts		Pulmonary embolism	serious				5809
35883	1 pts		Drug eruption	serious				5809
35884	1 pts		Erythema multiforme	serious				5809
35885	2 pts		Palmar-plantar erythrodysaesthesia syndrome	serious				5809
35886	1 pts		Rash	serious				5809
35887	1 pts		Arterial thrombosis	serious				5809
35888	8 pts		Hypertension	serious				5809
35889	4 pts		Hypertensive crisis	serious				5809
35890	44 pts		Leukopenia	below serious				5809
35891	103 pts		Neutropenia	below serious				5809
35892	48 pts		Thrombocytopenia	below serious				5809
35893	49 pts		Hypothyroidism	below serious				5809
35894	67 pts		Abdominal pain upper	below serious				5809
35895	252 pts		Diarrhoea	below serious				5809
35896	24 pts		Dyspepsia	below serious				5809
35897	174 pts		Nausea	below serious				5809
35898	27 pts		Stomatitis	below serious				5809
35899	71 pts		Vomiting	below serious				5809
35900	66 pts		Asthenia	below serious				5809
35901	133 pts		Fatigue	below serious				5809
35902	32 pts		Mucosal inflammation	below serious				5809
35903	27 pts		Viral upper respiratory tract infection	below serious				5809
35904	73 pts		Alanine aminotransferase increased	below serious				5809
35905	66 pts		Aspartate aminotransferase increased	below serious				5809
35906	24 pts		Blood alkaline phosphatase increased	below serious				5809
35907	29 pts		Blood bilirubin increased	below serious				5809
35908	32 pts		Blood thyroid stimulating hormone increased	below serious				5809
35909	36 pts		Neutrophil count decreased	below serious				5809
35910	30 pts		Platelet count decreased	below serious				5809
35911	79 pts		Decreased appetite	below serious				5809
35912	71 pts		Arthralgia	below serious				5809
35913	35 pts		Muscle spasms	below serious				5809
35914	45 pts		Myalgia	below serious				5809
35915	38 pts		Pain in extremity	below serious				5809
35916	26 pts		Dizziness	below serious				5809
35917	95 pts		Dysgeusia	below serious				5809
35918	135 pts		Headache	below serious				5809
35919	40 pts		Proteinuria	below serious				5809
35920	24 pts		Cough	below serious				5809
35921	31 pts		Dyspnoea	below serious				5809
35922	95 pts		Hair colour changes	below serious				5809
35923	61 pts		Palmar-plantar erythrodysaesthesia syndrome	below serious				5809
35924	42 pts		Rash	below serious				5809
35925	256 pts		Hypertension	below serious				5809
35926	1 pts		Neutropenia	grade 2			TRUE	5811
35927	1 pts		Aspartate aminotransferase increased	grade 2			TRUE	5811
35928	1 pts		Hyperbilirubinemia	grade 2			TRUE	5811
35929	50		Diarrhea	all grades				5811
35930	13		Hypertension	grade 3				5811
35931	13		AST increased	grade 3				5811
35932	25		ALT increased	all grades				5811
35933	13		Cough	all grades				5811
35934	50		Skin hypopigmentation	all grades				5811
35935	25		Weight decrease	all grades				5811
35936	13		Alopecia	all grades				5811
35937	13		Dizziness	all grades				5811
35938	25		Hyperbilirubinemia	all grades				5811
35939	25		Abdominal distension	all grades				5811
35940	25		Abdominal pain	all grades				5811
35941	13		Fatigue	all grades				5811
35942	13		Leukopenia	all grades				5811
35943	25		Muscle spasms	all grades				5811
35944	13		Upper respiratory tract infection	all grades				5811
35945	13		Hypercholesterolemia	grade 3				5811
35946	13		Gastrointestinal hemorrhage	grade 4				5811
35947	13		Hypoglycemia	grade 4				5811
35948	13		Transaminases increased	grade 4				5811
35949	2 pts		Aspartate aminotransferase increase	grade 3			TRUE	5815
35950	2 pts		Malaise	grade 3			TRUE	5815
35951	2 pts		ALT increased	grade 3			TRUE	5815
35952			Hepatotoxicity	severe|grade 5		WARNING		5808
35953	1 pts		Fatigue	grade 3	discontinuation	leads to discontinuation or dose reduction	TRUE	5810
35954	1 pts		Hypertension	grade 3	discontinuation	leads to discontinuation or dose reduction	TRUE	5814
35955	11 pts		ALT increased		discontinuation	leads to discontinuation		5812
35956	11 pts		AST increased		discontinuation	leads to discontinuation		5812
35957	11 pts		Bilirubin increased		discontinuation	leads to discontinuation		5812
35958	6 pts		Myocardial infarction		discontinuation	leads to discontinuation		5812
35959	6 pts		Ischemic stroke		discontinuation	leads to discontinuation		5812
35960	6 pts		Transient ischemic attack		discontinuation	leads to discontinuation		5812
35961	5 pts		Fatigue		discontinuation	leads to discontinuation		5812
35962	7 pts		Diarrhea		discontinuation	leads to discontinuation		5812
35963	7 pts		Anorexia		discontinuation	leads to discontinuation		5812
35964	7 pts		Vomiting		discontinuation	leads to discontinuation		5812
35965	3 pts		Proteinuria		discontinuation	leads to discontinuation		5812
35966	2 pts		Hypertension		discontinuation	leads to discontinuation		5812
35967	2 pts		Hemorrhage		discontinuation	leads to discontinuation		5812
35968	12 pts		Confusion		discontinuation	leads to discontinuation		5812
35969	12 pts		Infection		discontinuation	leads to discontinuation		5812
35970	12 pts		Hand-and-foot syndrome		discontinuation	leads to discontinuation		5812
35971	12 pts		Edema		discontinuation	leads to discontinuation		5812
35972	12 pts		Dehydration		discontinuation	leads to discontinuation		5812
35973	12 pts		Anemia		discontinuation	leads to discontinuation		5812
35974	12 pts		Anxiety		discontinuation	leads to discontinuation		5812
35975	12 pts		Convulsion		discontinuation	leads to discontinuation		5812
35976	12 pts		Atrial fibrillation		discontinuation	leads to dose reduction or interruption		5812
35977	20 pts		Hypertension		discontinuation	leads to dose reduction or interruption		5812
35978	17 pts		Gastrointestinal disturbance		discontinuation	leads to dose reduction or interruption		5812
35979	16 pts		Liver function test abnormal		discontinuation	leads to dose reduction or interruption		5812
35980	10 pts		Fatigue		discontinuation	leads to dose reduction or interruption		5812
35981	4 pts		Hematologic disorder		discontinuation	leads to dose reduction or interruption		5812
35982	5 pts		Rash		discontinuation	leads to dose reduction or interruption		5812
35983	5 pts		Proteinuria		discontinuation	leads to dose reduction or interruption		5813
35984	1 pts		Abdominal pain					5817
35985	1 pts		Increased salivation					5817
35986	1 pts		Lacrimation					5817
35987	1 pts		Vomiting					5817
35988	1 pts		Anxiety					5817
35989	1 pts		Tremor					5817
35990	1 pts		Watery diarrhea					5817
35991						No information on AE is provided		5818
35992				grade 5		No information on AE is provided		5816
35993	2 pts		Vision blurred	moderate	discontinuation	leads to discontinuation		5819
35994	1 pts		Eye discomfort	moderate	discontinuation	leads to discontinuation		5819
35995						No AEs are reported		5820
35996	3 pts		Dizziness					5821
35997	3 pts		Lightheadedness					5821
35998	1 pts		Nasal burning					5821
35999	1 pts		Consciousness abnormal			accidentally		5824
36000	1 pts		Hyperthermia			accidentally		5824
36001	4 pts		Dizziness					5823
36002	3 pts		Dry mouth					5823
36003	4 pts		Blurred vision					5823
36004						No AEs are reported		5825
36005			Blurred vision					5822
36006			Dizziness					5822
36007			Abdominal discomfort					5827
36008			Salivation					5827
36009			Flushed skin					5827
36010			Sweating					5827
36011			Nausea					5827
36012			Vomiting					5827
36013	27		Sweating			Sweating+flushes		5829
36014	27		Flushing			Sweating+flushes		5829
36015	12		Stomach cramps			Stomach cramps+diarrhea		5829
36016	12		Diarrhea			Stomach cramps+diarrhea		5829
36017	17		Headache			headache+dizziness		5829
36018	17		Dizziness			headache+dizziness		5829
36019	12		Visual disorders NEC					5829
36020	28		Urination abnormal NOS					5829
36021	12.9		Nausea					5828
36022	6.4		Abdominal distension					5828
36023	9.7		Abdominal cramps					5828
36024						AEs not mentioned		5826
36025	1 pts		Gastrointestinal haemorrhage	serious				5830
36026	1 pts		Cholecystitis acute	serious				5830
36027	1 pts		Bone abscess	serious				5830
36028	1 pts		Thoracic vertebral fracture	serious				5830
36029	1 pts		Kyphosis	serious				5830
36030	6 pts		Application site discharge	below serious				5830
36031	6 pts		Urinary tract infection	below serious				5830
36032	1 pts		Movement disorder	serious				5831
36033	10 pts		Urinary tract infection	below serious				5831
36034						No AEs are reported		5833
36035						No AEs are reported		5832
36036	15 pts		Chromaturia	grade 1				5838
36037	11 pts		Gastrointestinal disorders	grade 1				5838
36038	4 pts		Fatigue	grade 1				5838
36039	3 pts		Electrocardiogram QTc interval prolonged	grade 1				5838
36040	1 pts		Alopecia	grade 1				5838
36041	1 pts		Arthralgia	grade 1				5838
36042	1 pts		Nausea	grade 1				5838
36043	2 pts		Diarrhea	grade 1				5838
36044	2 pts		Chromaturia	grade 2				5838
36045	1 pts		Fatigue	grade 2				5838
36046	1 pts		Alopecia	grade 2				5838
36047	1 pts		Arthralgia	grade 2				5838
36048	1 pts		Nausea	grade 2				5838
36049	4 pts		Discoloration fecal	grade 1				5837
36050	9 pts		Chromaturia	grade 1				5837
36051	1 pts		Fatigue	grade 1				5837
36052	1 pts		Palpitations	grade 1				5837
36053	1 pts		Hunger	grade 1				5837
36054	1 pts		Nausea	grade 2				5837
36055	1 pts		Dyspnea	grade 2				5837
36056	1 pts		Alopecia	grade 2				5837
36057	2 pts		QTc				TRUE	5837
36058	3 pts		Discoloration fecal	grade 1				5834
36059	5 pts		Chromaturia	grade 1				5834
36060	1 pts		QTc				TRUE	5834
36061	5 pts		Fatigue	grade 2				5840
36062	2 pts		Anorexia	grade 2				5840
36063	1 pts		Nausea	grade 2				5840
36064	2 pts		Gastrointestinal disorders	grade 2				5840
36065	2 pts		Flatulence	grade 2				5840
36066	7 pts		Edema	grade 2				5840
36067	1 pts		Infection	grade 2				5840
36068	2 pts		Stomatitis	grade 2				5840
36069	1 pts		Thrombosis	grade 2				5840
36070	1 pts		Anemia	grade 2				5840
36071	1 pts		Neutropenia	grade 2				5840
36072	4 pts		Thrombocytopenia	grade 2				5840
36073	2 pts		Leukopenia	grade 2				5840
36074	6 pts		Fatigue	grade 3-4				5840
36075	2 pts		Edema	grade 3-4				5840
36076	2 pts		Infection	grade 3-4				5840
36077	1 pts		Thrombosis	grade 3				5840
36078	2 pts		Thrombosis	grade 4				5840
36079	1 pts		Thrombocytopenia	grade 3-4				5840
36080	4 pts		Chromaturia	grade 1				5836
36081	4 pts		Somnolence	grade 1				5836
36082	1 pts		Fatigue	grade 1				5836
36083	1 pts		Blood albumin decreased	grade 1				5836
36084	1 pts		Blood urine present	grade 1				5836
36085	1 pts		Electrocardiogram QTc interval prolonged	grade 2				5836
36086	1 pts		Rash	grade 2				5836
36087	3 pts		Chromaturia	grade 1				5835
36088	3 pts		Somnolence	grade 1				5835
36089	1 pts		Faeces discoloured	grade 1				5835
36090	1 pts		Fatigue	grade 2				5835
36091	2 pts		Electrocardiogram QTc interval prolonged	grade 2			TRUE	5835
36092	1 pts		Blood albumin decreased	grade 2				5835
36093	1 pts		Lymphocyte count decreased	grade 3				5835
36094	1 pts		Anemia	grade 1				5839
36095	1 pts		Anemia	grade 3-4				5839
36096	1 pts		Fatigue	grade 1				5839
36097	1 pts		Fatigue	grade 2				5839
36098	1 pts		Headache	grade 1				5839
36099	1 pts		Hyperglycemia	grade 1				5839
36100	2 pts		Nausea	grade 1				5839
36101	1 pts		Electrocardiogram QTc interval prolonged	grade 3-4				5839
36102						No adverse effects leading to discontinuation were reported.		5841
36103			DRESS syndrome		discontinuation			5844
36104	7.8		Gastrointestinal disorders		discontinuation			5842
36105	2		Pruritus		discontinuation			5842
36106	2		Fever		discontinuation			5842
36107	2		Chills		discontinuation			5842
36108			Hepatitis acute		discontinuation			5843
36109	8.3		Skin infection					5845
36110	25		Oral candidiasis					5845
36111	8.3		Pneumonia					5845
36112	8.3		Cushing's syndrome					5845
36113	8.3		Steroid acne					5845
36114	16.7		Diabetes mellitus					5845
36115	8.3		Anaemia					5845
36116	8.3		Neurosis					5845
36117	5.4		Injection site pain		discontinuation			5847
36118	87.3		Injection site pain					5846
36119	36.5		Injection site haematoma					5846
36120	36.5		Haematoma injection site					5846
36121	66.7		Injection site anaesthesia					5846
36122	66.7		Anaesthesia injection site					5846
36123	39.7		Injection site erythema					5846
36124	14.3		Injection site induration					5846
36125	87.3		Injection site oedema					5846
36126	4.8		Injection site pruritus					5846
36127	9.5		Headache					5846
36128	25.4		Injection site nodule					5846
36129	1.6		Injection site warmth					5846
36130	1.8		Serum transaminase increased		discontinuation			5848
36131			Vertigo		dose interruption	Recovered completely. causal relationships unlikely.		5849
36132			Swelling face			Recovered completely. causal relationships unlikely.		5849
36133			Epigastric pain		dose interruption	Recovered completely. causal relationships unlikely.		5849
36134			Nausea			Recovered completely. causal relationships unlikely.		5849
36135	2.9		Headache					5853
36136	2 pts		Flushing		discontinuation	leads to discontinuation		5852
36137	4.2		Headache					5852
36138	1 pts		Headache		discontinuation	leads to discontinuation		5852
36139	1 pts		Fatigue		discontinuation	leads to discontinuation		5852
36140	1 pts		Vertigo		discontinuation	leads to discontinuation		5852
36141	1 pts		Hypotension		discontinuation	leads to discontinuation		5850
36142	1 pts		Bradycardia		discontinuation	leads to discontinuation		5850
36143	1 pts		Seizure		discontinuation	leads to discontinuation		5850
36144	1 pts		Abdominal distension					5851
36145	1 pts		Dyspepsia					5851
36146	1 pts		Nausea					5851
36147	0.8		Anemia			No info about discontinuation		5854
36148			Tachycardia		discontinuation			5855
36149			Cyanosis		discontinuation			5855
36150			Drowsiness					5857
36151			Excitability					5857
36152	42		Drowsiness					5856
36153			Dry mouth			Dry Mouth/Dry Eyes - 25%		5856
36154			Dry eyes			Dry Mouth/Dry Eyes - 25%		5856
36155	17		Headaches					5856
36156	17		Lightheadedness					5856
36157	17		Nervousness					5856
36158	17		Concentration impaired					5856
36159	25		Numbness					5856
36160	17		Fatigue					5856
36161	8		Urination difficulty			1 patient		5856
36162			Vasoconstriction			WARNINGS		5858
36163	rare		Acute pulmonary oedema			WARNINGS		5858
36164			Sedation	grade 5		POISONING		5859
36165	7 pts		Dizziness					5860
36166	2 pts		Drowsiness	slight				5860
36167	1 pts		Loose stools					5860
36168	1 pts		Jaundice					5861
36169	1 pts		Supraventricular tachycardia					5863
36170	1 pts		Atrial fibrillation					5863
36171	1 pts		Myocardial ischemia		discontinuation			5862
36172	1 pts		Myocarditis		discontinuation			5864
36173						No adverse effects leading to discontinuation were reported.		5866
36174						No adverse effects were recorded.		5865
36175	2		CNS disorder (NOS)		discontinuation			5867
36176	6.4		Mastalgia		discontinuation			5868
36177	3.2		Facial swelling		discontinuation			5868
36178	3.2		Abdominal pain		discontinuation			5868
36179	3.2		Abdominal distension		discontinuation			5868
36180	3.2		Galactorrhoea		discontinuation			5868
36181	2.1		AST increased		discontinuation			5871
36182	2.1		ALT increased		discontinuation			5871
36183	2.1		Exanthema		discontinuation			5871
36184			Ventricular tachycardia		discontinuation			5870
36185			Ventricular tachycardia		discontinuation			5869
36186			Pneumonitis		discontinuation			5873
36187						The source does not contain information about AEs or lack thereof		5872
36188						No adverse effects leading to discontinuation were reported.		5875
36189			Drowsiness		discontinuation			5877
36190			Weight gain		discontinuation			5877
36191	25		Somnolence					5876
36192	5.6		Nausea					5876
36193	4.2		Drowsiness		discontinuation			5874
36194	2.5		Weight gain		discontinuation			5874
36195	5		Depression		discontinuation			5874
36196						No adverse effects were recorded.		5878
36197	29		Drowsiness					5880
36198	10		Dizziness					5880
36199	7		Dry mouth					5880
36200	14		Fatigue					5880
36201	2		Depression					5880
36202	5.3		Tiredness	grade 3	discontinuation			5879
36203	10.6		Oedema		discontinuation			5879
36204	10.6		Weight gain		discontinuation			5879
36205			Tachycardia		discontinuation			5883
36206			Dilated pupils		discontinuation			5882
36207			Dizziness		discontinuation			5882
36208			Ileus		discontinuation			5881
36209			Dry mouth		discontinuation			5881
36210			Dilated pupils		discontinuation			5881
36211	6.5		Palpitation		discontinuation			5885
36212	9		Dry mouth					5884
36213	9		Giddiness					5884
36214	1.3		Sleeplessness		discontinuation			5889
36215	0.63		Dizziness		discontinuation			5889
36216	1.9		Tachycardia		discontinuation			5889
36217	0.63		Motor activity retarded		discontinuation			5889
36218	0.63		Blurred vision		discontinuation			5889
36219	1.3		Headache		discontinuation			5889
36220	0.63		Drowsiness		discontinuation			5889
36221	0.63		Weight gain		discontinuation			5889
36222	1.3		Agitation		discontinuation			5889
36223	0.63		Perspiration excessive		discontinuation			5889
36224	1.3		Vomiting		discontinuation			5889
36225	1.3		Constipation		discontinuation			5889
36226	1.3		Nausea		discontinuation			5889
36227	0.63		Motor activity exaggerated		discontinuation			5889
36228	1.3		Tremor		discontinuation			5889
36229	0.63		Fainting		discontinuation			5889
36230	0.63		Depressed mood		discontinuation			5889
36231			Bradycardia		discontinuation			5886
36232			Hypotension		discontinuation			5886
36233			Giddiness		discontinuation			5886
36234			Complete heart block		discontinuation			5888
36235			Drowsiness		discontinuation			5887
36236			Dry mouth		discontinuation			5887
36237			Heart block		discontinuation			5887
36238	7.1		Epigastric discomfort		discontinuation			5891
36239						No adverse effects were recorded.		5890
36240	0.36		Fatigue		discontinuation			5892
36241						No adverse side effects were recorded.		5895
36242						No adverse side effects were recorded.		5894
36243	0.7		Hyperkalemia					5893
36244			Giant papillary conjunctivitis		discontinuation			5897
36245			Allergy		discontinuation			5897
36246	7.8		Drug intolerance		discontinuation	most (22/31) patients were discontinued for signs of local intolerance (giant papillary conjunctivitis, allergy, hypersensitivity, or follicles)		5897
36247			Hypersensitivity		discontinuation			5897
36248			Follicles conjunctivia		discontinuation			5897
36249	1		Near vision disturbance		discontinuation			5897
36250	0.7		Rash		discontinuation			5897
36251	0.35		Headache		discontinuation			5897
36252	0.35		Dyschromatopsia	grade 1	discontinuation			5897
36253	0.35		Lens opacity		discontinuation			5897
36254	0.35		Eye redness		discontinuation	most (22/31) patients were discontinued for signs of local intolerance (giant papillary conjunctivitis, allergy, hypersensitivity, or follicles)		5897
36255	35.9		Dry mouth					5896
36256	10.3		Visual disturbances					5896
36257	7		Polyuria			1 pt withdrawn on Day 3		5899
36258			Tremor		discontinuation	1 pt withdrawn on Day 2		5899
36259			Nervousness			1 pt withdrawn on Day 2		5899
36260	1 pts		Headache	grade 3	discontinuation	Only one had these AEs, 9 hrs after drug ingestion		5898
36261	1 pts		Syncope		discontinuation	Only one had these AEs, 9 hrs after drug ingestion		5898
36262	1 pts		Syncope		discontinuation	Only one had these AEs, 9 hrs after drug ingestion		5898
36263	1 pts		Nausea		discontinuation	Only one had these AEs, 9 hrs after drug ingestion		5898
36264	4		Skin reaction		discontinuation			5901
36265	4		Constipation		discontinuation			5901
36266	2.4		Hypoglycemia		discontinuation	increase of pre-existing hypoglycemic episodes		5900
36267	2.4		Nausea		discontinuation			5900
36268			Joint ache		discontinuation			5902
36269			Fever		discontinuation			5902
36270			Macular rash		discontinuation			5902
36271			Hypotension	grade 1	discontinuation			5902
36272			Lymphadenopathy cervical		discontinuation			5902
36273						No adverse effects leading to discontinuation were reported.		5903
36274	0.95		Weakness		discontinuation			5905
36275	0.95		Dizziness		discontinuation			5905
36276	3.6		Lethargy	grade 3	discontinuation			5904
36277	3.6		Depression	grade 3	discontinuation			5904
36278	51		Insomnia					5909
36279	29		Orthostatic hypotension					5909
36280	24		Bradycardia					5909
36281	30		Hypotension					5909
36282	19		Dizziness					5909
36283	11		Somnolence					5909
36284	13		Sedation					5909
36285	10		Dry mouth					5909
36286	0.9		Syncope					5909
36287	0.9		Tinnitus					5909
36288	13.5		Bradycardia					5909
36289	13.5		Orthostatic hypotension					5909
36290	55		Insomnia					5912
36291	42		Orthostatic hypotension					5912
36292	32		Bradycardia					5912
36293	30		Hypotension					5912
36294	23		Dizziness					5912
36295	12		Somnolence					5912
36296	13		Sedation					5912
36297	11		Dry mouth					5912
36298	1.4		Syncope					5912
36299	3.2		Tinnitus					5912
36300	21		Hypertension					5912
36301	22		Bradycardia					5912
36302	22		Orthostatic hypotension					5912
36303	51		Insomnia					5909
36304	29		Orthostatic hypotension					5909
36305	24		Bradycardia					5909
36306	30		Hypotension					5909
36307	19		Dizziness					5909
36308	11		Somnolence					5909
36309	13		Sedation					5909
36310	10		Dry mouth					5909
36311	0.9		Syncope					5909
36312	0.9		Tinnitus					5909
36313	13.5		Bradycardia		discontinuation			5909
36314	13.5		Orthostatic hypotension		discontinuation			5909
36315	55		Insomnia					5912
36316	42		Orthostatic hypotension					5912
36317	32		Bradycardia					5912
36318	30		Hypotension					5912
36319	23		Dizziness					5912
36320	12		Somnolence					5912
36321	13		Sedation					5912
36322	11		Dry mouth					5912
36323	1.4		Syncope					5912
36324	3.2		Tinnitus					5912
36325	21		Hypertension		discontinuation			5912
36326	22		Bradycardia		discontinuation			5912
36327	22		Orthostatic hypotension		discontinuation			5912
36328	1		Hypotension					5907
36329	3		Dizziness					5906
36330	3		Insomnia					5906
36331	2		Diarrhea					5906
36332	1		Orthostatic hypotension					5906
36333	2		Anxiety					5906
36334	2		Myalgia					5906
36335	<1		Syncope					5906
36336	<1		Somnolence					5906
36337	<1		Restlessness					5906
36338	2		Nausea					5906
36339	2		Vomiting					5906
36340	3		Hypotension					5910
36341	2		Dizziness					5910
36342	2		Insomnia					5910
36343	2		Diarrhea					5910
36344	2		Orthostatic hypotension					5910
36345	1		Anxiety					5910
36346	1		Myalgia					5910
36347	1		Syncope					5910
36348	1		Somnolence					5910
36349	1		Restlessness					5910
36350	<1		Nausea					5910
36351	<1		Vomiting					5910
36352	3		Bradycardia					5910
36353	2		Pain					5910
36354	1		Hypotension		discontinuation			5908
36355	3		Dizziness		discontinuation			5908
36356	3		Insomnia		discontinuation			5908
36357	2		Diarrhea		discontinuation			5908
36358	1		Orthostatic hypotension		discontinuation			5908
36359	2		Anxiety		discontinuation			5908
36360	2		Myalgia		discontinuation			5908
36361	<1		Syncope		discontinuation			5908
36362	<1		Somnolence		discontinuation			5908
36363	<1		Restlessness		discontinuation			5908
36364	2		Nausea		discontinuation			5908
36365	2		Vomiting		discontinuation			5908
36366	3		Hypotension		discontinuation			5911
36367	2		Dizziness		discontinuation			5911
36368	2		Insomnia		discontinuation			5911
36369	2		Diarrhea		discontinuation			5911
36370	2		Orthostatic hypotension		discontinuation			5911
36371	1		Anxiety		discontinuation			5911
36372	1		Myalgia		discontinuation			5911
36373	1		Syncope		discontinuation			5911
36374	1		Somnolence		discontinuation			5911
36375	1		Restlessness		discontinuation			5911
36376	<1		Nausea		discontinuation			5911
36377	<1		Vomiting		discontinuation			5911
36378	3		Bradycardia		discontinuation			5911
36379	2		Pain		discontinuation			5911
36380			Hepatitis acute		discontinuation			5913
36381	0.5		Eye swelling		discontinuation			5914
36382	2.9		Nausea					5914
36383	1.4		Abdominal pain upper					5914
36384	3.4		Headache					5914
36385	0.5		Asthenia					5914
36386	1.9		Vertigo					5914
36387			Coma			OVERDOSAGE		5915
36388			Dizziness					5916
36389			Drug intoxication					5916
36390			Euphoric					5916
36391			Tiredness					5916
36392	2.2		Confusion		discontinuation			5917
36393	2.2		Anxiety		discontinuation			5917
36394	4.4		Nausea		discontinuation			5917
36395	2.2		Sleepiness		discontinuation			5917
36396	2.2		Hallucinations		discontinuation			5917
36397	2.2		Restlessness		discontinuation			5917
36398	4.4		Vomiting					5917
36399						No patients discontinued treatment due to side effects.		5918
36400	18 pts		Hypotension					5919
36401	18 pts		Constipation					5919
36402	66.7		Nausea	grade 2-3			TRUE	5920
36403	66.7		Vomiting	grade 1-2				5920
36404	33.3		Dehydration	grade 2				5920
36405	66.7		Fatigue	grade 3			TRUE	5920
36406	33.3		Hyponatremia	grade 4				5920
36407	33.3		Nausea	grade 1			TRUE	5921
36408	33.3		Vomiting	grade 1-2			TRUE	5921
36409						No significant adverse effects were reported.		5922
36410						The source does not contain information about AEs or lack thereof		5923
36411			Drowsiness					5925
36412			Confused					5925
36413			Retrosternal pain					5925
36414			Hypertension					5925
36415			Heart rate high					5925
36416	18.2		Anxiety					5924
36417	9		Hypertension					5924
36418	13.6		Headache					5924
36419	31.8		Urinary frequency aggravated					5924
36420	9		Facial flushing					5924
36421	27.3		Tachycardia					5924
36422	13.6		Vertigo					5924
36423	4.5		Urticaria					5924
36424	4.5		Anorexia					5924
36425	4.5		Flatulence					5924
36426	4.5		Perspiration excessive					5924
36427	4.5		Epigastralgia					5924
36428						impossible to link AEs with the definite dose. All but one AE occurred at the highest doses (40 mg b.i.d.)		5926
36429	1 pts		Nausea		discontinuation			5927
36430	2 pts		Hypotension		discontinuation			5927
36431	1 pts		Tremor		discontinuation			5927
36432	1 pts		Cramps		discontinuation			5927
36433	1 pts		Itching		discontinuation			5927
36434	1 pts		Erythema		discontinuation			5927
36435	1 pts		Gastric pain					5928
36436	1 pts		Depression suicidal	serious				5929
36437	7 pts		Nausea	below serious				5929
36438	4 pts		Abdominal discomfort	below serious				5929
36439	3 pts		Dry mouth	below serious				5929
36440	5 pts		Somnolence	below serious				5929
36441	4 pts		Akathisia	below serious				5929
36442	4 pts		Dizziness	below serious				5929
36443	1 pts		Toxicity to various agents	serious				5930
36444	1 pts		Pain in extremity	serious				5930
36445	1 pts		Headache	serious				5930
36446	1 pts		Transient ischemic attack	serious				5930
36447	1 pts		Dyspnoea	serious				5930
36448	3 pts		Nausea	below serious				5930
36449	1 pts		Vomiting	below serious				5930
36450	4 pts		Toothache	below serious				5930
36451	2 pts		Nasopharyngitis	below serious				5930
36452	5 pts		Weight increased	below serious				5930
36453	6 pts		Back pain	below serious				5930
36454	2 pts		Dystonia	below serious				5930
36455	1 pts		Dizziness	below serious				5930
36456	1 pts		Sedation	below serious				5930
36457	6 pts		Anxiety	below serious				5930
36458	1 pts		Homicidal ideation	serious				5931
36459	1 pts		Diarrhoea	serious				5931
36460	10 pts		Somnolence	below serious				5931
36461	10 pts		Akathisia	below serious				5931
36462	6 pts		Sedation	below serious				5931
36463	14 pts		Nausea	below serious				5931
36464	9 pts		Vomiting	below serious				5931
36465	5 pts		Agitation	below serious				5931
36466	11 pts		Anxiety	below serious				5931
36467	12 pts		Somnolence	below serious				5932
36468	9 pts		Akathisia	below serious				5932
36469	2 pts		Sedation	below serious				5932
36470	15 pts		Nausea	below serious				5932
36471	7 pts		Vomiting	below serious				5932
36472	6 pts		Agitation	below serious				5932
36473	1 pts		Humerus fracture	serious				5933
36474	16 pts		Somnolence	below serious				5933
36475	10 pts		Dizziness	below serious				5933
36476	28 pts		Nausea	below serious				5933
36477	11 pts		Vomiting	below serious				5933
36478	9 pts		Insomnia	below serious				5933
36479	12 pts		Weight increased	below serious				5933
36480			Cerebrovascular disorder (NOS)		discontinuation	WARNINGS. Cerebrovascular Adverse Reactions in Elderly Patients with Dementia-Related Psychosis: Increased incidence of cerebrovascular adverse events (e.g., stroke, transient ischemic attack)		5938
36481			Neuroleptic malignant syndrome		discontinuation	WARNINGS		5938
36482			Tardive dyskinesia		discontinuation	WARNINGS		5938
36483			Hyperglycemia		discontinuation	WARNINGS		5938
36484			Diabetes mellitus		discontinuation	WARNINGS		5938
36485			Dyslipidemia		discontinuation	WARNINGS		5938
36486			Weight gain		discontinuation	WARNINGS		5938
36487			Hyperprolactinemia		discontinuation	WARNINGS		5938
36488			Leukopenia		discontinuation	WARNINGS		5938
36489			Neutropenia		discontinuation	WARNINGS		5938
36490			Agranulocytosis		discontinuation	WARNINGS		5938
36491			Orthostatic hypotension		discontinuation	WARNINGS		5938
36492			Syncope		discontinuation	WARNINGS		5938
36493			Suicidal behavior		discontinuation	WARNINGS. Increased risk of suicidal thinking and behavior in children, adolescents, and young adults taking antidepressants		5938
36494			Dystonia		discontinuation	Seven subjects (0.5%, 7/1508) discontinued clinical trials due to dystonic events – four were receiving LATUDA 80 mg/day and three were receiving LATUDA 120 mg/day.		5937
36495						This patient recovered without sequelae.		5936
36496						No AEs indicated		5935
36497						No adverse reactions leading to discontinuation were reported		5934
36498						All volunteers tolerated dichlorvos well.		5939
36499	3 pts		Hearing loss	severe	discontinuation	OTOTOXICITY		5940
36500	1 pts		Hearing loss	severe	discontinuation	OTOTOXICITY		5941
36501	1.37		Nausea		discontinuation	1 patient		5942
36502	11.43		Vomiting	severe	discontinuation	In 4 patients the vomiting was so severe and persistent that the treatment had to be discontinued.		5943
36503						No adverse effects leading to discontinuation were mentioned.		5944
36504						No adverse effects leading to discontinuation were reported.		5945
36505			Urticaria					5946
36506						No adverse effects leading to discontinuation were reported.		5947
36507						There were no deaths, serious AEs (SAEs), or discontinuations due to AEs.		5948
36508			Ventricular tachyarrhythmia					5949
36509			QT interval prolonged					5949
36510	1		Headache	grade 1				5950
36511	1		Dizziness	grade 1				5950
36512	1		Dry mouth	grade 1				5950
36513	1		Diarrhea	grade 1				5950
36514	5		Vomiting	grade 1				5950
36515	13		Nausea	grade 1				5950
36516	55		Loose stools					5951
36517			Hyperglycemia		discontinuation			5955
36518			Bradycardia		discontinuation			5955
36519			Hypertension		discontinuation			5955
36520			Respiratory depression		discontinuation			5955
36521			Miosis		discontinuation			5955
36522			CNS depression		discontinuation			5955
36523			CNS depression		discontinuation			5953
36524			Hypertension		discontinuation			5953
36525			Ecchymosis		discontinuation			5953
36526			Respiratory depression		discontinuation			5953
36527			Hyperglycemia		discontinuation			5953
36528			Respiratory depression		discontinuation			5954
36529			CNS depression		discontinuation			5954
36530			Incontinence urinary		discontinuation			5954
36531			Hypotension	grade 1	discontinuation			5954
36532			Bradycardia		discontinuation			5954
36533			Hyperglycemia		discontinuation			5954
36534			Miosis		discontinuation			5954
36535			Premature ventricular contractions		discontinuation			5954
36536			Respiratory depression		discontinuation			5952
36537			Tachycardia		discontinuation			5952
36538			CNS depression		discontinuation			5952
36539			Premature ventricular contractions		discontinuation			5952
36540			Hyperglycemia		discontinuation			5952
36541			Electrocardiogram change		discontinuation			5952
36542	1.5		AST increased		discontinuation			5956
36543	1.5		AST increased		discontinuation			5956
36544	10 pts		Vomiting	grade 1				5961
36545	5 pts		Peripheral neuropathy	grade 1				5961
36546	2 pts		Rash	grade 1				5961
36547	2 pts		Constipation	grade 1				5961
36548	1 pts		Weight loss	grade 1				5961
36549	4 pts		Vomiting	grade 2				5961
36550	2 pts		Skin erythema	grade 2				5961
36551	2 pts		Constipation	grade 2				5961
36552	1 pts		Arthralgia	grade 2				5961
36553	1 pts		Urinary retention	grade 2				5961
36554	1 pts		Hematotoxicity	grade 2				5961
36555	2 pts		Rash	grade 3				5961
36556	1 pts		Vomiting	grade 3				5961
36557	1 pts		Skin desquamation	grade 3				5961
36558	2 pts		Skin desquamation	grade 3-4			TRUE	5959
36559	1 pts		Peripheral neuropathy	grade 1	discontinuation	leads to discontinuation		5960
36560	3 pts		Arthralgia					5957
36561	3 pts		Hepatotoxicity	grade 3				5958
36562	1 pts		Rash		discontinuation	leads to discontinuation		5958
36563	1 pts		Fever		discontinuation	leads to discontinuation		5958
36564	2 pts		Peripheral neuropathy	grade 1				5958
36565	58 pts		Thrombocytopenia					5965
36566	35 pts		Neutropenia					5965
36567	33 pts		Anaemia					5965
36568	50 pts		Nausea	grade 1-2				5965
36569	43 pts		Abdominal pain	grade 1-2				5965
36570	37 pts		Lethargy	grade 1-2				5965
36571	34 pts		Vomiting	grade 1-2				5965
36572	34 pts		Constipation	grade 1-2				5965
36573	23 pts		Diarrhoea	grade 1-2				5965
36574	18 pts		Dyspnoea	grade 1-2				5965
36575	17 pts		Anorexia	grade 1-2				5965
36576	16 pts		Somnolence	grade 1-2				5965
36577	16 pts		Headache	grade 1-2				5965
36578	13 pts		Pain	grade 1-2				5965
36579	12 pts		Fever	grade 1-2				5965
36580	9 pts		Nausea	grade 3-4				5965
36581	6 pts		Abdominal pain	grade 3-4				5965
36582	16 pts		Lethargy	grade 3-4				5965
36583	11 pts		Vomiting	grade 3-4				5965
36584	6 pts		Constipation	grade 3-4				5965
36585	4 pts		Dyspnoea	grade 3-4				5965
36586	4 pts		Anorexia	grade 3-4				5965
36587	1 pts		Somnolence	grade 3-4				5965
36588	2 pts		Headache	grade 3-4				5965
36589	2 pts		Pain	grade 3-4				5965
36590	3 pts		Fever	grade 3-4				5965
36591	4 pts		Anaemia					5966
36592	10 pts		Leucopenia					5966
36593	9 pts		Neutropenia					5966
36594	17 pts		Thrombocytopenia					5966
36595	11 pts		Anorexia					5966
36596	12 pts		Chest pain					5966
36597	20 pts		Constipation					5966
36598	20 pts		Dyspnoea					5966
36599	20 pts		Malaise					5966
36600	28 pts		Nausea					5966
36601	10 pts		Pain					5966
36602	11 pts		Vomiting					5966
36603	3 pts		Lymphopenia					5963
36604	1 pts		Malaise				TRUE	5963
36605	1 pts		Anaemia					5964
36606	2 pts		Thrombocytopenia				TRUE	5964
36607	2 pts		Leucopenia					5964
36608	2 pts		Neutropenia					5964
36609	2 pts		Lymphopenia					5964
36610	3 pts		Thrombocytopenia				TRUE	5962
36611	2 pts		Leucopenia					5962
36612	3 pts		Neutropenia					5962
36613	49 pts		Thrombocytopenia	all grades				5967
36614	34 pts		Anemia	all grades				5967
36615	29 pts		Neutropenia	all grades				5967
36616	17 pts		Nausea	all grades				5967
36617	14 pts		Leukopenia	all grades				5967
36618	8 pts		Fatigue	all grades				5967
36619	7 pts		Vomiting	all grades				5967
36620	6 pts		Constipation	all grades				5967
36621	6 pts		Anorexia	all grades				5967
36622	2 pts		Asthenia	all grades				5967
36623	2 pts		Dyspnea	all grades				5967
36624	1 pts		Pain	all grades				5967
36625	1 pts		Hyponatremia	all grades				5967
36626	1 pts		Cough	all grades				5967
36627	37 pts		Thrombocytopenia	grade 3-4				5967
36628	15 pts		Anemia	grade 3-4				5967
36629	19 pts		Neutropenia	grade 3-4				5967
36630	1 pts		Nausea	grade 3-4				5967
36631	5 pts		Leukopenia	grade 3-4				5967
36632	3 pts		Fatigue	grade 3-4				5967
36633	1 pts		Vomiting	grade 3-4				5967
36634	1 pts		Constipation	grade 3-4				5967
36635	1 pts		Anorexia	grade 3-4				5967
36636	2 pts		Asthenia	grade 3-4				5967
36637	3 pts		Dyspnea	grade 3-4				5967
36638	4 pts		Pain	grade 3-4				5967
36639	5 pts		Hyponatremia	grade 3-4				5967
36640	1 pts		Cough	grade 3-4				5967
36641	16.7		Agitation		discontinuation			5971
36642	16.7		Hyperreflexia		discontinuation			5971
36643	14.3		Hallucinations		discontinuation			5972
36644	14.3		Nausea		discontinuation			5972
36645	28.6		Vomiting		discontinuation			5972
36646	14.3		Somnolence		discontinuation			5972
36647	14.3		Nausea		discontinuation			5972
36648	3.7		Esophageal pain		discontinuation	and dysphagia		5969
36649	3.7		Abdominal pain		discontinuation			5969
36650	7.7		Nausea		discontinuation			5970
36651	20.3		Fatigue	grade 1-2				5968
36652	4.7		Influenza-like symptoms	grade 1-2				5968
36653	12.5		Injury	grade 1-2				5968
36654	9.4		Convulsions aggravated	grade 1-2				5968
36655	20.3		Dizziness	grade 1-2				5968
36656	18.7		Abnormal gait	grade 1-2				5968
36657	29.7		Headache	grade 1-2				5968
36658	6.2		Abdominal pain	grade 1-2				5968
36659	4.7		Diarrhoea	grade 1-2				5968
36660	18.7		Dyspepsia	grade 1-2				5968
36661	25		Nausea	grade 1-2				5968
36662	18.7		Vomiting	grade 1-2				5968
36663	14.1		Somnolence	grade 1-2				5968
36664	4.7		Pharyngitis	grade 1-2				5968
36665	9.4		Upper respiratory tract infection	grade 1-2				5968
36666	14.1		Diplopia	grade 1-2				5968
36667	7.8		Abnormal vision	grade 1-2				5968
36668	4.7		Epilepsy		discontinuation			5968
36669	11.54		Polymorphic ventricular tachycardia	serious	discontinuation			5973
36670	3.85		Torsades de pointes	serious	discontinuation			5973
36671						None of the adverse events were judged to be related to the study drug		5974
36672	1 pts		Pollakiuria		discontinuation			5975
36673	100		Thrombocytopenia	grade 1			TRUE	5976
36674	42.9		Neutropenia	grade 3			TRUE	5978
36675						No patients were withdrawn because of toxicity.		5977
36676	66.7		Stomatitis	grade 4	dose reduction		TRUE	5979
36677	33.3		Diarrhea	grade 3	dose reduction		TRUE	5979
36678						No adverse effects leading to discontinuation were reported; no DLTs		5980
36679						No adverse effects leading to discontinuation were reported; no DLTs		5981
36680	33.3		Leukoencephalopathy		discontinuation			5982
36681	0.2		Pyrexia		discontinuation			5984
36682	0.5		Headache		discontinuation			5984
36683	0.4		Diarrhea		discontinuation			5984
36684	0.2		Liver function test abnormal		discontinuation			5984
36685	0.8		Abdominal pain upper		discontinuation			5984
36686	0.3		GGT increased		discontinuation			5984
36687	0.2		Decreased appetite		discontinuation			5984
36688	0.2		Asthenia		discontinuation			5984
36689	0.7		ALT increased		discontinuation			5984
36690	0.2		Dizziness		discontinuation			5984
36691	0.7		Abdominal pain		discontinuation			5984
36692	0.2		Depression		discontinuation			5984
36693	0.2		Nausea		discontinuation			5984
36694	0.5		Transaminases increased		discontinuation			5984
36695	0.2		Cough		discontinuation			5984
36696	8.3		Tension headache		discontinuation			5983
36697	8.3		CRP increased		discontinuation			5983
36698	8.3		Blood fibrinogen increased		discontinuation			5983
36699	8.3		Vomiting		discontinuation			5983
36700	8.3		Nausea		discontinuation			5983
36701						No serious adverse events were reported.		5985
36702	34 pts		Bleeding		discontinuation	leads to discontinuation		5986
36703	5 pts		Thrombocytopenia		discontinuation	leads to discontinuation		5986
36704	34 pts		Platelet aggregation inhibition		discontinuation	leads to discontinuation		5986
36705	1 pts		Numbness throat					5987
36706	1 pts		Flu symptoms					5987
36707	1 pts		AST increased	mild				5987
36708	1 pts		Alanine aminotransferase increase	mild				5987
36709	3 pts		Dizziness					5987
36710	2 pts		Numbness of tongue					5987
36711						No AEs were reported		5988
36712	4 pts		Disorder sleep					5989
36713	2 pts		Vomiting					5989
36714	2 pts		Stomatitis					5989
36715	1 pts		Diarrhea					5989
36716	1 pts		Neutropenic sepsis	grade 5	discontinuation	leads to discontinuation		5989
36717	4 pts		Eye disorders					5989
36718	2 pts		Bradycardia					5989
36719	4 pts		Skin toxicity					5989
36720	2 pts		Malaise				TRUE	5989
36721	2 pts		Myalgia				TRUE	5989
36722	1 pts		Headaches				TRUE	5989
36723	100		Deafness	grade 3			TRUE	5990
36724	100		Deafness	grade 3			TRUE	5990
36725	25		Deafness	grade 3			TRUE	5991
36726	25		Tinnitus	grade 3			TRUE	5991
36727	38		Headache					5992
36728	13		Dizziness					5992
36729	25		Abdominal pain					5992
36730	25		Nausea					5992
36731	13		Metrorrhagia					5992
36732	20		Dizziness	grade 1				5997
36733	10		Nausea	grade 1				5997
36734	10		Rash	grade 1				5997
36735	20		Somnolence	grade 1-2				5997
36736	10		Dizziness postural	grade 1				5997
36737	10		Dry mouth	grade 1				5997
36738	10		Hot flush	grade 1				5997
36739	10		Pyrexia	grade 1				5997
36740	10		Sedation	grade 1				5997
36741	10		Sinus tachycardia	grade 2				5997
36742	10		Vertigo	grade 1				5997
36743	3		Diarrhea					5994
36744	11		Dry mouth					5994
36745	3		Oropharyngeal pain					5994
36746	5		Loss of consciousness					5994
36747	5		Flush hot					5994
36748	2		Tachycardia					5998
36749	2		Diarrhea					5998
36750	3		Dry mouth					5998
36751	2		Dyspepsia					5998
36752	2		Oropharyngeal pain					5998
36753	12		Dizziness					5998
36754	3		Loss of consciousness					5998
36755	13		Somnolence					5998
36756	2		Flush hot					5998
36757			Loss of consciousness		discontinuation			5996
36758			Vertigo		discontinuation			5996
36759			Syncope		discontinuation			5996
36760			Presyncope		discontinuation			5996
36761			Infusion site pain		discontinuation			5996
36762			Loss of consciousness				TRUE	5996
36763			Syncope				TRUE	5996
36764			Somnolence				TRUE	5996
36765			Dizziness				TRUE	5996
36766			Fatigue				TRUE	5996
36767			Infusion related reaction				TRUE	5996
36768			Change in blood pressure				TRUE	5996
36769	13		Dizziness	grade 1				5995
36770	21		Somnolence	grade 1				5995
36771	93.7		Somnolence					5993
36772	9.4		Feeling of relaxation					5993
36773	6.3		Feeling abnormal					5993
36774	3.1		Psychomotor retardation					5993
36775	12.5		Euphoric mood					5993
36776	1 pts		Leukopenia	mild	discontinuation			5999
36777	4.1		Rash		discontinuation			6000
36778	2 pts		Hyponatremia	severe			TRUE	6001
36779	1 pts		Hypotension	serious			TRUE	6001
36780	1 pts		Peripheral edema	grade 3			TRUE	6005
36781	1 pts		Peripheral edema	grade 3			TRUE	6005
36782	2 pts		White blood cell count low					6002
36783	1 pts		Constipation					6002
36784	1 pts		Platelets decreased					6002
36785	1 pts		Nausea					6002
36786	1 pts		Arthralgia					6002
36787	1 pts		Glutamic-pyruvic transaminase increased					6002
36788	1 pts		Vomiting					6002
36789	1 pts		Absolute neutrophil count					6002
36790	2 pts		Hypocalcemia					6002
36791	1 pts		Weight gain					6002
36792	1 pts		Dry mouth					6002
36793	2 pts		Headache					6002
36794	2 pts		Dyspnea					6002
36795	4 pts		Allergic rhinitis					6002
36796	5 pts		Edema					6002
36797	3 pts		Fatigue					6002
36798	1 pts		Acute appendicitis		discontinuation			6003
36799	1 pts		Hemorrhage lung		discontinuation			6003
36800	1 pts		Fatigue		discontinuation			6003
36801	2 pts		Peripheral edema		discontinuation			6003
36802	1 pts		Hypoglycemia		discontinuation			6004
36803	1 pts		Hyperkalemia		discontinuation			6004
36804	2 pts		Hyperkalemia		discontinuation			6004
36805	1 pts		Atheroma coronary artery					6004
36806						There were 28 adverse events that were either possibly or probably related to the study drug; they were all mild or moderate in severity		6006
36807						No adverse effects leading to discontinuation were reported		6007
36808	1 pts		Cardiogenic shock		discontinuation	leads to discontinuation		6010
36809	1 pts		Leucopenia		discontinuation	leads to discontinuation		6010
36810	2 pts		Bleeding		discontinuation	leads to discontinuation		6008
36811	15 pts		Bleeding					6009
36812	2 pts		Renal insufficiency	grade 3-4	discontinuation	leads to discontinuation		6012
36813	4 pts		Transaminases increased		discontinuation	leads to discontinuation		6013
36814	3 pts		Rash		discontinuation	leads to discontinuation		6013
36815	3 pts		Vomiting		discontinuation	leads to discontinuation		6013
36816	2 pts		Arrhythmia		discontinuation	leads to discontinuation		6013
36817	2 pts		Myocardial ischemia		discontinuation	leads to discontinuation		6013
36818	2 pts		Nausea		discontinuation	leads to discontinuation		6013
36819						No AEs are reported		6011
36820	1 pts		Pulmonary toxicity		discontinuation			6014
36821						No adverse effects leading to discontinuation were reported		6016
36822						No serious adverse events were reported.		6015
36823						4 patients discontinued due to AEs (mostly involving the gastrointestinal tract), but they are not specified		6018
36824	2		Hematemesis		discontinuation			6017
36825	1 pts		Abdominal pain		discontinuation	leads to discontinuation		6019
36826	1 pts		ALT increased		discontinuation	leads to discontinuation		6019
36827	5 pts		Migraine		discontinuation	leads to discontinuation		6019
36828	1 pts		Myocardial ischemia		discontinuation	leads to discontinuation		6019
36829	1 pts		Cerebral ischemia		discontinuation	leads to discontinuation		6019
36830	1 pts		AST increased		discontinuation	leads to discontinuation		6019
36831						No AEs were reported		6020
36832			Loeffler's syndrome					6023
36833			Thrombocytopenia	grade 3	discontinuation			6024
36834						overdosage		6026
36835	44		Dermatitis	grade 3	discontinuation			6021
36836	4		Stomatitis	grade 3	discontinuation			6021
36837	4		Proteinuria	grade 3	discontinuation			6021
36838	4		Polyneuropathy	grade 3	discontinuation			6021
36839			Hepatitis					6022
36840	57.7		Dermatitis					6025
36841	30.8		Dermatitis		discontinuation			6025
36842	3.8		Loose stools					6025
36843	7.7		Stomatitis					6025
36844	3.8		Stomatitis		discontinuation			6025
36845	3.8		Proteinuria		discontinuation			6025
36846	3.8		Polyneuropathy		discontinuation			6025
36847	3.8		IgA deficiency		discontinuation			6025
36848			Nausea					6027
36849	19.2		Allergic dermatitis		discontinuation			6034
36850	5.1		Rash		discontinuation			6033
36851	2.6		Prurigo	grade 2				6033
36852	2.6		Eosinophilia	grade 2				6033
36853	5.4		Rash		discontinuation			6028
36854	1.8		Decreased appetite		discontinuation			6028
36855	1.8		Headache		discontinuation			6028
36856	1.8		Transaminases increased		discontinuation			6028
36857	5.4		Abdominal pain		discontinuation			6028
36858	3.6		Nausea		discontinuation			6028
36859	3.6		Abdominal pain upper		discontinuation			6028
36860	3.6		Vomiting		discontinuation			6028
36861	1.6		Maculopapular rash		discontinuation			6032
36862	1.6		Pruritus		discontinuation			6032
36863	2.6		Rash		discontinuation			6030
36864	2.6		Eosinophilia		discontinuation			6030
36865	2.6		Alkaline phosphatase increased		discontinuation			6030
36866	13		Allergic dermatitis	grade 3	discontinuation			6029
36867	1.4		Gastrointestinal disorders		discontinuation			6029
36868	8.9		Hypersensitivity		discontinuation			6031
36869	2.2		Alanine aminotransferase increase		discontinuation			6031
36870						No adverse effects leading to discontinuation were reported.		6035
36871						No adverse effects leading to discontinuation were reported.		6036
36872						No adverse effects leading to discontinuation were reported.		6037
36873			Cervical dystonia		discontinuation			6039
36874			Gastrointestinal discomfort					6038
36875			Nausea					6038
36876						The drug was well tolerated.		6040
36877			Insomnia		discontinuation	The AEs most commonly leading to discontinuation were nausea, headache, and insomnia		6041
36878			Headache		discontinuation	The AEs most commonly leading to discontinuation were nausea, headache, and insomnia		6041
36879			Nausea			The AEs most commonly leading to discontinuation were nausea, headache, and insomnia		6041
36880						No AEs were observed		6042
36881	10		Itching	grade 1				6043
36882						Formestane was well tolerated and no patient withdrew the treatment because of the onset of adverse events or reactions.		6044
36883	10.5		Injection site pain		dose reduction	In two patients, the dose was reduced to 250 mg fortnightly because of pain at the injection site.		6045
36884			Generalised exfoliative dermatitis		discontinuation			6048
36885						AEs were not observed		6047
36886	4.8		Nausea					6049
36887	14.3		Tiredness					6049
36888	14.3		Vomiting					6049
36889	9.5		Giddiness					6049
36890	9.5		Depression					6049
36891	9.5		Muscle stiffness					6049
36892	4.8		Dystonia					6049
36893						The source does not contain information about AEs or lack thereof		6046
36894						No adverse effects leading to discontinuation were reported.		6051
36895						No adverse effects leading to discontinuation were reported.		6050
36896	20		Headache	grade 1				6053
36897	5		Discomfort	grade 1				6052
36898	33.3		Testicular pain	grade 1-4				6054
36899	33.3		Chest pain	grade 2-3				6054
36900	100		Myalgia	grade 1-3			TRUE	6054
36901	16.7		Photophobia	grade 4				6054
36902	16.7		Ototoxicity	grade 1				6054
36903	33.3		Nausea	grade 1-2				6054
36904	40		Anorexia	grade 2-3				6055
36905	80		AST increased	grade 1				6055
36906	20		ALT increased	grade 1				6055
36907	20		Pain in limb	grade 3				6055
36908	20		Seizure	grade 3				6055
36909	100		Seizure					6056
36910	25		Pulmonary hemorrhage	grade 3			TRUE	6056
36911	50		Neuropathy	grade 3			TRUE	6056
36912			Anorexia			Anorexia or nausea: 50%		6056
36913			Nausea			Anorexia or nausea: 50%		6056
36914	33.3		Stomach pain					6057
36915	50		Neuropathy					6057
36916	16.7		Seizure					6057
36917			Anorexia			Anorexia or nausea: 66.7%		6057
36918			Nausea			Anorexia or nausea: 66.7%		6057
36919						No adverse effects leading to discontinuation were reported.		6058
36920						No AEs were observed		6059
36921	1.3		Dry mouth		discontinuation			6060
36922	1 pts		Headache	below serious				6061
36923	1 pts		Vulvovaginal discomfort	below serious				6061
36924	1 pts		Lymphadenopathy	below serious				6061
36925	1 pts		Nephrolithiasis	below serious				6061
36926	1 pts		Desmoid tumor	below serious				6061
36927	1 pts		Pyelonephritis	below serious				6061
36928	1 pts		Headache	below serious				6062
36929	1 pts		Dizziness	below serious				6062
36930	1 pts		Dysgeusia	below serious				6062
36931	1 pts		Vaginal discharge	below serious				6062
36932	1 pts		Vaginal odor	below serious				6062
36933	1 pts		Vulvovaginal pruritus	below serious				6062
36934	1 pts		Chromaturia	below serious				6062
36935	1 pts		Nausea	below serious				6062
36936	1 pts		Thermal burn	below serious				6062
36937	1 pts		ALT increased	below serious				6062
36938	1 pts		AST increased	below serious				6062
36939	1 pts		Oropharyngeal pain	below serious				6062
36940	1 pts		Gonorrhea	below serious				6062
36941	1 pts		Urinary tract infection	below serious				6062
36942	2 pts		Vaginal mycosis	below serious				6062
36943	1 pts		Tooth infection	below serious				6062
36944	9.6		Vulvovaginal candidiasis					6063
36945	3.6		Headache					6063
36946	3.6		Nausea					6063
36947	2.5		Diarrhea					6063
36948	2		Abdominal pain					6063
36949	2		Vulvovaginal pruritus					6063
36950						No information on AE is provided		6064
36951						The source does not contain information about AEs or lack thereof		6065
36952						AEs were not observed		6066
36953						The source does not contain information about AEs or lack thereof		6067
36954	1.2		Abdominal pain	grade 3				6068
36955	49		Biliary colic	grade 1-2				6068
36956	7.2		Jaundice	grade 1-2				6068
36957	42.7		Epigastric pain	grade 1-2				6068
36958	8.5		Nausea	grade 1-2				6068
36959	8.5		Fever	grade 1-2				6068
36960	6.1		Pruritus	grade 1-2				6068
36961	2.4		Urticaria	grade 1-2				6068
36962	100		Abdominal pain	grade 1				6072
36963	50		Fatigue	grade 1				6072
36964	75		Headache	grade 1-2				6072
36965	25		Diarrhea	grade 1				6072
36966	75		Nausea	grade 1				6072
36967	25		Vomiting	grade 1				6072
36968	25		Fever	grade 1-2				6072
36969	50		Dizziness	grade 1				6072
36970			Abdominal pain	grade 1-2				6076
36971			Fatigue	grade 1				6076
36972			Headache	grade 1-2				6076
36973			Diarrhea	grade 1-2				6076
36974			Vomiting	grade 1				6076
36975			Fever	grade 1-2				6076
36976			Dizziness	grade 1				6076
36977	56		Abdominal pain					6071
36978	23		Hyperhidrosis					6071
36979	9		Vertigo					6071
36980	8		Nausea					6071
36981	7		Urticaria					6071
36982	6		Vomiting					6071
36983	6		Headache					6071
36984	5		Dyspnea					6071
36985	4		Pruritus					6071
36986	4		Asthenia					6071
36987	4		Musculoskeletal chest pain					6071
36988	4		Cough					6071
36989	3		Decreased appetite					6071
36990	3		Chest pain					6071
36991	2		Pyrexia					6071
36992	2		Jaundice					6071
36993	2		Chest discomfort					6071
36994	< 2		Constipation					6071
36995	< 2		Biliary colic					6071
36996	< 2		Arthralgia					6071
36997	< 2		Back pain					6071
36998	< 2		Spinal pain					6071
36999	< 2		Chromaturia					6071
37000	93		Abdominal pain					6069
37001	25		Hyperhidrosis					6069
37002	18		Nausea					6069
37003	11		Urticaria					6069
37004	7		Vomiting					6069
37005	14		Headache					6069
37006	4		Pruritus					6069
37007	4		Musculoskeletal chest pain					6069
37008	18		Decreased appetite					6069
37009	7		Diarrhea					6069
37010	6.8		Bilirubin increased					6070
37011	4.5		AST increased					6070
37012	4.2		Alkaline phosphatase increased					6070
37013	3		ALT increased					6070
37014	5.7		Headache					6074
37015	5.7		Abdominal pain					6074
37016	2.9		Vomiting					6074
37017	2.9		Diarrhea					6074
37018	5.4		Dizziness					6073
37019	1.3		Abdominal pain					6073
37020	1.3		Diarrhea					6073
37021	1.9		Fever					6073
37022	6.4		Abdominal pain					6075
37023	10.6		Headache					6075
37024	4.3		Dizziness					6075
37025	2.1		Jaundice					6075
37026	3 pts		Leukopenia					6078
37027	3 pts		Neutropenia					6078
37028	3 pts		Thrombocytopenia					6078
37029	3 pts		Melaena					6078
37030	3 pts		Hematemesis					6078
37031	3 pts		Nausea					6078
37032	3 pts		Vomiting					6078
37033	1 pts		Arrhythmia	grade 3				6077
37034	1 pts		Febrile neutropenia	grade 3				6077
37035	1 pts		Neutropenia	grade 4				6077
37036	1 pts		Thrombocytopenia	grade 3				6080
37037	1 pts		Thrombocytopenia	grade 3				6081
37038	1 pts		Febrile neutropenia	grade 3				6081
37039	1 pts		Febrile neutropenia	grade 3				6079
37040	1 pts		Aspartate aminotransferase increase	grade 3				6079
37041	1 pts		Neutropenia	grade 4				6079
37042	1 pts		Alanine aminotransferase increase	grade 3				6079
37043	16.7		Thrombocytopenia				TRUE	6083
37044	40		Febrile neutropenia				TRUE	6082
37045	1.25		Pneumonia	grade 5	discontinuation			6084
37046						The source does not contain information about AEs or lack thereof		6086
37047						The source does not contain information about AEs or lack thereof		6085
37048	2 pts		Mental confusion		discontinuation	leads to discontinuation		6087
37049						No AEs were reported		6088
37050	4.3		Nausea					6089
37051	8.5		Dizziness					6089
37052	4.3		Headache					6089
37053						No AEs were observed		6090
37054						No AEs were observed		6091
37055	1 pts		Death	grade 5	discontinuation	leads to discontinuation		6092
37056						No adverse effects were recorded.		6094
37057						No adverse effects leading to discontinuation were reported.		6093
37058	6 pts		Dry mouth					6095
37059						No adverse effects leading to discontinuation were reported.		6096
37060						No adverse effects leading to discontinuation were reported.		6097
37061	6.7		Itching	grade 1				6098
37062	6.7		Burning skin	grade 1				6098
37063	3.9		Weakness					6099
37064	2.2		Epigastric pain					6099
37065	1.9		Nausea					6099
37066	1.7		Constipation					6099
37067	1.4		Dizziness					6099
37068	1.2		Headache					6099
37069			Death	grade 5				6101
37070						AEs were not observed		6100
37071			Cardiovascular collapse					6102
37072						No adverse events were reported in the fenticonazole group.		6104
37073						Drug was well tolerated in most of the patients. Only in 5 patients treated with fenticonazole were mild, local and short lasting side-effectsreported: burning in 2 cases, soreness in 2 cases and vaginal discharge in 1 case.		6105
37074						No adverse effects leading to discontinuation were reported		6106
37075						No adverse effects leading to discontinuation were reported		6103
37076						No serious adverse effects were recorded.		6107
37077						No adverse effects leading to discontinuation were reported.		6108
37078						No adverse effects leading to discontinuation were reported.		6109
37079	22		Nausea	grade 3				6110
37080	5		Vomiting	grade 3				6110
37081	1.6		Coma	grade 5	discontinuation			6110
37082	1.6		Encephalopathy	grade 5	discontinuation			6110
37083	1.6		Grand mal seizure	grade 5	discontinuation			6110
37084	40		Neutropenia	grade 4			TRUE	6111
37085	20		Thrombocytopenia	grade 4				6111
37086	33.3		Neutropenia	grade 3				6113
37087	50		Neutropenia	grade 4			TRUE	6112
37088	50		Neutropenia	grade 3				6112
37089	16.7		Thrombopenia	grade 4				6112
37090	16.7		Anemia	grade 3				6112
37091	16.7		Diarrhea	grade 4				6112
37092	16.7		Vomiting	grade 4				6112
37093						No significant side effects were observed at any dose level.		6114
37094						The source does not contain information about AEs or lack thereof		6116
37095						The source does not contain information about AEs or lack thereof		6115
37096			Drowsiness					6118
37097			Adrenergic syndrome	mild				6118
37098						No AEs were reported		6117
37099	1		Tachycardia		discontinuation			6121
37100	1		Fatigue		discontinuation			6121
37101	1		Dizziness		discontinuation			6121
37102	1 pts		Dyspepsia		discontinuation			6124
37103	1 pts		Abdominal pain		discontinuation			6124
37104	1 pts		Deliberate self-harm		discontinuation	BLACK BOX WARNING		6124
37105	0.2		Somnolence		discontinuation			6124
37106	1 pts		Vomiting		discontinuation			6124
37107	1 pts		Insomnia		discontinuation			6124
37108	1 pts		Headache		discontinuation			6124
37109	1 pts		Nausea		discontinuation			6124
37110	1 pts		Headache		discontinuation			6122
37111	2 pts		Somnolence		discontinuation			6122
37112	1 pts		Insomnia		discontinuation			6122
37113	1 pts		Suicidal ideation	serious	discontinuation	BLACK BOX WARNING		6122
37114	1 pts		Tachycardia		discontinuation			6122
37115	2 pts		Nausea		discontinuation			6122
37116	1 pts		Fatigue		discontinuation			6122
37117	2 pts		Irritability		discontinuation			6122
37118	1 pts		Abdominal pain		discontinuation			6122
37119	2 pts		Decreased appetite		discontinuation			6122
37120	1 pts		Somnolence					6119
37121	1		Anxiety		discontinuation			6123
37122	1		Diarrhea		discontinuation			6123
37123	1		Somnolence		discontinuation			6123
37124	1		Syncope		discontinuation			6123
37125	1		Abdominal pain		discontinuation			6123
37126	2		Somnolence		discontinuation			6120
37127	1		Dizziness		discontinuation			6120
37128	1		Fatigue		discontinuation			6120
37129	1		Tachycardia		discontinuation			6120
37130	1		Depression		discontinuation			6120
37131						No adverse effects leading to discontinuation were reported		6125
37132	83.3		Abnormal thinking					6126
37133	4.2		Hepatic failure	grade 5				6127
37134						No information on AE is provided		6129
37135						No information on AE is provided		6130
37136			Buccal mucosa ulceration		discontinuation	leads to dose interruption		6128
37137			Abdominal cramps		discontinuation	leads to dose interruption		6128
37138			Drowsiness					6132
37139						No information on AE is provided		6131
37140	25 pts		Eye disorders		discontinuation	leads to discontinuation		6134
37141	20 pts		Skin toxicity		discontinuation	leads to discontinuation		6134
37142	3 pts		Gastrointestinal symptom NOS		discontinuation	leads to discontinuation		6134
37143	4 pts		Abnormal liver function tests	grade 3	discontinuation	leads to discontinuation		6134
37144	5 pts		Abnormal liver function tests	grade 4	discontinuation	leads to discontinuation		6134
37145	1 pts		Abnormal lipid profile	grade 3	discontinuation	leads to discontinuation		6134
37146	2 pts		Abnormal lipid profile	grade 4	discontinuation	leads to discontinuation		6134
37147	1 pts		Nyctalopia	grade 1			TRUE	6143
37148	2 pts		Nyctalopia	grade 2			TRUE	6143
37149	1 pts		Nyctalopia	grade 3			TRUE	6143
37150	2 pts		Skin xerosis	grade 1				6143
37151	1 pts		Nyctalopia	grade 1			TRUE	6144
37152	1 pts		Skin xerosis	grade 1				6144
37153	1 pts		Skin xerosis	grade 1				6145
37154	1 pts		Skin xerosis	grade 2				6145
37155	1 pts		Conjunctivitis	grade 1				6145
37156	1 pts		Nyctalopia	grade 1			TRUE	6146
37157	1 pts		Skin xerosis	grade 1				6146
37158	3 pts		Skin xerosis	grade 2				6147
37159	1 pts		Hepatotoxicity	grade 2		MTD was not reached		6136
37160	2 pts		Diarrhea	grade 1		MTD was not reached		6136
37161	1 pts		Diarrhea	grade 2		MTD was not reached		6136
37162	5 pts		Anemia	grade 1				6133
37163	1 pts		Ocular discomfort	grade 1				6133
37164	1 pts		Photophobia	grade 1				6133
37165	5 pts		Fatigue	grade 1				6133
37166	4 pts		Nausea	grade 1				6133
37167	1 pts		Vomiting	grade 1				6133
37168	3 pts		Diarrhea	grade 1				6133
37169	2 pts		Lymphopenia	grade 1				6133
37170	1 pts		Creatinine decreased	grade 1				6133
37171	5 pts		Nyctalopia	grade 2				6133
37172	1 pts		Anemia	grade 2				6133
37173	7 pts		Ocular discomfort	grade 2				6133
37174	1 pts		Photophobia	grade 2				6133
37175	3 pts		Fatigue	grade 2				6133
37176	2 pts		Rash	grade 2				6133
37177	1 pts		Nausea	grade 2				6133
37178	1 pts		Vomiting	grade 2				6133
37179	1 pts		Diarrhea	grade 2				6133
37180	1 pts		Lymphopenia	grade 2				6133
37181	2 pts		Creatinine decreased	grade 2				6133
37182	1 pts		Fatigue	grade 3				6133
37183	1 pts		Nausea	grade 3				6133
37184	1 pts		Vomiting	grade 3				6133
37185	1 pts		Diarrhea	grade 3				6133
37186	1 pts		Thrombosis	grade 3				6133
37187	9 pts		Gastrointestinal disorder	grade 1				6139
37188	8 pts		Diarrhea	grade 1				6139
37189	1 pts		Diarrhea	grade 3				6139
37190	8 pts		Eye disorders	grade 1				6139
37191	8 pts		Triglyceride increased	grade 1				6139
37192	6 pts		Pain	grade 1				6139
37193	5 pts		LDL cholesterol increased	grade 1				6139
37194	5 pts		Constipation	grade 1				6139
37195	4 pts		Skin toxicity	grade 1				6139
37196	4 pts		Photosensitivity	grade 1				6139
37197	3 pts		Fatigue	grade 1				6139
37198	1 pts		Fatigue	grade 2				6139
37199	3 pts		Glucose increased	grade 1				6139
37200	2 pts		Arthritis	grade 1				6139
37201	2 pts		Conjunctivitis	grade 1				6139
37202	2 pts		Headache	grade 1				6139
37203	2 pts		Hot flashes	grade 1				6139
37204	2 pts		Nausea	grade 1				6139
37205	1 pts		Nyctalopia	grade 1				6139
37206	1 pts		Nyctalopia	grade 2				6139
37207	8 pts		Nyctalopia	grade 1				6140
37208	1 pts		Nausea	grade 1				6140
37209	2 pts		Nausea	grade 2				6140
37210	1 pts		Nausea	grade 3				6140
37211	1 pts		Vomiting	grade 2				6140
37212	1 pts		Vomiting	grade 3				6140
37213	2 pts		Diarrhea	grade 1				6140
37214	1 pts		Diarrhea	grade 2				6140
37215	1 pts		Diarrhea	grade 3			TRUE	6138
37216	1 pts		Allergic reaction	grade 3	discontinuation	leads to discontinuation	TRUE	6138
37217	1 pts		Diarrhea	grade 3			TRUE	6142
37218	1 pts		Diarrhea	grade 3		leads to dose reduction	TRUE	6135
37219						no DLTs were observed		6141
37220	1 pts		Thrombocytopenia	grade 4			TRUE	6135
37221	1 pts		Allergic reaction	grade 2			TRUE	6135
37222	1 pts		Diarrhea					6137
37223						No AEs were reported		6148
37224	8 pts		Nausea	grade 1				6151
37225	1 pts		Nausea	grade 2				6151
37226	3 pts		Vomiting	grade 1				6151
37227	2 pts		Vomiting	grade 2				6151
37228	4 pts		Diarrhea	grade 1				6151
37229	3 pts		Diarrhea	grade 2				6151
37230	12 pts		Fatigue	grade 1				6151
37231	2 pts		Fatigue	grade 2				6151
37232	3 pts		Fatigue	grade 3			TRUE	6151
37233	1 pts		Diarrhea	grade 3			TRUE	6153
37234	8 pts		Nausea	grade 1				6149
37235	3 pts		Nausea	grade 2				6149
37236	1 pts		Nausea	grade 3				6149
37237	5 pts		Vomiting	grade 1				6149
37238	2 pts		Vomiting	grade 2				6149
37239	1 pts		Vomiting	grade 3				6149
37240	4 pts		Diarrhea	grade 1				6149
37241	12 pts		Fatigue	grade 1				6149
37242	1 pts		Fatigue	grade 3			TRUE	6149
37243	2 pts		Nausea	grade 1				6150
37244	1 pts		Nausea	grade 2				6150
37245	3 pts		Vomiting	grade 1				6150
37246	1 pts		Diarrhea	grade 1				6150
37247	1 pts		Diarrhea	grade 2				6150
37248	5 pts		Fatigue	grade 1				6150
37249	2 pts		Fatigue	grade 2				6150
37250	1 pts		Fatigue	grade 3				6150
37251	7 pts		Anemia	grade 1				6154
37252	1 pts		Anemia	grade 2				6154
37253	11 pts		Neutropenia	grade 1				6154
37254	5 pts		Neutropenia	grade 2				6154
37255	6 pts		Thrombocytopenia	grade 1				6154
37256	3 pts		Thrombocytopenia	grade 2				6154
37257	2 pts		Thrombocytopenia	grade 3				6154
37258	3 pts		Allergy	grade 1				6154
37259	1 pts		Auditory nerve disorders	grade 1				6154
37260	3 pts		Constitutional syndrome	grade 1				6154
37261	9 pts		Constitutional syndrome	grade 2				6154
37262	6 pts		Constitutional syndrome	grade 3				6154
37263	7 pts		Skin toxicity	grade 1				6154
37264	5 pts		Skin toxicity	grade 2				6154
37265	1 pts		Skin toxicity	grade 3				6154
37266	1 pts		Endocrine disorders	grade 2				6154
37267	2 pts		Anorexia	grade 1				6154
37268	4 pts		Anorexia	grade 2				6154
37269	1 pts		Dehydration	grade 1				6154
37270	2 pts		Dehydration	grade 2				6154
37271	1 pts		Dehydration	grade 3				6154
37272	6 pts		Diarrhea	grade 1				6154
37273	1 pts		Mucositis	grade 4				6154
37274	3 pts		Nausea	grade 1				6154
37275	3 pts		Dysgeusia	grade 1				6154
37276	1 pts		Bleeding	grade 1				6154
37277	3 pts		Bleeding	grade 3				6154
37278	1 pts		Febrile neutropenia	grade 1				6154
37279	9 pts		Febrile neutropenia	grade 3				6154
37280	1 pts		Neutropenia	grade 1				6154
37281	9 pts		Neutropenia	grade 3				6154
37282	8 pts		Hepatic metabolic disorders	grade 1				6154
37283	1 pts		Hepatic metabolic disorders	grade 2				6154
37284	2 pts		Hepatic metabolic disorders	grade 3				6154
37285	1 pts		Hepatic metabolic disorders	grade 4				6154
37286	4 pts		Neurologic disorder NOS	grade 1				6154
37287	4 pts		Neurologic disorder NOS	grade 2				6154
37288	2 pts		Neurologic disorder NOS	grade 3				6154
37289	12 pts		Pain	grade 1				6154
37290	7 pts		Pain	grade 2				6154
37291	6 pts		Respiratory tract disorders NEC	grade 1				6154
37292	2 pts		Respiratory tract disorders NEC	grade 2				6154
37293	2 pts		Respiratory tract disorders NEC	grade 3				6154
37294	1 pts		Respiratory tract disorders NEC	grade 4				6154
37295	1 pts		Renal and urinary disorders	grade 1				6154
37296	12 pts		Vomiting	all grades				6152
37297	10 pts		Nausea	all grades				6152
37298	1 pts		Nausea	grade 3				6152
37299	7 pts		Diarrhea	all grades				6152
37300	3 pts		Neutropenia	all grades				6152
37301	1 pts		Neutropenia	grade 3				6152
37302	2 pts		Lymphopenia	all grades				6152
37303	1 pts		Lymphopenia	grade 3				6152
37304	2 pts		Thrombocytopenia	all grades				6152
37305	2 pts		Leukopenia	all grades				6152
37306	2 pts		Anemia	all grades				6152
37307	5 pts		ALT increased	all grades				6152
37308	2 pts		ALT increased	grade 3				6152
37309	3 pts		AST increased	all grades				6152
37310	4 pts		Weight loss	all grades				6152
37311	2 pts		Creatinine increased	all grades				6152
37312	4 pts		Hyponatremia	all grades				6152
37313	2 pts		Hyperkalemia	grade 3				6152
37314	2 pts		Hypoalbuminemia	all grades				6152
37315	2 pts		Hypokalemia	all grades				6152
37316	1 pts		Hypokalemia	grade 3				6152
37317	68		Musculoskeletal pain	grade 1-2				6155
37318	41		Nausea	grade 1-2				6155
37319	45		Fatigue	grade 1-2				6155
37320	32		Asthenia	grade 1-2				6155
37321	14		Vomiting	grade 1-2				6155
37322	14		Hot flashes	grade 1-2				6155
37323	23		Heartburn	grade 1-2				6155
37324	14		Abdominal pain	grade 1-2				6155
37325	14		Decreased appetite	grade 1-2				6155
37326	18		Constipation	grade 1-2				6155
37327	18		Depression	grade 1-2				6155
37328	5		Diarrhea	grade 1-2				6155
37329	23		Headache	grade 1-2				6155
37330	9		Musculoskeletal pain	grade 3-4				6155
37331	9		Nausea	grade 3-4				6155
37332	14		Vomiting	grade 3-4				6155
37333	5		Abdominal pain	grade 3-4				6155
37334	5		Constipation	grade 3-4				6155
37335			Headache					6157
37336			Flushing					6157
37337			Nausea					6157
37338			Injection site reaction					6157
37339	62		Asthenia					6156
37340	38		Nausea					6156
37341	62		Headache					6156
37342	31		Vomiting					6156
37343	31		Postural hypotension					6156
37344	85		Injection site reaction					6156
37345	31		Vasodilatation					6156
37346	31		Dizziness					6156
37347	1 pts		Nausea and vomiting	severe	discontinuation			6156
37348	1		Dizziness					6158
37349			Aspartate aminotransferase increased					6158
37350	3		Nausea					6158
37351			Aspartate aminotransferase increased					6158
37352	1		Constipation					6158
37353	4		Blood creatine phosphokinase increased					6158
37354	1		Vomiting					6158
37355	3		Diarrhea					6158
37356	2		Aspartate aminotransferase increased					6158
37357	3		Upper respiratory tract infection					6158
37358	2		Blood glucose increased					6158
37359	3		Alanine aminotransferase increase					6158
37360	1		Abdominal discomfort					6158
37361	1		Gastroenteritis					6158
37362	1		Neutrophil count decreased					6158
37363						adverse effects were combined for all doses		6159
37364	1 pts		Epigastric pain	severe	discontinuation			6160
37365	1 pts		Vomiting	severe				6160
37366	1 pts		Dizziness	severe				6160
37367						It's impossible to link AEs with the definite dose. The most frequently reported adverse events were headache (11%), nausea (10%) and diarrhea (10%)		6161
37368						No AEs were reported		6164
37369						No AEs were reported		6162
37370	12 pts		Pulmonary fibrosis	grade 3-4	discontinuation	leads to discontinuation		6163
37371	12.5		Vomiting		discontinuation			6167
37372						No adverse effects leading to discontinuation were reported.		6165
37373	12.5		Hyperventilation	grade 3	discontinuation	possibly related		6166
37374	12.5		Headache	grade 3	discontinuation	possibly related		6166
37375	12.5		ALT increased	grade 2	discontinuation			6166
37376	11.1		Angina	grade 3	discontinuation			6168
37377	11.1		Coronary vasospasm	grade 3	discontinuation			6168
37378	11.1		Sinus arrhythmia	grade 3	discontinuation			6168
37379	11.1		Weakness		discontinuation			6169
37380	11.1		Postural hypotension	grade 2	discontinuation			6169
37381	11.1		Nausea	grade 3	discontinuation			6169
37382	11.1		Vomiting	grade 3	discontinuation			6169
37383	11.1		Lightheadedness		discontinuation			6169
37384	11.1		Dizziness		discontinuation			6169
37385						No adverse effects leading to discontinuation were reported		6170
37386						AEs were not observed		6171
37387	16.7		Neutropenia	grade 4			TRUE	6173
37388	100		Neutropenia	grade 4			TRUE	6172
37389	8.3		Neutropenic fever	grade 3			TRUE	6174
37390	66.7		Neutropenia				TRUE	6175
37391						cipamfylline cream is well-tolerated		6176
37392	3 pts		Neutropenia	grade 4			TRUE	6178
37393	3 pts		Fatigue	grade 3			TRUE	6178
37394	1 pts		Febrile neutropenia	grade 5				6178
37395	3 pts		Neutropenia	grade 4			TRUE	6177
37396	2 pts		Thrombocytopenia	grade 4				6177
37397	2 pts		Anemia	grade 3				6177
37398	1 pts		Vomiting	grade 3				6177
37399	2 pts		Diarrhea	grade 2				6177
37400	3 pts		Fatigue	grade 3			TRUE	6177
37401	3 pts		Neuromuscular toxicity	grade 3			TRUE	6179
37402						there were no significant differences between the placebo and eniporide groups		6180
37403	37.5		Postural hypotension	grade 2				6181
37404	50		Dizziness					6181
37405			Dizziness					6182
37406						No AEs were reported		6183
37407	6 pts		Cardiovascular disorder		discontinuation	leads to discontinuation		6185
37408	8 pts		Cardiovascular disorder		discontinuation	leads to discontinuation		6186
37409	9 pts		Cardiovascular disorder		discontinuation	leads to discontinuation		6184
37410	5		Angina		discontinuation	unstable angina		6187
37411	2 pts		Nausea					6189
37412	1 pts		Transaminases increased	moderate	discontinuation	leads to discontinuation		6190
37413						Impossible to link AEs with the definite dose: a single episode of loose stool was reproducible in a second treatment period and was therefore considered to be a robable drug-related event		6188
37414	12 pts		Myalgia					6191
37415	6 pts		Rhinitis					6191
37416						No special events related to igmesine administration were detected by the investigators or reported by the subjects.		6192
37417						No information on AE is provided		6193
37418	7 pts		Dysgeusia					6196
37419	2 pts		Headache					6196
37420	1 pts		Vomiting					6196
37421	9 pts		Dysgeusia					6195
37422	24 pts		Dysgeusia					6197
37423	15 pts		Nausea					6197
37424	11 pts		Vomiting					6197
37425	5 pts		Diarrhea					6197
37426	8 pts		Fatigue					6197
37427	7 pts		Anemia					6197
37428	11 pts		Peripheral edema					6197
37429	9 pts		Headache					6197
37430	3 pts		Renal impairment					6197
37431	2 pts		Depression					6197
37432	10 pts		Death	grade 5	discontinuation	leads to discontinuation		6197
37433	12 pts		Death	grade 5	discontinuation	leads to discontinuation		6198
37434	25 pts		Dysgeusia					6198
37435	12 pts		Nausea					6198
37436	13 pts		Vomiting					6198
37437	7 pts		Anemia					6198
37438	6 pts		Peripheral edema					6198
37439	13 pts		Diarrhea					6198
37440	10 pts		Fatigue					6198
37441	4 pts		Headache					6198
37442	7 pts		Renal impairment					6198
37443	8 pts		Depression					6198
37444	14 pts		Nausea					6194
37445	10 pts		Death	grade 5	discontinuation	leads to discontinuation		6194
37446	11 pts		Vomiting					6194
37447	10 pts		Diarrhea					6194
37448	7 pts		Fatigue					6194
37449	10 pts		Anemia					6194
37450	6 pts		Peripheral edema					6194
37451	6 pts		Headache					6194
37452	9 pts		Renal impairment					6194
37453	29 pts		Dysgeusia					6194
37454	1 pts		Depression					6194
37455						Moguisteine was well tolerated and no serious adverse events were reported during the study.		6199
37456						Moguisteine was well tolerated and no serious adverse events were reported during the study.		6200
37457						No adverse effects leading to discontinuation were reported		6201
37458	3.4		Photosensitivity	grade 2	discontinuation			6203
37459	16.7		Nausea	grade 1				6202
37460						No information on AE is provided		6204
37461	16.7		Maculopapular rash		discontinuation			6207
37462	16.7		Itching		discontinuation			6206
37463	16.7		Skin eruption		discontinuation			6206
37464						No adverse effects leading to discontinuation were reported		6205
37465	2 pts		Headache	grade 1				6209
37466	1 pts		Headache	grade 2				6209
37467	1 pts		Diarrhoea	grade 1				6209
37468	2 pts		Diarrhoea	grade 2				6209
37469	1 pts		Dyspepsia	grade 1				6209
37470	2 pts		Flatulence	grade 1				6209
37471	1 pts		Nausea	grade 1				6209
37472	2 pts		Abdominal pain	grade 1				6209
37473	1 pts		Dry mouth	grade 1				6209
37474	1 pts		Insomnia	grade 1				6209
37475	1 pts		Taste perversion	grade 1				6209
37476	2 pts		Headache	grade 1				6208
37477	1 pts		Headache	grade 2				6208
37478	1 pts		Abnormal stools	grade 2				6208
37479	1 pts		Constipation	grade 2				6208
37480	1 pts		Diarrhoea	grade 2				6208
37481	1 pts		Dyspepsia	grade 1				6208
37482	1 pts		Melena	grade 1				6208
37483	1 pts		Nausea	grade 1				6208
37484	1 pts		Dizziness	grade 1				6208
37485	1 pts		Erythema	grade 1				6208
37486	1 pts		Pruritus	grade 1				6208
37487	2 pts		Rash	grade 1				6208
37488	2 pts		AST increased	grade 2				6208
37489	2 pts		ALT increased	grade 2				6208
37490	2 pts		Hyperchloremia	grade 2				6208
37491	1 pts		Bilirubin increased	grade 3				6208
37492	1 pts		AST increased	grade 2				6209
37493	1 pts		ALT increased	grade 2				6209
37494	1 pts		Hyperkalemia	grade 2				6209
37495	1 pts		Hyperchloremia	grade 2				6209
37496	1 pts		Hyponatremia	grade 3				6209
37497	1 pts		Hyperkalemia	grade 3				6209
37498	100		Confusion					6212
37499	100		Depressed level of consciousness					6212
37500	100		Vomiting					6212
37501	50		Bronchopneumonia					6212
37502	50		Headache					6212
37503	50		Dizziness	grade 1				6210
37504	42.9		Vomiting					6211
37505	42.9		Visual hallucinations					6211
37506	1 pts		Transient ischemic attack	moderate	discontinuation	leads to discontinuation		6213
37507	1 pts		Dizziness	moderate	discontinuation	leads to discontinuation		6214
37508						No adverse effects leading to discontinuation were reported.		6216
37509	50		Myelosuppression	grade 4			TRUE	6215
37510						AEs were not observed		6217
37511						The source does not contain information about AEs or lack thereof		6220
37512						The source does not contain information about AEs or lack thereof		6219
37513			Wheeze		discontinuation			6218
37514			Tachycardia		discontinuation			6218
37515			Salivation					6218
37516			Cyanosis		discontinuation			6218
37517			Cough					6218
37518	2 pts		Visual disturbance		discontinuation			6221
37519	1 pts		Thrombocytopenia		discontinuation			6221
37520	1.3		Diarrhoea		dose interruption			6222
37521	23		Vomiting					6222
37522	2.6		Stevens-Johnson syndrome		dose interruption			6222
37523	2.7		Vomiting		dose interruption			6222
37524	17		Anorexia		dose interruption			6222
37525	28		Giddiness					6222
37526	1.3		Skin rash		discontinuation			6222
37527	3		Jaundice		discontinuation|dose interruption			6222
37528	7		Cutaneous hypersensitivity					6222
37529						The source does not contain information about AEs or lack thereof		6224
37530			Hepatitis		discontinuation			6223
37531	1 pts		Thrombocytopenic purpura		discontinuation			6225
37532						No AEs are reported		6226
37533	2 pts		Anemia	severe	discontinuation	leads to discontinuation		6228
37534	3 pts		Cutaneous hypersensitivity		discontinuation	leads to discontinuation		6228
37535	1 pts		Myoclonic seizure NOS		discontinuation	leads to discontinuation		6230
37536			Arterial thromboembolism					6229
37537			Anemia		discontinuation	leads to dose reduction		6227
37538			Psychosis		discontinuation	1 patient		6231
37539			Delirium	severe	discontinuation	1 patient		6232
37540	24 pts		Nausea					6233
37541	21 pts		Abdominal pain					6233
37542	21 pts		Diarrhea					6233
37543	11 pts		Headache					6233
37544	5 pts		Vomiting					6233
37545	5 pts		Vertigo					6233
37546	1 pts		Anorexia					6233
37547	1 pts		Weakness					6233
37548	1 pts		Chest pain					6233
37549	50		Presyncope					6234
37550						No adverse effects leading to discontinuation were reported.		6235
37551			Allergic contact dermatitis		discontinuation			6238
37552						The source does not contain information about AEs or lack thereof		6237
37553						The source does not contain information about AEs or lack thereof		6236
37554			Hepatitis		discontinuation	POISONING		6239
37555			Agranulocytosis		discontinuation	POISONING		6239
37556	2 pts		Hepatitis	acute	discontinuation			6240
37557	1 pts		Hepatic failure	severe|grade 5				6240
37558			Jaundice			POISONING		6242
37559			Nausea			POISONING		6242
37560			Abdominal pain			POISONING		6242
37561			Jaundice	grade 5	discontinuation	POISONING		6241
37562			Coma		discontinuation			6243
37563			Respiratory depression		discontinuation			6243
37564			Hypotension					6243
37565			Hypothermia					6243
37566						None of the patients discontinued treatment because of the occurrence of side effects.		6244
37567	87		Injection site pain					6245
37568	13		Heartburn					6245
37569						No adverse effects leading to discontinuation were reported		6246
37570						No serious adverse drug reaction was recorded during the trial.		6247
37571			Hemorrhage			intoxication		6248
37572						No adverse effects were recorded.		6249
37573	0.79		Somnolence	grade 3	discontinuation			6250
37574	16		Headache					6251
37575	35		Dizziness	grade 1-2				6251
37576	6		Insomnia					6251
37577	1 pts		Hepatitis		discontinuation	leads to discontinuation		6252
37578	25		Hiccup					6253
37579			Nausea					6253
37580			Sedation					6253
37581	58.3		Somnolence	grade 2-3				6255
37582	8.3		Hypotension	grade 1-2				6255
37583			Hallucinations		dose reduction			6254
37584						The safety of esaprazole was good, no modifications of laboratory parameters being observed.		6256
37585						No adverse effects leading to discontinuation were reported		6257
37586						No side effects were noted		6258
37587						No side effects were noted		6259
37588	4 pts		Nausea					6260
37589	1 pts		Vomiting					6260
37590	4 pts		Muscle twitching					6260
37591	4 pts		Dysphoria					6260
37592	4 pts		Fatigue					6260
37593	2 pts		Dizziness					6260
37594	2 pts		Dyspnea					6260
37595	1 pts		Ear buzzing					6260
37596	2 pts		Vertigo					6260
37597	1 pts		Visual hallucinations					6260
37598	1 pts		Pruritus					6260
37599			Headache					6262
37600			Burning skin					6262
37601	20		Injection site pain					6262
37602			Eczema		discontinuation			6261
37603	0.9		Transaminases increased	moderate	discontinuation	Possibly related		6263
37604	0.9		Arrhythmia	moderate	discontinuation	Probably related		6263
37605	2.8		Elevated liver enzyme levels	moderate	discontinuation	Possibly/probably related		6263
37606	4 pts		Palpitation					6266
37607	4 pts		Nervousness					6266
37608	3 pts		Palpitation					6264
37609	3 pts		Nervousness					6264
37610	1 pts		Malignant hyperthermia	grade 5				6265
37611	1 pts		Nausea	grade 1				6268
37612	1 pts		Vomiting	grade 1				6268
37613	1 pts		Indigestion	grade 1				6268
37614	1 pts		Heartburn	grade 1				6268
37615	1 pts		Pain	grade 1				6268
37616	1 pts		Cramps	grade 1				6268
37617	1 pts		Decreased appetite	grade 1				6268
37618	4 pts		Headache	grade 1				6268
37619	1 pts		ALT increased	grade 1				6268
37620	1 pts		AST increased	grade 1				6268
37621	1 pts		Bilirubin increased	grade 1				6268
37622	1 pts		Pain	grade 2				6268
37623	1 pts		Cramps	grade 2				6268
37624	1 pts		ALT increased	grade 2				6268
37625	1 pts		AST increased	grade 2				6268
37626	1 pts		Bilirubin increased	grade 2				6268
37627	2 pts		Nausea	grade 1				6267
37628	2 pts		Vomiting	grade 1				6267
37629	3 pts		Indigestion	grade 1				6267
37630	3 pts		Heartburn	grade 1				6267
37631	2 pts		Pain	grade 1				6267
37632	2 pts		Cramps	grade 1				6267
37633	1 pts		Decreased appetite	grade 1				6267
37634	3 pts		Headache	grade 1				6267
37635	1 pts		ALT increased	grade 1				6267
37636	1 pts		AST increased	grade 1				6267
37637	1 pts		Bilirubin increased	grade 1				6267
37638	1 pts		Nausea	grade 2				6267
37639	1 pts		Vomiting	grade 2				6267
37640	1 pts		Pain	grade 2				6267
37641	1 pts		Cramps	grade 2				6267
37642	1 pts		Change in bowel habits	grade 2				6267
37643	1 pts		Headache	grade 2				6267
37644	2 pts		ALT increased	grade 2				6267
37645	2 pts		AST increased	grade 2				6267
37646	2 pts		Bilirubin increased	grade 2				6267
37647	1 pts		ALT increased	grade 3				6267
37648	1 pts		AST increased	grade 3				6267
37649	1 pts		Bilirubin increased	grade 3				6267
37650	18 pts		Agitation					6270
37651	12 pts		Headache					6270
37652	10 pts		Insomnia					6270
37653	7 pts		Anxiety					6270
37654	7 pts		Nervousness					6270
37655	4 pts		Psychosis					6270
37656	4 pts		GGT increased					6270
37657	4 pts		AST increased					6270
37658	4 pts		ALT increased					6270
37659	4 pts		Infection					6270
37660	4 pts		Dyspepsia					6270
37661	4 pts		Pruritus					6270
37662	4 pts		Rhinitis					6270
37663	3 pts		Sinusitis					6270
37664	3 pts		Cough increased					6270
37665	2 pts		Cardiovascular disorder					6270
37666	2 pts		Nausea					6270
37667	3 pts		Hypotension				TRUE	6269
37668	38.9		Haematuria					6272
37669	16.7		Indigestion					6272
37670	6.7		Vomiting					6272
37671	33.3		Drowsiness					6272
37672	5.5		Skin irritation	grade 1				6272
37673	11.1		Skin blotches					6272
37674			Alkaline phosphatase					6272
37675			Edema legs	grade 3	discontinuation			6271
37676			Proteinuria		discontinuation			6271
37677						AEs were not observed		6274
37678	4.2		Tinnitus					6273
37679	4.2		Headache					6273
37680	4.2		Drowsiness					6273
37681	4.2		Urinary frequency					6273
37682	29.2		Gastrointestinal disturbance					6273
37683						AEs were not observed		6275
37684			Trembling		dose reduction			6276
37685			Dizziness		dose reduction			6276
37686	4		Allergy		discontinuation			6277
37687	9		Hepatotoxicity		discontinuation			6278
37688						No adverse effects leading to discontinuation were reported.		6279
37689	10 pts		Gastrointestinal disorders					6283
37690	13 pts		Nausea					6282
37691	13 pts		Vomiting					6282
37692	8 pts		Hepatitis toxic				TRUE	6282
37693	8 pts		Transaminases increased				TRUE	6282
37694	3 pts		Bilirubin increased				TRUE	6282
37695	2 pts		Hepatitis acute				TRUE	6281
37696	2 pts		Hepatotoxicity	grade 5	discontinuation	leads to discontinuation	TRUE	6280
37697						No information on AE is provided		6285
37698						No information on AE is provided		6284
37699	15 pts		Nausea	grade 3-4				6291
37700	15 pts		Vomiting	grade 3-4				6291
37701	12 pts		Appetite lost	grade 2-4				6291
37702	3 pts		Diarrhoea	grade 1-2				6291
37703	2 pts		Pain	grade 2-3				6291
37704	1 pts		Constipation	grade 2				6291
37705	1 pts		Exercise dyspnoea	grade 2				6291
37706	1 pts		Fever	grade 2				6291
37707	1 pts		Nausea	grade 2			TRUE	6287
37708	2 pts		Nausea	grade 3			TRUE	6287
37709	1 pts		Vomiting	grade 2			TRUE	6287
37710	1 pts		Vomiting	grade 3			TRUE	6287
37711	1 pts		Diarrhea	grade 2			TRUE	6287
37712	1 pts		Diarrhea	grade 3			TRUE	6287
37713	1 pts		Constipation	grade 2				6287
37714	2 pts		AST increased	grade 2				6287
37715	1 pts		AST increased	grade 3				6287
37716	1 pts		ALT increased	grade 3				6287
37717	1 pts		Bilirubin increased	grade 3				6287
37718	1 pts		Abdominal cramps	grade 3				6287
37719	2 pts		Anorexia	grade 3				6287
37720	2 pts		Fatigue	grade 2				6287
37721	1 pts		Fatigue	grade 3				6287
37722	3 pts		Fever	grade 1				6287
37723	1 pts		Hepatotoxicity	grade 3			TRUE	6287
37724	2 pts		Nausea	grade 1				6286
37725	1 pts		Nausea	grade 2				6286
37726	4 pts		Diarrhea	grade 1				6286
37727	2 pts		Nausea	grade 2				6289
37728	2 pts		Vomiting	grade 2				6289
37729	1 pts		Diarrhea	grade 2				6289
37730	1 pts		Abdominal cramps	grade 3			TRUE	6289
37731	1 pts		Abdominal cramps	grade 4			TRUE	6289
37732	1 pts		Anorexia	grade 2				6289
37733	3 pts		Vomiting	grade 2				6290
37734	1 pts		Diarrhea	grade 2				6290
37735	1 pts		Bilirubin increased	grade 2			TRUE	6290
37736	1 pts		Anorexia	grade 2				6290
37737	1 pts		Nausea	grade 2				6288
37738	2 pts		Nausea	grade 3				6288
37739	1 pts		Vomiting	grade 2				6288
37740	1 pts		Vomiting	grade 3				6288
37741	1 pts		Diarrhea	grade 2				6288
37742	1 pts		Diarrhea	grade 3				6288
37743	1 pts		Abdominal cramps	grade 3				6288
37744	2 pts		SGOT increased	grade 2				6288
37745	1 pts		SGOT increased	grade 3				6288
37746	2 pts		Anorexia	grade 3				6288
37747	1 pts		Weight loss	grade 2				6288
37748	2 pts		Fatigue	grade 2				6288
37749	1 pts		Fatigue	grade 3				6288
37750			Jaundice	serious	discontinuation	leads to discontinuation		6292
37751			Contact dematitis					6293
37752						No drug related adverse effects leading to discontinuation were reported.		6294
37753						No AEs were observed		6295
37754						Therapy was not discontinued in any patient due to vitamin toxicity or for other safety reasons.		6296
37755			Adverse event	grade 5		No Aes are reported		6297
37756			Anaphylactic shock		discontinuation			6298
37757	15 pts		Infertility		discontinuation	leads to discontinuation		6299
37758						No AEs were reported		6301
37759						No AEs were reported		6300
37760	14 pts		Neuropathy					6305
37761	1 pts		Peripheral neuropathy	grade 1			TRUE	6303
37762	1 pts		Peripheral neuropathy	grade 1			TRUE	6304
37763	2 pts		Peripheral neuropathy	grade 1			TRUE	6302
37764	2		Serum transaminase increased					6306
37765	2		Nausea	grade 3				6306
37766	2		Vomiting	grade 3				6306
37767	2		Hypercalcaemia					6306
37768	2		Thrombophlebitis leg					6306
37769			Ichthyosis		discontinuation	Side effects of nafoxidine consisted mainly of ichtyosis (11 cases) which increased with duration of treatment. Though non-pruriginous this skin change was sometimes extremely severe and made it difficult to pursue the treatment.		6306
37770	4.3		Hypercalcemia		discontinuation			6307
37771	15		Increased appetite					6308
37772	36		Skin rash					6308
37773	37		Itching					6308
37774	68		Flushing					6308
37775	50		Nausea					6308
37776	15		Abdominal pain					6308
37777	30		Nausea					6309
37778	30		Vomiting					6309
37779	20		Diarrhoea					6309
37780	20		Abdominal cramps					6309
37781	10		Rash					6309
37782	10		Fever					6309
37783	10		Transaminases increased					6309
37784	10		Neutropenia					6309
37785			Death					6311
37786						AEs were not observed		6310
37787						AEs were not observed		6312
37788						The source does not contain information about AEs or lack thereof		6313
37789	1 pts		Vertigo		discontinuation			6314
37790	2 pts		Gastrointestinal disorder					6316
37791	1 pts		Nausea					6316
37792	2 pts		Gastrointestinal fullness					6316
37793	3 pts		Diarrhoea					6316
37794	2 pts		Exanthema					6316
37795	1 pts		Migraine					6316
37796	1 pts		Pain					6316
37797						No AEs were observed		6315
37798			Visual hallucinations		discontinuation			6317
37799	1 pts		Insomnia		discontinuation	leads to discontinuation		6318
37800	1 pts		Nausea		discontinuation	leads to discontinuation		6318
37801			Liver damage					6319
37802			Hepatitis		discontinuation	leads to discontinuation		6320
37803			Agranulocytosis		discontinuation			6323
37804	4		Cycloplegia		discontinuation			6322
37805						The doses for adverse reactions leading to discontinuation are not indicated. Some patients were withdrawn from the study because of drowsiness, but dose is unknown		6321
37806			Jaundice		discontinuation			6325
37807	3		Agranulocytosis		discontinuation	1 patient		6324
37808	20		Constipation	grade 3	discontinuation			6326
37809	20		Vomiting	grade 3	discontinuation			6326
37810	10		Urinary retention		discontinuation			6326
37811	10		Ileus	grade 5	discontinuation			6326
37812	50		Gastrointestinal disorder		discontinuation			6326
37813	20		Ileus	grade 3	discontinuation			6326
37814	2 pts		Dizziness		dose reduction	Four patients (19%) showed minor side effects, two dizziness, one drowsiness, and one nausea. Medication was reduced for three patients.		6328
37815	1 pts		Drowsiness		dose reduction	Four patients (19%) showed minor side effects, two dizziness, one drowsiness, and one nausea. Medication was reduced for three patients.		6328
37816	1 pts		Nausea		dose reduction	Four patients (19%) showed minor side effects, two dizziness, one drowsiness, and one nausea. Medication was reduced for three patients.		6328
37817	1 pts		Convulsive seizure					6330
37818	16 pts		Weight gain			The children averaged a weight gain of 1.86 lb.; the weight of one child remained stationary; three children lost a slight amount; the remainder gained from less than 1 lb. to 6 lb. each.		6330
37819	1 pts		Convulsive seizure			There were 19 who suffered from convulsive seizures. The pentylenetetrazol appeared to have no effect on any of these, except for one child who showed an increased number of convulsive seizures during treatment.		6327
37820	21 pts		Weight gain			The average gain of weight in this group was 2.03 lb. There were four children who lost weight and one whose weight remained stationary, the others gained from less than 1 lb. to 6 lb. each.		6327
37821	4 pts		Weight loss			The average gain of weight in this group was 2.03 lb. There were four children who lost weight and one whose weight remained stationary, the others gained from less than 1 lb. to 6 lb. each.		6327
37822	3 pts		Behavior disorder		discontinuation	In the ambulatory group, three children's treatments were discontinued because of disturbed behavior, which disappeared after the cessation of therapy.		6331
37823	9 pts		Weight loss					6329
37824	4.3		AST increased					6332
37825						No adverse reactions leading to discontinuation were reported		6333
37826			Liver injury		discontinuation	leads to discontinuation		6334
37827						The safety profile of Pidotimod was excellent as no serious adverse events have been reported		6335
37828	40		Malaise		discontinuation			6336
37829	40		Nausea		discontinuation			6336
37830	80		Feeling hot					6336
37831	40		Disorientation					6336
37832	40		Taste chemical					6336
37833	40		Rash					6336
37834			Nausea					6337
37835			Anorexia					6337
37836			Coma					6337
37837			Abnormal vision					6337
37838			Paresthesia					6337
37839			Facial flushing					6337
37840			Sweating increased					6337
37841			Feeling hot					6337
37842	33.3		Skin rash	grade 2				6338
37843	16.7		Vomiting		discontinuation			6338
37844	16.7		Nausea		discontinuation			6338
37845						No AEs were reported		6339
37846	16 pts		Pulse rapid					6340
37847						AEs were not observed		6341
37848						No AEs were observed		6342
37849	1 pts		Death	grade 5	discontinuation	leads to discontinuation (It has a low toxicity but amplifies the effect of other centrally acting drugs such as narcotics.)		6344
37850	1 pts		Agranulocytosis		discontinuation	leads to discontinuation		6343
37851						No adverse effects leading to discontinuation were reported		6345
37852	28		Myalgia					6346
37853	4		Pleuropericarditis		discontinuation			6346
37854	0.6		Myocardial infarction	grade 3	discontinuation			6346
37855	21		Edema face					6346
37856	2.4		Pleural effusion	grade 3	discontinuation			6346
37857	0.6		Myocardial infarction	grade 5	discontinuation			6346
37858	9.2		Bursitis					6346
37859	0.6		Pulmonary embolism	grade 5	discontinuation			6346
37860	17		Arthralgia					6346
37861	19		Peripheral edema					6346
37862	16.7		AST increased	grade 3			TRUE	6348
37863	16.7		ALT increased	grade 3			TRUE	6348
37864	33.3		ALT increased	grade 3-4			TRUE	6347
37865	33.3		AST increased	grade 3-4			TRUE	6347
37866	26.3		Neuritis					6349
37867	25		Leucopenia		dose interruption	<3,000 cells/mm3		6350
37868	43		Thrombocytopenia		dose interruption	<100,000 cells/mm3		6350
37869						AEs were not observed		6351
37870			Allergic contact dermatitis		discontinuation			6352
37871			Haematoporphyrinuria					6356
37872			Drowsiness					6353
37873			Death					6355
37874			Neuritis NOS					6354
37875			Haematoporphyrinuria					6354
37876	2 pts		Nausea and vomiting		dose reduction			6357
37877			Agranulocytosis	grade 5	discontinuation	leads to discontinuation		6358
37878			Application site pain		discontinuation	Pain and hypersensitivity of the application region: 2 patients		6359
37879						No AEs were reported		6360
37880			Hepatotoxicity		discontinuation	leads to discontinuation		6362
37881	1 pts		Back pain	severe	discontinuation	leads to discontinuation		6361
37882	1 pts		Prothrombin time increased	grade 5	discontinuation	leads to discontinuation		6361
37883	1 pts		Partial thromboplastin time prolonged	grade 5	discontinuation	leads to discontinuation		6361
37884			Keratopathy		discontinuation	AEs are reported		6364
37885			Retinopathy		discontinuation			6363
37886						No adverse effects leading to discontinuation were reported; no DLTs		6367
37887	14.3		Triglyceride increased		discontinuation		TRUE	6369
37888	28.6		Lipase increased	grade 3-4	discontinuation		TRUE	6369
37889			Liver damage	grade 4-5	discontinuation	at a dose of 350 mg/m2, two patients developed irreversible liver damage		6365
37890	20		Hypertriglyceridemia	grade 3	dose reduction			6368
37891	60		Hyperglycemia	grade 3-4			TRUE	6368
37892	10		Hypertriglyceridemia	grade 3-4			TRUE	6366
37893						No AEs were observed		6370
37894	3 pts		Facial spasm					6371
37895	6 pts		Tremor of hands					6371
37896	3 pts		Dry mouth					6371
37897	3 pts		Dizziness					6371
37898	2 pts		Insomnia					6371
37899	3 pts		Constipation					6371
37900	1 pts		Rash					6371
37901	2 pts		Movements abnormal					6371
37902	3 pts		Drowsiness					6371
37903	2 pts		Nausea					6371
37904	3 pts		Tremor					6371
37905	2 pts		Angina pectoris		discontinuation	leads to discontinuation		6374
37906	1 pts		Cataracts	severe	discontinuation	removed from the market		6372
37907	8 pts		Cataracts	severe	discontinuation	removed from the market		6375
37908	1 pts		Malabsorption syndrome		discontinuation	leads to discontinuation		6373
37909	1 pts		Mucosal atrophy	severe	discontinuation	leads to discontinuation		6373
37910			Vomiting					6376
37911			Headache		discontinuation			6376
37912			Fainting		discontinuation			6376
37913	16.7		Hyperventilation		discontinuation			6376
37914	16.7		Dizziness		discontinuation			6376
37915	16.7		Syncope		discontinuation			6376
37916						No adverse effects leading to discontinuation were reported.		6377
37917						No AEs were observed		6378
37918			Nausea	mild				6379
37919			Increased salivation					6379
37920			Anaphylactic shock	severe	discontinuation			6380
37921	3 pts		Nausea		discontinuation	leads to discontinuation		6381
37922	3 pts		Vomiting		discontinuation	leads to discontinuation		6381
37923	1 pts		Diarrhoea	mild				6381
37924	1 pts		Epigastric pain					6381
37925						No AEs are reported		6382
37926	3.8		Myasthenia					6383
37927	1 pts		Constipation		discontinuation			6383
37928	3.8		Headache					6383
37929			Drowsiness					6384
37930			Drowsiness					6384
37931	11 pts		Photosensitivity		discontinuation	leads to discontinuation		6386
37932						impossible to link AEs with the definite dose		6385
37933						The source does not contain information about AEs or lack thereof		6388
37934	13		Shock	grade 2				6387
37935						AEs were not observed		6389
37936			Epigastric burning					6390
37937			Acute renal failure	grade 5	discontinuation			6391
37938			Acute renal failure	grade 5	discontinuation	case 1		6392
37939			Acute renal failure		discontinuation	case 2		6393
37940			Acute renal failure	grade 5	discontinuation	8 cases of renal insufficiency have occurred following bunamiodyl sodium exposure, 6 terminating fatally; two of these cases, one fatal and one with recovery, occurred after a single 4.5 g dose.		6394
37941						The source does not contain information about AEs or lack thereof		6395
37942	30		Palpitation					6396
37943	30		Headache		discontinuation			6396
37944						Two patients dropped out due to intolerence to the drug. AEs are not specified.		6397
37945	6		Drug eruption		discontinuation	The eruption cleared a few weeks after stopping the carbromal containing drug		6399
37946	1		Addiction			Patient had been taking about 30 tablets of """"""""""""""""persomnia"""""""""""""""" (each containing carbromal 195 mg. and bromvaletone 65 mg.) daily for some months and had become lethargic, confused, and ataxic. Doctor had already formed the opinion that the subject was a persomnia addict and had sought psychiatric advice, but no mental disease had been found.		6400
37947	1		Drug eruption					6398
37948						No adverse reactions leading to discontinuation were reported		6401
37949			Vomiting					6402
37950			Diarrhoea					6402
37951	2 pts		Cystitis hemorrhagic	grade 1				6403
37952	1 pts		Cystitis hemorrhagic	grade 2	discontinuation	leads to discontinuation		6403
37953	1 pts		Alanine aminotransferase increased	grade 1		500 mg / day dose study was canceled		6404
37954	1 pts		Alkaline phosphatase increased	grade 1		500 mg / day dose study was canceled		6404
37955	1 pts		Anorexia	grade 2		500 mg / day dose study was canceled		6404
37956	2 pts		Aspartate aminotransferase increased	grade 1		500 mg / day dose study was canceled		6404
37957	1 pts		Creatine phosphokinase increased	grade 2		500 mg / day dose study was canceled		6404
37958	1 pts		Cystitis	grade 1		500 mg / day dose study was canceled		6404
37959	1 pts		Cystitis	grade 2		500 mg / day dose study was canceled		6404
37960	1 pts		Diarrhea	grade 1		500 mg / day dose study was canceled		6404
37961	3 pts		Fatigue	grade 1		500 mg / day dose study was canceled		6404
37962	1 pts		Hypophosphatemia	grade 2		500 mg / day dose study was canceled		6404
37963	1 pts		Hemoglobin decreased	grade 1		500 mg / day dose study was canceled		6404
37964	1 pts		Hemoglobin decreased	grade 2		500 mg / day dose study was canceled		6404
37965	1 pts		Hemoglobin decreased	grade 3		500 mg / day dose study was canceled		6404
37966	2 pts		Hemoglobinuria	grade 1		500 mg / day dose study was canceled		6404
37967	1 pts		Hemorrhage	grade 1		500 mg / day dose study was canceled		6404
37968	1 pts		Leukocyte count decreased	grade 1		500 mg / day dose study was canceled		6404
37969	4 pts		Lymphopenia	grade 1		500 mg / day dose study was canceled		6404
37970	2 pts		Lymphopenia	grade 2		500 mg / day dose study was canceled		6404
37971	1 pts		Lymphopenia	grade 3		500 mg / day dose study was canceled		6404
37972	2 pts		Nausea	grade 1		500 mg / day dose study was canceled		6404
37973	1 pts		Nausea	grade 2		500 mg / day dose study was canceled		6404
37974	1 pts		Neuropathy	grade 1		500 mg / day dose study was canceled		6404
37975	1 pts		Pain	grade 2		500 mg / day dose study was canceled		6404
37976	5 pts		Platelet count decreased	grade 1		500 mg / day dose study was canceled		6404
37977	1 pts		Proteinuria	grade 2		500 mg / day dose study was canceled		6404
37978	1 pts		Urinary frequency	grade 2		500 mg / day dose study was canceled		6404
37979	2 pts		Vomiting	grade 1		500 mg / day dose study was canceled		6404
37980	1 pts		Vomiting	grade 2		500 mg / day dose study was canceled		6404
37981						No adverse effects leading to discontinuation were reported		6405
37982						5 patients on denbufylline discontinued treatment due to nausea or heartburn (but AEs were not stratified by dose level)		6406
37983	5 pts		Psychosis					6407
37984			Photosensitive dermatitis					6408
37985	1 pts		Agitation		discontinuation			6409
37986	1 pts		Sweating		discontinuation			6409
37987						No side-effects were observed		6410
37988						No adverse effects leading to discontinuation were reported		6411
37989						The source does not contain information about AEs or lack thereof		6413
37990	100		Hepatitis acute	grade 1-3	discontinuation			6414
37991	36		Drowsiness					6412
37992	9		Renal failure					6412
37993	9		Rhabdomyolysis					6412
37994	36		Dizziness					6412
37995						No significant side effects were reported in the chronic human studies.		6415
37996						No subjects were discontinued from the study due to AEs; no subject had SAEs.		6417
37997	16.7		Anxiety		discontinuation			6418
37998	16.7		Myalgia		discontinuation			6418
37999	16.7		Headache		discontinuation			6418
38000	16.7		Vomiting		discontinuation			6418
38001	16.7		Diarrhea		discontinuation			6418
38002	16.7		ALT increased		discontinuation			6416
38003	16.7		AST increased		discontinuation			6416
38004						No adverse effects leading to discontinuation were reported		6419
38005	33.3		Liver failure	grade 5	discontinuation	Of the seven patients with severe hepatotoxicity, five died and two survived after liver transplantation.		6420
38006	33.3		Pancreatitis	grade 5	discontinuation	All five patients who died had both gross and microscopi- cal evidence of pancreatitis at autopsy.		6420
38007	33.3		Lactic acidosis	grade 5	discontinuation			6420
38008	46.7		Pancreatitis		discontinuation	All  seven  patients  with  severe hepatotoxicity  had  biochemical  evi- dence of pancreatitis, with progres- sive increases in serum lipase levels (up to a 50-fold increase).		6420
38009	46.7		Lactic acidosis		discontinuation			6420
38010	46.7		Liver failure		discontinuation			6420
38011	33.3		Neuropathy	grade 1-2	discontinuation			6420
38012						No patient reported any adverse event		6422
38013	8 pts		Proarrhythmic effect		discontinuation	leads to discontinuation		6421
38014	3 pts		Headache					6423
38015	1 pts		Faint		discontinuation	leads to discontinuation		6423
38016	1 pts		Gastrointestinal bleeding		discontinuation	leads to discontinuation		6423
38017						No adverse reactions leading to discontinuation were reported		6424
38018			Nausea		discontinuation	Nausea and gastric discomfort were noted after givinq a single dose of 2,000 mg. to two elderly patients.		6426
38019			Discomfort epigastric		discontinuation	Nausea and gastric discomfort were noted after givinq a single dose of 2,000 mg. to two elderly patients.		6426
38020						No adverse reactions leading to discontinuation were reported		6425
38021						No adverse reactions leading to discontinuation were reported		6427
38022			Hepatotoxicity	grade 5				6428
38023			Toxicity renal	grade 5				6428
38024	25		Oedema	grade 2	dose reduction			6430
38025	25		Hypoalbuminaemia	grade 2	dose reduction			6430
38026	25		Proteinuria		dose reduction			6430
38027	25		ALT increased				TRUE	6430
38028	25		Fainting	grade 3			TRUE	6429
38029	25		Hypotension	grade 1			TRUE	6429
38030	25		Blood creatinine increased	grade 2			TRUE	6429
38031	40		Nausea	grade 1-2	discontinuation	Four subjects who received gepirone-ER withdrew from the study because of these effects		6431
38032	70		Dizziness	grade 1-2		Four subjects who received gepirone-ER withdrew from the study because of these effects		6431
38033						The source does not contain information about AEs or lack thereof		6433
38034						The source does not contain information about AEs or lack thereof		6432
38035						The source does not contain information about AEs or lack thereof		6434
38036	2.8		Urticaria		discontinuation			6436
38037	5.5		Dizziness postural		discontinuation			6436
38038	2.8		Uraemia		discontinuation			6436
38039	20		Feeling of total lack of energy		discontinuation	two patients discontinued treatment		6435
38040	5		Diarrhoea					6435
38041	5		Headache					6435
38042	10		Dizziness postural					6435
38043	5		Frequency urinary					6435
38044	5		Anginal pain					6435
38045	25		Feeling of total lack of energy					6435
38046	0.6		Bleeding					6437
38047			Stomach pain					6437
38048			Nausea					6437
38049			Vomiting					6437
38050	7		Confusion					6438
38051	20		Nausea		discontinuation			6438
38052	13		Vomiting		discontinuation			6438
38053	13		Dizziness		discontinuation			6438
38054	7		Visual disorders NEC					6438
38055	7		Speech disorder					6440
38056	13		Confusion					6440
38057	13		Somnolence					6440
38058	13		Nausea		discontinuation			6440
38059	7		Vomiting		discontinuation			6440
38060	13		Dizziness		discontinuation			6440
38061	13		Headache					6440
38062	13		Hallucination					6440
38063	12.5		Difficulty sleeping					6439
38064	12.5		Dizziness					6439
38065	12.5		Vivid dreams					6439
38066	12.5		Nausea					6439
38067	12.5		Nightmares					6439
38068	25		Hallucinations	grade 1				6439
38069	100		Thrombocytopenia	grade 4			TRUE	6444
38070	100		Neutropenia	grade 4			TRUE	6444
38071						No information on AE is provided		6442
38072			Neutropenia	grade 4			TRUE	6443
38073						No information on AE is provided		6441
38074	1 pts		Arrhythmia		discontinuation	leads to discontinuation		6446
38075	1 pts		Creatine kinase increased		discontinuation	leads to discontinuation		6446
38076	1 pts		Visual hallucinations		discontinuation	leads to discontinuation		6445
38077	1 pts		Application site reaction		discontinuation	leads to discontinuation		6445
38078	1 pts		Anorexia	mild				6448
38079	3 pts		Ventricular ectopic beats					6448
38080	1 pts		Rashes, eruptions and exanthems NEC					6448
38081						No AEs were observed		6447
38082	1 pts		Hypertension					6449
38083	1 pts		Abnormal glucose tolerance					6449
38084	1 pts		Impotence					6449
38085						impossible to link AEs with the definite dose		6450
38086						No AEs are reported		6451
38087						No adverse effects leading to discontinuation were reported		6452
38088						No adverse effects leading to discontinuation were reported		6453
38089	9.3		Oedema		discontinuation	Oedema-related AEs		6454
38090	0.4		Congestive heart failure	severe	discontinuation			6454
38091						25% discontinued because of AEs, but they are not specified		6455
38092						No AEs were reported		6456
38093						No AEs were reported		6457
38094	2 pts		Atrial fibrillation					6458
38095	100		Discoloration urine	grade 1				6460
38096	51		Discoloration tongue	grade 1				6460
38097	5.5		Nausea	grade 1				6460
38098	2.7		Skin rash	grade 1				6460
38099	1.4		Anorexia	grade 1				6460
38100	1.4		Fatigue	grade 1				6460
38101			Contact dermatitis					6459
38102						No adverse effects leading to discontinuation were reported.		6461
38103	8.3		Headaches		discontinuation			6462
38104	8.3		Irritability		discontinuation			6462
38105	8.3		Emotional lability		discontinuation			6462
38106	0.28		Headache		discontinuation			6463
38107	0.28		Dizziness		discontinuation			6463
38108	0.91		Amenorrhea		discontinuation			6463
38109	0.22		Increased blood pressure		discontinuation			6463
38110	2.82		Bleeding		discontinuation			6463
38111	0.61		Weight loss		discontinuation			6463
38112	0.61		Weight gain		discontinuation			6463
38113	0.17		Nausea		discontinuation			6463
38114	1 pts		Cholestasis	grade 5	discontinuation	leads to discontinuation		6465
38115	1 pts		Peliosis hepatis	grade 5	discontinuation	leads to discontinuation		6464
38116	1 pts		Jaundice		discontinuation	leads to discontinuation		6466
38117	4 pts		Vomiting	grade 1				6469
38118	2 pts		Nausea	grade 1				6469
38119	1 pts		Thrombocytopenia	grade 1			TRUE	6469
38120	1 pts		Thrombocytopenia	grade 2			TRUE	6469
38121	1 pts		Thrombocytopenia	grade 3			TRUE	6469
38122	1 pts		Thrombocytopenia	grade 4			TRUE	6469
38123	3 pts		Granulocytopenia	grade 4			TRUE	6469
38124	2 pts		Thrombocytopenia	grade 1			TRUE	6473
38125	2 pts		Thrombocytopenia	grade 2			TRUE	6473
38126	1 pts		Thrombocytopenia	grade 3			TRUE	6473
38127	1 pts		Thrombocytopenia	grade 4			TRUE	6473
38128	1 pts		Granulocytopenia	grade 2			TRUE	6473
38129	1 pts		Granulocytopenia	grade 3			TRUE	6473
38130	1 pts		Granulocytopenia	grade 4			TRUE	6473
38131	17 pts		Diarrhea	grade 1-2				6472
38132	5 pts		Peripheral neuropathy				TRUE	6470
38133	4 pts		Neurotoxicity				TRUE	6470
38134	2 pts		Inability to work				TRUE	6470
38135	4 pts		Nausea	grade 1-2				6470
38136	4 pts		Vomiting	grade 1-2				6470
38137	4 pts		Anemia	grade 1				6470
38138	4 pts		Leucopenia	grade 1-2				6470
38139	4 pts		Neutropenia	grade 1-3				6470
38140	4 pts		Thrombocytopenia	grade 1-2				6470
38141	3 pts		Abdominal pain				TRUE	6467
38142	1 pts		Nausea					6468
38143	1 pts		Emesis					6468
38144	1 pts		Fever					6468
38145	1 pts		Neuropathy					6468
38146	1 pts		Anemia	grade 2				6471
38147	1 pts		Anemia	grade 3				6471
38148	2 pts		Nausea	grade 2				6471
38149	4 pts		Vomiting	grade 2				6471
38150	1 pts		Thrombocytopenia	grade 3				6471
38151	3 pts		Polyneuropathy					6471
38152	1 pts		Autonomic neuropathy					6471
38153						No adverse reactions leading to discontinuation were reported		6475
38154						No adverse reactions leading to discontinuation were reported		6474
38155	3 pts		Abdominal pain			None among 56 people who received pamaquine. Three people (5.4%) had abdominal pain, but not when large amounts of liquid were given with the tablet; no cyanosis.		6478
38156	10		Abdominal pain					6479
38157	5		Cardiac disorder NOS					6479
38158	69		Abdominal pain			Symptoms began after 4 days of pamaquine and lasted 3–4 days, recovered with no complications after treatment.		6480
38159	58		Urine discoloration			Symptoms began after 4 days of pamaquine and lasted 3–4 days, recovered with no complications after treatment.		6480
38160	45		Anorexia			Symptoms began after 4 days of pamaquine and lasted 3–4 days, recovered with no complications after treatment.		6480
38161	45		Jaundice			Symptoms began after 4 days of pamaquine and lasted 3–4 days, recovered with no complications after treatment.		6480
38162	39		Headache			Symptoms began after 4 days of pamaquine and lasted 3–4 days, recovered with no complications after treatment.		6480
38163	34		Nausea and vomiting			Symptoms began after 4 days of pamaquine and lasted 3–4 days, recovered with no complications after treatment.		6480
38164	25		Fever			Symptoms began after 4 days of pamaquine and lasted 3–4 days, recovered with no complications after treatment.		6480
38165	23		Weakness			Symptoms began after 4 days of pamaquine and lasted 3–4 days, recovered with no complications after treatment.		6480
38166	22		Backache			Symptoms began after 4 days of pamaquine and lasted 3–4 days, recovered with no complications after treatment.		6480
38167	5 pts		Haemoglobinuria			5 cases of haemoglobinuria occurred among Indian troops given standard treatment.		6476
38168	13 pts		Haemoglobinuria			13 Indian (mostly Punjabi) troops given blanket treatment developed haemoglobinuria while taking pamaquine and were admitted to hospital; three died.		6477
38169						No adverse reactions leading to discontinuation were reported		6481
38170						Premature termination due to side effects occured in 2 patients, but dosage and AEs are not indicated		6482
38171			Hepatotoxicity	grade 5	discontinuation			6486
38172			Blurred vision		discontinuation	case 1		6483
38173			Scotoma		discontinuation	case 1		6483
38174			Ataxia		discontinuation	case 1		6483
38175			Weakness in extremity		discontinuation	case 1		6483
38176			Maculo-papular rash		discontinuation	case 2		6484
38177			Blurred vision		discontinuation	case 2		6484
38178			Amblyopia		discontinuation	case 1		6485
38179						No serious adverse effects were recorded.		6487
38180			Stupor					6489
38181			Cyanosis	slight				6489
38182			Depression central nervous system	mild				6492
38183			Comatose					6490
38184			Constricted pupils					6490
38185			Coma			Coma with hypoactive deep tendon reflexes, miosis, pallor, and cyanosis		6491
38186			Coma			Coma with miosis and depressed respiration		6488
38187			Ataxia			Ataxia, incoherence, unable to see		6493
38188			Incoherent			Ataxia, incoherence, unable to see		6493
38189			Vision loss			Ataxia, incoherence, unable to see		6493
38190						No adverse reactions were reported		6494
38191	1 pts		Tonic-clonic seizures	grade 5				6495
38192	1 pts		Coma	grade 5				6495
38193	1 pts		Respiratory insufficiency	grade 5				6495
38194						No adverse effects were recorded.		6496
38195						No AEs are reported		6498
38196						No AEs are reported		6499
38197			Adverse event	grade 5		fatal overdose; no specific AEs reported		6497
38198						No serious AEs were reported.		6500
38199						Most of the patients in this study tolerated the weekly dosage schedule well with only minimal myelosuppression		6501
38200						Treatment was well tolerated		6502
38201	4		Abdominal pain					6503
38202	0.9		Nausea					6503
38203	53.7		Somnolence					6505
38204						There were no serious adverse events (SAEs) during the study and no AEs that lead to subject withdrawal.		6504
38205						No serious adverse drug reactions were observed, and no adverse events resulted in premature discontinuation.		6506
38206	11.1		Skin rash		discontinuation			6507
38207	5.6		Nausea		discontinuation			6507
38208	5.6		Vomiting		discontinuation			6507
38209	5.6		Headache		discontinuation			6507
38210	5.6		Elevated triglycerides				TRUE	6507
38211	5.6		CPK increased		discontinuation			6507
38212	5.6		LDH increased		discontinuation			6507
38213	5.6		AST increased		discontinuation			6507
38214	5.6		ALT increased		discontinuation			6507
38215	12.5		Methemoglobinemia		discontinuation		TRUE	6508
38216	37.5		Methemoglobinemia				TRUE	6508
38217	12.5		Histoplasmosis		discontinuation			6508
38218	12.5		Fever		discontinuation			6508
38219	12.5		Elevated triglycerides				TRUE	6508
38220	12.5		Flushing		discontinuation			6508
38221	12.5		Skin rash		discontinuation			6508
38222	3.6		Bone marrow depression		discontinuation	Fatality due to cardiorespiratory failure, anemia and bone marrow depres- sion. A possible relationship to study medication was noted by the investigator.		6509
38223	3.6		Acute renal failure		discontinuation			6509
38224	3.6		Bone marrow depression		discontinuation	Fatality due to cardiorespiratory failure, anemia and bone marrow depres- sion. A possible relationship to study medication was noted by the investigator.		6509
38225	3.6		Cardio-respiratory failure	grade 5	discontinuation	Fatality due to cardiorespiratory failure, anemia and bone marrow depres- sion. A possible relationship to study medication was noted by the investigator.		6509
38226	7.2		Nephrotic syndrome		discontinuation			6509
38227	7.2		Glomerulonephritis		discontinuation			6509
38228						No side-reactions were observed during the study		6510
38229	2 pts		Infection	serious				6512
38230	1 pts		Anaemia haemolytic	serious				6512
38231	1 pts		Cellulitis	serious				6512
38232	1 pts		Injury	serious				6512
38233	1 pts		Headache	serious				6512
38234	1 pts		Enteritis	serious				6512
38235	1 pts		Unintended pregnancy	serious				6512
38236	1 pts		Unintended pregnancy	serious				6512
38237	1 pts		Unintended pregnancy	serious				6512
38238	1 pts		Unintended pregnancy	serious				6512
38239	45 pts		Headache	below serious				6512
38240	30 pts		Upper respiratory tract infection	below serious				6512
38241	28 pts		Back pain	below serious				6512
38242	27 pts		Myalgia	below serious				6512
38243	25 pts		Abdominal pain	below serious				6512
38244	24 pts		Coughing	below serious				6512
38245	18 pts		Injury	below serious				6512
38246	14 pts		Pharyngitis	below serious				6512
38247	13 pts		Gastroenteritis	below serious				6512
38248	12 pts		Dizziness	below serious				6512
38249	12 pts		Arthralgia	below serious				6512
38250	32		Headache					6517
38251	32		Sinus headache					6517
38252	32		Migraine					6517
38253	32		Tension headache					6517
38254	5		Dizziness					6517
38255	5		Dizziness postural					6517
38256	35		Nervous system disorders					6517
38257	27		Musculoskeletal and connective tissue disorders					6517
38258	14		Back pain					6517
38259	31		Gastrointestinal disorders					6517
38260	5		Diarrhea					6517
38261	5		Nausea					6517
38262	2		Vomiting					6517
38263	4		ALT increased					6517
38264	2		Psychiatric disorders					6517
38265	1		Abnormal dreams					6517
38266	1		Insomnia					6517
38267	1		Nightmares					6517
38268	1		Sleep disorder					6517
38269	1		Somnambulism					6517
38270	1		Depression					6517
38271	1		Depressed mood					6517
38272	<1		Hemolytic anemia					6517
38273	<1		Anemia					6517
38274	<1		Thrombocytopenia					6517
38275	<1		Hyperacusis					6517
38276	<1		Meniere's disease					6517
38277	<1		Hyperbilirubinemia					6517
38278	<1		Jaundice cholestatic					6517
38279	<1		Blood bilirubin increased					6517
38280	<1		Blood creatinine increased					6517
38281	<1		Glomerular filtration rate decreased					6517
38282	<1		Amnesia					6517
38283	<1		Coordination abnormal					6517
38284	<1		Hyperesthesia					6517
38285	<1		Hypoesthesia					6517
38286	<1		Somnolence					6517
38287	<1		Visual field defect					6517
38288	<1		Urticaria					6517
38289	15		Headache					6516
38290	15		Sinus headache					6516
38291	15		Migraine					6516
38292	15		Tension headache					6516
38293	1		Dizziness					6516
38294	1		Dizziness postural					6516
38295	22		Nervous system disorders					6516
38296	29		Musculoskeletal and connective tissue disorders					6516
38297	14		Back pain					6516
38298	36		Gastrointestinal disorders					6516
38299	18		Diarrhea					6516
38300	7		Nausea					6516
38301	5		Vomiting					6516
38302	5		Psychiatric disorders					6516
38303	2		Abnormal dreams					6516
38304	2		Insomnia					6516
38305	2		Nightmares					6516
38306	2		Sleep disorder					6516
38307	2		Somnambulism					6516
38308	1		Anxiety disorder					6516
38309	1		Panic attack					6516
38310	7		Ear and labyrinth disorders					6516
38311	5		Motion sickness					6516
38312	5		Vertigo					6516
38313	5		Vertigo positional					6516
38314	1		Stress					6516
38315	32		Headache					6517
38316	32		Sinus headache					6517
38317	32		Migraine					6517
38318	32		Tension headache					6517
38319	5		Dizziness					6517
38320	5		Dizziness postural					6517
38321	35		Nervous system disorders					6517
38322	27		Musculoskeletal and connective tissue disorders					6517
38323	14		Back pain					6517
38324	31		Gastrointestinal disorders					6517
38325	5		Diarrhea					6517
38326	5		Nausea					6517
38327	2		Vomiting					6517
38328	4		ALT increased					6517
38329	2		Psychiatric disorders					6517
38330	1		Abnormal dreams					6517
38331	1		Insomnia					6517
38332	1		Nightmares					6517
38333	1		Sleep disorder					6517
38334	1		Somnambulism					6517
38335	1		Depression					6517
38336	1		Depressed mood					6517
38337	<1		Hemolytic anemia					6517
38338	<1		Anemia					6517
38339	<1		Thrombocytopenia					6517
38340	<1		Hyperacusis					6517
38341	<1		Meniere's disease					6517
38342	<1		Hyperbilirubinemia					6517
38343	<1		Jaundice cholestatic					6517
38344	<1		Blood bilirubin increased					6517
38345	<1		Blood creatinine increased					6517
38346	<1		Glomerular filtration rate decreased					6517
38347	<1		Amnesia					6517
38348	<1		Coordination abnormal					6517
38349	<1		Hyperesthesia					6517
38350	<1		Hypoesthesia					6517
38351	<1		Somnolence					6517
38352	<1		Visual field defect					6517
38353	<1		Urticaria					6517
38354	15		Headache					6516
38355	15		Sinus headache					6516
38356	15		Migraine					6516
38357	15		Tension headache					6516
38358	1		Dizziness					6516
38359	1		Dizziness postural					6516
38360	22		Nervous system disorders					6516
38361	29		Musculoskeletal and connective tissue disorders					6516
38362	14		Back pain					6516
38363	36		Gastrointestinal disorders					6516
38364	18		Diarrhea					6516
38365	7		Nausea					6516
38366	5		Vomiting					6516
38367	5		Psychiatric disorders					6516
38368	2		Abnormal dreams					6516
38369	2		Insomnia					6516
38370	2		Nightmares					6516
38371	2		Sleep disorder					6516
38372	2		Somnambulism					6516
38373	1		Anxiety disorder					6516
38374	1		Panic attack					6516
38375	7		Ear and labyrinth disorders					6516
38376	5		Motion sickness					6516
38377	5		Vertigo					6516
38378	5		Vertigo positional					6516
38379	1		Stress					6516
38380	0.7		ALT increased					6511
38381	0.4		Hemoglobin decreased					6511
38382	0.2		GFR decreased					6511
38383	0.5		Malaria					6511
38384	0.1		Pneumonia					6511
38385	0.1		Viral infection					6511
38386	0.1		Fall					6511
38387	0.1		Joint injury					6511
38388	0.1		Meniscus lesion					6511
38389	0.1		Thermal burn					6511
38390	0.1		Soft tissue injury					6511
38391	0.1		Upper limb fracture					6511
38392	0.1		Upper abdominal pain					6511
38393	0.1		Irritable bowel syndrome					6511
38394	0.1		Musculoskeletal pain					6511
38395	0.1		Depression					6511
38396	0.1		Metamorphopsia					6511
38397	0.1		Night blindness					6511
38398	0.1		Rash					6511
38399	0.1		Lactose intolerance					6511
38400	0.1		Hyperbilirubinemia					6511
38401	0.7		ALT increased		discontinuation			6511
38402	0.4		Hemoglobin decreased		discontinuation			6511
38403	0.2		GFR decreased		discontinuation			6511
38404	0.5		Malaria		discontinuation			6511
38405	0.1		Pneumonia		discontinuation			6511
38406	0.1		Viral infection		discontinuation			6511
38407	0.1		Fall		discontinuation			6511
38408	0.1		Joint injury		discontinuation			6511
38409	0.1		Meniscus lesion		discontinuation			6511
38410	0.1		Thermal burn		discontinuation			6511
38411	0.1		Soft tissue injury		discontinuation			6511
38412	0.1		Upper limb fracture		discontinuation			6511
38413	0.1		Upper abdominal pain		discontinuation			6511
38414	0.1		Irritable bowel syndrome		discontinuation			6511
38415	0.1		Musculoskeletal pain		discontinuation			6511
38416	0.1		Depression		discontinuation			6511
38417	0.1		Metamorphopsia		discontinuation			6511
38418	0.1		Night blindness		discontinuation			6511
38419	0.1		Rash		discontinuation			6511
38420	0.1		Lactose intolerance		discontinuation			6511
38421	0.1		Hyperbilirubinemia		discontinuation			6511
38422						No AEs reported		6519
38423						No AEs reported		6515
38424						No AEs reported		6514
38425						No AEs reported		6513
38426	4		CPK increased					6520
38427	2		Hemoglobin increased					6520
38428	2		Hypersensitivity					6520
38429	1 pts		Nausea		discontinuation			6518
38430	1 pts		Vomiting		discontinuation			6518
38431			Pulse rate increased					6522
38432			Blood pressure systolic increased					6522
38433						No information on AE is provided		6521
38434	20		Parkinsonism		discontinuation	dosage had to be reduced		6524
38435	10		Parkinsonism		discontinuation			6525
38436						No adverse reactions leading to discontinuation were reported		6523
38437	1 pts		Dizziness		discontinuation			6527
38438	2 pts		Nausea		dose reduction			6527
38439	1 pts		Nausea		discontinuation			6527
38440	1 pts		Drowsiness	severe	discontinuation			6527
38441	1 pts		Headache		dose reduction			6527
38442	5.5		Dizziness					6526
38443	4.6		Nausea					6526
38444	4.6		Vertigo					6526
38445	0.9		Somnolence					6526
38446	0.9		Abdominal pain					6526
38447						No AEs are reported		6528
38448						No AEs are reported		6529
38449	1 pts		Nausea	severe	discontinuation			6530
38450	1 pts		Vomiting	severe	discontinuation			6530
38451	1 pts		Tachycardia					6532
38452	1 pts		Dry mouth					6532
38453	7 pts		Drowsiness					6533
38454	6 pts		Dizziness					6533
38455						No AEs were reported		6531
38456						3 adverse effects leading to discontinuation were recorded, but not specified.		6534
38457	2 pts		Epigastric discomfort					6535
38458	2 pts		Nausea					6535
38459	1 pts		Dizziness					6535
38460	3 pts		Sweating					6535
38461	1 pts		Apprehension					6535
38462	3 pts		Fatigue					6535
38463	0.8		Hepatic failure		discontinuation			6536
38464			Bilirubin elevated					6536
38465	6.4		Atrial fibrillation					6536
38466	10.9		Tachycardia					6536
38467	2.3		Jaundice					6536
38468	41.7		Nausea					6536
38469	6.4		Headache					6536
38470	25.6		Vomiting		discontinuation			6536
38471			Elevated liver enzyme levels		discontinuation			6536
38472						No AEs were reported		6540
38473						No AEs were reported		6538
38474						No AEs were reported		6539
38475						No AEs were reported		6541
38476	1 pts		Diarrhoea					6537
38477						In most patients, drug-related AEs were mild, and no patient was withdrawn early from the study because of a drug-related AE.		6542
38478	6		Liver function test abnormal		discontinuation			6543
38479	1.2		ALT increased		discontinuation			6543
38480	1.2		ALT increased		discontinuation			6543
38481	1.2		AST increased		discontinuation			6543
38482	1.2		Rash		discontinuation			6543
38483	1.2		Hypersensitivity		discontinuation			6543
38484	1.2		Abdominal pain		discontinuation			6543
38485	1.2		Vomiting		discontinuation			6543
38486	1.2		Pyrexia		discontinuation			6543
38487	1.2		Pruritus		discontinuation			6543
38488	0.8		Nausea		discontinuation			6544
38489	0.8		Urine color abnormal		discontinuation			6544
38490	0.8		Dizziness		discontinuation			6544
38491	0.8		Hyperhidrosis		discontinuation			6544
38492			Dysphagia					6546
38493			Drowsiness					6545
38494			Dizziness					6545
38495			Dry mouth					6545
38496			Parkinsonism					6545
38497						AEs were not observed		6547
38498	20		Fall		discontinuation			6549
38499	10		Fainting		discontinuation			6549
38500	10		Dizziness		discontinuation			6549
38501	44		Dizziness					6548
38502	44		Sedation					6548
38503			Nausea					6550
38504			Vomiting					6550
38505			Parkinsonism	grade 1	discontinuation			6551
38506			Peripheral neuropathy		discontinuation			6551
38507			Cirrhosis liver	grade 5				6552
38508	2.5		Gastrointestinal disorder		discontinuation			6553
38509	1		Psychiatric symptom		discontinuation			6553
38510	1 pts		Neuroblastoma	serious				6554
38511	1 pts		Neuroblastoma	below serious				6554
38512	1 pts		Decreased appetite	below serious				6554
38513	1 pts		Insomnia	below serious				6554
38514	2 pts		Conjunctivitis	below serious				6554
38515	1 pts		Motion sickness	below serious				6554
38516	1 pts		Orthostatic hypotension	below serious				6554
38517	1 pts		Epistaxis	below serious				6554
38518	1 pts		Abdominal distension	below serious				6554
38519	1 pts		Rash	below serious				6554
38520	1 pts		Arthralgia	below serious				6554
38521	2 pts		Dysuria	below serious				6554
38522	3 pts		Dysmenorrhoea	below serious				6554
38523	1 pts		Ligament sprain	below serious				6554
38524	2 pts		Bronchitis	below serious				6554
38525	1 pts		Nasopharyngitis	below serious				6554
38526	1 pts		Pharyngitis	below serious				6554
38527	2 pts		Urinary tract infection	below serious				6554
38528	1 pts		Somnolence	below serious				6554
38529	1 pts		Rhinorrhoea	below serious				6554
38530	7 pts		Constipation	below serious				6554
38531	1 pts		Dyspepsia	below serious				6554
38532	2 pts		Fatigue	below serious				6554
38533	1 pts		Pain	below serious				6554
38534	1 pts		Muscle rupture	below serious				6554
38535	0.5		Abdominal pain		discontinuation	leads to discontinuation		6557
38536	0.3		Pyrexia		discontinuation	leads to discontinuation		6557
38537	3.5		Constipation					6555
38538	3.3		Headache					6556
38539	<2		Dyspepsia					6556
38540	0.5		Abdominal distension					6558
38541	0.5		Arthralgia					6558
38542	1		Muscle spasms					6558
38543	1		Fatigue					6558
38544	1		Bronchitis					6558
38545	0.5		Nasopharyngitis					6558
38546	1		Parasitic gastroenteritis					6558
38547	0.5		Pharyngitis					6558
38548	1		Urinary tract infection					6558
38549	1.5		Dysmenorrhea					6558
38550	1		Dysuria					6558
38551	0.5		Dizziness					6558
38552	1		Conjunctivitis					6558
38553	1		Diarrhea		discontinuation	leads to discontinuation		6559
38554						No AEs are reported		6560
38555						The source does not contain information about AEs or lack thereof		6561
38556						The source does not contain information about AEs or lack thereof		6562
38557						No drug-related adverse effects leading to discontinuation were recorded.		6565
38558			Drowsiness		discontinuation			6563
38559			Coma		discontinuation			6563
38560			Coma		discontinuation			6564
38561						No adverse effects leading to discontinuation were reported.		6566
38562						The source does not contain information about AEs or lack thereof		6567
38563						The source does not contain information about AEs or lack thereof		6568
38564						No AEs are reported		6569
38565						No AEs are reported		6570
38566	0.3		Bleeding		discontinuation	leads to discontinuation		6571
38567	0.6		Coronary artery dissection		discontinuation	leads to discontinuation		6571
38568	0.6		Coronary artery perforation		discontinuation	leads to discontinuation		6571
38569	0.6		Dyspnea		discontinuation	leads to discontinuation		6571
38570	1 pts		Epilepsy		discontinuation	leads to discontinuation		6573
38571	1 pts		Anxiety		discontinuation	leads to discontinuation		6573
38572	1 pts		Hepatic failure		discontinuation	leads to discontinuation		6573
38573	5 pts		Anxiety					6574
38574	6 pts		Insomnia					6574
38575	6 pts		Dry mouth					6574
38576	8 pts		Somnolence					6574
38577	1 pts		Photosensitivity allergic reac		discontinuation	leads to discontinuation		6572
38578	2 pts		Vulvovaginal pruritus					6575
38579	1 pts		Vaginal discharge					6575
38580	5 pts		Vulvovaginal burning sensation			leads to discontinuation		6575
38581	9 pts		Vulvovaginal burning sensation					6575
38582	2 pts		Haemorrhage vaginal					6575
38583	2 pts		Genital burning sensation					6575
38584	2 pts		Genital swelling					6575
38585	2 pts		Nasopharyngitis					6575
38586	3 pts		Application site pain					6575
38587	1 pts		Nausea					6575
38588	2 pts		Abdominal pain lower					6575
38589	2 pts		Diarrhea					6575
38590	1 pts		Nervous system disorders					6575
38591	4 pts		Skin and subcutaneous tissue disorders					6575
38592	2 pts		Renal and urinary disorders					6575
38593						No AEs were observed		6576
38594	1 pts		Gastroenteritis	serious				6577
38595	1 pts		Asthma	serious				6577
38596	1 pts		Biliary dyskinesia	serious				6577
38597	1 pts		Cholelithiasis	serious				6577
38598	1 pts		Musculoskeletal chest pain	serious				6577
38599	1 pts		Cervical vertebral fracture	serious				6577
38600	78 pts		Somnolence	below serious				6577
38601	56 pts		Dizziness	below serious				6577
38602	41 pts		Nausea	below serious				6577
38603	32 pts		Fatigue	below serious				6577
38604	30 pts		Upper respiratory tract infection	below serious				6577
38605	1 pts		Gastroenteritis viral	serious				6578
38606	1 pts		Breast cancer in situ	serious				6578
38607	1 pts		Liver function test abnormal	serious				6578
38608	1 pts		Meniscus lesion	serious				6578
38609	1 pts		Road traffic accident	serious				6578
38610	1 pts		Tibia fracture	serious				6578
38611	29 pts		Insomnia	below serious				6578
38612	26 pts		Somnolence	below serious				6578
38613	24 pts		Dizziness	below serious				6578
38614	20 pts		Nausea	below serious				6578
38615						No AEs are reported		6582
38616	1 pts		Seizures			intoxication		6583
38617			Hypotension	severe		WARNING		6580
38618			Syncope			WARNING		6580
38619	1.7		Dizziness		discontinuation	leads to discontinuation		6581
38620	1.2		Nausea		discontinuation	leads to discontinuation		6581
38621	1.1		Insomnia		discontinuation	leads to discontinuation		6581
38622	1.1		Somnolence		discontinuation	leads to discontinuation		6581
38623	1		Anxiety		discontinuation	leads to discontinuation		6581
38624	83		Dizziness					6579
38625	67		Nausea					6579
38626	83		Somnolence					6579
38627	16.7		Neutropenia	grade 3			TRUE	6584
38628	16.7		Thrombocytopenia	grade 3			TRUE	6584
38629	33.3		Anemia	grade 3			TRUE	6584
38630	16.7		Leucopenia	grade 3			TRUE	6584
38631	9.5		Cardiac failure	grade 2	discontinuation			6586
38632	4.8		Neutropenic sepsis	grade 5	discontinuation			6586
38633	14.3		Thrombocytopenia	grade 3-4	discontinuation			6586
38634	8.1		Hematotoxicity		discontinuation			6585
38635	2.3		Septic shock	grade 5	discontinuation			6585
38636	1.2		Arterial thrombosis	grade 5	discontinuation			6585
38637	3.5		Hepatic disease		discontinuation			6585
38638	1.2		Gastric ulcer		discontinuation			6585
38639	1.2		Fatigue		discontinuation			6587
38640	24.7		Hematotoxicity		discontinuation			6587
38641	6		Dyskinesia		discontinuation	leads to discontinuation		6591
38642			Hallucinations					6590
38643			Agitation					6590
38644			Dyskinesia					6590
38645	1		Visual hallucinations		discontinuation	leads to discontinuation		6592
38646	1		Hallucination olfactory		discontinuation	leads to discontinuation		6592
38647	1		Somatic hallucination		discontinuation	leads to discontinuation		6592
38648	1		Auditory hallucinations					6592
38649	0.7		Chest pain					6588
38650						No AEs are reported		6589
38651						AEs were not observed		6594
38652						The source does not contain information about AEs or lack thereof		6593
38653	1.75		Insomnia		discontinuation			6595
38654			Electrocardiogram abnormal		discontinuation	possible		6596
38655			Myasthenia gravis		discontinuation	possible		6596
38656			Lacrimation increased		discontinuation	probable		6596
38657			Muscle spasms		discontinuation	probable		6596
38658			Hyperhidrosis		discontinuation	probable		6596
38659			Somnolence		discontinuation	possible		6596
38660			Paraesthesia		discontinuation			6596
38661			Headache		discontinuation			6596
38662			Insomnia		discontinuation			6596
38663			Nightmare		discontinuation	probable		6596
38664			Fatigue		discontinuation			6596
38665			Vomiting		discontinuation	possible		6596
38666	19		Headache					6598
38667	16		Abdominal pain					6598
38668	16		Upper abdominal pain					6598
38669	16		Lower abdominal pain					6598
38670	16		Abdominal tenderness					6598
38671	16		Abdominal discomfort					6598
38672	16		Epigastric discomfort					6598
38673	14		Nausea					6598
38674	13		Diarrhea					6598
38675	5		Abdominal distension					6598
38676	4		Dizziness					6598
38677	3		Vomiting					6598
38678	3		Flatulence					6598
38679	2		Fatigue					6598
38680	2		Nausea					6598
38681	1		Headache					6598
38682	1		Diarrhea					6598
38683	1		Abdominal pain					6598
38684	19		Headache					6598
38685	16		Abdominal pain					6598
38686	16		Upper abdominal pain					6598
38687	16		Lower abdominal pain					6598
38688	16		Abdominal tenderness					6598
38689	16		Abdominal discomfort					6598
38690	16		Epigastric discomfort					6598
38691	14		Nausea					6598
38692	13		Diarrhea					6598
38693	5		Abdominal distension					6598
38694	4		Dizziness					6598
38695	3		Vomiting					6598
38696	3		Flatulence					6598
38697	2		Fatigue					6598
38698	2		Nausea		discontinuation			6598
38699	1		Headache		discontinuation			6598
38700	1		Diarrhea		discontinuation			6598
38701	1		Abdominal pain		discontinuation			6598
38702						No information		6597
38703	5.5		Diarrhea					6600
38704	5.5		Headache					6600
38705	5.5		Palpitations					6599
38706	5.5		Nausea					6599
38707	5.5		Pharyngitis					6599
38708	5.5		Headache					6599
38709	5.5		ALT increased		discontinuation			6599
38710	16.7		Headache	grade 1				6602
38711	11.9		Headache					6601
38712	5.1		Dizziness					6601
38713	3.4		Nausea					6601
38714	1.7		Nasopharyngitis					6601
38715	3.4		Fatigue					6601
38716	1.7		Vomiting					6601
38717	1.7		Diarrhea					6601
38718	1.7		Skin laceration					6601
38719			Swollen tongue		discontinuation			6605
38720			Dyspnea		discontinuation			6605
38721			Redness mouth		discontinuation			6605
38722			Gingival swelling		discontinuation			6605
38723			Rash trunk		discontinuation			6605
38724			Decreased appetite		discontinuation			6605
38725			Increased appetite		discontinuation			6605
38726			Inner restlessness		discontinuation			6605
38727			Redness of face		discontinuation			6605
38728			Pruritus		discontinuation			6605
38729			Hyperhidrosis		discontinuation			6605
38730			Dry mouth		discontinuation			6605
38731			Hoarseness		discontinuation			6605
38732			Malaise		discontinuation			6605
38733	0.4		Myocardial infarction		discontinuation			6607
38734	0.4		Palpitations		discontinuation			6607
38735	0.4		Ventricular tachycardia		discontinuation			6607
38736	0.9		QT interval prolonged		discontinuation			6607
38737	0.4		Blood glucose increased		discontinuation			6607
38738	0.4		Vertigo		discontinuation			6607
38739	0.4		Muscle spasms		discontinuation			6607
38740	0.4		Tremor		discontinuation			6607
38741	0.4		Nausea		discontinuation			6607
38742	0.3		Angina pectoris		discontinuation			6603
38743	0.3		Aortic valve incompetence		discontinuation			6603
38744	0.3		Atrial flutter		discontinuation			6603
38745	0.3		Creatine phosphokinase increased		discontinuation			6603
38746	0.3		Vertigo		discontinuation			6603
38747	0.3		Cataract		discontinuation			6603
38748	0.3		Lacrimation increased		discontinuation			6603
38749	0.3		Macular oedema		discontinuation			6603
38750	0.3		Maculopathy		discontinuation			6603
38751	0.3		Ocular vascular disorder		discontinuation			6603
38752	0.3		Papilloedema		discontinuation			6603
38753	0.3		Paraesthesia		discontinuation			6603
38754	0.3		Pain of skin		discontinuation			6603
38755	0.3		Rash erythematous		discontinuation			6603
38756	0.3		Anaemia iron deficiency		discontinuation			6603
38757	0.3		Depressed mood		discontinuation			6603
38758	0.3		Bronchospasm		discontinuation			6603
38759	1.1		Head titubation		discontinuation			6608
38760	2.2		Nausea		discontinuation			6608
38761	1.1		Diarrhea		discontinuation			6608
38762	1.1		GERD		discontinuation			6608
38763	1.1		Vomiting		discontinuation			6608
38764	1.1		Anxiety		discontinuation			6608
38765	1.1		Nightmare		discontinuation			6608
38766	1.3		Dyskinesia		discontinuation			6606
38767	0.4		Dizziness		discontinuation			6606
38768	0.4		Paraesthesia		discontinuation			6606
38769	0.4		Balance disorder		discontinuation			6606
38770	0.4		Tremor		discontinuation			6606
38771	0.4		Abdominal pain		discontinuation			6606
38772	0.4		Vomiting		discontinuation			6606
38773	0.4		Aphthous stomatitis		discontinuation			6606
38774	0.4		Constipation		discontinuation			6606
38775	0.4		Nausea		discontinuation			6606
38776	0.4		Asthenia		discontinuation			6606
38777	0.4		Chest discomfort		discontinuation			6606
38778	0.4		Muscle rigidity		discontinuation			6606
38779	0.9		Dyspnoea		discontinuation			6606
38780	0.4		Pneumonitis		discontinuation			6606
38781	0.4		Palpitations		discontinuation			6606
38782	0.4		Urinary tract infection		discontinuation			6606
38783	1.4		Dyskinesia		discontinuation			6604
38784	0.6		Parkinson's disease		discontinuation			6604
38785	0.2		Dizziness		discontinuation			6604
38786	0.2		Paraesthesia		discontinuation			6604
38787	0.2		Cognitive disorder		discontinuation			6604
38788	0.2		Presyncope		discontinuation			6604
38789	0.2		Abdominal pain		discontinuation			6604
38790	0.2		Vomiting		discontinuation			6604
38791	0.6		Hallucination, visual		discontinuation			6604
38792	0.2		Hallucination		discontinuation			6604
38793	0.2		Sleep terror		discontinuation			6604
38794	0.2		Asthenia		discontinuation			6604
38795	0.4		Muscle spasms		discontinuation			6604
38796	0.2		Basal cell carcinoma		discontinuation			6604
38797	0.2		Breast cancer		discontinuation			6604
38798	0.2		Non-Hodgkin's lymphoma		discontinuation			6604
38799	0.2		Arrhythmia		discontinuation			6604
38800	0.2		Ventricular tachycardia		discontinuation			6604
38801	0.2		Cataract subcapsular		discontinuation			6604
38802	0.2		Vision blurred		discontinuation			6604
38803	0.2		Change in ECG		discontinuation			6604
38804	0.2		QT interval prolonged		discontinuation			6604
38805	0.2		Blister		discontinuation			6604
38806	0.2		Hyperhidrosis		discontinuation			6604
38807	0.2		Fall		discontinuation			6604
38808	0.2		Subdural haematoma		discontinuation			6604
38809	0.2		Cachexia		discontinuation			6604
38810	1 pts		Colitis					6609
38811	1 pts		Enterocolitis					6609
38812	11 pts		Diarrhea					6609
38813	4 pts		Sepsis					6609
38814	1 pts		Cellulitis					6609
38815	1 pts		Clostridium difficile infection					6609
38816	3 pts		Pneumonia					6609
38817	2 pts		Acute kidney injury					6609
38818	2 pts		Creatinine increased					6609
38819	2 pts		Aspartate aminotransferase increased					6609
38820	1 pts		Bilirubin increased					6609
38821	1 pts		Gamma-glutamyltransferase increased					6609
38822	10 pts		Tumor lysis syndrome					6609
38823	1 pts		Epistaxis					6609
38824	1 pts		Cytokine release syndrome					6609
38825	1 pts		Hyperkalemia					6609
38826	1 pts		Hypoalbuminemia					6609
38827	3 pts		Hypocalcemia					6609
38828	1 pts		Hypokalemia					6609
38829	1 pts		Rash maculo-papular					6609
38830	13		Abdominal pain			Fourteen patients (26.9%) in the 200-mg arm discontinued treatment due to AEs; approximately half were due to a drug associated toxicity.		6615
38831	13		Asthenia			Fourteen patients (26.9%) in the 200-mg arm discontinued treatment due to AEs; approximately half were due to a drug associated toxicity.		6615
38832	13		Diarrhea		discontinuation	Fourteen patients (26.9%) in the 200-mg arm discontinued treatment due to AEs; approximately half were due to a drug associated toxicity.		6615
38833	10		Diarrhea		discontinuation	11 patients (20.8%) in the 50-mg arm discontinued treatment due to AEs; approximately half were due to a drug associated toxicity.		6616
38834	10		Abdominal pain		discontinuation	11 patients (20.8%) in the 50-mg arm discontinued treatment due to AEs; approximately half were due to a drug associated toxicity.		6616
38835	10		Asthenia		discontinuation	11 patients (20.8%) in the 50-mg arm discontinued treatment due to AEs; approximately half were due to a drug associated toxicity.		6616
38836	2 pts		Hypersensitivity reaction	grade 3			TRUE	6610
38837	2 pts		Diarrhea	grade 3			TRUE	6610
38838	1 pts		Dyspnea					6613
38839	3 pts		Infection					6613
38840	1 pts		Thrombocytopenia					6613
38841	7 pts		Skin toxicity					6613
38842	2 pts		Pain					6613
38843	2 pts		Asthenia					6613
38844	2 pts		Vasodilation					6613
38845	2 pts		Stomatitis					6613
38846	2 pts		Myalgia					6613
38847	2 pts		Vomiting					6613
38848	2 pts		Nausea					6613
38849	2 pts		Myalgia	grade 3			TRUE	6611
38850	2 pts		Syncope				TRUE	6611
38851	1 pts		Hypersensitivity	grade 3			TRUE	6618
38852	1 pts		Thrombocytopenia	grade 3			TRUE	6617
38853	1 pts		Emesis	grade 2			TRUE	6612
38854	1 pts		Rash	grade 2			TRUE	6612
38855	1 pts		Mouth ulcer	grade 2			TRUE	6612
38856	1 pts		Emesis	grade 3			TRUE	6612
38857	2 pts		Diarrhea	grade 1-2				6612
38858	1 pts		Emesis	grade 3				6614
38859	7 pts		Rash	grade 1-2				6614
38860	3 pts		Hypersensitivity	grade 1-2				6614
38861	6 pts		Mucositis	grade 1-2				6614
38862	1 pts		Thrombocytopenia	grade 4			TRUE	6614
38863	5 pts		Nausea	grade 1-2				6614
38864	3 pts		Diarrhea	grade 1-2				6614
38865	3.1		Abdominal pain	grade 3		highest available		6619
38866	3.1		Diarrhea	grade 3		highest available		6619
38867	3.1		Dyspepsia	grade 1-2		highest available		6619
38868	3.1		Nausea	grade 1-2		highest available		6619
38869	3.1		Headache	grade 1-2		highest available		6619
38870			GGT increased	grade 1				6620
38871	1 pts		Extrapyramidal disorder		discontinuation	leads to discontinuation		6621
38872	1 pts		Syncope		discontinuation	leads to discontinuation		6622
38873	1 pts		Tremor		discontinuation	leads to discontinuation		6623
38874	1 pts		Abnormal behavior		discontinuation	leads to discontinuation		6624
38875	1 pts		Anxiety		discontinuation	leads to discontinuation		6625
38876	1 pts		Panic attack		discontinuation	leads to discontinuation		6626
38877	25.5		Psychiatric disorders					6626
38878	5.5		Agitation					6626
38879	5.5		Anxiety					6626
38880	7.3		Aggression					6626
38881	5.5		Nightmare					6626
38882	21.8		Nervous system disorders					6626
38883	5.5		Somnolence					6626
38884	7.3		Fatigue					6626
38885	1 pts		Chills		discontinuation	leads to discontinuation		6627
38886	1 pts		Fatigue		discontinuation	leads to discontinuation		6628
38887	1 pts		Nausea		discontinuation	leads to discontinuation		6629
38888	1 pts		Vomiting		discontinuation	leads to discontinuation		6630
38889	1 pts		Psychomotor hyperactivity		discontinuation	leads to discontinuation		6631
38890	1 pts		Tonic clonic movements		discontinuation	leads to discontinuation		6632
38891	1 pts		Arrhythmia supraventricular		discontinuation	leads to discontinuation		6633
38892						impossible to link AEs with the definite dose		6634
38893	2 pts		Prostate infection			injected transrectally into the prostate under ultrasound guidance		6635
38894	1 pts		Sepsis			injected transrectally into the prostate under ultrasound guidance		6636
38895	1 pts		Pelvic pain			injected transrectally into the prostate under ultrasound guidance		6636
38896			Vomiting				TRUE	6637
38897			Headache	severe			TRUE	6637
38898	11.8		Confusion		discontinuation			6643
38899	11.8		Slurred speech		discontinuation			6643
38900	11.8		Attention concentration difficulty		discontinuation			6643
38901	100		Bilirubin elevated	grade 4	discontinuation			6639
38902	100		AST increased	grade 3				6640
38903	50		Dyspnea	grade 3				6640
38904						No information on AE is provided		6638
38905	20		Pulmonary edema	grade 3			TRUE	6641
38906	20		AST increased	grade 3			TRUE	6641
38907	12.5		Dyspnea	grade 3	discontinuation		TRUE	6642
38908	3.2		Transaminases increased					6644
38909	6.5		Hypertension					6644
38910	3.2		Hyperbilirubinemia					6644
38911	3.2		Anorexia					6644
38912	3.2		Eructation					6644
38913	3.2		Proteinuria					6644
38914	6.5		Asthenia					6644
38915	3.2		Rash					6644
38916	3.2		Thrombocytopenia					6644
38917	6.5		Nausea					6644
38918	6.5		Fatigue					6644
38919	3.2		Lethargy					6644
38920	3.2		Dizziness					6644
38921	9.7		Emesis					6644
38922	1 pts		Lethargy				TRUE	6645
38923	1 pts		Hypertension				TRUE	6645
38924	3 pts		Nausea				TRUE	6646
38925	2 pts		Emesis				TRUE	6646
38926	1 pts		Anorexia				TRUE	6646
38927	100		Mucositis				TRUE	6647
38928	50		Nausea	grade 3				6647
38929	100		Skin erythema				TRUE	6647
38930	50		Vomiting	grade 3				6647
38931	40		Granulocytopenia	grade 4			TRUE	6648
38932						No information on AE is provided		6650
38933						No information on AE is provided		6649
38934	2.6		Vomiting		discontinuation			6652
38935	2.6		Nausea		dose interruption			6652
38936	2.6		Vomiting		dose interruption			6652
38937	2.6		Nausea		discontinuation			6652
38938	3.4		Diarrhoea		discontinuation			6651
38939	3.4		Diarrhoea		dose interruption			6651
38940	2.1		Diarrhoea		discontinuation			6653
38941	2.1		Diarrhoea		dose interruption			6653
38942	2.1		Abdominal pain		discontinuation			6653
38943	2.1		Abdominal pain		dose interruption			6653
38944	0.7		Vomiting		discontinuation			6653
38945	0.7		Vomiting		dose interruption			6653
38946	3 pts		Aspartate aminotransferase increased					6654
38947	3 pts		Fever					6654
38948						No adverse effects leading to discontinuation were reported		6655
38949	7 pts		Headache					6656
38950	3 pts		Weakness					6656
38951	1 pts		Myalgia					6656
38952	4 pts		Abdominal pain					6656
38953	5 pts		Loose stools					6656
38954	1 pts		Anorexia					6656
38955	2 pts		Coughing					6656
38956	1 pts		Fever					6656
38957	2 pts		Nausea					6656
38958	3 pts		Pruritus					6656
38959	2 pts		Insomnia					6656
38960	2 pts		Dizziness					6656
38961	2 pts		Diarrhoea					6656
38962						No AEs were reported		6659
38963						No AEs were reported		6657
38964						No AEs were reported		6658
38965	5 pts		Gastrointestinal disorders					6660
38966	1 pts		Thrombocytopenia	grade 3				6661
38967	1 pts		Vomiting	grade 4			TRUE	6662
38968	1 pts		Diarrhea	grade 2				6662
38969	2 pts		Vomiting	grade 1				6662
38970	1 pts		Fatigue	grade 2				6662
38971	3 pts		Nausea	grade 2				6662
38972	1 pts		Neutropenia	grade 4			TRUE	6662
38973	1 pts		Diarrhea	grade 1				6662
38974	2 pts		Anorexia	grade 3				6662
38975	1 pts		Thrombocytopenia	grade 4			TRUE	6662
38976	1 pts		Fatigue	grade 2				6662
38977	1 pts		Diarrhea	grade 3				6662
38978	1 pts		Fatigue	grade 1				6662
38979	1 pts		Fatigue	grade 3				6662
38980	1 pts		Nausea	grade 2				6663
38981	2 pts		Nausea	grade 1				6663
38982	1 pts		Neurotoxicity	grade 3				6663
38983	1 pts		Thrombocytopenia	grade 2				6663
38984	1 pts		Neutropenia	grade 4			TRUE	6663
38985	1 pts		Thrombocytopenia	grade 1				6663
38986	1 pts		Anorexia	grade 1				6663
38987	1 pts		Anorexia	grade 2				6663
38988	2 pts		Vomiting	grade 1				6663
38989	2 pts		Diarrhea	grade 1				6663
38990	1 pts		Diarrhea	grade 2				6663
38991	1 pts		Fatigue	grade 1				6663
38992	1 pts		Fatigue	grade 2				6663
38993	1 pts		Fatigue	grade 3				6663
38994	1 pts		Creatinine increased	grade 1				6663
38995	20		Nausea		discontinuation			6664
38996	0.85		Neutropenia		discontinuation			6665
38997	0.85		Amnesia	serious				6665
38998	0.85		Diarrhea	serious				6665
38999	0.85		Suicidal ideation	serious				6665
39000						There were no serious AEs experienced in this study and no discontinuations from the study due to AEs.		6666
39001	5 pts		Cardiac failure					6667
39002	2 pts		Acute coronary syndrome					6667
39003	2 pts		Atrial fibrillation					6667
39004	5 pts		Arrhythmia					6667
39005	9 pts		Dizziness					6667
39006	3 pts		Nausea					6667
39007	9 pts		Constipation					6667
39008	10 pts		Respiratory tract infections					6667
39009	2 pts		Rash					6667
39010	2 pts		Pruritus					6667
39011	11 pts		Dyspnoea					6667
39012	7 pts		Blood creatinine increased					6667
39013	4 pts		Blood potassium increased					6667
39014	4 pts		Weight increase					6667
39015	12 pts		Musculoskeletal disorder					6667
39016	9 pts		Fatigue					6667
39017	2 pts		Renal failure					6667
39018	1 pts		Cardiac failure		discontinuation	leads to discontinuation		6667
39019	1 pts		Cardiac failure		discontinuation	leads to discontinuation		6667
39020	1 pts		Constipation		discontinuation	leads to discontinuation		6667
39021	1 pts		Pruritus		discontinuation	leads to discontinuation		6667
39022	1 pts		Renal failure		discontinuation	leads to discontinuation		6667
39023	2 pts		Heart failure	grade 5	discontinuation	leads to discontinuation		6667
39024	1 pts		Septicaemia	grade 5	discontinuation	leads to discontinuation		6667
39025	13.4		Thrombocytopenia					6672
39026	6.7		Anemia					6672
39027	7.1		Transaminases increased		discontinuation			6668
39028	7.1		Bilirubin total increased		discontinuation			6668
39029	7.1		CPK increased					6668
39030	16.7		Syncope	grade 2	discontinuation			6671
39031	16.7		Dizziness	grade 2	discontinuation			6671
39032	16.7		Nausea	grade 2	discontinuation			6671
39033	16.7		Vomiting	grade 2	discontinuation			6671
39034	16.7		Nausea					6669
39035	16.7		Dizziness					6669
39036	40		Infusion site pain					6670
39037	40		Infusion site rash					6670
39038						No information on AE is provided		6673
39039	16.7		Hyperbilirubinemia		discontinuation			6674
39040	7.1		Fatigue	grade 3	discontinuation		TRUE	6675
39041	7.1		Arthralgia	grade 1			TRUE	6675
39042	16.7		Pain in arm	grade 3	discontinuation			6674
39043	16.7		Arthralgia	grade 3	discontinuation			6674
39044	50		Rhinitis					6677
39045	16.7		Pharyngitis					6676
39046	16.7		Rhinitis					6676
39047	16.7		Epistaxis					6676
39048	16.7		Taste perversion					6676
39049	16.7		Headache					6676
39050	13		Agitation		discontinuation	leads to discontinuation		6678
39051	13		Aggression		discontinuation	leads to discontinuation		6678
39052	13		Catatonia		discontinuation	leads to discontinuation		6678
39053	8		Agitation		discontinuation	leads to discontinuation		6679
39054	8		Aggression		discontinuation	leads to discontinuation		6679
39055	8		Catatonia		discontinuation	leads to discontinuation		6679
39056	7		Agitation		discontinuation	leads to discontinuation		6680
39057	7		Aggression		discontinuation	leads to discontinuation		6680
39058	7		Catatonia		discontinuation	leads to discontinuation		6680
39059	1 pts		Grand mal convulsion	serious	discontinuation	leads to discontinuation		6678
39060	1 pts		Psychotic disorder	serious	discontinuation	leads to discontinuation		6678
39061	57.1		Fatigue	grade 1-2				6682
39062	57.1		Nausea	grade 1-2				6682
39063	28.6		Vomiting	grade 1				6682
39064	42.9		Diarrhea	grade 1-2				6682
39065	71.4		Thrombocytopenia	grade 1-3			TRUE	6682
39066	28.6		Neutropenia	grade 1-2				6682
39067	57.1		Anemia	grade 1-4				6682
39068	50		Thrombocytopenia	grade 1-4				6681
39069	25		Neutropenia	grade 1-3				6681
39070	62.5		Anemia	grade 1-3				6681
39071	62.5		Fatigue	grade 1-3				6681
39072	50		Nausea	grade 1-3				6681
39073	37.5		Vomiting	grade 1-3				6681
39074	12.5		Dehydration					6681
39075	12.5		Creatinine increased					6681
39076	12.5		Abnormal liver function tests					6681
39077	4 pts		Dizzy					6683
39078	4 pts		Headache					6683
39079	1 pts		Confused					6683
39080	4 pts		Ataxia					6683
39081	1 pts		Crying					6683
39082	1 pts		Dry skin					6683
39083	4 pts		Drowsiness					6683
39084	1 pts		Dysarthria					6683
39085	1 pts		Weakness					6683
39086	1 pts		Weird feeling					6683
39087	2 pts		Slurred speech					6683
39088	1 pts		Nystagmus					6683
39089	3 pts		Fall					6683
39090	1 pts		Runny nose					6683
39091	1 pts		Double vision					6683
39092	1 pts		Shaking					6683
39093	2 pts		Sedation					6683
39094	1 pts		Sneezing					6683
39095	1 pts		Sore throat					6683
39096	24 pts		Dizziness					6684
39097	11 pts		Somnolence					6684
39098	18 pts		Asthenia					6684
39099	10 pts		Depression					6684
39100	9 pts		Pain					6684
39101	9 pts		Dysphagia					6684
39102	8 pts		Rhinitis					6684
39103	7 pts		Dysarthria					6684
39104	6 pts		Headache					6684
39105	6 pts		Hypertension					6684
39106	6 pts		Constipation					6684
39107	6 pts		Anxiety					6684
39108	6 pts		Paresthesia					6684
39109	6 pts		Spastic paralysis					6684
39110	5 pts		Abdominal pain					6684
39111	5 pts		Foot drop					6684
39112	5 pts		Insomnia					6684
39113	5 pts		Dyspnea					6684
39114	5 pts		Lung disorder					6684
39115	4 pts		Nausea					6684
39116	4 pts		Muscle pain					6684
39117	4 pts		Twitching					6684
39118	4 pts		Pharyngitis					6684
39119	4 pts		Sinusitis					6684
39120	4 pts		Rash					6684
39121	3 pts		Neck pain					6684
39122	3 pts		Anorexia					6684
39123	3 pts		Diarrhea					6684
39124	3 pts		Flatulence					6684
39125	3 pts		Increased salivation					6684
39126	3 pts		Ecchymosis					6684
39127	3 pts		Dysautonomia					6684
39128	3 pts		Facial paralysis					6684
39129	3 pts		Apnea					6684
39130	1 pts		Dizziness		discontinuation	leads to discontinuation		6684
39131	1 pts		Reaction lymphoma-like		discontinuation	leads to discontinuation		6684
39132	24.1		Dyspepsia					6685
39133	36.8		Chills					6685
39134	11.5		Chest pain					6685
39135	24.1		Increased salivation					6685
39136	51.7		Nausea					6685
39137	75.9		Sweating					6685
39138	12.6		Syncope					6685
39139	6.9		Fecal incontinence					6685
39140	42.5		Vomiting					6685
39141	8		Nausea and vomiting					6685
39142	6.9		Dysphagia					6685
39143	2		Transaminases increased		discontinuation			6688
39144						The source does not contain information about AEs or lack thereof		6687
39145						The source does not contain information about AEs or lack thereof		6686
39146						Treatment was well tolerated		6689
39147						No adverse effects leading to discontinuation were reported		6690
39148						The source does not contain information about AEs or lack thereof		6692
39149						The source does not contain information about AEs or lack thereof		6691
39150	1.5		Aggressiveness					6693
39151	3		Headache					6693
39152	1.5		Insomnia		discontinuation			6693
39153	1.5		Tiredness		discontinuation			6693
39154	6		Dizziness					6693
39155	1.5		Weight gain					6693
39156	1 pts		Arrhythmia		discontinuation			6694
39157	25		Ventricular tachycardia					6695
39158						No AEs were observed		6697
39159						No AEs were observed		6696
39160	1 pts		Fatigue					6698
39161	1 pts		Blurred vision					6698
39162	1 pts		Dry mouth					6698
39163	4 pts		Dizziness	grade 1				6699
39164	6 pts		Sedation	grade 1				6699
39165	2 pts		Constipation	grade 1				6699
39166	2 pts		Dry mouth	grade 1				6699
39167	1 pts		Hypersalivation	grade 1				6699
39168	3 pts		Dizziness	grade 2-3				6699
39169	2 pts		Sedation	grade 2-3				6699
39170	2 pts		Constipation	grade 2-3				6699
39171	1 pts		Dry mouth	grade 2-3				6699
39172	2 pts		Hypersalivation	grade 2-3				6699
39173	1 pts		Constipation	grade 4				6699
39174	1 pts		Vomiting		discontinuation			6700
39175	1 pts		Vasovagal reaction		discontinuation			6700
39176	9.2		Dizziness		discontinuation			6701
39177	9.2		Headache		discontinuation			6701
39178						No AEs were reported		6702
39179						No adverse effects leading to discontinuation were reported		6703
39180			Seizure					6705
39181			Death					6704
39182	1 pts		Alanine aminotransferase increased	grade 3	discontinuation	leads to discontinuation	TRUE	6706
39183	1 pts		Aspartate aminotransferase increased	grade 3	discontinuation	leads to discontinuation	TRUE	6706
39184	1 pts		Sinus bradycardia	grade 1	discontinuation	leads to discontinuation	TRUE	6706
39185	6.25		Orthostatic dysregulation		discontinuation			6709
39186	3.1		Vertigo positional	severe	discontinuation			6709
39187						No adverse reactions leading to discontinuation were reported		6707
39188						No adverse reactions leading to discontinuation were reported		6708
39189	1 pts		Skin rash	severe	discontinuation	leads to discontinuation		6710
39190	1 pts		Fever	severe	discontinuation	leads to discontinuation		6710
39191	1 pts		Back pain	severe	discontinuation	leads to discontinuation		6710
39192						No AEs are reported		6711
39193	45.4		Nausea		discontinuation			6712
39194	45.4		Vomiting		discontinuation			6712
39195			Nausea		discontinuation			6713
39196			Vomiting		discontinuation			6713
39197			Anxiety		discontinuation			6713
39198			Agitation		discontinuation			6713
39199			Polydipsia		discontinuation			6713
39200			Polyuria		discontinuation			6713
39201			Increased appetite		discontinuation			6713
39202			Tachycardia		discontinuation			6713
39203			Tachypnea		discontinuation			6713
39204			Lactic acidosis		discontinuation			6713
39205			Hypoglycemia		discontinuation			6713
39206			Hypokalemia		discontinuation			6713
39207			Lactic acidosis		discontinuation			6714
39208	2.3		Bilirubin increased		discontinuation			6716
39209	2.3		Hypotension postural		discontinuation			6716
39210	2.3		Neutrophils		discontinuation			6716
39211	100		Akathisia					6718
39212	13.3		Aggressiveness		discontinuation			6717
39213	16.7		Drug-induced extrapyramidal side effects		dose reduction			6715
39214						No AEs were reported		6721
39215						No AEs were reported		6720
39216	12 pts		Fatigue					6719
39217	62 pts		Central nervous system disorder					6719
39218	55 pts		Headache					6719
39219	43 pts		Disorder respiratory system					6719
39220	32 pts		Rhinitis					6719
39221	45 pts		Gastrointestinal disorders					6719
39222	11 pts		Constipation					6719
39223	45 pts		Psychiatric disorders					6719
39224	24 pts		Insomnia					6719
39225						No adverse effects leading to discontinuation were reported.		6722
39226						the incidence of adverse events was higher in the placebo group		6723
39227						No serious adverse events		6725
39228	1 pts		Psychomotor hyperactivity		discontinuation	leads to discontinuation		6724
39229	14.3		Paralysis			TETRAETHYLAMMONIUM BROMIDIE		6726
39230	14.3		Drowsiness			TETRAETHYLAMMONIUM BROMIDIE		6726
39231	66.7		Dysphagia			tetraethyl ammonium chloride		6727
39232	66.7		Dysarthria			tetraethyl ammonium chloride		6727
39233	66.7		Nasal congestion			tetraethyl ammonium chloride		6727
39234	66.7		Respiration labored			tetraethyl ammonium chloride		6727
39235	100		Weakness generalized			tetraethyl ammonium chloride		6727
39236	100		Dry mouth			tetraethyl ammonium chloride		6727
39237	100		Numbness			tetraethyl ammonium chloride		6727
39238	100		Ptosis			tetraethyl ammonium chloride		6727
39239	100		Mydriasis			tetraethyl ammonium chloride		6727
39240	33.3		Vasomotor collapse			tetraethyl ammonium chloride		6727
39241	33.3		Asthma			tetraethyl ammonium chloride		6727
39242			Loose stools	grade 1-2				6729
39243			Cramps	grade 1-2				6729
39244			Diarrhoea	grade 1-2				6729
39245	8.3		Loose stools					6728
39246	1 pts		Vomiting		discontinuation	leads to discontinuation		6730
39247	3 pts		Headache					6730
39248	3 pts		Drowsiness					6730
39249	3 pts		Vertigo					6730
39250	3 pts		Nausea					6730
39251	2 pts		Renal insufficiency		discontinuation	leads to discontinuation		6733
39252	1 pts		Renal insufficiency		discontinuation	leads to discontinuation		6732
39253	2 pts		Backache					6731
39254	2 pts		Nausea					6731
39255	2 pts		Churning of stomach					6731
39256	1 pts		Hepatitis	acute	discontinuation	leads to discontinuation		6734
39257	25		Anemia	grade 3		previously treated patients		6738
39258	25		Stomatitis	grade 3		previously treated patients		6738
39259	25		Leucopenia	grade 2		previously treated patients		6738
39260	50		Thrombocytopenia	grade 4		previously treated patients		6738
39261	100		Thrombocytopenia	grade 4	dose reduction		TRUE	6735
39262	100		Leucopenia	grade 2	dose reduction		TRUE	6735
39263	100		Anemia	grade 1	dose reduction			6735
39264	100		Stomatitis	grade 3				6735
39265	25		Thrombocytopenia	grade 3		previously untreated patients		6739
39266	25		Stomatitis	grade 3		previously untreated patients		6739
39267	33.3		Maculopapular rash	grade 3	dose reduction		TRUE	6737
39268	33.3		Skin eruption	grade 3	dose reduction		TRUE	6737
39269	66.7		Thrombocytopenia	grade 3				6737
39270	33.3		Mucositis	grade 3	dose reduction		TRUE	6737
39271	20		Thrombocytopenia	grade 4		Of the 5 poor risk patients treated at 210 mg/m2/day as first cycle, 2 had grade 3 and 1 had grade 4 thrombocytopenia.	TRUE	6736
39272	40		Thrombocytopenia	grade 3		Of the 5 poor risk patients treated at 210 mg/m2/day as first cycle, 2 had grade 3 and 1 had grade 4 thrombocytopenia.	TRUE	6736
39273						No adverse effects leading to discontinuation were reported; no DLTs		6740
39274	25		Nausea		discontinuation	leads to discontinuation		6742
39275	25		Vomiting		discontinuation	leads to discontinuation		6742
39276	25		Fluid retention		discontinuation	leads to discontinuation		6742
39277	25		SGOT increased		discontinuation	leads to discontinuation		6742
39278	1 pts		Acne	severe				6741
39279						No adverse reactions were reported		6743
39280	100		Febrile neutropenia	grade 4			TRUE	6744
39281	100		Atrial fibrillation	grade 3			TRUE	6744
39282	100		Hyperbilirubinemia	grade 3			TRUE	6744
39283	100		Vomiting	grade 1-2				6744
39284	100		Thrombocytopenia	grade 3				6744
39285	100		Lymphopenia	grade 3				6744
39286	100		Anemia	grade 2				6744
39287	100		Death	grade 5			TRUE	6744
39288	5.3		Fatigue	grade 3			TRUE	6746
39289	5.3		Transaminitis	grade 3			TRUE	6746
39290	5.3		Atrial fibrillation	grade 3	discontinuation		TRUE	6746
39291	5.3		Creatinine increased	grade 3			TRUE	6746
39292	5.3		Electrocardiogram QTc interval prolonged	grade 3			TRUE	6746
39293	25		Transaminases increased	grade 3			TRUE	6745
39294			Peripheral edema	grade 1-2	discontinuation			6747
39295	1 pts		Nausea	grade 1				6751
39296	1 pts		Dizziness	grade 1				6749
39297	1 pts		Nausea	grade 1				6749
39298	1 pts		Headache	grade 1				6749
39299	1 pts		Dizziness	grade 2				6750
39300	1 pts		Nausea	grade 2				6750
39301	1 pts		Inappetence	grade 2				6750
39302	1 pts		Vomiting	grade 2				6750
39303	1 pts		Inappetence	grade 1				6748
39304	2 pts		Dizziness	grade 1				6748
39305	1 pts		Headache		discontinuation			6752
39306	1 pts		Nausea		discontinuation			6752
39307	2 pts		Allergic reaction		discontinuation			6752
39308	1 pts		Dizziness		discontinuation			6752
39309						Toxicities clearly associated with elacridar were not observed.		6753
39310						The number of side effects reported with XBD173 was comparable to the incidence in the placebo group.		6754
39311	71		Dacryostenosis acquired		discontinuation			6755
39312						No AEs are reported		6756
39313	1 pts		Headache		discontinuation	leads to discontinuation		6758
39314	1 pts		Night sweats		discontinuation	leads to discontinuation		6758
39315	1 pts		Pain in hip		discontinuation	leads to discontinuation		6758
39316	1 pts		Leg pain		discontinuation	leads to discontinuation		6758
39317	1 pts		Indigestion		discontinuation	leads to discontinuation		6758
39318	1 pts		Abdominal pain		discontinuation	leads to discontinuation		6758
39319	2 pts		Hyperprolactinemia		discontinuation	leads to discontinuation		6758
39320	2 pts		Transaminases increased		discontinuation	leads to discontinuation		6758
39321	2 pts		Hypertension		discontinuation	leads to discontinuation		6757
39322	2 pts		Bloating		discontinuation	leads to discontinuation		6757
39323	1 pts		Fluid retention		discontinuation	leads to discontinuation		6757
39324	1 pts		Headache		discontinuation	leads to discontinuation		6757
39325	1 pts		Night sweats		discontinuation	leads to discontinuation		6757
39326	1 pts		Pain in hip		discontinuation	leads to discontinuation		6757
39327	1 pts		Leg pain		discontinuation	leads to discontinuation		6757
39328	1 pts		Heartburn		discontinuation	leads to discontinuation		6757
39329	1 pts		Rash		discontinuation	leads to discontinuation		6757
39330	3 pts		Hyperglycemia		discontinuation	leads to discontinuation		6757
39331	1 pts		Hyperprolactinemia		discontinuation	leads to discontinuation		6757
39332						No AEs were reported		6760
39333	1 pts		Blood and lymphatic system disorders					6759
39334	8 pts		Cardiac disorders					6759
39335	1 pts		Eye disorders					6759
39336	6 pts		Gastrointestinal disorders					6759
39337	11 pts		General disorders and administration site conditions					6759
39338	14 pts		Infections and infestations					6759
39339	3 pts		Injury, poisoning and procedural complications					6759
39340	16 pts		Musculoskeletal and connective tissue disorders					6759
39341	9 pts		Nervous system disorders					6759
39342	2 pts		Renal and urinary disorders					6759
39343	6 pts		Respiratory, thoracic and mediastinal disorders					6759
39344	3 pts		Skin and subcutaneous tissue disorders					6759
39345	4 pts		Vascular disorders					6759
39346	1 pts		Sepsis	grade 5	discontinuation	leads to discontinuation		6759
39347	1 pts		Pneumonia	grade 5	discontinuation	leads to discontinuation		6759
39348	7.8		Somnolence					6761
39349	6.7		Headache					6761
39350	2 pts		Somnolence					6763
39351	1 pts		Headache					6763
39352	1 pts		Nausea					6763
39353	2 pts		Bleeding vaginal					6762
39354	5 pts		Fractures					6762
39355	18 pts		Hot flushes					6762
39356	15 pts		Leg cramps					6762
39357	7 pts		Leukorrhea					6762
39358	2		Leg cramps			leads to discontinuation		6762
39359	7		Leg cramps			leads to discontinuation		6762
39360	3 pts		Fractures					6764
39361	4 pts		Breast pain					6764
39362	24 pts		Hot flushes					6764
39363	4		Hot flushes			leads to discontinuation		6764
39364	20 pts		Leg cramps					6764
39365	3 pts		Bleeding vaginal					6764
39366	12 pts		Leukorrhea					6764
39367						No AEs were observed		6765
39368			Eczematous dermatitis		discontinuation			6766
39369						No adverse effects leading to discontinuation were reported		6767
39370	50		Blood sodium increased		dose interruption			6768
39371	5.9		Arthralgia	grade 3-4			TRUE	6772
39372	42.9		Arthralgia	grade 3-4			TRUE	6770
39373	88.9		Arthralgia	grade 3-4			TRUE	6771
39374	1 pts		Fatigue	grade 2				6769
39375	1 pts		Hepatotoxicity	grade 2				6769
39376	1 pts		Inflammatory polyarthritis		discontinuation		TRUE	6769
39377	2 pts		Myalgia	grade 3				6769
39378	2 pts		Edema	grade 2				6769
39379	1 pts		Thrombocytopenia				TRUE	6773
39380	1 pts		Elevated liver enzymes	serious				6774
39381	9.7		Fatigue	mild				6774
39382	3.2		Weakness	mild				6774
39383	3.2		Hepatitis NOS	mild				6774
39384	3.2		Jaundice NOS	mild				6774
39385	3.2		Paraesthesia	mild				6774
39386	3.2		Tremor	mild				6774
39387	3.2		Excitability	mild				6774
39388	3.2		Nervousness	mild				6774
39389	3.2		Dysuria	mild				6774
39390	3.2		Pruritus NOS	mild				6774
39391						There were no withdrawals due to adverse events.		6775
39392						No information on AE is provided: Pagoclone (dose, 4.8 mg) increased the scores on the LSD (dysphoria) scale of the Addiction Center Research Inventory (ARCI).		6776
39393	1 pts		Asthenia		discontinuation	leads to discontinuation		6777
39394						No adverse effects leading to discontinuation were reported		6778
39395	12.5		Syncope	grade 1				6779
39396	22		Headache	grade 1-2				6780
39397	9		Diarrhea	grade 1-2				6780
39398	6		Nausea	grade 1-2				6780
39399	3		Bronchitis	grade 1-2				6780
39400	2		Rhinitis	grade 1-2				6780
39401	3		Sinusitis	grade 1-2				6780
39402	9		Flu-like symptoms	grade 3	discontinuation			6781
39403	9		Lymphopenia	grade 3	discontinuation			6781
39404	9		Lymphopenia	grade 3	dose interruption			6781
39405			Localized skin reaction		discontinuation	38% of patients discontinued treatment for adverse events or local skin reaction		6782
39406	11.5		Central nervous system disorder		discontinuation	leads to discontinuation		6784
39407	1 pts		Hallucinations		discontinuation	leads to discontinuation		6784
39408	5 pts		Hallucinations		discontinuation	leads to discontinuation		6783
39409	24.1		Central nervous system disorder		discontinuation	leads to discontinuation		6783
39410						No adverse events related to study agent were reported.		6785
39411	1 pts		Elevated liver enzymes		discontinuation	leads to discontinuation		6786
39412	1 pts		Dry mouth					6788
39413						No AEs were observed		6788
39414						No AEs were observed		6787
39415						No AEs were observed		6789
39416						No AEs were observed		6790
39417	12.1		Heartburn	grade 1				6791
39418	15.1		Regurgitation	grade 1				6791
39419	45.4		Gas in stomach	grade 1-3				6791
39420	30.3		Distention	grade 1-4				6791
39421	27.3		Nausea	grade 1-3				6791
39422	6.1		Vomiting	grade 2-3				6791
39423	9.1		Stomach ache	grade 1				6791
39424	24.2		Bowel sounds increased	grade 1-3				6791
39425	6.1		Flatulence	grade 1-4				6791
39426	18.2		Diarrhoea	grade 1-4				6791
39427	3		Constipation	grade 4				6791
39428	33.3		Headache	grade 1-3				6791
39429	6.1		Dizziness	grade 1-2				6791
39430	33.3		Fatigue	grade 1-3				6791
39431	9.1		Nervousness	grade 1-2				6791
39432	3		Appetite lost	grade 2				6791
39433	9.1		Sweating	grade 1-2				6791
39434	3		Palpitations	grade 1				6791
39435			Gas in stomach	grade 1-2				6792
39436			Bloating	grade 1-3				6792
39437			Nausea	grade 1-2				6792
39438			Flatulence	grade 1-2				6792
39439			Headache	grade 1-2				6792
39440			Fatigue	grade 1-2				6792
39441			Appetite lost	grade 3				6792
39442			Heartburn	grade 1				6792
39443			Bowel sounds increased	grade 1				6792
39444			Diarrhea	grade 1				6792
39445			Constipation	grade 1				6792
39446			Sweating	grade 1				6792
39447			Palpitations	grade 1				6792
39448						AEs were not observed		6793
39449			Lightheadedness					6794
39450			Dysarthria					6794
39451			Abnormality of gait					6794
39452			Slurred speech					6794
39453						No adverse effects leading to discontinuation were reported		6796
39454						No adverse effects leading to discontinuation were reported		6795
39455						No adverse effects were recorded.		6797
39456						no adverse side effects were observed or reported		6799
39457			Ventricular fibrillation		discontinuation			6798
39458						No AEs were observed		6800
39459			Cardiac arrest	grade 5	discontinuation	WARNING		6803
39460			Respiratory arrest	grade 5	discontinuation	WARNING		6803
39461			Shock	serious	discontinuation	WARNING		6803
39462			Syncope	serious	discontinuation	WARNING		6803
39463			Arrhythmia	serious	discontinuation	WARNING		6803
39464			Hypertension	serious	discontinuation	WARNING		6803
39465			Hypotension	serious	discontinuation	WARNING		6803
39466			Dyspnea	serious	discontinuation	WARNING		6803
39467			Hypoxia	serious	discontinuation	WARNING		6803
39468			Chest pain	serious	discontinuation	WARNING		6803
39469			Respiratory distress	serious	discontinuation	WARNING		6803
39470			Stridor	serious	discontinuation	WARNING		6803
39471			Wheezing	serious	discontinuation	WARNING		6803
39472			Loss of consciousness	serious	discontinuation	WARNING		6803
39473			Convulsions	serious	discontinuation	WARNING		6803
39474			Anaphylactoid reaction	serious	discontinuation	WARNING		6802
39475			Urticaria		discontinuation	1 patient		6801
39476			Pruritus		discontinuation	1 patient		6801
39477			Dizziness		discontinuation			6801
39478			Chest pain		discontinuation			6801
39479			Dyspnea		discontinuation			6801
39480			Back pain		discontinuation			6801
39481			Intracranial hypertension		discontinuation			6804
39482			Blurred vision		discontinuation			6805
39483			Hematuria		discontinuation			6805
39484	1 pts		Humerus fracture	serious				6806
39485						No AEs are reported		6807
39486			Death			WARNING		6808
39487	3 pts		Creatine kinase increased		discontinuation	leads to discontinuation		6813
39488	1 pts		Renal impairment		discontinuation	leads to discontinuation		6813
39489	18 pts		Death		discontinuation	leads to discontinuation		6813
39490						No AEs were reported		6809
39491						No AEs were reported		6812
39492	1 pts		Acute renal failure		discontinuation	leads to discontinuation		6810
39493	1 pts		Creatine phosphokinase increased	grade 4	discontinuation	leads to discontinuation		6810
39494	1 pts		Respiratory failure		discontinuation	leads to discontinuation		6810
39495	4 pts		Cardiac failure		discontinuation	leads to discontinuation		6811
39496	2 pts		Hypokalemia	grade 1-2	discontinuation	leads to discontinuation		6811
39497	1 pts		Hypocalcemia	grade 4	discontinuation	leads to discontinuation		6811
39498	1 pts		Acute renal failure		discontinuation	leads to discontinuation		6811
39499	1 pts		Creatine phosphokinase increased	grade 4	discontinuation	leads to discontinuation		6811
39500	1 pts		Acute liver injury		discontinuation	leads to discontinuation		6811
39501	1 pts		Gastrointestinal bleeding		discontinuation	leads to discontinuation		6811
39502	2 pts		Nausea and vomiting		discontinuation	leads to discontinuation		6811
39503	7 pts		Upper respiratory tract infections	below serious				6815
39504	1 pts		Substance abuse	serious				6820
39505	5 pts		Oropharyngeal pain	below serious				6820
39506	3 pts		Pharyngitis	below serious				6820
39507	1 pts		Sinusitis	below serious				6820
39508	1 pts		Insomnia	below serious				6820
39509	2 pts		Upper respiratory tract infection	below serious				6820
39510	1 pts		Erosive oesophagitis	serious				6819
39511	1 pts		Convulsion	serious				6819
39512	6 pts		Headache	below serious				6819
39513	2 pts		Bronchitis	below serious				6819
39514	3 pts		Pharyngitis	below serious				6819
39515	3 pts		Sinusitis	below serious				6819
39516	2 pts		Insomnia	below serious				6819
39517	2 pts		Upper respiratory tract infection	below serious				6819
39518	1 pts		Animal scratch	serious				6816
39519	2 pts		Upper respiratory tract infection	below serious				6817
39520	2 pts		Diarrhoea	below serious				6817
39521	1 pts		Headache	below serious				6817
39522	1 pts		Cough	below serious				6817
39523	1 pts		Pyrexia	below serious				6817
39524	1 pts		Skin injury	below serious				6817
39525						No AEs are reported		6821
39526						impossible to link AEs with the definite dose		6827
39527						No AEs are reported		6825
39528			Hypertension	serious				6822
39529	0.7		Diarrhea		discontinuation	leads to discontinuation		6823
39530	0.5		Abdominal pain		discontinuation	leads to discontinuation		6824
39531	0.7		Diarrhea		discontinuation	leads to discontinuation		6828
39532	0.6		Abdominal pain		discontinuation	leads to discontinuation		6828
39533	0.2		Diarrhea		discontinuation	leads to discontinuation		6826
39534	3 pts		Dyspepsia		discontinuation	leads to discontinuation		6814
39535	2 pts		Eructation		discontinuation	leads to discontinuation		6814
39536	6 pts		Nausea		discontinuation	leads to discontinuation		6814
39537	6 pts		Vomiting		discontinuation	leads to discontinuation		6814
39538	1 pts		Erosive esophagitis		discontinuation	leads to discontinuation		6814
39539	1 pts		Dyspepsia		discontinuation	leads to discontinuation		6818
39540	1 pts		Eructation		discontinuation	leads to discontinuation		6818
39541	9 pts		Nausea		discontinuation	leads to discontinuation		6818
39542	6 pts		Vomiting		discontinuation	leads to discontinuation		6818
39543	1		Acute renal failure		discontinuation			6830
39544	1		Electrocardiogram QTc interval prolonged		discontinuation			6830
39545	1.29		Nephrotoxicity		discontinuation	WARNING		6831
39546			Clostridium difficile colitis	all grades	discontinuation	WARNING. May range from mild diarrhea to fatal colitis.		6833
39547			Electrocardiogram QTc interval prolonged		discontinuation	WARNING		6833
39548	1		Nausea		discontinuation			6832
39549	1		Rash		discontinuation			6832
39550			Dysgeusia					6829
39551			Nausea					6829
39552			Vomiting					6829
39553			Injection site erythema					6829
39554			Headache					6829
39555			Macular rash					6829
39556			Red man syndrome					6829
39557			Hypersensitivity		discontinuation	WARNING		6834
39558			Ototoxicity		discontinuation	WARNING		6834
39559			Superinfection		discontinuation	WARNING		6834
39560			Nausea		discontinuation			6835
39561			Hepatotoxicity		discontinuation	leads to discontinuation		6839
39562	1 pts		Grand mal convulsion			suicide attempt		6837
39563	1 pts		Cardiotoxicity			suicide attempt		6837
39564						No AEs are reported		6836
39565						No AEs are reported		6838
39566	1 pts		Drug-induced lupus erythematosus		discontinuation	leads to discontinuation		6840
39567	1 pts		Myalgia	severe	discontinuation	leads to discontinuation		6841
39568	69		Paresthesia					6843
39569	69		Dysesthesia					6843
39570	69		Oral dysesthesia					6843
39571	25		Abdominal pain					6843
39572	25		Upper abdominal pain					6843
39573	17		Dyspepsia					6843
39574	12		Dizziness					6843
39575	10		Nausea					6843
39576	8		Back pain					6843
39577	6		Hypoesthesia					6843
39578	6		Muscle spasms					6843
39579						No information on AEs is available		6842
39580	0.6		Convulsion			leads to discontinuation		6844
39581	0.6		Head titubation			leads to discontinuation		6844
39582	0.6		Tremor			leads to discontinuation		6844
39583	0.6		Unresponsive to stimuli			leads to discontinuation		6844
39584	0.6		Small cell lung cancer			leads to discontinuation		6844
39585	0.6		Metastases to central nervous system			leads to discontinuation		6844
39586	0.6		Lung cancer metastatic			leads to discontinuation		6844
39587	0.6		Pulmonary mass			leads to discontinuation		6844
39588	0.6		Bradycardia			leads to discontinuation		6844
39589	0.6		Pneumonia			leads to discontinuation		6844
39590	0.02		Bradycardia		discontinuation	WARNING		6846
39591	0.04		Hypotension		discontinuation	WARNING		6846
39592	0.02		Chest pain		discontinuation	WARNING		6846
39593	0.02		Electrocardiogram ST segment elevation		discontinuation	WARNING		6846
39594	0.02		Hot flush		discontinuation			6846
39595	0.02		Nausea		discontinuation			6846
39596	0.02		Swollen tongue		discontinuation			6846
39597	0.02		Rash		discontinuation			6846
39598	0.02		Presyncope		discontinuation			6846
39599	0.02		Injection site vesicles		discontinuation			6847
39600	0.02		Cardiac arrest		discontinuation	WARNING		6847
39601	0.02		Anaphylactic shock		discontinuation			6847
39602	0.9		Nausea					6845
39603	0.6		Chest discomfort					6845
39604	0.6		Chest pain					6845
39605	0.5		Injection site pain					6845
39606	2.1		Headache					6845
39607			Chest pain		discontinuation			6849
39608			Tachycardia		discontinuation			6849
39609			Supraventricular tachycardia		discontinuation			6851
39610			Premature ventricular contractions		discontinuation			6851
39611			Hypotension		discontinuation			6850
39612			Ventricular tachycardia		discontinuation			6850
39613			Ventricular tachycardia		discontinuation			6852
39614			Cyanosis		discontinuation			6853
39615			Coma		discontinuation			6853
39616			Hypotension		discontinuation			6853
39617			Ventricular tachycardia		discontinuation			6853
39618			Lethargy		discontinuation			6854
39619			Cyanosis		discontinuation			6855
39620			Lethargy		discontinuation			6855
39621			Gastric perforation	acute	discontinuation			6848
39622	3 pts		Adverse event	grade 5				6856
39623	2 pts		Cough					6858
39624	2 pts		Wheezing					6858
39625						Impossible to link AEs to this route of administration: The total number of recorded adverse events was 20. Of the 20 adverse events, 18 adverse events occurred after treatment with Ca-DTPA. Adverse events included headache, lightheadedness, chest pain, allergic reaction, dermatitis, metallic taste, nausea and diarrhea, and injection site reactions.		6857
39626	2 pts		Muscle spasms	grade 2				6859
39627	1 pts		Urinary incontinence	grade 2				6859
39628	2 pts		Bladder pain	grade 2				6859
39629	1 pts		Pain	grade 1				6859
39630	3 pts		Urethral pain	grade 2				6859
39631	6 pts		Bladder spasm	grade 1				6859
39632	1 pts		Bladder spasm	grade 2				6859
39633	1 pts		Urinary tract infection	grade 1				6859
39634	1 pts		Bladder discomfort	grade 1				6859
39635	1 pts		Bladder irritation	grade 1				6859
39636	2 pts		Bladder pain	grade 1				6859
39637	1.6		Rigors					6860
39638	0.5		Dry mouth					6860
39639	1.1		Dizziness					6860
39640	2.2		Dyspepsia					6860
39641	2.2		Diarrhoea					6860
39642	3.3		Abdominal pain					6860
39643	0.5		Pruritus					6860
39644	0.5		Constipation					6860
39645	3.8		Hyperhidrosis					6860
39646	0.5		Rash					6860
39647	2.2		Asthenia					6860
39648	9.8		Injection site pain					6860
39649	2.2		Nausea					6860
39650	3.3		Somnolence					6860
39651	0.5		Skin discoloration					6860
39652	0.5		Back pain					6860
39653	0.5		Anorexia					6860
39654	0.5		Vasodilatation					6860
39655	0.5		Neurosis					6860
39656	4.9		Headache		discontinuation	one patients withdrew		6860
39657	0.5		Vomiting		discontinuation			6860
39658	0.5		Hot flushes		discontinuation			6860
39659	0.5		Ache stomach		discontinuation			6860
39660						Among adverse events leading to patient’s dropout, few single episodes were serious and were all judged as unrelated to the study treatment.		6862
39661						There were no safety issues during or after treatment with any of the tested doses.		6861
39662	1 pts		Neutropenia	grade 4			TRUE	6871
39663	1 pts		Neutropenia	grade 4			TRUE	6872
39664	1 pts		Neutropenia	grade 4			TRUE	6875
39665	2 pts		Neutropenia	grade 4			TRUE	6869
39666	2 pts		Neutropenia	grade 4			TRUE	6873
39667	3 pts		Neutropenia	grade 4			TRUE	6870
39668	3 pts		Anorexia	grade 4			TRUE	6870
39669	14 pts		Hemoglobin decreased	grade 3				6868
39670	16 pts		Leukopenia	grade 3				6868
39671	3 pts		Lymphopenia	grade 3				6868
39672	12 pts		Neutrophils	grade 3				6868
39673	4 pts		Platelet count decreased	grade 3				6868
39674	9 pts		Leukopenia	grade 4				6868
39675	16 pts		Lymphopenia	grade 4				6868
39676	16 pts		Neutrophils	grade 4				6868
39677	4 pts		Platelet count decreased	grade 4				6868
39678	1 pts		Leukopenia	grade 1				6874
39679	5 pts		Leukopenia	grade 3				6874
39680	1 pts		Anemia	grade 1				6874
39681	3 pts		Anemia	grade 2				6874
39682	2 pts		Anemia	grade 4				6874
39683	2 pts		Myalgia	grade 1				6874
39684	4 pts		Myalgia	grade 2				6874
39685	2 pts		Myalgia	grade 3				6874
39686	1 pts		Thrombosis	grade 3				6874
39687	1 pts		Thrombosis	grade 4				6874
39688	1 pts		Embolism	grade 3				6874
39689	1 pts		Embolism	grade 4				6874
39690	1 pts		Abdominal pain	grade 1				6874
39691	2 pts		Abdominal pain	grade 2				6874
39692	2 pts		Abdominal pain	grade 3				6874
39693	1 pts		Infection	grade 2				6874
39694	1 pts		Infection	grade 3				6874
39695	1 pts		Infection	grade 4				6874
39696	2 pts		Alkaline phosphatase	grade 3				6874
39697	2 pts		ALT decreased	grade 3				6874
39698	2 pts		SGPT increased	grade 3				6874
39699	2 pts		AST increased	grade 3				6874
39700	2 pts		SGOT increased	grade 3				6874
39701	2 pts		Hemorrhage	grade 3				6874
39702	2 pts		Gastrointestinal bleeding					6874
39703	2 pts		Neutropenia	grade 3			TRUE	6865
39704	2 pts		Hypophosphatemia	grade 3			TRUE	6865
39705	1 pts		Neutropenia	grade 3			TRUE	6864
39706	1 pts		Creatinine increased	grade 3			TRUE	6864
39707	83		Fatigue	all grades				6863
39708	77		Anemia	all grades				6863
39709	10		Thrombosis	all grades				6863
39710	10		Neutropenia	all grades				6863
39711	2 pts		Myalgia	grade 3			TRUE	6866
39712	6 pts		Thrombocytopenia	grade 1				6867
39713	3 pts		Anemia	grade 3				6866
39714	35		Headache					6882
39715	18		Nasopharyngitis					6882
39716	15		Urinary tract infection					6882
39717	15		Cystitis					6882
39718	15		Kidney infection					6882
39719	12		Nausea					6882
39720	12		Pyrexia					6882
39721	9		Abdominal pain					6882
39722	9		Back pain					6882
39723	9		Cough					6882
39724	9		Diarrhea					6882
39725	9		Epistaxis					6882
39726	35		Headache					6882
39727	18		Nasopharyngitis					6882
39728	15		Urinary tract infection					6882
39729	15		Cystitis					6882
39730	15		Kidney infection					6882
39731	12		Nausea					6882
39732	12		Pyrexia					6882
39733	9		Abdominal pain					6882
39734	9		Back pain					6882
39735	9		Cough					6882
39736	9		Diarrhea					6882
39737	9		Epistaxis					6882
39738	8.82		Myalgia					6883
39739	8.82		Oropharyngeal pain					6883
39740	8.82		Hematuria					6883
39741	8.82		Insomnia					6883
39742	5.88		Dizziness					6883
39743	5.88		Hypoaesthesia					6883
39744	5.88		Asthenia					6883
39745	5.88		Chest pain					6883
39746	5.88		Weight increased					6883
39747	5.88		Torticollis					6883
39748	5.88		Atrial fibrillation					6883
39749	8.82		Myalgia					6883
39750	8.82		Oropharyngeal pain					6883
39751	8.82		Hematuria					6883
39752	8.82		Insomnia					6883
39753	5.88		Dizziness					6883
39754	5.88		Hypoaesthesia					6883
39755	5.88		Asthenia					6883
39756	5.88		Chest pain					6883
39757	5.88		Weight increased					6883
39758	5.88		Torticollis					6883
39759	5.88		Atrial fibrillation					6883
39760						Well tolerated dose		6880
39761						Well tolerated dose		6879
39762						Well tolerated dose		6878
39763						Well tolerated dose		6877
39764						Well tolerated dose		6876
39765						No information		6881
39766			Nephrotic syndrome					6885
39767			Death			OVERDOSAGE		6884
39768			Loss of consciousness		discontinuation			6886
39769			Hypotension		discontinuation			6886
39770			Respiratory depression	severe	discontinuation			6886
39771			Abdominal pain	severe	discontinuation			6886
39772			Vomiting		discontinuation			6886
39773			Diarrhea		discontinuation			6886
39774			Enterocolitis	severe	discontinuation			6886
39775			Erosive oesophagitis	severe	discontinuation			6886
39776			Gastritis erosive	severe	discontinuation			6886
39777			Ulceration	severe	discontinuation			6886
39778			Contact dermatitis		discontinuation			6886
39779			ALT increased		discontinuation			6886
39780			AST increased		discontinuation			6886
39781			Dizziness		discontinuation			6888
39782			Intracranial pressure increase		discontinuation			6888
39783			Nausea		discontinuation			6888
39784			Headache		discontinuation			6888
39785			Respiratory failure	grade 5	discontinuation			6887
39786			Cardiac arrhythmias	grade 5	discontinuation			6887
39787			Cardiac failure	grade 5	discontinuation			6887
39788	1 pts		Ataxia		discontinuation	leads to discontinuation		6889
39789	1 pts		Dysarthria		discontinuation	leads to discontinuation		6889
39790	1 pts		Hallucinations		discontinuation	leads to discontinuation		6889
39791	1 pts		Hepatomegaly		discontinuation	leads to discontinuation		6889
39792	1 pts		Rash					6891
39793	1 pts		Vitiligo					6891
39794	1 pts		Hypotension					6891
39795	1 pts		Fatigue					6891
39796	1 pts		Chills					6891
39797	1 pts		Nausea					6891
39798	1 pts		Autoimmune thyroiditis					6891
39799	1 pts		Pruritus					6891
39800	1 pts		Necrosis bowel		discontinuation	leads to discontinuation		6893
39801	3 pts		Hypotension					6890
39802	3 pts		Drowsiness					6890
39803	3 pts		Ataxia					6890
39804	1 pts		Lightheadedness		discontinuation	leads to discontinuation		6892
39805	1 pts		Generalized epileptic seizure		discontinuation	leads to discontinuation		6892
39806			Edema face		discontinuation	POISONING		6894
39807			Eyelid oedema		discontinuation	POISONING		6894
39808			Nausea		discontinuation	POISONING		6894
39809			Respiratory failure	grade 5		AE resulting in death		6895
39810			Hallucinations	grade 3-4	discontinuation			6896
39811			Fatigue	grade 3-4	discontinuation			6896
39812			Emesis	grade 3-4	discontinuation			6896
39813			Chest pain	grade 3-4	discontinuation			6896
39814			Myocardial hypoxia	grade 3-4	discontinuation			6896
39815			Bacterial resistance		discontinuation	WARNING		6897
39816						No information on AEs is available		6898
39817	3		Rash	grade 3-4				6901
39818	3		Fatigue	grade 3-4				6901
39819	3		Bilirubin total increased	grade 3-4				6901
39820	3		Conjugated bilirubin level increased	grade 3-4				6901
39821	6		Bilirubin unconjugated increased	grade 3-4				6901
39822	3		Lipase increased	grade 3-4				6901
39823	9		ALT increased	grade 3-4				6901
39824	9		Aspartate aminotransferase increased	grade 3-4				6901
39825	17		Thrombocytopenia	grade 3-4				6901
39826	14		Neutropenia	grade 3-4				6901
39827	5 pts		Thrombocytopenia		discontinuation	leads to discontinuation		6899
39828	1 pts		Neutropenia		discontinuation	leads to discontinuation		6899
39829	2 pts		Bilirubin increased		discontinuation	leads to discontinuation		6899
39830	2 pts		Hepatotoxicity		discontinuation	leads to discontinuation		6899
39831	1 pts		Skin rash		discontinuation	leads to discontinuation		6899
39832	1 pts		Rash		discontinuation	leads to discontinuation		6900
39833	1 pts		Pancreatitis		discontinuation	leads to discontinuation		6900
39834	1 pts		Myocardial infarction		discontinuation	leads to discontinuation		6900
39835	1 pts		Thrombocytopenia	grade 3	discontinuation	leads to discontinuation		6900
39836	1 pts		Neutropenia	grade 3	discontinuation	leads to discontinuation		6900
39837						No adverse reactions were reported		6904
39838						No adverse reactions were reported		6902
39839			Nausea	mild	discontinuation			6903
39840			Abdominal pain		discontinuation			6903
39841			Reaction skin	severe|grade 4|grade 5	discontinuation	WARNING		6905
39842			Stevens-Johnson syndrome	severe|grade 4|grade 5	discontinuation	WARNING		6905
39843			Hypersensitivity reaction	severe|grade 4|grade 5	discontinuation	WARNING		6905
39844			Toxic epidermal necrolysis	severe|grade 4|grade 5	discontinuation	WARNING		6905
39845			Immune reconstitution syndrome		discontinuation	WARNING		6905
39846	1 pts		Neurologic disorder NOS	serious				6908
39847	1 pts		Hypotension			accidentally		6914
39848						impossible to link AEs with the definite dose		6912
39849	1 pts		Wheezing			suicide attempt		6913
39850	0.7		Hypotension		discontinuation	leads to discontinuation		6906
39851	1.3		Dizziness		discontinuation	leads to discontinuation		6909
39852	1 pts		Abdominal distension		discontinuation	leads to discontinuation		6910
39853	1 pts		Rash	moderate	discontinuation	leads to discontinuation		6911
39854	1 pts		Congestive cardiac failure	moderate	discontinuation	leads to discontinuation		6907
39855	1 pts		Asthma		discontinuation	leads to discontinuation		6916
39856	18 pts		Apparent life threatening event					6915
39857	131 pts		Bronchitis					6915
39858	131 pts		Cough increased					6915
39859	131 pts		Dyspnea					6915
39860	131 pts		Lung disorder					6915
39861	67 pts		Tachycardia					6915
39862	67 pts		Palpitation					6915
39863	67 pts		Chest pain					6915
39864	67 pts		Arrhythmia					6915
39865	67 pts		Hypertension					6915
39866	67 pts		Dyspepsia					6915
39867	67 pts		Nausea					6915
39868	67 pts		Leg cramps					6915
39869	45 pts		Bronchitis		discontinuation	leads to discontinuation		6915
39870	45 pts		Cough increased		discontinuation	leads to discontinuation		6915
39871	45 pts		Dyspnea		discontinuation	leads to discontinuation		6915
39872	45 pts		Lung disorder		discontinuation	leads to discontinuation		6915
39873	1 pts		Cerebral edema		discontinuation	leads to discontinuation		6918
39874						No information on AE is provided		6917
39875	5.7		Diarrhea		discontinuation	leads to discontinuation		6919
39876	3.3		Diarrhea		discontinuation	leads to discontinuation		6920
39877	1.6		Diarrhea		discontinuation	leads to discontinuation		6921
39878	8 pts		Heart rate decreased				TRUE	6922
39879	1 pts		Sick sinus syndrome	serious				6925
39880	1 pts		Ileus	serious				6925
39881	1 pts		Subileus	serious				6925
39882	1 pts		Abscess intestinal	serious				6925
39883	1 pts		Contusion	serious				6925
39884	1 pts		Osteoarthritis	serious				6925
39885	1 pts		Adenosquamous cell carcinoma	serious				6925
39886	1 pts		Prostate cancer	serious				6925
39887	1 pts		Carotid sinus syndrome	serious				6925
39888	1 pts		Cerebrovascular accident	serious				6925
39889	1 pts		Pulmonary embolism	serious				6925
39890	1 pts		Respiratory failure	serious				6925
39891	1 pts		Deep vein thrombosis	serious				6925
39892	11 pts		Injection site erythema	below serious				6925
39893	2 pts		Injection site pain	below serious				6925
39894	6 pts		Injection site induration	below serious				6925
39895	7 pts		Nasopharyngitis	below serious				6925
39896	1 pts		Clostridium difficile colitis	serious				6926
39897	1 pts		Intervertebral disc protrusion	serious				6926
39898	14 pts		Injection site erythema	below serious				6926
39899	10 pts		Injection site pain	below serious				6926
39900	7 pts		Injection site induration	below serious				6926
39901	4 pts		Hot flush	below serious				6926
39902	1 pts		Atrioventricular block complete	serious				6927
39903	1 pts		Intervertebral disc protrusion	serious				6927
39904	1 pts		Osteoarthritis	serious				6927
39905	1 pts		Colon cancer metastatic	serious				6927
39906	1 pts		Depression	serious				6927
39907	1 pts		Chronic obstructive pulmonary disease	serious				6927
39908	1 pts		Hypertension	serious				6927
39909	18 pts		Injection site erythema	below serious				6927
39910	18 pts		Injection site pain	below serious				6927
39911	11 pts		Injection site induration	below serious				6927
39912	9 pts		Hypertension	below serious				6927
39913	8 pts		Hot flush	below serious				6927
39914	2.19		Injection site induration		discontinuation			6923
39915	1.46		Malaise		discontinuation			6923
39916	1.46		Hepatic function abnormal		discontinuation			6923
39917			QT interval prolonged		discontinuation	WARNING		6924
39918	1 pts		Anaemia iron deficiency	serious				6935
39919	1 pts		Hypertensive heart disease	serious				6935
39920	1 pts		Myocardial ischaemia	serious				6935
39921	1 pts		Abdominal pain	serious				6935
39922	1 pts		Appendicitis perforated	serious				6935
39923	1 pts		Rectal haemorrhage	serious				6935
39924	1 pts		Bronchiectasis	serious				6935
39925	1 pts		Traumatic brain injury	serious				6935
39926	1 pts		Upper limb fracture	serious				6935
39927	1 pts		Intervertebral disc protrusion	serious				6935
39928	1 pts		Hepatic neoplasm malignant	serious				6935
39929	1 pts		Prostate cancer	serious				6935
39930	1 pts		Haemorrhage intracranial	serious				6935
39931	1 pts		Suicidal behaviour	serious				6935
39932	1 pts		Urinary incontinence	serious				6935
39933	1 pts		Haemorrhage uterine	serious				6935
39934	12 pts		Vision blurred	below serious				6935
39935	10 pts		Abdominal pain	below serious				6935
39936	9 pts		Abdominal pain upper	below serious				6935
39937	37 pts		Constipation	below serious				6935
39938	14 pts		Diarrhoea	below serious				6935
39939	189 pts		Dry mouth	below serious				6935
39940	12 pts		Dyspepsia	below serious				6935
39941	7 pts		Vomiting	below serious				6935
39942	12 pts		Fatigue	below serious				6935
39943	15 pts		Urinary tract infection	below serious				6935
39944	8 pts		Dizziness	below serious				6935
39945	38 pts		Headache	below serious				6935
39946	4 pts		Dysuria	below serious				6935
39947	8 pts		Cough	below serious				6935
39948	8 pts		Hypertension	below serious				6935
39949	1 pts		Myocardial infarction	serious				6934
39950	1 pts		Colitis ulcerative	serious				6934
39951	1 pts		Cellulitis staphylococcal	serious				6934
39952	1 pts		Genitourinary tract infection	serious				6934
39953	1 pts		Intervertebral disc protrusion	serious				6934
39954	1 pts		Lung neoplasm malignant	serious				6934
39955	1 pts		Transitional cell carcinoma	serious				6934
39956	1 pts		Dysuria	serious				6934
39957	1 pts		Colic renal	serious				6934
39958	1 pts		Testicular torsion	serious				6934
39959	1 pts		Orthostatic hypotension	serious				6934
39960	6 pts		Abdominal pain	below serious				6934
39961	31 pts		Constipation	below serious				6934
39962	9 pts		Diarrhoea	below serious				6934
39963	100 pts		Dry mouth	below serious				6934
39964	9 pts		Dyspepsia	below serious				6934
39965	5 pts		Gastritis	below serious				6934
39966	6 pts		Nausea	below serious				6934
39967	6 pts		Influenza	below serious				6934
39968	5 pts		Nasopharyngitis	below serious				6934
39969	5 pts		Sinusitis	below serious				6934
39970	15 pts		Headache	below serious				6934
39971	9 pts		Insomnia	below serious				6934
39972	15 pts		Dysuria	below serious				6934
39973	11 pts		Urinary retention	below serious				6934
39974	5 pts		Erectile dysfunction	below serious				6934
39975	1 pts		Dry eye	below serious				6932
39976	2 pts		Abdominal pain	below serious				6932
39977	1 pts		Constipation	below serious				6932
39978	2 pts		Diarrhoea	below serious				6932
39979	13 pts		Dry mouth	below serious				6932
39980	1 pts		Dyschezia	below serious				6932
39981	1 pts		Oedema peripheral	below serious				6932
39982	2 pts		Nasopharyngitis	below serious				6932
39983	12 pts		Headache	below serious				6932
39984	1 pts		Pollakiuria	below serious				6932
39985	1 pts		Dry throat	below serious				6932
39986	1 pts		Oropharyngeal pain	below serious				6932
39987	1 pts		Myocardial infarction	serious				6933
39988	1 pts		Embolus pulmonary	serious				6933
39989	1 pts		Breast cancer	serious				6933
39990	1 pts		Colitis	serious				6933
39991	24 pts		Constipation	below serious				6933
39992	19 pts		Headache	below serious				6933
39993	21 pts		Cold	below serious				6933
39994	17 pts		Urinary tract infection	below serious				6933
39995	10 pts		Cough	below serious				6933
39996	10 pts		Nausea	below serious				6933
39997	9 pts		Dyspepsia	below serious				6933
39998	1 pts		Septic arthritis staphylococcal	serious				6936
39999	1 pts		Ankle fracture	serious				6936
40000	1 pts		Fall	serious				6936
40001	1 pts		Hip fracture	serious				6936
40002	1 pts		Tibia fracture	serious				6936
40003	1 pts		Diabetic ketoacidosis	serious				6936
40004	1 pts		Lymphoma	serious				6936
40005	1 pts		Renal failure acute	serious				6936
40006	1 pts		Otorrhoea	below serious				6936
40007	1 pts		Hypothyroidism	below serious				6936
40008	9 pts		Dry eye	below serious				6936
40009	4 pts		Abdominal pain	below serious				6936
40010	2 pts		Abdominal pain upper	below serious				6936
40011	1 pts		Colitis	below serious				6936
40012	15 pts		Constipation	below serious				6936
40013	98 pts		Dry mouth	below serious				6936
40014	5 pts		Dyspepsia	below serious				6936
40015	1 pts		Dysphagia	below serious				6936
40016	1 pts		Gastritis	below serious				6936
40017	2 pts		Gastrooesophageal reflux disease	below serious				6936
40018	1 pts		Haemorrhoids	below serious				6936
40019	1 pts		Lip dry	below serious				6936
40020	1 pts		Rectal prolapse	below serious				6936
40021	1 pts		Stomatitis	below serious				6936
40022	2 pts		Asthenia	below serious				6936
40023	5 pts		Fatigue	below serious				6936
40024	1 pts		Feeling abnormal	below serious				6936
40025	1 pts		Gait disturbance	below serious				6936
40026	1 pts		Oedema	below serious				6936
40027	1 pts		Acute sinusitis	below serious				6936
40028	1 pts		Bronchitis	below serious				6936
40029	2 pts		Cystitis	below serious				6936
40030	1 pts		Diverticulitis	below serious				6936
40031	2 pts		Gastroenteritis	below serious				6936
40032	1 pts		Gastroenteritis viral	below serious				6936
40033	2 pts		Herpes zoster	below serious				6936
40034	1 pts		Pharyngitis streptococcal	below serious				6936
40035	1 pts		Pneumonia primary atypical	below serious				6936
40036	1 pts		Tooth infection	below serious				6936
40037	5 pts		Upper respiratory tract infection	below serious				6936
40038	9 pts		Urinary tract infection	below serious				6936
40039	1 pts		Foot fracture	below serious				6936
40040	1 pts		Muscle injury	below serious				6936
40041	2 pts		Muscle strain	below serious				6936
40042	1 pts		Periorbital haematoma	below serious				6936
40043	1 pts		Procedural pain	below serious				6936
40044	1 pts		Blood glucose decreased	below serious				6936
40045	2 pts		Blood pressure increased	below serious				6936
40046	1 pts		Urine output decreased	below serious				6936
40047	1 pts		Hyperlipidaemia	below serious				6936
40048	1 pts		Hypertriglyceridaemia	below serious				6936
40049	1 pts		Pica	below serious				6936
40050	1 pts		Polydipsia	below serious				6936
40051	2 pts		Type 2 diabetes mellitus	below serious				6936
40052	3 pts		Arthralgia	below serious				6936
40053	1 pts		Arthritis	below serious				6936
40054	1 pts		Bursitis	below serious				6936
40055	3 pts		Flank pain	below serious				6936
40056	2 pts		Muscle spasms	below serious				6936
40057	1 pts		Muscular weakness	below serious				6936
40058	2 pts		Myalgia	below serious				6936
40059	1 pts		Myositis	below serious				6936
40060	1 pts		Neck pain	below serious				6936
40061	2 pts		Pain in extremity	below serious				6936
40062	1 pts		Basal cell carcinoma	below serious				6936
40063	1 pts		Amnesia	below serious				6936
40064	6 pts		Dizziness	below serious				6936
40065	11 pts		Headache	below serious				6936
40066	1 pts		Lethargy	below serious				6936
40067	1 pts		Memory impairment	below serious				6936
40068	1 pts		Nerve compression	below serious				6936
40069	1 pts		Paraesthesia	below serious				6936
40070	1 pts		Syncope	below serious				6936
40071	1 pts		Tremor	below serious				6936
40072	2 pts		Depression	below serious				6936
40073	5 pts		Insomnia	below serious				6936
40074	2 pts		Dysuria	below serious				6936
40075	1 pts		Haematuria	below serious				6936
40076	1 pts		Nephrolithiasis	below serious				6936
40077	1 pts		Polyuria	below serious				6936
40078	2 pts		Urinary hesitation	below serious				6936
40079	1 pts		Urinary incontinence	below serious				6936
40080	3 pts		Urinary retention	below serious				6936
40081	1 pts		Urine flow decreased	below serious				6936
40082	1 pts		Chronic obstructive pulmonary disease	below serious				6936
40083	3 pts		Dry throat	below serious				6936
40084	2 pts		Dysphonia	below serious				6936
40085	1 pts		Dyspnoea	below serious				6936
40086	1 pts		Epistaxis	below serious				6936
40087	3 pts		Nasal congestion	below serious				6936
40088	3 pts		Nasal dryness	below serious				6936
40089	3 pts		Oropharyngeal pain	below serious				6936
40090	2 pts		Rhinorrhoea	below serious				6936
40091	1 pts		Throat irritation	below serious				6936
40092	1 pts		Dermatitis contact	below serious				6936
40093	1 pts		Eczema	below serious				6936
40094	1 pts		Generalised pruritus	below serious				6936
40095	1 pts		Flushing	below serious				6936
40096	3 pts		Hypertension	below serious				6936
40097	4 pts		Vision blurred	below serious				6936
40098	1 pts		Coronary artery occlusion	serious				6928
40099	1 pts		Influenza	serious				6928
40100	1 pts		Urosepsis	serious				6928
40101	1 pts		Fall	serious				6928
40102	1 pts		Femur fracture	serious				6928
40103	1 pts		Haemarthrosis	serious				6928
40104	1 pts		Muscular weakness	serious				6928
40105	1 pts		Osteoarthritis	serious				6928
40106	1 pts		Bradycardia	below serious				6928
40107	1 pts		Cardiac failure congestive	below serious				6928
40108	1 pts		Ventricular extrasystoles	below serious				6928
40109	4 pts		Dry eye	below serious				6928
40110	1 pts		Discharge eye	below serious				6928
40111	1 pts		Eye haemorrhage	below serious				6928
40112	1 pts		Eye oedema	below serious				6928
40113	1 pts		Eye swelling	below serious				6928
40114	1 pts		Vitreous floaters	below serious				6928
40115	1 pts		Abdominal discomfort	below serious				6928
40116	2 pts		Abdominal distension	below serious				6928
40117	31 pts		Constipation	below serious				6928
40118	8 pts		Diarrhoea	below serious				6928
40119	66 pts		Dry mouth	below serious				6928
40120	7 pts		Dyspepsia	below serious				6928
40121	1 pts		Faecal incontinence	below serious				6928
40122	2 pts		Flatulence	below serious				6928
40123	3 pts		Gastrooesophageal reflux disease	below serious				6928
40124	1 pts		Haemorrhoids	below serious				6928
40125	1 pts		Hiatus hernia	below serious				6928
40126	5 pts		Nausea	below serious				6928
40127	1 pts		Tongue dry	below serious				6928
40128	8 pts		Fatigue	below serious				6928
40129	1 pts		Local swelling	below serious				6928
40130	1 pts		Oedema	below serious				6928
40131	1 pts		Therapeutic response unexpected	below serious				6928
40132	1 pts		Candidiasis	below serious				6928
40133	1 pts		Diverticulitis	below serious				6928
40134	1 pts		Herpes simplex	below serious				6928
40135	1 pts		Herpes zoster ophthalmic	below serious				6928
40136	1 pts		Oral herpes	below serious				6928
40137	1 pts		Pneumonia viral	below serious				6928
40138	5 pts		Sinusitis	below serious				6928
40139	1 pts		Tinea pedis	below serious				6928
40140	1 pts		Tooth abscess	below serious				6928
40141	1 pts		Vulvovaginal candidiasis	below serious				6928
40142	1 pts		Arthropod bite	below serious				6928
40143	3 pts		Contusion	below serious				6928
40144	1 pts		Laceration	below serious				6928
40145	1 pts		Post procedural haematoma	below serious				6928
40146	2 pts		Skeletal injury	below serious				6928
40147	1 pts		Blood glucose increased	below serious				6928
40148	2 pts		Blood pressure increased	below serious				6928
40149	1 pts		Blood uric acid increased	below serious				6928
40150	1 pts		International normalised ratio increased	below serious				6928
40151	1 pts		Residual urine volume increased	below serious				6928
40152	1 pts		Weight increased	below serious				6928
40153	2 pts		Gout	below serious				6928
40154	1 pts		Type 2 diabetes mellitus	below serious				6928
40155	4 pts		Back pain	below serious				6928
40156	1 pts		Bursitis	below serious				6928
40157	1 pts		Intervertebral disc degeneration	below serious				6928
40158	1 pts		Musculoskeletal chest pain	below serious				6928
40159	2 pts		Musculoskeletal pain	below serious				6928
40160	1 pts		Osteoporosis	below serious				6928
40161	1 pts		Trigger finger	below serious				6928
40162	1 pts		Skin cancer	below serious				6928
40163	1 pts		Diabetic neuropathy	below serious				6928
40164	3 pts		Dizziness	below serious				6928
40165	7 pts		Headache	below serious				6928
40166	1 pts		Hypersomnia	below serious				6928
40167	2 pts		Memory impairment	below serious				6928
40168	1 pts		Migraine	below serious				6928
40169	1 pts		Sinus headache	below serious				6928
40170	1 pts		Tremor	below serious				6928
40171	1 pts		Confusional state	below serious				6928
40172	1 pts		Depression	below serious				6928
40173	1 pts		Sleep disorder	below serious				6928
40174	4 pts		Dysuria	below serious				6928
40175	1 pts		Nephrolithiasis	below serious				6928
40176	1 pts		Urinary hesitation	below serious				6928
40177	9 pts		Urinary retention	below serious				6928
40178	1 pts		Urine odour abnormal	below serious				6928
40179	1 pts		Haemorrhage vaginal	below serious				6928
40180	1 pts		Asthma	below serious				6928
40181	1 pts		Bronchospasm	below serious				6928
40182	2 pts		Chronic obstructive pulmonary disease	below serious				6928
40183	7 pts		Cough	below serious				6928
40184	5 pts		Dry throat	below serious				6928
40185	1 pts		Dysphonia	below serious				6928
40186	1 pts		Dyspnoea exertional	below serious				6928
40187	1 pts		Epistaxis	below serious				6928
40188	1 pts		Nasal dryness	below serious				6928
40189	2 pts		Oropharyngeal pain	below serious				6928
40190	1 pts		Allergic rhinitis	below serious				6928
40191	2 pts		Sinus congestion	below serious				6928
40192	1 pts		Blister	below serious				6928
40193	1 pts		Ingrowing nail	below serious				6928
40194	1 pts		Onychoclasis	below serious				6928
40195	2 pts		Pruritus	below serious				6928
40196	1 pts		Generalised pruritus	below serious				6928
40197	1 pts		Urticaria	below serious				6928
40198	1 pts		Flushing	below serious				6928
40199	1 pts		Angina pectoris	serious				6937
40200	1 pts		Myocardial infarction	serious				6937
40201	1 pts		Prostate cancer	serious				6937
40202	1 pts		Chronic obstructive pulmonary disease	serious				6937
40203	1 pts		Hypertension	serious				6937
40204	3 pts		Vision blurred	below serious				6937
40205	12 pts		Constipation	below serious				6937
40206	51 pts		Dry mouth	below serious				6937
40207	6 pts		Dyspepsia	below serious				6937
40208						No adverse reactions leading to discontinuation were reported		6929
40209			Face angioedema		discontinuation	WARNING		6931
40210			Lip angioedema		discontinuation	WARNING		6931
40211			Oedema tongue		discontinuation	WARNING		6931
40212			Angioedema of larynx		discontinuation	WARNING		6931
40213	0.8		Dry mouth		discontinuation			6930
40214	33		Nausea	grade 1-2		1 patient	TRUE	6938
40215	33		Dizziness	grade 1-2		1 patient	TRUE	6938
40216	33		Appetite lost	grade 1-2		1 patient	TRUE	6938
40217	33		Vertigo	mild		1 patient	TRUE	6938
40218						No adverse reactions leading to discontinuation were reported		6939
40219						No AEs were reported		6940
40220	6		Diarrhea					6941
40221	6		Nausea					6941
40222	4		Nasopharyngitis					6941
40223	4		Dry mouth					6941
40224	3		Vomiting					6941
40225	3		Dizziness					6941
40226	3		Insomnia					6941
40227	2		Dyspnea		discontinuation			6942
40228			Hypersensitivity reaction		discontinuation	WARNING. (including anaphylaxis and anaphylactic shock)		6943
40229			Anaphylaxis		discontinuation	WARNING		6943
40230			Anaphylactic shock		discontinuation	WARNING		6943
40231			Infusion site reactions		discontinuation	WARNING		6943
40232			Thrombophlebitis		discontinuation	WARNING		6943
40233			Necrosis		discontinuation	WARNING		6943
40234			Vasculitis		discontinuation	WARNING		6943
40235	7 pts		Headache					6945
40236	7 pts		Fatigue					6945
40237						impossible to link AEs with the definite dose: The most frequently reported side effects included headache (32 subjects), injection site reactions (20 subjects), and fatigue (11 subjects).		6944
40238						No AEs are reported		6946
40239	2 pts		Splenic sequestration	serious				6955
40240	1 pts		Sudden death	serious				6955
40241	11 pts		Thrombocytopenia	below serious				6955
40242						No information on AE is provided		6947
40243	1 pts		Black hairy tongue		discontinuation	leads to discontinuation		6954
40244	1 pts		Melanonychia		discontinuation	leads to discontinuation		6954
40245						No information on AE is provided		6948
40246	1 pts		Myelosuppression	mild				6949
40247	1 pts		Myelosuppression	mild				6950
40248	1 pts		Leg ulcer		discontinuation	leads to discontinuation		6953
40249			Myelosuppression			WARNING		6952
40250			Malignant or unspecified tumours (SMQ)					6952
40251	1 pts		Epistaxis		discontinuation	leads to discontinuation		6951
40252	1 pts		Cellulitis	serious				6956
40253	1 pts		Suicide attempt	serious				6956
40254	1 pts		Postpartum depression	serious				6956
40255	1 pts		Bipolar disorder	serious				6956
40256	1 pts		Back pain	serious				6956
40257	1 pts		Small intestinal obstruction	serious				6956
40258	1 pts		Duodenal ulcer perforation	serious				6956
40259	1 pts		Coronary artery disease	serious				6956
40260	1 pts		Angina unstable	serious				6956
40261	1 pts		Encephalopathy toxic	serious				6956
40262	1 pts		Pelvic fracture	serious				6956
40263	1 pts		Ilium fracture	serious				6956
40264	1 pts		Hypertension	serious				6956
40265	35 pts		Nausea	below serious				6956
40266	21 pts		Diarrhoea	below serious				6956
40267	17 pts		Abdominal distension	below serious				6956
40268	1 pts		Irritable bowel syndrome	serious				6957
40269	1 pts		Intestinal obstruction	serious				6957
40270	1 pts		Pneumonia	serious				6957
40271	1 pts		Herpes zoster	serious				6957
40272	1 pts		Multiple sclerosis relapse	serious				6957
40273	1 pts		Migraine	serious				6957
40274	1 pts		Cholecystitis	serious				6957
40275	33 pts		Nausea	below serious				6957
40276	18 pts		Diarrhoea	below serious				6957
40277	13 pts		Flatulence	below serious				6957
40278	12 pts		Vomiting	below serious				6957
40279	15 pts		Nausea	below serious				6960
40280	14 pts		Bloating	below serious				6960
40281	12 pts		Diarrhea	below serious				6960
40282	11 pts		Abdominal pain	below serious				6960
40283	3 pts		Vomiting	below serious				6960
40284	1 pts		Abdominal pain	serious				6961
40285	1 pts		Nausea	serious				6961
40286	1 pts		Vomiting	serious				6961
40287	1 pts		Ankle fracture	serious				6961
40288	1 pts		Drug toxicity	serious				6961
40289	1 pts		Migraine	serious				6961
40290	1 pts		Nephrolithiasis	serious				6961
40291	1 pts		Hepatic enzyme increased	serious				6961
40292	24 pts		Diarrhea	below serious				6961
40293	21 pts		Nausea	below serious				6961
40294	15 pts		Abdominal pain	below serious				6961
40295	6 pts		Flatulence	below serious				6961
40296	7 pts		Urinary tract infection	below serious				6961
40297	6 pts		Back pain	below serious				6961
40298	5 pts		Arthralgia	below serious				6961
40299	5 pts		Gamma-glutamyltransferase increased	below serious				6961
40300	9 pts		Nausea	below serious				6962
40301	7 pts		Flatulence	below serious				6962
40302	2 pts		Upper respiratory tract infection	below serious				6962
40303	5 pts		Presyncope	below serious				6962
40304	2 pts		Dizziness	below serious				6962
40305	2 pts		Throat irritation	below serious				6962
40306	1 pts		Anaphylactoid reaction	serious				6967
40307	1 pts		Chest pain	serious				6967
40308	1 pts		Major depression	serious				6967
40309	1 pts		Hand-foot-and-mouth disease	serious				6967
40310	1 pts		Cellulitis	serious				6967
40311	1 pts		Rash	serious				6967
40312	34 pts		Headache	below serious				6967
40313	57 pts		Nausea	below serious				6967
40314	45 pts		Vomiting	below serious				6967
40315	28 pts		Diarrhoea	below serious				6967
40316	20 pts		Abdominal pain upper	below serious				6967
40317	1 pts		Colitis	serious				6966
40318	2 pts		Nausea	below serious				6966
40319	1 pts		Colitis	below serious				6966
40320	1 pts		Dyspepsia	below serious				6966
40321	1 pts		Rectal haemorrhage	below serious				6966
40322	1 pts		Vomiting	below serious				6966
40323	4 pts		Urinary tract infection	below serious				6966
40324	1 pts		Viral infection	below serious				6966
40325	1 pts		Hypophosphataemia	below serious				6966
40326	11 pts		Nausea	below serious				6963
40327	8 pts		Diarrhoea	below serious				6963
40328	19 pts		Nausea	below serious				6964
40329	6 pts		Dyspepsia	below serious				6964
40330	5 pts		Diarrhoea	below serious				6964
40331	5 pts		Headache	below serious				6964
40332	1 pts		Neutropenia	below serious				6965
40333	10 pts		Diarrhoea	below serious				6965
40334	2 pts		Nausea	below serious				6965
40335	1 pts		Abdominal pain	below serious				6965
40336	1 pts		Abdominal pain upper	below serious				6965
40337	1 pts		Dyspepsia	below serious				6965
40338	3 pts		Influenza	below serious				6965
40339	1 pts		Bronchitis	below serious				6965
40340	1 pts		Oral herpes	below serious				6965
40341	1 pts		Limb injury	below serious				6965
40342	1 pts		Lymphocyte count increased	below serious				6965
40343	1 pts		Dyslipidaemia	below serious				6965
40344	1 pts		Hyperuricaemia	below serious				6965
40345	1 pts		Dizziness	below serious				6965
40346	2 pts		Dysmenorrhoea	below serious				6965
40347	13 pts		Diarrhea	below serious				6958
40348	11 pts		Nausea	below serious				6958
40349	4 pts		Abdominal pain	below serious				6958
40350	4 pts		Vomiting	below serious				6958
40351	22 pts		Diarrhea	below serious				6959
40352	10 pts		Nausea	below serious				6959
40353	17 pts		Headache	below serious				6959
40354	9		Nausea		discontinuation	WARNING		6968
40355	2		Dyspnea		discontinuation	WARNING		6968
40356	45		Nausea					6969
40357	35		Diarrhea					6969
40358	27		Vomiting					6969
40359	14		Dizziness					6969
40360	12		Headache					6969
40361	8		Abdominal pain					6969
40362	8		Flash hot					6969
40363	8		Retching					6969
40364	4		Dyspnea					6969
40365	4		Pallor					6969
40366	4		Stomach discomfort					6969
40367	2		Anorexia					6969
40368	2		Asthenia					6969
40369	2		Chest discomfort					6969
40370	2		Dry mouth					6969
40371	2		Hyperhidrosis					6969
40372	2		Syncope					6969
40373	1 pts		Intestinal fistula	serious				6971
40374	1 pts		Pyrexia	serious				6971
40375	1 pts		Cholelithiasis	serious				6971
40376	1 pts		Device related infection	serious				6971
40377	1 pts		Gastroenteritis	serious				6971
40378	1 pts		Incision site infection	serious				6971
40379	1 pts		Urinary tract infection	serious				6971
40380	5 pts		Wound infection	serious				6971
40381	1 pts		Wound infection staphylococcal	serious				6971
40382	3 pts		Postoperative ileus	serious				6971
40383	1 pts		Postoperative wound complication	serious				6971
40384	1 pts		Dehydration	serious				6971
40385	1 pts		Aspiration pneumonia	serious				6971
40386	1 pts		Respiratory failure	serious				6971
40387	1 pts		Necrosis skin	serious				6971
40388	1 pts		Hypotension	serious				6971
40389	39 pts		Nausea	below serious				6971
40390	7 pts		Fatigue	below serious				6971
40391	7 pts		Dizziness	below serious				6971
40392	7 pts		Somnolence	below serious				6971
40393	12 pts		Urinary retention	below serious				6971
40394	1 pts		Abdominal pain upper	serious				6973
40395	1 pts		Abdominal wall haematoma	serious				6973
40396	1 pts		Intestinal obstruction	serious				6973
40397	2 pts		Nausea	serious				6973
40398	1 pts		Vomiting	serious				6973
40399	1 pts		Bacteraemia	serious				6973
40400	1 pts		Pneumonia	serious				6973
40401	2 pts		Wound infection staphylococcal	serious				6973
40402	1 pts		Incisional hernia, obstructive	serious				6973
40403	1 pts		Postoperative wound complication	serious				6973
40404	1 pts		Dyspnoea	serious				6973
40405	13 pts		Constipation	below serious				6973
40406	10 pts		Hypokalaemia	below serious				6973
40407	8 pts		Hypertension	below serious				6973
40408	1 pts		Nausea	below serious				6972
40409	1 pts		Vomiting	below serious				6972
40410	1 pts		Dizziness	below serious				6972
40411	2 pts		Headache	below serious				6972
40412	1 pts		Anxiety	below serious				6972
40413	1 pts		Diarrhea	below serious				6974
40414	1 pts		Dyspepsia	below serious				6974
40415	1 pts		Haemorrhoids	below serious				6974
40416	1 pts		Nausea	below serious				6974
40417	1 pts		Vomiting	below serious				6974
40418	1 pts		Pyrexia	below serious				6974
40419	1 pts		Oral candidiasis	below serious				6974
40420	1 pts		Joint sprain	below serious				6974
40421	1 pts		Band neutrophil count increased	below serious				6974
40422	1 pts		White blood cell count increased	below serious				6974
40423	1 pts		Food craving	below serious				6974
40424	1 pts		Hyperglycaemia	below serious				6974
40425	1 pts		Nuchal rigidity	below serious				6974
40426	1 pts		Headache	below serious				6974
40427	1 pts		Pelvic pain	below serious				6974
40428	1 pts		Orthostatic hypertension	below serious				6974
40429	1 pts		Arteriosclerosis	serious				6975
40430	4 pts		Abdominal pain	below serious				6975
40431	1 pts		Diarrhea	below serious				6975
40432	1 pts		Dyspepsia	below serious				6975
40433	2 pts		Nausea	below serious				6975
40434	2 pts		Vomiting	below serious				6975
40435	1 pts		Orthostatic hypertension	below serious				6975
40436	1 pts		Constipation	serious				6977
40437	1 pts		Nausea	serious				6977
40438	1 pts		Vomiting	serious				6977
40439	1 pts		Syncope	serious				6977
40440	2 pts		Abdominal pain	below serious				6977
40441	1 pts		Diarrhea	below serious				6977
40442	2 pts		Nausea	below serious				6977
40443	1 pts		Vomiting	below serious				6977
40444	1 pts		Anaemia	below serious				6970
40445	1 pts		Abdominal distension	below serious				6970
40446	1 pts		Abdominal pain	below serious				6970
40447	1 pts		Abdominal tenderness	below serious				6970
40448	1 pts		Constipation	below serious				6970
40449	1 pts		Diarrhoea	below serious				6970
40450	1 pts		Nausea	below serious				6970
40451	1 pts		Urinary tract infection	below serious				6970
40452	1 pts		Wound infection	below serious				6970
40453	1 pts		Headache	below serious				6970
40454	1 pts		Hypotension	below serious				6970
40455	1 pts		Impaired gastric emptying	serious				6976
40456	1 pts		Bronchitis	serious				6976
40457	1 pts		Cellulitis	serious				6976
40458	1 pts		Myositis ossificans	serious				6976
40459	21 pts		Abdominal pain	below serious				6976
40460	16 pts		Diarrhoea	below serious				6976
40461	10 pts		Flatulence	below serious				6976
40462	0.5		Vertigo		discontinuation	1 patient		6983
40463			Gastrointestinal perforation		discontinuation	WARNING		6982
40464			Diarrhea	severe	discontinuation	WARNING		6982
40465			Opiate withdrawal symptoms		discontinuation	WARNING		6982
40466			Gastrointestinal perforation		discontinuation	WARNING		6984
40467			Diarrhea	severe	discontinuation	WARNING		6984
40468			Opiate withdrawal symptoms		discontinuation	WARNING		6984
40469	2		Abdominal pain		discontinuation			6981
40470						No adverse reactions leading to discontinuation were reported		6979
40471						No adverse reactions leading to discontinuation were reported		6980
40472						No adverse reactions leading to discontinuation were reported		6978
40473	1 pts		Diaphoresis					6989
40474						No AEs are reported		6988
40475	1 pts		Premature ventricular contractions		discontinuation	leads to dose interruption		6987
40476	1 pts		Thrombocytopenia	serious	discontinuation	leads to discontinuation		6992
40477	1 pts		Hepatic enzyme increased		discontinuation	leads to dose interruption		6990
40478	1 pts		Orthostatic hypotension		discontinuation	leads to dose interruption		6990
40479	1 pts		Ventricular ectopics		discontinuation	leads to discontinuation		6991
40480	1 pts		Paresthesia		discontinuation	leads to discontinuation		6993
40481	1 pts		Anxiety		discontinuation	leads to discontinuation		6986
40482	1 pts		Arrhythmia		discontinuation	leads to discontinuation		6986
40483	1 pts		Erythema		discontinuation	leads to discontinuation		6986
40484	1 pts		Decreased appetite		discontinuation	leads to dose interruption		6986
40485	1 pts		Eructation		discontinuation	leads to dose interruption		6986
40486	1 pts		Liver function test abnormal		discontinuation	leads to dose interruption		6986
40487	2 pts		Nausea		discontinuation	leads to dose interruption		6986
40488	2 pts		Vomiting		discontinuation	leads to dose interruption		6986
40489	1 pts		Postural hypotension		discontinuation	leads to dose interruption		6986
40490	1 pts		Sinus tachycardia		discontinuation	leads to dose interruption		6986
40491	1 pts		Staphylococcal bacteremia		discontinuation	leads to dose interruption		6986
40492	1 pts		Insomnia		discontinuation	leads to dose modification		6986
40493			Injection site erythema					6985
40494			Paresthesia					6985
40495			Chest discomfort					6985
40496	1 pts		Neutropenic fever				TRUE	6995
40497	1 pts		Neutropenia				TRUE	6995
40498	1 pts		Low platelets		discontinuation	leads to dose interruption	TRUE	6995
40499	2 pts		Stomatitis		discontinuation	leads to dose interruption	TRUE	6995
40500	2 pts		Mucositis	grade 3			TRUE	6994
40501	1 pts		Mucositis	grade 3			TRUE	6996
40502	25		Fatigue	grade 3				6996
40503	6		Dyspnea	grade 4	discontinuation	leads to discontinuation		6996
40504	13		Back pain	grade 3				6996
40505	6		Dehydration	grade 3				6996
40506	6		Headache	grade 3				6996
40507	6		Malaise	grade 3				6996
40508	6		Chest pain (non-cardiac)	grade 3				6996
40509	6		Odynophagia	grade 3				6996
40510	6		Hand-and-foot syndrome	grade 3				6996
40511	6		Pleural effusion	grade 3				6996
40512	6		Respiratory obstruction unspecified	grade 3				6996
40513	6		Small intestine obstruction	grade 3				6996
40514	7		Mucositis		discontinuation	leads to discontinuation		6997
40515	5		Thrombocytopenia		discontinuation	leads to discontinuation		6997
40516	1 pts		Mucositis	grade 5	discontinuation	leads to discontinuation		6997
40517	1 pts		Febrile neutropenia	grade 5	discontinuation	leads to discontinuation		6997
40518	70		Gastrointestinal inflammation	all grades				6997
40519	17		Gastrointestinal inflammation	grade 3	discontinuation	leads to dose modification		6997
40520	4		Gastrointestinal inflammation	grade 4	discontinuation	leads to dose modification		6997
40521	70		Genitourinary tract infections and inflammations NEC	all grades				6997
40522	17		Genitourinary tract infections and inflammations NEC	grade 3	discontinuation	leads to dose modification		6997
40523	4		Genitourinary tract infections and inflammations NEC	grade 4	discontinuation	leads to dose modification		6997
40524	41		Thrombocytopenia	all grades				6997
40525	14		Thrombocytopenia	grade 3				6997
40526	19		Thrombocytopenia	grade 4	discontinuation	leads to dose modification		6997
40527	40		Nausea	all grades				6997
40528	4		Nausea	grade 3				6997
40529	36		Fatigue	all grades				6997
40530	5		Fatigue	grade 3				6997
40531	2		Fatigue	grade 4				6997
40532	34		Anemia	all grades				6997
40533	15		Anemia	grade 3				6997
40534	2		Anemia	grade 4				6997
40535	33		Constipation	all grades				6997
40536	32		Pyrexia	all grades				6997
40537	1		Pyrexia	grade 3				6997
40538	1		Pyrexia	grade 4				6997
40539	30		Edema	all grades				6997
40540	1		Edema	grade 3				6997
40541	28		Cough	all grades				6997
40542	1		Cough	grade 3				6997
40543	26		Epistaxis	all grades				6997
40544	25		Vomiting	all grades				6997
40545	2		Vomiting	grade 3				6997
40546	24		Neutropenia	all grades				6997
40547	13		Neutropenia	grade 3				6997
40548	7		Neutropenia	grade 4				6997
40549	21		Diarrhea	all grades				6997
40550	2		Diarrhea	grade 3				6997
40551	19		Dyspnea	all grades				6997
40552	7		Dyspnea	grade 3				6997
40553	15		Anorexia	all grades				6997
40554	3		Anorexia	grade 3				6997
40555	15		Hypokalemia	all grades				6997
40556	4		Hypokalemia	grade 3				6997
40557	1		Hypokalemia	grade 4				6997
40558	15		Rash	all grades				6997
40559	14		Pruritus	all grades				6997
40560	2		Pruritus	grade 3				6997
40561	14		Pharyngolaryngeal pain	all grades				6997
40562	1		Pharyngolaryngeal pain	grade 3				6997
40563	13		Alanine aminotransferase increased	all grades				6997
40564	5		Alanine aminotransferase increased	grade 3				6997
40565	13		Aspartate aminotransferase increased	all grades				6997
40566	5		Aspartate aminotransferase increased	grade 3				6997
40567	13		Transaminases increased	all grades				6997
40568	5		Transaminases increased	grade 3				6997
40569	12		Abdominal pain	all grades				6997
40570	4		Abdominal pain	grade 3				6997
40571	12		Pain in extremity	all grades				6997
40572	11		Back pain	all grades				6997
40573	3		Back pain	grade 3				6997
40574	11		Leukopenia	all grades				6997
40575	3		Leukopenia	grade 3				6997
40576	4		Leukopenia	grade 4				6997
40577	11		Night sweats	all grades				6997
40578	10		Asthenia	all grades				6997
40579	1		Asthenia	grade 3				6997
40580	10		Tachycardia	all grades				6997
40581	10		Upper respiratory tract infection	all grades				6997
40582	1		Upper respiratory tract infection	grade 3				6997
40583	1 pts		Sickle cell anaemia	serious				6999
40584	1 pts		Anaemia sickle cell	serious				6999
40585	1 pts		Vertigo	serious				6999
40586	1 pts		Pneumonia	serious				6999
40587	1 pts		Osteonecrosis	serious				6999
40588	11 pts		Pain	below serious				6999
40589	3 pts		Sickle cell anaemia with crisis	below serious				6999
40590	2 pts		Gingival bleeding	below serious				6999
40591	5 pts		Headache	below serious				6999
40592	2 pts		Death	serious				6998
40593	6 pts		Percutaneous coronary intervention	serious				6998
40594	17 pts		Anaemia	serious				7000
40595	3 pts		Hypersplenism	serious				7000
40596	1 pts		Splenic infarction	serious				7000
40597	1 pts		Thrombocytopenia	serious				7000
40598	1 pts		Cardiac failure	serious				7000
40599	1 pts		Tachycardia	serious				7000
40600	1 pts		Vertigo	serious				7000
40601	1 pts		Abdominal pain upper	serious				7000
40602	1 pts		Diarrhoea	serious				7000
40603	1 pts		Gingival bleeding	serious				7000
40604	1 pts		Chest pain	serious				7000
40605	1 pts		Non-cardiac chest pain	serious				7000
40606	1 pts		Hyperbilirubinaemia	serious				7000
40607	1 pts		Anaphylactic reaction	serious				7000
40608	1 pts		Acinetobacter bacteraemia	serious				7000
40609	1 pts		Bronchitis	serious				7000
40610	1 pts		Cellulitis	serious				7000
40611	1 pts		Cellulitis orbital	serious				7000
40612	1 pts		Enterovirus infection	serious				7000
40613	1 pts		Hepatitis C	serious				7000
40614	2 pts		Osteomyelitis acute	serious				7000
40615	1 pts		Parvovirus B19 infection	serious				7000
40616	1 pts		Pharyngitis	serious				7000
40617	6 pts		Plasmodium falciparum infection	serious				7000
40618	1 pts		Pneumonia streptococcal	serious				7000
40619	1 pts		Respiratory syncytial virus infection	serious				7000
40620	2 pts		Respiratory tract infection	serious				7000
40621	1 pts		Septic shock	serious				7000
40622	1 pts		Tooth abscess	serious				7000
40623	1 pts		Hand fracture	serious				7000
40624	1 pts		Haemoglobin decreased	serious				7000
40625	1 pts		Platelet count decreased	serious				7000
40626	1 pts		Serum ferritin increased	serious				7000
40627	1 pts		Musculoskeletal chest pain	serious				7000
40628	1 pts		Haemorrhage intracranial	serious				7000
40629	1 pts		Ruptured cerebral aneurysm	serious				7000
40630	1 pts		Renal papillary necrosis	serious				7000
40631	1 pts		Amenorrhoea	serious				7001
40632	15 pts		Acute chest syndrome	serious				7000
40633	1 pts		Asthma	serious				7000
40634	2 pts		Epistaxis	serious				7000
40635	1 pts		Lung disorder	serious				7000
40636	1 pts		Pleural effusion	serious				7000
40637	1 pts		Pneumothorax	serious				7000
40638	1 pts		Pulmonary hypertension	serious				7000
40639	1 pts		Ecchymosis	serious				7000
40640	1 pts		Purpura	serious				7000
40641	1 pts		Nail operation	serious				7000
40642	1 pts		Selective abortion	serious				7001
40643	1 pts		Deep vein thrombosis	serious				7000
40644	2 pts		Haematoma	serious				7000
40645	18 pts		Pain	below serious				7000
40646	33 pts		Malaria	below serious				7000
40647	11 pts		Rhinitis	below serious				7000
40648	44 pts		Upper respiratory tract infection	below serious				7000
40649	17 pts		Urinary tract infection	below serious				7000
40650	23 pts		Epistaxis	below serious				7000
40651	9 pts		Oropharyngeal pain	below serious				7000
40652	1 pts		Dizziness					7003
40653	2 pts		Alanine aminotransferase increased					7002
40654			Bleeding	grade 5|severe	discontinuation	WARNING		7004
40655	1 pts		Cardiac failure congestive	serious				7008
40656	2 pts		Myocardial infarction	serious				7008
40657	1 pts		Abdominal pain upper	serious				7008
40658	1 pts		Diarrhoea	serious				7008
40659	1 pts		Cystitis	serious				7008
40660	1 pts		Urinary tract infection	serious				7008
40661	1 pts		Dyspnoea	serious				7008
40662	1 pts		Interstitial lung disease	serious				7008
40663	1 pts		Orthopnoea	serious				7008
40664	1 pts		Hypertension	serious				7008
40665	1 pts		Poor peripheral circulation	serious				7008
40666	1 pts		Oedema peripheral	serious				7008
40667	1 pts		Alanine aminotransferase increased	serious				7008
40668	1 pts		Aspartate aminotransferase increased	serious				7008
40669	1 pts		Malignant fibrous histiocytoma	serious				7008
40670	1 pts		Fibrous histiocytoma malignant	serious				7008
40671	2 pts		Pneumonia	serious				7008
40672	1 pts		Cellulitis	serious				7008
40673	1 pts		Pyelonephritis	serious				7008
40674	1 pts		Acute myocardial infarction	serious				7008
40675	1 pts		Cardiac arrest	serious				7008
40676	1 pts		Gastrointestinal haemorrhage	serious				7008
40677	1 pts		Cauda equina syndrome	serious				7008
40678	1 pts		Dizziness	serious				7008
40679	1 pts		Arteriovenous fistula	serious				7008
40680	1 pts		Orthostatic hypotension	serious				7008
40681	1 pts		Cataract	serious				7008
40682	1 pts		Iridocyclitis	serious				7008
40683	1 pts		Pseudoexfoliation of lens capsule	serious				7008
40684	1 pts		Blood glucose increased	serious				7008
40685	1 pts		Calculus ureteric	serious				7008
40686	1 pts		Skin ulcer	serious				7008
40687	5 pts		Urinary tract infection	below serious				7008
40688	1 pts		Anaemia megaloblastic	serious				7009
40689	1 pts		Disseminated intravascular coagulation	serious				7009
40690	1 pts		Febrile neutropenia	serious				7009
40691	3 pts		Lymphopenia	serious				7009
40692	2 pts		Nephrogenic anaemia	serious				7009
40693	4 pts		Normochromic normocytic anaemia	serious				7009
40694	1 pts		Pernicious anaemia	serious				7009
40695	5 pts		Thrombocytopenia	serious				7009
40696	6 pts		Acute myocardial infarction	serious				7009
40697	2 pts		Adams-Stokes syndrome	serious				7009
40698	6 pts		Aortic valve stenosis	serious				7009
40699	78 pts		Atrial fibrillation	serious				7009
40700	22 pts		Atrial flutter	serious				7009
40701	1 pts		Atrioventricular block first degree	serious				7009
40702	1 pts		Bifascicular block	serious				7009
40703	14 pts		Bradycardia	serious				7009
40704	1 pts		Block bundle branch	serious				7009
40705	1 pts		Cardiac aneurysm	serious				7009
40706	5 pts		Cardiac arrest	serious				7009
40707	3 pts		Cardiac failure acute	serious				7009
40708	30 pts		Cardiac failure congestive	serious				7009
40709	2 pts		Cardiac tamponade	serious				7009
40710	1 pts		Cardiovascular disorder	serious				7009
40711	1 pts		Cardiovascular insufficiency	serious				7009
40712	1 pts		Diastolic dysfunction	serious				7009
40713	2 pts		Left ventricular failure	serious				7009
40714	2 pts		Pericardial effusion	serious				7009
40715	1 pts		Right ventricular dysfunction	serious				7009
40716	9 pts		Supraventricular tachycardia	serious				7009
40717	1 pts		Systolic dysfunction	serious				7009
40718	8 pts		Tachycardia	serious				7009
40719	1 pts		Tricuspid valve incompetence	serious				7009
40720	16 pts		Ventricular tachycardia	serious				7009
40721	1 pts		Tinnitus	serious				7009
40722	1 pts		Tympanic membrane perforation	serious				7009
40723	16 pts		Vertigo	serious				7009
40724	3 pts		Vertigo positional	serious				7009
40725	2 pts		Goitre	serious				7009
40726	1 pts		Hyperparathyroidism primary	serious				7009
40727	6 pts		Hyperthyroidism	serious				7009
40728	1 pts		Hypothyroidism	serious				7009
40729	1 pts		Toxic nodular goitre	serious				7009
40730	1 pts		Cataract cortical	serious				7009
40731	6 pts		Diabetic retinopathy	serious				7009
40732	2 pts		Glaucoma	serious				7009
40733	1 pts		Macular oedema	serious				7009
40734	1 pts		Retinal haemorrhage	serious				7009
40735	1 pts		Haemorrhage retinal	serious				7009
40736	1 pts		Retinal ischaemia	serious				7009
40737	1 pts		Ulcerative keratitis	serious				7009
40738	2 pts		Vision blurred	serious				7009
40739	1 pts		Abdominal discomfort	serious				7009
40740	2 pts		Abdominal hernia obstructive	serious				7009
40741	17 pts		Abdominal pain	serious				7009
40742	4 pts		Abdominal pain upper	serious				7009
40743	1 pts		Abdominal strangulated hernia	serious				7009
40744	1 pts		Anal polyp	serious				7009
40745	6 pts		Colitis ischaemic	serious				7009
40746	1 pts		Colitis ulcerative	serious				7009
40747	6 pts		Colonic polyp	serious				7009
40748	1 pts		Colonic pseudo-obstruction	serious				7009
40749	1 pts		Diverticular perforation	serious				7009
40750	1 pts		Diverticulitis intestinal haemorrhagic	serious				7009
40751	2 pts		Dyspepsia	serious				7009
40752	3 pts		Dysphagia	serious				7009
40753	3 pts		Enteritis	serious				7009
40754	1 pts		Faecaloma	serious				7009
40755	1 pts		Femoral hernia	serious				7009
40756	1 pts		Gastric antral vascular ectasia	serious				7009
40757	15 pts		Gastritis	serious				7009
40758	1 pts		Atrophic gastritis	serious				7009
40759	2 pts		Gastrointestinal inflammation	serious				7009
40760	2 pts		Gastrointestinal vascular malformation	serious				7009
40761	1 pts		Gingival bleeding	serious				7009
40762	2 pts		Haematemesis	serious				7009
40763	5 pts		Haemorrhoids	serious				7009
40764	2 pts		Hiatus hernia	serious				7009
40765	6 pts		Hernia inguinal	serious				7009
40766	5 pts		Intestinal obstruction	serious				7009
40767	1 pts		Large intestinal haemorrhage	serious				7009
40768	2 pts		Mallory-Weiss syndrome	serious				7009
40769	1 pts		Mesenteric artery thrombosis	serious				7009
40770	1 pts		Mesenteric vascular insufficiency	serious				7009
40771	4 pts		Nausea	serious				7009
40772	1 pts		Oesophageal obstruction	serious				7009
40773	1 pts		Oesophageal spasm	serious				7009
40774	1 pts		Oesophageal stenosis	serious				7009
40775	4 pts		Oesophagitis	serious				7009
40776	1 pts		Oesophagitis ulcerative	serious				7009
40777	1 pts		Pancreatic mass	serious				7009
40778	18 pts		Pancreatitis	serious				7009
40779	3 pts		Rectal prolapse	serious				7009
40780	1 pts		Retroperitoneal fibrosis	serious				7009
40781	3 pts		Small intestinal perforation	serious				7009
40782	1 pts		Tongue disorder	serious				7009
40783	5 pts		Umbilical hernia	serious				7009
40784	3 pts		Umbilical hernia, obstructive	serious				7009
40785	6 pts		Vomiting	serious				7009
40786	1 pts		Application site pain	serious				7009
40787	4 pts		Asthenia	serious				7009
40788	1 pts		Catheter site haemorrhage	serious				7009
40789	14 pts		Chest pain	serious				7009
40790	5 pts		Death	serious				7009
40791	3 pts		Device breakage	serious				7009
40792	1 pts		Device damage	serious				7009
40793	4 pts		Device malfunction	serious				7009
40794	1 pts		Exercise tolerance decreased	serious				7009
40795	3 pts		Fatigue	serious				7009
40796	1 pts		Feeling cold	serious				7009
40797	1 pts		General symptom	serious				7009
40798	1 pts		Hernia	serious				7009
40799	1 pts		Hernia obstructive	serious				7009
40800	3 pts		Healing impaired	serious				7009
40801	2 pts		Inflammation	serious				7009
40802	1 pts		Lipogranuloma	serious				7009
40803	1 pts		Medical device complication	serious				7009
40804	1 pts		Multi-organ disorder	serious				7009
40805	7 pts		Multi-organ failure	serious				7009
40806	1 pts		Necrobiosis	serious				7009
40807	1 pts		Necrosis	serious				7009
40808	4 pts		Oedema peripheral	serious				7009
40809	1 pts		Organ failure	serious				7009
40810	2 pts		Pain	serious				7009
40811	1 pts		Spinal pain	serious				7009
40812	3 pts		Systemic inflammatory response syndrome	serious				7009
40813	1 pts		Biliary dyskinesia	serious				7009
40814	1 pts		Biliary polyp	serious				7009
40815	13 pts		Cholecystitis	serious				7009
40816	22 pts		Cholecystitis acute	serious				7009
40817	3 pts		Hepatic failure	serious				7009
40818	1 pts		Hepatic ischaemia	serious				7009
40819	1 pts		Portal vein thrombosis	serious				7009
40820	1 pts		Allergy to venom	serious				7009
40821	1 pts		Anaphylactic shock	serious				7009
40822	1 pts		Autoimmune disorder	serious				7009
40823	1 pts		Cryoglobulinaemia	serious				7009
40824	3 pts		Hypersensitivity	serious				7009
40825	5 pts		Abscess limb	serious				7009
40826	1 pts		Acarodermatitis	serious				7009
40827	1 pts		Adenovirus infection	serious				7009
40828	3 pts		Arthritis bacterial	serious				7009
40829	3 pts		Bacteraemia	serious				7009
40830	1 pts		Bone abscess	serious				7009
40831	1 pts		Bronchiolitis	serious				7009
40832	10 pts		Bronchopneumonia	serious				7009
40833	1 pts		Campylobacter infection	serious				7009
40834	1 pts		Cellulitis gangrenous	serious				7009
40835	1 pts		Cervicitis	serious				7009
40836	1 pts		Cholangitis suppurative	serious				7009
40837	1 pts		Chronic sinusitis	serious				7009
40838	2 pts		Clostridial infection	serious				7009
40839	1 pts		Creutzfeldt-Jakob disease	serious				7009
40840	2 pts		Cystitis	serious				7009
40841	1 pts		Dengue fever	serious				7009
40842	10 pts		Diabetic foot infection	serious				7009
40843	9 pts		Diabetic gangrene	serious				7009
40844	1 pts		Ear infection	serious				7009
40845	1 pts		Empyema	serious				7009
40846	1 pts		Endocarditis enterococcal	serious				7009
40847	1 pts		Enterobacter pneumonia	serious				7009
40848	1 pts		Enterococcal bacteraemia	serious				7009
40849	2 pts		Enterocolitis infectious	serious				7009
40850	1 pts		Escherichia sepsis	serious				7009
40851	1 pts		Escherichia urinary tract infection	serious				7009
40852	1 pts		Gallbladder abscess	serious				7009
40853	22 pts		Gangrene	serious				7009
40854	28 pts		Gastroenteritis	serious				7009
40855	3 pts		Gastroenteritis viral	serious				7009
40856	1 pts		HIV infection	serious				7009
40857	1 pts		Hepatitis B	serious				7009
40858	3 pts		Infection	serious				7009
40859	2 pts		Infective exacerbation of chronic obstructive airways disease	serious				7009
40860	6 pts		Influenza	serious				7009
40861	1 pts		Intestinal gangrene	serious				7009
40862	1 pts		Klebsiella infection	serious				7009
40863	16 pts		Lobar pneumonia	serious				7009
40864	4 pts		Lower respiratory tract infection	serious				7009
40865	1 pts		Lyme disease	serious				7009
40866	1 pts		Meningitis	serious				7009
40867	1 pts		Oesophageal candidiasis	serious				7009
40868	2 pts		Otitis externa	serious				7009
40869	1 pts		Parametritis	serious				7009
40870	1 pts		Perihepatic abscess	serious				7009
40871	1 pts		Perinephric abscess	serious				7009
40872	1 pts		Periorbital cellulitis	serious				7009
40873	1 pts		Peritoneal abscess	serious				7009
40874	5 pts		Peritonitis	serious				7009
40875	1 pts		Peritonitis bacterial	serious				7009
40876	1 pts		Pneumococcal bacteraemia	serious				7009
40877	1 pts		Pneumococcal sepsis	serious				7009
40878	1 pts		Pneumocystis jiroveci infection	serious				7009
40879	151 pts		Pneumonia	serious				7009
40880	1 pts		Pneumonia chlamydial	serious				7009
40881	1 pts		Pneumococcal pneumonia	serious				7009
40882	3 pts		Post procedural infection	serious				7009
40883	1 pts		Post procedural sepsis	serious				7009
40884	1 pts		Prostatic abscess	serious				7009
40885	1 pts		Pseudomonal sepsis	serious				7009
40886	6 pts		Pulmonary sepsis	serious				7009
40887	11 pts		Pyelonephritis	serious				7009
40888	5 pts		Pyelonephritis acute	serious				7009
40889	3 pts		Renal abscess	serious				7009
40890	1 pts		Rhinitis	serious				7009
40891	21 pts		Sepsis	serious				7009
40892	1 pts		Sepsis syndrome	serious				7009
40893	11 pts		Septic shock	serious				7009
40894	3 pts		Infection staphylococcal	serious				7009
40895	1 pts		Staphylococcal sepsis	serious				7009
40896	1 pts		Streptococcal urinary tract infection	serious				7009
40897	4 pts		Subcutaneous abscess	serious				7009
40898	1 pts		Subdiaphragmatic abscess	serious				7009
40899	1 pts		Testicular abscess	serious				7009
40900	1 pts		Thrombophlebitis septic	serious				7009
40901	7 pts		Upper respiratory tract infection	serious				7009
40902	1 pts		Urinary tract infection bacterial	serious				7009
40903	1 pts		Urinary tract infection staphylococcal	serious				7009
40904	10 pts		Urosepsis	serious				7009
40905	1 pts		Vulval abscess	serious				7009
40906	1 pts		Accident	serious				7009
40907	1 pts		Anastomotic ulcer haemorrhage	serious				7009
40908	2 pts		Arteriovenous fistula site complication	serious				7009
40909	1 pts		Arteriovenous graft site haematoma	serious				7009
40910	1 pts		Bone fissure	serious				7009
40911	1 pts		Brachial plexus injury	serious				7009
40912	1 pts		Burns third degree	serious				7009
40913	1 pts		Cartilage injury	serious				7009
40914	1 pts		Clavicle fracture	serious				7009
40915	5 pts		Concussion	serious				7009
40916	4 pts		Contusion	serious				7009
40917	3 pts		Craniocerebral injury	serious				7009
40918	1 pts		Face injury	serious				7009
40919	3 pts		Facial bones fracture	serious				7009
40920	10 pts		Femoral neck fracture	serious				7009
40921	13 pts		Femur fracture	serious				7009
40922	3 pts		Foot fracture	serious				7009
40923	1 pts		Foreign body	serious				7009
40924	1 pts		Fracture	serious				7009
40925	1 pts		Graft thrombosis	serious				7009
40926	2 pts		Hand fracture	serious				7009
40927	5 pts		Head injury	serious				7009
40928	1 pts		Heart injury	serious				7009
40929	9 pts		Humerus fracture	serious				7009
40930	6 pts		Incisional hernia	serious				7009
40931	4 pts		Joint dislocation	serious				7009
40932	4 pts		Limb injury	serious				7009
40933	7 pts		Lower limb fracture	serious				7009
40934	1 pts		Multiple drug overdose intentional	serious				7009
40935	1 pts		Near drowning	serious				7009
40936	5 pts		Patella fracture	serious				7009
40937	3 pts		Pelvic fracture	serious				7009
40938	1 pts		Pneumothorax traumatic	serious				7009
40939	1 pts		Post concussion syndrome	serious				7009
40940	1 pts		Post procedural bile leak	serious				7009
40941	3 pts		Post procedural complication	serious				7009
40942	1 pts		Post procedural discharge	serious				7009
40943	1 pts		Post procedural haematuria	serious				7009
40944	1 pts		Postoperative thoracic procedure complication	serious				7009
40945	5 pts		Postoperative wound complication	serious				7009
40946	2 pts		Seroma	serious				7009
40947	1 pts		Skeletal injury	serious				7009
40948	1 pts		Skull fractured base	serious				7009
40949	2 pts		Spinal fracture	serious				7009
40950	1 pts		Splenic haematoma	serious				7009
40951	9 pts		Subdural haematoma	serious				7009
40952	1 pts		Suture related complication	serious				7009
40953	1 pts		Tooth fracture	serious				7009
40954	1 pts		Traumatic intracranial haemorrhage	serious				7009
40955	1 pts		Traumatic ulcer	serious				7009
40956	1 pts		Ulna fracture	serious				7009
40957	4 pts		Upper limb fracture	serious				7009
40958	2 pts		Vascular graft occlusion	serious				7009
40959	2 pts		Vascular graft thrombosis	serious				7009
40960	1 pts		Vascular pseudoaneurysm	serious				7009
40961	3 pts		Wound	serious				7009
40962	1 pts		Wound haemorrhage	serious				7009
40963	3 pts		Wound necrosis	serious				7009
40964	6 pts		Wrist fracture	serious				7009
40965	1 pts		Alanine aminotransferase increased	serious				7009
40966	1 pts		Blood bilirubin increased	serious				7009
40967	1 pts		Blood pressure abnormal	serious				7009
40968	1 pts		C-reactive protein increased	serious				7009
40969	1 pts		Electrocardiogram abnormal	serious				7009
40970	1 pts		Haemoglobin decreased	serious				7009
40971	1 pts		Heart rate increased	serious				7009
40972	1 pts		International normalised ratio increased	serious				7009
40973	1 pts		Prostatic specific antigen increased	serious				7009
40974	4 pts		Transaminases increased	serious				7009
40975	1 pts		Urine albumin/creatinine ratio increased	serious				7009
40976	1 pts		Decreased appetite	serious				7009
40977	1 pts		Diabetic complication	serious				7009
40978	8 pts		Diabetic ketoacidosis	serious				7009
40979	1 pts		Electrolyte imbalance	serious				7009
40980	1 pts		Fluid retention	serious				7009
40981	8 pts		Gout	serious				7009
40982	2 pts		Hyperglycaemic hyperosmolar nonketotic syndrome	serious				7009
40983	17 pts		Hyperkalaemia	serious				7009
40984	2 pts		Hypokalaemia	serious				7009
40985	2 pts		Ketoacidosis	serious				7009
40986	8 pts		Arthralgia	serious				7009
40987	1 pts		Arthropathy	serious				7009
40988	5 pts		Bursitis	serious				7009
40989	1 pts		Carpal collapse	serious				7009
40990	1 pts		Fracture nonunion	serious				7009
40991	3 pts		Gouty arthritis	serious				7009
40992	3 pts		Intervertebral disc degeneration	serious				7009
40993	4 pts		Intervertebral disc disorder	serious				7009
40994	1 pts		Joint stiffness	serious				7009
40995	6 pts		Lumbar spinal stenosis	serious				7009
40996	1 pts		Monarthritis	serious				7009
40997	4 pts		Muscular weakness	serious				7009
40998	2 pts		Myopathy	serious				7009
40999	1 pts		Myositis	serious				7009
41000	1 pts		Neuropathic arthropathy	serious				7009
41001	49 pts		Osteoarthritis	serious				7009
41002	1 pts		Osteoporotic fracture	serious				7009
41003	8 pts		Pain in extremity	serious				7009
41004	3 pts		Rotator cuff syndrome	serious				7009
41005	1 pts		Spinal disorder	serious				7009
41006	7 pts		Osteoarthritis spinal	serious				7009
41007	1 pts		Vertebral column mass	serious				7009
41008	1 pts		Abdominal neoplasm	serious				7009
41009	2 pts		Adenoma benign	serious				7009
41010	1 pts		Angiocentric lymphoma	serious				7009
41011	3 pts		B-cell lymphoma	serious				7009
41012	52 pts		Basal cell carcinoma	serious				7009
41013	1 pts		Basosquamous carcinoma	serious				7009
41014	2 pts		Benign neoplasm of bladder	serious				7009
41015	1 pts		Benign ovarian tumour	serious				7009
41016	1 pts		Benign renal neoplasm	serious				7009
41017	1 pts		Benign salivary gland neoplasm	serious				7009
41018	12 pts		Bladder cancer	serious				7009
41019	1 pts		Blast crisis in myelogenous leukaemia	serious				7009
41020	1 pts		Bone neoplasm malignant	serious				7009
41021	1 pts		Brain cancer metastatic	serious				7009
41022	1 pts		Breast cancer metastatic	serious				7009
41023	4 pts		Bronchial carcinoma	serious				7009
41024	1 pts		Burkitt's lymphoma	serious				7009
41025	1 pts		Central nervous system lymphoma	serious				7009
41026	1 pts		Cervix carcinoma	serious				7009
41027	2 pts		Choroid melanoma	serious				7009
41028	4 pts		Chronic lymphocytic leukaemia	serious				7009
41029	2 pts		Colon adenoma	serious				7009
41030	3 pts		Colon cancer metastatic	serious				7009
41031	1 pts		Endometrial cancer stage IV	serious				7009
41032	1 pts		Gastric cancer recurrent	serious				7009
41033	1 pts		Gastrointestinal tract adenoma	serious				7009
41034	1 pts		Head and neck cancer	serious				7009
41035	7 pts		Hepatic neoplasm malignant	serious				7009
41036	2 pts		Keratoacanthoma	serious				7009
41037	1 pts		Leiomyosarcoma	serious				7009
41038	1 pts		Lentigo maligna	serious				7009
41039	1 pts		Lip neoplasm malignant stage unspecified	serious				7009
41040	1 pts		Liposarcoma	serious				7009
41041	6 pts		Lung cancer metastatic	serious				7009
41042	1 pts		Lung carcinoma cell type unspecified recurrent	serious				7009
41043	1 pts		Lung carcinoma cell type unspecified stage III	serious				7009
41044	6 pts		Lung neoplasm	serious				7009
41045	19 pts		Lung neoplasm malignant	serious				7009
41046	1 pts		Lung squamous cell carcinoma stage II	serious				7009
41047	4 pts		Lung squamous cell carcinoma stage unspecified	serious				7009
41048	5 pts		Lymphoma	serious				7009
41049	11 pts		Malignant melanoma	serious				7009
41050	1 pts		Malignant melanoma in situ	serious				7009
41051	1 pts		Malignant palate neoplasm	serious				7009
41052	1 pts		Malignant peritoneal neoplasm	serious				7009
41053	1 pts		Meningioma	serious				7009
41054	1 pts		Mesothelioma	serious				7009
41055	1 pts		Mesothelioma malignant	serious				7009
41056	1 pts		Metastases to bone	serious				7009
41057	1 pts		Metastases to liver	serious				7009
41058	1 pts		Metastases to lung	serious				7009
41059	1 pts		Metastatic bronchial carcinoma	serious				7009
41060	2 pts		Metastatic gastric cancer	serious				7009
41061	1 pts		Metastatic neoplasm	serious				7009
41062	2 pts		Neoplasm malignant	serious				7009
41063	1 pts		Non-small cell lung cancer	serious				7009
41064	1 pts		Ocular neoplasm	serious				7009
41065	1 pts		Ovarian adenoma	serious				7009
41066	1 pts		Ovarian neoplasm	serious				7009
41067	1 pts		Pancreatic neoplasm	serious				7009
41068	41 pts		Prostate cancer	serious				7009
41069	1 pts		Renal cell carcinoma stage IV	serious				7009
41070	3 pts		Renal neoplasm	serious				7009
41071	1 pts		Retroperitoneal neoplasm	serious				7009
41072	1 pts		Rhabdomyosarcoma	serious				7009
41073	5 pts		Skin cancer	serious				7009
41074	7 pts		Squamous cell carcinoma of skin	serious				7009
41075	1 pts		Thyroid adenoma	serious				7009
41076	4 pts		Uterine cancer	serious				7009
41077	1 pts		Vascular neoplasm	serious				7009
41078	1 pts		Amnesia	serious				7009
41079	1 pts		Aphasia	serious				7009
41080	1 pts		Arachnoid cyst	serious				7009
41081	1 pts		Balance disorder	serious				7009
41082	1 pts		Brain injury	serious				7009
41083	1 pts		Carotid arteriosclerosis	serious				7009
41084	3 pts		Carotid artery disease	serious				7009
41085	3 pts		Carotid artery occlusion	serious				7009
41086	29 pts		Carotid artery stenosis	serious				7009
41087	1 pts		Cerebral arteriosclerosis	serious				7009
41088	1 pts		Cerebral circulatory failure	serious				7009
41089	1 pts		Cerebral ischaemia	serious				7009
41090	1 pts		Cerebral microangiopathy	serious				7009
41091	3 pts		Cerebrovascular disorder	serious				7009
41092	1 pts		Cervical root pain	serious				7009
41093	2 pts		Complex partial seizures	serious				7009
41094	2 pts		Dementia	serious				7009
41095	1 pts		Demyelinating polyneuropathy	serious				7009
41096	7 pts		Diabetic neuropathy	serious				7009
41097	16 pts		Dizziness	serious				7009
41098	1 pts		Encephalomalacia	serious				7009
41099	4 pts		Haemorrhagic stroke	serious				7009
41100	2 pts		Headache	serious				7009
41101	4 pts		Hemiparesis	serious				7009
41102	1 pts		Hemiplegia	serious				7009
41103	1 pts		Hemisensory neglect	serious				7009
41104	1 pts		Hydrocephalus	serious				7009
41105	1 pts		IIIrd nerve paresis	serious				7009
41106	1 pts		IVth nerve paralysis	serious				7009
41107	1 pts		Intracranial aneurysm	serious				7009
41108	1 pts		Ischaemic neuropathy	serious				7009
41109	4 pts		Ischaemic stroke	serious				7009
41110	1 pts		Mental impairment	serious				7009
41111	1 pts		Metabolic encephalopathy	serious				7009
41112	1 pts		Migraine	serious				7009
41113	1 pts		Monoplegia	serious				7009
41114	1 pts		Nerve root compression	serious				7009
41115	1 pts		Occipital neuralgia	serious				7009
41116	1 pts		Optic neuritis	serious				7009
41117	3 pts		Parkinson's disease	serious				7009
41118	1 pts		Parkinsonism	serious				7009
41119	5 pts		Presyncope	serious				7009
41120	1 pts		Radicular syndrome	serious				7009
41121	1 pts		Spinal cord infarction	serious				7009
41122	4 pts		Haemorrhage subarachnoid	serious				7009
41123	37 pts		Syncope	serious				7009
41124	1 pts		Tension headache	serious				7009
41125	1 pts		Encephalopathy toxic	serious				7009
41126	1 pts		Ulnar nerve palsy	serious				7009
41127	8 pts		VIIth nerve paralysis	serious				7009
41128	1 pts		Vascular encephalopathy	serious				7009
41129	1 pts		Vertebral artery stenosis	serious				7009
41130	1 pts		White matter lesion	serious				7009
41131	1 pts		Adjustment disorder	serious				7009
41132	3 pts		Anxiety	serious				7009
41133	2 pts		Bipolar disorder	serious				7009
41134	7 pts		Confusional state	serious				7009
41135	2 pts		Delirium	serious				7009
41136	7 pts		Mental status changes	serious				7009
41137	2 pts		Psychotic disorder	serious				7009
41138	2 pts		Acute prerenal failure	serious				7009
41139	3 pts		Azotaemia	serious				7009
41140	2 pts		Calculus urinary	serious				7009
41141	1 pts		Cystitis noninfective	serious				7009
41142	3 pts		Diabetic nephropathy	serious				7009
41143	13 pts		Nephrolithiasis	serious				7009
41144	2 pts		Nephropathy	serious				7009
41145	2 pts		Colic renal	serious				7009
41146	23 pts		Renal failure	serious				7009
41147	80 pts		Renal failure acute	serious				7009
41148	18 pts		Renal failure chronic	serious				7009
41149	5 pts		Urethral stenosis	serious				7009
41150	2 pts		Urinary bladder polyp	serious				7009
41151	1 pts		Urinary incontinence	serious				7009
41152	8 pts		Urinary retention	serious				7009
41153	1 pts		Acquired phimosis	serious				7009
41154	1 pts		Breast mass	serious				7009
41155	1 pts		Colpocele	serious				7009
41156	1 pts		Dysfunctional uterine bleeding	serious				7009
41157	2 pts		Endometrial hyperplasia	serious				7009
41158	2 pts		Epididymitis	serious				7009
41159	1 pts		Haemorrhage postmenopausal	serious				7009
41160	1 pts		Postmenopausal haemorrhage	serious				7009
41161	1 pts		Prostatic obstruction	serious				7009
41162	2 pts		Prostatomegaly	serious				7009
41163	1 pts		Rectocele	serious				7009
41164	1 pts		Haemorrhage uterine	serious				7009
41165	4 pts		Acute pulmonary oedema	serious				7009
41166	12 pts		Acute respiratory failure	serious				7009
41167	1 pts		Apnoea	serious				7009
41168	15 pts		Asthma	serious				7009
41169	71 pts		Chronic obstructive pulmonary disease	serious				7009
41170	8 pts		Epistaxis	serious				7009
41171	1 pts		Hypercapnia	serious				7009
41172	1 pts		Lung consolidation	serious				7009
41173	1 pts		Lung disorder	serious				7009
41174	2 pts		Nasal polyps	serious				7009
41175	1 pts		Nocturnal dyspnoea	serious				7009
41176	2 pts		Obstructive airways disorder	serious				7009
41177	1 pts		Pharyngeal hypertrophy	serious				7009
41178	10 pts		Aspiration pneumonia	serious				7009
41179	2 pts		Congestion pulmonary	serious				7009
41180	2 pts		Pulmonary congestion	serious				7009
41181	11 pts		Pulmonary embolism	serious				7009
41182	3 pts		Pulmonary fibrosis	serious				7009
41183	1 pts		Pulmonary haemorrhage	serious				7009
41184	8 pts		Pulmonary oedema	serious				7009
41185	1 pts		Pulmonary sarcoidosis	serious				7009
41186	1 pts		Reflux laryngitis	serious				7009
41187	1 pts		Respiratory arrest	serious				7009
41188	2 pts		Respiratory disorder	serious				7009
41189	1 pts		Snoring	serious				7009
41190	5 pts		Angioedema	serious				7009
41191	4 pts		Decubitus ulcer	serious				7009
41192	1 pts		Dermatitis contact	serious				7009
41193	1 pts		Drug eruption	serious				7009
41194	1 pts		Erythema	serious				7009
41195	1 pts		Hyperhidrosis	serious				7009
41196	1 pts		Keloid scar	serious				7009
41197	1 pts		Leukocytoclastic vasculitis	serious				7009
41198	1 pts		Panniculitis	serious				7009
41199	2 pts		Pemphigoid	serious				7009
41200	1 pts		Pruritus	serious				7009
41201	1 pts		Rash	serious				7009
41202	1 pts		Scar pain	serious				7009
41203	1 pts		Skin fibrosis	serious				7009
41204	1 pts		Skin reaction	serious				7009
41205	1 pts		Subcutaneous emphysema	serious				7009
41206	2 pts		Coronary revascularisation	serious				7009
41207	1 pts		Aortic calcification	serious				7009
41208	2 pts		Aortic occlusion	serious				7009
41209	1 pts		Arterial occlusive disease	serious				7009
41210	1 pts		Arteriovenous fistula	serious				7009
41211	6 pts		Extremity necrosis	serious				7009
41212	1 pts		Granulomatosis with polyangiitis	serious				7009
41213	5 pts		Haematoma	serious				7009
41214	3 pts		Haemorrhage	serious				7009
41215	17 pts		Hypertensive crisis	serious				7009
41216	1 pts		Hypoperfusion	serious				7009
41217	19 pts		Hypotension	serious				7009
41218	3 pts		Hypovolaemic shock	serious				7009
41219	6 pts		Orthostatic hypotension	serious				7009
41220	1 pts		Peripheral artery dissection	serious				7009
41221	18 pts		Peripheral artery stenosis	serious				7009
41222	21 pts		Disorder peripheral vascular	serious				7009
41223	1 pts		Shock	serious				7009
41224	3 pts		Thrombosis	serious				7009
41225	2 pts		Varicose vein	serious				7009
41226	1 pts		Vasculitis	serious				7009
41227	1 pts		Venous thrombosis	serious				7009
41228	170 pts		Constipation	below serious				7009
41229	321 pts		Diarrhoea	below serious				7009
41230	200 pts		Nausea	below serious				7009
41231	343 pts		Oedema peripheral	below serious				7009
41232	199 pts		Influenza	below serious				7009
41233	293 pts		Nasopharyngitis	below serious				7009
41234	330 pts		Upper respiratory tract infection	below serious				7009
41235	313 pts		Arthralgia	below serious				7009
41236	330 pts		Back pain	below serious				7009
41237	168 pts		Musculoskeletal pain	below serious				7009
41238	374 pts		Dizziness	below serious				7009
41239	349 pts		Hypertension	below serious				7009
41240	1 pts		Atrial fibrillation	below serious				7010
41241	1 pts		Chest pain	serious				7011
41242	5.1		Adverse event		discontinuation	leads to discontinuation. Particular AEs not reported		7005
41243	0.1		Lymphopenia		discontinuation	leads to discontinuation		7006
41244	0.5		Lymphopenia		discontinuation	leads to discontinuation		7007
41245	0.2		Rash		discontinuation	leads to discontinuation		7006
41246	0.3		Rash		discontinuation	leads to discontinuation		7007
41247	0.3		Blood creatinine increased		discontinuation	leads to discontinuation		7006
41248	0.1		Blood creatine phosphokinase increased		discontinuation	leads to discontinuation		7006
41249	0.2		Blood creatine phosphokinase increased		discontinuation	leads to discontinuation		7007
41250	1 pts		Stomatitis	grade 3			TRUE	7012
41251	1 pts		Asthenia	grade 3			TRUE	7012
41252	7 pts		Mucositis	grade 1-2				7012
41253	1 pts		Mucositis	grade 3-4				7012
41254	5 pts		Nausea	grade 1-2				7012
41255	1 pts		Thrombocytopenia	grade 1-2				7012
41256	1 pts		Diarrhea	grade 1-2				7012
41257	3 pts		Vomiting	grade 1-2				7012
41258	2 pts		Hypercholesterolemia	grade 3-4				7012
41259	1 pts		Hypertriglyceridemia	grade 3-4				7012
41260	2 pts		Peripheral edema	grade 1-2				7012
41261	2 pts		Weight loss	grade 1-2				7012
41262	2 pts		Taste perversion	grade 1-2				7012
41263	1 pts		Anorexia	grade 3			TRUE	7016
41264	1 pts		Hypertension	grade 3			TRUE	7015
41265	1 pts		Mucositis	grade 3			TRUE	7015
41266	1 pts		Gamma-glutamyltransferase increased	grade 3			TRUE	7015
41267	1 pts		Hypertriglyceridaemia	grade 4			TRUE	7015
41268	1 pts		Sepsis	grade 5			TRUE	7018
41269	1 pts		Mucositis	grade 5			TRUE	7018
41270	1 pts		Acidosis	grade 5			TRUE	7018
41271	1 pts		Reversible posterior leukoencephalopathy syndrome				TRUE	7018
41272	1 pts		Perianal ulcer	grade 2			TRUE	7018
41273	1 pts		Gamma-glutamyltransferase increased				TRUE	7018
41274	2 pts		Hypertriglyceridemia	grade 4			TRUE	7017
41275	1 pts		Gamma-glutamyltransferase increased				TRUE	7017
41276	1 pts		Alkaline phosphatase increased				TRUE	7017
41277	1 pts		Anorexia	grade 2			TRUE	7017
41278	51		Asthenia	all grades				7013
41279	11		Asthenia	grade 3-4				7013
41280	35		Edema	all grades				7013
41281	35		Edema face	all grades				7013
41282	35		Peripheral edema	all grades				7013
41283	3		Edema	grade 3-4				7013
41284	3		Edema face	grade 3-4				7013
41285	3		Peripheral edema	grade 3-4				7013
41286	28		Pain	all grades				7013
41287	5		Pain	grade 3-4				7013
41288	24		Pyrexia	all grades				7013
41289	1		Pyrexia	grade 3-4				7013
41290	19		Weight loss	all grades				7013
41291	1		Weight loss	grade 3-4				7013
41292	15		Headache	all grades				7013
41293	1		Headache	grade 3-4				7013
41294	16		Chest pain	all grades				7013
41295	1		Chest pain	grade 3-4				7013
41296	8		Chills	all grades				7013
41297	1		Chills	grade 3-4				7013
41298	41		Aphthous stomatitis	all grades				7013
41299	41		Glossitis	all grades				7013
41300	41		Mouth ulceration	all grades				7013
41301	41		Mucositis	all grades				7013
41302	41		Stomatitis	all grades				7013
41303	3		Aphthous stomatitis	grade 3-4				7013
41304	3		Glossitis	grade 3-4				7013
41305	3		Mouth ulceration	grade 3-4				7013
41306	3		Mucositis	grade 3-4				7013
41307	3		Stomatitis	grade 3-4				7013
41308	32		Anorexia	all grades				7013
41309	3		Anorexia	grade 3-4				7013
41310	37		Nausea	all grades				7013
41311	2		Nausea	grade 3-4				7013
41312	27		Diarrhea	all grades				7013
41313	1		Diarrhea	grade 3-4				7013
41314	21		Abdominal pain	all grades				7013
41315	4		Abdominal pain	grade 3-4				7013
41316	20		Constipation	all grades				7013
41317	19		Vomiting	all grades				7013
41318	2		Vomiting	grade 3-4				7013
41319	20		Infection NOS	all grades				7013
41320	20		Abscess	all grades				7013
41321	20		Bronchitis	all grades				7013
41322	20		Cellulitis	all grades				7013
41323	20		Herpes simplex	all grades				7013
41324	20		Herpes zoster	all grades				7013
41325	3		Infection NOS	grade 3-4				7013
41326	3		Abscess	grade 3-4				7013
41327	3		Bronchitis	grade 3-4				7013
41328	3		Cellulitis	grade 3-4				7013
41329	3		Herpes simplex	grade 3-4				7013
41330	3		Herpes zoster	grade 3-4				7013
41331	15		Cystitis	all grades				7013
41332	15		Dysuria	all grades				7013
41333	15		Hematuria	all grades				7013
41334	15		Urinary frequency	all grades				7013
41335	15		Urinary tract infection	all grades				7013
41336	1		Cystitis	grade 3-4				7013
41337	1		Dysuria	grade 3-4				7013
41338	1		Hematuria	grade 3-4				7013
41339	1		Urinary frequency	grade 3-4				7013
41340	1		Urinary tract infection	grade 3-4				7013
41341	12		Pharyngitis	all grades				7013
41342	10		Rhinitis	all grades				7013
41343	20		Back pain	all grades				7013
41344	3		Back pain	grade 3-4				7013
41345	18		Arthralgia	all grades				7013
41346	1		Arthralgia	grade 3-4				7013
41347	8		Myalgia	all grades				7013
41348	1		Myalgia	grade 3-4				7013
41349	28		Dyspnea	all grades				7013
41350	9		Dyspnea	grade 3-4				7013
41351	26		Cough	all grades				7013
41352	1		Cough	grade 3-4				7013
41353	12		Epistaxis	all grades				7013
41354	47		Eczema	all grades				7013
41355	47		Exfoliative dermatitis	all grades				7013
41356	47		Maculopapular rash	all grades				7013
41357	47		Pruritic rash	all grades				7013
41358	47		Pustular rash	all grades				7013
41359	47		Rash NOS	all grades				7013
41360	47		Vesiculobullous rash	all grades				7013
41361	5		Epistaxis	grade 3-4				7013
41362	5		Eczema	grade 3-4				7013
41363	5		Exfoliative dermatitis	grade 3-4				7013
41364	5		Maculopapular rash	grade 3-4				7013
41365	5		Pruritic rash	grade 3-4				7013
41366	5		Pustular rash	grade 3-4				7013
41367	5		Rash NOS	grade 3-4				7013
41368	5		Vesiculobullous rash	grade 3-4				7013
41369	19		Pruritus	all grades				7013
41370	1		Pruritus	grade 3-4				7013
41371	14		Nail disorder	all grades				7013
41372	11		Dry skin	all grades				7013
41373	1		Dry skin	grade 3-4				7013
41374	10		Acne	all grades				7013
41375	20		Taste loss	all grades				7013
41376	20		Taste perversion	all grades				7013
41377	12		Insomnia	all grades				7013
41378	1		Insomnia	grade 3-4				7013
41379	4		Depression	all grades				7013
41380	1		Gastrointestinal perforation	grade 5				7013
41381	7		Conjunctivitis					7013
41382	9		Hypersensitivity reaction					7013
41383	8		Pneumonia					7013
41384	7		Upper respiratory tract infection					7013
41385	1		Healing impaired					7013
41386	7		Hypertension					7013
41387	2		Venous thromboembolism					7013
41388	1		Thrombophlebitis					7013
41389	94		Hemoglobin decreased	all grades				7013
41390	20		Hemoglobin decreased	grade 3-4				7013
41391	53		Lymphocyte count decreased	all grades				7013
41392	16		Lymphocyte count decreased	grade 3-4				7013
41393	19		Neutrophil count decreased	all grades				7013
41394	5		Neutrophil count decreased	grade 3-4				7013
41395	40		Platelets decreased	all grades				7013
41396	1		Platelets decreased	grade 3-4				7013
41397	32		Leukocyte count decreased	all grades				7013
41398	1		Leukocyte count decreased	grade 3-4				7013
41399	68		Alkaline phosphatase increased	all grades				7013
41400	3		Alkaline phosphatase increased	grade 3-4				7013
41401	38		AST increased	all grades				7013
41402	2		AST increased	grade 3-4				7013
41403	57		Creatinine increased	all grades				7013
41404	3		Creatinine increased	grade 3-4				7013
41405	89		Glucose increased	all grades				7013
41406	16		Glucose increased	grade 3-4				7013
41407	49		Blood phosphorus decreased	all grades				7013
41408	18		Blood phosphorus decreased	grade 3-4				7013
41409	8		Bilirubin total increased	all grades				7013
41410	1		Bilirubin total increased	grade 3-4				7013
41411	87		Cholesterol total increased	all grades				7013
41412	2		Cholesterol total increased	grade 3-4				7013
41413	83		Triglyceride increased	all grades				7013
41414	44		Triglyceride increased	grade 3-4				7013
41415	21		Potassium decreased	all grades				7013
41416	5		Potassium decreased	grade 3-4				7013
41417			Interstitial lung disease	grade 5	discontinuation	leads to discontinuation		7014
41418	3 pts		Asthenia		discontinuation	leads to discontinuation		7014
41419	3 pts		Creatinine increased		discontinuation	leads to discontinuation		7014
41420	2 pts		Anemia		discontinuation	leads to discontinuation		7014
41421	2 pts		Abdominal pain		discontinuation	leads to discontinuation		7014
41422	2 pts		Peripheral edema		discontinuation	leads to discontinuation		7014
41423	1 pts		Cerebrovascular accident	grade 5	discontinuation	leads to discontinuation		7014
41424	1 pts		Dyspnea		discontinuation	leads to discontinuation		7014
41425	1 pts		Lung infiltration		discontinuation	leads to discontinuation		7014
41426			Anemia		discontinuation			7019
41427			Reticulocytosis		discontinuation			7019
41428			Anemia		discontinuation			7020
41429			Tremulousness		discontinuation			7020
41430			Headache		discontinuation			7020
41431			Nausea		discontinuation			7020
41432						No conjunctival or corneal toxicity		7021
41433						no adverse experiences were reported		7022
41434	1 pts		Agitation					7023
41435	1 pts		Groaning					7023
41436	1 pts		Speech loss					7023
41437	15		Neutropenia	grade 4				7024
41438	21		Diarrhea	grade 3-4				7024
41439			Leucopenia	grade 4		One chemotherapy course was delayed for2 weeks and two treatment schedules were deferredf or 1 week owing to gradeIV leucopenia.		7025
41440			Flushing					7026
41441			Itching					7026
41442						The source does not contain information about AEs or lack thereof		7027
41443	13 pts		Alkaline phosphatase increased	grade 1-2				7032
41444	8 pts		Anorexia	grade 1-2				7032
41445	8 pts		Nausea	grade 1-2				7032
41446	6 pts		Diarrhea	grade 1-2				7032
41447	7 pts		Transaminitis	grade 1-2				7032
41448	5 pts		Constipation	grade 1-2				7032
41449	5 pts		Hyperbilirubinemia	grade 1-2				7032
41450	5 pts		Vomiting	grade 1-2				7032
41451	3 pts		Fatigue	grade 1-2				7032
41452	2 pts		Dyspepsia	grade 1-2				7032
41453	3 pts		Creatinine increased	grade 1-2				7032
41454	2 pts		Arthralgia	grade 1-2				7032
41455	2 pts		Myalgia	grade 1-2				7032
41456	2 pts		Dizziness	grade 1-2				7032
41457	2 pts		GI hemorrhage	grade 1-2				7032
41458	2 pts		Headache	grade 1-2				7032
41459	2 pts		Anorexia	grade 3-4				7032
41460	2 pts		Nausea	grade 3-4				7032
41461	2 pts		Diarrhea	grade 3-4				7032
41462	1 pts		Fatigue	grade 3-4				7032
41463	1 pts		Dyspepsia	grade 3-4				7032
41464	1 pts		Depressed level of consciousness	grade 3-4				7032
41465	1 pts		CNS injury	grade 5	discontinuation	leads to discontinuation		7032
41466	2 pts		Neutropenia	all grades				7029
41467	1 pts		ALT increased	all grades				7029
41468	1 pts		AST increased	all grades				7029
41469	1 pts		Lipase increased	grade 4	discontinuation	leads to discontinuation	TRUE	7029
41470	1 pts		Amylase increased	grade 4	discontinuation	leads to discontinuation	TRUE	7029
41471	1 pts		Pancreatitis	grade 2	discontinuation	leads to discontinuation	TRUE	7029
41472	6 pts		Neutropenia	all grades				7035
41473	1 pts		Lipase increased	grade 4	discontinuation	leads to discontinuation	TRUE	7034
41474	1 pts		Abdominal pain	grade 3	discontinuation	leads to discontinuation	TRUE	7034
41475	1 pts		Pancreatitis		discontinuation	leads to discontinuation	TRUE	7034
41476	1 pts		Amylase increased	grade 3		leads to dose reduction		7036
41477	1 pts		Pancreatitis			leads to dose reduction		7036
41478	1 pts		ALT increased				TRUE	7033
41479	1 pts		Lipase increased				TRUE	7033
41480	1 pts		Anemia	grade 3-4				7030
41481	1 pts		Thrombocytopenia	grade 1-2				7030
41482	2 pts		Thrombocytopenia	grade 3-4				7030
41483	6 pts		Diarrhea	grade 1-2				7030
41484	4 pts		Nausea	grade 1-2				7030
41485	3 pts		Dyspepsia	grade 1-2				7030
41486	3 pts		Vomiting	grade 1-2				7030
41487	2 pts		Anorexia	grade 1-2				7030
41488	2 pts		Anorexia	grade 3-4				7030
41489	1 pts		Dysgeusia	grade 1-2				7030
41490	1 pts		Constipation	grade 1-2				7030
41491	1 pts		Flatulence	grade 1-2				7030
41492	1 pts		Gastritis	grade 1-2				7030
41493	1 pts		Diarrhea	grade 3			TRUE	7031
41494	3 pts		Diarrhea	grade 3			TRUE	7028
41495	3 pts		Anorexia	grade 3			TRUE	7028
41496	3 pts		Leukopenia	grade 1-2				7028
41497	3 pts		Thrombocytopenia	grade 3-4				7028
41498	2 pts		Diarrhea	grade 1-2				7028
41499	11 pts		Diarrhea	grade 3-4				7028
41500	1 pts		Nausea	grade 1-2				7028
41501	9 pts		Dyspepsia	grade 1-2				7028
41502	5 pts		Vomiting	grade 1-2				7028
41503	2 pts		Anorexia	grade 1-2				7028
41504	3 pts		Anorexia	grade 3-4				7028
41505	1 pts		Dysgeusia	grade 1-2				7028
41506	2 pts		Dysphagia	grade 1-2				7028
41507	1 pts		Gastritis	grade 1-2				7028
41508	2 pts		Hemorrhoids	grade 1-2				7028
41509	5.4		Hypertension		discontinuation	leads to discontinuation		7037
41510	5.4		Tachycardia		discontinuation	leads to discontinuation		7037
41511			Distributive shock					7042
41512			Acidosis metabolic					7042
41513	1 pts		Mental disorder NOS	severe				7040
41514	2 pts		Mental disorder NOS	severe				7041
41515						No AEs are reported		7039
41516						No AEs are reported		7038
41517						impossible to link AEs with the definite dose: The most frequently reported treatment-emergent, drug-related AEs in subjects receiving GS-9350 were headache, somnolence, and abnormal dreams; all were mild (grade 1) and each was reported in only two subjects across all GS-9350 doses.		7044
41518						impossible to link AEs with the definite dose: The most frequently reported treatment-emergent, drug-related AEs in subjects receiving GS-9350 were headache, somnolence, and abnormal dreams; all were mild (grade 1) and each was reported in only two subjects across all GS-9350 doses.		7043
41519			Anaphylaxis		discontinuation	WARNINGS		7045
41520	5 pts		Hypertension	below serious				7051
41521	1 pts		Rhabdomyolysis			attempt to suicide		7047
41522	1 pts		Wide complex tachycardia					7048
41523	1 pts		QT interval prolonged					7048
41524	1 pts		Liver injury		discontinuation	leads to discontinuation		7049
41525	1 pts		Fever		discontinuation	leads to discontinuation		7049
41526	1 pts		Vomiting		discontinuation	leads to discontinuation		7049
41527	1 pts		Jaundice		discontinuation	leads to discontinuation		7049
41528	1 pts		Phlebitis		discontinuation	leads to discontinuation		7050
41529						No information on AE is provided		7046
41530						No AEs were reported		7052
41531	1 pts		Gout	below serious				7054
41532	1 pts		Seasonal allergy	below serious				7053
41533	1 pts		Hand fracture	below serious				7053
41534	1 pts		Dysgeusia	below serious				7053
41535	1 pts		Rheumatoid lung	below serious				7053
41536	2.3					No AEs were reported		7055
41537	2.3					No AEs were reported		7056
41538	5.2		Bradyarrhythmia		discontinuation	leads to discontinuation		7058
41539	11.1		Fibrillation ventricular	grade 5	discontinuation	leads to discontinuation, rechallenge with a lower dosage		7057
41540	1 pts		Overdose	serious				7059
41541	1 pts		Suicide attempt	serious				7059
41542	13 pts		Tachycardia	below serious				7059
41543	19 pts		Nausea	below serious				7059
41544	6 pts		Abdominal pain upper	below serious				7059
41545	11 pts		Vomiting	below serious				7059
41546	4 pts		Nasopharyngitis	below serious				7059
41547	7 pts		Decreased appetite	below serious				7059
41548	20 pts		Headache	below serious				7059
41549	6 pts		Somnolence	below serious				7059
41550	12 pts		Tachycardia	below serious				7060
41551	22 pts		Nausea	below serious				7060
41552	7 pts		Abdominal pain upper	below serious				7060
41553	11 pts		Vomiting	below serious				7060
41554	7 pts		Nasopharyngitis	below serious				7060
41555	9 pts		Decreased appetite	below serious				7060
41556	19 pts		Headache	below serious				7060
41557	9 pts		Dizziness	below serious				7060
41558	8 pts		Somnolence	below serious				7060
41559	0.12		Angina pectoris		discontinuation	1 patient		7062
41560	0.12		Extrasystoles supraventricular		discontinuation	1 patient		7062
41561	0.12		Encephalopathy		discontinuation	1 patient		7062
41562	0.12		Mania		discontinuation	1 patient		7062
41563			Tachycardia		discontinuation	2 or more patients		7063
41564			Nausea		discontinuation	2 or more patients		7063
41565			Insomnia		discontinuation	2 or more patients		7063
41566			Agitation		discontinuation	2 or more patients		7063
41567			Constipation		discontinuation	2 or more patients		7063
41568			Hypertension		discontinuation	2 or more patients		7063
41569			Suicidal ideation		discontinuation	WARNING		7065
41570			Serotonin syndrome		discontinuation	WARNING		7065
41571			Blood pressure increased		discontinuation	WARNING		7065
41572			Heart rate increased		discontinuation	WARNING		7065
41573			Bleeding		discontinuation	WARNING		7065
41574			Angle closure glaucoma		discontinuation	WARNING		7065
41575			Urinary hesitation		discontinuation	WARNING		7065
41576			Urinary retention		discontinuation	WARNING		7065
41577			Mania		discontinuation	WARNING		7065
41578			Hypomania		discontinuation	WARNING		7065
41579			Hyponatremia		discontinuation	WARNING		7065
41580	1.5		Nausea		discontinuation			7064
41581						no AEs reported for individual doses - only for the range 40 - 120 mg		7061
41582						No SAEs were observed		7066
41583	1 pts		Cholecystitis chronic	serious				7068
41584	1 pts		Anxiety	serious				7068
41585	1 pts		Bipolar I disorder	serious				7068
41586	1 pts		Depression	serious				7068
41587	1 pts		Insomnia	serious				7068
41588	1 pts		Suicide attempt	serious				7068
41589	1 pts		Social stay hospitalisation	serious				7068
41590	12 pts		Nausea	below serious				7068
41591	29 pts		Headache	below serious				7068
41592	1 pts		Supraventricular tachycardia	serious				7069
41593	2 pts		Nausea	below serious				7069
41594	2 pts		Diarrhea	below serious				7069
41595	1 pts		Vomiting	below serious				7069
41596	2 pts		Fatigue	below serious				7069
41597	1 pts		Edema limbs	below serious				7069
41598	2 pts		Nervous system disorders	below serious				7069
41599	1 pts		Ataxia	below serious				7069
41600	1 pts		Alopecia	below serious				7069
41601	1 pts		Dry skin	below serious				7069
41602	1 pts		Nail infection	below serious				7069
41603	1 pts		Vaginal infection	below serious				7069
41604	2 pts		Agitation	below serious				7069
41605	1 pts		Insomnia	below serious				7069
41606	1 pts		Nervousness	below serious				7067
41607						No AEs are reported		7070
41608			Adverse event		discontinuation	impossible to link AEs with the definite dose: Because of the high number of adverse events in the armodafinil-treated subjects in this group, dosing of the other six subjects scheduled to receive 400 mg was halted after 7 days. Particular adverse events are not specified		7071
41609	1 pts		Stevens-Johnson syndrome		discontinuation			7072
41610	1		Headache		discontinuation	leads to discontinuation		7073
41611	2		Rash		discontinuation	leads to discontinuation		7074
41612	1		Angioneurotic edema		discontinuation	leads to discontinuation		7074
41613	1		Hyperhidrosis		discontinuation	leads to discontinuation		7074
41614	1		Rash papular		discontinuation	leads to discontinuation		7074
41615	2 pts		Thrombocytopenia		discontinuation	leads to discontinuation		7079
41616	2 pts		Neutropenia	grade 4			TRUE	7079
41617	1 pts		Febrile neutropenia	grade 4			TRUE	7079
41618	1 pts		Bilirubin elevated	grade 3			TRUE	7079
41619	1 pts		Diarrhoea	grade 3			TRUE	7079
41620	1 pts		Neutropenic infection	grade 3			TRUE	7079
41621	2 pts		Diarrhoea	grade 3			TRUE	7085
41622	1 pts		Neutropenia	grade 4			TRUE	7085
41623	5 pts		Febrile neutropenia	grade 4			TRUE	7087
41624	5 pts		Hypophosphatemia	grade 3			TRUE	7087
41625	5 pts		Neutropenia	grade 4			TRUE	7087
41626	25		Neutropenia					7078
41627	25		Febrile neutropenia					7078
41628	16.7		Anemia					7078
41629	16.7		Leukopenia					7078
41630	8.3		Lymphopenia					7078
41631	8.3		Diarrhoea					7078
41632	8.3		Dehydration					7078
41633	16.7		Platelet count decreased					7078
41634	8.3		White blood cell count decreased					7078
41635	2 pts		Neutropenic sepsis	grade 4			TRUE	7084
41636	2 pts		Febrile neutropenia	grade 3			TRUE	7084
41637	2 pts		Stoma site infection	grade 3			TRUE	7084
41638	57.1		Neutropenia					7077
41639	14.3		Febrile neutropenia					7077
41640	14.3		Hepatic failure					7077
41641	28.6		Leukopenia					7077
41642	14.3		Jaundice					7077
41643	14.3		Cholangitis					7077
41644	14.3		Hyperbilirubinemia					7077
41645	43.8		Diarrhea					7080
41646	37.5		Dysphagia					7080
41647	31.3		Nausea					7080
41648	25		Vomiting					7080
41649	25		Headache					7080
41650	3 pts		Anaphylactic reaction	serious	discontinuation	leads to discontinuation		7080
41651	1 pts		Transaminases increased	grade 2	discontinuation	leads to discontinuation		7080
41652	2 pts		Febrile neutropenia	grade 3			TRUE	7076
41653	1 pts		Febrile neutropenia	grade 3			TRUE	7086
41654			Neutropenia	grade 5		WARNING		7075
41655			Hypersensitivity reaction	severe		WARNING		7075
41656	9 pts		Neutropenia		discontinuation	leads to discontinuation		7081
41657	7 pts		Renal failure		discontinuation	leads to discontinuation		7081
41658	6 pts		Cellulitis		discontinuation	leads to discontinuation		7082
41659	6 pts		Pneumonia		discontinuation	leads to discontinuation		7082
41660	6 pts		Salmonellosis		discontinuation	leads to discontinuation		7082
41661	6 pts		Campylobacter infection		discontinuation	leads to discontinuation		7083
41662	6 pts		Urinary tract infection fungal		discontinuation	leads to discontinuation		7083
41663	5 pts		Hematuria		discontinuation	leads to discontinuation		7083
41664	5 pts		Neutropenic sepsis		discontinuation	leads to discontinuation		7083
41665	5 pts		Pneumococcal sepsis		discontinuation	leads to discontinuation		7083
41666	5 pts		Septic shock		discontinuation	leads to discontinuation		7083
41667	4 pts		Fatigue		discontinuation	leads to discontinuation		7083
41668	4 pts		Diarrhea		discontinuation	leads to discontinuation		7083
41669	3 pts		Abdominal pain		discontinuation	leads to discontinuation		7083
41670	3 pts		Febrile neutropenia		discontinuation	leads to discontinuation		7083
41671	2 pts		Anemia		discontinuation	leads to discontinuation		7083
41672	2 pts		Cardiac arrest		discontinuation	leads to discontinuation		7083
41673	2 pts		Deep vein thrombosis		discontinuation	leads to discontinuation		7083
41674	2 pts		Transaminases increased		discontinuation	leads to discontinuation		7083
41675	2 pts		Leukopenia		discontinuation	leads to discontinuation		7083
41676						AEs provided for the dose range		7090
41677	20		Mucositis	grade 2				7089
41678	16.7		Aspartate aminotransferase increased	grade 3				7088
41679	16.7		Palmar-plantar erythrodysesthesia syndrome	grade 3				7088
41680	33.3		Palmar-plantar erythrodysesthesia syndrome	grade 3				7096
41681	33.3		Aspartate aminotransferase increased	grade 3				7096
41682	33.3		Alanine aminotransferase increase	grade 3				7096
41683	33.3		Lipase increased	grade 3				7096
41684			Pulmonary embolism	grade 4				7094
41685	8		Diarrhea	grade 3				7093
41686	13		Fatigue	grade 3				7093
41687	3		Decreased appetite	grade 3				7093
41688	3		Nausea	grade 3				7093
41689	20		Palmar-plantar erythrodysesthesia syndrome	grade 3				7093
41690	5		Aspartate aminotransferase increased	grade 3				7093
41691	5		Alanine aminotransferase increased	grade 3				7093
41692	3		Weight decreased	grade 3				7093
41693	5		Hypertension	grade 3				7093
41694	18		Lipase increased	grade 3				7093
41695	8		Blood amylase increased	grade 3				7093
41696			Memory impairment	grade 3		OVERDOSAGE		7095
41697			Mental status changes	grade 3		OVERDOSAGE		7095
41698			Cognitive disturbance	grade 3		OVERDOSAGE		7095
41699			Weight loss	grade 2		OVERDOSAGE		7095
41700			Blood urea nitrogen increased	grade 1		OVERDOSAGE		7095
41701	7.7		Large intestine perforation		discontinuation	WARNING		7092
41702	7.7		Intracranial hemorrhage		discontinuation	WARNING		7092
41703	1.2		Fatigue		discontinuation			7091
41704	0.9		Asthenia		discontinuation			7091
41705	0.6		Death	grade 5	discontinuation			7091
41706	0.9		Diarrhea		discontinuation			7091
41707	0.6		Vomiting		discontinuation			7091
41708	0.3		Nausea		discontinuation			7091
41709	0.3		Constipation		discontinuation			7091
41710	0.3		Anal fistula		discontinuation			7091
41711	0.3		Dry mouth		discontinuation			7091
41712	0.3		Dysphagia		discontinuation			7091
41713	0.3		Gastrointestinal perforation		discontinuation			7091
41714	0.3		Pancreatitis		discontinuation			7091
41715	0.3		Palmar-plantar erythrodysesthesia syndrome		discontinuation			7091
41716	0.6		Pain in extremity		discontinuation			7091
41717	0.9		Proteinuria		discontinuation			7091
41718	0.3		Renal failure		discontinuation			7091
41719	1.8		Decreased appetite		discontinuation			7091
41720	0.3		Dehydration		discontinuation			7091
41721	0.3		Hyperkalemia		discontinuation			7091
41722	0.3		Adenocarcinoma		discontinuation			7091
41723	0.3		Leiomyoma		discontinuation			7091
41724	0.3		Anal abscess		discontinuation			7091
41725	0.3		Anorectal cellulitis		discontinuation			7091
41726	0.3		Device related infection		discontinuation			7091
41727	0.3		AST increased		discontinuation			7091
41728	0.3		Weight decreased		discontinuation			7091
41729	0.3		Cardiac failure		discontinuation			7091
41730	0.3		Ventricular arrhythmia		discontinuation			7091
41731	0.3		Hepatitis cholestatic		discontinuation			7091
41732	0.3		Muscle spasticity		discontinuation			7091
41733	0.3		Pneumothorax		discontinuation			7091
41734	0.3		Pulmonary embolism		discontinuation			7091
41735	0.6		Asthenia	grade 3	discontinuation			7091
41736	0.3		Anal fistula	grade 3	discontinuation			7091
41737	0.3		Gastrointestinal perforation	grade 3	discontinuation			7091
41738	0.3		Pancreatitis	grade 3	discontinuation			7091
41739	0.3		Pain in extremity	grade 3	discontinuation			7091
41740	0.9		Proteinuria	grade 3	discontinuation			7091
41741	0.3		Renal failure	grade 3	discontinuation			7091
41742	0.9		Decreased appetite	grade 3	discontinuation			7091
41743	0.3		Hyperkalemia	grade 3	discontinuation			7091
41744	0.3		Anal abscess	grade 3	discontinuation			7091
41745	0.3		Anorectal cellulitis	grade 3	discontinuation			7091
41746	0.3		Device related infection	grade 3	discontinuation			7091
41747	0.3		Weight decreased	grade 3	discontinuation			7091
41748	0.3		Hepatitis cholestatic	grade 3	discontinuation			7091
41749	0.3		Pneumothorax	grade 3	discontinuation			7091
41750	0.3		Pulmonary embolism	grade 3	discontinuation			7091
41751	16		Diarrhea		dose reduction			7091
41752	11		Palmar-plantar erythrodysesthesia syndrome		dose reduction			7091
41753	10		Fatigue		dose reduction			7091
41754	7.6		Hypertension		dose reduction			7091
41755	5.1		Diarrhea	grade 3	dose reduction			7091
41756	4.2		Palmar-plantar erythrodysesthesia syndrome	grade 3	dose reduction			7091
41757	3.6		Fatigue	grade 3	dose reduction			7091
41758	6		Hypertension	grade 3	dose reduction			7091
41759	22		Diarrhea		dose interruption			7091
41760	14		Palmar-plantar erythrodysesthesia syndrome		dose interruption			7091
41761	12		Fatigue		dose interruption			7091
41762	8.5		Nausea		dose interruption			7091
41763	7.6		Decreased appetite		dose interruption			7091
41764	7.6		Vomiting		dose interruption			7091
41765	5.1		Hypertension		dose interruption			7091
41766	8.2		Diarrhea	grade 3	dose interruption			7091
41767	7.3		Palmar-plantar erythrodysesthesia syndrome	grade 3	dose interruption			7091
41768	4.8		Fatigue	grade 3	dose interruption			7091
41769	1.2		Nausea	grade 3	dose interruption			7091
41770	1.2		Decreased appetite	grade 3	dose interruption			7091
41771	1.2		Vomiting	grade 3	dose interruption			7091
41772	4.5		Hypertension	grade 3	dose interruption			7091
41773	9.1		Fatigue	grade 3				7091
41774	4.2		Asthenia	grade 3				7091
41775	2.1		General physical health deterioration	grade 3				7091
41776	11.5		Diarrhea	grade 3				7091
41777	3.9		Nausea	grade 3				7091
41778	3.6		Abdominal pain	grade 3				7091
41779	2.4		Stomatitis	grade 3				7091
41780	2.1		Vomiting	grade 3				7091
41781	8.2		Palmar-plantar erythrodysesthesia syndrome	grade 3				7091
41782	14.8		Hypertension	grade 3				7091
41783	5.4		Anemia	grade 3				7091
41784	3		Dyspnea	grade 3				7091
41785	2.7		Pleural effusion	grade 3				7091
41786	2.4		Pulmonary embolism	grade 3				7091
41787	1.5		Pneumonia	grade 3				7091
41788	4.8		Hypomagnesemia	grade 3				7091
41789	4.5		Hypokalemia	grade 3				7091
41790	3.9		Hyponatremia	grade 3				7091
41791	3.6		Hypophosphatemia	grade 3				7091
41792	2.7		Decreased appetite	grade 3				7091
41793	1.8		Hypocalcemia	grade 3				7091
41794	2.1		Back pain	grade 3				7091
41795	1.5		Syncope	grade 3				7091
41796	2.4		Proteinuria	grade 3				7091
41797	2.7		Lipase increased	grade 3				7091
41798	2.4		ALT increased	grade 3				7091
41799	1.8		AST increased	grade 3				7091
41800	1.8		Weight decreased	grade 3				7091
41801	1.5		Blood bilirubin increased	grade 3				7091
41802	4 pts		Sedation					7098
41803	10 pts		Depressive symptom					7097
41804	1 pts		Muscle spasm	grade 3				7100
41805			Diarrhea		discontinuation	leads to dose interruption		7101
41806						impossible to link AEs with the definite dose: One subject experienced mild anorexia and another subject experienced mild laboratory abnormalities.		7099
41807	1 pts		Febrile neutropenia	grade 4			TRUE	7103
41808	1 pts		Oral candidiasis	grade 2			TRUE	7103
41809	57		Neutropenia	grade 3-4				7103
41810	14		Leukopenia	grade 1-2				7103
41811	14		Constipation	grade 1-2				7103
41812	14		Dry mouth	grade 1-2				7103
41813	29		Anorexia	grade 1-2				7103
41814	29		Fatigue	grade 1-2				7103
41815	14		Pyrexia	grade 1-2				7103
41816	14		Cough	grade 1-2				7103
41817	43		Alopecia	grade 1-2				7103
41818	14		Pruritic rash	grade 1-2				7103
41819	2 pts		Febrile neutropenia	grade 4			TRUE	7109
41820	3 pts		Febrile neutropenia	grade 4	discontinuation	leads to dose reduction	TRUE	7110
41821	1 pts		Fatigue	grade 3			TRUE	7102
41822	1 pts		Anorexia	grade 3			TRUE	7102
41823	11		Vomiting	grade 3				7102
41824	44		Nausea	grade 1-2				7102
41825	22		Neutropenia	grade 1-2				7102
41826	44		Diarrhea	grade 1-2				7102
41827	11		Anemia	grade 1-2				7102
41828	11		Alopecia	grade 1-2				7102
41829	22		Stomatitis	grade 1-2				7102
41830	1 pts		Fatigue	grade 3			TRUE	7107
41831	2 pts		Neutropenia	grade 3-4			TRUE	7108
41832	1 pts		Fatigue	grade 3			TRUE	7108
41833	1		Peripheral neuropathy		discontinuation	leads to discontinuation		7105
41834	12		Neutropenia		discontinuation	leads to dose reduction		7105
41835			Neutropenia	grade 3				7104
41836			Hypersensitivity	grade 3				7104
41837	6		Neurotoxicity		discontinuation	leads to discontinuation		7106
41838	1		Elevated liver enzymes		discontinuation	leads to discontinuation		7106
41839	1 pts		Oedema peripheral	serious				7111
41840	1 pts		Abdominal sepsis	serious				7111
41841	1 pts		Cellulitis	serious				7111
41842	1 pts		Bursitis	serious				7111
41843	1 pts		Breast cancer	serious				7111
41844	1 pts		Retroperitoneal cancer	serious				7111
41845	2 pts		Chronic inflammatory demyelinating polyradiculoneuropathy	serious				7111
41846	1 pts		Guillain Barre syndrome	serious				7111
41847	1 pts		Vasculitis	serious				7111
41848	1 pts		Leukopenia	below serious				7111
41849	1 pts		Ear pain	below serious				7111
41850	1 pts		Tinnitus	below serious				7111
41851	1 pts		Hypothyroidism	below serious				7111
41852	2 pts		Blepharitis	below serious				7111
41853	1 pts		Eye pain	below serious				7111
41854	1 pts		Meibomianitis	below serious				7111
41855	1 pts		Retinoschisis	below serious				7111
41856	2 pts		Vision blurred	below serious				7111
41857	1 pts		Visual acuity reduced	below serious				7111
41858	1 pts		Visual impairment	below serious				7111
41859	1 pts		Vitreous floaters	below serious				7111
41860	1 pts		Abdominal discomfort	below serious				7111
41861	1 pts		Abdominal mass	below serious				7111
41862	2 pts		Abdominal pain upper	below serious				7111
41863	1 pts		Change of bowel habit	below serious				7111
41864	1 pts		Chronic gastritis	below serious				7111
41865	3 pts		Diarrhoea	below serious				7111
41866	1 pts		Dysphagia	below serious				7111
41867	1 pts		Oesophagitis	below serious				7111
41868	1 pts		Tooth loss	below serious				7111
41869	1 pts		Chest discomfort	below serious				7111
41870	1 pts		Discomfort	below serious				7111
41871	1 pts		Local swelling	below serious				7111
41872	1 pts		Oedema peripheral	below serious				7111
41873	2 pts		Pyrexia	below serious				7111
41874	1 pts		Liver disorder	below serious				7111
41875	3 pts		Bronchitis	below serious				7111
41876	1 pts		Candida infection	below serious				7111
41877	1 pts		Ear infection	below serious				7111
41878	2 pts		Influenza	below serious				7111
41879	1 pts		Laryngitis	below serious				7111
41880	1 pts		Oral herpes	below serious				7111
41881	1 pts		Pharyngotonsillitis	below serious				7111
41882	1 pts		Tinea infection	below serious				7111
41883	1 pts		Tonsillitis bacterial	below serious				7111
41884	3 pts		Urinary tract infection	below serious				7111
41885	1 pts		Wound infection	below serious				7111
41886	1 pts		Back injury	below serious				7111
41887	4 pts		Fall	below serious				7111
41888	1 pts		Foot fracture	below serious				7111
41889	1 pts		Joint dislocation	below serious				7111
41890	1 pts		Ligament sprain	below serious				7111
41891	1 pts		Muscle hernia	below serious				7111
41892	1 pts		Muscle strain	below serious				7111
41893	1 pts		Procedural pain	below serious				7111
41894	1 pts		Tooth fracture	below serious				7111
41895	1 pts		Wound	below serious				7111
41896	2 pts		Alanine aminotransferase increased	below serious				7111
41897	1 pts		Amylase increased	below serious				7111
41898	1 pts		Aspartate aminotransferase increased	below serious				7111
41899	1 pts		Blood alkaline phosphatase increased	below serious				7111
41900	1 pts		Blood cholesterol increased	below serious				7111
41901	1 pts		Blood urine present	below serious				7111
41902	1 pts		Carbon monoxide diffusing capacity decreased	below serious				7111
41903	3 pts		Gamma-glutamyltransferase increased	below serious				7111
41904	1 pts		Grip strength decreased	below serious				7111
41905	1 pts		Heart rate increased	below serious				7111
41906	2 pts		Hepatic enzyme increased	below serious				7111
41907	1 pts		Hepatitis A virus test positive	below serious				7111
41908	1 pts		Serum ferritin decreased	below serious				7111
41909	1 pts		Fluid retention	below serious				7111
41910	1 pts		Hypercholesterolaemia	below serious				7111
41911	1 pts		Arthritis	below serious				7111
41912	1 pts		Arthropathy	below serious				7111
41913	4 pts		Back pain	below serious				7111
41914	1 pts		Exostosis	below serious				7111
41915	1 pts		Joint swelling	below serious				7111
41916	1 pts		Monarthritis	below serious				7111
41917	2 pts		Muscle spasms	below serious				7111
41918	1 pts		Muscle twitching	below serious				7111
41919	2 pts		Musculoskeletal pain	below serious				7111
41920	1 pts		Neck pain	below serious				7111
41921	1 pts		Osteoarthritis	below serious				7111
41922	7 pts		Pain in extremity	below serious				7111
41923	1 pts		Synovial cyst	below serious				7111
41924	1 pts		Tendon pain	below serious				7111
41925	1 pts		Torticollis	below serious				7111
41926	1 pts		Fibrous histiocytoma	below serious				7111
41927	1 pts		Haemangioma	below serious				7111
41928	1 pts		Malignant melanoma in situ	below serious				7111
41929	2 pts		Melanocytic naevus	below serious				7111
41930	1 pts		Uterine leiomyoma	below serious				7111
41931	1 pts		Coordination abnormal	below serious				7111
41932	3 pts		Dizziness	below serious				7111
41933	12 pts		Headache	below serious				7111
41934	1 pts		Migraine	below serious				7111
41935	5 pts		Paraesthesia	below serious				7111
41936	1 pts		Parkinsonism	below serious				7111
41937	2 pts		Sciatica	below serious				7111
41938	2 pts		Syncope	below serious				7111
41939	1 pts		Tremor	below serious				7111
41940	1 pts		Anxiety	below serious				7111
41941	1 pts		Hallucination	below serious				7111
41942	1 pts		Urinary tract inflammation	below serious				7111
41943	1 pts		Breast cyst	below serious				7111
41944	1 pts		Dysfunctional uterine bleeding	below serious				7111
41945	1 pts		Bronchial obstruction	below serious				7111
41946	1 pts		Dyspnoea exertional	below serious				7111
41947	1 pts		Allergic rhinitis	below serious				7111
41948	2 pts		Alopecia	below serious				7111
41949	1 pts		Dermatitis contact	below serious				7111
41950	1 pts		Ingrowing nail	below serious				7111
41951	1 pts		Lentigo	below serious				7111
41952	1 pts		Night sweats	below serious				7111
41953	1 pts		Petechiae	below serious				7111
41954	1 pts		Pruritus	below serious				7111
41955	1 pts		Rash erythematous	below serious				7111
41956	1 pts		Generalised rash	below serious				7111
41957	1 pts		Rash pruritic	below serious				7111
41958	1 pts		Skin fissures	below serious				7111
41959	2 pts		Urticaria	below serious				7111
41960	10 pts		Hypertension	below serious				7111
41961	2 pts		Bradycardia					7113
41962	1 pts		Carbon monoxide diffusing capacity decreased					7113
41963	1 pts		Electrocardiogram T wave abnormal					7113
41964	1 pts		Bradycardia			suicide attempt		7114
41965	1 pts		Hypotension			suicide attempt		7114
41966	1 pts		Appendicitis	serious				7112
41967	1 pts		Urinary tract infection	serious				7112
41968	10.9		Hyperlipidemia					7112
41969	10.9		Leukopenia					7112
41970	17.4		Lymphopenia					7112
41971	4.3		Constipation					7112
41972	13		Diarrhea					7112
41973	13		Stomatitis					7112
41974	2.2		Alanine aminotransferase increased					7112
41975	2.2		Aspartate aminotransferase increased					7112
41976	15.2		Cystitis					7112
41977	4.3		Bronchitis					7112
41978	3.8		Transaminases increased		discontinuation	leads to dose interupption		7116
41979	5 pts		Chest tightness	mild				7115
41980	6 pts		Headache	below serious				7121
41981	3 pts		Cough	below serious				7121
41982	3 pts		Diarrhoea	below serious				7119
41983	6 pts		Nasopharyngitis	below serious				7119
41984	1 pts		Atrial fibrillation	serious				7117
41985	1 pts		Pancreatitis acute	serious				7117
41986	1 pts		Small intestinal obstruction	serious				7117
41987	1 pts		Appendicitis	serious				7117
41988	1 pts		Appendicitis perforated	serious				7117
41989	1 pts		Infection	serious				7117
41990	1 pts		Pelvic abscess	serious				7117
41991	1 pts		Sinusitis	serious				7117
41992	1 pts		Upper respiratory tract infection	serious				7117
41993	1 pts		Accidental overdose	serious				7117
41994	1 pts		Fall	serious				7117
41995	1 pts		Femur fracture	serious				7117
41996	1 pts		Diabetes mellitus	serious				7117
41997	1 pts		Rotator cuff syndrome	serious				7117
41998	1 pts		Breast cancer	serious				7117
41999	1 pts		Syncope	serious				7117
42000	4 pts		Chronic obstructive pulmonary disease	serious				7117
42001	1 pts		Orthostatic hypotension	serious				7117
42002	1 pts		Disorder peripheral vascular	serious				7117
42003	8 pts		Influenza	below serious				7117
42004	24 pts		Nasopharyngitis	below serious				7117
42005	9 pts		Sinusitis	below serious				7117
42006	17 pts		Upper respiratory tract infection	below serious				7117
42007	5 pts		Urinary tract infection	below serious				7117
42008	5 pts		Arthralgia	below serious				7117
42009	12 pts		Muscle spasms	below serious				7117
42010	5 pts		Musculoskeletal pain	below serious				7117
42011	15 pts		Headache	below serious				7117
42012	17 pts		Cough	below serious				7117
42013	9 pts		Dyspnoea	below serious				7117
42014	10 pts		Oropharyngeal pain	below serious				7117
42015	1 pts		Angina pectoris	serious				7120
42016	1 pts		Sick sinus syndrome	serious				7120
42017	1 pts		Cataract	serious				7120
42018	1 pts		Rectal haemorrhage	serious				7120
42019	1 pts		Cholelithiasis	serious				7120
42020	1 pts		Pneumonia	serious				7120
42021	1 pts		Foot fracture	serious				7120
42022	1 pts		Hip fracture	serious				7120
42023	1 pts		Road traffic accident	serious				7120
42024	1 pts		Osteonecrosis	serious				7120
42025	1 pts		Lipoma	serious				7120
42026	1 pts		Syncope	serious				7120
42027	5 pts		Chronic obstructive pulmonary disease	serious				7120
42028	1 pts		Laryngeal leukoplakia	serious				7120
42029	1 pts		Pulmonary calcification	serious				7120
42030	1 pts		Claudication intermittent	serious				7120
42031	5 pts		Influenza	below serious				7120
42032	11 pts		Lower respiratory tract infection	below serious				7120
42033	26 pts		Nasopharyngitis	below serious				7120
42034	11 pts		Sinusitis	below serious				7120
42035	20 pts		Upper respiratory tract infection	below serious				7120
42036	8 pts		Urinary tract infection	below serious				7120
42037	8 pts		Arthralgia	below serious				7120
42038	4 pts		Muscle spasms	below serious				7120
42039	8 pts		Musculoskeletal pain	below serious				7120
42040	7 pts		Headache	below serious				7120
42041	15 pts		Cough	below serious				7120
42042	10 pts		Oropharyngeal pain	below serious				7120
42043	1 pts		Non-cardiac chest pain	serious				7122
42044	1 pts		Bronchitis	serious				7122
42045	1 pts		Pneumonia	serious				7122
42046	1 pts		Cerebrovascular accident	serious				7122
42047	1 pts		Chronic obstructive pulmonary disease	serious				7122
42048	1 pts		Haemoptysis	serious				7122
42049	2 pts		Supraventricular extrasystoles	below serious				7122
42050	2 pts		Ear pain	below serious				7122
42051	2 pts		Vomiting	below serious				7122
42052	2 pts		Oedema peripheral	below serious				7122
42053	2 pts		Seasonal allergy	below serious				7122
42054	4 pts		Bronchitis	below serious				7122
42055	10 pts		Nasopharyngitis	below serious				7122
42056	3 pts		Upper respiratory tract infection bacterial	below serious				7122
42057	2 pts		Viral upper respiratory tract infection	below serious				7122
42058	3 pts		Muscle spasms	below serious				7122
42059	5 pts		Headache	below serious				7122
42060	15 pts		Cough	below serious				7122
42061	2 pts		Epistaxis	below serious				7122
42062	6 pts		Oropharyngeal pain	below serious				7122
42063	4 pts		Hypertension	below serious				7122
42064	1 pts		Epidermal and dermal conditions	serious				7118
42065	1 pts		Inner ear signs and symptoms	below serious				7118
42066	1 pts		Joint related signs and symptoms	below serious				7118
42067	1 pts		Coughing and associated symptoms	below serious				7118
42068	1 pts		Dyspnea	serious	discontinuation	leads to discontinuation		7123
42069	1 pts		Wheezing	serious	discontinuation	leads to discontinuation		7123
42070	1 pts		Asthma	moderate	discontinuation	leads to discontinuation		7123
42071	1 pts		Cough	moderate	discontinuation	leads to discontinuation		7123
42072			Adverse event	grade 5		WARNING		7124
42073						No AEs are reported		7125
42074	1 pts		Myopathy		discontinuation	leads to discontinuation		7127
42075	1 pts		Leukocytoclastic vasculitis		discontinuation	leads to discontinuation		7127
42076	1 pts		Bone marrow toxicity	grade 5				7128
42077	1 pts		Epidermal necrolysis		discontinuation	leads to discontinuation		7130
42078			Adverse event	grade 5		acute intoxication		7126
42079			Agranulocytosis		discontinuation	withdrawn from markets		7129
42080	6 pts		Eye disorders NEC					7131
42081	1 pts		Bradycardia					7131
42082						accidental. No AEs are reported		7132
42083						No AEs are reported		7134
42084						No AEs are reported		7133
42085						impossible to link AEs with the definite dose: the most common AEs were gastrointestinal disorders (diarrhea 16.7%, nausea 12.1%, vomiting 7.6%, and upper abdominal pain 7.6%) and headache (6.1%)		7135
42086						impossible to link AEs with the definite dose: the most common AEs were gastrointestinal disorders (diarrhea 16.7%, nausea 12.1%, vomiting 7.6%, and upper abdominal pain 7.6%) and headache (6.1%)		7136
42087	1 pts		Xanthoma		discontinuation	leads to discontinuation		7140
42088	4 pts		Gamma-glutamyltransferase increased		discontinuation	leads to discontinuation		7137
42089	4 pts		Hyperglycemia		discontinuation	leads to discontinuation		7137
42090	6.3		Hyperglycemia	grade 3-4				7137
42091	7.7		Abdominal pain	grade 3-4				7137
42092	7.7		Blood alkaline phosphatase increased	grade 3-4				7137
42093	4 pts		Diarrhea		discontinuation	leads to discontinuation		7142
42094	4 pts		Lipase increased		discontinuation	leads to discontinuation		7142
42095			Diarrhea					7138
42096	1.2		Diarrhea		discontinuation	leads to discontinuation		7139
42097	1.2		Nausea		discontinuation	leads to discontinuation		7139
42098	1.2		Fatigue		discontinuation	leads to discontinuation		7139
42099	1.2		Cholelithiasis		discontinuation	leads to discontinuation		7139
42100	3.7		GGT increased		discontinuation	leads to discontinuation		7139
42101	1.2		Hepatic enzyme increased		discontinuation	leads to discontinuation		7139
42102	1.2		Lipase increased		discontinuation	leads to discontinuation		7139
42103	2.4		Hyperglycemia		discontinuation	leads to discontinuation		7139
42104	1.2		Tremor		discontinuation	leads to discontinuation		7139
42105	2.5		Diarrhea		discontinuation	leads to discontinuation		7141
42106	1.3		Nausea		discontinuation	leads to discontinuation		7141
42107	1.3		Fatigue		discontinuation	leads to discontinuation		7141
42108	1.3		Pituitary tumor benign		discontinuation	leads to discontinuation		7141
42109	2.5		GGT increased		discontinuation	leads to discontinuation		7141
42110	1.3		Cranial nerve paralysis		discontinuation	leads to discontinuation		7141
42111	1.3		Confusion state		discontinuation	leads to discontinuation		7141
42112	3.8		Hyperglycemia		discontinuation	leads to discontinuation		7141
42113	1.3		Tongue paralysis		discontinuation	leads to discontinuation		7141
42114	1.3		Adrenal insufficiency		discontinuation	leads to discontinuation		7141
42115	1.3		Fecal incontinence		discontinuation	leads to discontinuation		7141
42116	1.3		Asthenia		discontinuation	leads to discontinuation		7141
42117	1.3		ALT increased		discontinuation	leads to discontinuation		7141
42118	1.3		AST increased		discontinuation	leads to discontinuation		7141
42119	1.3		Immunoglobulin E increased		discontinuation	leads to discontinuation		7141
42120	1.3		QT interval prolonged		discontinuation	leads to discontinuation		7141
42121	1.3		Urinary incontinence		discontinuation	leads to discontinuation		7141
42122	1.3		Urticaria		discontinuation	leads to discontinuation		7141
42123	1.3		Hot flush		discontinuation	leads to discontinuation		7141
42124	1.3		Hypotension		discontinuation	leads to discontinuation		7141
42125	1 pts		Fatigue	grade 3	discontinuation	leads to dose reduction	TRUE	7144
42126	3 pts		Fatigue	grade 3			TRUE	7143
42127	1 pts		Nausea	grade 3			TRUE	7143
42128	1 pts		Vomiting	grade 3			TRUE	7143
42129	2 pts		Thrombocytopenia	grade 3			TRUE	7143
42130	1 pts		Atrial fibrillation	grade 4	discontinuation	leads to discontinuation	TRUE	7143
42131	2		Infection		discontinuation	leads to discontinuation		7145
42132	2		Fatigue		discontinuation	leads to discontinuation		7145
42133	2		QT interval prolonged		discontinuation	leads to discontinuation		7145
42134	2		Dyspnea		discontinuation	leads to discontinuation		7145
42135	2		Pyrexia		discontinuation	leads to discontinuation		7146
42136	1 pts		Dermatitis medicamentosa		discontinuation	leads to discontinuation		7146
42137	1 pts		Allergic dermatitis		discontinuation	leads to discontinuation		7146
42138	1 pts		Toxic skin eruption					7146
42139						There were no discontinuations due to side effects and no serious adverse events (SAEs).		7147
42140			Ectopic pregnancy			WARNINGS		7149
42141						Such high doses were well-tolerated; however, these women had a shortened menstrual cycle (uterine bleeding occurring 2-3 days earlier than would be expected) and in some women, the duration of bleeding was prolonged, although not excessive in amount (spotting).		7148
42142	0.09		Vomiting		discontinuation	One subject vomited within 15 minutes of treatment, which was considered related to treatment		7150
42143						No adverse effects leading to discontinuation were reported.		7151
42144	1 pts		Blindness		discontinuation	leads to discontinuation		7153
42145			Hypotension aggravated			WARNING		7152
42146			Blood cyanide increased			WARNING		7152
42147			Blood cyanide increased		discontinuation	leads to discontinuation		7154
42148	3.3		Constipation					7155
42149	3.9		Diarrhea					7155
42150	3.7		Dyspepsia					7155
42151	4.3		Nausea					7155
42152	2		Fatigue					7155
42153	3.5		Pain					7155
42154	3.5		Nasopharyngitis					7155
42155	3.3		Sinusitis					7155
42156	5.3		Upper respiratory tract infection					7155
42157	1.2		ALT increased					7155
42158	3.9		Arthralgia					7155
42159	6.3		Back pain					7155
42160	1.6		Muscle spasms					7155
42161	3.3		Myalgia					7155
42162	4.5		Pain in extremity					7155
42163	4.1		Dizziness					7155
42164	12.7		Headache					7155
42165	1 pts		Asthma late onset					7158
42166	1 pts		Myoclonus		discontinuation	leads to discontinuation		7156
42167	1 pts		Ataxia		discontinuation	leads to discontinuation		7157
42168	8 pts		Headache					7160
42169	2 pts		Nasal congestion					7160
42170	3 pts		Alanine aminotransferase increased					7160
42171	3 pts		Aspartate aminotransferase increased					7160
42172	3 pts		Blood amylase increased					7160
42173	3 pts		Blood creatinine increased					7160
42174	2 pts		Blood sodium increased					7160
42175	4 pts		Lipase increased					7160
42176	8 pts		Headache					7159
42177	3 pts		Diarrhoea					7159
42178	2 pts		Myalgia					7159
42179	2 pts		Rhinitis					7159
42180	1 pts		Dizziness					7159
42181	1 pts		Myasthenia					7159
42182	5 pts		Headache					7164
42183	2 pts		Nasal congestion					7164
42184	1 pts		Amylase serum increased					7164
42185	2 pts		Headache					7161
42186	1 pts		Nasal congestion					7161
42187	1 pts		Amylase serum increased					7161
42188	11 pts		Headache					7163
42189	4 pts		Pharyngitis					7163
42190	3 pts		Somnolence					7163
42191	2 pts		Back pain					7163
42192	18 pts		Headache					7162
42193	15 pts		Nausea					7162
42194	6 pts		Nasal congestion					7162
42195	6 pts		Decreased appetite					7162
42196	5 pts		Somnolence					7162
42197	5 pts		Abdominal pain					7162
42198	4 pts		Vomiting					7162
42199	2 pts		Dizziness					7162
42200	2 pts		Pharyngitis					7162
42201	2 pts		Abdominal distension					7162
42202	2 pts		Arthralgia					7162
42203	2 pts		Myalgia					7162
42204	2 pts		Neck stiffness					7162
42205	83 pts		Anemia	grade 1-2				7165
42206	26 pts		Neutropenia	grade 1-2				7165
42207	4 pts		Febrile neutropenia	grade 1-2				7165
42208	13 pts		Thrombocytopenia	grade 1-2				7165
42209	166 pts		Nausea	grade 1-2				7165
42210	88 pts		Vomiting	grade 1-2				7165
42211	66 pts		Constipation	grade 1-2				7165
42212	49 pts		Diarrhea	grade 1-2				7165
42213	49 pts		Stomatitis	grade 1-2				7165
42214	22 pts		Dyspepsia	grade 1-2				7165
42215	147 pts		Fatigue	grade 1-2				7165
42216	44 pts		Asthenia	grade 1-2				7165
42217	39 pts		Mucosal inflammation	grade 1-2				7165
42218	25 pts		Pyrexia	grade 1-2				7165
42219	33 pts		Weight loss	grade 1-2				7165
42220	83 pts		Decreased appetite	grade 1-2				7165
42221	17 pts		Dehydration	grade 1-2				7165
42222	18 pts		Hypokalemia	grade 1-2				7165
42223	36 pts		Dysgeusia	grade 1-2				7165
42224	161 pts		Alopecia	grade 1-2				7165
42225	37 pts		Anemia	grade 3-4				7165
42226	65 pts		Neutropenia	grade 3-4				7165
42227	44 pts		Febrile neutropenia	grade 3-4				7165
42228	9 pts		Thrombocytopenia	grade 3-4				7165
42229	10 pts		Nausea	grade 3-4				7165
42230	12 pts		Vomiting	grade 3-4				7165
42231	1 pts		Constipation	grade 3-4				7165
42232	6 pts		Diarrhea	grade 3-4				7165
42233	4 pts		Stomatitis	grade 3-4				7165
42234	10 pts		Fatigue	grade 3-4				7165
42235	4 pts		Asthenia	grade 3-4				7165
42236	2 pts		Mucosal inflammation	grade 3-4				7165
42237	2 pts		Weight loss	grade 3-4				7165
42238	6 pts		Decreased appetite	grade 3-4				7165
42239	6 pts		Dehydration	grade 3-4				7165
42240	19 pts		Hypokalemia	grade 3-4				7165
42241						Administration  of  single  doses  of  anacetrapib  acrossa  dose  range  2 mg  to  1000 mg  did  not  result  in  seriousadverse  experiences  or  discontinuations  due  to  adverse experiences.		7166
42242						1 patient discontinued due to unspecified treatment-related AE		7167
42243	1.2		Hyperglycemia					7168
42244	1 pts		Abdominal pain	grade 3	discontinuation	leads to dose interruption and dose reduction	TRUE	7172
42245						impossible to link AEs with the definite dose		7169
42246	3		Rash		discontinuation	leads to discontinuation		7170
42247	>1		Rash		discontinuation	leads to dose interruption or reduction		7170
42248	>1		Diarrhea		discontinuation	leads to dose interruption or reduction		7170
42249	>1		Fatigue		discontinuation	leads to dose interruption or reduction		7170
42250	>1		Nausea		discontinuation	leads to dose interruption or reduction		7170
42251	>1		Vomiting		discontinuation	leads to dose interruption or reduction		7170
42252	>1		Hypertension		discontinuation	leads to dose interruption or reduction		7170
42253	>1		Hematuria		discontinuation	leads to dose interruption or reduction		7170
42254	1		Fatigue		discontinuation	leads to discontinuation		7171
42255	0.7		Decreased appetite		discontinuation	leads to discontinuation		7171
42256	0.7		Weight decreased		discontinuation	leads to discontinuation		7171
42257	1 pts		Thrombocytopenia	serious				7173
42258	2 pts		Anaemia	below serious				7173
42259	1 pts		Leukopenia	below serious				7173
42260	2 pts		Neutropenia	below serious				7173
42261	1 pts		Diarrhoea	below serious				7173
42262	2 pts		Dyspepsia	below serious				7173
42263	3 pts		Nausea	below serious				7173
42264	1 pts		Asthenia	below serious				7173
42265	3 pts		Chills	below serious				7173
42266	1 pts		Fatigue	below serious				7173
42267	1 pts		Injection site erythema	below serious				7173
42268	2 pts		Upper respiratory tract infection	below serious				7173
42269	1 pts		Dyspnoea exertional	below serious				7173
42270	1 pts		Epistaxis	below serious				7173
42271	4 pts		Pruritus	below serious				7173
42272	1 pts		Congenital lymphoedema	below serious				7173
42273	1 pts		Vertigo	below serious				7173
42274	1 pts		Chest discomfort	below serious				7173
42275	1 pts		Liver tenderness	below serious				7173
42276	1 pts		Burns first degree	below serious				7173
42277	1 pts		Disturbance in attention	below serious				7173
42278	1 pts		Food aversion	below serious				7173
42279	1 pts		Sleep disorder	below serious				7173
42280	1 pts		Spontaneous penile erection	below serious				7173
42281	1 pts		Hot flush	below serious				7173
42282	1 pts		Haematuria	below serious				7173
42283	1 pts		Paraesthesia	serious				7174
42284	1 pts		Anaemia	below serious				7174
42285	1 pts		Leukopenia	below serious				7174
42286	1 pts		Lymphopenia	below serious				7174
42287	2 pts		Neutropenia	below serious				7174
42288	1 pts		Ascites	below serious				7174
42289	2 pts		Diarrhoea	below serious				7174
42290	1 pts		Haemorrhoids	below serious				7174
42291	2 pts		Nausea	below serious				7174
42292	1 pts		Asthenia	below serious				7174
42293	1 pts		Chills	below serious				7174
42294	2 pts		Fatigue	below serious				7174
42295	3 pts		Influenza like illness	below serious				7174
42296	1 pts		Irritability	below serious				7174
42297	2 pts		Pyrexia	below serious				7174
42298	1 pts		Nasopharyngitis	below serious				7174
42299	1 pts		Upper respiratory tract infection	below serious				7174
42300	1 pts		Hyperuricaemia	below serious				7174
42301	1 pts		Dizziness	below serious				7174
42302	2 pts		Headache	below serious				7174
42303	1 pts		Depression	below serious				7174
42304	3 pts		Insomnia	below serious				7174
42305	3 pts		Cough	below serious				7174
42306	1 pts		Dyspnoea exertional	below serious				7174
42307	2 pts		Epistaxis	below serious				7174
42308	2 pts		Pruritus	below serious				7174
42309	1 pts		Tachycardia	below serious				7174
42310	1 pts		Feeling of body temperature change	below serious				7174
42311	1 pts		Abscess limb	below serious				7174
42312	1 pts		Cellulitis	below serious				7174
42313	1 pts		Gastroenteritis	below serious				7174
42314	1 pts		Tooth fracture	below serious				7174
42315	1 pts		Arthralgia	below serious				7174
42316	1 pts		Muscular weakness	below serious				7174
42317	1 pts		Dysgeusia	below serious				7174
42318	1 pts		Hypoaesthesia	below serious				7174
42319	1 pts		Mental impairment	below serious				7174
42320	1 pts		Sciatica	below serious				7174
42321	1 pts		Anxiety	below serious				7174
42322	1 pts		Altered mood	below serious				7174
42323	1 pts		Productive cough	below serious				7174
42324	1 pts		Upper-airway cough syndrome	below serious				7174
42325	1 pts		Rash macular	below serious				7174
42326	16.7		Dysgeusia					7179
42327	16.7		Flatulence					7179
42328	16.7		Dizziness					7179
42329	16.7		Headache					7179
42330	16.7		Diarrhoea					7179
42331	11		Pyrexia					7176
42332	6		Abdominal pain					7176
42333	6		Nausea					7176
42334	4		Headache					7176
42335	4		Fatigue					7176
42336	3		Edema peripheral					7176
42337	7		Hyponatremia	serious				7176
42338	0.4		Anemia		discontinuation	leads to discontinuation		7176
42339	0.4		Pyrexia		discontinuation	leads to discontinuation		7176
42340	0.4		Myalgia		discontinuation	leads to discontinuation		7176
42341	8		Pyrexia					7175
42342	7		Abdominal pain					7175
42343	7		Nausea					7175
42344	7		Headache					7175
42345	3		Fatigue					7175
42346	4		Edema peripheral					7175
42347	8		Hyponatremia	serious				7175
42348	29.6		Gastrointestinal disorders					7178
42349	23.9		General disorders and administration site conditions					7178
42350	8.8		Nervous system disorders					7178
42351	10.1		Injury, poisoning and procedural complications					7178
42352	3.1		Infection					7178
42353	3.1		Infestation					7178
42354	4.4		Respiratory disorder					7178
42355	4.4		Thoracic disorders (excl lung and pleura)					7178
42356	4.4		Mediastinal disorders					7178
42357	6.9		Musculoskeletal disorder					7178
42358	6.9		Connective tissue disorders					7178
42359	3.8		Metabolism disorders NEC					7178
42360	3.8		General nutrition disorder					7178
42361	5		Skin disorder					7178
42362	5		Skin and subcutaneous tissue disorders					7178
42363	3.8		Blood disorder					7178
42364	3.8		Lymphatic system disorders NEC					7178
42365	3.1		Psychiatric disorders					7178
42366	1.3		Urinary tract disorder NOS					7178
42367	1.3		Renal disorder					7178
42368	2.5		Vascular disorders					7178
42369	1.9		Hepatobiliary disorders					7178
42370	2.5		Eye disorders					7178
42371	0.6		Cardiac disorders					7178
42372	25.2		Gastrointestinal disorders					7177
42373	14.8		General disorders and administration site conditions					7177
42374	7.8		Nervous system disorders					7177
42375	2.6		Injury, poisoning and procedural complications					7177
42376	9.6		Infection					7177
42377	9.6		Infestation					7177
42378	8.7		Respiratory disorder					7177
42379	8.7		Thoracic disorders (excl lung and pleura)					7177
42380	8.7		Mediastinal disorders					7177
42381	5.2		Musculoskeletal disorder					7177
42382	5.2		Connective tissue disorders					7177
42383	5.2		Metabolism disorders NEC					7177
42384	5.2		General nutrition disorder					7177
42385	1.7		Skin disorder					7177
42386	1.7		Skin and subcutaneous tissue disorders					7177
42387	3.5		Blood disorder					7177
42388	3.5		Lymphatic system disorders NEC					7177
42389	4.3		Psychiatric disorders					7177
42390	3.5		Urinary tract disorder NOS					7177
42391	3.5		Renal disorder					7177
42392	0.9		Vascular disorders					7177
42393	1.7		Hepatobiliary disorders					7177
42394	0.9		Eye disorders					7177
42395	0.9		Cardiac disorders					7177
42396	0.9		Disorder ear					7177
42397	0.9		Labyrinthine disorders					7177
42398	0.9		Endocrine disorders					7177
42399	2 pts		Sinusitis		discontinuation			7180
42400	1 pts		Oedema		discontinuation			7180
42401	2 pts		Deep vein thrombosis		discontinuation			7180
42402	2 pts		Fatigue		discontinuation			7180
42403	2 pts		Weight increase		discontinuation			7180
42404	3 pts		Fatigue		discontinuation			7181
42405	3 pts		Deep vein thrombosis		discontinuation			7181
42406	3 pts		Weight increase		discontinuation			7181
42407	2 pts		Oedema		discontinuation			7181
42408	3 pts		Sinusitis		discontinuation			7181
42409	2.4		Haemorrhage		discontinuation			7184
42410			Pulmonary embolism		discontinuation			7184
42411			Thrombosis venous deep		discontinuation			7184
42412			Epidural hematoma			CLASS WARNING		7186
42413			Spinal hematoma			CLASS WARNING		7186
42414	19 pts		Gastrointestinal bleeding	major		WARNING		7185
42415	2 pts		Intracranial hemorrhage	major		WARNING		7185
42416	1 pts		Bleeding	grade 5		WARNING		7185
42417	3.4		Electrocardiogram QTc interval prolonged	grade 1				7182
42418						No AEs reported. Doses higher than that cause risk of prolonged QTc		7183
42419	5 pts		Infection mycotic					7188
42420	3 pts		Influenza					7188
42421	15 pts		Nasopharyngitis					7188
42422	7 pts		Urinary tract infection					7188
42423	6 pts		Hypoglycaemia					7188
42424	4 pts		Pollakiuria					7188
42425	4 pts		Polyuria					7188
42426	2 pts		Pruritis					7188
42427	2 pts		Rash					7188
42428	25 pts		Hypoglycaemia					7189
42429	22 pts		Urinary tract infection					7189
42430	2 pts		Infection mycotic					7189
42431	3 pts		Nasopharyngitis					7187
42432	1 pts		Urinary tract infection					7187
42433	2 pts		Pollakiuria					7187
42434	3 pts		Dysuria					7187
42435	3 pts		Polyuria					7187
42436	1 pts		Arthralgia					7187
42437	1 pts		Muscle spasms					7187
42438	2 pts		Headache					7187
42439	16.7		Flushing	mild				7190
42440	16.7		Vomiting	mild				7191
42441	33.3		Feeling hot	mild				7191
42442	16.7		Somnolence	mild				7191
42443	2.6		Paresthesia	grade 1-2				7194
42444	2.9		Injection site erythema	grade 1-2				7194
42445	2.1		Injection site pruritus	grade 1-2				7194
42446	40		Nausea	grade 1-2				7193
42447	20.3		Flushing	grade 1-2				7193
42448	13.2		Injection site reactions	grade 1-2				7193
42449	11.3		Headache	grade 1-2				7193
42450	4.8		Vomiting	grade 1-2				7193
42451	3.3		Cough	grade 1-2				7193
42452	3.2		Fatigue	grade 1-2				7193
42453	2.7		Hot flush	grade 1-2				7193
42454	2.6		Paraesthesia	grade 1-2				7193
42455	2.2		Dizziness	grade 1-2				7193
42456	2.1		Nasal congestion	grade 1-2				7193
42457	8		Nausea		discontinuation			7193
42458	2		Headache		discontinuation			7193
42459	1		Vomiting		discontinuation			7193
42460	1		Flushing		discontinuation			7193
42461	1		Injection site reactions		discontinuation			7193
42462	<1		Flu-like symptoms	grade 1-2	discontinuation			7193
42463	<1		Increased blood pressure	grade 1-2	discontinuation			7193
42464	<2		Upper abdominal pain	grade 1-2				7193
42465	<2		Diarrhea	grade 1-2				7193
42466	<2		Myalgia	grade 1-2				7193
42467	<2		Arthralgia	grade 1-2				7193
42468	<2		Pain	grade 1-2				7193
42469	<2		Restless leg syndrome	grade 1-2				7193
42470	<2		Rhinorrhea	grade 1-2				7193
42471	<2		Creatine phosphokinase increased	grade 1-2				7193
42472	<2		Blood pressure increased	grade 1-2				7193
42473	<2		Pain in extremity	grade 1-2				7193
42474	<2		Hyperpigmentation skin	grade 1-2				7193
42475	50		Vomiting	grade 1-2				7192
42476	16.7		Diarrhoea					7196
42477						No information on AE is provided		7195
42478	5		C.difficile colitis		discontinuation			7197
42479	1 pts		Alanine aminotransferase increased	grade 3	discontinuation	leads to discontinuation	TRUE	7200
42480	1 pts		Aspartate aminotransferase increased	grade 4	discontinuation	leads to discontinuation	TRUE	7200
42481	1 pts		Acidosis lactic	grade 4	discontinuation	leads to discontinuation	TRUE	7200
42482	1 pts		Anion gap	grade 4	discontinuation	leads to discontinuation	TRUE	7200
42483	1 pts		Ketonaemia	grade 4	discontinuation	leads to discontinuation	TRUE	7200
42484	1 pts		Left ventricular systolic dysfunction	grade 3	discontinuation	leads to discontinuation	TRUE	7200
42485	7		Hyperglycemia		discontinuation	leads to dose reduction		7198
42486	5		Neutropenia		discontinuation	leads to dose reduction		7198
42487	5		Hypertension		discontinuation	leads to dose reduction		7198
42488	2		Pneumonitis		discontinuation	leads to discontinuation		7198
42489	2		Hyperglycemia		discontinuation	leads to discontinuation		7198
42490	3		Thrombocytopenia		discontinuation	leads to discontinuation		7199
42491	1.8		Neutropenia		discontinuation	leads to discontinuation		7199
42492	1.2		Anemia		discontinuation	leads to discontinuation		7199
42493	1.2		Nausea		discontinuation	leads to discontinuation		7199
42494	2.4		Fatigue		discontinuation	leads to discontinuation		7199
42495	1.2		Hypercalcemia		discontinuation	leads to discontinuation		7199
42496	1.6		Acute kidney injury		discontinuation	leads to discontinuation		7199
42497	3.6		Pneumonitis		discontinuation	leads to discontinuation		7199
42498	1.8		Febrile neutropenia		discontinuation	leads to dose reduction		7199
42499	2.4		Diarrhea		discontinuation	leads to dose reduction		7199
42500	5.4		Pyrexia		discontinuation	leads to dose reduction		7199
42501	1.8		Sepsis		discontinuation	leads to dose reduction		7199
42502	4.8		Hyperglycemia		discontinuation	leads to dose reduction		7199
42503	6		Pneumonitis		discontinuation	leads to dose reduction		7199
42504	50		Nausea					7202
42505	87.5		Gastrointestinal disorders					7202
42506	75		Vomiting					7202
42507	25		Diarrhea					7202
42508	12.5		Retching					7202
42509	12.5		Nervous system disorders					7202
42510	12.5		Dizziness					7202
42511	12.5		Feeling hot					7202
42512	12.5		Respiratory, thoracic and mediastinal disorders					7202
42513	12.5		Rhinorrhea					7202
42514	12.5		Skin and subcutaneous tissue disorders					7202
42515			Pruritus					7202
42516			Tendinitis	serious	discontinuation	WARNING		7201
42517			Tendon rupture	serious	discontinuation	WARNING		7201
42518			Peripheral neuropathy	serious	discontinuation	WARNING		7201
42519			Myasthenia gravis	serious	discontinuation	WARNING		7201
42520	0.1		Vomiting		discontinuation	leads to discontinuation		7204
42521	0.1		Hypersensitivity		discontinuation	leads to discontinuation		7204
42522	0.1		Hypersensitivity		discontinuation	leads to discontinuation		7203
42523	0.3		Urticaria		discontinuation	leads to discontinuation		7204
42524	0.1		Dermatitis allergic		discontinuation	leads to discontinuation		7204
42525	8.3		Congestive heart failure	grade 4	discontinuation			7210
42526	100		Hypotension		dose reduction		TRUE	7208
42527	16.7		Hypotension		dose reduction			7207
42528	16.7		Congestive heart failure		dose reduction			7207
42529	7.7		Hypotension		dose reduction			7205
42530	3.8		Heart block		dose reduction			7205
42531	31.6		Hypotension		dose reduction			7206
42532	5.3		Bradycardia		dose reduction			7206
42533	5.3		Congestive heart failure		dose reduction			7206
42534						No information on AE is provided		7209
42535	2 pts		Rash		discontinuation	leads to discontinuation		7211
42536	7		Nausea	all grades				7212
42537	6		Headache	all grades				7212
42538	6		Fatigue	all grades				7212
42539	5		Diarrhea	all grades				7212
42540	5		Abdominal pain	all grades				7212
42541	3		Dizziness	all grades				7212
42542	2		Rash	all grades				7212
42543	1		Abnormal dreams	all grades				7212
42544	1		Insomnia	all grades				7212
42545	5		Bilirubin total increased					7213
42546	2		Creatinine increased					7213
42547	4		Aspartate aminotransferase increase					7213
42548	7		Lipase increased					7213
42549	5		Creatine kinase increased					7213
42550	6 pts		Nausea	below serious				7214
42551	2 pts		Nasopharyngitis	below serious				7214
42552	6 pts		Sinusitis	below serious				7214
42553	6 pts		Upper respiratory tract infection	below serious				7214
42554	5 pts		Urinary tract infection	below serious				7214
42555	4 pts		Blood cholesterol increased	below serious				7214
42556	4 pts		Back pain	below serious				7214
42557	6 pts		Headache	below serious				7214
42558	3 pts		Migraine	below serious				7214
42559	1 pts		Abortion spontaneous	serious				7219
42560	6 pts		Nausea	below serious				7219
42561	4 pts		Urinary tract infection	below serious				7219
42562	6 pts		Vaginal mycosis	below serious				7219
42563	4 pts		Headache	below serious				7219
42564	4 pts		Migraine	below serious				7219
42565	6 pts		Acne	below serious				7219
42566	1 pts		Chest pain	serious				7215
42567	1 pts		Ureteric stenosis	serious				7215
42568	1 pts		Dyspnoea	serious				7215
42569	13 pts		Nasopharyngitis	below serious				7215
42570	14 pts		Sinusitis	below serious				7215
42571	38 pts		Headache	below serious				7215
42572	9 pts		Depression	below serious				7215
42573	16 pts		Insomnia	below serious				7215
42574	8 pts		Amenorrhoea	below serious				7215
42575	13 pts		Acne	below serious				7215
42576	6 pts		Night sweats	below serious				7215
42577	59 pts		Hot flush	below serious				7215
42578	1 pts		Appendicitis	serious				7217
42579	1 pts		Pyelonephritis	serious				7217
42580	1 pts		Synovitis	serious				7217
42581	1 pts		Anxiety	serious				7217
42582	1 pts		Calculus ureteric	serious				7217
42583	1 pts		Hydronephrosis	serious				7217
42584	1 pts		Nephrolithiasis	serious				7217
42585	2 pts		Endometriosis	serious				7217
42586	1 pts		Ovarian cyst ruptured	serious				7217
42587	11 pts		Nasopharyngitis	below serious				7217
42588	43 pts		Headache	below serious				7217
42589	15 pts		Anxiety	below serious				7217
42590	13 pts		Depression	below serious				7217
42591	18 pts		Insomnia	below serious				7217
42592	14 pts		Amenorrhoea	below serious				7217
42593	14 pts		Night sweats	below serious				7217
42594	105 pts		Hot flush	below serious				7217
42595	1 pts		Frequent bowel movements	serious				7216
42596	1 pts		Abscess oral	serious				7216
42597	1 pts		Procedural pain	serious				7216
42598	2 pts		Back pain	serious				7216
42599	1 pts		Intervertebral disc protrusion	serious				7216
42600	1 pts		Lumbar radiculopathy	serious				7216
42601	1 pts		Abortion spontaneous	serious				7216
42602	1 pts		Completed suicide	serious				7216
42603	1 pts		Colic renal	serious				7216
42604	2 pts		Endometriosis	serious				7216
42605	1 pts		Menorrhagia	serious				7216
42606	2 pts		Uterine polyp	serious				7216
42607	1 pts		Haemorrhage vaginal	serious				7216
42608	1 pts		Abortion induced	serious				7216
42609	42 pts		Headache	below serious				7216
42610	13 pts		Insomnia	below serious				7216
42611	13 pts		Mood swings	below serious				7216
42612	11 pts		Amenorrhoea	below serious				7216
42613	51 pts		Hot flush	below serious				7216
42614	2 pts		Appendicitis	serious				7218
42615	1 pts		Pharyngeal abscess	serious				7218
42616	1 pts		Postoperative abscess	serious				7218
42617	1 pts		Ligament sprain	serious				7218
42618	1 pts		Jaw cyst	serious				7218
42619	36 pts		Nausea	below serious				7218
42620	15 pts		Sinusitis	below serious				7218
42621	16 pts		Arthralgia	below serious				7218
42622	13 pts		Back pain	below serious				7218
42623	52 pts		Headache	below serious				7218
42624	24 pts		Insomnia	below serious				7218
42625	20 pts		Amenorrhoea	below serious				7218
42626	109 pts		Hot flush	below serious				7218
42627						No AEs are reported		7222
42628	0.8		Nausea		discontinuation	leads to discontinuation		7220
42629	0.6		Vomiting		discontinuation	leads to discontinuation		7220
42630	0.8		Headache		discontinuation	leads to discontinuation		7220
42631	0.4		Depression		discontinuation	leads to discontinuation		7220
42632	0.8		Hot flush		discontinuation	leads to discontinuation		7220
42633	0.4		Insomnia		discontinuation	leads to discontinuation		7220
42634	0.4		Irritability		discontinuation	leads to discontinuation		7220
42635	0.4		Mood swings		discontinuation	leads to discontinuation		7220
42636	0.2		Abdominal pain		discontinuation	leads to discontinuation		7220
42637	0.2		Acne		discontinuation	leads to discontinuation		7220
42638	0.4		Endometriosis		discontinuation	leads to discontinuation		7220
42639	0.2		Migraine		discontinuation	leads to discontinuation		7220
42640	1.5		Nausea		discontinuation	leads to discontinuation		7221
42641	0.4		Vomiting		discontinuation	leads to discontinuation		7221
42642	1		Headache		discontinuation	leads to discontinuation		7221
42643	0.6		Depression		discontinuation	leads to discontinuation		7221
42644	2.5		Hot flush		discontinuation	leads to discontinuation		7221
42645	0.4		Insomnia		discontinuation	leads to discontinuation		7221
42646	0.4		Irritability		discontinuation	leads to discontinuation		7221
42647	0.2		Mood swings		discontinuation	leads to discontinuation		7221
42648	0.4		Abdominal pain		discontinuation	leads to discontinuation		7221
42649	0.4		Acne		discontinuation	leads to discontinuation		7221
42650	0.4		Facial swelling		discontinuation	leads to discontinuation		7221
42651	0.4		Migraine		discontinuation	leads to discontinuation		7221
42652	0.4		Depressed mood		discontinuation	leads to discontinuation		7221
42653	0.6		Diarrhea		discontinuation	leads to discontinuation		7221
42654	0.4		ALT increased		discontinuation	leads to discontinuation		7221
42655	0.4		AST increased		discontinuation	leads to discontinuation		7221
42656	0.6		Arthralgia		discontinuation	leads to discontinuation		7221
42657	0.4		Rash		discontinuation	leads to discontinuation		7221
42658	13.3		Diarrhea		discontinuation			7224
42659	13.3		Abdominal pain		discontinuation			7224
42660						No adverse effects leading to discontinuation were reported.		7223
42661	50		Nausea	all grades				7226
42662	43		Diarrhea	all grades				7226
42663	34		Vomiting	all grades				7226
42664	34		Decreased appetite	all grades				7226
42665	6		Tumor lysis syndrome	all grades				7226
42666	14		Differentiation syndrome	all grades				7226
42667	12		Leukocytosis	all grades				7226
42668	12		Dysgeusia	all grades				7226
42669	5		Nausea	grade 3-4				7226
42670	8		Diarrhea	grade 3-4				7226
42671	2		Vomiting	grade 3-4				7226
42672	4		Decreased appetite	grade 3-4				7226
42673	6		Tumor lysis syndrome	grade 3-4				7226
42674	7		Differentiation syndrome	grade 3-4				7226
42675	6		Leukocytosis	grade 3-4				7226
42676	81		Bilirubin total increased	all grades				7226
42677	74		Calcium decreased	all grades				7226
42678	41		Potassium decreased	all grades				7226
42679	27		Blood phosphorus decreased	all grades				7226
42680	15		Bilirubin total increased	grade 3-4				7227
42681	8		Calcium decreased	grade 3-4				7227
42682	15		Potassium decreased	grade 3-4				7227
42683	8		Blood phosphorus decreased	grade 3-4				7227
42684	1		Leukocytosis		discontinuation	leads to discontinuation		7226
42685	4		Differentiation syndrome			leads to dose interruption		7226
42686	3		Leukocytosis			leads to dose interruption		7226
42687	3.7		Hyperbilirubinemia			leads to dose interruption		7227
42688	1.4		Hyperbilirubinemia			leads to discontinuation		7227
42689	4.2		Death	grade 5	discontinuation	leads to discontinuation, death associated with disease		7228
42690	11.7		Death	grade 5	discontinuation	leads to discontinuation, death associated with disease		7229
42691	1 pts		Abdominal distension			dose reduction, not qualified as DLT		7225
42692	1 pts		Diarrhea			dose reduction, not qualified as DLT		7225
42693	1 pts		Fatigue			dose reduction, not qualified as DLT		7225
42694	3 pts		Hyperbilirubinemia			dose reduction, not qualified as DLT		7225
42695	1 pts		Rash			dose reduction, not qualified as DLT		7225
42696	1.9		Headache		discontinuation	leads to discontinuation		7230
42697	3.7		Palmar-plantar erythrodysesthesia syndrome		discontinuation	leads to discontinuation		7235
42698	3.7		Palmar-plantar erythrodysesthesia syndrome		discontinuation	leads to discontinuation		7231
42699	1.9		Hyperkeratosis		discontinuation	leads to discontinuation		7238
42700	1.9		Neuralgia		discontinuation	leads to discontinuation		7233
42701	1 pts		Palmar-plantar erythrodysesthesia syndrome				TRUE	7235
42702	1 pts		Neuralgia				TRUE	7233
42703	1 pts		Fatigue				TRUE	7238
42704	1 pts		Diarrhea				TRUE	7230
42705	1 pts		Headache				TRUE	7230
42706	1 pts		Rash				TRUE	7230
42707	1 pts		Asthenia				TRUE	7230
42708	1 pts		Insomnia				TRUE	7230
42709	1 pts		Musculoskeletal pain				TRUE	7237
42710	1 pts		Neck pain				TRUE	7237
42711	1 pts		Neuralgia				TRUE	7237
42712	1 pts		Facial paresis				TRUE	7236
42713	1 pts		Confusional state				TRUE	7236
42714	33.3		Myalgia				TRUE	7232
42715	26.7		Arthralgia				TRUE	7232
42716	20		Fatigue				TRUE	7232
42717	13.3		Asthenia				TRUE	7232
42718	6.7		VIIth nerve paralysis				TRUE	7232
42719	6.7		Insomnia				TRUE	7232
42720	1 pts		Pancreatitis acute				TRUE	7234
42721	1 pts		Insomnia				TRUE	7234
42722			Nausea				TRUE	7245
42723			Vomiting				TRUE	7245
42724						AEs not reported		7240
42725	4.2		Phlebitis superficial		discontinuation			7241
42726	>10		Nausea	grade 1-2				7239
42727	<10		Vomiting	grade 1-2				7239
42728	2.4		Pyrexia		discontinuation			7244
42729	2.4		Pyrexia		discontinuation			7243
42730	4.2		Decreased appetite		discontinuation			7242
42731	4.2		Nausea		discontinuation			7242
42732	4.2		Vomiting		discontinuation			7242
42733	1.4		Deep vein thrombosis leg		discontinuation			7246
42734	8		Skin rash		discontinuation			7247
42735	2 pts		Dermatitis	all grades				7253
42736	3 pts		Sepsis	grade 3-4				7253
42737	3 pts		Sepsis	all grades				7253
42738	17 pts		Neutropenic fever	all grades				7253
42739	2 pts		Thrombocytopenia	all grades				7253
42740	17 pts		Diarrhea	all grades				7253
42741	1 pts		Epistaxis	all grades				7253
42742	1 pts		Peripheral edema	grade 3-4				7253
42743	2 pts		Diarrhea	grade 3-4				7253
42744	2 pts		Headache	grade 3-4				7253
42745	9 pts		Fatigue	all grades				7253
42746	7 pts		Nausea	all grades				7253
42747	3 pts		Anemia	grade 3-4				7253
42748	3 pts		Anemia	all grades				7253
42749	1 pts		Nausea	grade 3-4				7253
42750	8 pts		Pneumonia	all grades				7253
42751	9 pts		Peripheral edema	all grades				7253
42752	2 pts		Cough	all grades				7253
42753	2 pts		Thrombocytopenia	grade 3-4				7253
42754	2 pts		Hyperbilirubinemia	grade 3-4				7253
42755	1 pts		Stomatitis	grade 3-4				7253
42756	9 pts		Rash	all grades				7253
42757	6 pts		Headache	all grades				7253
42758	8 pts		Urinary tract infection	all grades				7253
42759	2 pts		Fatigue	grade 3-4				7253
42760	6 pts		Dermatitis	grade 3-4				7253
42761	3 pts		Hyperbilirubinemia	all grades				7253
42762	6 pts		Stomatitis	all grades				7253
42763	17 pts		Neutropenic fever	grade 3-4				7253
42764	8 pts		Pneumonia	grade 3-4				7253
42765	1 pts		Stomatitis	grade 3			TRUE	7248
42766	1 pts		Hyperbilirubinemia	grade 3			TRUE	7248
42767	6 pts		Pneumonia	all grades				7251
42768	1 pts		Diarrhea	grade 3-4				7251
42769	2 pts		Sepsis	grade 3-4				7251
42770	1 pts		Nausea	grade 3-4				7251
42771	3 pts		Rash	all grades				7251
42772	2 pts		Hyperbilirubinemia	all grades				7251
42773	6 pts		Stomatitis	all grades				7251
42774	1 pts		Hyperbilirubinemia	grade 3-4				7251
42775	4 pts		Stomatitis	grade 3-4				7251
42776	2 pts		Cough	all grades				7251
42777	2 pts		Epistaxis	all grades				7251
42778	2 pts		Multi-organ failure	all grades				7251
42779	2 pts		Multi-organ failure	grade 3-4				7251
42780	2 pts		Multi-organ failure	all grades				7251
42781	1 pts		Fatigue	all grades				7251
42782	6 pts		Pneumonia	grade 3-4				7251
42783	2 pts		Neutropenic fever	grade 3-4				7251
42784	2 pts		Dermatitis	all grades				7251
42785	3 pts		Diarrhea	all grades				7251
42786	3 pts		Nausea	all grades				7251
42787	3 pts		Peripheral edema	all grades				7251
42788	1 pts		Dermatitis	grade 3-4				7251
42789	2 pts		Sepsis	all grades				7251
42790	2 pts		Esophagitis	grade 3			TRUE	7250
42791						No AEs were observed		7249
42792	1 pts		Infusion site reactions	grade 3-4				7252
42793	16 pts		Thrombocytopenia	all grades				7252
42794	14 pts		Rash	all grades				7252
42795	2 pts		Stomatitis	grade 3-4				7252
42796	14 pts		Fatigue	all grades				7252
42797	11 pts		Thrombocytopenia	grade 3-4				7252
42798	6 pts		Stomatitis	all grades				7252
42799	16 pts		Neutropenia	all grades				7252
42800	8 pts		Neutropenia	grade 3-4				7252
42801	2 pts		Fatigue	grade 3-4				7252
42802	4 pts		Edema	all grades				7252
42803	6 pts		Leukopenia	grade 3-4				7252
42804	1 pts		Hyperglycemia	grade 3-4				7252
42805	11 pts		Hyperglycemia	all grades				7252
42806	8 pts		Nausea	all grades				7252
42807	6 pts		Decreased appetite	all grades				7252
42808	1 pts		Peripheral neuropathy	all grades				7252
42809	5 pts		Vomiting	all grades				7252
42810	6 pts		Infusion site reactions	all grades				7252
42811	13 pts		Leukopenia	all grades				7252
42812	17 pts		Anemia	all grades				7252
42813	4 pts		Constipation	all grades				7252
42814	5 pts		Diarrhea	all grades				7252
42815	5 pts		Pyrexia	all grades				7252
42816	13 pts		Anemia	grade 3-4				7252
42817	1 pts		Headache	grade 3-4				7252
42818	1 pts		Diarrhea	grade 3-4				7252
42819	5 pts		Headache	all grades				7252
42820	5 pts		Dyspnea	all grades				7252
42821	5 pts		Hypomagnesaemia	all grades				7252
42822	14		Lymphopenia	grade 3-5				7254
42823	29		Hypertension	grade 3-5				7254
42824	14		Aspartate aminotransferase increased	grade 3-5				7254
42825	29		Alkaline phosphatase increased	grade 3-5				7254
42826	14		Hyperbilirubinemia	grade 3-5				7254
42827	29		Anemia	grade 1-2				7254
42828	57		Leukopenia	grade 1-2				7254
42829	14		Neutropenia	grade 1-2				7254
42830	29		Thrombocytopenia	grade 1-2				7254
42831	14		Diarrhea	grade 1-2				7254
42832	14		Fatigue	grade 1-2				7254
42833	71		ALT increased	grade 1-2				7254
42834	1		Abdominal pain		discontinuation	leads to discontinuation		7255
42835	1		ALT increased		discontinuation	leads to discontinuation		7255
42836	1		Chest pain		discontinuation	leads to discontinuation		7255
42837	1		Headache		discontinuation	leads to discontinuation		7255
42838	1		Neutropenia		discontinuation	leads to discontinuation		7255
42839	1		Pneumonia		discontinuation	leads to discontinuation		7255
42840	1		Plasma cell myeloma		discontinuation	leads to discontinuation		7255
42841	1		Syncope		discontinuation	leads to discontinuation		7255
42842	1		Thrombocytopenia		discontinuation	leads to discontinuation		7255
42843	27.8		Scleral icterus					7261
42844	11.1		Abdominal pain					7261
42845	13.9		Headache					7261
42846	5.6		Dizziness					7261
42847	8.3		Nausea					7261
42848	2.8		Musculoskeletal chest pain					7261
42849	5.6		Headache					7263
42850	5.6		Scleral icterus					7262
42851	5.6		Abdominal pain					7262
42852	5.6		Nausea					7262
42853	14		Headache	grade 1				7256
42854	2		Ischaemia		discontinuation			7258
42855	2		Bone tuberculosis		discontinuation			7259
42856	2		Acute renal failure		discontinuation			7259
42857	2		Disseminated tuberculosis		discontinuation			7257
42858	2		Back pain		discontinuation			7257
42859	10		Nausea	grade 1-4				7264
42860	4		Diarrhea	grade 1-4				7264
42861	4		Headache	grade 1-4				7264
42862	3		Abdominal pain	grade 1-4				7264
42863	3		Dyspepsia	grade 1-4				7264
42864	3		Fatigue	grade 1-4				7264
42865	3		Rash	grade 1-4				7264
42866	3		Sleep disturbance	grade 1-4				7264
42867	2		Immune reconstitution inflammatory syndrome	grade 1-4				7264
42868	2		Somnolence	grade 1-4				7264
42869	2		Vomiting	grade 1-4				7264
42870	3		Immune reconstitution inflammatory syndrome	grade 3	discontinuation			7264
42871	5		ALT increased	grade 3-4				7264
42872	4		AST increased	grade 3-4				7264
42873	7		Direct bilirubin increased	grade 3				7264
42874	3		Bilirubin increased	grade 3-4				7264
42875	5		Serum cholesterol increased	grade 3				7264
42876	19		Creatinine increased	grade 3-4				7264
42877	2		Creatine kinase increased	grade 3-4				7264
42878	6		Hemoglobin decreased	grade 3-4				7264
42879	4		Hyperglycemia	grade 3-4				7264
42880	5		Lipase increased	grade 3-4				7264
42881	4		LDL cholesterol increased	grade 3-4				7264
42882	4		Neutrophils reduced	grade 3-4				7264
42883	5		Blood triglycerides increased	grade 3-4				7264
42884	3		Blood urates increased	grade 3-4				7264
42885			QT interval prolonged			prolongs QT by 12.9 ms		7260
42886	100		Diarrhea	grade 1-3			TRUE	7265
42887	83.3		Fatigue	grade 1-3				7265
42888	16.7		Abdominal pain	grade 1-2				7265
42889	66.7		Nausea	grade 1-2				7265
42890	16.7		Decreased appetite	grade 1-2				7265
42891	33.3		Insomnia	grade 1-2				7265
42892	50		Vomiting	grade 1-2				7265
42893	16.7		Constipation	grade 1-2				7265
42894	16.7		Dyspnea	grade 1-2				7265
42895	16.7		Headache	grade 1-2				7265
42896	16.7		Peripheral edema	grade 1-2				7265
42897	33.3		Asthenia	grade 1-4			TRUE	7265
42898	33.3		Back pain	grade 1-2				7265
42899	50		Urinary tract infection	grade 1-2				7265
42900	50		Dehydration	grade 1-3				7265
42901	16.7		Hypokalemia	grade 1-2				7265
42902	16.7		Weight decreased	grade 1-2				7265
42903	33.3		Dizziness	grade 1-2				7265
42904	16.7		Dry mouth	grade 1-2				7265
42905	16.7		Pain in extremity	grade 1-2				7265
42906	16.7		Rash	grade 1-2				7265
42907	16.7		Arthralgia	grade 3				7265
42908	14.3		Amylase increased	grade 3			TRUE	7268
42909	16.7		Fatigue	grade 3			TRUE	7266
42910			Blood lipase increased	grade 3			TRUE	7267
42911						No information on AEs is available		7272
42912						No information on AEs is available		7273
42913	2		Pneumonia		discontinuation	leads to discontinuation		7270
42914	2		Sepsis		discontinuation	leads to discontinuation		7270
42915	1		Dyspnea		discontinuation	leads to discontinuation		7270
42916						No information on AEs is available		7269
42917						No information on AEs is available		7271
42918						Laropiprant was safe and generally well tolerated at single doses of 1–900 mg. No subject discontinued because of an adverse event (AE).		7274
42919						Laropiprant was safe and generally well tolerated at multiple doses of 30–450 mg administered once daily for 10 days. No subject discontinued because of an adverse event (AE).		7275
42920	2 pts		Anaemia	serious				7276
42921	1 pts		Aplastic anaemia	serious				7276
42922	1 pts		Autoimmune haemolytic anaemia	serious				7276
42923	1 pts		Disseminated intravascular coagulation	serious				7276
42924	7 pts		Febrile neutropenia	serious				7276
42925	1 pts		Leukopenia	serious				7276
42926	1 pts		Neutropenia	serious				7276
42927	3 pts		Pancytopenia	serious				7276
42928	4 pts		Thrombocytopenia	serious				7276
42929	1 pts		Arrhythmia	serious				7276
42930	1 pts		Atrial fibrillation	serious				7276
42931	1 pts		Atrial flutter	serious				7276
42932	1 pts		Cardiac failure	serious				7276
42933	1 pts		Pericarditis	serious				7276
42934	1 pts		Sinus node dysfunction	serious				7276
42935	1 pts		Inappropriate antidiuretic hormone secretion	serious				7276
42936	1 pts		Colitis	serious				7276
42937	1 pts		Constipation	serious				7276
42938	1 pts		Food poisoning	serious				7276
42939	3 pts		Gastrointestinal haemorrhage	serious				7276
42940	1 pts		Lower gastrointestinal haemorrhage	serious				7276
42941	2 pts		Nausea	serious				7276
42942	1 pts		Pancreatitis	serious				7276
42943	1 pts		Stomatitis haemorrhagic	serious				7276
42944	1 pts		Upper gastrointestinal haemorrhage	serious				7276
42945	3 pts		Vomiting	serious				7276
42946	1 pts		Chest pain	serious				7276
42947	1 pts		Gait disturbance	serious				7276
42948	1 pts		Generalised oedema	serious				7276
42949	2 pts		Mucosal inflammation	serious				7276
42950	10 pts		Pyrexia	serious				7276
42951	1 pts		Acute hepatic failure	serious				7276
42952	1 pts		Hepatic cirrhosis	serious				7276
42953	1 pts		Hyperbilirubinaemia	serious				7276
42954	1 pts		Atypical pneumonia	serious				7276
42955	2 pts		Bacteraemia	serious				7276
42956	1 pts		BK virus infection	serious				7276
42957	1 pts		Bronchiolitis	serious				7276
42958	1 pts		Bronchitis	serious				7276
42959	4 pts		Bronchopulmonary aspergillosis	serious				7276
42960	3 pts		Cellulitis	serious				7276
42961	1 pts		Cellulitis orbital	serious				7276
42962	1 pts		Clostridium bacteraemia	serious				7276
42963	3 pts		Clostridium difficile colitis	serious				7276
42964	1 pts		Cytomegalovirus viraemia	serious				7276
42965	1 pts		Diverticulitis	serious				7276
42966	3 pts		Epstein-Barr virus infection	serious				7276
42967	1 pts		Escherichia urinary tract infection	serious				7276
42968	1 pts		Fusarium infection	serious				7276
42969	2 pts		Gastroenteritis	serious				7276
42970	1 pts		Gastroenteritis norovirus	serious				7276
42971	1 pts		Gastroenteritis rotavirus	serious				7276
42972	2 pts		Gastroenteritis viral	serious				7276
42973	1 pts		Gastrointestinal candidiasis	serious				7276
42974	2 pts		Herpes zoster	serious				7276
42975	1 pts		Implant site cellulitis	serious				7276
42976	1 pts		Infection	serious				7276
42977	1 pts		Klebsiella infection	serious				7276
42978	1 pts		Klebsiella sepsis	serious				7276
42979	1 pts		Meningitis aseptic	serious				7276
42980	1 pts		Bacterial meningitis	serious				7276
42981	1 pts		Mucormycosis	serious				7276
42982	1 pts		Nasopharyngitis	serious				7276
42983	1 pts		Neutropenic sepsis	serious				7276
42984	1 pts		Oesophageal candidiasis	serious				7276
42985	1 pts		Otitis media acute	serious				7276
42986	1 pts		Parainfluenzae virus infection	serious				7276
42987	1 pts		Periorbital cellulitis	serious				7276
42988	1 pts		Pharyngitis	serious				7276
42989	1 pts		Pilonidal cyst	serious				7276
42990	15 pts		Pneumonia	serious				7276
42991	1 pts		Pneumonia adenoviral	serious				7276
42992	3 pts		Pneumonia bacterial	serious				7276
42993	1 pts		Pneumonia parainfluenzae viral	serious				7276
42994	1 pts		Pneumonia respiratory syncytial viral	serious				7276
42995	1 pts		Pneumonia viral	serious				7276
42996	1 pts		Pseudomonas bronchitis	serious				7276
42997	1 pts		Respiratory tract infection	serious				7276
42998	1 pts		Retinitis viral	serious				7276
42999	2 pts		Rhinovirus infection	serious				7276
43000	8 pts		Sepsis	serious				7276
43001	4 pts		Sinusitis	serious				7276
43002	4 pts		Staphylococcal bacteraemia	serious				7276
43003	1 pts		Infection staphylococcal	serious				7276
43004	1 pts		Streptococcal bacteraemia	serious				7276
43005	1 pts		Systemic candida	serious				7276
43006	1 pts		Tonsillitis	serious				7276
43007	1 pts		Tooth infection	serious				7276
43008	1 pts		Upper respiratory tract infection bacterial	serious				7276
43009	4 pts		Urinary tract infection	serious				7276
43010	3 pts		Viral haemorrhagic cystitis	serious				7276
43011	1 pts		Viral infection	serious				7276
43012	1 pts		Delayed engraftment	serious				7276
43013	1 pts		Laceration	serious				7276
43014	1 pts		Haemorrhage subdural	serious				7276
43015	1 pts		Transfusion-related acute lung injury	serious				7276
43016	1 pts		Platelet count decreased	serious				7276
43017	1 pts		Diabetes mellitus	serious				7276
43018	1 pts		Failure to thrive	serious				7276
43019	1 pts		Gout	serious				7276
43020	1 pts		Hypernatraemia	serious				7276
43021	1 pts		Hypoglycaemia	serious				7276
43022	1 pts		Hypokalaemia	serious				7276
43023	1 pts		Lactose intolerance	serious				7276
43024	1 pts		Tetany	serious				7276
43025	1 pts		Arthralgia	serious				7276
43026	1 pts		Fibromyalgia	serious				7276
43027	1 pts		Muscular weakness	serious				7276
43028	2 pts		Acute lymphocytic leukaemia	serious				7276
43029	6 pts		Acute lymphocytic leukaemia recurrent	serious				7276
43030	1 pts		B-cell lymphoma recurrent	serious				7276
43031	1 pts		Basal cell carcinoma	serious				7276
43032	1 pts		Chronic myeloid leukaemia	serious				7276
43033	1 pts		Chronic myeloid leukaemia recurrent	serious				7276
43034	2 pts		Mantle cell lymphoma	serious				7276
43035	1 pts		Mycosis fungoides	serious				7276
43036	1 pts		Mycosis fungoides recurrent	serious				7276
43037	1 pts		Natural killer-cell leukaemia	serious				7276
43038	1 pts		Plasma cell myeloma	serious				7276
43039	2 pts		Plasma cell myeloma recurrent	serious				7276
43040	1 pts		Primary myelofibrosis	serious				7276
43041	3 pts		Squamous cell carcinoma	serious				7276
43042	1 pts		Encephalopathy	serious				7276
43043	3 pts		Headache	serious				7276
43044	1 pts		Encephalopathy hepatic	serious				7276
43045	1 pts		Migraine	serious				7276
43046	2 pts		Neurotoxicity	serious				7276
43047	1 pts		Posterior reversible encephalopathy syndrome	serious				7276
43048	2 pts		Sciatica	serious				7276
43049	2 pts		Syncope	serious				7276
43050	1 pts		Substance-induced psychotic disorder	serious				7276
43051	1 pts		Renal impairment	serious				7276
43052	2 pts		Acute respiratory distress syndrome	serious				7276
43053	1 pts		Acute respiratory failure	serious				7276
43054	1 pts		Asthma	serious				7276
43055	2 pts		Pleural effusion	serious				7276
43056	1 pts		Pleurisy	serious				7276
43057	1 pts		Aspiration pneumonia	serious				7276
43058	2 pts		Pneumothorax	serious				7276
43059	7 pts		Respiratory failure	serious				7276
43060	1 pts		Tonsillar disorder	serious				7276
43061	1 pts		Stevens-Johnson syndrome	serious				7276
43062	1 pts		Hypertensive crisis	serious				7276
43063	2 pts		Hypotension	serious				7276
43064	1 pts		Hypovolaemic shock	serious				7276
43065	1 pts		Orthostatic hypotension	serious				7276
43066	1 pts		Thrombosis	serious				7276
43067	3 pts		Venoocclusive disease	serious				7276
43068	24 pts		Anaemia	below serious				7276
43069	27 pts		Thrombocytopenia	below serious				7276
43070	24 pts		Dry eye	below serious				7276
43071	49 pts		Abdominal pain	below serious				7276
43072	108 pts		Diarrhoea	below serious				7276
43073	21 pts		Dry mouth	below serious				7276
43074	21 pts		Dyspepsia	below serious				7276
43075	106 pts		Nausea	below serious				7276
43076	79 pts		Vomiting	below serious				7276
43077	29 pts		Asthenia	below serious				7276
43078	20 pts		Chest pain	below serious				7276
43079	55 pts		Fatigue	below serious				7276
43080	45 pts		Mucosal inflammation	below serious				7276
43081	60 pts		Oedema peripheral	below serious				7276
43082	147 pts		Graft versus host disease	below serious				7276
43083	21 pts		Bacteraemia	below serious				7276
43084	19 pts		Nasopharyngitis	below serious				7276
43085	39 pts		Blood creatinine increased	below serious				7276
43086	31 pts		Hyperglycaemia	below serious				7276
43087	28 pts		Hyperkalaemia	below serious				7276
43088	23 pts		Hyponatraemia	below serious				7276
43089	30 pts		Arthralgia	below serious				7276
43090	21 pts		Myalgia	below serious				7276
43091	58 pts		Headache	below serious				7276
43092	29 pts		Tremor	below serious				7276
43093	23 pts		Anxiety	below serious				7276
43094	35 pts		Insomnia	below serious				7276
43095	62 pts		Cough	below serious				7276
43096	36 pts		Dyspnoea	below serious				7276
43097	25 pts		Epistaxis	below serious				7276
43098	34 pts		Erythema	below serious				7276
43099	31 pts		Pruritus	below serious				7276
43100	6.2		CMV infection		discontinuation			7278
43101	16.7		Vomiting	grade 3				7277
43102	50		Vessel puncture site pain	grade 1-2				7277
43103	16.7		Vessel puncture site hematoma	grade 1-2				7277
43104	1.6		Nausea		discontinuation			7279
43105	1.1		Acute myeloid leukemia recurrent		discontinuation			7279
43106	0.8		Graft versus host disease		discontinuation			7279
43107	0.8		Vomiting		discontinuation			7279
43108	0.5		Venoocclusive liver disease		discontinuation			7279
43109	0.5		Blood creatinine increased		discontinuation			7279
43110	0.5		Abdominal pain		discontinuation			7279
43111	0.2		Septic shock		discontinuation			7279
43112	4 pts		Cystic fibrosis lung	serious				7282
43113	1 pts		Haemoptysis	serious				7282
43114	10 pts		Cough	below serious				7282
43115	5 pts		Dyspnoea	below serious				7282
43116	6 pts		Rales	below serious				7282
43117	1 pts		Respiration abnormal	below serious				7282
43118	1 pts		Nasal turbinate abnormality	below serious				7282
43119	2 pts		Paranasal sinus hypersecretion	below serious				7282
43120	1 pts		Postnasal drip	below serious				7282
43121	1 pts		Nasal mucosal disorder	below serious				7282
43122	1 pts		Painful respiration	below serious				7282
43123	1 pts		Upper respiratory tract congestion	below serious				7282
43124	3 pts		Abdominal pain	below serious				7282
43125	2 pts		Constipation	below serious				7282
43126	3 pts		Nausea	below serious				7282
43127	1 pts		Flatulence	below serious				7282
43128	1 pts		Abdominal pain lower	below serious				7282
43129	1 pts		Aphthous stomatitis	below serious				7282
43130	1 pts		Dyspepsia	below serious				7282
43131	1 pts		Abdominal discomfort	below serious				7282
43132	1 pts		Abdominal distension	below serious				7282
43133	1 pts		Infrequent bowel movements	below serious				7282
43134	1 pts		Rectal haemorrhage	below serious				7282
43135	3 pts		Fatigue	below serious				7282
43136	1 pts		Chest pain	below serious				7282
43137	1 pts		Nodule	below serious				7282
43138	1 pts		Forced expiratory volume decreased	below serious				7282
43139	1 pts		C-reactive protein increased	below serious				7282
43140	2 pts		Sputum abnormal	below serious				7282
43141	1 pts		Electrocardiogram QT prolonged	below serious				7282
43142	4 pts		Headache	below serious				7282
43143	1 pts		Dizziness	below serious				7282
43144	1 pts		Migraine	below serious				7282
43145	2 pts		Back pain	below serious				7282
43146	1 pts		Neck pain	below serious				7282
43147	1 pts		Medial tibial stress syndrome	below serious				7282
43148	1 pts		Musculoskeletal discomfort	below serious				7282
43149	2 pts		Upper respiratory tract infection	below serious				7282
43150	1 pts		Nasopharyngitis	below serious				7282
43151	1 pts		Rhinitis	below serious				7282
43152	1 pts		Oral candidiasis	below serious				7282
43153	1 pts		Rash macular	below serious				7282
43154	1 pts		Dermatitis allergic	below serious				7282
43155	1 pts		Arthropod bite	below serious				7282
43156	1 pts		Sunburn	below serious				7282
43157	1 pts		Ear pain	below serious				7282
43158	1 pts		Anxiety	below serious				7282
43159	3 pts		Dyspnoea	below serious				7283
43160	2 pts		Rales	below serious				7283
43161	4 pts		Wheezing	below serious				7283
43162	1 pts		Respiration abnormal	below serious				7283
43163	1 pts		Nasal turbinate abnormality	below serious				7283
43164	1 pts		Rhonchi	below serious				7283
43165	1 pts		Nasal ulcer	below serious				7283
43166	1 pts		Pharyngeal erythema	below serious				7283
43167	1 pts		Sputum discoloured	below serious				7283
43168	2 pts		Constipation	below serious				7283
43169	2 pts		Post-tussive vomiting	below serious				7283
43170	1 pts		Aphthous stomatitis	below serious				7283
43171	1 pts		Dyspepsia	below serious				7283
43172	1 pts		Gastrointestinal sounds abnormal	below serious				7283
43173	1 pts		Gingival pain	below serious				7283
43174	3 pts		Fatigue	below serious				7283
43175	1 pts		Catheter site haematoma	below serious				7283
43176	1 pts		Oedema peripheral	below serious				7283
43177	1 pts		Forced expiratory volume decreased	below serious				7283
43178	1 pts		Neutrophil count increased	below serious				7283
43179	1 pts		White blood cell count increased	below serious				7283
43180	1 pts		Blood urine present	below serious				7283
43181	1 pts		Glucose urine	below serious				7283
43182	1 pts		Protein urine present	below serious				7283
43183	1 pts		Weight decreased	below serious				7283
43184	5 pts		Headache	below serious				7283
43185	1 pts		Sinus headache	below serious				7283
43186	3 pts		Myalgia	below serious				7283
43187	1 pts		Back pain	below serious				7283
43188	1 pts		Neck pain	below serious				7283
43189	1 pts		Joint range of motion decreased	below serious				7283
43190	1 pts		Musculoskeletal pain	below serious				7283
43191	1 pts		Rhinitis	below serious				7283
43192	1 pts		Gastroenteritis	below serious				7283
43193	1 pts		Pharyngitis streptococcal	below serious				7283
43194	1 pts		Sinusitis	below serious				7283
43195	1 pts		Vulvovaginal mycotic infection	below serious				7283
43196	1 pts		Rash macular	below serious				7283
43197	1 pts		Ecchymosis	below serious				7283
43198	1 pts		Lymphadenopathy	below serious				7283
43199	1 pts		Conjunctival hyperaemia	below serious				7283
43200	2 pts		Dyspnoea	below serious				7280
43201	4 pts		Productive cough	below serious				7280
43202	3 pts		Rales	below serious				7280
43203	2 pts		Lung hyperinflation	below serious				7280
43204	1 pts		Postnasal drip	below serious				7280
43205	1 pts		Tonsillar inflammation	below serious				7280
43206	1 pts		Constipation	below serious				7280
43207	1 pts		Post-tussive vomiting	below serious				7280
43208	1 pts		Flatulence	below serious				7280
43209	1 pts		Dry mouth	below serious				7280
43210	1 pts		Vomiting	below serious				7280
43211	1 pts		Irritability	below serious				7280
43212	1 pts		Forced expiratory volume decreased	below serious				7280
43213	2 pts		C-reactive protein increased	below serious				7280
43214	2 pts		Dizziness	below serious				7280
43215	1 pts		Hypogeusia	below serious				7280
43216	1 pts		Somnolence	below serious				7280
43217	1 pts		Clubbing	below serious				7280
43218	1 pts		Pain in extremity	below serious				7280
43219	3 pts		Upper respiratory tract infection	below serious				7280
43220	1 pts		Nasopharyngitis	below serious				7280
43221	1 pts		Rhinitis	below serious				7280
43222	2 pts		Cystic fibrosis lung	below serious				7280
43223	1 pts		Arthropod bite	below serious				7280
43224	1 pts		Ear pain	below serious				7280
43225	1 pts		Motion sickness	below serious				7280
43226	1 pts		Vertigo	below serious				7280
43227	1 pts		Polydipsia	below serious				7280
43228	1 pts		Anxiety	below serious				7280
43229	1 pts		Agitation	below serious				7280
43230	1 pts		Polyuria	below serious				7280
43231	1 pts		Hypertension	below serious				7280
43232	3 pts		Cystic fibrosis lung	serious				7281
43233	10 pts		Cough	below serious				7281
43234	4 pts		Dyspnoea	below serious				7281
43235	6 pts		Productive cough	below serious				7281
43236	3 pts		Rales	below serious				7281
43237	4 pts		Respiration abnormal	below serious				7281
43238	2 pts		Epistaxis	below serious				7281
43239	1 pts		Rhonchi	below serious				7281
43240	1 pts		Bronchospasm	below serious				7281
43241	1 pts		Constipation	below serious				7281
43242	2 pts		Abdominal pain upper	below serious				7281
43243	1 pts		Nausea	below serious				7281
43244	1 pts		Post-tussive vomiting	below serious				7281
43245	1 pts		Flatulence	below serious				7281
43246	1 pts		Abdominal pain lower	below serious				7281
43247	1 pts		Gastrointestinal sounds abnormal	below serious				7281
43248	3 pts		Fatigue	below serious				7281
43249	5 pts		Pyrexia	below serious				7281
43250	1 pts		Catheter site rash	below serious				7281
43251	1 pts		Hunger	below serious				7281
43252	1 pts		Forced expiratory volume decreased	below serious				7281
43253	1 pts		Sputum abnormal	below serious				7281
43254	1 pts		Neutrophil count increased	below serious				7281
43255	1 pts		White blood cell count increased	below serious				7281
43256	5 pts		Headache	below serious				7281
43257	1 pts		Dizziness	below serious				7281
43258	1 pts		Back pain	below serious				7281
43259	1 pts		Neck pain	below serious				7281
43260	1 pts		Arthritis	below serious				7281
43261	2 pts		Nasopharyngitis	below serious				7281
43262	1 pts		Rhinitis	below serious				7281
43263	1 pts		Urinary tract infection	below serious				7281
43264	1 pts		Rash erythematous	below serious				7281
43265	1 pts		Ear pain	below serious				7281
43266	1 pts		Middle ear effusion	below serious				7281
43267	1 pts		Decreased appetite	below serious				7281
43268	1 pts		Haematuria	below serious				7281
43269	1 pts		Proteinuria	below serious				7281
43270	1 pts		Haematoma	below serious				7281
43271	1 pts		Palpitations	below serious				7281
43272	52.6		Cough					7284
43273	26.3		Headache					7284
43274	15.8		Rales					7284
43275	31.6		Productive cough					7284
43276	21.1		Dyspnoea					7284
43277	21.1		Respiratory tract disorders NEC					7284
43278	15.8		Fatigue					7284
43279	26.3		Fever					7284
43280	11.8		Nasal congestion					7284
43281	10.5		Oropharyngeal pain					7284
43282	5.3		Sinus congestion					7284
43283	21.1		Respiration abnormal					7284
43284	10.5		Haemoptysis					7284
43285	5.3		Constipation					7284
43286	5.3		Abdominal pain					7284
43287	5.3		Myalgia					7284
43288	5.3		Post-tussive vomiting					7284
43289	5.3		Nausea					7284
43290	10.5		Nasopharyngitis					7284
43291	5.3		Dizziness					7284
43292	5.3		Back pain					7284
43293	10.5		Abdominal pain upper					7284
43294	5.3		Sputum abnormal					7284
43295	10.5		Epistaxis					7284
43296	>1		Peripheral neuropathy		discontinuation	leads to discontinuation		7287
43297	>1		Myelosuppression		discontinuation	leads to discontinuation		7287
43298	>3		Neutropenia		discontinuation	leads to dose interruption/reduction		7287
43299	>3		Hypoalbuminemia		discontinuation	leads to dose interruption		7287
43300	>3		Febrile neutropenia		discontinuation	leads to dose reduction		7287
43301	>3		Fatigue		discontinuation	leads to dose reduction		7287
43302	1 pts		Thrombocytopenia	grade 4			TRUE	7286
43303	2 pts		AST increased	grade 4			TRUE	7288
43304	2 pts		Neutropenia	grade 4			TRUE	7288
43305	2 pts		Fatigue	grade 3			TRUE	7288
43306	2 pts		Nausea	grade 2			TRUE	7288
43307	2 pts		Vomiting	grade 2			TRUE	7288
43308	2 pts		Diarrhea	grade 2			TRUE	7288
43309						No AEs are reported		7285
43310	1.9		Vein collapse		discontinuation			7290
43311	11.1		Diarrhoea					7289
43312	11.1		Pain					7289
43313	44.4		Headache					7289
43314	1 pts		Chest pain	serious				7292
43315	1 pts		Appendicitis	serious				7292
43316	3 pts		Abdominal pain	below serious				7292
43317	3 pts		Flatulence	below serious				7292
43318	1 pts		Abdominal pain upper	below serious				7292
43319	2 pts		Abdominal distension	below serious				7292
43320	2 pts		Anorectal discomfort	below serious				7292
43321	2 pts		Influenza like illness	below serious				7292
43322	1 pts		Headache	below serious				7292
43323	5 pts		Abdominal pain	below serious				7293
43324	3 pts		Flatulence	below serious				7293
43325	4 pts		Nausea	below serious				7293
43326	2 pts		Abdominal pain upper	below serious				7293
43327	2 pts		Abdominal distension	below serious				7293
43328	3 pts		Urinary tract infection	below serious				7293
43329	2 pts		Headache	below serious				7293
43330	1 pts		Hyperhidrosis	below serious				7293
43331	2 pts		Hot flush	below serious				7293
43332	1 pts		Left ventricular dysfunction	serious				7297
43333	9 pts		Abdominal pain	below serious				7297
43334	11 pts		Diarrhea	below serious				7297
43335	3 pts		Nausea	below serious				7297
43336	4 pts		Abdominal pain upper	below serious				7297
43337	2 pts		Vomiting	below serious				7297
43338	4 pts		Urinary tract infection	below serious				7297
43339	1 pts		Influenza like illness	below serious				7297
43340	2 pts		Fatigue	below serious				7297
43341	3 pts		Headache	below serious				7297
43342	2 pts		Dyspnea	below serious				7297
43343	2 pts		Hyperhidrosis	below serious				7297
43344	1 pts		Appendicitis	serious				7294
43345	1 pts		Hypersensitivity	serious				7294
43346	1 pts		Dehydration	serious				7294
43347	1 pts		Transient ischaemic attack	serious				7294
43348	1 pts		Supraventricular tachycardia	serious				7294
43349	1 pts		Ventricular extrasystoles	serious				7294
43350	1 pts		Deep vein thrombosis	serious				7294
43351	1 pts		Chronic obstructive pulmonary disease	serious				7294
43352	1 pts		Abdominal pain	serious				7294
43353	1 pts		Back pain	serious				7294
43354	1 pts		Muscular weakness	serious				7294
43355	1 pts		Pain in extremity	serious				7294
43356	1 pts		Patent ductus arteriosus	serious				7294
43357	1 pts		Ligament sprain	serious				7294
43358	16 pts		Abdominal pain	below serious				7294
43359	18 pts		Diarrhoea	below serious				7294
43360	1 pts		Appendicitis	serious				7295
43361	1 pts		Arthritis bacterial	serious				7295
43362	1 pts		Bronchitis	serious				7295
43363	1 pts		Otitis media	serious				7295
43364	1 pts		Parotitis	serious				7295
43365	7 pts		Pneumonia	serious				7295
43366	1 pts		Subcutaneous abscess	serious				7295
43367	1 pts		Adenocarcinoma	serious				7295
43368	1 pts		Adenocarcinoma of colon	serious				7295
43369	1 pts		Breast cancer	serious				7295
43370	1 pts		Squamous cell carcinoma of lung	serious				7295
43371	1 pts		Confusional state	serious				7295
43372	1 pts		Panic attack	serious				7295
43373	1 pts		Stress	serious				7295
43374	1 pts		Carotid artery stenosis	serious				7295
43375	1 pts		Cervicobrachial syndrome	serious				7295
43376	1 pts		Headache	serious				7295
43377	1 pts		Loss of consciousness	serious				7295
43378	2 pts		Encephalopathy toxic	serious				7295
43379	2 pts		Acute myocardial infarction	serious				7295
43380	1 pts		Myocardial infarction	serious				7295
43381	1 pts		Sinus tachycardia	serious				7295
43382	1 pts		Femoral artery occlusion	serious				7295
43383	1 pts		Orthostatic hypotension	serious				7295
43384	1 pts		Peripheral arterial occlusive disease	serious				7295
43385	1 pts		Disorder peripheral vascular	serious				7295
43386	1 pts		Dyspnoea	serious				7295
43387	1 pts		Pneumothorax	serious				7295
43388	2 pts		Pulmonary embolism	serious				7295
43389	2 pts		Abdominal pain	serious				7295
43390	1 pts		Constipation	serious				7295
43391	1 pts		Gastric volvulus	serious				7295
43392	1 pts		Bile duct stone	serious				7295
43393	1 pts		Cholelithiasis	serious				7295
43394	1 pts		Hepatitis	serious				7295
43395	1 pts		Necrosis skin	serious				7295
43396	1 pts		Arthralgia	serious				7295
43397	2 pts		Lumbar spinal stenosis	serious				7295
43398	1 pts		Muscle spasms	serious				7295
43399	1 pts		Myalgia	serious				7295
43400	2 pts		Neck pain	serious				7295
43401	5 pts		Osteoarthritis	serious				7295
43402	1 pts		Spinal column stenosis	serious				7295
43403	1 pts		Tenosynovitis	serious				7295
43404	1 pts		Sickle cell anaemia with crisis	serious				7295
43405	1 pts		Device dislocation	serious				7295
43406	1 pts		Blood potassium increased	serious				7295
43407	1 pts		Lower limb fracture	serious				7295
43408	2 pts		Overdose	serious				7295
43409	1 pts		Postoperative respiratory failure	serious				7295
43410	36 pts		Upper respiratory tract infection	below serious				7295
43411	50 pts		Abdominal pain	below serious				7295
43412	68 pts		Diarrhoea	below serious				7295
43413	49 pts		Nausea	below serious				7295
43414	36 pts		Vomiting	below serious				7295
43415	34 pts		Back pain	below serious				7295
43416	1 pts		Herpes zoster	serious				7296
43417	1 pts		Urinary tract infection	serious				7296
43418	1 pts		Lymphadenopathy mediastinal	serious				7296
43419	1 pts		Dehydration	serious				7296
43420	1 pts		Hypomagnesaemia	serious				7296
43421	1 pts		Sciatica	serious				7296
43422	1 pts		Cardiac failure congestive	serious				7296
43423	1 pts		Colitis ischaemic	serious				7296
43424	1 pts		Duodenitis	serious				7296
43425	1 pts		Enterocolitis	serious				7296
43426	1 pts		Gastritis	serious				7296
43427	1 pts		Cholelithiasis	serious				7296
43428	1 pts		Renal failure acute	serious				7296
43429	1 pts		Overdose	serious				7296
43430	1 pts		Radius fracture	serious				7296
43431	14 pts		Abdominal pain	below serious				7296
43432	24 pts		Diarrhoea	below serious				7296
43433	16.7		Abdominal pain					7298
43434	16.7		Diarrhea					7298
43435	11.1		Abdominal discomfort					7299
43436	11.1		Diarrhea					7299
43437	3.2		Abdominal pain		discontinuation	leads to discontinuation		7291
43438	3.2		Diarrhea		discontinuation	leads to discontinuation		7291
43439	3.2		Vomiting		discontinuation	leads to discontinuation		7291
43440	3.2		Nausea		discontinuation	leads to discontinuation		7291
43441	0.1		Colitis		discontinuation	leads to discontinuation		7291
43442	0.1		Diverticulitis		discontinuation	leads to discontinuation		7291
43443	0.1		Hematochezia		discontinuation	leads to discontinuation		7291
43444	0.5		Transaminases abnormal		discontinuation	leads to discontinuation		7291
43445	0.1		Edema peripheral		discontinuation	leads to discontinuation		7291
43446	0.1		Hyperglycemia		discontinuation	leads to discontinuation		7291
43447	0.1		Insomnia		discontinuation	leads to discontinuation		7291
43448	0.1		Generalized spasm		discontinuation	leads to discontinuation		7291
43449	0.1		Paralysis		discontinuation	leads to discontinuation		7291
43450	0.1		Photosensitivity		discontinuation	leads to discontinuation		7291
43451	0.1		Rash		discontinuation	leads to discontinuation		7291
43452	0.1		Thrombosis		discontinuation	leads to discontinuation		7291
43453	0.1		Supraventricular tachycardia		discontinuation	leads to discontinuation		7291
43454						No information on AE is provided		7300
43455	26		Diarrhoea		dose reduction			7302
43456	9		Nausea		dose reduction			7302
43457	28.6		Anorexia	grade 2-3	discontinuation		TRUE	7301
43458	71.4		Diarrhea	grade 1-3				7301
43459	57.1		Nausea	grade 1				7301
43460	28.6		Vomiting	grade 1				7301
43461						No adverse effects leading to discontinuation were reported; no DLTs		7305
43462	16.7		Dizziness				TRUE	7308
43463	33.3		Coordination abnormal	grade 3			TRUE	7308
43464	16.7		Tonic clonic movements	grade 3			TRUE	7308
43465	16.7		Somnolence	grade 3			TRUE	7308
43466						No adverse effects leading to discontinuation were reported; no DLTs		7306
43467	33.3		Coordination abnormal		dose reduction		TRUE	7309
43468						No adverse effects leading to discontinuation were reported; no DLTs		7304
43469						No adverse effects leading to discontinuation were reported; no DLTs		7303
43470	33.3		Ataxia	grade 1-2				7307
43471	33.3		Somnolence	grade 3	discontinuation		TRUE	7307
43472	33.3		Somnolence	grade 1				7307
43473	66.7		Euphoria	grade 1-2				7307
43474	33.3		Confusion	grade 3	discontinuation		TRUE	7307
43475	33.3		Speech disorder	grade 1-2				7307
43476	33.3		Mood alteration NOS	grade 1-2				7307
43477	33.3		Dizziness	grade 1-2				7307
43478	33.3		Confusion	grade 1				7307
43479	33.3		Ataxia	grade 3	discontinuation		TRUE	7307
43480	16.7		Nausea	grade 1-2				7312
43481	4.2		Vomiting	grade 1-2				7312
43482	8.3		Diarrhea	grade 1-2				7312
43483	4.2		Dizziness	grade 1-2				7312
43484	4.2		ALT increased	grade 1-2				7312
43485	4.2		Lipase increased	grade 1-3	discontinuation			7312
43486	11.9		Headache	grade 1-2				7314
43487	2.4		Nausea	grade 1-2				7314
43488	7.7		Dizziness	grade 1-2				7315
43489	7.7		Vomiting	grade 1-2				7315
43490	7.7		Nausea	grade 1-2				7315
43491	3.8		Vomiting		discontinuation			7315
43492	3.8		Nausea		discontinuation			7315
43493	16.7		Nausea	grade 1-2				7313
43494	4.2		Vomiting	grade 1-2				7313
43495	8.3		Diarrhea	grade 1-2				7313
43496	4.2		Dizziness	grade 1-2				7313
43497	4.2		ALT increased	grade 1-2				7313
43498	4.2		Lipase increased				TRUE	7313
43499			ALT increased	grade 2			TRUE	7310
43500			Elevated liver enzymes	grade 2				7311
43501	3.8		Nausea		discontinuation			7317
43502	7.7		Vomiting		discontinuation			7317
43503	7.7		Hallucination, visual		discontinuation			7317
43504	28		Nausea		discontinuation			7319
43505	12		Vomiting		discontinuation			7319
43506	12		Hallucination, visual		discontinuation			7319
43507						No information on AE is provided		7316
43508	5.9		Nausea		discontinuation			7318
43509	4.4		Dizziness		discontinuation			7318
43510	4.4		Somnolence		discontinuation			7318
43511	2.9		Headache		discontinuation			7318
43512	2.9		Asthenia		discontinuation			7318
43513	1.5		Blood pressure increased		discontinuation			7318
43514	1.5		Insomnia		discontinuation			7318
43515	1.5		Polyuria		discontinuation			7318
43516	2.9		Hallucinations		discontinuation			7318
43517	1.5		Vomiting		discontinuation			7318
43518						No AEs are reported		7320
43519	2.2		Ototoxicity					7323
43520	1.3		Tinnitus					7323
43521	1.3		Vertigo		discontinuation			7324
43522	2.7		Dizziness		discontinuation			7324
43523	1.4		Azotaemia		discontinuation			7324
43524	1.4		Hypotension		discontinuation			7324
43525	1.4		Type 2 diabetes mellitus		discontinuation			7324
43526	0.3		Blood creatinine increased		discontinuation			7325
43527			Hypotension	grade 1-2				7322
43528	0.7		Acute kidney injury		discontinuation			7326
43529	0.3		Chronic kidney disease		discontinuation			7326
43530	0.3		Metastatic neoplasm		discontinuation			7326
43531	0.3		Metastatic uterine cancer		discontinuation			7326
43532	0.3		Renal failure		discontinuation			7326
43533	0.3		Renal impairment		discontinuation			7326
43534	1.7		Abdominal pain					7321
43535	10.5		Nausea					7321
43536	8.8		Dizziness					7321
43537	7		Headache					7321
43538	17.5		Hypoesthesia					7321
43539	1.7		Flushing					7321
43540						No adverse effects leading to discontinuation were reported; no DLTs		7327
43541	1 pts		Dyspnea		discontinuation			7332
43542	2 pts		Atrioventricular block second degree		discontinuation			7332
43543	1 pts		ALT increased		discontinuation			7332
43544	1 pts		Palpitations		discontinuation			7332
43545	1 pts		Headache	grade 3				7332
43546	1 pts		ALT increased		discontinuation			7329
43547	1 pts		Headache	grade 3				7329
43548	2 pts		Macular edema	grade 3	discontinuation			7329
43549	1 pts		Atrioventricular block second degree		discontinuation			7329
43550	1 pts		Abdominal pain upper	grade 3				7329
43551	1 pts		Appendicitis	grade 3				7329
43552	1 pts		Bradycardia	grade 3	discontinuation			7329
43553	1 pts		Chest pain	grade 3				7329
43554	1 pts		Dyspnea	grade 3				7329
43555	1 pts		ALT increased		discontinuation			7334
43556	1 pts		Bradycardia		discontinuation			7334
43557	4 pts		Dyspnea		discontinuation			7334
43558	2 pts		Headache	grade 3				7334
43559	2 pts		Dyspnea exertional		discontinuation			7334
43560	1 pts		Palpitations		discontinuation			7334
43561	5 pts		Macular edema		discontinuation			7330
43562	5 pts		ALT increased		discontinuation			7330
43563	7 pts		Dyspnea		discontinuation			7330
43564	3 pts		AST increased		discontinuation			7330
43565	3 pts		Pregnancy		discontinuation			7330
43566	2 pts		Pregnancy of partner		discontinuation			7330
43567	2 pts		Hypertension		discontinuation			7330
43568	2 pts		Nausea		discontinuation			7330
43569	2 pts		Lymphocyte count decreased		discontinuation			7330
43570	6 pts		Headache	grade 3				7330
43571	2 pts		Drug-induced liver injury	grade 3				7330
43572	3 pts		Dyspnea		dose interruption			7330
43573	2 pts		Fatigue	grade 3				7330
43574	2 pts		Lymphocyte count decreased		dose interruption			7330
43575	2 pts		Hysterectomy	grade 3				7330
43576	2 pts		Intervertebral disc protrusion	grade 3				7330
43577	2 pts		Lymphopenia	grade 3	dose interruption			7330
43578	3 pts		Hepatic enzyme increased	grade 3	discontinuation			7330
43579	2 pts		Pain in extremity	grade 3				7330
43580	2 pts		Dyspnea		discontinuation			7335
43581	1 pts		Multiple sclerosis		discontinuation			7335
43582	1 pts		Macular edema		discontinuation			7335
43583	3 pts		Unintended pregnancy		discontinuation			7331
43584	2 pts		Multiple sclerosis		discontinuation			7331
43585	2 pts		Angioedema		discontinuation			7331
43586	2 pts		Abdominal pain					7331
43587	2 pts		Hepatocellular injury					7331
43588	2 pts		Nausea					7331
43589	2 pts		Edema peripheral					7331
43590	2 pts		Invasive ductal breast carcinoma		discontinuation			7331
43591	4 pts		Macular edema		discontinuation			7331
43592	3 pts		Dyspnea		discontinuation			7331
43593	1 pts		Unintended pregnancy		discontinuation			7333
43594	1 pts		Multiple sclerosis		discontinuation			7333
43595	1 pts		Angioedema		discontinuation			7333
43596	8.3		Somnolence					7328
43597	8.3		Sensory disturbance					7328
43598	1 pts		Lethargy					7328
43599						No adverse effects leading to discontinuation were reported		7336
43600						Pradigastat was generally well tolerated		7337
43601						impossible to link AEs with the definite dose		7338
43602						No AEs are reported		7339
43603	12		Diarrhoea					7340
43604	4		Nausea					7340
43605	5		Vomiting					7340
43606	2		Toothache					7340
43607	1		Dysphagia					7340
43608	5		Dry mouth					7340
43609	1		Fatigue					7340
43610	18		Nasopharyngitis					7340
43611	6		Urinary tract infection					7340
43612	20		Fall					7340
43613	4		Contusion					7340
43614	5		Laceration					7340
43615	9		Weight decreased					7340
43616	6		Creatinine renal clearance decreased					7340
43617	6		Back pain					7340
43618	10		Headache					7340
43619	4		Balance disorder					7340
43620	4		Dyskinesia					7340
43621	7		Dizziness					7340
43622	1		Akathisia					7340
43623	9		Chorea					7340
43624	2		Irritability					7340
43625	5		Depression					7340
43626	11		Insomnia					7340
43627	6		Anxiety					7340
43628	1		Restlessness					7340
43629	1		Suicidal ideation					7340
43630	6		Cough					7340
43631	1		Rash					7340
43632	2		Hypertension					7340
43633						No AEs were observed		7341
43634	1.1		Decreased creatinine clearance		discontinuation			7347
43635	>5		Diarrhea					7347
43636	>5		Nausea					7347
43637	>5		Vomiting					7347
43638	1		Diarrhoea		discontinuation			7350
43639	1		Rash		discontinuation			7350
43640	1		Nausea		discontinuation			7349
43641	2		Thrombocytosis					7350
43642	5.1		Diarrhoea					7350
43643	4		Nausea					7350
43644	2		Pyrexia					7350
43645	1		Bacteriuria					7350
43646	2		Influenza					7350
43647	2		ALT increased					7350
43648	1		AST increased					7350
43649	1		Bacterial test positive					7350
43650	1		Protein urine present					7350
43651	1		Red blood cells urine positive					7350
43652	1		White blood cells urine positive					7350
43653	7.1		Headache					7350
43654	3		Hypertension					7350
43655	1		Transaminases increased					7350
43656	1		Thrombocytosis					7348
43657	2		Abdominal pain					7348
43658	2		Diarrhoea					7348
43659	6.1		Nausea					7348
43660	2		Bacteriuria					7348
43661	1		ALT increased					7348
43662	2		AST increased					7348
43663	1		Bacterial test positive					7348
43664	1		Blood creatinine increased					7348
43665	1		White blood cells urine positive					7348
43666	2		Dysgeusia					7348
43667	3		Headache					7348
43668	2		Hypertension					7348
43669	1		Transaminases increased					7348
43670	5.9		Fatigue	grade 1				7345
43671	5.9		Blood creatinine increased	grade 1				7345
43672	5.9		Diarrhea	grade 1	discontinuation			7345
43673	5.9		Nausea	grade 2	discontinuation			7345
43674	5.9		Vomiting	grade 2	discontinuation			7345
43675	1		Anemia					7346
43676	6		Diarrhea					7346
43677	6		Nausea					7346
43678	3		Vomiting					7346
43679	2		Infusion site phlebitis					7346
43680	2		Pyrexia					7346
43681	3		Alanine aminotransferase increased					7346
43682	3		Aspartate aminotransferase increased					7346
43683	1		Lipase increased					7346
43684	<1		Blood creatinine increased					7346
43685	4		Headache					7346
43686	1		Central nervous system disorder NOS					7346
43687	2		Hypertension					7346
43688	16.7		Feeling of body temperature change	grade 1-2				7344
43689	16.7		Upper abdominal pain	grade 1-2				7343
43690	16.7		Diarrhea	grade 1-2				7343
43691	50		Infusion site erythema	grade 1-2				7343
43692	50		Infusion site pain	grade 1-2				7343
43693	16.7		Infusion site pruritus	grade 1-2				7343
43694	16.7		Infusion site swelling	grade 1-2				7343
43695	16.7		Dizziness	grade 1-2				7343
43696	16.7		Headache	grade 1-2				7343
43697	8.3		Diarrhea	grade 1-2				7342
43698	4.2		ALT increased	grade 1-2				7342
43699	33.3		Discoloration tongue	grade 1-2				7342
43700	4.2		Discoloration tooth	grade 1-2				7342
43701	4.2		Asthenia	grade 1-2				7342
43702	4.2		Feeling hot	grade 1-2				7342
43703	4.2		Feeling of body temperature change	grade 1-2				7342
43704	37.5		Infusion site erythema	grade 1-2				7342
43705	25		Infusion site pain	grade 1-2				7342
43706	20.8		Infusion site swelling	grade 1-2				7342
43707	4.2		AST increased	grade 1-2				7342
43708	4.2		Decreased appetite	grade 1-2				7342
43709	4.2		Arthralgia	grade 1-2				7342
43710	4.2		Muscle twitching	grade 1-2				7342
43711	4.2		Myalgia	grade 1-2				7342
43712	12.5		Headache	grade 1-2				7342
43713	4.2		Rash	grade 1-2				7342
43714	23 pts		Diastolic hypotension	below serious				7352
43715	1 pts		Acute respiratory failure	serious				7353
43716	1 pts		Aspiration	serious				7353
43717	1 pts		Chronic obstructive pulmonary disease	serious				7353
43718	1 pts		Dyspnoea	serious				7353
43719	1 pts		Organising pneumonia	serious				7353
43720	1 pts		Pleural effusion	serious				7353
43721	1 pts		Pneumomediastinum	serious				7353
43722	1 pts		Respiratory failure	serious				7353
43723	1 pts		Atrial fibrillation	serious				7353
43724	1 pts		Atrial tachycardia	serious				7353
43725	1 pts		Bradycardia	serious				7353
43726	1 pts		Lobar pneumonia	serious				7353
43727	1 pts		Confusional state	serious				7353
43728	85 pts		Hypertension	below serious				7353
43729	67 pts		Systolic hypertension	below serious				7353
43730	64 pts		Hypoxia	below serious				7353
43731	43 pts		Respiratory rate increased	below serious				7353
43732	13 pts		Hypertension	below serious				7351
43733	3 pts		Diastolic hypertension	below serious				7351
43734	2 pts		Systolic hypertension	below serious				7351
43735	6 pts		Respiratory acidosis	below serious				7351
43736	1.4		Bradypnea					7354
43737	1		Hypoxia					7354
43738	0.3		Respiratory depression					7354
43739	1.7		Nausea					7354
43740	1		Vomiting					7354
43741	1.7		Headache					7354
43742	1		Dizziness					7354
43743	0.7		Presyncope					7354
43744	0.3		Hematocrit decreased					7354
43745	0.7		Infections and infestations					7354
43746	58		Hypotension					7355
43747	42		Hypertension					7355
43748	19		Respiratory acidosis					7355
43749	10		Diastolic hypertension					7355
43750	6		Systolic hypertension					7355
43751	3		Bradycardia					7355
43752	3		Respiratory rate decreased					7355
43753	3		Diastolic hypotension					7355
43754	3		Blood pressure diastolic increased					7355
43755	3		Blood pressure increased					7355
43756	3		Blood pressure systolic increased					7355
43757	3		Upper respiratory tract infection					7355
43758	39		Hypotension					7356
43759	20		Hypertension					7356
43760	11		Bradycardia					7356
43761	10		Diastolic hypertension					7356
43762	8		Tachycardia					7356
43763	8		Diastolic hypotension					7356
43764	5		Systolic hypertension					7356
43765	0.33		Bradycardia		discontinuation			7357
43766	0.33		Hypertension		discontinuation			7357
43767	0.33		Hypotension		discontinuation			7357
43768	0.33		Hypoxia		discontinuation			7357
43769	0.33		Respiratory rate increased		discontinuation			7357
43770	33		Hypotension	grade 1				7357
43771	28		Hypertension	grade 1				7357
43772	25		Diastolic hypertension	grade 1				7357
43773	22		Systolic hypertension	grade 1				7357
43774	22		Hypoxia	grade 1				7357
43775	14		Respiratory rate increased	grade 1				7357
43776	14		Diastolic hypotension	grade 1				7357
43777	4		Nausea	grade 1				7357
43778	4		Bradycardia	grade 1				7357
43779	4		Pyrexia	grade 1				7357
43780	3		Headache	grade 1				7357
43781			QT interval prolonged					7360
43782	24		Hypoxia					7363
43783	14.6		Hypoxia					7362
43784	7		Bradycardia					7362
43785	40.3		Hypotension					7362
43786	15.8		Hypoxia					7359
43787	9.7		Bradycardia					7359
43788	53.9		Hypotension					7359
43789	33		Hypoxia					7361
43790	50		Hypotension					7361
43791						The number of patients in the highest dose range group, 23.744 mg to 33.116 mg, was too low to make definitive conclusions regarding the potential adverse event dose-response.		7358
43792	1 pts		Fatigue	grade 3			TRUE	7369
43793	2 pts		Thrombocytopenia	grade 4			TRUE	7366
43794	67		Neutropenia	grade 3-4				7366
43795	25		Leukopenia	grade 1-2				7366
43796	42		Leukopenia	grade 3-4				7366
43797	50		Anemia	grade 1-2				7366
43798	17		Lymphopenia	grade 1-2				7366
43799	33		Lymphopenia	grade 3-4				7366
43800	8		Thrombocytopenia	grade 1-2				7366
43801	42		Thrombocytopenia	grade 3-4				7366
43802	42		Vomiting	grade 1-2				7366
43803	33		Fatigue	grade 1-2				7366
43804	25		Nausea	grade 1-2				7366
43805	25		Electrocardiogram QTc interval prolonged	grade 1-2				7366
43806	17		Decreased appetite	grade 1-2				7366
43807	25		AST increased	grade 1-2				7366
43808	8		Asthenia	grade 1-2				7366
43809	8		Creatinine increased	grade 1-2				7366
43810	1 pts		Febrile neutropenia	grade 3			TRUE	7367
43811	1 pts		Febrile neutropenia	grade 3			TRUE	7368
43812	2 pts		QT interval prolonged	grade 3			TRUE	7368
43813	1 pts		Neutropenia	grade 4			TRUE	7368
43814	1 pts		Thrombocytopenia	grade 4			TRUE	7368
43815						No AEs are reported		7365
43816	10		Urinary tract infection	grade 1-2				7364
43817	1		Urinary tract infection	grade 3				7364
43818	15		Neutropenia	grade 1-2				7364
43819	50		Neutropenia	grade 3	discontinuation	leads to dose interruption		7364
43820	10		Neutropenia	grade 4	discontinuation	leads to dose interruption		7364
43821	12		Leukopenia	grade 1-2				7364
43822	20		Leukopenia	grade 3				7364
43823	1		Leukopenia	grade 4				7364
43824	16		Anemia	grade 1-2				7364
43825	1		Anemia	grade 3				7364
43826	<1		Anemia	grade 4				7364
43827	4		Lymphopenia	grade 1-2				7364
43828	6		Lymphopenia	grade 3				7364
43829	1		Lymphopenia	grade 4				7364
43830	17		Decreased appetite	grade 1-2				7364
43831	2		Decreased appetite	grade 3				7364
43832	21		Headache	grade 1-2				7364
43833	<1		Headache	grade 3				7364
43834	11		Insomnia	grade 1-2				7364
43835	<1		Insomnia	grade 3				7364
43836	11		Dyspnea	grade 1-2				7364
43837	1		Dyspnea	grade 3				7364
43838	18		Back pain	grade 1-2				7364
43839	2		Back pain	grade 3				7364
43840	50		Nausea	grade 1-2				7364
43841	2		Nausea	grade 3				7364
43842	34		Diarrhea	grade 1-2				7364
43843	1		Diarrhea	grade 3				7364
43844	25		Vomiting	grade 1-2				7364
43845	4		Vomiting	grade 3				7364
43846	2		Vomiting		discontinuation	leads to discontinuation		7364
43847	24		Constipation	grade 1-2				7364
43848	1		Constipation	grade 3				7364
43849	11		Stomatitis	grade 1-2				7364
43850	<1		Stomatitis	grade 3				7364
43851	10		Abdominal pain	grade 1-2				7364
43852	1		Abdominal pain	grade 3				7364
43853	33		Alopecia	grade 1-2				7364
43854	16		Rash	grade 1-2				7364
43855	1		Rash	grade 3				7364
43856	13		Pruritus	grade 1-2				7364
43857	1		Pruritus	grade 3				7364
43858	34		Fatigue	grade 1-2				7364
43859	2		Fatigue	grade 3				7364
43860	<1		Fatigue	grade 4				7364
43861	12		Pyrexia	grade 1-2				7364
43862	<1		Pyrexia	grade 3				7364
43863	12		Edema peripheral	grade 1-2				7364
43864	36		ALT increased	grade 1-2	discontinuation	leads to dose interruption		7364
43865	8		ALT increased	grade 3	discontinuation	leads to discontinuation | leads to dose interruption		7364
43866	2		ALT increased	grade 4	discontinuation	leads to discontinuation		7364
43867	37		AST increased	grade 1-2	discontinuation	leads to dose interruption		7364
43868	6		AST increased	grade 3	discontinuation	leads to discontinuation | leads to dose interruption		7364
43869	1		AST increased	grade 4	discontinuation	leads to discontinuation		7364
43870	8		Blood bilirubin increased	grade 1-2				7364
43871	8		Blood bilirubin increased	grade 3				7364
43872	2		Blood bilirubin increased	grade 4				7364
43873	59		Leukocyte count decreased	grade 1-2				7364
43874	31		Leukocyte count decreased	grade 3				7364
43875	3		Leukocyte count decreased	grade 4				7364
43876	33		Neutrophil count decreased	grade 1-2				7364
43877	49		Neutrophil count decreased	grade 3				7364
43878	11		Neutrophil count decreased	grade 4				7364
43879	55		Hemoglobin decreased	grade 1-2				7364
43880	2		Hemoglobin decreased	grade 3				7364
43881	37		Lymphocyte count decreased	grade 1-2				7364
43882	12		Lymphocyte count decreased	grade 3				7364
43883	2		Lymphocyte count decreased	grade 4				7364
43884	27		Platelet count decreased	grade 1-2				7364
43885	1		Platelet count decreased	grade 3				7364
43886	<1		Platelet count decreased	grade 4				7364
43887	19		Creatinine increased	grade 1-2				7364
43888	1		Creatinine increased	grade 3				7364
43889	7		Phosphate decreased	grade 1-2				7364
43890	5		Phosphate decreased	grade 3				7364
43891	1		Phosphate decreased	grade 4				7364
43892	9		Potassium decreased	grade 1-2				7364
43893	1		Potassium decreased	grade 3				7364
43894	1		Potassium decreased	grade 4				7364
43895	1 pts		QT interval prolonged	grade 2	discontinuation	fatal		7364
43896	1 pts		Hypokalemia	grade 3	discontinuation	fatal		7364
43897						No adverse effects leading to discontinuation were reported; no DLTs		7374
43898	16.7		Dysuria	grade 3			TRUE	7371
43899	16.7		Shortness of breath	grade 3			TRUE	7371
43900	16.7		Hematuria	grade 3	discontinuation|dose reduction		TRUE	7372
43901	6		Dysuria	grade 3			TRUE	7375
43902	3		Hematuria	grade 3			TRUE	7375
43903	100		Asphyxia	grade 5	discontinuation		TRUE	7370
43904	100		Hyponatraemia	grade 3	discontinuation		TRUE	7370
43905	25		Encephalopathy hepatic	grade 5	discontinuation		TRUE	7373
43906						No adverse effects leading to discontinuation were reported.		7377
43907			Musculoskeletal pain	grade 1-2				7376
43908			Headaches					7376
43909			Sinus tachycardia					7376
43910			Heart rate high					7376
43911	1 pts		Alanine aminotransferase increased	serious				7378
43912	1 pts		Aspartate aminotransferase increased	serious				7378
43913	1 pts		Gamma-glutamyltransferase increased	serious				7378
43914	1 pts		Diabetic ketoacidosis	serious				7378
43915	1 pts		Nephrolithiasis	serious				7378
43916	1 pts		Crohn's disease	serious				7379
43917	1 pts		Tonsillitis	serious				7379
43918	1 pts		Abortion	serious				7379
43919	1 pts		Depression	serious				7379
43920	3.1		Nausea					7381
43921	0.8		Vulvovaginal mycotic infection					7381
43922	0.6		Vulvovaginal candidiasis					7381
43923	3.1		Headache					7382
43924	2.8		Nasopharyngitis					7382
43925	1.6		Upper respiratory tract infection					7382
43926	1.2		Blood creatine phosphokinase increased					7382
43927	1		Diarrhea					7382
43928	1		Oropharyngeal pain					7382
43929						No AEs are reported		7380
43930	3 pts		Acne		discontinuation	leads to discontinuation		7383
43931	3 pts		Urticaria		discontinuation	leads to discontinuation		7383
43932			Nausea					7384
43933			Vomiting					7384
43934			Dyspepsia					7384
43935			Headache					7384
43936			Decreased appetite					7384
43937			Nausea					7385
43938			Vomiting					7385
43939			Dyspepsia					7385
43940			Headache					7385
43941			Decreased appetite					7385
43942			Gastrointestinal disorder (NOS)		discontinuation			7388
43943	57.4		Nausea					7388
43944	27.7		Vomiting					7388
43945	23.4		Diarrhea					7388
43946	12.8		Dyspepsia					7388
43947	6.4		Constipation					7388
43948	6.4		Nasopharyngitis					7388
43949	4.3		Gastroenteritis					7388
43950	4.3		Urinary tract infection					7388
43951	12.8		Fatigue					7388
43952	10.6		Asthenia					7388
43953	31.9		Anorexia					7388
43954	17		Decreased appetite					7388
43955	8.5		Musculoskeletal and connective tissue disorders					7388
43956	2.1		Hypertension					7388
43957	8.5		Injury, poisoning and procedural complications					7388
43958	2.1		Skin and subcutaneous tissue disorders					7388
43959	2.1		Respiratory, thoracic and mediastinal disorders					7388
43960	2.1		Cardiac disorders					7388
43961	2.1		Psychiatric disorders					7388
43962						AEs not reported		7387
43963						AEs not reported		7389
43964	12.5		Lipase increased		discontinuation			7390
43965	6.25		Decreased appetite		discontinuation			7390
43966	6.25		Nausea		discontinuation			7390
43967	3.1		Vomiting		discontinuation			7390
43968	46.9		Nausea					7390
43969	40.6		Vomiting					7390
43970	43.8		Eructation					7390
43971	28.1		Abdominal pain					7390
43972	12.5		Diarrhoea					7390
43973	21.9		Abdominal distension					7390
43974	31.3		Dyspepsia					7390
43975	15.6		Abdominal discomfort					7390
43976	12.5		Flatulence					7390
43977	9.4		Abdominal pain upper					7390
43978	9.4		Infrequent bowel movements					7390
43979	12.5		Toothache					7390
43980	78.1		Decreased appetite					7390
43981	31.3		Nasopharyngitis					7390
43982	37.5		Headache					7390
43983	25		Fatigue					7390
43984	9.4		Asthenia					7390
43985	21.9		Lipase increased					7390
43986	9.1		Lipase increased		discontinuation			7391
43987	9.1		Vomiting		discontinuation			7391
43988	9.1		Aortic aneurysm		discontinuation			7391
43989	54.5		Nausea					7391
43990	45.5		Vomiting					7391
43991	27.3		Eructation					7391
43992	18.2		Diarrhoea					7391
43993	9.1		Abdominal distension					7391
43994	36.4		Dyspepsia					7391
43995	27.3		Abdominal discomfort					7391
43996	9.1		Flatulence					7391
43997	9.1		Abdominal pain upper					7391
43998	90.9		Decreased appetite					7391
43999	18.2		Nasopharyngitis					7391
44000	36.4		Headache					7391
44001	18.2		Fatigue					7391
44002			Nausea		discontinuation			7392
44003			Diarrhea		discontinuation			7392
44004			Vomiting		discontinuation			7392
44005			Constipation		discontinuation			7392
44006			Abdominal pain		discontinuation			7392
44007			Thyroid tumor			PRECLINICAL WARNING		7393
44008	2.9		Nausea		discontinuation			7386
44009	1.7		Vomiting		discontinuation			7386
44010	0.9		Diarrhea		discontinuation			7386
44011	0.6		Abdominal pain		discontinuation			7386
44012	0.5		Abdominal pain upper		discontinuation			7386
44013	0.4		Abdominal discomfort		discontinuation			7386
44014	0.3		Dyspepsia		discontinuation			7386
44015	0.3		Constipation		discontinuation			7386
44016	0.3		Abdominal distension		discontinuation			7386
44017	0.2		Gastritis		discontinuation			7386
44018	0.2		GERD		discontinuation			7386
44019	0.2		Pancreatitis acute		discontinuation			7386
44020	0.7		Decreased appetite		discontinuation			7386
44021	0.3		Weight decreased		discontinuation			7386
44022	0.2		Lipase increased		discontinuation			7386
44023	0.2		Asthenia		discontinuation			7386
44024	1 pts		Leukopenia	serious				7397
44025	1 pts		Thrombocytopenia	serious				7397
44026	1 pts		Acute coronary syndrome	serious				7397
44027	1 pts		Atrial fibrillation	serious				7397
44028	2 pts		Atrioventricular block second degree	serious				7397
44029	3 pts		Bradycardia	serious				7397
44030	1 pts		Bundle branch block left	serious				7397
44031	1 pts		Myocardial ischaemia	serious				7397
44032	1 pts		Palpitations	serious				7397
44033	1 pts		Sinus tachycardia	serious				7397
44034	1 pts		Blindness	serious				7397
44035	3 pts		Macular oedema	serious				7397
44036	1 pts		Gastritis erosive	serious				7397
44037	1 pts		Incarcerated inguinal hernia	serious				7397
44038	1 pts		Hernia inguinal	serious				7397
44039	1 pts		Nausea	serious				7397
44040	1 pts		Umbilical hernia, obstructive	serious				7397
44041	1 pts		Vomiting	serious				7397
44042	2 pts		Asthenia	serious				7397
44043	1 pts		Fatigue	serious				7397
44044	2 pts		Pyrexia	serious				7397
44045	1 pts		Biliary colic	serious				7397
44046	1 pts		Cholecystitis	serious				7397
44047	1 pts		Cholecystitis acute	serious				7397
44048	1 pts		Cholelithiasis	serious				7397
44049	1 pts		Hepatotoxicity	serious				7397
44050	1 pts		Hypersensitivity	serious				7397
44051	1 pts		Appendiceal abscess	serious				7397
44052	3 pts		Appendicitis	serious				7397
44053	1 pts		Bacteraemia	serious				7397
44054	2 pts		Cellulitis	serious				7397
44055	1 pts		Chorioretinitis	serious				7397
44056	1 pts		Diverticulitis	serious				7397
44057	1 pts		Escherichia urinary tract infection	serious				7397
44058	1 pts		Hepatitis E	serious				7397
44059	1 pts		Herpes zoster	serious				7397
44060	1 pts		Herpes zoster meningitis	serious				7397
44061	1 pts		Labyrinthitis	serious				7397
44062	1 pts		Nasal abscess	serious				7397
44063	1 pts		Oral viral infection	serious				7397
44064	1 pts		Pyelonephritis chronic	serious				7397
44065	1 pts		Chronic pyelonephritis	serious				7397
44066	1 pts		Sepsis	serious				7397
44067	2 pts		Septic shock	serious				7397
44068	3 pts		Upper respiratory tract infection	serious				7397
44069	15 pts		Urinary tract infection	serious				7397
44070	5 pts		Urosepsis	serious				7397
44071	2 pts		Ankle fracture	serious				7397
44072	1 pts		Cervical vertebral fracture	serious				7397
44073	2 pts		Clavicle fracture	serious				7397
44074	5 pts		Concussion	serious				7397
44075	1 pts		Contusion	serious				7397
44076	1 pts		Eye contusion	serious				7397
44077	2 pts		Fall	serious				7397
44078	3 pts		Femoral neck fracture	serious				7397
44079	1 pts		Fracture displacement	serious				7397
44080	1 pts		Injury corneal	serious				7397
44081	4 pts		Laceration	serious				7397
44082	1 pts		Radius fracture	serious				7397
44083	1 pts		Fracture rib	serious				7397
44084	1 pts		Spinal compression fracture	serious				7397
44085	1 pts		Splenic rupture	serious				7397
44086	1 pts		Subdural haematoma	serious				7397
44087	1 pts		Thermal burn	serious				7397
44088	1 pts		Traumatic fracture	serious				7397
44089	1 pts		Traumatic haemorrhage	serious				7397
44090	1 pts		Traumatic haemothorax	serious				7397
44091	1 pts		Traumatic liver injury	serious				7397
44092	10 pts		Alanine aminotransferase increased	serious				7397
44093	5 pts		Aspartate aminotransferase increased	serious				7397
44094	2 pts		Blood bilirubin increased	serious				7397
44095	1 pts		Blood glucose increased	serious				7397
44096	1 pts		Carbon monoxide diffusing capacity decreased	serious				7397
44097	2 pts		Columbia suicide severity rating scale abnormal	serious				7397
44098	1 pts		Heart rate decreased	serious				7397
44099	1 pts		Hepatic enzyme abnormal	serious				7397
44100	1 pts		Hepatic enzyme increased	serious				7397
44101	1 pts		Pulmonary function test decreased	serious				7397
44102	1 pts		Walking distance test abnormal	serious				7397
44103	1 pts		Weight decreased	serious				7397
44104	2 pts		Dehydration	serious				7397
44105	1 pts		Haemochromatosis	serious				7397
44106	1 pts		Arthralgia	serious				7397
44107	1 pts		Arthritis	serious				7397
44108	1 pts		Back pain	serious				7397
44109	1 pts		Bursitis	serious				7397
44110	1 pts		Foot deformity	serious				7397
44111	1 pts		Lumbar spinal stenosis	serious				7397
44112	3 pts		Muscular weakness	serious				7397
44113	1 pts		Musculoskeletal pain	serious				7397
44114	1 pts		Osteoarthritis	serious				7397
44115	1 pts		Spinal deformity	serious				7397
44116	1 pts		Synovial cyst	serious				7397
44117	1 pts		Benign neoplasm of thyroid gland	serious				7397
44118	1 pts		Colon cancer stage IV	serious				7397
44119	1 pts		Endometrial cancer	serious				7397
44120	1 pts		Gastrointestinal melanoma	serious				7397
44121	1 pts		Lip squamous cell carcinoma	serious				7397
44122	1 pts		Lung adenocarcinoma metastatic	serious				7397
44123	2 pts		Malignant melanoma in situ	serious				7397
44124	1 pts		Melanocytic naevus	serious				7397
44125	1 pts		Neurofibroma	serious				7397
44126	2 pts		Seminoma	serious				7397
44127	1 pts		Squamous cell carcinoma	serious				7397
44128	1 pts		Aphasia	serious				7397
44129	1 pts		Ataxia	serious				7397
44130	1 pts		Brain injury	serious				7397
44131	1 pts		Brain stem infarction	serious				7397
44132	1 pts		Disturbance in attention	serious				7397
44133	1 pts		Dizziness	serious				7397
44134	5 pts		Epilepsy	serious				7397
44135	1 pts		Generalised tonic-clonic seizure	serious				7397
44136	1 pts		Head titubation	serious				7397
44137	3 pts		Hemiparesis	serious				7397
44138	1 pts		Intention tremor	serious				7397
44139	1 pts		Intracranial aneurysm	serious				7397
44140	1 pts		Ischaemic stroke	serious				7397
44141	2 pts		Multiple sclerosis	serious				7397
44142	2 pts		Partial seizures	serious				7397
44143	1 pts		Polyneuropathy	serious				7397
44144	1 pts		Radiculopathy	serious				7397
44145	4 pts		Seizure	serious				7397
44146	1 pts		Status migrainosus	serious				7397
44147	1 pts		Subarachnoid haematoma	serious				7397
44148	4 pts		Syncope	serious				7397
44149	3 pts		Trigeminal neuralgia	serious				7397
44150	1 pts		Abortion spontaneous	serious				7397
44151	1 pts		Anxiety	serious				7397
44152	1 pts		Anxiety disorder due to a general medical condition	serious				7397
44153	1 pts		Completed suicide	serious				7397
44154	1 pts		Depressed mood	serious				7397
44155	5 pts		Depression	serious				7397
44156	1 pts		Depression suicidal	serious				7397
44157	1 pts		Depressive symptom	serious				7397
44158	1 pts		Euphoric mood	serious				7397
44159	1 pts		Hallucination	serious				7397
44160	1 pts		Mania	serious				7397
44161	1 pts		Mental status changes	serious				7397
44162	1 pts		Psychotic disorder	serious				7397
44163	3 pts		Suicidal behaviour	serious				7397
44164	3 pts		Suicidal ideation	serious				7397
44165	1 pts		Acute kidney injury	serious				7397
44166	2 pts		Bladder dysfunction	serious				7397
44167	1 pts		Calculus bladder	serious				7397
44168	1 pts		Bladder calculus	serious				7397
44169	1 pts		Bladder neurogenic	serious				7397
44170	1 pts		Single functional kidney	serious				7397
44171	1 pts		Ureterolithiasis	serious				7397
44172	1 pts		Urethral stenosis	serious				7397
44173	1 pts		Urge incontinence	serious				7397
44174	2 pts		Urinary incontinence	serious				7397
44175	2 pts		Menorrhagia	serious				7397
44176	1 pts		Disorder ovarian	serious				7397
44177	1 pts		Aspiration pneumonia	serious				7397
44178	1 pts		Pulmonary hypertension	serious				7397
44179	1 pts		Respiratory depression	serious				7397
44180	1 pts		Respiratory disorder	serious				7397
44181	1 pts		Rash	serious				7397
44182	1 pts		Rash papular	serious				7397
44183	1 pts		Immobile	serious				7397
44184	1 pts		Deep vein thrombosis	serious				7397
44185	1 pts		Haematoma	serious				7397
44186	1 pts		Hypertension	serious				7397
44187	1 pts		Orthostatic hypotension	serious				7397
44188	1 pts		Venous thrombosis limb	serious				7397
44189	69 pts		Diarrhoea	below serious				7397
44190	73 pts		Nausea	below serious				7397
44191	89 pts		Upper respiratory tract infection	below serious				7397
44192	126 pts		Fall	below serious				7397
44193	58 pts		Alanine aminotransferase increased	below serious				7397
44194	60 pts		Pain in extremity	below serious				7397
44195	74 pts		Dizziness	below serious				7397
44196	159 pts		Headache	below serious				7397
44197	114 pts		Hypertension	below serious				7397
44198	5.9		Feeling hot					7401
44199	5.9		Dizziness					7401
44200	5.9		Headache					7401
44201	5.9		Presyncope					7401
44202	5.9		Blurred vision					7401
44203	5.9		Dry lips					7401
44204	5.9		Nasopharyngitis					7401
44205	5.9		Vaginal discharge					7401
44206	10		Hypertension		discontinuation	leads to discontinuation		7398
44207	0.1		Headache		discontinuation	leads to discontinuation		7399
44208	0.9		Transaminases increased		discontinuation	leads to discontinuation		7399
44209	1		Macular edema		discontinuation	leads to discontinuation		7400
44210	0.5		ALT increased		discontinuation	leads to discontinuation		7400
44211	0.3		Bradycardia		discontinuation	leads to discontinuation		7400
44212	0.3		GGT increased		discontinuation	leads to discontinuation		7400
44213	0.3		AST increased		discontinuation	leads to discontinuation		7400
44214	0.3		Depression		discontinuation	leads to discontinuation		7400
44215	0.3		Dizziness		discontinuation	leads to discontinuation		7400
44216	0.3		Fatigue		discontinuation	leads to discontinuation		7400
44217	0.3		Pulmonary function test decreased		discontinuation	leads to discontinuation		7400
44218	0.2		Angina pectoris		discontinuation	leads to discontinuation		7400
44219	0.2		Edema peripheral		discontinuation	leads to discontinuation		7400
44220	0.2		Seminoma		discontinuation	leads to discontinuation		7400
44221	0.2		Uveitis		discontinuation	leads to discontinuation		7400
44222	0.1		Lymphopenia		discontinuation	leads to discontinuation		7400
44223	0.1		Urinary tract infection		discontinuation	leads to discontinuation		7400
44224	2		Macular edema		discontinuation	leads to discontinuation		7396
44225	2		ALT increased		discontinuation	leads to discontinuation		7396
44226	2		ALT increased		discontinuation	leads to discontinuation		7396
44227	2		AST increased		discontinuation	leads to discontinuation		7396
44228	4		Dizziness		discontinuation	leads to discontinuation		7396
44229	2		Edema peripheral		discontinuation	leads to discontinuation		7396
44230	2		Headache		discontinuation	leads to discontinuation		7396
44231	4		Lymphopenia		discontinuation	leads to discontinuation		7396
44232	32		Headache					7395
44233	12.1		Dizziness					7395
44234	5.5		Nausea					7395
44235	20.8		Headache					7394
44236	5.7		Dizziness					7394
44237	4.2		Nausea					7394
44238	1 pts		Thrombosis venous deep					7403
44239	1 pts		Sepsis					7403
44240	1 pts		Abdominal pain				TRUE	7402
44241	1 pts		Diarrhea	grade 3			TRUE	7417
44242	3 pts		Gastrointestinal bleeding	grade 3			TRUE	7404
44243	3 pts		Febrile neutropenia	grade 4			TRUE	7404
44244	3 pts		Pneumonia	grade 3			TRUE	7404
44245	3 pts		Pulmonary hemorrhage	grade 3			TRUE	7404
44246	2 pts		Neutropenia	grade 4				7407
44247	3 pts		Thrombocytopenia	grade 3				7407
44248	1 pts		Bilirubin elevated	grade 3	discontinuation	leads to discontinuation	TRUE	7407
44249	1 pts		Alopecia	grade 3				7407
44250	1 pts		Diarrhea	grade 3				7407
44251	1 pts		Hypoxia	grade 3				7406
44252	1 pts		Neutropenia	grade 4	discontinuation	leads to discontinuation	TRUE	7405
44253	1 pts		Gastrointestinal bleeding	grade 5	discontinuation	leads to discontinuation		7407
44254	1 pts		Thrombocytopenia	grade 3	discontinuation	leads to discontinuation		7407
44255	1 pts		Neutropenia	grade 4	discontinuation	leads to discontinuation		7407
44256	3 pts		Anemia					7408
44257	5 pts		Leukopenia					7408
44258	5 pts		Neutropenia	grade 4			TRUE	7408
44259	3 pts		Lymphopenia					7408
44260	3 pts		Thrombocytopenia	grade 4			TRUE	7408
44261	1 pts		Febrile neutropenia					7408
44262	4 pts		Hypophosphatemia					7408
44263	2 pts		Hypoalbuminemia					7408
44264	3 pts		Hypoxia					7408
44265	2 pts		Infection					7408
44266	1 pts		ALT increased					7408
44267	30 pts		Fatigue	grade 1-2				7409
44268	14 pts		Alopecia	grade 1-2				7409
44269	19 pts		Nausea	grade 1-2				7409
44270	22 pts		Diarrhea	grade 1-2				7409
44271	37 pts		Thrombocytopenia	grade 1-2				7409
44272	19 pts		Neutropenia	grade 1-2				7409
44273	2 pts		Cardiotoxicity	grade 3-4				7409
44274	5 pts		Diarrhea	grade 3-4				7409
44275	1 pts		Fatigue	grade 3-4				7409
44276	5 pts		Febrile neutropenia	grade 3-4				7409
44277	2 pts		Infection	grade 3-4				7409
44278	1 pts		Sensory neuropathy	grade 3-4				7409
44279	31 pts		Thrombocytopenia	grade 3-4				7409
44280	23 pts		Neutropenia	grade 3-4				7409
44281	1 pts		Hematotoxicity	grade 4-5			TRUE	7412
44282	3 pts		Hematotoxicity	grade 4-5			TRUE	7411
44283	1 pts		Hematotoxicity	grade 4-5			TRUE	7414
44284	6 pts		Hematotoxicity	grade 4-5			TRUE	7416
44285	1 pts		Hematotoxicity	grade 4-5			TRUE	7410
44286	5 pts		Hematotoxicity	grade 4-5			TRUE	7413
44287	18 pts		Hematotoxicity	grade 4-5			TRUE	7415
44288	1 pts		Abdominal pain		discontinuation	leads to dose reduction		7418
44289	1 pts		Shortness of breath		discontinuation	leads to dose reduction		7418
44290	4.3		Abdominal pain		discontinuation	leads to discontinuation		7420
44291	2.1		GGT increased		discontinuation	leads to discontinuation		7420
44292	10		Gastrointestinal disorders		discontinuation	leads to discontinuation		7421
44293	7.1		Gastrointestinal disorders		discontinuation	leads to discontinuation		7419
44294	2.9		Psychiatric disorders		discontinuation	leads to discontinuation		7421
44295	2.9		Infections and infestations		discontinuation	leads to discontinuation		7421
44296	1.4		Skin and subcutaneous tissue disorders		discontinuation	leads to discontinuation		7421
44297	1.4		Skin and subcutaneous tissue disorders		discontinuation	leads to discontinuation		7419
44298	1.4		Cardiac disorders		discontinuation	leads to discontinuation		7419
44299	1.4		Hepatobiliary disorders		discontinuation	leads to discontinuation		7421
44300	1.4		Metabolism and nutrition disorders		discontinuation	leads to discontinuation		7421
44301	1.4		Renal and urinary disorders		discontinuation	leads to discontinuation		7421
44302	1.4		Respiratory, thoracic and mediastinal disorders		discontinuation	leads to discontinuation		7421
44303	1.4		Vascular disorders		discontinuation	leads to discontinuation		7421
44304	15		Headache					7422
44305	9		Nausea					7423
44306	4		Sinus congestion					7423
44307	4		Dizziness					7423
44308	0.2		Transaminases increased		discontinuation	leads to discontinuation		7423
44309						No information on AEs is available		7424
44310	6.25		Confusion		discontinuation			7426
44311	6.25		Ataxia		discontinuation			7426
44312	5.6		Dizziness		discontinuation			7428
44313	5.6		Mental status changes		dose interruption			7428
44314	6		Dizziness	grade 3	discontinuation			7425
44315	4.2		Nausea		discontinuation			7427
44316	10.3		Dizziness		discontinuation			7427
44317	7.4		Fatigue		discontinuation			7427
44318	17 pts		Dyskinesia					7429
44319	5 pts		Nausea					7429
44320	8 pts		Dizziness					7429
44321	5 pts		Constipation					7429
44322	5 pts		Insomnia					7429
44323	3 pts		Fall					7429
44324	5 pts		Flushing					7429
44325	3 pts		Headache					7429
44326	3 pts		Creatine phosphokinase increased					7429
44327	1 pts		Urinary tract infection					7429
44328	4 pts		Sudden onset of sleep					7429
44329	2 pts		Back pain					7429
44330	6 pts		Dyskinesia		discontinuation	leads to discontinuation		7430
44331	5 pts		Insomnia		discontinuation	leads to discontinuation		7430
44332	4 pts		Headache		discontinuation	leads to discontinuation		7430
44333	4 pts		Abdominal pain		discontinuation	leads to discontinuation		7430
44334	4 pts		Nausea		discontinuation	leads to discontinuation		7430
44335						No information on AE is provided		7431
44336	13.9		Headache					7432
44337	11.4		Dyspepsia					7432
44338	10.9		Abdominal pain					7432
44339	10		Crohn's disease					7432
44340	9		Nausea					7432
44341	8.5		Vomiting					7432
44342	5		Arthralgia					7432
44343	5		Pyrexia					7432
44344	5		Fatigue					7432
44345	2.5		Oropharyngeal pain					7432
44346	9		Constipation	grade 3				7436
44347	18		Nausea	grade 3				7436
44348	9		Vomiting	grade 3				7436
44349	9		Sepsis	grade 3				7436
44350	63		Neutropenia	grade 4		heavily pretreated	TRUE	7436
44351	18		Dyspnea	grade 3				7436
44352	9		Thrombocytopenia	grade 4				7436
44353	12.5		Febrile neutropenia	grade 3		heavily pretreated	TRUE	7439
44354	50		Neutropenia	grade 3-4		heavily pretreated	TRUE	7439
44355	12.5		Pneumonia	grade 3				7439
44356	12.5		Influenza	grade 3				7439
44357	16.7		Neutropenia	grade 3				7434
44358	25		Pleural effusion	grade 3	dose interruption		TRUE	7438
44359	50		Neutropenia	grade 3			TRUE	7438
44360	80		Stomatitis	grade 3		evaluable patients	TRUE	7433
44361	8.3		Bowel obstruction					7437
44362	8.3		Stomatitis	grade 3			TRUE	7437
44363	30		Stomatitis	grade 3		evaluable patients	TRUE	7435
44364						At a dose of 1.1 mg/m(2)/d, four of nine patients had grade 4 neutropenia of brief duration, which was not dose limiting.		7445
44365	50		Thrombocytopenia	grade 3			TRUE	7443
44366						No adverse effects leading to discontinuation were reported; no DLTs		7442
44367	33.3		Anemia	grade 3			TRUE	7440
44368	33.3		Neutropenia	grade 4			TRUE	7440
44369	33.3		Thrombocytopenia	grade 4			TRUE	7440
44370			Neutropenia			Neutropenia was defined as the dose-limiting toxicity. Eight of 70 courses (11%) administered at or above the maximum tolerated dose were associated with dose-limiting neutropenia.	TRUE	7444
44371			Neutropenia	grade 4		50% of first courses administered at the highest two dose levels were associated with grade 4 neutropenia. Neutropenia was defined as the dose-limiting toxicity. Eight of 70 courses (11%) administered at or above the maximum tolerated dose were associated with dose-limiting neutropenia.	TRUE	7441
44372	7.3		Pruritus					7446
44373	2.4		Urticaria					7446
44374	2.4		Dry skin					7446
44375	2.4		Blister					7446
44376	2.4		Wound					7446
44377	4 pts		Neurotoxicity	grade 1				7452
44378	1 pts		Headache	grade 1				7452
44379	2 pts		Leukocyte count decreased	grade 1				7452
44380	1 pts		Platelet count decreased	grade 1				7452
44381	2 pts		Nausea	grade 1				7452
44382	1 pts		Nausea	grade 2				7452
44383	2 pts		Vomiting	grade 1				7452
44384	1 pts		Vomiting	grade 2				7452
44385	3 pts		Neurotoxicity	grade 1				7449
44386	1 pts		Headache	grade 2				7449
44387	2 pts		Neurotoxicity	grade 2				7449
44388	1 pts		Neurotoxicity	grade 3				7449
44389	1 pts		Leukocyte count decreased	grade 2				7449
44390	1 pts		Absolute neutrophil count	grade 2				7449
44391	1 pts		Platelet count decreased	grade 1				7449
44392	4 pts		Nausea	grade 1				7449
44393	2 pts		Nausea	grade 2				7449
44394	1 pts		Nausea	grade 3				7449
44395	4 pts		Vomiting	grade 1				7449
44396	1 pts		Vomiting	grade 2				7449
44397	6 pts		Neurotoxicity	grade 1				7450
44398	1 pts		Neurotoxicity	grade 2				7450
44399	2 pts		Vision disorders	grade 3				7450
44400	2 pts		Leukocyte count decreased	grade 1				7450
44401	2 pts		Leukocyte count decreased	grade 2				7450
44402	3 pts		Absolute neutrophil count	grade 1				7450
44403	2 pts		Platelet count decreased	grade 1				7450
44404	1 pts		Nausea	grade 1				7450
44405	1 pts		Nausea	grade 2				7450
44406	1 pts		Vomiting	grade 2				7450
44407	3 pts		Anorexia	grade 1				7450
44408	6 pts		Neurotoxicity	grade 1			TRUE	7451
44409	2 pts		Neurotoxicity	grade 2			TRUE	7451
44410	1 pts		Neurotoxicity	grade 3			TRUE	7451
44411	2 pts		Headache	grade 1			TRUE	7451
44412	1 pts		Leukocyte count decreased	grade 1				7451
44413	1 pts		Leukocyte count decreased	grade 2				7451
44414	1 pts		Hemoglobin decreased	grade 2				7451
44415	4 pts		Nausea	grade 1				7451
44416	2 pts		Nausea	grade 2				7451
44417	3 pts		Vomiting	grade 1				7451
44418	1 pts		Anorexia	grade 1				7451
44419	1 pts		Motor polyneuropathy	grade 1				7448
44420	1 pts		Motor polyneuropathy	grade 3				7448
44421	5 pts		Neurotoxicity	grade 1				7448
44422	2 pts		Neurotoxicity	grade 2				7448
44423	1 pts		Neurotoxicity	grade 3				7448
44424	6 pts		WBC decreased	grade 1				7448
44425	2 pts		WBC decreased	grade 2				7448
44426	1 pts		Absolute neutrophil count	grade 1				7448
44427	1 pts		Absolute neutrophil count	grade 2				7448
44428	5 pts		Platelet count decreased	grade 1				7448
44429	1 pts		Platelet count decreased	grade 2				7448
44430	4 pts		Hemoglobin decreased	grade 2				7448
44431	1 pts		Hemoglobin decreased	grade 3				7448
44432	10 pts		Nausea	grade 1				7448
44433	4 pts		Nausea	grade 2				7448
44434	3 pts		Vomiting	grade 1				7448
44435	6 pts		Vomiting	grade 2				7448
44436	1 pts		Vomiting	grade 3				7448
44437	2 pts		Vomiting	grade 4				7448
44438	3 pts		Neurotoxicity	grade 3			TRUE	7447
44439	1 pts		Neurotoxicity	grade 1				7447
44440	1 pts		Nausea	grade 1				7447
44441	2 pts		Vomiting	grade 1				7447
44442	1		Drug eruption		discontinuation			7454
44443	0.4		Cardiac failure		discontinuation			7454
44444	0.4		Nausea		discontinuation			7454
44445	0.4		Rash		discontinuation			7454
44446	0.4		Generalized rash		discontinuation			7454
44447	0.4		Rash maculo-papular		discontinuation			7454
44448	0.4		Urticaria		discontinuation			7454
44449	0.2		Abdominal infection		discontinuation			7454
44450	0.2		Acne		discontinuation			7454
44451	0.2		ALT increased		discontinuation			7454
44452	0.2		Application site erythema		discontinuation			7454
44453	0.2		Ascites		discontinuation			7454
44454	0.2		AST increased		discontinuation			7454
44455	0.2		Blood alkaline phosphatase increased		discontinuation			7454
44456	0.2		Cough		discontinuation			7454
44457	0.2		Dermatitis allergic		discontinuation			7454
44458	0.2		Diarrhoea		discontinuation			7454
44459	0.2		Drug hypersensitivity		discontinuation			7454
44460	0.2		Dyspnoea		discontinuation			7454
44461	0.2		Oedema generalized		discontinuation			7454
44462	0.2		Hepatic enzyme increased		discontinuation			7454
44463	0.2		Hyperhidrosis		discontinuation			7454
44464	0.2		Hypokalaemia		discontinuation			7454
44465	0.2		Necrotizing fasciitis		discontinuation			7454
44466	0.2		Osteomyelitis		discontinuation			7454
44467	0.2		Osteomyelitis acute		discontinuation			7454
44468	0.2		Palpitations		discontinuation			7454
44469	0.2		Pleural effusion		discontinuation			7454
44470	0.2		Pneumonia		discontinuation			7454
44471	0.2		Pyrexia		discontinuation			7454
44472	0.2		Rash papular		discontinuation			7454
44473	0.2		Rash pruritic		discontinuation			7454
44474	0.2		Toxic epidermal necrolysis		discontinuation			7454
44475	0.2		Vomiting		discontinuation			7454
44476			Hypersensitivity	serious	discontinuation	WARNINGS		7456
44477			Diarrhea, Clostridium difficile		discontinuation	WARNINGS		7456
44478			Seroconversion test		discontinuation	WARNINGS		7456
44479	0.3		Hypersensitivity		discontinuation			7455
44480						No AEs indicated		7453
44481						No patients discontinued treatment due to side effects.		7458
44482	0.3		Hair color changes	grade 2	discontinuation	possibly related		7457
44483	6.2		Liver injury	grade 3	discontinuation		TRUE	7460
44484	66.7		Hand and foot skin reaction	grade 3	discontinuation		TRUE	7459
44485	33.3		Hand and foot skin reaction	grade 3	discontinuation		TRUE	7461
44486	33.3		Thrombocytopenia	grade 3	discontinuation		TRUE	7461
44487	16.7		Fatigue	grade 3	discontinuation		TRUE	7465
44488	11.9		Thrombocytopenia		dose interruption			7463
44489	11.9		Hand and foot skin reaction	grade 3	dose interruption			7463
44490	9.5		Hypertension	grade 3	dose interruption			7463
44491	2.4		Skin lesion		discontinuation			7463
44492	2.4		Chest pain	grade 3	discontinuation			7463
44493	2.4		Hemoptysis		discontinuation			7463
44494	2.4		Pancreatitis		discontinuation			7463
44495	2.4		Proteinuria		discontinuation			7463
44496	15		Hand and foot skin reaction	grade 3	dose interruption			7462
44497	0.4		Hypertension		discontinuation			7464
44498	1 pts		Chest pain	serious				7470
44499	1 pts		Transient ischaemic attack	serious				7470
44500	2 pts		Cough	below serious				7469
44501	2 pts		Back pain	below serious				7469
44502	1 pts		Rash	below serious				7469
44503	1 pts		COPD	below serious				7469
44504	2 pts		Fatigue	below serious				7469
44505	2 pts		Contusion	below serious				7469
44506	1 pts		Cough	below serious				7473
44507	1 pts		Rash	below serious				7473
44508	2 pts		Fatigue	below serious				7473
44509	2 pts		Nausea	below serious				7473
44510	1 pts		Contusion	below serious				7473
44511	2 pts		Rhinorrhoea	below serious				7473
44512	2 pts		Cough	below serious				7477
44513	1 pts		Back pain	below serious				7477
44514	3 pts		COPD	below serious				7477
44515	2 pts		Haematoma	below serious				7477
44516	2 pts		Cough	below serious				7466
44517	1 pts		Back pain	below serious				7466
44518	2 pts		Rash	below serious				7466
44519	1 pts		Nausea	below serious				7466
44520	1 pts		Rhinorrhoea	below serious				7466
44521	2 pts		Cough	below serious				7471
44522	1 pts		Back pain	below serious				7471
44523	2 pts		Cough	below serious				7476
44524	1 pts		Rash	below serious				7476
44525	1 pts		Supraventricular tachycardia	serious				7475
44526	3 pts		Dyspnea	below serious				7478
44527	1 pts		Back pain	below serious				7478
44528	1 pts		Angina unstable	serious				7467
44529	1 pts		Hypertension	serious				7467
44530	3 pts		Dyspnea	below serious				7467
44531	3 pts		Cough	below serious				7467
44532	2 pts		Back pain	below serious				7467
44533	1 pts		Intestinal obstruction	serious				7472
44534	5 pts		Headache	below serious				7472
44535	3 pts		Cough	below serious				7472
44536	1 pts		Back pain	below serious				7472
44537	2 pts		Oropharyngeal pain	below serious				7472
44538	1 pts		Blood pressure increased	below serious				7474
44539	1 pts		Chest discomfort	below serious				7474
44540	1 pts		COPD	below serious				7474
44541	2 pts		Contusion	below serious				7474
44542	1 pts		Dizziness	below serious				7474
44543	1 pts		Ear infection	below serious				7474
44544	1 pts		Eye swelling	below serious				7474
44545	1 pts		Oedema	below serious				7474
44546	1 pts		Oedema	below serious				7474
44547	2 pts		Headache	below serious				7474
44548	1 pts		Hypotension	below serious				7474
44549	1 pts		Muscle spasms	below serious				7474
44550	1 pts		Neck pain	below serious				7474
44551	1 pts		Rhonchi	below serious				7474
44552	1 pts		Tremor	below serious				7474
44553	1 pts		Basal cell carcinoma	below serious				7474
44554	1 pts		Eye contusion	below serious				7474
44555	1 pts		Furuncle	below serious				7474
44556	1 pts		Procedural pain	below serious				7474
44557	1 pts		Rash	below serious				7474
44558	1 pts		Sputum increased	below serious				7474
44559	1 pts		Chest pain	serious				7479
44560	1 pts		Acute myocardial infarction	serious				7479
44561	1 pts		Atrial fibrillation	serious				7479
44562	1 pts		Silent myocardial infarction	serious				7479
44563	1 pts		Upper gastrointestinal haemorrhage	serious				7479
44564	1 pts		Gastric volvulus	serious				7479
44565	1 pts		Cellulitis	serious				7479
44566	1 pts		Rheumatoid arthritis	serious				7479
44567	1 pts		Femur fracture	serious				7479
44568	1 pts		Panic attack	serious				7479
44569	7 pts		Headache	below serious				7479
44570	14 pts		Upper respiratory tract infection	below serious				7479
44571	7 pts		Nasopharyngitis	below serious				7479
44572	4 pts		Chronic obstructive pulmonary disease	serious				7468
44573	1 pts		Bronchiectasis	serious				7468
44574	1 pts		Hypoxia	serious				7468
44575	1 pts		Chest pain	serious				7468
44576	1 pts		Acute myocardial infarction	serious				7468
44577	1 pts		Upper gastrointestinal haemorrhage	serious				7468
44578	1 pts		Colon cancer	serious				7468
44579	1 pts		Squamous cell carcinoma	serious				7468
44580	1 pts		Pneumonia parainfluenzae viral	serious				7468
44581	1 pts		Migraine	serious				7468
44582	8 pts		Headache	below serious				7468
44583	6 pts		Nasopharyngitis	below serious				7468
44584	4		Cough					7480
44585	4		Nasopharyngitis					7480
44586	3		Upper respiratory tract infection					7480
44587	4		Headache					7480
44588	2		Back pain					7480
44589	1-2		Hypertension					7480
44590	1-2		Dizziness					7480
44591	1-2		Oropharyngeal pain					7480
44592	1-2		Bronchitis					7480
44593	0.5		Cough		discontinuation	leads to discontinuation		7481
44594	0.2		Bronchiectasis		discontinuation	leads to discontinuation		7481
44595	0.2		Bronchospasm paradoxical		discontinuation	leads to discontinuation		7481
44596	0.2		Hypoxia		discontinuation	leads to discontinuation		7481
44597	0.5		Bronchitis		discontinuation	leads to discontinuation		7481
44598	0.5		Pneumonia		discontinuation	leads to discontinuation		7481
44599	0.2		Gastroenteritis		discontinuation	leads to discontinuation		7481
44600	0.2		Upper respiratory tract infection		discontinuation	leads to discontinuation		7481
44601	0.2		Atypical pneumonia		discontinuation	leads to discontinuation		7481
44602	0.2		Pneumonia parainfluenzae viral		discontinuation	leads to discontinuation		7481
44603	0.2		Urinary tract infection		discontinuation	leads to discontinuation		7481
44604	0.2		Abdominal distension		discontinuation	leads to discontinuation		7481
44605	0.2		Dry mouth		discontinuation	leads to discontinuation		7481
44606	0.2		Oral pain		discontinuation	leads to discontinuation		7481
44607	0.2		Headache		discontinuation	leads to discontinuation		7481
44608	0.2		Acute myocardial infarction		discontinuation	leads to discontinuation		7481
44609	0.2		Colon cancer		discontinuation	leads to discontinuation		7481
44610	0.2		Hypertension		discontinuation	leads to discontinuation		7482
44611	14.3		Phlebitis		discontinuation			7483
44612	16.7		Atrial fibrillation		discontinuation			7487
44613	16.7		Vomiting		discontinuation			7486
44614	16.7		Intestinal bleeding		discontinuation			7486
44615	57.1		Bilirubin increased	grade 1			TRUE	7483
44616	42.8		GGT increased	grade 1			TRUE	7483
44617	42.8		Alkaline phosphatase increased	grade 1			TRUE	7483
44618	8.3		Seizure					7485
44619	16.7		Congestive heart failure					7485
44620	8.3		Hyperglycemia					7485
44621	8.3		Hypotension					7485
44622	25		Death					7485
44623	2.6		Acute hepatic failure	grade 5				7484
44624	2.6		Tachyarrhythmia	grade 5				7484
44625	7.9		Cardiac failure	grade 5				7484
44626	2.6		Hyperbilirubinaemia	grade 3-4				7484
44627	2.6		Retroperitoneal bleeding	grade 3-4				7484
44628	16		Pyrexia					7484
44629	16		Nausea					7484
44630	8		Constipation					7484
44631	13		Headaches					7484
44632	40		Phlebitis					7484
44633	11		Bradycardia					7484
44634	28		Bilirubin increased	grade 2				7484
44635	3		AST increased	grade 1				7484
44636	14		ALT increased	grade 1				7484
44637	27		GGT increased	grade 1				7484
44638	6		Glucose increased	grade 2				7484
44639			Hypertension		discontinuation			7488
44640						There were no serious AEs		7489
44641	53		Conjunctival hyperemia					7491
44642	20		Eye disorders NEC					7491
44643	5 - 10		Ocular signs and symptoms NEC					7491
44644						Twice a day dosing is not well tolerated		7490
44645						No adverse effects leading to discontinuation were reported; no DLTs		7493
44646	66.7		Dizziness					7492
44647	50		Diaphoresis					7492
44648	33.3		Lacrimation increased					7492
44649	66.7		Vomiting				TRUE	7492
44650	16.7		Nausea	grade 2				7492
44651	66.7		Nausea	grade 3			TRUE	7492
44652	20		Conjunctivitis		discontinuation			7495
44653			Loose stools	grade 1-2				7494
44654			Flatulence	grade 1-2				7494
44655			Bloating	grade 1-2				7494
44656	7 pts		Fatigue	grade 3			TRUE	7499
44657	2 pts		Fatigue	grade 3			TRUE	7496
44658	1 pts		Nausea	grade 2	discontinuation	leads to discontinuation	TRUE	7500
44659	70		Diarrhea	grade 1-2				7498
44660	20		Diarrhea	grade 3	discontinuation	leads to discontinuation		7498
44661	20		Diarrhea		discontinuation	leads to dose reduction		7498
44662	59		Nausea	grade 1-2				7498
44663	5		Nausea	grade 3				7498
44664	37		Abdominal pain	grade 1-2				7498
44665	2		Abdominal pain	grade 3				7498
44666	33		Vomiting	grade 1-2				7498
44667	2		Vomiting	grade 3				7498
44668	16		Constipation	grade 1-2				7498
44669	<1		Constipation	grade 3				7498
44670	14		Dry mouth	grade 1-2				7498
44671	14		Stomatitis	grade 1-2				7498
44672	26		Infection	grade 1-2				7498
44673	2		Infection	grade 5	discontinuation	leads to discontinuation		7498
44674	5		Stomatitis	grade 3				7498
44675	52		Asthenia	grade 1-2				7498
44676	52		Fatigue	grade 1-2				7498
44677	13		Asthenia	grade 3				7498
44678	13		Fatigue	grade 3				7498
44679	9		Fatigue		discontinuation	leads to dose reduction		7498
44680	11		Pyrexia	grade 1-2				7498
44681	13		Neutropenia	grade 1-2				7498
44682	19		Neutropenia	grade 3		Leads to dose interruption/dose reduction/delay		7498
44683	5		Neutropenia	grade 4		Leads to dose interruption/dose reduction/delay		7498
44684	13		Neutrophil count decreased	grade 1-2				7498
44685	19		Neutrophil count decreased	grade 3				7498
44686	5		Neutrophil count decreased	grade 4				7498
44687	20		Anemia	grade 1-2				7498
44688	20		Hematocrit decreased	grade 1-2				7498
44689	20		Hemoglobin decreased	grade 1-2				7498
44690	20		Red blood cell count decreased	grade 1-2				7498
44691	5		Anemia	grade 3				7498
44692	5		Hematocrit decreased	grade 3				7498
44693	5		Hemoglobin decreased	grade 3				7498
44694	5		Red blood cell count decreased	grade 3				7498
44695	16		Platelet count decreased	grade 1-2				7498
44696	16		Thrombocytopenia	grade 1-2				7498
44697	4		Platelet count decreased	grade 3				7498
44698	4		Thrombocytopenia	grade 3				7498
44699	11		Leukopenia	grade 1-2				7498
44700	11		White blood cell count decreased	grade 1-2				7498
44701	5		Leukopenia	grade 3				7498
44702	5		White blood cell count decreased	grade 3				7498
44703	<1		Leukopenia	grade 4				7498
44704	<1		White blood cell count decreased	grade 4				7498
44705	42		Decreased appetite	grade 1-2				7498
44706	3		Decreased appetite	grade 3				7498
44707	8		Dehydration	grade 1-2				7498
44708	2		Dehydration	grade 3				7498
44709	19		Cough	grade 1-2				7498
44710	15		Arthralgia	grade 1-2				7498
44711	20		Headache	grade 1-2				7498
44712	12		Dysgeusia	grade 1-2				7498
44713	11		Dizziness	grade 1-2				7498
44714	12		Alopecia	grade 1-2				7498
44715	12		Creatinine increased	grade 1-2				7498
44716	<1		Creatinine increased	grade 3				7498
44717	14		Weight decreased	grade 1-2				7498
44718	97		White blood cell decreased	grade 1-2				7498
44719	<1		White blood cell decreased	grade 3				7498
44720	63		Neutrophil count decreased	grade 1-2				7498
44721	28		Neutrophil count decreased	grade 3				7498
44722	68		Anemia	grade 1-2				7498
44723	28		Lymphocyte count decreased	grade 1-2				7498
44724	13		Lymphocyte count decreased	grade 3				7498
44725	<1		Lymphocyte count decreased	grade 4				7498
44726	28		ALT increased	grade 1-2				7498
44727	3		ALT increased	grade 3				7498
44728	26		AST increased	grade 1-2				7498
44729	4		AST increased	grade 3				7498
44730						No AEs are reported		7497
44731	2 pts		Maculopapular rash	grade 3			TRUE	7505
44732	1 pts		Conjunctivitis	grade 2			TRUE	7505
44733	1 pts		Tumor infection	grade 4			TRUE	7504
44734	4.2		Hyperglycemia	grade 3-4	discontinuation	ALPELISIB is a reason for the discontinuation		7503
44735	1.1		Rash	grade 3-4	discontinuation	ALPELISIB is a reason for the discontinuation		7503
44736	0.4		Diarrhea	grade 3-4	discontinuation	ALPELISIB is a reason for the discontinuation		7503
44737	1.1		Fatigue	grade 3-4	discontinuation	ALPELISIB is a reason for the discontinuation		7503
44738	0.4		Nausea	grade 3-4	discontinuation	ALPELISIB is a reason for the discontinuation		7503
44739	31.3		Hyperglycaemia	grade 3-4	discontinuation	leads to dose interruption/reduction. ALPELISIB is a reason for the dose modification		7503
44740	5.6		Diarrhoea	grade 3-4	discontinuation	leads to dose interruption/reduction. ALPELISIB is a reason for the dose modification		7503
44741	9.2		Rash	grade 3-4	discontinuation	leads to dose interruption/reduction. ALPELISIB is a reason for the dose modification		7503
44742	8.8		Rash maculo-papular	grade 3-4	discontinuation	leads to dose interruption/reduction. ALPELISIB is a reason for the dose modification		7503
44743	2.1		Stomatitis	grade 3-4	discontinuation	leads to dose interruption/reduction. ALPELISIB is a reason for the dose modification		7503
44744	1.4		Mucosal inflammation	grade 3-4	discontinuation	leads to dose interruption/reduction. ALPELISIB is a reason for the dose modification		7503
44745	1.4		Nausea	grade 3-4	discontinuation	leads to dose interruption/reduction. ALPELISIB is a reason for the dose modification		7503
44746	3.5		Lipase increased	grade 3-4	discontinuation	leads to dose interruption/reduction. ALPELISIB is a reason for the dose modification		7503
44747	0.7		Pyrexia	grade 3-4	discontinuation	leads to dose interruption/reduction. ALPELISIB is a reason for the dose modification		7503
44748	1.4		Fatigue	grade 3-4	discontinuation	leads to dose interruption/reduction. ALPELISIB is a reason for the dose modification		7503
44749	0.4		Pruritus	grade 3-4	discontinuation	leads to dose interruption/reduction. ALPELISIB is a reason for the dose modification		7503
44750	0.4		Vomiting	grade 3-4	discontinuation	leads to dose interruption/reduction. ALPELISIB is a reason for the dose modification		7503
44751	1.1		Asthenia	grade 3-4	discontinuation	leads to dose interruption/reduction. ALPELISIB is a reason for the dose modification		7503
44752	0.4		Decreased appetite	grade 3-4	discontinuation	leads to dose interruption/reduction. ALPELISIB is a reason for the dose modification		7503
44753	2.1		Alanine aminotransferase increased	grade 3-4	discontinuation	leads to dose interruption/reduction. ALPELISIB is a reason for the dose modification		7503
44754						No AEs are reported		7502
44755						No AEs are reported		7501
44756	2.9		Elevated liver enzyme levels		discontinuation			7506
44757	5 pts		Headache					7509
44758	3 pts		Nausea					7509
44759	2 pts		Vomiting					7509
44760	1 pts		Dizziness postural					7509
44761	1 pts		Earache					7509
44762						No information on AE is provided		7508
44763						No information on AE is provided		7507
44764	4 pts		Headache	below serious				7515
44765	2 pts		Nausea	below serious				7515
44766	1 pts		Acne	below serious				7515
44767	2 pts		Constipation	below serious				7515
44768	2 pts		Arthralgia	below serious				7515
44769	2 pts		Fall	below serious				7515
44770	2 pts		Paraesthesia	below serious				7515
44771	1 pts		Erosive oesophagitis	serious				7517
44772	1 pts		Thrombophlebitis	serious				7517
44773	3 pts		Headache	below serious				7517
44774	3 pts		Sinusitis	below serious				7517
44775	2 pts		Nausea	below serious				7517
44776	2 pts		Bronchitis	below serious				7517
44777	3 pts		Cough	below serious				7517
44778	2 pts		Insomnia	below serious				7517
44779	2 pts		Acne	below serious				7517
44780	2 pts		Cerumen impaction	below serious				7517
44781	1 pts		Fall	below serious				7517
44782	1 pts		Mouth ulceration	below serious				7517
44783	2 pts		Sinus congestion	below serious				7517
44784	3 pts		Headache	below serious				7511
44785	1 pts		Acne	below serious				7511
44786	2 pts		Back pain	below serious				7511
44787	1 pts		Arthralgia	below serious				7511
44788	1 pts		Cerumen impaction	below serious				7511
44789	2 pts		Mouth ulceration	below serious				7511
44790	2 pts		Influenza	below serious				7511
44791	2 pts		Dermatitis	below serious				7511
44792	1 pts		Lymphadenopathy	serious				7512
44793	1 pts		Angina pectoris	serious				7512
44794	1 pts		Volvulus	serious				7512
44795	1 pts		Pneumonia	serious				7512
44796	1 pts		Urinary tract infection	serious				7512
44797	1 pts		Joint dislocation	serious				7512
44798	1 pts		Migraine	serious				7512
44799	1 pts		Syncope	serious				7512
44800	1 pts		Abortion	serious				7513
44801	1 pts		Anxiety	serious				7512
44802	1 pts		Mental status changes	serious				7512
44803	1 pts		Cervical dysplasia	serious				7513
44804	1 pts		Hypertension	serious				7512
44805	6 pts		Pharyngitis	below serious				7512
44806	7 pts		Upper respiratory tract infection	below serious				7512
44807	10 pts		Viral upper respiratory tract infection	below serious				7512
44808	6 pts		Headache	below serious				7512
44809	1 pts		Diarrhoea	serious				7516
44810	1 pts		Gastric ulcer	serious				7516
44811	1 pts		Intestinal perforation	serious				7516
44812	1 pts		Nausea	serious				7516
44813	1 pts		Appendicitis	serious				7516
44814	1 pts		Diverticulitis	serious				7516
44815	1 pts		Influenza	serious				7516
44816	2 pts		Pneumonia	serious				7516
44817	1 pts		Urinary tract infection	serious				7516
44818	1 pts		Lipase increased	serious				7516
44819	1 pts		Osteonecrosis	serious				7516
44820	1 pts		Pain in extremity	serious				7516
44821	2 pts		Depression	serious				7516
44822	1 pts		Acute kidney injury	serious				7516
44823	1 pts		Deep vein thrombosis	serious				7516
44824	5 pts		Pharyngitis	below serious				7516
44825	8 pts		Upper respiratory tract infection	below serious				7516
44826	10 pts		Viral upper respiratory tract infection	below serious				7516
44827	3 pts		Headache	below serious				7516
44828	1 pts		Neutrophil count decreased	below serious				7514
44829	2 pts		Alanine aminotransferase increased	below serious				7510
44830	1 pts		Blood bilirubin increased	below serious				7510
44831	1 pts		Blood triglycerides increased	below serious				7510
44832	1 pts		Orthostatic hypotension	below serious				7510
44833						No AEs are reported		7519
44834						No AEs are reported		7518
44835			Pneumonia	serious|grade 5		WARNING		7520
44836			Systemic herpes zoster infection	serious|grade 5		WARNING		7520
44837			Urinary tract infection	serious|grade 5		WARNING		7520
44838			Venous thrombosis	serious|grade 5		WARNING		7520
44839			Pulmonary embolism	serious|grade 5		WARNING		7520
44840	1		Systemic herpes zoster infection		discontinuation	leads to discontinuation		7522
44841	1.6		Infestation		discontinuation	leads to discontinuation		7522
44842	0.2		Alanine aminotransferase increase		discontinuation	leads to discontinuation		7522
44843	1		Systemic herpes zoster infection		discontinuation	leads to discontinuation		7521
44844	0.6		Anemia		discontinuation	leads to discontinuation		7521
44845	85		Dermatitis acneiform	grade 1-2	discontinuation	leads to dose reduction/discontinuation		7524
44846	85		Acne	grade 1-2	discontinuation	leads to dose reduction/discontinuation		7524
44847	85		Skin exfoliation	grade 1-2	discontinuation	leads to dose reduction/discontinuation		7524
44848	2		Dermatitis acneiform	grade 3-4	discontinuation	leads to dose reduction/discontinuation		7524
44849	2		Acne	grade 3-4	discontinuation	leads to dose reduction/discontinuation		7524
44850	2		Skin exfoliation	grade 3-4	discontinuation	leads to dose reduction/discontinuation		7524
44851	51		Nausea	grade 1-2	discontinuation	leads to discontinuation		7524
44852	49		Vomiting	grade 1-2	discontinuation	leads to dose reduction		7524
44853	61		Diarrhoea	grade 1-2				7524
44854	51		Peripheral oedema	grade 1-2				7524
44855	39		Fatigue	grade 1-2	discontinuation	leads to dose reduction/discontinuation		7524
44856	2		Fatigue	grade 3-4	discontinuation	leads to dose reduction/discontinuation		7524
44857	12		Anaemia	grade 1-2				7524
44858	24		Anaemia	grade 3-4				7524
44859	17		Abdominal pain	grade 1-2				7524
44860	7		Abdominal pain	grade 3-4				7524
44861	20		Anorexia	grade 1-2				7524
44862	20		Constipation	grade 1-2				7524
44863	5		Constipation	grade 3-4				7524
44864	15		Dyspnoea	grade 1-2				7524
44865	2		Dyspnoea	grade 3-4				7524
44866	17		Pyrexia	grade 1-2				7524
44867	2		Pyrexia	grade 3-4				7524
44868	22		Dizziness	grade 1-2				7524
44869	1 pts		Pulmonary embolism	grade 4				7524
44870	1 pts		Generalised oedema	grade 4				7524
44871	25		Retinal deposits	grade 3-4				7523
44872	25		Retinopathy	grade 3-4				7523
44873	25		Papilloedema	grade 3-4				7523
44874	25		Chorioretinopathy	grade 3	discontinuation	leads to dose interruption/reduction	TRUE	7523
44875	25		Macular oedema	grade 3-4	discontinuation	leads to dose reduction		7523
44876	25		Retinal detachment	grade 3-4				7523
44877	25		Retinal disorder	grade 3-4				7523
44878	25		Dermatitis acneiform	grade 3	discontinuation	leads to dose interruption/reduction	TRUE	7523
44879	25		Acne	grade 3-4				7523
44880	25		Skin exfoliation	grade 3-4				7523
44881	25		Nausea	grade 1-2	discontinuation	leads to discontinuation		7523
44882	50		Vomiting	grade 1-2	discontinuation	leads to dose reduction		7523
44883	25		Diarrhoea	grade 1-2				7523
44884	50		Peripheral oedema	grade 1-2				7523
44885	25		Fatigue	grade 1-2	discontinuation	leads to dose reduction/discontinuation		7523
44886	25		Abdominal pain	grade 1-2				7523
44887	25		Anorexia	grade 1-2				7523
44888	25		Dyspnoea	grade 1-2				7523
44889	11		Retinal deposits	grade 1-2				7527
44890	11		Retinopathy	grade 1-2				7527
44891	11		Papilloedema	grade 1-2				7527
44892	11		Chorioretinopathy	grade 1-2	discontinuation	leads to dose reduction		7527
44893	11		Macular oedema	grade 1-2	discontinuation	leads to dose reduction		7527
44894	11		Retinal detachment	grade 1-2	discontinuation	leads to dose reduction		7527
44895	11		Retinal disorder	grade 1-2				7527
44896	75		Dermatitis acneiform	grade 1-2	discontinuation	leads to dose reduction/discontinuation		7527
44897	75		Acne	grade 1-2	discontinuation	leads to dose reduction/discontinuation		7527
44898	75		Skin exfoliation	grade 1-2	discontinuation	leads to dose reduction/discontinuation		7527
44899	2		Dermatitis acneiform	grade 3-4	discontinuation	leads to dose reduction/discontinuation		7527
44900	2		Acne	grade 3-4	discontinuation	leads to dose reduction/discontinuation		7527
44901	2		Skin exfoliation	grade 3-4	discontinuation	leads to dose reduction/discontinuation		7527
44902	61		Nausea	grade 1-2	discontinuation	leads to discontinuation		7527
44903	52		Vomiting	grade 1-2	discontinuation	leads to dose reduction		7527
44904	39		Diarrhoea	grade 1-2	discontinuation	leads to dose reduction		7527
44905	45		Peripheral oedema	grade 1-2				7527
44906	41		Fatigue	grade 1-2	discontinuation	leads to dose reduction/discontinuation		7527
44907	5		Fatigue	grade 3-4	discontinuation	leads to dose reduction/discontinuation		7527
44908	11		Anaemia	grade 1-2				7527
44909	7		Anaemia	grade 3-4				7527
44910	16		Abdominal pain	grade 1-2				7527
44911	2		Abdominal pain	grade 3-4				7527
44912	18		Anorexia	grade 1-2				7527
44913	14		Constipation	grade 1-2				7527
44914	11		Dyspnoea	grade 1-2				7527
44915	5		Dyspnoea	grade 3-4				7527
44916	16		Pyrexia	grade 1-2				7527
44917	11		Dizziness	grade 1-2				7527
44918	6		Left ventricular dysfunction		discontinuation	leads to dose interruption		7526
44919	5		Serous retinopathy		discontinuation	leads to dose interruption		7526
44920	3		Left ventricular dysfunction		discontinuation	leads to dose reduction		7526
44921	3		Serous retinopathy		discontinuation	leads to dose reduction		7526
44922	2		Colitis		discontinuation	leads to dose reduction		7526
44923	2		Hemorrhage		discontinuation	leads to discontinuation		7526
44924	1		Headache		discontinuation	leads to discontinuation		7526
44925	3		Fatigue	grade 3-4				7526
44926	4		Pyrexia	grade 3-4				7526
44927	1		Peripheral edema	grade 3-4				7526
44928	43		Fatigue	all grades				7526
44929	18		Pyrexia	all grades				7526
44930	13		Peripheral edema	all grades				7526
44931	2		Nausea	grade 3-4				7526
44932	3		Diarrhea	grade 3-4				7526
44933	2		Vomiting	grade 3-4				7526
44934	4		Abdominal pain	grade 3-4				7526
44935	41		Nausea	all grades				7526
44936	36		Diarrhea	all grades				7526
44937	30		Vomiting	all grades				7526
44938	28		Abdominal pain	all grades				7526
44939	22		Constipation	all grades				7526
44940	1		Rash	grade 3-4				7526
44941	22		Rash	all grades				7526
44942	3		Dizziness	grade 3-4				7526
44943	15		Dizziness	all grades				7526
44944	20		Visual impairment	all grades				7526
44945	3		Serous retinopathy	grade 3-4				7526
44946	20		Serous retinopathy	all grades				7526
44947	3		Hemorrhage	grade 3-4				7526
44948	19		Hemorrhage	all grades				7526
44949	6		Hypertension	grade 3-4				7526
44950	11		Hypertension	all grades				7526
44951	3.6		Anemia	grade 3-4				7526
44952	36		Anemia	all grades				7526
44953	13		Leukopenia	all grades				7526
44954	2.1		Lymphopenia	grade 3-4				7526
44955	13		Lymphopenia	all grades				7526
44956	3.1		Neutropenia	grade 3-4				7526
44957	13		Neutropenia	all grades				7526
44958	3.6		Creatinine increased	grade 3-4				7526
44959	93		Creatinine increased	all grades				7526
44960	5		Creatine phosphokinase increased	grade 3-4				7526
44961	58		Creatine phosphokinase increased	all grades				7526
44962	11		Gamma-glutamyltransferase increased	grade 3-4				7526
44963	45		Gamma-glutamyltransferase increased	all grades				7526
44964	6		ALT increased	grade 3-4				7526
44965	29		ALT increased	all grades				7526
44966	2.6		AST increased	grade 3-4				7526
44967	27		AST increased	all grades				7526
44968	0.5		Alkaline phosphatase increased	grade 3-4				7526
44969	21		Alkaline phosphatase increased	all grades				7526
44970	3.6		Hyponatremia	grade 3-4				7526
44971	18		Hyponatremia	all grades				7526
44972	27		Retinal deposits	grade 1-2	discontinuation	leads to dose reduction		7525
44973	27		Retinopathy	grade 1-2	discontinuation	leads to dose reduction		7525
44974	27		Papilloedema	grade 1-2				7525
44975	27		Chorioretinopathy	grade 1-2	discontinuation	leads to dose reduction		7525
44976	27		Macular oedema	grade 1-2	discontinuation	leads to dose reduction		7525
44977	27		Retinal detachment	grade 1-2	discontinuation	leads to dose reduction		7525
44978	27		Retinal disorder	grade 1-2				7525
44979	25		Mental status changes	grade 3			TRUE	7528
44980	25		Fatigue	grade 3			TRUE	7528
44981	25		Arterial hypertension	grade 3-4				7528
44982	5		Dizziness	grade 3-4				7529
44983	15		ALT increased	grade 3-4				7529
44984	5		AST increased	grade 3-4				7529
44985	15		Fatigue	grade 3-4				7529
44986	15		Arterial hypertension	grade 3-4				7529
44987	10		Diarrhea	grade 3-4				7529
44988	0.17		Cardio-respiratory arrest	grade 5	discontinuation	cardiorespiratory arrest/abdominal pain		7530
44989	0.17		Cerebral infarction	grade 5	discontinuation	depressed level of consciousness/cerebral infarction/cerebral hemorrhage		7530
44990	0.17		Hepatic failure	grade 5	discontinuation			7530
44991	0.17		Diarrhea	grade 5	discontinuation	diarrhea/vomiting		7530
44992	0.17		Upper gastrointestinal hemorrhage	grade 5	discontinuation			7530
44993	0.17		Asthenia	grade 5	discontinuation	asthenia/nausea		7530
44994	0.17		Cerebrovascular accident	grade 5	discontinuation			7530
44995	0.17		Hematemesis	grade 5	discontinuation			7530
44996	0.17		Gastrointestinal hemorrhage	grade 5	discontinuation			7530
44997	2		Skin disorder		dose reduction			7530
44998	5		Fatigue		discontinuation			7530
44999	2		Hyponatremia		discontinuation			7530
45000	2		Decreased appetite		discontinuation			7530
45001	2		Hyperbilirubinemia		discontinuation			7530
45002	3		Skin disorder		dose interruption			7530
45003	2		AST increased		discontinuation			7530
45004	1.8		Dyspnoea		discontinuation			7531
45005	0.17		Cerebral haemorrhage	grade 5	discontinuation	potentially drug toxicity		7531
45006	0.17		Intracranial haemorrhage	grade 5	discontinuation	potentially drug toxicity		7531
45007	0.17		Hypovolemic shock	grade 5	discontinuation	hypovolemic shock due to dissection of aortic aneurysm; potentially drug toxicity		7531
45008	0.17		Multi-organ failure	grade 5	discontinuation	potentially drug toxicity		7531
45009	0.17		Bowel perforation	grade 5	discontinuation	potentially drug toxicity		7531
45010	0.17		Pulmonary haemorrhage	grade 5	discontinuation	potentially drug toxicity		7531
45011	1.8		Vomiting		discontinuation			7531
45012	25		Rash	grade 3-4				7532
45013	50		Hyperglycemia	grade 3-4	discontinuation		TRUE	7532
45014	25		Diarrhea	grade 1-2				7532
45015	25		Anorexia	grade 1-2				7532
45016	75		Nausea	grade 1-2				7532
45017	25		Pruritus	grade 1-2				7532
45018	25		Altered mood	grade 1-2				7532
45019	25		Anxiety	grade 1-2				7532
45020	59		Rash	grade 1-4			TRUE	7533
45021	47		Hyperglycemia	grade 1-2				7533
45022	65		Diarrhea	grade 1-2				7533
45023	47		Anorexia	grade 1-2				7533
45024	24		Nausea	grade 1-2				7533
45025	29		Fatigue	grade 1-2				7533
45026	35		Pruritus	grade 1-4				7533
45027	29		Mucositis	grade 1-2				7533
45028	18		Altered mood	grade 1-4			TRUE	7533
45029	24		Anxiety	grade 1-2				7533
45030	6		Epigastralgia	grade 3			TRUE	7533
45031	50		Mood alteration NOS	grade 1-4			TRUE	7535
45032	32.7		Decreased appetite	grade 1-2				7534
45033	41.8		Diarrhea	grade 1-4				7534
45034	32.7		Nausea	grade 1-2				7534
45035	32.7		Hyperglycemia	grade 1-4				7534
45036	32.7		Rash	grade 1-4				7534
45037	23.6		Fatigue	grade 1-4				7534
45038	23.6		Stomatitis	grade 1-2				7534
45039	23.6		Asthenia	grade 1-4				7534
45040	20		Pruritus	grade 1-4				7534
45041	20		Anxiety	grade 1-4				7534
45042	21.8		Depression	grade 1-4				7534
45043	4.3		Asthenopia					7537
45044	19.6		Nausea					7537
45045	15.2		Vomiting				TRUE	7537
45046	10.9		Fatigue					7537
45047	4.3		Feeling hot					7537
45048	4.3		Gait disturbance					7537
45049	10.9		Dizziness					7537
45050	13		Headache					7537
45051	37		Somnolence					7537
45052	37		Euphoric mood					7537
45053	6.5		Pruritus					7537
45054	2.2		Elevated mood					7537
45055						No information on AE is provided		7536
45056	3 pts		Application site pain	moderate|severe	discontinuation	leads to discontinuation		7538
45057	1 pts		Impetigo	moderate	discontinuation	leads to discontinuation		7538
45058	2 pts		Application site urticaria	mild|moderate	discontinuation	leads to discontinuation		7538
45059	1 pts		Dermatitis atopic	severe	discontinuation	leads to discontinuation		7538
45060	1 pts		Application site irritation	mild	discontinuation	leads to discontinuation		7538
45061	1 pts		Application site rash	moderate				7538
45062						No adverse effects leading to discontinuation were recorded.		7540
45063						No patients discontinued treatment due to side effects.		7539
45064	6.7		Thrombocytopenia	grade 4				7542
45065	6.7		Leukopenia	grade 4				7542
45066	6.7		Neutropenia	grade 4				7542
45067	6.7		Diarrhea	grade 4				7542
45068	6.7		Vision blurred	grade 4				7542
45069	50		Neutropenic fever		dose reduction		TRUE	7544
45070	50		Neutropenia		dose reduction		TRUE	7544
45071	25		Pancytopenia				TRUE	7541
45072	25		Pneumonia				TRUE	7541
45073	25		Neutropenic fever				TRUE	7541
45074	6.7		Arterial hypotension				TRUE	7543
45075	6.7		Blood uric acid increased				TRUE	7543
45076	6.7		ALT increased				TRUE	7543
45077	13.3		AST increased				TRUE	7543
45078	33.3		Alkaline phosphatase serum increased	grade 3	discontinuation		TRUE	7548
45079	33.3		Anorexia	grade 3			TRUE	7548
45080	33.3		Fatigue	grade 3			TRUE	7548
45081						No adverse effects leading to discontinuation were reported; no DLTs		7545
45082			Alanine aminotransferase increase	grade 3-4				7547
45083	16.7		Thrombocytopenia	grade 3-4			TRUE	7546
45084	16.7		Deep vein thrombosis	grade 3-4	discontinuation			7546
45085	16.7		GGT increased					7546
45086	16.7		Alanine aminotransferase increased	grade 3-4			TRUE	7546
45087	25		WBC decreased	grade 3-4				7549
45088	25		Alanine aminotransferase increased	grade 3-4			TRUE	7549
45089	25		Neutropenia	grade 3-4			TRUE	7549
45090	50		Neutropenia	grade 3-4				7549
45091	25		Neutropenia	grade 3-4				7549
45092	1 pts		Cellulitis	grade 3			TRUE	7551
45093	1 pts		Neutropenia	grade 4			TRUE	7556
45094	1 pts		Alanine aminotransferase increase	grade 3			TRUE	7550
45095	1 pts		Aspartate aminotransferase increased	grade 3			TRUE	7550
45096	1 pts		Rash	grade 3			TRUE	7550
45097	33.3		Neutropenia	grade 3-4				7552
45098	40		ALT increased	grade 3-4				7552
45099	13.3		AST increased	grade 3-4				7552
45100	13.3		Anemia	grade 3				7552
45101	33.3		Diarrhea	grade 3				7552
45102	6.7		Pyrexia	grade 3				7552
45103	6.7		Nausea	grade 3				7552
45104	13.3		Rash maculo-papular	grade 3				7552
45105	13.3		Thrombocytopenia	grade 1-2				7552
45106	46.7		Fatigue	grade 1-2				7552
45107	46.7		Cough	grade 1-2				7552
45108	26.7		Headache	grade 1-2				7552
45109	26.7		Decreased appetite	grade 1-2				7552
45110	40		Dyspnoea	grade 1-2				7552
45111	26.7		Rash	grade 1-2				7552
45112	13.3		Upper respiratory tract infection	grade 1-2				7552
45113	6.7		Vomiting	grade 1-2				7552
45114	13.3		Chills	grade 1-2				7552
45115	26.7		Myalgia	grade 1-2				7552
45116	26.7		Edema peripheral	grade 1-2				7552
45117	20		Oropharyngeal pain	grade 1-2				7552
45118	26.7		Stomatitis	grade 1-2				7552
45119	31		Infection	grade 5|serious		WARNING		7555
45120	18		Diarrhea	grade 5|serious		WARNING		7555
45121	18		Colitis	grade 5|serious		WARNING		7555
45122	5		Epidermal and dermal conditions	grade 5|serious		WARNING		7555
45123	5		Pneumonitis	grade 5|serious		WARNING		7555
45124	36		Diarrhea		discontinuation	leads to discontinuation		7553
45125	36		Colitis		discontinuation	leads to discontinuation		7553
45126	36		Infection		discontinuation	leads to discontinuation		7553
45127	36		Rash		discontinuation	leads to discontinuation		7553
45128	29		Diarrhea		discontinuation	leads to dose reduction		7553
45129	29		Colitis		discontinuation	leads to dose reduction		7553
45130	29		Rash		discontinuation	leads to dose reduction		7553
45131	1		Transaminases increased		discontinuation	leads to discontinuation		7554
45132	1		Sepsis		discontinuation	leads to discontinuation		7554
45133	4		Transaminases increased		discontinuation	leads to dose reduction		7554
45134	3		Neutropenia		discontinuation	leads to dose reduction		7554
45135	2		Febrile neutropenia		discontinuation	leads to dose reduction		7554
45136	1		Lipase increased		discontinuation	leads to dose reduction		7554
45137	19		Diarrhea		discontinuation	leads to dose interruption		7554
45138	19		Colitis		discontinuation	leads to dose interruption		7554
45139	8		Rash		discontinuation	leads to dose interruption		7554
45140	10		Pneumonia		discontinuation	leads to dose interruption		7554
45141	8		Neutropenia		discontinuation	leads to dose interruption		7554
45142	6		Transaminases increased		discontinuation	leads to dose interruption		7554
45143	4		Pyrexia		discontinuation	leads to dose interruption		7554
45144	3		Anemia		discontinuation	leads to dose interruption		7554
45145	3		Febrile neutropenia		discontinuation	leads to dose interruption		7554
45146	3		Lipase increased		discontinuation	leads to dose interruption		7554
45147	3		Thrombocytopenia		discontinuation	leads to dose interruption		7554
45148						No AEs were observed		7558
45149	19.5		Constipation					7557
45150	9.8		Upper respiratory tract infection					7557
45151	4.9		Headache					7557
45152	7.3		Flu					7557
45153	7.3		Irritation skin					7557
45154	4.9		Fatigue					7557
45155	7.3		Insomnia					7557
45156	12.2		Stomachache					7557
45157	2.4		Irritability					7557
45158	4.9		Muscle spasm					7557
45159	4.9		Allergy					7557
45160	2.4		Abnormal dreams					7557
45161	13 pts		Fatigue	grade 3				7560
45162	7 pts		Rash	grade 3				7560
45163	6 pts		Dyspnea	grade 3				7560
45164	4 pts		Hypophosphatemia	grade 3				7560
45165	4 pts		Pleural effusion	grade 3				7560
45166	4 pts		Asthenia	grade 3				7560
45167	3 pts		Anemia	grade 3				7560
45168	3 pts		Dehydration	grade 3				7560
45169	3 pts		Dermatitis acneiform	grade 3				7560
45170	2 pts		Hypokalemia	grade 3				7560
45171	2 pts		Pneumonia	grade 3				7560
45172	3 pts		Syncope	grade 3				7560
45173	2 pts		Diarrhea	grade 3				7560
45174	1 pts		Hypophosphatemia	grade 4				7560
45175	1 pts		Pleural effusion	grade 4				7560
45176	1 pts		Hypokalemia	grade 4				7560
45177	1 pts		Pneumonia	grade 4				7560
45178	1 pts		Hypoxia	grade 4				7560
45179	7 pts		Fatigue	grade 3		leads to dose modification		7561
45180	3 pts		Nausea	grade 3	discontinuation	leads to discontinuation		7561
45181	8 pts		Neutropenia	grade 3		leads to dose modification		7561
45182	3 pts		Vomiting	grade 3	discontinuation	leads to discontinuation		7561
45183	1 pts		Anemia	grade 3				7561
45184	2 pts		Dyspnea	grade 3				7561
45185	1 pts		Thrombocytopenia	grade 3		leads to dose modification		7561
45186	1 pts		Pain	grade 3				7561
45187	1 pts		Arthralgia	grade 3				7561
45188	1 pts		Fatigue	grade 4				7561
45189	1 pts		Neutropenia	grade 4	discontinuation	leads to discontinuation		7561
45190	1 pts		Weakness of limbs		discontinuation	leads to discontinuation		7561
45191	1 pts		Hypoxia		discontinuation	leads to discontinuation		7561
45192	1 pts		Radiation pneumonitis		discontinuation	leads to discontinuation		7561
45193	1 pts		Fatigue		discontinuation	leads to discontinuation		7561
45194	1 pts		Mucositis		discontinuation	leads to discontinuation		7561
45195						No AEs were reported		7559
45196						No AEs are reported		7565
45197						No AEs are reported		7564
45198	0.06		Acute myocardial infarction	grade 5				7563
45199	0.18		Acute myocardial infarction	grade 5				7562
45200	0.17		Cardiac death	grade 5				7563
45201	0.06		Haemorrhagic stroke	grade 5				7562
45202	0.06		Ischaemic stroke	grade 5				7562
45203	0.06		Multiple organ dysfunction syndrome	grade 5				7563
45204	0.06		Septic shock	grade 5				7562
45205	0.06		Pneumonia	grade 5				7563
45206	0.06		Chronic obstructive pulmonary disease	grade 5				7563
45207	0.06		Depression	grade 5				7563
45208	0.06		Plasma cell myeloma	grade 5				7562
45209	0.3		Hyperglycaemia		discontinuation	leads to discontinuation		7567
45210	0.5		Hyperglycaemia		discontinuation	leads to discontinuation		7566
45211	0.1		Glomerular filtration rate decreased		discontinuation	leads to discontinuation		7567
45212	0.4		Glomerular filtration rate decreased		discontinuation	leads to discontinuation		7566
45213	0.3		Balanoposthitis		discontinuation	leads to discontinuation		7567
45214	0.1		Balanoposthitis		discontinuation	leads to discontinuation		7566
45215	0.1		Urinary tract infection		discontinuation	leads to discontinuation		7567
45216	0.2		Urinary tract infection		discontinuation	leads to discontinuation		7566
45217	0.2		Vulvovaginal mycotic infection		discontinuation	leads to discontinuation		7567
45218	0.1		Vulvovaginal mycotic infection		discontinuation	leads to discontinuation		7566
45219	0.1		Acute kidney injury		discontinuation	leads to discontinuation		7567
45220	0.1		Acute kidney injury		discontinuation	leads to discontinuation		7566
45221	0.1		Pollakiuria		discontinuation	leads to discontinuation		7567
45222	0.2		Pollakiuria		discontinuation	leads to discontinuation		7566
45223	0.1		Vulvovaginal pruritus		discontinuation	leads to discontinuation		7567
45224	0.1		Vulvovaginal pruritus		discontinuation	leads to discontinuation		7566
45225	0.1		Vulvovaginal candidiasis		discontinuation	leads to discontinuation		7567
45226	0.2		Vulvovaginal candidiasis		discontinuation	leads to discontinuation		7566
45227	0.1		Diarrhoea		discontinuation	leads to discontinuation		7567
45228	0.1		Diarrhoea		discontinuation	leads to discontinuation		7566
45229	0.2		Dizziness		discontinuation	leads to discontinuation		7567
45230	0.1		Nausea		discontinuation	leads to discontinuation		7567
45231	0.1		Nausea		discontinuation	leads to discontinuation		7566
45232	0.1		Weight decreased		discontinuation	leads to discontinuation		7567
45233	0.1		Weight decreased		discontinuation	leads to discontinuation		7566
45234	0.1		Abdominal pain upper		discontinuation	leads to discontinuation		7567
45235	0.1		Acute myocardial infarction		discontinuation	leads to discontinuation		7567
45236	0.1		Acute myocardial infarction		discontinuation	leads to discontinuation		7566
45237	0.1		Blood creatinine increased		discontinuation	leads to discontinuation		7567
45238	0.1		Blood creatinine increased		discontinuation	leads to discontinuation		7566
45239	0.1		Dysuria		discontinuation	leads to discontinuation		7567
45240	0.1		Dysuria		discontinuation	leads to discontinuation		7566
45241	0.1		Genital candidiasis		discontinuation	leads to discontinuation		7567
45242	0.1		Genital candidiasis		discontinuation	leads to discontinuation		7566
45243	0.1		Hypoglycaemia		discontinuation	leads to discontinuation		7567
45244	0.1		Hypoglycaemia		discontinuation	leads to discontinuation		7566
45245	0.1		Insomnia		discontinuation	leads to discontinuation		7567
45246	0.1		Insomnia		discontinuation	leads to discontinuation		7566
45247	0.1		Non-cardiac chest pain		discontinuation	leads to discontinuation		7567
45248	0.1		Non-cardiac chest pain		discontinuation	leads to discontinuation		7566
45249	0.1		Polyuria		discontinuation	leads to discontinuation		7567
45250	0.1		Polyuria		discontinuation	leads to discontinuation		7566
45251	0.1		Pruritus genital		discontinuation	leads to discontinuation		7567
45252	0.1		Pruritus genital		discontinuation	leads to discontinuation		7566
45253	0.1		Rash		discontinuation	leads to discontinuation		7567
45254	0.1		Rash		discontinuation	leads to discontinuation		7566
45255	0.1		Rheumatoid arthritis		discontinuation	leads to discontinuation		7567
45256	0.1		Incontinence urinary		discontinuation	leads to discontinuation		7566
45257	0.1		Abdominal pain		discontinuation	leads to discontinuation		7566
45258	0.1		Adenocarcinoma gastric		discontinuation	leads to discontinuation		7567
45259	0.1		Alanine aminotransferase increased		discontinuation	leads to discontinuation		7567
45260	0.1		Alopecia		discontinuation	leads to discontinuation		7566
45261	0.1		Arthralgia		discontinuation	leads to discontinuation		7566
45262	0.1		Aspartate aminotransferase increased		discontinuation	leads to discontinuation		7567
45263	0.1		Asthenia		discontinuation	leads to discontinuation		7567
45264	0.1		Asthma		discontinuation	leads to discontinuation		7566
45265	0.1		Benign ovarian tumor		discontinuation	leads to discontinuation		7566
45266	0.1		Blood glucose increased		discontinuation	leads to discontinuation		7567
45267	0.1		Breast cancer		discontinuation	leads to discontinuation		7567
45268	0.1		Cellulite		discontinuation	leads to discontinuation		7566
45269	0.1		Cerebral infarction		discontinuation	leads to discontinuation		7567
45270	0.1		Cerebrovascular accident		discontinuation	leads to discontinuation		7567
45271	0.1		Cholelithiasis		discontinuation	leads to discontinuation		7566
45272	0.1		Colon cancer		discontinuation	leads to discontinuation		7566
45273	0.1		Coronary artery disease		discontinuation	leads to discontinuation		7567
45274	0.1		Dermatitis allergic		discontinuation	leads to discontinuation		7566
45275	0.1		Diabetic foot		discontinuation	leads to discontinuation		7567
45276	0.1		Diabetic ketoacidosis		discontinuation	leads to discontinuation		7566
45277	0.1		Diabetic neuropathy		discontinuation	leads to discontinuation		7567
45278	0.1		Dry mouth		discontinuation	leads to discontinuation		7566
45279	0.1		Dyslipidaemia		discontinuation	leads to discontinuation		7567
45280	0.1		Dysphonia		discontinuation	leads to discontinuation		7566
45281	0.1		Endometrial adenocarcinoma		discontinuation	leads to discontinuation		7566
45282	0.1		Face injury		discontinuation	leads to discontinuation		7567
45283	0.1		Facial paralysis		discontinuation	leads to discontinuation		7567
45284	0.1		Fatigue		discontinuation	leads to discontinuation		7566
45285	0.1		Fungal skin infection		discontinuation	leads to discontinuation		7567
45286	0.1		Genital infection		discontinuation	leads to discontinuation		7567
45287	0.1		Haematuria		discontinuation	leads to discontinuation		7566
45288	0.1		Head discomfort		discontinuation	leads to discontinuation		7567
45289	0.1		Headache		discontinuation	leads to discontinuation		7566
45290	0.1		Hepatocellular injury		discontinuation	leads to discontinuation		7567
45291	0.1		Humerus fracture		discontinuation	leads to discontinuation		7567
45292	0.1		Hunger		discontinuation	leads to discontinuation		7567
45293	0.1		Hyperchlorhydria		discontinuation	leads to discontinuation		7567
45294	0.1		Jaundice cholestatic		discontinuation	leads to discontinuation		7566
45295	0.1		Liver disorder		discontinuation	leads to discontinuation		7566
45296	0.1		Malaise		discontinuation	leads to discontinuation		7566
45297	0.1		Metabolic acidosis		discontinuation	leads to discontinuation		7566
45298	0.1		Mood swings		discontinuation	leads to discontinuation		7566
45299	0.1		Musculoskeletal pain		discontinuation	leads to discontinuation		7567
45300	0.1		Myocardial infarction		discontinuation	leads to discontinuation		7567
45301	0.1		Nephropathy		discontinuation	leads to discontinuation		7567
45302	0.1		Nightmare		discontinuation	leads to discontinuation		7566
45303	0.1		Obesity		discontinuation	leads to discontinuation		7567
45304	0.1		Oral candidiasis		discontinuation	leads to discontinuation		7567
45305	0.1		Osteomyelitis acute		discontinuation	leads to discontinuation		7567
45306	0.1		Pain in extremity		discontinuation	leads to discontinuation		7567
45307	0.1		Pancreatic neoplasm		discontinuation	leads to discontinuation		7566
45308	0.1		Acute pancreatitis		discontinuation	leads to discontinuation		7567
45309	0.1		Penile pain		discontinuation	leads to discontinuation		7566
45310	0.1		Peripheral ischaemia		discontinuation	leads to discontinuation		7566
45311	0.1		Peripheral swelling		discontinuation	leads to discontinuation		7566
45312	0.1		Plasma cell myeloma		discontinuation	leads to discontinuation		7566
45313	0.1		Prurigo		discontinuation	leads to discontinuation		7566
45314	0.1		Pyelonephritis		discontinuation	leads to discontinuation		7567
45315	0.1		Pyelonephritis acute		discontinuation	leads to discontinuation		7567
45316	0.1		Rash maculo-papular		discontinuation	leads to discontinuation		7566
45317	0.1		Septic shock		discontinuation	leads to discontinuation		7566
45318	0.1		Thirst		discontinuation	leads to discontinuation		7567
45319	0.1		Urinary retention		discontinuation	leads to discontinuation		7567
45320	0.1		Urogenital infection fungal		discontinuation	leads to discontinuation		7567
45321	0.1		Vaginal infection		discontinuation	leads to discontinuation		7567
45322	0.1		Vision blurred		discontinuation	leads to discontinuation		7566
45323	0.1		Vulvovaginitis		discontinuation	leads to discontinuation		7566
45324	10 pts		Nausea		discontinuation			7568
45325	6 pts		Vomiting		discontinuation			7568
45326	9 pts		Vomiting		discontinuation			7568
45327						No clinically significant differences in adverse events were observed  between  control  subjects and those who received BMS-204352.		7569
45328	12.5		Taste disturbance		discontinuation	One subject discontinued early for amoderate taste disturbance after 2 min of a scheduled 5-min i.v.infusion, which caused the subject to have a moderate panic reaction.		7570
45329	33.3		Shortness of breath	grade 4			TRUE	7571
45330	33.3		Myocardial infarction	grade 3		acute reversible myocardial ischemia secondary to coronary artery vasospasm	TRUE	7571
45331	16.7		Weakness of limbs	grade 2			TRUE	7572
45332	100		Ataxia	grade 3-4			TRUE	7573
45333	50		Dizziness	grade 3-4			TRUE	7573
45334	100		Sensory neuropathy	grade 1-2			TRUE	7573
45335						No information on AE is provided		7575
45336						No information on AE is provided		7574
45337						No information on AE is provided		7577
45338			Nausea	grade 1-2				7576
45339			Diarrhea	grade 1-2				7576
45340			Fatigue	grade 1-2				7576
45341			Pruritis	grade 1-2				7576
45342	10		Gamma-glutamyltransferase increased					7578
45343	6		Alanine aminotransferase increased					7578
45344	4		Aspartate aminotransferase increased					7578
45345	1 pts		Lymphadenopathy	below serious				7588
45346	1 pts		Cardiovascular disorder	below serious				7588
45347	1 pts		Extrasystoles	below serious				7588
45348	8 pts		Vertigo	below serious				7588
45349	1 pts		Vision blurred	below serious				7588
45350	1 pts		Dyspepsia	below serious				7588
45351	1 pts		Hypoaesthesia oral	below serious				7588
45352	4 pts		Nausea	below serious				7588
45353	3 pts		Vomiting	below serious				7588
45354	3 pts		Asthenia	below serious				7588
45355	2 pts		Chest discomfort	below serious				7588
45356	10 pts		Fatigue	below serious				7588
45357	3 pts		Feeling cold	below serious				7588
45358	1 pts		Feeling hot	below serious				7588
45359	1 pts		Feeling of relaxation	below serious				7588
45360	2 pts		Malaise	below serious				7588
45361	1 pts		Pyrexia	below serious				7588
45362	1 pts		Thirst	below serious				7588
45363	1 pts		Arthralgia	below serious				7588
45364	2 pts		Limb discomfort	below serious				7588
45365	3 pts		Muscular weakness	below serious				7588
45366	1 pts		Musculoskeletal stiffness	below serious				7588
45367	1 pts		Ataxia	below serious				7588
45368	1 pts		Balance disorder	below serious				7588
45369	1 pts		Disturbance in attention	below serious				7588
45370	19 pts		Dizziness	below serious				7588
45371	1 pts		Dysaesthesia	below serious				7588
45372	1 pts		Fine motor delay	below serious				7588
45373	2 pts		Hypotonia	below serious				7588
45374	2 pts		Migraine	below serious				7588
45375	2 pts		Sedation	below serious				7588
45376	8 pts		Somnolence	below serious				7588
45377	3 pts		Tremor	below serious				7588
45378	1 pts		Euphoric mood	below serious				7588
45379	1 pts		Restlessness	below serious				7588
45380	1 pts		Polyuria	below serious				7588
45381	1 pts		Rash pruritic	below serious				7588
45382	2 pts		Palpitations	below serious				7580
45383	2 pts		Tinnitus	below serious				7580
45384	12 pts		Vertigo	below serious				7580
45385	1 pts		Halo vision	below serious				7580
45386	2 pts		Visual impairment	below serious				7580
45387	1 pts		Diarrhoea	below serious				7580
45388	1 pts		Hypoaesthesia oral	below serious				7580
45389	8 pts		Nausea	below serious				7580
45390	2 pts		Vomiting	below serious				7580
45391	7 pts		Asthenia	below serious				7580
45392	2 pts		Chest discomfort	below serious				7580
45393	17 pts		Fatigue	below serious				7580
45394	1 pts		Feeling abnormal	below serious				7580
45395	4 pts		Feeling cold	below serious				7580
45396	1 pts		Feeling hot	below serious				7580
45397	1 pts		Feeling of body temperature change	below serious				7580
45398	1 pts		Feeling of relaxation	below serious				7580
45399	1 pts		Gait disturbance	below serious				7580
45400	1 pts		Malaise	below serious				7580
45401	1 pts		Pyrexia	below serious				7580
45402	1 pts		Sensation of blood flow	below serious				7580
45403	1 pts		Thirst	below serious				7580
45404	1 pts		Gastroenteritis	below serious				7580
45405	1 pts		Herpes zoster	below serious				7580
45406	2 pts		Limb discomfort	below serious				7580
45407	5 pts		Muscular weakness	below serious				7580
45408	1 pts		Ataxia	below serious				7580
45409	1 pts		Balance disorder	below serious				7580
45410	1 pts		Coordination abnormal	below serious				7580
45411	3 pts		Disturbance in attention	below serious				7580
45412	21 pts		Dizziness	below serious				7580
45413	1 pts		Dysgeusia	below serious				7580
45414	1 pts		Head discomfort	below serious				7580
45415	1 pts		Headache	below serious				7580
45416	1 pts		Hypertonia	below serious				7580
45417	3 pts		Hypoaesthesia	below serious				7580
45418	9 pts		Paraesthesia	below serious				7580
45419	1 pts		Slow response to stimuli	below serious				7580
45420	10 pts		Somnolence	below serious				7580
45421	2 pts		Tremor	below serious				7580
45422	2 pts		Depressed mood	below serious				7580
45423	1 pts		Derealisation	below serious				7580
45424	1 pts		Insomnia	below serious				7580
45425	1 pts		Nervousness	below serious				7580
45426	1 pts		Hyperhidrosis	below serious				7580
45427	1 pts		Pruritus	below serious				7580
45428	2 pts		Flushing	below serious				7580
45429	1 pts		Peripheral coldness	below serious				7580
45430	1 pts		Dizziness	serious				7584
45431	1 pts		Cardiovascular disorder	below serious				7584
45432	1 pts		Tachycardia	below serious				7584
45433	12 pts		Vertigo	below serious				7584
45434	3 pts		Vision blurred	below serious				7584
45435	1 pts		Visual impairment	below serious				7584
45436	1 pts		Abdominal discomfort	below serious				7584
45437	2 pts		Abdominal pain upper	below serious				7584
45438	2 pts		Nausea	below serious				7584
45439	1 pts		Paraesthesia oral	below serious				7584
45440	1 pts		Vomiting	below serious				7584
45441	2 pts		Asthenia	below serious				7584
45442	1 pts		Chills	below serious				7584
45443	4 pts		Discomfort	below serious				7584
45444	15 pts		Fatigue	below serious				7584
45445	1 pts		Feeling abnormal	below serious				7584
45446	2 pts		Feeling cold	below serious				7584
45447	2 pts		Feeling hot	below serious				7584
45448	2 pts		Gait disturbance	below serious				7584
45449	1 pts		Malaise	below serious				7584
45450	1 pts		Blood pressure increased	below serious				7584
45451	1 pts		Cardiac murmur	below serious				7584
45452	1 pts		Transaminases increased	below serious				7584
45453	3 pts		Limb discomfort	below serious				7584
45454	1 pts		Muscle twitching	below serious				7584
45455	4 pts		Muscular weakness	below serious				7584
45456	3 pts		Balance disorder	below serious				7584
45457	1 pts		Disturbance in attention	below serious				7584
45458	26 pts		Dizziness	below serious				7584
45459	1 pts		Dizziness postural	below serious				7584
45460	1 pts		Dysaesthesia	below serious				7584
45461	5 pts		Hypoaesthesia	below serious				7584
45462	2 pts		Lethargy	below serious				7584
45463	12 pts		Paraesthesia	below serious				7584
45464	1 pts		Presyncope	below serious				7584
45465	8 pts		Somnolence	below serious				7584
45466	1 pts		Speech disorder	below serious				7584
45467	1 pts		Agitation	below serious				7584
45468	1 pts		Anxiety	below serious				7584
45469	1 pts		Hallucination, visual	below serious				7584
45470	1 pts		Insomnia	below serious				7584
45471	1 pts		Nervousness	below serious				7584
45472	1 pts		Restlessness	below serious				7584
45473	1 pts		Dyspnoea	below serious				7584
45474	1 pts		Flushing	below serious				7584
45475	1 pts		Hypertension	below serious				7584
45476	3 pts		Tachycardia	below serious				7586
45477	1 pts		Tinnitus	below serious				7586
45478	16 pts		Vertigo	below serious				7586
45479	1 pts		Diplopia	below serious				7586
45480	2 pts		Vision blurred	below serious				7586
45481	2 pts		Visual impairment	below serious				7586
45482	1 pts		Diarrhoea	below serious				7586
45483	3 pts		Dry mouth	below serious				7586
45484	2 pts		Dyspepsia	below serious				7586
45485	1 pts		Epigastric discomfort	below serious				7586
45486	1 pts		Hypoaesthesia oral	below serious				7586
45487	5 pts		Nausea	below serious				7586
45488	1 pts		Paraesthesia oral	below serious				7586
45489	1 pts		Vomiting	below serious				7586
45490	4 pts		Asthenia	below serious				7586
45491	1 pts		Chest discomfort	below serious				7586
45492	4 pts		Discomfort	below serious				7586
45493	16 pts		Fatigue	below serious				7586
45494	1 pts		Feeling abnormal	below serious				7586
45495	1 pts		Feeling cold	below serious				7586
45496	2 pts		Gait disturbance	below serious				7586
45497	2 pts		Malaise	below serious				7586
45498	1 pts		Thirst	below serious				7586
45499	1 pts		Hepatic enzyme increased	below serious				7586
45500	1 pts		Decreased appetite	below serious				7586
45501	2 pts		Limb discomfort	below serious				7586
45502	3 pts		Muscular weakness	below serious				7586
45503	1 pts		Musculoskeletal stiffness	below serious				7586
45504	2 pts		Ataxia	below serious				7586
45505	2 pts		Balance disorder	below serious				7586
45506	1 pts		Depressed level of consciousness	below serious				7586
45507	2 pts		Disturbance in attention	below serious				7586
45508	26 pts		Dizziness	below serious				7586
45509	2 pts		Dysaesthesia	below serious				7586
45510	1 pts		Dysarthria	below serious				7586
45511	2 pts		Facial paresis	below serious				7586
45512	1 pts		Hyperkinesia	below serious				7586
45513	4 pts		Hypoaesthesia	below serious				7586
45514	1 pts		Migraine	below serious				7586
45515	14 pts		Paraesthesia	below serious				7586
45516	8 pts		Somnolence	below serious				7586
45517	3 pts		Speech disorder	below serious				7586
45518	3 pts		Tremor	below serious				7586
45519	2 pts		Agitation	below serious				7586
45520	1 pts		Depressed mood	below serious				7586
45521	1 pts		Derealisation	below serious				7586
45522	1 pts		Disorientation	below serious				7586
45523	2 pts		Fear	below serious				7586
45524	1 pts		Illusion	below serious				7586
45525	1 pts		Insomnia	below serious				7586
45526	1 pts		Nightmare	below serious				7586
45527	2 pts		Restlessness	below serious				7586
45528	1 pts		Micturition urgency	below serious				7586
45529	2 pts		Hyperhidrosis	below serious				7586
45530	3 pts		Nausea	below serious				7587
45531	15 pts		Fatigue	below serious				7587
45532	14 pts		Dizziness	below serious				7587
45533	8 pts		Headache	below serious				7587
45534	1 pts		Hypoaesthesia	below serious				7587
45535	3 pts		Lethargy	below serious				7587
45536	10 pts		Somnolence	below serious				7587
45537	5 pts		Nausea	below serious				7579
45538	10 pts		Fatigue	below serious				7579
45539	18 pts		Dizziness	below serious				7579
45540	4 pts		Hypoaesthesia	below serious				7579
45541	4 pts		Lethargy	below serious				7579
45542	23 pts		Somnolence	below serious				7579
45543	6 pts		Nausea	below serious				7581
45544	7 pts		Fatigue	below serious				7581
45545	36 pts		Dizziness	below serious				7581
45546	5 pts		Headache	below serious				7581
45547	5 pts		Hypoaesthesia	below serious				7581
45548	7 pts		Lethargy	below serious				7581
45549	38 pts		Somnolence	below serious				7581
45550	2 pts		Photopsia	below serious				7593
45551	1 pts		Abdominal pain	below serious				7593
45552	1 pts		Flatulence	below serious				7593
45553	1 pts		Nausea	below serious				7593
45554	1 pts		Fatigue	below serious				7593
45555	2 pts		Muscle spasms	below serious				7593
45556	1 pts		Ataxia	below serious				7593
45557	6 pts		Dizziness	below serious				7593
45558	2 pts		Headache	below serious				7593
45559	1 pts		Lethargy	below serious				7593
45560	2 pts		Paraesthesia	below serious				7593
45561	1 pts		Presyncope	below serious				7593
45562	1 pts		Somnolence	below serious				7593
45563	1 pts		Tremor	below serious				7593
45564	1 pts		Visual field defect	below serious				7593
45565	1 pts		Sleep disorder	below serious				7593
45566	4 pts		Dizziness	below serious				7582
45567	2 pts		Headache	below serious				7582
45568	2 pts		Paraesthesia	below serious				7582
45569	3 pts		Somnolence	below serious				7582
45570	1 pts		Euphoric mood	below serious				7582
45571	4 pts		Fatigue	below serious				7583
45572	12 pts		Dizziness	below serious				7583
45573	6 pts		Headache	below serious				7583
45574	6 pts		Paraesthesia	below serious				7583
45575	7 pts		Somnolence	below serious				7583
45576	2 pts		Nausea	below serious				7585
45577	4 pts		Asthenia	below serious				7585
45578	3 pts		Discomfort	below serious				7585
45579	3 pts		Muscular weakness	below serious				7585
45580	23 pts		Dizziness	below serious				7585
45581	3 pts		Dysarthria	below serious				7585
45582	8 pts		Paraesthesia	below serious				7585
45583	3 pts		Restless legs syndrome	below serious				7585
45584	22 pts		Somnolence	below serious				7585
45585	9		Dizziness					7596
45586	4		Fatigue					7596
45587	3		Paresthesia					7596
45588	6		Sedation					7596
45589	3		Nausea and vomiting					7596
45590	1		Muscle weakness					7596
45591	15		Dizziness					7594
45592	5		Fatigue					7594
45593	7		Paresthesia					7594
45594	6		Sedation					7594
45595	4		Nausea and vomiting					7594
45596	1		Muscle weakness					7594
45597	17		Dizziness					7595
45598	6		Fatigue					7595
45599	9		Paresthesia					7595
45600	7		Sedation					7595
45601	4		Nausea and vomiting					7595
45602	2		Muscle weakness					7595
45603	1.4		Confusion					7592
45604	1.4		Delirium					7592
45605	1.4		Mental status changes					7592
45606	1.4		Disorientation					7592
45607	2.8		Dizziness		discontinuation			7591
45608	2.8		Light headedness		discontinuation			7591
45609	1.6		Somnolence		discontinuation			7591
45610	1.6		Sedation		discontinuation			7591
45611	0.7		Asthenia		discontinuation			7591
45612	0.7		Fatigue		discontinuation			7591
45613	0.7		Malaise		discontinuation			7591
45614	0.7		Weakness		discontinuation			7591
45615	0.8		Paresthesia		discontinuation			7591
45616	0.8		Hypoaesthesia		discontinuation			7591
45617	0.7		Nausea		discontinuation			7591
45618	0.7		Vomiting		discontinuation			7591
45619	2.1		Confusion		discontinuation			7591
45620	2.1		Delirium		discontinuation			7591
45621	2.1		Mental status changes		discontinuation			7591
45622	2.1		Disorientation		discontinuation			7591
45623	4.2		Dizziness		discontinuation			7592
45624	4.2		Light headedness		discontinuation			7592
45625	1.2		Somnolence		discontinuation			7592
45626	1.2		Sedation		discontinuation			7592
45627	2.5		Asthenia		discontinuation			7592
45628	2.5		Fatigue		discontinuation			7592
45629	2.5		Malaise		discontinuation			7592
45630	2.5		Weakness		discontinuation			7592
45631	1.8		Paresthesia		discontinuation			7592
45632	1.8		Hypoaesthesia		discontinuation			7592
45633	1.5		Nausea		discontinuation			7592
45634	1.5		Vomiting		discontinuation			7592
45635	1.4		Confusion		discontinuation			7592
45636	1.4		Delirium		discontinuation			7592
45637	1.4		Mental status changes		discontinuation			7592
45638	1.4		Disorientation		discontinuation			7592
45639						No AEs reported		7590
45640						No AEs reported		7589
45641	6.7		Fever					7597
45642	6.7		Hot flashes					7597
45643	6.7		Dizziness					7597
45644	26.7		Abdominal pain					7597
45645	50		Diarrhea					7597
45646	13.3		Flatulence					7597
45647	13.3		Coughing					7597
45648	16.6		Rhinitis					7597
45649	16.7		Proteinuria	grade 3			TRUE	7599
45650	16.7		Hypertension	grade 2			TRUE	7599
45651	33.3		Proteinuria	grade 3			TRUE	7598
45652	66.7		Hypertension	grade 3			TRUE	7598
45653	10.8		Proteinuria		dose reduction			7600
45654	9.5		Palmar-plantar erythrodysesthesia syndrome		dose reduction			7600
45655	10.8		Hypertension		dose reduction			7600
45656	16.7		T wave inversion	grade 1	discontinuation		TRUE	7601
45657	2.3		Thrombocytopenia		discontinuation			7602
45658	2.3		Hemorrhage intracranial	grade 5	discontinuation			7602
45659	2.3		Liver failure	grade 5	discontinuation			7602
45660	2.3		Hypertension		discontinuation			7602
45661	13.6		Palmar-plantar erythrodysaesthesia syndrome		dose reduction			7602
45662	6.8		Proteinuria		dose reduction			7602
45663	15.9		Palmar-plantar erythrodysesthesia syndrome		dose interruption			7602
45664	6.8		Skin rash		dose interruption			7602
45665	6.8		Fatigue		dose interruption			7602
45666	20.5		Hypertension		dose interruption			7602
45667	20.5		Hypertension		dose reduction			7602
45668	13.6		Proteinuria		dose interruption			7602
45669						No AEs were observed		7604
45670	5		Headache	grade 1				7605
45671	14		Nasopharyngitis					7603
45672	8		COPD exacerbation					7603
45673	6		Pneumonia					7603
45674	3		Headache					7603
45675	3		Bronchitis					7603
45676	2		Back pain					7603
45677	3		Coronary artery disease					7603
45678	16.7		Coronary artery disease					7607
45679	16.7		Chronic obstructive pulmonary disease					7607
45680	16.7		Pharyngeal inflammation					7607
45681	16.7		Pulmonary hypertension					7607
45682	16.7		Headache	grade 3				7607
45683	16.7		Hypertension	grade 3				7607
45684	16.7		Neutropenia	grade 4				7607
45685	16.7		Lipase increased	grade 3				7607
45686	16.7		Renal failure					7607
45687	4.8		Neuropathy peripheral	grade 1	discontinuation			7609
45688	3.7		Left ventricular dysfunction					7608
45689	3.7		Pneumonia					7608
45690	3.7		Gastroenteritis					7608
45691	3.7		Acute respiratory failure					7608
45692	3.7		Abdominal pain upper					7608
45693	3.7		Headache					7608
45694	3.7		Hemorrhage intracranial					7608
45695	3.7		Pyrexia					7608
45696	3.7		ALT increased					7608
45697	3.7		AST increased					7608
45698	3.7		Lipase increased					7608
45699	57.1		Thrombocytopenia	grade 3-4	dose reduction			7606
45700	14.3		Lipase increased		dose reduction			7606
45701	14.3		Dysesthesia		discontinuation			7606
45702	14.3		Skin rash		discontinuation			7606
45703			Palpitation		discontinuation			7610
45704	2.6		Pain in extremity		discontinuation			7610
45705	15.4		Fatigue		discontinuation			7610
45706	2.6		Platelet count increased		discontinuation			7610
45707	2.6		Thrombocytosis		discontinuation			7610
45708	2.6		Dyspnea		discontinuation			7610
45709						No adverse effects leading to discontinuation were reported; no DLTs		7613
45710	16.7		Encephalopathy	grade 3	dose interruption|dose reduction		TRUE	7611
45711	16.7		Fatigue	grade 3	discontinuation		TRUE	7611
45712	16.7		Hyperbilirubinemia	grade 3	discontinuation		TRUE	7611
45713	18.2		Posterior reversible encephalopathy syndrome		discontinuation			7612
45714	1 pts		Angina pectoris	serious				7614
45715	22 pts		Diarrhoea	serious				7614
45716	12 pts		Vomiting	serious				7614
45717	4 pts		Nausea	serious				7614
45718	2 pts		Abdominal pain	serious				7614
45719	2 pts		Pancreatitis	serious				7614
45720	1 pts		Abdominal pain upper	serious				7614
45721	1 pts		Abdominal strangulated hernia	serious				7614
45722	1 pts		Enterocele	serious				7614
45723	1 pts		Periodontal disease	serious				7614
45724	1 pts		Rectal cancer	serious				7614
45725	3 pts		Fatigue	serious				7614
45726	3 pts		Non-cardiac chest pain	serious				7614
45727	2 pts		Pyrexia	serious				7614
45728	1 pts		Asthenia	serious				7614
45729	2 pts		Cholelithiasis	serious				7614
45730	1 pts		Cholecystitis	serious				7614
45731	1 pts		Cholecystitis acute	serious				7614
45732	6 pts		Cellulitis	serious				7614
45733	5 pts		Erysipelas	serious				7614
45734	2 pts		Bronchitis	serious				7614
45735	1 pts		Anal abscess	serious				7614
45736	1 pts		Anorectal cellulitis	serious				7614
45737	1 pts		Appendicitis perforated	serious				7614
45738	1 pts		Cystitis	serious				7614
45739	1 pts		Escherichia urinary tract infection	serious				7614
45740	1 pts		Gastroenteritis	serious				7614
45741	1 pts		Gastroenteritis salmonella	serious				7614
45742	1 pts		Gastrointestinal viral infection	serious				7614
45743	1 pts		Herpes zoster	serious				7614
45744	1 pts		Infection localised	serious				7614
45745	1 pts		Ophthalmic herpes zoster	serious				7614
45746	1 pts		Rectal abscess	serious				7614
45747	1 pts		Streptococcal sepsis	serious				7614
45748	1 pts		Viral infection	serious				7614
45749	1 pts		Ankle fracture	serious				7614
45750	1 pts		Fracture	serious				7614
45751	1 pts		Multiple injuries	serious				7614
45752	1 pts		Sternal fracture	serious				7614
45753	1 pts		Wrist fracture	serious				7614
45754	4 pts		Alanine aminotransferase increased	serious				7614
45755	4 pts		Aspartate aminotransferase increased	serious				7614
45756	1 pts		Blood creatine increased	serious				7614
45757	1 pts		Blood thyroid stimulating hormone increased	serious				7614
45758	1 pts		Electrocardiogram T wave inversion	serious				7614
45759	1 pts		Staphylococcus test positive	serious				7614
45760	9 pts		Dehydration	serious				7614
45761	1 pts		Hypokalaemia	serious				7614
45762	1 pts		Hypomagnesaemia	serious				7614
45763	1 pts		Acute myeloid leukaemia	serious				7614
45764	1 pts		Benign female reproductive tract neoplasm	serious				7614
45765	1 pts		Breast cancer metastatic	serious				7614
45766	1 pts		Cancer pain	serious				7614
45767	1 pts		Glioblastoma	serious				7614
45768	1 pts		Glioma	serious				7614
45769	1 pts		Malignant melanoma	serious				7614
45770	1 pts		Malignant melanoma in situ	serious				7614
45771	1 pts		Malignant pleural effusion	serious				7614
45772	1 pts		Metastases to meninges	serious				7614
45773	3 pts		Syncope	serious				7614
45774	1 pts		Ageusia	serious				7614
45775	1 pts		Anosmia	serious				7614
45776	1 pts		Cerebral haemorrhage	serious				7614
45777	1 pts		Cerebral infarction	serious				7614
45778	1 pts		Paresis	serious				7614
45779	2 pts		Mental status changes	serious				7614
45780	3 pts		Renal failure acute	serious				7614
45781	2 pts		Renal failure	serious				7614
45782	1 pts		Hyperuricosuria	serious				7614
45783	1 pts		Colic renal	serious				7614
45784	1 pts		Endometrial hypertrophy	serious				7614
45785	1 pts		Endometriosis	serious				7614
45786	2 pts		Dyspnoea	serious				7614
45787	1 pts		Atelectasis	serious				7614
45788	1 pts		Dermatitis	serious				7614
45789	1 pts		Erythema	serious				7614
45790	1 pts		Hypotension	serious				7614
45791	1341 pts		Diarrhoea	below serious				7614
45792	605 pts		Nausea	below serious				7614
45793	364 pts		Vomiting	below serious				7614
45794	339 pts		Abdominal pain	below serious				7614
45795	212 pts		Abdominal pain upper	below serious				7614
45796	139 pts		Dyspepsia	below serious				7614
45797	85 pts		Stomatitis	below serious				7614
45798	73 pts		Abdominal distension	below serious				7614
45799	381 pts		Fatigue	below serious				7614
45800	77 pts		Pyrexia	below serious				7614
45801	72 pts		Urinary tract infection	below serious				7614
45802	118 pts		Alanine aminotransferase increased	below serious				7614
45803	101 pts		Aspartate aminotransferase increased	below serious				7614
45804	170 pts		Decreased appetite	below serious				7614
45805	159 pts		Muscle spasms	below serious				7614
45806	278 pts		Headache	below serious				7614
45807	146 pts		Dizziness	below serious				7614
45808	71 pts		Epistaxis	below serious				7614
45809	211 pts		Rash	below serious				7614
45810	85 pts		Dry skin	below serious				7614
45811	3 pts		Diarrhea	grade 3	discontinuation	leads to discontinuation	TRUE	7615
45812	5 pts		Fatigue	all grades	discontinuation	leads to discontinuation		7615
45813	92		Diarrhea	all grades	discontinuation	leads to discontinuation		7616
45814	49		Fatigue	all grades	discontinuation	leads to discontinuation		7616
45815	21		Abdominal pain	all grades				7616
45816	54		Nausea	all grades				7616
45817	49		Vomiting	all grades				7616
45818	33		Anorexia	all grades				7616
45819	8		Rash	all grades				7616
45820	1 pts		Diarrhea	grade 3	discontinuation	leads to discontinuation	TRUE	7620
45821	1 pts		Fatigue	all grades	discontinuation	leads to discontinuation		7620
45822	43		Nausea	all grades				7617
45823	2		Nausea	grade 3	discontinuation	leads to discontinuation		7617
45824	36		Abdominal pain	all grades				7617
45825	36		Abdominal pain upper	all grades				7617
45826	36		Abdominal pain lower	all grades				7617
45827	2		Abdominal pain	grade 3	discontinuation	leads to dose reduction/discontinuation		7617
45828	2		Abdominal pain upper	grade 3	discontinuation	leads to dose reduction/discontinuation		7617
45829	2		Abdominal pain lower	grade 3	discontinuation	leads to dose reduction/discontinuation		7617
45830	26		Vomiting	all grades				7617
45831	3		Vomiting	grade 3	discontinuation	leads to dose reduction/discontinuation		7617
45832	14		Stomatitis	all grades				7617
45833	14		Aphthous stomatitis	all grades				7617
45834	14		Mouth ulceration	all grades				7617
45835	14		Oral mucosal blistering	all grades				7617
45836	14		Mucosal inflammation	all grades				7617
45837	14		Oropharyngeal pain	all grades				7617
45838	14		Oral pain	all grades				7617
45839	14		Glossodynia	all grades				7617
45840	14		Glossitis	all grades				7617
45841	14		Cheilitis	all grades				7617
45842	0.3		Stomatitis	grade 3				7617
45843	0.3		Aphthous stomatitis	grade 3				7617
45844	0.3		Mouth ulceration	grade 3				7617
45845	0.3		Oral mucosal blistering	grade 3				7617
45846	0.3		Mucosal inflammation	grade 3				7617
45847	0.3		Oropharyngeal pain	grade 3				7617
45848	0.3		Oral pain	grade 3				7617
45849	0.3		Glossodynia	grade 3				7617
45850	0.3		Glossitis	grade 3				7617
45851	0.3		Cheilitis	grade 3				7617
45852	10		Dyspepsia	all grades				7617
45853	0.4		Dyspepsia	grade 3				7617
45854	5		Abdominal distension	all grades				7617
45855	0.3		Abdominal distension	grade 3				7617
45856	3		Dry mouth	all grades				7617
45857	0.1		Dry mouth	grade 3				7617
45858	27		Fatigue	all grades				7617
45859	2		Fatigue	grade 3	discontinuation	leads to dose reduction/discontinuation		7617
45860	9		Alanine aminotransferase increased	all grades				7617
45861	1		Alanine aminotransferase increased	grade 3	discontinuation	leads to dose reduction/discontinuation		7617
45862	0.2		Alanine aminotransferase increased	grade 4	discontinuation	leads to dose reduction/discontinuation		7617
45863	7		Aspartate aminotransferase increased	all grades				7617
45864	0.5		Aspartate aminotransferase increased	grade 3				7617
45865	0.2		Aspartate aminotransferase increased	grade 4				7617
45866	5		Urinary tract infection	all grades				7617
45867	0.1		Urinary tract infection	grade 3				7617
45868	5		Weight decreased	all grades				7617
45869	0.1		Weight decreased	grade 3				7617
45870	12		Decreased appetite	all grades				7617
45871	0.2		Decreased appetite	grade 3				7617
45872	4		Dehydration	all grades				7617
45873	0.9		Dehydration	grade 3				7617
45874	0.1		Dehydration	grade 4				7617
45875	11		Muscle spasms	all grades				7617
45876	0.1		Muscle spasms	grade 3				7617
45877	5		Epistaxis	all grades				7617
45878	18		Rash	all grades				7617
45879	18		Rash erythematous	all grades				7617
45880	18		Rash follicular	all grades				7617
45881	18		Generalized rash	all grades				7617
45882	18		Rash pruritic	all grades				7617
45883	18		Rash pustular	all grades				7617
45884	18		Maculopapular rash	all grades				7617
45885	18		Rash papular	all grades				7617
45886	18		Dermatitis	all grades				7617
45887	18		Dermatitis acneiform	all grades				7617
45888	18		Toxic skin eruption	all grades				7617
45889	0.6		Rash	grade 3				7617
45890	0.6		Rash erythematous	grade 3				7617
45891	0.6		Rash follicular	grade 3				7617
45892	0.6		Generalized rash	grade 3				7617
45893	0.6		Rash pruritic	grade 3				7617
45894	0.6		Rash pustular	grade 3				7617
45895	0.6		Maculopapular rash	grade 3				7617
45896	0.6		Rash papular	grade 3				7617
45897	0.6		Dermatitis	grade 3				7617
45898	0.6		Dermatitis acneiform	grade 3				7617
45899	0.6		Toxic skin eruption	grade 3				7617
45900	6		Dry skin	all grades				7617
45901	8		Nail disorder	all grades				7617
45902	8		Paronychia	all grades				7617
45903	8		Onychoclasis	all grades				7617
45904	8		Nail discoloration	all grades				7617
45905	8		Nail toxicity	all grades				7617
45906	8		Nail growth abnormal	all grades				7617
45907	8		Nail dystrophy	all grades				7617
45908	0.3		Nail disorder	grade 3				7617
45909	0.3		Paronychia	grade 3				7617
45910	0.3		Onychoclasis	grade 3				7617
45911	0.3		Nail discoloration	grade 3				7617
45912	0.3		Nail toxicity	grade 3				7617
45913	0.3		Nail growth abnormal	grade 3				7617
45914	0.3		Nail dystrophy	grade 3				7617
45915	2		Skin fissures	all grades				7617
45916	0.1		Skin fissures	grade 3				7617
45917	95		Diarrhea	all grades	discontinuation	leads to dose reduction/discontinuation	TRUE	7618
45918	40		Diarrhea	grade 3	discontinuation	leads to dose reduction/discontinuation	TRUE	7618
45919	0.1		Diarrhea	grade 4	discontinuation	leads to discontinuation	TRUE	7618
45920	11.1		Bilirubin increased	all grades				7619
45921	0.1		Bilirubin increased	grade 3				7619
45922	22.7		Alkaline phosphatase	all grades				7619
45923	12.5		Creatinine increased	all grades				7619
45924	0.1		Creatinine increased	grade 4				7619
45925	0.1		Creatinine increased	grade 3				7619
45926	11.2		Hypercalcemia	all grades				7619
45927	0.2		Hypercalcemia	grade 4				7619
45928	0.4		Hypercalcemia	grade 3				7619
45929	5.2		Hypermagnesemia	all grades				7619
45930	0.1		Hypermagnesemia	grade 4				7619
45931	0.9		Hypermagnesemia	grade 3				7619
45932	10.3		Hypernatremia	all grades				7619
45933	0.1		Hypernatremia	grade 4				7619
45934	0.1		Hypernatremia	grade 3				7619
45935	8.4		Hypoalbuminemia	all grades				7619
45936	0.1		Hypoalbuminemia	grade 3				7619
45937	48.9		Hypocalcemia	all grades				7619
45938	0.9		Hypocalcemia	grade 4				7619
45939	0.1		Hypocalcemia	grade 3				7619
45940	7.5		Hypokalemia	all grades				7619
45941	0.1		Hypokalemia	grade 4				7619
45942	0.3		Hypokalemia	grade 3				7619
45943	7.2		Hypomagnesemia	all grades				7619
45944	0.2		Hypomagnesemia	grade 4				7619
45945	0.4		Hypomagnesemia	grade 3				7619
45946	11.6		Hyponatremia	all grades				7619
45947	0.9		Hyponatremia	grade 3				7619
45948	40 pts		Thrombocytopenia	serious				7621
45949	14 pts		Anaemia	serious				7621
45950	2 pts		Neutropenia	serious				7621
45951	2 pts		Pancytopenia	serious				7621
45952	1 pts		Febrile neutropenia	serious				7621
45953	4 pts		Constipation	serious				7621
45954	2 pts		Intestinal obstruction	serious				7621
45955	2 pts		Subileus	serious				7621
45956	1 pts		Abdominal hernia	serious				7621
45957	1 pts		Abdominal pain upper	serious				7621
45958	1 pts		Ileus paralytic	serious				7621
45959	1 pts		Impaired gastric emptying	serious				7621
45960	1 pts		Obstruction gastric	serious				7621
45961	1 pts		Vomiting	serious				7621
45962	2 pts		Pneumonia	serious				7621
45963	1 pts		Bronchitis	serious				7621
45964	1 pts		Erysipelas	serious				7621
45965	1 pts		Infection	serious				7621
45966	1 pts		Pyelonephritis	serious				7621
45967	1 pts		Tracheobronchitis	serious				7621
45968	1 pts		Upper respiratory tract infection	serious				7621
45969	1 pts		Wound infection	serious				7621
45970	2 pts		Dyspnoea	serious				7621
45971	2 pts		Pulmonary embolism	serious				7621
45972	1 pts		Acute pulmonary oedema	serious				7621
45973	1 pts		Asthma	serious				7621
45974	1 pts		Pleuritic pain	serious				7621
45975	1 pts		Pneumonitis	serious				7621
45976	3 pts		Pyrexia	serious				7621
45977	2 pts		Disease progression	serious				7621
45978	2 pts		Non-cardiac chest pain	serious				7621
45979	1 pts		Mucosal inflammation	serious				7621
45980	1 pts		Angina pectoris	serious				7621
45981	1 pts		Cardiac failure	serious				7621
45982	1 pts		Pericardial effusion	serious				7621
45983	1 pts		Sinus tachycardia	serious				7621
45984	1 pts		Tachycardia	serious				7621
45985	2 pts		Myelodysplastic syndrome	serious				7621
45986	1 pts		Metastases to peritoneum	serious				7621
45987	1 pts		Undifferentiated sarcoma	serious				7621
45988	1 pts		Incisional hernia	serious				7621
45989	1 pts		Post procedural discomfort	serious				7621
45990	1 pts		Transfusion reaction	serious				7621
45991	1 pts		Neutrophil count decreased	serious				7621
45992	1 pts		Platelet count decreased	serious				7621
45993	1 pts		Transaminases increased	serious				7621
45994	1 pts		Depressed level of consciousness	serious				7621
45995	1 pts		Syncope	serious				7621
45996	1 pts		Transient ischaemic attack	serious				7621
45997	1 pts		Anxiety	serious				7621
45998	1 pts		Hallucination	serious				7621
45999	1 pts		Nephrolithiasis	serious				7621
46000	1 pts		Hypomagnesaemia	serious				7621
46001	1 pts		Type 2 diabetes mellitus	serious				7621
46002	1 pts		Cholecystitis	serious				7621
46003	1 pts		Cholestasis	serious				7621
46004	1 pts		Hepatic failure	serious				7621
46005	1 pts		Hypertensive crisis	serious				7621
46006	1 pts		Peripheral artery thrombosis	serious				7621
46007	1 pts		Pain management	serious				7621
46008	1 pts		Anaphylactoid reaction	serious				7621
46009	270 pts		Nausea	below serious				7621
46010	145 pts		Constipation	below serious				7621
46011	42 pts		Dyspepsia	below serious				7621
46012	34 pts		Dry mouth	below serious				7621
46013	36 pts		Abdominal pain upper	below serious				7621
46014	23 pts		Gastrooesophageal reflux disease	below serious				7621
46015	125 pts		Vomiting	below serious				7621
46016	36 pts		Urinary tract infection	below serious				7621
46017	19 pts		Bronchitis	below serious				7621
46018	41 pts		Nasopharyngitis	below serious				7621
46019	20 pts		Upper respiratory tract infection	below serious				7621
46020	55 pts		Cough	below serious				7621
46021	71 pts		Dyspnoea	below serious				7621
46022	21 pts		Oropharyngeal pain	below serious				7621
46023	168 pts		Fatigue	below serious				7621
46024	58 pts		Asthenia	below serious				7621
46025	26 pts		Mucosal inflammation	below serious				7621
46026	24 pts		Oedema peripheral	below serious				7621
46027	23 pts		Pyrexia	below serious				7621
46028	74 pts		Platelet count decreased	below serious				7621
46029	49 pts		Neutrophil count decreased	below serious				7621
46030	36 pts		White blood cell count decreased	below serious				7621
46031	24 pts		Gamma-glutamyltransferase increased	below serious				7621
46032	20 pts		Aspartate aminotransferase increased	below serious				7621
46033	20 pts		Blood creatinine increased	below serious				7621
46034	95 pts		Headache	below serious				7621
46035	61 pts		Dizziness	below serious				7621
46036	37 pts		Dysgeusia	below serious				7621
46037	25 pts		Neuropathy peripheral	below serious				7621
46038	29 pts		Anxiety	below serious				7621
46039	89 pts		Insomnia	below serious				7621
46040	21 pts		Hypokalaemia	below serious				7621
46041	93 pts		Decreased appetite	below serious				7621
46042	71 pts		Hypertension	below serious				7621
46043	32 pts		Hot flush	below serious				7621
46044	163 pts		Thrombocytopenia	below serious				7621
46045	178 pts		Anaemia	below serious				7621
46046	64 pts		Neutropenia	below serious				7621
46047	27 pts		Leukopenia	below serious				7621
46048	38 pts		Palpitations	below serious				7621
46049	23 pts		Tachycardia	below serious				7621
46050	32 pts		Photosensitivity reaction	below serious				7621
46051	28 pts		Alopecia	below serious				7621
46052	24 pts		Rash	below serious				7621
46053	19 pts		Dry skin	below serious				7621
46054	19 pts		Petechiae	below serious				7621
46055	49 pts		Back pain	below serious				7621
46056	23 pts		Muscle spasms	below serious				7621
46057	20 pts		Musculoskeletal pain	below serious				7621
46058	27 pts		Anaemia	serious				7622
46059	3 pts		Febrile neutropenia	serious				7622
46060	6 pts		Neutropenia	serious				7622
46061	1 pts		Pancytopenia	serious				7622
46062	59 pts		Thrombocytopenia	serious				7622
46063	1 pts		Retinal detachment	serious				7622
46064	1 pts		Abdominal pain lower	serious				7622
46065	1 pts		Diarrhoea	serious				7622
46066	1 pts		Enteritis	serious				7622
46067	5 pts		Intestinal obstruction	serious				7622
46068	1 pts		Intestinal perforation	serious				7622
46069	1 pts		Large intestinal obstruction	serious				7622
46070	14 pts		Small intestinal obstruction	serious				7622
46071	1 pts		Fatigue	serious				7622
46072	1 pts		Gait disturbance	serious				7622
46073	1 pts		General physical health deterioration	serious				7622
46074	1 pts		Cholecystitis	serious				7622
46075	1 pts		Appendicitis	serious				7622
46076	1 pts		Enterocolitis infectious	serious				7622
46077	2 pts		Lung infection	serious				7622
46078	1 pts		Neutropenic sepsis	serious				7622
46079	3 pts		Pneumonia	serious				7622
46080	1 pts		Pneumonia fungal	serious				7622
46081	1 pts		Pyelonephritis	serious				7622
46082	1 pts		Skin bacterial infection	serious				7622
46083	1 pts		Femoral neck fracture	serious				7622
46084	8 pts		Overdose	serious				7622
46085	1 pts		Postoperative hernia	serious				7622
46086	1 pts		Transfusion reaction	serious				7622
46087	1 pts		Wound complication	serious				7622
46088	1 pts		Hepatic enzyme increased	serious				7622
46089	1 pts		International normalised ratio increased	serious				7622
46090	1 pts		Neutrophil count decreased	serious				7622
46091	20 pts		Platelet count decreased	serious				7622
46092	1 pts		Decreased appetite	serious				7622
46093	1 pts		Arthralgia	serious				7622
46094	2 pts		Metastases to central nervous system	serious				7622
46095	1 pts		Myelodysplastic syndrome	serious				7622
46096	1 pts		Thyroid cancer	serious				7622
46097	1 pts		Device occlusion	serious				7622
46098	1 pts		Anxiety	serious				7622
46099	1 pts		Confusional state	serious				7622
46100	1 pts		Depression	serious				7622
46101	1 pts		Insomnia	serious				7622
46102	1 pts		Mania	serious				7622
46103	1 pts		Mental status changes	serious				7622
46104	1 pts		Psychotic disorder	serious				7622
46105	1 pts		Ureteric stenosis	serious				7622
46106	1 pts		Urethral stenosis	serious				7622
46107	1 pts		Urinary retention	serious				7622
46108	1 pts		Pleural effusion	serious				7622
46109	4 pts		Pneumonitis	serious				7622
46110	1 pts		Pulmonary embolism	serious				7622
46111	1 pts		Hypertension	serious				7622
46112	2 pts		Lymphocele	serious				7622
46113	306 pts		Anaemia	below serious				7622
46114	1 pts		Anaemia macrocytic	below serious				7622
46115	1 pts		Febrile neutropenia	below serious				7622
46116	2 pts		Haemorrhagic disorder	below serious				7622
46117	1 pts		Immune thrombocytopenic purpura	below serious				7622
46118	1 pts		Anaemia iron deficiency	below serious				7622
46119	1 pts		Leukocytosis	below serious				7622
46120	57 pts		Leukopenia	below serious				7622
46121	1 pts		Lymphadenitis	below serious				7622
46122	3 pts		Lymphadenopathy	below serious				7622
46123	12 pts		Lymphopenia	below serious				7622
46124	1 pts		Macrocytosis	below serious				7622
46125	126 pts		Neutropenia	below serious				7622
46126	210 pts		Thrombocytopenia	below serious				7622
46127	3 pts		Angina pectoris	below serious				7622
46128	1 pts		Metabolic cardiomyopathy	below serious				7622
46129	39 pts		Palpitations	below serious				7622
46130	12 pts		Sinus tachycardia	below serious				7622
46131	1 pts		Tachyarrhythmia	below serious				7622
46132	25 pts		Tachycardia	below serious				7622
46133	1 pts		Ventricular extrasystoles	below serious				7622
46134	2 pts		Cerumen impaction	below serious				7622
46135	1 pts		Excessive cerumen production	below serious				7622
46136	1 pts		Hypoacusis	below serious				7622
46137	1 pts		Meniere's disease	below serious				7622
46138	1 pts		Motion sickness	below serious				7622
46139	1 pts		Paraesthesia ear	below serious				7622
46140	11 pts		Tinnitus	below serious				7622
46141	13 pts		Vertigo	below serious				7622
46142	1 pts		Vertigo positional	below serious				7622
46143	1 pts		Disorder vestibular	below serious				7622
46144	1 pts		Hyperparathyroidism	below serious				7622
46145	1 pts		Thyroid mass	below serious				7622
46146	1 pts		Age-related macular degeneration	below serious				7622
46147	2 pts		Conjunctivitis allergic	below serious				7622
46148	1 pts		Diplopia	below serious				7622
46149	11 pts		Dry eye	below serious				7622
46150	1 pts		Eye disorder	below serious				7622
46151	1 pts		Eye oedema	below serious				7622
46152	4 pts		Eye pain	below serious				7622
46153	1 pts		Eye swelling	below serious				7622
46154	1 pts		Eyelid oedema	below serious				7622
46155	1 pts		Hypermetropia	below serious				7622
46156	1 pts		Lacrimation increased	below serious				7622
46157	1 pts		Myopia	below serious				7622
46158	2 pts		Ocular hyperaemia	below serious				7622
46159	2 pts		Photophobia	below serious				7622
46160	1 pts		Photopsia	below serious				7622
46161	1 pts		Retinal exudates	below serious				7622
46162	1 pts		Retinal haemorrhage	below serious				7622
46163	1 pts		Haemorrhage retinal	below serious				7622
46164	5 pts		Vision blurred	below serious				7622
46165	2 pts		Visual acuity reduced	below serious				7622
46166	5 pts		Visual impairment	below serious				7622
46167	3 pts		Vitreous floaters	below serious				7622
46168	4 pts		Abdominal hernia	below serious				7622
46169	41 pts		Abdominal pain upper	below serious				7622
46170	4 pts		Abdominal tenderness	below serious				7622
46171	1 pts		Anal fissure	below serious				7622
46172	2 pts		Anal haemorrhage	below serious				7622
46173	5 pts		Aphthous ulcer	below serious				7622
46174	1 pts		Cheilitis	below serious				7622
46175	1 pts		Chronic gastritis	below serious				7622
46176	1 pts		Coeliac disease	below serious				7622
46177	189 pts		Constipation	below serious				7622
46178	2 pts		Dental caries	below serious				7622
46179	1 pts		Diaphragmatic hernia	below serious				7622
46180	40 pts		Dry mouth	below serious				7622
46181	34 pts		Dyspepsia	below serious				7622
46182	6 pts		Dysphagia	below serious				7622
46183	3 pts		Epigastric discomfort	below serious				7622
46184	1 pts		Faecaloma	below serious				7622
46185	2 pts		Faeces discoloured	below serious				7622
46186	2 pts		Faeces soft	below serious				7622
46187	17 pts		Flatulence	below serious				7622
46188	2 pts		Gastric disorder	below serious				7622
46189	5 pts		Gastritis	below serious				7622
46190	1 pts		Gastritis erosive	below serious				7622
46191	1 pts		Gastrointestinal disorder	below serious				7622
46192	1 pts		Gastrointestinal haemorrhage	below serious				7622
46193	2 pts		Gastrointestinal motility disorder	below serious				7622
46194	3 pts		Gastrointestinal pain	below serious				7622
46195	25 pts		Gastrooesophageal reflux disease	below serious				7622
46196	3 pts		Gingival bleeding	below serious				7622
46197	1 pts		Gingival pain	below serious				7622
46198	1 pts		Glossodynia	below serious				7622
46199	1 pts		Haemorrhoidal haemorrhage	below serious				7622
46200	4 pts		Hiatus hernia	below serious				7622
46201	2 pts		Lip blister	below serious				7622
46202	1 pts		Lip disorder	below serious				7622
46203	3 pts		Lip swelling	below serious				7622
46204	4 pts		Melaena	below serious				7622
46205	2 pts		Mouth haemorrhage	below serious				7622
46206	4 pts		Mouth ulceration	below serious				7622
46207	278 pts		Nausea	below serious				7622
46208	1 pts		Oral dysaesthesia	below serious				7622
46209	2 pts		Oral mucosal blistering	below serious				7622
46210	1 pts		Oral mucosal discolouration	below serious				7622
46211	7 pts		Oral pain	below serious				7622
46212	1 pts		Pancreatic disorder	below serious				7622
46213	1 pts		Chronic pancreatitis	below serious				7622
46214	2 pts		Paraesthesia oral	below serious				7622
46215	1 pts		Proctalgia	below serious				7622
46216	5 pts		Rectal haemorrhage	below serious				7622
46217	1 pts		Regurgitation	below serious				7622
46218	1 pts		Salivary duct stenosis	below serious				7622
46219	1 pts		Salivary gland calculus	below serious				7622
46220	1 pts		Salivary hypersecretion	below serious				7622
46221	16 pts		Stomatitis	below serious				7622
46222	2 pts		Swollen tongue	below serious				7622
46223	1 pts		Tooth disorder	below serious				7622
46224	1 pts		Tooth impacted	below serious				7622
46225	6 pts		Toothache	below serious				7622
46226	108 pts		Vomiting	below serious				7622
46227	1 pts		Adhesion	below serious				7622
46228	78 pts		Asthenia	below serious				7622
46229	1 pts		Catheter site bruise	below serious				7622
46230	1 pts		Catheter site haematoma	below serious				7622
46231	3 pts		Catheter site pain	below serious				7622
46232	1 pts		Catheter site rash	below serious				7622
46233	1 pts		Catheter site vesicles	below serious				7622
46234	6 pts		Chills	below serious				7622
46235	3 pts		Discomfort	below serious				7622
46236	4 pts		Early satiety	below serious				7622
46237	1 pts		Facial pain	below serious				7622
46238	168 pts		Fatigue	below serious				7622
46239	1 pts		Feeling abnormal	below serious				7622
46240	1 pts		Feeling hot	below serious				7622
46241	2 pts		Gait disturbance	below serious				7622
46242	3 pts		General physical health deterioration	below serious				7622
46243	3 pts		Hernia	below serious				7622
46244	1 pts		Induration	below serious				7622
46245	1 pts		Injection site reaction	below serious				7622
46246	7 pts		Malaise	below serious				7622
46247	1 pts		Mass	below serious				7622
46248	23 pts		Mucosal inflammation	below serious				7622
46249	13 pts		Non-cardiac chest pain	below serious				7622
46250	30 pts		Oedema peripheral	below serious				7622
46251	16 pts		Pain	below serious				7622
46252	41 pts		Pyrexia	below serious				7622
46253	1 pts		Secretion discharge	below serious				7622
46254	1 pts		Sensation of foreign body	below serious				7622
46255	1 pts		Suprapubic pain	below serious				7622
46256	1 pts		Swelling	below serious				7622
46257	1 pts		Ulcer	below serious				7622
46258	1 pts		Vessel puncture site bruise	below serious				7622
46259	1 pts		Vessel puncture site haematoma	below serious				7622
46260	1 pts		Biliary dilatation	below serious				7622
46261	1 pts		Hepatic pain	below serious				7622
46262	1 pts		Hepatitis	below serious				7622
46263	1 pts		Hepatitis toxic	below serious				7622
46264	2 pts		Hyperbilirubinaemia	below serious				7622
46265	1 pts		Hypertransaminasaemia	below serious				7622
46266	1 pts		Liver disorder	below serious				7622
46267	1 pts		Contrast media reaction	below serious				7622
46268	2 pts		Hypersensitivity	below serious				7622
46269	1 pts		Acute sinusitis	below serious				7622
46270	1 pts		Anal abscess	below serious				7622
46271	12 pts		Bronchitis	below serious				7622
46272	2 pts		Candida infection	below serious				7622
46273	1 pts		Catheter site cellulitis	below serious				7622
46274	2 pts		Cellulitis	below serious				7622
46275	1 pts		Clostridium difficile colitis	below serious				7622
46276	5 pts		Conjunctivitis	below serious				7622
46277	1 pts		Device related infection	below serious				7622
46278	1 pts		Diverticulitis	below serious				7622
46279	2 pts		Ear infection	below serious				7622
46280	4 pts		Eye infection	below serious				7622
46281	1 pts		Fungal skin infection	below serious				7622
46282	3 pts		Furuncle	below serious				7622
46283	1 pts		Gastric infection	below serious				7622
46284	3 pts		Gastroenteritis	below serious				7622
46285	2 pts		Gastroenteritis viral	below serious				7622
46286	2 pts		Genital herpes	below serious				7622
46287	2 pts		Gingivitis	below serious				7622
46288	1 pts		Helicobacter gastritis	below serious				7622
46289	5 pts		Herpes zoster	below serious				7622
46290	4 pts		Hordeolum	below serious				7622
46291	1 pts		Infection	below serious				7622
46292	2 pts		Laryngitis	below serious				7622
46293	4 pts		Lung infection	below serious				7622
46294	1 pts		Medical device site infection	below serious				7622
46295	1 pts		Mucosal infection	below serious				7622
46296	1 pts		Nail infection	below serious				7622
46297	1 pts		Ophthalmic herpes simplex	below serious				7622
46298	7 pts		Oral herpes	below serious				7622
46299	1 pts		Oral infection	below serious				7622
46300	1 pts		Otitis externa	below serious				7622
46301	5 pts		Pharyngitis	below serious				7622
46302	8 pts		Pneumonia	below serious				7622
46303	9 pts		Rhinitis	below serious				7622
46304	1 pts		Sepsis	below serious				7622
46305	1 pts		Shigella infection	below serious				7622
46306	1 pts		Sialoadenitis	below serious				7622
46307	15 pts		Sinusitis	below serious				7622
46308	1 pts		Soft tissue infection	below serious				7622
46309	1 pts		Tinea pedis	below serious				7622
46310	1 pts		Tooth abscess	below serious				7622
46311	7 pts		Tooth infection	below serious				7622
46312	1 pts		Tracheitis	below serious				7622
46313	44 pts		Urinary tract infection	below serious				7622
46314	3 pts		Vaginal infection	below serious				7622
46315	3 pts		Viral infection	below serious				7622
46316	1 pts		Vulvitis	below serious				7622
46317	1 pts		Vulvovaginal mycotic infection	below serious				7622
46318	3 pts		Allergic transfusion reaction	below serious				7622
46319	1 pts		Animal bite	below serious				7622
46320	4 pts		Arthropod bite	below serious				7622
46321	1 pts		Bone contusion	below serious				7622
46322	1 pts		Compression fracture	below serious				7622
46323	22 pts		Contusion	below serious				7622
46324	12 pts		Fall	below serious				7622
46325	1 pts		Humerus fracture	below serious				7622
46326	2 pts		Incision site pain	below serious				7622
46327	2 pts		Joint dislocation	below serious				7622
46328	1 pts		Mallet finger	below serious				7622
46329	1 pts		Muscle rupture	below serious				7622
46330	1 pts		Post-traumatic pain	below serious				7622
46331	1 pts		Postoperative hernia	below serious				7622
46332	1 pts		Postoperative ileus	below serious				7622
46333	6 pts		Procedural pain	below serious				7622
46334	1 pts		Scar	below serious				7622
46335	1 pts		Spinal compression fracture	below serious				7622
46336	1 pts		Stoma site haemorrhage	below serious				7622
46337	1 pts		Stoma site inflammation	below serious				7622
46338	2 pts		Tooth fracture	below serious				7622
46339	1 pts		Vaccination complication	below serious				7622
46340	1 pts		Vascular access malfunction	below serious				7622
46341	1 pts		Wound complication	below serious				7622
46342	2 pts		Wound evisceration	below serious				7622
46343	2 pts		Wrist fracture	below serious				7622
46344	42 pts		Alanine aminotransferase increased	below serious				7622
46345	3 pts		Amylase increased	below serious				7622
46346	43 pts		Aspartate aminotransferase increased	below serious				7622
46347	1 pts		Blood alkaline phosphatase	below serious				7622
46348	42 pts		Blood alkaline phosphatase increased	below serious				7622
46349	7 pts		Blood bilirubin increased	below serious				7622
46350	1 pts		Blood calcium increased	below serious				7622
46351	1 pts		Blood chloride increased	below serious				7622
46352	4 pts		Blood cholesterol increased	below serious				7622
46353	1 pts		Blood creatine increased	below serious				7622
46354	55 pts		Blood creatinine increased	below serious				7622
46355	1 pts		Blood glucose decreased	below serious				7622
46356	4 pts		Blood glucose increased	below serious				7622
46357	3 pts		Blood lactate dehydrogenase increased	below serious				7622
46358	3 pts		Blood magnesium decreased	below serious				7622
46359	1 pts		Blood potassium increased	below serious				7622
46360	5 pts		Blood pressure increased	below serious				7622
46361	1 pts		Blood sodium decreased	below serious				7622
46362	4 pts		Blood urea increased	below serious				7622
46363	1 pts		Electrocardiogram QT prolonged	below serious				7622
46364	1 pts		Eosinophil count decreased	below serious				7622
46365	11 pts		Gamma-glutamyltransferase increased	below serious				7622
46366	2 pts		Haematocrit decreased	below serious				7622
46367	5 pts		Haemoglobin decreased	below serious				7622
46368	9 pts		Heart rate increased	below serious				7622
46369	1 pts		Hepatic enzyme increased	below serious				7622
46370	1 pts		Intraocular pressure increased	below serious				7622
46371	1 pts		Lipase increased	below serious				7622
46372	25 pts		Lymphocyte count decreased	below serious				7622
46373	3 pts		Mean cell volume increased	below serious				7622
46374	2 pts		Monocyte count decreased	below serious				7622
46375	1 pts		Monocyte count increased	below serious				7622
46376	82 pts		Neutrophil count decreased	below serious				7622
46377	129 pts		Platelet count decreased	below serious				7622
46378	1 pts		Platelet count increased	below serious				7622
46379	3 pts		Protein total decreased	below serious				7622
46380	4 pts		Red blood cell count decreased	below serious				7622
46381	1 pts		Sputum abnormal	below serious				7622
46382	20 pts		Weight decreased	below serious				7622
46383	74 pts		White blood cell count decreased	below serious				7622
46384	1 pts		Cachexia	below serious				7622
46385	92 pts		Decreased appetite	below serious				7622
46386	6 pts		Dehydration	below serious				7622
46387	3 pts		Diabetes mellitus	below serious				7622
46388	2 pts		Glucose tolerance impaired	below serious				7622
46389	1 pts		Hyperalbuminaemia	below serious				7622
46390	9 pts		Hypercalcaemia	below serious				7622
46391	3 pts		Hypercreatininaemia	below serious				7622
46392	19 pts		Hyperglycaemia	below serious				7622
46393	6 pts		Hyperkalaemia	below serious				7622
46394	1 pts		Hypermagnesaemia	below serious				7622
46395	1 pts		Hypernatraemia	below serious				7622
46396	1 pts		Hyperphosphataemia	below serious				7622
46397	1 pts		Hyperproteinaemia	below serious				7622
46398	2 pts		Hypertriglyceridaemia	below serious				7622
46399	2 pts		Hyperuricaemia	below serious				7622
46400	8 pts		Hypoalbuminaemia	below serious				7622
46401	2 pts		Hypocalcaemia	below serious				7622
46402	2 pts		Hypochloraemia	below serious				7622
46403	25 pts		Hypokalaemia	below serious				7622
46404	38 pts		Hypomagnesaemia	below serious				7622
46405	19 pts		Hyponatraemia	below serious				7622
46406	2 pts		Hypophosphataemia	below serious				7622
46407	1 pts		Hypoproteinaemia	below serious				7622
46408	1 pts		Type 2 diabetes mellitus	below serious				7622
46409	4 pts		Vitamin D deficiency	below serious				7622
46410	2 pts		Arthropathy	below serious				7622
46411	64 pts		Back pain	below serious				7622
46412	1 pts		Bone lesion	below serious				7622
46413	1 pts		Bone swelling	below serious				7622
46414	1 pts		Bursitis	below serious				7622
46415	1 pts		Exostosis	below serious				7622
46416	1 pts		Extremity contracture	below serious				7622
46417	3 pts		Hypercreatinaemia	below serious				7622
46418	2 pts		Intervertebral disc protrusion	below serious				7622
46419	2 pts		Joint effusion	below serious				7622
46420	7 pts		Joint swelling	below serious				7622
46421	1 pts		Muscle fatigue	below serious				7622
46422	12 pts		Muscular weakness	below serious				7622
46423	7 pts		Musculoskeletal stiffness	below serious				7622
46424	36 pts		Myalgia	below serious				7622
46425	1 pts		Myalgia intercostal	below serious				7622
46426	8 pts		Osteoarthritis	below serious				7622
46427	1 pts		Osteonecrosis	below serious				7622
46428	14 pts		Osteoporosis	below serious				7622
46429	38 pts		Pain in extremity	below serious				7622
46430	2 pts		Pain in jaw	below serious				7622
46431	1 pts		Periarthritis	below serious				7622
46432	2 pts		Arthropathy psoriatic	below serious				7622
46433	2 pts		Rotator cuff syndrome	below serious				7622
46434	1 pts		Scleroderma	below serious				7622
46435	1 pts		Sjogren's syndrome	below serious				7622
46436	1 pts		Soft tissue disorder	below serious				7622
46437	1 pts		Osteoarthritis spinal	below serious				7622
46438	2 pts		Spinal pain	below serious				7622
46439	1 pts		Spondylolisthesis	below serious				7622
46440	2 pts		Synovial cyst	below serious				7622
46441	1 pts		Tendon pain	below serious				7622
46442	1 pts		Tenosynovitis	below serious				7622
46443	1 pts		Basal cell carcinoma	below serious				7622
46444	1 pts		Benign neoplasm of skin	below serious				7622
46445	1 pts		Cancer pain	below serious				7622
46446	1 pts		Invasive breast carcinoma	below serious				7622
46447	2 pts		Lipoma	below serious				7622
46448	2 pts		Seborrhoeic keratosis	below serious				7622
46449	1 pts		Skin papilloma	below serious				7622
46450	1 pts		Aphasia	below serious				7622
46451	1 pts		Aphonia	below serious				7622
46452	1 pts		Aura	below serious				7622
46453	6 pts		Balance disorder	below serious				7622
46454	1 pts		Burning sensation	below serious				7622
46455	2 pts		Cognitive disorder	below serious				7622
46456	4 pts		Disturbance in attention	below serious				7622
46457	71 pts		Dizziness	below serious				7622
46458	1 pts		Dysaesthesia	below serious				7622
46459	25 pts		Dysgeusia	below serious				7622
46460	1 pts		Dyskinesia	below serious				7622
46461	1 pts		Facial nerve disorder	below serious				7622
46462	126 pts		Headache	below serious				7622
46463	1 pts		Hemiparesis	below serious				7622
46464	8 pts		Hypoaesthesia	below serious				7622
46465	1 pts		Loss of consciousness	below serious				7622
46466	1 pts		Mental impairment	below serious				7622
46467	1 pts		Motor dysfunction	below serious				7622
46468	2 pts		Neuralgia	below serious				7622
46469	31 pts		Neuropathy peripheral	below serious				7622
46470	11 pts		Paraesthesia	below serious				7622
46471	3 pts		Peripheral motor neuropathy	below serious				7622
46472	18 pts		Peripheral sensory neuropathy	below serious				7622
46473	3 pts		Polyneuropathy	below serious				7622
46474	1 pts		Radiculopathy	below serious				7622
46475	4 pts		Restless legs syndrome	below serious				7622
46476	9 pts		Sciatica	below serious				7622
46477	1 pts		Seizure	below serious				7622
46478	1 pts		Sinus headache	below serious				7622
46479	1 pts		Somnolence	below serious				7622
46480	1 pts		Speech disorder	below serious				7622
46481	5 pts		Syncope	below serious				7622
46482	1 pts		Tension headache	below serious				7622
46483	1 pts		Transient ischaemic attack	below serious				7622
46484	7 pts		Tremor	below serious				7622
46485	8 pts		Agitation	below serious				7622
46486	43 pts		Anxiety	below serious				7622
46487	3 pts		Confusional state	below serious				7622
46488	26 pts		Depression	below serious				7622
46489	1 pts		Dysphoria	below serious				7622
46490	3 pts		Emotional disorder	below serious				7622
46491	1 pts		Genito-pelvic pain/penetration disorder	below serious				7622
46492	2 pts		Hallucination	below serious				7622
46493	1 pts		Initial insomnia	below serious				7622
46494	119 pts		Insomnia	below serious				7622
46495	2 pts		Irritability	below serious				7622
46496	1 pts		Libido decreased	below serious				7622
46497	1 pts		Increased libido	below serious				7622
46498	1 pts		Libido increased	below serious				7622
46499	1 pts		Mania	below serious				7622
46500	1 pts		Mood swings	below serious				7622
46501	3 pts		Nervousness	below serious				7622
46502	1 pts		Nightmare	below serious				7622
46503	1 pts		Panic attack	below serious				7622
46504	1 pts		Psychotic disorder	below serious				7622
46505	3 pts		Restlessness	below serious				7622
46506	3 pts		Sleep disorder	below serious				7622
46507	2 pts		Stress	below serious				7622
46508	2 pts		Suicidal ideation	below serious				7622
46509	1 pts		Acute kidney injury	below serious				7622
46510	1 pts		Azotaemia	below serious				7622
46511	4 pts		Bladder discomfort	below serious				7622
46512	2 pts		Bladder pain	below serious				7622
46513	1 pts		Bladder spasm	below serious				7622
46514	2 pts		Chronic kidney disease	below serious				7622
46515	21 pts		Dysuria	below serious				7622
46516	1 pts		Leukocyturia	below serious				7622
46517	2 pts		Micturition disorder	below serious				7622
46518	2 pts		Nephritis	below serious				7622
46519	1 pts		Nephropathy	below serious				7622
46520	1 pts		Nocturia	below serious				7622
46521	11 pts		Pollakiuria	below serious				7622
46522	1 pts		Proteinuria	below serious				7622
46523	2 pts		Renal failure	below serious				7622
46524	1 pts		Renal pain	below serious				7622
46525	1 pts		Urethral pain	below serious				7622
46526	1 pts		Urinary tract obstruction	below serious				7622
46527	4 pts		Urinary tract pain	below serious				7622
46528	2 pts		Urine odour abnormal	below serious				7622
46529	1 pts		Breast discharge	below serious				7622
46530	2 pts		Breast tenderness	below serious				7622
46531	1 pts		Coital bleeding	below serious				7622
46532	3 pts		Dyspareunia	below serious				7622
46533	1 pts		Menopausal symptoms	below serious				7622
46534	1 pts		Metrorrhagia	below serious				7622
46535	1 pts		Uterine polyp	below serious				7622
46536	4 pts		Vaginal discharge	below serious				7622
46537	1 pts		Vaginal mucosal blistering	below serious				7622
46538	1 pts		Prolapse vaginal	below serious				7622
46539	2 pts		Vulvovaginal burning sensation	below serious				7622
46540	7 pts		Vulvovaginal dryness	below serious				7622
46541	3 pts		Vulvovaginal pain	below serious				7622
46542	2 pts		Atelectasis	below serious				7622
46543	74 pts		Cough	below serious				7622
46544	4 pts		Dysphonia	below serious				7622
46545	88 pts		Dyspnoea	below serious				7622
46546	1 pts		Dyspnoea at rest	below serious				7622
46547	17 pts		Dyspnoea exertional	below serious				7622
46548	23 pts		Epistaxis	below serious				7622
46549	1 pts		Hydrothorax	below serious				7622
46550	1 pts		Hypoxia	below serious				7622
46551	1 pts		Interstitial lung disease	below serious				7622
46552	21 pts		Nasal congestion	below serious				7622
46553	1 pts		Nasal discomfort	below serious				7622
46554	1 pts		Nasal dryness	below serious				7622
46555	2 pts		Painful respiration	below serious				7622
46556	2 pts		Pleuritic pain	below serious				7622
46557	1 pts		Aspiration pneumonia	below serious				7622
46558	14 pts		Productive cough	below serious				7622
46559	1 pts		Respiratory tract congestion	below serious				7622
46560	6 pts		Allergic rhinitis	below serious				7622
46561	9 pts		Rhinorrhoea	below serious				7622
46562	1 pts		Rhonchi	below serious				7622
46563	4 pts		Sinus pain	below serious				7622
46564	1 pts		Sleep apnoea syndrome	below serious				7622
46565	1 pts		Tonsillar disorder	below serious				7622
46566	2 pts		Upper-airway cough syndrome	below serious				7622
46567	2 pts		Acne	below serious				7622
46568	1 pts		Actinic keratosis	below serious				7622
46569	1 pts		Angioedema	below serious				7622
46570	1 pts		Blood blister	below serious				7622
46571	3 pts		Dermal cyst	below serious				7622
46572	1 pts		Dermatitis	below serious				7622
46573	1 pts		Dermatitis acneiform	below serious				7622
46574	2 pts		Dermatitis allergic	below serious				7622
46575	4 pts		Dermatitis contact	below serious				7622
46576	1 pts		Drug eruption	below serious				7622
46577	4 pts		Ecchymosis	below serious				7622
46578	6 pts		Erythema	below serious				7622
46579	1 pts		Erythema dyschromicum perstans	below serious				7622
46580	2 pts		Erythema multiforme	below serious				7622
46581	1 pts		Hirsutism	below serious				7622
46582	8 pts		Hyperhidrosis	below serious				7622
46583	1 pts		Ingrowing nail	below serious				7622
46584	2 pts		Macule	below serious				7622
46585	2 pts		Madarosis	below serious				7622
46586	3 pts		Nail disorder	below serious				7622
46587	1 pts		Nail growth abnormal	below serious				7622
46588	1 pts		Nail ridging	below serious				7622
46589	1 pts		Pain of skin	below serious				7622
46590	2 pts		Palmar-plantar erythrodysaesthesia syndrome	below serious				7622
46591	1 pts		Papule	below serious				7622
46592	28 pts		Petechiae	below serious				7622
46593	29 pts		Photosensitivity reaction	below serious				7622
46594	3 pts		Purpura	below serious				7622
46595	23 pts		Rash	below serious				7622
46596	2 pts		Rash pruritic	below serious				7622
46597	1 pts		Sebaceous gland disorder	below serious				7622
46598	3 pts		Skin discolouration	below serious				7622
46599	2 pts		Skin disorder	below serious				7622
46600	2 pts		Skin exfoliation	below serious				7622
46601	3 pts		Skin irritation	below serious				7622
46602	3 pts		Skin lesion	below serious				7622
46603	2 pts		Skin ulcer	below serious				7622
46604	2 pts		Swelling face	below serious				7622
46605	4 pts		Urticaria	below serious				7622
46606	1 pts		Blood pressure fluctuation	below serious				7622
46607	1 pts		Embolism	below serious				7622
46608	7 pts		Haematoma	below serious				7622
46609	54 pts		Hot flush	below serious				7622
46610	2 pts		Hyperaemia	below serious				7622
46611	81 pts		Hypertension	below serious				7622
46612	1 pts		Lymphocele	below serious				7622
46613	3 pts		Orthostatic hypotension	below serious				7622
46614	2 pts		Pallor	below serious				7622
46615	1 pts		Peripheral ischaemia	below serious				7622
46616	1 pts		Thrombosis	below serious				7622
46617	3 pts		Varicose vein	below serious				7622
46618	2 pts		Thrombocytopenia	grade 4	discontinuation	leads to discontinuation	TRUE	7623
46619	3 pts		Neutropenia	grade 1-2				7623
46620	1 pts		Neutropenia	grade 3				7623
46621	1 pts		Lymphopenia	grade 3				7623
46622	3 pts		Nausea	grade 1-2				7623
46623	3 pts		Vomiting	grade 1-2				7623
46624	2 pts		Constipation	grade 1-2				7623
46625	2 pts		Anorexia	grade 1-2				7623
46626	4 pts		Fatigue	grade 1-2				7623
46627	2 pts		Insomnia	grade 1-2				7623
46628	1 pts		Fatigue	grade 3			TRUE	7625
46629	1 pts		Pneumonitis	grade 3			TRUE	7626
46630	32		Thrombocytopenia	grade 1-2				7624
46631	29		Thrombocytopenia	grade 3-4				7624
46632	3		Thrombocytopenia		discontinuation	leads to discontinuation		7624
46633	25		Anemia	grade 1-2				7624
46634	25		Anemia	grade 3-4				7624
46635	1		Anemia		discontinuation	leads to discontinuation		7624
46636	2		Neutropenia		discontinuation	leads to discontinuation		7624
46637	10		Neutropenia	grade 1-2				7624
46638	20		Neutropenia	grade 3-4				7624
46639	12		Leukopenia	grade 1-2				7624
46640	5		Leukopenia	grade 3-4				7624
46641	10		Palpitations	grade 1-2				7624
46642	71		Nausea	grade 1-2				7624
46643	3		Nausea	grade 3-4				7624
46644	31		Abdominal distension	grade 1-2				7624
46645	2		Abdominal distension	grade 3-4				7624
46646	32		Vomiting	grade 1-2				7624
46647	2		Vomiting	grade 3-4				7624
46648	39.2		Constipation	grade 1-2				7624
46649	0.8		Constipation	grade 3-4				7624
46650	19.5		Mucositis	grade 1-2				7624
46651	0.5		Mucositis	grade 3-4				7624
46652	19.5		Stomatitis	grade 1-2				7624
46653	0.5		Stomatitis	grade 3-4				7624
46654	19.7		Diarrhea	grade 1-2				7624
46655	0.3		Diarrhea	grade 3-4				7624
46656	18		Dyspepsia	grade 1-2				7624
46657	9.7		Dry mouth	grade 1-2				7624
46658	0.3		Dry mouth	grade 3-4				7624
46659	49		Fatigue	grade 1-2				7624
46660	49		Fatigue	grade 1-2				7624
46661	8		Asthenia	grade 3-4				7624
46662	8		Asthenia	grade 3-4				7624
46663	24.7		Decreased appetite	grade 1-2				7624
46664	0.3		Decreased appetite	grade 3-4				7624
46665	12.2		Urinary tract infection	grade 1-2				7624
46666	0.8		Urinary tract infection	grade 3-4				7624
46667	6		Aspartate aminotransferase increased	grade 1-2				7624
46668	4		Aspartate aminotransferase increased	grade 3-4				7624
46669	6		Alanine aminotransferase increase	grade 1-2				7624
46670	4		Alanine aminotransferase increase	grade 3-4				7624
46671	18.2		Myalgia	grade 1-2				7624
46672	0.8		Myalgia	grade 3-4				7624
46673	17.2		Back pain	grade 1-2				7624
46674	0.8		Back pain	grade 3-4				7624
46675	12.7		Arthralgia	grade 1-2				7624
46676	0.3		Arthralgia	grade 3-4				7624
46677	25.7		Headache	grade 1-2				7624
46678	0.3		Headache	grade 3-4				7624
46679	18		Dizziness	grade 1-2				7624
46680	10		Dysgeusia	grade 1-2				7624
46681	26.7		Insomnia	grade 1-2				7624
46682	0.3		Insomnia	grade 3-4				7624
46683	10.7		Anxiety	grade 1-2				7624
46684	0.3		Anxiety	grade 3-4				7624
46685	23		Nasopharyngitis	grade 1-2				7624
46686	19		Dyspnea	grade 1-2				7624
46687	1		Dyspnea	grade 3-4				7624
46688	16		Cough	grade 1-2				7624
46689	20.5		Rash	grade 1-2				7624
46690	0.5		Rash	grade 3-4				7624
46691	11		Hypertension	grade 1-2				7624
46692	9		Hypertension	grade 3-4				7624
46693	<1		Hypertension		discontinuation	leads to discontinuation		7624
46694	60		Decreased hemoglobin	grade 1-2				7624
46695	25		Decreased hemoglobin	grade 3-4				7624
46696	37		Platelet count decreased	grade 1-2				7624
46697	35		Platelet count decreased	grade 3-4				7624
46698	59		WBC decreased	grade 1-2				7624
46699	7		WBC decreased	grade 3-4				7624
46700	32		Absolute neutrophil count decreased	grade 1-2				7624
46701	21		Absolute neutrophil count decreased	grade 3-4				7624
46702	1.4		Myelodysplastic syndrome	all grades				7624
46703	1 pts		Myelodysplastic syndrome	grade 5	discontinuation	leads to discontinuation		7624
46704	1-10		Tachycardia					7624
46705	1-10		Peripheral edema					7624
46706	1-10		Hypokalemia					7624
46707	1-10		Bronchitis					7624
46708	1-10		Conjunctivitis					7624
46709	1-10		Gamma-glutamyltransferase increased					7624
46710	1-10		Blood creatinine increased					7624
46711	1-10		Blood alkaline phosphatase increased					7624
46712	1-10		Weight decreased					7624
46713	1-10		Depression					7624
46714	1-10		Epistaxis					7624
46715	3.6		Basal cell carcinoma		discontinuation			7629
46716	5.4		Abdominal pain					7628
46717	5.4		Application site erosion					7628
46718	17.9		Application site erythema					7628
46719	7.1		Pruritus					7628
46720	0.7		Myalgia		discontinuation			7627
46721	11		Nausea					7633
46722	8		Anaemia					7633
46723	8		Arthralgia					7633
46724	8		Headache					7633
46725	6		Asthenia					7633
46726	6		Blood corticotrophin increased					7633
46727	6		Constipation					7633
46728	6		Depression					7633
46729	6		Dizziness					7633
46730	6		Fatigue					7633
46731	6		Hirsutism					7633
46732	6		Nasopharyngitis					7633
46733	6		Cortisol free urine decreased					7633
46734	3		Cough					7633
46735	3		Insomnia					7633
46736	3		Urinary tract infection					7633
46737	3		Rash			AEs prevented further dose escalation	TRUE	7633
46738	3		Visual impairment			AEs prevented further dose escalation	TRUE	7633
46739	3		Headache			AEs prevented further dose escalation	TRUE	7633
46740	3		Paresis cranial nerve			AEs prevented further dose escalation	TRUE	7633
46741	3		Pituitary tumour benign			AEs prevented further dose escalation	TRUE	7633
46742	3		Hypocortisolism			AEs prevented further dose escalation	TRUE	7633
46743	43.1		Adrenal insufficiency					7635
46744	38.7		Fatigue					7635
46745	37.2		Nausea	grade 1-2				7635
46746	30.7		Headache					7635
46747	21.2		Edema					7635
46748	19.7		Nasopharyngitis					7635
46749	19		Vomiting	grade 1-2				7635
46750	17.5		Arthralgia					7635
46751	15.3		Back pain					7635
46752	15.3		Rash					7635
46753	14.6		Diarrhea	grade 1-2				7635
46754	13.9		Blood corticotrophin increased					7635
46755	13.9		Dizziness					7635
46756	13.1		Abdominal pain	grade 1-2				7635
46757	12.4		Hypokalaemia					7635
46758	12.4		Myalgia					7635
46759	11.7		Decreased appetite					7635
46760	11.7		Hormone level abnormal					7635
46761	11.7		Hypotension					7635
46762	11.7		Urinary tract infection					7635
46763	10.9		Blood testosterone increased					7635
46764	10.9		Pyrexia					7635
46765	10.2		Anemia					7635
46766	10.2		Cough					7635
46767	10.2		Hypertension					7635
46768	10.2		Influenza					7635
46769	43.1		Adrenal insufficiency					7635
46770	38.7		Fatigue					7635
46771	37.2		Nausea	grade 1-2				7635
46772	30.7		Headache					7635
46773	21.2		Edema					7635
46774	19.7		Nasopharyngitis					7635
46775	19		Vomiting	grade 1-2				7635
46776	17.5		Arthralgia					7635
46777	15.3		Back pain					7635
46778	15.3		Rash					7635
46779	14.6		Diarrhea	grade 1-2				7635
46780	13.9		Blood corticotrophin increased					7635
46781	13.9		Dizziness					7635
46782	13.1		Abdominal pain	grade 1-2				7635
46783	12.4		Hypokalaemia					7635
46784	12.4		Myalgia					7635
46785	11.7		Decreased appetite					7635
46786	11.7		Hormone level abnormal					7635
46787	11.7		Hypotension					7635
46788	11.7		Urinary tract infection					7635
46789	10.9		Blood testosterone increased					7635
46790	10.9		Pyrexia					7635
46791	10.2		Anemia					7635
46792	10.2		Cough					7635
46793	10.2		Hypertension					7635
46794	10.2		Influenza					7635
46795	9.5		Hirsutism					7635
46796	8.8		Acne					7635
46797	8		Dyspepsia					7635
46798	8		Insomnia					7635
46799	7.3		Anxiety					7635
46800	7.3		Depression					7635
46801	7.3		Gastroenteritis					7635
46802	6.6		Malaise					7635
46803	6.6		Tachycardia					7635
46804	5.8		Alopecia					7635
46805	4.4		Transaminases increased					7635
46806	3.6		QT interval prolonged					7635
46807	1.5		Syncope					7635
46808	1.4		Neutropenia					7635
46809	13.1		Neutrophil count decreased					7635
46810	4		ALT increased	grade 1				7635
46811	4		AST increased	grade 1				7635
46812	0.72		Hypokalemia		discontinuation			7635
46813	5.8		Pituitary tumor NOS		discontinuation			7635
46814			Hypocortisolism		dose reduction			7634
46815	5.3		Headache	grade 3-5				7637
46816	5.3		Adrenal insufficiency	grade 3-5				7637
46817	21.1		Hypertension	grade 3-5				7637
46818	5.3		Anaemia	grade 3-5				7637
46819	5.3		Depression	grade 3-5				7637
46820	5.3		Lipase increased	grade 3-5				7637
46821	15.8		Pituitary-dependent Cushing's syndrome	grade 3-5				7637
46822			Electrocardiogram QTc interval prolonged					7630
46823	3.6		QT interval prolonged					7636
46824						No AEs reported		7632
46825						AEs not reported		7631
46826	9.7		Nasopharyngitis					7638
46827	6		Headache					7638
46828	6.8		Upper respiratory tract infection					7638
46829	2.6		Alanine aminotransferase increased					7638
46830	2.2		Back pain					7638
46831	2.2		Gamma-glutamyltransferase increased					7638
46832	2.2		Respiratory tract infection viral					7638
46833	1.8		Urinary tract infection					7638
46834	1.3		Hypercholesterolaemia					7638
46835	2.4		Hypertension					7638
46836	1.3		Pharyngitis					7638
46837	1.8		Rhinitis					7638
46838	2		Upper abdominal pain					7638
46839	6.7		Nasopharyngitis					7641
46840	7.6		Headache					7641
46841	4		Upper respiratory tract infection					7641
46842	4.7		Alanine aminotransferase increased					7641
46843	3.8		Back pain					7641
46844	3.3		Gamma-glutamyltransferase increased					7641
46845	3.3		Respiratory tract infection viral					7641
46846	3.8		Urinary tract infection					7641
46847	2.5		Hypercholesterolaemia					7641
46848	1.3		Hypertension					7641
46849	2.5		Pharyngitis					7641
46850	2		Rhinitis					7641
46851	1.3		Upper abdominal pain					7641
46852	26		Upper respiratory infection					7639
46853	10		Transaminases increased					7639
46854	4		Orthostatic hypotension					7639
46855	4		Urinary tract infection					7639
46856	4		Back pain					7639
46857	4		Hypertension					7639
46858	2		Abdominal pain upper					7639
46859	1		Hepatic enzymes increased		discontinuation	leads to discontinuation		7640
46860	5.3		Neutrophil count decreased		discontinuation			7647
46861	5.9		Neutropenia		discontinuation			7646
46862	5.9		Vomiting		discontinuation			7646
46863	16.7		Headache	grade 2				7643
46864	66.7		Neutropenia	grade 1-2	discontinuation			7642
46865	44.4		Headache	grade 1-2				7642
46866	33.3		Abdominal pain	grade 1-2				7642
46867	22.2		Diarrhea	grade 1-2				7642
46868	22.2		Nausea	grade 1-2				7642
46869	22.2		Dyspepsia	grade 1-2				7642
46870	22.2		Creatinine increased	grade 1-2				7642
46871	22.2		Dizziness	grade 1-2				7642
46872	22.2		Fatigue	grade 1-2				7642
46873	11.1		Neutropenia	grade 3	discontinuation			7644
46874	11.1		Vomiting	grade 2	discontinuation			7645
46875						No AEs are reported		7652
46876			Hepatotoxicity	grade 5		WARNING		7651
46877	4.9		ALT increased	all grades	discontinuation	leads to discontinuation		7649
46878	4.9		AST increased	all grades	discontinuation	leads to discontinuation		7649
46879	3.3		Hepatotoxicity	all grades	discontinuation	leads to discontinuation		7649
46880	13		ALT increased	all grades	discontinuation	leads to dose reduction or interruption		7649
46881	13		AST increased	all grades	discontinuation	leads to dose reduction or interruption		7649
46882	8		Nausea	all grades	discontinuation	leads to dose reduction or interruption		7649
46883	7		ALP increased	all grades	discontinuation	leads to dose reduction or interruption		7649
46884	4.9		Vomiting	all grades	discontinuation	leads to dose reduction or interruption		7649
46885	3.3		Bilirubin increased	all grades	discontinuation	leads to dose reduction or interruption		7649
46886	3.3		GGT increased	all grades	discontinuation	leads to dose reduction or interruption		7649
46887	3.3		Dizziness		discontinuation	leads to dose reduction or interruption		7649
46888	3.3		Abdominal pain		discontinuation	leads to dose reduction or interruption		7649
46889	1.6		Hypertension	all grades	discontinuation	leads to discontinuation		7650
46890	1.6		LDH increased	all grades	discontinuation	leads to discontinuation		7650
46891						impossible to link AEs with the definite dose		7648
46892	33.3		Electrocardiogram QTc interval prolonged					7653
46893	24		Electrocardiogram QTc interval prolonged	grade 3			TRUE	7654
46894	38		Electrocardiogram QTc interval prolonged	grade 3			TRUE	7658
46895	3		Vomiting	grade 3				7661
46896	3		Anorexia	grade 3				7661
46897	3		Fatigue	grade 3				7661
46898	4		Fatigue	grade 3				7657
46899	6		Anemia	grade 3				7661
46900	6		Anemia	grade 3				7659
46901	3		Hypocalcemia	grade 3				7661
46902	3		Pyrexia	grade 3				7661
46903	6		Eyelid edema	grade 3				7659
46904	6		Hypoalbuminemia	grade 3				7659
46905	6		Lung infection	grade 3				7659
46906	3		Pancytopenia	grade 3				7661
46907	4		Photosensitivity	grade 3				7657
46908	4		Thrombocytopenia	grade 3				7657
46909	62.5		Fatigue					7655
46910	25		Dysgeusia					7655
46911	37.5		Nausea					7655
46912	25		Vomiting					7655
46913	25		Edema peripheral					7655
46914	12.5		Peripheral sensory neuropathy					7655
46915	25		Anemia					7655
46916	25		Neutropenia					7655
46917	12.5		Electrocardiogram QT prolonged					7655
46918	12.5		Tumor pain					7655
46919	12.5		Abdominal distension					7655
46920	12.5		Leukopenia					7655
46921	12.5		Thrombocytopenia					7655
46922	25		Hyperglycemia					7655
46923	12.5		Dyspnea					7655
46924	12.5		Pain in extremity					7655
46925	20		Pancytopenia	grade 3	discontinuation		TRUE	7656
46926	20		Electrocardiogram QT prolonged	grade 3	discontinuation		TRUE	7656
46927	20		Febrile neutropenia				TRUE	7656
46928	2		Nausea	grade 3				7660
46929	8		Fatigue	grade 3				7660
46930	5		Thrombocytopenia	grade 3				7660
46931	30		Thrombocytopenia	grade 4				7660
46932	<1		Thrombocytopenia	grade 5				7660
46933	2		Pyrexia	grade 3				7660
46934	4		Musculoskeletal pain	grade 3				7660
46935	29		Anaemia	grade 3				7660
46936	1		Anaemia	grade 4				7660
46937	28		Febrile neutropenia	grade 3				7660
46938	2		Febrile neutropenia	grade 4				7660
46939	5		Neutropenia	grade 3				7660
46940	27		Neutropenia	grade 4				7660
46941	3		Vomiting	grade 3				7660
46942	11		Hypokalaemia	grade 3				7660
46943	1		Hypokalaemia	grade 4				7660
46944	2		Diarrhoea	grade 3				7660
46945	4		Electrocardiogram QT prolonged	grade 3				7660
46946	<1		Cough	grade 3				7660
46947	2		Rash	grade 3				7660
46948	2		Abdominal pain	grade 3				7660
46949	<1		Headache	grade 3				7660
46950	11		Septic shock	grade 3				7660
46951	6		Septic shock	grade 4				7660
46952	2		Septic shock	grade 5				7660
46953	3		Oedema peripheral	grade 3				7660
46954	2		Decreased appetite	grade 3				7660
46955	5		Dyspnoea	grade 3				7660
46956	<1		Dyspnoea	grade 4				7660
46957	5		White blood cell count decreased	grade 3				7660
46958	12		White blood cell count decreased	grade 4				7660
46959	2		Stomatitis	grade 3				7660
46960	<1		Stomatitis	grade 4				7660
46961	7		Pneumonia	grade 3				7660
46962	1		Pneumonia	grade 4				7660
46963	4		Pneumonia	grade 5				7660
46964	4		ALT increased	grade 3				7660
46965	3		Hypotension	grade 3				7660
46966	<1		Hypotension	grade 4				7660
46967	3		Graft versus host disease	grade 3				7660
46968	1		Graft versus host disease	grade 4				7660
46969	1		Graft versus host disease	grade 5				7660
46970	<1		Hypocalcaemia	grade 3				7660
46971	1		Petechiae	grade 3				7660
46972	1		Weight decreased	grade 3				7660
46973	4		Hypophosphataemia	grade 3				7660
46974	<1		Hypophosphataemia	grade 4				7660
46975	3		Hyponatremia	grade 3				7660
46976	<1		Hyponatremia	grade 4				7660
46977	4		Urinary tract infection	grade 3				7660
46978	<1		Urinary tract infection	grade 4				7660
46979	2		Upper respiratory tract infection	grade 3				7660
46980	3		Cellulitis	grade 3				7660
46981	1		Hyperglycaemia	grade 3				7660
46982	1		Hyperglycaemia	grade 4				7660
46983	2		Leukocytosis	grade 3				7660
46984	1		Leukocytosis	grade 4				7660
46985	<1		Leukocytosis	grade 5				7660
46986	1		Acute renal failure	grade 3				7660
46987	<1		Acute renal failure	grade 4				7660
46988			Acute renal failure	grade 5				7660
46989	5		Pancytopenia	grade 3				7660
46990	4		Syncope	grade 3				7660
46991	2		Clostridioides difficile infection	grade 3				7660
46992	<1		Clostridioides difficile infection	grade 4				7660
46993	3		Device related infection	grade 3				7660
46994	2		Lymphocyte count decreased	grade 3				7660
46995	1		Lymphocyte count decreased	grade 4				7660
46996	1		Intracranial haemorrhage	grade 4				7660
46997	2		Intracranial haemorrhage	grade 5				7660
46998	2		Pneumonia fungal	grade 3				7660
46999	1		Respiratory distress	grade 3				7660
47000	<1		Respiratory distress	grade 4				7660
47001	1		Respiratory distress	grade 5				7660
47002	2		Pneumonia		discontinuation			7660
47003	2		Intracranial haemorrhage		discontinuation			7660
47004	2		Graft versus host disease		discontinuation			7660
47005	2		Septic shock		discontinuation			7660
47006	1		QT interval prolonged	grade 2	discontinuation			7660
47007	5		QT interval prolonged		dose interruption			7660
47008	9		QT interval prolonged		dose reduction			7660
47009	7.8		Nasopharyngitis					7662
47010	6.3		Diarrhea					7662
47011	6.3		Pain in extremity					7662
47012	7.1		Arthralgia					7662
47013	8.6		Upper respiratory tract infection					7662
47014	6.7		Edema peripheral					7662
47015	6		Hypertension					7662
47016	3		Back pain					7662
47017	3.7		Musculoskeletal pain					7662
47018	5.6		Nausea					7662
47019	3.4		Headache					7662
47020	0.4		Hypertensive heart disease	grade 5				7662
47021						No adverse effects leading to discontinuation were reported		7663
47022						There were no differences in the general AEs between rolofylline and placebo		7664
47023						impossible to link AEs with the definite dose		7670
47024	33.3		Asthenia					7665
47025	33.3		Fatigue					7665
47026	100		Nausea					7665
47027	66.7		Vomiting					7665
47028	100		Diarrhea					7665
47029	33.3		Decreased appetite					7665
47030	33.3		Alanine aminotransferase increase					7665
47031	33.3		Transaminases increased					7665
47032	33.3		Headache					7665
47033	33.3		Abdominal pain					7665
47034	14.3		Dysgeusia					7665
47035	33.3		Dyspnea					7665
47036	1 pts		Torsades de pointes	grade 5	discontinuation	leads to discontinuation		7669
47037	2		Fatigue		discontinuation	leads to discontinuation		7666
47038	2		Asthenia		discontinuation	leads to discontinuation		7666
47039	21.2		Anemia		discontinuation	leads to dose reduction or interruption		7668
47040	19.8		Fatigue		discontinuation	leads to dose reduction or interruption		7668
47041	19.8		Asthenia		discontinuation	leads to dose reduction or interruption		7668
47042	21.2		Hemoglobin decreased		discontinuation	leads to dose reduction or interruption		7668
47043	17.2		Nausea		discontinuation	leads to dose reduction or interruption		7668
47044	11.4		Vomiting		discontinuation	leads to dose reduction or interruption		7668
47045	9.8		Alanine aminotransferase increased		discontinuation	leads to dose reduction or interruption		7668
47046	9.8		Thrombocytopenia		discontinuation	leads to dose reduction or interruption		7668
47047	6.6		Platelet count decreased		discontinuation	leads to dose reduction or interruption		7668
47048	6.3		Neutrophil count decreased		discontinuation	leads to dose reduction or interruption		7668
47049	6.3		Neutropenia		discontinuation	leads to dose reduction or interruption		7668
47050	5		Blood creatinine increased		discontinuation	leads to dose reduction or interruption		7668
47051	4.7		Abdominal pain		discontinuation	leads to dose reduction or interruption		7668
47052	4.7		Abdominal pain upper		discontinuation	leads to dose reduction or interruption		7668
47053	1.7		Intestinal obstruction		discontinuation	leads to discontinuation		7667
47054	1.7		Small intestinal obstruction		discontinuation	leads to discontinuation		7667
47055	1.3		Nausea		discontinuation	leads to discontinuation		7667
47056	1.1		Abdominal pain		discontinuation	leads to discontinuation		7667
47057	1.1		Abdominal pain upper		discontinuation	leads to discontinuation		7667
47058	2 pts		Dermatitis acneiform	grade 3-4				7671
47059	2 pts		Rash	grade 3-4				7671
47060	2 pts		Rash erythematous	grade 3-4				7671
47061	2 pts		Rash maculo-papular	grade 3-4				7671
47062	2 pts		Rash pruritic	grade 3-4				7671
47063	1 pts		Diarrhea	grade 3-4				7671
47064	3 pts		Nausea	grade 1-2				7671
47065	2 pts		Fatigue	grade 1-2				7671
47066	2 pts		Peripheral edema	grade 1-2				7671
47067	2 pts		Vomiting	grade 1-2				7671
47068	3 pts		Blurred vision	grade 1-2				7671
47069			Fatigue	grade 3			TRUE	7675
47070			Acneiform dermatitis	grade 3			TRUE	7674
47071			Pleural effusion	grade 3			TRUE	7674
47072	>5		Vomiting		discontinuation	leads to dose interruption/reduction		7672
47073	>5		Paronychia		discontinuation	leads to dose interruption/reduction		7672
47074	>5		Diarrhea		discontinuation	leads to dose interruption/reduction		7672
47075	>5		Nausea		discontinuation	leads to dose interruption/reduction		7672
47076	>5		Abdominal pain		discontinuation	leads to dose interruption/reduction		7672
47077	>5		Rash		discontinuation	leads to dose interruption/reduction		7672
47078	>5		Skin infection		discontinuation	leads to dose interruption/reduction		7672
47079	>5		Influenza like illness		discontinuation	leads to dose interruption/reduction		7672
47080	>5		Pyrexia		discontinuation	leads to dose interruption/reduction		7672
47081	>5		Weight gain		discontinuation	leads to dose interruption/reduction		7672
47082	2		Creatinine increased		discontinuation	leads to discontinuation		7673
47083	2		Weight increased		discontinuation	leads to discontinuation		7673
47084	2		Diarrhea		discontinuation	leads to discontinuation		7673
47085	2		Paronychia		discontinuation	leads to discontinuation		7673
47086	2		Malignant peripheral nerve sheath tumor		discontinuation	leads to discontinuation		7673
47087	2		Acute kidney injury		discontinuation	leads to discontinuation		7673
47088	2		Skin ulcer		discontinuation	leads to discontinuation		7673
47089	1.7		Headache		discontinuation			7680
47090	1.7		Diarrhea		discontinuation			7678
47091	1.7		Pulmonary embolus		discontinuation			7679
47092						No information on AE is provided		7676
47093						No information on AE is provided		7677
47094	1 pts		Anemia		discontinuation	leads to discontinuation		7686
47095	2 pts		Function liver abnormal		discontinuation	leads to discontinuation		7686
47096	23 pts		Myelosuppression			leads to dose reduction		7686
47097	53		Anemia	grade 1-4				7685
47098	35		Neutropenia	grade 1-4				7685
47099	27		Thrombocytopenia	grade 1-4				7685
47100	21		Decreased appetite	grade 1-4				7685
47101	33		Headache	grade 1-4				7685
47102	49		Nausea	grade 1-4				7685
47103	25		Vomiting	grade 1-4				7685
47104	22		Diarrhea	grade 1-4				7685
47105	25		Alopecia	grade 1-4				7685
47106	62		Fatigue	grade 1-4				7685
47107	38		Anemia	grade 3				7685
47108	18		Neutropenia	grade 3				7685
47109	11		Thrombocytopenia	grade 3				7685
47110	<1		Decreased appetite	grade 3				7685
47111	2		Headache	grade 3				7685
47112	<1		Nausea	grade 3				7685
47113	2		Vomiting	grade 3				7685
47114	1		Diarrhea	grade 3				7685
47115	3		Fatigue	grade 3				7685
47116	1		Anemia	grade 4				7685
47117	3		Neutropenia	grade 4				7685
47118	4		Thrombocytopenia	grade 4				7685
47119	19		Abdominal pain					7685
47120	17		Dizziness					7685
47121	17		Leukopenia					7685
47122	10		Dysgeusia					7685
47123	10		Dyspepsia					7685
47124	8		Stomatitis					7685
47125	7		Lymphopenia					7685
47126	90		Decreased hemoglobin	grade 1-4				7682
47127	84		Leukocyte count decreased	grade 1-4				7682
47128	68		Neutropenia	grade 1-4				7682
47129	76		Lymphocyte count low	grade 1-4				7682
47130	55		Platelets decreased	grade 1-4				7682
47131	54		Glucose increased	grade 1-4				7682
47132	37		Aspartate aminotransferase increase	grade 1-4				7682
47133	36		Alkaline phosphatase increased	grade 1-4				7682
47134	33		Alanine aminotransferase increase	grade 1-4				7682
47135	28		Calcium decreased	grade 1-4				7682
47136	39		Decreased hemoglobin	grade 3				7682
47137	14		Leukocyte count decreased	grade 3				7682
47138	17		Neutropenia	grade 3				7682
47139	17		Lymphocyte count low	grade 3				7682
47140	11		Platelets decreased	grade 3				7682
47141	2		Glucose increased	grade 3				7682
47142	2		Aspartate aminotransferase increase	grade 3				7682
47143	2		Alkaline phosphatase increased	grade 3				7682
47144	1		Alanine aminotransferase increase	grade 3				7682
47145	1		Calcium decreased	grade 3				7682
47146	0		Leukocyte count decreased	grade 4				7682
47147	3		Neutropenia	grade 4				7682
47148	1		Lymphocyte count low	grade 4				7682
47149	4		Platelets decreased	grade 4				7682
47150	16.67		Thrombocytopenia	grade 3	discontinuation	leads to discontinuation		7681
47151	16.67		Thrombocytopenia	grade 4	discontinuation	leads to discontinuation		7681
47152	2		Anemia		discontinuation	leads to discontinuation		7683
47153	1		Accidental overdose		discontinuation	leads to discontinuation		7683
47154	1		Cerebral hemorrhage		discontinuation	leads to discontinuation		7683
47155	1		Dyspnea		discontinuation	leads to discontinuation		7683
47156	1		Glioblastoma multiforme		discontinuation	leads to discontinuation		7683
47157	1		Headache		discontinuation	leads to discontinuation		7683
47158	1		Metastases to meninges		discontinuation	leads to discontinuation		7683
47159	1		Neutropenia		discontinuation	leads to discontinuation		7683
47160	1		Chronic obstructive airways disease		discontinuation	leads to discontinuation		7683
47161	1		Thrombocytopenia		discontinuation	leads to discontinuation		7683
47162	1		Transient ischemic attack		discontinuation	leads to discontinuation		7683
47163	1		Vomiting		discontinuation	leads to discontinuation		7683
47164	32		Anemia			leads to dose reduction		7684
47165	15		Neutropenia			leads to dose reduction		7684
47166	6		Thrombocytopenia			leads to dose reduction		7684
47167	>5		Anemia			leads to dose modification		7684
47168	>5		Neutropenia			leads to dose modification		7684
47169	>5		Thrombocytopenia			leads to dose modification		7684
47170	>5		Platelet count decreased			leads to dose modification		7684
47171	63.6		Diarrhea	grade 1-3				7687
47172	45.5		Fatigue	grade 1-3			TRUE	7687
47173	45.5		Decreased appetite	grade 1-2				7687
47174	72.7		Hyperglycemia	grade 1-4			TRUE	7687
47175	54.5		Nausea	grade 1-2				7687
47176	36.4		Stomatitis	grade 1-2				7687
47177	27.3		Rash	grade 1-3				7687
47178	36.4		Vomiting	grade 1-2				7687
47179	9.1		Dry mouth	grade 1-2				7687
47180	9.1		Colitis	grade 1-2				7687
47181	18.2		Leukopenia	grade 1-2				7687
47182	18.2		Pyrexia	grade 1-2				7687
47183	9.1		Pneumonitis	grade 3				7687
47184	9.1		Exfoliative rash	grade 3				7687
47185	9.1		Lung infection	grade 3				7687
47186	9.1		Skin exfoliation	grade 3				7687
47187	27.3		Hyponatremia	grade 1-2				7687
47188	18.2		ALT increased	grade 1-3				7687
47189	9.1		Anemia	grade 1-2				7687
47190	18.2		Headache	grade 1-2				7687
47191	9.1		Dyspnea	grade 1-2				7687
47192	27.3		Hypokalemia	grade 1-3				7687
47193	36.4		Dehydration	grade 1-2				7687
47194	27.3		Dizziness	grade 1-2				7687
47195	9.1		Respiratory syncytial virus infection	grade 3				7687
47196	9.1		Facial nerve disorder	grade 3				7687
47197	10		Acute renal failure	grade 3	discontinuation		TRUE	7688
47198	10		Hyperglycemia	grade 3			TRUE	7688
47199	33.3		Rash	grade 3	discontinuation			7692
47200	33.3		Diarrhea	grade 3	discontinuation			7692
47201	33.3		Lung infection	grade 3	discontinuation			7692
47202	33.3		Decreased appetite	grade 3	discontinuation			7689
47203	66.7		Colitis	grade 3	discontinuation			7690
47204	33.3		Gingivitis	grade 3	discontinuation			7690
47205	60.1		Diarrhea	grade 1-3	discontinuation			7691
47206						The safety proﬁle of S18886 was excellent, whatever the unit dose, with no attributable adverse events		7693
47207	1 pts		Electrocardiogram QTc interval prolonged	grade 3	dose reduction			7697
47208	1 pts		Diarrhea	grade 3	dose reduction			7697
47209	1 pts		Rash	grade 3	dose reduction			7697
47210	1 pts		Gastrointestinal discomfort	grade 1	dose reduction			7697
47211	1 pts		Gastrointestinal bleed	grade 3	discontinuation			7697
47212	1 pts		Blood creatinine increased	grade 2	dose interruption			7697
47213	1 pts		Hyperkalemia	grade 2	dose interruption			7697
47214	7		Nausea	grade 2				7697
47215	14		Fatigue	grade 2				7697
47216	7		Anorexia	grade 2				7697
47217	1 pts		Gastrointestinal bleed	grade 3	discontinuation			7694
47218	1 pts		Pneumonia	grade 3	dose interruption			7694
47219	1 pts		Electrocardiogram QTc interval prolonged	grade 3	dose reduction			7694
47220	5		Pruritus	grade 2				7694
47221	2		Dry skin	grade 2				7694
47222	2		Dysgeusia	grade 2				7694
47223	2		Mucosal inflammation	grade 2				7694
47224	2		Vomiting	grade 2				7694
47225	1 pts		Onychomadesis	grade 2	dose interruption			7694
47226	5		Diarrhea	grade 3				7694
47227	2		Fatigue	grade 3				7694
47228	1 pts		Pneumonitis	grade 3			TRUE	7696
47229	2 pts		Electrocardiogram QTc interval prolonged	grade 3			TRUE	7695
47230	2 pts		Diarrhea	grade 4	dose reduction		TRUE	7698
47231	14.3		Ataxia	grade 3			TRUE	7699
47232	14.3		Proteinuria	grade 3			TRUE	7699
47233	28.6		Hypertension	grade 3			TRUE	7699
47234	12.5		Hypertension				TRUE	7700
47235	12.5		Serum transaminase increased	grade 3-4			TRUE	7700
47236	8.3		Vomiting	grade 3			TRUE	7703
47237	25		Fatigue		dose interruption	dose interruption, reduction, or delay		7703
47238	8.3		Appetite decreased NOS	grade 3	dose interruption	dose interruption, reduction, or delay	TRUE	7703
47239	16.7		Vomiting		dose interruption	dose interruption, reduction, or delay		7703
47240	25		Neutropenia		dose interruption	dose interruption, reduction, or delay		7703
47241	8.3		Fatigue	grade 3			TRUE	7703
47242	25		Nausea		dose interruption	dose interruption, reduction, or delay		7703
47243	8.3		Nausea	grade 3			TRUE	7703
47244	25		Thrombocytopenia		dose interruption	dose interruption, reduction, or delay		7703
47245	8.3		Anemia		dose interruption	dose interruption, reduction, or delay		7703
47246	8.3		Essential tremor		dose interruption	dose interruption, reduction, or delay		7703
47247						No adverse effects leading to discontinuation were reported; no DLTs		7702
47248	33.3		Seizure	grade 3			TRUE	7701
47249	20		Asthenia	grade 2			TRUE	7704
47250	20		Nausea	grade 3			TRUE	7704
47251	20		Vomiting	grade 3			TRUE	7704
47252	6.8		Neutropenia	grade 4			TRUE	7708
47253	3.4		Neutropenia	grade 3			TRUE	7708
47254	6.8		Thrombocytopenia	grade 4			TRUE	7708
47255	3.4		Febrile neutropenia	grade 3			TRUE	7708
47256	3.4		QT interval prolonged	grade 3			TRUE	7708
47257	3.4		Fatigue	grade 3	discontinuation		TRUE	7708
47258	3.4		Weight decreased	grade 3	discontinuation		TRUE	7708
47259	100		Thrombocytopenia	grade 4			TRUE	7705
47260	100		Neutropenia	grade 4			TRUE	7705
47261	10		Neutropenia		discontinuation			7707
47262	10		Neutropenia	grade 3			TRUE	7707
47263	20		Febrile neutropenia	grade 4			TRUE	7707
47264	20		Thrombocytopenia	grade 4			TRUE	7707
47265	30		Neutropenia	grade 4			TRUE	7707
47266						No adverse effects leading to discontinuation were reported; no DLTs		7706
47267	33.3		Neutropenia	grade 4			TRUE	7709
47268	33.3		Thrombocytopenia	grade 4			TRUE	7709
47269	3 pts		Dry mouth	below serious				7710
47270	1 pts		Drug-induced extrapyramidal side effects	below serious				7710
47271	1 pts		Rash	below serious				7710
47272	4 pts		Sedation	below serious				7710
47273	1 pts		Status epilepticus	serious				7714
47274	1 pts		Constipation	below serious				7714
47275	1 pts		Vomiting	below serious				7714
47276	3 pts		Pyrexia	below serious				7714
47277	1 pts		Lower respiratory tract infection	below serious				7714
47278	1 pts		Upper respiratory tract infection	below serious				7714
47279	1 pts		Viral rash	below serious				7714
47280	1 pts		Accident	below serious				7714
47281	1 pts		Hepatic enzyme increased	below serious				7714
47282	1 pts		Urine ketone body absent	below serious				7714
47283	1 pts		Urine ketone body present	below serious				7714
47284	1 pts		Ketosis	below serious				7714
47285	2 pts		Ataxia	below serious				7714
47286	1 pts		Dysarthria	below serious				7714
47287	1 pts		Poor quality sleep	below serious				7714
47288	2 pts		Sedation	below serious				7714
47289	2 pts		Somnolence	below serious				7714
47290	3 pts		Abnormal behaviour	below serious				7714
47291	1 pts		Proteinuria	below serious				7714
47292	1 pts		Erythema	below serious				7714
47293	2 pts		Pyrexia	serious				7715
47294	1 pts		Rash maculo-papular	serious				7715
47295	1 pts		Vomiting	below serious				7715
47296	1 pts		Gait disturbance	below serious				7715
47297	1 pts		Pyrexia	below serious				7715
47298	1 pts		Pneumonia	below serious				7715
47299	1 pts		Decreased appetite	below serious				7715
47300	1 pts		Increased appetite	below serious				7715
47301	1 pts		Coordination abnormal	below serious				7715
47302	3 pts		Somnolence	below serious				7715
47303	1 pts		Irritability	below serious				7715
47304	1 pts		Rash	below serious				7715
47305	1 pts		Urticaria	below serious				7715
47306	1 pts		Parvovirus infection	serious				7712
47307	1 pts		Diplopia	below serious				7712
47308	2 pts		Abdominal pain upper	below serious				7712
47309	1 pts		Dry mouth	below serious				7712
47310	1 pts		Eructation	below serious				7712
47311	1 pts		Haematochezia	below serious				7712
47312	1 pts		Vomiting	below serious				7712
47313	1 pts		Erythema infectiosum	below serious				7712
47314	1 pts		Otitis media acute	below serious				7712
47315	1 pts		Pneumonia	below serious				7712
47316	1 pts		Viral infection	below serious				7712
47317	1 pts		Aspartate aminotransferase increased	below serious				7712
47318	1 pts		Liver function test abnormal	below serious				7712
47319	4 pts		Decreased appetite	below serious				7712
47320	1 pts		Ataxia	below serious				7712
47321	1 pts		Headache	below serious				7712
47322	2 pts		Sedation	below serious				7712
47323	1 pts		Tremor	below serious				7712
47324	1 pts		Rash	below serious				7712
47325	1 pts		Rash papular	below serious				7712
47326	1 pts		Abdominal distension	serious				7713
47327	1 pts		Abdominal pain	serious				7713
47328	1 pts		Gastrointestinal haemorrhage	serious				7713
47329	1 pts		Asthenia	serious				7713
47330	1 pts		Fatigue	serious				7713
47331	1 pts		Lower respiratory tract infection	serious				7713
47332	1 pts		Oral herpes	serious				7713
47333	1 pts		Pneumonia	serious				7713
47334	1 pts		Aspartate aminotransferase increased	serious				7713
47335	1 pts		Gamma-glutamyltransferase	serious				7713
47336	1 pts		Liver function test abnormal	serious				7713
47337	1 pts		Platelet count	serious				7713
47338	1 pts		Weight decreased	serious				7713
47339	1 pts		Decreased appetite	serious				7713
47340	1 pts		Hypophagia	serious				7713
47341	2 pts		Convulsion	serious				7713
47342	3 pts		Somnolence	serious				7713
47343	1 pts		Hypotonia	serious				7713
47344	1 pts		Lethargy	serious				7713
47345	1 pts		Myoclonus	serious				7713
47346	1 pts		Epistaxis	serious				7713
47347	1 pts		Hypovolaemic shock	serious				7713
47348	19 pts		Diarrhoea	below serious				7713
47349	9 pts		Vomiting	below serious				7713
47350	9 pts		Pyrexia	below serious				7713
47351	11 pts		Fatigue	below serious				7713
47352	7 pts		Upper respiratory tract infection	below serious				7713
47353	4 pts		Gamma-glutamyltransferase increased	below serious				7713
47354	4 pts		Transaminases increased	below serious				7713
47355	4 pts		Weight decreased	below serious				7713
47356	16 pts		Decreased appetite	below serious				7713
47357	19 pts		Somnolence	below serious				7713
47358	7 pts		Lethargy	below serious				7713
47359	5 pts		Convulsion	below serious				7713
47360	4 pts		Irritability	below serious				7713
47361	4 pts		Cough	below serious				7713
47362						No AEs are reported		7711
47363	1.3		Transaminases increased		discontinuation	leads to discontinuation		7716
47364	8		Transaminases increased					7716
47365	16		Decreased appetite					7716
47366	9		Diarrhea					7716
47367	3		Weight decreased					7716
47368	3		Abdominal discomfort					7716
47369	23		Somnolence					7716
47370	3		Sedation					7716
47371	4		Lethargy					7716
47372	11		Fatigue					7716
47373	11		Malaise					7716
47374	11		Asthenia					7716
47375	9		Irritability					7716
47376	9		Agitation					7716
47377	11		Insomnia					7716
47378	11		Sleep disorder					7716
47379	11		Poor quality sleep					7716
47380	3		Aggression					7716
47381	3		Anger					7716
47382	1		Drooling					7716
47383	1		Salivary hypersecretion					7716
47384	3		Gait disturbance					7716
47385	7		Infection viral					7716
47386	8		Pneumonia					7716
47387	1		Fungal infection					7716
47388	25		Infection NOS					7716
47389	7		Rash					7716
47390	3		Hypoxia					7716
47391	3		Respiratory failure					7716
47392	5.9		Transaminases increased		discontinuation	leads to discontinuation		7717
47393	16		Transaminases increased					7717
47394	22		Decreased appetite					7717
47395	20		Diarrhea					7717
47396	5		Weight decreased					7717
47397	3		Abdominal discomfort					7717
47398	25		Somnolence					7717
47399	6		Sedation					7717
47400	8		Lethargy					7717
47401	12		Fatigue					7717
47402	12		Malaise					7717
47403	12		Asthenia					7717
47404	5		Irritability					7717
47405	5		Agitation					7717
47406	5		Aggression					7717
47407	5		Anger					7717
47408	4		Drooling					7717
47409	4		Salivary hypersecretion					7717
47410	2		Gait disturbance					7717
47411	11		Infection viral					7717
47412	5		Pneumonia					7717
47413	3		Fungal infection					7717
47414	21		Infection NOS					7717
47415	13		Rash					7717
47416	3		Hypoxia					7717
47417	4		Gastroenteritis					7717
47418	5		Insomnia					7717
47419	5		Sleep disorder					7717
47420	5		Poor quality sleep					7717
47421	3		Respiratory failure					7717
47422	1 pts		Ear and labyrinth disorders					7718
47423	1 pts		Eye disorders					7718
47424	16 pts		Gastrointestinal disorders					7718
47425	2 pts		Infection					7718
47426	3 pts		Investigations					7718
47427	1 pts		Metabolism and nutrition disorders					7718
47428	7 pts		Musculoskeletal and connective tissue disorders					7718
47429	21 pts		Nervous system disorders					7718
47430	4 pts		Psychiatric disorders					7718
47431	6 pts		Respiratory, thoracic and mediastinal disorders					7718
47432	11 pts		Skin and subcutaneous tissue disorders					7718
47433	4 pts		Vascular disorders					7718
47434	68		Nausea					7720
47435	61		Dizziness					7720
47436	61		Hypoesthesia oral					7720
47437	48		Hypoesthesia					7720
47438	44		Paresthesia oral					7720
47439	34		Vomiting					7720
47440	52		Injection site irritation					7720
47441	1 pts		Arthralgia					7719
47442	1 pts		Back pain					7719
47443	1 pts		Chest discomfort					7719
47444	1 pts		Chills					7719
47445	4 pts		Dizziness					7719
47446	1 pts		Dry throat					7719
47447	1 pts		Feeling hot					7719
47448	4 pts		Headache					7719
47449	3 pts		Myalgia					7719
47450	2 pts		Nausea					7719
47451	10 pts		Paresthesia					7719
47452	8 pts		Paresthesia oral					7719
47453	3 pts		Pharyngeal paresthesia					7719
47454	2 pts		Pruritus					7719
47455	1 pts		Rash erythematous					7719
47456	1 pts		Throat tightness					7719
47457	1 pts		Wheezing					7719
47458	1.5		ALT increased					7721
47459	2.2		Constipation					7721
47460	2.2		Diarrhea					7721
47461	1		Gamma-glutamyltransferase increased					7721
47462	0.97		Dyspepsia		discontinuation			7722
47463	0.48		Appetite decreased NOS		discontinuation			7722
47464	0.48		Dysgeusia		discontinuation			7722
47465	1.4		Nausea		discontinuation			7722
47466	0.48		Constipation		discontinuation			7722
47467	0.48		Eructation		discontinuation			7722
47468	0.48		Gastrointestinal sounds abnormal		discontinuation			7722
47469	0.48		Reflux gastritis		discontinuation			7722
47470						No adverse effects were recorded.		7723
47471						AEs were not observed		7725
47472			Angioedema		discontinuation			7726
47473	3.23		Hypercalcaemia					7724
47474	3.23		Abdominal pain					7724
47475	3.23		Pruritus					7724
47476	3.23		Oedema peripheral					7724
47477	6.45		Muscae volitantes					7724
47478	9.68		Dyspepsia					7724
47479	3.23		Abscess					7724
47480	16.13		Pharyngitis					7724
47481	3.23		Macular oedema					7724
47482	3.23		Dermatitis fungal					7724
47483	3.23		Dizziness					7724
47484	3.23		Constipation					7724
47485	3.23		Pneumonia					7724
47486	3.23		Eye abnormality					7724
47487	6.45		Nausea					7724
47488	3.23		Hyperuricaemia					7724
47489	3.23		Upper respiratory tract infection					7724
47490	6.45		Arthralgia					7724
47491	6.45		Coughing					7724
47492	3.23		Urticaria					7724
47493	3.23		Granulomatous lesion					7724
47494	3.23		Sputum abnormal					7724
47495	3.23		Hearing decreased					7724
47496	3.23		Bronchitis					7724
47497	3.23		Hypertriglyceridaemia					7724
47498	3.23		Hepatic function abnormal					7724
47499	6.45		Headache					7724
47500	3.23		Hypoaesthesia					7724
47501			Vomiting					7728
47502			Headache					7728
47503	41.7		ALT increased					7728
47504	41.7		AST increased					7728
47505			Dizziness					7727
47506			Nausea					7727
47507			Vomiting					7727
47508			Diarrhea					7727
47509			Abdominal pain					7727
47510			Headache					7727
47511	16.7		AST increased					7727
47512	16.7		ALT increased					7727
47513						No adverse effects leading to discontinuation were reported.		7729
47514	25		Headache					7731
47515	25		Diarrhea					7731
47516	25		Abdominal pain					7731
47517						No information on AE is provided		7730
47518	1.88		Psychiatric symptom		discontinuation			7732
47519	0.63		Respiratory failure		discontinuation			7732
47520	0.63		Skin disorder		discontinuation			7732
47521						The source does not contain information about AEs or lack thereof		7735
47522			Death					7733
47523			Drug abuse		discontinuation			7734
47524	5 pts		Nausea					7736
47525	2 pts		Vomiting					7736
47526	11 pts		Thrombocytopenia				TRUE	7736
47527	13 pts		Leukopenia					7736
47528	2 pts		Vomiting					7739
47529	8 pts		Thrombocytopenia				TRUE	7739
47530	7 pts		Leukopenia					7739
47531	4 pts		Nausea					7739
47532	2 pts		Vomiting					7738
47533	4 pts		Thrombocytopenia				TRUE	7738
47534	3 pts		Leukopenia					7738
47535	5 pts		Nausea					7738
47536	3 pts		Nausea					7737
47537	1 pts		Vomiting					7737
47538	3 pts		Thrombocytopenia				TRUE	7737
47539	5		Leukopenia					7737
47540	17		Dissociation					7746
47541	3		Dizziness					7746
47542	7		Dry mouth					7746
47543	23		Headache					7746
47544	7		Nasopharyngitis					7746
47545	10		Nausea					7746
47546	3		Oropharyngeal pain					7746
47547	7		Paresthesia					7746
47548	7		Vertigo					7746
47549	3		Vomiting					7745
47550						No AEs are reported		7742
47551	1.2		Anxiety		discontinuation	leads to discontinuation		7740
47552	0.9		Depression		discontinuation	leads to discontinuation		7741
47553	0.6		Blood pressure increased		discontinuation	leads to discontinuation		7741
47554	0.6		Dizziness		discontinuation	leads to discontinuation		7741
47555	0.5		Suicidal ideation		discontinuation	leads to discontinuation		7741
47556	0.4		Dissociation		discontinuation	leads to discontinuation		7741
47557	0.4		Nausea		discontinuation	leads to discontinuation		7741
47558	0.4		Vomiting		discontinuation	leads to discontinuation		7741
47559	0.3		Headache		discontinuation	leads to discontinuation		7741
47560	0.3		Muscular weakness		discontinuation	leads to discontinuation		7741
47561	0.2		Vertigo		discontinuation	leads to discontinuation		7741
47562	0.2		Hypertension		discontinuation	leads to discontinuation		7741
47563	0.2		Panic attack		discontinuation	leads to discontinuation		7741
47564	0.2		Sedation		discontinuation	leads to discontinuation		7741
47565						No AEs are reported		7744
47566						No AEs are reported		7743
47567	7.5		Drowsiness					7747
47568	5.4		Headache					7747
47569	3.2		Irritability					7747
47570	2.7		Hypertonia					7747
47571	9.7		Sleep disturbance					7747
47572	1.6		Hypotonia					7747
47573	1.6		Dry mouth					7747
47574	1.6		Muscle weakness					7747
47575	1.1		Nausea					7747
47576	0.5		Lumbar pain					7747
47577	0.5		Tremor					7747
47578	0.5		Accommodation disturbance					7747
47579	0.5		Urination frequency of					7747
47580	8.6		Anxiety					7747
47581						No adverse effects leading to discontinuation were reported.		7748
47582			Blood pressure decreased			Several subjects experienced transient reductions in supine and standing systolic and diastolic BP		7749
47583	6		Epistaxis					7751
47584	9		Erythema					7751
47585	3		Headache					7751
47586	6		Pruritus					7751
47587	3		Abdominal distension					7751
47588	3		Rash		discontinuation			7751
47589			Prothrombin time increased	grade 1				7750
47590			Activated partial thromboplastin time increased	grade 1				7750
47591	2.4		Atrioventricular block	grade 2	discontinuation			7769
47592	8.3		Headache	grade 1				7770
47593	8.3		Headache	grade 2				7770
47594	8.3		Rash	grade 1				7770
47595	8.3		Rash	grade 2				7770
47596	16.7		Cough	grade 1				7770
47597	8.3		Dizziness		discontinuation	during administration of the loading doses		7770
47598	8.3		Hypersensitivity		discontinuation	during administration of the loading doses		7770
47599	8.3		Nausea		discontinuation	during administration of the loading doses		7770
47600	0.4		Pancytopenia		discontinuation			7767
47601	0.4		Cardiac arrest		discontinuation			7767
47602	0.4		Cardio-respiratory arrest		discontinuation			7767
47603	0.4		Congestive cardiomyopathy		discontinuation			7767
47604	0.4		Supraventricular tachycardia		discontinuation			7767
47605	0.4		Optic neuropathy		discontinuation			7767
47606	0.4		Dysphagia		discontinuation			7767
47607	0.4		Small intestinal obstruction		discontinuation			7767
47608	0.4		Vomiting		discontinuation			7767
47609	0.4		Chills		discontinuation			7767
47610	0.4		Hepatitis acute		discontinuation			7767
47611	0.4		Aspergillosis		discontinuation			7767
47612	0.4		Bronchopneumonia		discontinuation			7767
47613	0.4		Bronchopulmonary aspergillosis		discontinuation			7767
47614	0.4		Endocarditis		discontinuation			7767
47615	0.8		Fungal infection		discontinuation			7767
47616	0.4		Infection		discontinuation			7767
47617	0.4		Pneumonia		discontinuation			7767
47618	0.4		Sepsis		discontinuation			7767
47619	0.8		Septic shock		discontinuation			7767
47620	0.8		Blood bilirubin increased		discontinuation			7767
47621	0.4		Blood sodium decreased		discontinuation			7767
47622	0.4		Transaminases increased		discontinuation			7767
47623	0.4		Myositis		discontinuation			7767
47624	0.8		Convulsion		discontinuation			7767
47625	0.4		Encephalopathy		discontinuation			7767
47626	0.8		Epilepsy		discontinuation			7767
47627	0.8		Confusional state		discontinuation			7767
47628	0.8		Renal failure		discontinuation			7767
47629	0.4		Renal failure acute		discontinuation			7767
47630	0.4		Acute respiratory failure		discontinuation			7767
47631	0.8		Dyspnoea		discontinuation			7767
47632	0.4		Respiratory distress		discontinuation			7767
47633	0.8		Respiratory failure		discontinuation			7767
47634	0.4		Dermatitis		discontinuation			7767
47635	0.4		Dermatitis allergic		discontinuation			7767
47636	0.4		Hypotension		discontinuation			7767
47637	16.7		Diarrhea		discontinuation			7756
47638	16.7		Headache		discontinuation			7757
47639	0.2		Diarrhea		discontinuation			7752
47640	0.4		Vomiting		discontinuation			7753
47641	0.6		Blood creatinine increased		discontinuation			7754
47642	0.2		Headache		discontinuation			7755
47643	2.6		Diarrhea		discontinuation			7758
47644	5.1		Nausea		discontinuation			7759
47645	2.6		Vomiting		discontinuation			7760
47646	5.1		Disturbance in attention		discontinuation			7761
47647	5.1		Dizziness		discontinuation			7762
47648	7.7		Headache		discontinuation			7763
47649	7.7		Anxiety		discontinuation			7764
47650	7.7		Hot flush		discontinuation			7765
47651	0.4		Acute respiratory failure		discontinuation	Potential infusion-related TEAEs that led to study drug discontinuation		7768
47652	0.4		Chills		discontinuation	Potential infusion-related TEAEs that led to study drug discontinuation		7768
47653	0.8		Convulsion		discontinuation	Potential infusion-related TEAEs that led to study drug discontinuation		7768
47654	0.8		Dyspnoea		discontinuation	Potential infusion-related TEAEs that led to study drug discontinuation		7768
47655	0.4		Epilepsy		discontinuation	Potential infusion-related TEAEs that led to study drug discontinuation		7768
47656	0.4		Hypotension		discontinuation	Potential infusion-related TEAEs that led to study drug discontinuation		7768
47657	0.8		Respiratory failure		discontinuation	Potential infusion-related TEAEs that led to study drug discontinuation		7768
47658	8.3		Rash					7766
47659	2.2		Rash		discontinuation			7771
47660	2.2		Headache		discontinuation			7771
47661	2.2		Renal and urinary disorders		discontinuation			7771
47662	2.2		Supraventricular tachycardia		discontinuation			7771
47663	2.2		Loss of consciousness	grade 3	discontinuation			7771
47664	12.5		Urethritis	grade 1				7773
47665	12.5		Diarrhoea	grade 1				7773
47666	12.5		Occult blood positive	grade 1				7773
47667	12.5		Diarrhoea	grade 1				7772
47668	12.5		Occult blood positive	grade 1				7772
47669	10.81		Headache					7774
47670	2.7		Nausea					7774
47671	4.05		Eye redness					7774
47672	16.22		Facial flushing					7774
47673	0.4		Cellulitis		discontinuation	leads to discontinuation		7777
47674	0.3		Osteomyelitis		discontinuation	leads to discontinuation		7777
47675	1 pts		Mouth ulceration		discontinuation	leads to discontinuation		7775
47676	1 pts		Nausea		discontinuation	leads to discontinuation		7775
47677	1 pts		Rectal haemorrhage		discontinuation	leads to discontinuation		7775
47678	1 pts		Vomiting		discontinuation	leads to discontinuation		7775
47679	1 pts		Chest discomfort		discontinuation	leads to discontinuation		7775
47680	1 pts		Infusion site extravasation		discontinuation	leads to discontinuation		7775
47681	1 pts		Infusion site pain		discontinuation	leads to discontinuation		7775
47682	2 pts		Infusion site phlebitis		discontinuation	leads to discontinuation		7775
47683	1 pts		Infusion site thrombosis		discontinuation	leads to discontinuation		7775
47684	1 pts		Drug hypersensitivity		discontinuation	leads to discontinuation		7776
47685	1 pts		Urine ketone body present		discontinuation	leads to discontinuation		7776
47686	1 pts		Hyperglycaemia		discontinuation	leads to discontinuation		7776
47687	1 pts		Tenosynovitis		discontinuation	leads to discontinuation		7776
47688	1 pts		Somnolence		discontinuation	leads to discontinuation		7776
47689	1 pts		Erythema multiforme		discontinuation	leads to discontinuation		7776
47690	1 pts		Leukocytoclastic vasculitis		discontinuation	leads to discontinuation		7776
47691	2 pts		Pruritus		discontinuation	leads to discontinuation		7776
47692	1 pts		Rash		discontinuation	leads to discontinuation		7776
47693	1 pts		Rash macular		discontinuation	leads to discontinuation		7776
47694	1 pts		Urticaria		discontinuation	leads to discontinuation		7776
47695	1 pts		Hypotension		discontinuation	leads to discontinuation		7776
47696	7.8		Hyperbilirubinemia	grade 3-4	discontinuation			7778
47697			Dysplastic nevus					7779
47698						No adverse effects leading to discontinuation were reported.		7780
47699						No adverse effects leading to discontinuation were reported.		7781
47700	87.5		Conjunctival hyperemia					7783
47701	25		Creatine phosphokinase increased					7783
47702	12.5		Triglyceride increased					7783
47703	12.5		Red blood cell count decreased					7782
47704	12.5		White blood cell count increased					7782
47705	12.5		ALP increased					7782
47706	100		Conjunctival hyperemia					7782
47707	12.5		ALT increased					7782
47708	12.5		Hematocrit decreased					7782
47709	12.5		Hemoglobin decreased					7782
47710			Erythema		discontinuation	Itchy erythema		7784
47711	1 pts		Intervertebral disc protrusion	serious				7786
47712	16 pts		Nausea	below serious				7786
47713	11 pts		Dysgeusia	below serious				7786
47714	29 pts		Headache	below serious				7786
47715	11 pts		Pruritus	below serious				7786
47716	6 pts		Urticaria	below serious				7786
47717	1 pts		Feeling hot	serious				7785
47718	1 pts		Dysgeusia	serious				7785
47719	1 pts		Headache	serious				7785
47720	20 pts		Nausea	below serious				7785
47721	47 pts		Dysgeusia	below serious				7785
47722	30 pts		Headache	below serious				7785
47723	8 pts		Pruritus	below serious				7785
47724	10 pts		Urticaria	below serious				7785
47725	66.7		Dysgeusia					7787
47726	16.7		Headache					7787
47727	16.7		Fatigue					7787
47728	16.7		Nausea					7787
47729	8.3		Dizziness postural					7787
47730	8.3		Abdominal pain					7787
47731	16.7		Pharyngolaryngeal pain					7787
47732	8.3		Micturition urgency					7787
47733	1 pts		Anaphylactic shock		discontinuation	leads to discontinuation		7788
47734	1 pts		Hypersensitivity reaction		discontinuation	leads to discontinuation		7789
47735	1 pts		Hypersensitivity reaction		discontinuation	leads to discontinuation		7790
47736	1 pts		Tachycardia		discontinuation	leads to discontinuation		7791
47737	5		Vomiting	grade 3	discontinuation			7792
47738	1.7		Weight decrease	grade 2	discontinuation			7794
47739						There were no serious adverse events leading to discontinuation or episodes of hypoglycemia.		7795
47740						No adverse effects leading to discontinuation were reported.		7793
47741	0.7		Hypotension		discontinuation			7796
47742	0.7		Urticaria		discontinuation			7796
47743	1.4		Bradycardia		discontinuation			7796
47744	0.7		Dizziness		discontinuation			7796
47745	0.7		Ventricular tachycardia		discontinuation			7796
47746	0.7		Consciousness loss		discontinuation			7796
47747	0.7		Tachycardia NOS		discontinuation			7796
47748	0.7		Seizure		discontinuation			7796
47749	7.8		Sneezing					7797
47750	0.8		Cardiogenic shock		discontinuation			7797
47751	6.2		Paraesthesia					7797
47752	0.8		Confusion		discontinuation			7797
47753	14.7		Dysgeusia					7797
47754	0.8		Cold sweat		discontinuation			7797
47755	0.8		Nausea		discontinuation			7797
47756	0.8		Sinus arrest		discontinuation			7797
47757	0.8		Headache		discontinuation			7797
47758						No adverse effects leading to discontinuation were reported		7798
47759						No serious adverse events were reported.		7799
47760	0.4		ALT increased		discontinuation			7800
47761	0.4		AST increased		discontinuation			7800
47762	0.4		Diarrhoea		discontinuation			7800
47763	0.4		Bile duct stone		discontinuation			7800
47764	20		Hyponatremia		dose reduction		TRUE	7801
47765	20		Diarrhea		discontinuation		TRUE	7801
47766	60		Vomiting		discontinuation		TRUE	7801
47767	60		Nausea	grade 1-3	discontinuation		TRUE	7801
47768	11.1		Headache	severe	discontinuation			7802
47769						2 patients withdrew due to side effects, which are not specified		7803
47770						No information on AE is provided		7804
47771	3 pts		Headache					7807
47772	1 pts		Nausea					7807
47773	1 pts		Vomiting					7807
47774	1 pts		Headache					7806
47775	5 pts		Nausea					7806
47776	5 pts		Vomiting					7806
47777	2 pts		Dizziness					7806
47778	1 pts		Ecchymosis					7806
47779	19 pts		Nausea					7805
47780	11 pts		Vomiting					7805
47781	8 pts		Dizziness					7805
47782	8 pts		Headache					7805
47783	2 pts		Nasopharyngitis					7805
47784	4 pts		Hypertension					7805
47785	1 pts		Dizziness		discontinuation	leads to discontinuation		7808
47786	1 pts		Headache		discontinuation	leads to discontinuation		7808
47787	1 pts		Abdominal distension		discontinuation	leads to discontinuation		7808
47788	1 pts		Distention		discontinuation	leads to discontinuation		7808
47789	1 pts		Nausea		discontinuation	leads to discontinuation		7808
47790	1 pts		Vomiting		discontinuation	leads to discontinuation		7808
47791	1 pts		Fatigue		discontinuation	leads to discontinuation		7808
47792	1 pts		Local swelling		discontinuation	leads to discontinuation		7808
47793	1 pts		Peripheral edema		discontinuation	leads to discontinuation		7808
47794	1 pts		Gastroenteritis		discontinuation	leads to discontinuation		7808
47795	1 pts		ALT increased		discontinuation	leads to discontinuation		7808
47796	1 pts		Aspartate aminotransferase increased		discontinuation	leads to discontinuation		7808
47797	1 pts		Electrocardiogram abnormal		discontinuation	leads to discontinuation		7808
47798	1 pts		Myalgia		discontinuation	leads to discontinuation		7808
47799	1 pts		Dizziness postural		discontinuation	leads to discontinuation		7808
47800	1 pts		Migraine		discontinuation	leads to discontinuation		7808
47801	1 pts		Hot flush		discontinuation	leads to discontinuation		7808
47802	2 pts		Dizziness		discontinuation	leads to discontinuation		7808
47803	2 pts		Headache		discontinuation	leads to discontinuation		7808
47804	25		Nausea	grade 1				7810
47805	12.5		Headache	grade 1				7810
47806	12.5		Vomiting					7810
47807						No AEs were observed		7809
47808			DRESS syndrome		discontinuation			7811
47809	1 pts		Colitis	grade 3			TRUE	7812
47810						impossible to link AEs with the definite dose: The most common MK-8776 monotherapy–related (cycle 0) AEs in 43 treated patients were QTc prolongation, nausea, constipation, and fatigue.		7813
47811						adverse effects were combined for all doses		7814
47812						impossible to link AEs with the definite dose: Headache, diarrhea, and nausea were the commonly reported adverse events in both substudies, with headache being the most frequent		7815
47813						No AEs are reported		7817
47814						No AEs are reported		7816
47815	3 pts		Nausea	grade 1-2				7820
47816	3 pts		Vomiting	grade 1-2				7820
47817	3 pts		Diarrhea	grade 1-2				7820
47818	3 pts		Constipation	grade 1-2				7820
47819	1 pts		Abdominal pain	grade 1-2				7820
47820	1 pts		Dizziness	grade 1-2				7820
47821	2 pts		Somnolence	grade 1-2				7820
47822	2 pts		Peripheral neuropathy	grade 1-2				7820
47823	1 pts		Bone pain	grade 1-2				7820
47824	1 pts		Pruritus	grade 1-2				7820
47825	2 pts		Hepatic and hepatobiliary disorders NEC	grade 1-2				7820
47826	2 pts		Anorexia	grade 1-2				7820
47827	1 pts		Fatigue	grade 1-2				7820
47828	1 pts		Constipation	grade 2			TRUE	7821
47829	1 pts		Nausea	grade 3-4				7820
47830	1 pts		Vomiting	grade 3-4				7820
47831	1 pts		Hepatic and hepatobiliary disorders NEC	grade 3-4				7820
47832	6 pts		Fatigue	grade 3				7822
47833	3 pts		Constipation	grade 3				7822
47834	3 pts		Dehydration	grade 3				7822
47835	1 pts		Asthenia	grade 3				7822
47836	1 pts		Blood alkaline phosphatase increased	grade 3				7822
47837	1 pts		Anorexia	grade 3				7822
47838	1 pts		Hypoesthesia	grade 3				7822
47839	1 pts		Peripheral motor neuropathy	grade 3				7822
47840	1 pts		Peripheral sensory neuropathy	grade 3				7822
47841	1 pts		Hallucination	grade 3				7822
47842	1 pts		Mental status changes	grade 3				7822
47843	1 pts		Anemia	grade 3			TRUE	7822
47844	1 pts		Lymphopenia	grade 3			TRUE	7822
47845	1 pts		Laryngeal edema	grade 4				7822
47846	1 pts		Hereditary motor and sensory neuropathy				TRUE	7827
47847	1 pts		Fatigue				TRUE	7827
47848	1 pts		Hypertension				TRUE	7827
47849	1 pts		Nausea				TRUE	7827
47850	1 pts		Vomiting				TRUE	7827
47851	1 pts		Dehydration				TRUE	7827
47852	1 pts		Abdominal pain				TRUE	7827
47853	1 pts		Constipation				TRUE	7827
47854	1 pts		Hereditary motor and sensory neuropathy				TRUE	7824
47855	1 pts		Fatigue				TRUE	7824
47856	1 pts		Hypertension				TRUE	7824
47857	1 pts		Nausea				TRUE	7824
47858	1 pts		Vomiting				TRUE	7824
47859	1 pts		Dehydration				TRUE	7824
47860	1 pts		Abdominal pain				TRUE	7824
47861	1 pts		Constipation				TRUE	7824
47862	6 pts		Hereditary motor and sensory neuropathy				TRUE	7825
47863	6 pts		Fatigue				TRUE	7825
47864	6 pts		Hypertension				TRUE	7825
47865	6 pts		Nausea				TRUE	7825
47866	6 pts		Vomiting				TRUE	7825
47867	6 pts		Dehydration				TRUE	7825
47868	6 pts		Abdominal pain				TRUE	7825
47869	6 pts		Constipation				TRUE	7825
47870	2 pts		Hereditary motor and sensory neuropathy				TRUE	7819
47871	2 pts		Fatigue				TRUE	7819
47872	2 pts		Hypertension				TRUE	7819
47873	2 pts		Nausea				TRUE	7819
47874	2 pts		Vomiting				TRUE	7819
47875	2 pts		Dehydration				TRUE	7819
47876	2 pts		Abdominal pain				TRUE	7819
47877	2 pts		Constipation				TRUE	7819
47878	1 pts		Hereditary motor and sensory neuropathy				TRUE	7826
47879	1 pts		Fatigue				TRUE	7826
47880	1 pts		Hypertension				TRUE	7826
47881	1 pts		Nausea				TRUE	7826
47882	1 pts		Vomiting				TRUE	7826
47883	1 pts		Dehydration				TRUE	7826
47884	1 pts		Abdominal pain				TRUE	7826
47885	1 pts		Constipation				TRUE	7826
47886	2 pts		Hereditary motor and sensory neuropathy				TRUE	7823
47887	2 pts		Fatigue				TRUE	7823
47888	2 pts		Hypertension				TRUE	7823
47889	2 pts		Nausea				TRUE	7823
47890	2 pts		Vomiting				TRUE	7823
47891	2 pts		Dehydration				TRUE	7823
47892	2 pts		Abdominal pain				TRUE	7823
47893	2 pts		Constipation				TRUE	7823
47894	3 pts		Hereditary motor and sensory neuropathy				TRUE	7818
47895	3 pts		Fatigue				TRUE	7818
47896	3 pts		Hypertension				TRUE	7818
47897	3 pts		Nausea				TRUE	7818
47898	3 pts		Vomiting				TRUE	7818
47899	3 pts		Dehydration				TRUE	7818
47900	3 pts		Abdominal pain				TRUE	7818
47901	3 pts		Constipation				TRUE	7818
47902						No AEs were reported		7828
47903						No AEs were reported		7829
47904	100		Dizziness	grade 1-2				7830
47905	16.7		Headache	grade 1-2				7830
47906	33.3		Fatigue	grade 1-2				7830
47907	66.7		Dyspepsia	grade 1-2				7830
47908	66.7		Decreased appetite	grade 1-2				7830
47909	12.5		Tachycardia		discontinuation			7831
47910	12.5		Nausea		discontinuation			7831
47911	12.5		Vomiting		discontinuation			7831
47912	5		Hypotension		discontinuation			7832
47913	1.6		Vertigo		discontinuation			7833
47914	50		Headache	grade 1-2				7835
47915	16.7		Presyncope	grade 1-2				7835
47916	16.7		Nausea	grade 1-2				7835
47917	16.7		Vomiting	grade 1-2				7835
47918	16.7		Chest pain (non-cardiac)	grade 1-2				7835
47919	66.7		Headache	grade 1-2				7836
47920	16.7		Nausea	grade 1-2				7836
47921	16.7		Abnormal feces	grade 1-2				7836
47922	16.7		Headache	grade 1-2	discontinuation			7834
47923	16.7		Pain in extremity	grade 1-2				7834
47924	16.7		Nausea	grade 1-2				7834
47925	16.7		Vomiting	grade 1-2				7834
47926	16.7		Eczema	grade 1-2				7834
47927	16.7		Nasopharyngitis	grade 1-2				7834
47928	7.8		Vomiting	grade 1-2	discontinuation			7837
47929	31.1		Headache	grade 1-3	discontinuation			7837
47930			Headache					7838
47931						No AEs were reported		7839
47932	1 pts		Nasopharyngitis					7840
47933	2 pts		Upper respiratory tract infection					7840
47934	3 pts		Gastrointestinal disorders					7840
47935	2 pts		Enterocolitis					7840
47936	1 pts		Constipation					7840
47937	1 pts		Dental caries					7840
47938	1 pts		Diarrhoea					7840
47939	1 pts		Rash					7840
47940	1 pts		Chest pain					7840
47941	1 pts		Fracture rib					7840
47942	1 pts		Palpitations					7840
47943	2		Abdominal pain		discontinuation			7841
47944	2		Headache		discontinuation			7841
47945	2		Skin rash		discontinuation			7841
47946						No AEs were reported		7842
47947	1 pts		Dizziness				TRUE	7846
47948	1 pts		Alanine aminotransferase increased				TRUE	7843
47949	1 pts		Aspartate aminotransferase increased				TRUE	7843
47950	1 pts		Dizziness				TRUE	7844
47951	37		Fatigue	all grades				7848
47952	18		Pyrexia	all grades				7848
47953	15		Edema peripheral	all grades				7848
47954	29		Nausea	all grades				7848
47955	26		Vomiting	all grades				7848
47956	23		Constipation	all grades				7848
47957	22		Diarrhea	all grades				7848
47958	13		Abdominal pain	all grades				7848
47959	28		Dizziness	all grades				7848
47960	14		Headache	all grades				7848
47961	26		Cough	all grades				7848
47962	18		Dyspnea	all grades				7848
47963	10		Nasal congestion	all grades				7848
47964	3		Fatigue	grade 3-4				7848
47965	1		Pyrexia	grade 3-4				7848
47966	1		Nausea	grade 3-4				7848
47967	1		Vomiting	grade 3-4				7848
47968	1		Constipation	grade 3-4				7848
47969	2		Diarrhea	grade 3-4				7848
47970	2		Abdominal pain	grade 3-4				7848
47971	1		Dizziness	grade 3-4				7848
47972	2		Dyspnea	grade 3-4				7848
47973	15		Weight increased	all grades				7848
47974	14		Arthralgia	all grades				7848
47975	14		Myalgia	all grades				7848
47976	13		Muscular weakness	all grades				7848
47977	12		Back pain	all grades				7848
47978	12		Pain in extremity	all grades				7848
47979	13		Decreased appetite	all grades				7848
47980	11		Decreased appetite	all grades				7848
47981	4		Weight increased	grade 3-4				7848
47982	1		Arthralgia	grade 3-4				7848
47983	1		Myalgia	grade 3-4				7848
47984	1		Back pain	grade 3-4				7848
47985	1		Pain in extremity	grade 3-4				7848
47986	2		Decreased appetite	grade 3-4				7848
47987	2		Decreased appetite	grade 3-4				7848
47988	45		ALT increased	all grades				7849
47989	45		AST increased	all grades				7849
47990	35		Hypoalbuminemia	all grades				7849
47991	30		Alkaline phosphatase increased	all grades				7849
47992	42		Anemia	all grades				7849
47993	23		Neutropenia	all grades				7849
47994	3		ALT increased	grade 3-4				7849
47995	3		AST increased	grade 3-4				7849
47996	2		Hypoalbuminemia	grade 3-4				7849
47997	3		Alkaline phosphatase increased	grade 3-4				7849
47998	10		Anemia	grade 3-4				7849
47999	7		Neutropenia	grade 3-4				7849
48000	1 - 2		Brain edema		discontinuation	leads to discontinuation		7847
48001	1 - 2		Intestinal perforation		discontinuation	leads to discontinuation		7847
48002	1 - 2		Pericardial effusion		discontinuation	leads to discontinuation		7847
48003	1 - 2		Pleural effusion		discontinuation	leads to discontinuation		7847
48004	1 - 2		Small intestinal obstruction		discontinuation	leads to discontinuation		7847
48005	1 - 2		Dehydration		discontinuation	leads to discontinuation		7847
48006	1 - 2		Fatigue		discontinuation	leads to discontinuation		7847
48007	1 - 2		ALT increased		discontinuation	leads to discontinuation		7847
48008	1 - 2		AST increased		discontinuation	leads to discontinuation		7847
48009	1 - 2		Enterocutaneous fistula		discontinuation	leads to discontinuation		7847
48010	1 - 2		Amylase increased		discontinuation	leads to discontinuation		7847
48011	1 - 2		Lipase increased		discontinuation	leads to discontinuation		7847
48012	1 - 2		Muscular weakness		discontinuation	leads to discontinuation		7847
48013	1 - 2		Abdominal pain		discontinuation	leads to discontinuation		7847
48014	1 - 2		Asthenia		discontinuation	leads to discontinuation		7847
48015	1 - 2		Decreased appetite		discontinuation	leads to discontinuation		7847
48016	1 - 2		Dyspnea		discontinuation	leads to discontinuation		7847
48017	1 - 2		Hyponatremia		discontinuation	leads to discontinuation		7847
48018	1 - 2		Jaundice		discontinuation	leads to discontinuation		7847
48019	1 - 2		Syncope		discontinuation	leads to discontinuation		7847
48020	1 - 2		Vomiting		discontinuation	leads to discontinuation		7847
48021	1 - 2		Nausea		discontinuation	leads to discontinuation		7847
48022	1 - 2		Acute myeloid leukemia		discontinuation	leads to discontinuation		7847
48023	>20		Fatigue			leads to dose decreasing frequency		7847
48024	>20		Nausea			leads to dose decreasing frequency		7847
48025	>20		Dizziness			leads to dose decreasing frequency		7847
48026	>20		Vomiting			leads to dose decreasing frequency		7847
48027	>20		Anemia			leads to dose decreasing frequency		7847
48028	>20		AST increased			leads to dose decreasing frequency		7847
48029	>20		Cough			leads to dose decreasing frequency		7847
48030	>20		ALT increased			leads to dose decreasing frequency		7847
48031	>20		Constipation			leads to dose decreasing frequency		7847
48032	>20		Diarrhea			leads to dose decreasing frequency		7847
48033	6		ALT increased			leads to dose modification		7847
48034	6		AST increased			leads to dose modification		7847
48035	3		Dizziness			leads to dose modification		7847
48036						No information on AE is provided		7845
48037	50		Diarrhoea	grade 1-2				7850
48038	50		Nausea	grade 1-2				7850
48039	33.3		Gastrointestinal hypermotility	grade 1-2				7850
48040	16.7		Abdominal discomfort	grade 1-2				7850
48041	16.7		Syncope vasovagal	grade 3	discontinuation			7852
48042	33.3		Flushing	grade 1-2				7851
48043	33.3		Throat irritation	grade 1-2				7851
48044	16.7		Nausea	grade 1-2				7851
48045						no adverse events were reported at the 2 highest doses of 200 and 250 mg.		7853
48046	26 pts		Dizziness					7854
48047	7 pts		Somnolence					7854
48048	8 pts		Headache					7854
48049	6 pts		Insomnia					7854
48050	8 pts		Nausea					7854
48051	6 pts		Dry mouth					7854
48052						No information on AE is provided		7855
48053						No AEs were observed		7856
48054	7.7		Blood uric acid increased	grade 1-2				7857
48055	4.4		Headache	grade 1-2				7857
48056	2.8		Urinary tract infection	grade 1-2				7857
48057	3.9		Liver function test increased	grade 1-2				7857
48058	2.8		Nausea	grade 1-2				7857
48059	2.8		Sinusitis	grade 1-2				7857
48060	2.2		Nasopharyngitis	grade 1-2				7857
48061	2.2		Glomerular filtration rate decreased	grade 1-2				7857
48062	1.1		Diabetes mellitus	grade 1-2				7857
48063	3.3		Muscle spasms	grade 1-2				7857
48064	0.55		Muscle spasms		discontinuation			7857
48065	1.7		Myalgia	grade 1-2				7857
48066	0.55		Myalgia		discontinuation			7857
48067	3.9		Transaminases increased	grade 1-2				7857
48068	0.6		Muscular weakness	grade 1-2				7857
48069	0.6		Pain in extremity	grade 1-2				7857
48070	0.55		Pain in extremity		discontinuation			7857
48071	6		Arthralgia	grade 1-2				7858
48072	4.3		Hypertension	grade 1-2				7858
48073	3.4		Fatigue	grade 1-2				7858
48074	3.4		Urinary tract infection	grade 1-2				7858
48075	3		Back pain	grade 1-2				7858
48076	3		Dizziness	grade 1-2				7858
48077	2.6		Bronchitis	grade 1-2				7858
48078	2.1		Blood creatine phosphokinase increased	grade 1-2				7858
48079	2.1		Dyspepsia	grade 1-2				7858
48080	5.6		Pain in extremity	grade 1-2				7858
48081	4.7		Myalgia	grade 1-2				7858
48082	3.4		Myalgia		discontinuation			7858
48083	4.3		Muscle spasms	grade 1-2				7858
48084	0.4		Muscular weakness	grade 1-2				7858
48085	1.7		Gout	grade 1-2				7858
48086	1.7		Transaminases increased	grade 1-2				7858
48087	4.5		Upper respiratory tract infection					7863
48088	3.6		Muscle spasms					7863
48089	0.5		Muscle spasms		discontinuation			7863
48090	3.5		Hyperuricemia					7863
48091	3.3		Back pain					7863
48092	3.1		Abdominal pain					7863
48093	3		Bronchitis					7863
48094	3		Pain in extremity					7863
48095	0.3		Pain in extremity		discontinuation			7863
48096	2.8		Anemia					7863
48097	2.1		Elevated liver enzymes					7863
48098	0.4		Diarrhea		discontinuation			7863
48099	0.5		Tendon rupture					7859
48100	1.5		Gout					7859
48101	1.3		Benign prostatic hyperplasia					7859
48102	1.7		Atrial fibrillation					7859
48103						No AEs reported; QC prolongation not observed; no safety concerns		7861
48104						No information		7862
48105						No information		7860
48106						No adverse effects leading to discontinuation were reported; no DLTs		7865
48107	25		Syncope				TRUE	7864
48108	25		Dizziness				TRUE	7864
48109	33		Nausea	all grades				7867
48110	0.9		Nausea	grade 3-4				7867
48111	19		Diarrhea	all grades				7867
48112	24		Vomiting	all grades				7867
48113	1.8		Vomiting	grade 3-4				7867
48114	19		Constipation	all grades				7867
48115	0.9		Constipation	grade 3-4				7867
48116	17		Abdominal distension	all grades				7867
48117	17		Abdominal pain	all grades				7867
48118	17		Epigastric discomfort	all grades				7867
48119	29		Asthenia	all grades				7867
48120	1.8		Asthenia	grade 3-4				7867
48121	29		Fatigue	all grades				7867
48122	1.8		Fatigue	grade 3-4				7867
48123	14		Pyrexia	all grades				7867
48124	18		Cough	all grades				7867
48125	27		Dyspnea	all grades				7867
48126	1 pts		Dyspnea	grade 5				7867
48127	27		Exertional dyspnea	all grades				7867
48128	2.8		Dyspnea	grade 3-4				7867
48129	2.8		Exertional dyspnea	grade 3-4				7867
48130	37		Pneumonitis	all grades	discontinuation	leads to discontinuation		7867
48131	1.8		Pneumonitis	grade 3-4	discontinuation	leads to discontinuation		7867
48132	0.9		Hypoxia	all grades				7867
48133	28		Headache	all grades				7867
48134	28		Sinus headache	all grades				7867
48135	13		Peripheral sensory neuropathy	all grades				7867
48136	13		Paresthesia	all grades				7867
48137	0.9		Peripheral sensory neuropathy	grade 3-4				7867
48138	0.9		Paresthesia	grade 3-4				7867
48139	15		Acneiform dermatitis	all grades				7867
48140	15		Exfoliative rash	all grades				7867
48141	15		Rash	all grades				7867
48142	15		Pruritic rash	all grades				7867
48143	15		Pustular rash	all grades				7867
48144	1.8		Acneiform dermatitis	grade 3-4				7867
48145	1.8		Exfoliative rash	grade 3-4				7867
48146	1.8		Rash	grade 3-4				7867
48147	1.8		Pruritic rash	grade 3-4				7867
48148	1.8		Pustular rash	grade 3-4				7867
48149	11		Hypertension	all grades				7867
48150	5.5		Hypertension	grade 3-4	discontinuation	leads to discontinuation		7867
48151	12		Muscle spasms	all grades				7867
48152	10		Back pain	all grades				7867
48153	1.8		Back pain	grade 3-4				7867
48154	9.2		Musculoskeletal pain	all grades				7867
48155	9.2		Myalgia	all grades				7867
48156	14		Arthralgia	all grades				7867
48157	0.9		Arthralgia	grade 3-4				7867
48158	11		Pain in extremity	all grades				7867
48159	22		Decreased appetite	all grades				7867
48160	0.9		Decreased appetite	grade 3-4				7867
48161	7.3		Diplopia	all grades				7867
48162	7.3		Photophobia	all grades				7867
48163	7.3		Blurred vision	all grades				7867
48164	7.3		Visual acuity reduced	all grades				7867
48165	7.3		Visual impairment	all grades				7867
48166	7.3		Vitreous floaters	all grades				7867
48167	7.3		Visual field defect	all grades				7867
48168	7.3		Macular edema	all grades				7867
48169	7.3		Vitreous detachment	all grades				7867
48170	4.6		Pneumonia	all grades	discontinuation	leads to discontinuation		7867
48171	1.83		Pneumonia	grade 3-4	discontinuation	leads to discontinuation		7867
48172	1 pts		Pneumonia	grade 5				7867
48173	11		Insomnia	all grades				7867
48174	38		Aspartate aminotransferase increased	all grades				7867
48175	0.9		Aspartate aminotransferase increased	grade 3-4				7867
48176	38		Hyperglycemia	all grades				7867
48177	3.7		Hyperglycemia	grade 3-4	discontinuation	leads to dose reduction/discontinuation		7867
48178	27		Creatine phosphokinase increased	all grades	discontinuation	leads to dose reduction		7867
48179	2.8		Creatine phosphokinase increased	grade 3-4	discontinuation	leads to dose reduction		7867
48180	21		Lipase increased	all grades				7867
48181	4.6		Lipase increased	grade 3-4				7867
48182	34		Alanine aminotransferase increased	all grades				7867
48183	27		Amylase increased	all grades				7867
48184	3.7		Amylase increased	grade 3-4				7867
48185	15		Alkaline phosphatase increased	all grades				7867
48186	0.9		Alkaline phosphatase increased	grade 3-4				7867
48187	15		Phosphate decreased	all grades				7867
48188	1.8		Phosphate decreased	grade 3-4				7867
48189	23		Anemia	all grades				7867
48190	0.9		Anemia	grade 3-4				7867
48191	19		Lymphopenia	all grades				7867
48192	2.8		Lymphopenia	grade 3-4				7867
48193	1 pts		Respiratory failure	grade 5				7867
48194	1 pts		Pulmonary embolism	grade 5				7867
48195	1 pts		Bacterial meningitis	grade 5				7867
48196	1 pts		Urosepsis	grade 5				7867
48197	1 pts		Dyspnea		discontinuation	leads to discontinuation	TRUE	7866
48198	1 pts		Hypoxia		discontinuation	leads to discontinuation	TRUE	7866
48199	1 pts		Alanine aminotransferase increased				TRUE	7868
48200						No discontinuations due to an AE were reported during the phase IIa study		7873
48201						No adverse effects leading to discontinuation were reported.		7869
48202	4		Injection site pain		discontinuation			7870
48203	1.7		Injection site pain		discontinuation			7872
48204						No grade 3/4 adverse events (AEs), drug-related AEs, or AEs leading to discontinuation were reported.		7871
48205						No adverse effects leading to discontinuation were reported		7874
48206						No information on AE is provided		7875
48207	4.2		Urticaria	grade 1	discontinuation			7876
48208						No adverse effects leading to discontinuation were reported		7878
48209						No adverse effects leading to discontinuation were reported		7877
48210	12.5		Pallor	grade 1				7880
48211	20		Hypotension	grade 1				7879
48212	40		Nausea	grade 1				7879
48213	20		Cold sweat	grade 1				7879
48214	20		Nasal congestion	grade 1				7879
48215	20		Heartburn	grade 1				7879
48216	20		Headache	grade 1				7879
48217	6.7		Dyspnea	grade 2	discontinuation			7885
48218	6.7		Hypotension	grade 2	discontinuation			7885
48219	50		Hypotension	grade 2	discontinuation			7881
48220	33.3		Hypotension	grade 3	discontinuation			7883
48221	35.7		Hypotension	grade 1-3	discontinuation			7886
48222	20		Hypotension	grade 1-2	discontinuation			7882
48223	35.7		Hypotension	grade 1-2	discontinuation			7884
48224			Semen discoloration					7888
48225	75		Semen discoloration					7887
48226	12.5		Headache	grade 2				7889
48227	4 pts		Renal failure	grade 3				7892
48228	1 pts		Vomiting	grade 3			TRUE	7891
48229	1 pts		Acute renal failure	grade 3			TRUE	7891
48230	14 pts		Anemia	grade 1-2				7894
48231	8 pts		Hyperglycemia	grade 1-2				7894
48232	17 pts		Alkaline phosphatase increased	grade 1-2				7894
48233	14 pts		Fatigue	grade 1-2				7894
48234	12 pts		Peripheral sensory neuropathy	grade 1-2				7894
48235	14 pts		Platelet count decreased	grade 1-2				7894
48236	11 pts		Diarrhea	grade 1-2				7894
48237	15 pts		Hypoalbuminemia	grade 1-2				7894
48238	11 pts		Hyponatremia	grade 1-2				7894
48239	12 pts		Nausea	grade 1-2				7894
48240	13 pts		Hypomagnesemia	grade 1-2				7894
48241	8 pts		Lymphocyte count decreased	grade 1-2				7894
48242	13 pts		Pain	grade 1-2				7894
48243	12 pts		Alanine aminotransferase increased	grade 1-2				7894
48244	11 pts		Anorexia	grade 1-2				7894
48245	6 pts		Hypokalemia	grade 1-2				7894
48246	7 pts		Abdominal pain	grade 1-2				7894
48247	11 pts		Anxiety	grade 1-2				7894
48248	11 pts		Aspartate aminotransferase increased	grade 1-2				7894
48249	11 pts		Dysgeusia	grade 1-2				7894
48250	10 pts		Hypertension	grade 1-2				7894
48251	10 pts		Hypocalcemia	grade 1-2				7894
48252	9 pts		Weight loss	grade 1-2				7894
48253	9 pts		White blood cell decreased	grade 1-2				7894
48254	3 pts		Neutrophil count decreased	grade 1-2				7894
48255	7 pts		Constipation	grade 1-2				7894
48256	7 pts		Cough	grade 1-2				7894
48257	7 pts		Insomnia	grade 1-2				7894
48258	4 pts		Anemia	grade 3				7894
48259	9 pts		Hyperglycemia	grade 3				7894
48260	3 pts		Fatigue	grade 3				7894
48261	5 pts		Peripheral sensory neuropathy	grade 3				7894
48262	3 pts		Platelet count decreased	grade 3				7894
48263	5 pts		Diarrhea	grade 3				7894
48264	3 pts		Hyponatremia	grade 3				7894
48265	2 pts		Nausea	grade 3				7894
48266	5 pts		Lymphocyte count decreased	grade 3				7894
48267	1 pts		Anorexia	grade 3				7894
48268	5 pts		Abdominal pain	grade 3				7894
48269	4 pts		Hypokalemia	grade 3				7894
48270	1 pts		Hypertension	grade 3				7894
48271	1 pts		Weight loss	grade 3				7894
48272	4 pts		Neutrophil count decreased	grade 3				7894
48273	1 pts		Hyperglycemia	grade 4				7894
48274	1 pts		Hypoalbuminemia	grade 4				7894
48275	1 pts		Hypokalemia	grade 4				7894
48276	1 pts		Neutrophil count decreased	grade 4				7894
48277	4 pts		Vomiting	grade 1-2				7894
48278	4 pts		Back pain	grade 1-2				7894
48279	5 pts		Chronic kidney disease	grade 1-2				7894
48280	3 pts		Dehydration	grade 1-2				7894
48281	5 pts		Dizziness	grade 1-2				7894
48282	4 pts		Dyspnea	grade 1-2				7894
48283	5 pts		Edema limbs	grade 1-2				7894
48284	4 pts		Fever	grade 1-2				7894
48285	2 pts		Cardiac disorders	grade 1-2				7894
48286	4 pts		Chills	grade 1-2				7894
48287	4 pts		Gastroesophageal reflux disease	grade 1-2				7894
48288	3 pts		General disorders and administration site conditions	grade 1-2				7894
48289	2 pts		Hypophosphatemia	grade 1-2				7894
48290	4 pts		Sinus tachycardia	grade 1-2				7894
48291	4 pts		Urinary frequency	grade 1-2				7894
48292	3 pts		Activated partial thromboplastin time prolonged	grade 1-2				7894
48293	3 pts		Atelectasis	grade 1-2				7894
48294	3 pts		Blood bilirubin increased	grade 1-2				7894
48295	2 pts		Depression	grade 1-2				7894
48296	3 pts		Flatulence	grade 1-2				7894
48297	3 pts		Gastrointestinal disorders	grade 1-2				7894
48298	3 pts		Pleural effusion	grade 1-2				7894
48299	3 pts		Urinary tract infection	grade 1-2				7894
48300	2 pts		Ventricular arrhythmia	grade 1-2				7894
48301	2 pts		Ascites	grade 1-2				7894
48302	2 pts		Blurred vision	grade 1-2				7894
48303	1 pts		Dysphagia	grade 1-2				7894
48304	2 pts		Edema face	grade 1-2				7894
48305	2 pts		Fall	grade 1-2				7894
48306	3 pts		Vomiting	grade 3				7894
48307	1 pts		Back pain	grade 3				7894
48308	2 pts		Dehydration	grade 3				7894
48309	1 pts		Dyspnea	grade 3				7894
48310	1 pts		Fever	grade 3				7894
48311	2 pts		Cardiac disorders	grade 3				7894
48312	1 pts		General disorders and administration site conditions	grade 3				7894
48313	2 pts		Hypophosphatemia	grade 3				7894
48314	1 pts		Depression	grade 3				7894
48315	3 pts		Leukocytosis	grade 3				7894
48316	3 pts		Thromboembolic event	grade 3				7894
48317	1 pts		Ventricular arrhythmia	grade 3				7894
48318	1 pts		Dysphagia	grade 3				7894
48319	2 pts		Generalized muscle weakness	grade 1-2				7894
48320	2 pts		Headache	grade 1-2				7894
48321	2 pts		Hypernatremia	grade 1-2				7894
48322	1 pts		Hypoxia	grade 1-2				7894
48323	2 pts		Nasal congestion	grade 1-2				7894
48324	2 pts		Palpitations	grade 1-2				7894
48325	2 pts		Pericardial effusion	grade 1-2				7894
48326	2 pts		Productive cough	grade 1-2				7894
48327	2 pts		Proteinuria	grade 1-2				7894
48328	2 pts		Rash maculo-papular	grade 1-2				7894
48329	2 pts		Respiratory, thoracic and mediastinal disorders	grade 1-2				7894
48330	2 pts		Skin and subcutaneous tissue disorders	grade 1-2				7894
48331	2 pts		Weight gain	grade 1-2				7894
48332	1 pts		Enterocolitis infectious	grade 3				7894
48333	1 pts		Esophageal infection	grade 3				7894
48334	1 pts		GGT increased	grade 3				7894
48335	1 pts		Glucose intolerance	grade 3				7894
48336	1 pts		Infections and infestations	grade 3				7894
48337	1 pts		Lung infection	grade 3				7894
48338	1 pts		Pancreatitis	grade 3				7894
48339	1 pts		Sepsis	grade 4				7894
48340	2 pts		Lymphopenia	grade 4				7890
48341	1 pts		Pulmonary embolus	grade 4	discontinuation	leads to discontinuation	TRUE	7890
48342	1 pts		Hyponatremia	grade 4	discontinuation	leads to discontinuation	TRUE	7890
48343	1 pts		Dehydration	grade 4	discontinuation	leads to discontinuation	TRUE	7890
48344	1 pts		Hyponatremia	grade 4	discontinuation	leads to discontinuation	TRUE	7890
48345	1 pts		Hypotension	grade 4	discontinuation	leads to discontinuation	TRUE	7890
48346	29 pts		Hyperglycemia	grade 1				7893
48347	61 pts		Hypomagnesemia	grade 1				7893
48348	17 pts		Hypoalbuminemia	grade 1				7893
48349	37 pts		Hypokalemia	grade 1				7893
48350	18 pts		Hypocalcemia	grade 1				7893
48351	10 pts		Diarrhea	grade 1				7893
48352	38 pts		Hyponatremia	grade 1				7893
48353	28 pts		Aspartate aminotransferase increased	grade 1				7893
48354	28 pts		SGOT increased	grade 1				7893
48355	21 pts		Nausea	grade 1				7893
48356	21 pts		Hyperbilirubinemia	grade 1				7893
48357	23 pts		Alanine aminotransferase increase	grade 1				7893
48358	23 pts		ALT increased	grade 1				7893
48359	10 pts		Fatigue	grade 1				7893
48360	18 pts		Proteinuria	grade 1				7893
48361	25 pts		Partial thromboplastin time prolonged	grade 1				7893
48362	24 pts		Alkaline phosphatase increased	grade 1				7893
48363	6 pts		Cardiac troponin T increased	grade 1				7893
48364	16 pts		Left ventricular systolic dysfunction	grade 1				7893
48365	16 pts		Headache	grade 1				7893
48366	5 pts		Hemoglobin decreased	grade 2				7893
48367	19 pts		Hyperglycemia	grade 2				7893
48368	4 pts		Hypomagnesemia	grade 2				7893
48369	44 pts		Hypoalbuminemia	grade 2				7893
48370	29 pts		Hypocalcemia	grade 2				7893
48371	32 pts		Diarrhea	grade 2				7893
48372	22 pts		Hypophosphatemia	grade 2				7893
48373	32 pts		Disseminated intravascular coagulation	grade 2				7893
48374	6 pts		Aspartate aminotransferase increased	grade 2				7893
48375	6 pts		SGOT increased	grade 2				7893
48376	16 pts		Nausea	grade 2				7893
48377	10 pts		Hyperbilirubinemia	grade 2				7893
48378	9 pts		Alanine aminotransferase increase	grade 2				7893
48379	9 pts		ALT increased	grade 2				7893
48380	20 pts		Fatigue	grade 2				7893
48381	15 pts		Proteinuria	grade 2				7893
48382	1 pts		Partial thromboplastin time prolonged	grade 2				7893
48383	6 pts		Alkaline phosphatase increased	grade 2				7893
48384	7 pts		Cardiac troponin T increased	grade 2				7893
48385	6 pts		Left ventricular systolic dysfunction	grade 2				7893
48386	9 pts		Headache	grade 2				7893
48387	53 pts		Hemoglobin decreased	grade 3				7893
48388	18 pts		Hyperglycemia	grade 3				7893
48389	1 pts		Neutropenia	grade 3				7893
48390	1 pts		Thrombocytopenia	grade 3				7893
48391	1 pts		Hypomagnesemia	grade 3				7893
48392	4 pts		Hypoalbuminemia	grade 3				7893
48393	23 pts		Hypokalemia	grade 3				7893
48394	9 pts		Hypocalcemia	grade 3				7893
48395	13 pts		Diarrhea	grade 3				7893
48396	8 pts		Hyponatremia	grade 3				7893
48397	24 pts		Hypophosphatemia	grade 3				7893
48398	13 pts		Disseminated intravascular coagulation	grade 3				7893
48399	7 pts		Aspartate aminotransferase increased	grade 3				7893
48400	7 pts		SGOT increased	grade 3				7893
48401	1 pts		Nausea	grade 3			TRUE	7893
48402	5 pts		Hyperbilirubinemia	grade 3				7893
48403	4 pts		Alanine aminotransferase increase	grade 3				7893
48404	4 pts		ALT increased	grade 3				7893
48405	3 pts		Fatigue	grade 3				7893
48406	5 pts		Partial thromboplastin time prolonged	grade 3				7893
48407	27 pts		Febrile neutropenia	grade 3				7893
48408	8 pts		Cardiac troponin T increased	grade 3				7893
48409	4 pts		Left ventricular systolic dysfunction	grade 3				7893
48410	1 pts		Headache	grade 3				7893
48411	9 pts		Hemoglobin decreased	grade 4				7893
48412	1 pts		Hyperglycemia	grade 4				7893
48413	66 pts		Neutropenia	grade 4				7893
48414	66 pts		Thrombocytopenia	grade 4				7893
48415	66 pts		Leukopenia	grade 4				7893
48416	66 pts		Lymphopenia	grade 4				7893
48417	1 pts		Hypocalcemia	grade 4				7893
48418	1 pts		Hyponatremia	grade 4				7893
48419	1 pts		Disseminated intravascular coagulation	grade 4				7893
48420	1 pts		Hyperbilirubinemia	grade 4				7893
48421	1 pts		Febrile neutropenia	grade 4				7893
48422	6 pts		Cardiac troponin T increased	grade 4				7893
48423	1 pts		Diarrhea	grade 3			TRUE	7893
48424	9 pts		Electrocardiogram QTc interval prolonged	grade 1				7893
48425	22 pts		Cough	grade 1				7893
48426	4 pts		Dyspnea	grade 1				7893
48427	19 pts		Blood bicarbonate low	grade 1				7893
48428	17 pts		Edema limbs	grade 1				7893
48429	9 pts		Anorexia	grade 1				7893
48430	15 pts		Vomiting	grade 1				7893
48431	3 pts		Hypotension	grade 1				7893
48432	5 pts		Pleural effusion	grade 1				7893
48433	6 pts		Electrocardiogram QTc interval prolonged	grade 2				7893
48434	3 pts		Cough	grade 2				7893
48435	5 pts		Dyspnea	grade 2				7893
48436	5 pts		Blood bicarbonate low	grade 2				7893
48437	7 pts		Edema limbs	grade 2				7893
48438	10 pts		Anorexia	grade 2				7893
48439	8 pts		Vomiting	grade 2				7893
48440	13 pts		Hypotension	grade 2				7893
48441	12 pts		Pleural effusion	grade 2				7893
48442	9 pts		Electrocardiogram QTc interval prolonged	grade 3				7893
48443	13 pts		Dyspnea	grade 3				7893
48444	4 pts		Anorexia	grade 3				7893
48445	3 pts		Hypotension	grade 3				7893
48446	3 pts		Pleural effusion	grade 3				7893
48447	1 pts		Electrocardiogram QTc interval prolonged	grade 4				7893
48448	2 pts		Dyspnea	grade 4				7893
48449	2 pts		Hypotension	grade 4				7893
48450	2 pts		Pleural effusion	grade 4				7893
48451	1 pts		Hypotension	grade 5				7893
48452						No adverse effects leading to discontinuation were reported		7895
48453	1.2		Vomiting					7896
48454	1.2		Abdominal pain					7896
48455	1.2		Syncope					7896
48456	1.2		Bradycardia					7896
48457	24		Nausea	grade 1				7898
48458	7		Abdominal pain	grade 1				7898
48459	4		Dyspepsia	grade 1				7898
48460	2		Abdominal discomfort	grade 1				7898
48461	2		Epigastric discomfort	grade 1				7898
48462	2		Vomiting	grade 1				7898
48463	6		Headache	grade 1				7898
48464	4		Dizziness	grade 1				7898
48465	4		Dermatitis contact	grade 1				7898
48466	2		Erythema	grade 1				7898
48467	2		Hyperhidrosis	grade 1				7898
48468	2		Decreased appetite	grade 1				7898
48469	2		Hypocalcemia	grade 1				7898
48470	2		Pain in extremity	grade 1				7898
48471	2		Hematuria	grade 1				7898
48472	2		Pallor	grade 1				7898
48473			Heart rate increased					7898
48474	5		Angina unstable					7897
48475	5		Fluid overload					7897
48476	11		Nausea		discontinuation			7899
48477	2		Pulmonary embolism		discontinuation			7899
48478	2		Pulmonary hypertension		discontinuation			7899
48479	2		Deep vein thrombosis		discontinuation			7899
48480	5		Cough		discontinuation			7899
48481	2		Dermatitis acneiform		discontinuation			7899
48482	2		Respiratory distress syndrome		discontinuation			7899
48483	2		Hemoglobin decreased		discontinuation			7899
48484	2		Transient ischemic attack		discontinuation			7899
48485	25		Ataxia				TRUE	7902
48486	25		Dizziness				TRUE	7902
48487	12.5		Confusion				TRUE	7902
48488	12.5		Fatigue	grade 2-3			TRUE	7902
48489						No adverse effects leading to discontinuation were reported; no DLTs		7901
48490	25		Mental status changes	grade 2			TRUE	7903
48491	25		Memory impairment	grade 1			TRUE	7903
48492	25		Dizziness	grade 2			TRUE	7903
48493	25		Fatigue	grade 2			TRUE	7903
48494	50		Mental status changes	grade 3			TRUE	7900
48495	50		Ataxia	grade 3			TRUE	7900
48496	25		Fever	grade 1			TRUE	7900
48497	25		Hallucinations	grade 2			TRUE	7900
48498	25		Trembling	grade 1		tremors	TRUE	7900
48499	25		Agitation	grade 1			TRUE	7900
48500	25		Slurred speech				TRUE	7900
48501						No information on AE is provided		7904
48502	16.7		Headache	grade 3			TRUE	7905
48503	16.7		Unconjugated bilirubinemia	grade 3	discontinuation		TRUE	7906
48504	16.7		Unconjugated bilirubinemia	grade 3			TRUE	7908
48505	16.7		Fatigue	grade 3			TRUE	7909
48506	16.7		Unconjugated bilirubinemia	grade 2	dose interruption		TRUE	7909
48507	1.8		Cerebrovascular accident	grade 3	discontinuation			7907
48508	1.8		Respiratory failure	grade 5	discontinuation			7907
48509			Skin rash	grade 3			TRUE	7912
48510			Anorexia	grade 3			TRUE	7912
48511			Diarrhoea	grade 3			TRUE	7912
48512			Vomiting	grade 3			TRUE	7912
48513			Skin rash	grade 3			TRUE	7913
48514			Thrombocytopenia	grade 3			TRUE	7914
48515			Acute renal failure	grade 3	discontinuation		TRUE	7914
48516			Neutropenia	grade 3			TRUE	7914
48517			Skin rash	grade 3			TRUE	7914
48518	14.3		Pneumonia		discontinuation			7914
48519			Nausea					7911
48520			Vomiting					7911
48521			Anorexia					7911
48522			Fatigue					7911
48523			Pyrexia					7911
48524	53		Thrombocytopenia	grade 3-4				7911
48525	23		Neutropenia	grade 3-4				7911
48526			Thrombocytopenia				TRUE	7910
48527			Rash				TRUE	7910
48528	7		Upper respiratory tract infection					7915
48529	11		Anxiety					7915
48530	16		Muscular weakness					7915
48531	11		Sinusitis					7915
48532	11		Cough					7915
48533	25		Constipation					7915
48534	14		Insomnia					7915
48535	2		Muscle spasticity					7915
48536	11		Salivary hypersecretion					7915
48537	11		Depression					7915
48538	14		Dyspnea					7915
48539	11		Dysarthria					7915
48540	9		Dysphagia					7915
48541	25		Fall					7915
48542	14		Headache					7915
48543	16		Dry mouth					7915
48544	2		Oedema peripheral					7915
48545	1.5		Pancreatitis		discontinuation			7917
48546						multiple oral doses of up to 600 mg BID for 7 days were well tolerated, with no serious or severe adverse events and incidences of adverse events similar to those reported with placebo		7916
48547	3 pts		Leukocyte count decreased	grade 1			TRUE	7921
48548	2 pts		Leukocyte count decreased	grade 2			TRUE	7921
48549	1 pts		Leukocyte count decreased	grade 3			TRUE	7921
48550	2 pts		Granulocyte count decreased	grade 2			TRUE	7921
48551	3 pts		Granulocyte count decreased	grade 3			TRUE	7921
48552	1 pts		Granulocyte count decreased	grade 4			TRUE	7921
48553	4 pts		Leukocyte count decreased	grade 1			TRUE	7920
48554	1 pts		Leukocyte count decreased	grade 2			TRUE	7920
48555	2 pts		Granulocyte count decreased	grade 2			TRUE	7920
48556	1 pts		Granulocyte count decreased	grade 3			TRUE	7920
48557	1 pts		Leukocyte count decreased	grade 1			TRUE	7918
48558	3 pts		Leukocyte count decreased	grade 3			TRUE	7918
48559	1 pts		Granulocyte count decreased	grade 1			TRUE	7918
48560	3 pts		Granulocyte count decreased	grade 4			TRUE	7918
48561	9 pts		Thrombocytopenia	grade 4			TRUE	7919
48562	9 pts		Anemia	grade 4			TRUE	7919
48563	9 pts		Granulocytopenia	grade 4			TRUE	7919
48564	3 pts		Leukopenia	grade 1				7928
48565	3 pts		Thrombocytopenia	grade 1				7928
48566	1 pts		Thrombocytopenia	grade 3				7928
48567	1 pts		Thrombocytopenia	grade 4				7928
48568	3 pts		Anemia	grade 1				7928
48569	2 pts		Anemia	grade 2				7928
48570	1 pts		Hemorrhage	grade 2				7928
48571	1 pts		Hepatic and hepatobiliary disorders NEC	grade 1				7928
48572	2 pts		Hepatic and hepatobiliary disorders NEC	grade 2				7928
48573	2 pts		Hepatic and hepatobiliary disorders NEC	grade 3				7928
48574	1 pts		Hepatic and hepatobiliary disorders NEC	grade 4				7928
48575	1 pts		Nausea	grade 1				7928
48576	6 pts		Nausea	grade 2				7928
48577	7 pts		Nausea	grade 3				7928
48578	2 pts		Nausea	grade 4				7928
48579	1 pts		Vomiting	grade 1				7928
48580	6 pts		Vomiting	grade 2				7928
48581	7 pts		Vomiting	grade 3				7928
48582	2 pts		Vomiting	grade 4				7928
48583	1 pts		Diarrhea	grade 2				7928
48584	1 pts		Diarrhea	grade 3				7928
48585	29 pts		Nausea				TRUE	7927
48586	29 pts		Vomiting				TRUE	7927
48587	29 pts		Anorexia				TRUE	7927
48588	3 pts		Vomiting		discontinuation	leads to discontinuation	TRUE	7927
48589	3 pts		Anorexia		discontinuation	leads to discontinuation	TRUE	7927
48590	2 pts		Nausea				TRUE	7926
48591	2 pts		Vomiting				TRUE	7926
48592	2 pts		Nausea			leads to dose reduction	TRUE	7925
48593	2 pts		Vomiting			leads to dose reduction	TRUE	7925
48594			Gastrointestinal toxicity			abstract is available only		7924
48595			Thrombocytopenia			abstract is available only		7924
48596			Transaminases increased			abstract is available only		7924
48597			Gastrointestinal toxicity			abstract is available only	TRUE	7922
48598			Thrombocytopenia			abstract is available only	TRUE	7922
48599			Anaphylactic reaction			abstract is available only		7923
48600	2.25		Renal impairment					7929
48601	4.49		Renal failure unspecified					7929
48602	1		Dyspnea	grade 1-2	discontinuation	Elinogrel therapy was associated withan increased incidence of dyspnea, which was generally mild		7930
48603	1 pts		Cognitive disturbance	grade 3	discontinuation	leads to dose interruption	TRUE	7936
48604	1 pts		Fatigue	grade 3	discontinuation	leads to dose interruption	TRUE	7936
48605	1 pts		Eosinophilic myocarditis	grade 4				7936
48606	1 pts		Creatinine increased	grade 2			TRUE	7937
48607	1 pts		Dysgeusia	grade 2			TRUE	7938
48608	1 pts		Fatigue	grade 2			TRUE	7938
48609	1 pts		Pulmonary edema	grade 3			TRUE	7938
48610	4		Blood creatinine increased		discontinuation	leads to dose interruption/reduction		7931
48611	3.7		Fatigue		discontinuation	leads to dose interruption/reduction		7931
48612	3.1		Anemia		discontinuation	leads to dose interruption/reduction		7931
48613	2.8		Diarrhea		discontinuation	leads to dose interruption		7931
48614	2.8		Pyrexia		discontinuation	leads to dose interruption		7931
48615	2.5		Dizziness		discontinuation	leads to dose interruption/reduction		7931
48616	2.3		Dyspnea		discontinuation	leads to dose interruption		7931
48617	2.3		Nausea		discontinuation	leads to dose interruption		7931
48618	2.3		Pneumonia		discontinuation	leads to dose interruption		7931
48619	2		Cognitive disorder		discontinuation	leads to dose interruption		7931
48620	2		Neutropenia		discontinuation	leads to dose interruption		7931
48621	1.4		Weight increased		discontinuation	leads to dose reduction		7931
48622	0.3		Pneumonia		discontinuation	leads to discontinuation		7932
48623	0.6		Cardio-respiratory arrest		discontinuation	leads to discontinuation		7932
48624	0.6		Dyspnea		discontinuation	leads to discontinuation		7932
48625	0.6		Fatigue		discontinuation	leads to discontinuation		7932
48626	0.3		Pulmonary edema		discontinuation	leads to discontinuation		7933
48627	0.3		Pulmonary embolism		discontinuation	leads to discontinuation		7933
48628	0.3		Myocarditis		discontinuation	leads to discontinuation		7933
48629	0.3		Cardiogenic shock		discontinuation	leads to discontinuation		7933
48630	0.3		Pericardial effusion		discontinuation	leads to discontinuation		7933
48631	0.3		Malaise		discontinuation	leads to discontinuation		7933
48632	0.3		Peripheral edema		discontinuation	leads to discontinuation		7933
48633	0.3		Sepsis		discontinuation	leads to discontinuation		7933
48634	1		Arthralgia		discontinuation	leads to dose reduction		7935
48635	1.1		Decreased appetite		discontinuation	leads to dose interruption		7934
48636	1.1		Hypotension		discontinuation	leads to dose interruption		7934
48637	0.8		Hypoxia		discontinuation	leads to dose interruption		7934
48638						No AEs were reported		7940
48639						No AEs were reported		7939
48640	1 pts		Abdominal discomfort					7941
48641	2 pts		Crying					7941
48642	2 pts		Fatigue					7941
48643	1 pts		Food poisoning					7941
48644	1 pts		Headache					7941
48645	1 pts		Insomnia					7941
48646	1 pts		Rash					7941
48647	3 pts		Bleeding vaginal					7941
48648	1.7		Nausea	grade 3-4		4 pts		7943
48649	0.4		Decreased appetite	grade 3-4		1 pt		7943
48650	0.4		Vomiting	grade 3-4		1 pt		7943
48651	0.8		Fatigue	grade 3-4		2 pts		7943
48652	7.2		Musculoskeletal pain	grade 3-4		17 pts		7943
48653	1.3		ALT increased		dose interruption			7943
48654	1.7		Musculoskeletal pain		dose interruption			7943
48655	1.7		Nausea					7943
48656	1.7		Musculoskeletal pain		discontinuation			7943
48657	1.3		Nausea		discontinuation			7943
48658	3.4		Nausea		dose interruption			7943
48659			Gastrointestinal disorder	grade 1-3	discontinuation			7942
48660	1 pts		Alanine aminotransferase increase	grade 3			TRUE	7944
48661	1 pts		Retinal pigment epithelium atrophy	grade 2	discontinuation	leads to discontinuation	TRUE	7949
48662	3 pts		Hyperphosphatemia					7950
48663	56		Stomatitis	all grades				7947
48664	47		Diarrhea	all grades				7947
48665	45		Dry mouth	all grades				7947
48666	28		Constipation	all grades				7947
48667	23		Abdominal pain	all grades				7947
48668	21		Nausea	all grades				7947
48669	13		Vomiting	all grades				7947
48670	38		Decreased appetite	all grades				7947
48671	54		Fatigue	all grades				7947
48672	14		Pyrexia	all grades				7947
48673	41		Onycholysis	all grades				7947
48674	34		Dry skin	all grades				7947
48675	26		Palmar-plantar erythrodysaesth.	all grades				7947
48676	26		Alopecia	all grades				7947
48677	11		Nail discoloration	all grades				7947
48678	28		Dry eye	all grades				7947
48679	17		Vision blurred	all grades				7947
48680	10		Lacrimation increased	all grades				7947
48681	37		Dysgeusia	all grades				7947
48682	17		Paronychia	all grades				7947
48683	17		Urinary tract infection	all grades				7947
48684	11		Conjunctivitis	all grades				7947
48685	11		Oropharyngeal pain	all grades				7947
48686	10		Dyspnea	all grades				7947
48687	11		Hematuria	all grades				7947
48688	20		Musculoskeletal pain	all grades				7947
48689	11		Arthralgia	all grades				7947
48690	16		Weight decreased	all grades				7947
48691	9		Stomatitis	grade 3-4				7947
48692	2		Diarrhea	grade 3-4				7947
48693	1		Constipation	grade 3-4				7947
48694	2		Abdominal pain	grade 3-4				7947
48695	1		Nausea	grade 3-4				7947
48696	2		Vomiting	grade 3-4				7947
48697	10		Fatigue	grade 3-4				7947
48698	1		Pyrexia	grade 3-4				7947
48699	10		Onycholysis	grade 3-4				7947
48700	6		Palmar-plantar erythrodysaesth.	grade 3-4				7947
48701	6		Dry eye	grade 3-4				7947
48702	1		Dysgeusia	grade 3-4				7947
48703	3		Paronychia	grade 3-4				7947
48704	6		Urinary tract infection	grade 3-4				7947
48705	1		Oropharyngeal pain	grade 3-4				7947
48706	2		Dyspnea	grade 3-4				7947
48707	2		Hematuria	grade 3-4				7947
48708	94		Gastrointestinal disorders	all grades				7947
48709	90		Metabolism and nutrition disorders	all grades				7947
48710	75		Skin and subcutaneous tissue disorders	all grades				7947
48711	62		Eye disorders	all grades				7947
48712	57		Nervous system disorders	all grades				7947
48713	56		Infections and infestations	all grades				7947
48714	40		Respiratory, thoracic and mediastinal disorders	all grades				7947
48715	38		Renal and urinary disorders	all grades				7947
48716	31		Musculoskeletal and connective tissue disorders	all grades				7947
48717	24		Gastrointestinal disorders	grade 3-4				7947
48718	16		Metabolism and nutrition disorders	grade 3-4				7947
48719	16		Skin and subcutaneous tissue disorders	grade 3-4				7947
48720	11		Eye disorders	grade 3-4				7947
48721	5		Nervous system disorders	grade 3-4				7947
48722	20		Infections and infestations	grade 3-4				7947
48723	7		Respiratory, thoracic and mediastinal disorders	grade 3-4				7947
48724	10		Renal and urinary disorders	grade 3-4				7947
48725	35		Hemoglobin decreased	all grades				7947
48726	19		Platelet count decreased	all grades				7947
48727	17		Leukocyte count decreased	all grades				7947
48728	10		Neutrophil count decreased	all grades				7947
48729	76		Phosphate increased	all grades				7947
48730	52		Creatinine increased	all grades				7947
48731	40		Sodium decreased	all grades				7947
48732	41		Alanine aminotransferase increased	all grades				7947
48733	41		Alkaline phosphatase increased	all grades				7947
48734	37		Albumin decreased	all grades				7947
48735	30		Aspartate aminotransferase increased	all grades				7947
48736	30		Magnesium decreased	all grades				7947
48737	24		Phosphate decreased	all grades				7947
48738	22		Calcium increased	all grades				7947
48739	16		Potassium increased	all grades				7947
48740	10		Fasting blood glucose increased	all grades				7947
48741	3		Hemoglobin decreased	grade 3-4				7948
48742	1		Platelet count decreased	grade 3-4				7948
48743	2		Neutrophil count decreased	grade 3-4				7948
48744	1		Phosphate increased	grade 3-4				7948
48745	5		Creatinine increased	grade 3-4				7948
48746	16		Sodium decreased	grade 3-4				7948
48747	1		Alanine aminotransferase increased	grade 3-4				7948
48748	1		Alkaline phosphatase increased	grade 3-4				7948
48749	1		Magnesium decreased	grade 3-4				7948
48750	9		Phosphate decreased	grade 3-4				7948
48751	3		Calcium increased	grade 3-4				7948
48752	1		Acute myocardial infarction	grade 5	discontinuation	leads to discontinuation		7946
48753	6		Eye disorders		discontinuation	leads to discontinuation		7946
48754	24		Hyperphosphatemia			leads to dose interruption		7946
48755	17		Stomatitis			leads to dose interruption		7946
48756	17		Eye disorders			leads to dose interruption		7946
48757	8		Palmar-plantar erythrodysaesthesia syndrome			leads to dose interruption		7946
48758	23		Eye disorders			leads to dose reduction		7946
48759	15		Stomatitis			leads to dose reduction		7946
48760	7		Hyperphosphatemia			leads to dose reduction		7946
48761	7		Palmar-plantar erythrodysaesthesia syndrome			leads to dose reduction		7946
48762	7		Paronychia			leads to dose reduction		7946
48763	6		Nail dystrophy			leads to dose reduction		7946
48764						No information on AE is provided		7945
48765						No  clinically  relevant  side-effects  occurred.		7951
48766	2		Uterine bleeding	grade 3	discontinuation			7952
48767						No adverse effects leading to discontinuation were reported; no DLTs		7953
48768	100		Mucositis oral	grade 3			TRUE	7955
48769						No information on AE is provided		7962
48770	16.7		Mucositis	grade 3			TRUE	7963
48771	16.7		Mucositis	grade 3			TRUE	7960
48772	50		Mucositis	grade 3			TRUE	7968
48773	50		Hyperbilirubinemia	grade 3			TRUE	7968
48774	50		Exfoliative rash	grade 3			TRUE	7968
48775	50		Hand-and-foot syndrome	grade 3			TRUE	7968
48776						No information on AE is provided		7954
48777	14.3		Sepsis	grade 3			TRUE	7961
48778	11.1		Hyponatremia	grade 3			TRUE	7956
48779	66.7		Febrile neutropenia	grade 3			TRUE	7966
48780	33.3		AST increased	grade 3			TRUE	7966
48781	66.7		Febrile neutropenia	grade 3			TRUE	7971
48782	33.3		Thrombocytopenia	grade 4			TRUE	7971
48783	16.7		Neutropenia	grade 4			TRUE	7964
48784	16.7		Febrile neutropenia	grade 4			TRUE	7957
48785	33.3		Febrile neutropenia	grade 3			TRUE	7967
48786	16.7		Mucosal inflammation	grade 3			TRUE	7967
48787	33.3		Febrile neutropenia	grade 3			TRUE	7969
48788	33.3		Mucosal inflammation	grade 3			TRUE	7969
48789	16.7		Corneal epithelium disorder	grade 3			TRUE	7969
48790	100		Febrile neutropenia	grade 3-4			TRUE	7970
48791	100		Mucosal inflammation	grade 3			TRUE	7970
48792	50		Pneumonia	grade 5			TRUE	7970
48793	50		Toxic epidermal necrolysis	grade 4			TRUE	7970
48794	6		Fatigue	grade 3-4	discontinuation			7959
48795	3		Fluid overload		discontinuation			7959
48796	3		Blister		discontinuation			7959
48797	9		Thrombocytopenia		dose reduction			7959
48798	3		Febrile neutropenia		dose reduction			7959
48799	3		Mucosal inflammation		dose reduction			7959
48800	3		Neutropenia		dose reduction			7959
48801	9		Vomiting		dose reduction			7959
48802	6		Diarrhea		dose reduction			7959
48803	6		Pyrexia		dose reduction			7959
48804	3		Lipase increased		dose reduction			7959
48805	3		Pneumonia		dose reduction			7959
48806	3		Nausea		dose reduction			7959
48807	3		Bacteremia		dose reduction			7959
48808	3		Punctate keratitis		dose reduction			7958
48809	5		Thrombocytopenia		dose reduction			7965
48810	2		Neutropenia		dose reduction			7965
48811	2		Lipase increased		dose reduction			7965
48812	2		Blood amylase increased		dose reduction			7965
48813	2		Arthritis bacterial		discontinuation			7965
48814	2		Pneumonia		discontinuation			7965
48815	2		Sepsis		discontinuation			7965
48816	2		Septic shock		discontinuation			7965
48817	4		Thrombocytopenia		discontinuation			7965
48818	2		Febrile neutropenia		discontinuation			7965
48819	4		Hypercalcemia		discontinuation			7965
48820	2		Dehydration		discontinuation			7965
48821	2		Respiratory distress syndrome		discontinuation			7965
48822	2		Dyspnea		discontinuation			7965
48823	2		Cardiac failure congestive		discontinuation			7965
48824	2		Renal failure		discontinuation			7965
48825	6.5		ALT increased		discontinuation			7972
48826	2.2		QT interval prolonged		discontinuation			7972
48827	15		Vomiting	grade 2				7975
48828	8		Nausea	grade 2				7975
48829	2		Throat tightness	grade 2	discontinuation			7975
48830	2		Dizziness	grade 2				7975
48831	16		Nausea					7974
48832	20		Diarrhea					7974
48833	8		ALT increased					7974
48834	12		Vomiting					7974
48835	4		AST increased					7974
48836	8		Flatulence					7974
48837	8		Gastroesophageal reflux disease					7973
48838						No information on AE is provided		7976
48839	36		Diarrhea					7977
48840	19		Flatulence					7977
48841	19		Abdominal pain					7977
48842	21		Nausea					7977
48843	9		Fatigue					7977
48844	11		Dizziness					7977
48845	11		Hyperhidrosis					7977
48846	4		Abdominal discomfort					7977
48847	8		Feeling hot					7977
48848	6		Eructation					7977
48849	6		Feces soft					7977
48850	6		Somnolence					7977
48851						No adverse effects leading to discontinuation were reported		7978
48852						No adverse effects leading to discontinuation were reported		7979
48853						No adverse effects leading to discontinuation were reported		7980
48854						No immediate or long-term side effects related to I3C were found		7982
48855	25		Nausea				TRUE	7981
48856	25		Vomiting				TRUE	7981
48857						No adverse events related to study agent were reported in the multiple-dose study.		7983
48858			Dehydration	grade 3			TRUE	7987
48859			Hypotension	grade 3			TRUE	7986
48860			Mucositis	grade 3			TRUE	7986
48861						No information on AE is provided		7984
48862			Parkinsonism		discontinuation			7985
48863	17.5		Cardiac failure					7988
48864	17.5		Ventricular tachycardia					7988
48865	2.5		Arrhythmia		discontinuation			7988
48866	2.5		Nausea		discontinuation			7988
48867	32.5		Infusion site pain					7988
48868	2.5		Vomiting		discontinuation			7988
48869	17.5		Arrhythmia					7988
48870	17.5		Atrial fibrillation					7988
48871						12% were discontinued - AEs are not specified		7989
48872	33.3		ALT increased		discontinuation			7990
48873	33.3		AST increased		discontinuation			7990
48874	23.5		Headache					7991
48875	5.9		Lymphopenia		discontinuation			7991
48876	11.8		Infectious diarrhoea	grade 2	dose interruption			7991
48877	25		AST increased	grade 3	dose reduction		TRUE	7995
48878	25		Thrombocytopenia	grade 3	dose reduction		TRUE	7995
48879	33.3		AST increased	grade 3	dose reduction		TRUE	7992
48880	33.3		Neutropenia	grade 4	dose reduction		TRUE	7992
48881	16.7		Fatigue	grade 3	dose reduction		TRUE	7996
48882	16.7		Neutropenia	grade 4	dose reduction		TRUE	7996
48883	16.7		ALT increased	grade 3	dose reduction		TRUE	7996
48884	16.7		AST increased	grade 3	dose reduction		TRUE	7996
48885						No adverse effects leading to discontinuation were reported; no DLTs		7993
48886						No adverse effects leading to discontinuation were reported.		7994
48887	7		Infusion site pain					8002
48888	7		Infusion site phlebitis					8002
48889	7		Injection site reaction					8002
48890	3		Alanine aminotransferase increased					8002
48891	3		Aspartate aminotransferase increased					8002
48892	3		Liver function test increased					8002
48893	3		Nausea					8002
48894	3		Hypokalemia					8002
48895	3		Insomnia					8002
48896	2		Headache					8002
48897	<2		Anemia					8002
48898	<2		Thrombocytopenia					8002
48899	<2		Atrial fibrillation					8002
48900	<2		Palpitations					8002
48901	<2		Abdominal pain					8002
48902	<2		Constipation					8002
48903	<2		Dyspepsia					8002
48904	<2		Epigastric discomfort					8002
48905	<2		Gastritis erosive					8002
48906	<2		Clostridium difficile colitis					8002
48907	<2		Oropharyngeal candidiasis					8002
48908	<2		Vulvovaginal candidiasis					8002
48909	<2		Somnolence					8002
48910	<2		Urinary retention					8002
48911	<2		Anxiety					8002
48912	12		Diarrhea					8001
48913	5		Nausea					8001
48914	3		Vomiting					8001
48915	2		Alanine aminotransferase increased					8001
48916	2		Aspartate aminotransferase increased					8001
48917	2		Liver function test increased					8001
48918	<2		Anemia					8001
48919	<2		Thrombocytopenia					8001
48920	<2		Atrial fibrillation					8001
48921	<2		Palpitations					8001
48922	<2		Abdominal pain					8001
48923	<2		Constipation					8001
48924	<2		Dyspepsia					8001
48925	<2		Epigastric discomfort					8001
48926	<2		Gastritis erosive					8001
48927	<2		Clostridium difficile colitis					8001
48928	<2		Oropharyngeal candidiasis					8001
48929	<2		Vulvovaginal candidiasis					8001
48930	<2		Somnolence					8001
48931	<2		Urinary retention					8001
48932	<2		Anxiety					8001
48933	7		Infusion site pain					8002
48934	7		Infusion site phlebitis					8002
48935	7		Injection site reaction					8002
48936	3		Alanine aminotransferase increased					8002
48937	3		Aspartate aminotransferase increased					8002
48938	3		Liver function test increased					8002
48939	3		Nausea					8002
48940	3		Hypokalemia					8002
48941	3		Insomnia					8002
48942	2		Headache					8002
48943	<2		Anemia					8002
48944	<2		Thrombocytopenia					8002
48945	<2		Atrial fibrillation					8002
48946	<2		Palpitations					8002
48947	<2		Abdominal pain					8002
48948	<2		Constipation					8002
48949	<2		Dyspepsia					8002
48950	<2		Epigastric discomfort					8002
48951	<2		Gastritis erosive					8002
48952	<2		Clostridium difficile colitis					8002
48953	<2		Oropharyngeal candidiasis					8002
48954	<2		Vulvovaginal candidiasis					8002
48955	<2		Somnolence					8002
48956	<2		Urinary retention					8002
48957	<2		Anxiety					8002
48958	12		Diarrhea					8001
48959	5		Nausea					8001
48960	3		Vomiting					8001
48961	2		Alanine aminotransferase increased					8001
48962	2		Aspartate aminotransferase increased					8001
48963	2		Liver function test increased					8001
48964	<2		Anemia					8001
48965	<2		Thrombocytopenia					8001
48966	<2		Atrial fibrillation					8001
48967	<2		Palpitations					8001
48968	<2		Abdominal pain					8001
48969	<2		Constipation					8001
48970	<2		Dyspepsia					8001
48971	<2		Epigastric discomfort					8001
48972	<2		Gastritis erosive					8001
48973	<2		Clostridium difficile colitis					8001
48974	<2		Oropharyngeal candidiasis					8001
48975	<2		Vulvovaginal candidiasis					8001
48976	<2		Somnolence					8001
48977	<2		Urinary retention					8001
48978	<2		Anxiety					8001
48979	1 pts		Infectious pleural effusion					8003
48980	1 pts		Lung abscess					8003
48981	1 pts		Pneumonia					8003
48982	1 pts		Pulmonary tuberculosis					8003
48983	1 pts		Acute respiratory distress syndrome					8003
48984	1 pts		Acute respiratory failure					8003
48985	1 pts		Chronic obstructive pulmonary disease					8003
48986	1 pts		Pulmonary edema					8003
48987	2 pts		Vomiting					8003
48988	1 pts		Abdominal pain upper					8003
48989	1 pts		Infusion site phlebitis					8003
48990	1 pts		Injection site reaction					8003
48991	1 pts		Hepatitis toxic					8003
48992	1 pts		Infectious pleural effusion		discontinuation			8003
48993	1 pts		Lung abscess		discontinuation			8003
48994	1 pts		Pneumonia		discontinuation			8003
48995	1 pts		Pulmonary tuberculosis		discontinuation			8003
48996	1 pts		Acute respiratory distress syndrome		discontinuation			8003
48997	1 pts		Acute respiratory failure		discontinuation			8003
48998	1 pts		Chronic obstructive pulmonary disease		discontinuation			8003
48999	1 pts		Pulmonary edema		discontinuation			8003
49000	2 pts		Vomiting		discontinuation			8003
49001	1 pts		Abdominal pain upper		discontinuation			8003
49002	1 pts		Infusion site phlebitis		discontinuation			8003
49003	1 pts		Injection site reaction		discontinuation			8003
49004	1 pts		Hepatitis toxic		discontinuation			8003
49005						No SAEs were reported		7998
49006						No SAEs were reported		8000
49007						No information		7997
49008						No information		7999
49009	1 pts		Sleep paralysis	moderate				8004
49010	2.9		Somnolence		discontinuation	leads to discontinuation		8006
49011	1.3		Nightmares		discontinuation	leads to discontinuation		8006
49012	0.6		Palpitations		discontinuation	leads to discontinuation		8006
49013	1		Somnolence		discontinuation	leads to discontinuation		8007
49014	0.3		Nightmares		discontinuation	leads to discontinuation		8007
49015	1 pts		Headache					8005
49016	1 pts		Sleep paralysis					8005
49017	1 pts		Insomnia					8005
49018						Lersivirine was well tolerated. There were no dose delays or reductions, and no discontinuations following the start of dosing.		8010
49019						Lersivirine was well tolerated. There were no dose delays or reductions, and no discontinuations following the start of dosing.		8011
49020						There were no deaths, serious AEs, or withdrawals due to AEs		8008
49021	3.1		Abdominal distension		discontinuation			8009
49022	33.3		Hypoxia	grade 3	dose interruption		TRUE	8013
49023	33.3		Dyspnea	grade 3				8013
49024	33.3		QT interval prolonged	grade 3			TRUE	8013
49025	33.3		Dyspnea	grade 4	dose interruption		TRUE	8013
49026	16.7		Hypoxia	grade 3	discontinuation		TRUE	8012
49027	16.7		Fatigue	grade 3	discontinuation		TRUE	8012
49028	16.7		Fatigue	grade 3			TRUE	8012
49029	16.7		Anaemia	grade 3				8012
49030	5.3		Feelings of weakness		discontinuation			8014
49031	5.3		Vasodilatation		discontinuation			8014
49032	5.3		Seizures		discontinuation			8014
49033	10.5		Nausea		discontinuation			8014
49034	10.5		Vomiting		discontinuation			8014
49035	3.4		Anxiety		discontinuation			8017
49036	3.4		Acute renal failure		discontinuation			8017
49037						No information on AE is provided		8015
49038						No information on AE is provided		8016
49039						No information on AE is provided		8019
49040						No information on AE is provided		8018
49041	8.3		Atrial flutter	grade 3			TRUE	8022
49042	8.3		Atrial fibrillation	grade 3			TRUE	8022
49043	6.25		Anorexia	grade 3			TRUE	8023
49044	6.25		Dyspnea	grade 3			TRUE	8023
49045	6.25		Fatigue	grade 3			TRUE	8023
49046	6.25		Diarrhea	grade 3	discontinuation		TRUE	8023
49047	5.3		Asthenia	grade 3			TRUE	8025
49048	5.3		Diarrhea	grade 3	discontinuation		TRUE	8025
49049	3.6		Vision disorders	grade 3			TRUE	8021
49050	82		Diarrhea	grade 1-3	discontinuation		TRUE	8021
49051	43		Nausea					8021
49052	32		Fatigue					8021
49053	43		Night blindness	grade 1-2				8021
49054	18		Vomiting					8021
49055	29		Photopsia	grade 1-2				8021
49056	29		Blurred vision	grade 1-2				8021
49057	7		Asthenia					8021
49058	36		Visual impairment	grade 1-2				8021
49059	11		Anemia					8021
49060	4		Decreased appetite					8021
49061	100		Diarrhea					8020
49062	81.3		Fatigue					8020
49063	68.8		Night blindness					8020
49064	62.5		Nausea	grade 1-2	discontinuation			8020
49065	50		Vision blurred					8020
49066	43.8		Headache					8020
49067	43.8		Photopsia					8020
49068	31.3		Decreased appetite					8020
49069	31.3		Vomiting					8020
49070	25		Back pain					8020
49071	25		Rash					8020
49072	18.8		Abdominal pain					8020
49073	18.8		Anemia					8020
49074	18.8		Dry mouth					8020
49075	18.8		Non-cardiac chest pain					8020
49076	18.8		Pain in extremity					8020
49077	12.5		ALT increased					8020
49078	12.5		Constipation					8020
49079	12.5		Cough					8020
49080	12.5		Halo vision					8020
49081	12.5		Muscle spasms					8020
49082	12.5		Pain of skin					8020
49083	12.5		Photophobia					8020
49084	12.5		Retinogram abnormal					8020
49085	12.5		Urinary tract infection					8020
49086	12.5		Weight decrease					8020
49087	60		Musculoskeletal pain	grade 3	dose reduction			8024
49088	60		Diarrhea	grade 3	dose reduction			8024
49089	60		Chest pain	grade 3	dose reduction			8024
49090						No information on AE is provided. AEs were mild to moderate and resolved without sequelae; no serious adverse events occurred.		8026
49091	1 pts		Hemorrhage		discontinuation	p80		8027
49092	1 pts		Acute kidney injury		discontinuation			8027
49093	1 pts		Staphylococcal sepsis		discontinuation			8027
49094	1 pts		Subdural hematoma		discontinuation			8027
49095	1 pts		Blood bilirubin increased		discontinuation			8027
49096	2 pts		Alanine aminotransferase increased		discontinuation			8027
49097	2 pts		Liver injury		discontinuation			8028
49098	1 pts		ALT increased		dose reduction	800 mcg/kg/day -> 400 mcg/kg/day -> 140 mcg/kg/day		8028
49099	1 pts		Diarrhea		dose reduction	540 mcg/kg/day -> 400 mcg/kg/day		8028
49100						No information on AE is provided		8029
49101						No information on AE is provided		8030
49102						DLTs were observed at the dose level of 55 mg, but they are not specified.		8031
49103	7		Respiratory tract infection		dose interruption	grade >= 1		8032
49104	42.7		Thrombocytopenia		discontinuation|dose interruption	grade >= 1		8032
49105	5.7		Neutropenia		dose reduction	grade >= 1		8032
49106	4.5		Pyrexia		dose interruption	grade >= 1		8032
49107	28.7		Neutropenia		dose interruption	grade >= 1		8032
49108	9.6		Anemia		dose interruption	grade >= 1		8032
49109	10.8		Thrombocytopenia		discontinuation	grade >= 1		8032
49110	22.3		Thrombocytopenia		dose reduction	grade >= 1		8032
49111	5.7		Leukopenia		dose interruption	grade >= 1		8032
49112	3.2		Death	grade 5		The cause of death was listed as adverse event for 5 patients (3.2%) and progressive disease for 7 patients (4.5%).		8032
49113	25		Liver function test increased	grade 3			TRUE	8037
49114	10		Liver function test increased	grade 3			TRUE	8035
49115	10		AST increased	grade 3			TRUE	8036
49116	10		ALT increased	grade 3			TRUE	8036
49117	10		Hyperbilirubinemia	grade 3			TRUE	8034
49118	66.7		Liver function test increased	grade 3			TRUE	8033
49119	14.3		Proteinuria	grade 3			TRUE	8039
49120	4.3		Cholestatic hepatitis	grade 4	discontinuation			8038
49121						No information on AE is provided		8040
49122	1.3		Vomiting		discontinuation			8041
49123	2.6		Loose stools		discontinuation			8041
49124	3.8		Dizziness		discontinuation			8041
49125	1.3		Parasthesia		discontinuation			8041
49126	1.3		Flushing		discontinuation			8041
49127	1 pts		Akathisia					8042
49128	1 pts		Constipation					8042
49129	1 pts		Hypertension					8042
49130	2 pts		Headache					8042
49131	1 pts		Dysesthesia					8042
49132	1 pts		Cognitive disorders					8042
49133	1 pts		Facial flushing					8042
49134	1 pts		Myoclonic jerks					8042
49135	2 pts		Drowsiness					8042
49136	2 pts		Dizziness					8042
49137	1 pts		Diarrhea					8042
49138	2 pts		Dizziness					8043
49139	2 pts		Orthostatic hypotension					8043
49140	1 pts		Anxiety					8043
49141	1 pts		Hallucination					8043
49142	1 pts		Somnolence					8043
49143	1 pts		Back pain					8043
49144			Alanine aminotransferase increased		discontinuation	Frequency is not indicated. The most common Aes leading to discontinuation were those for increased transaminases. the most commonly reported Aes were those of Alt increase, followed by ASt increase and hematocrit increase, and the incidence for these Aes in all cases was numerically higher in the Mk-0773 group compared to placebo		8044
49145			Aspartate aminotransferase increased		discontinuation	Frequency is not indicated. The most common Aes leading to discontinuation were those for increased transaminases. the most commonly reported Aes were those of Alt increase, followed by ASt increase and hematocrit increase, and the incidence for these Aes in all cases was numerically higher in the Mk-0773 group compared to placebo		8044
49146			ALT increased					8045
49147			Weight increased					8045
49148			LDL cholesterol increased					8045
49149	1 pts		Fatigue	grade 3			TRUE	8046
49150	1 pts		Allergic reaction	grade 3-4				8047
49151	1 pts		Pruritus	grade 1-2				8047
49152	5 pts		Fatigue	grade 1-2				8047
49153	2 pts		Fatigue	grade 3-4				8047
49154	1 pts		Weight loss	grade 1-2				8047
49155	3 pts		Abdominal cramp	grade 1-2				8047
49156	3 pts		Abdominal bloating	grade 1-2				8047
49157	1 pts		Anorexia	grade 3-4				8047
49158	2 pts		Constipation	grade 1-2				8047
49159	1 pts		Diarrhea	grade 1-2				8047
49160	1 pts		Dysphagia	grade 1-2				8047
49161	2 pts		Nausea	grade 1-2				8047
49162	1 pts		Odynophagia	grade 1-2				8047
49163	1 pts		Faeces discoloured	grade 1-2				8047
49164	2 pts		Taste alteration	grade 1-2				8047
49165	1 pts		Erectile dysfunction	grade 1-2				8047
49166	4 pts		Urine discoloration	grade 1-2				8047
49167	2 pts		Anemia	grade 1-2			TRUE	8047
49168	1 pts		Anemia	grade 3-4			TRUE	8047
49169	1 pts		Leukopenia	grade 1-2			TRUE	8047
49170	5 pts		Lymphopenia	grade 1-2			TRUE	8047
49171	1 pts		Lymphopenia	grade 3-4			TRUE	8047
49172	1 pts		Pancytopenia	grade 5			TRUE	8047
49173	1 pts		Hyperbilirubinemia	grade 3-4				8047
49174	1 pts		Alkaline phosphatase increased	grade 1-2				8047
49175	1 pts		SGOT increased	grade 1-2				8047
49176	1 pts		SGPT increased	grade 1-2				8047
49177	1 pts		Mucositis	grade 3-4				8047
49178	2 pts		Sore tongue	grade 1-2				8047
49179	1 pts		Blood bicarbonate decreased	grade 1-2				8047
49180	1 pts		Hypertension	grade 1-2				8047
49181	1 pts		Hypoalbuminemia	grade 3-4				8047
49182	1 pts		Pain muscle	grade 1-2				8047
49183	12.5		Hypotension	grade 3	discontinuation		TRUE	8049
49184	100		Flu-like symptoms	grade 2	dose reduction			8048
49185	100		Injection site reaction	grade 2	dose reduction			8048
49186	66.7		Fatigue	grade 2	dose reduction			8048
49187	66.7		Malaise	grade 2	dose reduction			8048
49188	33.3		Arthralgia	grade 1				8048
49189	33.3		Nausea	grade 1				8048
49190	33.3		Cough	grade 1				8048
49191	33.3		Dehydration	grade 1				8048
49192	66.7		Vomiting	grade 1				8048
49193	33.3		Oral pain	grade 1				8048
49194	33.3		Dyspnea	grade 1				8048
49195	100		Flu-like symptoms	grade 1-2				8050
49196	100		Injection site reaction	grade 1-2				8050
49197	100		Fatigue	grade 1-2				8050
49198	50		Anorexia	grade 1-2				8050
49199	33.3		Malaise	grade 1-2				8050
49200	16.7		Arthralgia	grade 1-2				8050
49201	33.3		Nausea	grade 1-2				8050
49202	50		Cough	grade 1-2				8050
49203	33.3		Dehydration	grade 1-2				8050
49204	16.7		Oral pain	grade 1-2				8050
49205	33.3		Rash	grade 1-2				8050
49206	16.7		Dyspnea	grade 1-2				8050
49207	50		Dysphagia	grade 1-2				8050
49208	16.7		Hypomagnesemia	grade 1-2				8050
49209	10 pts					AEs were not specified		8052
49210	2 pts					AEs were not specified		8051
49211						No AEs were observed		8054
49212	16.7		Nausea	grade 1				8053
49213	16.7		Malaise	grade 1				8053
49214	33.3		Headache	grade 1				8053
49215	16.7		Rash	grade 1	discontinuation			8055
49216	9.7		Increased blood pressure	grade 2-3				8056
49217	3.2		Headache	grade 1				8056
49218	3.2		Chest pain	grade 1				8056
49219	9.7		Irritability	grade 1				8056
49220	16.1		Sleep disturbance	grade 1-2				8056
49221	1.5		Cardiac disorders					8058
49222	1.5		Sinus bradycardia					8058
49223	4.6		Infections and infestations					8058
49224	1.5		Influenza					8058
49225	1.5		Pharyngitis					8058
49226	1.5		Pneumonia					8058
49227	1.5		Musculoskeletal and connective tissue disorders					8058
49228	1.5		Arthritis reactive					8058
49229	1.5		Nervous system disorders					8058
49230	3.1		Headache					8058
49231	1.5		Somnolence					8058
49232	4.6		Respiratory, thoracic and mediastinal disorders					8058
49233	1.5		Cough					8058
49234	1.5		Dyspnoea					8058
49235	1.5		Pharyngolaryngeal pain					8058
49236	1.5		Productive cough					8058
49237	1.5		Skin and subcutaneous tissue disorders					8058
49238	1.5		Hyperhidrosis					8058
49239	1.5		Pruritus					8058
49240	1.5		Rash					8058
49241	1.5		Skin fissures					8058
49242	3.1		Vascular disorders					8058
49243	3.1		Hypertension					8058
49244			ALT increased	grade 3		who had a history of fatty hepatosis		8058
49245			AST increased	grade 3		who had a history of fatty hepatosis		8058
49246	8.6		Fatigue					8057
49247	2.9		Gastroenteritis					8057
49248	2.9		Infection					8057
49249	2.9		Headache					8057
49250	2.9		Listlessness					8057
49251						TRV130 was well‐tolerated up to the highest dose tested of 7 mg IV over 1 hour		8060
49252			Opioid abuse		discontinuation			8059
49253			Opioid type dependence		discontinuation			8059
49254			Respiratory depression	grade 5	discontinuation			8059
49255			Withdrawal syndrome neonatal	grade 4	discontinuation			8059
49256			QT interval prolonged		discontinuation			8059
49257						No AEs are reported		8062
49258						No AEs are reported		8061
49259	50		ST segment depression		discontinuation			8065
49260	100		Feeling hot					8063
49261	100		Chest discomfort					8063
49262	100		Chest discomfort		discontinuation			8063
49263	50		ST segment depression		discontinuation			8063
49264	50		Catheter site pain					8063
49265	50		Troponin increased		discontinuation			8063
49266	50		Dizziness postural					8063
49267	50		Dizziness					8063
49268	31		Catheter site pain					8064
49269	19		Headache					8064
49270	12		Dizziness					8064
49271	6		Catheter site haematoma					8064
49272	6		Catheter site pain					8064
49273	6		Pharyngolaryngeal pain					8064
49274	31		Dizziness postural					8064
49275	77		Visual disturbance	grade 1-3			TRUE	8067
49276	77		Diarrhea	grade 1-2				8067
49277	46		Fatigue	grade 1-2				8067
49278	38		Nausea	grade 1-2				8067
49279	8		Injection site reactions	grade 1-2				8067
49280	15		Infusion reaction	grade 1-2				8067
49281	23		Dizziness	grade 1-2				8067
49282	31		Dry mouth	grade 1-2				8067
49283	38		Anemia	grade 1-2				8067
49284	8		Insomnia	grade 1-2				8067
49285	15		Abdominal pain	grade 1-2				8067
49286	8		Headache	grade 1-2				8067
49287	15		Rash	grade 1-2				8067
49288	15		Hemoglobin decreased	grade 1-2				8067
49289	8		Hypotension	grade 1-2				8067
49290	92.3		Diarrhea	grade 1-3				8068
49291	54		Visual disturbance	grade 1-2				8068
49292	62		Fatigue	grade 1-2				8068
49293	62		Nausea	grade 1-2				8068
49294	46		Injection site reactions	grade 1-2				8068
49295	46		Infusion reaction	grade 1-2				8068
49296	62		Dizziness	grade 1-2				8068
49297	15		Dry mouth	grade 1-2				8068
49298	23		Anemia	grade 1-2				8068
49299	15		Insomnia	grade 1-2				8068
49300	31		Muscle spasms	grade 1-2				8068
49301	23		Abdominal pain	grade 1-2				8068
49302	23		Headache	grade 1-2				8068
49303	8		Rash	grade 1-2				8068
49304	15		Weight decreased	grade 1-2				8068
49305	31		Decreased appetite	grade 1-2				8068
49306	31		Dysphonia	grade 1-2				8068
49307	31		Hypotension	grade 1-2				8068
49308	15		Pruritis	grade 1-2				8068
49309	20		Hypotension	grade 3				8066
49310	60		Diarrhea	grade 1-2				8066
49311	80		Visual disturbances	grade 1-2				8066
49312	60		Fatigue	grade 1-2				8066
49313	60		Nausea	grade 1-2				8066
49314	20		Injection site reactions	grade 1-2				8066
49315	100		Infusion reaction	grade 1-2				8066
49316	60		Dizziness	grade 1-2				8066
49317	40		Dry mouth	grade 1-2				8066
49318	40		Insomnia	grade 1-2				8066
49319	40		Muscle spasms	grade 1-2				8066
49320	40		Abdominal pain	grade 1-2				8066
49321	20		Headache	grade 1-2				8066
49322	60		Rash	grade 1-2				8066
49323	60		Weight decreased	grade 1-2				8066
49324	40		Decreased appetite	grade 1-2				8066
49325	20		Dysphonia	grade 1-2				8066
49326	40		Pruritis	grade 1-2				8066
49327	5.3		Liver enzyme abnormal	grade 3			TRUE	8069
49328	40		Gastrointestinal hemorrhage	grade 1-2			TRUE	8070
49329	25		Abnormal vision		discontinuation	spots in the visual fields		8072
49330						No adverse effects leading to discontinuation were reported		8071
49331	60		Fatigue	grade 3				8073
49332	77		Fatigue	grade 1-3				8074
49333	58		Nausea	grade 1-3				8074
49334	8		Headache	grade 1-2				8074
49335	42		Constipation	grade 1-2				8074
49336	27		Diarrhea	grade 1-2				8074
49337	31		Anorexia	grade 1-3				8074
49338	27		Dizziness	grade 1-2				8074
49339	23		Hot flush	grade 1-2				8074
49340	12		Hypokalemia	grade 3				8074
49341	23		Muscle spasms	grade 1-2				8074
49342	4		Vomiting	grade 3				8074
49343	15		Hyperglycemia	grade 1-3				8074
49344	19		Hypertension	grade 1-3				8074
49345	8		Lymphopenia	grade 1-3				8074
49346	12		Lipase increased	grade 1-2				8074
49347	5		Hypertension	grade 3	discontinuation			8075
49348	5		Dyspnea		discontinuation			8075
49349	5		Fatigue		discontinuation			8075
49350	8		Pneumonitis	grade 2-3	discontinuation			8075
49351	2.5		Adrenal insufficiency		discontinuation			8075
49352	33.3		Pancreatitis	grade 2	discontinuation			8077
49353	33.3		Pancreatitis	grade 3	discontinuation			8076
49354	6.3		Hyperhidrosis	moderate				8078
49355	6.3		Asthenia	mild				8078
49356	6.3		Dry mouth	mild				8078
49357	13		Bleeding	grade 3-4		AEs leading to PCI-27483 dose discontinuation - 50%, but they are not specified; AEs leading to PCI-27483 dose modification - 75%, but they are not specified.		8079
49358			Gastrointestinal hemorrhage		discontinuation	The most common AEs leading to PCI-27483 discontinuation were gastrointestinal disorders, including gastrointestinal hemorrhage, and increased INR.		8079
49359			INR increased		discontinuation	The most common AEs leading to PCI-27483 discontinuation were gastrointestinal disorders, including gastrointestinal hemorrhage, and increased INR.		8079
49360			Gastrointestinal disorders		discontinuation	The most common AEs leading to PCI-27483 discontinuation were gastrointestinal disorders, including gastrointestinal hemorrhage, and increased INR.		8079
49361						No adverse effects leading to discontinuation were reported; no DLTs		8080
49362	100		Diarrhea	grade 2	discontinuation|dose interruption		TRUE	8081
49363	33.3		Hypokalemia	grade 3	dose interruption		TRUE	8082
49364	33.3		Stomatitis		discontinuation|dose interruption		TRUE	8082
49365	33.3		Muscle weakness		discontinuation|dose interruption		TRUE	8082
49366	33.3		Retinal detachment	grade 1	discontinuation		TRUE	8083
49367	100		Neutropenia	grade 4			TRUE	8084
49368	100		Leukopenia	grade 4			TRUE	8084
49369	50		Anemia					8084
49370	100		Thrombocytopenia	grade 4			TRUE	8084
49371	50		Lung infection					8084
49372	50		Epistaxis					8084
49373	100		Neutropenia	grade 4			TRUE	8090
49374	83.3		Leukopenia	grade 4			TRUE	8090
49375	50		Thrombocytopenia	grade 3		with bleeding	TRUE	8089
49376	100		Neutropenia	grade 4			TRUE	8088
49377	66.7		Leukopenia	grade 4			TRUE	8088
49378	66.7		Thrombocytopenia	grade 4			TRUE	8088
49379	100		Neutropenia					8086
49380	66.7		Leukopenia					8086
49381	66.7		Anemia					8086
49382	66.7		Thrombocytopenia					8086
49383	33.3		Febrile neutropenia					8086
49384	75		Neutropenia					8085
49385	50		Leukopenia					8085
49386	25		Fatigue					8085
49387	92		Neutrophil count decreased	all grades				8087
49388	46		Platelet count decreased	all grades				8087
49389	33		Anemia	all grades				8087
49390	28		White blood cell decreased	all grades				8087
49391	28		Fatigue	all grades				8087
49392	15		Nausea	all grades				8087
49393	12		Febrile neutropenia	all grades				8087
49394	12		Headache	all grades				8087
49395	8		Diarrhea	all grades				8087
49396	7		Anorexia	all grades				8087
49397	4		Fever	all grades				8087
49398	4		Dehydration	all grades				8087
49399						There were no serious AEs		8091
49400	1 pts		Increased blood pressure	mild				8092
49401	1 pts		Bilirubin elevated	mild				8092
49402	1 pts		Glucose increased	mild				8092
49403	2 pts		GGT increased	mild				8092
49404	1 pts		AST increased	mild				8092
49405	1 pts		Alanine aminotransferase increased	mild				8092
49406			Electrocardiogram T wave abnormal				TRUE	8095
49407			Atrioventricular nodal reentrant tachycardia				TRUE	8095
49408						No information on AE is provided		8099
49409			Ventricular tachyarrhythmia				TRUE	8100
49410			Hyperbilirubinaemia				TRUE	8102
49411			Fatigue				TRUE	8093
49412	50		Ventricular tachycardia		discontinuation	increased ventricular ectopicity was associated with palpitations, dizziness, and breathlessness	TRUE	8093
49413						No information on AE is provided		8097
49414			T wave inversion				TRUE	8094
49415			Electrocardiogram ST segment depression				TRUE	8094
49416			Chronic hepatic failure				TRUE	8094
49417			Ventricular tachycardia				TRUE	8094
49418			Electrocardiogram QTc interval prolonged				TRUE	8098
49419			Hypertension				TRUE	8098
49420	33.3		Thrombocytopenia	grade 3				8096
49421	66.7		Asthenia	grade 1-3	discontinuation			8096
49422	50		Diarrhea	grade 1-2				8096
49423	16.7		Edema peripheral	grade 1-2				8096
49424	33.3		Peripheral sensory neuropathy	grade 1-2				8096
49425	16.7		Constipation	grade 1-2				8096
49426	16.7		Insomnia	grade 3				8096
49427	50		Neuralgia	grade 1-2				8096
49428	16.7		Cardiac arrest	grade 3				8096
49429	16.7		Vomiting	grade 1-2				8096
49430	16.7		Nausea	grade 1-2				8096
49431	16.7		Abdominal pain	grade 3				8096
49432	16.7		Erythema	grade 1-2				8096
49433	16.7		Muscle spasms	grade 1-2				8096
49434	33.3		Neuropathy peripheral	grade 1-2				8096
49435	16.7		Tachycardia	grade 1-2				8096
49436	16.7		Electrocardiogram QTc interval prolonged	grade 3	discontinuation		TRUE	8101
49437	16.7		Torsades de pointes	grade 2	discontinuation		TRUE	8101
49438	16.7		Atrial fibrillation	grade 3	discontinuation		TRUE	8101
49439						here were no severe TEAEs, noserious TEAEs, no discontinuations due to TEAEs, and no deaths.		8103
49440	4.8		Headache					8104
49441	4.8		Dizziness					8104
49442	4.8		Dysgeusia					8104
49443	9.5		Fatigue					8104
49444	9.5		Back pain					8104
49445	4.8		Muscle spasms					8104
49446	1.8		Nausea					8106
49447	1.5		Urinary tract infection					8106
49448	2.3		Transaminases increased					8106
49449	0.2		Back pain					8106
49450	2		Nausea					8107
49451	1		Urinary tract infection					8107
49452	1		Dizziness					8107
49453	2		Nausea					8109
49454	<1		Hypersensitivity					8109
49455	<1		Dyspnea					8109
49456	<1		Rash	grade 3				8109
49457						No AEs reported, no known sequelae		8105
49458						No information		8108
49459	3 pts		Hypertension		discontinuation			8111
49460	2 pts		Hypertension		discontinuation			8112
49461	1 pts		Hypertension		discontinuation			8110
49462	50		Infusion site pain		dose reduction			8113
49463						No adverse effects leading to discontinuation were reported; no DLTs		8114
49464	0		Adverse event		discontinuation	No discontinuation in the treatment period.		8118
49465	1		Schizophrenia	serious	discontinuation			8116
49466	1		Liver function test abnormal		discontinuation			8116
49467	<1		Mental status changes		discontinuation			8117
49468	2		Somnolence		discontinuation			8117
49469	<1		Blood creatine increased		discontinuation			8117
49470	<1		Fatigue		discontinuation			8117
49471	1		Schizophrenia		discontinuation			8117
49472	1		Liver function test abnormal		discontinuation			8117
49473	1		Neutrophil count decreased		discontinuation			8117
49474	<1		Blood creatine phosphokinase increased		discontinuation			8117
49475	1		Glycosylated hemoglobin increased		discontinuation			8117
49476	<1		Priapism		discontinuation			8117
49477	<1		Rectal hemorrhage		discontinuation			8117
49478	<1		Rash		discontinuation			8117
49479	1		Weight increased		discontinuation			8117
49480	1		Drug abuse		discontinuation			8117
49481	<1		Vomiting		discontinuation			8117
49482	<1		Headache		discontinuation			8117
49483	<1		Pleural effusion		discontinuation			8117
49484	1 pts		Malaise		discontinuation			8115
49485	1 pts		Dizziness		discontinuation			8115
49486	1 pts		Hypertension		discontinuation			8115
49487	1 pts		Anxiety		discontinuation			8115
49488	2 pts		Suicidal ideation		discontinuation			8115
49489	1 pts		Irritability		discontinuation			8115
49490	1 pts		Intentional overdose		discontinuation			8120
49491	1 pts		Blood insulin increased					8120
49492	1 pts		Viral gastroenteritis		discontinuation			8120
49493	1 pts		Blood glucose increased		discontinuation			8120
49494	1 pts		Dizziness		discontinuation			8120
49495	1 pts		Suicide attempt		discontinuation			8120
49496	1 pts		Dyslipidemia		discontinuation			8119
49497	1 pts		Dizziness		discontinuation			8119
49498	1 pts		Nausea		discontinuation			8119
49499	1 pts		Seizure		discontinuation			8119
49500	1 pts		Pleural effusion		discontinuation			8119
49501	1 pts		Electrocardiogram change		discontinuation			8119
49502	8 pts		Alanine aminotransferase increased	all grades				8122
49503	2 pts		Anemia	all grades				8122
49504	8 pts		Aspartate aminotransferase increased	all grades				8122
49505	9 pts		Creatinine increased	all grades				8122
49506	4 pts		Cough	all grades				8122
49507	1 pts		Decreased appetite	all grades				8122
49508	7 pts		Dyspnea	all grades				8122
49509	1 pts		Hypertension	all grades				8122
49510	2 pts		Nausea	all grades				8122
49511	11 pts		Edema peripheral	all grades				8122
49512	5 pts		Alanine aminotransferase increased	grade 3-4				8122
49513	4 pts		Aspartate aminotransferase increased	grade 3-4				8122
49514	1 pts		Dyspnea	grade 3-4				8122
49515	2 pts		ALT increased	all grades				8126
49516	2 pts		AST increased	all grades				8126
49517	2 pts		Diarrhea	all grades				8126
49518	1 pts		Dry skin	all grades				8126
49519	2 pts		Fatigue	all grades				8126
49520	3 pts		Malaise	all grades				8126
49521	1 pts		Nasopharyngitis	all grades				8126
49522	4 pts		Nausea	all grades				8126
49523	1 pts		Peripheral edema	all grades				8126
49524	2 pts		Platelet count decreased	all grades				8126
49525	1 pts		Pruritus	all grades				8126
49526	2 pts		Pyrexia	all grades				8126
49527	1 pts		Maculopapular rash	all grades				8126
49528	1 pts		Vomiting	all grades				8126
49529	3 pts		ALT increased	all grades				8124
49530	3 pts		AST increased	all grades				8124
49531	2 pts		Diarrhea	all grades				8124
49532	1 pts		Dizziness	all grades				8124
49533	1 pts		Fatigue	all grades				8124
49534	1 pts		Headache	all grades				8124
49535	2 pts		Malaise	all grades				8124
49536	1 pts		Nasopharyngitis	all grades				8124
49537	6 pts		Nausea	all grades				8124
49538	1 pts		Paronychia	all grades				8124
49539	2 pts		Peripheral edema	all grades				8124
49540	3 pts		Platelet count decreased	all grades				8124
49541	3 pts		Pyrexia	all grades				8124
49542	1 pts		Rash	all grades				8124
49543	1 pts		Maculopapular rash	all grades				8124
49544	2 pts		Stomatitis	all grades				8124
49545	6 pts		Vomiting	all grades				8124
49546	3 pts		ALT increased	grade 3-4				8124
49547	3 pts		AST increased	grade 3-4				8124
49548	1 pts		Pyrexia	grade 3-4				8124
49549	1 pts		Maculopapular rash	grade 3-4				8124
49550	4 pts		Diarrhea	all grades				8127
49551	2 pts		Dizziness	all grades				8127
49552	4 pts		Dry skin	all grades				8127
49553	3 pts		Fatigue	all grades				8127
49554	1 pts		Myalgia	all grades				8127
49555	3 pts		Nasopharyngitis	all grades				8127
49556	3 pts		Nausea	all grades				8127
49557	2 pts		Paronychia	all grades				8127
49558	1 pts		ALT increased	all grades				8121
49559	1 pts		Diarrhea	all grades				8121
49560	1 pts		Dizziness	all grades				8121
49561	1 pts		Fatigue	all grades				8121
49562	2 pts		Headache	all grades				8121
49563	1 pts		Malaise	all grades				8121
49564	1 pts		Myalgia	all grades				8121
49565	1 pts		Nasopharyngitis	all grades				8121
49566	1 pts		Nausea	all grades				8121
49567	2 pts		Paronychia	all grades				8121
49568	3 pts		Alanine aminotransferase increased	grade 3			TRUE	8125
49569	3 pts		AST increased	grade 3			TRUE	8125
49570	3 pts		Alanine aminotransferase increased	grade 4			TRUE	8125
49571	3 pts		AST increased	grade 4			TRUE	8125
49572	3 pts		Drug-induced liver injury	grade 4			TRUE	8125
49573	1 pts		Fatigue	grade 2			TRUE	8127
49574	1 pts		Nausea	grade 2			TRUE	8127
49575	1 pts		Myalgia	grade 2			TRUE	8127
49576	3 pts		Pyrexia	grade 2			TRUE	8121
49577	3 pts		Skin reaction	grade 3			TRUE	8121
49578	3 pts		Anaphylactic shock	grade 3			TRUE	8121
49579	1 pts		Anaphylactic shock		discontinuation	leads to discontinuation		8123
49580	1 pts		Headache		discontinuation	leads to discontinuation		8123
49581	1 pts		Skin reaction		discontinuation	leads to discontinuation		8123
49582	1 pts		Myalgia		discontinuation	leads to discontinuation		8123
49583	1 pts		Peripheral edema		discontinuation	leads to discontinuation		8123
49584	2 pts		Pyrexia		discontinuation	leads to discontinuation		8123
49585	1		Thrombocytopenia	grade 4				8130
49586	23		Thrombocytopenia	grade 3				8130
49587	22		Thrombocytopenia	grade 1-2				8130
49588	1		Hyponatremia	grade 4				8130
49589	8		Hyponatremia	grade 3				8130
49590	3		Hyponatremia	grade 1-2				8130
49591	12		Nausea	grade 3				8130
49592	60		Nausea	grade 1-2				8130
49593	14		Fatigue	grade 3				8130
49594	52		Fatigue	grade 1-2				8130
49595	5		Decreased appetite	grade 3				8130
49596	49		Decreased appetite	grade 1-2				8130
49597	7		Vomiting	grade 3				8130
49598	49		Vomiting	grade 1-2				8130
49599	55		Weight loss	grade 1-2				8130
49600	11		Anemia	grade 3				8130
49601	29		Anemia	grade 1-2				8130
49602	30		Dysgeusia	grade 1-2				8130
49603	1		Blurred vision	grade 3				8130
49604	21		Blurred vision	grade 1-2				8130
49605	1		Diarrhea	grade 3				8130
49606	19		Diarrhea	grade 1-2				8130
49607	8		Constipation	grade 1-2				8130
49608	14		Dizziness	grade 1-2				8130
49609						No AEs are reported		8128
49610	15		Thrombocytopenia	grade 4		leads to dose modification		8129
49611	9		Neutropenia	grade 4		leads to dose modification		8129
49612	1		Anaemia	grade 4				8129
49613	11		Fatigue	grade 3		leads to dose modification		8129
49614	8		Hyponatraemia	grade 3				8129
49615	6		Nausea	grade 3		leads to dose modification		8129
49616	1		Dyspnoea	grade 4				8129
49617	3		Diarrhea	grade 3	discontinuation	leads to dose modification		8129
49618	4		Pyrexia	grade 3	discontinuation	leads to dose modification		8129
49619	1 pts		Acute respiratory distress syndrome	grade 5				8129
49620	1 pts		Cerebrovascular accident	grade 5				8129
49621	3 pts		Sepsis	grade 5				8129
49622						No adverse effects leading to discontinuation were reported		8131
49623						DLTs occurred in two patients, but they are not specified		8133
49624	3.9		Infusion site reaction		discontinuation			8132
49625	18.5		Asthenia		dose reduction			8134
49626	25.9		Upper respiratory tract infection		dose interruption			8134
49627	11.1		Suicidal ideation	grade 5				8134
49628	29.6		Depression	grade 4	dose reduction	Hospitalization		8134
49629	14.8		Injection site reaction	grade 4	dose interruption	Hospitalization		8134
49630	23.1		Spontaneous penile erection			n = 13 male patients		8134
49631			Hyperhidrosis					8134
49632			Pneumonia			Hospitalization		8134
49633			Pleuritis			Hospitalization		8134
49634			Adrenal insufficiency			Hospitalization		8134
49635			Eosinophilia		dose interruption|dose reduction			8134
49636			Panic attack	grade 1		Hospitalization		8134
49637						No serious adverse reactions occurred		8135
49638	38		Headache	grade 1				8136
49639	25		Photosensitivity reaction	grade 1				8136
49640	13		Acne	grade 1				8136
49641	13		Nausea	grade 1				8136
49642	57		Faeces discoloured	grade 1				8137
49643	43		Headache	grade 1				8137
49644	14		Constipation	grade 1				8137
49645	14		Dyspepsia	grade 1				8137
49646	14		Nausea	grade 2				8137
49647	14		Vomiting	grade 2	discontinuation			8137
49648	10		DRESS syndrome		discontinuation			8138
49649	10		Function liver abnormal		discontinuation			8138
49650						Treatment with sutezolid was generally safe and well tolerated. No subject required dose reduction or premature discontinuation.		8139
49651	16.7		Abdominal pain					8140
49652	33.3		Flatulence					8140
49653	66.7		Diarrhea					8140
49654	50		Nausea					8140
49655	12 pts		Pruritus					8141
49656	10 pts		Xerosis					8141
49657	3 pts		Skin fragility					8141
49658	3 pts		Hair disorder					8141
49659	2 pts		Dry skin					8141
49660	11 pts		Cheilitis					8141
49661	2 pts		Dry mouth					8141
49662	10 pts		Triglyceride increased					8141
49663	2 pts		Headache					8141
49664	4 pts		Epistaxis					8141
49665	2 pts		Diarrhoea					8142
49666	2 pts		Fatigue					8142
49667	2 pts		Nausea					8142
49668	2 pts		AST increased					8142
49669	1 pts		ALT increased					8142
49670	1 pts		Dyspnea					8142
49671						No information on AE is provided		8143
49672						No information on AE is provided		8144
49673	17		Hypertension	grade 1-2				8146
49674	33		Diarrhoea	grade 1-2				8146
49675	17		Flatulence	grade 1-2				8146
49676	17		Nausea	grade 1-2				8146
49677	17		Vomiting	grade 1-2				8146
49678	12.5		Hypertension	grade 3			TRUE	8149
49679	16.7		Hypertension	grade 3			TRUE	8145
49680	16.7		Anorexia	grade 1-2				8147
49681	16.7		Constipation	grade 1-2				8147
49682	50		Diarrhea	grade 1-2				8147
49683	16.7		Nausea	grade 1-2				8147
49684	16.7		Vomiting	grade 1-2				8147
49685	50		Fatigue	grade 1-2				8147
49686	50		Hoarseness	grade 1-2				8147
49687	16.7		Hypertension	grade 3			TRUE	8148
49688	33.3		Metabolic acidosis				TRUE	8155
49689	33.3		Respiratory failure				TRUE	8155
49690						No information on AE is provided		8150
49691	16.7		Ileus	grade 3			TRUE	8154
49692	16.7		Dyspnea	grade 3			TRUE	8154
49693						No information on AE is provided		8151
49694	33.3		Hypoxia	grade 4	discontinuation		TRUE	8153
49695	33.3		Nephritis interstitial	grade 2	discontinuation		TRUE	8153
49696	20		Pneumonia		discontinuation			8152
49697	13		Sepsis		discontinuation			8152
49698	13		Dyspnea		discontinuation			8152
49699	8		Altered mood		discontinuation			8156
49700	2		Syncope		discontinuation			8156
49701	2		Vertigo		discontinuation			8156
49702	16		Vertigo		discontinuation			8156
49703	2		Pain of skin		discontinuation			8156
49704	2		Hypervigilance		discontinuation			8156
49705	2		Ear and labyrinth disorders		discontinuation			8156
49706	22.4		Nausea					8156
49707	4.1		Vomiting					8156
49708	59.2		Dry mouth					8156
49709	4.1		Toothache					8156
49710	12.2		Abdominal pain					8156
49711	18.4		Diarrhoea					8156
49712	16.3		Constipation					8156
49713	10.2		Faeces hard					8156
49714	6.1		Faecaloma					8156
49715	16.5		Insomnia					8156
49716	2		Dyssomnia					8156
49717	6.1		Hypervigilance					8156
49718	12.2		Dizziness					8156
49719						No information on AE is provided		8159
49720						No information on AE is provided		8160
49721			Diarrhea	grade 1-2				8158
49722			Abdominal discomfort	grade 1-2				8158
49723			Nausea	grade 1-2				8158
49724			Vomiting	grade 1-2				8158
49725			Chills	grade 1-2				8158
49726			Fatigue	grade 1-2				8158
49727			Headache	grade 1-2				8158
49728			Dizziness	grade 1-2				8158
49729	87.5		Diarrhea	grade 1-2				8157
49730	50		Abdominal discomfort	grade 1-2				8157
49731	37.5		Abdominal pain	grade 1-2				8157
49732	37.5		Nausea	grade 1-2				8157
49733	37.5		Dizziness	grade 1-2				8157
49734	37.5		Headache	grade 1-2				8157
49735	25		Vomiting	grade 1-2				8157
49736	20 pts		Thrombocytopenia					8162
49737	2 pts		Anemia					8162
49738	4 pts		Neutropenia					8162
49739	1 pts		Pneumonia					8162
49740	62.9		Diarrhoea	all grades				8161
49741	62.9		Oedema peripheral	all grades				8161
49742	57.1		Fatigue	all grades				8161
49743	40		Dyspnoea	all grades				8161
49744	42.9		Nausea	all grades				8161
49745	42.9		Decreased appetite	all grades				8161
49746	40		Hypotension	all grades				8161
49747	37.1		Febrile neutropenia	all grades				8161
49748	37.1		Dizziness	all grades				8161
49749	31.4		Cough	all grades				8161
49750	31.4		Pyrexia	all grades				8161
49751	31.4		Asthenia	all grades				8161
49752	28.6		Hypokalaemia	all grades				8161
49753	20		Constipation	all grades				8161
49754	22.9		Insomnia	all grades				8161
49755	22.9		Rash	all grades				8161
49756	25.7		Pneumonia	all grades				8161
49757	22.9		Vomiting	all grades				8161
49758	22.9		Thrombocytopenia	all grades				8161
49759	29		Diarrhoea	grade 3-4				8161
49760	22.9		Fatigue	grade 3-4				8161
49761	20		Dyspnoea	grade 3-4				8161
49762	2.9		Decreased appetite	grade 3-4				8161
49763	11.4		Hypotension	grade 3-4				8161
49764	28.6		Febrile neutropenia	grade 3-4				8161
49765	2.9		Cough	grade 3-4				8161
49766	8.6		Asthenia	grade 3-4				8161
49767	8.6		Hypokalaemia	grade 3-4				8161
49768	17.1		Pneumonia	grade 3-4				8161
49769	22.9		Thrombocytopenia	grade 3-4				8161
49770	12 pts		Febrile neutropenia					8161
49771	5 pts		Disease progression					8161
49772	5 pts		Atrial fibrillation					8161
49773	5 pts		Pneumonia					8161
49774	1 pts		Pyrexia					8161
49775	2 pts		Cardiac failure congestive					8161
49776	1 pts		Cellulitis					8161
49777	2 pts		Dyspnoea					8161
49778	1 pts		Multi-organ failure					8161
49779	3 pts		Rectal haemorrhage					8161
49780	1 pts		Atrial fibrillation	grade 5	discontinuation	leads to discontinuation		8161
49781	1 pts		Left ventricular dysfunction	grade 5	discontinuation	leads to discontinuation		8161
49782	1 pts		Hepatitis acute	grade 5	discontinuation	leads to discontinuation		8164
49783	1 pts		Respiratory failure	grade 5	discontinuation	leads to discontinuation		8164
49784	1 pts		Pneumonia	grade 5	discontinuation	leads to discontinuation		8164
49785	2 pts		Anemia	grade 1-2				8163
49786	5 pts		Diarrhea	grade 1-2				8163
49787	3 pts		Nausea	grade 1-2				8163
49788	3 pts		Mucositis	grade 1-2				8163
49789	3 pts		Fatigue	grade 1-2				8163
49790	3 pts		Edema	grade 1-2				8163
49791	3 pts		QT interval prolonged	grade 1-2				8163
49792	5 pts		Ejection fraction decreased	grade 1-2				8163
49793	2 pts		Thrombocytopenia	grade 1-2				8163
49794	2 pts		Dizziness	grade 1-2				8163
49795	2 pts		Maculopapular rash	grade 1-2				8163
49796	1 pts		Acute coronary syndrome	grade 3-4			TRUE	8163
49797	1 pts		Diarrhea	grade 3-4				8163
49798	1 pts		Nausea	grade 3-4				8163
49799	1 pts		Fatigue	grade 3-4				8163
49800	1 pts		QT interval prolonged	grade 3-4				8163
49801	12.5		Nausea	grade 3				8168
49802	37.5		Transaminases increased	grade 3-4			TRUE	8168
49803	12.5		Hyperbilirubinemia	grade 3			TRUE	8168
49804	25		Bicarbonate decreased serum	grade 1				8168
49805	33.3		Fever	grade 1-2				8166
49806	22.2		Methemoglobinemia	grade 2				8166
49807	22.2		Bone pain	grade 2				8166
49808	22.2		Metabolic acidosis	grade 1				8166
49809	22.2		Gastrointestinal mucositis	grade 1-3				8166
49810	22.2		Bacteremia					8166
49811	22.2		Pneumonia fungal					8166
49812	22.2		Febrile neutropenia					8166
49813	38		Neutropenia	grade 3-4			TRUE	8167
49814	17		Hypertension	grade 3			TRUE	8169
49815	100		Hypoxia	grade 3			TRUE	8165
49816	50		AST increased	grade 4			TRUE	8165
49817	50		Anorexia	grade 3				8165
49818	50		Fatigue	grade 3				8165
49819	50		Thrombocytopenia	grade 4				8165
49820	50		Neutropenia	grade 4				8165
49821	50		Anemia	grade 3				8165
49822	37.9		Upper respiratory tract infection	grade 1-2				8173
49823	24.1		Gastroenteritis	grade 1-2				8173
49824	51.7		Diarrhea	grade 1-2				8173
49825	37.9		Vomiting	grade 1-2				8173
49826	24.1		Abdominal pain	grade 1-2				8173
49827	41.4		Rhabdomyolysis	grade 1-2				8173
49828	20.7		Pyrexia	grade 1-2				8173
49829	20.7		Headache	grade 1-2				8173
49830	> 5		Nausea	grade 1-2				8173
49831	> 5		Abdominal distension	grade 1-2				8173
49832	> 5		Flatulence	grade 1-2				8173
49833	> 5		Acne	grade 1-2				8173
49834	3.4		Abdominal pain		discontinuation			8173
49835	3.4		Diarrhea	grade 2	discontinuation			8173
49836	31.25		Diarrhea					8175
49837	68.75		Gastrointestinal upset					8175
49838	37.5		Emesis					8175
49839	68.75		Musculoskeletal pain					8175
49840	31.25		Rhabdomyolysis					8175
49841	18.75		Fatigue					8175
49842	31.25		Headache					8175
49843	93.75		Viral infection					8175
49844	25		Pain localized					8175
49845	6.25		Dermatitis					8175
49846	6.25		Hemorrhoids					8175
49847	6.25		Depression					8175
49848	6.25		Constipation					8175
49849	6.25		Nail avulsion					8175
49850	6.25		Vertigo					8175
49851	6.25		Tooth injury					8175
49852	58.3		Diarrhea					8174
49853	16.7		Constipation					8174
49854	16.7		Abdominal pain					8174
49855	25		Vomiting					8174
49856	8.3		Anorexia					8174
49857	8.3		Acne					8174
49858						MTD AEs not reported		8172
49859	60		Abdominal pain					8176
49860	44		Diarrhea					8176
49861	44		Vomiting					8176
49862	14		Nausea					8176
49863						Information about AEs not found		8171
49864						Information about AEs not found		8170
49865	1.3		Nausea					8178
49866	2.6		Diarrhea					8178
49867	1.3		Abdominal pain					8178
49868	1.3		Vomiting					8178
49869	1.3		Medical device site reaction					8178
49870	2.6		Vessel puncture site pain					8178
49871	1.3		Electrocardiogram QT prolonged					8178
49872	1.3		AST increased					8178
49873	2.6		Headache					8178
49874	1.3		Insomnia					8178
49875	1.3		Cough					8178
49876	1.3		Oropharyngeal pain					8178
49877	2		Nausea					8185
49878	1.4		Dizziness					8185
49879	2.5		Nausea					8187
49880	2.1		Dizziness					8187
49881	2.7		Upper respiratory tract infection			Within 30 Days After Any Dose		8181
49882	2.5		Nausea			Within 30 Days After Any Dose		8181
49883	2.3		Nasopharyngitis			Within 30 Days After Any Dose		8181
49884	2		Dizziness			Within 30 Days After Any Dose		8181
49885	1.3		Upper respiratory tract infection			Within 30 Days After Any Dose		8186
49886	2.9		Nausea			Within 30 Days After Any Dose		8186
49887	1		Nasopharyngitis			Within 30 Days After Any Dose		8186
49888	2.3		Dizziness			Within 30 Days After Any Dose		8186
49889	0.4		ALT increased					8182
49890	0.2		AST increased					8182
49891	0.2		ALP increased					8182
49892	16.7		Headache	grade 1-2				8177
49893	16.7		Nausea	grade 1-2				8177
49894	16.7		Abdominal discomfort	grade 1-2				8177
49895	16.7		Abdominal pain upper	grade 1-2				8177
49896	16.7		Application site irritation	grade 1-2				8177
49897	16.7		Herpes simplex	grade 1-2				8177
49898	0.2		Nausea		discontinuation			8183
49899	0.2		Thrombocytopenia		discontinuation			8183
49900	0.2		Urticaria		discontinuation			8183
49901	0.2		Vomiting		discontinuation			8183
49902	0.2		Abnormal ECG		discontinuation			8179
49903	0.2		Extrasystoles		discontinuation			8179
49904	0.2		Nausea		discontinuation			8179
49905	0.2		Palpitations		discontinuation			8179
49906	0.2		Pruritus		discontinuation			8179
49907	0.2		ALT increased		discontinuation			8179
49908	0.2		AST increased		discontinuation			8179
49909	8.2		Nasopharyngitis	grade 1-2				8183
49910	11.6		Upper respiratory tract infection	grade 1-2				8183
49911	6.9		Sinusitis	grade 1-2				8183
49912	5.4		Urinary tract infection	grade 1-2				8183
49913	4.2		Influenza	grade 1-2				8183
49914	4.7		Nausea	grade 1-2				8183
49915	3.2		Bronchitis	grade 1-2				8183
49916	2.5		Blood creatine phosphokinase increased	grade 1-2				8183
49917	2.2		ALT increased	grade 1-2				8183
49918	1.7		AST increased	grade 1-2				8183
49919	3.5		Back pain	grade 1-2				8183
49920	1		Nephrolithiasis	grade 1-2				8183
49921	1.2		Dizziness	grade 1-2				8183
49922	1.5		Anxiety	grade 1-2				8183
49923	2		Cough	grade 1-2				8183
49924	2.5		Diarrhea	grade 1-2				8183
49925	2.7		Arthralgia	grade 1-2				8183
49926	1.7		Gastroenteritis viral	grade 1-2				8183
49927	0.5		Muscle strain	grade 1-2				8183
49928	3.2		Depression	grade 1-2				8183
49929	1.5		Migraine	grade 1-2				8183
49930	1		Abdominal pain	grade 1-2				8183
49931	3.2		Epididymitis	grade 1-2				8183
49932	3.2		Testicular pain	grade 1-2				8183
49933	11.5		Nasopharyngitis	grade 1-2				8179
49934	10.8		Upper respiratory tract infection	grade 1-2				8179
49935	6.4		Sinusitis	grade 1-2				8179
49936	6.4		Urinary tract infection	grade 1-2				8179
49937	6.1		Influenza	grade 1-2				8179
49938	4.6		Nausea	grade 1-2				8179
49939	4.4		Bronchitis	grade 1-2				8179
49940	3.9		Blood creatine phosphokinase increased	grade 1-2				8179
49941	3.7		ALT increased	grade 1-2				8179
49942	3.4		AST increased	grade 1-2				8179
49943	3.4		Back pain	grade 1-2				8179
49944	3.2		Nephrolithiasis	grade 1-2				8179
49945	2.9		Dizziness	grade 1-2				8179
49946	2.7		Anxiety	grade 1-2				8179
49947	2.7		Cough	grade 1-2				8179
49948	2.7		Diarrhea	grade 1-2				8179
49949	2.4		Arthralgia	grade 1-2				8179
49950	2.4		Gastroenteritis viral	grade 1-2				8179
49951	2.4		Muscle strain	grade 1-2				8179
49952	1.2		Depression	grade 1-2				8179
49953	1		Migraine	grade 1-2				8179
49954	0.5		Abdominal pain	grade 1-2				8179
49955	2		Nausea					8184
49956	2		Somnolence					8184
49957	< 1		Dry mouth					8184
49958	4		Nausea					8180
49959	3		Somnolence					8180
49960	2		Dry mouth					8180
49961			Nausea		discontinuation			8180
49962	10.1		Diarrhea	grade 1-2				8189
49963	10.1		Nausea	grade 1-2				8189
49964	3.6		Constipation	grade 1-2				8189
49965	8.7		Fatigue	grade 1-2				8189
49966	7.2		Edema peripheral	grade 1-2				8189
49967	6.5		Urinary tract infection	grade 1-2				8189
49968	1.4		Upper respiratory tract infection	grade 1-2				8189
49969	5.1		Hyperkalemia	grade 1-2				8189
49970	5.8		Headache	grade 1-2				8189
49971	5.1		Dizziness	grade 1-2				8189
49972	7.2		Renal failure acute	grade 1-2				8189
49973	5.1		Renal failure chronic	grade 1-2				8189
49974	4.3		Dyspnea	grade 1-2				8189
49975	8		Hypertension	grade 1-2				8189
49976	4.3		Hypotension	grade 1-2				8189
49977						No information on AE is provided		8188
49978			Stomatitis	grade 3			TRUE	8191
49979	25		Thrombosis	grade 3			TRUE	8190
49980	25		AST increased	grade 3			TRUE	8190
49981	25		ALT increased	grade 3			TRUE	8190
49982	25		Anorexia	grade 3			TRUE	8190
49983	3.2		Nausea		discontinuation	leads to discontinuation		8192
49984	12.9		Headache					8192
49985	6.5		Nausea					8192
49986	6.5		Vomiting					8192
49987	3.2		Cough					8192
49988	3.2		Hypertension					8192
49989	4.4		Syncope					8193
49990	15.4		Hypotension					8193
49991			Fetal damage		discontinuation			8194
49992						No adverse effects leading to discontinuation were reported; no DLTs		8196
49993	16.7		Myocardial infarction	grade 3			TRUE	8198
49994	14.3		Myocardial infarction	grade 3			TRUE	8195
49995	3.2		Myocardial infarction	grade 4	discontinuation			8197
49996	100		Chills	grade 1-2				8202
49997	83		Pyrexia	grade 1-3				8202
49998	33		Tachycardia	grade 1-2				8202
49999	17		Diarrhoea	grade 1-2				8202
50000	17		Anorexia	grade 1-2				8202
50001	67		Myalgia	grade 1-2				8202
50002	17		Back pain	grade 1-2				8202
50003	67		Headache	grade 1-2				8202
50004	7.1		Cholecystitis	grade 4	discontinuation			8204
50005			Chills		discontinuation			8199
50006			Hot flush		discontinuation			8200
50007			Pyrexia		discontinuation			8200
50008			Tremor		discontinuation			8201
50009			Hypotension		discontinuation			8201
50010	1.8		ALT increased	grade 2	discontinuation			8203
50011	2		ALT increased	grade 3	discontinuation			8205
50012	1.8		Neutropenia	grade 2	discontinuation			8205
50013	3.6		Pyrexia	grade 1	discontinuation			8205
50014	1.8		Nausea	grade 1	discontinuation			8205
50015	3.6		Chills	grade 2	discontinuation			8205
50016	1.8		Myalgia	grade 2	discontinuation			8205
50017	1.8		Headache	grade 2	discontinuation			8205
50018	1.8		Vomiting	grade 2	discontinuation			8205
50019	1.8		Chills	grade 2	discontinuation			8205
50020	1.8		Arthralgia	grade 2	discontinuation			8205
50021	1.8		Pyrexia	grade 3	discontinuation			8205
50022	1 pts		Dyspepsia					8206
50023	1 pts		Insomnia					8206
50024	2 pts		Nasopharyngitis					8206
50025	1 pts		Musculoskeletal pain					8206
50026	1 pts		Myalgia					8206
50027	2 pts		Hematuria microscopic					8206
50028	1 pts		Abdominal pain					8206
50029	1 pts		Fatigue					8206
50030	1 pts		Glucosuria					8206
50031	1 pts		Leukocyturia					8206
50032	3 pts		Tachycardia					8206
50033	7 pts		Diarrhea					8207
50034	4 pts		Nausea					8207
50035	4 pts		Abdominal pain upper					8207
50036	3 pts		Dyspepsia					8207
50037	3 pts		Pyrexia					8207
50038	8 pts		Nasopharyngitis					8207
50039	6 pts		Urinary tract infection					8207
50040	2 pts		Upper respiratory tract infection					8207
50041	3 pts		Pharyngitis					8207
50042	3 pts		Viral infection					8207
50043	3 pts		Cystitis					8207
50044	4 pts		Blood alkaline phosphatase increased					8207
50045	8 pts		Rheumatoid arthritis					8207
50046	5 pts		Arthralgia					8207
50047	19 pts		Musculoskeletal stiffness					8207
50048	3 pts		Headache					8207
50049	4 pts		Oropharyngeal pain					8207
50050	1 pts		Hypertension					8207
50051	4 pts		Hepatocellular injury					8207
50052	1 pts		Gamma-glutamyltransferase increased					8207
50053	1 pts		Hematuria					8207
50054	1 pts		Bladder pain					8207
50055	1 pts		Ketonuria					8207
50056	1 pts		Leukocyturia					8207
50057	1 pts		Nocturia					8207
50058	1 pts		Renal amyloidosis					8207
50059	1 pts		Renal failure chronic					8207
50060						No patient withdrew from the study.		8208
50061						No AEs related to the drug.: Two subjects enrolled in 150 mg cohort developed grade II skin acute urticaria during the study. Urticaria was found in chest, eyes. It occurred 1.5–2.0 h after dosing and resolved within 3 h without any specific intervention. This event was not considered related to the study drug.		8209
50062						No AEs related to the drug.: Diarrhea was deemed not suspected to be related to study medication and resolved without any treatment.		8210
50063						No dose-limiting adverse events and no serious adverse events were reported or observed		8211
50064						No dose-limiting adverse events and no serious adverse events were reported or observed		8212
50065						No information on AE is provided		8213
50066	12.5		Headache	grade 3			TRUE	8215
50067	11.1		Headache	grade 3			TRUE	8216
50068	13.3		Headache	grade 3			TRUE	8217
50069	33.3		Headache	grade 3			TRUE	8214
50070	6.7		Hypertension	grade 3			TRUE	8217
50071	16.7		Amylase increased	grade 3			TRUE	8214
50072	3.4		Headache		discontinuation			8218
50073	1.7		Upper abdominal pain		discontinuation			8218
50074	1.7		Bilirubin increased		discontinuation			8218
50075	1.7		Cholangitis		discontinuation			8218
50076	1.7		Fatigue		discontinuation			8218
50077	1.7		General physical health deterioration		discontinuation			8218
50078	1.7		Hepatic enzyme increased		discontinuation			8218
50079	1.7		Edema		discontinuation			8218
50080	1.7		Peripheral edema		discontinuation			8218
50081	1.7		Vomiting		discontinuation			8218
50082	12.5		Urticaria		discontinuation	subjects with moderate renal impairement		8221
50083	4		Diarrhea					8219
50084	4		Infusion site reactions					8219
50085	3		Constipation					8219
50086	3		Rash					8219
50087	2		Candidiasis					8219
50088	2		Cough					8219
50089	2		Elevated liver enzymes					8219
50090	2		Headache					8219
50091	2		Hypokalemia					8219
50092	2		Nausea					8219
50093	2		Vomiting					8219
50094	0.3		Diarrhea		discontinuation			8219
50095	0.3		Drug hypersensitivity		discontinuation			8219
50096	0.3		Hepatic enzymes increased		discontinuation			8219
50097	0.3		Death	grade 5	discontinuation			8219
50098	<2		Thrombocytosis					8219
50099	<2		Congestive heart failure					8219
50100	<2		Bradycardia					8219
50101	<2		Atrial fibrillation					8219
50102	<2		Abdominal pain					8219
50103	<2		Dry mouth					8219
50104	<2		Stomatitis					8219
50105	<2		Pyrexia					8219
50106	<2		Peripheral edema					8219
50107	<2		Cholelithiasis					8219
50108	<2		Cholecystitis					8219
50109	<2		Gallbladder pain					8219
50110	<2		Drug hypersensitivity					8219
50111	<2		Clostridium difficile infection					8219
50112	<2		Prothrombin time prolonged					8219
50113	<2		Red blood cells urine positive					8219
50114	<2		Creatine phosphokinase increased					8219
50115	<2		Decreased appetite					8219
50116	<2		Hypocalcemia					8219
50117	<2		Fluid overload					8219
50118	<2		Dysgeusia					8219
50119	<2		Seizure					8219
50120	<2		Dyspnea					8219
50121	<2		Pleural effusion					8219
50122	<2		Pruritis					8219
50123	<2		Insomnia					8219
50124	<2		Restlessness					8219
50125	16		Elevated liver enzymes					8220
50126	11		Hypokalemia					8220
50127	9		Diarrhea					8220
50128	5		Hypomagnesemia					8220
50129	5		Atrial fibrillation					8220
50130	26.4		Death	grade 5	discontinuation			8220
50131			Elevated liver enzymes		discontinuation			8220
50132	<4		Thrombocytopenia					8220
50133	<4		Thrombocytosis					8220
50134	<4		Myocardial infarction					8220
50135	<4		Atrial flutter					8220
50136	<4		Nausea					8220
50137	<4		Vomiting					8220
50138	<4		Abdominal pain					8220
50139	<4		Cholecystitis					8220
50140	<4		Cholestasis					8220
50141	<4		Clostridium difficile infection					8220
50142	<4		Oral candidiasis					8220
50143	<4		Prothrombin time prolonged					8220
50144	<4		Activated partial thromboplastin time					8220
50145	<4		Hypocalcemia					8220
50146	<4		Hyperkalemia					8220
50147	<4		Seizure					8220
50148	<4		Acute interstitial nephritis					8220
50149	<4		Cough					8220
50150	<4		Rash					8220
50151	2.4		Anemia					8224
50152	4.8		Neutropenia					8224
50153	9.5		Atopic dermatitis					8224
50154	14		Acne					8224
50155	9.5		Headache					8224
50156	7.1		Nasopharyngitis					8224
50157	9.5		CPK increased					8224
50158	7.1		Nausea					8224
50159			Adverse event	grade 5		WARNING		8222
50160	2 pts		Anemia		discontinuation	leads to discontinuation		8223
50161	2 pts		Vertigo		discontinuation	leads to discontinuation		8223
50162	2 pts		Bronchitis		discontinuation	leads to discontinuation		8223
50163	2 pts		ALT increased		discontinuation	leads to discontinuation		8223
50164	3 pts		Aspartate aminotransferase increased		discontinuation	leads to discontinuation		8223
50165	2 pts		Increased serum creatinine		discontinuation	leads to discontinuation		8223
50166	2 pts		Headache		discontinuation	leads to discontinuation		8223
50167	6 pts		Somnolence					8226
50168	7 pts		Postural orthostatic tachycardia syndrome					8226
50169	5 pts		Orthostatic hypotension					8226
50170	1 pts		Vomiting					8226
50171	1 pts		Nausea					8226
50172	1 pts		Dizziness					8226
50173	1 pts		Dysarthria					8226
50174	1 pts		Anxiety					8226
50175	1 pts		Blurred vision					8226
50176	5 pts		Somnolence					8227
50177	1 pts		Orthostatic hypotension					8227
50178	1 pts		Headache					8227
50179	1 pts		Nausea					8227
50180	1 pts		Akathisia					8227
50181	1 pts		Restlessness					8227
50182	8 pts		Somnolence					8225
50183	1 pts		Akathisia					8225
50184	1 pts		Orthostatic hypotension					8225
50185	2 pts		Extrapyramidal disorder					8225
50186	1 pts		Headache					8225
50187	2 pts		Anxiety					8225
50188	2 pts		Oromandibular dystonia					8225
50189	1 pts		Constipation					8225
50190	1 pts		Dizziness					8225
50191	1 pts		Nausea					8225
50192	1 pts		Orthostatic heart rate response increased					8225
50193	1 pts		Akathisia					8225
50194	2 pts		Dystonia					8225
50195	2 pts		Oromandibular dystonia					8225
50196	2 pts		Extrapyramidal disorder					8225
50197						impossible to link AEs with the definite dose		8229
50198	0.2		Neoplasms malignant site unspecified NEC		discontinuation	leads to discontinuation		8228
50199	0.2		Aortic stenosis		discontinuation	leads to discontinuation		8228
50200	0.2		Dyspnea		discontinuation	leads to discontinuation		8228
50201	0.2		Leukostasis		discontinuation	leads to discontinuation		8228
50202	0.5		Thrombocytopenia		discontinuation	leads to discontinuation		8228
50203	0.2		Pulmonary fibrosis		discontinuation	leads to discontinuation		8228
50204	0.2		Hemorrhagic bullae		discontinuation	leads to discontinuation		8228
50205	0.2		Chest pain (non-cardiac)		discontinuation	leads to discontinuation		8228
50206	1 pts		Leukoencephalopathy	grade 5	discontinuation	leads to discontinuation		8230
50207	1 pts		Exanthema	grade 2	discontinuation	leads to discontinuation		8230
50208	1 pts		Rash	grade 2	discontinuation	leads to discontinuation		8230
50209	1 pts		Hemolysis	grade 3	discontinuation	leads to discontinuation		8230
50210	1 pts		Hypersensitivity reaction	grade 3	discontinuation	leads to discontinuation		8230
50211	1 pts		ALT increased	grade 3	discontinuation	leads to discontinuation		8230
50212	1 pts		Aspartate aminotransferase increase	grade 3	discontinuation	leads to discontinuation		8230
50213	50		Anemia	grade 3	discontinuation			8231
50214	50		Neutropenia	grade 3	discontinuation			8231
50215	50		Neutropenia	grade 4			TRUE	8231
50216	50		Febrile neutropenia	grade 3			TRUE	8231
50217	5.6		Septic shock	grade 5	discontinuation			8232
50218	5.6		Anemia	grade 3	discontinuation			8232
50219	5.6		Dehydration				TRUE	8232
50220	5.6		Neutropenia				TRUE	8232
50221	5.6		Sepsis				TRUE	8232
50222			Diarrhea	grade 1-2				8233
50223			Abdominal pain	grade 1-2				8233
50224			Fatigue	grade 1-2				8233
50225			Nausea	grade 1-2				8233
50226			Vomiting	grade 1-2				8233
50227			Anorexia	grade 1-2				8233
50228						No adverse effects leading to discontinuation were reported; no DLTs		8234
50229			Taste alteration					8235
50230			Smell alteration					8235
50231			Abdominal pain					8235
50232			Nausea					8235
50233			Diarrhoea					8235
50234			Hematuria microscopic					8235
50235						No AEs were reported		8236
50236	1 pts		ALT increased					8237
50237	1 pts		Glutamate dehydrogenase					8237
50238						No AEs are reported		8239
50239						No AEs are reported		8238
50240						No AEs are reported		8240
50241	11.1		Nausea	grade 3	dose interruption			8241
50242	11.1		Vomiting		dose interruption			8241
50243	7		Eye disorders	grade 3	discontinuation			8242
50244	2 pts		Anaemia	grade 3				8243
50245	1 pts		Electrocardiogram QT prolonged	grade 3				8243
50246	1 pts		Asthenia	grade 3				8243
50247	3 pts		Electrocardiogram QT prolonged					8243
50248	2 pts		Constipation					8243
50249	1 pts		Vomiting					8243
50250	1 pts		Nausea					8243
50251	1 pts		Peripheral oedema					8243
50252	1 pts		Anaemia					8243
50253	2 pts		Insomnia					8243
50254	1 pts		Rash					8243
50255	7 pts		Rhinorrhea					8244
50256	16 pts		Nasal discomfort					8244
50257	7 pts		Nasal congestion					8244
50258	6 pts		Throat irritation					8244
50259	1 pts		Oropharyngeal pain					8244
50260	1 pts		Dry throat					8244
50261	1 pts		Diarrhoea	below serious				8248
50262	1 pts		Upper respiratory tract infection	below serious				8248
50263	1 pts		Blood creatine phosphokinase increased	below serious				8248
50264	1 pts		Musculoskeletal pain	below serious				8248
50265	1 pts		Fatigue	below serious				8249
50266	1 pts		Papule	below serious				8249
50267	1 pts		Diarrhoea	below serious				8247
50268	1 pts		Arthropod bite	below serious				8247
50269	6		Diarrhea	all grades				8245
50270	5		Nausea	all grades				8245
50271	5		Headache	all grades				8245
50272	3		Fatigue	all grades				8245
50273	3		Abnormal dreams	all grades				8245
50274	2		Dizziness	all grades				8245
50275	2		Insomnia	all grades				8245
50276	2		Amylase	grade 3-4				8246
50277	1		ALT increased	grade 3-4				8246
50278	2		AST increased	grade 3-4				8246
50279	4		Creatine kinase	grade 3-4				8246
50280	2		Neutrophils	grade 3-4				8246
50281	2		LDL cholesterol	grade 3-4				8246
50282						No adverse effects leading to discontinuation were reported.		8252
50283	1.25		Gastroesophagitis		discontinuation			8250
50284	1.25		Upper gastrointestinal hemorrhage		discontinuation			8250
50285	1.25		Vomiting		discontinuation			8250
50286	1.25		Constipation		discontinuation			8250
50287	1.25		Chest discomfort		discontinuation			8250
50288	1.25		Hyponatremia		discontinuation			8250
50289			Intestinal obstruction		discontinuation			8251
50290			Diverticulitis		discontinuation			8251
50291			Intestinal perforation		discontinuation			8251
50292			Ischemic enterocolitis		discontinuation			8251
50293			Gastrointestinal bleeding		discontinuation			8251
50294			Gastrointestinal ulcer		discontinuation			8251
50295			Constipation		discontinuation			8251
50296	7 pts		Vertigo	below serious				8255
50297	3 pts		Asthenia	below serious				8255
50298	3 pts		Fatigue	below serious				8255
50299	5 pts		Dizziness	below serious				8255
50300	4 pts		Headache	below serious				8255
50301	8 pts		Somnolence	below serious				8255
50302	1 pts		Thrombocytopenia	serious				8257
50303	1 pts		Vascular purpura	serious				8257
50304	3 pts		Vertigo	below serious				8257
50305	4 pts		Nausea	below serious				8257
50306	6 pts		Fatigue	below serious				8257
50307	5 pts		Dizziness	below serious				8257
50308	2 pts		Headache	below serious				8257
50309	8 pts		Somnolence	below serious				8257
50310	4 pts		Neutropenia	below serious				8256
50311	1 pts		Neurotoxicity	serious				8253
50312	2 pts		Neutropenia	below serious				8253
50313	3 pts		Fatigue	below serious				8258
50314	4 pts		Dizziness	below serious				8258
50315	1 pts		Abortion spontaneous	serious				8254
50316	1 pts		Jaw fracture	serious				8254
50317	1 pts		Vaginal hemorrhage	serious				8254
50318	5 pts		Convulsion	below serious				8254
50319	3 pts		Fatigue	below serious				8254
50320	14 pts		Headache	below serious				8254
50321	8 pts		Nasopharyngitis	below serious				8254
50322	8 pts		Somnolence	below serious				8254
50323	1 pts		Amnesia	serious				8259
50324	1 pts		Gastritis erosive	serious				8259
50325	1 pts		Grand mal convulsion	serious				8259
50326	1 pts		Psychotic disorder	serious				8259
50327	7 pts		Dizziness	below serious				8259
50328	4 pts		Fatigue	below serious				8259
50329	18 pts		Headache	below serious				8259
50330	5 pts		Irritability	below serious				8259
50331	6 pts		Somnolence	below serious				8259
50332	1 pts		Humerus fracture	serious				8260
50333	1 pts		Status epilepticus	serious				8260
50334	2 pts		Convulsion	below serious				8260
50335	8 pts		Fatigue	below serious				8260
50336	9 pts		Headache	below serious				8260
50337	1 pts		Irritability	below serious				8260
50338	2 pts		Nasopharyngitis	below serious				8260
50339	6 pts		Nausea	below serious				8260
50340	8 pts		Somnolence	below serious				8260
50341	8 pts		Vertigo	below serious				8260
50342	1 pts		Neutropenia	serious				8261
50343	1 pts		Diabetes mellitus inadequate control	serious				8261
50344	1 pts		Psychotic disorder	serious				8261
50345	1 pts		Headache	serious				8261
50346	1 pts		Dizziness	serious				8261
50347	1 pts		Postictal state	serious				8261
50348	7 pts		Convulsion	serious				8261
50349	1 pts		Status epilepticus	serious				8261
50350	1 pts		Vertigo	serious				8261
50351	1 pts		Myocardial ischaemia	serious				8261
50352	1 pts		Abdominal pain	serious				8261
50353	2 pts		Pregnancy	serious				8261
50354	1 pts		Chest pain	serious				8261
50355	1 pts		Drowning	serious				8261
50356	1 pts		Fatigue	serious				8261
50357	1 pts		Drug toxicity	serious				8261
50358	1 pts		Overdose	serious				8261
50359	1 pts		Burns second degree	serious				8261
50360	1 pts		Skin laceration	serious				8261
50361	27 pts		Fatigue	below serious				8261
50362	31 pts		Dizziness	below serious				8261
50363	40 pts		Somnolence	below serious				8261
50364	2 pts		Somnolence	severe				8264
50365	1 pts		Blurred vision					8264
50366	2 pts		Dizziness					8264
50367	1 pts		Agitation					8264
50368	1 pts		Bradyphrenia					8264
50369	1 pts		Disorientation					8264
50370	1 pts		Euphoric mood					8264
50371	2 pts		Somnolence					8265
50372	1 pts		Blurred vision					8265
50373	3 pts		Dizziness					8265
50374	1 pts		Agitation					8265
50375	1 pts		Bradyphrenia					8265
50376	1 pts		Disorientation					8265
50377	1 pts		Euphoric mood					8265
50378	1.4		Convulsion		discontinuation	leads to discontinuation		8266
50379	0.7		Somnolence		discontinuation	leads to discontinuation		8266
50380	0.6		Depression		discontinuation	leads to discontinuation		8266
50381	0.6		Dizziness		discontinuation	leads to discontinuation		8266
50382	0.5		Fatigue		discontinuation	leads to discontinuation		8266
50383	0.5		Suicidal ideation		discontinuation	leads to discontinuation		8266
50384	0.5		Suicide attempt		discontinuation	leads to discontinuation		8266
50385						impossible to link AEs with the definite dose		8263
50386	57.1		Somnolence					8262
50387	42.9		Dizziness					8262
50388	3 pts		Headache		discontinuation	leads to discontinuation		8268
50389	3 pts		Blepharoconjunctivitis		discontinuation	leads to discontinuation		8268
50390	23 pts		Eye disorders NEC		discontinuation	leads to discontinuation		8267
50391						incidence of adverse events was similar as placebo group		8269
50392	33 pts		Eye disorders NEC					8270
50393	7 pts		Eye disorders NEC					8271
50394			Drug dependence		discontinuation			8272
50395			Psychosis		discontinuation			8272
50396	3.3		Dry mouth		discontinuation			8275
50397	3.3		Dry mouth		discontinuation			8275
50398			Dyskinesia		discontinuation			8273
50399			Subarachnoid hemorrhage					8274
50400	71.4		Nervous system disorders					8276
50401	22.1		Somnolence	grade 1-2				8278
50402	22.1		Dizziness	grade 1-2				8278
50403	12.4		Headache	grade 1-2				8278
50404	11.5		Nausea	grade 1-2				8278
50405	10.6		Fatigue	grade 1-2				8278
50406	9.7		Nystagmus	grade 1-2				8278
50407	8		Balance disorder	grade 1-2				8278
50408	8		Urinary tract infection	grade 1-2				8278
50409	7.1		Upper respiratory tract infection	grade 1-2				8278
50410	6.2		Tremor	grade 1-2				8278
50411	6.2		Nasopharyngitis	grade 1-2				8278
50412	5.3		Constipation	grade 1-2				8278
50413	5.3		Diarrhea	grade 1-2				8278
50414	5.3		Vomiting	grade 1-2				8278
50415	0.9		Anxiety	grade 1-2				8278
50416			Tachycardia		discontinuation			8278
50417			Gastroesophageal reflux disease		discontinuation			8278
50418			Drug hypersensitivity		discontinuation			8278
50419			Nystagmus		discontinuation			8278
50420			Aggression		discontinuation			8278
50421			Depression		discontinuation			8278
50422			Dyspnea		discontinuation			8278
50423	1		Vertigo					8277
50424	6		Diplopia					8277
50425	2		Vision blurred					8277
50426	6		Nausea					8277
50427	2		Constipation					8277
50428	1		Diarrhea					8277
50429	2		Vomiting					8277
50430	1		Dry mouth					8277
50431	2		Abdominal pain					8277
50432	2		Dyspepsia					8277
50433	2		Nasopharyngitis					8277
50434	1		Pharyngitis					8277
50435	2		Urinary tract infection					8277
50436	1		Head injury					8277
50437	1		Alanine aminotransferase increased					8277
50438	1		Aspartate aminotransferase increased					8277
50439	2		Weight decreased					8277
50440	3		Decreased appetite					8277
50441	4		Back pain					8277
50442	2		Musculoskeletal chest pain					8277
50443	19		Somnolence					8277
50444	18		Dizziness					8277
50445	12		Fatigue					8277
50446	10		Headache					8277
50447	3		Balance disorder					8277
50448	1		Gait disturbance					8277
50449	2		Dysarthria					8277
50450	3		Nystagmus					8277
50451	2		Ataxia					8277
50452	2		Aphasia					8277
50453	2		Dysgeusia					8277
50454	2		Memory impairment					8277
50455	1		Sedation					8277
50456	2		Confusional state					8277
50457	1		Irritability					8277
50458	2		Suicidal ideation					8277
50459	1		Dysmenorrhea					8277
50460	2		Pruritus					8277
50461	2		Rash papular					8277
50462	1		Vertigo					8280
50463	7		Diplopia					8280
50464	2		Vision blurred					8280
50465	6		Nausea					8280
50466	4		Constipation					8280
50467	3		Diarrhea					8280
50468	4		Vomiting					8280
50469	1		Dry mouth					8280
50470	2		Abdominal pain					8280
50471	2		Dyspepsia					8280
50472	4		Nasopharyngitis					8280
50473	2		Pharyngitis					8280
50474	5		Urinary tract infection					8280
50475	1		Alanine aminotransferase increased					8280
50476	1		Aspartate aminotransferase increased					8280
50477	1		Decreased appetite					8280
50478	2		Back pain					8280
50479	1		Musculoskeletal chest pain					8280
50480	22		Somnolence					8280
50481	22		Dizziness					8280
50482	14		Fatigue					8280
50483	12		Headache					8280
50484	5		Balance disorder					8280
50485	3		Gait disturbance					8280
50486	1		Dysarthria					8280
50487	7		Nystagmus					8280
50488	3		Ataxia					8280
50489	1		Aphasia					8280
50490	1		Memory impairment					8280
50491	1		Sedation					8280
50492	2		Confusional state					8280
50493	1		Suicidal ideation					8280
50494	2		Dysmenorrhea					8280
50495	1		Pruritus					8280
50496	1		Asthenia					8280
50497	3		Tremor					8280
50498	1		Pollakiuria					8280
50499	1		Hiccups					8280
50500	3		Dyspnea					8280
50501	6		Vertigo					8282
50502	15		Diplopia					8282
50503	2		Palpitations					8282
50504	4		Vision blurred					8282
50505	9		Nausea					8282
50506	8		Constipation					8282
50507	5		Diarrhea					8282
50508	5		Vomiting					8282
50509	3		Dry mouth					8282
50510	1		Abdominal pain					8282
50511	5		Nasopharyngitis					8282
50512	2		Head injury					8282
50513	4		Alanine aminotransferase increased					8282
50514	3		Aspartate aminotransferase increased					8282
50515	1		Weight decreased					8282
50516	5		Decreased appetite					8282
50517	5		Back pain					8282
50518	37		Somnolence					8282
50519	33		Dizziness					8282
50520	24		Fatigue					8282
50521	10		Headache					8282
50522	9		Balance disorder					8282
50523	8		Gait disturbance					8282
50524	7		Dysarthria					8282
50525	6		Nystagmus					8282
50526	6		Ataxia					8282
50527	4		Aphasia					8282
50528	3		Asthenia					8282
50529	2		Dysgeusia					8282
50530	2		Memory impairment					8282
50531	2		Migraine					8282
50532	2		Sedation					8282
50533	1		Tremor					8282
50534	3		Confusional state					8282
50535	2		Euphoric mood					8282
50536	2		Irritability					8282
50537	1		Dysmenorrhea					8282
50538	1		Hiccups					8282
50539	>1		Ataxia		discontinuation			8281
50540	>1		Dizziness		discontinuation			8281
50541	>1		Somnolence		discontinuation			8281
50542	>1		Diplopia		discontinuation			8281
50543	>1		Nystagmus		discontinuation			8281
50544	>1		Vertigo		discontinuation			8281
50545	0.4		Cognitive deterioration		discontinuation			8281
50546	0.9		ALT increased					8277
50547	1.8		ALT increased					8279
50548	2.7		ALT increased					8282
50549	8.3		Potassium serum increased					8277
50550	9.1		Potassium serum increased					8279
50551	10.8		Potassium serum increased					8282
50552	50		Nausea	grade 3			TRUE	8283
50553	20		Fatigue	grade 3	dose reduction			8284
50554	20		Amylase increased	grade 3	dose reduction			8284
50555	20		Lipase increased	grade 3	dose reduction			8285
50556	14.3		Febrile neutropenia				TRUE	8286
50557	42.9		Neutropenia	grade 3-4	discontinuation			8286
50558						The source does not contain information about AEs or lack thereof		8288
50559	25		Lightheadedness	grade 1				8287
50560	25		Flatulence					8290
50561	38		Abdominal pain upper					8290
50562	13		Nausea					8290
50563	75		Diarrhoea					8290
50564	45		Diarrhoea					8291
50565	18		Nausea					8291
50566	1.4		Diarrhea		discontinuation			8289
50567	0.6		Hypertension	serious				8289
50568	2.6		Ventricular tachycardia		discontinuation			8292
50569	0.9		Abnormal behavior		discontinuation			8294
50570	0.9		Attention deficit hyperactivity disorder		discontinuation			8294
50571	0.9		Visual hallucinations		discontinuation			8294
50572	0.9		Visual hallucinations		discontinuation			8294
50573	0.9		Hypnopompic hallucination		discontinuation			8294
50574	3.5		Insomnia		discontinuation			8294
50575	0.9		Hallucinations, mixed		discontinuation			8294
50576	0.9		Chest pain		discontinuation			8294
50577	0.9		Irritability		discontinuation			8294
50578	0.9		Costochondritis		discontinuation			8294
50579	0.9		Pruritus		discontinuation			8294
50580	1.3		Insomnia	grade 3	discontinuation			8293
50581	0.65		Paranoia	grade 3	discontinuation			8293
50582	0.65		Visual hallucinations	grade 3	discontinuation			8293
50583	0.65		Anxiety	grade 3	discontinuation			8293
50584						No information on AE is provided		8295
50585	1.7		Dizziness		discontinuation			8297
50586	1.2		Constipation		discontinuation			8297
50587	0.8		Headache		discontinuation			8297
50588	1.9		Constipation		discontinuation			8296
50589	0.8		AST increased		discontinuation			8296
50590	0.5		Headache		discontinuation			8300
50591	1.6		Dizziness		discontinuation			8300
50592	0.5		Nausea		discontinuation			8300
50593	0.5		Gastrointestinal disorders		discontinuation			8300
50594	0.5		Mental status changes		discontinuation			8300
50595	1.6		Psychiatric disorders		discontinuation			8300
50596	1.3		Gastrointestinal disorders		discontinuation			8299
50597	0.4		Dizziness		discontinuation			8299
50598	0.4		Nausea		discontinuation			8299
50599	0.4		Headache		discontinuation			8299
50600	0.9		Insomnia		discontinuation			8299
50601	0.9		Anxiety		discontinuation			8299
50602	0.9		Mental status changes		discontinuation			8299
50603			Anxiety		discontinuation			8298
50604			Injection site phlebitis		discontinuation			8298
50605						Eighteen (45%) participants reported adverse events after administration of ELBASVIR compared with 4 (50%) after administration of placebo		8301
50606	35		Apnea					8302
50607	8		Nausea					8302
50608	4		Vomiting					8302
50609	35		Pain					8302
50610	8		Rash					8302
50611	8		Headache					8302
50612						No adverse effects are mentioned		8303
50613	3.3		Taste bitter					8304
50614	1.7		Heartburn					8304
50615	6.7		Gastrointestinal disturbance					8304
50616						No AEs were reported		8305
50617	1 pts		Prothrombin time ratio increased	severe	discontinuation	leads to drug interruption		8307
50618	1 pts		Constipation	mild	discontinuation	leads to discontinuation		8307
50619	2 pts		Transaminases increased	moderate	discontinuation	leads to discontinuation		8307
50620	1 pts		Thyroid stimulating hormone decreased	moderate	discontinuation	leads to discontinuation		8307
50621	1 pts		Erectile dysfunction	mild	discontinuation	leads to drug interruption		8307
50622	2 pts		Transaminases increased	moderate	discontinuation	leads to drug interruption		8306
50623	2 pts		Abdominal pain	grade 1-2	discontinuation	leads to drug interruption| discontinuation		8306
50624	16.7		Tetany		discontinuation			8310
50625	3 pts		Blood calcium decreased	grade 1-3	discontinuation			8309
50626	1 pts		Fatigue		discontinuation			8308
50627	0.3		Abdominal discomfort		discontinuation|dose interruption			8313
50628	1.9		Blood calcium decreased		discontinuation|dose interruption			8313
50629	1.3		Hypocalcemia		discontinuation|dose interruption			8313
50630	0.3		Anorexia		discontinuation|dose interruption			8313
50631	0.9		Nausea		discontinuation|dose interruption			8313
50632	0.3		Death	grade 5	discontinuation			8313
50633	0.3		Vomiting		discontinuation|dose interruption			8313
50634	0.7		Diarrhea		discontinuation|dose interruption			8311
50635	0.7		Pruritus		discontinuation|dose interruption			8311
50636	0.7		Vomiting		discontinuation|dose interruption			8311
50637	0.7		Gastritis erosive		discontinuation|dose interruption			8311
50638	2.9		Blood calcium decreased		discontinuation|dose interruption			8311
50639	0.7		Chest discomfort		discontinuation|dose interruption			8311
50640	0.7		Nausea		discontinuation|dose interruption			8311
50641	2.6		Eczema		discontinuation|dose interruption			8312
50642	5.1		Blood calcium decreased		discontinuation|dose interruption			8312
50643						No adverse effects leading to discontinuation were reported		8315
50644						SMT C1100 was well tolerated.		8314
50645						No severe AEs, no discontinuations due to an AE, no deaths, and no seriousAEs were reported during the study.		8316
50646	2 pts		Diarrhea					8319
50647	1 pts		Liver injury					8319
50648	1 pts		Injury to kidney					8319
50649	14 pts		Gastrointestinal disorder					8317
50650	3 pts		Hyperuricaemia					8317
50651	25 pts		Gastrointestinal disorder					8318
50652	7 pts		Hyperuricaemia					8318
50653	66.7		Neurotoxicity	grade 3		could be due to Fazarabine or to DMSO		8321
50654	100		Fluid overload					8321
50655	80		Granulocytopenia				TRUE	8320
50656	17		Diarrhoea	grade 1				8322
50657	17		Diarrhoea	grade 1				8323
50658	5		Rash		discontinuation			8324
50659						No temporary discontinuations or withdrawals due to AEs were required, and no serious AEs or deaths were reported		8325
50660	2		Palpitations					8326
50661	4.1		Constipation					8326
50662	2		Pain in extremity					8326
50663	2		Dizziness					8326
50664	10.2		Headache					8326
50665	2		Somnolence					8326
50666	2		Anxiety					8326
50667	2		Euphoric mood					8326
50668	0.5		Neutropenia		discontinuation			8327
50669	0.5		Neoplasm progression		discontinuation			8327
50670	0.4		Neoplasm malignant		discontinuation			8327
50671	0.2		Febrile neutropenia		discontinuation			8327
50672	0.2		Leukopenia		discontinuation			8327
50673	0.1		Thrombocytopenia		discontinuation			8327
50674	0.1		Peritonitis		discontinuation			8327
50675	0.1		Troponin increased		discontinuation			8327
50676	0.2		Stomatitis		discontinuation			8327
50677	0.2		ALT increased		discontinuation			8327
50678	0.2		Platelet count decreased		discontinuation			8327
50679	0.1		Angina pectoris		discontinuation			8327
50680	0.1		Myocardial ischaemia		discontinuation			8327
50681	0.1		Creatinine renal clearance decreased		discontinuation			8327
50682	1.5		Febrile neutropenia					8328
50683	1		Neutropenia					8328
50684	0.6		Vomiting					8328
50685	0.5		Anaemia					8328
50686	0.3		Leukopenia					8328
50687	0.4		Pneumonia					8328
50688	0.3		Urinary tract infection					8328
50689	0.2		Pulmonary embolism					8328
50690	0.3		Cardiopulmonary failure					8328
50691	0.3		Stomatitis					8328
50692	0.2		Asthenia					8328
50693	0.2		Neoplasm malignant					8328
50694	0.1		Nausea					8328
50695	0.1		Peritonitis					8328
50696	0.1		Renal failure					8328
50697	0.2		Abdominal pain					8328
50698	0.2		Diarrhoea					8328
50699	0.2		Multi-organ failure					8328
50700	0.2		Pyrexia					8328
50701	0.2		Femur fracture					8328
50702	0.2		Neoplasm progression					8328
50703	0.2		Metrorrhagia					8328
50704	0.2		Haemoptysis					8328
50705	0.1		Thrombocytopenia					8328
50706	0.1		Electrolyte imbalance					8328
50707	0.1		Convulsion					8328
50708	0.1		Deep vein thrombosis					8328
50709	1.3		ALT increased	grade 3				8329
50710	0.8		AST increased	grade 3				8329
50711	0.1		AST increased	grade 4				8329
50712	0.4		Alkaline phosphatase increased	grade 3				8329
50713	7.8		Hyperglycemia	grade 3				8329
50714	0.6		Hyperglycemia	grade 4				8329
50715	1.4		Hypokalemia	grade 3				8329
50716	0.4		Hypokalemia	grade 4				8329
50717	4.9		Hyponatremia	grade 3				8329
50718	0.6		Hyponatremia	grade 4				8329
50719						No AEs are reported		8331
50720						No AEs are reported		8330
50721						No AEs are reported		8332
50722						No AEs were reported		8333
50723	1 pts		Skin and subcutaneous tissue disorders					8335
50724	1 pts		Dermatitis contact					8335
50725	1 pts		Nervous system disorders					8335
50726	1 pts		Headache					8335
50727	1 pts		Infection					8336
50728	1 pts		Rhinitis					8336
50729	1 pts		Feeling cold					8336
50730	1 pts		Skin and subcutaneous tissue disorders					8334
50731	1 pts		Dermatitis contact					8334
50732	1 pts		Diarrhea					8334
50733	1 pts		Dry mouth					8334
50734	1 pts		Flatulence					8334
50735	2 pts		Nasal congestion					8334
50736	1 pts		Headache					8334
50737	1 pts		Infection					8334
50738	1 pts		Upper respiratory tract infection					8334
50739	1 pts		Fatigue					8334
50740	50		Diarrhea	grade 3-4		800 mg MBP twice a day was deemed as intolerable, principally because of gastro-intestinal adverse events (AEs) in all patients: 50.0% of patients (n =6/ 12) experienced grade ≥3 diarrhea as a dose-limiting event, although not fulfilling the protocol definition of a DLT.		8337
50741	8.3		Bone marrow failure	grade 3			TRUE	8337
50742	2 pts		Vomiting		discontinuation		TRUE	8339
50743	2 pts		Nausea	grade 1-2			TRUE	8339
50744	1 pts		Fatigue	grade 3			TRUE	8341
50745	1 pts		Alkaline phosphatase increased	grade 3			TRUE	8342
50746	1 pts		Gamma glutamyl transpeptidase increased	grade 4			TRUE	8342
50747	1 pts		ALT increased	grade 3	discontinuation		TRUE	8340
50748	1 pts		AST increased	grade 3	discontinuation		TRUE	8340
50749	3 pts		Nausea	grade 1				8338
50750	3 pts		Vomiting	grade 1				8338
50751	1 pts		Fatigue	grade 2				8338
50752	11		Fatigue	grade 3			TRUE	8343
50753	25		Allergic reaction	grade 3			TRUE	8344
50754	25		Maculo-papular rash	grade 3			TRUE	8344
50755	25		Allergic urticaria	grade 3			TRUE	8344
50756	24 pts		Pneumonia	serious				8347
50757	3 pts		Lower respiratory tract infection	serious				8347
50758	3 pts		Bronchitis	serious				8347
50759	1 pts		Lung infection	serious				8347
50760	4 pts		Herpes zoster	serious				8347
50761	1 pts		Herpes zoster disseminated	serious				8347
50762	3 pts		Sinusitis	serious				8347
50763	2 pts		Upper respiratory tract infection	serious				8347
50764	1 pts		Tonsillitis	serious				8347
50765	2 pts		Gastroenteritis	serious				8347
50766	1 pts		Appendicitis	serious				8347
50767	1 pts		Diverticulitis	serious				8347
50768	4 pts		Influenza	serious				8347
50769	2 pts		Metapneumovirus infection	serious				8347
50770	1 pts		Picornavirus infection	serious				8347
50771	1 pts		Pneumonia viral	serious				8347
50772	2 pts		Cellulitis	serious				8347
50773	1 pts		Bacterial infection	serious				8347
50774	1 pts		Parainfluenzae virus infection	serious				8347
50775	1 pts		Pneumonia parainfluenzae viral	serious				8347
50776	1 pts		Pneumococcal sepsis	serious				8347
50777	1 pts		Pneumococcal pneumonia	serious				8347
50778	1 pts		Pneumonia streptococcal	serious				8347
50779	1 pts		Escherichia sepsis	serious				8347
50780	1 pts		Sepsis	serious				8347
50781	3 pts		Back pain	serious				8347
50782	1 pts		Musculoskeletal chest pain	serious				8347
50783	1 pts		Pain in extremity	serious				8347
50784	4 pts		Fracture pathological	serious				8347
50785	3 pts		Osteonecrosis of jaw	serious				8347
50786	1 pts		Osteonecrosis	serious				8347
50787	1 pts		Rotator cuff syndrome	serious				8347
50788	1 pts		Osteoarthritis	serious				8347
50789	1 pts		Kyphosis	serious				8347
50790	2 pts		Basal cell carcinoma	serious				8347
50791	1 pts		Squamous cell carcinoma of lung	serious				8347
50792	1 pts		Bronchial carcinoma	serious				8347
50793	1 pts		Malignant melanoma	serious				8347
50794	1 pts		Uterine cancer	serious				8347
50795	4 pts		Diarrhoea	serious				8347
50796	1 pts		Pancreatitis	serious				8347
50797	1 pts		Pancreatitis acute	serious				8347
50798	1 pts		Colitis ischaemic	serious				8347
50799	1 pts		Periodontal disease	serious				8347
50800	1 pts		Diaphragmatic hernia	serious				8347
50801	1 pts		Gastritis	serious				8347
50802	1 pts		Constipation	serious				8347
50803	1 pts		Hernia inguinal	serious				8347
50804	1 pts		Vomiting	serious				8347
50805	1 pts		Haematemesis	serious				8347
50806	1 pts		Umbilical hernia	serious				8347
50807	5 pts		Pyrexia	serious				8347
50808	1 pts		Pain	serious				8347
50809	2 pts		Meniscus injury	serious				8347
50810	1 pts		Haemorrhage subarachnoid	serious				8347
50811	1 pts		Joint dislocation	serious				8347
50812	1 pts		Ligament sprain	serious				8347
50813	1 pts		Bone contusion	serious				8347
50814	1 pts		Overdose	serious				8347
50815	1 pts		Ulnar nerve injury	serious				8347
50816	1 pts		Dyspnoea	serious				8347
50817	2 pts		Chronic obstructive pulmonary disease	serious				8347
50818	2 pts		Pleural effusion	serious				8347
50819	1 pts		Organising pneumonia	serious				8347
50820	1 pts		Pleurisy	serious				8347
50821	2 pts		Myocardial ischaemia	serious				8347
50822	1 pts		Cardiac failure	serious				8347
50823	1 pts		Spinal cord compression	serious				8347
50824	1 pts		Cerebral ischaemia	serious				8347
50825	1 pts		Somnolence	serious				8347
50826	1 pts		Post herpetic neuralgia	serious				8347
50827	1 pts		C-reactive protein increased	serious				8347
50828	1 pts		Hypercalcaemia	serious				8347
50829	1 pts		Generalised rash	serious				8347
50830	1 pts		Rash macular	serious				8347
50831	1 pts		Jugular vein thrombosis	serious				8347
50832	1 pts		Subclavian vein thrombosis	serious				8347
50833	1 pts		Diplopia	serious				8347
50834	1 pts		Hepatic function abnormal	serious				8347
50835	1 pts		Device dislocation	serious				8347
50836	1 pts		Radicular pain	serious				8347
50837	100 pts		Upper respiratory tract infection	below serious				8347
50838	40 pts		Bronchitis	below serious				8347
50839	37 pts		Herpes zoster	below serious				8347
50840	28 pts		Conjunctivitis	below serious				8347
50841	20 pts		Pharyngitis	below serious				8347
50842	20 pts		Sinusitis	below serious				8347
50843	136 pts		Diarrhoea	below serious				8347
50844	154 pts		Nausea	below serious				8347
50845	105 pts		Vomiting	below serious				8347
50846	41 pts		Constipation	below serious				8347
50847	76 pts		Back pain	below serious				8347
50848	86 pts		Arthralgia	below serious				8347
50849	39 pts		Musculoskeletal pain	below serious				8347
50850	35 pts		Muscle spasms	below serious				8347
50851	37 pts		Bone pain	below serious				8347
50852	22 pts		Myalgia	below serious				8347
50853	79 pts		Fatigue	below serious				8347
50854	79 pts		Pyrexia	below serious				8347
50855	36 pts		Influenza like illness	below serious				8347
50856	30 pts		Asthenia	below serious				8347
50857	34 pts		Oedema peripheral	below serious				8347
50858	43 pts		Headache	below serious				8347
50859	41 pts		Neuropathy peripheral	below serious				8347
50860	36 pts		Peripheral sensory neuropathy	below serious				8347
50861	33 pts		Dizziness	below serious				8347
50862	27 pts		Paraesthesia	below serious				8347
50863	87 pts		Cough	below serious				8347
50864	29 pts		Oropharyngeal pain	below serious				8347
50865	26 pts		Productive cough	below serious				8347
50866	41 pts		Thrombocytopenia	below serious				8347
50867	25 pts		Neutropenia	below serious				8347
50868	29 pts		Anaemia	below serious				8347
50869	28 pts		Pruritus	below serious				8347
50870	24 pts		Rash maculo-papular	below serious				8347
50871	24 pts		Rash macular	below serious				8347
50872	31 pts		Insomnia	below serious				8347
50873	1 pts		Nausea	grade 3	discontinuation	leads to dose interruption	TRUE	8350
50874	1 pts		Vomiting	grade 3	discontinuation	leads to dose interruption	TRUE	8350
50875	1 pts		Diarrhea	grade 3	discontinuation	leads to dose interruption	TRUE	8350
50876	1 pts		Nausea	grade 3	discontinuation	leads to dose interruption	TRUE	8348
50877	1 pts		Vomiting	grade 3	discontinuation	leads to dose interruption	TRUE	8348
50878	1 pts		Diarrhea	grade 3	discontinuation	leads to dose interruption	TRUE	8348
50879	1 pts		Erythema multiforme	grade 3	discontinuation	leads to dose delays or dose reduction	TRUE	8348
50880	1 pts		Thrombocytopenia	grade 3	discontinuation	leads to dose reduction	TRUE	8349
50881	1 pts		Diarrhea	grade 3	discontinuation	leads to dose reduction	TRUE	8354
50882	1 pts		Renal failure	grade 2			TRUE	8354
50883	1 pts		Dyspnea	grade 2			TRUE	8354
50884	19		Upper respiratory tract infection	grade 1-2				8351
50885	<1		Upper respiratory tract infection	grade 3				8351
50886	28		Peripheral neuropathies	grade 1-2				8351
50887	2		Peripheral neuropathies	grade 3				8351
50888	42		Diarrhea	grade 1-2				8351
50889	6		Diarrhea	grade 3				8351
50890	34		Constipation	grade 1-2				8351
50891	<1		Constipation	grade 3				8351
50892	26		Nausea	grade 1-2				8351
50893	2		Nausea	grade 3				8351
50894	22		Vomiting	grade 1-2				8351
50895	1		Vomiting	grade 3				8351
50896	19		Rash	grade 1-2				8351
50897	3		Rash	grade 3				8351
50898	21		Back pain	grade 1-2				8351
50899	<1		Back pain	grade 3				8351
50900	25		Edema peripheral	grade 1-2				8351
50901	2		Edema peripheral	grade 3				8351
50902	78		Thrombocytopenia	grade 1-2				8351
50903	26		Thrombocytopenia	grade 3				8351
50904	67		Neutropenia	grade 1-2				8351
50905	26		Neutropenia	grade 3				8351
50906	3		Blurred vision	all grades				8351
50907	5		Dry eye					8351
50908	6		Conjunctivitis					8351
50909	1 pts		Nausea		discontinuation	10 of cycle 1		8345
50910	1 pts		Vomiting		discontinuation	10 of cycle 1		8345
50911	1 pts		Diarrhea		discontinuation	10 of cycle 1		8345
50912	1 pts		Erythema		discontinuation	day 11 of cycle 1		8345
50913	1 pts		Rash		discontinuation	day 11 of cycle 1		8345
50914	2 pts		Renal failure					8346
50915	1 pts		Thrombocytopenia		discontinuation			8346
50916	1 pts		Diarrhea		discontinuation			8346
50917	1 pts		Nausea and vomiting		discontinuation			8346
50918	1 pts		Hypercalcemia		discontinuation			8346
50919	1 pts		Dyspnea		discontinuation			8346
50920			Diarrhea		discontinuation	leads to discontinuation		8352
50921	0.8		Fatigue		discontinuation	leads to discontinuation		8352
50922	0.8		Asthenia		discontinuation	leads to discontinuation		8352
50923	0.6		Peripheral sensory neuropathy		discontinuation	leads to discontinuation		8352
50924	0.6		Septic shock		discontinuation	leads to discontinuation		8352
50925	8.6		Thrombocytopenia		discontinuation	leads to dose delays or dose reduction		8353
50926	0.8		Cataract		discontinuation	it  wasn't considered related to study treatment		8356
50927	0.3		Conjunctival edema	grade 1	discontinuation			8355
50928	0.3		Conjunctival irritation	grade 1	discontinuation			8355
50929	0.3		Scleritis	grade 3	discontinuation	considered unrelated to study treatment		8355
50930						No information on AE is provided		8357
50931	6 pts		Abdominal pain					8358
50932	12 pts		Accidental injury					8358
50933	12 pts		Asthenia					8358
50934	6 pts		Back pain					8358
50935	12 pts		Chest pain					8358
50936	12 pts		Fever					8358
50937	29 pts		Flu syndrome					8358
50938	3 pts		Headache					8358
50939	24 pts		Infection					8358
50940	38 pts		Injection site reaction					8358
50941	35 pts		Pain					8358
50942	3 pts		Arrhythmia					8358
50943	6 pts		Atrial fibrillation					8358
50944	6 pts		Cardiovascular disorder					8358
50945	6 pts		Electrocardiogram abnormal					8358
50946	3 pts		Hemorrhage					8358
50947	21 pts		Hypertension					8358
50948	3 pts		Hypotension					8358
50949	9 pts		Tachycardia					8358
50950	6 pts		Vascular disorder					8358
50951	6 pts		Anorexia					8358
50952	3 pts		Constipation					8358
50953	35 pts		Diarrhea					8358
50954	6 pts		Gastrointestinal disorder					8358
50955	12 pts		Nausea					8358
50956	21 pts		Vomiting					8358
50957	6 pts		Parathyroid disorder					8358
50958	12 pts		Anemia					8358
50959	6 pts		Hypercalcemia					8358
50960	6 pts		Hyperkalemia					8358
50961	12 pts		Hypervolemia					8358
50962	3 pts		Peripheral edema					8358
50963	3 pts		Weight decrease					8358
50964	6 pts		Weight increase					8358
50965	6 pts		Depression					8358
50966	15 pts		Dizziness					8358
50967	12 pts		Paresthesia					8358
50968	3 pts		Bronchitis					8358
50969	18 pts		Cough increased					8358
50970	3 pts		Dyspnea					8358
50971	15 pts		Pharyngitis					8358
50972	6 pts		Rhinitis					8358
50973	3 pts		Sinusitis					8358
50974	3 pts		Pruritus					8358
50975	3 pts		Rash					8358
50976	9 pts		Taste perversion					8358
50977	6 pts		Failure kidney					8358
50978	30		Leukorrhea					8360
50979	19		Endometrial disorder			increased endometrial thickness		8360
50980	17		Uterus enlarged					8360
50981	7		Uterovaginal prolapse					8360
50982	17		Urinary incontinence					8360
50983	9		Micturition frequency increased					8360
50984	17		Lower abdominal pain					8360
50985	10		Hot flushes					8360
50986	6		Leg cramps					8360
50987	17		Hot flushes					8362
50988	0.5		Breast pain					8362
50989	19		Leukorrhea					8362
50990	13		Bleeding					8362
50991	26		Endometrial disorder					8362
50992	6		Uterovaginal prolapse					8362
50993	1		Cervical polyp					8362
50994	74		Edema					8361
50995	11		Endometrial polyp					8361
50996	73		Edema					8364
50997	10		Endometrial polyp					8363
50998	70		Edema					8363
50999	75		Edema					8359
51000	6		Endometrial polyp					8359
51001	1 pts		Atrioventricular block	serious				8365
51002	1 pts		Myocardial infarction	serious				8365
51003	1 pts		Pneumonia	serious				8365
51004	1 pts		Urinary tract infection	serious				8365
51005	1 pts		Hip fracture	serious				8365
51006	1 pts		Back pain	serious				8365
51007	1 pts		Osteoarthritis	serious				8365
51008	1 pts		Rheumatoid arthritis	serious				8365
51009	1 pts		Colonic polyp	serious				8365
51010	1 pts		Syncope	serious				8365
51011	1 pts		Dysmenorrhoea	serious				8365
51012	1 pts		Transient ischaemic attack	serious				8365
51013	25 pts		Visual acuity reduced	below serious				8365
51014	33 pts		Instillation site irritation	below serious				8365
51015	29 pts		Instillation site reaction	below serious				8365
51016	36 pts		Dysgeusia	below serious				8365
51017	1 pts		Vertigo	serious				8366
51018	1 pts		Thyrotoxic crisis	serious				8366
51019	1 pts		Renal cancer	serious				8366
51020	28 pts		Instillation site irritation	below serious				8366
51021	25 pts		Instillation site reaction	below serious				8366
51022	58 pts		Dysgeusia	below serious				8366
51023	1 pts		Pneumonia	serious				8367
51024	1 pts		Cerebrovascular accident	serious				8367
51025	1 pts		Transient ischaemic attack	serious				8367
51026	1 pts		Lung neoplasm malignant	serious				8367
51027	65 pts		Instillation site irritation	below serious				8367
51028	45 pts		Instillation site reaction	below serious				8367
51029	46 pts		Dysgeusia	below serious				8367
51030	1.4		Lacrimation increased		discontinuation	leads to discontinuation		8368
51031	1.8		Instillation site reaction		discontinuation	leads to discontinuation		8368
51032	1.4		Visual acuity reduced		discontinuation	leads to discontinuation		8368
51033	1.8		Dysgeusia		discontinuation	leads to discontinuation		8368
51034	1.4		Instillation site reaction		discontinuation	leads to discontinuation		8370
51035	1.1		Instillation site irritation		discontinuation	leads to discontinuation		8369
51036	2 pts		Headache		discontinuation	leads to discontinuation		8369
51037	1 pts		Anemia	serious				8371
51038	1 pts		Fluid retention	serious				8371
51039	1 pts		Cardiac arrest	serious				8371
51040	1 pts		Cardiac ventricular thrombosis	serious				8371
51041	1 pts		Vessel perforation	serious				8371
51042	1 pts		Abdominal pain lower	serious				8371
51043	1 pts		Hepatic cirrhosis	serious				8371
51044	1 pts		Portal vein thrombosis	serious				8371
51045	1 pts		Acute kidney injury	serious				8371
51046	1 pts		Multiorgan failure	serious				8371
51047	3 pts		Nasopharyngitis	below serious				8371
51048	6 pts		Headache	below serious				8371
51049	3 pts		Diarrhea	below serious				8371
51050	3 pts		Pyrexia	below serious				8371
51051	3 pts		Procedural pain	below serious				8371
51052	5		Headache					8372
51053	5		Portal vein thrombosis	serious				8372
51054	2.34		Anemia					8373
51055	1.17		Splenomegaly					8373
51056	1.17		Atrial fibrillation					8373
51057	0.58		Cardiac arrest					8373
51058	0.58		Cardiac ventricular thrombosis					8373
51059	0.58		Circadian dysrhythmia					8373
51060	5.85		Ascites					8373
51061	1.17		Abdominal distension					8373
51062	6.43		Constipation					8373
51063	4.09		Diarrhea					8373
51064	0.58		Hemorrhagic erosive gastritis					8373
51065	0.58		Mesenteric vein thrombosis					8373
51066	1.75		Nausea					8373
51067	0.58		Rectal hemorrhage					8373
51068	0.58		Upper gastrointestinal hemorrhage					8373
51069	1.17		Vomiting					8373
51070	0.58		Acute hepatic failure					8373
51071	1.17		Hepatic function abnormal					8373
51072	0.58		Portal hypertension					8373
51073	5.26		Nasopharyngitis					8373
51074	0.58		Bronchitis					8373
51075	24		Aspartate aminotransferase increased					8373
51076	16.4		Alanine aminotransferase increased					8373
51077	7.01		Fibrin D dimer increased					8373
51078	5.85		Fibrin degradation products increased					8373
51079	7.6		Blood bilirubin increased					8373
51080	10.5		Oxygen saturation decreased					8373
51081	3.51		Fatigue					8373
51082	0.58		Peripheral edema					8373
51083	4.68		Pyrexia					8373
51084	1.17		Cough					8373
51085	2.92		Pruritis					8373
51086	2.34		Rash					8373
51087	7.7		Confusional state	grade 3	discontinuation		TRUE	8377
51088	7.7		Balance disorder	grade 3			TRUE	8377
51089	7.7		Hallucinations	grade 2	dose reduction		TRUE	8377
51090	7.7		Mental status changes	grade 3			TRUE	8377
51091						no DLTs		8376
51092	11.1		Cognitive disorder	grade 3			TRUE	8378
51093	11.1		Hallucination visual	grade 3			TRUE	8378
51094	50		Insomnia				TRUE	8374
51095	50		Hallucination visual				TRUE	8374
51096	50		Gait disturbance				TRUE	8374
51097	50		Feeling drunk				TRUE	8374
51098	33.3		Dizziness				TRUE	8380
51099	33.3		Hallucination				TRUE	8380
51100						no DLTs		8375
51101	25		Cognitive impairment	grade 3			TRUE	8379
51102	25		Auditory hallucinations	grade 3			TRUE	8379
51103	25		Unsteady gait	grade 3			TRUE	8379
51104	25		Visual disturbance	grade 1			TRUE	8379
51105	25		Orientation disturbed	grade 3			TRUE	8379
51106	4.8		Disorientation		discontinuation			8383
51107	8.3		Sinoatrial block		discontinuation	transient sinus pause lasting for approximately 5 sec after administration of 50 mg of mavoglurant occurring 2 minutes after the end of infusion		8382
51108						No severe or serious AEs or any events leading to study discontinuation were reported in this study		8381
51109						No AEs were observed		8385
51110						No AEs were observed		8384
51111	1 pts		Encephalopathy		discontinuation			8386
51112			Dermatitis venenata					8387
51113	11.7		Leukopenia	grade 4				8389
51114	1.7		Leukopenia	grade 4	discontinuation	Patient died		8389
51115	1.7		Sepsis	grade 5	discontinuation	two treatment-related deaths		8389
51116	5		Thrombocytopenia	grade 4	discontinuation	treatment-related deaths	TRUE	8389
51117	20		Thrombocytopenia	grade 4	dose interruption		TRUE	8389
51118	20		Myelosuppression	grade 5	discontinuation		TRUE	8388
51119	20		Hepatic failure	grade 5	discontinuation			8388
51120	20		Sepsis	grade 5	discontinuation			8388
51121	16.7		Lethargy	grade 3				8391
51122	16.7		Fatigue	grade 3				8391
51123	16.7		Insomnia	grade 4				8391
51124			Diarrhea	grade 1				8390
51125			Glossitis	grade 1				8390
51126	100		Dysgeusia	grade 2	discontinuation			8390
51127			Abdominal pain	grade 2				8390
51128	100		Nausea	grade 1	discontinuation			8390
51129			Dyspepsia	grade 1				8390
51130						No adverse effects leading to discontinuation were reported		8392
51131	2 pts		Bilirubin increased	all grades				8394
51132	2 pts		Chills	all grades				8394
51133	3 pts		Conjunctival hyperemia	all grades				8394
51134	1 pts		Constipation	all grades				8394
51135	3 pts		Decreased appetite	all grades				8394
51136	5 pts		Diarrhea	all grades				8394
51137	1 pts		Diarrhea	grade 3-4			TRUE	8394
51138	3 pts		Fatigue	all grades				8394
51139	3 pts		Headache	all grades				8394
51140	3 pts		Hot flush	all grades				8394
51141	4 pts		Hypertension	all grades				8394
51142	2 pts		Injection site phlebitis	all grades				8394
51143	1 pts		Nasopharyngitis	all grades				8394
51144	5 pts		Nausea	all grades				8394
51145	2 pts		Pyrexia	all grades				8394
51146	3 pts		Sinus bradycardia	all grades				8394
51147	1 pts		Ventricular extrasystoles	all grades				8394
51148	3 pts		Vomiting	all grades				8394
51149	1 pts		Lymphopenia	grade 3			TRUE	8394
51150	1 pts		Hypertension	grade 2			TRUE	8394
51151	1 pts		Anemia	grade 3				8394
51152	1 pts		Anemia	grade 3				8395
51153	5 pts		Neutropenia	all grades				8393
51154	3 pts		Neutropenia	grade 3-4			TRUE	8393
51155	5 pts		Decreased appetite	all grades				8393
51156	5 pts		Constipation	all grades				8393
51157	5 pts		Nausea	all grades				8393
51158	5 pts		Fatigue	all grades				8393
51159	4 pts		Face edema	all grades				8393
51160	5 pts		Hiccups	all grades				8393
51161	2 pts		Headache	all grades				8393
51162	2 pts		Hypertension	all grades				8393
51163	3 pts		Dysgeusia	all grades				8393
51164	1 pts		Tumor pain	all grades				8393
51165	3 pts		Edema peripheral	all grades				8393
51166						No adverse effects leading to discontinuation were reported		8397
51167						No adverse effects leading to discontinuation were reported		8396
51168	67		Diarrhea	grade 3			TRUE	8399
51169	7.1		Diarrhea	grade 3			TRUE	8407
51170	100		Fatigue	grade 3			TRUE	8398
51171	100		Rash	grade 3			TRUE	8398
51172	56		Fatigue					8399
51173	44		Nausea					8399
51174	44		Decreased appetite					8399
51175	44		Vomiting					8399
51176	44		Hyperglycemia					8399
51177	22		Dyspnea					8399
51178	22		Pyrexia					8399
51179	22		Constipation					8399
51180	44		Mucositis					8399
51181	11		Urinary tract infection					8399
51182	11		Abdominal pain					8399
51183	44		Rash					8399
51184	33		Cough					8399
51185	33		Anemia					8399
51186	22		Headache					8399
51187	11		AST increased					8399
51188	100		Diarrhea					8398
51189	67		Nausea					8398
51190	33		Decreased appetite					8398
51191	33		Hyperglycemia					8398
51192	33		Mucositis					8398
51193	33		Cough					8398
51194	56		Diarrhea					8402
51195	56		Fatigue					8402
51196	49		Nausea					8402
51197	30		Decreased appetite					8402
51198	40		Vomiting					8402
51199	21		Hyperglycemia					8402
51200	18		Dyspnea					8402
51201	21		Pyrexia					8402
51202	12		Constipation					8402
51203	11		Mucositis					8402
51204	14		Back pain					8402
51205	18		Urinary tract infection					8402
51206	19		Abdominal pain					8402
51207	12		Rash					8402
51208	18		Cough					8402
51209	19		Peripheral edema					8402
51210	9		Anemia					8402
51211	5		Headache					8402
51212	11		AST increased					8402
51213	16.7		Folliculitis	grade 2			TRUE	8406
51214	12.5		Diarrhea	grade 3			TRUE	8408
51215	20		Stomatitis	grade 3			TRUE	8403
51216	20		Hypertension	grade 3		and grade 1 elevated troponin	TRUE	8403
51217	20		Hypophosphatemia	grade 3		and grade 2 diarrhea	TRUE	8403
51218						No information on AE is provided		8401
51219						No information on AE is provided		8400
51220	16.7		Mucositis	grade 3			TRUE	8404
51221	14.3		Central serous retinopathy	grade 3			TRUE	8405
51222	1 pts		Syncope vasovagal	below serious				8416
51223	1 pts		Nasopharyngitis	below serious				8416
51224	1 pts		Headache	below serious				8412
51225	1 pts		Epistaxis	below serious				8414
51226	1 pts		Headache	below serious				8410
51227	3 pts		Headache	below serious				8415
51228	1 pts		Vomiting	below serious				8409
51229	1 pts		Orthostatic hypotension	below serious				8411
51230	1 pts		Headache	below serious				8413
51231	1 pts		Vomiting	below serious				8413
51232	1 pts		Muscle spasms	below serious				8413
51233	20		Dyskinesia					8418
51234	3		Dizziness					8418
51235	6		Constipation					8418
51236	3		Dry mouth					8418
51237	3		Hallucination					8418
51238	3		Insomnia					8418
51239	5		Blood creatine increased					8418
51240	4		Weight decreased					8418
51241	5		Hypotension orthostatic					8418
51242	3		Hypertension					8418
51243	3		Dyskinesia		discontinuation			8418
51244	3		Nausea					8417
51245	0.2		Hepatic enzyme increased	grade 2	discontinuation			8421
51246	0.8		Hallucinations		discontinuation			8427
51247	1.7		Hallucinations		discontinuation			8426
51248	1.7		Hallucinations		discontinuation			8424
51249	0.3		Visual hallucinations		discontinuation			8424
51250						AEs not reported		8422
51251	2		Nausea and vomiting		discontinuation			8425
51252			Creatine kinase increased		discontinuation			8419
51253			Creatine kinase increased		discontinuation			8419
51254	0.4		Pulmonary embolism	grade 3	discontinuation			8419
51255	0.4		Cholecystitis acute	grade 3	discontinuation			8419
51256	0.4		Delirium febrile	grade 2	discontinuation			8419
51257	0.4		Osteoarthritis	grade 1	dose interruption			8420
51258	0.4		Superficial spreading melanoma	grade 1	discontinuation			8420
51259	0.4		Malignant melanoma	grade 3	discontinuation			8420
51260	0.4		Jealous delusion	grade 3	discontinuation			8420
51261	0.4		Head injury	grade 3	discontinuation			8419
51262	0.4		Atrioventricular block complete	grade 1	discontinuation			8419
51263	0.4		Depression	grade 1			TRUE	8419
51264	0.4		Abnormal behaviour	grade 3			TRUE	8419
51265	0.4		Hallucination, auditory	grade 3	dose interruption			8419
51266	2		Nausea		discontinuation			8423
51267	1.4		Constipation		discontinuation			8423
51268	1		Hallucination		discontinuation			8423
51269	1		Dizziness		discontinuation			8423
51270	1		Dyskinesia		discontinuation			8423
51271	4.7		Bleeding		discontinuation			8428
51272	12.5		Application site itching	grade 1				8429
51273	0.5		Rosacea	grade 1	discontinuation			8430
51274	0.5		Seborrheic dermatitis	grade 2	discontinuation			8430
51275	0.5		Skin tightness	grade 3	discontinuation			8430
51276	0.5		Eczema	grade 4	discontinuation			8430
51277	1 pts		Abdominal pain					8431
51278	2 pts		Nausea					8431
51279	8 pts		Pyrexia					8431
51280	2 pts		Haemoglobin decreased					8431
51281	3 pts		Haemoglobin increased					8431
51282	2 pts		Alanine aminotransferase increased					8431
51283	4 pts		Aspartate aminotransferase increased					8431
51284	2 pts		Blood glucose decreased					8431
51285	5 pts		Headache					8431
51286	4 pts		Dizziness					8431
51287	2 pts		Skin and subcutaneous tissue disorders					8431
51288	28 pts		Hypotension					8431
51289	12 pts		Gastrointestinal disorders					8432
51290	2 pts		Abdominal pain					8432
51291	9 pts		Nausea					8432
51292	33 pts		Injection site pain					8432
51293	10 pts		Pyrexia					8432
51294	3 pts		Haemoglobin decreased					8432
51295	3 pts		Haemoglobin increased					8432
51296	71 pts		Alanine aminotransferase increased					8432
51297	103 pts		Aspartate aminotransferase increased					8432
51298	10 pts		Blood glucose decreased					8432
51299	5 pts		Blood creatinine increased					8432
51300	21 pts		Hypoglycaemia					8432
51301	4 pts		Headache					8432
51302	5 pts		Dizziness					8432
51303	11 pts		Dysgeusia					8432
51304	78 pts		Hypotension					8432
51305	1 pts		Rheumatoid arthritis flare up		discontinuation			8433
51306	1 pts		Gastrointestinal infection		discontinuation			8433
51307	3 pts		Gastrointestinal disorder		discontinuation			8433
51308	2 pts		Skin disorder		discontinuation			8433
51309	3 pts		Elevated liver enzyme levels		discontinuation			8433
51310						no DLTs		8437
51311	33.3		Multi-organ failure	grade 5	discontinuation			8438
51312	33.3		Heart failure		discontinuation			8438
51313						no DLTs		8436
51314	50		Transaminases increased				TRUE	8440
51315	25		Multiorgan failure	grade 5	discontinuation		TRUE	8440
51316	25		Sepsis syndrome	grade 5	discontinuation		TRUE	8440
51317	9		Acute renal failure	grade 5	discontinuation			8435
51318	9		Brain natriuretic peptide increased	grade 1	dose reduction		TRUE	8435
51319	9		Aspartate aminotransferase increased	grade 1	dose reduction		TRUE	8435
51320	9		Acute hepatic failure	grade 4	discontinuation			8435
51321	9		Hyperbilirubinemia	grade 2	discontinuation		TRUE	8439
51322	9		Acute renal failure	grade 2	discontinuation		TRUE	8439
51323	9		Acute myocarditis	grade 3	discontinuation		TRUE	8439
51324	50		Blood creatinine increased	grade 3	discontinuation			8434
51325	50		Blood bilirubin increased	grade 3	discontinuation			8434
51326	62		Rash	grade 1-3				8441
51327	56		Diarrhea	grade 1-3				8441
51328	25		Dry skin	grade 1-2				8441
51329	44		Fatigue	grade 1-2				8441
51330	6		Pruritus	grade 1-2				8441
51331	31		ALT increased	grade 1-2				8441
51332	14.3		Macular rash	grade 3			TRUE	8442
51333	14.3		Drug hypersensitivity	grade 3			TRUE	8442
51334	14.3		Muscular weakness	grade 3			TRUE	8442
51335	14.3		Hepatic enzyme increased	grade 3			TRUE	8442
51336	14.3		Asthenia	grade 3			TRUE	8442
51337	14.3		Rash	grade 3			TRUE	8442
51338	19		Anemia	grade 1-3				8441
51339	25		QT prolonged	grade 1-3				8441
51340	44		Pyrexia	grade 1-2				8441
51341	25		Dyspnea	grade 1-2				8441
51342	31		Nausea	grade 1-2				8441
51343	12		Constipation	grade 1-2				8441
51344	6		Asthenia	grade 3				8441
51345	12		Febrile neutropenia	grade 3				8441
51346	1 pts		Maculopapular rash	grade 3	discontinuation			8443
51347	1 pts		Diarrhea	grade 1-3	dose reduction			8443
51348	4		Rash	grade 3			TRUE	8443
51349	1 pts		Pruritus	grade 3	discontinuation			8443
51350	1 pts		Lipase increased	grade 2	discontinuation			8443
51351	1 pts		Diarrhea	grade 3	discontinuation			8443
51352	1 pts		Transaminases increased	grade 2	discontinuation			8443
51353	1 pts		ALT increased	grade 1	dose reduction			8443
51354	1 pts		Neutropenia	grade 3	dose reduction			8443
51355	1 pts		Pyrexia	grade 2	dose reduction			8443
51356	1 pts		Pruritic rash	grade 3	dose reduction			8443
51357	1 pts		Macular rash	grade 3	dose reduction			8443
51358	1 pts		Vomiting	grade 2	discontinuation			8443
51359	1 pts		Nausea	grade 2	discontinuation			8443
51360	1 pts		Generalized rash	grade 3			TRUE	8444
51361	1 pts		Lipase increased	grade 4	discontinuation		TRUE	8444
51362	1 pts		Maculopapular rash	grade 3	dose reduction		TRUE	8444
51363	1 pts		Suicidal ideation	serious				8445
51364	18		Cluster headache					8450
51365	18		Headache					8450
51366	18		Migraine					8450
51367	18		Premenstrual headache					8450
51368	18		Tension headache					8450
51369	6		Initial insomnia					8450
51370	6		Insomnia					8450
51371	6		Middle insomnia					8450
51372	6		Poor quality sleep					8450
51373	6		Nausea					8450
51374	5		Pharyngitis					8450
51375	5		Rhinitis					8450
51376	5		Sinusitis					8450
51377	5		Upper respiratory tract infection					8450
51378	5		Upper respiratory tract inflammation					8450
51379	5		Viral upper respiratory tract infection					8450
51380	5		Arthralgia					8450
51381	5		Back pain					8450
51382	5		Carpal tunnel syndrome					8450
51383	5		Limb discomfort					8450
51384	5		Musculoskeletal pain					8450
51385	5		Myalgia					8450
51386	5		Neck pain					8450
51387	5		Osteoarthritis					8450
51388	5		Pain in extremity					8450
51389	5		Sciatica					8450
51390	5		Nervousness					8450
51391	5		Stress					8450
51392	5		Stress at work					8450
51393	3		Heart rate increased					8450
51394	3		Sinus tachycardia					8450
51395	3		Tachycardia					8450
51396	3		Hallucination visual					8450
51397	3		Hypnagogic hallucination					8450
51398	3		Irritability					8450
51399	3		Abdominal discomfort					8450
51400	3		Abdominal pain					8450
51401	3		Abdominal pain upper					8450
51402	3		Dyssomnia					8450
51403	3		Sleep disorder					8450
51404	3		Sleep paralysis					8450
51405	3		Sleep talking					8450
51406	3		Decreased appetite					8450
51407	2		Cataplexy					8450
51408	2		Dry mouth					8450
51409	2		Eczema					8450
51410	2		Erythema migrans					8450
51411	2		Rash					8450
51412	2		Urticaria					8450
51413	18		Cluster headache					8450
51414	18		Headache					8450
51415	18		Migraine					8450
51416	18		Premenstrual headache					8450
51417	18		Tension headache					8450
51418	6		Initial insomnia					8450
51419	6		Insomnia					8450
51420	6		Middle insomnia					8450
51421	6		Poor quality sleep					8450
51422	6		Nausea					8450
51423	5		Pharyngitis					8450
51424	5		Rhinitis					8450
51425	5		Sinusitis					8450
51426	5		Upper respiratory tract infection					8450
51427	5		Upper respiratory tract inflammation					8450
51428	5		Viral upper respiratory tract infection					8450
51429	5		Arthralgia					8450
51430	5		Back pain					8450
51431	5		Carpal tunnel syndrome					8450
51432	5		Limb discomfort					8450
51433	5		Musculoskeletal pain					8450
51434	5		Myalgia					8450
51435	5		Neck pain					8450
51436	5		Osteoarthritis					8450
51437	5		Pain in extremity					8450
51438	5		Sciatica					8450
51439	5		Nervousness					8450
51440	5		Stress					8450
51441	5		Stress at work					8450
51442	3		Heart rate increased					8450
51443	3		Sinus tachycardia					8450
51444	3		Tachycardia					8450
51445	3		Hallucination visual					8450
51446	3		Hypnagogic hallucination					8450
51447	3		Irritability					8450
51448	3		Abdominal discomfort					8450
51449	3		Abdominal pain					8450
51450	3		Abdominal pain upper					8450
51451	3		Dyssomnia					8450
51452	3		Sleep disorder					8450
51453	3		Sleep paralysis					8450
51454	3		Sleep talking					8450
51455	3		Decreased appetite					8450
51456	2		Cataplexy					8450
51457	2		Dry mouth					8450
51458	2		Eczema					8450
51459	2		Erythema migrans					8450
51460	2		Rash					8450
51461	2		Urticaria					8450
51462			Anxiety					8449
51463			Depression					8449
51464			Insomnia					8449
51465			Hypnagogic hallucination					8449
51466			Cataplexy					8449
51467			Myalgia					8449
51468			Somnolence					8449
51469			Abdominal pain					8449
51470			Headache					8449
51471			Anxiety		discontinuation			8449
51472			Depression		discontinuation			8449
51473			Insomnia		discontinuation			8449
51474			Hypnagogic hallucination		discontinuation			8449
51475			Cataplexy		discontinuation			8449
51476			Myalgia		discontinuation			8449
51477			Somnolence		discontinuation			8449
51478			Abdominal pain		discontinuation			8449
51479			Headache		discontinuation			8449
51480						No Aes are reported		8448
51481						No Aes are reported		8446
51482						No Aes are reported		8447
51483	1.25		Erythema		discontinuation	2 patients with erythema, 1 discontinued		8451
51484			Respiratory rate decreased			poisoning		8452
51485			Respiratory rhythm disorder			poisoning		8452
51486			Corneal reflex decreased			poisoning		8452
51487			Fixed dilated pupils			poisoning		8452
51488	33		Dry mouth					8453
51489	33		Fatigue					8453
51490	67		Muscular weakness	grade 3			TRUE	8453
51491	100		Headache					8453
51492	67		Vision blurred					8453
51493	33		Diarrhoea					8453
51494	33		Dizziness					8453
51495	33		Vomiting					8453
51496	33		Arthralgia					8453
51497	67		Pain in extremity					8453
51498	33		Abdominal pain					8453
51499	33		Chest pain					8453
51500	33		Dysarthria	grade 3			TRUE	8453
51501	2.6		Muscular weakness	grade 3			TRUE	8455
51502	2.6		Peripheral neuropathy	grade 3			TRUE	8455
51503	38		Dry mouth					8454
51504	38		Constipation					8454
51505	50		Fatigue					8454
51506	50		Muscular weakness					8454
51507	32		Headache					8454
51508	32		Nausea					8454
51509	29		Vision blurred					8454
51510	21		Diarrhoea					8454
51511	32		Dizziness					8454
51512	32		Dysgeusia					8454
51513	18		Vomiting					8454
51514	21		Dyspnoea					8454
51515	18		Paraesthesia					8454
51516	15		Arthralgia					8454
51517	18		Hypertension					8454
51518	21		Pain in extremity					8454
51519	12		Abdominal pain					8454
51520	15		Cough					8454
51521	21		Myalgia					8454
51522	12		Chest pain					8454
51523	24		Decreased appetite					8454
51524	21		Hypoaesthesia					8454
51525	3		Acute myocardial infarction					8454
51526	3		Atrial fibrillation					8454
51527	3		Cardiomyopathy					8454
51528	3		Ejection fraction decreased					8454
51529	3		Intraocular pressure increased					8454
51530	3		Left ventricular dysfunction					8454
51531	3		Optic nerve disorder					8454
51532	3		Pancreatitis					8454
51533	3		Pulmonary oedema					8454
51534	3		Viral cardiomyopathy					8454
51535	25		Vasodilatation					8456
51536	38.6		Migraine headache					8457
51537	25		Nausea and vomiting					8457
51538	14.5		Vulvovaginal mycotic infection					8457
51539	13.3		Abdominal pain lower					8457
51540	12.5		Dysmenorrhea					8457
51541	11.8		Vaginal discharge					8457
51542	10		Genitourinary tract infection					8457
51543	9.5		Breast discomfort					8457
51544	7.5		Disorder menstrual					8457
51545	7.2		Diarrhea					8457
51546	5.5		Pruritus genital					8457
51547	>= 2 pts		Thrombosis NOS					8457
51548	>= 2 pts		Psychiatric disorder NOS					8457
51549	>= 2 pts		Drug hypersensitivity					8457
51550	>= 2 pts		Abortions spontaneous					8457
51551	1.7		Menometrorrhagia		discontinuation	leads to discontinuation		8457
51552	1.3		Migraine headache		discontinuation	leads to discontinuation		8457
51553	1.3		Vulvovaginal mycotic infection		discontinuation	leads to discontinuation		8457
51554	1.2		Nausea and vomiting		discontinuation	leads to discontinuation		8457
51555	1.4		Uterine myoma expulsion		discontinuation	leads to discontinuation		8457
51556	2 pts		Headache					8458
51557	4 pts		Rash					8458
51558	1 pts		Nausea					8458
51559	2 pts		Oropharyngeal pain					8458
51560	2 pts		Abdominal pain					8458
51561	1 pts		Dizziness					8458
51562	2 pts		Dysgeusia					8458
51563	3 pts		Diarrhoea					8458
51564	4 pts		Dizziness					8459
51565	3 pts		Abdominal pain					8459
51566	3 pts		Fatigue					8459
51567	3 pts		Headache					8459
51568	3 pts		Oropharyngeal pain					8459
51569	5 pts		Diarrhoea					8460
51570	3 pts		Headache					8460
51571	2 pts		Abdominal pain					8460
51572	2 pts		Back pain					8460
51573	2 pts		Nausea					8460
51574	2 pts		Neck pain					8460
51575	2 pts		Rash					8460
51576	1 pts		Arthralgia					8460
51577	1 pts		Constipation					8460
51578	1 pts		Fatigue					8460
51579	1 pts		Myalgia					8460
51580	1 pts		Respiratory tract infection					8460
51581	1 pts		Urinary tract infection					8460
51582	1 pts		Diarrhoea					8460
51583	1 pts		Alanine aminotransferase increased					8460
51584	1 pts		Angioedema					8460
51585	1 pts		Aspartate aminotransferase increased					8460
51586	1 pts		Alkaline phosphatase increased					8460
51587	1 pts		Conjunctivitis					8460
51588	1 pts		Dermatitis allergic					8460
51589	1 pts		Dysgeusia					8460
51590	1 pts		Erythema multiforme					8460
51591	1 pts		Flushing					8460
51592	1 pts		Hepatic enzyme increased					8460
51593	1 pts		Herpes zoster					8460
51594	1 pts		Nausea					8460
51595	1 pts		Neutrophil count decreased					8460
51596	1 pts		Rash					8460
51597	1 pts		Respiratory tract infection					8460
51598	1 pts		Tracheitis					8460
51599	1 pts		Urticaria					8460
51600	1 pts		Vertigo					8460
51601	1 pts		White blood cell count decreased					8460
51602	12.5		Nausea		discontinuation			8461
51603	12.5		Nightmares		discontinuation			8461
51604						AEs not reported		8462
51605	11.1		Headache		discontinuation			8463
51606	8.3		Myalgia		discontinuation			8465
51607	9.1		Feeling hot		discontinuation			8466
51608	9.1		Myalgia		discontinuation			8466
51609	9.1		Disturbance in attention		discontinuation			8466
51610	9.1		Dysaesthesia		discontinuation			8466
51611	9.1		Palpitations		discontinuation			8466
51612	9.1		Tinnitus		discontinuation			8466
51613	9.1		Dizziness		discontinuation			8466
51614	9.1		Dry mouth		discontinuation			8466
51615			Headache		discontinuation			8467
51616			Diarrhea		discontinuation			8467
51617			Nausea		discontinuation			8467
51618			Myalgia		discontinuation			8467
51619			Abdominal pain		discontinuation			8467
51620			Pain in extremity		discontinuation			8467
51621			Dizziness		discontinuation			8467
51622	65		Headache					8468
51623	42		Diarrhoea					8469
51624	26		Pain in jaw					8470
51625	33		Nausea					8471
51626	16		Myalgia					8472
51627	18		Vomiting					8473
51628	17		Pain in extremity					8474
51629	12		Flushing					8475
51630	11		Arthralgia					8476
51631	8		Anaemia					8477
51632	8		Abdominal pain					8478
51633	6		Decreased appetite					8479
51634	3		Pain					8480
51635	13		Nasopharyngitis					8481
51636			Nausea			OVERDOSAGE		8464
51637	66.7		Agitation					8482
51638	50		Confusion					8482
51639	33.3		Delirium					8482
51640	50		Paranoid reaction					8482
51641	16.7		Coordination abnormal					8482
51642	16.7		Aphasia					8482
51643	50		Hallucination					8482
51644	1 pts		Hypertension		discontinuation	leads to discontinuation		8484
51645	1 pts		Insomnia		discontinuation	leads to discontinuation		8484
51646	1 pts		Dyspepsia		discontinuation	leads to discontinuation		8484
51647	1 pts		Pruritic rash		discontinuation	leads to discontinuation		8484
51648	2 pts		ALT increased		discontinuation	leads to discontinuation		8486
51649	2 pts		AST increased		discontinuation	leads to discontinuation		8486
51650	7 pts		Asthenia	grade 2	discontinuation	leads to discontinuation		8485
51651	7 pts		Nausea	grade 2	discontinuation	leads to discontinuation		8485
51652	7 pts		Vomiting	grade 2	discontinuation	leads to discontinuation		8485
51653	7 pts		GGT increased	grade 3	discontinuation	leads to discontinuation		8485
51654	7 pts		Drug hypersensitivity	grade 4	discontinuation	leads to discontinuation		8485
51655	7 pts		Drug-induced liver injury	grade 3	discontinuation	leads to discontinuation		8485
51656	7 pts		Blood uric acid increased	grade 3	discontinuation	leads to discontinuation		8485
51657	7 pts		Acute kidney injury	grade 4	discontinuation	leads to discontinuation		8485
51658	7.1		Headache					8483
51659	4		Febrile neutropenia	grade 4			TRUE	8488
51660	4		Stomatitis	grade 3			TRUE	8488
51661	50		Neutropenia	grade 4	discontinuation|dose reduction		TRUE	8490
51662	50		Acute tubular necrosis		dose interruption|dose reduction			8490
51663	100		Stomatitis	grade 2-3	discontinuation|dose reduction		TRUE	8490
51664	100		Serum creatinine increased		discontinuation|dose reduction		TRUE	8490
51665	20		Lymphocytopenia	grade 4				8487
51666	80		Lymphocytopenia	grade 3-4				8487
51667	40		Serum creatinine increased				TRUE	8487
51668						No adverse effects leading to discontinuation were reported; no DLTs		8489
51669	33.3		Rash	grade 3			TRUE	8492
51670	33.3		Electrocardiogram QTc interval prolonged	grade 3			TRUE	8492
51671						No information on AE is provided		8494
51672	12.5		Electrocardiogram QTc interval prolonged	grade 3			TRUE	8493
51673	6.25		Electrocardiogram QTc interval prolonged	grade 3			TRUE	8495
51674	33.3		Tremor	grade 3			TRUE	8491
51675	33.3		Electrocardiogram QTc interval prolonged	grade 3			TRUE	8491
51676	61.6		Dysgeusia	grade 1-2				8500
51677	84.7		Decreased appetite	grade 1-4			TRUE	8500
51678	69.2		Fatigue	grade 1-2				8500
51679	69.3		Nausea	grade 1-4				8500
51680	46.2		Vomiting	grade 1-2				8500
51681	7.7		Alopecia	grade 1				8500
51682	23.1		Dehydration	grade 1-2				8500
51683	23.1		Hyponatremia	grade 3				8500
51684	23.1		Pyrexia	grade 1-2				8500
51685	7.7		Thrombocytopenia	grade 4			TRUE	8500
51686	16.7		Hyponatremia	grade 3			TRUE	8501
51687	14.3		Maculopapular rash	grade 3			TRUE	8499
51688	14.3		Confusion	grade 2		multiple toxicities	TRUE	8499
51689	14.3		Nausea	grade 2		multiple toxicities	TRUE	8499
51690	14.3		Dehydration	grade 2		multiple toxicities	TRUE	8499
51691	14.3		Anorexia	grade 1		multiple toxicities	TRUE	8499
51692	14.3		Rash	grade 3			TRUE	8496
51693	14.3		Confusion	grade 2			TRUE	8496
51694	14.3		Nausea	grade 2			TRUE	8496
51695	14.3		Dehydration	grade 2			TRUE	8496
51696	16.7		Hyponatremia	grade 3			TRUE	8498
51697						No information on AE is provided		8497
51698						No information on AE is provided		8502
51699						No AEs were observed		8504
51700	62.5		ALT increased				TRUE	8503
51701	62.5		AST increased				TRUE	8503
51702	25		Upper respiratory tract infection					8503
51703	50		Lactate dehydrogenase increased				TRUE	8503
51704	12.5		Nasopharyngitis					8503
51705	25		Dizziness					8503
51706	12.5		Sinusitis					8503
51707	12.5		Viral gastroenteritis					8503
51708	12.5		Muscle spasms					8503
51709	12.5		Rash					8503
51710	12.5		Productive cough					8503
51711	14.3		Anxiety	grade 1-2				8506
51712	28.6		Headache	grade 1-2				8506
51713	14.3		Blood in stool	grade 1-2				8506
51714	14.3		Hiccups	grade 1-2				8506
51715	42.9		Nausea	grade 1-2				8506
51716	41.7		Nausea	grade 1-2				8505
51717	25		Headache	grade 1-2				8505
51718	41.7		Loose stools	grade 1-2				8505
51719	25		Stomachache	grade 1-2				8505
51720	8.3		Hiccups	grade 1-2				8505
51721	33.3		Depression mental	grade 1-2				8505
51722	8.3		Vomiting	grade 1-2				8505
51723	8.3		Tiredness	grade 1-2				8505
51724	8.3		Abdominal bloating	grade 1-2				8505
51725	8.3		Flatulence	grade 1-2				8505
51726	8.3		Disorientation	grade 1-2	discontinuation	accompanied by lightheadedness and emotional lability (depressed mood and feelings of sadness)		8505
51727	11.1		ALT increased	grade 1-2	discontinuation			8507
51728	0.2		Vertigo		discontinuation			8508
51729	0.2		Abdominal pain		discontinuation			8508
51730	0.6		Diarrhea		discontinuation			8508
51731	1.8		Nausea		discontinuation			8508
51732	0.2		Vomiting		discontinuation			8508
51733	0.2		Fatigue		discontinuation			8508
51734	0.7		Irritability		discontinuation			8508
51735	0.3		Anorexia		discontinuation			8508
51736	0.2		Disturbance in attention		discontinuation			8508
51737	0.2		Dizziness		discontinuation			8508
51738	0.2		Headache		discontinuation			8508
51739	0.3		Affect lability		discontinuation			8508
51740	0.1		Aggression		discontinuation			8508
51741	0.4		Agitation		discontinuation			8508
51742	0.2		Anger		discontinuation			8508
51743	2.2		Anxiety		discontinuation			8508
51744	0.2		Anxiety disorder		discontinuation			8508
51745	0.4		Crying		discontinuation			8508
51746	1.4		Depressed mood		discontinuation			8508
51747	1.8		Depression		discontinuation			8508
51748	0.4		Depressive symptom		discontinuation			8508
51749	0.6		Insomnia		discontinuation			8508
51750	0.3		Major depression		discontinuation			8508
51751	0.5		Altered mood		discontinuation			8508
51752	0.3		Mood swings		discontinuation			8508
51753	0.3		Nervousness		discontinuation			8508
51754	0.2		Panic attack		discontinuation			8508
51755	0.2		Hyperhidrosis		discontinuation			8508
51756	0.3		Pruritus		discontinuation			8508
51757	0.2		Pruritus generalized		discontinuation			8508
51758	0.2		Hot flush		discontinuation			8508
51759	1 pts		Abdominal distension	below serious				8509
51760	1 pts		Axillary pain	below serious				8509
51761	1 pts		Back pain	below serious				8509
51762	1 pts		Dizziness	below serious				8509
51763	1 pts		Dry throat	below serious				8509
51764	1 pts		Dyspepsia	below serious				8509
51765	1 pts		Fatigue	below serious				8509
51766	1 pts		Flatulence	below serious				8509
51767	1 pts		Flushing	below serious				8509
51768	1 pts		Musculoskeletal pain	below serious				8509
51769	3 pts		Nausea	below serious				8509
51770	1 pts		Neck pain	below serious				8509
51771	1 pts		Neutropenia	below serious				8509
51772	1 pts		Paraesthesia	below serious				8509
51773	1 pts		Pruritus	below serious				8509
51774	1 pts		Throat irritation	below serious				8509
51775	1 pts		Urticaria	below serious				8509
51776	1 pts		Constipation	below serious				8510
51777	1 pts		Diarrhoea	below serious				8510
51778	1 pts		Dizziness	below serious				8510
51779	1 pts		Dyspepsia	below serious				8510
51780	2 pts		Fatigue	below serious				8510
51781	1 pts		Flatulence	below serious				8510
51782	5 pts		Headache	below serious				8510
51783	1 pts		Myalgia	below serious				8510
51784	1 pts		Tension headache	below serious				8510
51785	1 pts		Embolism pulmonary	serious				8511
51786	61 pts		Headache	below serious				8511
51787	20 pts		Nausea	below serious				8511
51788	9 pts		Vomiting	below serious				8511
51789	1 pts		Disturbance in attention	below serious				8511
51790	4 pts		Migraine	below serious				8511
51791	1 pts		Dysgeusia	below serious				8511
51792	1 pts		Paraesthesia	below serious				8511
51793	1 pts		Syncope	below serious				8511
51794	6 pts		Abdominal pain upper	below serious				8511
51795	5 pts		Dry mouth	below serious				8511
51796	2 pts		Abdominal distension	below serious				8511
51797	1 pts		Abdominal discomfort	below serious				8511
51798	1 pts		Abdominal pain lower	below serious				8511
51799	1 pts		Chapped lips	below serious				8511
51800	1 pts		Dental caries	below serious				8511
51801	1 pts		Epigastric discomfort	below serious				8511
51802	1 pts		Eructation	below serious				8511
51803	1 pts		Food poisoning	below serious				8511
51804	1 pts		Hypoaesthesia oral	below serious				8511
51805	1 pts		Paraesthesia oral	below serious				8511
51806	1 pts		Toothache	below serious				8511
51807	1 pts		Uvulitis	below serious				8511
51808	6 pts		Nasopharyngitis	below serious				8511
51809	1 pts		Acute sinusitis	below serious				8511
51810	1 pts		Bacterial vaginosis	below serious				8511
51811	1 pts		Bronchitis	below serious				8511
51812	1 pts		Conjunctivitis	below serious				8511
51813	1 pts		Fungal infection	below serious				8511
51814	1 pts		Gastroenteritis viral	below serious				8511
51815	1 pts		Influenza	below serious				8511
51816	1 pts		Kidney infection	below serious				8511
51817	1 pts		Pharyngitis	below serious				8511
51818	1 pts		Sinusitis	below serious				8511
51819	1 pts		Tooth abscess	below serious				8511
51820	1 pts		Upper respiratory tract infection	below serious				8511
51821	1 pts		Urinary tract infection	below serious				8511
51822	1 pts		Viral infection	below serious				8511
51823	4 pts		Pyrexia	below serious				8511
51824	3 pts		Pain	below serious				8511
51825	2 pts		Chills	below serious				8511
51826	1 pts		Asthenia	below serious				8511
51827	1 pts		Malaise	below serious				8511
51828	1 pts		Oedema peripheral	below serious				8511
51829	1 pts		Thirst	below serious				8511
51830	3 pts		Rash	below serious				8511
51831	1 pts		Alopecia	below serious				8511
51832	1 pts		Dermatitis contact	below serious				8511
51833	1 pts		Hyperhidrosis	below serious				8511
51834	1 pts		Palpable purpura	below serious				8511
51835	1 pts		Rash pruritic	below serious				8511
51836	1 pts		Hypertrophy skin	below serious				8511
51837	1 pts		Swelling face	below serious				8511
51838	1 pts		Muscle tightness	below serious				8511
51839	1 pts		Musculoskeletal pain	below serious				8511
51840	1 pts		Osteoarthritis	below serious				8511
51841	1 pts		Pain in jaw	below serious				8511
51842	1 pts		Tendonitis	below serious				8511
51843	4 pts		Muscle strain	below serious				8511
51844	2 pts		Ligament sprain	below serious				8511
51845	1 pts		Head injury	below serious				8511
51846	1 pts		Skin abrasion	below serious				8511
51847	1 pts		Sunburn	below serious				8511
51848	1 pts		Upper limb fracture	below serious				8511
51849	2 pts		Depression	below serious				8511
51850	2 pts		Nervousness	below serious				8511
51851	1 pts		Dysphoria	below serious				8511
51852	1 pts		Irritability	below serious				8511
51853	1 pts		Panic attack	below serious				8511
51854	1 pts		Nasal congestion	below serious				8511
51855	1 pts		Embolism pulmonary	below serious				8511
51856	1 pts		Respiratory tract congestion	below serious				8511
51857	1 pts		Sputum retention	below serious				8511
51858	1 pts		Vasomotor rhinitis	below serious				8511
51859	2 pts		Blood pressure systolic increased	below serious				8511
51860	1 pts		Abnormal electroencephalogram	below serious				8511
51861	1 pts		Haematocrit decreased	below serious				8511
51862	1 pts		Haemoglobin decreased	below serious				8511
51863	1 pts		Heart rate increased	below serious				8511
51864	2 pts		Ear pain	below serious				8511
51865	1 pts		Vertigo	below serious				8511
51866	1 pts		Lymphadenopathy	below serious				8511
51867	1 pts		Ventricular extrasystoles	below serious				8511
51868	1 pts		Eye irritation	below serious				8511
51869	1 pts		Dysuria	below serious				8511
51870	1 pts		Irregular menstruation	below serious				8511
51871	1 pts		Menstruation irregular	below serious				8511
51872	1 pts		Peripheral coldness	below serious				8511
51873	12		Headache					8515
51874	5		Nausea					8515
51875	2		Abdominal pain					8515
51876	2		Vomiting					8515
51877	2		Abnormal EEG		discontinuation	leads to discontinuation		8515
51878	2		Upset stomach		discontinuation	leads to discontinuation		8515
51879	2		Dry mouth		discontinuation	leads to discontinuation		8515
51880	2		Mental concentration decreased		discontinuation	leads to discontinuation		8515
51881	2		Dysphoria		discontinuation	leads to discontinuation		8515
51882	2		Nausea	grade 1	discontinuation	leads to discontinuation		8515
51883	2		Fever		discontinuation	leads to discontinuation		8515
51884	2		Diarrhea	grade 2	discontinuation	leads to discontinuation		8515
51885	2		Headache	grade 3	discontinuation	leads to discontinuation		8515
51886	2		Palpable purpura	grade 1	discontinuation	leads to discontinuation		8515
51887	2		Chills		discontinuation	leads to discontinuation		8515
51888	2		Redness facial	grade 1-2	discontinuation	leads to discontinuation		8515
51889	2		Facial swelling		discontinuation	leads to discontinuation		8515
51890	2		Pruritus facial		discontinuation	leads to discontinuation		8515
51891	< 2		Gastrointestinal disorders		discontinuation	leads to discontinuation		8515
51892	< 2		Malaise		discontinuation	leads to discontinuation		8515
51893	< 2		Abnormal electroencephalogram		discontinuation	leads to discontinuation		8515
51894	< 2		Hematocrit decreased		discontinuation	leads to discontinuation		8515
51895	< 2		Hemoglobin decreased		discontinuation	leads to discontinuation		8515
51896	< 2		Heart rate increased		discontinuation	leads to discontinuation		8515
51897	< 2		Arthralgia		discontinuation	leads to discontinuation		8516
51898	< 2		Osteoarthritis		discontinuation	leads to discontinuation		8516
51899	< 2		Neurological disorders NEC		discontinuation	leads to discontinuation		8516
51900	< 2		Psychiatric disorders		discontinuation	leads to discontinuation		8516
51901	< 2		Oropharyngeal pain		discontinuation	leads to discontinuation		8516
51902	< 2		Skin and subcutaneous tissue disorders		discontinuation	leads to discontinuation		8516
51903	< 2		Abnormal EEG	grade 1	discontinuation	leads to discontinuation		8517
51904	< 2		Abdominal discomfort	grade 1	discontinuation	leads to discontinuation		8517
51905	< 2		Dry mouth	grade 1	discontinuation	leads to discontinuation		8517
51906	< 2		Dysphoria	grade 1	discontinuation	leads to discontinuation		8517
51907	< 2		Disturbance in attention	grade 1	discontinuation	leads to discontinuation		8517
51908	< 2		Fever	grade 1	discontinuation	leads to discontinuation		8517
51909	< 2		Diarrhea	grade 2	discontinuation	leads to discontinuation		8517
51910	< 2		Nausea	grade 1	discontinuation	leads to discontinuation		8517
51911	< 2		Headache	grade 3	discontinuation	leads to discontinuation		8517
51912	< 2		Palpable purpura	grade 1	discontinuation	leads to discontinuation		8517
51913	< 2		Chills	grade 1	discontinuation	leads to discontinuation		8517
51914	< 2		Erythema	grade 1	discontinuation	leads to discontinuation		8517
51915	< 2		Pruritus	grade 1	discontinuation	leads to discontinuation		8517
51916	< 2		Facial swelling	grade 1	discontinuation	leads to discontinuation		8517
51917	12.5		Feeling abnormal					8514
51918	12.5		Back pain					8514
51919	12.5		Headache					8514
51920	12.5		Neutropenia					8513
51921	12.5		Constipation					8513
51922	12.5		Headache					8513
51923						Have not AE		8512
51924			Nausea	grade 1				8518
51925			ALT increased					8518
51926			ALT increased		discontinuation			8523
51927			ALT increased					8519
51928	0.4		ALT increased		discontinuation			8520
51929	0.4		AST increased		discontinuation			8520
51930	0.4		ALT increased		discontinuation			8522
51931	0.4		AST increased		discontinuation			8522
51932	0.04		Hypersensitivity		discontinuation			8521
51933	0.04		Dyspnea		discontinuation			8521
51934	50		Nausea					8524
51935	33.3		Headache					8524
51936	33.3		Pruritus					8525
51937	16.7		Nausea					8525
51938	33.3		Headache					8525
51939	33.3		Rash					8525
51940			QT interval prolonged					8526
51941	35.1		Headache					8526
51942	7		Pruritus					8526
51943	7		Rash papular					8526
51944	7		Constipation					8526
51945	14		Nausea					8526
51946	3.5		Dermatitis contact					8526
51947	7		Pruritus generalized					8526
51948	5.3		Diarrhea					8526
51949	1.8		Upper respiratory tract infection					8526
51950	6		Blood creatinine increased		dose interruption			8528
51951	3.1		ALT increased		dose interruption			8528
51952	1.6		Dyspnea		discontinuation			8528
51953	1.6		General physical health deterioration		discontinuation			8528
51954	5		Edema		discontinuation			8528
51955	4.3		Pleural effusion		dose interruption			8528
51956	23		Edema		dose interruption			8528
51957	2.7		Pleural effusion		dose reduction			8528
51958	1.2		Pneumonitis		discontinuation			8528
51959	2.4		Pneumonia		dose interruption			8528
51960	2		Pleural effusion		discontinuation			8528
51961	2.7		Blood creatinine increased		dose reduction			8528
51962	19		Edema		dose reduction			8528
51963	14.3		Fatigue	grade 3			TRUE	8527
51964			Abdominal compartment syndrome	grade 5				8529
51965						Information about AEs not found		8530
51966	88.9		Erythema					8535
51967	88.9		Skin irritation					8536
51968	4 pts		Skin exfoliation	all grades				8534
51969	4 pts		Erythema	all grades				8534
51970	8 pts		Skin irritation	all grades		dose modification	TRUE	8534
51971	7.5		Application site irritation					8532
51972	2.4		Application site pruritus					8532
51973	2.6		Sunburn					8532
51974	< 1		Application site pain					8532
51975	< 1		Application site dryness					8532
51976	< 1		Application site discoloration					8532
51977	< 1		Application site rash					8532
51978	< 1		Application site swelling					8532
51979	< 1		Application site erosion					8532
51980	< 1		Erythema					8532
51981	< 1		Dermatitis allergic					8532
51982	30.6		Skin erythema	grade 1				8532
51983	37.5		Scale	grade 1				8532
51984	39		Dry skin face	grade 1				8532
51985	35.6		Stinging skin	grade 1				8532
51986	28.4		Skin erythema	grade 2				8532
51987	27.1		Scale	grade 2				8532
51988	29.7		Dry skin face	grade 2				8532
51989	20.6		Stinging skin	grade 2				8532
51990	6.2		Skin erythema	grade 3				8532
51991	4.9		Scale	grade 3				8532
51992	4.8		Dry skin face	grade 3				8532
51993	5.9		Stinging skin	grade 3				8532
51994	26.5		Skin erythema	grade 1				8532
51995	29.7		Skin scarring	grade 1				8532
51996	32.9		Dry skin	grade 1				8532
51997	26.1		Stinging skin	grade 1				8532
51998	18.9		Skin erythema	grade 2				8532
51999	13.7		Skin scarring	grade 2				8532
52000	16.1		Dry skin	grade 2				8532
52001	10.9		Stinging skin	grade 2				8532
52002	5.2		Skin erythema	grade 3				8532
52003	1.7		Skin scarring	grade 3				8532
52004	1.8		Dry skin	grade 3				8532
52005	4.3		Stinging skin	grade 3				8532
52006	1.1		Application site irritation		discontinuation			8533
52007	0.1		Application site erosion		discontinuation			8533
52008	0.1		Application site pain		discontinuation			8533
52009	0.2		Acne		discontinuation			8533
52010	0.2		Skin irritation		discontinuation			8533
52011	0.1		Dermatitis allergic		discontinuation			8533
52012	0.1		Bronchitis		discontinuation			8533
52013	0.1		Muscle rupture		discontinuation			8533
52014	0.1		Tibia fracture		discontinuation			8533
52015	0.1		Major depression		discontinuation			8533
52016	0.1		Suicide attempt		discontinuation			8533
52017						No AEs reported		8531
52018	1 pts		Paralytic ileus					8537
52019	1 pts		Constipation	mild				8537
52020	26		Diarrhea	grade 1-2				8539
52021	33		Nausea	grade 1-2				8539
52022	19		Fatigue	grade 1-2				8539
52023	3		Vomiting	grade 1-2				8539
52024	4		Acne	grade 3				8539
52025	4		Dermatitis acneiform	grade 3				8539
52026	4		Skin exfoliation	grade 3				8539
52027	4		Alanine aminotransferase increased	grade 3				8539
52028	11		Aspartate aminotransferase increased	grade 2				8539
52029	2 pts		Alanine aminotransferase increased	grade 3	discontinuation	leads to dose interruption	TRUE	8538
52030	2 pts		Aspartate aminotransferase increased	grade 3	discontinuation	leads to dose interruption	TRUE	8538
52031	1.5		Hepatotoxicity		discontinuation	leads to discontinuation		8540
52032	1		Diarrhea		discontinuation	leads to discontinuation		8540
52033	8		Hepatotoxicity		discontinuation	leads to dose reduction		8540
52034	6		Diarrhea		discontinuation	leads to dose reduction		8540
52035	14.3		Pruritus	grade 3			TRUE	8541
52036	14.3		ALT increased	grade 3			TRUE	8541
52037	14.3		AST increased	grade 3			TRUE	8541
52038	14.3		Diarrhea	grade 3			TRUE	8541
52039	14.3		Vomiting	grade 3			TRUE	8541
52040	14.3		Dehydration	grade 3			TRUE	8541
52041	14.3		Creatinine increased	grade 3			TRUE	8541
52042	14.3		Rash	grade 3			TRUE	8544
52043	50		Rash	grade 3			TRUE	8545
52044	50		Diarrhea	grade 2			TRUE	8545
52045	50		Hypotension	grade 2			TRUE	8545
52046	50		Anemia	grade 2			TRUE	8545
52047	50		Creatinine increased	grade 1			TRUE	8545
52048	75.6		Rash	grade 1-3				8543
52049	38.3		Diarrhea	grade 1-3				8543
52050	34.8		Fatigue	grade 1-3				8543
52051	34.8		Nausea	grade 1-3				8543
52052	24.3		Decreased appetite	grade 1-2				8543
52053	24.3		Pruritus	grade 1-3				8543
52054	16.5		Vomiting	grade 1-3				8543
52055	11.3		Edema peripheral	grade 1-3				8543
52056	9.6		Anemia	grade 1-3				8543
52057	8.7		Dehydration	grade 1-3				8543
52058	8.7		Alopecia	grade 1-2				8543
52059			Retinopathy		discontinuation			8542
52060						No adverse effects leading to discontinuation were reported.		8546
52061	1 pts		Nausea					8549
52062	1 pts		Vomiting					8549
52063	1 pts		Granulocyte count high	grade 5		polymorphonuclear		8549
52064	1 pts		Granulocyte count high	grade 5		polymorphonuclear		8549
52065	1 pts		Leukopenia	grade 5				8549
52066	1 pts		Hemorrhage	grade 5				8549
52067	1 pts		Renal disorder NOS	grade 5				8549
52068	1 pts		Liver injury	grade 5				8549
52069	4 pts		Anorexia					8548
52070	1 pts		Leukopenia					8548
52071	1 pts		Weight loss	severe				8548
52072	1 pts		Neutrophilia					8548
52073	1 pts		Nausea					8548
52074	1 pts		Vomiting					8548
52075	1 pts		Vomiting					8547
52076	1 pts		White blood cell increased	grade 5				8547
52077	1 pts		Hemorrhage	grade 5				8547
52078			Drowsiness	slight				8550
52079						No significant safety findings were observed		8553
52080	3.8		Chest discomfort		discontinuation			8551
52081	0.3		Pyrexia		discontinuation			8552
52082	0.3		Drug hypersensitivity		discontinuation			8552
52083	0.3		Hypersensitivity		discontinuation			8552
52084	0.3		Septic shock		discontinuation			8552
52085	0.7		Infusion related reaction		discontinuation			8552
52086	100		Urinary incontinence	grade 3			TRUE	8554
52087	100		Unspecified visual disturbance	grade 2			TRUE	8554
52088	100		Anxiety	grade 3			TRUE	8554
52089						No adverse effects leading to discontinuation were reported; no DLTs		8556
52090	33.3		Urinary incontinence				TRUE	8557
52091	33.3		Visual disturbance	grade 3			TRUE	8557
52092	66.7		Slurred speech				TRUE	8557
52093	33.3		Confusion				TRUE	8557
52094	33.3		Dysphasia				TRUE	8557
52095	66.7		Tremor (excl congenital)				TRUE	8557
52096	33.3		Anxiety	grade 2			TRUE	8557
52097	14.3		Dyspnoea				TRUE	8555
52098			Abdominal pain				TRUE	8558
52099			Renal failure				TRUE	8558
52100			Diarrhea				TRUE	8559
52101	4.2		Diarrhea				TRUE	8560
52102	16.7		International normalized ratio increased				TRUE	8561
52103	16.7		Diarrhea				TRUE	8561
52104	16.7		Sudden death				TRUE	8561
52105	6.7		Diarrhoea					8562
52106	5.3		Skin rash	grade 3			TRUE	8567
52107	5.3		Electrocardiogram T wave inversion	grade 3			TRUE	8567
52108	14.3		Skin rash	grade 3			TRUE	8568
52109	14.3		Dyskinesia	grade 2			TRUE	8568
52110	14.3		Hypophosphatemia	grade 3			TRUE	8563
52111	14.3		Decreased appetite	grade 3			TRUE	8563
52112	42.9		Hepatic enzyme increased					8563
52113	8		Pruritic rash	grade 2			TRUE	8565
52114	16.7		Macular rash	grade 3			TRUE	8569
52115	16.7		Maculopapular rash	grade 3			TRUE	8569
52116	33.3		Fatigue	grade 3			TRUE	8570
52117						None of the DLT-evaluable patients experienced a DLT during Cycle 1.		8566
52118	16.7		Fatigue	grade 3			TRUE	8564
52119			Neutropenia	grade 3	discontinuation	leads to dose reduction	TRUE	8571
52120			Headache	grade 3	discontinuation	leads to dose reduction	TRUE	8572
52121	34		Constipation	all grades				8578
52122	14		Nausea	all grades				8578
52123	0.7		Nausea	grade 3-4				8578
52124	12		Diarrhea	all grades				8578
52125	7		Vomiting	all grades				8578
52126	26		Fatigue	all grades				8578
52127	26		Asthenia	all grades				8578
52128	1.3		Fatigue	grade 3-4				8578
52129	1.3		Asthenia	grade 3-4				8578
52130	22		Peripheral edema	all grades				8578
52131	22		Edema	all grades				8578
52132	22		Eyelid edema	all grades				8578
52133	22		Localized edema	all grades				8578
52134	22		Face edema	all grades				8578
52135	0.7		Peripheral edema	grade 3-4				8578
52136	0.7		Edema	grade 3-4				8578
52137	0.7		Eyelid edema	grade 3-4				8578
52138	0.7		Localized edema	grade 3-4				8578
52139	0.7		Face edema	grade 3-4				8578
52140	23		Myalgia	all grades				8578
52141	23		Musculoskeletal pain	all grades				8578
52142	15		Rash	all grades				8578
52143	15		Rash maculo-papular	all grades				8578
52144	15		Dermatitis acneiform	all grades				8578
52145	15		Erythema	all grades				8578
52146	15		Generalized rash	all grades				8578
52147	15		Rash macular	all grades				8578
52148	15		Rash papular	all grades				8578
52149	15		Exfoliative rash	all grades				8578
52150	15		Pruritic rash	all grades				8578
52151	0.7		Rash	grade 3-4				8578
52152	0.7		Rash maculo-papular	grade 3-4				8578
52153	0.7		Dermatitis acneiform	grade 3-4				8578
52154	0.7		Erythema	grade 3-4				8578
52155	0.7		Generalized rash	grade 3-4				8578
52156	0.7		Rash macular	grade 3-4				8578
52157	0.7		Rash papular	grade 3-4				8578
52158	0.7		Exfoliative rash	grade 3-4				8578
52159	0.7		Pruritic rash	grade 3-4				8578
52160	3.3		Dysgeusia	all grades				8578
52161	3.3		Hypogeusia	all grades				8578
52162	0.7		Dysgeusia	grade 3-4				8578
52163	0.7		Hypogeusia	grade 3-4				8578
52164	4.6		Blurred vision	all grades				8578
52165	4.6		Visual impairment	all grades				8578
52166	4.6		Vitreous floaters	all grades				8578
52167	4.6		Visual acuity reduced	all grades				8578
52168	4.6		Diplopia	all grades				8578
52169	11		Bradycardia	all grades				8578
52170	11		Sinus bradycardia	all grades				8578
52171	12		Blood creatinine increased	all grades				8578
52172	12		Creatinine renal clearance decreased	all grades				8578
52173	12		Glomerular filtration rate decreased	all grades				8578
52174	12		Acute kidney injury	all grades				8578
52175	3.9		Blood creatinine increased	grade 3-4				8578
52176	3.9		Creatinine renal clearance decreased	grade 3-4	discontinuation	leads to discontinuation | leads to dose reduction		8578
52177	3.9		Glomerular filtration rate decreased	grade 3-4	discontinuation	leads to discontinuation | leads to dose reduction		8578
52178	3.9		Acute kidney injury	grade 3-4	discontinuation	leads to discontinuation | leads to dose reduction		8578
52179	1 pts		Cardiac arrest	grade 5				8578
52180	1 pts		Pneumonia	grade 5				8578
52181	3.3		Pneumonia		discontinuation	leads to dose reduction		8578
52182	54		Hyperbilirubinemia	all grades				8578
52183	5		Hyperbilirubinemia	grade 3-4	discontinuation	leads to discontinuation | leads to dose reduction		8578
52184	50		AST increased	all grades				8577
52185	6		AST increased	grade 3-4	discontinuation	leads to discontinuation | leads to dose reduction		8577
52186	50		Alkaline phosphatase increased	all grades				8577
52187	40		ALT increased	all grades				8577
52188	6		ALT increased	grade 3-4	discontinuation	leads to discontinuation | leads to dose reduction		8577
52189	38		Creatinine increased	all grades				8577
52190	4.1		Creatinine increased	grade 3-4				8577
52191	37		CPK increased	all grades				8575
52192	2.8		CPK increased	grade 3-4				8575
52193	29		Hypocalcemia	all grades				8577
52194	22		Hyperglycemia	all grades				8574
52195	2.2		Hyperglycemia	grade 3-4				8574
52196	18		Hyponatremia	all grades				8577
52197	6		Hyponatremia	grade 3-4				8577
52198	17		Hypokalemia	all grades				8577
52199	2		Hypokalemia	grade 3-4				8577
52200	14		Hypoalbuminemia	all grades				8576
52201	12		Hyperkalemia	all grades				8578
52202	1.4		Hyperkalemia	grade 3-4				8578
52203	9		Hypophosphatemia	all grades				8578
52204	1.4		Hypophosphatemia	grade 3-4				8578
52205	7		Gamma-glutamyltransferase increased	all grades				8575
52206	0.7		Gamma-glutamyltransferase increased	grade 3-4				8575
52207	62		Anemia	all grades				8577
52208	7		Anemia	grade 3-4				8577
52209	14		Lymphopenia	all grades				8577
52210	1.4		Lymphopenia	grade 3-4				8577
52211	14		Neutropenia	all grades				8577
52212	9.9		Weight gain					8578
52213	5.3		Photosensitivity reaction					8578
52214	3.3		Stomatitis					8578
52215	1.3		Interstitial lung disease					8578
52216	1.3		Drug-induced liver injury					8578
52217	19		Cough	all grades				8573
52218	17		Headache	all grades				8579
52219	0.8		Headache	grade 3-4				8579
52220	16		Dyspnea	all grades				8579
52221	3.17		Dyspnea	grade 3-4				8579
52222	1 pts		Dyspnea	grade 5				8579
52223	12		Back pain	all grades				8579
52224	1 pts		Type 2 diabetes mellitus	serious				8580
52225	1 pts		Grand mal convulsion	serious				8580
52226	1 pts		Suicide attempt	serious				8580
52227	1 pts		Angioedema	serious				8580
52228	8 pts		Weight increased	below serious				8580
52229	9 pts		Akathisia	below serious				8580
52230	4 pts		Dizziness	below serious				8580
52231	13 pts		Insomnia	below serious				8580
52232	6 pts		Constipation	below serious				8581
52233	13 pts		Akathisia	below serious				8581
52234	5 pts		Dizziness	below serious				8581
52235	5 pts		Insomnia	below serious				8581
52236	1 pts		Thrombocytopenia	serious				8582
52237	1 pts		Varicella	serious				8582
52238	1 pts		Akathisia	serious				8582
52239	1 pts		Dystonia	serious				8582
52240	8 pts		Akathisia	below serious				8582
52241			Somnolence					8584
52242			Akathisia					8584
52243			Weight gain					8584
52244	0.3		Anaemia folate deficiency		discontinuation	leads to discontinuation		8585
52245	0.3		Acute myocardial infarction		discontinuation	leads to discontinuation		8586
52246	0.3		Vomiting		discontinuation	leads to discontinuation		8586
52247	0.3		Irritability		discontinuation	leads to discontinuation		8587
52248	0.3		Ankle fracture		discontinuation	leads to discontinuation		8587
52249	0.3		Aspartate aminotransferase increased		discontinuation	leads to discontinuation		8587
52250	0.3		Agitation		discontinuation	leads to discontinuation		8587
52251	0.3		Hallucination		discontinuation	leads to discontinuation		8587
52252	0.3		Aggression		discontinuation	leads to discontinuation		8587
52253	0.3		Rash		discontinuation	leads to discontinuation		8588
52254	0.1		Coronary artery disease		discontinuation	leads to discontinuation		8588
52255	0.1		Gastrooesophageal reflux disease		discontinuation	leads to discontinuation		8588
52256	0.1		Irritability		discontinuation	leads to discontinuation		8588
52257	0.1		Oedema peripheral		discontinuation	leads to discontinuation		8588
52258	0.4		Hepatic enzyme increased		discontinuation	leads to discontinuation		8588
52259	0.1		Blood creatine phosphokinase increased		discontinuation	leads to discontinuation		8588
52260	0.1		Blood triglycerides increased		discontinuation	leads to discontinuation		8588
52261	0.1		Hypoglycaemia		discontinuation	leads to discontinuation		8588
52262	0.2		Rhabdomyolysis		discontinuation	leads to discontinuation		8588
52263	0.1		Convulsion		discontinuation	leads to discontinuation		8588
52264	0.1		Dizziness		discontinuation	leads to discontinuation		8588
52265	0.1		Psychomotor hyperactivity		discontinuation	leads to discontinuation		8588
52266	0.1		Agitation		discontinuation	leads to discontinuation		8588
52267	0.1		Hallucination		discontinuation	leads to discontinuation		8588
52268	0.1		Hostility		discontinuation	leads to discontinuation		8588
52269	1.1		Irritability		discontinuation	leads to discontinuation		8589
52270	1.1		Electrocardiogram QT prolonged		discontinuation	leads to discontinuation		8589
52271	1.1		Akathisia		discontinuation	leads to discontinuation		8589
52272	1.1		Syncope		discontinuation	leads to discontinuation		8589
52273	1.1		Tremor		discontinuation	leads to discontinuation		8589
52274	1.1		Agitation		discontinuation	leads to discontinuation		8589
52275						No AEs are reported		8583
52276			Coma					8590
52277	0.1		Somnolence		discontinuation			8592
52278	0.3		Anxiety		discontinuation			8592
52279	0.1		Sinus bradycardia		discontinuation			8592
52280	0.1		Herpes zoster		discontinuation			8592
52281	0.1		Hypoacusis		discontinuation			8592
52282	0.3		Uncontrolled hypertension		discontinuation			8591
52283	0.3		Gastroenteritis		discontinuation			8591
52284	0.3		Abdominal pain upper		discontinuation			8591
52285	0.3		Fall		discontinuation			8591
52286	1 pts		Encephalopathy	grade 4	discontinuation	leads to discontinuation	TRUE	8600
52287	1 pts		Diarrhea	grade 3			TRUE	8594
52288	1 pts		Rash	grade 3			TRUE	8594
52289	79		Diarrhea	all grades				8595
52290	14		Diarrhea	grade 3-5				8595
52291	66		Rash	all grades				8595
52292	66		Dermatitis acneiform	all grades				8595
52293	66		Rash pruritic	all grades				8595
52294	66		Generalized rash	all grades				8595
52295	66		Dermatitis	all grades				8595
52296	66		Exfoliative rash	all grades				8595
52297	66		Rash erythematous	all grades				8595
52298	66		Rash maculo-papular	all grades				8595
52299	10		Rash	grade 3-5				8595
52300	10		Dermatitis acneiform	grade 3-5				8595
52301	10		Rash pruritic	grade 3-5				8595
52302	10		Generalized rash	grade 3-5				8595
52303	10		Dermatitis	grade 3-5				8595
52304	10		Exfoliative rash	grade 3-5				8595
52305	10		Rash erythematous	grade 3-5				8595
52306	10		Rash maculo-papular	grade 3-5				8595
52307	66		Fatigue	all grades				8595
52308	7		Fatigue	grade 3-5				8595
52309	34		Peripheral edema	all grades				8595
52310	34		Periorbital edema	all grades				8595
52311	34		Edema	all grades				8595
52312	34		Edema face	all grades				8595
52313	41		Nausea	all grades				8595
52314	48		Vomiting	all grades				8595
52315	24		Abnormal sensation in eye	all grades				8595
52316	24		Retinal edema	all grades				8595
52317	24		Photopsia	all grades				8595
52318	24		Blurred vision	all grades				8595
52319	24		Central serous retinopathy	all grades				8595
52320	24		Vitreous floaters	all grades				8595
52321	24		Eye disorder NOS	all grades				8595
52322	3		Abnormal sensation in eye	grade 3-5				8595
52323	3		Retinal edema	grade 3-5				8595
52324	3		Photopsia	grade 3-5				8595
52325	3		Blurred vision	grade 3-5				8595
52326	3		Central serous retinopathy	grade 3-5				8595
52327	3		Vitreous floaters	grade 3-5				8595
52328	3		Eye disorder NOS	grade 3-5				8595
52329	35		Abdominal pain upper	all grades				8595
52330	35		Abdominal pain lower	all grades				8595
52331	35		Abdominal discomfort	all grades				8595
52332	35		Abdominal tenderness	all grades				8595
52333	3		Abdominal pain upper	grade 3-5				8595
52334	3		Abdominal pain lower	grade 3-5				8595
52335	3		Abdominal discomfort	grade 3-5				8595
52336	3		Abdominal tenderness	grade 3-5				8595
52337	10		Stomatitis	all grades				8595
52338	10		Dry skin	all grades				8595
52339			Rash	grade 3			TRUE	8593
52340	2 pts		Central serous retinopathy	grade 3	discontinuation	leads to dose reduction	TRUE	8593
52341	56		Diarrhea	all grades				8596
52342	67		Rash	all grades				8596
52343	67		Dermatitis acneiform	all grades				8596
52344	67		Rash pruritic	all grades				8596
52345	67		Generalized rash	all grades				8596
52346	67		Dermatitis	all grades				8596
52347	67		Exfoliative rash	all grades				8596
52348	67		Rash erythematous	all grades				8596
52349	67		Rash maculo-papular	all grades				8596
52350	4		Rash	grade 3-5	discontinuation	leads to dose reduction	TRUE	8596
52351	4		Dermatitis acneiform	grade 3-5	discontinuation	leads to dose reduction	TRUE	8596
52352	4		Rash pruritic	grade 3-5	discontinuation	leads to dose reduction	TRUE	8596
52353	4		Generalized rash	grade 3-5	discontinuation	leads to dose reduction	TRUE	8596
52354	4		Dermatitis	grade 3-5	discontinuation	leads to dose reduction	TRUE	8596
52355	4		Exfoliative rash	grade 3-5	discontinuation	leads to dose reduction	TRUE	8596
52356	4		Rash erythematous	grade 3-5	discontinuation	leads to dose reduction	TRUE	8596
52357	4		Rash maculo-papular	grade 3-5	discontinuation	leads to dose reduction	TRUE	8596
52358	33		Fatigue	all grades				8596
52359	11		Fatigue	grade 3-5				8596
52360	33		Peripheral edema	all grades				8596
52361	33		Periorbital edema	all grades				8596
52362	33		Edema	all grades				8596
52363	33		Edema face	all grades				8596
52364	22		Nausea	all grades				8596
52365	11		Vomiting	all grades				8596
52366	15		Abnormal sensation in eye	all grades				8596
52367	15		Retinal edema	all grades				8596
52368	15		Photopsia	all grades				8596
52369	15		Blurred vision	all grades				8596
52370	15		Central serous retinopathy	all grades				8596
52371	15		Vitreous floaters	all grades				8596
52372	15		Eye disorder NOS	all grades				8596
52373	11		Stomatitis	all grades				8596
52374	7		Dry skin	all grades				8596
52375	2.4		Aspartate aminotransferase increased		discontinuation	leads to discontinuation		8599
52376	1.6		Gamma-glutamyltransferase increased		discontinuation	leads to discontinuation		8599
52377	1.6		Alanine aminotransferase increased		discontinuation	leads to discontinuation		8599
52378	1.6		Rash		discontinuation	leads to discontinuation		8599
52379	1.2		Pyrexia		discontinuation	leads to discontinuation		8599
52380	2		Retinal detachment		discontinuation	leads to discontinuation		8599
52381	11		Rash			leads to dose interruption or reduction		8599
52382	9		Diarrhea			leads to dose interruption or reduction		8599
52383	7		Chorioretinopathy			leads to dose interruption or reduction		8599
52384	6		Pyrexia			leads to dose interruption or reduction		8599
52385	6		Vomiting			leads to dose interruption or reduction		8599
52386	5		Nausea			leads to dose interruption or reduction		8599
52387	4.9		Creatine phosphokinase increased			leads to dose interruption or reduction		8599
52388	54		Diarrhea	grade 1-2				8599
52389	6		Diarrhea	grade 3-4				8599
52390	40		Nausea	grade 1-2				8599
52391	1		Nausea	grade 3-4				8599
52392	23		Vomiting	grade 1-2				8599
52393	1		Vomiting	grade 3-4				8599
52394	13		Stomatitis	grade 1-2				8599
52395	13		Aphthous stomatitis	grade 1-2				8599
52396	13		Mouth ulceration	grade 1-2				8599
52397	13		Mucosal inflammation	grade 1-2				8599
52398	1		Stomatitis	grade 3-4				8599
52399	1		Aphthous stomatitis	grade 3-4				8599
52400	1		Mouth ulceration	grade 3-4				8599
52401	1		Mucosal inflammation	grade 3-4				8599
52402	42		Solar dermatitis	grade 1-2				8599
52403	42		Sunburn	grade 1-2				8599
52404	42		Photosensitivity reaction	grade 1-2				8599
52405	4		Solar dermatitis	grade 3-4				8599
52406	4		Sunburn	grade 3-4				8599
52407	4		Photosensitivity reaction	grade 3-4				8599
52408	14		Acneiform dermatitis	grade 1-2				8599
52409	2		Acneiform dermatitis	grade 3-4				8599
52410	26		Pyrexia	grade 1-2				8599
52411	2		Pyrexia	grade 3-4				8599
52412	10		Chills	grade 1-2				8599
52413	11		Hypertension	grade 1-2				8599
52414	4		Hypertension	grade 3-4				8599
52415	12		Hemorrhage	grade 1-2				8599
52416	12		Rectal hemorrhage	grade 1-2				8599
52417	12		Melena	grade 1-2				8599
52418	12		Hemorrhoidal hemorrhage	grade 1-2				8599
52419	12		Gastrointestinal hemorrhage	grade 1-2				8599
52420	12		Hematemesis	grade 1-2				8599
52421	12		Hematochezia	grade 1-2				8599
52422	12		Gingival bleeding	grade 1-2				8599
52423	12		Metrorrhagia	grade 1-2				8599
52424	12		Uterine hemorrhage	grade 1-2				8599
52425	12		Hemorrhagic ovarian cyst	grade 1-2				8599
52426	12		Menometrorrhagia	grade 1-2				8599
52427	12		Menorrhagia	grade 1-2				8599
52428	12		Vaginal hemorrhage	grade 1-2				8599
52429	12		Hemoptysis	grade 1-2				8599
52430	12		Hemorrhage pulmonary	grade 1-2				8599
52431	12		Cerebral hemorrhage	grade 1-2				8599
52432	12		Subarachnoid hemorrhage	grade 1-2				8599
52433	12		Subgaleal hematoma	grade 1-2				8599
52434	12		Hematuria	grade 1-2				8599
52435	12		Epistaxis	grade 1-2				8599
52436	12		Contusion	grade 1-2				8599
52437	12		Traumatic hematoma	grade 1-2				8599
52438	12		Ecchymosis	grade 1-2				8599
52439	12		Purpura	grade 1-2				8599
52440	12		Nail bed bleeding	grade 1-2				8599
52441	12		Ocular hemorrhage	grade 1-2				8599
52442	12		Eye hemorrhage	grade 1-2				8599
52443	12		Conjunctival hemorrhage	grade 1-2				8599
52444	12		Retinal hemorrhage	grade 1-2				8599
52445	1		Hemorrhage	grade 3-4				8599
52446	1		Rectal hemorrhage	grade 3-4				8599
52447	1		Melena	grade 3-4				8599
52448	1		Hemorrhoidal hemorrhage	grade 3-4				8599
52449	1		Gastrointestinal hemorrhage	grade 3-4				8599
52450	1		Hematemesis	grade 3-4				8599
52451	1		Hematochezia	grade 3-4				8599
52452	1		Gingival bleeding	grade 3-4				8599
52453	1		Metrorrhagia	grade 3-4				8599
52454	1		Uterine hemorrhage	grade 3-4				8599
52455	1		Hemorrhagic ovarian cyst	grade 3-4				8599
52456	1		Menometrorrhagia	grade 3-4				8599
52457	1		Menorrhagia	grade 3-4				8599
52458	1		Vaginal hemorrhage	grade 3-4				8599
52459	1		Hemoptysis	grade 3-4				8599
52460	1		Hemorrhage pulmonary	grade 3-4				8599
52461	1		Cerebral hemorrhage	grade 3-4				8599
52462	1		Subarachnoid hemorrhage	grade 3-4				8599
52463	1		Subgaleal hematoma	grade 3-4				8599
52464	1		Hematuria	grade 3-4				8599
52465	1		Epistaxis	grade 3-4				8599
52466	1		Contusion	grade 3-4				8599
52467	1		Traumatic hematoma	grade 3-4				8599
52468	1		Ecchymosis	grade 3-4				8599
52469	1		Purpura	grade 3-4				8599
52470	1		Nail bed bleeding	grade 3-4				8599
52471	1		Ocular hemorrhage	grade 3-4				8599
52472	1		Eye hemorrhage	grade 3-4				8599
52473	1		Conjunctival hemorrhage	grade 3-4				8599
52474	1		Retinal hemorrhage	grade 3-4				8599
52475	14		Vision blurred	grade 1-2				8599
52476	14		Visual acuity reduced	grade 1-2				8599
52477	14		Visual impairment	grade 1-2				8599
52478	<1		Vision blurred	grade 3-4				8599
52479	<1		Visual acuity reduced	grade 3-4				8599
52480	<1		Visual impairment	grade 3-4				8599
52481	13		Chorioretinopathy	grade 1-2				8599
52482	<1		Chorioretinopathy	grade 3-4				8599
52483	10		Retinal detachment	grade 1-2				8599
52484	10		Detachment of retinal pigment epithelium	grade 1-2				8599
52485	10		Detachment of macular retinal pigment epithelium	grade 1-2				8599
52486	2		Retinal detachment	grade 3-4				8599
52487	2		Detachment of retinal pigment epithelium	grade 3-4				8599
52488	2		Detachment of macular retinal pigment epithelium	grade 3-4				8599
52489	15		Alopecia					8599
52490	11		Hyperkeratosis					8599
52491	10		Erythema					8599
52492	96.3		Creatinine increased	grade 1-2				8599
52493	3.3		Creatinine increased	grade 3-4				8599
52494	65		AST increased	grade 1-2				8599
52495	8		AST increased	grade 3-4				8599
52496	57		ALT increased	grade 1-2				8599
52497	11		ALT increased	grade 3-4				8599
52498	64		Alkaline phosphatase increased	grade 1-2				8599
52499	7		Alkaline phosphatase increased	grade 3-4				8599
52500	65		Creatine phosphokinase increased	grade 1-2				8598
52501	14		Creatine phosphokinase increased	grade 3-4				8598
52502	56		Hypophosphatemia	grade 1-2				8599
52503	12		Hypophosphatemia	grade 3-4				8599
52504	44		GGT increased	grade 1-2				8599
52505	21		GGT increased	grade 3-4				8599
52506	32		Hyponatremia	grade 1-2				8599
52507	6		Hyponatremia	grade 3-4				8599
52508	41.2		Hypoalbuminemia	grade 1-2				8599
52509	0.8		Hypoalbuminemia	grade 3-4				8599
52510	20.5		Hypokalemia	grade 1-2				8599
52511	4.5		Hypokalemia	grade 3-4				8599
52512	23.1		Hyperkalemia	grade 1-2				8599
52513	2.9		Hyperkalemia	grade 3-4				8599
52514	23.6		Hypocalcemia	grade 1-2				8599
52515	0.4		Hypocalcemia	grade 3-4				8599
52516	66.5		Anemia	grade 1-2				8599
52517	2.5		Anemia	grade 3-4				8599
52518	63		Lymphopenia	grade 1-2				8597
52519	10		Lymphopenia	grade 3-4				8597
52520	18		Thrombocytopenia	grade 1-2				8599
52521	1 pts		Uterine leiomyoma	serious				8611
52522	1 pts		Pneumonia	serious				8611
52523	4 pts		Pharyngitis	below serious				8611
52524	5 pts		Dizziness	below serious				8611
52525	1 pts		Coronary artery disease	serious				8605
52526	1 pts		Gastritis	serious				8605
52527	1 pts		Lung infection	serious				8605
52528	1 pts		Acidosis	serious				8605
52529	1 pts		Osteoarthritis	serious				8605
52530	1 pts		Colorectal cancer	serious				8605
52531	1 pts		Syncope	serious				8605
52532	1 pts		Ectopic pregnancy	serious				8605
52533	1 pts		Calculus ureteric	serious				8605
52534	1 pts		Hydronephrosis	serious				8605
52535	31 pts		Hyperlipidaemia	below serious				8605
52536	1 pts		Urinary infection	below serious				8606
52537	8 pts		Muscle soreness	below serious				8607
52538	3 pts		Increased urinary frequency	below serious				8608
52539	2 pts		Vaginal itching	below serious				8608
52540	1 pts		Nausea	below serious				8608
52541	2 pts		Dry mouth	below serious				8608
52542	1 pts		Urinary tract infection	below serious				8608
52543	2 pts		Urinary tract infection	below serious				8609
52544	1 pts		Low back pain	below serious				8609
52545	3 pts		Vaginal infection	below serious				8610
52546	2 pts		Urinary tract infections	below serious				8610
52547						No AEs are reported		8603
52548	2 pts		Protein urine present					8602
52549	12.5		Abdominal pain upper					8601
52550	12.5		Back pain					8601
52551	12.5		Nausea					8601
52552	1 pts		Ketoacidosis		discontinuation	leads to discontinuation		8604
52553	1 pts		Pyrexia	serious				8614
52554	1 pts		Compression fracture	serious				8614
52555	3 pts		Wound haemorrhage	below serious				8614
52556	4 pts		Dermatitis contact	below serious				8614
52557	2 pts		Pruritis	below serious				8614
52558	2 pts		Haematuria	below serious				8614
52559	7 pts		Aspartate aminotransferase increased	below serious				8614
52560	13 pts		Blood lactate dehydrogenase increased	below serious				8614
52561	10 pts		Gamma-glutamyltransferase increased	below serious				8614
52562	9 pts		Platelet count increased	below serious				8614
52563	11 pts		Blood alkaline phosphatase increased	below serious				8614
52564	1 pts		Spinal compression fracture	serious				8612
52565	9 pts		Nasopharyngitis	below serious				8612
52566	5 pts		Headache	below serious				8612
52567	2 pts		Wound haemorrhage	below serious				8612
52568	6 pts		Constipation	below serious				8612
52569	7 pts		Dermatitis contact	below serious				8612
52570	3 pts		Erythema	below serious				8612
52571	5 pts		Pruritis	below serious				8612
52572	4 pts		Haematuria	below serious				8612
52573	7 pts		Aspartate aminotransferase increased	below serious				8612
52574	17 pts		Blood lactate dehydrogenase increased	below serious				8612
52575	10 pts		Gamma-glutamyltransferase increased	below serious				8612
52576	9 pts		Blood urine present	below serious				8612
52577	6 pts		Haemoglobin decreased	below serious				8612
52578	14 pts		Platelet count increased	below serious				8612
52579	12 pts		Blood alkaline phosphatase increased	below serious				8612
52580	1 pts		Myocardial infarction	serious				8613
52581	10 pts		Nasopharyngitis	below serious				8613
52582	8 pts		Insomnia	below serious				8613
52583	6 pts		Headache	below serious				8613
52584	1 pts		Wound haemorrhage	below serious				8613
52585	2 pts		Dermatitis contact	below serious				8613
52586	6 pts		Erythema	below serious				8613
52587	7 pts		Hemorrhage subcutaneous	below serious				8613
52588	6 pts		Pruritis	below serious				8613
52589	1 pts		Haematuria	below serious				8613
52590	7 pts		Aspartate aminotransferase increased	below serious				8613
52591	16 pts		Blood lactate dehydrogenase increased	below serious				8613
52592	9 pts		Blood urine present	below serious				8613
52593	6 pts		Haemoglobin decreased	below serious				8613
52594	12 pts		Platelet count increased	below serious				8613
52595	1 pts		Nasopharyngitis	serious				8615
52596	1 pts		Asthma	serious				8615
52597	1 pts		Joint dislocation	serious				8615
52598	6 pts		Wound haemorrhage	below serious				8615
52599	2 pts		Dermatitis contact	below serious				8615
52600	3 pts		Erythema	below serious				8615
52601	5 pts		Hemorrhage subcutaneous	below serious				8615
52602	7 pts		Haematuria	below serious				8615
52603	16 pts		Blood lactate dehydrogenase increased	below serious				8615
52604	11 pts		Gamma-glutamyltransferase increased	below serious				8615
52605	15 pts		Blood urine present	below serious				8615
52606	7 pts		Haemoglobin decreased	below serious				8615
52607	6 pts		Platelet count increased	below serious				8615
52608	11 pts		Blood alkaline phosphatase increased	below serious				8615
52609						impossible to link AEs with the definite dose		8616
52610						impossible to link AEs with the definite dose		8618
52611						impossible to link AEs with the definite dose		8617
52612			Activated partial thromboplastin time prolonged			suicide attempt		8619
52613			Ischemic stroke		discontinuation	WARNING		8621
52614	3.9		Bleeding		discontinuation	leads to discontinuation		8620
52615	4.4		Osteoarthritis spinal					8623
52616	6.8		Cystitis					8623
52617	62.9		Nasopharyngitis					8623
52618	7.8		Hypertension					8623
52619	22.5		Contusion					8623
52620	6.4		Gastritis					8623
52621	25.6		Urine calcium increased					8623
52622	5.1		Stomach discomfort					8623
52623	5.9		Pain in extremity					8623
52624	21		Blood calcium increased					8623
52625	2.1		Cancer					8623
52626	7		Stomatitis					8623
52627	13.6		Back pain					8623
52628	15.5		Osteoarthritis					8623
52629	10.2		Arthralgia					8623
52630	10.2		Eczema					8623
52631	7.2		Dermatitis contact					8623
52632	1.3		Urolithiasis					8623
52633	7.4		Constipation					8623
52634	9.7		Headache					8623
52635	6.4		Insomnia					8623
52636	9.5		Diarrhea					8623
52637	8.7		Gastroenteritis					8623
52638	2.8		Exanthem					8623
52639	8.5		Periarthritis					8623
52640	5.5		Dizziness					8623
52641	7.2		Spinal fracture					8623
52642	6.1		Cataract					8623
52643	5.5		Joint sprain					8623
52644	0.8		Death	grade 5		leads to discontinuation		8623
52645	1 pts		Leukocyturia			Urine leukocyte positive		8622
52646	2 pts		Alanine aminotransferase increased					8622
52647	1 pts		Aspartate aminotransferase increased					8622
52648	1 pts		Lactate dehydrogenase increased					8622
52649	1 pts		Leukocyte count increased					8622
52650	1 pts		Neutrophil count increased					8622
52651	1 pts		Triglyceride increased					8622
52652	1 pts		Urobilinogen					8622
52653	1 pts		Pharynx dry					8622
52654	1 pts		Rash					8622
52655	1 pts		Diarrhea					8622
52656	2.3		Haemoglobin high		discontinuation			8624
52657	2.3		PSA increased		discontinuation			8624
52658	63		Hypertension					8627
52659	58		Nausea					8627
52660	50		Diarrhoea					8627
52661	63		Stomatitis					8627
52662	29		Proteinuria					8627
52663	33		Vomiting					8627
52664	38		Lethargy					8627
52665	46		Dysphonia					8627
52666	46		Dry skin					8627
52667	21		Fatigue					8627
52668	21		Anorexia					8627
52669	33		Constipation					8627
52670	29		Headache					8627
52671	29		Abdominal pain					8627
52672	1 pts		Febrile neutropenia	grade 3			TRUE	8632
52673	1 pts		Thrombocytopenia	grade 4			TRUE	8630
52674	1 pts		Hypertension	grade 3			TRUE	8631
52675	1 pts		Fatigue	grade 3			TRUE	8631
52676	2 pts		Proteinuria	grade 3			TRUE	8626
52677	57		Hypertension					8626
52678	43		Nausea					8626
52679	57		Diarrhoea					8626
52680	57		Stomatitis					8626
52681	43		Proteinuria					8626
52682	14		Vomiting					8626
52683	29		Lethargy					8626
52684	43		Dysphonia					8626
52685	14		Dry skin					8626
52686	14		Fatigue					8626
52687	29		Anorexia					8626
52688	14		Constipation					8626
52689	29		Headache					8626
52690	1.15		Hypertension		discontinuation	leads to discontinuation		8628
52691	1.15		Asthenia		discontinuation	leads to discontinuation		8628
52692	13		Hypertension		discontinuation	leads to dose reduction		8628
52693	11		Proteinuria		discontinuation	leads to dose reduction		8628
52694	10		Decreased appetite		discontinuation	leads to dose reduction		8628
52695	10		Diarrhea		discontinuation	leads to dose reduction		8628
52696						Adverse reactions were similar to the adverse events reported in the clinical studies at the recommended dose		8625
52697	0.77		Proteinuria		discontinuation	leads to discontinuation		8629
52698	0.77		Renal failure acute		discontinuation	leads to discontinuation		8629
52699	0.77		Sepsis		discontinuation	leads to discontinuation		8629
52700	0.38		Abdominal pain upper		discontinuation	leads to discontinuation		8629
52701	0.38		Accidental overdose		discontinuation	leads to discontinuation		8629
52702	0.38		Acute myocardial infarction		discontinuation	leads to discontinuation		8629
52703	0.38		Acute respiratory failure		discontinuation	leads to discontinuation		8629
52704	0.38		Ataxia		discontinuation	leads to discontinuation		8629
52705	0.38		Blood alkaline phosphatase increased		discontinuation	leads to discontinuation		8629
52706	0.38		Cardio-respiratory arrest		discontinuation	leads to discontinuation		8629
52707	0.38		Cerebral microangiopathy		discontinuation	leads to discontinuation		8629
52708	0.38		Dizziness		discontinuation	leads to discontinuation		8629
52709	0.38		Epilepsy		discontinuation	leads to discontinuation		8629
52710	0.38		QT interval prolonged		discontinuation	leads to discontinuation		8629
52711	0.38		Fatigue		discontinuation	leads to discontinuation		8629
52712	0.38		Glossitis		discontinuation	leads to discontinuation		8629
52713	0.38		Hemorrhagic stroke		discontinuation	leads to discontinuation		8629
52714	0.38		Hyponatremia		discontinuation	leads to discontinuation		8629
52715	0.38		Laryngeal necrosis		discontinuation	leads to discontinuation		8629
52716	0.38		Memory impairment		discontinuation	leads to discontinuation		8629
52717	0.38		Myalgia		discontinuation	leads to discontinuation		8629
52718	0.38		Myocardial infarction		discontinuation	leads to discontinuation		8629
52719	0.38		Oropharyngeal pain		discontinuation	leads to discontinuation		8629
52720	0.38		Pneumonia		discontinuation	leads to discontinuation		8629
52721	0.38		Pulmonary embolism		discontinuation	leads to discontinuation		8629
52722	0.38		Sciatica		discontinuation	leads to discontinuation		8629
52723	0.38		Skin ulcer		discontinuation	leads to discontinuation		8629
52724	0.38		Spinal cord compression		discontinuation	leads to discontinuation		8629
52725	0.38		Stomatitis		discontinuation	leads to discontinuation		8629
52726	0.38		Vascular pseudoaneurysm		discontinuation	leads to discontinuation		8629
52727	14.6		Weight decreased		discontinuation	leads to dose reduction or interruption		8629
52728	14.2		Nausea		discontinuation	leads to dose reduction or interruption		8629
52729	12.3		Palmar-plantar erythrodysesthesia syndrome		discontinuation	leads to dose reduction or interruption		8629
52730	10.3		Asthenia		discontinuation	leads to dose reduction or interruption		8629
52731	9.9		Fatigue		discontinuation	leads to dose reduction or interruption		8629
52732	8.8		Stomatitis		discontinuation	leads to dose reduction or interruption		8629
52733	8		Vomiting		discontinuation	leads to dose reduction or interruption		8629
52734	5.4		Headache		discontinuation	leads to dose reduction or interruption		8629
52735	5		Arthralgia		discontinuation	leads to dose reduction or interruption		8629
52736	3.8		Abdominal pain		discontinuation	leads to dose reduction or interruption		8629
52737	3.5		Dehydration		discontinuation	leads to dose reduction or interruption		8629
52738	3		Myalgia		discontinuation	leads to dose reduction or interruption		8629
52739	3		Pneumonia		discontinuation	leads to dose reduction or interruption		8629
52740	2.7		Dysphonia		discontinuation	leads to dose reduction or interruption		8629
52741	2.7		Thrombocytopenia		discontinuation	leads to dose reduction or interruption		8629
52742	2.3		Dizziness		discontinuation	leads to dose reduction or interruption		8629
52743	2.3		Dysgeusia		discontinuation	leads to dose reduction or interruption		8629
52744	2.3		Dyspepsia		discontinuation	leads to dose reduction or interruption		8629
52745	2.3		Dysphagia		discontinuation	leads to dose reduction or interruption		8629
52746	2.3		Edema peripheral		discontinuation	leads to dose reduction or interruption		8629
52747	2.3		Oropharyngeal pain		discontinuation	leads to dose reduction or interruption		8629
52748	2.3		Platelet count decreased		discontinuation	leads to dose reduction or interruption		8629
52749			Nausea					8633
52750			Headache					8633
52751			Dizziness					8633
52752			Head discomfort					8633
52753			Dizziness postural					8633
52754			Diarrhea					8633
52755			Headache					8634
52756			Dry mouth					8634
52757			Nausea					8634
52758			Migraine					8634
52759			Nausea			leads to dose reduction		8635
52760			Vomiting			leads to dose reduction		8635
52761			Diarrhea			leads to dose reduction		8635
52762	2.2		Electrocardiogram QT prolonged		discontinuation	leads to dose interruption or reduction		8637
52763	1.9		Neutropenia		discontinuation	leads to dose interruption or reduction		8637
52764	1		Pneumonitis	grade 5	discontinuation	leads to discontinuation		8637
52765	4 pts		Pneumonia	grade 5	discontinuation	leads to discontinuation		8637
52766	2 pts		Cerebral hemorrhage	grade 5	discontinuation	leads to discontinuation		8637
52767	41		Diarrhea	grade 1-2				8637
52768	1		Diarrhea	grade 3-4				8637
52769	16.5		Nausea	grade 1-2				8637
52770	0.5		Nausea	grade 3-4				8637
52771	15.3		Decreased appetite	grade 1-2				8637
52772	0.7		Decreased appetite	grade 3-4				8637
52773	14.8		Constipation	grade 1-2				8637
52774	0.2		Constipation	grade 3-4				8637
52775	12		Stomatitis	grade 1-2				8637
52776	40.5		Rash	grade 1-2				8637
52777	40.5		Generalized rash	grade 1-2				8637
52778	40.5		Rash erythematous	grade 1-2				8637
52779	40.5		Rash macular	grade 1-2				8637
52780	40.5		Rash maculo-papular	grade 1-2				8637
52781	40.5		Rash papular	grade 1-2				8637
52782	40.5		Rash pustular	grade 1-2				8637
52783	40.5		Erythema	grade 1-2				8637
52784	40.5		Folliculitis	grade 1-2				8637
52785	40.5		Acne	grade 1-2				8637
52786	40.5		Dermatitis	grade 1-2				8637
52787	40.5		Acneiform dermatitis	grade 1-2				8637
52788	0.5		Rash	grade 3-4				8637
52789	0.5		Generalized rash	grade 3-4				8637
52790	0.5		Rash erythematous	grade 3-4				8637
52791	0.5		Rash macular	grade 3-4				8637
52792	0.5		Rash maculo-papular	grade 3-4				8637
52793	0.5		Rash papular	grade 3-4				8637
52794	0.5		Rash pustular	grade 3-4				8637
52795	0.5		Erythema	grade 3-4				8637
52796	0.5		Folliculitis	grade 3-4				8637
52797	0.5		Acne	grade 3-4				8637
52798	0.5		Dermatitis	grade 3-4				8637
52799	0.5		Acneiform dermatitis	grade 3-4				8637
52800	31		Dry skin	grade 1-2				8637
52801	31		Eczema	grade 1-2				8637
52802	31		Skin fissures	grade 1-2				8637
52803	31		Xerosis	grade 1-2				8637
52804	25		Disorder nail	grade 1-2				8637
52805	25		Nail bed disorder	grade 1-2				8637
52806	25		Nail bed inflammation	grade 1-2				8637
52807	25		Nail bed tenderness	grade 1-2				8637
52808	25		Nail discoloration	grade 1-2				8637
52809	25		Nail dystrophy	grade 1-2				8637
52810	25		Nail infection	grade 1-2				8637
52811	25		Nail ridging	grade 1-2				8637
52812	25		Onychoclasis	grade 1-2				8637
52813	25		Onycholysis	grade 1-2				8637
52814	25		Onychomadesis	grade 1-2				8637
52815	25		Paronychia	grade 1-2				8637
52816	14		Pruritus	grade 1-2				8637
52817	13.8		Cough	grade 1-2				8637
52818	0.2		Cough	grade 3-4				8637
52819	13.5		Fatigue	grade 1-2				8637
52820	0.5		Fatigue	grade 3-4				8637
52821	12.3		Back pain	grade 1-2				8637
52822	0.7		Back pain	grade 3-4				8637
52823	9.8		Headache	grade 1-2				8637
52824	0.2		Headache	grade 3-4				8637
52825	1.8		Pneumonia	grade 1-2				8637
52826	2.2		Pneumonia	grade 3-4				8637
52827	4.6		Deep vein thrombosis	grade 1-2				8637
52828	4.6		Jugular vein thrombosis	grade 1-2				8637
52829	4.6		Pulmonary embolism	grade 1-2				8637
52830	2.4		Deep vein thrombosis	grade 3-4				8637
52831	2.4		Jugular vein thrombosis	grade 3-4				8637
52832	2.4		Pulmonary embolism	grade 3-4				8637
52833	2.7		Cerebrovascular accident					8637
52834	22.6		Hyponatremia	grade 1-2				8637
52835	3.4		Hyponatremia	grade 3-4				8637
52836	19.3		Hypermagnesemia	grade 1-2				8637
52837	0.7		Hypermagnesemia	grade 3-4				8637
52838	59.7		Lymphopenia	grade 1-2				8637
52839	3.3		Lymphopenia	grade 3-4				8637
52840	52.8		Thrombocytopenia	grade 1-2				8637
52841	1.2		Thrombocytopenia	grade 3-4				8637
52842	43.8		Anemia	grade 1-2				8637
52843	0.2		Anemia	grade 3-4				8637
52844	29.6		Neutropenia	grade 1-2				8637
52845	3.4		Neutropenia	grade 3-4				8637
52846	60		Rash			probability evaluation according to regression. 95% CI 53-67%		8636
52847	58		Diarrhea			probability evaluation according to regression. 95% CI 51-65%		8636
52848	1 pts		Neutropenia	grade 3			TRUE	8641
52849	2 pts		Neutropenia	grade 3-4			TRUE	8643
52850	2 pts		Neutropenia	grade 3-4			TRUE	8644
52851						impossible to link AEs with the definite dose		8640
52852	6		Neutropenia		discontinuation	leads to discontinuation		8642
52853	1		Asthenia		discontinuation	leads to discontinuation		8642
52854	1		Fatigue		discontinuation	leads to discontinuation		8642
52855	1 pts		Neutropenia	grade 4	discontinuation	leads to discontinuation		8639
52856	1 pts		Nausea					8638
52857	1 pts		Vomiting					8638
52858	1 pts		Dizziness					8638
52859	1 pts		Pyrexia	serious				8645
52860	1 pts		Cellulitis	serious				8645
52861	1 pts		Gastroenteritis salmonella	serious				8645
52862	1 pts		Sinusitis bacterial	serious				8645
52863	7 pts		Thrombocytopenia	below serious				8645
52864	2 pts		Abdominal pain upper	below serious				8645
52865	2 pts		Constipation	below serious				8645
52866	23 pts		Diarrhoea	below serious				8645
52867	3 pts		Gastrooesophageal reflux disease	below serious				8645
52868	15 pts		Nausea	below serious				8645
52869	12 pts		Vomiting	below serious				8645
52870	3 pts		Asthenia	below serious				8645
52871	9 pts		Fatigue	below serious				8645
52872	4 pts		Influenza like illness	below serious				8645
52873	2 pts		Mucosal dryness	below serious				8645
52874	4 pts		Pyrexia	below serious				8645
52875	5 pts		Nasopharyngitis	below serious				8645
52876	4 pts		Sinusitis	below serious				8645
52877	5 pts		Upper respiratory tract infection	below serious				8645
52878	2 pts		Urinary tract infection	below serious				8645
52879	2 pts		Platelet count decreased	below serious				8645
52880	3 pts		Arthralgia	below serious				8645
52881	3 pts		Muscle spasms	below serious				8645
52882	3 pts		Dysgeusia	below serious				8645
52883	6 pts		Headache	below serious				8645
52884	2 pts		Polyneuropathy	below serious				8645
52885	3 pts		Depression	below serious				8645
52886	3 pts		Cough	below serious				8645
52887	7 pts		Oropharyngeal pain	below serious				8645
52888	2 pts		Paranasal sinus hypersecretion	below serious				8645
52889	1 pts		Gamma glutamyl transpeptidase increased	grade 3			TRUE	8646
52890	2 pts		Thrombocytopenia	grade 3-4				8646
52891	2 pts		Leukopenia	grade 3-4				8646
52892	5 pts		Neutropenia	grade 3-4				8646
52893	4 pts		Nausea	grade 1-2				8646
52894	3 pts		Stomatitis	grade 1-2				8646
52895	3 pts		Vomiting	grade 1-2				8646
52896	1 pts		Fatigue	grade 3-4				8646
52897	4 pts		Fever	grade 1-2				8646
52898	5 pts		Decreased appetite	grade 1-2				8646
52899	2 pts		Hypoalbuminemia	grade 1-2				8646
52900	3 pts		Rash	grade 1-2				8646
52901	2 pts		Electrocardiogram T wave abnormal				TRUE	8650
52902	1 pts		Hypertriglyceridemia	grade 4			TRUE	8647
52903	25		Diarrhea	severe|grade 5		WARNING		8649
52904			Arrhythmia	severe		WARNING		8649
52905	17 pts		Diarrhea		discontinuation	leads to discontinuation		8648
52906	6 pts		Thrombocytopenia		discontinuation	leads to discontinuation		8648
52907	11 pts		Fatigue		discontinuation	leads to discontinuation		8648
52908	11 pts		Asthenia		discontinuation	leads to discontinuation		8648
52909	14 pts		Peripheral neuropathy		discontinuation	leads to discontinuation		8648
52910	28		Thrombocytopenia		discontinuation	leads to dose interruption or modification		8648
52911						The incidence of AEs and serious AEs was not different among the rolapitant- and placebo treated groups.		8655
52912						impossible to link AEs with the definite dose: The most common AEs in part 1 in the rolapitant group were dizziness (28%), polyuria (11%), and nausea (11%).		8652
52913	1 pts		Nausea	moderate	discontinuation	leads to discontinuation		8653
52914	1 pts		Retching	moderate	discontinuation	leads to discontinuation		8653
52915	1 pts		Cough	moderate	discontinuation	leads to discontinuation		8653
52916	1 pts		Hyperhidrosis	moderate	discontinuation	leads to discontinuation		8653
52917	1 pts		Abdominal pain	mild	discontinuation	leads to discontinuation		8653
52918	1 pts		Dry mouth	mild	discontinuation	leads to discontinuation		8653
52919	1 pts		Dyspnea	mild	discontinuation	leads to discontinuation		8653
52920	1 pts		Visual impairment	mild	discontinuation	leads to discontinuation		8653
52921	1 pts		Feeling hot	mild	discontinuation	leads to discontinuation		8653
52922	1 pts		Abdominal discomfort	mild	discontinuation	leads to discontinuation		8654
52923	1 pts		Diarrhea	mild	discontinuation	leads to discontinuation		8654
52924	1 pts		Presyncope	mild	discontinuation	leads to discontinuation		8654
52925	1 pts		Feeling hot	mild	discontinuation	leads to discontinuation		8654
52926	1 pts		Headache	mild	discontinuation	leads to discontinuation		8654
52927	1 pts		Dizziness	mild	discontinuation	leads to discontinuation		8654
52928	1 pts		Dry mouth	mild	discontinuation	leads to discontinuation		8654
52929	1 pts		Back pain	mild	discontinuation	leads to discontinuation		8651
52930	1 pts		Dizziness		discontinuation	leads to discontinuation		8651
52931	1 pts		Creatine kinase increased	grade 3-4				8656
52932	3 pts		Rhabdomyolysis					8656
52933	54		Muscle spasms	all grades				8660
52934	3		Muscle spasms	grade 3	discontinuation	leads to discontinuation		8660
52935	32		Musculoskeletal pain	all grades				8660
52936	1		Musculoskeletal pain	grade 3				8660
52937	19		Myalgia	all grades	discontinuation	leads to dose interruption or reduction		8660
52938	53		Alopecia	all grades	discontinuation	leads to discontinuation		8660
52939	10		Pruritus	all grades				8660
52940	15		Headache	all grades				8660
52941	1		Headache	grade 3				8660
52942	41		Fatigue	all grades				8660
52943	14		Pain	all grades				8660
52944	1		Pain	grade 3				8660
52945	39		Nausea	all grades				8660
52946	32		Diarrhea	all grades				8660
52947	1		Diarrhea	grade 3	discontinuation	leads to dose interruption or reduction		8660
52948	18		Abdominal pain	all grades				8660
52949	11		Vomiting	all grades				8660
52950	30		Weight decreased	all grades				8660
52951	3		Weight decreased	grade 3	discontinuation	leads to discontinuation		8660
52952	23		Decreased appetite	all grades				8660
52953	1		Decreased appetite	grade 3	discontinuation	leads to discontinuation		8660
52954	92		Increased serum creatinine	all grades				8660
52955	61		Creatine kinase increased	all grades				8660
52956	51		Hyperglycemia	all grades				8660
52957	4		Hyperglycemia	grade 3-4				8660
52958	43		Lipase increased	all grades				8660
52959	19		Alanine aminotransferase increased	all grades				8660
52960	4		Aspartate aminotransferase increased	grade 3-4				8660
52961	16		Amylase increased	all grades				8660
52962	32		Anemia	all grades				8660
52963	28		Lymphopenia	all grades				8660
52964	3		Lymphopenia	grade 3-4				8660
52965	4		Alanine aminotransferase increased	grade 3-4	discontinuation	leads to dose interruption or reduction		8662
52966	19		Aspartate aminotransferase increased	all grades	discontinuation	leads to dose interruption or reduction		8662
52967	1		Amylase increased	grade 3-4	discontinuation	leads to discontinuation		8661
52968	4		Asthenia		discontinuation	leads to discontinuation | leads to dose interruption or reduction		8662
52969	46		Dysgeusia	all grades	discontinuation	leads to discontinuation | leads to dose interruption or reduction		8663
52970	4		Fatigue	grade 3	discontinuation	leads to discontinuation | leads to dose interruption or reduction		8663
52971	1		Nausea	grade 3	discontinuation	leads to discontinuation | leads to dose interruption or reduction		8663
52972	1		Vomiting	grade 3	discontinuation	leads to dose interruption or reduction		8663
52973	8		Creatine kinase increased	grade 3-4	discontinuation	leads to dose interruption or reduction		8663
52974	13		Lipase increased	grade 3-4	discontinuation	leads to discontinuation | leads to dose interruption or reduction		8663
52975	1 pts		Arthralgia		discontinuation	leads to discontinuation		8664
52976	1 pts		Dysphagia		discontinuation	leads to discontinuation		8664
52977	1 pts		General physical health deterioration		discontinuation	leads to discontinuation		8664
52978	1 pts		Abdominal pain upper		discontinuation	leads to discontinuation		8664
52979	1 pts		Agitation		discontinuation	leads to discontinuation		8664
52980	1 pts		Depression		discontinuation	leads to discontinuation		8664
52981	1 pts		Dry mouth		discontinuation	leads to discontinuation		8664
52982	1 pts		Lumbar vertebral fracture		discontinuation	leads to discontinuation		8664
52983	1		Rhabdomyolysis		discontinuation	leads to dose interruption or reduction		8665
52984	1		Dizziness		discontinuation	leads to dose interruption or reduction		8665
52985	1		Pneumonia		discontinuation	leads to dose interruption or reduction		8665
52986	1		Muscular weakness		discontinuation	leads to dose interruption or reduction		8665
52987	1		Blood uric acid increased		discontinuation	leads to dose interruption or reduction		8666
52988	1		Angina pectoris		discontinuation	leads to dose interruption or reduction		8666
52989	1		Anorectal infection		discontinuation	leads to dose interruption or reduction		8666
52990	1		Back pain		discontinuation	leads to dose interruption or reduction		8666
52991	1		Bile duct stone		discontinuation	leads to dose interruption or reduction		8666
52992	1		Cough		discontinuation	leads to dose interruption or reduction		8666
52993	1		Disturbance in attention		discontinuation	leads to dose interruption or reduction		8666
52994	1		Femoral neck fracture		discontinuation	leads to dose interruption or reduction		8666
52995	1		Gastric ulcer		discontinuation	leads to dose interruption or reduction		8666
52996	1		Influenza		discontinuation	leads to dose interruption or reduction		8666
52997	1		Sleep disorder		discontinuation	leads to dose interruption or reduction		8666
52998	1		Spinal compression fracture		discontinuation	leads to dose interruption or reduction		8666
52999	1		Upper respiratory tract infection		discontinuation	leads to dose interruption or reduction		8666
53000	9		Muscle spasms		discontinuation	leads to discontinuation		8657
53001	6		Alopecia		discontinuation	leads to discontinuation | leads to dose interruption or reduction		8657
53002	5		Dysgeusia		discontinuation	leads to discontinuation		8657
53003	5		Weight decreased		discontinuation	leads to discontinuation | leads to dose interruption or reduction		8657
53004	2		Fatigue		discontinuation	leads to discontinuation | leads to dose interruption or reduction		8657
53005	1		Asthenia		discontinuation	leads to discontinuation		8657
53006	4		Nausea		discontinuation	leads to discontinuation | leads to dose interruption or reduction		8657
53007	2		Creatine kinase increased		discontinuation	leads to discontinuation | leads to dose interruption or reduction	TRUE	8657
53008	5		Decreased appetite		discontinuation	leads to discontinuation | leads to dose interruption or reduction		8657
53009	1		Arthralgia		discontinuation	leads to discontinuation		8657
53010	1		Dysphagia		discontinuation	leads to discontinuation		8657
53011	1		General physical health deterioration		discontinuation	leads to discontinuation		8657
53012	2		Ageusia		discontinuation	leads to discontinuation		8657
53013	2		Dehydration		discontinuation	leads to discontinuation		8657
53014	1		Anemia		discontinuation	leads to discontinuation		8658
53015	1		Constipation		discontinuation	leads to discontinuation		8658
53016	1		Hypertension		discontinuation	leads to discontinuation		8658
53017	1		Hypogeusia		discontinuation	leads to discontinuation		8658
53018	5		Diarrhea		discontinuation	leads to dose interruption or reduction		8659
53019	1		Gastroenteritis viral		discontinuation	leads to dose interruption or reduction		8659
53020	1		Rhabdomyolysis		discontinuation	leads to dose interruption or reduction		8659
53021	2		Alanine aminotransferase increased		discontinuation	leads to dose interruption or reduction		8659
53022	2		Aspartate aminotransferase increased		discontinuation	leads to dose interruption or reduction		8659
53023	1		Dizziness		discontinuation	leads to dose interruption or reduction		8659
53024	3		Myalgia		discontinuation	leads to dose interruption or reduction		8659
53025	1		Muscular weakness		discontinuation	leads to dose interruption or reduction		8659
53026	1		Blood uric acid increased		discontinuation	leads to dose interruption or reduction		8659
53027	7		Vomiting		discontinuation	leads to dose interruption or reduction		8659
53028	1		Dyspnea		discontinuation	leads to dose interruption or reduction		8659
53029	1		Myoglobin blood increased		discontinuation	leads to dose interruption or reduction		8659
53030	1		Hypogeusia		discontinuation	leads to dose interruption or reduction		8659
53031	1		Amylase increased		discontinuation	leads to dose interruption or reduction		8659
53032	1		Malaise		discontinuation	leads to dose interruption or reduction		8659
53033	3.1		Urinary tract infection		discontinuation			8670
53034	26.2		Diarrhea					8670
53035	23.1		Urinary tract infection					8670
53036	16.9		Pain in extremity					8670
53037	15.4		Influenza					8670
53038	15.4		Headache					8670
53039	13.8		Nasopharyngitis					8670
53040	12.3		Upper abdominal pain					8670
53041	12.3		Nausea					8670
53042	10.8		Vomiting					8670
53043	9.2		Lacrimation decreased					8670
53044	7.7		Myalgia					8670
53045	7.7		Punctate keratitis					8670
53046	7.7		Back pain					8670
53047	6.2		Vaginal infection					8670
53048	6.2		Peripheral edema					8670
53049	6.2		Constipation					8670
53050	6.2		Pharyngitis					8670
53051	6.2		Upper respiratory tract infection					8670
53052	6.2		Thermal burn					8670
53053	6.2		Anxiety					8670
53054	6.2		Depression					8670
53055	6.2		Erectile dysfunction					8670
53056	4.6		Paresthesia					8670
53057	4.6		Abdominal pain					8670
53058	4.6		Weight decreased					8670
53059	4.6		Vertigo					8670
53060	3.1		Neuralgia					8670
53061	3.1		Pharyngolaryngeal pain					8670
53062	3.1		Muscle spasms					8670
53063	3.1		AV block first degree					8670
53064	3.1		Dizziness					8670
53065	1.5		Hypoesthesia					8670
53066	4.8		Transient ischemic attack	grade 1	discontinuation			8671
53067	24		Fall					8671
53068	24		Diarrhea					8671
53069	19		Pain in extremity					8671
53070	14		Dizziness					8671
53071	14		Dyspnea					8671
53072	14		Vomiting					8671
53073	14		Constipation					8671
53074	4.8		Ankle fracture					8671
53075	4.8		Malaise					8671
53076	4.8		Urinary retention					8671
53077	11.4		Diarrhea					8672
53078	9.1		Upper abdominal pain					8672
53079	11.4		Urinary tract infection					8672
53080	14.2		Diarrhea					8668
53081	8		Upper abdominal pain					8668
53082	12.5		Urinary tract infection					8668
53083	10.2		Hypersensitivity					8672
53084	26.1		Hepatotoxicity					8672
53085	6.8		Dysfunction thyroid					8672
53086	14.8		Hypersensitivity					8668
53087	21.6		Hepatotoxicity					8668
53088	9.1		Dysfunction thyroid					8668
53089	33		Cardiac arrhythmia					8672
53090	48.9		Hypotension orthostatic					8672
53091	55.7		Infection					8672
53092	37.5		Cardiac arrhythmia					8668
53093	42		Hypotension orthostatic					8668
53094	65.9		Infection					8668
53095	62.5		Infection					8674
53096	0.6		Pancreatitis					8668
53097	12.5		Pneumonia					8672
53098	15.3		Pneumonia					8668
53099	14.4		Pneumonia					8674
53100	2.3		Coordination and balance disturbances					8672
53101	2.3		Balance disorder					8672
53102	30.7		Fall					8672
53103	42		Accidental injury					8672
53104	9.1		Coordination and balance disturbances					8668
53105	8.5		Balance disorder					8668
53106	24.4		Fall					8668
53107	35.2		Accidental injury					8668
53108	33		Falling					8672
53109	30		Falling					8668
53110	31.1		Falling					8674
53111	8		Lens disorder					8672
53112	10.2		Lens disorder					8668
53113	9.5		Lens disorder					8674
53114	26.1		Hepatotoxicity					8672
53115	21.6		Hepatotoxicity					8668
53116	23.1		Hepatotoxicity					8674
53117	6.8		Dysfunction thyroid					8672
53118	9.1		Dysfunction thyroid					8668
53119	8.3		Dysfunction thyroid					8674
53120	23.9		Asthenic conditions					8672
53121	25.6		Asthenic conditions					8668
53122	25		Asthenic conditions					8674
53123	1.1		T4 increased					8672
53124	0.6		T4 increased					8668
53125	13.6		TSH increased					8672
53126	16.5		TSH increased					8668
53127	23.9		T4 increased					8672
53128	24.4		T4 increased					8668
53129	51		Retinol binding protein increased					8672
53130	44		Retinol binding protein increased					8668
53131	5.68		ALT increased	grade 1				8672
53132	4.55		ALT increased	grade 1				8668
53133	3.41		AST increased					8672
53134	7.39		AST increased					8668
53135	5.68		ALP increased					8672
53136	6.25		ALP increased					8668
53137	1.14		Bilirubin total increased					8672
53138	0.57		Bilirubin total increased					8668
53139			Hordeolum	grade 1				8667
53140	>10		Urinary tract infection	grade 1-2				8673
53141	>10		Vaginal infection	grade 1-2				8673
53142	>10		Diarrhoea	grade 1-2				8673
53143	>10		Upper abdominal pain	grade 1-2				8673
53144	4.5		Flatulence					8669
53145	3.4		Liver function test increased					8669
53146						The source does not contain information about AEs or lack thereof		8675
53147	7.7		Beta-N-acetyl-D-glucosaminidase increased					8676
53148	15.4		Blood triglycerides increased					8676
53149	15.4		Alpha 1 microglobulin					8676
53150	7.7		Gouty arthritis					8676
53151	7.7		Beta 2 microglobulin					8676
53152	30.8		Beta 2 microglobulin urine					8676
53153						No adverse effects leading to discontinuation were reported.		8678
53154						No serious AEs were reported at any point in the study, and no randomized participants discontinued because of AEs.		8677
53155						No adverse effects leading to discontinuation were reported		8679
53156	33.3		Dizziness	grade 1-2	discontinuation			8680
53157	16.7		Headache	grade 1	discontinuation			8680
53158	16.7		Pallor of skin	grade 1	discontinuation			8680
53159	16.7		Malaise	grade 2	discontinuation			8680
53160	16.7		Abdominal pain	grade 1	discontinuation			8680
53161	33.3		Nausea	grade 2	discontinuation			8680
53162						No adverse effects leading to discontinuation were reported		8681
53163	11.1		Pulmonary toxicity				TRUE	8682
53164	11.1		Nausea				TRUE	8682
53165	11.1		Hyperglycemia				TRUE	8682
53166	11.1		Vomiting				TRUE	8682
53167	9		Hyperglycemia	grade 3			TRUE	8685
53168						No adverse effects leading to discontinuation were reported; no DLTs		8684
53169	50		Hypophosphatemia	grade 3	dose reduction		TRUE	8683
53170	66.7		Thrombocytopenia	grade 4			TRUE	8686
53171			Thrombocytopenia				TRUE	8687
53172	66.7		Thrombocytopenia	grade 4			TRUE	8691
53173	16.7		Thrombocytopenia	grade 4			TRUE	8692
53174	66.7		Thrombocytopenia	grade 4			TRUE	8695
53175	20		Thrombocytopenia	grade 4			TRUE	8694
53176	20		Febrile neutropenia	grade 4			TRUE	8694
53177	42.8		Thrombocytopenia	grade 4			TRUE	8693
53178	11.1		Diarrhea	grade 3			TRUE	8696
53179	11.1		Acute renal failure	grade 5			TRUE	8696
53180	20		Anaemia					8688
53181	20		Blood creatinine increased					8688
53182	20		Dehydration					8688
53183	20		Hyperglycaemia					8688
53184	20		Cancer pain					8688
53185	20		Lymphoma					8688
53186	20		Neoplasm malignant					8688
53187	20		Anuria					8688
53188	20		Pulmonary embolism					8688
53189	33.3		Deep vein thrombosis					8689
53190	6.7		QT interval prolonged					8690
53191	63.3		Nausea	grade 1-2				8690
53192	60		Fatigue	grade 1-4				8690
53193	50		Diarrhea	grade 1-2				8690
53194	46.7		Thrombocytopenia	grade 1-4				8690
53195	43.3		Cough	grade 1-2				8690
53196	36.7		Vomiting	grade 1-2				8690
53197	33.3		Constipation	grade 1-2				8690
53198	26.7		Decreased appetite	grade 1-2				8690
53199	26.7		Headache	grade 1-2				8690
53200	26.7		Peripheral edema	grade 1-2				8690
53201	26.7		Anemia	grade 1-2				8690
53202	23.3		Neutropenia	grade 1-4				8690
53203	23.3		Dysgeusia	grade 1-2				8690
53204	23.3		Sinusitis	grade 1-2				8690
53205	20		Insomnia	grade 1-2				8690
53206	20		Chills	grade 1-2				8690
53207	6.7		Hyperglycemia	grade 2-4				8690
53208	6.7		Performance status decreased	grade 2-4				8690
53209	6.7		Arthralgia	grade 2-4				8690
53210	3.3		Activated partial thromboplastin time prolonged	grade 3-4				8690
53211	3.3		Anemia	grade 3-4				8690
53212	3.3		Atrial fibrillation	grade 3-4				8690
53213	3.3		Back pain	grade 3-4				8690
53214	3.3		Cellulitis	grade 3-4				8690
53215	3.3		Deep vein thrombosis	grade 3-4				8690
53216	3.3		Diarrhea	grade 3-4				8690
53217	3.3		Hydronephrosis	grade 3-4				8690
53218	3.3		Hypoglycaemia	grade 3-4				8690
53219	3.3		Hypokalaemia	grade 3-4				8690
53220	3.3		Hypophosphataemia	grade 3-4				8690
53221	3.3		International normalized ratio increased	grade 3-4				8690
53222	3.3		Jugular vein thrombosis	grade 3-4				8690
53223	3.3		Leukopenia	grade 3-4				8690
53224	3.3		Lymphopenia	grade 3-4				8690
53225	3.3		Melena	grade 3-4				8690
53226	3.3		Mental status changes	grade 3-4				8690
53227	3.3		Muscular weakness	grade 3-4				8690
53228	3.3		Myalgia	grade 3-4				8690
53229	3.3		Platelet count decreased	grade 3-4				8690
53230	3.3		Sinusitis	grade 3-4				8690
53231	3.3		Small intestinal obstruction	grade 3-4				8690
53232	3.3		Spinal column stenosis	grade 3-4				8690
53233	3.3		Viral infection	grade 3-4				8690
53234	66.7		Nausea					8697
53235	66.7		Diarrhea					8697
53236	16.7		Fatigue					8697
53237	16.7		Anorexia					8697
53238	16.7		Gastrooesophageal reflux disease					8697
53239	33.3		Vomiting					8697
53240	16.7		Asthenia					8697
53241	16.7		Upper respiratory tract infection					8697
53242	16.7		Back pain					8697
53243	33.3		Rash					8697
53244	16.7		Odynophagia					8697
53245	16.7		Neutropenia					8697
53246	33.3		Function liver abnormal	grade 3	discontinuation		TRUE	8697
53247	32.7		Nausea					8698
53248	30.9		Diarrhea					8698
53249	25.5		Dyspepsia					8698
53250	21.8		Fatigue					8698
53251	21.8		Anorexia					8698
53252	18.2		Gastrooesophageal reflux disease					8698
53253	10.9		Vomiting					8698
53254	12.7		Anemia					8698
53255	14.5		Asthenia					8698
53256	12.7		Upper respiratory tract infection					8698
53257	9.1		Back pain					8698
53258	12.7		Insomnia					8698
53259	12.7		Rash					8698
53260	12.7		Constipation					8698
53261	9.1		Cough					8698
53262	12.7		Odynophagia					8698
53263	10.9		Headache					8698
53264	5.5		Neutropenia					8698
53265	9.1		Pyrexia					8698
53266	24		Pain	grade 1-3	discontinuation			8699
53267	47		Diarrhea	grade 1-3	dose interruption			8699
53268	5.9		Esophageal ulcer	grade 1-2	dose interruption			8699
53269	5.9		Soft tissue necrosis	grade 3				8699
53270	59		Nausea	grade 1-2				8699
53271	53		Fatigue	grade 1-3				8699
53272	47		Upper respiratory infection	grade 1-2				8699
53273	24		Asthenia	grade 1-2				8699
53274	24		Constipation	grade 1-2				8699
53275	24		Decreased appetite	grade 1-2				8699
53276	24		Memory impairment	grade 1-2				8699
53277	41		Dyspepsia	grade 1-2				8699
53278	18		Dizziness	grade 1-2				8699
53279	18		Peripheral edema	grade 1-2				8699
53280	18		Pyrexia	grade 1-2				8699
53281	18		Vomiting	grade 1-2				8699
53282	18		Weight decreased	grade 1-2				8699
53283	7 pts		Neutropenia	all grades				8703
53284	8 pts		Alopecia	all grades				8703
53285	9 pts		Diarrhea	all grades				8703
53286	7 pts		Leukopenia	all grades				8703
53287	7 pts		Nausea	all grades				8703
53288	6 pts		Stomatitis	all grades				8703
53289	7 pts		Fatigue	all grades				8703
53290	3 pts		Decreased appetite	all grades				8703
53291	2 pts		Hypersomnia	all grades				8703
53292	5 pts		Vomiting	all grades				8703
53293	3 pts		Oral candidiasis	all grades				8703
53294	3 pts		Thrombocytopenia	all grades				8703
53295	2 pts		Anemia	all grades				8703
53296	1 pts		Febrile neutropenia	all grades				8703
53297	1 pts		Memory impairment	all grades				8703
53298	6 pts		Neutropenia	grade 3-4				8703
53299	5 pts		Leukopenia	grade 3-4				8703
53300	1 pts		Febrile neutropenia	grade 3-4			TRUE	8703
53301	1 pts		Diarrhea	grade 3-4				8703
53302	1 pts		Fatigue	grade 3-4				8703
53303	2 pts		Nausea	grade 3-4				8703
53304	1 pts		Stomatitis	grade 3-4				8703
53305	2 pts		Vomiting	grade 3-4				8703
53306	3 pts		Neutropenia	all grades				8701
53307	2 pts		Alopecia	all grades				8701
53308	1 pts		Diarrhea	all grades				8701
53309	1 pts		Leukopenia	all grades				8701
53310	1 pts		Nausea	all grades				8701
53311	2 pts		Stomatitis	all grades				8701
53312	1 pts		Fatigue	all grades				8701
53313	1 pts		Decreased appetite	all grades				8701
53314	1 pts		Hypersomnia	all grades				8701
53315	1 pts		Oral candidiasis	all grades				8701
53316	1 pts		Thrombocytopenia	all grades				8701
53317	1 pts		Anemia	all grades				8701
53318	2 pts		Febrile neutropenia	all grades				8701
53319	1 pts		Memory impairment	all grades				8701
53320	3 pts		Neutropenia	grade 3-4				8701
53321	2 pts		Leukopenia	grade 3-4				8701
53322	2 pts		Febrile neutropenia	grade 3-4				8701
53323	1 pts		Diarrhea	grade 3-4				8701
53324	1 pts		Fatigue	grade 3-4				8701
53325	17 pts		Neutropenia	all grades				8702
53326	16 pts		Diarrhea	all grades				8702
53327	14 pts		Alopecia	all grades				8702
53328	15 pts		Stomatitis	all grades				8702
53329	11 pts		Fatigue	all grades				8702
53330	6 pts		Anemia	all grades				8702
53331	6 pts		Decreased appetite	all grades				8702
53332	5 pts		Nausea	all grades				8702
53333	3 pts		Palmar-plantar erythrodysesthesia syndrome	all grades				8702
53334	6 pts		Pruritus	all grades				8702
53335	6 pts		Pyrexia	all grades				8702
53336	3 pts		Rash maculo-papular	all grades				8702
53337	6 pts		Thrombocytopenia	all grades				8702
53338	6 pts		WBC decreased	all grades				8702
53339	5 pts		Abdominal pain	all grades				8702
53340	4 pts		Febrile neutropenia	all grades				8702
53341	1 pts		Hypokalemia	all grades				8702
53342	2 pts		Leukopenia	all grades				8702
53343	2 pts		Oral pain	all grades				8702
53344	3 pts		Vomiting	all grades				8702
53345	15 pts		Neutropenia	grade 3-4				8702
53346	4 pts		Diarrhea	grade 3-4				8702
53347	1 pts		Alopecia	grade 3-4				8702
53348	3 pts		Stomatitis	grade 3-4				8702
53349	1 pts		Fatigue	grade 3-4				8702
53350	3 pts		Anemia	grade 3-4				8702
53351	1 pts		Palmar-plantar erythrodysesthesia syndrome	grade 3-4				8702
53352	1 pts		Pyrexia	grade 3-4				8702
53353	3 pts		Thrombocytopenia	grade 3-4				8702
53354	5 pts		WBC decreased	grade 3-4				8702
53355	4 pts		Febrile neutropenia	grade 3-4				8702
53356	2 pts		Leukopenia	grade 3-4				8702
53357	5 pts		Neutropenia	all grades				8700
53358	3 pts		Diarrhea	all grades				8700
53359	3 pts		Alopecia	all grades				8700
53360	2 pts		Stomatitis	all grades				8700
53361	2 pts		Fatigue	all grades				8700
53362	4 pts		Anemia	all grades				8700
53363	1 pts		Nausea	all grades				8700
53364	3 pts		Palmar-plantar erythrodysesthesia syndrome	all grades				8700
53365	3 pts		Rash maculo-papular	all grades				8700
53366	1 pts		Febrile neutropenia	all grades				8700
53367	3 pts		Hypokalemia	all grades				8700
53368	2 pts		Leukopenia	all grades				8700
53369	2 pts		Oral pain	all grades				8700
53370	1 pts		Vomiting	all grades				8700
53371	5 pts		Neutropenia	grade 3-4				8700
53372	1 pts		Stomatitis	grade 3			TRUE	8700
53373	3 pts		Anemia	grade 3-4				8700
53374	1 pts		Febrile neutropenia	grade 3-4				8700
53375	1 pts		Hypokalemia	grade 3-4				8700
53376	2 pts		Leukopenia	grade 3-4				8700
53377	1 pts		Neutropenia	grade 4			TRUE	8700
53378	15 pts		Neutrophil count decreased	grade 3				8704
53379	10 pts		Anemia	grade 3				8704
53380	10 pts		White blood cell decreased	grade 3				8704
53381	8 pts		Mucositis oral	grade 3				8704
53382	7 pts		Lymphocyte count decreased	grade 3				8704
53383	5 pts		Platelet count decreased	grade 3				8704
53384	4 pts		Febrile neutropenia	grade 3				8704
53385	3 pts		Fatigue	grade 3				8704
53386	3 pts		Palmar-plantar erythrodysesthesia syndrome	grade 3				8704
53387	1 pts		Leukocytosis	grade 3				8704
53388	1 pts		Anal mucositis	grade 3				8704
53389	1 pts		Diarrhea	grade 3				8704
53390	2 pts		Nausea	grade 3				8704
53391	1 pts		Typhlitis	grade 3				8704
53392	1 pts		Vomiting	grade 3				8704
53393	1 pts		Lung infection	grade 3				8704
53394	1 pts		Alanine aminotransferase increased	grade 3				8704
53395	1 pts		Aspartate aminotransferase increased	grade 3				8704
53396	1 pts		Skin disorder	grade 3				8704
53397	1 pts		Hypertension	grade 3				8704
53398	15 pts		Neutrophil count decreased	grade 4				8704
53399	6 pts		White blood cell decreased	grade 4				8704
53400	1 pts		Mucositis oral	grade 4				8704
53401	5 pts		Platelet count decreased	grade 4				8704
53402	3 pts		Febrile neutropenia	grade 4				8704
53403	1 pts		Sepsis	grade 4				8704
53404	1 pts		Acute generalized exanthematous pustulosis		discontinuation	leads to discontinuation		8705
53405	1 pts		Asthenia		discontinuation	leads to discontinuation		8705
53406	1 pts		Febrile neutropenia		discontinuation	leads to discontinuation		8705
53407	1 pts		Plasma cell myeloma		discontinuation	leads to discontinuation		8705
53408	1 pts		Thrombocytopenia		discontinuation	leads to discontinuation		8705
53409	73 pts		Anemia	all grades				8705
53410	65 pts		Neutropenia	all grades				8705
53411	53 pts		Thrombocytopenia	all grades				8705
53412	46 pts		Stomatitis	all grades				8705
53413	63 pts		Diarrhea	all grades				8705
53414	48 pts		Pyrexia	all grades				8705
53415	49 pts		Fatigue	all grades				8705
53416	34 pts		Nausea	all grades				8705
53417	39 pts		Leukopenia	all grades				8705
53418	27 pts		Decreased appetite	all grades				8705
53419	16 pts		Constipation	all grades				8705
53420	43 pts		Alopecia	all grades				8705
53421	20 pts		Vomiting	all grades				8705
53422	21 pts		Peripheral edema	all grades				8705
53423	14 pts		Cough	all grades				8705
53424	15 pts		Platelet count decreased	all grades				8705
53425	24 pts		Asthenia	all grades				8705
53426	19 pts		Pruritus	all grades				8705
53427	14 pts		Dyspnea	all grades				8705
53428	29 pts		Febrile neutropenia	all grades				8705
53429	45 pts		Anemia	grade 3-4				8705
53430	59 pts		Neutropenia	grade 3-4				8705
53431	40 pts		Thrombocytopenia	grade 3-4				8705
53432	14 pts		Stomatitis	grade 3-4				8705
53433	9 pts		Diarrhea	grade 3-4				8705
53434	3 pts		Pyrexia	grade 3-4				8705
53435	9 pts		Fatigue	grade 3-4				8705
53436	2 pts		Nausea	grade 3-4				8705
53437	31 pts		Leukopenia	grade 3-4				8705
53438	3 pts		Decreased appetite	grade 3-4				8705
53439	2 pts		Vomiting	grade 3-4				8705
53440	13 pts		Platelet count decreased	grade 3-4				8705
53441	3 pts		Asthenia	grade 3-4				8705
53442	1 pts		Pruritus	grade 3-4				8705
53443	2 pts		Dyspnea	grade 3-4				8705
53444	29 pts		Febrile neutropenia	grade 3-4				8705
53445						No adverse effects leading to discontinuation were reported; no DLTs		8708
53446	33.3		Neutropenia	grade 3	discontinuation	Febrile neutropenia. Both patients recovered afterwithholding drug lasting 8 and 4 days, respectively.	TRUE	8709
53447						No adverse effects leading to discontinuation were reported		8707
53448	33.3		Myocardial infarction	grade 5	discontinuation		TRUE	8706
53449	33.3		Sepsis	grade 5	discontinuation		TRUE	8706
53450	1.6		Elevated liver enzymes		discontinuation			8710
53451	6.7		Asthenia		discontinuation			8711
53452	6.7		Macular edema		discontinuation	bilateral central subfoveal edema		8711
53453	6.7		General physical health deterioration		discontinuation			8711
53454			Transaminases increased				TRUE	8712
53455			Thrombocytopenia				TRUE	8712
53456	1 pts		Alanine aminotransferase increase	grade 3				8713
53457	1 pts		Aspartate aminotransferase increased	grade 2				8713
53458			Transaminases increased					8713
53459	33.3		Mucositis oral	grade 3-4	dose interruption	Stomatitis/mucosal inflammation	TRUE	8718
53460	16.7		Mucositis oral	grade 3-4		Stomatitis/mucosal inflammation	TRUE	8715
53461	16.7		Pseudomonal sepsis		dose reduction			8715
53462	16.7		Cellulitis		dose reduction			8715
53463						No adverse effects leading to discontinuation were reported; no DLTs		8717
53464	20		Neutropenia	grade 4			TRUE	8714
53465	20		Proteinuria	grade 3	discontinuation			8714
53466	25		Febrile neutropenia	grade 4			TRUE	8719
53467	25		Neutropenia	grade 4			TRUE	8719
53468						No adverse effects leading to discontinuation were reported; no DLTs		8716
53469						No adverse effects leading to discontinuation were reported; no DLTs		8720
53470	33.3		ALT increased	grade 3	dose reduction		TRUE	8721
53471	2 pts		Headache					8723
53472	1 pts		Loose stools					8722
53473	4		Neutropenia	grade 4			TRUE	8726
53474	4		Infection	grade 2			TRUE	8725
53475	16.7		Neutropenia	grade 4			TRUE	8728
53476	16.7		Infection	grade 3			TRUE	8728
53477	16.7		Fatigue	grade 3			TRUE	8728
53478	16.7		Neutropenic infection	grade 4			TRUE	8728
53479	16.7		Gamma-glutamyltransferase increased	grade 3			TRUE	8728
53480	33.3		Pruritus	grade 3			TRUE	8724
53481	33.3		Rash	grade 3			TRUE	8724
53482	33.3		Neutropenia	grade 3			TRUE	8724
53483						No adverse effects leading to discontinuation were reported; no DLTs		8727
53484	66.7		Headache	grade 3			TRUE	8729
53485	33.3		Nausea	grade 3			TRUE	8729
53486	33.3		Vomiting	grade 3			TRUE	8729
53487	66.7		Bell's palsy	grade 2				8729
53488	16.7		Hypophosphatemia	grade 3			TRUE	8731
53489	16.7		Macular rash	grade 3			TRUE	8731
53490	16.7		Amylase increased				TRUE	8731
53491	16.7		Lipase increased				TRUE	8731
53492	9.1		Fatigue	grade 2				8730
53493	72.7		Anemia	grade 2				8730
53494	9.1		Pleural effusion	grade 2				8730
53495	9.1		Hypercalcemia	grade 3				8730
53496	9.1		Hypoalbuminemia	grade 2				8730
53497	0.9		Lymphocyte count decreased	grade 2-3				8730
53498	9.1		Depression	grade 2				8730
53499	9.1		Back pain	grade 2				8730
53500	9.1		Diarrhea	grade 3				8730
53501	18.2		Constipation	grade 2				8730
53502	18.2		Urinary retention	grade 2-3				8730
53503	9.1		Urinary tract discomfort	grade 2				8730
53504	9.1		Thromboembolic event	grade 3				8730
53505	9.1		Upper respiratory infection	grade 2				8730
53506	9.1		Skin pain	grade 2				8730
53507	18.2		Facial nerve disorder	grade 2				8730
53508	9.1		Eye disorder	grade 2				8730
53509	9.1		Headache	grade 2				8730
53510	9.1		Pain in extremity	grade 2				8730
53511	18.2		Vomiting	grade 2-3				8730
53512	9.1		Dehydration	grade 2				8730
53513	18.2		Bowel obstruction	grade 2-3				8730
53514	9.1		Lymphopenia	grade 3				8730
53515	19 pts		Diarrhea					8737
53516	6 pts		Acne					8737
53517	4 pts		Abdominal pain					8737
53518	4 pts		Acne pustular					8737
53519	11 pts		Rash					8737
53520	6 pts		Dry skin					8737
53521	5 pts		Gastrointestinal disorders					8737
53522	5 pts		Diarrhea	grade 1-2				8736
53523	2 pts		Vomiting	grade 1-2				8736
53524	6 pts		Acne	grade 1-2				8736
53525	4 pts		Dry skin	grade 1-2				8736
53526	3 pts		Pruritus	grade 1-2				8736
53527	2 pts		Rash	grade 1-2				8736
53528	5 pts		Hypertension	grade 1-2				8736
53529	2 pts		Fatigue	grade 1-2				8736
53530	1 pts		Hypokalemia	grade 1-2				8736
53531	1 pts		Fatigue	grade 2	discontinuation	leads to discontinuation		8735
53532	1 pts		Anorexia	grade 2	discontinuation	leads to discontinuation		8735
53533	26 pts		Diarrhoea	grade 1				8734
53534	14 pts		Dermatitis acneiform	grade 1				8734
53535	21 pts		Dry skin	grade 1				8734
53536	10 pts		Rash	grade 1				8734
53537	10 pts		Asthenia	grade 1				8734
53538	12 pts		Anorexia	grade 1				8734
53539	5 pts		Hypertension	grade 1				8734
53540	6 pts		Creatinine increased	grade 1				8734
53541	5 pts		Nausea	grade 1				8734
53542	7 pts		Rhinitis	grade 1				8734
53543	7 pts		Nervous system disorders	grade 1				8734
53544	6 pts		Vomiting	grade 1				8734
53545	3 pts		Fatigue	grade 1				8734
53546	8 pts		Eye disorders	grade 1				8734
53547	6 pts		Exfoliative rash	grade 1				8734
53548	4 pts		Pruritus	grade 1				8734
53549	5 pts		Epistaxis	grade 1				8734
53550	24 pts		Diarrhoea	grade 2				8734
53551	9 pts		Dermatitis acneiform	grade 2				8734
53552	9 pts		Rash	grade 2				8734
53553	7 pts		Asthenia	grade 2				8734
53554	4 pts		Anorexia	grade 2				8734
53555	7 pts		Hypertension	grade 2				8734
53556	7 pts		Creatinine increased	grade 2				8734
53557	7 pts		Nausea	grade 2				8734
53558	2 pts		Nervous system disorders	grade 2				8734
53559	3 pts		Vomiting	grade 2				8734
53560	4 pts		Fatigue	grade 2				8734
53561	1 pts		Eye disorders	grade 2				8734
53562	1 pts		Exfoliative rash	grade 2				8734
53563	1 pts		Pruritus	grade 2				8734
53564	6 pts		Diarrhoea	grade 3				8734
53565	1 pts		Asthenia	grade 3				8734
53566	1 pts		Anorexia	grade 3				8734
53567	3 pts		Hypertension	grade 3				8734
53568	1 pts		Nervous system disorders	grade 3				8734
53569	2 pts		Fatigue	grade 3				8734
53570	1 pts		Exfoliative rash	grade 3				8734
53571	1 pts		Diarrhoea	grade 3		dosing was interrupted on days 2–3 and days 17–28	TRUE	8732
53572	1 pts		Renal insufficiency	grade 3			TRUE	8732
53573	1 pts		Diarrhoea	grade 3			TRUE	8733
53574	1 pts		Renal insufficiency	grade 3			TRUE	8733
53575	1 pts		Diarrhoea	grade 4				8733
53576						No AEs were observed		8739
53577						No AEs were observed		8738
53578	16.7		Headache					8740
53579	16.7		Flatulence					8740
53580	16.7		Vomiting					8740
53581	16.7		Constipation					8740
53582	16.7		Blood glucose decreased					8740
53583						No AEs were observed		8741
53584	1 pts		Fatigue	grade 3			TRUE	8745
53585	1 pts		Blood bilirubin increased	grade 3			TRUE	8746
53586	1 pts		Fatigue	grade 3			TRUE	8747
53587	13		ALT increased	grade 3-4				8742
53588	38		Nausea	grade 1-2				8742
53589	38		Vomiting	grade 1-2				8742
53590	25		AST increased	grade 1-2				8742
53591	13		Blood bilirubin increased	grade 1-2				8742
53592	38		Fatigue	grade 1-2				8742
53593	38		Decreased appetite	grade 1-2				8742
53594	13		Peripheral edema	grade 1-2				8742
53595	13		Hypoalbuminemia	grade 1-2				8742
53596	25		Diarrhea	grade 1-2				8742
53597	13		Protein total decreased	grade 1-2				8742
53598	13		Stomatitis	grade 1-2				8742
53599	13		Dyspepsia	grade 1-2				8742
53600	1.8		Peripheral edema	all grades	discontinuation	leads to discontinuation		8743
53601	1.8		Pneumonitis	all grades	discontinuation	leads to discontinuation		8743
53602	1.5		Fatigue	all grades	discontinuation	leads to discontinuation		8743
53603	>2		Peripheral edema		discontinuation	leads to dose interruption/reduction		8743
53604	>2		Blood creatinine increased		discontinuation	leads to dose interruption/reduction		8743
53605	>2		Nausea		discontinuation	leads to dose interruption/reduction		8743
53606	>2		Vomiting		discontinuation	leads to dose interruption		8743
53607	>2		Lipase increased		discontinuation	leads to dose interruption		8743
53608	>2		ALT increased		discontinuation	leads to dose interruption/reduction		8743
53609	>2		Dyspnea		discontinuation	leads to dose interruption		8743
53610	>2		Amylase increased		discontinuation	leads to dose interruption		8743
53611	>2		AST increased		discontinuation	leads to dose interruption		8743
53612	>2		Blood bilirubin increased		discontinuation	leads to dose interruption		8743
53613	>2		Fatigue		discontinuation	leads to dose interruption		8743
53614	>2		Pneumonia		discontinuation	leads to dose interruption		8743
53615	0.6		Peripheral edema	grade 3-4	discontinuation	leads to discontinuation		8744
53616	0.3		Pneumonitis	grade 3-4	discontinuation	leads to discontinuation		8744
53617	0.9		Fatigue	grade 3-4	discontinuation	leads to discontinuation		8744
53618	0.9		ALT increased	all grades	discontinuation	leads to discontinuation		8744
53619	0.6		ALT increased	grade 3-4	discontinuation	leads to discontinuation		8744
53620	0.9		AST increased	all grades	discontinuation	leads to discontinuation		8744
53621	0.6		AST increased	grade 3-4	discontinuation	leads to discontinuation		8744
53622						No serious drug-related adverse events or dose-limiting toxicities were observed.		8748
53623	50		Diarrhea	grade 1				8750
53624	8.3		Aphthous stomatitis	grade 1				8750
53625	8.3		Flatulence	grade 1				8750
53626	8.3		Nausea	grade 1				8750
53627	25		Back pain	grade 1				8750
53628	8.3		Musculoskeletal pain	grade 1				8750
53629			Diarrhea					8749
53630			Dizziness					8749
53631			Back pain					8749
53632	12.5		Rash	grade 3			TRUE	8752
53633	20		Diarrhea	grade 3			TRUE	8751
53634	20		Rash	grade 3			TRUE	8751
53635	20		Nausea				TRUE	8753
53636	20		Vomiting				TRUE	8753
53637	20		ALT increased				TRUE	8753
53638	14.3		ALT increased				TRUE	8759
53639	14.3		GGT increased				TRUE	8759
53640	14.3		Hypermagnesemia				TRUE	8759
53641	16.7		Hematuria				TRUE	8755
53642	12.5		GGT increased				TRUE	8760
53643	8.3		Insomnia				TRUE	8756
53644	33.3		Nausea				TRUE	8758
53645	33.3		Vomiting				TRUE	8758
53646						No AEs were observed		8754
53647	85.7		Febrile neutropenia					8761
53648	24		Febrile neutropenia					8757
53649	24		Nausea					8757
53650	24		Vomiting					8757
53651			Febrile neutropenia				TRUE	8762
53652			Klebsiella pneumoniae infection			associated with febrile neutropenia	TRUE	8762
53653	14.3		Thrombocytopenia	grade 3			TRUE	8763
53654	12.5		Fatigue	grade 3			TRUE	8764
53655	12.5		Asthenia	grade 3			TRUE	8764
53656	14.3		Fatigue	grade 3			TRUE	8769
53657	14.3		Mucositis	grade 3			TRUE	8769
53658	8.3		Mucositis	grade 3			TRUE	8765
53659	16.7		Hyperglycemia	grade 1-3				8765
53660	66.7		Mucositis	grade 3			TRUE	8770
53661	50		Hyperglycemia	grade 3			TRUE	8767
53662	50		Dehydration	grade 3			TRUE	8767
53663	50		Fatigue	grade 3			TRUE	8767
53664	50		Thrombocytopenia	grade 3			TRUE	8767
53665	18.2		Hypertransaminasaemia	grade 1-4	discontinuation			8768
53666	10		Hyperglycaemia	grade 1-4	discontinuation			8766
53667	14.3		Neutropenia	grade 4	dose interruption|dose reduction		TRUE	8775
53668	14.3		Fatigue	grade 3	discontinuation		TRUE	8775
53669	12.5		Hypertension	grade 1	discontinuation			8772
53670	12.5		Fatigue	grade 3			TRUE	8772
53671	12.5		Febrile neutropenia	grade 3-4			TRUE	8772
53672	50		Neutropenia	grade 4	dose interruption		TRUE	8776
53673						No adverse effects leading to discontinuation were reported; no DLTs		8774
53674	8.3		Febrile neutropenia				TRUE	8773
53675	8.3		Mucositis				TRUE	8773
53676	28.6		Azotemia	grade 1-2	dose reduction			8771
53677	14.3		Febrile neutropenia				TRUE	8771
53678	14.3		Nausea				TRUE	8771
53679	14.3		Neutropenia			Neutropenia with rigors	TRUE	8778
53680	14.3		Febrile neutropenia				TRUE	8778
53681	16.7		Mucositis	grade 3			TRUE	8777
53682	16.7		Liver function test abnormal	grade 3			TRUE	8777
53683	33.3		Febrile neutropenia				TRUE	8777
53684			Dry cough					8780
53685	33.3		Pneumonitis	grade 3			TRUE	8782
53686			Pneumonitis	grade 3			TRUE	8779
53687			Hypoxia	grade 3			TRUE	8781
53688						No adverse effects leading to discontinuation were reported		8784
53689						Posttreatment AEs with a reasonable possibilityfor a causal relationship with the study medication was reported by 1 subject (11.1%) in the 15-mg-twice-daily treatment group (unspecified).		8783
53690	1 pts		Sweating		discontinuation			8785
53691	1 pts		Dyskinesia		discontinuation			8785
53692	1 pts		Nausea		discontinuation			8785
53693	1 pts		Dizziness		discontinuation			8785
53694	1 pts		Anxiety		discontinuation			8785
53695	2		Creatinine increased	grade 4	discontinuation			8786
53696	2		Headache	grade 3				8786
53697	2		Sepsis	grade 4	discontinuation			8786
53698	2		Creatinine increased	grade 3				8786
53699	2		Hypotension	grade 3				8786
53700	4		Allergic rash	grade 3				8786
53701	2		Adult respiratory distress syndrome	grade 5	discontinuation			8786
53702	2		Sepsis	grade 3				8786
53703	2		Nausea	grade 3				8786
53704	6		Hypoxemia	grade 3				8786
53705	0.9		Drug hypersensitivity	serious				8787
53706	0.9		Sepsis	serious				8787
53707	1.9		Cellulitis	serious	discontinuation			8787
53708	0.9		Deep vein thrombosis	serious				8787
53709	0.9		Myoclonus	serious				8787
53710	0.9		Hernia inguinal	serious				8787
53711	0.9		Hypersensitivity	serious				8787
53712	0.9		Biliary dyskinesia	serious				8787
53713	0.9		Colitis	serious				8787
53714	0.9		Intestinal perforation	serious				8787
53715	0.9		Enteritis	serious				8787
53716	0.9		Non-cardiac chest pain	serious				8787
53717	0.9		Urosepsis	serious				8787
53718	0.9		Wound dehiscence	serious				8787
53719	0.9		Aspiration pneumonia	serious				8787
53720	2.2		Fatigue		discontinuation			8789
53721	1.6		ALT increased		discontinuation			8789
53722	1.6		Headache		discontinuation			8789
53723	1		AST increased		discontinuation			8789
53724						No discontinuations due to treatment-related AEs were reported		8788
53725						No information on AE is provided		8790
53726			Headache					8791
53727	8.3		Nausea		dose reduction			8792
53728	2.1		Skin rash	grade 1	discontinuation			8793
53729			Somnolence					8794
53730	3.3		Somnolence		discontinuation			8796
53731	0.8		Irritability		discontinuation			8796
53732	0.8		Fatigue		discontinuation			8796
53733	0.8		Nightmare		discontinuation			8796
53734	0.8		Insomnia		discontinuation			8796
53735	13.6		Somnolence					8795
53736	1.2		Headache					8795
53737	2.5		Fatigue					8795
53738	1.2		Irritability					8795
53739	2.5		Abnormal dreams					8795
53740	2.5		Headache		discontinuation			8798
53741	1.3		Fatigue		discontinuation			8798
53742	1.3		Periorbital cellulitis		discontinuation			8798
53743	1.3		Atrial fibrillation		discontinuation			8799
53744	1.2		Upper respiratory tract infection		discontinuation			8797
53745	1.2		Acute cholecystitis		discontinuation			8797
53746	33.3		Hypertension	grade 3			TRUE	8800
53747	33.3		Dehydration	grade 3			TRUE	8800
53748	4		Left ventricular dysfunction	grade 3	discontinuation			8801
53749	20		Blood creatinine increased				TRUE	8802
53750	20		Renal failure	grade 3			TRUE	8802
53751	20		Diarrhea					8802
53752	20		Nausea					8802
53753	20.6		Blood creatinine increased				TRUE	8803
53754	44.1		Diarrhea					8803
53755	26.5		Nausea					8803
53756	5.9		Fatigue					8803
53757	8.8		Vomiting					8803
53758	8.8		Anemia					8803
53759	5.9		Hyperuricemia					8803
53760	5.9		Thrombocytopenia					8803
53761	11.6		Anemia	grade 3-4				8804
53762	3.2		Hyperuricemia	grade 3-4				8804
53763	2.9		Fatigue	grade 3-4	discontinuation			8804
53764	2.2		Diarrhea	grade 3-4	discontinuation			8804
53765	2.2		Thrombocytopenia	grade 3-4				8804
53766	1.4		Hyperkalemia	grade 3-4				8804
53767	0.7		Acute kidney injury	grade 3-4	discontinuation			8804
53768	0.7		ALT increased	grade 3-4				8804
53769	0.7		Allergic reaction	grade 3-4				8804
53770	0.7		AST increased	grade 3-4				8804
53771	0.7		Cardiac disorders	grade 3-4				8804
53772	0.7		Depression	grade 3-4				8804
53773	0.7		Dyspnea	grade 3-4				8804
53774	0.7		Hypophosphatemia	grade 3-4				8804
53775	0.7		Hypotension	grade 3-4				8804
53776	0.7		Lipase increased	grade 3-4				8804
53777	0.7		Nausea	grade 3-4				8804
53778	0.7		Pain	grade 3-4				8804
53779	0.7		Pain in extremity	grade 3-4				8804
53780	0.7		Thromboembolic event	grade 3-4				8804
53781	0.7		Thrombotic thrombocytopenic purpura	grade 3-4				8804
53782	0.7		Tumour lysis syndrome	grade 3-4				8804
53783	0.7		Vomiting	grade 3-4				8804
53784	0.7		QT interval prolonged		discontinuation			8804
53785	0.7		Blood uric acid increased		discontinuation			8804
53786	0.7		Drug hypersensitivity		discontinuation			8804
53787						No adverse effects leading to discontinuation were specified		8806
53788						No adverse effects leading to discontinuation were reported		8805
53789	18 pts		Thrombocytopenia	all grades				8811
53790	10 pts		Thrombocytopenia	grade 3-4				8811
53791	9 pts		Neutropenia	all grades				8811
53792	4 pts		Neutropenia	grade 3-4				8811
53793	2 pts		Diarrhea	all grades				8811
53794	1 pts		Diarrhea	grade 3-4				8811
53795	1 pts		Nausea	all grades				8811
53796	1 pts		Vomiting	all grades				8811
53797	1 pts		Anorexia	all grades				8811
53798	3 pts		Atrial fibrillation	all grades				8811
53799	5 pts		Abnormal ECG	all grades				8811
53800	1 pts		Hypertension	all grades				8811
53801	1 pts		Tremor	all grades				8811
53802	2 pts		Diarrhea	grade 3			TRUE	8809
53803	1 pts		Sudden death	grade 5			TRUE	8810
53804	2 pts		Anemia	grade 3				8807
53805	6 pts		Anemia	all grades				8807
53806	1 pts		Neutropenia	grade 3				8807
53807	2 pts		Neutropenia	all grades				8807
53808	1 pts		Thrombocytopenia	grade 3				8807
53809	16 pts		Thrombocytopenia	all grades				8807
53810	1 pts		Cardiac disorders	all grades				8807
53811	4 pts		Diarrhea	grade 3				8807
53812	18 pts		Diarrhea	all grades				8807
53813	2 pts		Asthenia	grade 3				8807
53814	8 pts		Asthenia	all grades				8807
53815	19 pts		Investigations	all grades				8807
53816	1 pts		Hypocalcemia	grade 3				8807
53817	4 pts		Hypocalcemia	all grades				8807
53818	5 pts		Nervous system disorders	all grades				8807
53819	2 pts		Renal and urinary disorders	all grades				8807
53820	1 pts		Respiratory, thoracic and mediastinal disorders	all grades				8807
53821	1 pts		Rash	grade 3				8807
53822	1 pts		Rash	all grades				8807
53823	1 pts		Dyspepsia	grade 3			TRUE	8808
53824	1 pts		Dyspepsia	grade 3	discontinuation	leads to discontinuation		8808
53825	1 pts		Thrombocytopenia	grade 3	discontinuation	leads to discontinuation		8808
53826	2 pts		Dehydration		discontinuation	leads to discontinuation		8813
53827	2 pts		Fatigue		discontinuation	leads to discontinuation		8813
53828	2 pts		Nausea		discontinuation	leads to discontinuation		8813
53829	2 pts		Vomiting		discontinuation	leads to discontinuation		8813
53830	1 pts		Fatigue	grade 2	discontinuation	leads to discontinuation	TRUE	8812
53831	2 pts		Dehydration	grade 2-3	discontinuation	leads to discontinuation	TRUE	8812
53832	1 pts		Dizziness	grade 2			TRUE	8812
53833	1 pts		Hypotension	grade 2			TRUE	8812
53834	1 pts		Nausea	grade 3	discontinuation	leads to discontinuation	TRUE	8812
53835	1 pts		Vomiting	grade 3	discontinuation	leads to discontinuation	TRUE	8812
53836	17		Hypoxia	grade 3			TRUE	8817
53837	17		Pleural effusion	grade 3			TRUE	8817
53838	20		Peripheral oedema	grade 3			TRUE	8816
53839						impossible to link AEs with the definite dose		8814
53840	4 pts		Electrocardiogram QTc interval prolonged	grade 3	discontinuation	leads to discontinuation		8816
53841			Fetal damage	grade 5		WARNING		8815
53842						No adverse side effects were recorded.		8818
53843						No adverse effects leading to discontinuation were reported.		8819
53844						No adverse effects mentioned		8820
53845	83 pts		Hyperphosphataemia					8821
53846	59 pts		Stomatitis					8821
53847	43 pts		Fatigue					8821
53848	41 pts		Alopecia					8821
53849	37 pts		Dry eyes					8821
53850						No information on AE is provided		8822
53851	83.3		Dry skin					8823
53852	16.7		Pruritus					8823
53853	33.3		Fatigue	grade 1-3	discontinuation			8823
53854	50		Nausea					8823
53855	33.3		Constipation					8823
53856	16.7		Dyspepsia					8823
53857	16.7		Vomiting					8823
53858	16.7		Dizziness					8823
53859	33.3		Headache					8823
53860	16.7		Anorexia	grade 3				8823
53861	16.7		Arthralgia					8823
53862	16.7		Dry eye					8823
53863	16.7		Weight decrease					8823
53864	7.7		Anorexia	grade 3	discontinuation			8824
53865	7.7		Vomiting	grade 2	discontinuation			8824
53866	15.4		Nausea	grade 2	discontinuation			8824
53867	2.8		Hyponatremia	grade 3	discontinuation			8825
53868	25		QT interval prolonged		discontinuation		TRUE	8826
53869	25		Thrombocytopenia	grade 4			TRUE	8826
53870	50		Fatigue	grade 2-3				8826
53871	25		Neutropenia	grade 4			TRUE	8828
53872	25		Thrombocytopenia	grade 3			TRUE	8828
53873	25		Upper gastrointestinal hemorrhage	grade 3			TRUE	8828
53874	25		Diarrhea	grade 3			TRUE	8828
53875						no DLTs were noted in the group treated with 280 mg/m2/day		8827
53876						No adverse effects leading to discontinuation were reported; no DLTs		8830
53877	50		Cytokine release syndrome	grade 3	discontinuation		TRUE	8831
53878	50		Cytokine release syndrome	grade 4	discontinuation		TRUE	8829
53879						No AEs were reported		8832
53880	3 pts		Anemia	grade 1-2				8834
53881	1 pts		Anemia	grade 3-4				8834
53882	1 pts		Leukopenia	grade 1-2				8834
53883	1 pts		Thrombocytopenia	grade 1-2				8834
53884	2 pts		Thrombocytopenia	grade 3-4				8834
53885	12 pts		Nausea	grade 1-2				8834
53886	6 pts		Vomiting	grade 1-2				8834
53887	5 pts		Diarrhea	grade 1-2				8834
53888	7 pts		Fatigue	grade 1-2				8834
53889	3 pts		Fatigue	grade 3-4				8834
53890	10 pts		Alanine aminotransferase increase	grade 1-2				8834
53891	10 pts		Aspartate aminotransferase increased	grade 1-2				8834
53892	2 pts		Alanine aminotransferase increase	grade 3-4				8834
53893	2 pts		Aspartate aminotransferase increased	grade 3-4				8834
53894	3 pts		Hyperbilirubinemia	grade 1-2				8834
53895	3 pts		Azotemia	grade 1-2				8834
53896	6 pts		Anorexia	grade 1-2				8834
53897	1 pts		Anorexia	grade 3-4				8834
53898	6 pts		Hyperglycemia	grade 1-2				8834
53899	1 pts		Hyperglycemia	grade 3-4				8834
53900	2 pts		Dehydration	grade 1-2				8834
53901	2 pts		Hypokalemia	grade 1-2				8834
53902	1 pts		Headache	grade 3-4				8834
53903	2 pts		Abdominal pain	all grades				8833
53904	9 pts		Abnormal liver function tests	all grades				8833
53905	3 pts		Abnormal liver function tests	grade 3-4				8833
53906	1 pts		Anemia	all grades				8833
53907	4 pts		Anorexia	all grades				8833
53908	4 pts		Constipation	all grades				8833
53909	7 pts		Diarrhea	all grades				8833
53910	3 pts		Dizziness	all grades				8833
53911	9 pts		Fatigue	all grades				8833
53912	3 pts		Fluid retention	all grades				8833
53913	1 pts		Fluid retention	grade 3-4				8833
53914	4 pts		Hyperglycemia	all grades				8833
53915	1 pts		Hyperglycemia	grade 3-4				8833
53916	4 pts		Musculoskeletal discomfort	all grades				8833
53917	19 pts		Nausea	all grades				8833
53918	19 pts		Vomiting	all grades				8833
53919	8 pts		Skin disorder	all grades				8833
53920	8 pts		Disorder nail	all grades				8833
53921	2 pts		Cognitive disorder		discontinuation	leads to dose interruption and reduction		8835
53922	2 pts		Aphasia		discontinuation	leads to dose interruption and reduction		8835
53923	2 pts		Irritability		discontinuation	leads to dose interruption and reduction		8835
53924	1.4		Respiratory failure		discontinuation	leads to discontinuation		8836
53925	0.7		Dyspnea		discontinuation	leads to discontinuation		8836
53926	0.7		Myocardial infarction		discontinuation	leads to discontinuation		8836
53927	0.7		Cognitive disorder NEC		discontinuation	leads to discontinuation		8836
53928	0.7		Mood disorder		discontinuation	leads to discontinuation		8836
53929	7		Edema		discontinuation	leads to dose interruption		8836
53930	6		Hypertriglyceridemia		discontinuation	leads to dose interruption		8836
53931	5		Peripheral neuropathy		discontinuation	leads to dose interruption		8836
53932	4.4		Cognitive disorder NEC		discontinuation	leads to dose interruption		8836
53933	3.7		Lipase increased		discontinuation	leads to dose interruption		8836
53934	3.4		Hypercholesterolemia		discontinuation	leads to dose interruption		8836
53935	3.1		Mood disorder		discontinuation	leads to dose interruption		8836
53936	2.7		Dyspnea		discontinuation	leads to dose interruption		8836
53937	2.7		Pneumonia		discontinuation	leads to dose interruption		8836
53938	2		Hypertension		discontinuation	leads to dose interruption		8836
53939	6		Edema		discontinuation	leads to dose reduction		8836
53940	4.7		Peripheral neuropathy		discontinuation	leads to dose reduction		8836
53941	4.1		Cognitive disorder NEC		discontinuation	leads to dose reduction		8836
53942	3.1		Mood disorder		discontinuation	leads to dose reduction		8836
53943	0.3		Acute leukemia		discontinuation	leads to discontinuation		8837
53944	0.3		Brain compression		discontinuation	leads to discontinuation		8837
53945	0.3		Embolism		discontinuation	leads to discontinuation		8837
53946	0.3		Hallucinations		discontinuation	leads to discontinuation		8837
53947	0.3		Headache		discontinuation	leads to discontinuation		8837
53948	0.3		Hydrocephalus		discontinuation	leads to discontinuation		8837
53949	0.3		Hypoxia		discontinuation	leads to discontinuation		8837
53950	0.3		Leukocytosis		discontinuation	leads to discontinuation		8837
53951	0.3		Loss of consciousness		discontinuation	leads to discontinuation		8837
53952	0.3		Lung infection		discontinuation	leads to discontinuation		8837
53953	0.3		Mental status changes		discontinuation	leads to discontinuation		8837
53954	0.3		Parkinsonian gait		discontinuation	leads to discontinuation		8837
53955	0.3		Peripheral swelling		discontinuation	leads to discontinuation		8837
53956	0.3		Thrombocytopenia		discontinuation	leads to discontinuation		8837
53957	0.3		Tinnitus		discontinuation	leads to discontinuation		8837
53958	0.3		Vomiting		discontinuation	leads to discontinuation		8837
53959	1.7		Hypertriglyceridemia		discontinuation	leads to dose reduction		8837
53960	1		Arthralgia		discontinuation	leads to dose reduction		8837
53961	1		Dizziness		discontinuation	leads to dose reduction		8837
53962	1		Hallucinations		discontinuation	leads to dose reduction		8837
53963	1		Weight increased		discontinuation	leads to dose reduction		8837
53964	1.7		Blood amylase increased		discontinuation	leads to dose interruption		8837
53965	1.7		Diarrhea		discontinuation	leads to dose interruption		8837
53966	1.7		Fatigue		discontinuation	leads to dose interruption		8837
53967	1.7		Asthenia		discontinuation	leads to dose interruption		8837
53968	1.4		Dizziness		discontinuation	leads to dose interruption		8837
53969	1.4		Fall		discontinuation	leads to dose interruption		8837
53970	1.4		Hyperglycemia		discontinuation	leads to dose interruption		8837
53971	1.4		Pyrexia		discontinuation	leads to dose interruption		8837
53972	1		ALT increased		discontinuation	leads to dose interruption		8837
53973	1		Anemia		discontinuation	leads to dose interruption		8837
53974	1		Arthralgia		discontinuation	leads to dose interruption		8837
53975	1		Atrial fibrillation		discontinuation	leads to dose interruption		8837
53976	1		Back pain		discontinuation	leads to dose interruption		8837
53977	1		Ejection fraction decreased		discontinuation	leads to dose interruption		8837
53978	1		Mental status changes		discontinuation	leads to dose interruption		8837
53979	1		Pericardial effusion		discontinuation	leads to dose interruption		8837
53980	1		Pleural effusion		discontinuation	leads to dose interruption		8837
53981	1		Acute respiratory failure		discontinuation	leads to dose interruption		8837
53982	1		Respiratory failure		discontinuation	leads to dose interruption		8837
53983	1		Vomiting		discontinuation	leads to dose interruption		8837
53984	1		Weight increased		discontinuation	leads to dose interruption		8837
53985	14.3		Depressed level of consciousness	grade 4			TRUE	8838
53986	28.6		Thrombotic microangiopathy	grade 3			TRUE	8838
53987	33.3		Hypertension	grade 3			TRUE	8839
53988	37.5		Hypertension		discontinuation			8840
53989	6.2		Proteinuria		discontinuation			8840
53990	33.3		ALT increased	grade 3			TRUE	8841
53991	33.3		Fatigue	grade 3			TRUE	8841
53992	50		Hyperphosphatemia	grade 1-2			TRUE	8842
53993						No adverse effects leading to discontinuation were reported		8844
53994	66.7		Hypotension	grade 3			TRUE	8843
53995	50		Ataxia	grade 3			TRUE	8850
53996	66.7		Tremor	grade 2-3			TRUE	8850
53997	16.7		Ataxia	grade 2			TRUE	8847
53998	16.7		Tremor	grade 2			TRUE	8847
53999	16.7		Tremor	grade 2			TRUE	8848
54000	16.7		Nausea	grade 3			TRUE	8848
54001	16.7		Vomiting	grade 3			TRUE	8848
54002	16.7		Creatinine increased	grade 2			TRUE	8848
54003	50		Tremor	grade 2-3			TRUE	8849
54004	20		Lipase increased	grade 3			TRUE	8846
54005			Nausea					8845
54006			Diarrhea					8845
54007			Tremor					8845
54008			Vomiting					8845
54009			Fatigue					8845
54010			Ataxia	grade 4				8845
54011			Dehydration					8845
54012			Dizziness					8845
54013	10		Ataxia	grade 3	discontinuation			8851
54014	10		Haemolytic uraemic syndrome	grade 3	discontinuation			8851
54015	10		Thrombotic microangiopathy	grade 3	discontinuation			8851
54016	2 pts		Neutropenia	grade 3				8854
54017	1 pts		Lymphopenia	grade 3				8854
54018	1 pts		Thrombocytopenia	grade 3				8854
54019	1 pts		Anemia	grade 3				8854
54020	1 pts		Leucopenia	grade 3				8854
54021	1 pts		Nausea	grade 3				8854
54022	1 pts		Diarrhea	grade 3				8854
54023	1 pts		Hypophosphatemia	grade 3				8854
54024	1 pts		Myelosuppression	grade 4	discontinuation		TRUE	8855
54025	1 pts		Supraventricular tachyarrhythmia		discontinuation		TRUE	8855
54026	1 pts		Neutropenia	grade 4			TRUE	8853
54027	1 pts		Pancytopenia	grade 4			TRUE	8853
54028	1 pts		Fatigue	grade 3			TRUE	8853
54029	2 pts		Vomiting	grade 2				8852
54030	1 pts		Fatigue	grade 2				8852
54031	1 pts		Anemia	grade 3				8852
54032	1 pts		Hyponatremia	grade 3				8852
54033	2 pts		Thrombocytopenia	grade 3				8852
54034	2 pts		Nausea	grade 3				8852
54035	1 pts		Leukopenia	grade 4				8852
54036	5 pts		Neutropenia	grade 4				8852
54037	5		Erythematous rash	grade 3			TRUE	8858
54038	14.3		Stomatitis	grade 3			TRUE	8860
54039	57.1		Erythematous rash	grade 3-4			TRUE	8860
54040	100		Skin rash	grade 3			TRUE	8856
54041	2.6		Stomatitis	grade 3			TRUE	8859
54042	2.6		Skin rash	grade 3	discontinuation		TRUE	8859
54043	18.4		Skin rash	grade 3	dose interruption|dose reduction		TRUE	8859
54044	5.3		Skin rash	grade 3			TRUE	8859
54045	17.6		Skin rash	grade 3			TRUE	8857
54046	5.9		Dermatitis acneiform	grade 3			TRUE	8857
54047	4.3		Neutropenic infection	grade 5	discontinuation			8861
54048						no DLTs were observed		8863
54049	25		Nausea	grade 3			TRUE	8862
54050	25		Deep vein thrombosis	grade 3			TRUE	8862
54051	25		Vomiting	grade 3			TRUE	8862
54052	25		Abdominal pain	grade 3			TRUE	8862
54053	25		Mental status changes	grade 3			TRUE	8862
54054	25		Diarrhea	grade 3			TRUE	8862
54055	25		Fatigue	grade 3			TRUE	8862
54056	25		Fatigue	grade 4			TRUE	8862
54057	11		Heartburn	grade 1				8865
54058	11		Feeling hot	grade 1				8865
54059	11		Cannula site pain	grade 1				8865
54060	11		C-reactive protein increased	grade 1				8865
54061	11		Pain of extremities	grade 1				8865
54062	11		Headache	grade 1				8865
54063	11		Throat irritation	grade 1				8865
54064	10		Hypertension					8864
54065	3		Hemoglobin decreased					8864
54066	17		Hemoglobin increased					8864
54067	14		Nausea					8864
54068	10		Vomiting					8864
54069	8.3		Diarrhoea	grade 1-2				8866
54070	25		Nausea	grade 1-2				8866
54071	8.3		Vomiting	grade 1-2				8866
54072	8.3		Haemoglobin decreased	grade 1-2				8866
54073	8.3		Anorexia	grade 1-2				8866
54074	8.3		Peripheral oedema	grade 1-2				8866
54075	16.7		Fatigue	grade 1-2				8866
54076	8.3		Alopecia	grade 1-2				8866
54077	8.3		Phlebitis	grade 1-2				8866
54078	8.3		Blood lactate dehydrogenase	grade 1-2				8866
54079	23.8		Platelet count decreased	grade 1-2				8867
54080	33.3		Neutrophil count decreased	grade 1-3				8867
54081	4.8		Neutropenia	grade 1-3				8867
54082	23.8		White blood cell count decreased	grade 1-2				8867
54083	16.7		Anemia	grade 1-2				8867
54084	2.4		Weight decreased	grade 1-2				8867
54085	35.7		Nausea	grade 1-2				8867
54086	19		Constipation	grade 1-2				8867
54087	19		Vomiting	grade 1-2				8867
54088	14.3		Diarrhea	grade 1-2				8867
54089	11.9		Ascites	grade 1-2				8867
54090	2.4		Stomatitis	grade 1-2				8867
54091	21.4		Pyrexia	grade 1-2				8867
54092	26.2		Fatigue	grade 1-2				8867
54093	11.9		Edema peripheral	grade 1-2				8867
54094	4.8		Malaise	grade 1-2				8867
54095	14.3		Asthenia	grade 1-2				8867
54096	52.4		Decreased appetite	grade 1-2				8867
54097	9.5		Hypoalbuminemia	grade 1-2				8867
54098	16.7		Rash	grade 1-2				8867
54099	4.8		Rash maculo-papular	grade 1-2				8867
54100	11.9		Nasopharyngitis	grade 1-2				8867
54101	11.9		Cancer pain	grade 1-2				8867
54102	9.5		Insomnia	grade 1-2				8867
54103	2.4		Upper gastrointestinal hemorrhage	grade 3				8867
54104	2.4		Pneumocystis jirovecii pneumonia	grade 3				8867
54105			Aspiration pneumonia	grade 5				8867
54106			Cardiac failure	grade 5				8867
54107			Small intestinal obstruction	grade 5				8867
54108	2 pts		White blood cell count increased	serious	dose interruption			8868
54109	2 pts		White blood cell count increased	serious	discontinuation			8868
54110	2 pts		Bacterial sepsis	serious	dose interruption			8868
54111	2 pts		Bacterial sepsis	serious	discontinuation			8868
54112	1 pts		Diarrhea					8869
54113	1 pts		Fatigue					8869
54114	2 pts		Fatigue					8869
54115	2 pts		Vomiting					8869
54116	1 pts		Dyspepsia					8870
54117	1 pts		Headache					8870
54118	1 pts		Nausea					8870
54119	1 pts		Abdominal distension					8870
54120	2 pts		Diarrhea					8870
54121	1 pts		Fatigue					8870
54122	1 pts		Loose stools					8870
54123	1 pts		Abdominal pain upper					8870
54124	42.9		Diarrhea	grade 3			TRUE	8871
54125	14.3		Skin toxicity					8871
54126	14.3		Stomatitis	grade 1-2				8871
54127	57.1		Diarrhea	grade 1-2				8871
54128	100		Rash	grade 1-2				8871
54129	28.6		Asthenia	grade 1-2				8871
54130	14.3		Nausea	grade 1-2				8871
54131	28.6		Nausea	grade 3				8871
54132	14.3		Vomiting	grade 1-2				8871
54133	28.6		Vomiting	grade 3				8871
54134	28.6		Dry skin	grade 1-2				8871
54135	14.3		Anorexia	grade 1-2				8871
54136	28.6		Dehydration	grade 1-2				8871
54137	14.3		Pruritus	grade 1-2				8871
54138	53.8		Diarrhea	grade 1-2				8873
54139	30.8		Diarrhea	grade 3				8873
54140	46.1		Rash	grade 1-2				8873
54141	15.4		Rash	grade 3				8873
54142	30.8		Stomatitis	grade 1-2				8873
54143	46.1		Nausea	grade 1-2				8873
54144	15.4		Vomiting	grade 1-2				8873
54145	23.1		Anorexia	grade 1-2				8873
54146	23.1		Dry skin	grade 1-2				8873
54147	7.7		Asthenia	grade 1-2				8873
54148	7.7		Dehydration	grade 1-2				8873
54149	7.7		Dehydration	grade 3				8873
54150	15.4		Pruritus	grade 1-2				8873
54151	100		Diarrhea	grade 3			TRUE	8875
54152			Diarrhea		discontinuation			8876
54153	76.9		Diarrhea	grade 1-2				8874
54154	23.1		Diarrhea	grade 3				8874
54155	100		Rash	grade 1-2				8874
54156	76.9		Asthenia	grade 1-2				8874
54157	23.1		Nausea	grade 1-2				8874
54158	15.4		Nausea	grade 3				8874
54159	38.7		Stomatitis	grade 1-2				8874
54160	7.7		Stomatitis	grade 3				8874
54161	46.1		Anorexia	grade 1-2				8874
54162	7.7		Anorexia	grade 3				8874
54163	23.1		Vomiting	grade 1-2				8874
54164	7.7		Vomiting	grade 3				8874
54165	15.4		Dehydration	grade 1-2				8874
54166	23.1		Dry skin	grade 1-2				8874
54167	30.8		Taste perversion	grade 1-2				8874
54168	23.1		Exfoliative dermatitis	grade 1-2				8874
54169	7.7		Pruritus	grade 1-2				8874
54170	15.4		Constipation	grade 1-2				8874
54171	5		Diarrhea	grade 3			TRUE	8872
54172	90		Diarrhea	grade 1-4				8872
54173	75		Nausea	grade 1-4				8872
54174	70		Asthenia	grade 1-4				8872
54175	65		Anorexia	grade 1-4				8872
54176	50		Abdominal pain	grade 1-4				8872
54177	50		Rash	grade 1-2				8872
54178	60		Vomiting	grade 1-4				8872
54179	50		Skin disorder	grade 1-4				8872
54180	50		Stomatitis	grade 1-2				8872
54181	40		Fever	grade 1-4				8872
54182	25		Pain	grade 1-4				8872
54183	25		Diarrhea	grade 3	discontinuation			8879
54184	25		Diarrhea	grade 2	dose reduction			8879
54185	25		Rash	grade 2	dose reduction			8879
54186			Diarrhea	grade 3			TRUE	8877
54187			Diarrhea	grade 3	dose reduction			8878
54188			Hypotension	grade 3	dose reduction			8878
54189			Dehydration	grade 3	dose reduction			8878
54190						There were no deaths, other serious or severe adverse events or discontinuations due to adverse events during any of the studies.		8880
54191						There were no deaths, other serious or severe adverse events or discontinuations due to adverse events during any of the studies.		8881
54192	1 pts		Blepharospasm		discontinuation			8882
54193						No information on AE is provided		8884
54194	2		Rash					8883
54195	4		Diarrhoea					8883
54196	8		Tremor					8883
54197	2		Pharyngitis					8883
54198	4		Urinary tract infection					8883
54199	4		ALT increased					8883
54200	2		Dizziness					8883
54201	4		Fatigue					8883
54202	2		Nausea					8883
54203	4		Chest pain					8883
54204	5.9		Insomnia					8885
54205	29		Neutropenia				TRUE	8888
54206	29		Thrombocytopenia				TRUE	8888
54207	2 pts		Febrile neutropenia				TRUE	8886
54208	1 pts		Febrile neutropenia				TRUE	8887
54209	100		Maculopapular rash	grade 2-3	discontinuation		TRUE	8889
54210	14.3		Maculopapular rash	grade 3			TRUE	8890
54211	40		Rash	grade 1-3			TRUE	8891
54212			Maculopapular rash	grade 3			TRUE	8892
54213	33.3		Febrile neutropenia	grade 3	discontinuation		TRUE	8894
54214	33.3		Febrile neutropenia	grade 3	discontinuation		TRUE	8896
54215	33.3		Erythema multiforme	grade 3	discontinuation		TRUE	8896
54216	4		Rash	grade 3	discontinuation			8895
54217	3		Pneumonitis		discontinuation			8895
54218	3		Diarrhoea	grade 3-4	discontinuation			8895
54219	2		Abdominal pain		discontinuation			8895
54220	2		Stomatitis		discontinuation			8895
54221	3		Transaminases increased	grade 3	discontinuation			8895
54222	10		Diarrhoea	grade 3	discontinuation			8893
54223	7		Rash	grade 3	discontinuation			8893
54224						No adverse effects leading to discontinuation were reported		8897
54225	20 pts		Diarrhea	all grades				8903
54226	13 pts		Rash	all grades				8903
54227	16 pts		Stomatitis	all grades				8903
54228	11 pts		Pruritus	all grades				8903
54229	11 pts		Decreased appetite	all grades				8903
54230	6 pts		Dermatitis acneiform	all grades				8903
54231	3 pts		Palmar-plantar erythrodysaesthesia syndrome	all grades				8903
54232	6 pts		Rhinorrhea	all grades				8903
54233	13 pts		Paronychia	all grades				8903
54234	6 pts		Mucosal inflammation	all grades				8903
54235	4 pts		Nausea	all grades				8903
54236	4 pts		Vomiting	all grades				8903
54237	3 pts		Fatigue	all grades				8903
54238	6 pts		Dry skin	all grades				8903
54239	3 pts		Diarrhea	grade 3-4				8903
54240	1 pts		Stomatitis	grade 3-4				8903
54241	1 pts		Pruritus	grade 3-4				8903
54242	2 pts		Decreased appetite	grade 3-4				8903
54243	2 pts		Dermatitis acneiform	grade 3-4				8903
54244	2 pts		Dry skin	grade 3-4				8903
54245	48 pts		Diarrhea	all grades				8902
54246	46 pts		Rash	all grades				8902
54247	40 pts		Stomatitis	all grades				8902
54248	33 pts		Pruritus	all grades				8902
54249	20 pts		Decreased appetite	all grades				8902
54250	17 pts		Acne	all grades				8902
54251	2 pts		Dermatitis acneiform	all grades				8902
54252	18 pts		Palmar-plantar erythrodysaesthesia syndrome	all grades				8902
54253	14 pts		Rhinorrhea	all grades				8902
54254	13 pts		Paronychia	all grades				8902
54255	13 pts		Mucosal inflammation	all grades				8902
54256	11 pts		Nausea	all grades				8902
54257	10 pts		Vomiting	all grades				8902
54258	8 pts		Fatigue	all grades				8902
54259	8 pts		Skin exfoliation	all grades				8902
54260	6 pts		Dry skin	all grades				8902
54261	6 pts		Weight decreased	all grades				8902
54262	8 pts		Diarrhea	grade 3-4				8902
54263	1 pts		Rash	grade 3-4				8902
54264	1 pts		Decreased appetite	grade 3-4				8902
54265	1 pts		Mucosal inflammation	grade 3-4				8902
54266	1 pts		Nausea	grade 3-4				8902
54267	1 pts		Vomiting	grade 3-4				8902
54268	1 pts		Diarrhea				TRUE	8904
54269	1 pts		Diarrhea				TRUE	8905
54270	3 pts		Diarrhea				TRUE	8901
54271	2 pts		Diarrhea				TRUE	8899
54272	1 pts		Nausea				TRUE	8901
54273	1 pts		Mucosal inflammation				TRUE	8901
54274	1 pts		Decreased appetite				TRUE	8900
54275	1 pts		Diarrhea				TRUE	8898
54276	16.7		Fatigue	grade 3			TRUE	8907
54277	16.7		Troponin T increased	grade 3			TRUE	8907
54278	16.7		QT interval prolonged	grade 3	discontinuation		TRUE	8907
54279	16.7		Febrile neutropenia				TRUE	8906
54280						No treatment related adverse effects leading to discontinuation were reported		8908
54281	33.3		Neutropenia	grade 3				8910
54282	33.3		Anemia	grade 3				8910
54283	66.7		Thrombocytopenia	grade 4			TRUE	8910
54284	33.3		Fatigue	grade 3			TRUE	8910
54285	33.3		Lower gastrointestinal haemorrhage	grade 3			TRUE	8910
54286	16.7		Hypersensitivity	grade 4			TRUE	8913
54287	7.7		Diarrhea	grade 3			TRUE	8914
54288	33.3		Neutropenia	grade 3				8913
54289	16.7		Anemia	grade 3				8913
54290	16.7		Hypertension	grade 4				8913
54291	16.7		Dyspnea	grade 4				8913
54292	33.3		Fatigue	grade 3				8913
54293						No information on AE is provided		8909
54294			Convulsion		discontinuation			8915
54295			Venous injury		discontinuation			8915
54296			Dermatitis		discontinuation			8915
54297			Thrombocytopenia		discontinuation			8915
54298	33.3		Thrombocytopenia	grade 4			TRUE	8912
54299	9.1		Infusion related reaction	grade 3			TRUE	8911
54300	40		Diarrhea	grade 1-3	discontinuation			8916
54301	20		Presyncope	grade 1-3			TRUE	8916
54302	20		Somnolence	grade 1-3	discontinuation			8916
54303	60		Maculopapular rash	grade 1-2				8916
54304	20		Acneiform dermatitis	grade 1-2				8916
54305	60		Lymphedema	grade 1-3				8916
54306	20		Vomiting	grade 1-2				8916
54307	40		Fatigue	grade 1-2				8916
54308	40		Abnormal dreams	grade 1-2				8916
54309	20		Macular rash	grade 1-3	discontinuation			8916
54310	9.1		Pain of skin	grade 1-3			TRUE	8920
54311	9.1		Papular rash	grade 1-3			TRUE	8920
54312	27		Acneiform dermatitis	grade 1-3				8920
54313	36		Diarrhea	grade 1-2				8920
54314	36		Nausea	grade 1-2				8920
54315	36		Lymphedema	grade 1-3				8920
54316	18		Vomiting	grade 1-2				8920
54317	36		Fatigue	grade 1-2				8920
54318	18		Maculopapular rash	grade 1-2				8920
54319	27		Rash	grade 1-2				8920
54320	10		Ventricular dysfunction	grade 3	discontinuation			8919
54321	10		Chorioretinopathy	grade 1	dose reduction			8919
54322	90		Acneiform dermatitis	grade 1-2				8921
54323	60		Diarrhea	grade 1-2				8921
54324	40		Nausea	grade 1-2				8921
54325	50		Lymphedema	grade 1-2				8921
54326	30		Vomiting	grade 1-2				8921
54327	20		Fatigue	grade 1-2				8921
54328	30		Abnormal dreams	grade 1-2				8921
54329	10		Abdominal pain	grade 3				8921
54330	10		Retinal vein occlusion	grade 2				8921
54331	16.7		Hypophosphatemia				TRUE	8918
54332	16.7		Lipase increased	grade 3			TRUE	8917
54333	0.3		Pneumonia		discontinuation			8922
54334	0.3		Atrioventricular block	severe	discontinuation			8922
54335	0.3		Hemorrhage	severe	discontinuation			8922
54336	0.3		Fracture		dose interruption			8922
54337	0.3		Abdominal pain		discontinuation			8922
54338	0.3		Cardiac failure	severe	discontinuation			8922
54339	16.7		Syncope	grade 3			TRUE	8925
54340	16.7		Myalgia	grade 3	discontinuation		TRUE	8923
54341	33.3		Neutropenia	grade 3-4				8924
54342	33.3		Leukopenia	grade 3-4				8924
54343	6 pts		Diarrhea	grade 1				8928
54344	3 pts		Erythema	grade 1				8928
54345	3 pts		Rash	grade 1				8928
54346	3 pts		Pruritus	grade 1				8928
54347	4 pts		Fatigue	grade 1				8928
54348	5 pts		Headache	grade 1				8928
54349	8 pts		Nausea	grade 1				8928
54350	3 pts		Vomiting	grade 1				8928
54351	2 pts		Diarrhea	grade 2				8928
54352	1 pts		Erythema	grade 2				8928
54353	1 pts		Rash	grade 2				8928
54354	1 pts		Pruritus	grade 2				8928
54355	6 pts		Fatigue	grade 2				8928
54356	1 pts		Headache	grade 2				8928
54357	1 pts		Hypophosphatemia	grade 2				8928
54358	3 pts		Nausea	grade 2				8928
54359	2 pts		Hypophosphatemia	grade 3				8928
54360	6 pts		Diarrhea	grade 1				8926
54361	6 pts		Erythema	grade 1				8926
54362	6 pts		Rash	grade 1				8926
54363	6 pts		Pruritus	grade 1				8926
54364	2 pts		Fatigue	grade 1				8926
54365	2 pts		Headache	grade 1				8926
54366	11 pts		Nausea	grade 1				8926
54367	4 pts		Vomiting	grade 1				8926
54368	2 pts		Diarrhea	grade 2				8926
54369	2 pts		Erythema	grade 2				8926
54370	2 pts		Rash	grade 2				8926
54371	2 pts		Pruritus	grade 2				8926
54372	6 pts		Fatigue	grade 2				8926
54373	8 pts		Hypophosphatemia	grade 2				8926
54374	3 pts		Nausea	grade 2				8926
54375	4 pts		Vomiting	grade 2				8926
54376	1 pts		Diarrhea	grade 3				8926
54377	3 pts		Erythema	grade 3				8926
54378	3 pts		Rash	grade 3				8926
54379	3 pts		Pruritus	grade 3				8926
54380	3 pts		Hypophosphatemia	grade 3				8926
54381	15 pts		Nausea	all grades				8927
54382	12 pts		Fatigue	all grades				8927
54383	7 pts		Hypophosphatemia	all grades				8927
54384	6 pts		Anorexia	all grades				8927
54385	5 pts		Anemia	all grades				8927
54386	5 pts		Headache	all grades				8927
54387	5 pts		Vomiting	all grades				8927
54388	5 pts		ALT increased	all grades				8927
54389	4 pts		AST increased	all grades				8927
54390	4 pts		Diarrhea	all grades				8927
54391	1 pts		Hypophosphatemia	grade 3-4				8927
54392	1 pts		Headache	grade 3-4				8927
54393	1 pts		ALT increased	grade 3-4				8927
54394	1 pts		AST increased	grade 3-4				8927
54395	1 pts		Diarrhea	grade 3-4				8927
54396	5 pts		Anemia	all grades				8930
54397	3 pts		Anemia	grade 3-4				8930
54398	3 pts		Neutropenia	all grades				8930
54399	1 pts		Neutropenia	grade 3-4				8930
54400	3 pts		Thrombocytopenia	all grades				8930
54401	1 pts		Thrombocytopenia	grade 3-4				8930
54402	6 pts		Diarrhea	all grades				8930
54403	2 pts		Diarrhea	grade 3-4				8930
54404	5 pts		Abdominal pain	all grades				8930
54405	1 pts		Abdominal pain	grade 3-4				8930
54406	5 pts		Nausea	all grades				8930
54407	4 pts		Vomiting	all grades				8930
54408	5 pts		Fatigue	all grades				8930
54409	1 pts		Diarrhea					8931
54410	6 pts		Diarrhea					8932
54411	1 pts		Abdominal pain					8932
54412	1 pts		Nausea					8932
54413	4 pts		Decreased appetite					8932
54414	1 pts		Vomiting					8932
54415	1 pts		Diarrhea					8932
54416	1 pts		ALP increased					8932
54417	2 pts		Diarrhea					8929
54418	1 pts		Abdominal pain					8929
54419	2 pts		Decreased appetite					8929
54420	1 pts		Diarrhea					8929
54421	1 pts		Anemia					8929
54422	1 pts		Gamma glutamyl transpeptidase increased					8929
54423	1 pts		ALP increased					8929
54424	1 pts		Troponin T increased					8929
54425	1 pts		Hemoglobin decreased					8929
54426	25		Urticaria	grade 3			TRUE	8936
54427	25		Fatigue	grade 2	dose reduction			8936
54428	25		Dizziness	grade 1	dose reduction			8936
54429	25		Vomiting	grade 1	dose reduction			8936
54430	25		Nausea	grade 1	dose reduction			8936
54431	16.7		Stomatitis	grade 3			TRUE	8938
54432	16.7		Blood creatinine increased	grade 2	discontinuation		TRUE	8948
54433	16.7		Fatigue	grade 3			TRUE	8948
54434	16.7		Nausea	grade 2	dose interruption		TRUE	8948
54435	16.7		Vomiting	grade 2	dose interruption		TRUE	8948
54436	11.1		Erythematous rash	grade 3			TRUE	8942
54437	14.3		Asthenia	grade 3	dose interruption			8933
54438	14.3		Mucosal inflammation	grade 3	discontinuation			8933
54439	14.3		Thrombocytopenia	grade 3	dose interruption			8933
54440	12.5		Hyperglycaemia	grade 3			TRUE	8937
54441	12.5		Anaemia	grade 4			TRUE	8937
54442	12.5		Maculopapular rash	grade 3			TRUE	8937
54443	14.3		Hyperglycaemia	grade 3			TRUE	8947
54444	7.7		Maculo-papular rash	grade 3			TRUE	8940
54445	7.7		Diarrhoea	grade 3			TRUE	8940
54446	7.7		Asthenia	grade 3			TRUE	8940
54447	7.7		Ventricular fibrillation	grade 5			TRUE	8940
54448	6.7		Dry mouth	grade 3			TRUE	8939
54449	6.7		Fatigue	grade 3			TRUE	8939
54450	6.7		Asthenia	grade 3			TRUE	8939
54451	12.5		Hypophosphatemia	grade 3			TRUE	8943
54452	16.7		Stomatitis	grade 3			TRUE	8945
54453	16.7		Dehydration	grade 3			TRUE	8945
54454	16.7		Asthenia	grade 3			TRUE	8945
54455	8.3		Stomatitis	grade 3			TRUE	8946
54456	50		Stomatitis	grade 3			TRUE	8935
54457	23.1		Stomatitis	grade 2-3			TRUE	8944
54458	7.7		Asthenia	grade 3			TRUE	8944
54459	7.7		Fatigue	grade 3			TRUE	8944
54460	33.3		Fatigue	grade 3			TRUE	8934
54461	33.3		Asthenia	grade 3			TRUE	8934
54462	33.3		Stomatitis	grade 3			TRUE	8934
54463						No information on AE is provided		8941
54464	100		Diarrhea	grade 1-4	discontinuation			8949
54465	100		Stomatitis	grade 1-3				8949
54466	33.3		Nausea	grade 1-2				8949
54467	33.3		Vomiting	grade 1-2				8949
54468	33.3		Acne	grade 1-2				8949
54469	33.3		Rash	grade 1-2				8949
54470	33.3		Dermatitis acneiform	grade 1-2				8949
54471	33.3		Pruritus	grade 1-2				8949
54472	33.3		Dysgeusia	grade 1-2				8949
54473	100		Diarrhea	grade 1-3				8950
54474	50		Stomatitis	grade 1-2				8950
54475	16.7		Dyspepsia	grade 1-2				8950
54476	16.7		Nausea	grade 1-2				8950
54477	16.7		Vomiting	grade 1-2				8950
54478	33.3		Acne	grade 1-3				8950
54479	33.3		Rash	grade 1-3			TRUE	8950
54480	33.3		Skin exfoliation	grade 1-3				8950
54481	16.7		Dry skin	grade 1-2				8950
54482	33.3		Dermatitis acneiform	grade 1-2				8950
54483	33.3		Pruritus	grade 1-2				8950
54484	16.7		Fatigue	grade 1-2				8950
54485	16.7		Dysgeusia	grade 1-2				8950
54486	16.7		Gastritis		discontinuation			8950
54487	16.7		Diarrhea		discontinuation			8951
54488	20		Diarrhea		discontinuation			8952
54489	25		Cutaneous symptom		discontinuation			8953
54490	14.3		Respiratory failure	grade 5	discontinuation		TRUE	8956
54491	14.3		Febrile neutropenia	grade 3			TRUE	8956
54492	14.3		Asthenia	grade 3			TRUE	8954
54493	14.3		Acute renal failure	grade 3			TRUE	8954
54494	14.3		Leukopenia	grade 3			TRUE	8954
54495	14.3		Septic shock	grade 5	discontinuation		TRUE	8954
54496						No adverse effects leading to discontinuation were reported; no DLTs		8955
54497	5.3		Rash		discontinuation			8958
54498			Hypertension		discontinuation			8957
54499	8.3		Hyperglycaemia				TRUE	8963
54500	8.3		Fatigue	grade 3			TRUE	8963
54501	8.3		Hyponatraemia	grade 3			TRUE	8963
54502	8.3		Hypokalaemia	grade 4			TRUE	8963
54503	8.3		Skin rash	grade 3			TRUE	8963
54504	8.3		Glycosuria				TRUE	8963
54505	25		GGT increased				TRUE	8963
54506	33.3		Hypokalaemia				TRUE	8962
54507	33.3		Asthenia				TRUE	8962
54508	33.3		Vomiting				TRUE	8962
54509	33.3		Nausea				TRUE	8962
54510						No adverse effects leading to discontinuation were reported; no DLTs		8961
54511	33.3		Asthenia				TRUE	8959
54512	33.3		Hypokalaemia				TRUE	8959
54513						No adverse effects leading to discontinuation were reported; no DLTs		8960
54514						No adverse effects leading to discontinuation were reported		8965
54515						There were no serious adverse events reported during thestudy  and  no  subjects  were  withdrawn  due  to  adverse events.		8964
54516	2.7		Adverse event		discontinuation			8966
54517						No adverse effects leading to discontinuation were reported.		8967
54518	85		Diarrhea					8968
54519	92		Fatigue					8968
54520	38		Thrombocytopenia					8968
54521	54		Nausea					8968
54522	62		Neutropenia					8968
54523	46		Pyrexia					8968
54524	31		Cough					8968
54525	46		Headache					8968
54526	31		Anemia					8968
54527	31		Dyspnea					8968
54528	8		Dizziness					8968
54529	23		Abdominal pain					8968
54530	31		Upper respiratory tract infection					8968
54531	31		Peripheral edema					8968
54532	15		Muscle spasms					8968
54533	8		Sinusitis					8968
54534	23		Contusion					8968
54535	15		Vomiting					8968
54536	8		Pneumonia					8968
54537	15		Constipation					8968
54538	8		Urinary tract infection					8968
54539	15		Decreased appetite					8968
54540	15		Hypocalcemia					8968
54541	15		Hyponatremia					8968
54542	8		Pneumonitis	grade 3			TRUE	8968
54543	11.1		Thrombocytopenia	grade 4			TRUE	8970
54544	2.6		Thrombocytopenia	grade 4			TRUE	8969
54545	2.6		Mental status changes	grade 3			TRUE	8969
54546	5.9		ALT increased		discontinuation	possibly drug related		8971
54547	5.9		Atrial fibrillation		discontinuation			8971
54548	5.9		ALT increased	grade 3	discontinuation			8971
54549	14.3		Hyperamylasaemia	grade 3			TRUE	8972
54550	14.3		Cardiac arrhythmia	grade 3			TRUE	8972
54551	57		Nausea	grade 1-2				8972
54552	43		Fatigue	grade 1-2				8972
54553	29		Feeling cold	grade 1-2				8972
54554	29		Inflammation	grade 1-2				8972
54555	14		Hypercalcaemia	grade 1-2				8972
54556	14		Arthralgia	grade 1-2				8972
54557	14		Musculoskeletal stiffness	grade 1-2				8972
54558	12		Abdominal pain	grade 1-2				8974
54559	12		Constipation	grade 1-2				8974
54560	6		Nausea	grade 1-2				8974
54561	18		Fatigue	grade 1-2				8974
54562	6		Feeling cold	grade 1-2				8974
54563	41		Inflammation	grade 1-2				8974
54564	12		Pain	grade 1-2				8974
54565	6		Pyrexia	grade 1-2				8974
54566	24		Blood fibrinogen increased	grade 1-2				8974
54567	24		C-reactive protein increased	grade 1-2				8974
54568	6		Haemoglobin decreased	grade 1-2				8974
54569	12		Monocyte count increased	grade 1-2				8974
54570	12		Neutrophil count increased	grade 1-2				8974
54571	6		Platelet count increased	grade 1-2				8974
54572	18		Erythrocyte sedimentation rate increased	grade 1-2				8974
54573	24		White blood cell count increased	grade 1-2				8974
54574	18		Hyperamylasaemia	grade 3				8974
54575	6		Hypercalcaemia	grade 1-2				8974
54576	6		Muscular weakness	grade 1-2				8974
54577	6		Musculoskeletal stiffness	grade 1-2				8974
54578	18		Myalgia	grade 1-2				8974
54579	6		Pain in extremity	grade 1-2				8974
54580	6		Headache	grade 1-2				8974
54581	6		Insomnia	grade 1-2				8974
54582	6		Eczema	grade 1-2				8974
54583			Muscle pain		discontinuation			8973
54584			Joint pain		discontinuation			8973
54585	1 pts		Neutropenia	grade 4			TRUE	8980
54586	1 pts		Thrombocytopenia	grade 4			TRUE	8980
54587			Alanine aminotransferase increased	grade 4			TRUE	8980
54588			Aspartate aminotransferase increase	grade 4			TRUE	8980
54589			Fatigue	grade 3			TRUE	8980
54590			Cardiotoxicity	grade 2			TRUE	8980
54591			Nausea	grade 3			TRUE	8980
54592			Vomiting	grade 3			TRUE	8980
54593			Diarrhoea	grade 3			TRUE	8980
54594	1 pts		Thrombocytopenia	grade 4			TRUE	8976
54595	52		Pain	all grades				8978
54596	47		Fatigue	all grades				8978
54597	36		Nausea	all grades				8978
54598	24		Vomiting	all grades				8978
54599	21		Constipation	all grades				8978
54600	16		Diarrhea	all grades				8978
54601	13		Abdominal pain	all grades				8978
54602	26		Decreased appetite	all grades				8978
54603	18		Cough	all grades				8978
54604	16		Dyspnea	all grades				8978
54605	18		Hemorrhage	all grades				8978
54606	18		Headache	all grades				8978
54607	16		Anemia	all grades				8978
54608	16		Weight decreased	all grades				8978
54609	7		Pain	grade 3-4				8978
54610	1.6		Fatigue	grade 3-4				8978
54611	1.6		Abdominal pain	grade 3-4				8978
54612	4.8		Decreased appetite	grade 3-4				8978
54613	4.8		Dyspnea	grade 3-4				8978
54614	4.8		Hemorrhage	grade 3-4				8978
54615	13		Anemia	grade 3-4				8978
54616	7		Weight decreased	grade 3-4				8978
54617	2		Mood disorder NOS		discontinuation	leads to discontinuation		8978
54618	49		Decreased hemoglobin	all grades				8979
54619	36		Lymphocyte count decreased	all grades				8979
54620	19		White blood cell count decreased	all grades				8979
54621	36		Triglyceride increased	all grades				8979
54622	33		Glucose increased	all grades				8979
54623	30		Sodium decreased	all grades				8979
54624	28		Phosphate decreased	all grades				8979
54625	23		Albumin decreased	all grades				8979
54626	23		Alkaline phosphatase increased	all grades				8979
54627	20		Potassium decreased	all grades				8979
54628	18		Aspartate aminotransferase increased	all grades				8979
54629	16		Calcium decreased	all grades				8979
54630	16		Glucose decreased	all grades				8979
54631	15		Partial thromboplastin time prolonged	all grades				8979
54632	14		Alanine aminotransferase increased	all grades				8979
54633	12		Creatinine increased	all grades				8979
54634	12		Potassium increased	all grades				8979
54635	15		Decreased hemoglobin	grade 3-4				8979
54636	13		Lymphocyte count decreased	grade 3-4				8979
54637	3.3		Triglyceride increased	grade 3-4				8979
54638	1.6		Glucose increased	grade 3-4				8979
54639	1.7		Sodium decreased	grade 3-4				8979
54640	1.7		Phosphate decreased	grade 3-4				8979
54641	1.7		Alkaline phosphatase increased	grade 3-4				8979
54642	1.7		Potassium decreased	grade 3-4				8979
54643	3.5		Aspartate aminotransferase increased	grade 3-4				8979
54644	5		Partial thromboplastin time prolonged	grade 3-4				8979
54645	3.4		Alanine aminotransferase increased	grade 3-4				8979
54646	2		Mood disorder NOS		discontinuation	leads to discontination		8977
54647	2		Decreased appetite			leads to dose reduction		8977
54648	2		Thrombocytopenia	grade 4		maximum tolerated dose (MTD) was not reached within the evaluated dose range of 100 mg to 1600 mg BID in patients with cancer	TRUE	8975
54649	16.7		Somnolence	grade 1-2				8981
54650	5.5		Dizziness	grade 1-2				8981
54651	5.5		Light headedness	grade 1-2				8981
54652			Vision abnormal	grade 1				8982
54653			Vision abnormal	grade 1				8983
54654			Sedation	grade 1				8983
54655						No adverse effects leading to discontinuation were reported; no DLTs		8985
54656	33.3		Ataxia	grade 3	discontinuation		TRUE	8984
54657	16.7		Vertigo	grade 1	discontinuation			8984
54658	16.7		Short-term memory loss	grade 1-2	discontinuation			8984
54659	16.7		Confusion	grade 1-2	discontinuation			8984
54660	33.3		Cerebellar disorder NOS		discontinuation	Cerebellar dysfunction	TRUE	8984
54661	16.7		Incoordination	grade 1	discontinuation			8984
54662	33.3		Esophagitis	grade 3	discontinuation			8987
54663	66.7		Hyperglycemia	grade 3	dose reduction			8986
54664	6.7		Hypoglycemia	grade 3			TRUE	8988
54665	13.3		Esophagitis	grade 3	discontinuation			8988
54666	6.7		Nausea	grade 2	discontinuation			8988
54667	6.7		Rash	grade 3	discontinuation			8988
54668	13.3		Diarrhea	grade 2-3	dose reduction			8988
54669	13.3		Mucosal inflammation	grade 2	dose reduction			8988
54670	13.3		Dysphagia	grade 2	dose reduction			8988
54671	13.3		Fatigue	grade 2	dose reduction			8988
54672	25		Stomatitis	grade 1	dose interruption			8990
54673	25		Hypoglycemia	grade 4			TRUE	8990
54674	13.3		Decreased appetite	grade 2	discontinuation			8991
54675	20		Hyperglycemia	grade 3			TRUE	8989
54676	20		Rash	grade 3			TRUE	8989
54677	20		ALT increased	grade 3	discontinuation			8989
54678			Diarrhoea					8994
54679			Nausea					8994
54680			Abnormal bowel sounds					8994
54681			Stomach discomfort					8994
54682			Vomiting					8994
54683			Headache					8994
54684	21		Headache					8995
54685	15		Diarrhoea		discontinuation			8995
54686	15		Nausea					8995
54687	7		Vomiting					8995
54688	3		Abdominal pain upper					8995
54689	2		Flatulence					8995
54690			Headache					8992
54691			Nausea					8992
54692			Vomiting					8992
54693			Diarrhoea					8992
54694			Flatulence					8992
54695						No AEs were observed		8993
54696	100		Fatigue	grade 1-3	discontinuation		TRUE	8996
54697	100		Nausea	grade 1-2				8996
54698	75		Mucositis	grade 1-2				8996
54699	100		Decreased appetite	grade 1-2				8996
54700	25		Diarrhea	grade 1-2				8996
54701	25		Constipation	grade 1-2				8996
54702	100		Vomiting	grade 1-2				8996
54703	50		Dyspnea	grade 1-2				8996
54704	25		Dry mouth	grade 1-2				8996
54705	25		Anemia	grade 3				8996
54706	50		Back pain	grade 1-2				8996
54707	60		Fatigue	grade 3	discontinuation		TRUE	8999
54708	100		Mucositis	grade 3	discontinuation		TRUE	8999
54709	78		Fatigue	grade 1-3				8997
54710	51.2		Nausea	grade 1-3				8997
54711	48.8		Mucositis	grade 1-3				8997
54712	41.5		Decreased appetite	grade 1-2				8997
54713	41.5		Diarrhea	grade 1-2				8997
54714	41.5		Rash	grade 1-3				8997
54715	31.7		Constipation	grade 1-2				8997
54716	29.3		Vomiting	grade 1-3				8997
54717	31.7		Pruritus	grade 1-2				8997
54718	19.5		Cough	grade 1-2				8997
54719	17.1		Dyspnea	grade 1-3				8997
54720	19.5		Dry mouth	grade 1-2				8997
54721	17.1		Anemia	grade 1-2				8997
54722	17.1		Back pain	grade 1-3				8997
54723	14.6		Hypokalemia	grade 1-3				8997
54724	17.1		Lower respiratory tract infection	grade 1-3				8997
54725	19		Liver function test increased	grade 1-2				8998
54726	61.5		Anaemia	all grades				8998
54727	23		Blood cholesterol increased	grade 1-2				8998
54728	39		Blood creatinine increased	grade 1-2				8998
54729	27		Constipation	grade 1-2				8998
54730	27		Cough	grade 1-2				8998
54731	23.1		Decreased appetite	all grades				8998
54732	19		Diarrhoea	grade 1-2				8998
54733	23.1		Dyspnoea	all grades				8998
54734	38.5		Fatigue	all grades				8998
54735	23		Hypercalcaemia	grade 1-2				8998
54736	23		Hyperglycaemia	grade 1-2				8998
54737	19		Hypertriglyceridaemia	grade 1-2				8998
54738	23		Hypocalcaemia	grade 1-2				8998
54739	15		Infection	grade 1-2				8998
54740	27		Lethargy	grade 1-2				8998
54741	38.5		Nausea	all grades				8998
54742	26.9		Vomiting	all grades				8998
54743			Transaminases increased					9000
54744	33.3		Peripheral edema	grade 3	discontinuation		TRUE	9001
54745	33.3		Intraventricular hemorrhage	grade 3	discontinuation		TRUE	9001
54746	33.3		Headache	grade 3	discontinuation		TRUE	9001
54747	33.3		Dyspnea	grade 3	discontinuation		TRUE	9001
54748						No DLTs were seen at 15 mg		9002
54749	2		Abdominal discomfort	grade 1-2				9008
54750	11		Abdominal pain	grade 1-2				9007
54751	2		Abdominal pain	grade 1-2				9008
54752	3		Upper abdominal pain	grade 1-2				9007
54753	2		Upper abdominal pain	grade 1-2				9008
54754	8		Diarrhea	grade 1-2				9007
54755	4		Diarrhea	grade 1-2				9008
54756	6		Dyspepsia	grade 1-2				9008
54757	6		Toothache	grade 1-2				9008
54758	3		Vomiting	grade 1-2				9007
54759	2		Vomiting	grade 1-2				9008
54760	3		Fatigue	grade 1-2				9007
54761	11		Implant site discoloration	grade 1-2				9008
54762	19		Implant site discoloration	grade 1-2				9007
54763	8		Pain	grade 1-2				9008
54764	3		Viral gastroenteritis	grade 1-2				9007
54765	16		Influenza	grade 1-2				9007
54766	4		Influenza	grade 1-2				9008
54767	21		Nasopharyngitis	grade 1-2				9007
54768	12		Nasopharyngitis	grade 1-2				9008
54769	6		Sinusitis	grade 1-2				9008
54770	8		Upper respiratory tract infection	grade 1-2				9007
54771	2		Upper respiratory tract infection	grade 1-2				9008
54772	5		Blood in urine	grade 1-2				9007
54773	10		Arthralgia	grade 1-2				9008
54774	5		Back pain	grade 1-2				9007
54775	12		Back pain	grade 1-2				9008
54776	6		Musculoskeletal pain	grade 1-2				9008
54777	3		Myalgia	grade 1-2				9007
54778	6		Myalgia	grade 1-2				9008
54779	3		Pain in extremity	grade 1-2				9007
54780	4		Pain in extremity	grade 1-2				9008
54781	2		Dizziness	grade 1-2				9008
54782	34		Headache	grade 1-3				9007
54783	40		Headache	grade 1-2				9008
54784	3		Migraine	grade 1-2				9007
54785	6		Migraine	grade 1-2				9008
54786	2		Sinus headache	grade 1-2				9008
54787	13		Cough	grade 1-2				9007
54788	2		Cough	grade 1-2				9008
54789	16		Oropharyngeal pain	grade 1-2				9007
54790	4		Oropharyngeal pain	grade 1-2				9008
54791	5		Eczema	grade 1-2				9007
54792	8		Pigmentation disorder	grade 1-2				9007
54793	2		Pigmentation disorder	grade 1-2				9008
54794	5		Pruritus	grade 1-2				9007
54795	4		Pruritus	grade 1-2				9008
54796	4		Melanocytic nevus	grade 1-2				9008
54797	18		Nausea	grade 1-2				9007
54798	19		Nausea	grade 1-2				9008
54799	21		Implant site reaction	grade 1-2				9009
54800	19		Nausea	grade 1-2				9009
54801	7		Oropharyngeal pain	grade 1-2				9009
54802	6		Cough	grade 1-2				9009
54803	6		Fatigue	grade 1-2				9009
54804	4		Skin hyperpigmentation	grade 1-2				9009
54805	4		Dizziness	grade 1-2				9009
54806	4		Melanocytic nevus	grade 1-2				9009
54807	4		Respiratory tract infection	grade 1-2				9009
54808	2		Somnolence	grade 1-2				9009
54809	2		Porphyria non-acute	grade 1-2				9009
54810	2		Skin irritation	grade 1-2				9009
54811	10		Implant site discoloration	grade 1-2				9009
54812			Darkened skin		discontinuation			9006
54813						Information about AEs not found. The results have not been published to date: https://www.sciencedirect.com/science/article/pii/S0190962216308829		9005
54814			Nausea		discontinuation			9003
54815			Migraine		discontinuation			9010
54816			Crohn's disease		discontinuation			9004
54817	11.1		Hyperglycemia		discontinuation			9016
54818	11.1		Hyperglycemia		discontinuation			9017
54819	11.1		Hyperglycemia		discontinuation			9012
54820	2		Headache					9011
54821	2		Tachycardia	grade 1				9011
54822	1		Headache	grade 3	discontinuation			9014
54823	1		Cholecystitis	grade 3	discontinuation			9015
54824	1		Hypoglycaemia	grade 3	discontinuation			9013
54825	1		Angina pectoris	grade 3	discontinuation			9013
54826	1		Papillary thyroid cancer	grade 3	discontinuation			9013
54827			Contact dermatitis					9019
54828			Contact dermatitis					9018
54829	83.3		Somnolence					9021
54830	33.3		Dizziness					9021
54831	16.7		Diplopia					9021
54832	16.7		Disturbance in attention					9021
54833	16.7		Fatigue					9021
54834	16.7		Headache					9021
54835	16.7		Nausea					9021
54836	37.5		Muscle weakness					9020
54837	12.5		Negative myoclonus	grade 1				9020
54838	12.5		Somnolence	grade 3				9020
54839	7.1		Nausea		discontinuation			9022
54840						Across the AZD9668 5, 20 and 60 mg bid treatment groups, there was no evidence of any dose-dependent increase in AEs, SAEs or AEs leading to discontinuation and no differences from placebo.		9023
54841	9		Diarrhea	grade 3-4			TRUE	9025
54842	50		Acute myocardial infarction	grade 5	discontinuation		TRUE	9027
54843	50		Cardiac ischemia	grade 3-4			TRUE	9027
54844						No DLT occurred in eight patients who received 80 mg/m2 17-DMAG.		9026
54845	25		Acidosis	grade 3	discontinuation	patient died	TRUE	9024
54846	25		Nausea	grade 2	discontinuation	patient died	TRUE	9024
54847	25		Hyponatremia	grade 3	discontinuation	patient died	TRUE	9024
54848	25		Diarrhea	grade 3	discontinuation	patient died	TRUE	9024
54849	25		Anorexia	grade 2	discontinuation	patient died	TRUE	9024
54850	25		Dehydration	grade 3	discontinuation	patient died	TRUE	9024
54851	25		Vomiting	grade 2	discontinuation	patient died	TRUE	9024
54852	25		Blood creatinine increased	grade 3		patient died		9024
54853	25		AST increased	grade 4	discontinuation	patient died	TRUE	9024
54854	25		Acute hypotension	grade 4	discontinuation	patient died	TRUE	9024
54855	25		Fatigue	grade 3			TRUE	9024
54856	25		Fever	grade 2	discontinuation	patient died	TRUE	9024
54857	25		Hypoalbuminemia	grade 3			TRUE	9024
54858	25		Acute renal failure	grade 5	discontinuation	patient died	TRUE	9024
54859	1.61		Bleeding		discontinuation			9028
54860						No adverse effects leading to discontinuation were reported		9029
54861	33.3		Dizziness					9030
54862	16.7		Dysacusis					9030
54863	33.3		Dysacusis					9030
54864	7.5		Gastro-intestinal disorder NOS		discontinuation			9031
54865	15		Skin disorder		discontinuation			9031
54866	1.5		Morphea		discontinuation			9033
54867	1.5		Morphea		discontinuation			9034
54868	1.5		Morphea		discontinuation			9035
54869	0.4		Morphea		discontinuation			9032
54870						No adverse effects leading to discontinuation were reported; no DLTs		9037
54871	22.2		ALT increased	grade 3	dose reduction		TRUE	9036
54872	22 pts		Dizziness					9038
54873	9 pts		Headache					9038
54874	3 pts		Somnolence					9038
54875	8 pts		Nausea					9038
54876	3 pts		Diarrhea					9038
54877	2 pts		Back pain					9038
54878	6 pts		Blurred vision					9038
54879	4 pts		Insomnia					9038
54880	4 pts		Disorder sleep					9038
54881	3 pts		Pruritus					9038
54882	4 pts		Decreased appetite					9038
54883	3 pts		Palpitations					9038
54884	1 pts		Bronchitis		discontinuation	leads to discontinuation		9038
54885	1 pts		Dizziness		discontinuation	leads to discontinuation		9038
54886	1 pts		Nodal rhythm		discontinuation	leads to discontinuation		9038
54887	1 pts		Tremor	grade 1-2	discontinuation	leads to discontinuation		9038
54888	1 pts		Atrioventricular block second degree	serious				9040
54889	1 pts		Fear of needles	serious				9040
54890	1 pts		Femoral neck fracture	serious				9040
54891	1 pts		Foot fracture	serious				9040
54892	1 pts		Spinal compression fracture	serious				9040
54893	7 pts		Nausea	below serious				9040
54894	14 pts		Constipation	below serious				9040
54895	3 pts		Weight increased	below serious				9040
54896	17 pts		Extrapyramidal disorder	below serious				9040
54897	13 pts		Akathisia	below serious				9040
54898	8 pts		Sedation	below serious				9040
54899	5 pts		Dizziness	below serious				9040
54900	15 pts		Insomnia	below serious				9040
54901	6 pts		Anxiety	below serious				9040
54902	11 pts		Nausea	below serious				9046
54903	9 pts		Constipation	below serious				9046
54904	9 pts		Vomiting	below serious				9046
54905	5 pts		Weight increased	below serious				9046
54906	14 pts		Extrapyramidal disorder	below serious				9046
54907	14 pts		Akathisia	below serious				9046
54908	7 pts		Sedation	below serious				9046
54909	7 pts		Tremor	below serious				9046
54910	24 pts		Insomnia	below serious				9046
54911	8 pts		Anxiety	below serious				9046
54912	1 pts		Aggression	serious				9051
54913	1 pts		Agitation	serious				9051
54914	1 pts		HIV test positive	serious				9051
54915	11 pts		Nausea	below serious				9051
54916	8 pts		Constipation	below serious				9051
54917	8 pts		Vomiting	below serious				9051
54918	19 pts		Extrapyramidal disorder	below serious				9051
54919	13 pts		Akathisia	below serious				9051
54920	12 pts		Sedation	below serious				9051
54921	9 pts		Dizziness	below serious				9051
54922	24 pts		Insomnia	below serious				9051
54923	8 pts		Anxiety	below serious				9051
54924	3 pts		Mania	serious				9044
54925	1 pts		Akathisia	serious				9044
54926	1 pts		Convulsion	serious				9044
54927	1 pts		Suicidal ideation	serious				9044
54928	17 pts		Dyspepsia	below serious				9044
54929	16 pts		Nausea	below serious				9044
54930	16 pts		Vomiting	below serious				9044
54931	14 pts		Constipation	below serious				9044
54932	11 pts		Diarrhoea	below serious				9044
54933	8 pts		Abdominal discomfort	below serious				9044
54934	9 pts		Pyrexia	below serious				9044
54935	35 pts		Akathisia	below serious				9044
54936	24 pts		Extrapyramidal disorder	below serious				9044
54937	19 pts		Tremor	below serious				9044
54938	18 pts		Headache	below serious				9044
54939	14 pts		Dizziness	below serious				9044
54940	10 pts		Somnolence	below serious				9044
54941	10 pts		Restlessness	below serious				9044
54942	9 pts		Insomnia	below serious				9044
54943	1 pts		Aggression	serious				9052
54944	1 pts		Endometrial cancer	serious				9052
54945	1 pts		Hospitalisation	serious				9052
54946	1 pts		Pulmonary embolism	serious				9052
54947	16 pts		Nausea	below serious				9052
54948	8 pts		Constipation	below serious				9052
54949	15 pts		Vomiting	below serious				9052
54950	7 pts		Dyspepsia	below serious				9052
54951	29 pts		Akathisia	below serious				9052
54952	19 pts		Headache	below serious				9052
54953	16 pts		Extrapyramidal disorder	below serious				9052
54954	4 pts		Tremor	below serious				9052
54955	9 pts		Dizziness	below serious				9052
54956	16 pts		Insomnia	below serious				9052
54957	15 pts		Restlessness	below serious				9052
54958	1 pts		Depression	serious				9045
54959	19 pts		Nausea	below serious				9045
54960	18 pts		Constipation	below serious				9045
54961	14 pts		Vomiting	below serious				9045
54962	10 pts		Dyspepsia	below serious				9045
54963	38 pts		Akathisia	below serious				9045
54964	20 pts		Headache	below serious				9045
54965	12 pts		Extrapyramidal disorder	below serious				9045
54966	10 pts		Tremor	below serious				9045
54967	7 pts		Dizziness	below serious				9045
54968	17 pts		Insomnia	below serious				9045
54969	10 pts		Restlessness	below serious				9045
54970	12 pts		Nausea	below serious				9039
54971	4 pts		Akathisia	below serious				9039
54972	16 pts		Insomnia	below serious				9039
54973	1 pts		Fall	serious				9041
54974	1 pts		Injury	serious				9041
54975	1 pts		Hypomania	serious				9041
54976	12 pts		Nausea	below serious				9041
54977	7 pts		Akathisia	below serious				9041
54978	10 pts		Somnolence	below serious				9041
54979	1 pts		Fall	serious				9047
54980	1 pts		Lower limb fracture	serious				9047
54981	1 pts		Vertigo CNS origin	serious				9047
54982	12 pts		Nausea	below serious				9047
54983	21 pts		Akathisia	below serious				9047
54984	10 pts		Somnolence	below serious				9047
54985	17 pts		Insomnia	below serious				9047
54986	9 pts		Restlessness	below serious				9047
54987	5 pts		Suicidal ideation	serious				9054
54988	3 pts		Schizophrenia, paranoid type	serious				9054
54989	2 pts		Social stay hospitalisation	serious				9054
54990	1 pts		Convulsion	serious				9054
54991	1 pts		Drug abuse	serious				9054
54992	1 pts		Extrapyramidal disorder	serious				9054
54993	1 pts		Foreign body	serious				9054
54994	1 pts		Haematemesis	serious				9054
54995	1 pts		Insomnia	serious				9054
54996	1 pts		Intentional product misuse	serious				9054
54997	1 pts		Intervertebral disc protrusion	serious				9054
54998	1 pts		Overdose	serious				9054
54999	1 pts		Pneumonia	serious				9054
55000	1 pts		Psychiatric evaluation	serious				9054
55001	1 pts		Psychotic behaviour	serious				9054
55002	1 pts		Pyrexia	serious				9054
55003	1 pts		Restlessness	serious				9054
55004	1 pts		Rhabdomyolysis	serious				9054
55005	1 pts		Suicide attempt	serious				9054
55006	1 pts		Victim of crime	serious				9054
55007	39 pts		Constipation	below serious				9054
55008	46 pts		Dyspepsia	below serious				9054
55009	48 pts		Nausea	below serious				9054
55010	49 pts		Weight increased	below serious				9054
55011	148 pts		Akathisia	below serious				9054
55012	55 pts		Extrapyramidal disorder	below serious				9054
55013	92 pts		Headache	below serious				9054
55014	39 pts		Anxiety	below serious				9054
55015	110 pts		Insomnia	below serious				9054
55016	70 pts		Restlessness	below serious				9054
55017	2 pts		Schizophrenia, paranoid type	serious				9053
55018	1 pts		Pneumonia	serious				9053
55019	1 pts		Ankle fracture	serious				9053
55020	1 pts		Drug ineffective	serious				9053
55021	1 pts		Fall	serious				9053
55022	1 pts		Hypersensitivity	serious				9053
55023	1 pts		Multiple injuries	serious				9053
55024	1 pts		Pain in extremity	serious				9053
55025	1 pts		Road traffic accident	serious				9053
55026	6 pts		Extrapyramidal disorder	below serious				9053
55027	8 pts		Headache	below serious				9053
55028	8 pts		Nasopharyngitis	below serious				9053
55029	8 pts		Tremor	below serious				9053
55030	1 pts		Abortion	serious				9048
55031	8 pts		Nausea	below serious				9049
55032	5 pts		Fatigue	below serious				9049
55033	15 pts		Akathisia	below serious				9049
55034	11 pts		Insomnia	below serious				9049
55035	11 pts		Restlessness	below serious				9049
55036	1 pts		Depression	serious				9042
55037	13 pts		Nausea	below serious				9042
55038	9 pts		Fatigue	below serious				9042
55039	9 pts		Akathisia	below serious				9042
55040	8 pts		Insomnia	below serious				9042
55041	1 pts		Anaemia iron deficiency	serious				9043
55042	1 pts		Asthma	serious				9043
55043	6 pts		Nausea	below serious				9043
55044	10 pts		Akathisia	below serious				9043
55045	8 pts		Dizziness	below serious				9043
55046	8 pts		Somnolence	below serious				9043
55047	8 pts		Sedation	below serious				9043
55048	1 pts		Bipolar disorder	serious				9050
55049	1 pts		Suicidal ideation	serious				9050
55050	15 pts		Nausea	below serious				9050
55051	9 pts		Akathisia	below serious				9050
55052	6 pts		Dizziness	below serious				9050
55053	6 pts		Somnolence	below serious				9050
55054	5 pts		Sedation	below serious				9050
55055	12 pts		Insomnia	below serious				9050
55056	12 pts		Restlessness	below serious				9050
55057			Akathisia		discontinuation	leads to discontinuation		9056
55058	2.7		Schizophrenia aggravated		discontinuation	leads to discontinuation		9058
55059	2		Psychotic disorder		discontinuation	leads to discontinuation		9058
55060	2 pts		ALT increased		discontinuation	leads to discontinuation		9058
55061	2 pts		AST increased		discontinuation	leads to discontinuation		9058
55062	1 pts		Bilirubin increased		discontinuation	leads to discontinuation		9058
55063	0.9		Akathisia		discontinuation	leads to discontinuation		9058
55064	0.3		Extrapyramidal disorder		discontinuation	leads to discontinuation		9058
55065	0.2		Restlessness		discontinuation	leads to discontinuation		9058
55066	0.2		Dystonia		discontinuation	leads to discontinuation		9058
55067	0.2		Parkinsonism		discontinuation	leads to discontinuation		9058
55068	0.2		Salivary hypersecretion		discontinuation	leads to discontinuation		9058
55069	0.2		Tremor		discontinuation	leads to discontinuation		9058
55070	0.2		Musculoskeletal stiffness		discontinuation	leads to discontinuation		9058
55071			Adverse event	grade 5		WARNING		9055
55072	2		Akathisia		discontinuation	leads to discontinuation		9057
55073	33.3		Proteinuria				TRUE	9059
55074	16.7		Diarrhea				TRUE	9059
55075	16.7		Thrombocytopenia				TRUE	9059
55076						dose reductions occurred in 1/3 patients - not specified in the 30 mg cohort		9060
55077	25		Nausea	grade 3			TRUE	9063
55078	25		Anorexia	grade 2			TRUE	9063
55079	50		Nausea	grade 3			TRUE	9062
55080	50		QT prolonged	grade 3	dose reduction		TRUE	9062
55081	50		Hypertension	grade 3	dose reduction		TRUE	9062
55082	50		Lethargy	grade 3	dose reduction		TRUE	9062
55083	50		Vomiting	grade 3			TRUE	9062
55084	16.7		Diarrhea	grade 3			TRUE	9061
55085						No information on AE is provided		9065
55086						No information on AE is provided		9064
55087	2.4		Bronchitis					9066
55088	2.4		Pulmonary tuberculosis					9066
55089	55.2		Increased LDL					9066
55090	61		ALT increased					9066
55091	43.9		AST increased					9066
55092	4.9		Neutropenia	grade 2-3				9066
55093	4.9		Lymphopenia	grade 2				9066
55094	2.5		ALT increased	grade 2	discontinuation			9068
55095	10		Hyperthyroidism		discontinuation			9067
55096	10		Stomatitis		discontinuation			9067
55097	10		Pharyngitis		discontinuation			9067
55098	10		Dry mouth		discontinuation			9067
55099	10		Edema face		discontinuation			9067
55100	10		Conjunctivitis		discontinuation			9067
55101	1 pts		Face injury	serious				9071
55102	1 pts		Skeletal injury	serious				9071
55103	1 pts		Psychotic disorder	serious				9071
55104	4 pts		Nasopharyngitis	below serious				9071
55105	5 pts		Headache	below serious				9071
55106	1 pts		Sudden cardiac death	serious				9069
55107	1 pts		Appendicitis	serious				9069
55108	1 pts		Cellulitis	serious				9069
55109	1 pts		Pneumonia	serious				9069
55110	1 pts		Depression	serious				9069
55111	1 pts		Suicidal ideation	serious				9069
55112	3 pts		Diarrhoea	below serious				9069
55113	3 pts		Nasopharyngitis	below serious				9069
55114	1 pts		Cardio-respiratory arrest	serious				9070
55115	1 pts		Alcohol interaction	serious				9070
55116	1 pts		Pneumonia	serious				9070
55117	1 pts		Psychomotor hyperactivity	serious				9070
55118	5 pts		Diarrhoea	below serious				9070
55119	2 pts		Nasopharyngitis	below serious				9070
55120	5 pts		Headache	below serious				9070
55121			QT prolonged		discontinuation			9081
55122			Vesicular rash		discontinuation			9081
55123			Psychotic disorder		discontinuation			9081
55124			Schizophrenia exacerbated		discontinuation			9081
55125			Suicidal ideation		discontinuation			9075
55126			Sudden cardiac death		discontinuation			9075
55127			Insomnia		discontinuation			9080
55128			Cardio-respiratory arrest		discontinuation			9080
55129			Psychomotor hyperactivity		discontinuation			9080
55130	0.8		Dysphagia	grade 2	discontinuation			9088
55131	0.8		Hypersomnia	grade 2	discontinuation			9074
55132	0.8		Sudden cardiac death	grade 3	discontinuation			9091
55133	0.8		Communication disorder	grade 2	discontinuation			9090
55134	0.8		Cognitive disorder	grade 2	discontinuation			9087
55135	0.8		Chorea	grade 2	discontinuation			9089
55136	0.8		Chorea	grade 3	discontinuation			9082
55137	0.8		Suicidal ideation	grade 1	discontinuation			9086
55138	0.8		Anxiety	grade 2	discontinuation			9085
55139	0.8		Paranoia	grade 2	discontinuation			9084
55140	0.8		Major depression	grade 3	discontinuation			9079
55141	0.8		Mental status changes	grade 3	discontinuation			9073
55142	0.8		Depression	grade 1	discontinuation			9083
55143	0.8		Depression	grade 2	discontinuation			9078
55144	0.8		Failure to thrive	grade 3	discontinuation			9072
55145			Confusional state		discontinuation			9077
55146	0.3		Somnolence		discontinuation			9076
55147	0.3		Disturbance in attention		discontinuation			9076
55148	0.7		Anxiety		discontinuation			9076
55149	0.3		Insomnia		discontinuation			9076
55150	0.7		Depression		discontinuation			9076
55151	0.3		Suicide attempt		discontinuation			9076
55152	0.3		Homicidal ideation		discontinuation			9076
55153	0.3		Fatigue		discontinuation			9076
55154	0.3		Asthenia		discontinuation			9076
55155	1 pts		Pruritus		discontinuation	leads to discontinuation		9093
55156	1 pts		Rash					9093
55157	1 pts		Lower respiratory tract infection		discontinuation	leads to discontinuation		9092
55158	9.4		Gastrointestinal disorders					9092
55159	7.1		Infection					9092
55160	8.2		Nervous system disorders					9092
55161	1.2		Skin disorder					9092
55162	1.2		Skin and subcutaneous tissue disorders					9092
55163	1.2		Vascular disorders					9092
55164	1.2		Respiratory disorder					9092
55165	1.2		Thoracic disorders (excl lung and pleura)					9092
55166	1.2		Mediastinal disorders					9092
55167	6 pts		Angina pectoris	serious				9094
55168	2 pts		Aortic valve stenosis	serious				9094
55169	2 pts		Cardiac failure	serious				9094
55170	3 pts		Cardiac failure congestive	serious				9094
55171	1 pts		Cardiogenic shock	serious				9094
55172	1 pts		Coronary artery occlusion	serious				9094
55173	2 pts		Myocardial infarction	serious				9094
55174	1 pts		Supraventricular tachycardia	serious				9094
55175	1 pts		Ventricular tachycardia	serious				9094
55176	1 pts		Abdominal discomfort	serious				9094
55177	1 pts		Constipation	serious				9094
55178	1 pts		Gastric ulcer	serious				9094
55179	1 pts		Impaired gastric emptying	serious				9094
55180	1 pts		Large intestine polyp	serious				9094
55181	1 pts		Oesophageal ulcer haemorrhage	serious				9094
55182	1 pts		Vomiting	serious				9094
55183	1 pts		Death	serious				9094
55184	1 pts		Device issue	serious				9094
55185	2 pts		Medical device complication	serious				9094
55186	3 pts		Non-cardiac chest pain	serious				9094
55187	1 pts		Acute hepatic failure	serious				9094
55188	1 pts		Cholangitis	serious				9094
55189	1 pts		Hyperbilirubinaemia	serious				9094
55190	1 pts		Arthritis bacterial	serious				9094
55191	1 pts		Bronchitis	serious				9094
55192	1 pts		Device related infection	serious				9094
55193	2 pts		Gastroenteritis	serious				9094
55194	1 pts		H1N1 influenza	serious				9094
55195	1 pts		Lobar pneumonia	serious				9094
55196	2 pts		Osteomyelitis	serious				9094
55197	6 pts		Pneumonia	serious				9094
55198	1 pts		Septic embolus	serious				9094
55199	1 pts		Upper respiratory tract infection	serious				9094
55200	1 pts		Viral upper respiratory tract infection	serious				9094
55201	1 pts		Wound infection	serious				9094
55202	2 pts		Arteriovenous fistula site complication	serious				9094
55203	1 pts		Graft haemorrhage	serious				9094
55204	1 pts		Hip fracture	serious				9094
55205	1 pts		Postoperative respiratory distress	serious				9094
55206	1 pts		Road traffic accident	serious				9094
55207	1 pts		Scapula fracture	serious				9094
55208	1 pts		Shunt thrombosis	serious				9094
55209	1 pts		Subdural haematoma	serious				9094
55210	1 pts		Vascular graft complication	serious				9094
55211	1 pts		Diabetes mellitus inadequate control	serious				9094
55212	2 pts		Hyperglycaemia	serious				9094
55213	4 pts		Hyperkalaemia	serious				9094
55214	1 pts		Hypervolaemia	serious				9094
55215	1 pts		Metabolic acidosis	serious				9094
55216	1 pts		Biliary cancer metastatic	serious				9094
55217	1 pts		Lung neoplasm	serious				9094
55218	1 pts		Malignant melanoma	serious				9094
55219	1 pts		Cerebrovascular accident	serious				9094
55220	1 pts		Syncope	serious				9094
55221	1 pts		Anxiety	serious				9094
55222	1 pts		Delirium	serious				9094
55223	1 pts		Mental status changes	serious				9094
55224	1 pts		Urinary retention	serious				9094
55225	2 pts		Acute pulmonary oedema	serious				9094
55226	1 pts		Acute respiratory distress syndrome	serious				9094
55227	1 pts		Asthma	serious				9094
55228	2 pts		Dyspnoea	serious				9094
55229	1 pts		Aortic stenosis	serious				9094
55230	1 pts		Granulomatosis with polyangiitis	serious				9094
55231	1 pts		Hypertensive emergency	serious				9094
55232	2 pts		Hypotension	serious				9094
55233	1 pts		Shock	serious				9094
55234	1 pts		Haemorrhagic shock	serious				9094
55235	1 pts		Venous stenosis	serious				9094
55236	18 pts		Diarrhoea	below serious				9094
55237	31 pts		Nausea	below serious				9094
55238	25 pts		Vomiting	below serious				9094
55239	153 pts		Blood calcium decreased	below serious				9094
55240	18 pts		Hypocalcaemia	below serious				9094
55241	30 pts		Muscle spasms	below serious				9094
55242	17 pts		Pain in extremity	below serious				9094
55243	13 pts		Paraesthesia	below serious				9094
55244	14 pts		Hypotension	below serious				9094
55245	2 pts		Atrial fibrillation	serious				9095
55246	1 pts		Atrioventricular block complete	serious				9095
55247	1 pts		Cardiac failure	serious				9095
55248	1 pts		Coronary artery disease	serious				9095
55249	1 pts		Coronary artery stenosis	serious				9095
55250	1 pts		Ventricular tachycardia	serious				9095
55251	1 pts		Constipation	serious				9095
55252	1 pts		Faecaloma	serious				9095
55253	1 pts		Gastric antral vascular ectasia	serious				9095
55254	1 pts		Haematemesis	serious				9095
55255	2 pts		Lower gastrointestinal haemorrhage	serious				9095
55256	1 pts		Catheter site haematoma	serious				9095
55257	3 pts		Pyrexia	serious				9095
55258	1 pts		Surgical failure	serious				9095
55259	1 pts		Cholangitis	serious				9095
55260	1 pts		Hepatitis acute	serious				9095
55261	1 pts		Arteriovenous fistula site infection	serious				9095
55262	1 pts		Bacteraemia	serious				9095
55263	1 pts		Burn infection	serious				9095
55264	2 pts		Cellulitis	serious				9095
55265	1 pts		Diverticulitis	serious				9095
55266	1 pts		Herpes zoster meningoencephalitis	serious				9095
55267	1 pts		Influenza	serious				9095
55268	1 pts		Meningitis aseptic	serious				9095
55269	1 pts		Ophthalmic herpes zoster	serious				9095
55270	1 pts		Prostatic abscess	serious				9095
55271	2 pts		Sepsis	serious				9095
55272	1 pts		Skin graft infection	serious				9095
55273	1 pts		Staphylococcal bacteraemia	serious				9095
55274	1 pts		Viral myocarditis	serious				9095
55275	1 pts		Arteriovenous fistula aneurysm	serious				9095
55276	1 pts		Face injury	serious				9095
55277	1 pts		Fall	serious				9095
55278	1 pts		Postoperative respiratory failure	serious				9095
55279	1 pts		Procedural hypotension	serious				9095
55280	1 pts		Procedural vomiting	serious				9095
55281	1 pts		Skin graft failure	serious				9095
55282	1 pts		Subdural haematoma	serious				9095
55283	2 pts		Tibia fracture	serious				9095
55284	1 pts		Toxicity to various agents	serious				9095
55285	1 pts		Hepatic enzyme increased	serious				9095
55286	1 pts		Hyperglycaemia	serious				9095
55287	6 pts		Hyperkalaemia	serious				9095
55288	1 pts		Hypervolaemia	serious				9095
55289	2 pts		Metabolic acidosis	serious				9095
55290	1 pts		Brain injury	serious				9095
55291	1 pts		Tremor	serious				9095
55292	1 pts		Uraemic encephalopathy	serious				9095
55293	1 pts		Confusional state	serious				9095
55294	1 pts		Haematuria	serious				9095
55295	1 pts		Nephrolithiasis	serious				9095
55296	1 pts		Renal cyst haemorrhage	serious				9095
55297	1 pts		Urethral stenosis	serious				9095
55298	1 pts		Urinary retention	serious				9095
55299	1 pts		Hypoxia	serious				9095
55300	1 pts		Non-cardiogenic pulmonary oedema	serious				9095
55301	2 pts		Respiratory distress	serious				9095
55302	1 pts		Palpable purpura	serious				9095
55303	1 pts		Hypertension	serious				9095
55304	1 pts		Hypertension malignant	serious				9095
55305	1 pts		Venous stenosis	serious				9095
55306	35 pts		Diarrhoea	below serious				9095
55307	23 pts		Nausea	below serious				9095
55308	19 pts		Vomiting	below serious				9095
55309	16 pts		Arteriovenous fistula site complication	below serious				9095
55310	168 pts		Blood calcium decreased	below serious				9095
55311	17 pts		Hypocalcaemia	below serious				9095
55312	14 pts		Back pain	below serious				9095
55313	28 pts		Muscle spasms	below serious				9095
55314	20 pts		Headache	below serious				9095
55315	18 pts		Hypertension	below serious				9095
55316	1 pts		Pneumonia	serious				9096
55317	1 pts		Hypocalcaemia	serious				9096
55318	1 pts		Intervertebral disc protrusion	serious				9096
55319	2 pts		Atrioventricular block first degree	below serious				9096
55320	2 pts		Upper respiratory tract infection	below serious				9096
55321	10 pts		Blood calcium decreased	below serious				9096
55322	2 pts		Hyperphosphataemia	below serious				9096
55323	2 pts		Hypoproteinaemia	below serious				9096
55324	4 pts		Muscle spasms	below serious				9096
55325	2 pts		Dermatitis allergic	below serious				9096
55326	4 pts		Pruritus	below serious				9096
55327	2 pts		Rash	below serious				9096
55328	2 pts		Hypertension	below serious				9096
55329	4 pts		Hypotension	below serious				9096
55330						impossible to link AEs with the definite dose		9098
55331	5 pts		Calcium decreased		discontinuation	leads to discontinuation		9097
55332	1 pts		Nausea		discontinuation	leads to discontinuation		9097
55333	1 pts		Vomiting		discontinuation	leads to discontinuation		9097
55334	1 pts		Chest discomfort		discontinuation	leads to discontinuation		9097
55335	1 pts		GI malformation		discontinuation	leads to discontinuation		9097
55336	1 pts		Hemiparesis		discontinuation	leads to discontinuation		9097
55337	1 pts		Hyperhidrosis		discontinuation	leads to discontinuation		9097
55338			Nausea	grade 2-3				9099
55339	80		ALT increased	grade 1-3			TRUE	9099
55340	80		AST increased	grade 1-3			TRUE	9099
55341	80		Alkaline phosphatase increased	grade 1-3				9099
55342	80		Gamma-glutamyltransferase increased	grade 2-4				9099
55343	20		Bilirubin increased	grade 1-3				9099
55344			Creatinine increased	grade 1-2				9099
55345						No information on AE is provided		9101
55346	11.1		Headache	grade 1-2				9100
55347	11.1		Dizziness	grade 1-2				9100
55348	11.1		Tremor	grade 1-2				9100
55349	11.1		Neck pain	grade 1-2				9100
55350	11.1		Blurred vision	grade 1-2				9100
55351	11.1		Abdominal distension	grade 1-2				9100
55352	11.1		Hypoglycemia	grade 1-2				9100
55353	11.1		Hematoma	grade 1-2				9100
55354	0.06		Transaminases increased		discontinuation			9102
55355	0.03		Liver function test abnormal		discontinuation			9102
55356	0.03		Hepatitis acute		dose interruption			9103
55357			Gastrointestinal disorders					9106
55358	>3		Nausea		discontinuation	leads to dose interruption		9110
55359	66		Diarrhea	all grades				9111
55360	62		Nausea	all grades				9111
55361	40		Anemia	all grades				9111
55362	39		Vomiting	all grades				9111
55363	19		Asthenia	all grades				9111
55364	12		Muscle spasms	all grades				9111
55365	10		Blood creatinine increased	all grades				9111
55366	10		Pain in extremity	all grades				9111
55367	9		Alanine aminotransferase increased	all grades				9111
55368	9		Headache	all grades				9111
55369	9		Weight increased	all grades				9111
55370	8		Dizziness	all grades				9111
55371	8		Bone pain	all grades				9111
55372	6		Urinary tract infection	all grades				9111
55373	6		Dysuria	all grades				9111
55374	5		Aspartate aminotransferase increased	all grades				9111
55375	5		Diarrhea	grade 3-4				9111
55376	30		Anemia	grade 3-4				9112
55377	3.1		Vomiting	grade 3-4				9112
55378	5		Asthenia	grade 3-4				9112
55379	1		Blood creatinine increased	grade 3-4				9112
55380	47		Thrombocytopenia	all grades				9112
55381	23		Neutropenia	all grades				9112
55382	35		Lipase increased	all grades				9112
55383	26		Hyponatremia	all grades				9112
55384	24		Amylase increased	all grades				9112
55385	12		Thrombocytopenia	grade 3-4				9112
55386	5		Neutropenia	grade 3-4				9112
55387	10		Lipase increased	grade 3-4				9112
55388	5		Hyponatremia	grade 3-4				9112
55389	2.1		Amylase increased	grade 3-4				9112
55390	5		Cardiac failure	all grades				9112
55391	3		Cardiac failure	grade 3-4	discontinuation	leads to discontinuation		9110
55392	1		Cardiac failure	grade 5	discontinuation	leads to discontinuation		9110
55393	2		Thrombocytopenia		discontinuation	leads to discontinuation		9110
55394	2		Myocardial ischemia		discontinuation	leads to discontinuation		9110
55395	2		Diarrhea		discontinuation	leads to discontinuation		9110
55396	2		Blood creatinine increased		discontinuation	leads to discontinuation		9110
55397	>3		Diarrhea			leads to dose interruption		9110
55398	>3		Nausea			leads to dose interruption		9110
55399	6		Anemia			leads to dose reduction		9110
55400	3		Diarrhea			leads to dose reduction		9110
55401	3		Vomiting			leads to dose reduction		9110
55402	2		Thrombocytopenia			leads to dose reduction		9110
55403						No information on AEs is available		9107
55404	2		Anemia		discontinuation	leads to discontinuation		9108
55405	2		Diarrhea		discontinuation	leads to discontinuation		9108
55406	2		Nausea		discontinuation	leads to discontinuation		9108
55407	1		Amylase increased		discontinuation	leads to discontinuation		9108
55408	1		Lipase increased		discontinuation	leads to discontinuation		9108
55409	1		Anemia		discontinuation	leads to discontinuation		9114
55410	6		Thrombocytopenia		discontinuation	leads to discontinuation		9115
55411	2		Neutropenia		discontinuation	leads to discontinuation		9115
55412	4		Vomiting		discontinuation	leads to discontinuation		9115
55413	2		Blood creatinine increased		discontinuation	leads to discontinuation		9115
55414	2		Diarrhea		discontinuation	leads to discontinuation		9115
55415	2		Nausea		discontinuation	leads to discontinuation		9115
55416	1		Amylase increased		discontinuation	leads to discontinuation		9115
55417	3		Lipase increased		discontinuation	leads to discontinuation		9115
55418	2		Fatigue		discontinuation	leads to discontinuation		9115
55419	10		Vomiting	all grades	discontinuation	leads to dose interruption or reduction		9108
55420	3		Vomiting	grade 3-4	discontinuation	leads to dose interruption or reduction		9108
55421	8		Anemia	all grades	discontinuation	leads to dose interruption or reduction		9108
55422	5		Anemia	grade 3-4	discontinuation	leads to dose interruption or reduction		9108
55423	3		Thrombocytopenia	all grades	discontinuation	leads to dose interruption or reduction		9108
55424	2		Thrombocytopenia	grade 3-4	discontinuation	leads to dose interruption or reduction		9108
55425	3		Fatigue	all grades	discontinuation	leads to dose interruption or reduction		9108
55426	3		Fatigue	grade 3-4	discontinuation	leads to dose interruption or reduction		9108
55427	8		Diarrhea	all grades	discontinuation	leads to dose interruption or reduction		9115
55428	3		Diarrhea	grade 3-4	discontinuation	leads to dose interruption or reduction		9115
55429	6		Nausea	all grades	discontinuation	leads to dose interruption or reduction		9115
55430	4		Nausea	grade 3-4	discontinuation	leads to dose interruption or reduction		9115
55431	11		Vomiting	all grades	discontinuation	leads to dose interruption or reduction		9115
55432	7		Vomiting	grade 3-4	discontinuation	leads to dose interruption or reduction		9115
55433	18		Anemia	all grades	discontinuation	leads to dose interruption or reduction		9115
55434	14		Anemia	grade 3-4	discontinuation	leads to dose interruption or reduction		9115
55435	7		Thrombocytopenia	all grades	discontinuation	leads to dose interruption or reduction		9115
55436	6		Thrombocytopenia	grade 3-4	discontinuation	leads to dose interruption or reduction		9115
55437	5		Fatigue	all grades	discontinuation	leads to dose interruption or reduction		9115
55438	5		Fatigue	grade 3-4	discontinuation	leads to dose interruption or reduction		9115
55439	2 pts		Cardiac disorders	grade 5	discontinuation	leads to discontinuation		9109
55440	2 pts		Cardiac disorders	grade 5	discontinuation	leads to discontinuation		9113
55441						No information on AE is provided		9104
55442						Doses up to 680 mg once daily (maximum tolerated dose) were well tolerated in the dose escalation phase in patients with MF.		9105
55443						No information on AE is provided		9116
55444	2.6		Thrombocytopenia	grade 4			TRUE	9117
55445	22.2		Insomnia	grade 1-2				9118
55446	11.1		Alkaline phosphatase increased	grade 1-2				9118
55447	22.2		Brain natriuretic peptide increased	grade 1-2				9118
55448	22.2		Constipation	grade 1-2				9118
55449	22.2		Decreased appetite	grade 1-2				9118
55450	22.2		Leukopenia	grade 1-2				9118
55451	11.1		Pyrexia	grade 1-2				9118
55452	11.1		Rash	grade 1-2				9118
55453	11.1		Anemia	grade 3				9118
55454	11.1		Biliary tract infection	grade 3				9118
55455	11.1		Duodenal ulcer	grade 3				9118
55456	11.1		Hypophosphatemia	grade 4				9118
55457	11.1		Lipase increased	grade 3				9118
55458	11.1		Sepsis	grade 3				9118
55459	11.1		Small intestinal hemorrhage	grade 3				9118
55460	11.1		Hemoglobin decreased	grade 3				9118
55461	12.5		Skin rash	grade 3			TRUE	9122
55462	12.5		Hyperglycemia	grade 3			TRUE	9122
55463	12.5		Mucosal inflammation	grade 3			TRUE	9122
55464	25		Mucosal inflammation	grade 3			TRUE	9119
55465	25		Skin rash	grade 3			TRUE	9119
55466	2.4		Mucosal inflammation	grade 3	discontinuation		TRUE	9120
55467	2.4		AST increased				TRUE	9120
55468	2.4		ALT increased				TRUE	9120
55469	42.9		Mucosal inflammation	grade 3			TRUE	9121
55470	14.3		ALT increased	grade 2				9121
55471	14.3		Mucosal inflammation	grade 3				9121
55472	14.3		Inflammation of mouth	grade 3		Stomatitis		9121
55473						No related severe adverse event was observed, no DLTs		9124
55474	50		ALT increased	grade 3			TRUE	9126
55475	50		Vomiting	grade 2		equivalent DLT		9126
55476	50		Nausea	grade 2		equivalent DLT		9126
55477	50		Anorexia	grade 2		equivalent DLT		9126
55478	12.5		Fatigue		dose reduction			9125
55479	12.5		Anorexia		dose reduction			9125
55480	50		Fatigue	grade 2	dose interruption|dose reduction		TRUE	9123
55481	50		Fatigue	grade 3	dose reduction		TRUE	9123
55482	50		Vomiting		dose reduction			9123
55483	1 pts		Neutropenia	grade 3			TRUE	9129
55484	1 pts		Neutropenia	grade 4			TRUE	9131
55485	1 pts		Acute renal failure	grade 3			TRUE	9128
55486	2 pts		Diarrhea	grade 2-3			TRUE	9128
55487	2 pts		Vomiting	grade 2-3			TRUE	9128
55488	1 pts		Fatigue	grade 2			TRUE	9128
55489	1 pts		Nausea	grade 2			TRUE	9128
55490	1 pts		Thrombocytopenia	grade 3	discontinuation	leads to dose reduction	TRUE	9130
55491	1 pts		Diarrhea	grade 3			TRUE	9127
55492	1 pts		Renal failure	grade 2	discontinuation	leads to dose reduction	TRUE	9127
55493	1 pts		Failure respiratory	grade 2	discontinuation	leads to dose reduction	TRUE	9127
55494						No adverse effects leading to discontinuation were reported		9133
55495						No adverse effects leading to discontinuation were reported		9134
55496						No adverse effects leading to discontinuation were reported		9132
55497			Renal insufficiency	grade 4			TRUE	9135
55498			Hyperbilirubinaemia	grade 3			TRUE	9135
55499			Dehydration	grade 4			TRUE	9135
55500	1 pts		Chest pain (non-cardiac)	serious				9145
55501	6 pts		Nausea	below serious				9145
55502	3 pts		Abdominal pain	below serious				9145
55503	1 pts		Vomiting	below serious				9145
55504	4 pts		Dizziness	below serious				9145
55505	1 pts		Pancreatitis	serious				9144
55506	1 pts		Pneumonia	serious				9144
55507	1 pts		Major depression	serious				9144
55508	1 pts		Affective disorder	serious				9144
55509	11 pts		Nausea	below serious				9144
55510	6 pts		Abdominal pain	below serious				9144
55511	7 pts		Vomiting	below serious				9144
55512	5 pts		Constipation	below serious				9144
55513	12 pts		Headache	below serious				9144
55514	1 pts		Pancreatitis acute	serious				9139
55515	9 pts		Nausea	below serious				9139
55516	4 pts		Abdominal pain	below serious				9139
55517	7 pts		Vomiting	below serious				9139
55518	10 pts		Constipation	below serious				9139
55519	5 pts		Dizziness	below serious				9139
55520	1 pts		Alcoholic pancreatitis	serious				9143
55521	1 pts		Pancreatitis acute	serious				9143
55522	1 pts		Appendicitis perforated	serious				9143
55523	18 pts		Nausea	below serious				9143
55524	13 pts		Abdominal pain	below serious				9143
55525	12 pts		Vomiting	below serious				9143
55526	6 pts		Constipation	below serious				9143
55527	11 pts		Dizziness	below serious				9143
55528	7 pts		Headache	below serious				9143
55529	1 pts		Abdominal pain	serious				9146
55530	1 pts		Abdominal pain upper	serious				9146
55531	1 pts		Hiatus hernia	serious				9146
55532	1 pts		Pancreatitis	serious				9146
55533	1 pts		Pancreatitis acute	serious				9146
55534	1 pts		Bronchitis	serious				9146
55535	2 pts		Diverticulitis	serious				9146
55536	2 pts		Influenza	serious				9146
55537	1 pts		Fasciitis necrotising	serious				9146
55538	1 pts		Angina pectoris	serious				9146
55539	1 pts		Myocardial infarction	serious				9146
55540	1 pts		Presyncope	serious				9146
55541	1 pts		Primary progressive multiple sclerosis	serious				9146
55542	1 pts		Syncope	serious				9146
55543	1 pts		Syncope vasovagal	serious				9146
55544	1 pts		Hypertension	serious				9146
55545	1 pts		Hypertensive crisis	serious				9146
55546	1 pts		Joint dislocation	serious				9146
55547	1 pts		Road traffic accident	serious				9146
55548	1 pts		Intervertebral disc protrusion	serious				9146
55549	2 pts		Osteoarthritis	serious				9146
55550	1 pts		Conversion disorder	serious				9146
55551	1 pts		Neoplasm thyroid	serious				9146
55552	1 pts		Abortion spontaneous	serious				9146
55553	1 pts		Depression	serious				9146
55554	27 pts		Constipation	below serious				9146
55555	34 pts		Nausea	below serious				9146
55556	22 pts		Vomiting	below serious				9146
55557	3 pts		Abdominal pain	serious				9140
55558	1 pts		Colitis	serious				9140
55559	1 pts		Diverticulum intestinal hemorrhagic	serious				9140
55560	1 pts		Pancreatitis	serious				9140
55561	2 pts		Pancreatitis acute	serious				9140
55562	1 pts		Bronchitis	serious				9140
55563	1 pts		Cellulitis	serious				9140
55564	1 pts		Diverticulitis	serious				9140
55565	1 pts		Gastroenteritis	serious				9140
55566	1 pts		Pneumonia	serious				9140
55567	1 pts		Rectal abscess	serious				9140
55568	1 pts		Acute myocardial infarction	serious				9140
55569	2 pts		Angina pectoris	serious				9140
55570	1 pts		Angina unstable	serious				9140
55571	1 pts		Coronary artery disease	serious				9140
55572	1 pts		Stress cardiomyopathy	serious				9140
55573	1 pts		Intracranial pressure increased	serious				9140
55574	1 pts		Arteriosclerosis	serious				9140
55575	1 pts		Deep vein thrombosis	serious				9140
55576	1 pts		Hematoma	serious				9140
55577	1 pts		Radius fracture	serious				9140
55578	2 pts		Road traffic accident	serious				9140
55579	1 pts		Skull fracture	serious				9140
55580	1 pts		Subdural hematoma	serious				9140
55581	1 pts		Arthritis	serious				9140
55582	1 pts		Back pain	serious				9140
55583	1 pts		Alanine aminotransferase increased	serious				9140
55584	1 pts		Aspartate aminotransferase increased	serious				9140
55585	1 pts		Hepatic enzyme increased	serious				9140
55586	1 pts		Diabetes mellitus	serious				9140
55587	2 pts		Anxiety	serious				9140
55588	1 pts		Acute respiratory failure	serious				9140
55589	1 pts		Respiratory failure	serious				9140
55590	1 pts		Cholecystitis chronic	serious				9140
55591	1 pts		Hydronephrosis	serious				9140
55592	44 pts		Constipation	below serious				9140
55593	31 pts		Nausea	below serious				9140
55594	19 pts		Vomiting	below serious				9140
55595	25 pts		Upper respiratory tract infection	below serious				9140
55596	1 pts		Abdominal discomfort	serious				9147
55597	1 pts		Gastric ulcer	serious				9147
55598	1 pts		Pancreatitis acute	serious				9147
55599	1 pts		Appendicitis	serious				9147
55600	1 pts		Bacterial pyelonephritis	serious				9147
55601	1 pts		Pyelonephritis	serious				9147
55602	1 pts		Chest pain	serious				9147
55603	1 pts		Angina pectoris	serious				9147
55604	1 pts		Pseudomeningocele	serious				9147
55605	1 pts		Hepatic enzyme increased	serious				9147
55606	1 pts		Ovarian cyst ruptured	serious				9147
55607	33 pts		Constipation	below serious				9147
55608	31 pts		Nausea	below serious				9147
55609	19 pts		Nasopharyngitis	below serious				9147
55610	1 pts		Colitis ischemic	serious				9141
55611	1 pts		Dyspepsia	serious				9141
55612	1 pts		Hiatus hernia	serious				9141
55613	1 pts		Pancreatitis acute	serious				9141
55614	1 pts		Umbilical hernia	serious				9141
55615	1 pts		Urinary tract infection	serious				9141
55616	1 pts		Chest pain	serious				9141
55617	1 pts		Chest pain (non-cardiac)	serious				9141
55618	1 pts		Headache	serious				9141
55619	1 pts		Myasthenia gravis	serious				9141
55620	1 pts		Hepatitis	serious				9141
55621	1 pts		Concussion	serious				9141
55622	1 pts		Electrocardiogram T wave abnormal	serious				9141
55623	1 pts		Suicide attempt	serious				9141
55624	1 pts		Dysfunctional uterine bleeding	serious				9141
55625	1 pts		Dermatitis contact	serious				9141
55626	30 pts		Constipation	below serious				9141
55627	33 pts		Nausea	below serious				9141
55628	22 pts		Upper respiratory tract infection	below serious				9141
55629	23 pts		Headache	below serious				9141
55630	1 pts		Pancreatic mass	serious				9142
55631	10 pts		Nausea	below serious				9142
55632	3		Rash					9150
55633	3		Rash					9148
55634			Nausea					9136
55635			Abdominal pain					9136
55636			Constipation					9136
55637	7		Abdominal pain		discontinuation			9152
55638	2.3		Constipation		discontinuation			9152
55639	2.3		Nausea		discontinuation			9152
55640	1.8		Headache		discontinuation			9152
55641	1.8		Dizziness		discontinuation			9152
55642	1.2		Vomiting		discontinuation			9152
55643	1.2		Fatigue		discontinuation			9152
55644	1.8		Dry mouth		discontinuation			9152
55645	1.2		Somnolence		discontinuation			9152
55646	1.2		Pruritis		discontinuation			9152
55647	1.4		Abdominal pain		discontinuation			9149
55648	1.5		Constipation		discontinuation			9149
55649	0.1		Headache		discontinuation			9149
55650	0.1		Dizziness		discontinuation			9149
55651	0.2		Vomiting		discontinuation			9149
55652	0.1		Somnolence		discontinuation			9149
55653	1.5		Abdominal pain		discontinuation			9151
55654	1.1		Constipation		discontinuation			9151
55655	0.6		Nausea		discontinuation			9151
55656	0.4		Headache		discontinuation			9151
55657	0.1		Dizziness		discontinuation			9151
55658	0.1		Vomiting		discontinuation			9151
55659	0.1		Pruritis		discontinuation			9151
55660	2.6		Dizziness					9149
55661	1.9		Fatigue					9149
55662	1.9		Anxiety					9149
55663	1.2		Depression					9149
55664	1.1		Somnolence					9149
55665	2.6		Dizziness					9151
55666	2.6		Fatigue					9151
55667	1.2		Anxiety					9151
55668	1.1		Depression					9151
55669	0.1		Somnolence					9151
55670	7.1		Nausea					9149
55671	8.1		Constipation					9149
55672	4.6		Abdominal pain					9149
55673	4.2		Vomiting					9149
55674	3.2		Flatulence					9149
55675	2.7		Abdominal distension					9149
55676	8.1		Nausea					9151
55677	7.4		Constipation					9151
55678	4.1		Abdominal pain					9151
55679	4		Vomiting					9151
55680	2.6		Flatulence					9151
55681	2.6		Abdominal distension					9151
55682	3.3		Upper respiratory tract infection					9151
55683	4.1		Nasopharyngitis					9151
55684	3.3		Sinusitis					9151
55685	3.2		Bronchitis					9151
55686	2.7		Gastroenteritis viral					9151
55687	2.1		Urinary tract infection					9151
55688	5.1		Upper respiratory tract infection					9149
55689	3		Nasopharyngitis					9149
55690	2.6		Sinusitis					9149
55691	2.9		Bronchitis					9149
55692	1.4		Gastroenteritis viral					9149
55693	1.7		Urinary tract infection					9149
55694	4		Headache					9151
55695	2.6		Dizziness					9151
55696	4.3		Headache					9149
55697	3.2		Dizziness					9149
55698	2.6		Fatigue					9151
55699	1.9		Fatigue					9149
55700	2.1		ALT increased					9151
55701	2.5		ALT increased					9149
55702	2.5		Hypertension					9151
55703	1.4		Hypertension					9149
55704	1.9		Bilirubin elevated					9151
55705	1.3		Bilirubin elevated					9149
55706	0.9		Alkaline phosphatase					9151
55707	0.8		Alkaline phosphatase					9149
55708						Information about MTD AEs not found		9138
55709						Information about MTD AEs not found		9137
55710	75		Dysuria	grade 2	discontinuation		TRUE	9156
55711			Haematuria				TRUE	9156
55712			Haematuria				TRUE	9154
55713	33.3		Dysuria	grade 2			TRUE	9154
55714	12.5		Dysuria	grade 2				9155
55715	12.5		Haematuria	grade 2				9155
55716	33.3		Thrombocytopaenia		discontinuation			9153
55717	66.7		Diarrhoea	grade 3	dose reduction			9153
55718	33.3		Diarrhoea	grade 2	discontinuation			9153
55719	33.3		Myelosuppression	grade 3	dose reduction		TRUE	9153
55720	33.3		Neutropenic sepsis		dose reduction		TRUE	9153
55721	33.3		Neutropenic sepsis		discontinuation			9153
55722	33.3		Myelosuppression	grade 4	discontinuation			9153
55723	33.3		Multiorgan failure	grade 5	discontinuation			9153
55724			Abdominal cramps					9157
55725			Abdominal pain					9157
55726			Flatulence					9157
55727	2 pts		Palpitations	below serious				9161
55728	4 pts		Vessel puncture site pain	below serious				9162
55729	5 pts		Constipation	below serious				9162
55730	3 pts		Headache	below serious				9162
55731	1 pts		Maculopapular rash	below serious				9162
55732	1 pts		Cardiac failure	serious				9158
55733	1 pts		Abdominal wall haematoma	serious				9158
55734	1 pts		Ascites	serious				9158
55735	1 pts		Splenic artery aneurysm	serious				9158
55736	1 pts		Oedema	serious				9158
55737	1 pts		Parotitis	serious				9158
55738	1 pts		Rotator cuff syndrome	serious				9158
55739	1 pts		Encephalopathy hepatic	serious				9158
55740	1 pts		Syncope	serious				9158
55741	1 pts		Interstitial lung disease	serious				9158
55742	2 pts		Varicose vein	serious				9158
55743	39 pts		Pruritus	below serious				9158
55744	4 pts		Eczema	below serious				9158
55745	17 pts		Nasopharyngitis	below serious				9158
55746	5 pts		Influenza	below serious				9158
55747	1 pts		Sinusitis	below serious				9158
55748	4 pts		Bronchitis	below serious				9158
55749	5 pts		Constipation	below serious				9158
55750	5 pts		Abdominal discomfort	below serious				9158
55751	11 pts		Fatigue	below serious				9158
55752	4 pts		Arthralgia	below serious				9158
55753	12 pts		Headache	below serious				9158
55754	5 pts		Oropharyngeal pain	below serious				9158
55755	2 pts		Palpitations	below serious				9158
55756	4 pts		Procedural pain	below serious				9158
55757	4 pts		Hypothyroidism	below serious				9158
55758	1 pts		Osteopenia	below serious				9158
55759	3 pts		Dizziness	below serious				9158
55760	1 pts		Depression	below serious				9158
55761	1 pts		Myalgia	below serious				9158
55762	1 pts		Cystitis	below serious				9158
55763	2 pts		Asthenia	below serious				9158
55764	1 pts		Gastritis	below serious				9158
55765	1 pts		Oesophageal varices	below serious				9158
55766	1 pts		Varices oesophageal	below serious				9158
55767	1 pts		Ascites	below serious				9158
55768	2 pts		Cholelithiasis	below serious				9158
55769	3 pts		Contusion	below serious				9158
55770	3 pts		Gastroenteritis	below serious				9158
55771	2 pts		Dental caries	below serious				9158
55772	1 pts		Dermatitis	below serious				9158
55773	3 pts		Night sweats	below serious				9158
55774	1 pts		Hypoaesthesia	below serious				9158
55775	1 pts		Scratch	below serious				9158
55776	1 pts		Erythema	below serious				9158
55777	1 pts		Vertigo	below serious				9158
55778	1 pts		Tooth infection	below serious				9158
55779	2 pts		Ear pain	below serious				9158
55780	2 pts		Lower respiratory tract infection	below serious				9158
55781	3 pts		Sleep disorder	below serious				9158
55782	1 pts		Anaemia	serious				9159
55783	1 pts		Erysipelas	serious				9159
55784	1 pts		Pneumonia	serious				9159
55785	1 pts		Clavicle fracture	serious				9159
55786	1 pts		Post procedural haemorrhage	serious				9159
55787	1 pts		Radius fracture	serious				9159
55788	1 pts		Wrist fracture	serious				9159
55789	1 pts		Intervertebral disc protrusion	serious				9159
55790	2 pts		Osteoarthritis	serious				9159
55791	50 pts		Pruritus	below serious				9159
55792	4 pts		Rash	below serious				9159
55793	2 pts		Eczema	below serious				9159
55794	4 pts		Sinusitis	below serious				9159
55795	1 pts		Bronchitis	below serious				9159
55796	5 pts		Constipation	below serious				9159
55797	17 pts		Fatigue	below serious				9159
55798	5 pts		Oedema peripheral	below serious				9159
55799	5 pts		Pyrexia	below serious				9159
55800	7 pts		Arthralgia	below serious				9159
55801	6 pts		Cough	below serious				9159
55802	6 pts		Oropharyngeal pain	below serious				9159
55803	5 pts		Palpitations	below serious				9159
55804	1 pts		Osteopenia	below serious				9159
55805	2 pts		Hypertension	below serious				9159
55806	1 pts		Depression	below serious				9159
55807	3 pts		Myalgia	below serious				9159
55808	2 pts		Cystitis	below serious				9159
55809	1 pts		Herpes zoster	below serious				9159
55810	2 pts		Neck pain	below serious				9159
55811	2 pts		Pneumonia	below serious				9159
55812	3 pts		Dry mouth	below serious				9159
55813	1 pts		Gastritis	below serious				9159
55814	3 pts		Influenza like illness	below serious				9159
55815	1 pts		Ascites	below serious				9159
55816	2 pts		Contusion	below serious				9159
55817	1 pts		Gastroenteritis	below serious				9159
55818	2 pts		Dry skin	below serious				9159
55819	1 pts		Sciatica	below serious				9159
55820	1 pts		Bone pain	below serious				9159
55821	1 pts		Depressed mood	below serious				9159
55822	1 pts		Anaemia iron deficiency	below serious				9159
55823	2 pts		Nasal congestion	below serious				9159
55824	1 pts		Excoriation	below serious				9159
55825	2 pts		Gastric polyps	below serious				9159
55826	1 pts		Low density lipoprotein increased	below serious				9159
55827	2 pts		Fasciitis plantar	below serious				9159
55828	2 pts		Rash pruritic	below serious				9159
55829	3 pts		Scratch	below serious				9159
55830	3 pts		Erythema	below serious				9159
55831	1 pts		Cardiac murmur	below serious				9159
55832	2 pts		Rectal haemorrhage	below serious				9159
55833	1 pts		Cataract	below serious				9159
55834	1 pts		Abdominal pain lower	below serious				9159
55835	1 pts		Headache	serious				9160
55836	1 pts		Blood electrolytes abnormal	serious				9160
55837	1 pts		Gastritis	serious				9160
55838	1 pts		Hyperbilirubinaemia	serious				9160
55839	1 pts		Major depression	serious				9160
55840	2 pts		Pancreatitis acute	serious				9160
55841	1 pts		Renal failure acute	serious				9160
55842	2 pts		Vomiting	serious				9160
55843	1 pts		Abdominal distension	below serious				9160
55844	2 pts		Abdominal pain	below serious				9160
55845	1 pts		Accidental overdose	below serious				9160
55846	1 pts		Arrhythmia	below serious				9160
55847	1 pts		Arthralgia	below serious				9160
55848	1 pts		Cholestatic pruritus	below serious				9160
55849	1 pts		Clostridium difficile infection	below serious				9160
55850	1 pts		Confusional state	below serious				9160
55851	2 pts		Dizziness	below serious				9160
55852	1 pts		Electrocardiogram QT prolonged	below serious				9160
55853	1 pts		Electrolyte imbalance	below serious				9160
55854	1 pts		Escherichia urinary tract infection	below serious				9160
55855	1 pts		Faeces pale	below serious				9160
55856	1 pts		Fatigue	below serious				9160
55857	1 pts		Flank pain	below serious				9160
55858	1 pts		Flatulence	below serious				9160
55859	2 pts		Headache	below serious				9160
55860	1 pts		Hyperventilation	below serious				9160
55861	1 pts		Hypotension	below serious				9160
55862	1 pts		Increased tendency to bruise	below serious				9160
55863	1 pts		Infection	below serious				9160
55864	2 pts		Insomnia	below serious				9160
55865	1 pts		Migraine	below serious				9160
55866	1 pts		Muscular weakness	below serious				9160
55867	1 pts		Musculoskeletal pain	below serious				9160
55868	4 pts		Nausea	below serious				9160
55869	1 pts		Neutrophil count increased	below serious				9160
55870	4 pts		Oedema peripheral	below serious				9160
55871	1 pts		Respiration abnormal	below serious				9160
55872	1 pts		Skin lesion	below serious				9160
55873	1 pts		Skin ulcer	below serious				9160
55874	1 pts		Soft tissue mass	below serious				9160
55875	2 pts		Tachycardia	below serious				9160
55876	1 pts		Oesophageal varices	below serious				9160
55877	1 pts		Varices oesophageal	below serious				9160
55878	1 pts		Vertigo	below serious				9160
55879	2 pts		Vomiting	below serious				9160
55880	10		Pruritus		discontinuation	leads to discontinuation		9164
55881			Ascites					9163
55882			Jaundice					9163
55883			Portal hypertension					9163
55884			Primary biliary cholangitis					9163
55885						No severe or serious AEs were reported.		9165
55886	16.7		Vomiting	grade 3			TRUE	9171
55887	16.7		Dehydration	grade 3			TRUE	9171
55888	16.7		Hypophosphatemia	grade 3			TRUE	9171
55889	14.3		Hypophosphatemia	grade 3			TRUE	9170
55890						No adverse effects leading to discontinuation were reported; no DLTs		9167
55891	20		Gastrointestinal hemorrhage	grade 5	discontinuation		TRUE	9172
55892	20		Hallucinations	grade 3			TRUE	9172
55893	14.3		Diarrhea			multiple myeloma; 330 mg/day; n=1	TRUE	9166
55894	14.3		Hypotension			multiple myeloma; 330 mg/day; n=1	TRUE	9166
55895	25		Tumor lysis syndrome			Waldenström macroglobulinemia; 240 mg/day; n=1; multiple myeloma; 240 mg/day; n=1	TRUE	9168
55896	14.3		Hypotension			multiple myeloma; 300 mg/day; n=1	TRUE	9169
55897	12.5		Vomiting			Waldenström macroglobulinemia; 270 mg/day; n=1	TRUE	9173
55898						No information on AE is provided		9177
55899	14.3		Abdominal pain	grade 3			TRUE	9179
55900	14.3		Anorexia	grade 4			TRUE	9179
55901	14.3		Vomiting	grade 3			TRUE	9179
55902	33.3		Fatigue	grade 4	discontinuation			9175
55903	33.3		Pain	grade 3	discontinuation			9175
55904	33.3		Chest pain	grade 3	discontinuation			9175
55905	12.5		Pericardial effusion	grade 2			TRUE	9178
55906	14.3		Thrombocytopenia	grade 3			TRUE	9180
55907	14.3		Asthenia	grade 3			TRUE	9180
55908	100		Discoloration urine	grade 1				9174
55909	66.7		Diarrhea	grade 1-2				9174
55910	100		Feces discolored	grade 1				9174
55911	100		Fatigue	grade 1-2	discontinuation			9174
55912	100		Anorexia	grade 1-2				9174
55913	66.7		Abdominal pain	grade 1-2	discontinuation			9174
55914	66.7		Face edema	grade 1				9174
55915	33.3		Nausea	grade 2				9174
55916	66.7		Upper abdominal pain	grade 1				9174
55917	33.3		Chest pain	grade 1				9174
55918	33.3		Vomiting	grade 2				9174
55919	33.3		Alkaline phosphatase increased	grade 1				9174
55920	33.3		Albumin decreased	grade 2				9174
55921	33.3		Atrial fibrillation	grade 2				9174
55922	33.3		Sinus tachycardia	grade 1				9174
55923	16.7		Arrhythmia	grade 3			TRUE	9176
55924	7.7		Herpes zoster	grade 2	discontinuation			9181
55925	7.7		Thrombocytopenia	grade 4				9181
55926	6 pts		Diarrhea					9184
55927	4 pts		Nausea					9184
55928	3 pts		Vomiting					9184
55929	2 pts		Fatigue					9184
55930	2 pts		Edema peripheral					9184
55931	2 pts		Pyrexia					9184
55932	2 pts		Anemia					9184
55933	2 pts		Constipation					9184
55934	3 pts		Abdominal distension					9184
55935	2 pts		Dyspnea					9184
55936	3 pts		Decreased appetite					9184
55937	1 pts		Epistaxis					9184
55938	2 pts		Thrombocytopenia					9184
55939	2 pts		Abdominal pain					9184
55940	2 pts		Back pain					9184
55941	1 pts		Insomnia					9184
55942	1 pts		Cardiac murmur					9184
55943	1 pts		Dizziness					9184
55944	2 pts		Night sweats					9184
55945	1 pts		Neutropenia					9184
55946	1 pts		Chills					9184
55947	1 pts		Cough					9184
55948	2 pts		Dehydration					9184
55949	1 pts		Hyperbilirubinemia					9184
55950	7 pts		Diarrhea					9183
55951	5 pts		Nausea					9183
55952	3 pts		Vomiting					9183
55953	3 pts		Fatigue					9183
55954	2 pts		Edema peripheral					9183
55955	2 pts		Pyrexia					9183
55956	2 pts		Anemia					9183
55957	1 pts		Constipation					9183
55958	1 pts		Abdominal distension					9183
55959	1 pts		Dyspnea					9183
55960	1 pts		Asthenia					9183
55961	1 pts		Thrombocytopenia					9183
55962	1 pts		Back pain					9183
55963	1 pts		Insomnia					9183
55964	1 pts		Hyperuricemia					9183
55965	1 pts		Cardiac murmur					9183
55966	1 pts		Dizziness					9183
55967	1 pts		Night sweats					9183
55968	1 pts		Chills					9183
55969	1 pts		Dehydration					9183
55970	1 pts		Petechiae					9183
55971	6 pts		Diarrhea					9182
55972	4 pts		Nausea					9182
55973	3 pts		Vomiting					9182
55974	1 pts		Fatigue					9182
55975	3 pts		Edema peripheral					9182
55976	2 pts		Pyrexia					9182
55977	3 pts		Anemia					9182
55978	1 pts		Constipation					9182
55979	2 pts		Abdominal distension					9182
55980	3 pts		Dyspnea					9182
55981	2 pts		Asthenia					9182
55982	1 pts		Decreased appetite					9182
55983	1 pts		Epistaxis					9182
55984	1 pts		Thrombocytopenia					9182
55985	1 pts		Abdominal pain					9182
55986	3 pts		Hyperuricemia					9182
55987	2 pts		Cardiac murmur					9182
55988	1 pts		Dizziness					9182
55989	1 pts		Night sweats					9182
55990	1 pts		Chills					9182
55991	1 pts		Dehydration					9182
55992	1 pts		Pain in extremity					9182
55993	1 pts		QT prolonged	grade 3	discontinuation	leads to discontinuation	TRUE	9186
55994	1 pts		Diarrhea	grade 3		leads to dose interruption	TRUE	9187
55995	1 pts		Diarrhea	grade 2		leads to dose reduction	TRUE	9183
55996	2 pts		Diarrhea	grade 3		leads to dose interruption	TRUE	9182
55997	2 pts		Nausea	grade 1		leads to dose interruption	TRUE	9182
55998	2 pts		Vomiting	grade 1		leads to dose interruption	TRUE	9182
55999	2 pts		Dizziness	grade 2		leads to dose interruption	TRUE	9182
56000	2 pts		Gait disturbance	grade 2		leads to dose interruption	TRUE	9182
56001	2 pts		Performance status decreased	grade 2		leads to dose interruption	TRUE	9182
56002	2 pts		Vision blurred	grade 2		leads to dose interruption	TRUE	9182
56003	14 pts		Diarrhea	grade 1				9185
56004	2 pts		Fatigue	grade 1				9185
56005	9 pts		Nausea	grade 1				9185
56006	6 pts		Edema peripheral	grade 1				9185
56007	7 pts		Vomiting	grade 1				9185
56008	3 pts		Abdominal pain	grade 1				9185
56009	7 pts		Insomnia	grade 1				9185
56010	4 pts		Pruritus	grade 1				9185
56011	5 pts		Pain in extremity	grade 1				9185
56012	4 pts		Night sweats	grade 1				9185
56013	1 pts		Bone pain	grade 1				9185
56014	4 pts		Asthenia	grade 1				9185
56015	5 pts		Constipation	grade 1				9185
56016	4 pts		Dyspnea	grade 1				9185
56017	2 pts		Hyperuricemia	grade 1				9185
56018	4 pts		Pyrexia	grade 1				9185
56019	2 pts		Rash	grade 1				9185
56020	3 pts		Upper respiratory tract infection	grade 1				9185
56021	4 pts		Weight decreased	grade 1				9185
56022	9 pts		Diarrhea	grade 2				9185
56023	11 pts		Fatigue	grade 2				9185
56024	6 pts		Nausea	grade 2				9185
56025	5 pts		Edema peripheral	grade 2				9185
56026	3 pts		Vomiting	grade 2				9185
56027	3 pts		Abdominal pain	grade 2				9185
56028	2 pts		Insomnia	grade 2				9185
56029	4 pts		Pruritus	grade 2				9185
56030	2 pts		Pain in extremity	grade 2				9185
56031	3 pts		Night sweats	grade 2				9185
56032	1 pts		Anemia	grade 2				9185
56033	1 pts		Bone pain	grade 2				9185
56034	1 pts		Asthenia	grade 2				9185
56035	4 pts		Cardiac murmur	grade 2				9185
56036	1 pts		Rash	grade 2				9185
56037	1 pts		Upper respiratory tract infection	grade 2				9185
56038	5 pts		Diarrhea	grade 3				9185
56039	4 pts		Fatigue	grade 3				9185
56040	1 pts		Nausea	grade 3				9185
56041	1 pts		Edema peripheral	grade 3				9185
56042	1 pts		Vomiting	grade 3				9185
56043	3 pts		Abdominal pain	grade 3				9185
56044	1 pts		Pruritus	grade 3				9185
56045	3 pts		Anemia	grade 3				9185
56046	4 pts		Bone pain	grade 3				9185
56047	1 pts		Dyspnea	grade 3				9185
56048	1 pts		Rash	grade 3				9185
56049	1 pts		Fatigue	grade 4				9185
56050	1 pts		Pain in extremity	grade 4				9185
56051	2 pts		Anemia	grade 4				9185
56052	2 pts		Hyperuricemia	grade 4				9185
56053	2 pts		Pneumonia	serious				9188
56054	2 pts		Urinary tract infection	serious				9188
56055	1 pts		Bronchopneumonia	serious				9188
56056	1 pts		Lower respiratory tract infection	serious				9188
56057	1 pts		Fall	serious				9188
56058	1 pts		Femoral neck fracture	serious				9188
56059	1 pts		Hip fracture	serious				9188
56060	1 pts		Laceration	serious				9188
56061	1 pts		Malignant neoplasm of thorax	serious				9188
56062	1 pts		Dementia	serious				9188
56063	1 pts		Depressed level of consciousness	serious				9188
56064	1 pts		Transient ischaemic attack	serious				9188
56065	1 pts		Aggression	serious				9188
56066	1 pts		Renal failure acute	serious				9188
56067	9 pts		Anaemia	below serious				9188
56068	7 pts		Oedema peripheral	below serious				9188
56069	13 pts		Lower respiratory tract infection	below serious				9188
56070	6 pts		Cellulitis	below serious				9188
56071	20 pts		Fall	below serious				9188
56072	5 pts		Blood potassium increased	below serious				9188
56073	19 pts		Agitation	below serious				9188
56074	9 pts		Aggression	below serious				9188
56075	5 pts		Anxiety	below serious				9188
56076	5 pts		Behavioural and psychiatric symptoms of dementia	below serious				9188
56077	1 pts		Cardiac disorders					9191
56078	2 pts		Gastrointestinal disorders					9191
56079	2 pts		Nervous system disorders					9191
56080	2 pts		Nervous system disorders					9190
56081	1 pts		General system disorders NEC					9190
56082	1 pts		Vascular disorders					9190
56083	5 pts		Gastrointestinal disorders					9189
56084	6 pts		Nervous system disorders					9189
56085	3 pts		General system disorders NEC					9189
56086	1 pts		Nausea		discontinuation	leads to discontinuation		9189
56087	2 pts		Vomiting		discontinuation	leads to discontinuation		9189
56088	1 pts		Dyspepsia		discontinuation	leads to discontinuation		9189
56089	1 pts		Nausea		discontinuation	leads to discontinuation		9195
56090	1 pts		Vomiting		discontinuation	leads to discontinuation		9195
56091	2		Hallucination		discontinuation	leads to discontinuation		9193
56092	1		Fatigue		discontinuation	leads to discontinuation		9193
56093			Heart failure	grade 5		WARNING		9192
56094			Pneumonia	grade 5		WARNING		9192
56095	0.5		Confusional state		discontinuation	leads to discontinuation		9194
56096	1.5		Psychotic disorder		discontinuation	leads to discontinuation		9194
56097	1.5		Mental status changes		discontinuation	leads to discontinuation		9194
56098	0.5		Headache		discontinuation	leads to discontinuation		9194
56099	0.5		Asthenia		discontinuation	leads to discontinuation		9194
56100	1		Infections and infestations		discontinuation	leads to discontinuation		9194
56101	1		Urinary tract infection		discontinuation	leads to discontinuation		9194
56102	0.5		Pollakiuria		discontinuation	leads to discontinuation		9194
56103	0.5		Dehydration		discontinuation	leads to discontinuation		9194
56104	0.5		Respiratory distress		discontinuation	leads to discontinuation		9194
56105	1 pts		Cardiac failure	grade 4			TRUE	9196
56106	4		Cardiac failure congestive	grade 3-4				9196
56107	2		Ejection fraction decreased	grade 3-4				9196
56108	2		Cardio-respiratory arrest	grade 3-4				9196
56109	2		Hypophosphatemia	grade 3-4				9196
56110	5		Adverse event		discontinuation	impossible to link AEs with the definite dose: the highest dose was associated with more AEs and discontinuations due to AEs than either placebo or rasagiline		9197
56111	20		Fatigue	grade 3				9198
56112	20		Ataxia	grade 3	discontinuation			9198
56113	20		Creatinine increased	grade 3				9198
56114	20		Dizziness	grade 2			TRUE	9198
56115	25		Convulsion	grade 3	discontinuation			9200
56116	20		Creatinine increased	grade 2	discontinuation			9206
56117	14.3		Erythema multiforme	grade 3	discontinuation			9203
56118	5.5		Hypoxia	grade 3	discontinuation			9205
56119	5.5		Rash	grade 3	discontinuation			9205
56120	12.5		AST increased	grade 3	discontinuation			9199
56121	12.5		Eosinophilia	grade 3	discontinuation			9204
56122	1.7		Abdominal pain	grade 2	discontinuation			9201
56123	1.7		AST increased	grade 2	discontinuation			9201
56124	1.7		Drug hypersensitivity	grade 2	discontinuation			9201
56125	1.7		Dyspnea exertional	grade 2	discontinuation			9201
56126	1.7		Infusion related reaction	grade 2	discontinuation			9201
56127	1.7		Nausea	grade 2	discontinuation			9201
56128	1.7		Thrombocytopenia	grade 2-3	discontinuation			9201
56129	1.7		Neutropenia	grade 3	discontinuation			9201
56130	3.4		ALT increased	grade 3	discontinuation			9201
56131	25		Thrombocytopenia	grade 4			TRUE	9202
56132	17		Fatigue		dose interruption			9207
56133	17		Diarrhea		dose interruption			9207
56134	17		Decreased appetite		dose reduction			9207
56135	50		Hyperglycemia		dose interruption			9207
56136	17		Nausea		dose interruption|dose reduction			9207
56137	32		Diarrhea					9208
56138	32		Decreased appetite					9208
56139	11		Vomiting					9208
56140	21		Muscle spasms					9208
56141	32		Hyperglycemia					9208
56142	32		Nausea					9208
56143	32		Fatigue					9208
56144	25		Orthostatic hypotension					9212
56145	62.5		Orthostatic hypotension					9213
56146	50		Orthostatic hypotension					9211
56147	13.64		Orthostatic hypotension					9210
56148	1.8		Kidney dysfunction		discontinuation	leads to discontinuation		9209
56149	1.7		Hypotension		discontinuation	leads to discontinuation		9209
56150	1.3		Hyperkalemia		discontinuation	leads to discontinuation		9209
56151	7.14		Cardiovascular syncope	grade 3				9216
56152	4.5		Intestinal obstruction	grade 3	discontinuation	possibly related to drug		9215
56153						No adverse effects leading to discontinuation were reported		9214
56154	3.7		Neurocardiogenic syncope		discontinuation			9217
56155			Nausea					9219
56156	16		Nausea					9218
56157	14		Urinary tract infection					9218
56158	14		Headache					9218
56159	9		Arthralgia					9218
56160	8		Upper respiratory tract infection					9218
56161	8		Vomiting					9218
56162	8		Pyrexia					9218
56163	8		Pneumonia					9218
56164	8		Back pain					9218
56165	8		Pain in extremity					9218
56166	7		Nasopharyngitis					9218
56167	7		Cough					9218
56168	6		Constipation					9218
56169	6		Fatigue					9218
56170	5		Hypokalaemia					9218
56171	5		Haematuria					9218
56172	3		Diarrhoea					9218
56173	3		Abdominal pain					9218
56174	3		Pharyngolaryngeal pain					9218
56175	3		Pruritus					9218
56176	1		Drug hypersensitivity					9218
56177	5		Alkaline phosphatase increased					9218
56178	31		GGT increased					9218
56179	3		Hemoglobin increased					9218
56180	6		Platelet count increased					9218
56181						No information on AE is provided		9220
56182			Heart rate increased					9221
56183			Nausea		discontinuation			9224
56184			Intestinal perforation		discontinuation			9224
56185	96.6		Nausea	grade 1-3			TRUE	9223
56186	58.6		Dysgeusia					9223
56187	58.6		Constipation				TRUE	9223
56188	82.8		Vomiting				TRUE	9223
56189	58.6		Diarrhea				TRUE	9223
56190	37.9		Chromaturia					9223
56191	41.4		Fatigue				TRUE	9223
56192	34.5		Decreased appetite					9223
56193	31		Asthenia					9223
56194	51.7		Weight decreased					9223
56195	10.3		AST increased					9223
56196	10.3		ALT increased					9223
56197	63.6		Nausea					9222
56198	63.6		Dysgeusia					9222
56199	54.5		Constipation					9222
56200	63.6		Vomiting					9222
56201	63.6		Diarrhea					9222
56202	63.6		Chromaturia					9222
56203	9.1		Fatigue					9222
56204	27.3		Decreased appetite					9222
56205	36.4		Asthenia					9222
56206	9.1		Weight decreased					9222
56207	1 pts		Dizziness		discontinuation			9225
56208	1 pts		Headaches		discontinuation			9225
56209	1 pts		Nausea and vomiting		discontinuation			9226
56210	1 pts		Dizziness		discontinuation			9226
56211	1 pts		Insomnia		discontinuation			9226
56212	1 pts		Dizziness		discontinuation			9226
56213	1 pts		Diarrhea		discontinuation			9226
56214	66.7		Muscular weakness	grade 3-4	discontinuation		TRUE	9227
56215	33.3		Diarrhea	grade 3			TRUE	9227
56216	16.7		Fatigue	grade 3	discontinuation		TRUE	9229
56217	16.7		Muscular weakness	grade 3	discontinuation		TRUE	9229
56218	16.7		Blood phosphorus abnormal	grade 3			TRUE	9230
56219	33.3		Weakness	grade 3			TRUE	9228
56220	33.3		Fatigue	grade 3			TRUE	9228
56221						No AEs were observed		9231
56222	10		Diarrhoea					9232
56223	10		Nausea					9232
56224	7		Dizziness					9232
56225	7		Urinary tract infection					9232
56226	6		Agitation					9232
56227	6		Confusion state					9232
56228	3		Upper respiratory tract infection					9232
56229	9		Vomiting					9232
56230	4		Headache					9232
56231	6		Constipation					9232
56232	9		Depression					9232
56233	9		Eosinophilia					9232
56234	7		Nasopharyngitis					9232
56235	7		Pneumonia					9232
56236	4		Rash					9232
56237	3		Urinary incontinence					9232
56238	1		Blood glucose increased					9232
56239	12.9		Urinary tract infection					9233
56240	9		Fall					9233
56241	8.5		Dizziness					9233
56242	8.3		Diarrhea					9233
56243	7		Upper respiratory tract infection					9233
56244	6.7		Depression					9233
56245	6		Agitation					9233
56246	5.7		Constipation					9233
56247	5.1		Nasopharyngitis					9233
56248	4.7		Nausea					9233
56249	4.7		Headache					9233
56250	3.5		Back pain					9233
56251	46		Nausea	grade 1-2				9234
56252	30		Dizziness	grade 1-2				9234
56253	21		Vomiting	grade 1-2				9234
56254	18		Abnormal dreams	grade 1-2				9234
56255	21		Asthenia	grade 1-2				9234
56256	19		Headache	grade 1-2				9234
56257	6		Diarrhea	grade 1-2				9234
56258	7		Dyspepsia	grade 1-2				9234
56259	10		Insomnia	grade 1-2				9234
56260	1.5		Palpitation		discontinuation			9234
56261	1 pts		Panic attack	serious				9236
56262	1 pts		Alcohol withdrawal syndrome	serious				9236
56263	1 pts		Major depression	serious				9236
56264	1 pts		Osteoarthritis	serious				9236
56265	1 pts		Pineal neoplasm	serious				9236
56266	1 pts		Migraine	serious				9236
56267	45 pts		Diarrhea	below serious				9236
56268	1 pts		Abdominal pain	serious				9237
56269	1 pts		Diarrhea	serious				9237
56270	47 pts		Diarrhea	below serious				9237
56271						No information on AE is provided		9238
56272	1 pts		Diarrhea					9239
56273	3 pts		Diarrhea					9240
56274	1 pts		Abdominal pain					9240
56275	1 pts		Headache					9240
56276	6.5		Diarrhea		discontinuation	leads to discontinuation		9241
56277	6.5		Diarrhea		discontinuation	leads to discontinuation		9235
56278	13 pts		Diarrhea					9242
56279	12 pts		ALT increased					9242
56280	5 pts		Nasopharyngitis					9242
56281	6 pts		Nausea					9242
56282	5 pts		Vomiting					9242
56283	4 pts		Urinary tract infection					9242
56284	5 pts		AST increased					9242
56285	1 pts		GGT increased					9242
56286	5 pts		Headache					9242
56287	4 pts		Cough					9242
56288	1 pts		Syncope					9242
56289						No AEs were reported		9243
56290	33.3		Granulocytopenia	grade 4			TRUE	9301
56291	33.3		Granulocytopenia	grade 3				9301
56292	50		Anemia	grade 3			TRUE	9295
56293	100		Granulocytopenia	grade 4				9295
56294	50		Granulocytopenia	grade 4				9246
56295	16.7		Granulocytopenia	grade 3				9246
56296	66.7		Fatigue	grade 1-2				9245
56297	66.7		Nausea	grade 1-2				9245
56298	66.7		Anorexia	grade 1-2				9245
56299	33.3		Diarrhea	grade 1-2				9245
56300	33.3		Taste abnormality	grade 1-2				9245
56301	66.7		Anemia	grade 1-2				9245
56302	16.7		Fatigue	grade 3-4				9296
56303	16.7		Anorexia	grade 3-4				9296
56304	50		Granulocytopenia	grade 3-4			TRUE	9302
56305	100		Granulocytopenia	grade 3-4				9303
56306	100		Granulocytopenia	grade 3-4				9296
56307	100		Granulocytopenia	grade 3-4			TRUE	9245
56308	33.3		Anemia	grade 3-4				9303
56309	33.3		Anemia	grade 3-4				9245
56310	66.7		Fatigue	grade 1-2		OVERDOSAGE		9244
56311	50		Nausea	grade 1-2				9244
56312	16.7		Diarrhea	grade 1-2				9244
56313	66.7		Nausea	grade 3			TRUE	9300
56314	33.3		Granulocytopenia	grade 3-4			TRUE	9297
56315	33.3		Granulocytopenia	grade 3-4				9299
56316	66.7		Granulocytopenia	grade 3-4			TRUE	9300
56317	66.7		Granulocytopenia	grade 3-4			TRUE	9244
56318	33.3		Anemia	grade 3-4				9298
56319	3.2		Neutropenia		discontinuation			9272
56320	1.9		Anemia		discontinuation			9273
56321	1.9		Febrile neutropenia		discontinuation			9274
56322	1.9		Neutrophil count decreased		discontinuation			9275
56323	1.5		Fatigue		discontinuation			9276
56324	1.3		Diarrhea		discontinuation			9277
56325	0.9		Nausea		discontinuation			9278
56326	0.9		Decreased appetite		discontinuation			9279
56327	0.8		Vomiting		discontinuation			9280
56328	0.6		Asthenia		discontinuation			9281
56329	0.4		Mucosal inflammation		discontinuation			9282
56330	0.4		Blood alkaline phosphatase increased		discontinuation			9283
56331	0.4		Platelet count decreased		discontinuation			9284
56332	23.8		Neutropenia	grade 3-4				9285
56333	18.9		Neutrophil count decreased	grade 3-4				9286
56334	15.6		Anemia	grade 3-4				9287
56335	10.9		White blood cell count decreased	grade 3-4				9288
56336	3.9		Fatigue	grade 3-4				9289
56337	3.8		Blood bilirubin increased	grade 3-4				9290
56338	3.8		Febrile neutropenia	grade 3-4				9291
56339	3.6		Decreased appetite	grade 3-4				9292
56340	3.4		Asthenia	grade 3-4				9293
56341	3.2		Blood alkaline phosphatase increased	grade 3-4				9294
56342	3		GGT increased	grade 3-4				9247
56343	3		Diarrhea	grade 3-4				9248
56344	2.4		Leukopenia	grade 3-4				9249
56345	2.4		Platelet count decreased	grade 3-4				9250
56346	2.3		Dyspnea	grade 3-4				9251
56347	2.3		General physical health deterioration	grade 3-4				9252
56348	2.1		Abdominal pain	grade 3-4				9253
56349	2.1		Hypokalemia	grade 3-4				9254
56350	2.1		Thrombocytopenia	grade 3-4				9255
56351	2.1		Vomiting	grade 3-4				9256
56352	1.1		Pyrexia	grade 3-5				9257
56353	0.2		Constipation	grade 3-5				9258
56354	0.4		Cough	grade 3-5				9259
56355	0.2		Edema peripheral	grade 3-5				9260
56356	0.4		Stomatitis	grade 3-5				9261
56357	1.7		Back pain	grade 3-5				9262
56358	0.2		Weight decreased	grade 3-5				9263
56359	0.2		Abdominal pain upper	grade 3-5				9264
56360	0.9		Ascites	grade 3-5				9265
56361	0.4		Mucosal inflammation	grade 3-5				9266
56362	1.1		AST increased	grade 3-5				9267
56363	1.3		Hyponatremia	grade 3-5				9268
56364	1.7		Back pain	grade 3-5				9269
56365	0.6		Tumor pain	grade 3-5				9270
56366	1.5		Hypertension	grade 3-5				9271
56367	33.3		Neutropenia	grade 3-4			TRUE	9308
56368	16.7		Herpes zoster	grade 3			TRUE	9308
56369	50		Neutropenia	grade 3				9307
56370	50		Leukopenia	grade 3				9307
56371	50		Fatigue	grade 3				9307
56372	50		Urinary tract infection	grade 2				9307
56373	50		Arthralgia	grade 2				9307
56374	50		Hypoalbuminemia	grade 2				9307
56375	50		Hypophosphatemia	grade 2				9307
56376	50		Hyperglycemia	grade 2				9307
56377						No information on AE is provided		9306
56378						No information on AE is provided		9304
56379	61.5		Neutropenia	grade 1-4				9305
56380	46.2		Anemia	grade 1-4				9305
56381	30.8		Febrile neutropenia	grade 1-4				9305
56382	50		Diarrhea	grade 1-4				9305
56383	38.5		Thrombocytopenia	grade 1-4				9305
56384	34.6		Nausea	grade 1-4				9305
56385	30.8		ALT increased	grade 1-4				9305
56386	26.9		Pyrexia	grade 1-4				9305
56387	23.1		Headache	grade 1-2				9305
56388	23.1		Leukopenia	grade 1-4				9305
56389	19.2		Hyperbilirubinemia	grade 1-4				9305
56390	26.9		Arthralgia	grade 1-4				9305
56391	23.1		Pharyngolaryngeal pain	grade 1-2				9305
56392	15.4		Hypokalemia	grade 1-4				9305
56393	19.2		Stomatitis	grade 1-2				9305
56394	15.4		AST increased	grade 1-4				9305
56395	19.2		Rash	grade 1-4				9305
56396	26.9		Abdominal pain upper	grade 1-2				9305
56397	11.5		Fatigue	grade 1-2				9305
56398	23.1		Myalgia	grade 1-2				9305
56399	11.5		Mucosal inflammation	grade 1-4				9305
56400	11.5		Edema peripheral	grade 1-2				9305
56401	11.5		Dyspnea	grade 1-2				9305
56402	15.4		Vomiting	grade 1-2				9305
56403	53		Nausea	grade 1-2				9309
56404	5 pts		Nausea		discontinuation	Leads to dose reduction		9309
56405	53		Diarrhea	grade 1-2				9309
56406	2		Diarrhea	grade 3-4				9309
56407	4 pts		Diarrhea		discontinuation	Leads to dose reduction		9309
56408	49		Fatigue	grade 1-2				9309
56409	6		Fatigue	grade 3-4				9309
56410	29		Decreased appetite	grade 1-2				9309
56411	24		Vomiting	grade 1-2				9309
56412	18		Constipation	grade 1-2				9309
56413	20		Headache	grade 1-2				9309
56414	10		Anemia	grade 1-2				9309
56415	8		Anemia	grade 3-4				9309
56416	10		Cough	grade 1-2				9309
56417	12		Neutropenia	grade 1-2				9309
56418	8		Neutropenia	grade 3-4				9309
56419	16		Back pain	grade 1-2				9309
56420	2		Back pain	grade 3-4				9309
56421	8		Upper respiratory tract infection	grade 1-2				9309
56422	1 pts		Nausea	grade 3			TRUE	9311
56423	1 pts		Abdominal pain	grade 2			TRUE	9311
56424	1 pts		Vomiting	grade 3			TRUE	9311
56425	1 pts		Epigastralgia	grade 3			TRUE	9311
56426	> 20		Neutropenia	all grades				9310
56427	45		Neutrophil count decreased	all grades				9310
56428	41		Neutropenia	grade 3-4	discontinuation	leads to dose adjustment		9310
56429	41		Neutrophil count decreased	grade 3-4				9310
56430	> 20		Diarrhea	all grades				9310
56431	<1		Diarrhea	grade 3-4				9310
56432	<1		Nausea	grade 3-4				9310
56433	> 20		Nausea	all grades				9310
56434	> 20		Anemia	all grades				9310
56435	18		Anemia	grade 3-4				9310
56436	29		Hemoglobin decreased	all grades				9310
56437	18		Hemoglobin decreased	grade 3-4				9310
56438	> 20		Upper respiratory tract infection	all grades				9310
56439	> 20		Thrombocytopenia	all grades				9310
56440	15		Thrombocytopenia	grade 3-4	discontinuation	leads to discontinuation | leads to dose adjustment		9310
56441	22		Platelet count decreased	all grades				9310
56442	15		Platelet count decreased	grade 3-4				9310
56443	> 20		Fatigue	all grades				9310
56444	2		Fatigue	grade 3-4				9310
56445	2		Pneumonia	serious				9310
56446	2		Febrile neutropenia	serious	discontinuation	leads to dose adjustments		9310
56447	2		Pyrexia	serious				9310
56448	2		Anemia hemolytic autoimmune	serious	discontinuation	leads to discontinuation		9310
56449	2		Anemia	serious				9310
56450	2		Tumor lysis syndrome	serious				9310
56451	15		Vomiting	all grades				9310
56452	<1		Vomiting	grade 3-4				9310
56453	14		Constipation	all grades				9310
56454	11		Peripheral edema	all grades				9310
56455	<1		Peripheral edema	grade 3-4				9310
56456	22		Upper respiratory tract infection	all grades				9310
56457	1		Upper respiratory tract infection	grade 3-4				9310
56458	8		Pneumonia	all grades				9310
56459	5		Pneumonia	grade 3-4				9310
56460	12		Hypokalemia	all grades				9310
56461	4		Hypokalemia	grade 3-4				9310
56462	10		Back pain	all grades				9310
56463	<1		Back pain	grade 3-4				9310
56464	15		Headache	all grades				9310
56465	<1		Headache	grade 3-4				9310
56466	13		Cough	all grades				9310
56467						The source does not contain information about AEs or lack thereof		9312
56468						There were no serious adverse events observed during the study		9313
56469	0		Death	grade 5				9314
56470						No noticeable side effect was observed.		9315
56471	1 pts		Cholecystectomy	serious				9316
56472	1 pts		Sleep apnoea syndrome	serious				9316
56473	1 pts		Epididymitis	serious				9316
56474	1 pts		Renal infarct	serious				9316
56475	1 pts		Intervertebral disc protrusion	serious				9316
56476	1 pts		Lumbar spinal stenosis	serious				9316
56477	1 pts		Prostatic specific antigen increased	serious				9316
56478	1 pts		In-stent coronary artery restenosis	serious				9316
56479	1 pts		Urinary tract infection	serious				9316
56480	1 pts		Cholangitis acute	serious				9316
56481	1 pts		Haemorrhoids	serious				9316
56482	1 pts		Malignant ascites	serious				9316
56483	1 pts		Cerebral infarction	serious				9316
56484	2 pts		Brain stem haemorrhage	serious				9316
56485	1 pts		Coronary artery stenosis	serious				9316
56486	1 pts		Arteriosclerosis coronary artery	serious				9316
56487	11 pts		Gastric polyps	below serious				9316
56488	12 pts		Constipation	below serious				9316
56489	43 pts		Nasopharyngitis	below serious				9316
56490			Hyponatremia		discontinuation			9317
56491			Myalgia	grade 3	discontinuation			9319
56492			Cutaneous lupus erythematosus		discontinuation			9319
56493			Fever		discontinuation			9319
56494			Cutaneous lupus erythematosus		discontinuation			9318
56495						AEs were not observed		9320
56496						There were no studyrelated adverse events.		9322
56497						No adverse effects leading to discontinuation were reported.		9321
56498						AEs were not observed		9324
56499						The source does not contain information about AEs or lack thereof		9323
56500						No AEs were observed		9325
56501	25		Nausea					9326
56502						No AEs were reported		9327
56503	8.3		Abdominal distension		discontinuation			9328
56504	8.3		Vomiting	grade 3	discontinuation			9328
56505	8.3		Upper abdominal pain		discontinuation			9328
56506	8.3		Nausea		discontinuation			9328
56507	8.3		Diarrhea		discontinuation			9328
56508	8.3		Chest pain		discontinuation			9328
56509			Consciousness loss		discontinuation			9329
56510			Agitation		discontinuation			9330
56511			Somnolence		discontinuation			9330
56512			Dystonia		discontinuation			9330
56513						No adverse effects leading to discontinuation were reported.		9331
56514	16.7		Hypercalcemia	grade 4			TRUE	9332
56515	16.7		Alanine aminotransferase increased	grade 4				9332
56516	16.7		Gamma-glutamyltransferase increased	grade 4				9332
56517	9 pts		Phlebitis			Phlebitis at the infusion site		9333
56518			Headache					9333
56519			Fatigue					9333
56520	5.5		Nervousness		dose interruption			9335
56521	5.5		Insomnia		discontinuation			9335
56522	3.3		Abdominal pain					9334
56523	1.7		Nausea					9334
56524	3.3		Headache	grade 1				9334
56525	1 pts		Rash	below serious				9337
56526	1 pts		Depression	below serious				9337
56527	2 pts		Swallowing difficult	below serious				9337
56528	5 pts		Nausea	below serious				9338
56529	1 pts		Dry mouth	below serious				9338
56530	2 pts		Constipation	below serious				9338
56531	1 pts		Dizziness	below serious				9338
56532	1 pts		Skin rash	below serious				9340
56533	1 pts		Bloating	below serious				9339
56534	1 pts		Anaphylactoid reaction		discontinuation	leads to discontinuation		9341
56535	1 pts		Angioedema		discontinuation	leads to discontinuation		9341
56536	1 pts		Respiratory distress		discontinuation	leads to discontinuation		9341
56537						No information on AE is provided		9336
56538	1 pts		Ventricular bigeminy					9342
56539	30		Fatigue			no maximum tolerated dose was reached		9343
56540	30		Asthenia			no maximum tolerated dose was reached		9343
56541	9		Chest pain			no maximum tolerated dose was reached		9343
56542	5		Diarrhoea			no maximum tolerated dose was reached		9343
56543	1 pts		Low density lipoprotein increased			leads to discontinuation		9344
56544	21.1		Low density lipoprotein increased	all grades				9344
56545	7 pts		Hand-and-foot syndrome			leads to dose reduction		9344
56546	2 pts		Arrhythmia			leads to dose reduction		9344
56547	1 pts		Gastrointestinal hemorrhage			leads to discontinuation		9344
56548	2 pts		Pneumothorax			leads to discontinuation		9344
56549	1 pts		Fatigue			leads to dose reduction		9344
56550	3 pts		Platelet count decreased	grade 3-4				9344
56551	1 pts		Hypophosphatemia			leads to discontinuation		9344
56552	44.6		Hypertriglyceridemia	all grades				9344
56553	7 pts		Hemoptysis			leads to discontinuation		9344
56554	11.6		Urinary tract infection	all grades				9344
56555	2 pts		Proteinuria			leads to discontinuation		9344
56556	3 pts		Pneumonia			leads to discontinuation		9344
56557	1 pts		Mucositis oral			leads to discontinuation		9344
56558	3 pts		Venous thromboembolism			leads to discontinuation		9344
56559	2 pts		Hypertriglyceridemia			leads to dose reduction		9344
56560	2 pts		Interstitial lung disease			leads to discontinuation		9344
56561	1 pts		Fatigue			leads to discontinuation		9344
56562	1 pts		Dyspnea			leads to dose reduction		9344
56563	3 pts		Cough	grade 3-4				9344
56564	2 pts		Respiratory failure			leads to discontinuation		9344
56565	1 pts		Hand and foot syndrome			leads to discontinuation		9344
56566	43.9		Hand-and-foot syndrome	all grades				9344
56567	31.3		Low density lipoprotein increased	all grades				9344
56568	3 pts		Hypertension			leads to dose reduction		9344
56569	1 pts		Appendicitis			leads to discontinuation		9344
56570	45.9		Anorexia	all grades				9344
56571	1 pts		Diarrhea			leads to dose reduction		9344
56572	11.2		Headache	all grades				9344
56573	1 pts		Hypertension			leads to discontinuation		9344
56574	10.5		Platelet count decreased	all grades				9344
56575	28.2		Pharyngalgia	all grades				9344
56576	1 pts		Hepatic disease			leads to dose reduction		9344
56577	1 pts		Abdominal pain			leads to discontinuation		9344
56578	2 pts		Gamma-glutamyltransferase increased	grade 3-4				9344
56579	23.1		Mucositis oral	all grades				9344
56580	2 pts		Anorexia			leads to dose reduction		9344
56581	3 pts		Diarrhea	grade 3-4				9344
56582	20.4		Hemoptysis	all grades				9344
56583	1 pts		Fatigue	grade 3-4				9344
56584	2 pts		Mucositis oral			leads to dose reduction		9344
56585	67.7		Hypertension	all grades		leads to dose reduction		9344
56586	23.5		Hyponatremia	all grades				9344
56587	2 pts		Pharyngalgia	grade 3-4				9344
56588	35.4		Diarrhea	all grades				9344
56589	52		Fatigue	all grades				9344
56590	24 pts		Hyponatremia	grade 3-4				9344
56591	15		Hematuria	all grades				9344
56592	3 pts		Mucositis oral	grade 3-4				9344
56593	23.1		Dysphonia	all grades				9344
56594	11 pts		Hand-and-foot syndrome	grade 3-4				9344
56595	5 pts		Pharyngalgia	grade 3-4				9344
56596	41.5		Cough	all grades				9344
56597	28.9		Proteinuria	all grades				9344
56598	13.6		Hypertension	grade 3-4				9344
56599	26.2		Blood bilirubin increased	all grades				9344
56600	12.6		Upper respiratory infection	all grades				9344
56601	16 pts		GGT increased	grade 3-4				9344
56602	41.8		Hypercholesteremia	all grades				9344
56603	9 pts		Hypertriglyceridemia	grade 3-4				9344
56604	23.1		Weight loss	all grades				9344
56605	3 pts		Dysphonia	grade 3-4				9344
56606	7 pts		Proteinuria	grade 3-4				9344
56607	9 pts		Hemoptysis	grade 3-4				9344
56608	3 pts		Anorexia	grade 3-4				9344
56609	19		Weight loss	all grades				9345
56610	26		Proteinuria	all grades				9345
56611	27		Palmar-plantar erythrodysesthesia syndrome	all grades				9345
56612	1 pts		Proteinuria	grade 3				9345
56613	14		Gamma-glutamyltransferase increased	all grades				9345
56614	54		Hypertension	all grades				9345
56615	13		Low density lipoprotein increased	all grades				9345
56616	1 pts		Alanine aminotransferase increased	grade 3				9345
56617	12		Oropharyngeal pain	all grades				9345
56618	12		Abdominal pain	all grades				9345
56619	17		Aspartate aminotransferase increased	all grades				9345
56620	3 pts		Weight loss	grade 3				9345
56621	43		Decreased appetite	all grades				9345
56622	11		Globulin urine present	all grades				9345
56623	2 pts		Electrocardiogram QTc interval prolonged	grade 3				9345
56624	36		Hypothyroidism	all grades				9345
56625	11		Neutrophil count decreased	all grades				9345
56626	14		Dysphonia	all grades				9345
56627	10		Rash	all grades				9345
56628	1 pts		Electrocardiogram QTc interval prolonged	grade 3				9345
56629	10		Nausea	all grades				9345
56630	17		Diarrhea	all grades				9345
56631	15		Hypercholesterolemia	all grades				9345
56632	5		Hyperglycemia	all grades				9345
56633	1 pts		Insomnia	all grades				9345
56634	3 pts		Gamma-glutamyltransferase increased	grade 3				9345
56635	57		Fatigue	all grades				9345
56636	2		Fatigue	grade 3				9345
56637	14		Hypertriglyceridemia	all grades				9345
56638	13		Lymphocytopenia	all grades				9345
56639	17		Leukopenia	all grades				9345
56640	1 pts		Low density lipoprotein increased	grade 3				9345
56641	16		Hypertension	grade 3				9345
56642	6		Decreased appetite	grade 3				9345
56643	2 pts		Lymphocytopenia	grade 3				9345
56644	1 pts		Hypothyroidism	grade 3				9345
56645	1 pts		Oropharyngeal pain	grade 4				9345
56646	2 pts		Palmar-plantar erythrodysesthesia syndrome	grade 3				9345
56647	3 pts		Death	grade 5		leads to discontinuation		9345
56648	14		Alanine aminotransferase increased	all grades				9345
56649						No AEs were reported		9346
56650	3 pts		Skin hypopigmentation					9347
56651	6 pts		Cardiotoxicity		discontinuation	leads to discontinuation		9348
56652						No AEs were reported		9350
56653			Adverse drug reaction	moderate				9349
56654			Generalised convulsion			OVERDOSAGE?		9352
56655			Respiration spontaneous decreased			OVERDOSAGE?		9352
56656			Cyanosis			OVERDOSAGE?		9352
56657			Spasms					9351
56658			Cyanosis					9351
56659			Respiration spontaneous decreased					9351
56660						No AEs were reported		9353
56661	16 pts		Fatigue	all grades				9354
56662	8 pts		Nausea	all grades				9354
56663	5 pts		Dysgeusia	all grades				9354
56664	5 pts		Asthenia	all grades				9354
56665	5 pts		Cough	all grades				9354
56666	4 pts		Anorexia	all grades				9354
56667	4 pts		Dyspnea	all grades				9354
56668	4 pts		Injection site pain	all grades				9354
56669	3 pts		Injection site burning	all grades				9354
56670	3 pts		Vision blurred	all grades				9354
56671	3 pts		Headache	all grades				9354
56672	3 pts		Chest pain	all grades				9354
56673	3 pts		Pyrexia	all grades				9354
56674	1 pts		Fatigue	grade 3				9354
56675	1 pts		Asthenia	grade 3				9354
56676	1 pts		Chest pain	grade 3				9354
56677	2 pts		Dyspnea	grade 4				9354
56678	1 pts		Chest pain	grade 4				9354
56679	23 pts		Flank pain					9355
56680	5 pts		Urine volume decreased					9355
56681	6 pts		Nausea					9355
56682	6 pts		Vomiting					9355
56683	10 pts		Proteinuria					9355
56684	8 pts		Occult blood					9355
56685						No AEs were observed		9356
56686	3.3		Abdominal distension	grade 3	discontinuation			9358
56687	3.3		Palpitations	grade 3	discontinuation			9358
56688						No information on AE is provided		9357
56689						No serious and nonserious adverse events were observed throughout the study		9359
56690	1 pts		Visual impairment	grade 1				9364
56691	1 pts		Nausea	grade 1				9364
56692	1 pts		Vomiting	grade 1				9364
56693	3 pts		Fatigue	grade 1				9364
56694	1 pts		Bilirubin increased	grade 1				9364
56695	2 pts		Ageusia	grade 1				9364
56696	2 pts		Dysgeusia	grade 1				9364
56697	3 pts		Headache	grade 1			TRUE	9364
56698	2 pts		Balance disorder	grade 1				9364
56699	2 pts		Sensory disturbance	grade 1			TRUE	9364
56700	2 pts		Dizziness	grade 1				9364
56701	1 pts		Dysarthria	grade 1				9364
56702	1 pts		Somnolence	grade 1				9364
56703	1 pts		Confusional state	grade 1				9364
56704	1 pts		Dysphemia	grade 1				9364
56705	1 pts		Hallucination	grade 1				9364
56706	1 pts		Pelvic pain	grade 1				9364
56707	1 pts		Alopecia	grade 1				9364
56708	1 pts		Rash	grade 1				9364
56709	1 pts		Atrial fibrillation	grade 2				9364
56710	2 pts		Fatigue	grade 2				9364
56711	1 pts		Hypocalcemia	grade 2				9364
56712	2 pts		Dizziness	grade 2			TRUE	9364
56713	1 pts		Muscle contractions involuntary	grade 2				9364
56714	2 pts		Confusional state	grade 2			TRUE	9364
56715	1 pts		ALT increased	grade 3-4			TRUE	9364
56716	1 pts		AST increased	grade 3-4			TRUE	9364
56717	1 pts		Muscle contractions involuntary	grade 3-4				9364
56718	1 pts		Intra-abdominal hemorrhage	grade 3-4				9364
56719	1 pts		ALT increased	grade 3-4	discontinuation	leads to discontinuation	TRUE	9362
56720	1 pts		AST increased	grade 3-4	discontinuation	leads to discontinuation	TRUE	9362
56721	2 pts		Dizziness		discontinuation	leads to discontinuation	TRUE	9361
56722	1 pts		Confusion		discontinuation	leads to discontinuation	TRUE	9361
56723	1 pts		Hallucinations		discontinuation	leads to discontinuation	TRUE	9361
56724	1 pts		Speech impairment NOS		discontinuation	leads to discontinuation	TRUE	9361
56725	1 pts		Fatigue		discontinuation	leads to discontinuation	TRUE	9361
56726	1 pts		Neurotoxicity		discontinuation	leads to discontinuation	TRUE	9361
56727	2 pts		Vomiting	grade 1-2				9360
56728	2 pts		Nausea	grade 1-2				9360
56729	1 pts		Dizziness	grade 1-2			TRUE	9360
56730	2 pts		Tremor	grade 1-2			TRUE	9360
56731	1 pts		Somnolence	grade 1-2				9360
56732	1 pts		Headache	grade 1-2				9360
56733	1 pts		Lethargy	grade 1-2				9360
56734	1 pts		Electrocardiogram QT prolonged	grade 1-2				9360
56735	1 pts		Fatigue	grade 1-2				9360
56736	1 pts		Cough	grade 1-2				9360
56737	1 pts		Vertigo	grade 1-2				9360
56738	1 pts		Hypokalemia	grade 1-2				9360
56739	1 pts		Dizziness	grade 3-4			TRUE	9360
56740	1 pts		Osteonecrosis	grade 3-4				9360
56741	2 pts		Vomiting	grade 1-2				9363
56742	1 pts		Constipation	grade 1-2				9363
56743	2 pts		Nausea	grade 1-2				9363
56744	2 pts		Dizziness	grade 1-2				9363
56745	1 pts		Tremor	grade 1-2				9363
56746	1 pts		Ataxia	grade 1-2				9363
56747	3 pts		Electrocardiogram QT prolonged	grade 1-2				9363
56748	1 pts		Hemoglobin decreased	grade 1-2				9363
56749	1 pts		Fatigue	grade 1-2				9363
56750	1 pts		Vertigo	grade 1-2				9363
56751	1 pts		Confusional state	grade 1-2				9363
56752	1 pts		Thrombophlebitis	grade 1-2				9363
56753	1 pts		Dyskinesia	grade 3-4			TRUE	9363
56754	1 pts		Electrocardiogram QT prolonged	grade 3-4			TRUE	9363
56755	1 pts		Fatigue	grade 3-4				9363
56756	1 pts		Disorientation	grade 3-4				9363
56757						No adverse effects leading to discontinuation were reported; no DLTs		9366
56758			Hypotension	grade 3		resolved within 2 to 5 days	TRUE	9365
56759			Hypersensitivity reaction	grade 3		resolved within 2 to 5 days	TRUE	9365
56760	2 pts		Catheter related infection	grade 3-4				9369
56761	5 pts		Lung infection	grade 3-4				9369
56762	9 pts		Febrile neutropenia	grade 3-4				9369
56763	3 pts		Sepsis	grade 3-4				9369
56764	4 pts		Hypertension	grade 3-4				9369
56765	2 pts		Hypotension	grade 3-4				9369
56766	1 pts		Heart failure	grade 3-4				9369
56767	1 pts		Cardiac troponin increased	grade 3-4				9369
56768	1 pts		Sinus tachycardia	grade 3-4				9369
56769	1 pts		Alanine aminotransferase increased	grade 3-4				9369
56770	2 pts		Aspartate aminotransferase increased	grade 3-4				9369
56771	1 pts		Bilirubin increased	grade 3-4				9369
56772	1 pts		Alkalosis	grade 3-4				9369
56773	3 pts		Hypokalemia	grade 3-4				9369
56774	5 pts		Hyponatremia	grade 3-4				9369
56775	2 pts		Hypophosphatemia	grade 3-4				9369
56776	3 pts		Hyperglycemia	grade 3-4				9369
56777	1 pts		Hyperuricemia	grade 3-4				9369
56778	1 pts		Hypoalbuminemia	grade 3-4				9369
56779	1 pts		Syncope	grade 3-4				9369
56780	6 pts		Hypoxia	grade 3-4				9369
56781	1 pts		Respiratory failure	grade 3-4				9369
56782	1 pts		Fall	grade 3-4				9369
56783	1 pts		Rash maculo-papular	grade 3-4				9369
56784	8 pts		Thrombocytopenia	grade 1-2				9368
56785	11 pts		Fatigue	grade 1-2				9368
56786	8 pts		Nausea	grade 1-2				9368
56787	8 pts		Anemia	grade 1-2				9368
56788	8 pts		Creatinine increased	grade 1-2				9368
56789	8 pts		Leukopenia	grade 1-2				9368
56790	4 pts		Lymphopenia	grade 1-2				9368
56791	4 pts		Hypophosphatemia	grade 1-2				9368
56792	7 pts		Neutropenia	grade 1-2				9368
56793	6 pts		Diarrhea	grade 1-2				9368
56794	4 pts		Anorexia	grade 1-2				9368
56795	5 pts		Hypoalbuminemia	grade 1-2				9368
56796	4 pts		Vomiting	grade 1-2				9368
56797	4 pts		Dizziness	grade 1-2				9368
56798	4 pts		Myalgia	grade 1-2				9368
56799	4 pts		Constipation	grade 1-2				9368
56800	4 pts		ALT increased	grade 1-2				9368
56801	4 pts		Alkaline phosphatase increased	grade 1-2				9368
56802	2 pts		Weight loss	grade 1-2				9368
56803	3 pts		AST increased	grade 1-2				9368
56804	3 pts		Concentration impaired	grade 1-2				9368
56805	3 pts		Dry mouth	grade 1-2				9368
56806	3 pts		Dysgeusia	grade 1-2				9368
56807	3 pts		Headache	grade 1-2				9368
56808	3 pts		Hyponatremia	grade 1-2				9368
56809	2 pts		Cough	grade 1-2				9368
56810	2 pts		Dehydration	grade 1-2				9368
56811	2 pts		Edema limbs	grade 1-2				9368
56812	2 pts		Hypermagnesemia	grade 1-2				9368
56813	2 pts		Hypernatremia	grade 1-2				9368
56814	2 pts		Hypersomnia	grade 1-2				9368
56815	2 pts		International normalized ratio	grade 1-2				9368
56816	5 pts		Thrombocytopenia	grade 3-4				9368
56817	2 pts		Nausea	grade 3-4				9368
56818	2 pts		Anemia	grade 3-4				9368
56819	3 pts		Lymphopenia	grade 3-4				9368
56820	3 pts		Hypophosphatemia	grade 3-4				9368
56821	1 pts		Anorexia	grade 3-4				9368
56822	1 pts		Weight loss	grade 3-4				9368
56823	1 pts		Psychiatric disorders	grade 3-4				9368
56824	1 pts		Thromboembolic event	grade 3-4				9368
56825	1 pts		Hematuria	grade 3-4				9368
56826	1 pts		Thrombocytopenia	grade 3			TRUE	9368
56827	1 pts		Psychosis	grade 4			TRUE	9368
56828	1 pts		Thrombocytopenia	grade 3			TRUE	9367
56829	13.3		Flatulence	grade 1				9370
56830	13.3		Heartburn	grade 1				9370
56831	13.3		Nausea	grade 2				9370
56832	13.3		Stomachache	grade 1				9370
56833	33.3		Leukopenia	grade 1				9371
56834	11.1		Neutropenia	grade 1				9371
56835	33.3		Anemia	grade 1-2				9371
56836	11.1		Thrombocytopenia	grade 1				9371
56837	44.4		Diarrhea	grade 1-2				9371
56838	55.5		Nausea	grade 1-2				9371
56839	33.3		Vomiting	grade 1-2				9371
56840	77.8		Anorexia	grade 1-3				9371
56841	44.4		Fatigue	grade 1-3				9371
56842	22.2		Constipation	grade 1-2				9371
56843	33.3		Bilirubin total increased	grade 1-3				9371
56844	88.9		AST increased	grade 1-3				9371
56845	66.7		ALT increased	grade 1-3				9371
56846	88.9		ALP increased	grade 1-3				9371
56847	88.9		GGT increased	grade 1-3				9371
56848	11.1		Creatinine increased	grade 2				9371
56849	100		Hyperglycemia	grade 1-3				9371
56850						No adverse effects leading to discontinuation were reported; no DLTs		9372
56851						No adverse effects leading to discontinuation were reported; no DLTs		9374
56852	33.3		Aspartate aminotransferase increased	grade 3			TRUE	9373
56853	33.3		Maculopapular rash	grade 3		drug eruption (maculopapular rash on trunk, lower extremities, face, arm, and back)	TRUE	9373
56854	40		Hypotension	grade 2				9377
56855	20		Hypotension	grade 3			TRUE	9377
56856	20		Hypotension	grade 4			TRUE	9377
56857	16.7		Elevated liver enzymes				TRUE	9376
56858	14.3		Pneumonitis	grade 3			TRUE	9375
56859	14.3		Maculopapular rash	grade 3			TRUE	9378
56860			Acute renal failure	grade 3			TRUE	9379
56861			Diarrhea	grade 3			TRUE	9379
56862						No adverse effects leading to discontinuation were reported; no DLTs		9381
56863			Diarrhea	grade 3			TRUE	9382
56864			Vomiting	grade 3			TRUE	9382
56865			Nausea	grade 3			TRUE	9382
56866						No adverse effects leading to discontinuation were reported; no DLTs		9380
56867						There were no deaths and no serious adverse events reported during the study, and none of the subjects withdrew from the study due to adverse events		9383
56868						There were no serious adverse events, and no subject required medical attention.		9385
56869						No adverse effects leading to discontinuation were reported		9384
56870						There were no serious adverse events		9386
56871	11.1		Rash	grade 3		One of nine patients in the 20 mg BID cohort experienced a grade 3 rash 19 days after starting AZD8330, which resolved after a 21-day treatment interruption.	TRUE	9388
56872	33.3		Hallucinations				TRUE	9387
56873						impossible to link AEs with the definite dose		9389
56874	15.4		Toxic reaction (NOS)					9390
56875	4 pts		Cyanosis					9390
56876	4 pts		Gastrointestinal disorders		discontinuation	Gastrointestinal intolerance to the drug, evidenced by nausea, cramps and vomiting, forced discontinuance of use of the drug in four cases ; of these, two patients also used alcohol at the same time, which appeared to accentuate the irritant effect of the neoprontosil.		9390
56877	1 pts		Chills and fever		discontinuation	Only one patient, who suffered from chills, fever and vomiting, was acutely sick from the use of the drug and recovery was immediate on discontinuing its use.		9390
56878	1 pts		Light headedness					9391
56879	1 pts		Headache	mild				9391
56880						No information on AE is provided		9392
56881	1.8		Hyperactive bowel sounds	grade 1				9395
56882	3.6		Abdominal distension	grade 1				9395
56883	1.8		Constipation	grade 1				9395
56884	1.8		Dizziness	grade 1				9395
56885	1.8		Somnolence	grade 1				9395
56886	3.6		Blurred vision	grade 1				9395
56887	3.6		Decreased plasma fibrinogen	grade 1				9395
56888	1.8		Leukocyte count decreased	grade 1				9395
56889	10		Erythema		discontinuation			9393
56890	10		Hepatic function abnormal		discontinuation			9394
56891	10		Erythema		discontinuation			9396
56892	10		Erythema		discontinuation			9397
56893	10		Hepatic function abnormal		discontinuation			9397
56894						No adverse effects leading to discontinuation were reported		9398
56895						No adverse effects leading to discontinuation were reported		9399
56896						No AEs were observed		9400
56897						No AEs were observed		9401
56898			Sinusitis		discontinuation	leads to discontinuation		9402
56899			Nasopharyngitis		discontinuation	leads to discontinuation		9402
56900			Nasal congestion		discontinuation	leads to discontinuation		9402
56901			Headache		discontinuation	leads to discontinuation		9402
56902			Infection respiratory		discontinuation	leads to discontinuation		9402
56903	5 pts		Epistaxis		discontinuation	leads to discontinuation		9403
56904	1 pts		Increased intraocular pressure		discontinuation	leads to discontinuation		9403
56905	2 pts		Colon cancer		discontinuation	leads to discontinuation		9403
56906	2 pts		Nasal septum ulceration		discontinuation	leads to discontinuation		9403
56907	2 pts		Nasal discomfort		discontinuation	leads to discontinuation		9403
56908	2 pts		Sinusitis		discontinuation	leads to discontinuation		9403
56909	1 pts		Nasal congestion		discontinuation	leads to discontinuation		9403
56910	1 pts		Headache		discontinuation	leads to discontinuation		9403
56911	1 pts		Nasal mucosal disorder		discontinuation	leads to discontinuation		9403
56912	1 pts		Colic					9404
56913	1 pts		Salivation					9404
56914	1 pts		Paresis					9404
56915	46.7		Pruritus					9405
56916	30		Burning skin					9405
56917	20		Pain localized					9405
56918	3.3		Localised edema					9405
56919	4		Vomiting					9406
56920	2 pts		Pain of skin					9407
56921	6 pts		Soft tissue infection	serious	discontinuation			9407
56922	6 pts		Condition aggravated	serious	discontinuation			9407
56923	1 pts		Inflammation of wound					9407
56924	1 pts		Pruritic rash					9407
56925	1 pts		Wound complication					9407
56926	6 pts		Wound infection	serious	discontinuation			9407
56927	6 pts		Wound necrosis	serious	discontinuation			9407
56928						No AEs were observed		9408
56929	1.2		Hepatitis toxic	serious	discontinuation			9409
56930						No AEs were reported		9410
56931						No AEs were reported		9411
56932	2 pts		Dizziness					9416
56933	1 pts		Tiredness					9416
56934	1 pts		Shortness of breath					9416
56935	1 pts		Faintness					9416
56936	0.7		Sweating increased					9412
56937	2.2		Arthralgia					9412
56938	2.9		Dizziness					9412
56939	8.8		Headache					9412
56940	1.1		Hypoaesthesia					9412
56941	0.7		Dry mouth					9412
56942	0.4		Bradycardia					9412
56943	1.5		Insomnia					9412
56944	2.6		Diarrhea					9412
56945	1.5		Nausea					9412
56946	1.1		Vomiting					9412
56947	< 1		Bradycardia		discontinuation	leads to discontinuation		9413
56948	< 1		Fatigue		discontinuation	leads to discontinuation		9413
56949	1		Sweating increased					9414
56950	2.7		Arthralgia					9414
56951	3.5		Dizziness					9414
56952	10.9		Headache					9414
56953	1.5		Hypoaesthesia					9414
56954	1.3		Dry mouth					9414
56955	0.5		Bradycardia					9414
56956	2.5		Insomnia					9414
56957	0.2		Depression					9414
56958	3.5		Diarrhea					9414
56959	2.2		Nausea					9414
56960	1.5		Vomiting					9414
56961	< 1		Bradycardia		discontinuation	leads to discontinuation		9415
56962	< 1		Fatigue		discontinuation	leads to discontinuation		9415
56963						No adverse effects leading to discontinuation were reported; no DLTs		9418
56964	14.3		Infusion reaction	grade 3			TRUE	9417
56965	14.3		Liver failure	grade 5	discontinuation		TRUE	9417
56966	14.3		Vomiting	grade 3			TRUE	9417
56967	16.7		Diarrhea	grade 3			TRUE	9419
56968						No adverse reactions leading to discontinuation were reported		9420
56969	2 pts		Neutropenia	grade 4			TRUE	9421
56970			Hypotension		discontinuation			9423
56971			Loss of consciousness		discontinuation			9423
56972			Hypotension		discontinuation			9422
56973			Drowsiness		discontinuation			9422
56974	1.2		Urticaria		discontinuation			9424
56975	2.5		Hypotension		discontinuation			9424
56976	3.8		Cough		discontinuation			9425
56977	2.4		Failure heart		discontinuation			9425
56978	1.6		Hyperkalaemia		discontinuation			9425
56979			Taste perversion		discontinuation	Taste perversion/appetite decreased - 1.6%		9425
56980			Decreased appetite		discontinuation	Taste perversion/appetite decreased - 1.6%		9425
56981	1		Rash		discontinuation			9425
56982	1.4		Hypotension		discontinuation			9425
56983	0.8		Angio-oedema		discontinuation			9425
56984	1		Arrhythmia		discontinuation			9425
56985	1		Myocardial infarction		discontinuation			9425
56986	0.8		Kidney dysfunction		discontinuation			9425
56987	0.8		Stroke		discontinuation			9425
56988	0.5		Angina		discontinuation			9425
56989			Disorder fetal		discontinuation	WARNING		9426
56990						No information on AE is provided		9427
56991	1 pts		Perioral dermatitis					9428
56992						No information on AE is provided		9429
56993	1 pts		Stevens Johnson syndrome		discontinuation	leads to discontinuation		9432
56994	2 pts		Drug rash with eosinophilia and systemic symptoms		discontinuation	leads to discontinuation		9434
56995						No information on AE is provided		9430
56996	1 pts		Diarrhoea		discontinuation	leads to discontinuation		9433
56997	2 pts		Pruritus		discontinuation	leads to discontinuation		9433
56998	2 pts		Rash		discontinuation	leads to discontinuation		9433
56999	4.3		Inflammation injection site					9431
57000	2.4		Hypersensitivity					9431
57001	1.4		Gastrointestinal disorder					9431
57002	3 pts		Urticaria					9436
57003	4 pts		Itchy rash					9436
57004						No information on AE is provided		9435
57005	74 pts		Dyspnea	serious				9443
57006	28 pts		Cholelithiasis	serious				9443
57007	20 pts		Embolism and thrombosis	serious				9443
57008	6 pts		Aspiration	serious				9443
57009	4 pts		Dysphagia	serious				9443
57010	4 pts		Pneumonia	serious				9443
57011	5 pts		Cholecystitis	serious				9443
57012	4 pts		Hypersensitivity reaction	serious				9443
57013	3 pts		Death	serious				9443
57014	3 pts		Abdominal pain NOS	serious				9443
57015	3 pts		Clostridium difficile colitis	serious				9443
57016	3 pts		Diarrhea	serious				9443
57017	2 pts		Death	serious				9443
57018	2 pts		Dehydration	serious				9443
57019	2 pts		Hematoma	serious				9443
57020	2 pts		Hypoxia	serious				9443
57021	2 pts		Pneumothorax	serious				9443
57022	1 pts		Atelectasis	serious				9443
57023	1 pts		Biliary sludge	serious				9443
57024	1 pts		Cardiac arrhythmia	serious				9443
57025	1 pts		Cognitive disturbance	serious				9443
57026	1 pts		Colitis	serious				9443
57027	1 pts		Confusion	serious				9443
57028	1 pts		Cough	serious				9443
57029	1 pts		Febrile neutropenia	serious				9443
57030	1 pts		Gastritis	serious				9443
57031	1 pts		Hemorrhage stomach	serious				9443
57032	1 pts		Hemorrhage	serious				9443
57033	1 pts		Operative hemorrhage	serious				9443
57034	1 pts		Infection	serious				9443
57035	1 pts		Bronchitis	serious				9443
57036	1 pts		Vaginal infection NOS	serious				9443
57037	1 pts		Abdominal infection	serious				9443
57038	1 pts		Left ventricular diastolic dysfunction	serious				9443
57039	1 pts		Thrombosis in device	serious				9443
57040	1 pts		Agitation	serious				9443
57041	1 pts		Anxiety	serious				9443
57042	1 pts		Ileal obstruction	serious				9443
57043	1 pts		Obstruction gastric	serious				9443
57044	1 pts		Chest wall pain	serious				9443
57045	1 pts		Thorax pain	serious				9443
57046	1 pts		Headache	serious				9443
57047	1 pts		Pain stomach	serious				9443
57048	1 pts		Hypokalemia	serious				9443
57049	1 pts		Urinary retention	serious				9443
57050	1 pts		Ventricular tachyarrhythmia	serious				9443
57051	1 pts		Vomiting	serious				9443
57052	7 pts		Pancreatitis	serious				9443
57053	152 pts		Diarrhea	below serious				9443
57054	158 pts		Cholelithiasis	below serious				9443
57055	98 pts		Catheter site related reaction	below serious				9443
57056	92 pts		Desquamation	below serious				9443
57057	100 pts		Biliary sludge	below serious				9443
57058	66 pts		Constipation	below serious				9443
57059	75 pts		Abdominal pain NOS	below serious				9443
57060	64 pts		Nausea	below serious				9443
57061	53 pts		Headache	below serious				9443
57062	54 pts		Edema limbs	below serious				9443
57063	46 pts		Lower extremity dysfunction	below serious				9443
57064	53 pts		Back pain	below serious				9443
57065	47 pts		Joint pain	below serious				9443
57066	40 pts		Insomnia	below serious				9443
57067	35 pts		Swallowing difficult	below serious				9443
57068	42 pts		Infection	below serious				9443
57069	39 pts		Upper extremity dysfunction	below serious				9443
57070	41 pts		Cough	below serious				9443
57071	34 pts		Anxiety	below serious				9443
57072	34 pts		Neck pain	below serious				9443
57073	38 pts		Pain in extremity	below serious				9443
57074	33 pts		Pruritis	below serious				9443
57075	27 pts		Fever	below serious				9443
57076	32 pts		ALT increased	below serious				9443
57077	25 pts		Chest wall pain	below serious				9443
57078	24 pts		Heartburn-like dyspepsia	below serious				9443
57079	25 pts		Dysarthria	below serious				9443
57080	27 pts		Weakness generalized	below serious				9443
57081	24 pts		Bruising	below serious				9443
57082	24 pts		Fracture	below serious				9443
57083	24 pts		Vomiting	below serious				9443
57084	18 pts		Pain	below serious				9443
57085	20 pts		Infection upper respiratory	below serious				9443
57086	23 pts		AST increased	below serious				9443
57087	19 pts		Hypersensitivity reaction	below serious				9443
57088	16 pts		Hypertension	below serious				9443
57089	20 pts		Lymphopenia	below serious				9443
57090			Anaphylactic shock	grade 5		Overdosage		9441
57091			Anaphylactic shock	grade 5		Overdosage		9440
57092			Cholelithiasis		discontinuation			9439
57093			Pulmonary edema		discontinuation			9439
57094	0.5		Elevated liver enzymes	grade 2	discontinuation			9442
57095			Hallucination	grade 2				9438
57096			Liver cholestasis	grade 2				9438
57097			Thrombocytopenia	grade 3				9437
57098			Neutropenia	grade 3				9437
57099			Loss of consciousness		discontinuation			9448
57100			Exanthema generalised		discontinuation			9448
57101			Esophageal burn	severe	discontinuation			9448
57102			Hemorrhagic gastritis		discontinuation			9448
57103			Cardiopulmonary arrest	grade 5	discontinuation			9449
57104			Ventricular tachycardia		discontinuation			9446
57105			Cardiac arrhythmia		discontinuation			9447
57106			Tachyarrhythmia		discontinuation			9447
57107			Ventricular extrasystoles		discontinuation			9447
57108			Cyanosis		discontinuation			9445
57109			Lethargy		discontinuation			9444
57110	33.3		Mucositis	grade 3			TRUE	9450
57111	33.3		Thrombocytopenia	grade 4			TRUE	9450
57112	25		Leucopenia	grade 4			TRUE	9451
57113	25		Mucositis	grade 4			TRUE	9451
57114	25		Bloody diarrhoea	grade 4			TRUE	9451
57115	2 pts		Neuropsychiatric symptoms		discontinuation			9452
57116	14 pts		Sedation					9455
57117	6 pts		Salivation					9455
57118	6 pts		Constipation					9455
57119	5 pts		Nausea and vomiting					9455
57120	4 pts		Dizziness					9455
57121	4 pts		Fever					9455
57122	20		Dry mouth					9453
57123	10		Urinary hesitancy					9453
57124	60		Constipation					9453
57125	60		Nausea					9453
57126	70		Dyspepsia					9453
57127	40		Headache					9453
57128	100		Somnolence					9453
57129	90		Lethargy					9453
57130	30		Myoclonus					9453
57131	20		Stuttering					9453
57132	80		Sialorrhea					9453
57133	50		Sweating					9453
57134	40		Urinary frequency					9453
57135	20		Dysphagia					9453
57136	10		Orthostatic hypotension					9453
57137	60		Dizziness					9453
57138	50		Increased appetite					9453
57139	13 pts		Orthostatic hypotension		discontinuation	Two patients were discontinued		9456
57140	1 pts		Sedation		discontinuation	Sedation, dysphagia		9456
57141	1 pts		Dysphagia		discontinuation	Sedation, dysphagia		9456
57142	2 pts		Fever		discontinuation	Fever, tachycardia		9456
57143	2 pts		Tachycardia		discontinuation	Fever, tachycardia		9456
57144	1 pts		Myocarditis		discontinuation			9456
57145	3 pts		Leukopenia		discontinuation	“Red” WBC		9456
57146	1 pts		Parkinsonism		discontinuation			9456
57147	3 pts		Myocardial infarction		discontinuation	Two patients were discontinued		9456
57148	1 pts		Ataxia		discontinuation			9456
57149	1 pts		Cardiomyopathy		discontinuation			9456
57150	28 pts		Sedation					9456
57151	25 pts		Hypersalivation					9456
57152	16 pts		Constipation					9456
57153	8 pts		Weight gain					9456
57154	4 pts		Leukopenia					9456
57155	3 pts		Tachycardia					9456
57156	2 pts		Leukopenia					9456
57157	2 pts		Seizure					9456
57158	1 pts		Dysphagia					9456
57159	1 pts		Fever			Fever and fatigue		9456
57160	1 pts		Fatigue			Fever and fatigue		9456
57161	21		Drowsiness					9454
57162	17		Tachycardia					9454
57163	16		Constipation					9454
57164	14		Dizziness					9454
57165	13		Hypotension					9454
57166	13		Hyperthermia					9454
57167	13		Salivation					9454
57168	12		Hypertension					9454
57169	10		Headache					9454
57170	10		Nausea and vomiting					9454
57171	5		Dry mouth					9454
57172	33.3		Headache	grade 1				9457
57173	33.3		Dizziness	grade 1				9457
57174	33.3		Musculoskeletal pain	grade 1				9457
57175	16.7		Abdominal pain	grade 1				9457
57176	33.3		Neutrophils increased	grade 1				9457
57177	12.5		Infusion site thrombosis					9458
57178	25		ALT increased					9458
57179	25		AST increased					9458
57180	12.5		Amylase increased					9458
57181	12.5		Bilirubin increased					9458
57182	12.5		Blood pressure diastolic decreased					9458
57183	12.5		Blood pressure diastolic increased					9458
57184	12.5		Blood pressure systolic increased					9458
57185	12.5		Hemoglobin decreased					9458
57186	25		Lipase increased					9458
57187	12.5		Oropharyngeal pain					9458
57188	16.7		Increased serum creatinine				TRUE	9460
57189	25		Pericarditis	grade 4	discontinuation		TRUE	9459
57190	50		Increased serum creatinine	grade 2			TRUE	9459
57191	33.3		Diarrhea		discontinuation		TRUE	9461
57192	33.3		Asthenia		discontinuation		TRUE	9461
57193	33.3		Hyperglycaemia	grade 4	discontinuation		TRUE	9464
57194	33.3		Diarrhoea	grade 3	discontinuation		TRUE	9464
57195	33.3		Diarrhoea	grade 2	dose reduction			9464
57196	33.3		Thrombocytopenia	grade 3	dose reduction			9464
57197	33.3		Hyperglycaemia	grade 3			TRUE	9462
57198	25		Diarrhoea	grade 3			TRUE	9463
57199	25		Thrombocytopenia	grade 4	dose reduction			9463
57200	25		Neutropenia	grade 3	dose reduction			9463
57201	14.3		Diarrhoea	grade 1	discontinuation			9467
57202	14.3		Fatigue	grade 1	discontinuation			9467
57203	14.3		Nausea	grade 1	discontinuation			9467
57204	14.3		Pneumonitis	grade 1	discontinuation			9467
57205	28.6		Diarrhoea	grade 2	dose reduction			9465
57206	56		Diarrhea	grade 1-3				9466
57207	52		Thrombocytopenia	grade 1-4				9466
57208	44		Fatigue	grade 1-3				9466
57209	28		Nausea	grade 1-2				9466
57210	20		Neutropenia	grade 1-4				9466
57211	20		Constipation	grade 1-2				9466
57212	8		Vomiting	grade 1-2				9466
57213	8		Fever	grade 1-2				9466
57214	4		Anemia	grade 1-2				9466
57215	12		Cough	grade 1-2				9466
57216	8		Hypokalemia	grade 1-2				9466
57217	8		Abdominal pain	grade 1-2				9466
57218	12		Edema	grade 1-2				9466
57219	4		Hyperglycemia	grade 3				9466
57220						No adverse effects leading to discontinuation were reported; no DLTs		9469
57221	50		Palmar-plantar erythrodysesthesia syndrome	grade 3		A DLT of palmar–plantar erythrodysesthesia (PPE) was observed in the first patient treated at a dose level of 250 mg/m2, with a similar grade 2 adverse event noted in the second patient enrolled at this dose, although not fulfilling DLT criteria.	TRUE	9468
57222						No AEs were reported		9470
57223						No adverse effects leading to discontinuation were reported		9471
57224			Alopecia					9472
57225						No adverse effects leading to discontinuation were specified		9473
57226						No adverse reactions leading to discontinuation were reported		9475
57227						No adverse reactions leading to discontinuation were reported		9474
57228	100		Hyperphosphatemia		dose reduction			9476
57229	33.3		Onychalgia		dose reduction			9476
57230	33.3		Paronychia		dose reduction			9476
57231	33.3		Diarrhea					9476
57232	66.7		Nausea					9476
57233	33.3		Constipation					9476
57234	33.3		Decreased appetite					9476
57235	100		Nail changes					9476
57236	33.3		Dry mouth					9476
57237	33.3		Stomatitis					9476
57238	33.3		Abdominal pain					9476
57239	33.3		Dyspnea					9476
57240	33.3		Vomiting					9476
57241	66.7		Alopecia					9476
57242	33.3		Dry skin					9476
57243	33.3		Back pain					9476
57244	66.6		Dysgeusia					9476
57245	33.3		Dry eye					9476
57246	33.3		Mucosal inflammation					9476
57247	33.3		Edema peripheral					9476
57248	16.7		Dry mouth	grade 2	dose reduction		TRUE	9478
57249	16.7		Dry eyes	grade 2	dose reduction		TRUE	9478
57250	10		Hypercalcemia	grade 3	discontinuation		TRUE	9479
57251	10		Hyperamylasemia	grade 3			TRUE	9479
57252	11.1		Hyperbilirubinemia	grade 3	dose reduction		TRUE	9477
57253	11.1		Hyperphosphatemia	grade 3	dose reduction		TRUE	9477
57254	11.1		Stomatitis	grade 3			TRUE	9477
57255			Muscle cramps					9480
57256			Discomfort					9480
57257			Loss of sensing			in feet and arms		9480
57258			Burning sensation					9480
57259			Dyspnea					9480
57260			Irritability					9480
57261						The source does not contain information about AEs or lack thereof		9481
57262	40		Numbness				TRUE	9484
57263	20		Hypotension				TRUE	9484
57264	40		Leukopenia	grade 2			TRUE	9484
57265	40		Thrombocytopenia	grade 2			TRUE	9484
57266			Hypotension				TRUE	9482
57267			Pruritus	grade 1-2				9482
57268			Circumoral paresthesia	grade 1-2				9482
57269			Myelosuppression	grade 1-2				9482
57270			Slurred speech	grade 1-2				9482
57271			Gastrointestinal bleeding	grade 1-2				9482
57272	60		Hypotension		dose reduction		TRUE	9483
57273	6		Headache					9485
57274	22		Nausea					9485
57275	22		Vomiting					9485
57276	26		Urinary retention					9485
57277						No adverse effects leading to discontinuation were reported		9487
57278						All administrations were well-tolerated and no compound-related side-effects were observed.		9486
57279						No adverse reactions leading to discontinuation were reported		9488
57280						No AEs were observed		9490
57281						No AEs were observed		9489
57282						No AEs were observed		9491
57283	2		Urticaria		discontinuation			9492
57284	28.6		Nausea					9493
57285	14.3		Vomiting					9493
57286	14.3		Meteorism					9493
57287	16.7		Diarrhea	grade 1				9494
57288	33.3		Nausea					9494
57289	16.7		Hemorrhoids					9494
57290	16.7		Retrograde ejaculation					9494
57291	9.1		Headache					9495
57292	6.1		Abdominal pain					9495
57293	6.1		Anxiety					9495
57294	6.1		Diarrhea					9495
57295	6.1		Irritability					9495
57296	6.1		Nausea					9495
57297	6.1		Rash		discontinuation			9495
57298	6.1		Upper respiratory tract infection					9495
57299	6.1		Emotional disturbance NOS					9495
57300	1 pts		Vitreous hemorrhage	serious				9500
57301	1 pts		Pulmonary embolism	serious				9500
57302	1 pts		Umbilical hernia	serious				9500
57303	1 pts		Vomiting	serious				9500
57304	1 pts		Wrist surgery	below serious				9500
57305	1 pts		Chalazion	below serious				9500
57306	2 pts		Chest cold	below serious				9500
57307	1 pts		Constipation	below serious				9500
57308	1 pts		Rash	below serious				9500
57309	1 pts		Epidermoid cyst	below serious				9500
57310	1 pts		Epiretinal membrane	below serious				9500
57311	2 pts		Injuries NEC	below serious				9500
57312	1 pts		Fatigue	below serious				9500
57313	1 pts		Knee swelling	below serious				9500
57314	1 pts		Gout	below serious				9500
57315	1 pts		Head cold	below serious				9500
57316	2 pts		Headaches	below serious				9500
57317	1 pts		Glare	below serious				9500
57318	1 pts		Leg pain	below serious				9500
57319	1 pts		Neck stiffness	below serious				9500
57320	1 pts		Nocturnal leg muscle cramps	below serious				9500
57321	1 pts		Hypertension ocular	below serious				9500
57322	1 pts		Pain in (r) shoulder	below serious				9500
57323	2 pts		Preretinal hemorrhage	below serious				9500
57324	1 pts		Prostatitis	below serious				9500
57325	1 pts		Pain ankle	below serious				9500
57326	1 pts		Foot pain	below serious				9500
57327	1 pts		Sleep apnea	below serious				9500
57328	2 pts		Stomach virus	below serious				9500
57329	1 pts		Tooth extraction	below serious				9500
57330	1 pts		Urinary retention	below serious				9500
57331	1 pts		Chest pain	serious				9496
57332	1 pts		Abortion spontaneous	serious				9496
57333	3 pts		Nausea	below serious				9496
57334	3 pts		Sinusitis	below serious				9496
57335	0.5		Headache		discontinuation			9499
57336	0.5		Hypersensitivity		discontinuation			9499
57337	0.5		Vomiting		discontinuation			9498
57338	0.5		Dysphagia		discontinuation			9498
57339	0.5		Hypersensitivity		discontinuation			9498
57340	0.45		Dyspepsia		discontinuation			9497
57341	0.45		Abdominal pain		discontinuation			9497
57342	0.45		Nausea		discontinuation			9497
57343	0.45		Vomiting		discontinuation			9497
57344	0.45		Chest pain		discontinuation			9497
57345	0.45		Dyspnea		discontinuation			9497
57346	12.5		Anaphylactic reaction	grade 3			TRUE	9502
57347	16.7		Fatigue	grade 3			TRUE	9501
57348	50		Fatigue	grade 2			TRUE	9501
57349	16.7		Vision loss		discontinuation			9504
57350	25		Diarrhea	grade 2			TRUE	9503
57351	25		Myocardial infarction	grade 4			TRUE	9503
57352	25		Diarrhea	grade 3-4	discontinuation			9503
57353	25		Vomiting	grade 3-4	discontinuation			9503
57354	25		Dehydration	grade 3-4	discontinuation			9503
57355	2 pts		Diarrhea	grade 1				9506
57356	1 pts		Dizziness	grade 1-2				9506
57357	1 pts		Malaise	grade 1-2				9506
57358	1 pts		Mood change	grade 1				9506
57359	1 pts		Motor dysfunction	grade 1				9506
57360	1 pts		Myalgia	grade 1				9506
57361	3 pts		Nausea	grade 1				9506
57362	2 pts		Nosebleed	grade 1				9506
57363	1 pts		Pruritus	grade 1				9506
57364	1 pts		Skin rash	grade 1-2				9506
57365	3 pts		Stomatitis	grade 1				9506
57366	10.8		Acne					9505
57367	4.9		Pseudofolliculitis barbae					9505
57368	4.1		Stinging skin					9505
57369	4		Headache					9505
57370	3.5		Burning skin					9505
57371	3.3		Dry skin					9505
57372	3.1		Pruritus					9505
57373	2.5		Erythema					9505
57374	2.2		Tingling skin					9505
57375	1.9		Dyspepsia					9505
57376	1.8		Skin irritation					9505
57377	1.5		Rash					9505
57378	1.3		Alopecia					9505
57379	1.3		Dizziness					9505
57380	1		Folliculitis					9505
57381	0.9		Ingrown hair					9505
57382	0.7		Edema face					9505
57383	0.7		Anorexia					9505
57384	0.7		Nausea					9505
57385	0.3		Asthenia					9505
57386	0.1		Vertigo					9505
57387	2 pts		Blood creatinine increased	grade 1				9507
57388	1		Xerostomia	grade 2-3				9507
57389	4 pts		Leukopenia	grade 2				9507
57390	1		Phlebitis	grade 2				9507
57391	4		Muscle cramps	grade 3				9507
57392	5		Anorexia	grade 2-3				9507
57393	4		Vomiting	grade 3				9507
57394	8		Fatigue	grade 2-3				9507
57395	1		Drug fever	grade 2				9507
57396	1 pts		Colonic perforation	grade 4				9510
57397	1 pts		Hypophosphatemia	grade 4				9510
57398	1 pts		Thromboembolism	grade 4				9510
57399	11 pts		Lymphopenia	grade 2-3				9510
57400	10 pts		Anemia	grade 2-3				9510
57401	1 pts		Pulmonary embolism	grade 4				9511
57402	1 pts		Alanine aminotransferase increase	grade 3				9508
57403	1 pts		Colonic perforation	grade 4				9509
57404						No adverse effects were reported or observed in any of the 9 subjects.		9512
57405						No adverse effects leading to discontinuation were reported		9513
57406						No serious adverse events were reported or observed.		9514
57407			Contact dermatitis			patch test		9515
57408			Syncope					9517
57409			Irregular pulse					9517
57410			Faintness					9516
57411	2 pts		Anemia					9518
57412	6 pts		Nausea					9518
57413	5 pts		Dyspepsia					9518
57414	5 pts		Diarrhea					9518
57415	4 pts		Constipation					9518
57416	3 pts		Abdominal pain upper					9518
57417	2 pts		Gastroesophageal reflux disease					9518
57418	2 pts		Vomiting					9518
57419	2 pts		Stomach discomfort					9518
57420	2 pts		Abdominal pain					9518
57421	2 pts		Edema peripheral					9518
57422	1 pts		Arthralgia					9518
57423	2 pts		Back pain					9518
57424	3 pts		Headache					9518
57425	3 pts		Hypertension					9518
57426	2 pts		Dizziness	grade 1				9519
57427	1 pts		Dry skin	grade 1				9519
57428	1 pts		Insomnia	grade 1				9519
57429	1 pts		Gastrointestinal disorder (NOS)	grade 1				9519
57430	1 pts		Forgetfulness	grade 1				9519
57431						No AEs were reported		9520
57432						No AEs were reported		9521
57433	24		Thrombocytopenia	grade 3-4	discontinuation			9523
57434	5		Alanine aminotransferase increased	grade 3-4	discontinuation			9523
57435	2		Diarrhea		dose interruption			9523
57436			Diarrhea	grade 3			TRUE	9524
57437			Diarrhea	grade 3			TRUE	9522
57438	16.7		Central retinal vein occlusion		discontinuation			9525
57439						No patients withdrew from the study after fluocinolone acetonide device implantation. Population size is number of eyes		9527
57440	2.4		Increased intraocular pressure		discontinuation	Population size is number of eyes		9526
57441			Intraocular pressure abnormal			5 of the 14 subjects who discontinued due to an adverse event. Dose not indicated for discontinued: (110/278, 0.59 mg; 168/278, 2.1 mg)		9528
57442	2.2		Neutropenia					9529
57443	2.2		Stomatitis					9529
57444	2.2		Pneumonia					9529
57445	2.2		Dehydration					9529
57446	2.2		Hypotension					9529
57447			Status epilepticus					9531
57448			Abdominal pain					9530
57449			Nausea					9530
57450			Diarrhoea					9530
57451			Suicidal ideation		discontinuation	WARNINGS		9533
57452			Serotonin syndrome		discontinuation	WARNINGS		9533
57453			Hypomania			WARNINGS		9533
57454			Seizures		discontinuation	WARNINGS		9533
57455			Hyponatremia		discontinuation	WARNINGS		9533
57456	9		Nausea		discontinuation			9532
57457	4		Insomnia		discontinuation			9532
57458	4		Somnolence		discontinuation			9532
57459	3		Headache		discontinuation			9532
57460	2		Asthenia		discontinuation			9532
57461	2		Vomiting		discontinuation			9532
57462	2		Nervousness		discontinuation			9532
57463	2		Agitation		discontinuation			9532
57464	2		Dizziness		discontinuation			9532
57465			Secondary adrenocortical insufficiency		discontinuation			9540
57466	38		Gynecomastia					9535
57467	32		Peripheral edema					9535
57468	19		Gastrointestinal discomfort					9535
57469	8		Deep vein thrombosis					9535
57470	5		Skin rash					9535
57471	5		Hypertension					9535
57472	2		Transaminases increased					9535
57473	1 pts		Vomiting		discontinuation	One patient failed to continue with the infusion beyond its commencement because of intolerable vomiting.		9536
57474	13 pts		Nausea and vomiting	grade 1			TRUE	9534
57475	4 pts		Nausea and vomiting	grade 2			TRUE	9534
57476	2 pts		Weight gain				TRUE	9534
57477	2 pts		Edema				TRUE	9534
57478						No AEs were observed		9538
57479	17 pts		Nausea					9539
57480	17 pts		Bone pain					9539
57481	1 pts		Perineal pain					9539
57482	4 pts		Deep vein thrombosis					9539
57483	3 pts		Toxic reaction (NOS)	grade 2	dose reduction	Three patients had Grade 2 toxicity (elevated liver enzyme, diarrhea, and somnolence), of them two patients required dose reductions.		9537
57484	2 pts		Toxic reaction (NOS)	grade 3	discontinuation	Grade 3 toxicity was seen in two patients both of whom had diarrhea and required discontinuation of fosfestrol.		9537
57485						No adverse effects leading to discontinuation were reported.		9541
57486			Visual disturbance	grade 3			TRUE	9543
57487			Dehydration	serious			TRUE	9544
57488			Thrombocytopenia	grade 3			TRUE	9542
57489			Hyponatremia	grade 3			TRUE	9542
57490						AEs are not stratified by doses. """"""""""""""""5 patients experienced AEs related to CUDC-427 that led to discontinuation and included grade 3 pruritus, and fatigue, and grade 2 drug hypersensitivity, pneumonitis, rash, and QT prolongation.""""""""""""""""		9545
57491	100		Diarrhea	grade 1-2				9547
57492	100		Rash	grade 1-2				9547
57493	100		Nausea	grade 1-2				9547
57494	67		Fatigue	grade 1-2				9547
57495	67		Vomiting	grade 1-2				9547
57496	33		Peripheral edema	grade 1-2				9547
57497	100		Asthenia	grade 1-2				9547
57498	100		Decreased appetite	grade 1-2				9547
57499	33		Dry skin	grade 1-2				9547
57500	67		Periorbital edema	grade 1-2				9547
57501	66.7		Rash	grade 1-3			TRUE	9546
57502	16.7		Myocardial infarction	grade 3			TRUE	9548
57503	16.7		Rash	grade 3			TRUE	9548
57504	16.7		Dermatitis acneiform	grade 3			TRUE	9548
57505						impossible to link AEs with the definite dose: The most common treatment-related toxicities were nausea (64%), diarrhea (28%), and fatigue (28%).		9549
57506	14 pts		Hiccup	mild				9550
57507						impossible to link AEs with the definite dose		9551
57508						No AEs were observed		9552
57509						No AEs were observed		9553
57510	46		Anemia					9554
57511	3		Leucopenia					9554
57512	16		Allergic dermatitis					9554
57513	3		Allergic dermatitis		discontinuation			9554
57514	1.5		Allergic rhinitis					9554
57515			Headache	grade 1				9554
57516	35		Nausea	grade 1				9554
57517	7		Vomiting					9554
57518	3		Erythema nodosum leprosum					9554
57519	10		Iridocyclitis					9554
57520	1.5		Lymphadenitis					9554
57521	13		Dizziness	moderate				9556
57522	13		Abdominal pain					9556
57523	1 pts		Nausea					9555
57524	1 pts		Absolute neutrophil count decreased					9555
57525						GSK2256294 was well-tolerated with no serious adverse events (AEs) attributable to the drug		9557
57526						No subjects were withdrawn for adverse events in the repeat dose cohorts.		9558
57527	25		Hypocalcemia	grade 2			TRUE	9559
57528	25		Hypocalcemia	grade 3	discontinuation		TRUE	9559
57529	25		Hypophosphatemia	grade 3	discontinuation		TRUE	9559
57530	25		Fatigue	grade 3	discontinuation			9559
57531	25		Nausea	grade 3	discontinuation			9559
57532						There were no DLTs observed		9561
57533	8.3		Dyspnea		discontinuation			9560
57534	8.3		Fatigue		discontinuation			9560
57535	8.3		Vomiting		discontinuation			9560
57536	8.3		Urinary retention		discontinuation			9560
57537						No information on AE is provided		9562
57538	20		Encephalopathy	grade 3	discontinuation			9564
57539	14		Encephalopathy	grade 5	discontinuation			9563
57540	100		Thrombocytopenia	grade 4			TRUE	9565
57541	28.6		Thrombocytopenia	grade 3	dose reduction			9563
57542	10		Dizziness	grade 2				9568
57543	10		Nausea	grade 2				9568
57544	8		Appetite lost			accidental double dosage		9567
57545	8		Heart rate increased			accidental double dosage		9567
57546	8		Bad dreams			accidental double dosage		9567
57547	8		Difficulty sleeping			accidental double dosage		9567
57548						AEs were not observed		9566
57549	12.5		Dizziness					9570
57550	12.5		Loose stools					9569
57551	12.5		Epigastric discomfort					9569
57552	12.5		Anorexia					9569
57553	50		Diarrhea					9569
57554	12.5		Fatigue					9569
57555	50		Abdominal pain					9569
57556	12.5		Dizziness					9569
57557	12.5		Bone pain	grade 3		long bone pain	TRUE	9571
57558	14.3		Pelvic pain	grade 3			TRUE	9572
57559	14.3		Hyperglycemia	grade 3			TRUE	9572
57560	14.3		Non-cardiac chest pain	grade 3			TRUE	9572
57561	14.3		Myalgia	grade 3			TRUE	9572
57562	14.3		Bone pain	grade 3		long bone pain	TRUE	9572
57563	60		Asthenia	grade 1-2				9573
57564	40		Insomnia	grade 1-2				9573
57565	100		Diarrhoea	grade 1-4	discontinuation			9573
57566	40		Nausea	grade 1-2				9573
57567	40		Anorexia	grade 1-2				9573
57568	20		Abdominal pain	grade 1-2				9573
57569	40		Vomiting	grade 1-2				9573
57570	20		Weight loss	grade 1-2				9573
57571	20		Dizziness	grade 1-2				9573
57572	60		Tremor	grade 1-3			TRUE	9573
57573	40		Cerebellar syndrome	grade 1-2				9573
57574	20		Balance disorder	grade 1-2				9573
57575	20		Muscle spasms	grade 1-2				9573
57576	20		ALT increased	grade 1-2				9573
57577	20		AST increased	grade 1-2				9573
57578	20		Dehydration	grade 3-4				9573
57579	40		Hyponatremia	grade 3-4				9573
57580	20		Decreased appetite	grade 1			TRUE	9573
57581	20		Dysdiadochokinesis	grade 1			TRUE	9573
57582	20		Fatigue	grade 1			TRUE	9573
57583	20		Hyperreflexia	grade 1			TRUE	9573
57584	16.7		Digestion impaired	grade 3	discontinuation			9575
57585	4.5		Myoclonus	grade 3			TRUE	9574
57586	4.5		Diarrhoea	grade 3			TRUE	9574
57587	4.5		Electrocardiogram QTc interval prolonged	grade 3			TRUE	9574
57588	4.5		ALT increased	grade 3			TRUE	9574
57589	4.5		AST increased	grade 3			TRUE	9574
57590	50		Asthenia	grade 1-4				9574
57591	41		Insomnia	grade 1-2				9574
57592	82		Diarrhoea	grade 1-4				9574
57593	27		Nausea	grade 1-2				9574
57594	32		Anorexia	grade 1-2				9574
57595	14		Abdominal pain	grade 1-2				9574
57596	23		Vomiting	grade 1-2				9574
57597	9		Weight loss	grade 1-2				9574
57598	27		Dizziness	grade 1-2				9574
57599	27		Tremor	grade 1-2				9574
57600	14		Ataxia	grade 1-2				9574
57601	4		Cerebellar syndrome	grade 1-2				9574
57602	14		Balance disorder	grade 1-2				9574
57603	9		Headache	grade 1-2				9574
57604	9		Muscle spasms	grade 1-2				9574
57605	9		ALT increased	grade 1-4				9574
57606	9		AST increased	grade 1-4				9574
57607	4		Myoclonus	grade 3-4				9574
57608	4		Neurotoxicity	grade 3-4				9574
57609	4		Presyncope	grade 3-4	discontinuation			9574
57610	4		Syncope	grade 3-4	discontinuation			9574
57611	9		QT interval prolonged	grade 3-4	discontinuation			9574
57612			Fatigue	grade 3-4	discontinuation			9574
57613			Adverse event	grade 5				9580
57614			Respiratory depression	grade 5		WARNING		9578
57615			Addiction			WARNING		9578
57616			Withdrawal syndrome neonatal			WARNING		9577
57617			Electrocardiogram QTc interval prolonged					9576
57618	1		Vomiting		discontinuation	leads to discontinuation		9579
57619	1		Nausea		discontinuation	leads to discontinuation		9579
57620	1		Headache		discontinuation	leads to discontinuation		9579
57621	1		Dizziness		discontinuation	leads to discontinuation		9579
57622			Sleepiness		discontinuation			9583
57623			Nausea		discontinuation			9583
57624			Respiratory arrest	grade 5	discontinuation			9584
57625			Cardio-respiratory arrest	grade 5	discontinuation			9582
57626	1.14		Somnolence	serious	discontinuation			9586
57627	1.14		Aspiration pneumonia	grade 5	discontinuation			9586
57628	1.14		Toxic skin eruption	serious	discontinuation			9586
57629	1.14		Nausea and vomiting	serious	discontinuation			9586
57630						2 patients withdrew due to AEs, but they are not specified		9581
57631			Respiratory depression		discontinuation	WARNING		9585
57632			Addiction		discontinuation	WARNING		9587
57633			Abuse		discontinuation	WARNING		9587
57634			Intentional drug misuse		discontinuation	WARNING		9587
57635			Respiratory depression	grade 3-5	discontinuation	WARNING		9587
57636			Withdrawal syndrome neonatal	grade 3-5	discontinuation	WARNING. Prolonged use of DILAUDID Oral Solution or DILAUDID Tabletsduring pregnancy can result in neonatal opioid withdrawal syndrome, which may be life-threatening if not recognized and treated.		9587
57637			Sedation		discontinuation	WARNING. Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death.		9587
57638			Coma	grade 5	discontinuation	WARNING. Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death.		9587
57639	25		Nausea		discontinuation			9588
57640	25		Epigastric pain		discontinuation			9588
57641	20		Gastrointestinal disorder		discontinuation			9589
57642	4		Photophobia		discontinuation			9589
57643	2		Photosensitivity		discontinuation			9589
57644	7		Light-headed feeling					9593
57645	7		Hypotension					9593
57646						AEs were not observed		9591
57647			Headache					9590
57648			Vertigo					9590
57649			Sleepiness					9590
57650			Photophobia					9590
57651			Tachycardia					9590
57652	2.3		Ventricular tachycardia		discontinuation			9592
57653						No AEs were reported		9594
57654	2 pts		Headache					9595
57655						No drug-related adverse effects leading to discontinuation were recorded.		9596
57656	16.7		Myelosuppression	grade 4				9598
57657						No adverse effects leading to discontinuation were reported; no DLTs		9599
57658	66.7		Thrombocytopenia	grade 4	discontinuation		TRUE	9600
57659	33.3		Neutropenia	grade 4			TRUE	9600
57660	33.3		Fatigue	grade 3			TRUE	9600
57661	33.3		Neutropenia	grade 3	discontinuation		TRUE	9600
57662	14.3		Nausea	grade 3			TRUE	9597
57663	14.3		Thrombocytopenia	grade 4			TRUE	9597
57664	54 pts		Contact dermatitis		discontinuation			9601
57665	4.4		Chest pain	grade 1-2				9603
57666	6.4		Nausea	grade 1-2				9603
57667	1.6		Vomiting	grade 1-2				9603
57668	5.2		Allergic skin reaction	grade 1-2				9603
57669	0.8		Bronchospasm	grade 3				9603
57670	4.4		Warmth	grade 1-2				9603
57671	0.4		Bad taste	grade 1-2				9603
57672	17		Nephropathy			in patients with renal impairment undergoing coronary angiography		9604
57673			Cyanosis	grade 3-5				9602
57674			Bradycardia	grade 3-5				9602
57675			Acidosis	grade 3-5				9602
57676			Pulmonary hemorrhage	grade 3-5				9602
57677			Convulsions	grade 3-5				9602
57678			Coma	grade 4-5				9602
57679			Cardiac arrest	grade 4-5				9602
57680						No information on AE is provided		9605
57681	3		Hemorrhoidal bleeding	grade 1				9606
57682	3		Bleeding rectal	grade 2				9606
57683	3		Gastroesophageal reflux					9606
57684	100		Increased serum creatinine	grade 1	discontinuation			9607
57685	57.1		Diarrhoea					9608
57686	42.9		Rhinitis					9608
57687	28.6		Headache					9608
57688	57.1		Fatigue					9608
57689	14.3		Vomiting					9608
57690	28.6		Upper respiratory tract infection					9608
57691	42.9		Anaemia					9608
57692	14.3		Oral herpes					9608
57693	28.6		Lower respiratory tract infection					9608
57694	14.3		Musculoskeletal chest pain					9608
57695	28.6		Anorexia					9608
57696	14.3		Herpes simplex					9608
57697	1 pts		Dry eyes	grade 2				9608
57698	83.3		Neurotoxicity	grade 1				9610
57699	66.7		Diarrhea	grade 1				9610
57700	16.7		Diarrhea	grade 3				9610
57701	16.7		Nausea	grade 1				9610
57702	33.3		Nausea	grade 2				9610
57703	33.3		Vomiting	grade 1				9610
57704	16.7		Vomiting	grade 2				9610
57705	20		Neutropenia				TRUE	9613
57706	40		Diarrhea	grade 3			TRUE	9614
57707	33.3		Diarrhea	grade 3			TRUE	9615
57708	33.3		Nausea	grade 3			TRUE	9612
57709	33.3		Vomiting	grade 3			TRUE	9612
57710	33.3		Diarrhea	grade 3			TRUE	9612
57711	33.3		Paresthesia	grade 3			TRUE	9612
57712	33.3		Febrile neutropenia	grade 4			TRUE	9612
57713			Urticaria					9611
57714			Anaphylactic shock		discontinuation			9616
57715						AEs not reported		9609
57716						No serious adverse events were reported during the study and no subjects discontinued treatment due to adverse events.		9617
57717						No serious adverse events were reported during the study and no subjects discontinued treatment due to adverse events.		9618
57718			Hypotension	grade 1-2				9619
57719	25		Flushing	grade 1-2				9619
57720	25		Pruritus	grade 1-2				9619
57721	25		Musculoskeletal and connective tissue disorders	grade 1-2				9619
57722	25		Fatigue	grade 1-2				9619
57723	25		Hypersensitivity	grade 1-2				9619
57724	25		Injection site paraesthesia	grade 1-2				9619
57725	25		Paraesthesia	grade 1-2				9619
57726	25		Anaphylactic reaction	grade 3				9619
57727			Hypotension	grade 1-2				9620
57728	33.3		Flushing	grade 1-2				9620
57729	33.3		Hypersensitivity	grade 1-2				9620
57730	33.3		Injection site paraesthesia	grade 1-2				9620
57731	21.4		Hypersensitivity	grade 1-3	discontinuation			9621
57732	uncommon		Dyspnea	grade 3-4				9624
57733	uncommon		Pulmonary edema	grade 3-4				9624
57734	most common		Vomiting	grade 3-4	dose interruption			9623
57735			Urticaria	grade 3-4	dose interruption			9623
57736	uncommon		Abdominal pain	grade 1-2	discontinuation			9624
57737			Urticaria	grade 3-4	dose interruption			9622
57738	54		Irritability		discontinuation			9625
57739	2		Disorientation					9625
57740	4		Abdominal pain	grade 1				9625
57741	2		Movements abnormal					9625
57742	2		Urination frequency of					9625
57743	6		Difficulty sleeping					9625
57744	2		Increased appetite					9625
57745	2		Twitching facial					9625
57746	2		Aggression					9625
57747	2		Facial rash	grade 1				9625
57748	2		Speech slurred					9625
57749	2		Laughter					9625
57750	2		Spinning sensation					9625
57751	12.5		ALT increased	grade 3	dose interruption|dose reduction		TRUE	9629
57752	12.5		Death	grade 5			TRUE	9629
57753	12.5		Weight decreased	grade 1-2				9629
57754	37.5		Vomiting	grade 1-2				9629
57755	37.5		Dysgeusia	grade 1-2				9629
57756	12.5		Hyponatremia	grade 3				9629
57757	50		Nausea	grade 1-2				9629
57758	12.5		Abdominal pain	grade 1-2				9629
57759	12.5		Alkaline phosphatase increased	grade 3				9629
57760	37.5		AST increased	grade 2-3				9629
57761	37.5		Dyspnea	grade 2-5				9629
57762	12.5		Pyrexia	grade 1-2				9629
57763	62.5		Fatigue	grade 1-2				9629
57764	12.5		Night sweats	grade 1-2				9629
57765	12.5		Headache	grade 1-2				9629
57766	50		Anorexia	grade 1-2				9629
57767	12.5		Influenza-like symptoms	grade 1-2				9629
57768	16.7		AST increased	grade 3			TRUE	9628
57769	16.7		ALT increased	grade 3			TRUE	9628
57770	25		Prothrombin time ratio increased	grade 3	discontinuation		TRUE	9632
57771	75		AST increased	grade 4			TRUE	9632
57772	75		Thrombocytopenia	grade 4	discontinuation		TRUE	9632
57773	25		GGT increased	grade 3	discontinuation		TRUE	9632
57774	25		Fatigue	grade 3	discontinuation		TRUE	9632
57775	25		Hepatic failure	grade 4	discontinuation		TRUE	9632
57776	25		Bilirubinemia	grade 3	discontinuation		TRUE	9632
57777	50		Anorexia	grade 3	discontinuation		TRUE	9632
57778	25		Dehydration	grade 3	discontinuation		TRUE	9632
57779	75		ALT increased	grade 4			TRUE	9632
57780	14		Diarrhea	grade 3			TRUE	9627
57781	14		Edema limbs	grade 3			TRUE	9627
57782	14		Liver failure	grade 3			TRUE	9627
57783	11		AST increased	grade 3			TRUE	9626
57784	22		Diarrhea	grade 3			TRUE	9626
57785						The source does not contain information about AEs or lack thereof		9631
57786	11		Electrocardiogram QTc interval prolonged	grade 3			TRUE	9630
57787	50		Myalgia	grade 3	dose reduction		TRUE	9633
57788	50		Pain	grade 3	dose reduction		TRUE	9633
57789	50		Stomatitis	grade 3	dose reduction		TRUE	9633
57790	50		Arthralgia	grade 3	dose reduction		TRUE	9633
57791	6.25		Blurred vision	grade 2			TRUE	9634
57792	6.25		Dermatitis acneiform	grade 2			TRUE	9634
57793	6.25		Myalgia		discontinuation			9634
57794	94.3		Leukopenia			leads to dose reduction		9635
57795	94.3		Neutropenia			leads to dose reduction		9635
57796	62.3		Thrombocytopenia			leads to dose reduction		9635
57797	52.8		Nausea			leads to dose reduction		9635
57798	50		Nausea	grade 1-3			TRUE	9636
57799	10		Fatigue	grade 3			TRUE	9636
57800	10		Colitis	grade 3			TRUE	9636
57801	50		Diarrhea	grade 1-2				9636
57802	30		Dry mouth	grade 1-2				9636
57803	40		Vomiting	grade 1-3				9636
57804	20		Asthenia	grade 2-3				9636
57805	50		Mucosal inflammation	grade 1-2				9636
57806	20		Weight decreased	grade 1				9636
57807	40		Decreased appetite	grade 1-2				9636
57808	20		Alopecia	grade 1				9636
57809	10		Dry skin	grade 2				9636
57810	10		Hair color changes	grade 1				9636
57811	12.5		Thrombocytopenia	grade 4			TRUE	9640
57812	14.3		Thrombocytopenia	grade 4			TRUE	9641
57813	11.1		Thrombocytopenia	grade 4			TRUE	9642
57814	80		Diarrhea	grade 1				9638
57815	40		Dry mouth	grade 1				9638
57816	80		Nausea	grade 1-2				9638
57817	80		Vomiting	grade 1-3				9638
57818	60		Asthenia	grade 1-2				9638
57819	20		Decreased appetite	grade 1				9638
57820	20		Hypophosphatemia	grade 2				9638
57821	60		Alopecia	grade 1-2				9638
57822	40		Dry skin	grade 1				9638
57823	20		Hair color changes	grade 1				9638
57824	76		Diarrhea		dose reduction			9637
57825	3.6		Diarrhea		discontinuation			9643
57826	1.8		Nausea		discontinuation			9643
57827	1.8		Platelet count decreased		discontinuation			9643
57828	4.5		Squamous cell carcinoma of skin	grade 3-4	discontinuation			9639
57829	7.7		Erythema	grade 1				9644
57830	2		Skin irritation	grade 1-2				9645
57831						no AEs reported		9648
57832						no AEs reported		9647
57833			Drowsiness					9646
57834	1 pts		Fever		discontinuation	leads to discontinuation\leads to dose reduction		9649
57835	1 pts		Pulmonary infiltration		discontinuation	leads to discontinuation\leads to dose reduction		9649
57836	1 pts		Eosinophilia		discontinuation	leads to discontinuation\leads to dose reduction		9649
57837			Drowsiness					9650
57838						Mercumatilin did not produce any evidence of systemic toxicity.		9651
57839	25 pts		Intoxication		discontinuation	leads to discontinuation		9652
57840						No information on AE is provided		9653
57841	9		Anemia	grade 4	discontinuation		TRUE	9655
57842	50		Anemia	grade 3			TRUE	9654
57843	66.7		Anemia	grade 2-3	dose reduction			9654
57844	45.4		Hypersensitivity					9657
57845	1		Erythema		dose interruption			9656
57846			Ischemic stroke					9659
57847			Heart failure		discontinuation			9658
57848	1 pts		Palmar-plantar erythrodysesthesia syndrome	grade 3			TRUE	9661
57849	1 pts		Mucositis	grade 2			TRUE	9660
57850	1 pts		Neuropathy	grade 2			TRUE	9660
57851	1 pts		Fatigue	grade 2			TRUE	9660
57852						MGL-3196 appeared safe and was well-tolerated		9662
57853						No adverse effects leading to discontinuation were reported		9664
57854						No drug-related serious AEs occurred and there were no significant differences in AEs in any organ system for any dose of MK-0557 compared to placebo.		9663
57855						MK-0557 was well tolerated.		9665
57856						No AEs were reported		9666
57857						no serious drug-related adverse events were reported		9667
57858	33.3		ALT increased	grade 3			TRUE	9668
57859	33.3		AST increased	grade 3			TRUE	9668
57860	33.3		Amylase increased	grade 3			TRUE	9668
57861	33.3		Hypokalaemia	grade 3			TRUE	9668
57862	5.6		Nausea	grade 2-3			TRUE	9669
57863						No adverse effects leading to discontinuation were reported		9670
57864	1 pts		Pyrexia					9671
57865	1 pts		Hypertension					9671
57866	2 pts		Dyspnoea					9671
57867	1 pts		Dyspnoea exertional					9671
57868						no AEs reported		9672
57869						No severe adverse reactions occurred		9673
57870						No adverse effects leading to discontinuation were reported		9674
57871			Hallucination					9675
57872	10		ALT increased	grade 1				9677
57873						The source does not contain information about AEs or lack thereof		9676
57874						There were no significant drug-related AEs in any treatment groups, no serious AEs and no subjects withdrew from the study due to treatment-related AEs.		9678
57875						No adverse effects leading to discontinuation were reported		9679
57876	7.2		Amylase increased	grade 1				9680
57877	3.6		Emesis	grade 1				9680
57878	3.6		Nausea	grade 1				9680
57879	5		Nausea	grade 1				9681
57880	5		Vomiting	grade 1				9681
57881	10		Fatigue	grade 1				9681
57882	5		Stomach pain	grade 1				9681
57883	5		Cognitive disturbance	grade 1				9681
57884	5		Tinnitus	grade 1				9681
57885	5		Dysgeusia	grade 1				9681
57886	5		Dizziness	grade 1-2				9682
57887	35		Hypophosphatemia	grade 1-2				9682
57888	15		Anorexia	grade 1-2				9682
57889	20		Gait disturbance	grade 1-2				9682
57890	25		Nausea	grade 1-2				9682
57891	25		Vomiting	grade 1-2				9682
57892	25		Diarrhea	grade 1-2				9682
57893	5		Platelet count decreased	grade 1-2				9682
57894	5		Confusion	grade 1-2				9682
57895						No adverse effects leading to discontinuation were reported		9683
57896	0.4		Cardiac failure		discontinuation	leads to discontinuation		9685
57897	0.6		Hypertension		discontinuation	leads to dose interruption		9685
57898	0.5		Diarrhea		discontinuation	leads to dose interruption		9685
57899	0.5		Pneumonia		discontinuation	leads to dose interruption		9685
57900	0.7		Fatigue		discontinuation	leads to dose reduction		9685
57901	0.3		Hypertension		discontinuation	leads to dose reduction		9685
57902	0.3		Nausea		discontinuation	leads to dose reduction		9685
57903						impossible to link AEs with the definite dose		9684
57904	20		Hyperglycaemia	grade 3			TRUE	9688
57905						No adverse effects leading to discontinuation were reported; no DLTs		9686
57906	33.3		Fatigue	grade 3			TRUE	9689
57907	33.3		Urticaria	grade 3			TRUE	9689
57908	33.3		Cardiomyopathy	grade 3			TRUE	9689
57909						No adverse effects leading to discontinuation were reported; no DLTs		9687
57910	12.5		Myalgia	grade 3			TRUE	9693
57911	3		Fatigue	grade 3			TRUE	9692
57912	3		Nausea	grade 3			TRUE	9692
57913	3		Lipase increased	grade 3			TRUE	9692
57914	12.5		Gamma-glutamyltransferase incr.	grade 4	discontinuation		TRUE	9691
57915	25		Pruritis	grade 3			TRUE	9691
57916	12.5		Papular rash	grade 3			TRUE	9691
57917	12.5		Macular rash	grade 3			TRUE	9691
57918						There were no DLTs observed with the once a day dosing schedule		9690
57919						No adverse effects leading to discontinuation were reported		9694
57920						Oral OTZ was well tolerated in CAPD patients and did not result in any serious adverse events.		9695
57921						No adverse effects leading to discontinuation were reported.		9697
57922						No adverse effects leading to discontinuation were reported.		9696
57923						There were no drug-related adverse events and no serious adverse events.		9698
57924						The source does not contain information about AEs or lack thereof		9699
57925			Contact dermatitis		discontinuation			9700
57926						No AEs were reported		9701
57927	1 pts		Swallowing difficult		discontinuation	leads to dose reduction		9702
57928						No AEs were observed		9703
57929	16.6		ALT increased	grade 1				9704
57930	8.3		AST increased	grade 1				9704
57931	14.3		Nausea	grade 2				9706
57932	14.3		Vomiting	grade 2				9706
57933	42.8		Fatigue	grade 1				9706
57934	44.4		Nausea	grade 2			TRUE	9709
57935			Fatigue	grade 2			TRUE	9709
57936	44.4		Pyrosis	grade 2			TRUE	9709
57937	11.1		Stomatitis	grade 3	dose interruption			9709
57938	11.1		Diarrhea	grade 2	dose interruption			9709
57939	11.1		Fatigue	grade 3	dose interruption			9709
57940	11.1		Anorexia	grade 3	dose interruption			9709
57941	11.1		Nausea	grade 2	dose interruption			9709
57942	11.1		Vomiting	grade 2	dose interruption			9709
57943	11.1		Nausea	grade 2				9707
57944	22.2		Vomiting	grade 2				9707
57945	100		Nausea	grade 2-3			TRUE	9705
57946	33.3		Vomiting	grade 3			TRUE	9705
57947	11.1		Belching	grade 3	discontinuation			9708
57948	11.1		Bloating	grade 3	discontinuation			9708
57949	11.1		Fatigue	grade 2	discontinuation			9708
57950	11.1		Vomiting	grade 2	discontinuation			9708
57951	11.1		Anorexia	grade 1-2	discontinuation			9708
57952	11.1		Sweating increased	grade 2	discontinuation			9708
57953			Hypothermia			OVERDOSAGE		9711
57954			Circulatory failure			OVERDOSAGE		9711
57955			Death			OVERDOSAGE		9711
57956	1.8		Gravitational oedema		discontinuation			9710
57957	0.4		Cough		discontinuation			9710
57958	0.4		Dizziness		discontinuation			9710
57959	0.4		Fatigue		discontinuation			9710
57960	0.4		Irritability		discontinuation			9710
57961	0.4		Pulmonary embolism		discontinuation			9710
57962	2.8		Cough		discontinuation	leads to discontinuation		9712
57963			Skin and subcutaneous conditions NEC					9713
57964			Dystonia					9714
57965						No AEs were reported		9715
57966	5		Insomnia		discontinuation			9716
57967	5		Hallucinations		discontinuation			9716
57968	5		Anorexia		discontinuation			9716
57969	5		Nervousness		discontinuation	‘feeling jittery’’		9716
57970	28.6		Febrile neutropenia	grade 3-4			TRUE	9717
57971	14.3		Neutropenia	grade 4			TRUE	9717
57972	6.7		Febrile neutropenia	grade 3			TRUE	9719
57973	15.4		Neutropenia	grade 2-3			TRUE	9718
57974	7.7		Hyperbilirubinemia	grade 2			TRUE	9718
57975	7.7		Supraventricular tachycardia	grade 2			TRUE	9718
57976	20		Injection site injury					9720
57977	20		Cough					9720
57978						No adverse effects leading to discontinuation were reported		9721
57979						No patients had dose reductions or temporary discontinuations attributable to AEs.		9722
57980						No information on AE is provided		9723
57981						28 events by seven subjects. The most frequently reported AEs across all treatment groups were headache, diarrhea, and conjunctivitis.		9724
57982	33.3		Nausea	grade 3			TRUE	9725
57983	33.3		Vomiting	grade 3			TRUE	9725
57984	33.3		Hepatic failure	grade 4			TRUE	9725
57985						No toxicities were found up to 1,000 mg/infusion		9726
57986						without adverse effects		9727
57987			Gastrointestinal disorder		discontinuation	18 patients on picotamide were withdrawn because of side effects occurring predominantly in the gastrointestinal tract		9728
57988						No adverse effects leading to discontinuation were reported.		9729
57989			Dizziness					9730
57990			Dysphoria	grade 1				9733
57991	3.1		Emesis		discontinuation			9731
57992	3.1		Blurred vision		discontinuation			9731
57993	12.5		Feeling detached					9731
57994	3.1		Dizziness					9731
57995	6.2		Drowsiness					9731
57996	6.2		Nervous					9731
57997	6.2		Shaking					9731
57998	6.2		Headaches					9731
57999	3.1		Hangover					9731
58000	6.2		Taste metallic					9731
58001	3.1		Cramps leg					9731
58002	6.2		Upset stomach					9731
58003	6.2		Constipation					9731
58004	4.2		Dizziness	grade 3				9732
58005	2.1		Diaphoresis	grade 3				9732
58006			Constipation					9735
58007			Delirium					9735
58008			Dysphoria					9735
58009			Euphoria					9735
58010			Sedation					9735
58011			Seizure					9734
58012						No AEs are reported		9736
58013			Nausea					9738
58014			Vomiting					9738
58015	5 pts		Nausea					9737
58016	2 pts		Vomiting					9737
58017						No Aes are reported		9740
58018			Nausea					9739
58019			Vomiting					9739
58020			Lightheadedness					9739
58021			Throat burning sensation of	mild				9739
58022	2 pts		Nausea					9741
58023						No information on AE is provided: frequency of side effects was equal to placebo medication and UV light sensitivity was not or only marginally increased.		9743
58024						No information on AE is provided: frequency of side effects was equal to placebo medication and UV light sensitivity was not or only marginally increased.		9742
58025			Vomiting	grade 3				9744
58026			Nausea	grade 2				9744
58027			Adverse event	grade 5		POISONING		9746
58028			Squamous cell carcinoma		discontinuation			9745
58029						There were no serious adverse drug reactions and no adverse drug reactions that resulted in early withdrawal from the study		9747
58030			Tachycardia	grade 5				9748
58031			Bilateral blindness					9751
58032	1 pts		Respiratory distress	grade 5				9752
58033	1 pts		Blindness					9749
58034	1 pts		Hearing loss					9749
58035	1 pts		Cardiotoxicity			attempt to suicide		9750
58036	11.1		Creatine phosphokinase increased	grade 3			TRUE	9755
58037	25		Creatine phosphokinase increased	grade 3			TRUE	9754
58038	25		Creatine phosphokinase increased	grade 4			TRUE	9753
58039	3		Rash		discontinuation			9756
58040	3		Left ventricular ejection fraction decreased	grade 2	discontinuation			9756
58041	3		Dyspnea	grade 2	discontinuation			9756
58042						AEs are not specified		9758
58043						AEs are not specified		9757
58044						No adverse effects leading to discontinuation were reported.		9759
58045	10		Headache			Week 8		9760
58046	5		Palpitation			Week 8		9760
58047	10		Dullness			Week 8		9760
58048	5		Nervousness			Week 8		9760
58049	5		Anorexia			Constipation		9760
58050	20		Constipation			Week 8		9760
58051	10		Insomnia			Week 8		9760
58052	5		Trembling			Week 8		9760
58053	5		Vomiting			Week 8		9760
58054	5		Dysuria			Week 8		9760
58055	5		Dry mouth			Week 8		9760
58056	15		Dizziness			Week 8		9760
58057						No adverse effects leading to discontinuation were reported; no DLTs		9763
58058	9.5		Thrombocytopaenia	grade 4			TRUE	9762
58059	28.6		Thrombocytopaenia	grade 4			TRUE	9764
58060	16.7		Nausea	grade 2			TRUE	9761
58061	3.8		Headache		discontinuation			9765
58062						No adverse effects leading to discontinuation were reported; no DLTs		9766
58063						No adverse effects leading to discontinuation were reported; no DLTs		9767
58064	33.3		Gastrointestinal haemorrhage	grade 3			TRUE	9768
58065	66.7		Diarrhoea	grade 3			TRUE	9769
58066	1 pts		Diarrhea		discontinuation	leads to discontinuation. overdose without ill effects		9771
58067	39 pts		Gastrointestinal disorders					9770
58068			Burn					9772
58069			Redness					9772
58070			Scales					9772
58071						No adverse effects leading to discontinuation were reported		9773
58072	6.7		Photophobia		discontinuation			9774
58073	6.7		Diarrhea		discontinuation			9774
58074	1 pts		Nausea alone		discontinuation			9775
58075	1 pts		Dizziness		discontinuation			9775
58076	3		Diaphoresis	marked				9776
58077	3		Diaphoresis	slight				9776
58078	2		Deafness					9776
58079	2		Tinnitus	marked				9776
58080	2		Tinnitus	slight				9776
58081	1		Deafness					9776
58082	2		Deafness					9776
58083	1		Deafness					9776
58084	2		Nausea and vomiting		discontinuation	When the patients showed definite signs of nausea or vomited, administration was stopped.		9776
58085	2		Nausea	slight	discontinuation	When the patients showed definite signs of nausea or vomited, administration was stopped.		9776
58086	1		Nausea	marked	discontinuation	When the patients showed definite signs of nausea or vomited, administration was stopped.		9776
58087	21		Nausea		discontinuation	When the patients showed definite signs of nausea or vomited, administration was stopped.		9776
58088	4		Delirium	slight				9776
58089	1		Delirium	marked				9776
58090	1		Hyperactive delirium					9776
58091	1		Delirium					9776
58092	9		Dermatitis		discontinuation	In one of these drug therapy was discontinued and the lesion disappeared.		9777
58093	6		Nausea and vomiting		discontinuation	Nausea and vomiting occurred in six cases, but in only one was it severe enough to warrant discontinuing further administration of the drug.		9777
58094	1		Nitrogen retention					9777
58095	1		Hematuria					9777
58096	2		Drug fever					9777
58097	2		Burning eyes					9777
58098	1		Conjunctival injection					9777
58099	1		Anemia					9777
58100						No adverse effects leading to discontinuation were reported; no DLTs		9779
58101	50		Alanine aminotransferase increased	grade 3	discontinuation		TRUE	9778
58102	50		Aspartate aminotransferase increased		discontinuation		TRUE	9778
58103	50		Decreased appetite		discontinuation		TRUE	9778
58104						No adverse effects leading to discontinuation were reported		9781
58105						Well tolerated		9780
58106						No adverse effects leading to discontinuation were reported		9782
58107	5.6		Free T4 increased					9783
58108						No adverse effects leading to discontinuation were reported		9784
58109						No side effects were reported		9785
58110						No serious adverse events occurred.		9786
58111	1 pts		Nausea	grade 2				9787
58112	2 pts		Nausea	grade 3			TRUE	9787
58113	1 pts		Vomiting	grade 2				9787
58114	1 pts		Vomiting	grade 3			TRUE	9787
58115	1 pts		Diarrhea	grade 2				9787
58116	1 pts		Diarrhea	grade 3			TRUE	9787
58117	1 pts		Constipation	grade 2				9787
58118	1 pts		ALT	grade 3				9787
58119	1 pts		Abdominal cramps	grade 3				9787
58120	2 pts		Anorexia	grade 3				9787
58121	2 pts		Fatigue	grade 2				9787
58122	1 pts		Fatigue	grade 3				9787
58123	3 pts		Fever	grade 1				9787
58124	2 pts		Nausea	grade 2			TRUE	9788
58125	2 pts		Vomiting	grade 2			TRUE	9788
58126	1 pts		Diarrhea	grade 2			TRUE	9788
58127	1 pts		Cramp	grade 3				9788
58128	1 pts		Cramp	grade 4				9788
58129	1 pts		Anorexia	grade 2				9788
58130						The source does not contain information about AEs or lack thereof		9789
58131	1 pts		Hepatic insufficiency		discontinuation	leads to discontinuation		9790
58132	22		Indigestion					9791
58133	22		Hiccough					9791
58134	7 pts		Myelosuppression				TRUE	9791
58135	57		Leukopenia					9791
58136	29		Thrombocytopenia					9791
58137	82		Somnolence					9791
58138	52		Anemia					9791
58139	73		Headache					9791
58140	91		Nausea					9791
58141	91		Vomiting					9791
58142	91		Anorexia					9791
58143	56		Illusion					9791
58144	73		Diarrhea					9791
58145	22		Memory impairment					9791
58146	3 pts		Gastrointestinal disturbance					9792
58147						No clinically relevant change. It was well-tolerated up to the dose level 800 mg/day.		9794
58148	7 pts		Nausea					9793
58149	7 pts		Diarrhoea					9793
58150	2 pts		Arthralgia					9793
58151	5 pts		Dyspepsia					9793
58152	3 pts		Skeletal pain					9793
58153	6 pts		Vomiting					9793
58154	75		Gastrointestinal symptom NOS		discontinuation	leads to discontinuation	TRUE	9793
58155	31		Gastrointestinal symptom NOS		discontinuation	leads to discontinuation	TRUE	9795
58156			Contact dermatitis					9796
58157			Hepatitis					9800
58158			Nausea			OVERDOSAGE		9798
58159			Vomiting			OVERDOSAGE		9798
58160			Diarrhea			OVERDOSAGE		9798
58161			Death					9801
58162			Paresthesia distal					9797
58163			Anesthesia					9799
58164						There were no drop-outs during the trial, and no adverse events were reported.		9802
58165	25		Neutropenia	grade 4	dose reduction			9804
58166	8.3		Neutropenic fever	grade 5	discontinuation	1 patient died		9804
58167	8.3		Stomatitis	grade 3-4				9804
58168	25		Neutropenic fever					9804
58169	50		Stomatitis	grade 3-4		Stomatitis was severe in the first six patients, whichnecessitated a reduction in dosing for subsequent patients to 4 days of therapy.		9805
58170	50		Neutropenic fever					9805
58171	100		Neutropenia	grade 3-4	dose reduction	Neutropenia was severe in the first six patients, which necessitated a reduction in dosing for subsequent patients to 4 days of therapy.		9805
58172	9		Elevated liver enzymes		discontinuation			9806
58173	50		Skin erythema	grade 3	discontinuation	Patient died		9803
58174	50		Fever	grade 3	discontinuation	Patient died		9803
58175	50		Hypotension	grade 3	discontinuation	Patient died		9803
58176	50		Neutropenia	grade 4				9803
58177	50		Multiple organ failure	grade 5	discontinuation	Patient died		9803
58178	50		Mucositis		discontinuation	Patient died		9803
58179	50		Hepatic insufficiency		discontinuation	Patient died		9803
58180	50		Renal insufficiency		discontinuation	Patient died		9803
58181	50		Disseminated intravascular coagulation	grade 3	discontinuation	Patient died		9803
58182	50		Neutropenia		discontinuation	Patient died		9803
58183			Cerebral dysfunction					9807
58184			Neutropenia				TRUE	9807
58185	2.9		WBC decreased					9808
58186	1		Proteinuria					9808
58187	1		Postponement of menstruation					9808
58188			Kaposi's sarcoma		discontinuation			9810
58189	11.9		Liver injury					9809
58190	4.8		Hypertension					9809
58191	2.4		Hyperglycemia					9809
58192	4.8		Reaction gastrointestinal					9809
58193	8.5		Leukocytopenia					9809
58194						No adverse effects leading to discontinuation were reported; no DLTs		9811
58195	22.2		Dizziness		discontinuation			9812
58196	11.1		Postural hypotension	grade 3	discontinuation			9812
58197	11.1		Palpitations	grade 3	discontinuation			9812
58198			Postural hypotension	grade 3	discontinuation			9814
58199	12.5		Postural hypotension	grade 3				9813
58200	2 pts		ALT increased	grade 3			TRUE	9815
58201	2 pts		AST increased	grade 3			TRUE	9815
58202	2 pts		Direct bilirubin increased	grade 3			TRUE	9815
58203	2 pts		GGT increased	grade 2				9815
58204	1 pts		AST increased	grade 3			TRUE	9817
58205	1 pts		ALT increased	grade 3			TRUE	9817
58206	1 pts		Diarrhea	grade 3			TRUE	9817
58207	1 pts		ALT increased	grade 3			TRUE	9816
58208	1 pts		GGT increased	grade 3			TRUE	9816
58209	2 pts		AST increased	grade 2				9816
58210						No information on AE is provided		9818
58211	16.7		Headache					9819
58212			Dizziness					9819
58213			Nausea					9819
58214			Visual disorders NEC					9819
58215			Worsening of auditory acuity					9819
58216			Lightheadedness					9819
58217			Hepatocellular carcinoma					9820
58218			Angiosarcoma					9820
58219	5 pts		Convulsions					9821
58220						No adverse effects were recorded.		9822
58221						discontinuation due to progressive disease		9823
58222						No adverse effects leading to discontinuation were reported		9824
58223						WNT-974 treatment was generally well tolerated		9825
58224	60		Erythematous rash	grade 2-3			TRUE	9826
58225	12.5		Fluid overload	grade 3			TRUE	9828
58226	12.5		Troponin I increased	grade 1			TRUE	9828
58227	1		Thrombotic microangiopathy	grade 4	discontinuation			9827
58228	1		Hyperbilirubinemia		discontinuation			9827
58229	3.1		Rash		discontinuation			9827
58230	1.2		Function liver abnormal		discontinuation			9829
58231	0.6		Pustular rash		discontinuation			9829
58232	0.6		Pleural effusion		discontinuation			9829
58233	0.6		ALT increased		discontinuation			9829
58234						No AEs were reported		9830
58235	1 pts		Febrile neutropenia				TRUE	9835
58236	1 pts		Infection	grade 3			TRUE	9835
58237	1 pts		Anemia	grade 1				9835
58238	4 pts		Nausea and vomiting	grade 1				9832
58239	1 pts		Fatigue	grade 3				9832
58240	1 pts		Neutropenia	grade 4			TRUE	9832
58241	1 pts		Anemia	grade 2				9832
58242	1 pts		Vomiting	grade 2				9831
58243	1 pts		Diarrhea	grade 3				9831
58244	1 pts		Hyperbilirubinemia				TRUE	9831
58245	1 pts		Alopecia	grade 1				9831
58246	1 pts		Rash	grade 3				9831
58247	2 pts		Mucositis	grade 3			TRUE	9831
58248	1 pts		Anorexia	grade 3				9831
58249	1 pts		Nausea	grade 3				9831
58250	1 pts		Anorexia	grade 2				9834
58251	1 pts		Alopecia	grade 2				9834
58252	1 pts		Mucositis				TRUE	9834
58253	1 pts		Nausea	grade 3				9834
58254	1 pts		Aspartate aminotransferase increase	grade 1				9834
58255	2 pts		Vomiting	grade 2				9834
58256	1 pts		Rash	grade 2				9834
58257	3 pts		Diarrhea	grade 1				9833
58258	1 pts		Aspartate aminotransferase increase	grade 2				9833
58259	1 pts		Alanine aminotransferase increase	grade 2				9833
58260	2 pts		Anorexia	grade 1				9833
58261	2 pts		Mucositis	grade 1				9833
58262	1 pts		Rash	grade 1				9833
58263	1 pts		Alopecia	grade 2				9833
58264	4 pts		Vomiting	grade 1				9833
58265	1 pts		Indigestion	grade 1				9833
58266	1 pts		Nausea	grade 2				9833
58267	1 pts		Dysgeusia	grade 1				9833
58268	8		Sepsis	grade 5	discontinuation		TRUE	9837
58269	33.3		Fever				TRUE	9836
58270	33.3		Neutropenia	grade 4			TRUE	9836
58271						XL228 is generally well tolerated at the MTD of 6.5 mg/kg, with the most common XL228-related adverse events of neutropenia, hyperglycemia, hypotension, fatigue, diarrhea, nausea, dysgeusia, and hypoesthesia oral. No adverse effects leading to discontinuation were reported, no DLT.		9838
58272			Acute kidney injury	grade 3			TRUE	9843
58273			Rash	grade 3			TRUE	9843
58274	25		Rash	grade 3			TRUE	9842
58275	33.3		Autoimmune hepatitis	grade 3			TRUE	9845
58276			Diarrhea	grade 3			TRUE	9839
58277	9.5		Visual disturbances	grade 2	discontinuation			9844
58278	16.7		Diarrhea	grade 3			TRUE	9840
58279	16.7		Pancreatitis	grade 3			TRUE	9840
58280	11.1		Diarrhea	grade 3			TRUE	9841
58281	11.1		Arthralgia	grade 3			TRUE	9841
58282	11.1		Rash	grade 3			TRUE	9841
58283			Headache			the incidence of headaches tended to increase with dose		9846
58284						The source does not contain information about AEs or lack thereof		9847
58285						ABT-102 was safe and adequately tolerated		9848
58286						ABT-102 was safe and adequately tolerated		9849
58287	66.7		Acneiform dermatitis	grade 3	discontinuation		TRUE	9851
58288	14.3		Stomatitis	grade 2	dose interruption			9850
58289	14.3		Fatigue	grade 3	discontinuation		TRUE	9850
58290	14.3		Acneiform dermatitis	grade 3				9850
58291	14.3		Acneiform dermatitis	grade 2	dose interruption			9850
58292	14.3		Acneiform dermatitis	grade 3	discontinuation		TRUE	9850
58293			Nausea	grade 2	discontinuation			9852
58294			Vomiting	grade 2	discontinuation			9853
58295	33		Neutropenia	grade 4			TRUE	9855
58296	33		Febrile neutropenia	grade 4			TRUE	9855
58297	16.7		Febrile neutropenia	grade 3			TRUE	9857
58298	16.7		Thrombocytopenia	grade 3			TRUE	9857
58299	16.7		Febrile neutropenia	grade 3			TRUE	9858
58300	33		Hypokalemia				TRUE	9854
58301	67		Febrile neutropenia	grade 3			TRUE	9854
58302	33		Vomiting	grade 3			TRUE	9854
58303	33		Diarrhea	grade 3			TRUE	9854
58304	16.7		Decreased appetite				TRUE	9856
58305	16.7		Diarrhea	grade 3			TRUE	9856
58306	16.7		Vomiting	grade 3			TRUE	9856
58307	16.7		Fatigue	grade 3			TRUE	9860
58308	16.7		Troponin I increased	grade 3			TRUE	9859
58309			Electrocardiogram QTc interval prolonged			AZD3839 was tolerated up to the highest dose of 300 mg. There were no serious adverse events reported.		9861
58310						No adverse effects leading to discontinuation were reported		9862
58311						No deaths or other serious adverse events occurred during this study and no subjects discontinued the study because of an AE.		9863
58312	33.3		Cystitis	grade 2	discontinuation			9865
58313	33.3		Anorexia	grade 3	discontinuation		TRUE	9865
58314	33.3		Macular edema	grade 2	discontinuation			9865
58315	33.3		ALT increased	grade 3			TRUE	9867
58316	33.3		Night blindness	grade 3	discontinuation		TRUE	9867
58317	33.3		Gamma-glutamyltransferase increased	grade 3			TRUE	9867
58318	33.3		AST increased	grade 3			TRUE	9867
58319	33.3		Visual impairment	grade 3			TRUE	9867
58320						No adverse effects leading to discontinuation were reported; no DLTs		9866
58321	20		Septic shock	grade 4	discontinuation		TRUE	9864
58322	20		Pneumonia	grade 4	discontinuation		TRUE	9864
58323	20		Febrile neutropenia	grade 3			TRUE	9864
58324	20		Anemia	grade 3	discontinuation			9864
58325	20		Platelet count decreased	grade 3			TRUE	9864
58326	20		Respiratory failure	grade 4	discontinuation		TRUE	9864
58327	16.7		Neutropenia	grade 3	dose interruption		TRUE	9868
58328	25		Thrombocytopenia	grade 4			TRUE	9870
58329	1.5		Malaise		discontinuation			9869
58330	1.5		Thrombocytopenia		discontinuation			9869
58331	1.5		Neutropenia		discontinuation			9869
58332	1.5		Intestinal adhesion lysis		discontinuation			9869
58333	5.9		Vomiting		discontinuation			9869
58334	1.5		Oculogyric crisis		discontinuation			9869
58335	2.9		Fatigue		discontinuation			9869
58336	1.5		ECOG performance status worsened		discontinuation			9869
58337	1.5		Nausea		discontinuation			9869
58338	1.5		Dyspnea		discontinuation			9869
58339	1.5		Pulmonary embolism and thrombosis		discontinuation			9869
58340	1.5		Asthenia		discontinuation			9869
58341	5 pts		Fatigue	all grades				9872
58342	6 pts		Nausea	all grades				9872
58343	4 pts		Diarrhea	all grades				9872
58344	4 pts		Hyperglycemia	all grades				9872
58345	3 pts		Mucositis	all grades				9872
58346	3 pts		Decreased appetite	all grades				9872
58347	2 pts		Vomiting	all grades				9872
58348	1 pts		Asthenia	all grades				9872
58349	2 pts		Rash	all grades				9872
58350	2 pts		Dysgeusia	all grades				9872
58351	2 pts		Arthralgia	all grades				9872
58352	2 pts		Glycosylated hemoglobin increased	all grades				9872
58353	2 pts		Pruritus	all grades				9872
58354	2 pts		Dry mouth	all grades				9872
58355	1 pts		Dyspnea	all grades				9872
58356	2 pts		Thrombocytopenia	all grades				9872
58357	1 pts		Fatigue	grade 3-4				9872
58358	1 pts		Hyperglycemia	grade 3-4				9872
58359	1 pts		Rash	grade 3-4				9872
58360	7 pts		Fatigue	all grades				9871
58361	3 pts		Nausea	all grades				9871
58362	5 pts		Diarrhea	all grades				9871
58363	4 pts		Hyperglycemia	all grades				9871
58364	5 pts		Mucositis	all grades				9871
58365	2 pts		Decreased appetite	all grades				9871
58366	5 pts		Vomiting	all grades				9871
58367	3 pts		Asthenia	all grades				9871
58368	3 pts		Rash	all grades				9871
58369	1 pts		Dysgeusia	all grades				9871
58370	2 pts		Arthralgia	all grades				9871
58371	2 pts		Glycosylated hemoglobin increased	all grades				9871
58372	1 pts		Dyspnea	all grades				9871
58373	2 pts		Rash pruritic	all grades				9871
58374	1 pts		Fatigue	grade 3-4				9871
58375	1 pts		Diarrhea	grade 3-4				9871
58376	2 pts		Hyperglycemia	grade 3-4				9871
58377	2 pts		Mucositis	grade 3-4				9871
58378	1 pts		Rash	grade 3-4				9871
58379	1 pts		Arthralgia	grade 3-4				9871
58380	2 pts		Rash pruritic	grade 3-4				9871
58381	2 pts		Death	grade 5	discontinuation	leads to discontinuation		9875
58382	1 pts		Hyperglycemia	grade 3			TRUE	9875
58383	2 pts		Death	grade 5	discontinuation	leads to discontinuation		9872
58384	1 pts		Rash	grade 3			TRUE	9872
58385	1 pts		Death	grade 5	discontinuation	leads to discontinuation		9871
58386	1 pts		Fatigue	grade 3			TRUE	9871
58387	1 pts		Mucositis	grade 3			TRUE	9871
58388	36 pts		Diarrhea	all grades				9874
58389	25 pts		Stomatitis	all grades				9874
58390	18 pts		Nausea	all grades				9874
58391	7 pts		Vomiting	all grades				9874
58392	7 pts		Dry mouth	all grades				9874
58393	5 pts		Abdominal pain	all grades				9874
58394	31 pts		Fatigue	all grades				9874
58395	11 pts		Asthenia	all grades				9874
58396	7 pts		Malaise	all grades				9874
58397	6 pts		Mucosal inflammation	all grades				9874
58398	7 pts		Blood creatinine increased	all grades				9874
58399	5 pts		AST increased	all grades				9874
58400	13 pts		Hyperglycemia	all grades				9874
58401	12 pts		Decreased appetite	all grades				9874
58402	8 pts		Dehydration	all grades				9874
58403	8 pts		Dysgeusia	all grades				9874
58404	19 pts		Pruritus	all grades				9874
58405	18 pts		Rash	all grades				9874
58406	12 pts		Maculopapular rash	all grades				9874
58407	6 pts		Rash macular	all grades				9874
58408	18 pts		Diarrhea	grade 3				9874
58409	5 pts		Stomatitis	grade 3				9874
58410	1 pts		Nausea	grade 3				9874
58411	2 pts		Vomiting	grade 3				9874
58412	1 pts		Abdominal pain	grade 3				9874
58413	10 pts		Fatigue	grade 3				9874
58414	3 pts		Asthenia	grade 3				9874
58415	1 pts		Blood creatinine increased	grade 3				9874
58416	2 pts		AST increased	grade 3				9874
58417	1 pts		Decreased appetite	grade 3				9874
58418	1 pts		Dehydration	grade 3				9874
58419	2 pts		Pruritus	grade 3				9874
58420	1 pts		Rash	grade 3				9874
58421	3 pts		Maculopapular rash	grade 3				9874
58422	1 pts		Rash macular	grade 3				9874
58423	19 pts		Diarrhea	all grades		leads to dose reduction		9873
58424	14 pts		Stomatitis	all grades		leads to dose reduction		9873
58425	12 pts		Nausea	all grades		leads to dose reduction		9873
58426	5 pts		Vomiting	all grades		leads to dose reduction		9873
58427	5 pts		Dry mouth	all grades		leads to dose reduction		9873
58428	3 pts		Abdominal pain	all grades		leads to dose reduction		9873
58429	14 pts		Fatigue	all grades		leads to dose reduction		9873
58430	4 pts		Asthenia	all grades		leads to dose reduction		9873
58431	4 pts		Malaise	all grades		leads to dose reduction		9873
58432	3 pts		Mucosal inflammation	all grades		leads to dose reduction		9873
58433	3 pts		Blood creatinine increased	all grades		leads to dose reduction		9873
58434	2 pts		AST increased	all grades		leads to dose reduction		9873
58435	8 pts		Hyperglycemia	all grades		leads to dose reduction		9873
58436	8 pts		Decreased appetite	all grades		leads to dose reduction		9873
58437	4 pts		Dehydration	all grades		leads to dose reduction		9873
58438	5 pts		Dysgeusia	all grades		leads to dose reduction		9873
58439	12 pts		Pruritus	all grades		leads to dose reduction		9873
58440	12 pts		Rash	all grades		leads to dose reduction		9873
58441	9 pts		Maculopapular rash	all grades		leads to dose reduction		9873
58442	4 pts		Rash macular	all grades		leads to dose reduction		9873
58443						No information on AE is provided		9876
58444						No information on AE is provided		9877
58445	20		ALT increased	grade 3	discontinuation		TRUE	9879
58446	20		Erythematous rash	grade 3	discontinuation		TRUE	9879
58447	12.8		Gamma-glutamyltransferase increased	grade 1-2				9878
58448	5.1		Blood thyroid stimulating hormone increased	grade 1-2				9878
58449	2.6		Neutropenia	grade 1-3				9878
58450	5.1		Blood alkaline phosphatase increased	grade 1-2				9878
58451	30.8		Alanine aminotransferase increased	grade 1-4	discontinuation			9878
58452	30.8		Aspartate aminotransferase increased	grade 1-3				9878
58453	5.1		Dyspepsia	grade 1-2				9878
58454	5.1		Nausea	grade 1-2				9878
58455	2.6		Vomiting	grade 1-2				9878
58456	23.1		Diarrhea	grade 1-2				9878
58457	17.9		Fatigue	grade 1-2				9878
58458	7.7		Pyrexia	grade 1-2				9878
58459	7.7		Dehydration	grade 1-2				9878
58460	7.7		Pruritus	grade 1-2				9878
58461	5.1		Erythema	grade 1-2				9878
58462	7.7		Dizziness	grade 1-2				9878
58463	5.1		Headache	grade 1-2				9878
58464	7.7		Muscle spasms	grade 1-2				9878
58465	5.1		Anemia	grade 1-3				9878
58466	10.3		Hyponatremia	grade 1-3				9878
58467	7.7		Hypokalemia	grade 1-2				9878
58468	12.8		Abdominal pain	grade 1-2				9878
58469	17.9		Decreased appetite	grade 1-2				9878
58470	15.4		Blood creatinine increased	grade 1-2				9878
58471	7.7		Tachycardia	grade 1-2				9878
58472	17.9		Cough	grade 1-2				9878
58473	7.7		Rash	grade 1-2				9878
58474	2.6		Sepsis	grade 4	discontinuation			9878
58475	14.3		Stomatitis				TRUE	9882
58476	16.7		Hyperglycemia				TRUE	9880
58477	16.7		Asthenia				TRUE	9880
58478	16.7		Fatigue				TRUE	9880
58479						No adverse effects leading to discontinuation were reported; no DLTs		9881
58480	16.7		Transaminases increased				TRUE	9883
58481	16.7		Stomatitis				TRUE	9883
58482	20		Bronchospasm	grade 3			TRUE	9884
58483	20		Lipase increased	grade 3			TRUE	9888
58484	3.3		Lipase increased	grade 3			TRUE	9890
58485	7.1		Arthralgia	grade 2			TRUE	9892
58486	11.1		Acute coronary syndrome	grade 2			TRUE	9886
58487	8.3		Lipase increased	grade 3			TRUE	9889
58488	8.3		Abdominal pain	grade 3			TRUE	9889
58489	6.25		Bronchospasm	grade 3			TRUE	9885
58490	7.7		Acute coronary syndrome	grade 3			TRUE	9887
58491	8.3		Myalgia	grade 2			TRUE	9893
58492	8.3		Arthralgia	grade 2			TRUE	9893
58493	5.7		Lipase increased	grade 3			TRUE	9891
58494	33.3		ALT increased	grade 3			TRUE	9894
58495	33.3		AST increased	grade 3			TRUE	9894
58496	25		Dermatitis acneiform					9895
58497	25		Lacrimation increased					9895
58498	50		Paronychia					9895
58499	25		Vision blurred					9895
58500	25		Migraine					9895
58501	25		Rash pustular					9895
58502	25		Ileus	serious				9895
58503	25		Sinusitis					9895
58504	50		Abdominal pain					9895
58505	100		Diarrhoea					9895
58506	25		Pyrexia	serious				9895
58507	25		Dry skin					9895
58508	25		Cough					9895
58509	25		Nausea					9895
58510	50		Blood creatinine increased					9895
58511	25		Stomatitis					9895
58512	25		Pneumonia	serious				9895
58513	25		Dehydration	serious				9895
58514	25		Blood urea increased					9895
58515	25		Vomiting					9895
58516	25		Hyponatraemia	serious				9895
58517	25		Ingrowing nail					9895
58518	25		Weight decreased					9895
58519	25		Dyspnoea	serious				9895
58520	50		Mucosal inflammation					9895
58521	25		Anaemia	serious				9895
58522	25		Dry eye					9895
58523	25		Malaise					9895
58524	25		Decreased appetite					9895
58525	25		Pruritus					9895
58526	25		Conjunctivitis					9895
58527	25		Dyspnoea					9895
58528	50		Hypokalaemia					9895
58529	25		Epistaxis					9895
58530	50		Headache					9895
58531	25		Flushing					9895
58532	25		Rhinorrhoea					9895
58533	50		Rash					9895
58534	50		Diarrhea	grade 3	discontinuation		TRUE	9896
58535	50		Nausea	grade 3	discontinuation		TRUE	9896
58536	50		Vomiting	grade 3	discontinuation		TRUE	9896
58537	28.6		Neutropenia	grade 3				9897
58538	28.6		Thrombocytopenia	grade 3				9897
58539	25		Neutropenia	grade 3				9900
58540	25		Hemoglobin decreased	grade 3				9900
58541	42		Neutropenia	grade 3				9898
58542	9		Neutropenia	grade 4				9898
58543	18		Leucopenia	grade 3				9898
58544	<1		Leucopenia	grade 4				9898
58545	25		Thrombocytopenia	grade 3				9898
58546	2		Thrombocytopenia	grade 4				9898
58547	4		Anaemia	grade 3				9898
58548	2		Hyperglycaemia	grade 3				9898
58549	4		Hypertriglyceridaemia	grade 3				9898
58550	1		Hypertriglyceridaemia	grade 3				9898
58551	<1		Nausea	grade 3				9898
58552	6		Hypokalaemia	grade 3				9898
58553	<1		Hypokalaemia	grade 3				9898
58554	2		Diarrhoea	grade 3				9898
58555	1		Hypocalcaemia	grade 3				9898
58556	5		GGT increased	grade 3				9898
58557	1		Anorexia	grade 3				9898
58558	<1		Urinary tract infection	grade 3				9898
58559	1		Cough	grade 3				9898
58560	<1		Fatigue	grade 3				9898
58561	<1		Vomiting	grade 3				9898
58562	<1		Upper respiratory tract infection	grade 3				9898
58563	1		Weight loss	grade 3				9898
58564	2		Blood creatine phosphokinase increased	grade 3				9898
58565	<1		Blood creatine phosphokinase increased	grade 3				9898
58566	2		Hypophosphataemia	grade 3				9898
58567	<1		Hypophosphataemia	grade 3				9898
58568	31		Neutropenia	grade 3				9899
58569	53		Neutropenia	grade 4				9899
58570	8		Thrombocytopenia	grade 3				9899
58571	2		Thrombocytopenia	grade 4				9899
58572	18		Anemia	grade 3				9899
58573	12		Febrile neutropenia	grade 3				9899
58574	8		Function liver abnormal	grade 3				9899
58575	16		Infection	grade 3				9899
58576	16		Somnolence			A total of 3 of 13 patients with somnolence responded to dose reduction		9902
58577	6		Irritability					9902
58578	5		Increased appetite			A total of 1 of 4 patients with increased appetite responded to dose reduction		9902
58579	2.5		Abdominal pain					9902
58580			Disorientation					9904
58581			Abnormal behaviour					9904
58582	4 pts		Sleepiness					9903
58583	3 pts		Constipation					9903
58584	2 pts		Abnormal behaviour NOS					9903
58585	19 pts		Weight gain			The increase in weight has affected all our patients with only one exception. With a low dose of cyproheptadine (< 16 mg daily) the increase in weight during a six-month period has been 2.9±1.8 kg. With a larger dose taken for the same length of time the weight increase has been 4.2 ± 5.2 kg.		9901
58586			Drowsiness			The drowsiness is usually transient and lasts up to four weeks after starting treatment.		9901
58587			Fatigue					9905
58588			Diarrhea					9905
58589			Nausea					9905
58590			Hyperglycemia					9905
58591			Anemia					9905
58592			Edema					9905
58593			ALT increased					9905
58594			AST increased					9905
58595			Serum alkaline phosphatase elevated					9905
58596						No information on AE is provided		9906
58597	33.3		Hypophosphatemia	grade 3			TRUE	9908
58598	33.3		ALT increased	grade 3			TRUE	9908
58599	66.7		Fatigue	grade 3			TRUE	9908
58600	33.3		Muscle weakness	grade 3			TRUE	9908
58601	14.3		Hypophosphatemia	grade 3			TRUE	9909
58602	14.3		Hematuria	grade 3			TRUE	9909
58603	10		GGT increased	grade 3			TRUE	9907
58604	10		Anorexia	grade 3			TRUE	9907
58605	10		Fatigue	grade 3			TRUE	9907
58606	10		Hyponatremia	grade 3			TRUE	9907
58607	10		Confusion	grade 3			TRUE	9907
58608						No AEs were observed		9910
58609	25		Abdominal pain	all grades				9911
58610	25		Weight decreased	all grades				9911
58611	25		Fatigue	grade 3-4				9911
58612	75		Decreased appetite	all grades				9911
58613	25		Dyspnea	all grades				9911
58614	75		Constipation	all grades				9911
58615	25		Hypokalemia	grade 3-4				9911
58616	25		Dizziness	all grades				9911
58617	50		Pain	all grades				9911
58618	50		Vomiting	all grades				9911
58619	50		Back pain	all grades				9911
58620	25		Diarrhea	all grades				9911
58621	25		Dysgeusia	all grades				9911
58622	75		Nausea	all grades				9911
58623	1 pts		Radiation pneumonitis	grade 3			TRUE	9913
58624	1 pts		Fatigue	grade 3			TRUE	9914
58625	1 pts		Rhabdomyolysis	grade 4	discontinuation		TRUE	9912
58626	50		Nausea	grade 4			TRUE	9915
58627	25		Vomiting	grade 4			TRUE	9916
58628	25		Vomiting	grade 4			TRUE	9916
58629	25		Dysarthria	grade 2	discontinuation			9916
58630	25		Non-cardiac chest pain	grade 2	discontinuation			9916
58631	25		Acute kidney injury	grade 2	discontinuation			9916
58632	25		Nausea	grade 3	discontinuation			9916
58633	25		Agitation	grade 2	discontinuation			9916
58634	16.7		Hallucinations	grade 1	discontinuation			9917
58635	16.7		Muscle spasms	grade 1	discontinuation			9917
58636	16.7		Paresthesia	grade 1	discontinuation			9917
58637	16.7		Diarrhea	grade 3			TRUE	9918
58638	33.3		Diarrhea				TRUE	9921
58639	16.7		Skin rash				TRUE	9919
58640	33.3		Diarrhea				TRUE	9920
58641						No information on AE is provided		9924
58642						No information on AE is provided		9922
58643						No information on AE is provided		9923
58644						It's impossible to link AEs with the definite dose. All adverse events were mild (grade 1), except for one subject with an asymptomatic elevated lipase level (grade 3), seven subjects with moderate (defined as analgesia-requiring) headaches (grade 2), and one subject with moderate diarrhea (grade 2); all abnormalities except for the one grade 3 lipase elevation resolved during the study or in follow-up. No serious adverse events were reported, and no subject missed a dose or was discontinued from the study because of adverse effects.		9925
58645	25		Hypertension	grade 3			TRUE	9926
58646	12.5		Hypertension		discontinuation			9926
58647	1 pts		Hyperthermia					9928
58648			Hyperthermia			statistically significant attenuation of hyperthermia at the highest dose (10 mg dose of AMG 517) on days 2 through 7		9927
58649						The dose was well tolerated		9929
58650	14.3		Alanine aminotransferase increased		discontinuation		TRUE	9930
58651	14.3		Aspartate aminotransferase increased		discontinuation		TRUE	9930
58652	9		Febrile neutropenia	grade 4	discontinuation		TRUE	9931
58653						No adverse effects leading to discontinuation were reported; no DLTs		9933
58654	14.3		Rash	grade 3				9934
58655	14.3		Nausea	grade 2	dose interruption			9934
58656	14.3		Dizziness	grade 3				9934
58657	14.3		Fatigue	grade 3			TRUE	9934
58658						No adverse effects leading to discontinuation were reported; no DLTs		9932
58659						No adverse effects leading to discontinuation were reported; no DLTs		9935
58660	20		Fatigue	grade 3			TRUE	9936
58661	20		Febrile neutropenia	grade 3			TRUE	9936
58662	20		Hypokalemia	grade 3			TRUE	9936
58663	20		Mucositis	grade 3			TRUE	9936
58664	6.7		Mucositis	grade 3			TRUE	9937
58665						No adverse effects are mentioned		9938
58666	11.1		Rash		discontinuation		TRUE	9939
58667	11.1		Maculopapular rash		discontinuation		TRUE	9939
58668	33.3		Fatigue		discontinuation		TRUE	9940
58669						No AEs were observed		9943
58670						No AEs were observed		9941
58671	16.7		Ataxia	grade 2			TRUE	9945
58672	14.3		Dizziness	grade 3			TRUE	9946
58673	20		Hallucination	grade 2			TRUE	9947
58674	20		Anxiety	grade 3			TRUE	9947
58675			Dizziness	grade 1				9942
58676	16.7		Lung infiltration	grade 3	discontinuation		TRUE	9944
58677	16.7		Presyncope	grade 3	dose interruption		TRUE	9948
58678	3 pts		Nausea	grade 1				9949
58679	1 pts		Dizziness	grade 1				9949
58680	1 pts		Dyspepsia	grade 1				9949
58681	2 pts		Nausea				TRUE	9950
58682	2 pts		Vomiting				TRUE	9950
58683	2 pts		Abdominal pain				TRUE	9950
58684						No information on AE is provided		9951
58685	50		Bradycardia	grade 1-2				9954
58686	33.3		Neutropenia	grade 3-4				9954
58687	16.7		Fatigue	grade 1-2				9954
58688	50		Hypertension	grade 1-2				9954
58689	33.3		Rash	grade 1-2				9954
58690	16.7		Leukopenia	grade 3-4				9954
58691	33.3		Stomatitis	grade 1-2				9954
58692	16.7		Pyrexia	grade 1-2				9954
58693	16.7		ALT increased	grade 3-4	discontinuation			9954
58694	16.7		AST increased	grade 3-4	discontinuation			9954
58695	12.5		Troponin T increased	grade 3	discontinuation		TRUE	9957
58696	16.7		Blood sodium decreased	grade 4				9954
58697	16.7		Haemoglobin decreased	grade 3				9954
58698	12.5		ALT increased	grade 3	discontinuation		TRUE	9956
58699	12.5		AST increased	grade 3	discontinuation		TRUE	9956
58700	12.5		Neutropenia	grade 4	discontinuation		TRUE	9956
58701	12.5		Thrombocytopenia	grade 4	discontinuation		TRUE	9956
58702	12.5		Pneumonia	grade 3	discontinuation			9956
58703	12.5		GGT increased	grade 3	discontinuation			9956
58704	33.3		Interstitial lung disease	grade 3	discontinuation			9960
58705	25		Fatigue	grade 1-3				9953
58706	50		Neutropenia	grade 1-3			TRUE	9953
58707	25		Anemia	grade 1-2				9953
58708	75		Serum transaminase increased	grade 1-2				9953
58709	25		Nausea	grade 1-2				9953
58710	25		Pyrexia	grade 1-2				9953
58711	13		Vomiting	grade 1-2				9953
58712	13		Constipation	grade 1-2				9953
58713	13		Diarrhea	grade 1-2				9953
58714	25		Thrombocytopenia	grade 1-3				9953
58715	13		Peripheral edema	grade 1-2				9953
58716	13		Cough	grade 1-2				9953
58717	13		ALP increased	grade 1-2				9953
58718	13		Myocardial ischemia	grade 3	discontinuation		TRUE	9952
58719	16.7		Troponin I increased	grade 3	discontinuation		TRUE	9958
58720	16.7		Nausea	grade 3			TRUE	9959
58721	71		Neutropenia	grade 1-3				9955
58722	43		Anemia					9955
58723	29		Serum transaminase increased					9955
58724	14		Nausea					9955
58725	29		Vomiting					9955
58726	14		Constipation					9955
58727	29		Diarrhea					9955
58728	29		ALP increased					9955
58729	14		Hyperglycemia	grade 1-3				9955
58730	28		Hypophosphatemia	grade 1-3				9955
58731	14		Chest pain	grade 1-3				9955
58732	14		Diarrhea	grade 1-3				9955
58733	57.1		ALT increased	grade 1-3	discontinuation		TRUE	9962
58734	71.4		Stomatitis					9962
58735	57.1		Rash					9962
58736	42.9		Decreased appetite					9962
58737	57.1		Nausea					9962
58738	57.1		AST increased					9962
58739	42.9		Blood lactate dehydrogenase increased					9962
58740	28.6		Diarrhea					9962
58741	42.9		Vomiting					9962
58742	42.9		Pruritus					9962
58743	42.9		Blood alkaline phosphatase increased					9962
58744	42.9		GGT increased					9962
58745	28.6		Somnolence					9962
58746	10		Nausea	grade 1-2				9961
58747	20		Stomatitis	grade 1-2				9961
58748	30		ALT increased	grade 1-3			TRUE	9961
58749	30		AST increased	grade 1-3			TRUE	9961
58750	10		GGT increased	grade 1-2				9961
58751	20		Fatigue	grade 1-2				9961
58752	20		Hyperglycaemia	grade 1-2				9961
58753	14		ALT increased	grade 3			TRUE	9964
58754	18		Nausea	grade 1-2				9963
58755	18		Stomatitis	grade 1-2				9963
58756	27		ALT increased	grade 1-3			TRUE	9963
58757	27		AST increased	grade 1-3			TRUE	9963
58758	9		GGT increased	grade 3			TRUE	9963
58759	9		Fatigue	grade 1-2				9963
58760	27		Hyperglycaemia	grade 1-2				9963
58761						There were no serious adverse events  ordeaths  during  the  study,  and  no  subjects  withdrewfrom the study as a result of adverse events		9966
58762						No adverse effects leading to discontinuation were reported		9965
58763	18.2		Diarrhea	grade 3	discontinuation		TRUE	9967
58764	18.2		Vomiting	grade 3	discontinuation		TRUE	9967
58765						n the SAD study there were no serious adverse events (SAEs), and no subject was withdrawn as a result of treatment-emergent adverse events (TEAEs).		9968
58766						In the MAD study there were no SAEs, and no subjects were discontinued due to AEs.		9969
58767						DLTs occurred in 7/77 pts in the BLZ945 arm (increases in amylase, lipase, AST, ALP, worsening of elevated amylase, sudden death), AEs are not stratified by dose groups		9970
58768	33.3		Transaminases increased	grade 3			TRUE	9971
58769	16.7		QT interval prolonged	grade 3			TRUE	9971
58770	16.7		Transaminitis	grade 3-4			TRUE	9972
58771	34.6		Diarrhea	grade 1-2				9972
58772	12		Anorexia	grade 1				9972
58773	46.1		Asthenia	grade 1-2				9972
58774	4		Acneiform dermatitis	grade 1				9972
58775	76.9		Skin rash	grade 1-2				9972
58776	15		AST increased	grade 3				9972
58777	61.5		ALT increased	grade 2-3				9972
58778	67		Diarrhea	grade 1				9971
58779	33		Anorexia	grade 1				9971
58780	33		Asthenia	grade 1				9971
58781	33		Acneiform dermatitis	grade 1-2				9971
58782	33		Skin rash	grade 1-2				9971
58783	33		AST increased	grade 3-4				9971
58784	33		ALT increased	grade 2-3				9971
58785						No adverse effects leading to discontinuation were reported		9973
58786	1.4		Ventricular extrasystoles	mild	discontinuation	possibly drug-related		9974
58787	1.4		Supraventricular extrasystoles	mild	discontinuation	possibly drug-related		9974
58788	100		Diarrhea	grade 1-4				9976
58789	75		Nausea	grade 1-4				9976
58790	50		Stomatitis	grade 1-2				9976
58791	25		Fatigue	grade 1-2				9976
58792	75		Rash	grade 1-4				9976
58793	25		Decreased appetite	grade 1-2				9976
58794	50		Vomiting	grade 1-2				9976
58795	50		Dry skin	grade 1-2				9976
58796	25		Anemia	grade 1-2				9976
58797	66.7		Diarrhea	grade 1-2				9975
58798	33.3		Nausea	grade 1-2				9975
58799	33.3		Stomatitis	grade 1-2				9975
58800	66.7		Fatigue	grade 1-4	dose reduction		TRUE	9975
58801	66.7		Decreased appetite	grade 1-2				9975
58802	33.3		Vomiting	grade 1-2				9975
58803	100		Hyperglycemia	grade 3-4				9975
58804	33.3		Anemia	grade 1-2				9975
58805	33.3		Abdominal pain	grade 3-4				9975
58806	33.3		Encephalopathy	grade 3	discontinuation		TRUE	9975
58807	14.3		Liver function test increased	grade 3			TRUE	9977
58808	40		Diarrhea	grade 3	dose reduction		TRUE	9978
58809	20		Stomatitis	grade 3	dose reduction		TRUE	9978
58810	57.1		Diarrhea	grade 1-2				9977
58811	42.9		Stomatitis	grade 1-2				9977
58812	14.3		Fatigue	grade 1-2				9977
58813	14.3		Rash	grade 1-2				9977
58814	28.6		Dry skin	grade 1-2				9977
58815	14.3		Hyperglycemia	grade 3-4				9977
58816	14.3		Anemia	grade 3-4				9977
58817	14.3		Abdominal pain	grade 1-2				9977
58818	3		Bilirubin increased		dose reduction			9981
58819	1.5		Lactate dehydrogenase increased		dose reduction			9981
58820	48		Fatigue	grade 1-4	dose reduction			9981
58821	1.5		Arrhythmia		dose reduction			9981
58822	1.5		Blurred vision		dose reduction			9981
58823	1.5		Abdominal cramp		discontinuation			9981
58824	1.5		Diarrhea		dose reduction			9981
58825	1.5		Anemia		dose reduction			9981
58826	1.5		Ataxia		dose reduction			9981
58827	57		Diarrhea	grade 1-4				9981
58828	52		Nausea	grade 1-2				9981
58829	25		Rash	grade 1-2				9981
58830	22		Edema	grade 1-2				9981
58831	21		Vomiting	grade 1-4				9981
58832	18		Abdominal pain	grade 1-2				9981
58833	18		Anorexia	grade 1-4				9981
58834	13		Edema face	grade 1-2				9981
58835	1.5		Stroke		discontinuation			9981
58836	30.8		Diarrhea	grade 1-2				9979
58837	15.4		Asthenia	grade 1-2				9979
58838	7.7		Rash	grade 1-2				9979
58839	75		Diarrhea	grade 1-2				9980
58840	50		Asthenia	grade 1-3				9980
58841	12.5		Rash	grade 1-2				9980
58842	12.5		Nausea	grade 1-2				9980
58843	25		Vomiting	grade 1-2				9980
58844	80		Diarrhea	grade 1-2				9982
58845	40		Asthenia	grade 1-3				9982
58846	20		Rash	grade 1-2				9982
58847	33.3		Nausea	grade 1-2				9982
58848	33.3		Vomiting	grade 1-2				9982
58849	11.1		Thrombocytopenia	grade 3	discontinuation			9983
58850	6.7		Thrombocytopenia	grade 3			TRUE	9986
58851	6.7		Pulmonary embolism	grade 4			TRUE	9986
58852	20		Hyperbilirubinemia	grade 3			TRUE	9984
58853	20		ALT increased	grade 3			TRUE	9984
58854						No adverse effects leading to discontinuation were reported		9985
58855	1 pts		Leukopenia					9987
58856	1 pts		Elevated liver enzymes					9987
58857	3 pts		Rash					9988
58858	8 pts		Headaches					9988
58859	6 pts		Gastrointestinal symptom NOS					9988
58860	2 pts		Vomiting					9988
58861	2 pts		Gastrointestinal discomfort					9988
58862	1 pts		Decreased appetite					9988
58863	1 pts		Heartburn					9988
58864	3 pts		Tiredness					9988
58865	2 pts		Dizziness					9988
58866	1 pts		Difficulty sleeping					9988
58867	1 pts		Palpitations					9988
58868	1 pts		Tachycardia					9988
58869						AEs were not observed		9989
58870	25		Headache					9990
58871	12.5		Ache stomach	grade 1				9990
58872	25		Nausea	grade 1				9990
58873	25		Abdominal pain	grade 1				9990
58874	12.5		Dizziness	grade 1				9990
58875	12.5		Muscle pain	grade 1				9990
58876	1 pts		Syncope					9991
58877	1 pts		Hallucination visual				TRUE	9991
58878	1 pts		Dehydration		dose reduction		TRUE	9991
58879	1 pts		Diarrhea	severe			TRUE	9991
58880	1 pts		Nausea	severe			TRUE	9991
58881	1 pts		Vomiting	severe			TRUE	9991
58882	2 pts		Hallucination visual	grade 2			TRUE	9992
58883	2 pts		Peripheral sensory neuropathy	grade 2			TRUE	9992
58884	1 pts		Peripheral sensory neuropathy	grade 2			TRUE	9993
58885						No adverse effects leading to discontinuation were reported		9994
58886						No adverse effects leading to discontinuation were reported		9995
58887						No information on AE is provided		9996
58888	22.2		Nausea	grade 1				9998
58889	11.1		Stomach burning sensation of					9998
58890	55.6		Hyperhomocysteinaemia					9998
58891	33.3		Creatinine serum increased					9998
58892	11.1		AST increased					9998
58893	11.1		ALT increased					9998
58894	11.1		Creatine kinase increased					9998
58895						AEs not reported		9997
58896			Stomach pain					10000
58897			Bloating					10000
58898			Constipation	grade 2				10000
58899			Blood homocysteine increased	grade 1				9999
58900	5		Nausea					10001
58901	5		Vomiting					10001
58902	5 pts		Neutropenia	grade 4	dose reduction			10003
58903	2 pts		Neutropenia	grade 4				10002
58904	1 pts		Febrile neutropenia				TRUE	10002
58905	28.6		Neutropenia	grade 3-4	dose reduction		TRUE	10005
58906	28.6		Anemia	grade 1-2				10005
58907	28.6		Infusion site reaction	grade 1-2				10005
58908	42.9		Thrombocytopenia	grade 3-4	dose reduction		TRUE	10005
58909	25		Neutropenia	grade 1-4	discontinuation		TRUE	10006
58910	25		Anemia	grade 1-4				10006
58911	12.5		Infusion site reaction	grade 1-2				10006
58912	25		Phlebitis	grade 1-2				10006
58913	12.5		Thromboembolism	grade 3-4				10006
58914	12.5		Chest pain	grade 3-4				10006
58915	42.9		Neutropenia	grade 1-4	dose reduction		TRUE	10004
58916	14.4		Embolism pulmonary		discontinuation		TRUE	10004
58917	16.7		Infusion site reaction	grade 1				10007
58918	16.7		Phlebitis	grade 1				10007
58919	50		Thromboembolism	grade 3-4				10007
58920	5.9		Portal vein thrombosis		discontinuation			10008
58921	29.4		Embolism pulmonary		discontinuation			10008
58922	33.3		Blood glucose increased					10010
58923	33.3		Blood glucose increased					10011
58924						No information on AE is provided		10009
58925	16.7		Mouth ulceration	grade 3				10014
58926	7.7		Transaminases increased	grade 3				10018
58927	<1		Rash	grade 3-4				10015
58928	2		Pain	grade 3-4				10015
58929	1		Transaminases increased	grade 3-4				10015
58930	<1		Nausea	grade 3-4				10015
58931						AEs not reported		10012
58932	16.7		Rash	grade 3		Dose reduction	TRUE	10013
58933	16.7		Rash	grade 3		Dose reduction	TRUE	10019
58934	16.7		Hand and foot syndrome	grade 3		Dose reduction	TRUE	10019
58935	1		ALT increased	grade 3-4				10016
58936	1		Aspartate aminotransferase increased	grade 3-4				10016
58937	1		Impaired liver function	grade 3-4				10016
58938	1		Leucopenia	grade 3-4				10016
58939	1		Neutropenia	grade 3-4				10016
58940	1		Dizziness	grade 3-4				10016
58941	2		Numbness of limbs	grade 3-4				10016
58942	0.7		Leukopenia	grade 3-4				10017
58943	2		ALT increased	grade 3-4				10017
58944	2.7		Aspartate aminotransferase increased	grade 3-4				10017
58945	11.1		Atrial fibrillation	grade 3			TRUE	10021
58946	20		Vomiting	grade 3			TRUE	10020
58947						The cream was tolerated well and there were no treatment-related allergic or irritation reactions  on  any of the tested  sites either after the  first 24  hours nor after the  repeated test 2 weeks later. No local skin or systemic reactions were noted.		10022
58948	11		Orthostatic dizziness					10023
58949	6 pts		Alanine aminotransferase increase					10023
58950	6 pts		Aspartate aminotransferase increase					10023
58951	6 pts		Dizziness					10024
58952	6 pts		Light-headed					10024
58953	1 pts		Nausea					10024
58954	1 pts		Tiredness					10024
58955	1 pts		Drowsiness					10024
58956	2 pts		Light-headed					10025
58957	2 pts		Dizziness					10025
58958	1 pts		Headache					10025
58959	1 pts		Drowsiness					10025
58960			Abdominal pain					10027
58961			Dizziness					10027
58962			Fatigue					10027
58963			Hot flushes					10027
58964			Nausea					10027
58965			Sweating					10027
58966	0.3		Iritis	grade 2	discontinuation			10028
58967	0.3		Meibomianitis	grade 1	discontinuation			10028
58968						AEs not reported. Estimated figure		10026
58969	28.6		Creatine phosphokinase increased	grade 4			TRUE	10030
58970	14.3		Muscle weakness	grade 3			TRUE	10030
58971	14.3		Aspartate aminotransferase increased	grade 3			TRUE	10030
58972	14.3		Alanine aminotransferase increased	grade 3			TRUE	10030
58973	33.3		Creatine phosphokinase increased	grade 4			TRUE	10029
58974	33.3		Aspartate aminotransferase increased	grade 2-3			TRUE	10029
58975	33.3		Alanine aminotransferase increased	grade 2-3			TRUE	10029
58976	1.3		Aspartate aminotransferase increased	grade 2-4	discontinuation			10031
58977	1.3		Alanine aminotransferase increased	grade 2-4	discontinuation			10031
58978	0.4		Gastrointestinal disturbance		discontinuation			10031
58979	0.27		Rash		discontinuation			10031
58980	0.13		Myalgia		discontinuation			10031
58981	0.27		Myopathy		discontinuation			10031
58982	0.13		Arthralgia		discontinuation			10031
58983	0.13		Insomnia		discontinuation			10031
58984	0.13		Weight gain		discontinuation			10031
58985	14.3		Thrombocytopenia	grade 4			TRUE	10033
58986	25		Visual disturbance	grade 2			TRUE	10032
58987	25		Back pain	grade 3			TRUE	10032
58988	50		Chest pain - cardiac	grade 3	discontinuation		TRUE	10032
58989						No adverse effects leading to discontinuation were reported, no DLT		10036
58990						No adverse effects leading to discontinuation were reported, no DLT		10035
58991	50		Vomiting	grade 3			TRUE	10034
58992	50		Nausea	grade 3			TRUE	10034
58993						Impossible to link AEs with the definite dose: The most frequent treatment-emergent adverse events were procedural headache and catheter site pain.		10037
58994	1 pts		Diarrhoea	grade 3			TRUE	10039
58995	11.1		Hypersensitivity	grade 3				10038
58996						There were no serious adverse events and no discontinuations due to adverse events in the Phase I studies.		10040
58997						There were no serious adverse events and no discontinuations due to adverse events in the Phase I studies.		10041
58998						Dose limiting toxicity has not been reached		10042
58999						No information on AE is provided		10044
59000	16.7		Febrile neutropenia	grade 3			TRUE	10045
59001	20		Febrile neutropenia	grade 4			TRUE	10046
59002	20		Infection	grade 3			TRUE	10046
59003						No information on AE is provided		10043
59004						No adverse effects leading to discontinuation were reported; no DLTs		10049
59005	50		Somnolence	grade 2			TRUE	10051
59006	50		Fatigue	grade 3			TRUE	10051
59007	50		Confusion	grade 3			TRUE	10051
59008	50		Cognitive disorder	grade 3			TRUE	10051
59009	33.3		Cognitive disorder	grade 3			TRUE	10047
59010	33.3		Hallucination	grade 3			TRUE	10047
59011	16.7		Hepatotoxicity	grade 3			TRUE	10050
59012	16.7		Somnolence				TRUE	10048
59013	16.7		Transaminitis				TRUE	10048
59014	1 pts		Rash	grade 3			TRUE	10057
59015	1 pts		Left ventricular ejection fraction decreased	grade 3			TRUE	10057
59016	3 pts		Diarrhea	all grades				10052
59017	1 pts		Blurred vision	all grades				10052
59018	1 pts		Ataxia	all grades				10052
59019	1 pts		Dizziness	all grades				10052
59020	2 pts		Rash	all grades				10052
59021	2 pts		Fatigue	all grades				10052
59022	1 pts		Nausea	all grades				10052
59023	1 pts		Gait disturbance	all grades				10052
59024	2 pts		Visual disturbance	all grades				10052
59025	1 pts		Optic neuropathy					10058
59026	1 pts		Rash	grade 3				10058
59027	1 pts		Unsteady gait	grade 3				10058
59028	1 pts		Confusion	grade 3			TRUE	10054
59029	1 pts		Dizziness	grade 3			TRUE	10054
59030	1 pts		Rash	grade 3			TRUE	10059
59031	1 pts		Diarrhea	grade 3			TRUE	10059
59032	1 pts		Syncope	grade 3			TRUE	10059
59033	1 pts		Confusion	grade 3			TRUE	10053
59034	1 pts		Rash	grade 3			TRUE	10055
59035	8		Confusional state	grade 3				10056
59036	8		Diarrhea	grade 3				10056
59037	15		Peripheral edema	grade 1-2				10056
59038	15		Epistaxis	grade 1-2				10056
59039	8		Dyspnea	grade 3				10056
59040	1 pts		Blurred vision		discontinuation			10056
59041	38		Nausea	grade 1-2				10056
59042	1 pts		Fatigue		discontinuation			10056
59043	8		Rash	grade 3				10056
59044	8		Asthenia	grade 1-2				10056
59045	1 pts		Hallucinations		discontinuation			10056
59046	8		Dermatitis acneiform	grade 1-2				10056
59047	8		Myalgia	grade 1-2				10056
59048	38		Vomiting	grade 1-2				10056
59049	15		Dry mouth	grade 1-2				10056
59050	15		Dyspepsia	grade 1-2				10056
59051	15		Edema face	grade 1-2				10056
59052	8		Headache	grade 1-2				10056
59053	8		Weight gain	grade 1-2				10056
59054	6 pts		Diarrhea					10060
59055	6 pts		Nausea					10060
59056	8.3		Fatigue	grade 3			TRUE	10062
59057	20		Rash	grade 3	discontinuation		TRUE	10061
59058	20		Fatigue	grade 2	discontinuation		TRUE	10061
59059	8.3		Colitis	grade 3	discontinuation			10062
59060	8.3		Rash	grade 3	discontinuation			10062
59061	8.3		Headache	grade 3	discontinuation			10062
59062	8.3		Dyspnea	grade 3	discontinuation			10062
59063			Nausea			three of eight subjects reported a total of five adverseevents, the most common (60%) being nausea		10063
59064						The source does not contain information about AEs or lack thereof		10064
59065			Vertigo		discontinuation			10065
59066			Nausea		discontinuation			10065
59067			Epigastric pain		discontinuation			10065
59068	1		Skin rash		discontinuation			10065
59069	10		Lactate dehydrogenase increased	grade 1				10068
59070	10		Albumin increased	grade 1				10068
59071	20		Carbon dioxide low	grade 1				10068
59072	10		Glucose increased	grade 1				10068
59073	10		Chloride increased	grade 1				10068
59074	10		Eosinophil count increased	grade 1				10068
59075	20		Blood phosphate increased	grade 1				10068
59076	10		Blood lactate dehydrogenase decreased	grade 1				10068
59077	10		Red eye	grade 1				10066
59078	70		Diarrhea	grade 1-3				10066
59079	20		Flatulence	grade 1				10066
59080	30		Nausea	grade 1				10066
59081	30		Abdominal pain	grade 1				10066
59082	10		Chest pain	grade 1				10066
59083	10		Dizziness	grade 1				10066
59084	10		Dry mouth	grade 1				10066
59085	10		Urine color abnormal	grade 1				10066
59086	6		Skin rash	grade 3	discontinuation			10069
59087	3		Constipation	grade 2	discontinuation			10069
59088	3		Allergic reaction	grade 2				10069
59089	6		Diarrhea	grade 2				10069
59090	71		Abdominal pain					10067
59091	86		Loose stools					10067
59092	36		Upper respiratory tract infection NOS					10067
59093	21		Headache					10067
59094	7		Bloating					10067
59095	7		Urinary tract infection NOS					10067
59096	14		Fatigue					10067
59097	14		Creatine kinase					10067
59098	7		Dyspepsia					10067
59099	13		Flatulence					10067
59100	29		Skin rash					10067
59101	21		Microalbuminuria					10067
59102	7		Edema lower limb					10067
59103	36		Nausea					10067
59104	7		Abnormal liver function tests		discontinuation			10067
59105	7		Constipation					10067
59106	71		Diarrhea	grade 1-3				10067
59107	25		AST increased	grade 3			TRUE	10070
59108	25		Hypotension	grade 2			TRUE	10070
59109	25		Cardiac arrhythmia	grade 2			TRUE	10070
59110	25		Troponin T increased	grade 2			TRUE	10070
59111	25		Atrial fibrillation paroxysmal	grade 1			TRUE	10070
59112	75		Fatigue	grade 1-2				10070
59113	50		Diarrhea	grade 1-2				10070
59114	50		Vomiting	grade 1-2				10070
59115	75		Nausea	grade 1				10070
59116	25		Neutropenia	grade 1				10070
59117	25		Thrombopenia	grade 1				10070
59118	25		Leucopenia	grade 1-2				10070
59119	50		AST/ALT ratio abnormal	grade 1-4				10070
59120	16.7		AST increased	grade 3			TRUE	10073
59121	33.3		Hypertension	grade 3			TRUE	10072
59122	16.7		Electrocardiogram QTc interval prolonged	grade 3			TRUE	10071
59123	16.7		Electrocardiogram QTc interval prolonged	grade 3			TRUE	10073
59124	16.7		AST/ALT ratio abnormal	grade 3			TRUE	10071
59125	16.7		Electrolyte disturbance	grade 3			TRUE	10071
59126	33.3		Leucopenia	grade 1-2			TRUE	10071
59127	16.7		Neutropenia	grade 1			TRUE	10071
59128	16.7		Thrombopenia	grade 1			TRUE	10071
59129	50		Nausea	grade 1-2				10071
59130	33.3		Vomiting	grade 1-2				10071
59131	33.3		Diarrhea	grade 1-2				10071
59132	100		Fatigue	grade 1-2				10071
59133	83.3		AST/ALT ratio abnormal	grade 1-2				10071
59134						Ro 20-1724 had no adverse systemic or cutaneous effects		10074
59135						No adverse effects leading to discontinuation were reported		10075
59136	15.4		Fall					10077
59137	13.2		Diarrhea					10077
59138	12.1		Urinary tract infection					10077
59139	13.2		Depression					10077
59140	15.4		Nausea					10077
59141	8.8		Headache					10077
59142	12.1		Dizziness					10077
59143	6.6		Agitation					10077
59144	7.7		Fatigue					10077
59145	8.8		Vomiting					10077
59146	4.4		Confusional state					10077
59147	3.3		Upper respiratory tract infection					10077
59148	8.8		Insomnia					10077
59149	12.5		Headache	grade 1				10076
59150	12.5		Abdominal bloating	grade 1				10076
59151	12.5		Paresthesia	grade 2				10076
59152						No AEs were observed		10079
59153	100		Creatinine increased	grade 2-3	discontinuation		TRUE	10078
59154	100		Creatinine increased		discontinuation			10080
59155	100		Blood urea nitrogen increased		discontinuation			10080
59156	1 pts		Partial thromboplastin time prolonged	grade 3				10083
59157	1 pts		Fatigue	grade 3				10083
59158	1 pts		Nausea	grade 3				10083
59159	1 pts		Creatinine decreased	grade 4				10083
59160	1 pts		Anemia					10081
59161	3 pts		Neutropenia				TRUE	10085
59162	1 pts		Anemia				TRUE	10085
59163	2 pts		Abdominal pain					10085
59164	1 pts		Diarrhea					10085
59165	1 pts		Vomiting					10085
59166	1 pts		Hyperbilirubinemia					10085
59167	2 pts		Alanine aminotransferase increase					10085
59168	2 pts		Aspartate aminotransferase increased					10085
59169	1 pts		Acute renal failure					10085
59170	1 pts		Hypokalemia					10085
59171	1 pts		Hypocalcemia					10085
59172	1 pts		Hyperuricemia					10085
59173	2 pts		Hypoxia					10085
59174	1 pts		Dyspnea					10085
59175	1 pts		Lung infiltration					10085
59176	2 pts		Hypotension					10085
59177	1 pts		Capillary leak syndrome					10085
59178	1 pts		Dizziness					10085
59179	2 pts		Pneumonia					10085
59180	1 pts		Otitis media					10085
59181	2 pts		Asthenia					10085
59182	2 pts		Fatigue					10085
59183	1 pts		Chest pain (non-cardiac)					10085
59184	1 pts		Dehydration					10085
59185	4 pts		Tumor lysis syndrome					10085
59186	7 pts		Neutropenia				TRUE	10084
59187	6 pts		Anemia				TRUE	10084
59188	1 pts		Thrombocytopenia				TRUE	10084
59189	4 pts		Febrile neutropenia					10084
59190	1 pts		Cholecystitis					10084
59191	1 pts		Acute renal failure					10084
59192	1 pts		Hypokalemia					10084
59193	1 pts		Hypercalcemia					10084
59194	2 pts		Pneumonia					10084
59195	1 pts		Cellulitis					10084
59196	1 pts		Sepsis					10084
59197	1 pts		Streptococcal bacteremia					10084
59198	1 pts		Hyperglycemia					10084
59199	4 pts		Myelosuppression					10082
59200						No adverse effects leading to discontinuation were reported		10086
59201	16.7		Fatigue	grade 3			TRUE	10089
59202	33.3		Fatigue	grade 3			TRUE	10087
59203						No adverse effects leading to discontinuation were reported; no DLTs		10088
59204	3		Hypertension	grade 3			TRUE	10090
59205	3		Brain metastases	grade 5		bleeding brain metastases	TRUE	10090
59206	3		Stomatitis	grade 3			TRUE	10090
59207	3		Diarrhea	grade 3			TRUE	10090
59208						No AEs were reported		10091
59209						No AEs were reported		10092
59210						No adverse effects leading to discontinuation were reported; no DLTs		10094
59211						No adverse effects leading to discontinuation were reported; no DLTs		10093
59212	1 pts		Herpes zoster	grade 3	discontinuation			10096
59213	2 pts		Lymphopenia	grade 4				10096
59214	1 pts		Anemia	grade 4				10095
59215	1 pts		Cellulitis	serious	discontinuation			10097
59216	2 pts		Lymphopenia	grade 4				10097
59217	100		Hypercalcemia	grade 1-3			TRUE	10100
59218	25		Creatinine increased	grade 1				10100
59219	75		Bilirubin increased	grade 2-3				10100
59220	25		Lactate dehydrogenase increased	grade 1				10100
59221	100		Nausea	grade 1-2				10100
59222	50		Anorexia	grade 2				10100
59223	100		Fatigue	grade 1-2				10100
59224	88.9		Hypercalcemia	grade 2-4			TRUE	10099
59225	88.9		Creatinine increased	grade 1				10099
59226	88.9		Nausea	grade 1-3				10099
59227	66.7		Anorexia	grade 1-3				10099
59228	88.9		Fatigue	grade 1-3				10099
59229	33.3		Proteinuria	grade 1				10101
59230	66.7		Serum creatinine increased	grade 1				10101
59231	100		Serum creatinine increased	grade 3-4	discontinuation		TRUE	10098
59232	100		Proteinuria	grade 1			TRUE	10098
59233	50		Blood urea nitrogen increased	grade 2			TRUE	10098
59234			Nausea	grade 1				10102
59235			Vomiting	grade 1				10102
59236			Hypertension				TRUE	10104
59237						No AEs were observed		10103
59238						No information on AE is provided		10108
59239			Diarrhea				TRUE	10113
59240			Rash				TRUE	10110
59241			Fatigue				TRUE	10110
59242			Fatigue				TRUE	10112
59243			Diarrhea				TRUE	10112
59244			Lipase increased				TRUE	10112
59245						No information on AE is provided		10106
59246			Fatigue	grade 3			TRUE	10109
59247			Diarrhea	grade 3			TRUE	10109
59248	16.7		Mood alteration NOS	grade 3			TRUE	10111
59249	16.7		Fatigue	grade 3			TRUE	10111
59250	16.7		Hemoptysis	grade 3			TRUE	10111
59251						No information on AE is provided		10107
59252			Fatigue	grade 3			TRUE	10105
59253			Diarrhea	grade 3			TRUE	10105
59254			Lipase increased	grade 3			TRUE	10105
59255			Pituitary hemorrhage	grade 3			TRUE	10105
59256			Hypertension	grade 2			TRUE	10105
59257	38		Leukocytosis	all grades				10116
59258	19		Differentiation syndrome	all grades				10116
59259	34		Diarrhea	all grades				10116
59260	31		Nausea	all grades				10116
59261	28		Mucositis	all grades				10116
59262	20		Constipation	all grades				10116
59263	18		Vomiting	all grades				10116
59264	16		Abdominal pain	all grades				10116
59265	39		Fatigue	all grades				10116
59266	32		Edema	all grades				10116
59267	23		Pyrexia	all grades				10116
59268	16		Chest pain	all grades				10116
59269	26		Electrocardiogram QT prolonged	all grades				10116
59270	18		Decreased appetite	all grades				10116
59271	8		Tumor lysis syndrome	all grades				10116
59272	36		Arthralgia	all grades				10116
59273	18		Myalgia	all grades				10116
59274	16		Headache	all grades				10116
59275	12		Neuropathy	all grades				10116
59276	22		Cough	all grades				10116
59277	33		Dyspnea	all grades				10116
59278	13		Pleural effusion	all grades				10116
59279	26		Rash	all grades				10116
59280	12		Hypotension	all grades				10116
59281	8		Leukocytosis	grade 3-4				10116
59282	13		Differentiation syndrome	grade 3-4				10116
59283	2		Diarrhea	grade 3-4				10116
59284	1		Nausea	grade 3-4				10116
59285	3		Mucositis	grade 3-4				10116
59286	1		Constipation	grade 3-4				10116
59287	1		Vomiting	grade 3-4				10116
59288	1		Abdominal pain	grade 3-4				10116
59289	3		Fatigue	grade 3-4				10116
59290	1		Edema	grade 3-4				10116
59291	1		Pyrexia	grade 3-4				10116
59292	3		Chest pain	grade 3-4				10116
59293	10		Electrocardiogram QT prolonged	grade 3-4				10116
59294	2		Decreased appetite	grade 3-4				10116
59295	6		Tumor lysis syndrome	grade 3-4				10116
59296	4		Arthralgia	grade 3-4				10116
59297	1		Myalgia	grade 3-4				10116
59298	1		Neuropathy	grade 3-4				10116
59299	<1		Cough	grade 3-4				10116
59300	9		Dyspnea	grade 3-4				10116
59301	3		Pleural effusion	grade 3-4				10116
59302	2		Rash	grade 3-4				10116
59303	4		Hypotension	grade 3-4				10116
59304	60		Hemoglobin decreased	all grades				10116
59305	39		Sodium decreased	all grades				10117
59306	38		Magnesium decreased	all grades				10117
59307	32		Uric acid increased	all grades				10117
59308	31		Potassium decreased	all grades				10117
59309	27		Alkaline phosphatase increased	all grades				10117
59310	27		Aspartate aminotransferase increased	all grades				10117
59311	25		Phosphate decreased	all grades				10117
59312	23		Creatinine increased	all grades				10117
59313	15		Alanine aminotransferase increased	all grades				10117
59314	16		Bilirubin increased	all grades				10117
59315	46		Hemoglobin decreased	grade 3-4				10117
59316	4		Sodium decreased	grade 3-4				10117
59317	6		Uric acid increased	grade 3-4				10117
59318	6		Potassium decreased	grade 3-4				10117
59319	1		Alkaline phosphatase increased	grade 3-4				10117
59320	1		Aspartate aminotransferase increased	grade 3-4				10117
59321	8		Phosphate decreased	grade 3-4				10117
59322	1		Creatinine increased	grade 3-4				10117
59323	1		Alanine aminotransferase increased	grade 3-4				10117
59324	1		Bilirubin increased	grade 3-4				10117
59325	1		Guillain Barre syndrome		discontinuation	leads to discontinuation		10115
59326	1		Rash		discontinuation	leads to discontinuation		10115
59327	1		Stomatitis		discontinuation	leads to discontinuation		10115
59328	1		Creatinine increased		discontinuation	leads to discontinuation		10115
59329	7		QT prolonged			leads to dose interruption		10115
59330	3		Differentiation syndrome			leads to dose interruption		10115
59331	3		Leukocytosis			leads to dose interruption		10115
59332	3		Dyspnea			leads to dose interruption		10115
59333	1		QT prolonged			leads to dose reduction		10115
59334	1		Diarrhea			leads to dose reduction		10115
59335	1		Nausea			leads to dose reduction		10115
59336	1		Decreased hemoglobin			leads to dose reduction		10115
59337	1		Transaminases increased			leads to dose reduction		10115
59338	2		Sepsis	grade 4	discontinuation	leads to discontinuation		10118
59339	2		Fungal infection		discontinuation	leads to discontinuation		10118
59340	2		Pneumonia		discontinuation	leads to discontinuation		10118
59341	1		Renal insufficiency		discontinuation	leads to discontinuation		10118
59342	43		Infections and infestations					10119
59343	40		Blood and lymphatic system disorders					10119
59344	15		Respiratory, thoracic and mediastinal disorders					10119
59345	11		Cardiac disorders					10119
59346	11		Gastrointestinal disorders					10119
59347	8		Metabolism and nutrition disorders					10119
59348	8		Nervous system disorders					10119
59349	4		Musculoskeletal and connective tissue disorders					10119
59350	4		Injury, poisoning and procedural complications					10119
59351	4		Renal and urinary disorders					10119
59352	3		Vascular disorders					10119
59353	2		Neoplasm					10119
59354	2		Skin and subcutaneous tissue disorders					10119
59355	1		Immune system disorders					10119
59356	1		Psychiatric disorders					10119
59357	1		Ear and labyrinth disorders					10119
59358	1		Hepatobiliary disorders					10119
59359						No information on AE is provided		10114
59360	4.2		ALT increased		discontinuation			10120
59361						No serious or life-threatening adverse events were deemed to  be related to study drug.		10121
59362	16.7		Confusional state	grade 3			TRUE	10125
59363	16.7		Paranoia	grade 3			TRUE	10125
59364						No DLTs were observed at 450 mg QD.		10123
59365	16.7		Mental status changes	grade 3			TRUE	10124
59366	16.7		Delirium	grade 3			TRUE	10124
59367	100		Muscular weakness	grade 3			TRUE	10122
59368	15.4		Neutropenia	grade 3	discontinuation	Two patients at the 7 mg/m2 dose level experienced grade 3 neutropenia on day15 in cycle 2 and cycle 3, respectively, requiring the dose to be held. The dose was subsequently reduced to 6 mg/m2 in both patients.		10128
59369	66.7		Neutropenia	grade 3	discontinuation			10129
59370	28.6		AST increased	grade 3			TRUE	10126
59371	28.6		ALT increased	grade 3			TRUE	10126
59372						No adverse effects leading to discontinuation were reported; no DLTs		10127
59373	33.3		Peripheral neuropathy	grade 2	discontinuation			10130
59374	66.7		CNS toxicity	grade 2-3	discontinuation			10130
59375			Death	grade 5				10131
59376	37.5		Peripheral neuropathy	grade 1-2	discontinuation			10131
59377	12.5		Peripheral neuropathy	grade 1-2	discontinuation			10132
59378	60		Peripheral neuropathy	grade 1-2	discontinuation			10133
59379						The source does not contain information about AEs or lack thereof		10134
59380	0.3		GGT increased					10135
59381	3.8		Bronchitis					10135
59382	1.4		Cough		discontinuation			10135
59383	0.3		Orthostatic hypotension					10135
59384	1.7		Dizziness		discontinuation			10136
59385	2.5		Nausea		discontinuation			10136
59386			Abdominal pain	grade 3				10137
59387			Hemoptysis	grade 3				10137
59388			Diarrhea	grade 2-3			TRUE	10137
59389			Nausea	grade 2			TRUE	10137
59390			Vomiting	grade 2			TRUE	10137
59391			Abdominal cramp	grade 1			TRUE	10137
59392	4 pts		Anaemia					10138
59393	3 pts		Nausea					10138
59394	4 pts		Vomiting					10138
59395	1 pts		Diarrhoea					10138
59396	1 pts		Fatigue					10138
59397	1 pts		Anaemia					10138
59398	1 pts		Neutropenia					10138
59399	1 pts		Leukopenia					10138
59400	1 pts		Thrombocytopenia					10138
59401	1 pts		Nausea					10138
59402	1 pts		Vomiting					10138
59403	1 pts		Asthenia					10138
59404	1 pts		AST increased					10138
59405	1 pts		ALP increased					10138
59406	1 pts		Dehydration					10138
59407	1 pts		Hyponatraemia					10138
59408	58 pts		Neutropenia	all grades				10139
59409	49 pts		Leukocytopenia	all grades				10139
59410	38 pts		Anemia	all grades				10139
59411	23 pts		Alopecia	all grades				10139
59412	18 pts		Decreased appetite	all grades				10139
59413	17 pts		Lymphocytopenia	all grades				10139
59414	14 pts		Malaise	all grades				10139
59415	12 pts		Sinus bradycardia	all grades				10139
59416	11 pts		Thrombocytopenia	all grades				10139
59417	10 pts		Bradycardia	all grades				10139
59418	9 pts		Pyrexia	all grades				10139
59419	9 pts		Edema peripheral	all grades				10139
59420	8 pts		Diarrhea	all grades				10139
59421	8 pts		Febrile neutropenia	all grades				10139
59422	7 pts		Rash	all grades				10139
59423	42 pts		Neutropenia	grade 3-4				10139
59424	33 pts		Leukocytopenia	grade 3-4				10139
59425	16 pts		Anemia	grade 3-4				10139
59426	1 pts		Decreased appetite	grade 3-4				10139
59427	9 pts		Lymphocytopenia	grade 3-4				10139
59428	2 pts		Thrombocytopenia	grade 3-4				10139
59429	1 pts		Diarrhea	grade 3-4				10139
59430	8 pts		Febrile neutropenia	grade 3-4				10139
59431	12.5		Rash	grade 3			TRUE	10140
59432	12.5		Hyperglycemia	grade 3			TRUE	10140
59433	25		Hyperglycemia	grade 4			TRUE	10142
59434	16.7		Colitis	grade 5	discontinuation	complicated by septicemia		10141
59435	12.5		Pneumonitis	grade 3	discontinuation			10140
59436	7.1		Pneumonitis	grade 3	discontinuation			10143
59437	7.1		Pneumonia	grade 5	discontinuation			10143
59438	57		Diarrhea	grade 2				10144
59439	86		Nausea	grade 2-3			TRUE	10144
59440	57		Asthenia	grade 2-3	discontinuation	1 patient discontinued due to grade 3 asthenia	TRUE	10144
59441	29		Hyperglycemia	grade 2				10144
59442	14		Decreased appetite	grade 2				10144
59443	29		Rash	grade 2				10144
59444	29		Vomiting	grade 2				10144
59445	100		Diarrhea	grade 2-3				10145
59446	13.8		Diarrhea	grade 3	dose reduction			10145
59447	3.4		Diarrhea	grade 3	dose interruption			10145
59448	86.2		Nausea	grade 1-2	discontinuation	1 patient discontinued due to grade 2 nausea and grade 1 vomiting		10145
59449	69		Vomiting	grade 1-2	discontinuation	1 patient discontinued due to grade 2 nausea and grade 1 vomiting		10145
59450	27.6		Asthenia	grade 2-3	dose reduction			10145
59451	13.8		Decreased appetite	grade 1-2				10145
59452	27.6		Hyperglycemia	grade 2-3	dose interruption			10145
59453	24.1		Dyspepsia	grade 1-2				10145
59454	17.2		Abdominal pain upper	grade 1-2				10145
59455	6.9		Musculoskeletal pain	grade 1-2				10145
59456	3.4		Headache	grade 1-2				10145
59457	3.4		Dyspnea	grade 1-2				10145
59458	6.9		Abdominal distension	grade 1-2				10145
59459	3.4		Abdominal pain	grade 1-2				10145
59460	3.4		Arthralgia	grade 1-2				10145
59461	3.4		AST increased	grade 1-2				10145
59462	10.3		Dry skin	grade 1-2				10145
59463	6.9		Dysgeusia	grade 1-2				10145
59464	10.3		Hypomagnesemia	grade 1-2				10145
59465	10.3		Rash	grade 1-2				10145
59466	3.4		Hypophosphatemia	grade 3				10145
59467	3.4		Toxic skin eruption	grade 3	dose interruption			10145
59468	3.4		Renal failure	grade 2				10145
59469	87.5		Diarrhea	grade 1-3				10146
59470	87.5		Nausea	grade 1-3			TRUE	10146
59471	62.5		Decreased appetite	grade 1-2				10146
59472	50		Vomiting	grade 1-2				10146
59473	25		Fatigue	grade 1-2				10146
59474	25		Hyperglycemia	grade 1-3				10146
59475	25		AST increased	grade 1-2				10146
59476	25		ALT increased	grade 1-2				10146
59477	25		Blood insulin increased	grade 1-2				10146
59478	12.5		Blood creatinine increased	grade 1-2				10146
59479	25		Glucose urine present	grade 1-2				10146
59480	12.5		Rash	grade 1-2				10146
59481	12.5		Dysgeusia	grade 1-2				10146
59482	12.5		Colitis	grade 3				10146
59483	33.3		Dehydration	grade 1-3		one event of grade 3 dehydration	TRUE	10147
59484						adverse effects were combined for all doses		10148
59485			Dizziness	moderate				10149
59486			Headache	moderate				10149
59487						No AEs were reported		10150
59488	0.8		Ischemic stroke	grade 2	discontinuation			10152
59489						No adverse effects leading to discontinuation were reported		10151
59490	3.35		Dizziness		discontinuation			10154
59491	2.79		Fatigue		discontinuation			10154
59492	0.4		Hypotension orthostatic		discontinuation	The most common adverse event leading to discontinuation, hypotension/orthostatic hypotension, was reported by 0.4% (8/2146) patients randomized to Edarbi 40 mg or 80 mg		10155
59493						No adverse reactions leading to discontinuation were reported		10153
59494	50		Diarrhea	grade 1-3			TRUE	10156
59495	50		Abdominal pain	grade 1-2				10156
59496	38		Nausea	grade 1-2				10156
59497	13		Loose stools	grade 1-2				10156
59498	38		Flatulence	grade 1-2				10156
59499	25		Fecal occult blood positive	grade 1-2				10156
59500	25		ALT increased	grade 1-2				10156
59501	38		Rash	grade 1-2				10156
59502	25		Pruritus	grade 1-3			TRUE	10156
59503	13		Erythema	grade 1-2				10156
59504	13		Pyrexia	grade 1-2				10156
59505	25		Lymph node pain	grade 1-2				10156
59506	13		Nasopharyngitis	grade 1-2				10156
59507	13		Thrombocytopenia	grade 1-2				10156
59508	50		Headache	grade 1-2				10156
59509	13		Pain	grade 3	discontinuation		TRUE	10156
59510	13		Deep vein thrombosis	grade 3			TRUE	10159
59511	13		Rash	grade 3	discontinuation		TRUE	10159
59512	38		ALT increased	grade 1-3	discontinuation		TRUE	10157
59513	25		Fatigue	grade 1-3			TRUE	10157
59514	13		Hypoesthesia	grade 3			TRUE	10157
59515	13		Lymphadenopathy	grade 3			TRUE	10157
59516	13		Deep vein thrombosis	grade 3	discontinuation		TRUE	10157
59517	25		Diarrhea	grade 1-2				10157
59518	13		Abdominal pain	grade 1-2				10157
59519	38		Loose stools	grade 1-2				10157
59520	13		Fecal occult blood positive	grade 1-2				10157
59521	13		Rash	grade 1-2				10157
59522	13		Pruritus	grade 1-2				10157
59523	13		Erythema	grade 1-2				10157
59524	13		Lymph node pain	grade 1-2				10157
59525	25		Pain in limb	grade 1-2	discontinuation			10157
59526	25		Nasopharyngitis	grade 1-2				10157
59527	25		Headache	grade 1-2				10157
59528	13		Bilirubinuria	grade 1-2				10157
59529	16.7		Hepatotoxicity	grade 3			TRUE	10158
59530	16.7		Pneumonia	grade 3			TRUE	10161
59531	16.7		Thrombocytopenia	grade 4			TRUE	10161
59532	14.3		Deep vein thrombosis	grade 3			TRUE	10160
59533	14.3		Pruritic rash		discontinuation			10160
59534	14.3		Weight decreased		discontinuation			10160
59535	14.3		Macular rash		discontinuation			10160
59536	14.3		Oral candidiasis		discontinuation			10160
59537	14.3		Vomiting		discontinuation			10160
59538	14.3		Pneumonia		discontinuation			10160
59539	14.3		Deep vein thrombosis		discontinuation			10160
59540	16.7		Abnormal liver function tests		discontinuation			10158
59541	16.7		Hepatotoxicity		discontinuation			10158
59542	13		Back pain		discontinuation			10157
59543	13		Abdominal pain		discontinuation			10159
59544	13		Arthralgia		discontinuation			10159
59545	13		Pain in limb		discontinuation			10159
59546	13		Peripheral swelling		discontinuation			10159
59547	13		Erythema		discontinuation			10159
59548	13		Pruritus		discontinuation			10159
59549	13		Hypersensitivity		discontinuation			10156
59550	13		Erythema		discontinuation			10156
59551	13		Pruritus		discontinuation			10156
59552						No AEs are reported		10162
59553	1 pts		Reticulocyte count		discontinuation	leads to discontinuation		10163
59554	1 pts		White blood cell decreased		discontinuation	leads to discontinuation		10163
59555	3 pts		Vomiting		discontinuation	leads to discontinuation		10165
59556	13		Diarrhea					10165
59557	10.9		Headache					10165
59558	6.5		Nausea					10165
59559	4.3		Abdominal pain					10165
59560	4.3		Vomiting					10165
59561	0.2		Abdominal discomfort		discontinuation	leads to discontinuation		10164
59562	0.2		Diarrhea		discontinuation	leads to discontinuation		10164
59563	0.2		Vomiting		discontinuation	leads to discontinuation		10164
59564	0.2		Osteomyelitis		discontinuation	leads to discontinuation		10164
59565						No adverse effects leading to discontinuation were reported		10166
59566	50		Palpitations	grade 1	discontinuation			10167
59567	50		Oropharyngeal pain	grade 1	discontinuation			10167
59568	50		Skin rash	grade 3			TRUE	10167
59569	16.7		Diarrhea	grade 3			TRUE	10168
59570	5.9		Maculopapular rash	grade 2	dose reduction			10169
59571	5.9		Nausea	grade 2	dose reduction			10169
59572	5.9		Diarrhea	grade 2	dose reduction			10169
59573	5.9		Allergic urticaria		discontinuation			10169
59574	6.5		Dissociation					10171
59575	6.5		Euphoric mood					10171
59576	19.4		Dizziness					10171
59577	19.4		Headache					10171
59578	12.9		Nausea					10171
59579	9.7		Abnormal thinking					10171
59580	3.2		Euphoric mood					10171
59581	3.2		Palpitations					10171
59582	6.5		Sinus tachycardia					10171
59583						adverse effects were combined for all doses		10170
59584	79		Diarrhea	grade 1-2				10172
59585	8		Diarrhea	grade 3-4				10172
59586	40.6		Mucosal inflammation	grade 1-2				10172
59587	40.6		Stomatitis	grade 1-2				10172
59588	4.4		Mucosal inflammation	grade 3-4				10172
59589	4.4		Stomatitis	grade 3-4				10172
59590	17.7		Nausea	grade 1-2				10172
59591	1.3		Nausea	grade 3-4				10172
59592	13		Constipation	grade 1-2				10172
59593	12		Mouth ulceration	grade 1-2				10172
59594	46		Dermatitis acneiform	grade 1-2				10172
59595	46		Rash	grade 1-2				10172
59596	46		Rash maculo-papular	grade 1-2				10172
59597	23		Dermatitis acneiform	grade 3-4				10172
59598	23		Rash	grade 3-4				10172
59599	23		Rash maculo-papular	grade 3-4				10172
59600	56		Nail infection	grade 1-2				10172
59601	56		Nail toxicity	grade 1-2				10172
59602	56		Onychoclasis	grade 1-2				10172
59603	56		Onycholysis	grade 1-2				10172
59604	56		Onychomadesis	grade 1-2				10172
59605	56		Paronychia	grade 1-2				10172
59606	8		Nail infection	grade 3-4				10172
59607	8		Nail toxicity	grade 3-4				10172
59608	8		Onychoclasis	grade 3-4				10172
59609	8		Onycholysis	grade 3-4				10172
59610	8		Onychomadesis	grade 3-4				10172
59611	8		Paronychia	grade 3-4				10172
59612	28.2		Dry skin	grade 1-2				10172
59613	28.2		Xerosis	grade 1-2				10172
59614	1.8		Dry skin	grade 3-4				10172
59615	1.8		Xerosis	grade 3-4				10172
59616	22.6		Alopecia	grade 1-2				10172
59617	0.4		Alopecia	grade 3-4				10172
59618	20.1		Pruritus	grade 1-2				10172
59619	20.1		Pruritus generalized	grade 1-2				10172
59620	20.1		Rash pruritic	grade 1-2				10172
59621	0.9		Pruritus	grade 3-4				10172
59622	0.9		Pruritus generalized	grade 3-4				10172
59623	0.9		Rash pruritic	grade 3-4				10172
59624	14.1		Palmar-plantar erythrodysesthesia syndrome	grade 1-2				10172
59625	0.9		Palmar-plantar erythrodysesthesia syndrome	grade 3-4				10172
59626	9.2		Dermatitis	grade 1-2				10172
59627	1.8		Dermatitis	grade 3-4				10172
59628	27.9		Decreased appetite	grade 1-2				10172
59629	3.1		Decreased appetite	grade 3-4				10172
59630	23.8		Weight decreased	grade 1-2				10172
59631	2.2		Weight decreased	grade 3-4				10172
59632	21		Cough	grade 1-2				10172
59633	19		Epistaxis	grade 1-2				10172
59634	19		Nasal inflammation	grade 1-2				10172
59635	19		Nasal mucosal disorder	grade 1-2				10172
59636	19		Nasal mucosal ulcer	grade 1-2				10172
59637	19		Rhinitis	grade 1-2				10172
59638	10.8		Dyspnea	grade 1-2				10172
59639	2.2		Dyspnea	grade 3-4				10172
59640	10.7		Upper respiratory tract infection	grade 1-2				10172
59641	1.3		Upper respiratory tract infection	grade 3-4				10172
59642	10		Chest pain	grade 1-2				10172
59643	19		Conjunctivitis	grade 1-2				10172
59644	14		Pain in extremity	grade 1-2				10172
59645	11.1		Musculoskeletal pain	grade 1-2				10172
59646	0.9		Musculoskeletal pain	grade 3-4				10172
59647	10.8		Asthenia	grade 1-2				10172
59648	2.2		Asthenia	grade 3-4				10172
59649	10.6		Insomnia	grade 1-2				10172
59650	0.4		Insomnia	grade 3-4				10172
59651	9		Fatigue	all grades				10172
59652	9		Skin fissures	all grades				10172
59653	1.3		Hypertrichosis	all grades				10172
59654	3.5		Skin exfoliation	all grades				10172
59655	9		Vomiting	all grades				10172
59656	7		Dysgeusia	all grades				10172
59657	2.6		Interstitial lung disease	all grades				10172
59658	1.8		Keratitis	all grades				10172
59659	1.3		Dehydration	all grades				10172
59660	43.1		Anemia	grade 1-2				10172
59661	0.9		Anemia	grade 3-4				10172
59662	36		Lymphopenia	grade 1-2				10172
59663	6		Lymphopenia	grade 3-4				10172
59664	44		Hypoalbuminemia	grade 1-2				10172
59665	38.6		ALT increased	grade 1-2				10172
59666	1.4		ALT increased	grade 3-4				10172
59667	35		Hyperglycemia	grade 1-2				10172
59668	1		Hyperglycemia	grade 3-4				10172
59669	34.5		AST increased	grade 1-2				10172
59670	0.5		AST increased	grade 3-4				10172
59671	31.6		Hypocalcemia	grade 1-2				10172
59672	1.4		Hypocalcemia	grade 3-4				10172
59673	22		Hypokalemia	grade 1-2				10172
59674	7		Hypokalemia	grade 3-4				10172
59675	23.1		Hyponatremia	grade 1-2				10172
59676	2.9		Hyponatremia	grade 3-4				10172
59677	24		Creatinine increased	grade 1-2				10172
59678	21.5		Alkaline phosphatase increased	grade 1-2				10172
59679	0.5		Alkaline phosphatase increased	grade 3-4				10172
59680	21.5		Hypomagnesemia	grade 1-2				10172
59681	0.5		Hypomagnesemia	grade 3-4				10172
59682	15.5		Hyperbilirubinemia	grade 1-2				10172
59683	0.5		Hyperbilirubinemia	grade 3-4				10172
59684	1		Maculopapular rash		discontinuation	leads to discontinuation		10173
59685	1		Interstitial lung disease		discontinuation	leads to discontinuation		10173
59686	2		Pneumonitis		discontinuation	leads to discontinuation		10173
59687	1		Stomatitis		discontinuation	leads to discontinuation		10173
59688	1		Diarrhea		discontinuation	leads to discontinuation		10173
59689	1		Dermatitis acneiform		discontinuation	leads to discontinuation		10173
59690	0.4		Bronchopulmonary aspergillosis		discontinuation	leads to discontinuation		10173
59691	0.4		Cerebral infarction		discontinuation	leads to discontinuation		10173
59692	0.4		Infection		discontinuation	leads to discontinuation		10173
59693	0.4		Keratitis		discontinuation	leads to discontinuation		10173
59694	0.4		Keratolysis exfoliativa acquired		discontinuation	leads to discontinuation		10173
59695	0.4		Liver injury		discontinuation	leads to discontinuation		10173
59696	0.4		Lung infection		discontinuation	leads to discontinuation		10173
59697	0.4		Lymphocyte count decreased		discontinuation	leads to discontinuation		10173
59698	0.4		Malaise		discontinuation	leads to discontinuation		10173
59699	0.4		Malnutrition		discontinuation	leads to discontinuation		10173
59700	0.4		Muscular weakness		discontinuation	leads to discontinuation		10173
59701	0.4		Respiratory failure		discontinuation	leads to discontinuation		10173
59702	0.4		Urinary tract infection		discontinuation	leads to discontinuation		10173
59703						No information on AEs is available		10174
59704	57.1		Hypertension	grade 1-3	dose interruption	350 mg/m2 for only 2 days and were subsequently de-escalated to 200 mg/m	TRUE	10175
59705	57.1		Neutropenia	grade 1-3	dose interruption			10175
59706	14.3		White blood cell decreased	grade 1-2				10175
59707	14.3		Abdominal pain	grade 1-2				10175
59708	28.6		Anorexia	grade 1-2				10175
59709	28.6		Constipation	grade 1-2				10175
59710	28.6		Diarrhea	grade 1-2				10175
59711	14.3		Dry mouth	grade 1-2				10175
59712	14.3		Dysgeusia	grade 1-2				10175
59713	28.6		Dysphonia	grade 1-2				10175
59714	14.3		Mucositis	grade 1-2				10175
59715	42.8		Nausea	grade 1-2				10175
59716	14.3		Weight loss	grade 1-2				10175
59717	42.8		Fatigue	grade 1-2				10175
59718	14.3		Electrocardiogram low voltage	grade 1-2				10175
59719	14.3		Peripheral edema	grade 1-2				10175
59720	14.3		Proteinuria	grade 1-2				10175
59721	14.3		Blurred vision	grade 1-2				10175
59722	28.6		Dizziness	grade 1-2				10175
59723	14.3		Hair color changes	grade 1-2				10175
59724	14.3		Hair thinning	grade 1-2				10175
59725	42.8		Headache	grade 1-2				10175
59726	14.3		Horner's syndrome	grade 1-2				10175
59727	14.3		Toe injury	grade 1-2				10175
59728	14.3		Mental status changes	grade 1-2				10175
59729	14.3		Pain	grade 1-2				10175
59730	14.3		Pruritis	grade 1-2				10175
59731	14.3		Sinus congestion	grade 1-2				10175
59732	14.3		Urticaria	grade 1-2				10175
59733	14.3		Watering eyes	grade 1-2				10175
59734	14.3		Hypertension	grade 4	dose reduction		TRUE	10177
59735	14.3		Pain	grade 3	dose reduction		TRUE	10177
59736	14.3		Cholecystitis	grade 3	dose reduction		TRUE	10177
59737	12.5		Fatigue	grade 3			TRUE	10176
59738	12.5		Dehydration	grade 3			TRUE	10176
59739	12.5		Hyponatremia	grade 3			TRUE	10176
59740	12.5		Anemia	grade 1-2				10176
59741	12.5		Abdominal distension	grade 1-2				10176
59742	37.5		Anorexia	grade 1-2				10176
59743	12.5		Belching	grade 1-2				10176
59744	12.5		Cholecystitis	grade 1-2				10176
59745	12.5		Constipation	grade 1-2				10176
59746	25		Dehydration	grade 1-3			TRUE	10176
59747	12.5		Diarrhea	grade 1-2				10176
59748	12.5		Dysgeusia	grade 1-2				10176
59749	25		Dyspepsia	grade 1-2				10176
59750	12.5		GI hemorrhage	grade 3				10176
59751	12.5		Melena	grade 1-2				10176
59752	37.5		Mucositis	grade 1-2				10176
59753	50		Nausea	grade 1-2				10176
59754	12.5		Weight loss	grade 1-2				10176
59755	62.5		Fatigue	grade 1-3			TRUE	10176
59756	12.5		Night sweats	grade 1-2				10176
59757	12.5		Pyrexia	grade 1-2				10176
59758	75		Hypertension	grade 1-3				10176
59759	12.5		Electrocardiogram QTc interval prolonged	grade 3				10176
59760	12.5		Hyperkalemia	grade 1-2				10176
59761	12.5		Hyponatremia	grade 3				10176
59762	12.5		Hypophosphatemia	grade 1-2				10176
59763	12.5		Proteinuria	grade 1-2				10176
59764	12.5		Dizziness	grade 1-2				10176
59765	12.5		Dry skin	grade 1-2				10176
59766	12.5		Fissures of skin	grade 1-2				10176
59767	12.5		Headache	grade 1-2				10176
59768	12.5		Pain	grade 1-2				10176
59769	12.5		Palmar-plantar erythrodysaesthesia syndrome	grade 1-2				10176
59770	12.5		Tinnitus	grade 1-2				10176
59771						No information on AE is provided		10179
59772						No information on AE is provided		10178
59773	1		Gastroenteritis		discontinuation			10180
59774	1		Pyelonephritis		discontinuation			10180
59775	1		Gastroenteritis		discontinuation			10182
59776	2.5		Gastric ulcer perforation		discontinuation			10181
59777						No adverse effects are observed		10183
59778						The source does not contain information about AEs or lack thereof		10184
59779			Urticaria					10186
59780			Anxiety					10186
59781			Apnoea					10185
59782			Myoclonus					10185
59783			Hypotension					10185
59784			Tachycardia					10185
59785			Seizures					10187
59786			Apnoea					10187
59787			Cardiac arrest					10187
59788			Acidosis	grade 3				10187
59789			Hypokalaemia					10187
59790			Brain hypoxia					10187
59791	3.8		Bleeding		discontinuation			10188
59792	2.3		Uterine fibroids		discontinuation			10188
59793	0.76		Gallstones		discontinuation			10188
59794	0.76		Endometrial polyp		discontinuation			10188
59795	9		Bleeding vaginal		discontinuation			10194
59796	1.2		Dizziness		discontinuation			10190
59797	1.2		Fluid retention		discontinuation			10190
59798			Cardiovascular disorder		discontinuation	WARNING		10191
59799			Myocardial infarction		discontinuation	WARNING		10189
59800			Stroke		discontinuation	WARNING		10189
59801			Breast cancer invasive NOS		discontinuation	WARNING		10189
59802			Embolism pulmonary		discontinuation	WARNING		10189
59803			Deep vein thrombosis		discontinuation	WARNING		10189
59804			Dementia		discontinuation	WARNING		10195
59805			Bone density abnormal		discontinuation	WARNING		10192
59806	8.2		Bleeding		discontinuation			10193
59807	2.1		Amenorrhea		discontinuation			10193
59808	2		Weight gain		discontinuation			10193
59809						No adverse effects leading to discontinuation were reported.		10196
59810	62.5		Fatigue	grade 1-3	discontinuation		TRUE	10197
59811	37.5		Diarrhea					10197
59812	12.5		Decreased appetite					10197
59813	25		Hemoglobin decreased					10197
59814	12.5		Dyspnea					10197
59815	25		Hypoalbuminemia					10197
59816	37.5		Hyperglycemia	grade 2-3				10197
59817	25		AST increased					10197
59818	12.5		Hypokalemia	grade 3	dose reduction		TRUE	10197
59819	25		Vomiting					10197
59820	25		Dizziness					10197
59821	25		Blood alkaline phosphatase increased					10197
59822	25		Edema peripheral					10197
59823	12.5		Sinus tachycardia					10197
59824	12.5		Infusion site pain					10197
59825	12.5		Injection site reaction					10197
59826	25		Headache					10197
59827	25		Hypotension					10197
59828	12.5		Thrombosis	grade 3				10197
59829	12.5		Hypoxia	grade 3	discontinuation		TRUE	10199
59830	14.3		AST increased	grade 3	discontinuation		TRUE	10200
59831	57.1		Fatigue	grade 1-3				10198
59832	57.1		Diarrhea					10198
59833	28.6		Decreased appetite					10198
59834	14.3		Hemoglobin decreased	grade 3				10198
59835	14.3		Dyspnea					10198
59836	14.3		Hyperglycemia	grade 3				10198
59837	14.3		Nausea					10198
59838	14.3		Hypokalemia					10198
59839	14.3		Dizziness					10198
59840	14.3		Constipation					10198
59841	14.3		Edema peripheral					10198
59842	28.6		Abdominal pain					10198
59843	28.6		Cough					10198
59844	14.3		Urinary tract infection					10198
59845	14.3		Sinus tachycardia					10198
59846	14.3		Infusion site pain					10198
59847	14.3		Dehydration					10198
59848	14.3		Hypotension					10198
59849	14.3		Neutrophil count decreased	grade 3				10198
59850	14.3		Neutropenia	grade 4				10198
59851	14.3		Peripheral neuropathy	grade 1				10198
59852	14.3		Aspartate aminotransferase increase	grade 4			TRUE	10201
59853	28.6		ALT increased	grade 2-3			TRUE	10201
59854						No adverse effects leading to discontinuation were reported; no DLTs		10202
59855	16.7		Hypoglycemia					10203
59856	12.5		Hypoglycemia		dose reduction			10204
59857	16.7		Hypoglycemia		dose reduction			10206
59858	33.3		Hypertriglyceridemia					10205
59859	33.3		Hypoglycemia					10205
59860	22.2		Hyperuricemia					10205
59861	11.1		PR interval prolonged					10205
59862	44.4		Sinus bradycardia					10205
59863	11.1		Sinus arrhythmia					10205
59864	11.1		Myasthenia		discontinuation			10207
59865						No adverse effects leading to discontinuation were recorded.		10209
59866	66.7		Diarrhea	grade 3	dose interruption		TRUE	10210
59867	33.3		Diarrhea	grade 3	dose interruption|dose reduction		TRUE	10208
59868	3.7		Pulmonary embolism	grade 5			TRUE	10212
59869	3.7		Hypophosphatemia	grade 3			TRUE	10212
59870	33.3		Febrile neutropenia	grade 4			TRUE	10215
59871	33.3		Hyponatremia	grade 3			TRUE	10216
59872	33.3		Neutropenia	grade 4			TRUE	10216
59873	33.3		Neutropenia	grade 4			TRUE	10217
59874	33.3		Transaminases increased	grade 3-4			TRUE	10217
59875	14		Nausea	grade 1-2				10211
59876	14		Leucopenia	grade 3-4				10211
59877	29		Anemia	grade 3-4				10211
59878	57		Neutropenia	grade 3-4				10211
59879	57		Thrombocytopenia	grade 3-4			TRUE	10211
59880	57		Fatigue	grade 1-2				10211
59881	14		Dehydration	grade 3			TRUE	10211
59882	14		Diarrhea	grade 1-2				10214
59883	29		Pyrexia	grade 1-2				10214
59884	29		Leucopenia	grade 1-2				10214
59885	29		Nausea	grade 1-2				10214
59886	29		Thrombocytopenia	grade 1-4				10214
59887	57		Neutropenia	grade 3-4			TRUE	10214
59888	14		Fatigue	grade 1-2				10214
59889	14		Anemia	grade 3-4				10214
59890	20		Leucopenia	grade 3-4				10213
59891	10		Fatigue	grade 1-2				10213
59892	40		Neutropenia	grade 3-4				10213
59893	10		Pyrexia	grade 1-2				10213
59894	10		Cough	grade 1-2				10213
59895	30		Nausea	grade 1-2				10213
59896	10		Dyspnea	grade 1-2				10213
59897	10		Thrombocytopenia	grade 1-2				10213
59898	10		Sepsis	grade 4			TRUE	10213
59899	40		Anemia	grade 1-2				10213
59900	1 pts		Lymphadenopathy	mild				10218
59901	1 pts		Coughing	mild				10218
59902	1 pts		Upper respiratory tract infection					10218
59903						No adverse effects were recorded.		10219
59904	27		Asthenia					10220
59905	35		Dizziness					10220
59906	23		Somnolence					10220
59907	19		Paresthesia					10220
59908						No AEs were observed		10222
59909						No AEs were observed		10221
59910	16.7		AST increased	grade 2	dose interruption|dose reduction			10223
59911	16.7		ALT increased	grade 2	dose interruption|dose reduction			10223
59912	16.7		Maculopapular rash	grade 2	dose interruption|dose reduction			10223
59913	16.7		Hypotension	grade 3-4		possibly related	TRUE	10223
59914	16.7		Gastrointestinal hemorrhage	grade 4		possibly related	TRUE	10223
59915	16.7		Diarrhea	grade 1		possibly related	TRUE	10223
59916	1 pts		Thrombocytopenia	grade 4	dose reduction			10225
59917	1 pts		Pneumonia	grade 5				10224
59918	1 pts		Febrile neutropenia	grade 3				10224
59919	3.6		Fatigue					10226
59920	7.1		Headache					10226
59921	3.6		Nasopharyngitis					10226
59922	20		Fatigue	grade 3			TRUE	10231
59923	20		Diarrhoea	grade 3			TRUE	10231
59924	33.3		Thrombocytopenia	grade 4			TRUE	10230
59925	16.7		Neutropenia	grade 4			TRUE	10230
59926	16.7		Hyponatraemia	grade 3			TRUE	10230
59927	25		Impaired taste	grade 2	dose interruption	dysgeusia	TRUE	10228
59928	25		Thrombocytopenia	grade 4			TRUE	10228
59929	25		Fatigue	grade 2	dose reduction		TRUE	10228
59930	28.6		Thrombocytopenia	grade 4			TRUE	10233
59931	33.3		Thrombocytopenia	grade 4			TRUE	10227
59932	33.3		Mucositis	grade 2			TRUE	10227
59933	83		Thrombocytopenia	grade 4			TRUE	10232
59934	20		Fatigue	grade 3			TRUE	10229
59935	20		Thrombocytopenia	grade 3			TRUE	10229
59936	20		Vomiting	grade 3			TRUE	10229
59937	40		Diarrhoea	grade 3			TRUE	10229
59938	14.3		Anemia	grade 4			TRUE	10234
59939	2 pts		Alanine aminotransferase increase	grade 3			TRUE	10237
59940	4 pts		Nausea	grade 1-2				10237
59941	3 pts		Vomiting	grade 1-2				10237
59942	1 pts		Anorexia	grade 1-2				10237
59943	2 pts		Diarrhea	grade 1-2				10237
59944	1 pts		Rash	grade 1-2				10237
59945	3 pts		Aspartate aminotransferase increase	grade 1-2				10237
59946	3 pts		Fatigue	grade 1-2				10237
59947	1 pts		Abdominal pain	grade 1-2				10238
59948	3 pts		Vomiting	grade 1-2				10238
59949	1 pts		Alanine aminotransferase increase	grade 3			TRUE	10238
59950	2 pts		Aspartate aminotransferase increase	grade 3			TRUE	10238
59951	5 pts		Nausea	grade 1-2				10238
59952	1 pts		Rash	grade 3-4				10238
59953	2 pts		Anorexia	grade 1-2				10238
59954	1 pts		Rash	grade 3			TRUE	10235
59955	1 pts		Diarrhea	grade 3			TRUE	10235
59956	1 pts		Alanine aminotransferase increase	grade 3			TRUE	10235
59957	1 pts		Fatigue	grade 3-4				10235
59958	2 pts		Anorexia	grade 1-2				10235
59959	4 pts		Nausea	grade 1-2				10235
59960	3 pts		Vomiting	grade 1-2				10235
59961	1 pts		Aspartate aminotransferase increase	grade 1-2				10235
59962	1 pts		Myalgia	grade 3-4				10236
59963	1 pts		Alanine aminotransferase increase	grade 3-4				10236
59964	3 pts		Abdominal pain	grade 1-2				10236
59965	1 pts		Fatigue	grade 1-2				10236
59966	11 pts		Diarrhea	grade 1-2				10236
59967	5 pts		Rash	grade 1-2				10236
59968	7 pts		Nausea	grade 1-2				10236
59969	6 pts		Vomiting	grade 1-2				10236
59970	1 pts		Anorexia	grade 1-2				10236
59971	4 pts		Aspartate aminotransferase increase	grade 1-2				10236
59972	2 pts		Dry mouth	grade 1-2				10236
59973	16.7		Transaminitis	grade 3			TRUE	10239
59974	36.8		Neutropenia	grade 1-2				10240
59975	10.5		Headache					10240
59976	15.8		Neutropenia					10241
59977	16.7		Drug hypersensitivity		discontinuation			10243
59978	16.7		Fanconi syndrome		discontinuation			10243
59979	16.7		Maculo-papular rash		discontinuation			10242
59980						No adverse effects leading to discontinuation were reported. No deaths and serious adverse events were reported.		10244
59981						No adverse effects leading to discontinuation were reported		10245
59982	2 pts		Diarrhea	grade 3			TRUE	10246
59983	2 pts		Abdominal pain	grade 3			TRUE	10246
59984	71 pts		Skin exfoliation	all grades				10247
59985	17 pts		Nail disorder	all grades				10247
59986	3 pts		Vomiting	grade 3-4				10247
59987	1 pts		Hyperkeratosis	grade 3-4				10247
59988	1 pts		Dry skin	grade 3-4				10247
59989	6 pts		AST increased	grade 3-4				10247
59990	46 pts		Dry skin	all grades				10247
59991	3 pts		Fatigue	grade 3-4				10247
59992	3 pts		Nausea	grade 3-4				10247
59993	96 pts		Rash	all grades				10247
59994	25 pts		Abdominal pain	all grades				10247
59995	75 pts		Pruritus	all grades				10247
59996	32 pts		Hyperkeratosis	all grades				10247
59997	27 pts		Fatigue	all grades				10247
59998	1 pts		Decreased appetite	grade 3-4				10247
59999	1 pts		Platelet count decreased	grade 3-4				10247
60000	4 pts		Skin exfoliation	grade 3-4				10247
60001	24 pts		Platelet count decreased	all grades				10247
60002	32 pts		Upper abdominal pain	all grades				10247
60003	77 pts		Nausea	all grades				10247
60004	38 pts		Vomiting	all grades				10247
60005	61 pts		Palmar-plantar erythrodysesthesia syndrome	all grades				10247
60006	10 pts		Rash	grade 3-4				10247
60007	1 pts		Upper abdominal pain	grade 3-4				10247
60008	16 pts		Pyrexia	all grades				10247
60009	40 pts		ALT increased	all grades				10247
60010	24 pts		Dyspepsia	all grades				10247
60011	101 pts		Diarrhea	all grades				10247
60012	3 pts		Abdominal pain	grade 3-4				10247
60013	35 pts		AST increased	all grades				10247
60014	4 pts		Diarrhea	grade 3-4				10247
60015	67 pts		Decreased appetite	all grades				10247
60016	5 pts		Palmar-plantar erythrodysesthesia syndrome	grade 3-4				10247
60017	26 pts		Constipation	all grades				10247
60018	1 pts		Pruritus	grade 3-4				10247
60019	8 pts		ALT increased	grade 3-4				10247
60020	19 pts		Skin hyperpigmentation	all grades				10247
60021	3 pts		Vomiting	grade 3-4				10248
60022	2 pts		Interstitial lung disease	grade 3				10248
60023	1 pts		Epidermal necrolysis	grade 5	discontinuation	leads to discontinuation		10248
60024	62 pts		Diarrhea	all grades				10248
60025	4 pts		Hyperkeratosis	grade 3-4				10248
60026	38 pts		Skin exfoliation	all grades				10248
60027	5 pts		Diarrhea	grade 3-4				10248
60028	43 pts		Rash	all grades				10248
60029	35 pts		Palmar-plantar erythrodysesthesia syndrome	all grades				10248
60030	44 pts		Nausea	all grades				10248
60031	43 pts		Hyperkeratosis	all grades				10248
60032	1 pts		Skin exfoliation	grade 3-4				10248
60033	7 pts		Palmar-plantar erythrodysesthesia syndrome	grade 3-4				10248
60034	33 pts		Alanine aminotransferase increased	all grades				10248
60035	7 pts		Rash	grade 3-4				10248
60036	1 pts		Nausea	grade 3-4				10248
60037	5 pts		Alanine aminotransferase increased	grade 3-4				10248
60038	37 pts		Vomiting	all grades				10248
60039						No SAEs were observed		10249
60040	1.6		Hyponatremia				TRUE	10252
60041	7.7		Hyponatremia				TRUE	10254
60042	7.7		Anorexia				TRUE	10254
60043	7.7		Diarrhea				TRUE	10254
60044	100		Diarrhea	all grades			TRUE	10250
60045	50		Nausea	all grades			TRUE	10250
60046	75		Vomiting	grade 1-2				10250
60047	50		ALT increased	grade 1-2				10250
60048	50		Decreased appetite	grade 1-2				10250
60049	75		Peripheral sensory neuropathy	grade 1-2				10250
60050	50		AST increased	grade 1-2				10250
60051	75		Blood creatinine increased	grade 1-2				10250
60052	25		Constipation	grade 1-2				10250
60053	50		Hyponatremia	all grades			TRUE	10250
60054	75		Platelet count decreased	grade 1-2				10250
60055	75		Dysgeusia	grade 1-2				10250
60056	25		Malaise	grade 1-2				10250
60057	25		Rash	grade 1-2				10250
60058	25		Interstitial lung disease	grade 1-2				10250
60059	100		Diarrhea	all grades				10251
60060	80		Nausea	all grades				10251
60061	60		Vomiting	grade 1-2				10251
60062	80		ALT increased	all grades				10251
60063	20		Decreased appetite	grade 1-2				10251
60064	50		Peripheral sensory neuropathy	all grades				10251
60065	40		AST increased	grade 1-2				10251
60066	50		Blood creatinine increased	grade 1-2				10251
60067	30		Constipation	grade 1-2				10251
60068	100		Hyponatremia	all grades				10251
60069	30		Platelet count decreased	grade 1-2				10251
60070	10		Dysgeusia	grade 1-2				10251
60071	60		Malaise	all grades				10251
60072	10		Rash	grade 1-2				10251
60073	10		Electrocardiogram QTc interval prolonged	grade 1-2				10251
60074	1.3		Infectious pleural effusion		discontinuation			10253
60075	1.3		Pneumonia		discontinuation			10253
60076	1.3		Pyelonephritis		discontinuation			10253
60077	1.3		Sepsis		discontinuation			10253
60078	1.3		Hyponatremia		discontinuation			10253
60079	1.3		Metastases to meninges		discontinuation			10253
60080	1.3		Organizing pneumonia		discontinuation			10253
60081	3 pts		ALT increased	grade 3			TRUE	10255
60082	2 pts		AST increased	grade 3			TRUE	10255
60083	3 pts		Alkaline phosphatase increased	grade 3			TRUE	10255
60084	2 pts		ALT increased	grade 3			TRUE	10257
60085	3 pts		AST increased	grade 3			TRUE	10257
60086	3 pts		Alkaline phosphatase increased	grade 3			TRUE	10257
60087	1 pts		Gamma-glutamyltransferase increased	grade 3			TRUE	10257
60088	2 pts		ALT increased	grade 3			TRUE	10256
60089	2 pts		AST increased	grade 3			TRUE	10256
60090	3 pts		Alkaline phosphatase increased	grade 3			TRUE	10256
60091	1 pts		Hypertension	grade 2			TRUE	10258
60092	1 pts		Dermatitis acneiform	grade 2			TRUE	10258
60093	1 pts		Memory impairment	grade 2			TRUE	10258
60094	1 pts		Hyperbilirubinaemia	grade 2			TRUE	10258
60095	72		Edema	all grades				10261
60096	61		Asthenia	all grades				10261
60097	14		Pyrexia	all grades				10261
60098	64		Nausea	all grades				10261
60099	38		Vomiting	all grades				10261
60100	37		Diarrhea	all grades				10261
60101	31		Abdominal pain	all grades				10261
60102	23		Constipation	all grades				10261
60103	16		Dyspepsia	all grades				10261
60104	48		Cognitive impairment	all grades				10261
60105	22		Dizziness	all grades				10261
60106	17		Headache	all grades				10261
60107	16		Disorder sleep	all grades				10261
60108	15		Taste disorder	all grades				10261
60109	13		Mood disorder	all grades				10261
60110	38		Decreased appetite	all grades				10261
60111	33		Lacrimation increased	all grades				10261
60112	23		Rash	all grades				10261
60113	21		Hair color changes	all grades				10261
60114	13		Alopecia	all grades				10261
60115	17		Dyspnea	all grades				10261
60116	12		Pleural effusion	all grades				10261
60117	13		Weight decreased	all grades				10261
60118	2		Edema	grade 3-4				10261
60119	9		Asthenia	grade 3-4				10261
60120	0.5		Pyrexia	grade 3-4				10261
60121	2.5		Nausea	grade 3-4				10261
60122	2		Vomiting	grade 3-4				10261
60123	4.9		Diarrhea	grade 3-4				10261
60124	6		Abdominal pain	grade 3-4				10261
60125	1.5		Constipation	grade 3-4				10261
60126	4.9		Cognitive impairment	grade 3-4				10261
60127	0.5		Dizziness	grade 3-4				10261
60128	0.5		Headache	grade 3-4				10261
60129	1		Mood disorder	grade 3-4				10261
60130	2.9		Decreased appetite	grade 3-4				10261
60131	2.1		Rash	grade 3-4				10261
60132	0.5		Hair color changes	grade 3-4				10261
60133	2.5		Dyspnea	grade 3-4				10261
60134	2		Pleural effusion	grade 3-4				10261
60135	1		Weight decreased	grade 3-4				10261
60136	1		Sepsis	grade 5	discontinuation	leads to discontinuation		10260
60137	1		Tumor hemorrhage	grade 5	discontinuation	leads to discontinuation		10260
60138	>1 pts		Fatigue		discontinuation	leads to discontinuation		10260
60139	>1 pts		Abdominal pain		discontinuation	leads to discontinuation		10260
60140	>1 pts		Vomiting		discontinuation	leads to discontinuation		10260
60141	>1 pts		Sepsis		discontinuation	leads to discontinuation		10260
60142	>1 pts		Anemia		discontinuation	leads to discontinuation		10260
60143	>1 pts		Acute kidney injury		discontinuation	leads to discontinuation		10260
60144	>1 pts		Encephalopathy		discontinuation	leads to discontinuation		10260
60145	>2		Anemia			leads to dose interruption		10260
60146	>2		Fatigue			leads to dose interruption		10260
60147	>2		Nausea			leads to dose interruption		10260
60148	>2		Vomiting			leads to dose interruption		10260
60149	>2		Hyperbilirubinemia			leads to dose interruption		10260
60150	>2		Memory impairment			leads to dose interruption		10260
60151	>2		Diarrhea			leads to dose interruption		10260
60152	>2		Cognitive disorder			leads to dose interruption		10260
60153	>2		Abdominal pain			leads to dose interruption		10260
60154	>2		Fatigue			leads to dose reduction		10260
60155	>2		Anemia			leads to dose reduction		10260
60156	>2		Hyperbilirubinemia			leads to dose reduction		10260
60157	>2		Memory impairment			leads to dose reduction		10260
60158	>2		Nausea			leads to dose reduction		10260
60159	>2		Periorbital edema			leads to dose reduction		10260
60160	81		Decreased hemoglobin	all grades				10262
60161	62		Leukocyte count decreased	all grades				10262
60162	43		Neutrophil count decreased	all grades				10262
60163	27		Platelets decreased	all grades				10262
60164	24		INR increased	all grades				10262
60165	13		Activated partial thromboplastin time increased	all grades				10262
60166	69		Bilirubin increased	all grades				10262
60167	51		Aspartate aminotransferase increased	all grades				10262
60168	49		Phosphate decreased	all grades				10262
60169	34		Potassium decreased	all grades				10262
60170	31		Albumin decreased	all grades				10262
60171	29		Magnesium decreased	all grades				10262
60172	29		Creatinine increased	all grades				10262
60173	28		Sodium decreased	all grades				10262
60174	19		Alanine aminotransferase increased	all grades				10262
60175	14		Alkaline phosphatase increased	all grades				10262
60176	28		Decreased hemoglobin	grade 3-4				10262
60177	5		Leukocyte count decreased	grade 3-4				10262
60178	6		Neutrophil count decreased	grade 3-4				10262
60179	0.5		Platelets decreased	grade 3-4				10262
60180	0.6		INR increased	grade 3-4				10262
60181	9		Bilirubin increased	grade 3-4				10262
60182	1.5		Aspartate aminotransferase increased	grade 3-4				10262
60183	13		Phosphate decreased	grade 3-4				10262
60184	6		Potassium decreased	grade 3-4				10262
60185	2		Albumin decreased	grade 3-4				10262
60186	1		Magnesium decreased	grade 3-4				10262
60187	7		Sodium decreased	grade 3-4				10262
60188	0.5		Alanine aminotransferase increased	grade 3-4				10262
60189	1		Alkaline phosphatase increased	grade 3-4				10262
60190			Neurologic disorder NOS	grade 3				10259
60191	37.5		Anemia	grade 1-2				10263
60192	50		Fatigue	grade 1-2				10263
60193	50		Aphasia	grade 1-2				10263
60194	25		Headache	grade 1-2				10263
60195	25		Hyperglycemia	grade 1-2				10263
60196	12.5		Hypocalcemia	grade 1-2				10263
60197	37.5		Hypokalemia	grade 1-2				10263
60198	12.5		WBC decreased	grade 1-2				10263
60199	12.5		ALP increased	grade 1-2				10263
60200	25		Decreased appetite	grade 1-2				10263
60201	25		Dysarthria	grade 1-2				10263
60202	12.5		Fall	grade 1-2				10263
60203	12.5		Hyponatremia	grade 1-2				10263
60204	12.5		Lymphocyte count decreased	grade 1-2				10263
60205	25		Muscular weakness	grade 1-2				10263
60206	12.5		Pyramidal tract syndrome	grade 1-2				10263
60207	25		Upper respiratory tract infection	grade 1-2				10263
60208	25		Blood creatinine increased	grade 1-2				10263
60209	25		Confusional state	grade 1-2				10263
60210	25		Diarrhea	grade 1-2				10263
60211	25		Myalgia	grade 1-2				10263
60212	25		Pain in extremity	grade 1-2				10263
60213	25		Tinnitus	grade 1-2				10263
60214	12.5		ALT increased	grade 4			TRUE	10263
60215	12.5		AST increased	grade 4			TRUE	10263
60216	12.5		Left ventricular ejection fraction decreased	grade 3				10263
60217	28.6		AST increased	grade 3	discontinuation		TRUE	10265
60218	14.3		AST increased	grade 3	dose reduction		TRUE	10267
60219						No information on AE is provided		10266
60220	58		Fatigue					10264
60221	68		Nausea					10264
60222	53		AST increased					10264
60223	47		Diarrhoea					10264
60224	32		Decreased appetite					10264
60225	37		Vomiting					10264
60226	37		Constipation					10264
60227	32		Dry mouth					10264
60228	21		ALT increased					10264
60229	21		Blood creatinine increased					10264
60230	5		Hypoalbuminaemia					10264
60231	5		Blood alkaline phosphatase increased					10264
60232	16		Blood lactate dehydrogenase increased					10264
60233	26		Dry skin					10264
60234	16		Dysgeusia					10264
60235	11		Anxiety					10264
60236	26		Dizziness					10264
60237	16		Dyspepsia					10264
60238	11		Dyspnoea					10264
60239	5		Hyperphosphatemia	grade 1				10264
60240	11		Ocular toxicity	grade 1-2				10264
60241	5		Nail toxicity	grade 1				10264
60242	47		Abnormal liver function tests					10264
60243	11		Cardiotoxicity					10264
60244	33.3		Nausea	grade 3			TRUE	10268
60245	33.3		Vomiting	grade 3			TRUE	10268
60246	33.3		Diarrhea	grade 3			TRUE	10268
60247	33.3		Hyperglycemia	grade 3			TRUE	10268
60248	33.3		Decreased appetite	grade 3			TRUE	10268
60249	4.3		Aspartate aminotransferase increased	grade 3			TRUE	10270
60250	4.3		ALT increased	grade 3			TRUE	10270
60251	4.3		Hyperosmolar state	grade 3			TRUE	10270
60252	4.3		Nausea	grade 3			TRUE	10270
60253	12.5		Drug-induced hepatitis	grade 3			TRUE	10271
60254	12.5		ALT increased	grade 3			TRUE	10271
60255	12.5		Aspartate aminotransferase increased	grade 3			TRUE	10271
60256						No information on AE is provided		10269
60257	8.8		Vomiting		discontinuation			10272
60258	1 pts		Blood and lymphatic system disorders					10275
60259	1 pts		Neutropenia					10275
60260	6 pts		Gastrointestinal disorders					10275
60261	4 pts		Nausea					10275
60262	1 pts		Investigations					10275
60263	1 pts		Platelet count decreased					10275
60264	5 pts		Nervous system disorders					10275
60265	5 pts		Headache					10275
60266	4 pts		Blood and lymphatic system disorders					10274
60267	3 pts		Neutropenia					10274
60268	3 pts		Thrombocytopenia					10274
60269	4 pts		Gastrointestinal disorder (NOS)					10274
60270	3 pts		Nausea					10274
60271	3 pts		Investigations					10274
60272	1 pts		Absolute neutrophil count					10274
60273	3 pts		Platelet count decreased					10274
60274	2 pts		WBC decreased					10274
60275	1 pts		Nervous system disorders					10274
60276	1 pts		Headache					10274
60277	12 pts		Gastrointestinal disorders					10273
60278	5 pts		Diarrhea					10273
60279	8 pts		Nausea					10273
60280	23 pts		Infection					10273
60281	5 pts		Upper respiratory tract infection					10273
60282	7 pts		Viral upper respiratory tract infection					10273
60283	7 pts		Nervous system disorders					10273
60284	3 pts		Dizziness					10273
60285	4 pts		Headache					10273
60286	10 pts		Skin disorder					10273
60287	7 pts		Dermatitis atopic					10273
60288	10.9		Somnolence					10277
60289	5.4		Anticholinergic syndrome					10277
60290	4.1		Balance disorder					10277
60291	3.4		Headache					10277
60292	2.7		Akathisia					10277
60293	2.6		Vomiting					10277
60294	2.3		Nausea					10277
60295	2.3		Arthralgia					10277
60296						No information on AE is provided		10279
60297	1 pts		Syncope		discontinuation	leads to discontinuation		10276
60298	1 pts		Syncope		discontinuation	leads to discontinuation		10278
60299	1 pts		Cardiac failure		discontinuation	leads to discontinuation		10278
60300	40		Fatigue					10280
60301	10		Nausea					10280
60302	10		Pruritus					10280
60303	20		Decreased appetite					10280
60304	10		Diarrhea					10280
60305	10		Gastritis					10280
60306	10		Hypomagnesemia					10280
60307	10		Hypotension					10280
60308	10		Skin hypopigmentation					10280
60309	10		Weight decreased		discontinuation	leads to discontinuation		10280
60310	0.7		Pneumonitis		discontinuation	WARNING		10289
60311	0.2		Colitis		discontinuation	WARNING		10287
60312	0.2		Hepatitis	grade 4	discontinuation	WARNING		10284
60313	0.2		Hypophysitis	grade 4	discontinuation	WARNING		10285
60314	0.48		Nephritis	grade 3-4	discontinuation	WARNING		10286
60315	0.2		Hyperthyroidism	grade 3	discontinuation	WARNING		10288
60316	2 pts		Renal failure		discontinuation	leads to discontinuation		10290
60317	2 pts		Pain		discontinuation	leads to discontinuation		10290
60318	47		Fatigue	all grades				10281
60319	17		Peripheral edema	all grades				10281
60320	1		Peripheral edema	grade 3				10281
60321	14		Chills	all grades				10281
60322	11		Pyrexia	all grades				10281
60323	30		Nausea	all grades				10281
60324	21		Constipation	all grades				10281
60325	20		Diarrhea	all grades				10281
60326	16		Vomiting	all grades				10281
60327	12		Abdominal pain	all grades				10281
60328	30		Cough	all grades				10281
60329	1		Cough	grade 3				10281
60330	18		Dyspnea	all grades				10281
60331	30		Pruritus	all grades				10281
60332	29		Rash	all grades				10281
60333	11		Vitiligo	all grades				10281
60334	26		Decreased appetite	all grades				10281
60335	20		Arthralgia	all grades				10281
60336	18		Pain in extremity	all grades				10281
60337	1		Pain in extremity	grade 3				10281
60338	14		Myalgia	all grades				10281
60339	1		Myalgia	grade 3				10281
60340	12		Back pain	all grades				10281
60341	1		Back pain	grade 3				10281
60342	16		Headache	all grades				10281
60343	11		Dizziness	all grades				10281
60344	14		Anemia	all grades				10281
60345	5		Anemia	grade 3				10281
60346	14		Insomnia	all grades				10281
60347	11		Upper respiratory tract infection	all grades				10281
60348	1		Upper respiratory tract infection	grade 3				10281
60349	40		Hyperglycemia	all grades				10281
60350	2		Hyperglycemia	grade 3-4				10281
60351	35		Hyponatremia	all grades				10281
60352	9		Hyponatremia	grade 3-4				10281
60353	34		Hypoalbuminemia	all grades				10281
60354	25		Hypertriglyceridemia	all grades				10281
60355	24		Aspartate aminotransferase increased	all grades				10281
60356	2		Aspartate aminotransferase increased	grade 3-4				10281
60357	24		Hypocalcemia	all grades				10281
60358	1		Hypocalcemia	grade 3-4				10281
60359	55		Anemia	all grades				10281
60360	8		Anemia	grade 3-4				10281
60361	7		Fatigue	grade 3	discontinuation	leads to discontinuation		10282
60362	2		Dyspnea	grade 3	discontinuation	leads to discontinuation		10282
60363	0.2		Paresis		discontinuation	leads to discontinuation		10283
60364	0.2		Partial seizures		discontinuation	leads to discontinuation		10283
60365	0.2		Septic shock		discontinuation	leads to discontinuation		10283
60366	0.2		Hemiparesis		discontinuation	leads to discontinuation		10283
60367	1 pts		Autoimmune hepatitis		discontinuation	leads to discontinuation		10283
60368	1 pts		Dyspnea		discontinuation	leads to discontinuation		10283
60369	1 pts		Fatigue		discontinuation	leads to discontinuation		10283
60370	1 pts		Hemiparesis		discontinuation	leads to discontinuation		10283
60371	1 pts		Hyperthyroidism		discontinuation	leads to discontinuation		10283
60372	1 pts		Hypophysitis		discontinuation	leads to discontinuation		10283
60373	1 pts		Hypoxia		discontinuation	leads to discontinuation		10283
60374	1 pts		Partial seizures		discontinuation	leads to discontinuation		10283
60375	1 pts		Pneumonitis		discontinuation	leads to discontinuation		10283
60376	1 pts		Septic shock		discontinuation	leads to discontinuation		10283
60377	53		Gastrointestinal disturbance			MMF formulated as Bafiertam 190 mg and DMF formulated as Tecfidera 240 mg deliver bioequivalent exposure of MMF.		10292
60378						No information on AE is provided		10291
60379	2 pts		Psychiatric disorders		discontinuation	leads to discontinuation		10293
60380						No AEs are reported		10294
60381	1 pts		Bone pain	grade 3	discontinuation	leads to discontinuation	TRUE	10295
60382	1 pts		Fever	grade 3	discontinuation	leads to discontinuation	TRUE	10296
60383	1 pts		Gastrointestinal disorder	grade 3	discontinuation	leads to discontinuation	TRUE	10296
60384	47		Pain					10297
60385	42		Asthenia					10297
60386	36		Fever					10297
60387	32		Chills					10297
60388	26		Headache					10297
60389	22		Abdominal pain					10297
60390	22		Back pain					10297
60391	20		Infection					10297
60392	10		Flu syndrome					10297
60393	6		Accidental injury					10297
60394	3		Allergic reaction					10297
60395	5		Tachycardia					10297
60396	7		Congestive heart failure					10297
60397	33		Nausea					10297
60398	25		Diarrhea					10297
60399	23		Vomiting					10297
60400	8		Nausea and vomiting					10297
60401	14		Anorexia					10297
60402	4		Anemia					10297
60403	3		Leukopenia					10297
60404	10		Peripheral edema					10297
60405	8		Edema					10297
60406	7		Bone pain					10297
60407	6		Arthralgia					10297
60408	14		Insomnia					10297
60409	13		Dizziness					10297
60410	9		Paresthesia					10297
60411	6		Depression					10297
60412	2		Peripheral neuritis					10297
60413	1		Neuropathy					10297
60414	26		Cough increased					10297
60415	22		Dyspnea					10297
60416	14		Rhinitis					10297
60417	12		Pharyngitis					10297
60418	9		Sinusitis					10297
60419	18		Rash					10297
60420	2		Herpes simplex					10297
60421	2		Acne					10297
60422	5		Urinary tract infection					10297
60423			Ventricular dysfunction		discontinuation	WARNING		10297
60424			Congestive heart failure		discontinuation	WARNING		10297
60425	2 pts		Nausea and vomiting	severe				10299
60426	8 pts		Urticaria					10299
60427	34 pts		Sleepiness					10299
60428			Paresis	grade 1		Minimal complications (5.85) in our series included transient manifestations of a mild paresis or confusion and transient worsening of a pre-existing sign or symptom such as dysphasia or hemiparesis.		10298
60429			Confusion	grade 1		Minimal complications (5.85) in our series included transient manifestations of a mild paresis or confusion and transient worsening of a pre-existing sign or symptom such as dysphasia or hemiparesis.		10298
60430	3.3		Hemiplegia	significant		Significant complications (3.3%) included the development of hemiplegia or sensory loss not previously present, and persistent worsening of a pre-existing complaint.		10298
60431	3.3		Sensory loss	significant		Significant complications (3.3%) included the development of hemiplegia or sensory loss not previously present, and persistent worsening of a pre-existing complaint.		10298
60432	4 pts		Nausea	below serious				10300
60433	3 pts		Dizziness	below serious				10300
60434	4 pts		Insomnia	below serious				10300
60435	21.9		Insomnia	grade 1		fasted		10309
60436	15.6		Headache	grade 1		fasted		10309
60437	9.4		Hypervigilance	grade 1		fasted		10309
60438	9.4		Decreased appetite	grade 1		fasted		10309
60439	9.4		Nausea	grade 1		fasted		10309
60440	21.9		Insomnia	grade 1		fed		10309
60441	12.5		Headache	grade 1		fed		10309
60442	12.5		Hypervigilance	grade 1		fed		10309
60443	9.4		Decreased appetite	grade 1		fed		10309
60444	6.3		Nausea	grade 1		fed		10309
60445	9		Decreased appetite					10302
60446	5		Insomnia					10302
60447	6		Anxiety					10302
60448	16		Headache					10302
60449	2		Palpitations					10302
60450	7		Nausea					10302
60451	4		Dry mouth					10302
60452	3		Constipation					10302
60453	<2		Agitation					10302
60454	<2		Bruxism					10302
60455	<2		Irritability					10302
60456	<2		Cough					10302
60457	<2		Hyperhidrosis					10302
60458	<2		Feeling jittery					10302
60459	<2		Thirst					10302
60460	<2		Chest discomfort					10302
60461	<2		Chest pain					10302
60462	<2		Weight decreased					10302
60463	6		Decreased appetite					10306
60464	4		Anxiety					10306
60465	3		Irritability					10306
60466	2		Dizziness					10306
60467	3		Palpitations					10306
60468	8		Nausea					10306
60469	4		Diarrhea					10306
60470	3		Abdominal pain					10306
60471	3		Dry mouth					10306
60472	3		Feeling jittery					10306
60473	2		Chest discomfort					10306
60474	2		Hyperhidrosis					10306
60475	<2		Bruxism					10306
60476	<2		Restlessness					10306
60477	<2		Disturbance in attention					10306
60478	<2		Tremor					10306
60479	<2		Cough					10306
60480	<2		Dyspnea					10306
60481	<2		Constipation					10306
60482	<2		Vomiting					10306
60483	<2		Weight decreased					10306
60484	7		Headache					10304
60485	7		Nausea					10304
60486	2		Decreased appetite					10304
60487	2		Anxiety					10304
60488	2		Dry mouth					10304
60489	2		Diarrhea					10304
60490	9		Headache					10305
60491	5		Nausea					10305
60492	7		Decreased appetite					10305
60493	3		Anxiety					10305
60494	3		Dry mouth					10305
60495	4		Diarrhea					10305
60496	13		Headache					10303
60497	9		Nausea					10303
60498	8		Decreased appetite					10303
60499	7		Anxiety					10303
60500	4		Dry mouth					10303
60501	5		Diarrhea					10303
60502	0.5		Anxiety		discontinuation			10303
60503	0.5		Palpitations		discontinuation			10303
60504	0.5		Restlessness		discontinuation			10303
60505			Blood pressure systolic increased					10307
60506			Blood pressure diastolic increased					10307
60507			Heart rate increased					10307
60508	0.48		Blood pressure increased		discontinuation			10308
60509	0.24		Hypertension		discontinuation			10308
60510	42.9		Hypervigilance					10301
60511	23.8		Elevated mood					10301
60512	21.4		Dry mouth					10301
60513	21.4		Nausea					10301
60514	19		Feeling of relaxation					10301
60515	19		Decreased appetite					10301
60516	19		Hyperhidrosis					10301
60517	16.7		Insomnia					10301
60518	14.3		Headache					10301
60519	14.3		Restlessness					10301
60520	11.9		Palpitations					10301
60521	7.1		Paresthesia					10301
60522	2.4		Blood pressure increased	grade 1	discontinuation			10301
60523	2.4		Nervousness	grade 1	discontinuation			10301
60524	1 pts		Vomiting		discontinuation	leads to discontinuation		10310
60525	1 pts		Apnoeic attack		discontinuation	leads to discontinuation		10310
60526	1 pts		Death		discontinuation	leads to discontinuation		10310
60527	2 pts		Nausea and vomiting					10311
60528	10 pts		Light headedness					10311
60529	26		Headache	grade 1-2				10314
60530	19		Diarrhea	grade 1-2				10314
60531	19		Abdominal pain	grade 1-2				10314
60532	19		Upper abdominal pain	grade 1-2				10314
60533	16		Nausea	grade 1-2				10314
60534	14		Fatigue	grade 1-2				10314
60535	13		Rash	grade 1-2				10314
60536	14		Urticaria	grade 1-2				10314
60537	10		Generalized rash	grade 1-2				10314
60538	14		Maculo-papular rash	grade 1-2				10314
60539	14		Pruritic rash	grade 1-2				10314
60540	14		Papular rash	grade 1-2				10314
60541	14		Erythematous rash	grade 1-2				10314
60542	14		Vesicular rash	grade 1-2				10314
60543	12		Pyrexia	grade 1-2				10314
60544	1 pts		Diarrhea	grade 3				10314
60545	1 pts		Nausea	grade 3				10314
60546	1 pts		Rash	grade 3				10314
60547	3 pts		Generalized rash	grade 3				10314
60548	1 pts		Headache	serious				10314
60549	1 pts		Hypersensitivity	serious				10314
60550	1 pts		Pulmonary embolism	serious				10314
60551	>1 pts		Headache			Dose interruption		10314
60552	>1 pts		Diarrhea			Dose interruption		10314
60553	>1 pts		Rash			Dose interruption		10314
60554	2.3		Vomiting			Dose interruption		10314
60555	19.3		Sickle cell anemia with crisis			Dose interruption		10315
60556	1 pts		Abdominal pain			Dose interruption		10315
60557	5.7		Acute chest syndrome			Dose interruption		10315
60558	3.4		Diarrhea			Dose reduction		10315
60559	2.3		Rash			Dose reduction		10315
60560	2.3		Sickle cell anemia with crisis			Dose reduction		10315
60561	2.3		Generalized rash			Dose reduction		10315
60562	2.3		Sickle cell anemia with crisis		discontinuation			10315
60563	1.1		Nausea		discontinuation			10315
60564	1.1		Chest pain		discontinuation			10315
60565	1.1		Angina pectoris		discontinuation			10315
60566	1.1		Paresthesia		discontinuation			10315
60567	1.1		Pneumonia		discontinuation			10315
60568	1.1		Pulmonary embolism		discontinuation			10315
60569	1.1		Pulmonary sepsis		discontinuation			10315
60570	1.1		Abdominal pain		discontinuation			10315
60571						No Aes are reported		10313
60572						No Aes are reported		10312
60573	<1		Vomiting	grade 3-4	dose interruption	21% All Grades, 5% dose interruption; Upper respiratory tract infection includes Upper respiratory tract infection, sinusitis, nasopharyngitis, rhinitis		10316
60574	<1		Death	grade 5		Serious infections may lead to death.		10316
60575	5		Neutropenia		dose interruption			10316
60576	<1		Upper respiratory tract infection	grade 3-4	dose interruption	21% All Grades; Upper respiratory tract infection includes Upper respiratory tract infection, sinusitis, nasopharyngitis, rhinitis		10316
60577	5		Transaminases increased		discontinuation|dose interruption			10316
60578			Diarrhea	grade 3-4	discontinuation|dose interruption	diarrhea/colitis:10%; 58% All Grades, 6% discontinuation, 4% dose reduction		10316
60579			Colitis			diarrhea/colitis:10%; 58% All Grades, 6% discontinuation, 4% dose reduction		10316
60580	2.9		Rash	grade 3-4	dose interruption	grades >= 3		10317
60581	1.4		Neutropenia	grade 3-4	dose interruption	grades >= 3		10317
60582	4.3		Transaminases increased		discontinuation|dose interruption|dose reduction	1.4% (dose reduction)		10317
60583	4.3		Sepsis	grade 3-4		1.4% (dose interruption); grades >= 3		10317
60584	2.9		Upper respiratory tract infection		discontinuation|dose interruption|dose reduction			10317
60585	1.4		Nausea		dose interruption	4.3% (dose interruption)		10317
60586	1.4		Musculoskeletal pain		dose interruption			10317
60587			Diarrhea		discontinuation	5.1% (discontinuation), 2.9% (dose reduction)		10317
60588	2.9		Abdominal pain		dose interruption			10317
60589	4.3		Vomiting		dose interruption			10317
60590	1.4		Fatigue		dose interruption|dose reduction			10317
60591	4.3		Pneumonia		dose interruption			10317
60592	1.4		Death	grade 5	discontinuation|dose interruption|dose reduction	Due to bacteremia, sepsis, and organ dysfunction (considered to be related to umbralisib)		10317
60593	2.8		Pneumonia	grade 3-4	dose interruption	grades >= 3		10317
60594			Diarrhea	grade 3-4	discontinuation|dose interruption|dose reduction	Diarrhea/colitis: 2.8%; grades >= 3		10317
60595			Colitis	grade 3-4		Diarrhea/colitis: 2.8%; grades >= 3		10317
60596			Colitis		discontinuation|dose interruption	5.1% (discontinuation), 2.9% (dose reduction)		10317
60597	4 pts		Upper respiratory tract infection	below serious				10321
60598	3 pts		Influenza	below serious				10321
60599	15 pts		Headache	below serious				10321
60600	7 pts		Dizziness	below serious				10321
60601	2 pts		Migraine	below serious				10321
60602	18 pts		Diarrhoea	below serious				10321
60603	15 pts		Nausea	below serious				10321
60604	4 pts		Abdominal pain upper	below serious				10321
60605	4 pts		Vomiting	below serious				10321
60606	2 pts		Abdominal pain	below serious				10321
60607	5 pts		Pruritus	below serious				10321
60608	11 pts		Fatigue	below serious				10321
60609	1 pts		Intervertebral disc degeneration	serious				10319
60610	1 pts		Sinus tachycardia	serious				10319
60611	1 pts		Biliary colic	serious				10319
60612	1 pts		Hyperbilirubinaemia	serious				10319
60613	1 pts		Pregnancy of partner	serious				10319
60614	2 pts		Upper respiratory tract infection	below serious				10319
60615	2 pts		Rhinitis	below serious				10319
60616	13 pts		Headache	below serious				10319
60617	6 pts		Migraine	below serious				10319
60618	14 pts		Diarrhoea	below serious				10319
60619	12 pts		Nausea	below serious				10319
60620	7 pts		Abdominal pain upper	below serious				10319
60621	4 pts		Vomiting	below serious				10319
60622	4 pts		Abdominal pain	below serious				10319
60623	2 pts		Pruritus	below serious				10319
60624	8 pts		Headache	below serious				10320
60625	5 pts		Loose stools	below serious				10320
60626	2 pts		Flatulence	below serious				10320
60627	2 pts		Amylase serum increased	below serious				10320
60628	1		Nausea		discontinuation	leads to discontinuation		10323
60629	1		Diarrhea		discontinuation	leads to discontinuation		10323
60630	<1		Vomiting		discontinuation	leads to discontinuation		10323
60631	<1		Fatigue		discontinuation	leads to discontinuation		10323
60632	<1		Migraine		discontinuation	leads to discontinuation		10323
60633	<1		Abdominal pain upper		discontinuation	leads to discontinuation		10323
60634	<1		Decreased appetite		discontinuation	leads to discontinuation		10323
60635	<1		Depressed mood		discontinuation	leads to discontinuation		10323
60636	<1		Depression		discontinuation	leads to discontinuation		10323
60637	<1		Abdominal distension		discontinuation	leads to discontinuation		10323
60638	<1		Dyspepsia		discontinuation	leads to discontinuation		10323
60639	3		Nausea		discontinuation	leads to discontinuation		10322
60640	2		Diarrhea		discontinuation	leads to discontinuation		10322
60641	2		Headache		discontinuation	leads to discontinuation		10322
60642	1		Dizziness		discontinuation	leads to discontinuation		10322
60643	1		Vomiting		discontinuation	leads to discontinuation		10322
60644	1		Fatigue		discontinuation	leads to discontinuation		10322
60645	<1		Migraine		discontinuation	leads to discontinuation		10322
60646	<1		Abdominal pain upper		discontinuation	leads to discontinuation		10322
60647	<1		Decreased appetite		discontinuation	leads to discontinuation		10322
60648	<1		Depressed mood		discontinuation	leads to discontinuation		10322
60649	<1		Abdominal distension		discontinuation	leads to discontinuation		10322
60650						No AEs are reported		10318
60651	1 pts		Lipase increased	grade 3		leads to dose interruption	TRUE	10329
60652	1 pts		Lipase increased	grade 3		leads to dose reduction	TRUE	10324
60653	1 pts		Creatine phosphokinase increased	grade 4		leads to dose reduction	TRUE	10326
60654	52		Alopecia	grade 1-4				10327
60655	21		Palmar-plantar erythrodysesthesia syndrome	grade 1-4				10327
60656	13		Dry skin	grade 1-4				10327
60657	11		Pruritus	grade 1-4				10327
60658	42		Fatigue	grade 1-4				10327
60659	17		Peripheral edema	grade 1-4				10327
60660	13		Asthenia	grade 1-4				10327
60661	39		Nausea	grade 1-4				10327
60662	36		Abdominal pain	grade 1-4				10327
60663	34		Constipation	grade 1-4				10327
60664	28		Diarrhea	grade 1-4				10327
60665	21		Vomiting	grade 1-4				10327
60666	11		Stomatitis	grade 1-4				10327
60667	32		Myalgia	grade 1-4				10327
60668	18		Arthralgia	grade 1-4				10327
60669	15		Muscle spasms	grade 1-4				10327
60670	27		Decreased appetite	grade 1-4				10327
60671	19		Weight decreased	grade 1-4				10327
60672	19		Headache	grade 1-4				10327
60673	14		Hypertension	grade 1-4				10327
60674	13		Dyspnea	grade 1-4				10327
60675	3.5		Fatigue	grade 3-4				10327
60676	1.2		Peripheral edema	grade 3-4				10327
60677	1.2		Asthenia	grade 3-4				10327
60678	3.5		Nausea	grade 3-4				10327
60679	7		Abdominal pain	grade 3-4				10327
60680	1.2		Constipation	grade 3-4				10327
60681	1.2		Diarrhea	grade 3-4				10327
60682	3.5		Vomiting	grade 3-4				10327
60683	1.2		Myalgia	grade 3-4				10327
60684	1.2		Decreased appetite	grade 3-4				10327
60685	7		Hypertension	grade 3-4				10327
60686	1.2		Anemia		discontinuation	leads to discontinuation		10327
60687	2.4		General physical health deterioration		discontinuation	leads to discontinuation		10327
60688	1.2		Cardiac failure		discontinuation	leads to discontinuation		10327
60689	1.2		Palmar-plantar erythrodysesthesia syndrome		discontinuation	leads to discontinuation		10327
60690	1.2		Vomiting		discontinuation	leads to discontinuation		10327
60691	35		Activated partial thromboplastin time increased	grade 1-4				10327
60692	3.5		Nausea			leads to dose interruption		10327
60693	2.4		Blood bilirubin increased			leads to dose interruption		10327
60694	2.4		Palmar-plantar erythrodysesthesia syndrome			leads to dose interruption		10327
60695	>1.2		Abdominal pain			leads to dose reduction		10327
60696	>1.2		Agitation			leads to dose reduction		10327
60697	>1.2		Alopecia			leads to dose reduction		10327
60698	>1.2		Arthritis			leads to dose reduction		10327
60699	>1.2		Dermatosis			leads to dose reduction		10327
60700	>1.2		Gastrointestinal disorder			leads to dose reduction		10327
60701	>1.2		Hyperesthesia			leads to dose reduction		10327
60702	>1.2		Myalgia			leads to dose reduction		10327
60703	>1.2		Palmar-plantar erythrodysesthesia syndrome			leads to dose reduction		10327
60704	>1.2		Weight decreased			leads to dose reduction		10327
60705	21		INR increased	grade 1-4				10328
60706	10		Neutrophil count decreased	grade 1-4				10328
60707	32		Lipase increased	grade 1-4				10328
60708	26		Phosphate decreased	grade 1-4				10328
60709	26		Triglyceride increased	grade 1-4				10328
60710	23		Calcium decreased	grade 1-4				10328
60711	22		Blood bilirubin increased	grade 1-4				10328
60712	21		CPK increased	grade 1-4				10328
60713	17		Sodium decreased	grade 1-4				10328
60714	16		Creatinine increased	grade 1-4				10328
60715	13		Amylase serum increased	grade 1-4				10328
60716	12		ALT increased	grade 1-4				10328
60717	3.8		INR increased	grade 3-4				10328
60718	7		Lipase increased	grade 3-4				10328
60719	4.9		Phosphate decreased	grade 3-4				10328
60720	2.4		Triglyceride increased	grade 3-4				10328
60721	1.2		CPK increased	grade 3-4				10328
60722	2.4		Sodium decreased	grade 3-4				10328
60723	1.2		Amylase serum increased	grade 3-4				10328
60724	1.2		ALT increased	grade 3-4				10328
60725						MTD was not reached. No information on AE is provided.		10325
60726						No information on AE is provided		10331
60727	5 pts		Death	grade 5	discontinuation	leads to discontinuation, Deaths possibly related to meropenem		10330
60728	1 pts		Liver injury		discontinuation	leads to discontinuation		10332
60729						No information on AE is provided		10333
60730	0.3		Fatigue		discontinuation	leads to discontinuation		10334
60731	0.5		Asthenia		discontinuation	leads to discontinuation		10334
60732	0.5		Hypotension		discontinuation	leads to discontinuation		10334
60733	0.2		Diarrhea		discontinuation	leads to discontinuation		10334
60734	0.4		Nausea		discontinuation	leads to discontinuation		10334
60735	0.2		Vomiting		discontinuation	leads to discontinuation		10334
60736	0.2		Headache		discontinuation	leads to discontinuation		10334
60737	0.4		Dizziness		discontinuation	leads to discontinuation		10334
60738	0.1		Paresthesia		discontinuation	leads to discontinuation		10334
60739	0.1		Libido decreased		discontinuation	leads to discontinuation		10334
60740	0.1		Vertigo		discontinuation	leads to discontinuation		10334
60741	0.7		Cough		discontinuation	leads to discontinuation		10334
60742	0.1		Upper respiratory infection		discontinuation	leads to discontinuation		10334
60743	0.1		Common cold		discontinuation	leads to discontinuation		10334
60744	0.1		Nasal congestion		discontinuation	leads to discontinuation		10334
60745	0.1		Influenza		discontinuation	leads to discontinuation		10334
60746	0.4		Rash		discontinuation	leads to discontinuation		10334
60747	0.4		Impotence		discontinuation	leads to discontinuation		10334
60748	0.2		Chest pain		discontinuation	leads to discontinuation		10335
60749	0.7		Abdominal pain		discontinuation	leads to discontinuation		10335
60750	1.7		Hypotension		discontinuation	leads to discontinuation		10335
60751	0.5		Diarrhea		discontinuation	leads to discontinuation		10335
60752	1.2		Dizziness		discontinuation	leads to discontinuation		10335
60753	0.2		Headache		discontinuation	leads to discontinuation		10335
60754	0.5		Rash		discontinuation	leads to discontinuation		10335
60755			Flushing					10341
60756			Elevated liver enzymes					10341
60757	1 pts		ALT increased	grade 2	discontinuation	leads to discontinuation		10341
60758	1 pts		AST increased	grade 2	discontinuation	leads to discontinuation		10341
60759	1 pts		ALT increased	grade 2	discontinuation	leads to dose reduction		10341
60760	1 pts		AST increased	grade 2	discontinuation	leads to discontinuation		10341
60761	1 pts		Malaise		discontinuation	leads to discontinuation		10342
60762	11		ALT increased	grade 2				10337
60763	11		AST increased	grade 2				10337
60764	12		ALT increased	grade 2				10338
60765	12		AST increased	grade 2				10338
60766	14		ALT increased	grade 2				10339
60767	14		AST increased	grade 2				10339
60768	2		ALT increased	grade 3				10338
60769	2		AST increased	grade 3				10338
60770	7		ALT increased	grade 3				10339
60771	7		AST increased	grade 3				10339
60772	0.3		Bilirubin increased	grade 2				10337
60773	2		Transaminases increased	grade 2				10340
60774			Fetal damage					10336
60775	1.7		Fluid retention					10337
60776	1		Function liver abnormal		discontinuation	leads to discontinuation		10337
60777	2.8		Intraocular pressure increased		discontinuation			10343
60778			Acute myopia		discontinuation	WARNING		10346
60779			Angle closure glaucoma		discontinuation	WARNING		10346
60780			Diabetes		discontinuation	WARNING. Latent diabetes mellitus may become manifest and diabetic patients given thiazides may require adjustment of their insulin dose.		10346
60781			Hypoglycemia		discontinuation	WARNING. Latent diabetes mellitus may become manifest and diabetic patients given thiazides may require adjustment of their insulin dose.		10346
60782			Renal disease		discontinuation	WARNING. Cumulative effects of the thiazides may develop in patients with impaired renal function.		10346
60783	1.12		Fatigue		discontinuation			10345
60784	1.12		Hypokalemia		discontinuation			10345
60785	1.12		Dry mouth		discontinuation			10345
60786			Acute myopia		discontinuation	WARNING		10344
60787			Angle closure glaucoma		discontinuation	WARNING		10344
60788			Acute renal failure			WARNINGS		10348
60789						No adverse reactions leading to discontinuation were reported		10347
60790	4 pts		Nausea	severe	discontinuation			10351
60791	4 pts		Vomiting	severe	discontinuation			10351
60792	1 pts		Diarrhea	mild	discontinuation			10349
60793	1 pts		Skin rash		discontinuation			10351
60794			Fixed drug eruption		discontinuation			10350
60795	1 pts		Eruption lichenoid	severe	discontinuation	leads to discontinuation		10353
60796						No information on AE is provided		10352
60797						No information on AE is provided		10354
60798	11 pts		Upper respiratory tract infection					10355
60799	4 pts		Nasopharyngitis					10355
60800	4 pts		Headache					10355
60801	5 pts		Acne					10355
60802	3 pts		Nausea					10355
60803	1 pts		Diarrhea					10355
60804	1 pts		Abdominal discomfort					10355
60805	3 pts		Sinusitis					10355
60806	3 pts		Viral upper respiratory tract infection					10355
60807	1 pts		Folliculitis					10355
60808	1 pts		Atopic dermatitis					10355
60809	3 pts		Neutrophil count decreased					10355
60810	3 pts		Abdominal pain					10355
60811	3 pts		Oropharyngeal pain					10355
60812						No adverse effects leading to discontinuation were reported.		10357
60813						No adverse effects leading to discontinuation were reported.		10356
60814						No AEs are reported		10358
60815	0.6		Dry mouth		discontinuation			10365
60816	0.6		Schizophrenia aggravated		discontinuation			10365
60817	32.5		Somnolence					10359
60818	8.4		Dry mouth					10359
60819	4.8		Nausea					10359
60820	8.4		Dizziness					10359
60821	2.4		Akathisia					10359
60822	16.7		Somnolence					10363
60823	4.8		Dry mouth					10363
60824	6		Nausea					10363
60825	4.8		Dizziness					10363
60826	1.2		Akathisia					10363
60827	1.2		Tachycardia					10363
60828	40		Headache	grade 1-2				10364
60829	40		Sedation	grade 1				10364
60830	1.3		Headache		discontinuation			10360
60831	0.7		Orthostatic hypotension	grade 3	discontinuation			10360
60832	0.7		Convulsions	grade 3	discontinuation			10362
60833	19.3		Headache	grade 1-2				10360
60834	17.3		Somnolence	grade 1-2				10360
60835	12.7		Sedation	grade 1-2				10360
60836	10.7		Nausea	grade 1-2				10360
60837	7.3		Dry mouth	grade 1-2				10360
60838	6.7		Dizziness	grade 1-2				10360
60839	6.7		Constipation	grade 1-2				10360
60840	5.3		Fatigue	grade 1-2				10360
60841	4		Akathisia	grade 1-2				10362
60842	16		Headache	grade 1-2				10362
60843	11.3		Somnolence	grade 1-2				10362
60844	9.3		Sedation	grade 1-2				10362
60845	4.7		Nausea	grade 1-2				10362
60846	6		Dry mouth	grade 1-2				10362
60847	4.7		Dizziness	grade 1-2				10362
60848	4		Constipation	grade 1-2				10362
60849	4.7		Fatigue	grade 1-2				10362
60850	1.3		Akathisia	grade 1-2				10362
60851	1.3		Dyskinesia	grade 1-2				10362
60852	24		Somnolence					10361
60853	9		Nausea					10361
60854	6		Dry mouth					10361
60855	5		Dizziness					10361
60856	4		Creatine phosphokinase increased					10361
60857	3		Fatigue					10361
60858	3		Vomiting					10361
60859	2		Transaminases increased					10361
60860	2		Decreased appetite					10361
60861			Spasm of muscle					10361
60862			Swallowing difficult					10361
60863			Difficulty breathing					10361
60864			Protrusion tongue					10361
60865	6.7		Extrapyramidal symptoms					10361
60866			Akathisia					10361
60867			Extrapyramidal disorder					10361
60868			Muscle spasms					10361
60869			Restlessness					10361
60870			Musculoskeletal stiffness					10361
60871			Dyskinesia					10361
60872			Dystonia					10361
60873			Muscle twitching					10361
60874			Tardive dyskinesia					10361
60875			Tremor					10361
60876			Drooling					10361
60877			Muscle contractions involuntary					10361
60878	60		Hyperphosphatemia	grade 1-4				10367
60879	33		Decreased appetite	grade 1-4				10367
60880	23		Hypophosphatemia	grade 1-4				10367
60881	15		Dehydration	grade 1-4				10367
60882	49		Alopecia	grade 1-4				10367
60883	43		Nail toxicity	grade 1-4				10367
60884	20		Dry skin	grade 1-4				10367
60885	15		Palmar-plantar erythrodysesthesia syndrome	grade 1-4				10367
60886	47		Diarrhea	grade 1-4				10367
60887	40		Nausea	grade 1-4				10367
60888	35		Constipation	grade 1-4				10367
60889	35		Stomatitis	grade 1-4				10367
60890	34		Dry mouth	grade 1-4				10367
60891	27		Vomiting	grade 1-4				10367
60892	23		Abdominal pain	grade 1-4				10367
60893	42		Fatigue	grade 1-4				10367
60894	18		Edema peripheral	grade 1-4				10367
60895	40		Dysgeusia	grade 1-4				10367
60896	16		Headache	grade 1-4				10367
60897	35		Dry eye	grade 1-4				10367
60898	25		Arthralgia	grade 1-4				10367
60899	20		Back pain	grade 1-4				10367
60900	19		Pain in extremity	grade 1-4				10367
60901	16		Urinary tract infection	grade 1-4				10367
60902	16		Weight loss	grade 1-4				10367
60903	1.4		Decreased appetite	grade 3-4				10367
60904	12		Hypophosphatemia	grade 3-4				10367
60905	3.4		Dehydration	grade 3-4				10367
60906	2.1		Nail toxicity	grade 3-4				10367
60907	0.7		Dry skin	grade 3-4				10367
60908	4.1		Palmar-plantar erythrodysesthesia syndrome	grade 3-4				10367
60909	2.7		Diarrhea	grade 3-4				10367
60910	2.1		Nausea	grade 3-4				10367
60911	0.7		Constipation	grade 3-4				10367
60912	5		Stomatitis	grade 3-4				10367
60913	1.4		Vomiting	grade 3-4				10367
60914	4.8		Abdominal pain	grade 3-4				10367
60915	4.8		Fatigue	grade 3-4				10367
60916	0.7		Edema peripheral	grade 3-4				10367
60917	0.7		Dry eye	grade 3-4				10367
60918	6		Arthralgia	grade 3-4				10367
60919	2.7		Back pain	grade 3-4				10367
60920	2.1		Pain in extremity	grade 3-4				10367
60921	2.7		Urinary tract infection	grade 3-4				10367
60922	2.1		Weight loss	grade 3-4				10367
60923	>= 2		Pyrexia					10367
60924	>= 2		Cholangitis					10367
60925	>= 2		Pleural effusion					10367
60926	>= 2		Acute kidney injury					10367
60927	>= 2		Cholangitis infective					10367
60928	>= 2		Failure to thrive					10367
60929	>= 2		Bile duct obstruction					10367
60930	>= 2		Sepsis					10367
60931	>= 2		Pleural effusion					10367
60932	>= 1		Intestinal obstruction		discontinuation			10367
60933	>= 1		Acute kidney injury		discontinuation			10367
60934	>= 1		Stomatitis		dose interruption			10367
60935	>= 1		Palmar-plantar erythrodysesthesia syndrome		dose interruption			10367
60936	>= 1		Arthralgia		dose interruption			10367
60937	>= 1		Fatigue		dose interruption			10367
60938	>= 1		Abdominal pain		dose interruption			10367
60939	>= 1		AST increased		dose interruption			10367
60940	>= 1		Asthenia		dose interruption			10367
60941	>= 1		Pyrexia		dose interruption			10367
60942	>= 1		ALT increased		dose interruption			10367
60943	>= 1		Cholangitis		dose interruption			10367
60944	>= 1		Small intestinal obstruction		dose interruption			10367
60945	>= 1		Alkaline phosphatase increased		dose interruption			10367
60946	>= 1		Diarrhea		dose interruption			10367
60947	>= 1		Hyperbilirubinemia		dose interruption			10367
60948	>= 1		Electrocardiogram QT prolonged		dose interruption			10367
60949	>= 1		Decreased appetite		dose interruption			10367
60950	>= 1		Dehydration		dose interruption			10367
60951	>= 1		Hypercalcemia		dose interruption			10367
60952	>= 1		Hyperphosphatemia		dose interruption			10367
60953	>= 1		Hypophosphatemia		dose interruption			10367
60954	>= 1		Back pain		dose interruption			10367
60955	>= 1		Pain in extremity		dose interruption			10367
60956	>= 1		Syncope		dose interruption			10367
60957	>= 1		Acute kidney injury		dose interruption			10367
60958	>= 1		Onychomadesis		dose interruption			10367
60959	>= 1		Hypotension		dose interruption			10367
60960	>= 1		Stomatitis		dose reduction			10367
60961	>= 1		Arthralgia		dose reduction			10367
60962	>= 1		Palmar-plantar erythrodysesthesia syndrome		dose reduction			10367
60963	>= 1		Asthenia		dose reduction			10367
60964	>= 1		Onychomadesis		dose reduction			10367
60965	43		Decreased hemoglobin	grade 1-4				10367
60966	36		Lymphocyte count decreased	grade 1-4				10367
60967	28		Platelets decreased	grade 1-4				10367
60968	27		Leukocyte count increased	grade 1-4				10367
60969	18		Leukocyte count decreased	grade 1-4				10367
60970	94		Phosphate increased	grade 1-4				10367
60971	68		Phosphate decreased	grade 1-4				10367
60972	43		ALT increased	grade 1-4				10367
60973	43		AST increased	grade 1-4				10367
60974	43		Calcium increased	grade 1-4				10367
60975	41		Alkaline phosphatase increased	grade 1-4				10367
60976	41		Creatinine increased	grade 1-4				10367
60977	39		Sodium decreased	grade 1-4				10367
60978	36		Glucose increased	grade 1-4				10367
60979	34		Albumin decreased	grade 1-4				10367
60980	30		Urate increased	grade 1-4				10367
60981	26		Bilirubin increased	grade 1-4				10367
60982	26		Potassium decreased	grade 1-4				10367
60983	17		Calcium decreased	grade 1-4				10367
60984	12		Potassium increased	grade 1-4				10367
60985	11		Glucose decreased	grade 1-4				10367
60986	6		Decreased hemoglobin	grade 3-4				10367
60987	8		Lymphocyte count decreased	grade 3-4				10367
60988	3.4		Platelets decreased	grade 3-4				10367
60989	0.7		Leukocyte count increased	grade 3-4				10367
60990	1.4		Leukocyte count decreased	grade 3-4				10367
60991	38		Phosphate decreased	grade 3-4				10367
60992	4.1		ALT increased	grade 3-4				10367
60993	6		AST increased	grade 3-4				10367
60994	4.1		Calcium increased	grade 3-4				10367
60995	11		Alkaline phosphatase increased	grade 3-4				10367
60996	1.4		Creatinine increased	grade 3-4				10367
60997	12		Sodium decreased	grade 3-4				10367
60998	0.7		Glucose increased	grade 3-4				10367
60999	10		Urate increased	grade 3-4				10367
61000	6		Bilirubin increased	grade 3-4				10367
61001	5		Potassium decreased	grade 3-4				10367
61002	2.7		Calcium decreased	grade 3-4				10367
61003	2.1		Potassium increased	grade 3-4				10367
61004	1.4		Glucose decreased	grade 3-4				10367
61005						DLT not observed		10366
61006	11		Thrombocytopenia	grade 1-2				10368
61007	7		Anaemia	grade 1-2				10368
61008	2		Neutropenia	grade 1-2				10368
61009	2		Febrile neutropenia	grade 1-2				10368
61010	43		Fatigue	grade 1-2				10368
61011	34		Constipation	grade 1-2				10368
61012	32		Nausea	grade 1-2				10368
61013	20		Peripheral oedema	grade 1-2				10368
61014	5		Pneumonia	grade 1-2				10368
61015	20		ALT increased	grade 1-2				10368
61016	18		AST increased	grade 1-2				10368
61017	21		Hypomagnesaemia	grade 1-2				10368
61018	16		Diarrhoea	grade 1-2				10368
61019	18		Hypoalbuminaemia	grade 1-2				10368
61020	14		Hypokalaemia	grade 1-2				10368
61021	18		Cough	grade 1-2				10368
61022	14		Pyrexia	grade 1-2				10368
61023	16		Insomnia	grade 1-2				10368
61024	9		Abdominal pain	grade 1-2				10368
61025	14		Hyperkalaemia	grade 1-2				10368
61026	14		Headache	grade 1-2				10368
61027	14		Dyspnoea	grade 1-2				10368
61028	11		Haemorrhoids	grade 1-2				10368
61029	9		Stomatitis	grade 1-2				10368
61030	11		Oedema	grade 1-2				10368
61031	11		Weight decreased	grade 1-2				10368
61032	11		Hyponatraemia	grade 1-2				10368
61033	9		Back pain	grade 1-2				10368
61034	11		Muscle spasms	grade 1-2				10368
61035	9		Acute kidney injury	grade 1-2				10368
61036	11		Oropharyngeal pain	grade 1-2				10368
61037	52		Thrombocytopenia	grade 1-4				10368
61038	32		Anaemia	grade 1-4				10368
61039	32		Neutropenia	grade 1-4				10368
61040	18		Febrile neutropenia	grade 1-4				10368
61041	16		Leukopenia	grade 1-4				10368
61042	43		Fatigue	grade 1-4				10368
61043	36		Constipation	grade 1-4				10368
61044	32		Nausea	grade 1-4				10368
61045	20		Peripheral oedema	grade 1-4				10368
61046	20		Pneumonia	grade 1-4				10368
61047	20		ALT increased	grade 1-4				10368
61048	20		AST increased	grade 1-4				10368
61049	20		Hypomagnesaemia	grade 1-4				10368
61050	18		Diarrhoea	grade 1-4				10368
61051	18		Hypoalbuminaemia	grade 1-4				10368
61052	18		Hypokalaemia	grade 1-4				10368
61053	18		Cough	grade 1-4				10368
61054	16		Pyrexia	grade 1-4				10368
61055	16		Insomnia	grade 1-4				10368
61056	14		Abdominal pain	grade 1-4				10368
61057	14		Hyperkalaemia	grade 1-4				10368
61058	14		Headache	grade 1-4				10368
61059	14		Dyspnoea	grade 1-4				10368
61060	11		Haemorrhoids	grade 1-4				10368
61061	11		Stomatitis	grade 1-4				10368
61062	11		Oedema	grade 1-4				10368
61063	11		Weight decreased	grade 1-4				10368
61064	11		Hyponatraemia	grade 1-4				10368
61065	11		Back pain	grade 1-4				10368
61066	11		Muscle spasms	grade 1-4				10368
61067	11		Acute kidney injury	grade 1-4				10368
61068	11		Oropharyngeal pain	grade 1-4				10368
61069	5		Thrombocytopenia	grade 3				10368
61070	23		Anaemia	grade 3				10368
61071	5		Neutropenia	grade 3				10368
61072	14		Febrile neutropenia	grade 3				10368
61073	11		Leukopenia	grade 3				10368
61074	2		Constipation	grade 3				10368
61075	16		Pneumonia	grade 3				10368
61076	2		AST increased	grade 3				10368
61077	2		Diarrhoea	grade 3				10368
61078	5		Hypokalaemia	grade 3				10368
61079	2		Pyrexia	grade 3				10368
61080	5		Abdominal pain	grade 3				10368
61081	2		Stomatitis	grade 3				10368
61082	2		Back pain	grade 3				10368
61083	36		Thrombocytopenia	grade 4				10368
61084	2		Anaemia	grade 4				10368
61085	25		Neutropenia	grade 4				10368
61086	2		Febrile neutropenia	grade 4				10368
61087	5		Leukopenia	grade 4				10368
61088	2		Acute kidney injury	grade 4				10368
61089	2		Bacteraemia		discontinuation			10368
61090	1		Febrile neutropenia		discontinuation			10369
61091	1		Pneumonia		discontinuation			10369
61092	18		Neutropenia		dose interruption			10369
61093	8		Febrile neutropenia		dose interruption			10369
61094	6		Thrombocytopenia		dose interruption			10369
61095	5		Anemia		dose interruption			10369
61096	12		Neutropenia		dose reduction			10369
61097	3		Anemia		dose reduction			10369
61098	3		Thrombocytopenia		dose reduction			10369
61099	29		Fatigue	grade 1-4				10369
61100	24		Hemorrhage	grade 1-4				10369
61101	10		Edema	grade 1-4				10369
61102	7		Pyrexia	grade 1-4				10369
61103	20		Constipation	grade 1-4				10369
61104	18		Mucositis	grade 1-4				10369
61105	25		Nausea	grade 1-4				10369
61106	16		Diarrhea	grade 1-4				10369
61107	12		Transaminases increased	grade 1-4				10369
61108	9		Abdominal pain	grade 1-4				10369
61109	5		Vomiting	grade 1-4				10369
61110	9		Myalgia	grade 1-4				10369
61111	9		Arthralgia	grade 1-4				10369
61112	17		Dyspnea	grade 1-4				10369
61113	7		Cough	grade 1-4				10369
61114	10		Febrile neutropenia	grade 1-4				10369
61115	12		Rash	grade 1-4				10369
61116	16		Dizziness	grade 1-4				10369
61117	22		Headache	grade 1-4				10369
61118	4		Neuropathy	grade 1-4				10369
61119	10		Decreased appetite	grade 1-4				10369
61120	6		Upper respiratory tract infection	grade 1-4				10369
61121	7		Pneumonia	grade 1-4				10369
61122	6		Sepsis	grade 1-4				10369
61123	4		Cellulitis	grade 1-4				10369
61124	9		Renal impairment	grade 1-4				10369
61125	5		Weight decreased	grade 1-4				10369
61126	4		Fall	grade 1-4				10369
61127	6		Insomnia	grade 1-4				10369
61128	4		Hypotension	grade 1-4				10369
61129	3		Arrhythmia	grade 1-4				10369
61130	2		Fatigue	grade 3-4				10369
61131	2		Hemorrhage	grade 3-4				10369
61132	1		Mucositis	grade 3-4				10369
61133	1		Transaminases increased	grade 3-4				10369
61134	2		Myalgia	grade 3-4				10369
61135	1		Arthralgia	grade 3-4				10369
61136	3		Dyspnea	grade 3-4				10369
61137	10		Febrile neutropenia	grade 3-4				10369
61138	1		Rash	grade 3-4				10369
61139	1		Dizziness	grade 3-4				10369
61140	1		Decreased appetite	grade 3-4				10369
61141	7		Pneumonia	grade 3-4				10369
61142	6		Sepsis	grade 3-4				10369
61143	1		Cellulitis	grade 3-4				10369
61144	1		Sweet's syndrome					10369
61145	0.5		Tumor lysis syndrome					10369
61146	79		Leukocyte count decreased	grade 1-4				10369
61147	79		Platelet count decreased	grade 1-4				10369
61148	70		Neutrophil count decreased	grade 1-4				10369
61149	58		Hemoglobin decreased	grade 1-4				10369
61150	19		Glucose increased	grade 1-4				10369
61151	22		Albumin decreased	grade 1-4				10369
61152	22		Alkaline phosphatase increased	grade 1-4				10369
61153	14		Glucose decreased	grade 1-4				10369
61154	13		Alanine aminotransferase increased	grade 1-4				10369
61155	9		Sodium decreased	grade 1-4				10369
61156	16		Calcium decreased	grade 1-4				10369
61157	6		Aspartate aminotransferase increased	grade 1-4				10369
61158	7		Creatinine increased	grade 1-4				10369
61159	65		Leukocyte count decreased	grade 3-4				10369
61160	65		Platelet count decreased	grade 3-4				10369
61161	65		Neutrophil count decreased	grade 3-4				10369
61162	41		Hemoglobin decreased	grade 3-4				10369
61163	1		Albumin decreased	grade 3-4				10369
61164	1		Alkaline phosphatase increased	grade 3-4				10369
61165	1		Alanine aminotransferase increased	grade 3-4				10369
61166	2		Sodium decreased	grade 3-4				10369
61167	1		Aspartate aminotransferase increased	grade 3-4				10369
61168	39		Dry mouth	grade 1-4				10374
61169	37		Diarrhea	grade 1-4				10374
61170	25		Constipation	grade 1-4				10374
61171	23		Nausea	grade 1-4				10374
61172	23		Abdominal pain	grade 1-4				10374
61173	15		Vomiting	grade 1-4				10374
61174	35		Hypertension	grade 1-4				10374
61175	35		Fatigue	grade 1-4				10374
61176	33		Edema	grade 1-4				10374
61177	27		Rash	grade 1-4				10374
61178	23		Headache	grade 1-4				10374
61179	18		Cough	grade 1-4				10374
61180	16		Dyspnea	grade 1-4				10374
61181	17		QT interval prolonged	grade 1-4				10374
61182	15		Hemorrhage	grade 1-4				10374
61183	3.4		Diarrhea	grade 3-4				10374
61184	0.6		Constipation	grade 3-4				10374
61185	0.6		Nausea	grade 3-4				10374
61186	1.9		Abdominal pain	grade 3-4				10374
61187	0.3		Vomiting	grade 3-4				10374
61188	18		Hypertension	grade 3-4				10374
61189	2		Fatigue	grade 3-4				10374
61190	0.3		Edema	grade 3-4				10374
61191	0.7		Rash	grade 3-4				10374
61192	1.4		Headache	grade 3-4				10374
61193	2.3		Cough	grade 3-4				10374
61194	4		QT interval prolonged	grade 3-4				10374
61195	1.9		Hemorrhage	grade 3-4				10374
61196	51		AST increased	grade 1-4		Denominator for AE is based on the number of patients with baseline available, which ranged from 675 to 692 patients		10372
61197	45		ALT increased	grade 1-4		Denominator for AE is based on the number of patients with baseline available, which ranged from 675 to 692 patients		10372
61198	44		Glucose increased	grade 1-4		Denominator for AE is based on the number of patients with baseline available, which ranged from 675 to 692 patients		10372
61199	42		Albumin decreased	grade 1-4		Denominator for AE is based on the number of patients with baseline available, which ranged from 675 to 692 patients		10372
61200	41		Calcium decreased	grade 1-4		Denominator for AE is based on the number of patients with baseline available, which ranged from 675 to 692 patients		10372
61201	37		Creatinine increased	grade 1-4		Denominator for AE is based on the number of patients with baseline available, which ranged from 675 to 692 patients		10372
61202	36		Alkaline phosphatase increased	grade 1-4		Denominator for AE is based on the number of patients with baseline available, which ranged from 675 to 692 patients		10372
61203	31		Cholesterol total increased	grade 1-4		Denominator for AE is based on the number of patients with baseline available, which ranged from 675 to 692 patients		10372
61204	27		Sodium decreased	grade 1-4		Denominator for AE is based on the number of patients with baseline available, which ranged from 675 to 692 patients		10372
61205	24		Magnesium decreased	grade 1-4		Denominator for AE is based on the number of patients with baseline available, which ranged from 675 to 692 patients		10372
61206	24		Potassium increased	grade 1-4		Denominator for AE is based on the number of patients with baseline available, which ranged from 675 to 692 patients		10372
61207	23		Bilirubin increased	grade 1-4		Denominator for AE is based on the number of patients with baseline available, which ranged from 675 to 692 patients		10372
61208	22		Glucose decreased	grade 1-4		Denominator for AE is based on the number of patients with baseline available, which ranged from 675 to 692 patients		10372
61209	43		Leukocyte count decreased	grade 1-4		Denominator for AE is based on the number of patients with baseline available, which ranged from 675 to 692 patients		10372
61210	33		Platelets decreased	grade 1-4		Denominator for AE is based on the number of patients with baseline available, which ranged from 675 to 692 patients		10372
61211	8		AST increased	grade 3-4		Denominator for AE is based on the number of patients with baseline available, which ranged from 675 to 692 patients		10372
61212	9		ALT increased	grade 3-4		Denominator for AE is based on the number of patients with baseline available, which ranged from 675 to 692 patients		10372
61213	2.2		Glucose increased	grade 3-4		Denominator for AE is based on the number of patients with baseline available, which ranged from 675 to 692 patients		10372
61214	0.7		Albumin decreased	grade 3-4		Denominator for AE is based on the number of patients with baseline available, which ranged from 675 to 692 patients		10372
61215	3.8		Calcium decreased	grade 3-4		Denominator for AE is based on the number of patients with baseline available, which ranged from 675 to 692 patients		10372
61216	1		Creatinine increased	grade 3-4		Denominator for AE is based on the number of patients with baseline available, which ranged from 675 to 692 patients		10372
61217	2.3		Alkaline phosphatase increased	grade 3-4		Denominator for AE is based on the number of patients with baseline available, which ranged from 675 to 692 patients		10372
61218	0.1		Cholesterol total increased	grade 3-4		Denominator for AE is based on the number of patients with baseline available, which ranged from 675 to 692 patients		10372
61219	7		Sodium decreased	grade 3-4		Denominator for AE is based on the number of patients with baseline available, which ranged from 675 to 692 patients		10372
61220	0.6		Magnesium decreased	grade 3-4		Denominator for AE is based on the number of patients with baseline available, which ranged from 675 to 692 patients		10372
61221	1.2		Potassium increased	grade 3-4		Denominator for AE is based on the number of patients with baseline available, which ranged from 675 to 692 patients		10372
61222	2		Bilirubin increased	grade 3-4		Denominator for AE is based on the number of patients with baseline available, which ranged from 675 to 692 patients		10372
61223	0.7		Glucose decreased	grade 3-4		Denominator for AE is based on the number of patients with baseline available, which ranged from 675 to 692 patients		10372
61224	1.6		Leukocyte count decreased	grade 3-4		Denominator for AE is based on the number of patients with baseline available, which ranged from 675 to 692 patients		10372
61225	2.7		Platelets decreased	grade 3-4				10375
61226	>2		Pneumonia	grade 4				10373
61227	>2		ALT increased			leads to dose interruption		10373
61228	>2		AST increased			leads to dose interruption		10373
61229	>2		Hypertension			leads to dose interruption		10373
61230	>2		Diarrhea			leads to dose interruption		10373
61231	>2		Pyrexia			leads to dose interruption		10373
61232	>2		QT interval prolonged			leads to dose interruption		10373
61233	>2		ALT increased			leads to dose reduction		10373
61234	>2		AST increased			leads to dose reduction		10373
61235	>2		Fatigue			leads to dose reduction		10373
61236	0.4		ALT increased	grade 4	discontinuation	leads to discontinuation		10373
61237	0.4		Sepsis	grade 4	discontinuation	leads to discontinuation		10373
61238	0.3		AST increased	grade 4	discontinuation	leads to discontinuation		10373
61239	0.3		Drug hypersensitivity	grade 4	discontinuation	leads to discontinuation		10373
61240	0.3		Fatigue	grade 4	discontinuation	leads to discontinuation		10373
61241	0.3		Thrombocytopenia	grade 4	discontinuation	leads to discontinuation		10373
61242	0.4		Sepsis	grade 5	discontinuation	leads to discontinuation		10373
61243	0.4		Cardiac arrest	grade 5	discontinuation	leads to discontinuation		10373
61244	0.4		Respiratory failure	grade 5	discontinuation	leads to discontinuation		10373
61245						No information on AE is provided		10371
61246						No information on AE is provided		10370
61247	3.4		Pneumonia		discontinuation	leads to discontinuation		10376
61248	0.8		Hepatitis B		discontinuation	leads to dose reduction		10376
61249	3		Diarrhea					10378
61250	2		Bronchitis					10378
61251	1		Nausea					10378
61252	1		Nasopharyngitis					10378
61253	1		Headache					10378
61254	2		Diarrhea					10377
61255	1		Bronchitis					10377
61256	1		Nasopharyngitis					10377
61257	4		Headache					10377
61258	1.3		Cyanosis					10380
61259			Death					10379
61260			Pneumonia					10382
61261			Superficial femoral vein thrombosis					10383
61262			Oedema					10381
61263			Photosensitive dermatitis					10384
61264	2 pts		Gastrointestinal disorder NOS		discontinuation			10386
61265	1 pts		Dizziness		discontinuation			10386
61266	1 pts		Abdominal pain	serious	discontinuation			10385
61267						No serious adverse events related to study drug occurred, and there were no discontinuations due to adverse events.		10388
61268						No serious adverse events related to study drug occurred, and there were no discontinuations due to adverse events.		10387
61269	1 pts		Injection site nodule	grade 1	discontinuation	at Week 62		10389
61270	>5		Neutropenia		discontinuation|dose interruption|dose reduction			10391
61271	>1		Pneumonia		discontinuation|dose interruption|dose reduction			10391
61272	>5		Pneumonia		dose interruption|dose reduction			10391
61273						No adverse effects leading to discontinuation were reported.		10390
